FN Clarivate Analytics Web of Science
VR 1.0
PT S
AU Jung, HJ
   Kim, HJ
   Hong, SN
   Hong, JO
   Jeong, HK
   Je, JH
   Kim, BR
   Yoo, HS
AF Jung, HJ
   Kim, HJ
   Hong, SN
   Hong, JO
   Jeong, HK
   Je, JH
   Kim, BR
   Yoo, HS
BE Seibert, JA
TI Computed microtomography (mu CT) with unmonochromatized synchrotron
   x-rays for cancerous human breast tissue and mouse vertebra
SO 2001 IEEE NUCLEAR SCIENCE SYMPOSIUM, CONFERENCE RECORDS, VOLS 1-4
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT IEEE Nuclear Science Symposium
CY NOV 04-10, 2001
CL SAN DIEGO, CA
SP IEEE, Nucl Plasma Sci Soc
DE synchrotron radiation; unmonochromatized x-ray; computed microtomography
   (mu CT); spatial resolution; modulation transfer function (MTF)
ID RADIATION MICROTOMOGRAPHY; PHANTOM; IMAGE
AB The use of x-ray computed microtomography (gCT) has increased in biomedical research and industrial applications. The inherited high quality of synchrotron radiation (SR) x-rays such as high flux, collimation, and coherence have been used recently to produce radiographic images with high lateral resolution and contrast. A simple and stable imaging system using unmonochromatized SR source based on the principle of phase contrast x-ray imaging consists of a CCD detector coupled with optical lens system at the Pohang Light Source (PLS) 5C1 beamline. The spatial resolution of the imaging system was determined using the modulation transfer function (MTF), which was measured by sequential calculations obtained from sharp edge images. Projection image datawere obtained at 250 steps over 180 degrees of rotation with an acquisition time of 30 to 150 msec per projection image, depending on the imaged object materials, and tomographic images were reconstructed using a simple filtered backprojection algorithm. Although the use of a monochromatic x-ray beam has demonstrated for high resolution and enhanced contrast, our approach uses unmonochromatized SR x-ray beam and show similar image capability without sophisticated x-ray optics in a relatively shorter exposure time, less than two orders of exposure time. The current PLS 50 SR imaging system can produce projection images at a spatial resolution of 8.3 ?m over a field of view of about 5 mm at an exposure time of 30 msec per projection image for 1.5x optical magnification. This study presents the results of SR muCT images upon cancerous human breast tissue containing microcalcifications, mouse lumbar vertebra, and mouse coccygeal vertebra. The unmonochromatized SR muCT imaging system provides an effective means of evaluating microstructures, not only in biomedical specimens but also in inorganic samples.
C1 Yonsei Univ, Coll Med, Dept Radiol,BK21 Project Med Sci, Res Inst Radiol Sci,Seodaemoon Ku, Seoul 120751, South Korea.
RP Kim, HJ (reprint author), Yonsei Univ, Coll Med, Dept Radiol,BK21 Project Med Sci, Res Inst Radiol Sci,Seodaemoon Ku, 134 Shinchon Dong, Seoul 120751, South Korea.
CR Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006
   Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9
   Dowd BA, 1999, P SOC PHOTO-OPT INS, V3772, P224, DOI 10.1117/12.363725
   Fetterly KA, 2000, MED PHYS, V27, P2669, DOI 10.1118/1.1326449
   Hwu Y, 1999, J APPL PHYS, V86, P4613, DOI 10.1063/1.371411
   HWU Y, 2001, NUCL INSTRUMENTS MET, P1294
   Kim HJ, 2001, PROC SPIE, V4320, P409, DOI 10.1117/12.430898
   Kim HJ, 2001, IEEE T NUCL SCI, V48, P837, DOI 10.1109/23.940172
   Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017
   Meyer RR, 2000, MICROSC RES TECHNIQ, V49, P269
   Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736
   Shimizu F, 2000, PROC SPIE, V3977, P196
   Stamatakis HC, 2000, DENTOMAXILLOFAC RAD, V29, P28, DOI 10.1038/sj.dmfr.4600497
   Takeda T, 1998, J SYNCHROTRON RADIAT, V5, P1133, DOI 10.1107/S0909049597020116
   Takeda T, 2000, RADIOLOGY, V214, P298, DOI 10.1148/radiology.214.1.r00ja08298
   Umetani K, 2000, PROC SPIE, V3977, P522, DOI 10.1117/12.384528
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-7324-3
J9 IEEE NUCL SCI CONF R
PY 2002
BP 1673
EP 1677
PG 5
WC Engineering, Electrical & Electronic; Nuclear Science & Technology;
   Imaging Science & Photographic Technology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Engineering; Nuclear Science & Technology; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
GA BV30L
UT WOS:000178495800367
DA 2018-10-19
ER

PT S
AU Wu, SJ
   Jeng, CA
   Huang, JL
AF Wu, SJ
   Jeng, CA
   Huang, JL
BE Yuhas, DE
   Schneider, SC
TI Ultrasonic evaluation of thermally shocked Cr3C2/Al2O3
SO 2002 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE International Ultrasonic Symposium
CY OCT 08-11, 2002
CL MUNICH, GERMANY
SP IEEE Ultrason, Ferroelect & Frequency Control Soc
DE ultrasound; NDE; Cr3C2/Al2O3 composite
ID MECHANICAL-PROPERTIES; COMPOSITES; MICROSTRUCTURE
AB Chromium carbide (Cr3C2) has been proved to be a potential material for toughening alumina in biomedical and industrial applications because of its high Young"s modulus and erosion resistance. On the other hand, TiC/Al2O3 composite has been used a magnetic head slider due to its good wear resistance and mechanical strength. In this study we prepare samples of Cr3C2/Al2O3 composite by injection moulding method. To use this ceramic material as structural components when the temperature varies rapidly, it is necessary to be able to estimate damage or thermal shock cracking. Ultrasonic attenuation measurements are made for assessment of thermal shock damage. Results show that the attenuation increases as the shock temperature raises. Corresponding SEM pictures show although the size of micro-crack doesn't change the depth of the micro-cracks increases. It is demonstrated that ultrasonic attenuation proves to be a reliable tool for evaluating micro-fractures in solids.
C1 I Shou Univ, Dept Mech Engn, Kaohsiung, Taiwan.
RP Wu, SJ (reprint author), I Shou Univ, Dept Mech Engn, Kaohsiung, Taiwan.
CR FU CT, 1994, J MATER SCI, V29, P2671, DOI 10.1007/BF00356816
   FU CT, 1993, J MATER SCI, V28, P6285, DOI 10.1007/BF01352185
   HEFETZ M, 1992, J AM CERAM SOC, V75, P1839, DOI 10.1111/j.1151-2916.1992.tb07205.x
   Huang JL, 1999, CERAM INT, V25, P141, DOI 10.1016/S0272-8842(98)00014-5
   Huang JL, 1997, MATER CHEM PHYS, V51, P211, DOI 10.1016/S0254-0584(97)80309-4
   JENGA CA, IN PRESS CERAMICS IN
   Lii DF, 1996, J CERAM SOC JPN, V104, P796, DOI 10.2109/jcersj.104.796
   ROKHLIN SL, 1993, CERAMIC ENG SCI P, V7, P454
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-7582-3
J9 ULTRASON
PY 2002
BP 873
EP 876
DI 10.1109/ULTSYM.2002.1193536
PG 4
WC Acoustics; Engineering, Electrical & Electronic; Instruments &
   Instrumentation
SC Acoustics; Engineering; Instruments & Instrumentation
GA BW47M
UT WOS:000182111700194
DA 2018-10-19
ER

PT S
AU Stokes, DJ
   Rea, SM
   Porter, AE
   Best, SM
   Bonfield, W
AF Stokes, DJ
   Rea, SM
   Porter, AE
   Best, SM
   Bonfield, W
BE Moss, SC
TI Characterisation of biomedical materials, cells & interfaces using
   environmental SEM (ESEM)
SO ADVANCED BIOMATERIALS-CHARACTERIZATION, TISSUE ENGINEERING AND
   COMPLEXITY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposia on Physical Characterization of Biological Materials and
   Systems/Polymeric Biomaterials for Tissue Engineering/BioInspired
   Materials-Moving Toward Complexity
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
ID ELECTRON
AB The ability of Environmental Scanning Electron Microscopy (ESEM) to image insulating and/or moist specimens without the need for the removal of volatile components or the application of a conductive coating has significantly increased the potential range of experiments and observations that can be performed at the high resolution of electron microscopy. Such a technological advance has particularly important implications for the study of soft matter, complex fluids and biological specimens [1], Thus an important field of research to which ESEM can be applied is the study of materials for biomedical applications such as tissue engineering. The bioactivity of these materials is dependent upon such factors as phase composition, chemical composition, surface activity, crystallinity and microstructure. Using ESEM it is possible to obtain surface-sensitive, specimen-dependent secondary electron images (in the absence of specimen coating), yielding potentially new perspectives on microstructure to complement information derived from other techniques. We have used ESEM to study the apposition of bone on hydroxyapatite-based biomedical materials, from both in vitro and in vivo investigations.
C1 Univ Cambridge, Dept Phys, Cavendish Lab, Polymers & Colloids Grp, Cambridge CB3 0HE, England.
RP Stokes, DJ (reprint author), Univ Cambridge, Dept Phys, Cavendish Lab, Polymers & Colloids Grp, Madingley Rd, Cambridge CB3 0HE, England.
CR BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   CAMERON RE, 1994, J MICROSC-OXFORD, V173, P227, DOI 10.1111/j.1365-2818.1994.tb03445.x
   Feenstra L, 1983, BIOCERAMICS CALCIUM, P131
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Stokes DJ, 1998, LANGMUIR, V14, P4402, DOI 10.1021/la980281c
   Vajda EG, 1998, SCANNING, V20, P527, DOI 10.1002/sca.1998.4950200708
NR 6
TC 5
Z9 5
U1 0
U2 4
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-647-8
J9 MATER RES SOC SYMP P
PY 2002
VL 711
BP 113
EP 118
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BU92B
UT WOS:000177402200016
DA 2018-10-19
ER

PT S
AU Devesa, L
   Vaz, M
   Cirne, JS
   Rilo, N
   Leal, R
AF Devesa, L
   Vaz, M
   Cirne, JS
   Rilo, N
   Leal, R
BE Vieira, T
TI Detection of impact defects in laminated composites by holographic
   interferometry
SO ADVANCED MATERIALS FORUM I
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st International Materials Symposium (Materials 2001)
CY APR 09-11, 2001
CL UNIV COIMBRA, COIMBRA, PORTUGAL
SP Portuguese Soc Mat
HO UNIV COIMBRA
DE composites; interferometry; non-destructive tests
ID SHEAROGRAPHY
AB The use of laminate carbon fibre composite materials has been growing in a substantial way in the last decade. Some industries like the aerospace, aeronautical, automotive and biomedical benefit from the introduction of new structural solutions that became possible by using these materials. However, during the life in service of the composite components the material is exposed to a great variety of external attacks. Casual impacts, heat variations and water ingestion may provoke invisible degradation that can lead to a posterior collapse. For this reason the detection of eventual defects is very important and its inspection using non-destructive techniques of primordial importance.
   In this paper is proposed the use of holographic interferometry techniques for non-destructive detection of defects caused by low velocity impacts in laminate carbon fibre composites.
C1 Univ Coimbra, Ctr Engn Mecan, CEMUC, Dept Engn Mecan, PT-3030 Coimbra, Portugal.
   FEUP, DEMEGI, Lab Opt & Mecan Expt, LOME, PT-4200465 Oporto, Portugal.
RP Devesa, L (reprint author), Univ Coimbra, Ctr Engn Mecan, CEMUC, Dept Engn Mecan, PT-3030 Coimbra, Portugal.
RI Vaz, Mario/I-5613-2015
OI Vaz, Mario/0000-0002-6347-9608
CR CHOUSAL JC, 1994, 10 INT C EXP MECH LI, P373
   Ettemeyer A, 2000, OPT ENG, V39, P212, DOI 10.1117/1.602354
   Hung YY, 1998, OPT ENG, V37, P1406, DOI 10.1117/1.601656
   LEENDERT.JA, 1973, J PHYS E SCI INSTRUM, V6, P1107, DOI 10.1088/0022-3735/6/11/019
   LOKBERG O, 1987, APPL OPTICS OPTICAL
   Maas AAM, 1997, OPT LASER ENG, V26, P351, DOI 10.1016/0143-8166(95)00138-7
   SANTOS F, 1996, THESIS FEUP
   Sirohi RS, 1999, OPT ENG, V38, P1582, DOI 10.1117/1.602210
NR 8
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-905-9
J9 KEY ENG MAT
PY 2002
VL 230-2
BP 279
EP 282
DI 10.4028/www.scientific.net/KEM.230-232.279
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BV62B
UT WOS:000179553200063
DA 2018-10-19
ER

PT S
AU Marques, N
   Davim, JP
AF Marques, N
   Davim, JP
BE Vieira, T
TI Tribological comparative study of conventional and composite materials
   in biomedical applications
SO ADVANCED MATERIALS FORUM I
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st International Materials Symposium (Materials 2001)
CY APR 09-11, 2001
CL UNIV COIMBRA, COIMBRA, PORTUGAL
SP Portuguese Soc Mat
HO UNIV COIMBRA
DE composites; hip prostheses; SEM; tribology
ID POLYETHYLENE; WEAR
AB `Ultra-High Molecular Weight Polyethylene (UHMWPE) is used as acetabular component of total hip prostheses. However, at long term, prostheses failure can occur with the increasing of wear debris. Research with composite materials is being developed for orthopaedic applications. Carbon fibre reinforced Peek (CFR Peek) is a structural composite with biomedical applications.
   The tribological performance of UHMWPE and 30% CFR Peek was studied against steel, under distilled water lubricated environment at 37degreesC.
   A pin-on-disk Plint-TE67 was used to evaluate the tribological performance of both materials. Accelerated test condition was used in order to perform a sliding distance equivalent to two years lifetime of a hip prostheses. A contact stress of 5 MPa and a sliding velocity of 0.5 m/s were applied. Counterface roughness was measured to an arithmetic mean value, Ra, of 0.05 mum.
   The best performance in terms of friction coefficient and wear rate was observed for CFR Peek.
   Scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) X-Ray microanalysis were used to identify the effect of test conditions on the pin's contact surface.
C1 Univ Aveiro, Ctr Mech Technol & Automat, Dept Mech Engn, PT-3810193 Aveiro, Portugal.
RP Marques, N (reprint author), Univ Aveiro, Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, PT-3810193 Aveiro, Portugal.
RI Davim, Joao Paulo/D-2314-2009; Group, GAME/B-3464-2014
OI Davim, Joao Paulo/0000-0002-5659-3111; 
CR AGRAWAL CM, 1995, ENCY HDB BIOMATERI A, V2
   CLARKE IC, 1981, ENG MED, V10, P115
   Dong H, 1999, WEAR, V225, P146, DOI 10.1016/S0043-1648(98)00356-1
   Dumbleton J. H., 1981, TRIBOLOGY NATURAL AR
   MAHARAJ GR, 1993, ASTM PUBLICATION
   MCKELLOP H, 1978, J BIOMED MATER RES, V12, P895, DOI 10.1002/jbm.820120611
   Mcnie CM, 2000, J MATER SCI-MATER M, V11, P163, DOI 10.1023/A:1008979608563
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P317, DOI 10.1002/jbm.820120306
   STJOHN KR, 1995, ENCY HDB BIOMATERI A, V2
   UMSWORTH A, 1975, J LUBRICATION TECHNO, P377
NR 10
TC 7
Z9 7
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-905-9
J9 KEY ENG MAT
PY 2002
VL 230-2
BP 487
EP 490
DI 10.4028/www.scientific.net/KEM.230-232.487
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BV62B
UT WOS:000179553200112
DA 2018-10-19
ER

PT S
AU Yu, T
   Chiellini, F
   Schmaljohan, D
   Solaro, R
   Ober, C
AF Yu, T
   Chiellini, F
   Schmaljohan, D
   Solaro, R
   Ober, C
BE Fedynyshyn, TH
TI Microfabrication of hydrogels for biomedical applications
SO ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XIX, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 19th Annual Conference on Advances in Resist Technology and Processing
CY MAR 04-06, 2002
CL SANTA CLARA, CA
SP SPIE, Semiconductor Equipment & Mat Int, Int SEMATECH
DE photolithography; microfabrication; hydrogel; 2-hydroxyethyl
   methacrylate
ID PHOTOLITHOGRAPHY; FABRICATION
AB Hydrogels have gained general acceptance as biocompatible materials and are the basis of many promising applications in tissue engineering, drug release formulations and biosensors. Polymer processing techniques that can generate miniature hydrogel micro structures are not only critical as scaffolds for tissue re-growth but also very effective for increasing the efficiency of drug delivery and biosensors. Our approach is to use both optical and soft lithographic methods to microfabricate hydrogels. In this paper, we describe a photolithographic process to pattern hydrogel materials and analyze factors influencing sensitivity and lateral resolution. The model system we are investigating is based on 2-hydroxyethyl methacrylate (HEMA), which is well known for its non-toxicity and its widespread use in the contact lens industry.
C1 Cornell Univ, Ithaca, NY 14850 USA.
RP Yu, T (reprint author), Cornell Univ, Ithaca, NY 14850 USA.
RI Chiellini, Federica/F-3233-2010
OI Chiellini, Federica/0000-0003-4680-9975; Ober,
   Christopher/0000-0002-3805-3314
CR Chen GP, 1998, LANGMUIR, V14, P6610, DOI 10.1021/la9806303
   Chiellini F, 2001, MACROMOL RAPID COMM, V22, P1284, DOI 10.1002/1521-3927(20011001)22:15<1284::AID-MARC1284>3.0.CO;2-M
   Jackman RJ, 1999, LANGMUIR, V15, P2973, DOI 10.1021/la981591y
   Martin BD, 2000, LANGMUIR, V16, P9944, DOI 10.1021/la001053x
   Naghash HJ, 1997, POLYMER, V38, P1187, DOI 10.1016/S0032-3861(96)00615-5
   NOVOTNY DB, 1986, J ELECTROCHEM SOC, V133, P2600, DOI 10.1149/1.2108487
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   SHEPPARD NF, 1995, SENSOR ACTUAT B-CHEM, V28, P95, DOI 10.1016/0925-4005(94)01542-P
   STONE JM, 1963, RAD OPTICS INTRO CLA, P191
   SUDHOLTER EJR, 1990, ANAL CHIM ACTA, V230, P59, DOI 10.1016/S0003-2670(00)82761-0
   WEN M, IS T ANN C 1997 50, P564
   YU T, 2000, POLYM PREPR AM CHEM, V41, P1699
NR 12
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4436-7
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4690
BP 854
EP 860
DI 10.1117/12.474288
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied; Polymer
   Science
SC Materials Science; Optics; Physics; Polymer Science
GA BV17J
UT WOS:000178056500093
DA 2018-10-19
ER

PT J
AU Wendel, A
AF Wendel, A
TI Do we need a "chair of alternative methods", and where?
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article; Proceedings Paper
CT Symposium on Use of Animals in Research: A Science-Society Controversy
CY MAR   12, 2002
CL MAINZ, GERMANY
DE professorship; research; commentary; alternative methods; humane science
AB During the last two decades, the field of in vitro technology has been successfully developed and its use is continuously growing. Advanced tests avoiding animal experiments will be increasingly required for routine industrial applications e.g. for pharmacological high-throughput screening. Moreover and even more importantly, the availability of human cell based methods is essential for future quality assurance and risk assessment in the fields of health and consumer protection as well as environmental protection. Thereby, the potential of such advanced in vitro methods extends fiar beyond the mere replacement of regulated tests.
   In practice, the introduction and expansion of this technology has been achieved predominantly by offering funding and awards to the scientific community After this initiation phase, the next consequent step to exploit this knowledge clearly consists in academic promotion of this new scientific culture in an institutionalised,form. The tasks of such a chair focussed oil advanced in vitro tests - most probably the first of its kind world-wide - would cover in addition to (a) research and (b) teaching, (c) the sharpening of social conscience for the topic. (a) While the validation of alternative methods was formally established by founding institutions like ZEBET in Berlin oil the national and ECVAM in Ispra on the European level, the development of further new and more sophisticated in vitro methods to date emerge predominantly as a by-product of basic research. A considerable push might now be given by the structured search for new methods with a spill-over,for research-based up-to-date teaching.
   (b) The field of alternative methods is more than a panel of advanced in vitro techniques: A culture of systematic evaluation and validation of in vitro tests has been developed, which has bearing far beyond the replacement of animal experiments. In vitro systems inherently prone to artefacts require the highest level of quality control and assurance. A successful initiative to establish a Good Cell Culture Practice (GCCP) in analogy to Good Laboratory Practice (GLP) has evolved out of the field of in vitro alternatives. The concept of validating the relevance of an in vitro test in comparison to the respective in vivo situation represents a consequent translation of evidence-based medicine into in vitro biomedicine. In other words: It does no longer suffice that an in vitro model is plausible - it has to prove its suitability and quality.
   (c) The broad implementation of advanced in vitro technology into curricula implies development of lectures, courses and other teaching materials including virtual education offers. Such a basis will allow efficient spreading of knowledge and ease transnational acceptance. Last but not least, taking over the leadership for erecting a chair for alternative methods represents a major political signal that demonstrates to the public the willingness to adapt academic education to modern social awareness. A location for such an initiative needs to be found that is in the centre of Europe, has the necessary infrastructure of surrounding biomedical research, international networks for the evaluation and validation of tests, technology transfer to industrial use and access to relevant publication organs.
   The unequivocal answer to the question in the heading is therefore: we need a chair for in vitro alternatives because (i) the patient is our primary concern but the animal is not just secondary (ii) man's responsibility for the integrity of all creatures including the own species makes it mandatory.
C1 Univ Konstanz, Fac Biol, D-78457 Constance, Germany.
RP Wendel, A (reprint author), Univ Konstanz, Fac Biol, Univ Str 10, D-78457 Constance, Germany.
NR 0
TC 4
Z9 4
U1 2
U2 6
PU SPEKTRUM AKADEMISCHER VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 2002
VL 19
IS 2
BP 64
EP 68
PG 5
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 580NB
UT WOS:000177239700004
PM 12098011
DA 2018-10-19
ER

PT S
AU Corcione, CE
   Greco, A
   Licciulli, A
   Martena, M
   Maffezzoli, A
AF Corcione, CE
   Greco, A
   Licciulli, A
   Martena, M
   Maffezzoli, A
BE Kuljanic, E
TI Ceramic components built by stereolithography
SO AMST 02: ADVANCED MANUFACTURING SYSTEMS AND TECHNOLOGY, PROCEEDINGS
SE CISM COURSES AND LECTURES
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Manufacturing Systems and
   Technology (AMST 02)
CY JUN, 2002
CL UDINE, ITALY
DE stereolitography; alumina
ID SUSPENSIONS
AB Stererolithography (SL) is a rapid prototyping process traditionally used to produce polymeric parts for various applications in aerospace, biomedical, automotive and electronics fields. Though it is a promising process for production of advanced ceramics, a number of critical points need still a proper solution: develop materials for functional prototypes, avoid interlayer delamination, obtain mechanical performances. In this work the production of ceramic green starting from specially formulated photocurable suspensions is presented. In particular, Al2O3 ceramic precursor have been built with an experimental stereolithography system, and the ceramic objects have been obtained from pyrolisis of the organic binder and subsequent sintering. Finally, characterization of mechanical properties and microstructure of the samples is presented. In addition, a 3D System SLA250 machine has been modified in order to build ceramic objects. A new loading vat with varying capacity has been projected and built, in order to produce parts with lower material quantities. The building and recoating parameters of the machine have been studied and modified to work with high-viscosity formulations.
C1 Univ Lecce, Dept Innovat Engn, I-73100 Lecce, Italy.
RP Corcione, CE (reprint author), Univ Lecce, Dept Innovat Engn, I-73100 Lecce, Italy.
RI esposito corcione, carola/M-9542-2015; Greco, Antonio/H-9930-2013;
   maffezzoli, alfonso/L-7217-2015
OI esposito corcione, carola/0000-0002-3056-1162; Greco,
   Antonio/0000-0002-0621-622X; maffezzoli, alfonso/0000-0002-6371-4030
CR Agarwala M, 1995, RAPID PROTOTYPING J, V1, P26, DOI 10.1108/13552549510078113
   ALWOOD CI, 1996, SAMPE J, V32, P55
   Brady GA, 1998, J MATER SCI, V33, P4551, DOI 10.1023/A:1004416705140
   Burns M, 1993, AUTOMATED FABRICATIO
   Edirisinghe M, 1997, MATER WORLD, V5, P138
   Greco A, 2001, J MATER SCI, V36, P99, DOI 10.1023/A:1004899027360
   Jacobs P. F., 1992, RAPID PROTOTYPING MA
   KNITTER R, 2001, FABRICATION CERAMIC
   MARCUS HL, 1993, ADV MATER PROCESS, V9, P28
   WALLER DJ, 1992, AM CERAM SOC BULL, V7, P1648
NR 10
TC 0
Z9 0
U1 1
U2 6
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, A-1201 VIENNA, AUSTRIA
SN 0254-1971
BN 3-211-83689-6
J9 CISM COUR L
PY 2002
IS 437
BP 731
EP 739
PG 9
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BV95R
UT WOS:000180518500085
DA 2018-10-19
ER

PT J
AU Kanazawa, H
   Sunamoto, T
   Ayano, E
   Matsushima, Y
   Kikuchi, A
   Okano, T
AF Kanazawa, H
   Sunamoto, T
   Ayano, E
   Matsushima, Y
   Kikuchi, A
   Okano, T
TI Temperature-responsive chromatography using poly(N-isopropylacrylamide)
   hydrogel-modified silica
SO ANALYTICAL SCIENCES
LA English
DT Article
ID SURFACES; SYSTEM
AB Poly(N-isopropylacrylamide) (PNIPAAm) has the sharpest phase transition of the class of thermo-sensitive N-alkyl acrylamide polymers. We developed a new method of HPLC using packing materials modified with cross-linked poly(N-isopropylacrylamide) (PNIPAAm) hydrogel. A temperature-responsive surface was prepared by polymerization of NIPAAm in the presence of a cross-linker on the silica support. The surface properties and functions of the stationary phases change in response to the external temperature. Therefore it easily changes the interaction of a solute with the surface with a constant aqueous mobile phase. A temperature-responsive elution behavior was observed on the separation of steroids and PTH-amino acids. The method is expected to be applicable to separation in the pharmaceutical and biomedical fields.
C1 Kyoritsu Coll Pharmaceut Sci, Tokyo 1058512, Japan.
   Tokyo Womens Med Univ, Inst Biomed Engn, Shinjuku Ku, Tokyo 1628666, Japan.
RP Kanazawa, H (reprint author), Kyoritsu Coll Pharmaceut Sci, 1-5-30 Shiba Koen, Tokyo 1058512, Japan.
RI Okano, Teruo/J-4028-2012
OI Kanazawa, Hideko/0000-0003-2550-470X
CR BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   CHEN GH, 1993, BIOCONJUGATE CHEM, V4, P509, DOI 10.1021/bc00024a013
   Kanazawa H, 1997, J PHARMACEUT BIOMED, V15, P1545, DOI 10.1016/S0731-7085(96)02004-3
   Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j
   Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k
   Kanazawa H, 2000, ANAL CHEM, V72, P5961, DOI 10.1021/ac0004658
   Kanazawa H, 1998, TRAC-TREND ANAL CHEM, V17, P435, DOI 10.1016/S0165-9936(98)00044-2
   KOBAYASHI J, 2000, IKOGAKUCHIRYO, V12, P670
   Matsukata M, 1996, BIOCONJUGATE CHEM, V7, P96, DOI 10.1021/bc950082u
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   Yakushiji T, 1998, LANGMUIR, V14, P4657, DOI 10.1021/la980090+
   YAMAMOTO K, 2000, ENV SCI, V7, P1047
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
NR 17
TC 71
Z9 71
U1 1
U2 33
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PD JAN
PY 2002
VL 18
IS 1
BP 45
EP 48
DI 10.2116/analsci.18.45
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 512YK
UT WOS:000173351000009
PM 11817726
OA Bronze
DA 2018-10-19
ER

PT J
AU Zelikin, AN
   Lynn, DM
   Farhadi, J
   Martin, I
   Shastri, V
   Langer, R
AF Zelikin, AN
   Lynn, DM
   Farhadi, J
   Martin, I
   Shastri, V
   Langer, R
TI Erodible conducting polymers for potential biomedical applications
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE biomaterials; cell differentiation; conducting materials; polymers;
   polypyrroles
ID BONE-FORMATION; COPOLYMERIZATION; PYRROLE
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Kantonsspital Basel, Dept Surg, Div Res, Basel, Switzerland.
RP Shastri, V (reprint author), MIT, Dept Chem Engn, Room E25-342, Cambridge, MA 02139 USA.
RI Zelikin, Alexander/J-3659-2012
OI Zelikin, Alexander/0000-0002-9864-321X
FU NIGMS NIH HHS [1 F32 GM20227-01, GM26698]
CR BERLIN A, 1998, ELECT OPTICAL POLYM, P47
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Donat-Bouillud A, 1997, CHEM MATER, V9, P2815, DOI 10.1021/cm9701926
   GREGORY RV, 1989, SYNTHETIC MET, V28, pC823
   GuiseppiElie A, 1996, MATER RES SOC SYMP P, V413, P439
   Heeger A.J., 2001, ANGEW CHEM, V113, P2660
   Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0
   HONG YL, 1995, CHEM MATER, V7, P1999, DOI 10.1021/cm00059a003
   IBRAHIM SK, 1995, J ELECTROANAL CHEM, V387, P139, DOI 10.1016/0022-0728(95)03957-I
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   LIVACHE T, 1994, NUCLEIC ACIDS RES, V22, P2915, DOI 10.1093/nar/22.15.2915
   MacDiarmid A., 2001, ANGEW CHEM, V113, P2649
   MacDiarmid AG, 2001, ANGEW CHEM INT EDIT, V40, P2581, DOI 10.1002/1521-3773(20010716)40:14<2581::AID-ANIE2581>3.0.CO;2-2
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   REYNOLDS JR, 1987, MACROMOLECULES, V20, P958, DOI 10.1021/ma00171a011
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SHASTRI V, 1995, THESIS RENSSELAER PO
   Shastri VP, 1999, MATER RES SOC SYMP P, V550, P215
   SHIRAKAWA H, 2001, ANGEW CHEM, V113, P2642
   Shirakawa Hideki, 2001, Angew Chem Int Ed Engl, V40, P2574, DOI 10.1002/1521-3773(20010716)40:14<2574::AID-ANIE2574>3.0.CO;2-N
   Vernitskaya TV, 1997, RUSS CHEM REV, V66, P443, DOI DOI 10.1070/RC1997V066N05ABEH000261
   WONG J, 1995, P NATL ACAD SCI USA, V91, P3201
   Zelikin A, 1999, J ORG CHEM, V64, P3379, DOI 10.1021/jo9823339
NR 27
TC 77
Z9 80
U1 0
U2 29
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2002
VL 41
IS 1
BP 141
EP 144
DI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 509BR
UT WOS:000173124900028
PM 12491465
DA 2018-10-19
ER

PT J
AU Lendlein, A
   Kelch, S
AF Lendlein, A
   Kelch, S
TI Shape-memory polymers
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Review
DE block copolymers; material science; polymers; shape-memory polymers
ID ETHYLENE-VINYL ACETATE; POLYETHER-BASED POLYURETHANES; BUTADIENE
   BLOCK-COPOLYMER; HEAT SHRINKABLE PRODUCTS; SOFT-SEGMENT; POLY(VINYL
   ALCOHOL); HYBRID-COMPOSITES; BIOMEDICAL APPLICATIONS; SMART SYSTEMS;
   HYDROGEL
C1 GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Alvarez-Lorenzo C, 2000, MACROMOLECULES, V33, P8693, DOI 10.1021/ma000603v
   AOYAGI T, 1994, J CONTROL RELEASE, V32, P87
   Ashley S., 2001, SCI AM
   Baffler WJ, 1963, J APPL PHYS, V34, P1475
   Bahary W. S., 1967, RUBBER CHEM TECHNOL, V40, P1529
   BASSIRI ITG, 1967, J POLYM SCI POL LETT, V5, P871
   BERGER M, 1963, J POLYM SCI PART A, V1, P2945, DOI 10.1002/pol.1963.100010916
   Brennan M, 2001, CHEM ENG NEWS, V79, P5, DOI 10.1021/cen-v079n006.p005
   BRIBER RM, 1983, J MACROMOL SCI PHYS, VB22, P509, DOI 10.1080/00222348308224773
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   CAPACCIO G, 1982, COLLOID POLYM SCI, V260, P46, DOI 10.1007/BF01447675
   Chang L.C., 1951, T AIME, V189, P47, DOI [10.1007/BF03398954, DOI 10.1007/BF03398954]
   CHARLESBY A, 1952, PROC R SOC LON SER-A, V215, P187, DOI 10.1098/rspa.1952.0206
   Charlesby A, 1960, ATOMIC RAD POLYM, P198
   CHEN W, 1983, RADIAT PHYS CHEM, V22, P593, DOI 10.1016/0146-5724(83)90068-7
   Chowdhury SR, 2000, POLYM DEGRAD STABIL, V70, P199, DOI 10.1016/S0141-3910(00)00107-5
   Chowdhury SR, 2000, J APPL POLYM SCI, V77, P2088, DOI 10.1002/1097-4628(20000829)77:9<2088::AID-APP27>3.0.CO;2-N
   COWIE JMG, 1991, POLYM CHEM PHYSICS M
   COWIE JMG, 1997, CHEM PHYSIK SYNTHETI, P278
   DEDEURWAERDER R, 1959, J CHIM PHYS PCB, V56, P940, DOI 10.1051/jcp/1959560940
   EDGAR OB, 1952, J POLYM SCI, V8, P1, DOI 10.1002/pol.1952.120080101
   FAKIROV S, 1975, MAKROMOL CHEM, V176, P2459
   FALBE J, 1998, ROMPP LEXIKON CHEM, V5, P3449
   FALBE J, 1998, ROMPP LEXIKON CHEM, V4, P2586
   FALBE J, 1998, ROMPP LEXIKON CHEM, V5, P3415
   FALBE J, 1998, ROMPP LEXIKON CHEM, V5, P3506
   FLORY PJ, 1969, PRINCIPLES POLYM CHE, P432
   *FLUK CHEM GMBH, 2001, LAB CHEM, P1231
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   GAUR U, 1981, J PHYS CHEM-US, V10, P1010
   GAUR U, 1983, J PHYS CHEM-US, V12, P56
   GAUR U, 1981, J PHYS CHEM-US, V10, P1023
   Goethals EJ, 1998, MACROMOL SYMP, V132, P57, DOI 10.1002/masy.19981320108
   GRIEVESON BM, 1960, POLYMER, V1, P499, DOI 10.1016/0032-3861(60)90065-3
   HAYASHI S, 1994, P ANN TECHN C EXH PL, P1998
   He XW, 1996, POLYM J, V28, P452, DOI 10.1295/polymj.28.452
   HIRAI T, 1992, J APPL POLYM SCI, V46, P1449, DOI 10.1002/app.1992.070460815
   HIRAI T, 1992, J APPL POLYM SCI, V45, P1849, DOI 10.1002/app.1992.070451019
   Hron P, 1999, ANGEW MAKROMOL CHEM, V268, P29
   HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525
   Jeong HM, 2000, J MATER SCI, V35, P279, DOI 10.1023/A:1004728814128
   Jeong HM, 2000, POLYMER, V41, P1849, DOI 10.1016/S0032-3861(99)00334-1
   JOHNS DB, 1984, RING OPENING POLYM, V1, P461
   Kagami Y, 1996, MACROMOL RAPID COMM, V17, P539, DOI 10.1002/marc.1996.030170806
   Kim BK, 1998, POLYMER, V39, P2803, DOI 10.1016/S0032-3861(97)00616-2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   KLEINHEINS G, 1984, KUNSTST-GER PLAST+, V74, P445
   KLEINHEINS G, 1986, KUNSTST-GER PLAST+, V76, P1069
   Kobayashi K., 1992, US-A 5128197, Patent No. 5128197
   Kumar S, 1997, J APPL POLYM SCI, V64, P823, DOI 10.1002/(SICI)1097-4628(19970502)64:5<823::AID-APP1>3.0.CO;2-R
   LAURENCIN CT, 1995, BIOMEDICAL APPL SYNT
   Lee YM, 1996, J APPL POLYM SCI, V62, P301, DOI 10.1002/(SICI)1097-4628(19961010)62:2<301::AID-APP5>3.0.CO;2-0
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Li FK, 1999, J APPL POLYM SCI, V71, P1063, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1063::AID-APP4>3.0.CO;2-A
   Li FK, 1997, J APPL POLYM SCI, V64, P1511, DOI 10.1002/(SICI)1097-4628(19970523)64:8<1511::AID-APP8>3.0.CO;2-K
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Li FK, 1998, POLYMER, V39, P6929, DOI 10.1016/S0032-3861(98)00099-8
   Li Y, 1997, J APPL POLYM SCI, V63, P1173, DOI 10.1002/(SICI)1097-4628(19970228)63:9<1173::AID-APP9>3.0.CO;2-E
   Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W
   Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   Luo XL, 1997, J APPL POLYM SCI, V64, P2433, DOI 10.1002/(SICI)1097-4628(19970620)64:12<2433::AID-APP17>3.0.CO;2-1
   Machi S, 1996, RADIAT PHYS CHEM, V47, P333, DOI 10.1016/0969-806X(95)00125-H
   MANTOVANI D, 2000, JOM, V10, P36
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Mather PT, 1999, MACROMOLECULES, V32, P1194, DOI 10.1021/ma981210n
   Mather PT, 2000, POLYM PREPR, V41, P528
   MERKEL M, 2000, TASCHENBUCH WERKSTOF, P358
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Nakayama K, 1991, INT POLYM SCI TECHN, V18, pT43
   NATA G, 1965, SCIENCE, V147, P269
   NATHAN A, 1992, MACROMOLECULES, V25, P4476, DOI 10.1021/ma00044a004
   Osada Y, 1998, ADV MATER, V10, P827, DOI 10.1002/(SICI)1521-4095(199808)10:11<827::AID-ADMA827>3.0.CO;2-L
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Otsuka K., 1998, SHAPE MEMORY MAT
   REDING FP, 1962, J POLYM SCI, V57, P483, DOI 10.1002/pol.1962.1205716538
   Reyntjens WG, 1999, MACROMOL RAPID COMM, V20, P251, DOI 10.1002/(SICI)1521-3927(19990501)20:5<251::AID-MARC251>3.0.CO;2-2
   SAKURAI K, 1993, J APPL POLYM SCI, V47, P937, DOI 10.1002/app.1993.070470521
   SAKURAI K, 1994, POLYMER, V35, P4238, DOI 10.1016/0032-3861(94)90602-5
   Sakurai K, 1997, J MACROMOL SCI PHYS, V36, P703, DOI 10.1080/00222349708212397
   SAKURAI K, 1989, J APPL POLYM SCI, V38, P1191, DOI 10.1002/app.1989.070380616
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P2493, DOI 10.1002/app.1975.070190912
   SHALABY SW, 1994, BIOMEDICAL POLYM
   SHIRAI Y, 1988, MITSUBISHI TECH B, V184, P1
   Silver F., 1989, BIOCOMPATIBILITY INT
   Skakalova V, 1997, MACROMOL CHEM PHYS, V198, P3161, DOI 10.1002/macp.1997.021981014
   SMITH TL, 1977, POLYM ENG SCI, V17, P129, DOI 10.1002/pen.760170302
   SUZUKI H, 1985, J POLYM SCI POL PHYS, V23, P1671, DOI 10.1002/pol.1985.180230818
   TAKAHASHI T, 1996, J APPL POLYM SCI, V1061, P60
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P296, DOI 10.1299/jsmea1988.35.3_296
   Tobushi H, 1996, J PHYS IV, V6, P377, DOI 10.1051/jp4:1996136
   UCHIDA M, 1995, MACROMOLECULES, V28, P4583, DOI 10.1021/ma00117a031
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   VanCaeter P, 1997, POLYM BULL, V39, P589, DOI 10.1007/s002890050190
   Wang MT, 1999, J POLYM SCI POL PHYS, V37, P101, DOI 10.1002/(SICI)1099-0488(19990115)37:2<101::AID-POLB1>3.0.CO;2-X
   Wang MT, 1997, POLYM ADVAN TECHNOL, V8, P136, DOI 10.1002/(SICI)1099-1581(199703)8:3<136::AID-PAT621>3.0.CO;2-I
   Wang MT, 1998, EUR POLYM J, V34, P1, DOI 10.1016/S0014-3057(97)00082-7
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wei ZG, 1998, J MATER SCI, V33, P3763, DOI 10.1023/A:1004674630156
   WILKES KE, 2000, JOM, V10, P45
   WOODS DW, 1954, NATURE, V174, P753, DOI 10.1038/174753b0
   Yang DZ, 2000, MATER DESIGN, V21, P503, DOI 10.1016/S0261-3069(00)00008-X
   ZHANG XM, 1995, J CHEM PHYS, V102, P551, DOI 10.1063/1.469434
   1986, ENCY POLYM SCI ENG, V11, P366
   1986, ENCY POLYM SCI ENG, V6, P410
NR 110
TC 1580
Z9 1622
U1 115
U2 1375
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2002
VL 41
IS 12
BP 2034
EP 2057
DI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
PG 24
WC Chemistry, Multidisciplinary
SC Chemistry
GA 565UB
UT WOS:000176386900004
PM 19746597
DA 2018-10-19
ER

PT J
AU Mair, RW
   Walsworth, RL
AF Mair, RW
   Walsworth, RL
TI Novel MRI applications of laser-polarized noble gases
SO APPLIED MAGNETIC RESONANCE
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Magnetic Resonance Microscopy
CY SEP, 2001
CL NOTTINGHAM, ENGLAND
ID NUCLEAR-MAGNETIC-RESONANCE; DEPENDENT DIFFUSION-COEFFICIENT;
   HYPERPOLARIZED XE-129 NMR; TO-VOLUME RATIO; POROUS-MEDIA;
   CROSS-POLARIZATION; FIELD-GRADIENT; LIQUID XENON; SPIN-ECHO;
   LONGITUDINAL RELAXATION
AB Gas-phase nuclear magnetic resonance (NMR) has great potential as a probe for a variety of interesting physical and biomedical problems that are not amenable to study by water or similar liquid. However, NMR of gases was largely neglected due to the low signal obtained from the thermally polarized gases with very low sample density. The advent of optical pumping techniques for enhancing the polarization of the noble gases He-3 and Xe-129 has bought new life to this field, especially in medical imaging where He-3 lung inhalation imaging is approaching a clinical application. However, there are numerous applications in materials science that also benefit from the use of these gases. We review primarily nonmedical applications of laser-polarized noble gases for both NMR imaging and spectroscopy and highlight progress with examples from our laboratory including high-resolution imaging at millitesla applied field strength and velocity imaging of convective flow. Porous media microstucture has been probed with both thermal and laser-polarized xenon, as xenon is an ideal probe due to low surface interaction with the grains of the porous media.
C1 Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA.
RP Mair, RW (reprint author), Harvard Smithsonian Ctr Astrophys, 60 Garden St,MS 59, Cambridge, MA 02138 USA.
CR Abragam A., 1983, PRINCIPLES NUCL MAGN
   ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0
   Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054
   Augustine MP, 1998, APPL PHYS LETT, V72, P1908, DOI 10.1063/1.121223
   BAX A, 1982, 2 DIMENSIONAL NUCL M
   Bencsik M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.065302
   BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460
   BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679
   Bock M, 1997, MAGNET RESON MED, V38, P890, DOI 10.1002/mrm.1910380607
   Bowers CR, 1999, J AM CHEM SOC, V121, P9370, DOI 10.1021/ja991443+
   BOWERS CR, 1993, CHEM PHYS LETT, V205, P168, DOI 10.1016/0009-2614(93)89223-5
   Brunner E, 1998, J MAGN RESON, V130, P145, DOI 10.1006/jmre.1997.1296
   Brunner E, 1999, J MAGN RESON, V138, P155, DOI 10.1006/jmre.1998.1675
   BUTLER JP, 2002, J PHYS CONDENS MATT, V14, P297
   Callaghan P.T., 1991, PRINCIPLES NUCL MAGN
   CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0
   Callaghan PT, 1998, J MAGN RESON, V133, P148, DOI 10.1006/jmre.1998.1417
   Callaghan PT, 1997, REV SCI INSTRUM, V68, P4263, DOI 10.1063/1.1148340
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   DARASSE L, 1997, CR ACAD SCI II B, V324, P691
   DAVIES GR, 1994, CHEM PHYS LETT, V230, P237, DOI 10.1016/0009-2614(94)01151-6
   deSwiet TM, 1996, J CHEM PHYS, V104, P206, DOI 10.1063/1.470890
   Dimitrov IE, 1999, MAGN RESON IMAGING, V17, P267, DOI 10.1016/S0730-725X(98)00106-4
   DONASCIMENTO GC, 1992, MEAS SCI TECHNOL, V3, P370, DOI 10.1088/0957-0233/3/4/006
   Durand E, 2002, MAGNET RESON MED, V47, P75, DOI 10.1002/mrm.10047
   ECKERT G, 1992, NUCL INSTRUM METH A, V320, P53, DOI 10.1016/0168-9002(92)90769-Z
   Fitzgerald RJ, 1998, CHEM PHYS LETT, V284, P87, DOI 10.1016/S0009-2614(97)01332-8
   Fukushima E, 1999, ANNU REV FLUID MECH, V31, P95, DOI 10.1146/annurev.fluid.31.1.95
   GAEDE HC, 1995, APPL MAGN RESON, V8, P373, DOI 10.1007/BF03162652
   Guillot G, 2001, MAGN RESON IMAGING, V19, P391, DOI 10.1016/S0730-725X(01)00254-5
   GUILLOT G, 1999, EUR RADIOL, V9, pB25
   Haake M, 1998, CHEM PHYS LETT, V292, P686, DOI 10.1016/S0009-2614(98)00732-5
   HASSON KC, 1990, PHYS REV A, V41, P3672, DOI 10.1103/PhysRevA.41.3672
   HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602
   HURLIMANN MD, 1994, J MAGN RESON SER A, V111, P169, DOI 10.1006/jmra.1994.1243
   Hurlimann MD, 1998, J MAGN RESON, V131, P232, DOI 10.1006/jmre.1998.1364
   Kaiser LG, 2000, P NATL ACAD SCI USA, V97, P2414, DOI 10.1073/pnas.050012497
   Kaiser LG, 2001, J MAGN RESON, V149, P144, DOI 10.1006/jmre.2000.2283
   Kauczor HU, 1998, EUR RADIOL, V8, P820, DOI 10.1007/s003300050479
   Kuethe DO, 1998, MAGNET RESON MED, V39, P85, DOI 10.1002/mrm.1910390114
   LATOUR LL, 1993, J MAGN RESON SER A, V101, P342, DOI 10.1006/jmra.1993.1056
   LIZAK MJ, 1991, J MAGN RESON, V95, P548, DOI 10.1016/0022-2364(91)90168-S
   LONG HW, 1993, J AM CHEM SOC, V115, P8491, DOI 10.1021/ja00071a086
   Luhmer M, 1999, J AM CHEM SOC, V121, P3502, DOI 10.1021/ja9841916
   MacNamara E, 1999, J PHYS CHEM B, V103, P1158, DOI 10.1021/jp984081l
   MacNamara E, 2000, CHEM PHYS LETT, V317, P165, DOI 10.1016/S0009-2614(99)01355-X
   Mair RW, 1998, J MAGN RESON, V135, P478, DOI 10.1006/jmre.1998.1588
   Mair RW, 1999, PHYS REV LETT, V83, P3324, DOI 10.1103/PhysRevLett.83.3324
   Mair RW, 1997, J RHEOL, V41, P901, DOI 10.1122/1.550864
   Mair RW, 2000, PHYS REV E, V61, P2741, DOI 10.1103/PhysRevE.61.2741
   Mair RW, 2001, MAGN RESON IMAGING, V19, P345, DOI 10.1016/S0730-725X(01)00247-8
   MANSFIELD P, 1982, ADV MAGNETIC RESON S, V2
   Meersmann T, 2000, J PHYS CHEM A, V104, P11665, DOI 10.1021/jp002322v
   MITRA PP, 1993, PHYS REV B, V47, P8565, DOI 10.1103/PhysRevB.47.8565
   MOHANTY S, 1970, J CHEM PHYS, V53, P461, DOI 10.1063/1.1673814
   Mohoric A, 1999, J MAGN RESON, V136, P22, DOI 10.1006/jmre.1998.1594
   Moudrakovski IL, 2000, J MAGN RESON, V144, P372, DOI 10.1006/jmre.2000.2078
   Navon G, 1996, SCIENCE, V271, P1848, DOI 10.1126/science.271.5257.1848
   Patyal BR, 1997, J MAGN RESON, V126, P58, DOI 10.1006/jmre.1997.1159
   Peled S, 1999, J MAGN RESON, V140, P320, DOI 10.1006/jmre.1999.1850
   RAFTERY D, 1991, PHYS REV LETT, V66, P584, DOI 10.1103/PhysRevLett.66.584
   Rinck P A, 1984, Rofo, V140, P239, DOI 10.1055/s-2008-1052964
   Room T, 1997, PHYS REV B, V55, P11604, DOI 10.1103/PhysRevB.55.11604
   Rubin SM, 2000, P NATL ACAD SCI USA, V97, P9472, DOI 10.1073/pnas.170278897
   Ruppert K, 2000, MAGNET RESON MED, V44, P349, DOI 10.1002/1522-2594(200009)44:3<349::AID-MRM2>3.0.CO;2-J
   Saam B, 1996, CHEM PHYS LETT, V263, P481, DOI 10.1016/S0009-2614(96)01238-9
   Sauer KL, 1997, CHEM PHYS LETT, V277, P153, DOI 10.1016/S0009-2614(97)00876-2
   Schmidt DM, 1997, J MAGN RESON, V129, P184, DOI 10.1006/jmre.1997.1258
   Song YQ, 1998, J CHEM PHYS, V108, P6233, DOI 10.1063/1.476030
   Song YQ, 2000, NATURE, V406, P178, DOI 10.1038/35018057
   Song YQ, 2000, CONCEPT MAGNETIC RES, V12, P6, DOI 10.1002/(SICI)1099-0534(2000)12:1<6::AID-CMR3>3.0.CO;2-U
   Song YQ, 1998, SOLID STATE NUCL MAG, V10, P247, DOI 10.1016/S0926-2040(97)00078-7
   Sozzani P, 2000, ANGEW CHEM INT EDIT, V39, P2695, DOI 10.1002/1521-3773(20000804)39:15<2695::AID-ANIE2695>3.0.CO;2-M
   Stapf S, 1998, PHYS REV E, V58, P6206, DOI 10.1103/PhysRevE.58.6206
   STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690
   STREEVER RL, 1961, PHYS REV, V121, P20, DOI 10.1103/PhysRev.121.20
   Swanson SD, 1999, MAGNET RESON MED, V42, P1137, DOI 10.1002/(SICI)1522-2594(199912)42:6<1137::AID-MRM19>3.3.CO;2-W
   Tseng CH, 1999, PHYS REV E, V59, P1785, DOI 10.1103/PhysRevE.59.1785
   Tseng CH, 1998, PHYS REV LETT, V81, P3785, DOI 10.1103/PhysRevLett.81.3785
   Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629
   West J B, 1982, Physiologist, V25, pS21
   Wolber J, 1998, CHEM PHYS LETT, V296, P391, DOI 10.1016/S0009-2614(98)01050-1
   Wong GP, 1999, J MAGN RESON, V141, P217, DOI 10.1006/jmre.1999.1904
NR 83
TC 12
Z9 12
U1 0
U2 9
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0937-9347
EI 1613-7507
J9 APPL MAGN RESON
JI Appl. Magn. Reson.
PY 2002
VL 22
IS 2
BP 159
EP 173
DI 10.1007/BF03166100
PG 15
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA 562QU
UT WOS:000176211100004
DA 2018-10-19
ER

PT S
AU Rizzi, G
   Groppetti, R
   Salvarani, L
   Scrivani, A
AF Rizzi, G
   Groppetti, R
   Salvarani, L
   Scrivani, A
BE Brown, S
   Clarke, I
   Williams, P
TI A contribution to the production and characterization of new biomedical
   coatings: Fluorohydroxyapatite coatings
SO BIOCERAMICS 14
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CALIFORNIA
SP Int Soc Ceram Med
DE fluorohydroxyapatite coating; titanium coating; plasma spray coating;
   roughness
AB In order to improve the osteo-integration of the implant the state-of-art specifies the use of coatings such as hydroxyapatite (HA; Ca-5(PO4)(3)OH). The research deals now with new materials and modification of HA, in order to improve the stability and mechanical properties of the coatings or more generally of the implant. A promising material is fluorohydroxyapatite (FHA, Ca-5(PO4)(3)OH1-xFx). This paper addresses the production and characterization of Vacuum Plasma Sprayed Fluorohydroxyapatite coating for orthopedic endoprosthesis. The spray trials have been carried out on Ti6A14V alloy substrates preventively blasted by means of corundum. In order to improve adhesion of FHA to titanium substrates two different titanium bond coats have been tested: the first with lower roughness and porosity named Type A and the second with higher roughness and porosity named Type B. A complete structural and mechanical characterization has been carried out: coating thickness, closed porosity and superficial porosity, microhardness, roughness have been measured.
C1 Biocoatings Srl, I-43040 Parma, Italy.
   Univ Parma, Dept Ind Engn, Parma, Italy.
RP Rizzi, G (reprint author), Biocoatings Srl, Via A Volta 3, I-43040 Parma, Italy.
CR BRACALI P, 1999, P AITEM 99 BRESC IT
   RANZ X, 1997, BIOCERAMICS, V10
   VANBLITTERSWIJK CA, 1991, BONE-BIOMATERIAL INTERFACE, P295
NR 3
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MAT
PY 2002
VL 218-2
BP 93
EP 96
DI 10.4028/www.scientific.net/KEM.218-220.93
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300020
DA 2018-10-19
ER

PT S
AU Paulussen, S
   Vangeneugden, D
   Goossens, O
   Dekempeneer, E
AF Paulussen, S
   Vangeneugden, D
   Goossens, O
   Dekempeneer, E
BE Aizenberg, J
   McKittrick, JM
   Orme, CA
TI Antimicrobial coatings obtained in an atmospheric pressure dielectric
   barrier glow discharge
SO BIOLOGICAL BIOMIMETIC MATERIALS-PROPERTIES TO FUNCTION
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biological and Biomimetic Materials - Properties to
   Function held at the 2002 MRS Spring Meeting
CY APR 01-05, 2002
CL SAN FRANCISCO, CA
SP Mat Res Soc
ID PLASMA DEPOSITION; BIOMEDICAL APPLICATIONS; ADSORPTION; ADHESION;
   PROTEIN; ENERGY
AB This paper addresses the development of plasma polymer coatings that should prevent bacteria from adhering to medical devices, implants, textile fibers, packaging materials, etc. The two main parameters affecting bacterial colonization onto surfaces are the surface energy and the surface roughness. Both parameters can be adjusted by the deposition of a thin plasma polymer coating in an atmospheric pressure dielectric barrier glow discharge. According to SEM, FTIR, SPM, XPS and contact angle measurements, smooth, hydrophilic plasma polymer coatings were obtained under specific plasma conditions starting from 2-hydroxyethyl methacrylate (HEMA) and ethyl diazoacetate (EDA).
C1 Vlaamse Instelling Technol Onderzoek, Flemish Inst Technol Res, Mat Technol Div, B-2400 Mol, Belgium.
RP Paulussen, S (reprint author), Vlaamse Instelling Technol Onderzoek, Flemish Inst Technol Res, Mat Technol Div, Boeretang 200, B-2400 Mol, Belgium.
CR Arciola CR, 2002, BIOMATERIALS, V23, P1495, DOI 10.1016/S0142-9612(01)00275-7
   CLAROTTI G, 1991, J MEMBRANE SCI, V61, P289, DOI 10.1016/0376-7388(91)80022-X
   COUSSOTRICO P, 1994, EUR POLYM J, V30, P1327, DOI 10.1016/0014-3057(94)90146-5
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P113, DOI 10.1016/0927-7765(96)01288-X
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Goossens O, 2001, SURF COAT TECH, V142, P474, DOI 10.1016/S0257-8972(01)01140-9
   Janocha B, 2001, SURF COAT TECH, V142, P1051, DOI 10.1016/S0257-8972(01)01279-8
   Massines F, 1998, J APPL PHYS, V83, P2950, DOI 10.1063/1.367051
   MASSINES F, 1996, AIP C P, V363, P306
   MIQIN Z, 1998, BIOMATERIALS, V19, P953
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353
   Salge J, 1996, SURF COAT TECH, V80, P1, DOI 10.1016/0257-8972(95)02676-2
NR 14
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-660-5
J9 MATER RES SOC SYMP P
PY 2002
VL 724
BP 179
EP 184
PG 6
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing; Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BV76S
UT WOS:000179970700025
DA 2018-10-19
ER

PT J
AU Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
AF Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
TI Iodine-containing cellulose mixed esters as radiopaque polymers for
   direct embolization of cerebral aneurysms and arteriovenous
   malformations
SO BIOMATERIALS
LA English
DT Article
DE embolization; embolic liquids; aneurysms; arteriovenous malformations;
   cellulose esters; iodine-containing cellulose mixed esters; cellulose
   acetate iodobenzoates; radiopacity
ID VINYL ALCOHOL COPOLYMER; ACETATE POLYMER; DIRECT THROMBOSIS;
   LITHIUM-CHLORIDE; BIOMEDICAL APPLICATIONS; CLINICAL-EXPERIENCE;
   IN-VITRO; N,N-DIMETHYLACETAMIDE; BIOMATERIAL; COMBINATION
AB The present study deals with the synthesis and characterization of radiopaque polymers which could, when solubilized in an appropriate water-miscible solvent, be useful embolic materials for the treatment of cerebral aneurysms and arteriovenous malformations. For this purpose cellulose (both microcrystalline and powdered) and partially substituted cellulose acetate (two different viscosity grades) were selected as starting materials to prepare iodine-containing polymers through various synthetic routes. The materials obtained were characterized by IR and NMR spectroscopy, molecular weight, iodine content, radiopacity and solubility in selected injectable organic solvents. The embolic liquids were evaluated for their precipitation behavior in a phosphate buffer solution (pH 7.4) mimicking physiological conditions using an in vitro aneurysm model. A sheep model was also used to assess in vivo the radiopacity and precipitation properties of a highly concentrated solution of a cellulose acetate 2,3,4-triiodobenzoate mixed ester. AH materials with 4-iodo- and 2,3,5-triiodobenzoyl groups gave sufficient radiopacity to be regarded as possible embolization materials, whereas iododeoxycellulose and iododeoxycellulose acetate were not radiopaque because of their low iodine content. Esters synthesized using cellulose as starting material were not soluble in the selected organic solvents due to the presence of many residual hydroxyl groups, but could be used for other biomedical applications where insoluble radiopaque materials are used. In contrast, solubility of the materials as well as satisfactory precipitation properties were ensured using cellulose acetate as the starting material. In conclusion, cellulose acetate iodobenzoate mixed esters dissolved in diglyme or dimethyl isosorbide (dimethyl sulfoxide is probably less appropriate because of its toxicity and hemolytic properties) could be useful embolic liquids for the treatment of cerebral aneurysms or arteriovenous malformations. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Div Diagnost & Intervent Radiol, Geneva, Switzerland.
   INRA, APHP, Ctr Res Intenvent Radiol, Jouy En Josas, France.
RP Doelker, E (reprint author), Univ Geneva, Sch Pharm, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.
CR BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   CHALOUPKA JC, 1993, J NEUROSURG, V78, P1006
   CHALOUPKA JC, 1994, AM J NEURORADIOL, V15, P1107
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DOELKER E, 1987, POWDER TECHNOL, V52, P207, DOI 10.1016/0032-5910(87)80106-7
   DOTTER CT, 1975, RADIOLOGY, V114, P227, DOI 10.1148/114.1.227
   Gailloud P, 1997, SURG RADIOL ANAT, V19, P119
   Gardner TS, 1942, J AM CHEM SOC, V64, P1539, DOI 10.1021/ja01259a014
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   Heinze T, 1998, MACROMOL CHEM PHYSIC, V199, P2341, DOI 10.1002/macp.1998.021991101
   HEUSER E, 1950, J AM CHEM SOC, V72, P670, DOI 10.1021/ja01158a007
   HIROTSUNE N, 1996, ADV INTERVENTIONAL N, P149
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KINUGASA K, 1993, J NEUROSURG, V78, P1007
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   KINUGASA K, 1994, NEUROSURGERY, V35, P755, DOI 10.1227/00006123-199410000-00027
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   KINUGASA K, 1995, J NEUROSURG, V83, P34, DOI 10.3171/jns.1995.83.1.0034
   LAURENT A, 1997, J NEURORADIOLOGY, V24, P314
   LAURENT A, 2001, UNPUB PDA J PHARM SC
   MALM CJ, 1954, ANAL CHEM, V26, P188, DOI 10.1021/ac60085a029
   MALM CJ, 1948, J AM CHEM SOC, V70, P2740, DOI 10.1021/ja01188a031
   Mandai S, 1998, INTERV NEURORADIOL, V4, P173, DOI 10.1177/15910199980040S135
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   MCCORMICK CL, 1990, CARBOHYD RES, V208, P183, DOI 10.1016/0008-6215(90)80098-N
   MCCORMICK CL, 1987, POLYMER, V28, P2317, DOI 10.1016/0032-3861(87)90393-4
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Mottu F, 2000, PDA J PHARM SCI TECH, V54, P456
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mottu F, 2001, PDA J PHARM SCI TECH, V55, P16
   MOTTU F, 1999, BIOMATERIALS, V21, P803
   MOTTU F, 2000, Patent No. 0003814
   SAMARANAYAKE G, 1993, CARBOHYD POLYM, V22, P1, DOI 10.1016/0144-8617(93)90159-2
   SAMPEI K, 1996, ADV INTERVENTIONAL N, P293
   Schoniger W., 1955, MIKROCHIM ACTA, V1, P123
   SUGIU K, 1995, J NEUROSURG, V83, P531, DOI 10.3171/jns.1995.83.3.0531
   TAKI W, 1992, J NEUROSURG, V77, P37, DOI 10.3171/jns.1992.77.1.0037
   TAKI W, 1990, AM J NEURORADIOL, V11, P163
   TERADA T, 1991, J NEUROSURG, V75, P655, DOI 10.3171/jns.1991.75.4.0655
   Tipson RS, 1944, J ORG CHEM, V9, P235, DOI 10.1021/jo01185a005
   TIPSON RS, 1947, J ORG CHEM, V12, P133, DOI 10.1021/jo01165a017
   TIPSON RS, 1953, ADV CARBOHYD CHEM, P107
   Tokunaga K, 1998, NEUROSURGERY, V42, P1135, DOI 10.1097/00006123-199805000-00108
   TOKUNAGA K, 1996, ADV INTERVENTIONAL N, P15
   Williamson SL, 1998, J MACROMOL SCI PURE, VA35, P1915, DOI 10.1080/10601329808000987
   WOLFROM ML, 1941, J AM CHEM SOC, V63, P1688
   YAMASHITA K, 1994, AM J NEURORADIOL, V15, P1103
NR 48
TC 61
Z9 63
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 121
EP 131
DI 10.1016/S0142-9612(01)00087-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400015
PM 11762830
DA 2018-10-19
ER

PT S
AU Thissen, H
   Hayes, JP
   Muir, BW
   Atkin, M
   Harvey, EC
AF Thissen, H
   Hayes, JP
   Muir, BW
   Atkin, M
   Harvey, EC
BE Nicolau, DV
   Lee, AP
TI Spatially controlled surface chemistry by excimer laser ablation of thin
   films
SO BIOMEDICAL APPLICATIONS OF MICRO- AND NANOENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Symposium on Smart Materials, Nano-, and Micro-Smart
   Systems
CY DEC 16-18, 2002
CL RMIT UNIV, MELBOURNE, AUSTRALIA
SP SPIE, Univ Arkansas, Natl Inst Adv Ind Sci & Technol, Cooperat Res Ctr Microtechnol, Dept Def, Australia, Swinburne Univ Technol, Adelaide Univ, Japanese Soc Electr Packaging, New Energy & Ind Technol Dev Org
HO RMIT UNIV
DE excimer laser; plasma polymerization; spatial control; surface
   modification; wettability; XPS; AFM
ID PLASMA POLYMERS; CELL; PROTEIN; CULTURE
AB Two-dimensional control over the surface chemistry of substrate materials is of interest to a wide range of applications from microelectronics to biomedical diagnostics. Here, we describe a general principle for creating spatially controlled surface chemistries by subsequent deposition of thin plasma polymer coatings followed by laser ablation. The creation of surfaces with spatially controlled wettability was used as an example. Plasma polymerization of n-heptylamine produced a hydrophilic surface on silicon wafer substrates while subsequent plasma polymerization of perfluoro-1,3- dimethylcyclohexane produced a hydrophobic surface. Excimer laser ablation at an energy density of 125 mJ/cm(2) was used to remove a defined thickness of the two-layer coating, completely removing the upper layer without exposing the substrate material. Excimer laser ablation resulted in two-dimensional control over the surface chemistry with a resolution of ca. 1 mum. Surface modifications were characterized by X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM). Contact angle measurements were used to estimate the wettability of modified surfaces. The method was shown to be suitable for the precise control over the location of droplets containing aqueous solutions. In conclusion, the method described here represents an effective tool for the production of substrates with spatially controlled surface chemistry and wettability.
C1 CSIRO, Mol Sci, Clayton, Vic 3169, Australia.
RP Thissen, H (reprint author), CSIRO, Mol Sci, Bag 10, Clayton, Vic 3169, Australia.
RI Thissen, Helmut/D-3835-2011; Muir, Benjamin/D-2206-2013
CR Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dyer P. E., 1992, PHOTOCHEMICAL PROCES
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Ghantasala MK, 1999, P SOC PHOTO-OPT INS, V3874, P85, DOI 10.1117/12.361208
   GOWER MC, 1993, LASER PROCESSING MAN, pCH8
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hartley P. G., 2000, Plasmas and Polymers, V5, P47, DOI 10.1023/A:1009508426115
   HECHT J, 1992, LASER GUIDEBOOK
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Matsuda T, 1994, ASAIO J, V40, pM594, DOI 10.1097/00002480-199407000-00068
   Rose D, 1999, DRUG DISCOV TODAY, V4, P411, DOI 10.1016/S1359-6446(99)01388-4
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Thissen H, 2001, P SOC PHOTO-OPT INS, V4590, P57, DOI 10.1117/12.454588
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Thissen H, 2001, P SOC PHOTO-OPT INS, V4234, P177, DOI 10.1117/12.424405
   Xia YN, 2001, CURR OPIN COLLOID IN, V6, P54, DOI 10.1016/S1359-0294(00)00088-1
NR 21
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4732-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4937
BP 107
EP 114
DI 10.1117/12.469160
PG 8
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BW27F
UT WOS:000181394800013
DA 2018-10-19
ER

PT S
AU Lyoo, WS
   Kim, JH
   Kim, SS
   Ghim, HD
AF Lyoo, WS
   Kim, JH
   Kim, SS
   Ghim, HD
BE Nicolau, DV
   Lee, AP
TI Biomedical applications of stereoregular poly(vinyl alcohol) micro- and
   nanoparticles
SO BIOMEDICAL APPLICATIONS OF MICRO- AND NANOENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Symposium on Smart Materials, Nano-, and Micro-Smart
   Systems
CY DEC 16-18, 2002
CL RMIT UNIV, MELBOURNE, AUSTRALIA
SP SPIE, Univ Arkansas, Natl Inst Adv Ind Sci & Technol, Cooperat Res Ctr Microtechnol, Dept Def, Australia, Swinburne Univ Technol, Adelaide Univ, Japanese Soc Electr Packaging, New Energy & Ind Technol Dev Org
HO RMIT UNIV
DE P(VPi/VAc); PVA micro and nanoparticles; heterogeneous saponification;
   embolic material; drug release
ID SUSPENSION POLYMERIZATION; VINYL-ACETATE; SAPONIFICATION; EMBOLIZATION;
   MICROFIBRILS; STABILITY; PIVALATE)
AB Syndiotactic poly(vinyl alcohol) (PVA)/poly(vinyl pivalate/vinyl acetate) (P(VPi/VAc)) and atactic PVA/PVAc micro- and nanoparticles with skin/core structure have been prepared by heterogeneous saponification of P(VPi/VAc) and PVAc micro- and nanoparticles. Especially, to prepare P(VPi/VAc) and PVAc microparticles having various particle sizes and uniform particle size distribution, vinyl pivalate (VPi)/vinyl acetate (VAc) and VAc were suspension-polymerized using a low-temperature initiator, 2,2'-azobis(2,4-dimethylvaleronitrile). P(VPi/VAc) particles are promising precursor of stereoregular PVA embolic materials which can be introduced through catheters in the management of gastrointestinal bleeders, arteriovenous malformations, hemangiomas, and traumatic rupture of blood vessels. Monodisperse and/or nearly monodisperse P(VPi/VAc) and PVAc microparticles with various particle diameters were obtained by controlling suspension polymerization conditions. Monodisperse P(VPi/VAc) and PVAc microparticles having various particle sizes were partially saponified in the heterogeneous system. PVA/P(VPi/VAc) and PVA/PVAc microparticles having various tacticity and degree of saponification were produced by controlling various polymerization and saponification conditions. The coating of stereoregular PVA micro- and nanoparticles for drug release experiments was conducted with the strepo-avidin-alkaline phosphatase conjugate in variable conditions of pH value, coating buffer, and reaction temperature. Protein-coated syndiotactic PVA micro-and nanoparticles, which does not crosslinking, were more superior to controllability of drug release, durability, and dimensional stability to water and blood than atactic one.
C1 Yeungnam Univ, Sch Text, Adv Res Ctr, PVA, Kyongsan 712749, South Korea.
RP Lyoo, WS (reprint author), Yeungnam Univ, Sch Text, Adv Res Ctr, PVA, Kyongsan 712749, South Korea.
CR BALARAMAN KS, 1983, J POLYM SCI POL LETT, V21, P87, DOI 10.1002/pol.1983.130210203
   CHERNGJU K, 1992, J APPL POLYM SCI, V46, P2147
   Cho JD, 1999, MACROMOLECULES, V32, P6236, DOI 10.1021/ma9908402
   Choi JH, 2001, MACROMOLECULES, V34, P2964, DOI 10.1021/ma001710s
   Choi JH, 1999, MACROMOL CHEM PHYSIC, V200, P1421, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1421::AID-MACP1421>3.0.CO;2-O
   CHUANG VP, 1981, AM J ROENTGENOL, V136, P729, DOI 10.2214/ajr.136.4.729
   CHUANG VP, 1980, RADIOLOGY, V135, P2959
   DEMACHI H, 1991, CARDIOVASC INTER RAD, V14, P158, DOI 10.1007/BF02577719
   GIANNETTI E, 1986, J POLYM SCI POL CHEM, V24, P2517, DOI 10.1002/pola.1986.080241012
   HA WS, 2000, Patent No. 6124033
   HERMAN WO, 1927, BER DTSCH CHEM GES, V60, P1658
   JOSEPH M, 1996, AM J NEURORADIOL, V17, P525
   Kwark YJ, 1996, POLYM J, V28, P851, DOI 10.1295/polymj.28.851
   Lyoo WS, 1998, MACROMOLECULES, V31, P4253, DOI 10.1021/ma971741w
   Lyoo WS, 1998, POLYM J, V30, P424, DOI 10.1295/polymj.30.424
   Lyoo WS, 2001, MACROMOLECULES, V34, P2615, DOI 10.1021/ma001624s
   Lyoo WS, 1998, COLLOID POLYM SCI, V276, P951, DOI 10.1007/s003960050333
   Lyoo WS, 1997, POLYM ENG SCI, V37, P1259, DOI 10.1002/pen.11770
   Lyoo WS, 1996, POLYMER, V37, P3121, DOI 10.1016/0032-3861(96)89414-6
   Lyoo WS, 1997, J POLYM SCI POL CHEM, V35, P55, DOI 10.1002/(SICI)1099-0518(19970115)35:1<55::AID-POLA7>3.0.CO;2-1
   Lyoo WS, 2001, J APPL POLYM SCI, V82, P108, DOI 10.1002/app.1829
   MASUDA M, 1991, POLYVINYL ALCOHOL DE
   MURAKAMI R, 1993, POLYM J, V25, P205, DOI 10.1295/polymj.25.205
   REMY B, 1996, AM J NEURORADIOL, V17, P541
   SAKURADA I, 1963, KOBUNSHI KAGAKU, V20, P491
   Sakurada I., 1985, POLYVINYL ALCOHOL FI
   SANDLER SR, 1980, POLYM SYNTHESIS
   Staudinger H, 1927, BER DTSCH CHEM GES, V60, P1782, DOI 10.1002/cber.19270600811
NR 28
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4732-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4937
BP 326
EP 333
DI 10.1117/12.487563
PG 8
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BW27F
UT WOS:000181394800036
DA 2018-10-19
ER

PT S
AU Faris, GW
   Hryndza, M
AF Faris, GW
   Hryndza, M
BE Bornhop, DJ
   Dunn, DA
   Mariella, RP
   Murphy, CJ
   Nicolau, DV
   Nie, S
   Palmer, M
   Raghavachari, R
TI Properties of upconverting chelates
SO BIOMEDICAL NANOTECHNOLOGY ARCHITECTURES AND APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biomedical Nanotechnology Architectures and Applications
CY JAN 20-24, 2002
CL SAN JOSE, CA
SP SPIE
DE upconverting chelates; biomedical diagnostics; optical reporters;
   contrast agents; optical labels
ID PHOSPHOR REPORTERS
AB Upconverting chelates are anew type of optical reporter with multiple advantages for biomedical diagnostics. We describe these materials and report spectroscopic properties relevant to their use.
C1 SRI Int, Mol Phys Lab, Menlo Pk, CA 94025 USA.
RP Faris, GW (reprint author), SRI Int, Mol Phys Lab, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.
CR AUZEL FE, 1973, P IEEE, V61, P758, DOI 10.1109/PROC.1973.9155
   Chen YH, 1997, P SOC PHOTO-OPT INS, V2980, P338, DOI 10.1117/12.273530
   Chen YH, 1999, PROC SPIE, V3600, P151, DOI 10.1117/12.351025
   ESTEROWITZ L, 1968, APPL OPTICS, V7, P2053, DOI 10.1364/AO.7.002053
   Faris G. W., 1996, OSA Trends in Optics and Photonics on Biomedical Optical Spectroscopy and Diagnostics. Vol.3. From the Topical Meeting, P225
   Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902
   MITA Y, 1999, PHOSPHOR HDB, P643
   Wright J. C., 1976, Radiationless processes in molecules and condensed phases, P239
   Wright WH, 1997, P SOC PHOTO-OPT INS, V2985, P248, DOI 10.1117/12.274357
   Wright WH, 1998, P SOC PHOTO-OPT INS, V3260, P245, DOI 10.1117/12.307099
NR 10
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4365-4
J9 PROC SPIE
PY 2002
VL 4626
BP 449
EP 452
DI 10.1117/12.472111
PG 4
WC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
SC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
GA BU92U
UT WOS:000177419500053
DA 2018-10-19
ER

PT S
AU Yu, P
   Nolte, DD
   Melloch, MR
AF Yu, P
   Nolte, DD
   Melloch, MR
BE Oraevsky, AA
TI Laser-based ultrasound detection through turbid media
SO BIOMEDICAL OPTOACOUSTICS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Optoacoustics III
CY JAN 20-21, 2002
CL SAN JOSE, CA
SP SPIE
DE homodyne system; ultrasound detection; holographic interferometry;
   photorefractive materials
ID PHOTOREFRACTIVE QUANTUM-WELLS; OPTICAL COHERENCE TOMOGRAPHY; CRYSTAL
AB Adaptive laser-based ultrasound detection uses laser homodyne detection in an adaptive interferometer to detect ultrasound displacements. This technique has been applied to non-destructive evaluation for detection of surface displacements. However, in biomedical ultrasound applications, ultrasound displacements of interest may be inside tissue and the detection light beam may need to propagate through turbid media. Here we report laser-based adaptive ultrasonic detection that can detect ultrasound displacements inside or through turbid media using a fsec-laser as the light source in an adaptive optical coherence detection scheme. The use of an interferometer and a femtosecond laser gates out the unwanted scatter while still allowing homodyne detection. In our laser-based ultrasound system, an adaptive Mach-Zehnder interferometer is based upon two-wave mixing in semiconductor quantum-well films. It provides depth information inside the sample by adjusting the optical delay in the reference beam arm. Homodyne detection was experimentally studied for low intensity and highly wavefront distortion caused by turbid media. Using this system, ultrasonic homodyne signals through 11 MFP turbid media have been successfully detected.
C1 Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.
RP Yu, P (reprint author), Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.
CR BLOUIN A, 1994, APPL PHYS LETT, V65, P932, DOI 10.1063/1.112153
   CAND A, 1994, APPL PHYS LETT, V64, P414, DOI 10.1063/1.111141
   DELAYE P, 1995, APPL PHYS LETT, V67, P3251, DOI 10.1063/1.114888
   deMontmorillon LA, 1996, OPT COMMUN, V129, P293, DOI 10.1016/0030-4018(96)00190-3
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   ING RK, 1991, APPL PHYS LETT, V59, P3233, DOI 10.1063/1.105742
   Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439
   Lahiri I, 1998, APPL PHYS LETT, V73, P1041, DOI 10.1063/1.122078
   Nolte DD, 1999, J APPL PHYS, V85, P6259, DOI 10.1063/1.370284
   Nolte DD, 2001, J OPT SOC AM B, V18, P195, DOI 10.1364/JOSAB.18.000195
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   WATSON GH, 1987, PHYS REV LETT, V58, P945, DOI 10.1103/PhysRevLett.58.945
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4357-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4618
BP 128
EP 136
DI 10.1117/12.469857
PG 9
WC Acoustics; Engineering, Biomedical; Optics
SC Acoustics; Engineering; Optics
GA BU92P
UT WOS:000177417900017
DA 2018-10-19
ER

PT J
AU Thangamani, N
   Chinnakali, K
   Gnanam, FD
AF Thangamani, N
   Chinnakali, K
   Gnanam, FD
TI The effect of powder processing on densification, microstructure and
   mechanical properties of hydroxyapatite
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE sintering; mechanical properties; apatite; biomedical applications
ID SINTERING BEHAVIOR; GRAIN-SIZE; CERAMICS; HARDNESS; HYDROXYLAPATITE;
   BRITTLENESS; STRENGTH
AB The influence of powder processing and sintering temperature on densification, microstructure and mechanical properties of hydroxyapatite (HAp) ceramics was studied. The as-dried, calcined and processed HAp powders were uniaxially compacted and sintered at various temperatures (1000-1400 degreesC) for 3 h. The as-dried and processed powders, attained 97% of theoretical density (TD) at 1100 degreesC) at higher sintering temperatures, the density of the as-dried powder compact was found to decrease. A uniform microstructure with fine grain size (2.3 pm) was observed for material obtained from processed powder, whereas exaggerated grain growth with closed pores were observed in as-dried and unprocessed powder compacts. The Vickers' hardness, fracture toughness and flexural strength of HAp were determined and a maximum value of 6.3 GPa and 0.88 MPam(1/2) and 60.3 MPa, respectively were obtained for processed compact. The processing of HAp has improved its densification, microstructure homogeneity and mechanical properties. (C) 2002 Elsevier Science Ltd and Techna S.r.l. All rights reserved.
C1 Indian Inst Sci, Dept Met, Bangalore 560012, Karnataka, India.
   Anna Univ, Ctr Ceram Technol, Chennai 600025, India.
   Anna Univ, Dept Phys, Madras 600025, Tamil Nadu, India.
RP Thangamani, N (reprint author), Indian Inst Sci, Dept Met, Bangalore 560012, Karnataka, India.
RI Chinnakali, K/D-1017-2009
OI Nithyanantham, Thangamani/0000-0002-7026-6379
CR Aizawa M, 1999, J MATER SCI, V34, P2865, DOI 10.1023/A:1004635418655
   ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   BEST S, 1994, J MATER SCI-MATER M, V5, P16
   BROOK RJ, 1969, J AM CERAM SOC, V52, P339, DOI 10.1111/j.1151-2916.1969.tb11941.x
   COBLE RL, 1963, PROGR CERAMIC SCI, V3, P197
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   HILLERT M, 1965, ACTA METALL MATER, V13, P227, DOI 10.1016/0001-6160(65)90200-2
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Krell A, 1998, MAT SCI ENG A-STRUCT, V245, P277, DOI 10.1016/S0921-5093(97)00724-7
   KRELL A, 1995, J AM CERAM SOC, V78, P1417, DOI 10.1111/j.1151-2916.1995.tb08508.x
   LAWN BR, 1980, J AM CERAM SOC, V63, P574, DOI 10.1111/j.1151-2916.1980.tb10768.x
   LAWN BR, 1979, J AM CERAM SOC, V62, P347, DOI 10.1111/j.1151-2916.1979.tb19075.x
   LAWN BR, 1976, J MATER SCI, V11, P573, DOI 10.1007/BF00540940
   Luo P, 1996, BIOMATERIALS, V17, P1959, DOI 10.1016/0142-9612(96)00019-1
   MURRAY MGS, 1995, J MATER SCI, V30, P3061, DOI 10.1007/BF01209218
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   PUAJINDANETR S, 1994, BRIT CERAM T, V93, P96
   RICE RW, 1994, J AM CERAM SOC, V77, P2539, DOI 10.1111/j.1151-2916.1994.tb04641.x
   Richerson D.W., 1922, MODERN CERAMIC ENG P
   ROYER A, 1993, J MATER SCI-MATER M, V4, P76, DOI 10.1007/BF00122982
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   THANGAMANI N, IN PRESS BIOMATERIAL
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
NR 26
TC 65
Z9 66
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2002
VL 28
IS 4
BP 355
EP 362
AR PII S0272-8842(01)00102-X
DI 10.1016/S0272-8842(01)00102-X
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 557XW
UT WOS:000175935200002
DA 2018-10-19
ER

PT J
AU Dybczynski, R
AF Dybczynski, R
TI Considerations on the accuracy of determination of some essential and/or
   toxic trace elements in biological materials
SO CHEMIA ANALITYCZNA
LA English
DT Review
DE accuracy; precision; interlaboratory comparisons; CRMs; trace analysis;
   biological materials
ID NEUTRON-ACTIVATION ANALYSIS; DEFINITIVE METHOD
AB In our times many important decisions in the field of biomedical sciences, nutrition, estimation of environmental pollution etc. may depend on the reliability of chemical measurements. While most of laboratories produce the results with a good or reasonable precision, the situation with the accuracy of these results is very often much worse. The results of the determination of several essential and toxic elements obtained in some international interlaboratory comparisons are shown and discussed from the standpoint of their accuracy. It is pointed out that good precision is not always accompanied by a good accuracy and that gross errors may frequently occur. The possible origins of such errors are briefly outlined. The significance of the methods with,guaranteed accuracy" is indicated and examples of such methods based on radiochemical NAA are presented. The importance of certified reference materials (CRMs) for quality assurance in inorganic trace analysis is emphasized and the attention is given to the problem of homogeneity of these materials especially when using microchemical techniques.
C1 Inst Nucl Chem & Technol, Dept Analyt Chem, PL-03195 Warsaw, Poland.
RP Dybczynski, R (reprint author), Inst Nucl Chem & Technol, Dept Analyt Chem, Ul Dorodna 16, PL-03195 Warsaw, Poland.
CR BYRNE AR, 1987, FRESEN Z ANAL CHEM, V326, P723, DOI 10.1007/BF00473540
   Danko B, 1997, J RADIOANAL NUCL CH, V216, P51, DOI 10.1007/BF02034495
   DEBIEVRE P, 1990, FRESEN J ANAL CHEM, V337, P766, DOI 10.1007/BF00322250
   DYBCZYNSKI R, 1994, J RADIOAN NUCL CH AR, V181, P43, DOI 10.1007/BF02037546
   DYBCZYNSKI R, 1993, FRESEN J ANAL CHEM, V345, P99, DOI 10.1007/BF00322563
   Dybczynski R, 2001, FRESEN J ANAL CHEM, V370, P126, DOI 10.1007/s002160100722
   DYBCZYNSKI R, 1989, J RADIOAN NUCL CH AR, V130, P365, DOI 10.1007/BF02041356
   Dybczynski R, 1996, J ANAL CHEM+, V51, P1206
   Dybczynski R, 1998, FRESEN J ANAL CHEM, V360, P384, DOI 10.1007/s002160050718
   DYBCZYNSKI R, 1997, PREPARATION CERTIFIC
   DYBCZYNSKI R, 1996, PREPARATION CERTIFIC
   DYBCZYNSKI R, 1998, REFERENCE MAT THEIR, P1
   Dybczynski R, 1980, TRACE ELEMENT ANAL C, P657
   HORWITZ W, 1982, ANAL CHEM, V54, P67
   Namiesnik J, 1999, SCI TOTAL ENVIRON, V228, P243, DOI 10.1016/S0048-9697(99)00053-4
   SMITS R, 2000, LC GC EUR, V13, P460
   Stoeppler M., 2001, REFERENCE MAT CHEM
   URIANO GA, 1977, CRC CR REV ANAL CHEM, V6, P361, DOI 10.1080/10408347708542696
   VERSIECK J, 1980, ANAL CHIM ACTA, V116, P217, DOI 10.1016/S0003-2670(01)95205-5
   VERSIECK J, 1984, QUALITY ASSURANCE BI, P71
   von Lehmden D J, 1974, Anal Chem, V46, P239, DOI 10.1021/ac60338a004
   ZEILLER E, 1990, INTERCOMPARISON STUD, P69
NR 22
TC 4
Z9 4
U1 0
U2 3
PU INSTYTUT CHEMII FIZYCZNEJ PAN
PI WARSAW
PA UL KASPRZAKA 44/52, 01-224 WARSAW, POLAND
SN 0009-2223
J9 CHEM ANAL-WARSAW
JI Chem. Anal.
PY 2002
VL 47
IS 3
BP 325
EP 334
PG 10
WC Chemistry, Analytical
SC Chemistry
GA 565JX
UT WOS:000176367600002
DA 2018-10-19
ER

PT J
AU Boguschewski, FH
   Seyfarth, M
   Heidrich, JP
AF Boguschewski, FH
   Seyfarth, M
   Heidrich, JP
TI Evaluation of two Mg2+-selective electrodes by means of a flow-through
   device
SO CLINICAL CHEMISTRY AND LABORATORY MEDICINE
LA English
DT Article; Proceedings Paper
CT 14th European Congress of Clinical Chemistry and Laboratory Medicine
CY MAY 26-31, 2001
CL PRAGUE, CZECH REPUBLIC
SP IFCC, FESCC
DE calcium interference; ISE evaluation; online measurement; Mg2+-ISE; POCT
   : point-of-care-testing; quality control material
ID ION-SELECTIVE ELECTRODES; CONTROLLED HEMODIALYSIS; IONIZED MAGNESIUM;
   CALCIUM; IMG2+; BLOOD; NOVA; PH
AB Monitoring the ionized magnesium (Mg2+) concentration in critically ill patients can prevent development of serious and potentially fatal complications. The analyzers KONE Microlyte 6 (KONE Instruments, Espoo, Finland) and NOVA CRT (NOVA Biomedical, Waltham, MA, USA) provide the discontinuous measurement of Mg2+ and were evaluated in several studies. It was our objective to integrate the Mg2+-selective electrodes into a device for continuous online measurements. This device is suitable not only for research but also for a specific evaluation of electrode characteristics. It allowed us to compare the genuine electrodes and reference systems independently of their specific analyzers. Precision, accuracy, response time, limit of detection, drift and interferences were assessed by continuous flowthrough measurements and discussed in comparison to the results of previous studies. The NOVA electrode proved to be superior regarding accuracy, sensitivity and selectivity, especially with respect to calcium. It was demonstrated that current commercial serumlike control materials were not appropriate for quality control of the assessed Mg2+-electrodes. However, despite the fact that the electrodes are commercially used for discontinuous measurements, both sensor types can be used for continuous online measurements in an extracorporeal circulation in a rat model. The NOVA electrode showed superior characteristics with this application as well. This study should also be understood as a contribution to the development of devices for online analyzers used in pointofcaretesting.
C1 Med Univ Lubeck, Inst Clin Chem, D-23538 Lubeck, Germany.
RP Heidrich, JP (reprint author), Med Univ Lubeck, Inst Clin Chem, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM heidrich@medinf.mu-luebeck.de
CR Altura Bella T., 1994, Scandinavian Journal of Clinical and Laboratory Investigation, V54, P53, DOI 10.3109/00365519409095211
   ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P77, DOI 10.3109/00365519409095213
   Burnett RW, 2000, CLIN CHEM LAB MED, V38, P363, DOI 10.1515/CCLM.2000.052
   ELIN RJ, 1994, AM J CLIN PATHOL, V102, P616, DOI 10.1093/ajcp/102.5.616
   Guilbault G. G., 1976, PURE APPL CHEM, V48, P129
   HEIDRICH JP, 1993, FRESEN J ANAL CHEM, V347, P299, DOI 10.1007/BF00323976
   Heidrich JP, 1998, CLIN CHEM LAB MED, V36, P847, DOI 10.1515/CCLM.1998.149
   HRISTOVA EN, 1996, CLIN CHEM, V42, P880
   Huijgen HJ, 1999, CLIN CHEM LAB MED, V37, P465, DOI 10.1515/CCLM.1999.075
   Kulpmann Wolf R., 1996, Scandinavian Journal of Clinical and Laboratory Investigation, V56, P251
   LEWENSTAM A, 1994, SCAND J CLIN LAB INV, V54, P37, DOI 10.3109/00365519409095209
   *RICHTL BUND QUAL, 1988, DTSCH ARZTEBLATT A, V11, P699
   Ritter C, 1996, SCAND J CLIN LAB INV, V56, P275, DOI 10.3109/00365519609088647
   RYAN MF, 1991, ANN CLIN BIOCHEM, V28, P19, DOI 10.1177/000456329102800103
   SAUR PMM, 1994, EUR J CLIN CHEM CLIN, V32, P539
   SCHINDLER JG, 1991, BIOMED TECH, V36, P271, DOI 10.1515/bmte.1991.36.11.271
   Spichiger-Keller U. E., 1998, CHEM SENSORS BIOSENS
   VANINGEN HE, 1994, CLIN CHEM, V40, P52
   WONG ET, 1983, AM J CLIN PATHOL, V79, P348
NR 19
TC 1
Z9 1
U1 0
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1434-6621
EI 1437-4331
J9 CLIN CHEM LAB MED
JI Clin. Chem. Lab. Med.
PY 2002
VL 40
IS 3
BP 308
EP 311
DI 10.1515/CCLM.2002.049
PG 4
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 549XN
UT WOS:000175472700016
PM 12005223
DA 2018-10-19
ER

PT S
AU Dunsby, C
   Gu, Y
   Ansari, Z
   Parsons-Karavassilis, D
   Siegel, J
   Itoh, M
   Iwamoto, S
   Headley, W
   Melloch, MR
   Nolte, DD
   French, PMW
AF Dunsby, C
   Gu, Y
   Ansari, Z
   Parsons-Karavassilis, D
   Siegel, J
   Itoh, M
   Iwamoto, S
   Headley, W
   Melloch, MR
   Nolte, DD
   French, PMW
BE Tuchin, VV
   Izatt, JA
   Fujimoto, JG
TI Low coherence photorefractive holography for high-speed 3D imaging,
   including through scattering media
SO COHERENCE DOMAIN OPTICAL METHODS IN BIOMEDICAL SCIENCE AND CLINICAL
   APPLICATIONS VI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Coherence Domain Optical Methods in Biomedical Science and
   Clinical Applications VI
CY JAN 21-23, 2002
CL SAN JOSE, CA
SP SPIE
DE photorefractive holography; biomedical imaging; coherence gating; low
   coherence interferometry; high frame-rate imaging; broadband laser
   source
ID MULTIPLE-QUANTUM WELLS; FRANZ-KELDYSH GEOMETRY; LIGHT; MICROSCOPY;
   TOMOGRAPHY
AB Low coherence photorefractive holography is a wide-field technique for 3-D imaging that offers a unique mechanism to discriminate against a background of diffuse light. This provides a wide-field method to image through scattering materials that we have demonstrated may be implemented at frame rates as high as similar to470/second. We present our recently developed low coherence photorefractive microscope and demonstrate how it may be realised using a spatially coherent broadband c.w. diode-pumped solid-state laser. This can provide real-time sectioned images of moving 3-D objects using only a simple uncooled 8-bit CCD camera. We also demonstrate a photorefractive 3-D imaging technique that exploits structured illumination and photorefractive holography to achieve a real-time wide-field sectioning microscope that may be applied to fluorescence, as well as reflected light. We also discuss issues for improving the sensitivity and spectral coverage of photorefractive holography using semi-insulating MQW devices.
C1 Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.
RP Dunsby, C (reprint author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.
RI Siegel, Jan/C-7031-2009
OI Siegel, Jan/0000-0002-6159-7299
CR ADLER CL, 1995, OPT COMMUN, V114, P375, DOI 10.1016/0030-4018(94)00637-A
   Balasubramanian S, 1999, APPL PHYS B-LASERS O, V68, P863, DOI 10.1007/s003400050716
   Beaurepaire E, 1998, OPT LETT, V23, P244, DOI 10.1364/OL.23.000244
   CHAN KP, 1994, ELECTRON LETT, V30, P1753, DOI 10.1049/el:19941193
   GU Y, CLEO 2001
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Hyde SCW, 1996, IEEE J SEL TOP QUANT, V2, P965, DOI 10.1109/2944.577323
   Iwamoto S, 2001, OPT LETT, V26, P22, DOI 10.1364/OL.26.000022
   Iwamoto S, 2001, J APPL PHYS, V89, P5889, DOI 10.1063/1.1370364
   Jones R, 1998, IEEE J SEL TOP QUANT, V4, P360, DOI 10.1109/2944.686743
   Jones RL, 1998, EPRI J, V23, P2
   LEITH EN, 1991, OPT LETT, V16, P1820, DOI 10.1364/OL.16.001820
   Neil MAA, 2000, J MICROSC-OXFORD, V197, P1
   Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905
   Nolte DD, 1999, J APPL PHYS, V85, P6259, DOI 10.1063/1.370284
   Parsons-Karavassilis D, 2000, OPT COMMUN, V181, P361, DOI 10.1016/S0030-4018(00)00776-8
   REBANE A, 1998, NATURE, V331, P378
   Rollins AM, 1998, OPT EXPRESS, V3, P219, DOI 10.1364/OE.3.000219
   STETSON KA, 1967, J OPT SOC AM, V57, P1060, DOI 10.1364/JOSA.57.001060
   Tziraki M, 2000, APPL PHYS B-LASERS O, V70, P151, DOI 10.1007/s003400050023
   WANG Q, 1992, J OPT SOC AM B, V9, P1626, DOI 10.1364/JOSAB.9.001626
NR 21
TC 1
Z9 1
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4358-1
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4619
BP 98
EP 106
DI 10.1117/12.470469
PG 9
WC Engineering, Biomedical; Optics; Imaging Science & Photographic
   Technology
SC Engineering; Optics; Imaging Science & Photographic Technology
GA BU92Q
UT WOS:000177418300016
DA 2018-10-19
ER

PT J
AU Kazanci, M
   Cohn, D
   Marom, G
   Migliaresi, C
   Pegoretti, A
AF Kazanci, M
   Cohn, D
   Marom, G
   Migliaresi, C
   Pegoretti, A
TI Fatigue characterization of polyethylene fiber reinforced polyolefin
   biomedical composites
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article
DE polymer-matrix composites (PMCs); fatigue; filament winding;
   polyethylene-butene copolymers
ID HIGH-DENSITY POLYETHYLENE; FRACTURE-BEHAVIOR; CHAIN STRUCTURE;
   POLYPROPYLENE; MORPHOLOGY; MECHANISMS
AB Filament wound flat strip composites of polyethylene fiber reinforced ethylene-butene copolymers were produced and their fatigue behavior under cyclic loading was studied. Three different copolymer compositions and two different winding angles were employed in order to study the effects of branching density in the polymeric matrix and of reinforcement angle on the fatigue response of the composite. The results were in agreement with published fatigue models, showing that the short-term fatigue behavior, at relatively high stress levels, was controlled by the static properties of the materials, exhibiting better fatigue resistance for lower branching density of the copolymer and for a smaller reinforcement angle. However, the long-term fatigue behavior, at moderate stress levels, was governed by the fatigue rate of degradation, which decreased with the branching density and winding angle. The fatigue induced creep resulted in fiber reorientation in the loading direction, which in turn generated high residual properties. It was concluded that various polymer/angle combinations could result in fatigue-proof composites of significant residual properties at 10(6) fatigue cycles. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Hebrew Univ Jerusalem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel.
   Univ Trent, Dept Mat Engn, I-38050 Trent, Italy.
RP Marom, G (reprint author), Hebrew Univ Jerusalem, Casali Inst Appl Chem, Givat Ram Campus, IL-91904 Jerusalem, Israel.
RI Pegoretti, Alessandro/F-1240-2010
OI Pegoretti, Alessandro/0000-0001-9641-9735
CR EGAN BJ, 1995, J MATER SCI, V30, P3307, DOI 10.1007/BF00349874
   EGAN BJ, 1995, J MATER SCI, V30, P3351, DOI 10.1007/BF00349879
   FEIGELSHTEIN D, 2000, ADV COMPOS LETT, V9, P346
   Gamstedt EK, 1999, COMPOS SCI TECHNOL, V59, P759, DOI 10.1016/S0266-3538(98)00119-5
   Harcup JP, 2000, POLYM ENG SCI, V40, P627, DOI 10.1002/pen.11193
   KADOTA K, 1993, J APPL POLYM SCI, V49, P863, DOI 10.1002/app.1993.070490512
   Kavesh S, 1995, INT J POLYM MATER, V30, P15, DOI 10.1080/00914039508031459
   Kazanci M, 2001, J MATER SCI, V36, P2845, DOI 10.1023/A:1017990001113
   KAZANCI M, 2002, IN PRESS J MAT SCI M
   Krzypow DJ, 2000, BIOMATERIALS, V21, P2081, DOI 10.1016/S0142-9612(00)00138-1
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   Pegoretti A, 1999, COMPOS SCI TECHNOL, V59, P1055, DOI 10.1016/S0266-3538(98)00143-2
   Pegoretti A, 2000, COMPOS SCI TECHNOL, V60, P1181, DOI 10.1016/S0266-3538(00)00024-5
   Shalom S, 1997, COMPOS SCI TECHNOL, V57, P1423, DOI 10.1016/S0266-3538(97)00084-5
   Staubli HU, 1999, AM J SPORT MED, V27, P27
   STREBEL JJ, 1994, J APPL POLYM SCI, V52, P1815, DOI 10.1002/app.1994.070521216
   TALREJA R, 1981, P ROY SOC LOND A MAT, V378, P461, DOI 10.1098/rspa.1981.0163
   Talreja R, 1987, FATIGUE COMPOSITE MA
   YEH JT, 1995, MACROMOL CHEM PHYSIC, V196, P705, DOI 10.1002/macp.1995.021960302
   ZHOU Y, 1991, POLYM ENG SCI, V31, P711, DOI 10.1002/pen.760311005
NR 20
TC 21
Z9 21
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PY 2002
VL 33
IS 4
BP 453
EP 458
AR PII S1359-835X(02)00002-7
DI 10.1016/S1359-835X(02)00002-7
PG 6
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA 534ZW
UT WOS:000174620500001
DA 2018-10-19
ER

PT B
AU Vincent, L
   Fridrici, V
   Fouvry, S
   Kapsa, P
AF Vincent, L
   Fridrici, V
   Fouvry, S
   Kapsa, P
BE Zhang, S
   Zhou, ZR
   Liu, JJ
   Zhu, MH
TI Contact damage in assemblies
SO CONTRIBUTIONS OF SURFACE ENGINEERING TO MODERN MANUFACTURING AND
   REMANUFACTURING
LA English
DT Proceedings Paper
CT 3rd International Conference on Surface Engineering
CY OCT 10-13, 2002
CL CHENGDU, PEOPLES R CHINA
SP Chinese Mech Engn Soc, SW Jiaotong Univ
DE fretting; surface damage; cracking; wear; assemblies
AB To determine and optimise the durability of assemblies in industrial installations, damage induced by contacts has to be taken into account. Indeed, when two contacting surfaces are submitted to tangential loading due to vibrations for instance, small amplitude displacements are induced at the inter-face. Depending on the materials and the normal and tangential loadings, this phenomenon, known as fretting, can lead to crack nucleation (and possible propagation if one of the component is subjected to a fatigue loading) or to loss of matter. In both cases, the industrial structure is in danger. Industrial branches under concern are civil and mechanical engineering, aeronautics, nuclear, biomedical and automotive industries...
   Industrial examples of damage induced by fretting will be presented and ways of prevention and improvement (such as surface treatments, lubrication -.) will be discussed.
C1 Ecole Cent Lyon, CNRS, UMR 5513, Dept Mat & Surfaces, F-69130 Ecully, France.
RP Vincent, L (reprint author), Ecole Cent Lyon, CNRS, UMR 5513, Dept Mat & Surfaces, 36,Ave Guy de Collongue, F-69130 Ecully, France.
CR Amontons G., 1699, FROTTEMENT DIVERSES
   ATTIA MH, 1993, ASME S CONTACT PROBL
   BERTHIER Y, 1988, VELOCITY ACCOMMODATI, P25
   BILL RC, 1977, ASLE T, P236
   BLAU PJ, 1992, ASM HDB, V18, P1
   CHIVERS TC, 1985, PI MECH ENG, P325
   COULOMB M, 1773, MEMOIRES MATH PHYSIQ
   Dang Van K., 1973, MEMORIAL ARTILLERIE
   Dowson D, 1966, ELASTOHYDRODYNAMIC L
   DUBOURG MC, 1994, LONDON MECH ENG PUBL
   Fouvry S, 1996, WEAR, V200, P186, DOI 10.1016/S0043-1648(96)07306-1
   Frene J., 1988, LUBRIFICATION HYDROD
   FRIDRICI V, 2000, IN PRESS INT C TRIB
   GODET M, 1990, TRIBOLOGY SERIES, V17
   GODET M, 1987, CONTINUITY DRY FRICT
   GODET M, 1984, 3 BODY APPROACH MECH, P437
   Hertz H, 1896, MISCELLANEOUS PAPERS
   Johnson K. L., 1985, CONTACT MECH
   Kalker J., 1990, 3 DIMENSIONAL ELASTI
   LEROY J. M., 1989, THESIS INSA LYON
   LIM C, 1987, ACTA METALL, P1
   MCDOWELL OJ, 1953, ASTM, P40
   Mindlin R. D., 1953, ASME, P327
   PETIOU C, 1994, THESIS ECOLE CENTRAL
   SAUGER E, 1997, THESIS ECOLE CENTRAL
   SPROLES ES, 1978, WEAR, V47, P387, DOI 10.1016/0043-1648(78)90167-9
   VINGSBO O, 1988, WEAR, V126, P131, DOI 10.1016/0043-1648(88)90134-2
   Waterhouse R. B., 1972, FRETTING CORROSION
   Waterhouse R. B., 1981, FRETTING FATIGUE
   WATERHOUSE RB, 1992, AM SOC TEST MATER, V1159, P13, DOI 10.1520/STP25806S
   ZHOU ZR, 1992, WEAR, V155, P317, DOI 10.1016/0043-1648(92)90091-L
   ZHOU ZR, 1995, WEAR, V181, P531
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SOUTHWEST JIAOTONG UNIV PRESS
PI CHENGDU
PA ERHUAN RD, CHENGDU 610031, SICHUAN, PEOPLES R CHINA
BN 7-81057-661-5
PY 2002
BP 34
EP 41
PG 8
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BV99R
UT WOS:000180624600006
DA 2018-10-19
ER

PT B
AU Dong, H
AF Dong, H
BE Zhang, S
   Zhou, ZR
   Liu, JJ
   Zhu, MH
TI Surface engineering of prosthetic bearing surfaces
SO CONTRIBUTIONS OF SURFACE ENGINEERING TO MODERN MANUFACTURING AND
   REMANUFACTURING
LA English
DT Proceedings Paper
CT 3rd International Conference on Surface Engineering
CY OCT 10-13, 2002
CL CHENGDU, PEOPLES R CHINA
SP Chinese Mech Engn Soc, SW Jiaotong Univ
DE surface engineering; joint prostheses
ID DIAMOND-LIKE CARBON; OF-THE-ART; ORTHOPEDIC APPLICATIONS; HIP
   PROSTHESES; COATINGS; WEAR; BIOCOMPATIBILITY; HYDROXYAPATITE;
   PERFORMANCE; LAYERS
AB Surface engineering has been emerging as one of the most promising technologies to improve the tribological properties of biomedical materials. thus achieving enhanced performance and prolonged life span. One of our current researches at the University of Birmingham has been directed at developing novel surface engineering technologies for biomedical materials towards long-life total joint replacements, which has great potential of improving quality of life and contributing to social and economic sustainable development. In this paper, the state-of-the-art of surface engineering of biomedical materials is briefly overviewed. By way of example, our recent progress in surface engineering of biomedical materials for joint prosthesis is then reported. Finally, future research directions and trends in the surface engineering of biomedical materials are identified and discussed.
C1 Univ Birmingham, Sch Engn, Surface Engn Grp, Birmingham, W Midlands, England.
RP Dong, H (reprint author), Univ Birmingham, Sch Engn, Surface Engn Grp, Birmingham, W Midlands, England.
CR AISENBERG S, 1971, J APPL PHYSICS
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ANTTILA A, 1999, NEW DIAM FRONT C TEC, P283
   BELL T, 1995, P INT C SURF SCI ENG, P9
   Bell T., 1998, CHINA SURFACE ENG, P40
   BLOYCE A, 1994, ASM HDB, V5, P840
   CHANDRA L, 1995, J MATER SCI-MATER M, V6, P581, DOI 10.1007/BF00121282
   CHARNLEY J, 1979, LOW FRICTION ARTHOPL
   CLARKE IC, 1992, AM SOC TEST MATER, V1144, P7, DOI 10.1520/STP14848S
   COLL BF, 1988, SURF COAT TECH, V36, P867, DOI 10.1016/0257-8972(88)90027-8
   COLL BF, 1991, ASTM F 4 WORKSH ION
   COLLINS GA, 1991, MAT SCI ENG A-STRUCT, V139, P171, DOI 10.1016/0921-5093(91)90613-R
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   Dong H, 1999, WEAR, V225, P146, DOI 10.1016/S0043-1648(98)00356-1
   Dong H, 2000, J MATER SCI LETT, V19, P1147, DOI 10.1023/A:1006755008958
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   DONG H, 2001, Patent No. 6210807
   DONG H, 1999, SPORTS ENG, P213
   DOWSON D, 1992, ASM HDB, V18, P656
   ELLIS R, 1998, TIMES           0219
   ENKE K, 1980, APPL PHYS LETT, V36, P291, DOI 10.1063/1.91465
   EVANS AC, 1991, SURF COAT TECH, V47, P662, DOI 10.1016/0257-8972(91)90338-W
   Harman MK, 1997, J ARTHROPLASTY, V12, P938, DOI 10.1016/S0883-5403(97)90164-9
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   JONES AHS, 2000, C FRICT LUBR WEAR AR
   JONES AHS, P 12 IFHTSE C I ENG, V3, P35
   LAFFARGUE P, 1998, METALS BIOMATERIALS, P486
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Lausmaa J., 1991, Surface Engineering, V7, P311
   LIFSHITZ Y, 1999, DIAM RELAT MATER, P1660
   Lillard RS, 1997, CORROS SCI, V39, P1605, DOI 10.1016/S0010-938X(97)00064-4
   MALCHAU H, 1996, 63 ANN M AM AC ORTH
   *MAT STRAT COMM, 1995, MAT TECHN FOR BIOM
   ONATE JI, 2001, SURFACE COATINGS TEC, P1056
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   Rolinski E., 1987, Surface Engineering, V3, P35
   RUCK DM, 1997, PROTECTIVE COATINGS, P649
   Saikko V, 2001, BIOMATERIALS, V22, P1507, DOI 10.1016/S0142-9612(00)00306-9
   SCHMALZRIED TP, 1992, J BONE JOINT SURG
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   SUCHANEK W, PROCESSING PROPERTIE
   SUIRE R, 1988, Patent No. 4790851
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sun Y, 1999, HEAT TREAT MET-UK, V26, P9
   Sun Y, 1999, SURF ENG, V15, P49, DOI 10.1179/026708499322911647
   Thanner J, 1999, ACTA ORTHOP SCAND, V70, P155, DOI 10.3109/17453679909011255
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   VIDOVSZKY TJ, 1998, HIP SURG MAT DEV, P317
   WILES P, 1957, BRIT J SURG, P488
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   Willmann G, 1996, BRIT CERAM T, V95, P212
   Zeng A., 2002, DIAM RELAT MATER, V2002, P160
   Zhang Z.L., 1985, SURF ENG, V1, P131, DOI DOI 10.1179/SUR.1985.1.2.131
NR 58
TC 1
Z9 1
U1 0
U2 1
PU SOUTHWEST JIAOTONG UNIV PRESS
PI CHENGDU
PA ERHUAN RD, CHENGDU 610031, SICHUAN, PEOPLES R CHINA
BN 7-81057-661-5
PY 2002
BP 457
EP 464
PG 8
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BV99R
UT WOS:000180624600095
DA 2018-10-19
ER

PT J
AU Lindblad, MS
   Liu, Y
   Albertsson, AC
   Ranucci, E
   Karlsson, S
AF Lindblad, MS
   Liu, Y
   Albertsson, AC
   Ranucci, E
   Karlsson, S
TI Polymers from renewable resources
SO DEGRADABLE ALIPHATIC POLYESTERS
SE ADVANCES IN POLYMER SCIENCE
LA English
DT Review
DE monomers from renewable resources; polymers from renewable resources;
   1,3-propanediol; succinic acid; lactones; cyclohexanedimethanol;
   polyethyleneglycol; chain-extension; poly(ester-urethane)s;
   poly(ester-carbonate)s
ID POLY(LACTIC-GLYCOLIC ACID); BIODEGRADABLE POLYMERS; SUCCINIC ACID;
   1,3-PROPANEDIOL; SEGMENTS
AB From the point of view of making novel polymers with inherent environment-favorable properties such as renewability and degradability, a series of interesting monomers are found in the metabolisms and cycles of nature. This review presents and discusses a number of aliphatic polyesters which show interesting applications as biomedical materials and degradable packages. Available from nature are amino acids, microbial metabolites from the conversion of glucose and other monosaccharides (e.g., acetic acid, acetone, 2,3-butanediol, butyric acid, isopropanol, propionic acid), lactic acid, ethanol and fatty acids. A series of biodegradable polymers with different properties and different potential industrial uses were made starting with succinic acid and/or 1,3-propanediol. There were two routes for making the polyester-based materials; the direct ring-opening polymerization of lactones (cyclic esters) synthesized from 1,3-propanediol, and the chain-extension of alpha,omega-dihydroxy-terminated oligomeric polyesters produced by thermal polycondensation of 1,3-propanediol and succinic acid (oligo(propylene succinate)s).
C1 Royal Inst Technol, Dept Polymer Technol, SE-10044 Stockholm, Sweden.
RP Lindblad, MS (reprint author), Royal Inst Technol, Dept Polymer Technol, SE-10044 Stockholm, Sweden.
RI Karlsson, Sigbritt/D-6935-2014; Ranucci, Elisabetta/J-3899-2015;
   Albertsson, Ann-Christine/Q-6107-2016
OI Karlsson, Sigbritt/0000-0002-5394-7850; Ranucci,
   Elisabetta/0000-0002-6402-2650; Albertsson,
   Ann-Christine/0000-0001-8696-9143
CR ALBERTSSON AC, 1988, ACTA POLYM, V39, P95, DOI 10.1002/actp.1988.010390118
   Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523
   DECKWER WD, 1995, FEMS MICROBIOL REV, V16, P143, DOI 10.1111/j.1574-6976.1995.tb00162.x
   Freund A., 1881, MONATSH CHEM, V2, P636, DOI 10.1007/BF01516545
   Lee PC, 1999, PROCESS BIOCHEM, V35, P49, DOI 10.1016/S0032-9592(99)00031-X
   Liu Y, 2001, J POLYM SCI POL CHEM, V39, P2508, DOI 10.1002/pola.1227
   Liu Y, UNPUB
   Nghiem NP, 1997, APPL BIOCHEM BIOTECH, V63-5, P565, DOI 10.1007/BF02920454
   OIU Y, 2001, J POLYM SCI POL CHEM, V39, P630
   Penco M, 1996, POLYM ADVAN TECHNOL, V7, P536
   Penco M, 1998, MACROMOL CHEM PHYSIC, V199, P1737, DOI 10.1002/(SICI)1521-3935(19980801)199:8<1737::AID-MACP1737>3.3.CO;2-W
   Ranucci E, 2000, MACROMOL RAPID COMM, V21, P680, DOI 10.1002/1521-3927(20000601)21:10<680::AID-MARC680>3.0.CO;2-Y
   Wilke D, 1999, APPL MICROBIOL BIOT, V52, P135, DOI 10.1007/s002530051500
NR 13
TC 83
Z9 90
U1 1
U2 57
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
J9 ADV POLYM SCI
PY 2002
VL 157
BP 139
EP 161
PG 23
WC Polymer Science
SC Polymer Science
GA BU66S
UT WOS:000176673500005
DA 2018-10-19
ER

PT S
AU Sasov, A
AF Sasov, A
BE Bonse, U
TI Desktop x-ray micro-CT instruments
SO DEVELOPMENTS IN X-RAY TOMOGRAPHY III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd Conference on Developments in X-Ray Tomography
CY AUG 02-03, 2001
CL SAN DIEGO, CA
SP SPIE
DE x-ray; 3D reconstruction; micro-CT; microtomography; tomosynthesis;
   nondestructive testing
AB An X-ray microtomograph (or micro-CT) is an instrument for non-destructive 3-dimensional reconstruction of the object's internal microstructure without physical cut or time consuming specimen preparation. By using modem technology in x-ray sources and detectors several micro-CT systems were created as a simply usable desktop instrument. First micro-CT system is a laboratory instruments giving true spatial resolution over a ten million times more detailed (in the term of volume parts) than the medical CT-scanners. The instrument contains a sealed microfocus X-ray source, a cooled X-ray digital CCD-camera and a Dual Pentium computer for system control and 3D-reconstructions twining under Windows 2000. The instrument includes possibilities for image analysis in the non-destructively reconstructed internal microstructure and realistic 3D visualization. During scanning objects are displaced in normal environment conditions, without vacuum or preparation. Another micro-CT scanner is a low-cost portable instrument, which can be connected to any external Pentium-based PC. Third instrument - microlaminograph - can create nondestructive slicing in any place of big planar objects (electronic assemblies, PCBs, etc.). This system uses principles of tomosynthesis from incomplete dataset for slicing in internal object's layers. The main application areas for micro-CT and microlaminography systems are biomedical research, material sciences, electronic components, etc.
C1 Skyscan, Aartselaar, Belgium.
RP Sasov, A (reprint author), Vluchtenburgstr 3, B-2630 Aartselaar, Belgium.
CR SASOV A, 1998, MICROSCOPY ANAL, P21
   SASOV AY, 1987, J MICROSC-OXFORD, V147, P169, DOI 10.1111/j.1365-2818.1987.tb02829.x
NR 2
TC 3
Z9 3
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4217-8
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4503
BP 282
EP 290
DI 10.1117/12.452854
PG 9
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BU16C
UT WOS:000175177400032
DA 2018-10-19
ER

PT S
AU Thoma, GR
   Ford, G
   Le, D
   Li, ZR
AF Thoma, GR
   Ford, G
   Le, D
   Li, ZR
BE Lopresti, EP
   Hu, J
   Kashi, R
TI Text verification in an automated system for the extraction of
   bibliographic data
SO DOCUMENT ANALYSIS SYSTEM V, PROCEEDINGS
SE LECTURE NOTES IN COMPUTER SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th International Workshop on Document Analysis Systems
CY AUG 19-21, 2002
CL PRINCETON, NEW JERSEY
SP Avaya Inc
ID DOCUMENT IMAGES
AB An essential stage in any text extraction system is the manual verification of the printed material converted by OCR. This proves to be the most labor-intensive step in the process. In a system built and deployed at the National Library of Medicine to automatically extract bibliographic data from scanned biomedical journals, alternative means were considered to validate the text. This paper describes two approaches and gives preliminary performance data.
C1 Natl Lib Med, Bethesda, MD 20894 USA.
RP Thoma, GR (reprint author), Natl Lib Med, Bethesda, MD 20894 USA.
CR Ford G, 2001, PROC SPIE, V4307, P241
   FORD GM, P 1999 S DOC IM UND, P321
   Hauser SE, 2000, P SOC PHOTO-OPT INS, V3967, P248
   Kim J, 2001, P SOC PHOTO-OPT INS, V4307, P111
   Lasko TA, 2001, P SOC PHOTO-OPT INS, V4307, P232
   *LHNCBC NLM, 2001, AUT PROD BIBL REC ME
   LI Z, 2001, CHARACTER VERIFICATI
   MOORE A, 1994, TRICKS MAKE OCR WORK
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
BN 3-540-44068-2
J9 LECT NOTES COMPUT SC
PY 2002
VL 2423
BP 423
EP 432
PG 10
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods
SC Computer Science
GA BY01S
UT WOS:000187252700046
OA Bronze
DA 2018-10-19
ER

PT S
AU Marquez, GJ
   Renn, MJ
   Miller, WD
AF Marquez, GJ
   Renn, MJ
   Miller, WD
BE BarCohen, Y
   Zhang, QM
   Fukada, E
   Bauer, S
   Chrisey, DB
   Danforth, SC
TI Aerosol-based direct-write of biological materials for biomedical
   applications
SO ELECTROACTIVE POLYMERS AND RAPID PROTOTYPING
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Rapid Prototyping Technologies-From Tissue Engineering to
   Conformal Electronics held at the 2001 MRS Fall Meeting
CY NOV 28-30, 2001
CL BOSTON, MA
SP Mat Res Soc
DE tissue engineering; cell-aerosolization; biomolecule; micropatterning;
   direct-write; biological material deposition
ID LIVING CELLS; SURFACE
AB Applying life sciences and engineering principles to the study of cells and engineered tissue has resulted in various successes. These endeavors are poised towards development of functional neo-organs used as native tissue substitutes. Concurrent with this goal, research arenas are directed in the general areas of biocompatible polymer scaffolds, biomimmetic extracellular matrices, control of stem cell differentiation, biomolecule signaling, and directed material delivery. Optomec Inc. is developing an aerosol-based direct-write process for deposition of biological materials into three dimensional, micron-scale patterns. The process uses pneumatic atomization to produce aerosol droplets of proteinacious colloidal dispersions and whole cell suspensions. The droplets are entrained in an air stream and deposited with a proprietary deposition tool. The biological materials can be seeded into three dimensional polymer scaffolds and various substrate surfaces. Optomec's direct write process has applicability to the additive fabrication of engineered tissue, Other applications of the direct write tool include rapid prototyping of analytical biosensors, hybrid BioMEMS, and bio-chip microarray devices.
C1 Optomec Inc, Albuquerque, NM 87109 USA.
RP Marquez, GJ (reprint author), Optomec Inc, 3911 Singer NE, Albuquerque, NM 87109 USA.
CR Bhattacharjee Y, 2000, SCIENCE, V290, P1477
   Chrisey D.B., 2002, DIRECT WRITE TECHNOL, P1
   CHRISEY DB, 2000, LASER FOCUS WORLD, P113
   COOLEY PW, 2001, METHODS MOL BIOL, V170
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   MCGILL RA, 2002, DIRECT WRITE TECHNOL, P475
   MILLER D, 2001, HDI, V4, P20
   NIKLASON LE, 1999, SCIENCE, V284, P389
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Renn M. J., 2002, DIRECT WRITE TECHNOL, P475
   Simon F, 1996, MACROMOL SYMP, V103, P243, DOI 10.1002/masy.19961030122
   WU PK, IN PRESS THIN SOLID
NR 13
TC 9
Z9 9
U1 0
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-634-6
J9 MATER RES SOC SYMP P
PY 2002
VL 698
BP 343
EP 349
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA BU86W
UT WOS:000177251300044
DA 2018-10-19
ER

PT B
AU Zilgalvis, N
AF Zilgalvis, N
BE Glasa, J
TI Addressing research in genetics on the European level
SO ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA
LA English
DT Proceedings Paper
CT International Bioethics Conference on Ethics of Human Genetics
CY OCT 23-24, 2002
CL BRATISLAVA, SLOVAKIA
SP Council Europe
DE biomedical research; biological materials; commercialisation;
   confidentiality; discrimination; ethics committees; intellectual
   property rights; genetics; stigmatisation
AB The subject of research in genetics is addressed with an emphasis on the protection of the human being as a subject of research. The focal point ranges from the issues related to an intervention undertaken on a human being to the issues related to the protection of the individual in regard to the future destination of his/her biological materials. Issues of the latter group include protection of privacy, confidentiality, discrimination, stigmatisation, commercialisation and intellectual property rights.
   The main focus is on the "system" of a Convention and protocols elaborated by the Council of Europe because of its leading role in bioethics and its focus on human rights, dating back to the European Convention on Human Rights in 1950. The proposition of the author is that observance of human rights, particularly in this field, is necessary for its own sake but also to ensure sustainable scientific and economic development. The concentration is on the provisions related to genetics and research in the Convention, and in the draft additional Protocol on Human Genetics. However, the contributions of the European Union and other international institutions to this field are also noted and discussed.
C1 Council Europe, Div Bioeth, F-67075 Strasbourg, France.
RP Zilgalvis, N (reprint author), Council Europe, Div Bioeth, F-67075 Strasbourg, France.
CR *ASS NAT, 2001, DEL UN EUR
   CHARLES B, 2001, DOCUMENTS INFORMATIO, P27
   CORDIER L, 1997, INT J PHARM MED, V11, P137
   CRAIG P, 1998, EULAW TEXT CASES MAT, P8
   Hendriks A C, 2001, Med Law, V20, P37
   HURIET C, 2000, 267, P15
   LEVITS E, 2000, LIKUMS TIESIBAS, V2, P335
   LWOFF L, 2002, SECRETARY CDBI WORKI
NR 8
TC 0
Z9 0
U1 0
U2 0
PU CHARIS
PI BRATISLAVA
PA SPOL SRO, IPELSKA 3, 821 07 BRATISLAVA, SLOVAKIA
BN 80-88743-51-6
PY 2002
BP 17
EP 25
PG 9
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA BX31A
UT WOS:000184907000001
DA 2018-10-19
ER

PT S
AU Motz, G
   Ziegler, G
AF Motz, G
   Ziegler, G
GP TTP
TI Simple processibility of precursor-derived SiCN coatings by optimised
   precursors
SO EURO CERAMICS VII, PT 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 7th Conference of the European-Ceramic-Society
CY SEP 09-13, 2001
CL BRUGGE, BELGIUM
SP European Ceram Soc, Belgian Ceram Soc
DE precursors; coatings; pyrolysis
AB Two different special tailored solid and very good soluble precursors in the systems Si-C-N (ABSE) and Si-C-N-Ti (TiP) have been developed for applications as polymer and ceramic-like coating materials. With corresponding precursor solutions in toluene or octane different substrates (metals, ceramics, glass, plastics) with complex-shaped geometry can be coated by using simple dip- and spray-coating techniques. The degree of ceramisation of the resulting coatings is adjustable by temperature selection.
   The relatively cheap ABSE polysilazane shows not only an excellent resistance against moisture and air, but also the ceramic yield after pyrolysis (1500 degreesC) in air is much higher than in nitrogen (85 vs. 75 %). Therefore, processing and pyrolysis are possible in air. The critical thickness of the pure ABSE layer after pyrolysis is about 5 mum. With passive fillers (ceramic and graphite powders) or active fillers (metal, polymer powder) it is possible to produce thicker coatings or layers with special properties (electrical conductivity, hardness, colour). For producing ceramic-like layers on thermally sensitive substrates or for manufacturing fine ceramic structures, for example on Al2O3 substrates, pyrolysis with different laser types is very suitable.
   In contrast to the ABSE polymer, the TiP precursor is expensive and very moisture sensitive. Because of this reactivity, the adhesion of the TiP layer to the substrates is very strong (chemical bonding between substrate and layer by bridging oxygen atoms), The incorporated titanium atoms lead to very good biomedical compatibility. Especially the functional groups at the polymer backbone make a further modification with biomolecules possible.
   Whereas the ABSE polymer is suitable for applications on an industrial scale, the TIP precursor is very advantageous for special applications.
C1 Univ Bayreuth, Inst Mat Res, IMAI, D-95440 Bayreuth, Germany.
RP Motz, G (reprint author), Univ Bayreuth, Inst Mat Res, IMAI, POB 101251, D-95440 Bayreuth, Germany.
RI Motz, Gunter/P-1653-2014
CR BEHNCKE HH, 1993, HTM, V48, P304
   KRAUSS HJ, 1968, J BIOL CHEM, V213, P6281
   MOORE S, 1968, J BIOL CHEM, V243, P6281
   Motz G, 2000, CERAMIC ENG SCI P, V21, P307
   MOTZ G, Patent No. 19847352
NR 5
TC 5
Z9 5
U1 2
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-882-6
J9 KEY ENG MAT
PY 2002
VL 206-2
BP 475
EP 478
DI 10.4028/www.scientific.net/KEM.206-213.475
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BT32X
UT WOS:000172651400118
DA 2018-10-19
ER

PT J
AU Ruiz, A
   Hernandez, M
   Jimenez, A
   Sotomayor, A
   Sanchez, O
   Ramos, A
   San Emeterio, JL
   Sanz, PT
AF Ruiz, A
   Hernandez, M
   Jimenez, A
   Sotomayor, A
   Sanchez, O
   Ramos, A
   San Emeterio, JL
   Sanz, PT
TI Approaches to simulate temporal responses in piezoelectric stages
   involved in ultrasonic sensor/actuator systems
SO FERROELECTRICS
LA English
DT Article; Proceedings Paper
CT 10th International Meeting on Ferroelectricity (IMF-10)
CY SEP 03-07, 2001
CL MADRID, SPAIN
DE piezoelectric transducers; equivalent circuits; PSPICE
ID TRANSDUCERS; MODEL
AB Commercial ultrasonic equipment employing wideband piezoelectric transduction systems, usually operate in through-transmission (T-T) or pulse-echo mode. These systems, which include one or more piezoelectric stages, are widely used in areas such as biomedical imaging, non-destructive evaluation and characterization of material properties. In this paper different electrical T-T and pulse-echo simulation schemes, modeling piezoelectric devices and associated pulsed electronics, are proposed and used for studying temporal responses under practical conditions. Employing PSPICE, several responses are analyzed for specific devices in the MHz range. Two alternative electrical models for the reception stage are comparatively evaluated in pulse-echo situations. Comparisons between simulated performances and experimental measurements are also presented, showing a good agreement in T-T and pulse-echo signal conditions.
C1 CSIC, Inst Acust, Dpto Senales Sistemas & Tecn, Madrid, Spain.
   Univ La Habana, Fac Ciencias Fis, Havana, Cuba.
   ICIMAF, Dpto Ultrason, Havana, Cuba.
RP Ruiz, A (reprint author), CSIC, Inst Acust, Dpto Senales Sistemas & Tecn, Madrid, Spain.
RI Ramos, Antonio/K-5863-2014
OI Ramos, Antonio/0000-0003-0684-8742
CR DENVENTER JV, 2000, IEEE T ULTRASON FERR, V47, P1014
   HAYWARD G, 1984, J ACOUST SOC AM, V76, P369, DOI 10.1121/1.391138
   LEACH WM, 1994, IEEE T ULTRASON FERR, V41, P60, DOI 10.1109/58.265821
   LEEDOM DA, 1971, IEEE T SON ULTRASON, VSU18, P128, DOI 10.1109/T-SU.1971.29608
   Maione E, 1999, IEEE T ULTRASON FERR, V46, P399, DOI 10.1109/58.753029
   MASON WP, 1948, ELECTROMECHANICAL TH
   MORRIS SA, 1986, IEEE T ULTRASON FERR, V33, P295, DOI 10.1109/T-UFFC.1986.26832
   Puttmer A, 1997, IEEE T ULTRASON FERR, V44, P60, DOI 10.1109/58.585191
   Ramos A, 2000, ULTRASONICS, V38, P553, DOI 10.1016/S0041-624X(99)00072-4
   REDWOOD M, 1961, J ACOUST SOC AM, V33, P527, DOI 10.1121/1.1908709
   RHYNE TL, 1978, IEEE T SON ULTRASON, V25, P98, DOI 10.1109/T-SU.1978.30994
   Wu L, 1999, SENSOR ACTUAT A-PHYS, V75, P186, DOI 10.1016/S0924-4247(99)00067-9
NR 12
TC 0
Z9 0
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0015-0193
J9 FERROELECTRICS
JI Ferroelectrics
PY 2002
VL 273
BP 2621
EP 2626
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 580CM
UT WOS:000177217000041
DA 2018-10-19
ER

PT J
AU Stoffels, E
AF Stoffels, E
TI Biomedical applications of electric gas discharges
SO HIGH TEMPERATURE MATERIAL PROCESSES
LA English
DT Article
ID ARGON PLASMA COAGULATION; ATMOSPHERIC-PRESSURE; STERILIZATION;
   MECHANISMS
AB A survey of applications of electrically generated plasmas in health cam is given. Gas discharges are common tools for surface processing in material science, and nowadays they raise much interest in the medical technology. A wide variety of plasmas facilitates many kinds of surface treatment low-pressure coating of artificial implants, plasma sterilisation of medical equipment, coagulation and vaporisation of pathological tissue using atmospheric arc-like discharges. Special attention is given to non-thermal gas discharges generated under atmospheric pressure. Possibilities of refined tissue treatment using non-destructive atmospheric plasmas are discussed.
C1 Eindhoven Univ Technol, Dept Phys, NL-5600 MB Eindhoven, Netherlands.
RP Stoffels, E (reprint author), Eindhoven Univ Technol, Dept Phys, POB 513, NL-5600 MB Eindhoven, Netherlands.
CR Bergler W, 1997, J LARYNGOL OTOL, V111, P381
   Brand CU, 1998, DERMATOLOGY, V197, P152, DOI 10.1159/000017988
   BUTTER RS, 1995, J CHEM VAPOR DEPOSIT, V3, P1892
   Dubinov AE, 2000, IEEE T PLASMA SCI, V28, P180, DOI 10.1109/27.842898
   DUMKUM C, 1997, DIAM RELAT MATER, V6, P8025
   ELKIN B, 1999, SURF COAT TECH, V116, P86
   Hagelaar GJM, 2000, J APPL PHYS, V88, P2252, DOI 10.1063/1.1287529
   Haverlag M, 1991, THESIS EINDHOVEN U T
   HERRMANN HW, 2000, 27 IEEE INT C PLASM, P82
   Hoeben WFLM, 2000, PLASMA SOURCES SCI T, V9, P361, DOI 10.1088/0963-0252/9/3/315
   Janca J, 2001, PLASMA CHEM PLASMA P, V21, P565, DOI 10.1023/A:1012051102101
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899
   Liu CJ, 2001, PLASMA CHEM PLASMA P, V21, P301, DOI 10.1023/A:1011098824117
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792
   Moselhy M, 2001, APPL PHYS LETT, V79, P1240, DOI 10.1063/1.1397760
   Niemz M, 1996, LASER TISSUE INTERAC
   Ohl A, 1999, J MATER SCI-MATER M, V10, P747, DOI 10.1023/A:1008943625715
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   Park J, 2001, J APPL PHYS, V89, P20, DOI 10.1063/1.1323753
   PRINCE MR, 1987, IEEE J QUANTUM ELECT, V23, P1783, DOI 10.1109/JQE.1987.1073225
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Roth JR, 2000, IEEE T PLASMA SCI, V28, P56, DOI 10.1109/27.842864
   Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71
   SESSLER MJ, 1995, J CANCER RES CLIN, V121, P235, DOI 10.1007/BF01366968
   Slager C. J., 1997, THESIS ERASMUS U ROT
   STOFFELS E, 2002, UNPUB PLASMA SOURCES
   VANBLANKENSTEIN JH, 1993, J APPL PHYSIOL, V75, P1201
   WAYE JD, 1998, SURG TECHNOLOGY INT, V7, P1
   Yoshiki H, 2001, JPN J APPL PHYS 2, V40, pL360, DOI 10.1143/JJAP.40.L360
NR 32
TC 16
Z9 16
U1 1
U2 5
PU BEGELL HOUSE INC
PI NEW YORK
PA 145 MADISON AVE, NEW YORK, NY 10016 USA
SN 1093-3611
J9 HIGH TEMP MATER P-US
JI High Temp. Mater. Process
PY 2002
VL 6
IS 2
BP 191
EP 202
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 633CD
UT WOS:000180260900007
DA 2018-10-19
ER

PT J
AU Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
AF Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
TI Dual material rapid prototyping techniques for the development of
   biomedical devices. Part 2: Secondary powder deposition
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE drug delivery devices (DDD); dual material RP; electrography; rapid
   prototyping (RP); selective laser sintering (SLS)
AB polymeric drug-delivery devices play an important role in drug administration. However, the current polymeric drug delivery device fabrication methods lack precision. This impairs the quality of the devices, resulting in a decrease in the efficiency and effectiveness of drug delivery. The concept of building parts layer by layer out of powdered raw materials makes selective laser sintering (SLS) a suitable process for fabricating polymeric matrix drug delivery devices. The current SLS process is not capable of processing two or more materials separately. This work, explores the possibilities of using SLS to perform a dual material operation by developing two process models. The two processes can then be integrated to form a dual or multimaterial fabrication technique and act as a foundation for future work in multimaterial applications such as polymeric drug delivery device fabrication. Accordingly. two papers are presented.
   In this paper, Part 2, the emphasis is on a secondary powder-deposition method, which is an electrostatic technique based on electrography. Developed toner on the photoconductor is scraped off using mechanical shearing and is deposited using an electrostatic force by electroplating. Results have shown that by reducing the distance between the photoconductor and surface of deposition, the resolution of the printout can be refined. Other important factors include the efficiency of powder removal from the photoconductor, printing speed, and the traversing speed during deposition.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Chua, Chee Kai/B-6171-2009; Leong, Kah-Fai/B-6183-2009
CR ANDRUS PG, 1965, XEROGRAPHY RELATED P, pCH14
   Bartenev G. M., 1981, FRICTION WEAR POLYM
   CHUA CK, 1997, RAPID PROTOTYPING J
   DEPALMA VM, 1982, PHOTOGR SCI ENG, V26, P198
   FITZGERALD S, 1996, THESIS VIRGINIA POLY
   Liew CL, 2001, INT J ADV MANUF TECH, V18, P717, DOI 10.1007/s001700170014
   LING WM, 1998, FUT RAP PROT VIRT C
   MACE T, 1988, LASER JET UNLIMITED
   MELVIN LS, 1995, P SOL FREEF FABR S
   MELVIN LS, 1991, P SOL FREEF FABR S
   Schein L. B., 1992, ELECTROPHOTOGRAPHY D
   UMAN MA, 1968, J APPL PHYS, V39, P5162, DOI 10.1063/1.1655938
   WILLIAMS EM, 1984, PHYSICS TECHNOLOGY X
NR 13
TC 31
Z9 31
U1 0
U2 10
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2002
VL 19
IS 9
BP 679
EP 687
DI 10.1007/s001700200113
PG 9
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 569ZF
UT WOS:000176632800008
DA 2018-10-19
ER

PT J
AU Britchi, M
   Olteanu, M
   Jitianu, G
   Neagoe, O
   Branzei, M
   Gheorghe, D
   Nita, P
AF Britchi, M
   Olteanu, M
   Jitianu, G
   Neagoe, O
   Branzei, M
   Gheorghe, D
   Nita, P
TI Vitroceramic coatings on metallic supports with biomedical applications
SO INTERNATIONAL JOURNAL OF MATERIALS & PRODUCT TECHNOLOGY
LA English
DT Article
DE vitroceramic coatings; enamelling process; titanium; CrNi austenitic
   steels; biocompatible; bioactive materials
ID BIOMATERIALS; CERAMICS
AB Vitroceramic coatings from the oxidic system SiO2-CaO-B2O3-TiO2-R2O (R = Na and K) were applied on metallic supports (titanium and austenitic steels with high Cr and Ni contents). The coating procedure was classical enamelling. The metals were coated by either immersion or by painting over a thin layer from a mixture of frit (having the best composition for each metallic support) with a liquid mixture (triethanol amine: ethyl alcohol = 1: 10), mixture which was subsequently fired at the enamelling temperature. A good adherence between the two different materials has been thus achieved. Vitroceramic coating metallic support couples were then characterized by optical microscopy (OM), electronic microscopy (EDS) and wavelength dispersive spectrometry (WDS), and X-ray diffraction (XRD). The adherence of the vitroceramic layers onto metallic supports was tested by microhardness trials at the interface. The processes at the interface, i.e. gas bubble evolution, micropore formation, chemical bonding and diffusion, were evidenced. These coating layers can be employed as both bioactive and biocompatible materials.
C1 IG Murgulescu Romanian Acad, Inst Phys Chem, Bucharest, Romania.
   Politecn Univ Bucharest, Sci & Engn Mat Fac, Bucharest, Romania.
   Aviat Met METAV SA, Bucharest, Romania.
RI BRANZEI, MIHAI/C-7101-2012
CR BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   COLAN H, 1968, ED DIDACTICA PEDAGOG, P117
   DAVID HK, 1998, CURRENT OPINION SOLI, P309
   Frigge M, 1996, MIKROCHIM ACTA, P299
   FUJIO T, 1982, Patent No. 2080281
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1995, J NON-CRYST SOLIDS, V180, P292, DOI 10.1016/0022-3093(94)00464-1
   JAMES PF, 1995, J NON-CRYST SOLIDS, V181, P1, DOI 10.1016/0022-3093(94)00515-X
   Kasuga T, 1999, BIOMATERIALS, V20, P1415, DOI 10.1016/S0142-9612(99)00047-2
   LUPESCU M, 1997, THESIS BUCHAREST
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Saha SK, 1998, PHYS CHEM GLASSES, V39, P118
   Saha SK, 1996, SURF INTERFACE ANAL, V24, P113, DOI 10.1002/(SICI)1096-9918(199602)24:2<113::AID-SIA100>3.0.CO;2-C
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   YOKOKAWA H, 1993, J ELECTROCHEM SOC, V140, P3565, DOI 10.1149/1.2221127
NR 16
TC 0
Z9 0
U1 1
U2 3
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0268-1900
J9 INT J MATER PROD TEC
JI Int. J. Mater. Prod. Technol.
PY 2002
VL 17
IS 7
BP 568
EP 579
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 559PW
UT WOS:000176035400003
DA 2018-10-19
ER

PT J
AU Kros, A
   Jansen, JA
   Holder, SJ
   Nolte, RJM
   Sommerdijk, NAJM
AF Kros, A
   Jansen, JA
   Holder, SJ
   Nolte, RJM
   Sommerdijk, NAJM
TI Silane-based hybrids for biomedical applications
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE sol-gel; silica; biocompatibility; biomedical; amperometric biosensor;
   polysilane; self-assembly; copolymers
ID COIL BLOCK-COPOLYMERS; SOL-GEL PROCESS; GLUCOSE SENSORS; ENCAPSULATION;
   TISSUE
AB In this paper, the preparation of different hybrid silane materials is presented and their possible use in biomedical applications is discussed. The first example describes the development of biocompatible coatings based on sol-gel silicates, which can be used as a protective coating for implantable glucose sensors. Blending the silica with different organic polymers modified the properties of the resulting sot-gel materials. Their biocompatibility, both in vivo and in vitro, and their applications on biosensors were investigated. In the second example, an amphiphilic block copolymer comprising hydrophilic poly(ethylene oxide) blocks and hydrophobic poly(methylphenylsilane) segments is presented. In aqueous medium, this polymer forms vesicles in which a fluorescent dye is encapsulated. It was demonstrated that the vesicle aggregates could be broken up using UV irradiation. indicating that these vesicles were potentially interesting as controlled release systems. Monolayer studies confirmed that after photolytic cleavage of the poly(methylphenylsilane) segments, no organized structures were formed from the remaining material.
C1 Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   Univ Nijmegen, Dept Organ Chem, NSR Ctr, NL-6525 ED Nijmegen, Netherlands.
   Univ Nijmegen, Dept Biomat, NL-6500 AH Nijmegen, Netherlands.
   Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England.
RP Sommerdijk, NAJM (reprint author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.
RI Jansen, John/H-8055-2014; Sommerdijk, Nico/B-7239-2013; kros,
   alexander/H-6900-2012; Nolte, Roeland/C-9930-2013; Holder,
   Simon/B-4942-2009
OI Sommerdijk, Nico/0000-0002-8956-195X; Nolte,
   Roeland/0000-0002-5612-7815; Holder, Simon/0000-0001-8977-9257; kros,
   alexander/0000-0002-3983-3048
CR ABEL EW, 1994, ORGNAOPOLYSILANES CO
   AVNIR D, 1995, ACCOUNTS CHEM RES, V28, P328, DOI 10.1021/ar00056a002
   Brunette D., 1996, NANOFABRICATION BIOS, P335
   Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343
   Clery D, 1997, SCIENCE, V277, P1213, DOI 10.1126/science.277.5330.1213
   DemoustierChampagne S, 1997, J POLYM SCI POL CHEM, V35, P1939, DOI 10.1002/(SICI)1099-0518(19970730)35:10<1939::AID-POLA8>3.0.CO;2-I
   Francois B, 1995, ADV MATER, V7, P1041, DOI 10.1002/adma.19950071217
   Gerritsen M, 1998, J INVEST SURG, V11, P163, DOI 10.3109/08941939809098031
   Gerritsen M, 2000, BIOMATERIALS, V21, P71, DOI 10.1016/S0142-9612(99)00136-2
   GOUGH DA, 1995, DIABETES, V44, P1005, DOI 10.2337/diab.44.9.1005
   Hempenius MA, 1998, J AM CHEM SOC, V120, P2798, DOI 10.1021/ja972910v
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hesby RM, 1997, J PROSTHET DENT, V77, P414, DOI 10.1016/S0022-3913(97)70167-7
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, P9
   Holder SJ, 1998, CHEM COMMUN, P1445, DOI 10.1039/a803250e
   Horbett TA, 1995, ACS S SERIES, V602
   Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372
   Jenekhe SA, 1998, SCIENCE, V279, P1903, DOI 10.1126/science.279.5358.1903
   KERNER W, 1993, BIOSENS BIOELECTRON, V8, P473, DOI 10.1016/0956-5663(93)80032-K
   KOOPAL CGJ, 1992, BIOSENS BIOELECTRON, V7, P461, DOI 10.1016/0956-5663(92)80003-T
   KROS A, IN PRESS ADV MAT
   Kumaki J, 1998, J AM CHEM SOC, V120, P423, DOI 10.1021/ja973613t
   Mark J.E., 1992, INORGANIC POLYM
   MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006
   NARANG U, 1994, ANAL CHEM, V66, P3139, DOI 10.1021/ac00091a023
   OSAHENI JA, 1995, J AM CHEM SOC, V117, P7389, DOI 10.1021/ja00133a012
   Peterson KP, 1998, P SOC EXP BIOL MED, V218, P365
   Price C., 1982, DEV BLOCK COPOLYMERS, V1, P39
   Ruokolainen J, 1998, SCIENCE, V280, P557, DOI 10.1126/science.280.5363.557
   Selb J. G., 1985, DEV BLOCK COPOLYMERS, V2, P327
   Sommerdijk NAJM, 2000, MACROMOLECULES, V33, P8289, DOI 10.1021/ma0011385
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Stupp SI, 1998, CURR OPIN COLLOID IN, V3, P20, DOI 10.1016/S1359-0294(98)80037-X
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Tian D, 1996, POLYMER, V37, P3983, DOI 10.1016/0032-3861(96)00199-1
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Wright J. D., 2001, SOL GEL MAT CHEM APP
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523
NR 39
TC 16
Z9 16
U1 0
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2002
VL 16
IS 2
BP 143
EP 155
DI 10.1163/156856102317293678
PG 13
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 531FA
UT WOS:000174404300003
DA 2018-10-19
ER

PT J
AU Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
AF Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
TI Serum protein absorption on silk fibroin fibers and films: Surface
   opsonization and binding strength
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID COMPLEMENT ACTIVATION; POLYMER SURFACES; SOLID-SURFACES; ADSORPTION;
   ALPHA-1-MICROGLOBULIN
AB Fibroin, the core of the silk filament protein, has been proposed as a biomaterial for different biomedical applications since it can be engineered as a thread, fabric or film. Infrared spectroscopy suggests that the dissolution of the fibroin filaments and subsequent casting of the fibroin solution into films followed by treatment with methanol alters the protein structure leading to an increase in amorphous domains. The adsorption of serum proteins on fabrics and films showed different hydrophobic binding strengths for the two materials with the protein binding being greatest for the more hydrophobic fibroin fibers. Differences between the materials were also observed in the adsorption of key immunoproteins. Although the C3 fragment of the complement system was adsorbed on both the surfaces, it appeared to be activated preferentially on the fibroin films and not on the fibroin fibers, whereas the Bb and C1q factors were only significantly present on the fibroin fabric. IgG appeared to be adsorbed, although to different extents, on both types of fibroin substrates. These results suggest that the biocompatibility of the silk fibroin may be affected by changes in protein structure induced by processing the material.
C1 Univ Trent, Dipartimento Ingn Mat, I-38050 Trent, Italy.
   Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Motta, A (reprint author), Univ Trent, Dipartimento Ingn Mat, Via Mesiano 77, I-38050 Trent, Italy.
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR AMBROSE EJ, 1951, NATURE, V167, P264, DOI 10.1038/167264a0
   ANDERSON JM, 1988, AM SOC ARTIF INTERN, V28, P767
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   HIRABAYASHI K, 1968, SEN-I GAKKAISHI, V24, P392
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   KATAOKA K, 1976, KOBUNSHI RONBUNSHU, V33, P453, DOI 10.1295/koron.33.453
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 26
TC 29
Z9 29
U1 1
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2002
VL 17
IS 1
BP 23
EP 35
DI 10.1106/088391102023195
PG 13
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 551KF
UT WOS:000175559600002
DA 2018-10-19
ER

PT J
AU Vaz, CA
   Mano, JF
   Fossen, M
   van Tuil, RF
   de Graaf, LA
   Reis, RL
   Cunha, AA
AF Vaz, CA
   Mano, JF
   Fossen, M
   van Tuil, RF
   de Graaf, LA
   Reis, RL
   Cunha, AA
TI Mechanical, dynamic-mechanical, and thermal properties of soy
   protein-based thermoplastics with potential biomedical applications
SO JOURNAL OF MACROMOLECULAR SCIENCE-PHYSICS
LA English
DT Article
DE thermoplastic proteins; injection molding; dynamic-mechanical analysis;
   biomaterials
ID BIOMATERIALS; GLUTEN; WATER
AB In this study the tensile and the dynamic-mechanical behavior of injection-molded samples of various soy protein thermoplastic compounds were evaluated as a function of the amount of glycerol, type and amount of ceramic reinforcement, and eventual incorporation of coupling agents. The incorporation of glycerol into a soy-based matrix resulted in its plasticization, as confirmed by the drop in stiffness (storage and elastic modulus) above 20degreesC and a decrease in the protein glass transition temperature. Differential scanning calorimetric thermograms proved the occurrence of conformational changes in the soy protein during processing. Furthermore, the developed soy protein-based thermoplastics showed a thermal stability up to 100degreesC, as confirmed by thermogravimetric analysis, The reinforcement of the soy protein matrix with a ceramic filler (tricalcium phosphate) was shown to be effective for amounts above 10% w/w. The introduction of an amino-coupling agent led to a plasticizing effect, detected in the mechanical and dynamic-mechanical properties of the resulting materials. The results also show a good qualitative agreement between the properties obtained from quasi-static and dynamic experiments. The materials present a range of properties that might allow for their use eventually in a range of biomedical applications.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Agrotechnol Res Inst, ATO, NL-6700 AA Wageningen, Netherlands.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM jinano@dep.uminho.pt
RI Mano, Joao/A-4418-2009; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Mano, Joao/0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Group,
   3Bs/0000-0002-5195-3456; Cunha M., Antonio/0000-0003-3860-7732
CR ADRIANO KP, 1994, J APPL BIOMATER, V5, P133
   Cheftel J., 1985, AMINO ACIDS PEPTIDES, P245
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Cherian G, 1996, CEREAL CHEM, V73, P618
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   di Gioia L, 1998, CEREAL CHEM, V75, P514, DOI 10.1094/CCHEM.1998.75.4.514
   Ferreira SHP, 1993, J FOOD SCI, V58, P378
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   French D, 1984, ORG STARCH GRANULES, P183
   JOHNSON LA, 1992, US INFORM, V3, P282
   McCrum N.G., 1991, ANELASTIC DIELECTRIC
   PAETAU I, 1994, IND ENG CHEM RES, V33, P1821, DOI 10.1021/ie00031a023
   Richard J, 1996, TRENDS POLYM SCI, V4, P272
   Seal R, 1980, APPL PROTEIN CHEM, P87
   Sepe M., 1998, DYNAMIC MECH ANAL PL
   SHEARD PR, 1986, J FOOD TECHNOL, V21, P627
   Singh H., 1991, TRENDS FOOD SCI TECH, V2, P196, DOI DOI 10.1016/0924-2244
   Smits ALM, 1999, COLLOQ INRA, P179
   van Soest JJG, 1999, J APPL POLYM SCI, V74, P2207, DOI 10.1002/(SICI)1097-4628(19991128)74:9<2207::AID-APP10>3.3.CO;2-V
   VAZ CM, 2002, UNPUB
   Wang S, 1996, J MACROMOL SCI PURE, VA33, P557, DOI 10.1080/10601329608010878
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 23
TC 32
Z9 32
U1 1
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0022-2348
J9 J MACROMOL SCI PHYS
JI J. Macromol. Sci.-Phys.
PY 2002
VL B41
IS 1
BP 33
EP 46
DI 10.1081/MB-120002344
PG 14
WC Polymer Science
SC Polymer Science
GA 534CU
UT WOS:000174567700003
DA 2018-10-19
ER

PT J
AU Giannoulis, CS
   Desai, TA
AF Giannoulis, CS
   Desai, TA
TI Characterization of proteins and fibroblasts on thin inorganic films
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SILICON SURFACES; ELLIPSOMETRY; CELLS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and material microstructure. One of the goals in the development of silicon-based biomedical devices such as biosensors or drug delivery systems is improved biocompatibility which may be achieved through the deposition or adsorption of thin films. In this study, films of single crystal silicon, stoichiometric and low stress silicon nitride, doped and undoped polysilicon, as well as Arg-Gly-Asp (RGD) peptide adsorbed surfaces characterized in terms of protein adsorption or cellular adhesion for a period of four days. Protein adsorption studies using fibrinogen and albumin, two proteins implicated in cellular adhesion and surface activity, reveal that low stress silicon nitride surfaces have a 223%+/-2.50% greater protein adsorption compared to undoped polysilicon surfaces, followed by silicon nitride, unmodified silicon, and doped polysilicon surfaces, respectively. The thickness of the adsorbed albumin and fibrinogen layer on various thin films was measured by ellipsometry and compared to contact angle measurements. The greatest cellular adhesion was observed on undoped polysilicon, followed by unmodified (control) silicon, low stress silicon nitride, silicon nitride, and doped polysilicon surfaces. Cellular binding supports the differential protein adsorption found on modified and unmodified silicon surfaces. Understanding the biological response to thin films will allow us to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices. (C) 2002 Kluwer Academic Publishers.
C1 Univ Illinois, Dept Bioengn MC 063, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn MC 063, 851 S Morgan St, Chicago, IL 60607 USA.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   HANSFORD DJ, 1999, THESIS U CALIFORNIA
   Henry S, 1999, J PHARM SCI, V88, P948
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JAEGER RC, 1998, INTRO MICROELECTRONI, V5
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ratner B. D., 1997, SURFACE MODIFICATION
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   TUNER JN, 1999, EXP NEUROL, V156, P33
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 19
TC 16
Z9 16
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 75
EP 80
DI 10.1023/A:1013646805593
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300015
PM 15348209
DA 2018-10-19
ER

PT J
AU Pradny, M
   Petrovicky, P
   Fronkova, V
   Vacik, J
   Smetana, K
AF Pradny, M
   Petrovicky, P
   Fronkova, V
   Vacik, J
   Smetana, K
TI Evaluation of biocompatibility of the copolymer of 2-hydroxyethyl
   methacrylate with 2-(methylsulfanyl)ethyl methacrylate
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FIBRONECTIN ADSORPTION; HYDROGELS; ADHESION; BINDING; NEURONS
AB This study compares subcutaneous and intracerebral biocompatibilty of two hydrogels: copolymer of 2-hydroxyethyl methacrylate with 2-(methylsulfanyl)ethyl methacrylate and poly(2-hydroxyethyl methacrylate) as reference polymer. The experimental copolymer was more biologically inert than poly(2-hydroxyethyl methacrylate) in both the studied parameters, hence the former material is a suitable candidate for biomedical application. (C) 2002 Kluwer Academic Publishers.
C1 Acad Sci Czech Republ, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic.
   Charles Univ, Fac Med 1, Inst Anat, Prague 12000 2, Czech Republic.
RP Pradny, M (reprint author), Acad Sci Czech Republ, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic.
RI Pradny, Martin/H-8496-2014; Smetana, Karel/D-7039-2017
OI Smetana, Karel/0000-0002-7878-8403
CR FIFKOVA E, 1961, STEREOTAXIC ATLAS BR, P653
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   Michalek J, 1996, ANGEW MAKROMOL CHEM, V239, P151, DOI 10.1002/apmc.1996.052390113
   Paxinos G, 1982, RAT BRAIN STEREOTAXI
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PETROVICKY P, 1995, J BRAIN RES, V36, P539
   SCHERERSINGLER U, 1983, J NEUROSCI METH, V9, P229, DOI 10.1016/0165-0270(83)90085-7
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Smetana K, 1997, BIOMATERIALS, V18, P1009, DOI 10.1016/S0142-9612(97)00037-9
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   SMETANA K, 1995, J MATER SCI-MATER M, V6, P32, DOI 10.1007/BF00121244
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
   SWANSON LW, 1992, BRAIN MAPS STRUCTURE
   TAKASHI I, 1970, POLYM J, V1, P278
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 17
TC 9
Z9 9
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 107
EP 111
DI 10.1023/A:1013659208319
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300020
PM 15348214
DA 2018-10-19
ER

PT J
AU Spilimbergo, S
   Elvassore, N
   Bertucco, A
AF Spilimbergo, S
   Elvassore, N
   Bertucco, A
TI Microbial inactivation by high-pressure
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE inactivation; supercritical CO2; B. subtilis; P. aeruginosa;
   semi-continuous apparatus
ID SUPERCRITICAL CARBON-DIOXIDE; BUBBLE METHOD; MICROORGANISMS;
   STERILIZATION
AB High-pressure treatments are receiving a great deal of attention for the inactivation of micro-organisms in foodstuff processing, pressure instead of temperature is used as stabilizing factor. In this context, high hydrostatic pressure treatment is the most studied alternative process., many works reported successful results in inactivating a wide range of micro-organisms under different operative conditions such as temperature. cycles of pressure. exposure time. Furthermore. a number of processes using high pressure treatment (HPT) has already' been put into the market. Nevertheless this new technology presents the main limitation to be very expensive and difficult to control and manage because of the extremely high pressure employed. so that the widespread industrial diffusion in industry field appears cumbersome. The treatment with supercritical CO2 could become a relevant alternative to HPT in the field of microbial inactivation of food as well as an innovative technique for the sterilization of thermally and hydrolytically sensitive polymeric materials in biomedical applications, such as polymeric particles for drug delivery or polymeric implants. It has been demonstrated that the effect of microbial inactivation assuring healthy food preservation is already consistent at pressures moderated (lower than 200 bar) when compared with those employed by traditional hydrostatic-pressure HPT methods (2000-7000 bar). In this work the anti-microbial potential of compressed CO2 was investigated against gram-negative bacteria, gram-positive bacteria and spores.- as model species, Pseudomonas aeruginosa, Bacillus subtilis and spores of B. subtilis were used. The experiments were performed in a semi-continous apparatus at different but mild operative conditions. Excellent results were obtained for micro-organisms, under appropriate conditions the survival ratio of bacteria could be reduced to about seven orders of magnitude. Inactivation of spores under the same conditions, found to be conflicting in open literature. was not satisfactory. Spore inactivation was possible by coupling combination of higher temperature and longer contact time conditions. The application of pressure cycles was also found to be beneficial. (C) 2002 Elsevier Science B.V, All rights reserved.
C1 Univ Padua, Dept Chem Engn, I-35131 Padua, Italy.
RP Spilimbergo, S (reprint author), Univ Padua, Dept Chem Engn, Via Marzolo 9, I-35131 Padua, Italy.
OI Spilimbergo, Sara/0000-0002-8176-2220
CR Basset J, 1932, CR HEBD ACAD SCI, V195, P1431
   Bertucco A., 2001, HIGH PRESSURE PROCES, P626
   CLOUSTON JG, 1969, J BACTERIOL, V97, P684
   CLOUSTON JG, 1970, J BACTERIOL, V103, P140
   DEKANT W, 1998, ULLMANNS ENCY IND CH
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   ELVASSORE N, 2000, P 7 M SUP FLUIDS, V2, P773
   Enomoto A, 1997, J FERMENT BIOENG, V83, P305, DOI 10.1016/S0922-338X(97)80999-3
   Enomoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1133, DOI 10.1271/bbb.61.1133
   GOULD GW, 1970, J GEN MICROBIOL, V60, P335, DOI 10.1099/00221287-60-3-335
   HAAS GJ, 1989, J FOOD SAFETY, V9, P253, DOI 10.1111/j.1745-4565.1989.tb00525.x
   Hong SI, 1999, J FOOD SCI, V64, P728, DOI 10.1111/j.1365-2621.1999.tb15120.x
   ISHIKAWA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1949, DOI 10.1271/bbb.59.1949
   Ishikawa H, 1997, BIOSCI BIOTECH BIOCH, V61, P1022, DOI 10.1271/bbb.61.1022
   JONES RP, 1982, ENZYME MICROB TECH, V4, P210, DOI 10.1016/0141-0229(82)90034-5
   KAMIHIRA M, 1987, AGR BIOL CHEM TOKYO, V51, P407, DOI 10.1080/00021369.1987.10868053
   LIN HM, 1993, CHEM ENG J BIOCH ENG, V52, pB29
   Ludwig H., 1994, HIGH PRESSURE RES, V12, P193
   LUDWIG H, 1997, PHARM IND, V59, P335
   LUNDGREN L, 1966, PHYSIOL PLANTARUM, V19, P403, DOI 10.1111/j.1399-3054.1966.tb07031.x
   NAKAMURA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1297, DOI 10.1271/bbb.58.1297
   SALE AJH, 1970, J GEN MICROBIOL, V60, P323, DOI 10.1099/00221287-60-3-323
   SARTORELLO S, 2000, THESIS U PADUA
   SCHRECK C, 1997, HIGH PRESSURE RES BI
   SEYDERHELM I, 1994, ZFL, V43, P17
   Smelt JPPM, 1992, HIGH PRESSURE BIOTEC, V224, P361
   SOJKA B, 1994, PHARM IND, V56, P660
   Sojka B, 1997, PHARM IND, V59, P436
   SPECK ML, 1976, COMPENDIUM METHODS M, P107
   TIMSON WJ, 1965, BIOTECHNOL BIOENG, V7, P139, DOI 10.1002/bit.260070124
   TOEWS KL, 1995, ANAL CHEM, V67, P4040, DOI 10.1021/ac00118a002
   TOPHAM S, 1998, ULLMANNS ENCY IND CH
   ZOBELL CE, 1949, J BACTERIOL, V57, P179
NR 33
TC 130
Z9 151
U1 1
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JAN
PY 2002
VL 22
IS 1
BP 55
EP 63
DI 10.1016/S0896-8446(01)00106-1
PG 9
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 510CN
UT WOS:000173191300005
DA 2018-10-19
ER

PT J
AU Saiki, M
   da Silva, MC
   Fulfaro, R
   Vasconcellos, MBA
AF Saiki, M
   da Silva, MC
   Fulfaro, R
   Vasconcellos, MBA
TI Study on instrumental neutron activation analysis of aluminium in
   geological and biological reference materials
SO JOURNAL OF TRACE AND MICROPROBE TECHNIQUES
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Trace Elements in Humans
CY OCT 04-06, 2001
CL ATHENS, GREECE
DE instrumental neutron activation analysis; aluminium; reference materials
ID SAMPLES
AB The determinations of Al are of great interest in the environmental and biomedical studies as well as in the evaluation of the economic potential in ore prospecting programs. Reliable determinations of this element by instrumental neutron activation analysis (INAA) have been a challenge for several researchers. The major difficulties are the interferences of P and Si that form Al-28, the same radioisotope used in the analysis of Al. The elements Na and Cl can also interfere with the detection of Al, when they are present in large quantities. The detection of Al is often masked by high radio-activities of 24 Na and 38 Cl. This work presents results of Al determinations in several kinds of biological and geological reference materials and the results indicate a good agreement with the certified values. In some samples, the contribution of P and Si interferences were considered in the Al determination by using correction factors determined experimentally. The detection limit values in Al determinations were also evaluated.
C1 IPEN CNEN SP, Div Radiochem, BR-05422970 Sao Paulo, SP, Brazil.
RP Saiki, M (reprint author), IPEN CNEN SP, Div Radiochem, POB 11049, BR-05422970 Sao Paulo, SP, Brazil.
EM mitiko@curiango.upen.br
RI Vasconcellos, Marina/E-8538-2014; Saiki, Mitiko/B-7975-2012
OI Saiki, Mitiko/0000-0003-2197-3592
CR BLOTCKY AJ, 1992, ANAL CHEM, V64, P2910, DOI 10.1021/ac00047a006
   Bode P, 1997, J RADIOANAL NUCL CH, V215, P87, DOI 10.1007/BF02109883
   BOGDANOVICH E, 1992, J RADIOAN NUCL CH LE, V164, P293, DOI 10.1007/BF02164952
   CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007
   GLADNEY ES, 1983, GEOSTANDARD NEWSLETT, V7, P223
   GREENBERG RR, 1983, ANAL CHEM, V55, P1160, DOI 10.1021/ac00258a041
   *I PESQ TECN EST S, 1982, CERT AN CALC DOL
   *INT AT EN AG, 1995, SURV REF MAT, V5
   LANDSBERGER S, 1989, J RADIOAN NUCL CH LE, V137, P443, DOI 10.1007/BF02168351
   *NAT BUR STAND, 1988, CERT AN STAND REF MA
   *NAT I STAND TECHN, 1992, CERT AN STAND REF MA
   National Bureau of Standards, 1982, CERT AN STAND REF MA
   Okamoto K., 1985, ANAL SCI, V1, P206
   PICCOT D, COMMUNICATION
   Shoop DM, 1998, J RADIOANAL NUCL CH, V236, P103, DOI 10.1007/BF02386325
   Stamatelatos IE, 1999, J RADIOANAL NUCL CH, V241, P483, DOI 10.1007/BF02347201
   VANDALSEM DJ, 1995, J RADIOAN NUCL CH AR, V192, P131, DOI 10.1007/BF02037745
   WEGINWAR RG, 1989, J RADIOAN NUCL CH AR, V133, P317, DOI 10.1007/BF02060504
NR 18
TC 2
Z9 2
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0733-4680
J9 J TRACE MICROPROBE T
JI J. Trace Microprobe Tech.
PY 2002
VL 20
IS 4
BP 517
EP 525
DI 10.1081/TMA-120015613
PG 9
WC Chemistry, Analytical
SC Chemistry
GA 622EF
UT WOS:000179633000008
DA 2018-10-19
ER

PT S
AU Vaitkuviene, A
   Auksorius, E
   Fuchs, D
   Gavriushin, V
AF Vaitkuviene, A
   Auksorius, E
   Fuchs, D
   Gavriushin, V
BE Longo, L
   Hofstetter, AG
   Pascu, ML
   Waidelich, WRA
TI Multivariate analysis of endometrial tissue fluorescence spectra
SO LASER FLORENCE 2001: A WINDOW ON THE LASER MEDICINE WORLD
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Annual Laser Florence 2001 Conference
CY NOV 07-11, 2001
CL FLORENCE, ITALY
SP Int Acad Laser Med & Surg, Inst Laser Med Florence, SPIE, SPIE Romania Chapter, Opt Soc Amer, European Opt Soc, Int Soc Laser Med & Surg, World Assoc Laser Therapy, Romanian Soc Laser Med & Biol, Natl Inst Laser, Plasma & Radiat Phys, Eastern Europe Confederat Natl Soc Plast Aesthet Surg & Aesthet Med, Int Acad Light Med, Amer Acad Dermatol, Laser Inst Amer, Canadian Soc Aesthet Plast Surg, Czech Med Soc J E Purkynje, Radiobiol Soc, Union Int Med Esthet, Italian Soc Aesthet Med, Polish Soc Aesthet Med, Italian Coll Phlebol, Soc Italiana Teraple Integrate Flebolinfolog, Fed Nazl Coll IPASVI, President Italian Republic, Univ Degli Stud Firenze, Reg Toscana, Scuol Pie Fiorentine Republic, Ente Cassa Risparmio Firenze
DE fluorescence spectroscopy; multivariate analysis; endometrial tissue
ID LINEAR DISCRIMINANT-ANALYSIS
AB Background and Objective: The detailed multivariate analysis of endometrial tissue fluorescence spectra was done. Spectra underlying features and classification algorithm were analyzed. An effort has been made to determinate the importance of neopterin component in endometrial premalignization.
   Study Design/Materials and Methods: Biomedical tissue fluorescence was measured by excitation with the Nd YAG laser third harmonic. Multivariate analysis techniques were used to analyze fluorescence spectra. Biomedical optics group at Vilnius University analyzed the neopterin substance supplied by Institute of Medical Chemistry and Biochemistry of Innsbruck University.
   Results: Seven statistically significant spectral compounds were found. The classification algorithm classifying samples to histopathological categories was developed and resulted in sensitivity of 80% and specificity 93% for malignant vs. hyperplastic and normal.
   Conclusions: Fluorescence spectra could be classified with high accuracy. Spectral variation underlying features can be extracted.
   Neopterin component might play important role in endometrial hyperplasia development.
C1 Vilnius State Univ, Inst Mat Sci & Appl Res, Vilnius, Lithuania.
RP Vaitkuviene, A (reprint author), Vilnius State Univ, Inst Mat Sci & Appl Res, Vilnius, Lithuania.
RI Auksorius, Egidijus/I-1377-2018
OI Auksorius, Egidijus/0000-0002-3742-067X
CR Albert A., 1987, MULTIVARIATE INTERPR
   HARRIES ML, 1995, J LARYNGOL OTOL, V109, P108
   Ramadan Z, 1998, CHEMOMETR INTELL LAB, V40, P165, DOI 10.1016/S0169-7439(98)00020-3
   RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555
   Wu W, 1996, ANAL CHIM ACTA, V329, P257, DOI 10.1016/0003-2670(96)00142-0
NR 5
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4690-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4903
BP 29
EP 33
DI 10.1117/12.486633
PG 5
WC Engineering, Biomedical; Optics; Surgery
SC Engineering; Optics; Surgery
GA BV65A
UT WOS:000179637300004
DA 2018-10-19
ER

PT J
AU Hedia, HSM
   Shabara, MAN
AF Hedia, HSM
   Shabara, MAN
TI Effect of notch tip sharpness and pre-cracking on the stress intensity
   factor - Part I: Finite element analysis of compact tension specimen
SO MATERIALPRUFUNG
LA English
DT Article
AB The aim of the study reported in this paper was to investigate the effect of notch angle, notch tip radius and pre-cracking on the stress intensity factor, K-I, for compact tension specimens, CT. The study was conducted using finite element analysis (FEA) in association with ANSYS program. Two models were considered in the analysis. A compact tension specimen having a blunt notch without pre-crack represented the first model, while the second model was represented by a CT specimen having a blunt notch with a pre-crack. Five different engineering materials, usually used in biomedical applications were considered. A linear elastic fracture mechanics (LEFM) approach applied to plain strain condition was used.
C1 Mansoura Univ, Mansoura, Egypt.
RP Hedia, HSM (reprint author), Mansoura Univ, Mansoura, Egypt.
RI Hedia, Hassan/I-8289-2012
CR *ANSYS, 1992, ANSYS US MAN VERS 5
   ASHABY MF, 1980, ENG MAT, V1
   *ASTM, 1983, 39983 ASTM E
   Canister Jr W.D., 1994, MAT SCI ENG
   GLAUICO HP, 2001, IN PRESS FRACTURE TE
   GLINKA G, 1987, INT J FATIGUE, V9, P143, DOI 10.1016/0142-1123(87)90069-7
   NISITANI H, 1989, JSME INT J I, V32
   PAPADOPOULOS GA, 1988, ENG FRACT MECH, V31, P271, DOI 10.1016/0013-7944(88)90071-9
   RUBIO C, 1999, S REC DEV STUD IMP C
   Shabara MAN, 1996, ENG FRACT MECH, V54, P533, DOI 10.1016/0013-7944(95)00207-3
   Taylor D., 1994, ENG FAIL ANAL, V1, P275
   WILSON WK, 1974, T ASME
NR 12
TC 5
Z9 5
U1 0
U2 1
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATERIALPRUFUNG
JI Materialprufung
PY 2002
VL 44
IS 4
BP 117
EP 121
PG 5
WC Materials Science, Characterization & Testing
SC Materials Science
GA 550HP
UT WOS:000175497800001
DA 2018-10-19
ER

PT J
AU Hedia, HSM
   Fattah, AA
AF Hedia, HSM
   Fattah, AA
TI Effect of notch tip sharpness and pre-cracking on the stress intensity
   factor - Part II: Investigation of the shear loading mode
SO MATERIALPRUFUNG
LA English
DT Article
ID FRACTURE
AB In addition to the previous paper published in this issue, the effects of crack notch angle, crack notch radius and pre-crack length for compact tension specimen on the behavior of stress intensity factor (SIF) for the shear loading mode are presented in this contribution. Again, two models with a blunt notch have been analyzed. The first model represents a compact tension specimen with a pre-crack while the second one does not have a pre-crack. Similar to the previous contribution, five different engineering materials have been examined which are usually used for biomedical applications. The analyses were accomplished using linear elastic fracture mechanics (LEFM) approach applied in the plain strain field. The study was conducted using finite element program ANSYS.
C1 Mansoura Univ, Fac Engn, Prod Engn & Mech Design Dept, Mansoura, Egypt.
RP Hedia, HSM (reprint author), Mansoura Univ, Fac Engn, Prod Engn & Mech Design Dept, Mansoura, Egypt.
RI Hedia, Hassan/I-8289-2012
CR ASHABY MF, 1980, ENG MAT, V1
   Canister Jr W.D., 1994, MAT SCI ENG
   CHU SJ, 1990, ENG FRACT MECH, V35, P1093, DOI 10.1016/0013-7944(90)90137-6
   HE MY, 2001, ENG FRACT MECH, V65, P1
   Hedia HS, 1996, MED ENG PHYS, V18, P647, DOI 10.1016/S1350-4533(96)00025-2
   HEDIA HS, 2002, MATERIALPRUFUNG, V44
   HEDIA HS, 2000, J BIOMEDICAL MAT ENG, V10, P141
   Heywood R. B, 1962, DESIGNING FATIGUE
   Shabara MAN, 1996, ENG FRACT MECH, V54, P533, DOI 10.1016/0013-7944(95)00207-3
   YOON SH, 1990, INT J FRACTURE, V43, pR3, DOI 10.1007/BF00018129
   YUM YJ, 1991, INT J FRACTURE, V47, P53, DOI 10.1007/BF00037039
   1992, ANSYS US MAN VERS 5
NR 12
TC 4
Z9 4
U1 0
U2 1
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATERIALPRUFUNG
JI Materialprufung
PY 2002
VL 44
IS 4
BP 122
EP 125
PG 4
WC Materials Science, Characterization & Testing
SC Materials Science
GA 550HP
UT WOS:000175497800002
DA 2018-10-19
ER

PT B
AU Hench, LL
   Xynos, ID
   Edgar, AJ
   Buttery, LDK
   Polak, JM
AF Hench, LL
   Xynos, ID
   Edgar, AJ
   Buttery, LDK
   Polak, JM
BE McLean, M
TI A genetic basis for biomedical materials
SO MATERIALS SCIENCE AND ENGINEERING: ITS NUCLEATION AND GROWTH
LA English
DT Proceedings Paper
CT Conference on Materials Science and Engineering
CY MAY 14-15, 2001
CL IMPERIAL COLL SCI, TECHNOL & MED, LONDON, ENGLAND
HO IMPERIAL COLL SCI, TECHNOL & MED
ID GLASS-CERAMICS; HUMAN OSTEOBLASTS; IONIC PRODUCTS; BONE-FORMATION;
   BIOGLASS; INTERFACE; BIOCERAMICS; DISSOLUTION; EXPRESSION; TISSUE
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP Hench, LL (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RI Buttery, Lee/C-5627-2015
OI Buttery, Lee/0000-0003-3808-6770
CR ANDERSSON O, 1990, J MAT SCI MAT MED
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   CLARK AE, 1976, J AM CERAM SOC, V59, P37, DOI 10.1111/j.1151-2916.1976.tb09382.x
   DOUEK E, 1991, P 4 INT S BIOC MED L
   Fetner A E, 1994, Compendium, V15, P935
   GREENLEE TK, 1972, J BIOMED MATER RES, V6, P235, DOI 10.1002/jbm.820060312
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L. L., 1975, NBS SPEC PUBL, V415, P19
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1993, INTRO BIOCERAMICS
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1982, BIOCOMPATIBILITY ORT, V2, pCH6
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hulbert S. F., 1987, HIGH TECH CERAMICS, P189
   KANGASNIEMI K, 1990, HDB BIOACTIVE CERAMI, V1, P97
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Kokubo T., 1990, HDB BIOACTIVE CERAMI, P41
   Lobel K., 1996, CLIN PERFORMANCE SKE, P214
   Merwin GE, 1990, HDB BIOACTIVE CERAMI, V1, P323
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   RECK R, 1988, BIOCERAMICS MAT CHAR, V253, P100
   Shapoff C A, 1997, Compend Contin Educ Dent, V18, P352
   Stanley HR, 1997, INT J ORAL MAX IMPL, V12, P95
   STANLEY HR, 1996, CLIN PERFORMANCE SKE, P255
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1, P283
   WILSON J, 1994, BIOCERAMICS, V7, P415
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1
   YAMAMURO T, AW GLASS CERAMIC CLI, P89
   YAMAMURO T, 1988, BIOCERAMICS MAT CHAR, P107
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 51
TC 4
Z9 4
U1 0
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
BN 1-902653-59-9
PY 2002
BP 283
EP 296
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BW12K
UT WOS:000180939900022
DA 2018-10-19
ER

PT J
AU Tamizifar, M
   Omidvar, H
   Salehi, SMT
   Salehpour, Z
   Khoshkalam, O
AF Tamizifar, M
   Omidvar, H
   Salehi, SMT
   Salehpour, Z
   Khoshkalam, O
TI Effect of processing parameters on shear bands in non-isothermal hot
   forging of Ti-6Al-4V
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
ID TI-6AL-2SN-4ZR-2MO-0.1SI; DEFORMATION
AB The alloy system Ti - 6Al - 4V is the prominent Ti alloy system for aerospace and biomedical applications, as a result of its mechanical property balance and biocompatibility. Since the mechanical characterisation of Ti - 6Al - 4V is strongly sensitive to processing parameters there is relationship between processing variables, i.e. strain rate and temperature, microstructure, and properties under different loading conditions. Two phase (alpha+beta) titanium alloys undergo flow instabilities and are susceptible to shear bands or regions of localised deformation crossing many grains during hot forging under non-isothermal conditions (dies and workpiece at different temperatures). Under such conditions shear bands can be generated even in materials without flow softening attributes. This occurs if the forging parameters lead to large amounts of heat transfer between the dies and the workpiece. This study investigates the occurrence of shear bands during non-isothermal, hot forging of Ti - 6Al - 4V in order to evaluate the process parameters that generally lead to shear bands in conventional hot forging of metals. Upset compression tests on cylindrical specimens were conducted in a mechanical press and lateral side pressing tests on long, round bars were performed in either a mechanical press or a hydraulic press. The tests ranged from axisymmetric to plane strain compression. In upset specimens shear bands occurred at an angle of 45degrees to the compression axis and bands of intense deformation separated chill zones from the deforming bulk. Observation also demonstrated that the fracture might be owing to microvoids nucleated at weak points in sections of the shear surfaces. For plane strain deformation, shear bands were found to initiate along zero extension directions in a manner analogous to the formation and propagation of shear bands in isothermal hot forging. Although the shear band features at hot forging temperatures were similar to each other, there was a difference in the hardness and thickness of the shear bands depending on deformation mode, amount, and temperature.
C1 Iran Univ Sci & Technol, Tehran 16844, Iran.
RP Tamizifar, M (reprint author), Iran Univ Sci & Technol, Tehran 16844, Iran.
CR DADRAS P, 1981, METALL TRANS A, V12, P1867, DOI 10.1007/BF02643797
   IMAM MA, 1996, STP1273 ASTM, P3
   KIM YW, 1991, MICROSTRUCTURE PROPE, P647
   Lee WS, 1998, MAT SCI ENG A-STRUCT, V241, P48, DOI 10.1016/S0921-5093(97)00471-1
   OMIDVAR H, TREATISE MECH BEHAV
   Semiatin SL, 1998, MAT SCI ENG A-STRUCT, V256, P92, DOI 10.1016/S0921-5093(98)00814-4
   SEMIATIN SL, 1983, METALL TRANS A, V14, P105, DOI 10.1007/BF02643743
   Semiatin SL, 1998, MAT SCI ENG A-STRUCT, V243, P1, DOI 10.1016/S0921-5093(97)00776-4
   SEMIATIN SL, 1983, METALL TRANS A, V14, P2363, DOI 10.1007/BF02663312
   SEMIATIN SL, 1981, METALL TRANS A, V12, P1705, DOI 10.1007/BF02643753
   SEMIATIN SL, 1980, PROCESS MODELING FUN, P387
   SEMIATIN SL, 1984, FORMABILITY WORKABIL, P13
   SHMIATIN SL, 1996, ADV SCI TECHN TIT AL, P3
   WEISS I, 1986, METALL TRANS A, V17, P1935, DOI 10.1007/BF02644991
NR 14
TC 4
Z9 5
U1 1
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD JAN
PY 2002
VL 18
IS 1
BP 21
EP 29
DI 10.1179/026708301125000168
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 524PR
UT WOS:000174022500003
DA 2018-10-19
ER

PT J
AU Vena, P
   Contro, R
AF Vena, P
   Contro, R
TI Micromechanical analysis of the trabecular bone stress state at the
   interface with metallic biomedical devices
SO MECCANICA
LA English
DT Article; Proceedings Paper
CT 15th Congress of AIMETA
CY SEP 26-29, 2001
CL SICILY, ITALY
DE microstructures; interface behaviour; finite elements; multi-scale
   computing; iterative techniques
ID FINITE-ELEMENT MODELS; ACCURACY
AB An iterative procedure for the stress analysis at interfaces between dissimilar materials is presented. The problem is specialised to the case of biomaterial interfaces with particular reference to materials which are characterised by tiny microstructures. The procedure is based on a recursive analysis of small size problems defined upon subdomains obtained by partitioning the whole structural domain. The kinematic boundary conditions are iteratively adjusted by using appropriate preconditioners. The numerical example reported in this paper shows that the procedure is effective regardless of the degree of material heterogeneity, in contrast with the results obtained by using a coarse mesh for the whole domain. The procedure seems to be a promising one for determining the structural strength of interfaces between trabecular bone and metal implants requiring accurate evaluation of stress at the scale level of the single microstructure exhibited by the bone.
C1 Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, I-20133 Milan, Italy.
RP Vena, P (reprint author), Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
RI Vena, Pasquale/F-6684-2013
OI Vena, Pasquale/0000-0003-2229-5156
CR Charras GT, 2000, J BIOMECH, V33, P255, DOI 10.1016/S0021-9290(99)00141-4
   Guldberg RE, 1998, J BIOMECH ENG-T ASME, V120, P289, DOI 10.1115/1.2798314
   Jacobs CR, 1999, J BIOMECH, V32, P1159, DOI 10.1016/S0021-9290(99)00115-3
   Le Tallec P, 1994, COMPUT MECH ADV, V1, P121
   Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4
   Pistoia W, 2001, J BIOMECH ENG-T ASME, V123, P176, DOI 10.1115/1.1352734
   Terada K, 2000, INT J SOLIDS STRUCT, V37, P2285, DOI 10.1016/S0020-7683(98)00341-2
   Wentorf R, 1999, COMPUT METHOD APPL M, V172, P273, DOI 10.1016/S0045-7825(98)00232-1
   ZOHDI TI, 1999, COMPUT METHODS APPL, V172, P3
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0025-6455
J9 MECCANICA
JI Meccanica
PY 2002
VL 37
IS 4-5
BP 431
EP 439
DI 10.1023/A:1020852108109
PG 9
WC Mechanics
SC Mechanics
GA 606DG
UT WOS:000178717800012
DA 2018-10-19
ER

PT S
AU Bashkansky, M
   Reintjes, J
AF Bashkansky, M
   Reintjes, J
BE Meyendorf, N
   Baaklini, GY
   Michel, B
TI Subsurface detection and characterization of Hertzian cracks in advanced
   ceramic materials using optical coherence tomography.
SO NONDESTRUCTIVE EVALUATION AND RELIABILITY OF MICRO-AND NANOMATERIAL
   SYSTEMS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 1st Conference on Nondestructive Evaluation and Reliability of Micro-
   and Nanomaterial Systems
CY MAR, 2002
CL SAN DIEGO, CA
SP SPIE
DE NDE; optical coherence tomography; optical gating
AB Optical Coherence Tomography (OCT) is an active optical imaging technique that is capable of three-dimensional resolution better than 10 microns in all dimensions. OCT was originally developed as a non-invasive technique in biomedical field. It also found uses in the NDE of various materials including ceramics, plastics and composites. In various ceramics OCT can be used to detect microscopic, subsurface defects at depths approaching hundreds of microns. The depth of penetration depends on the material and on the wavelength of light. Here we demonstrate an application of OCT to the subsurface imaging in various materials and, in particular, to the detection of a surface-penetrating Hertzian crack in a Si3N4 ceramic ball. We present measured subsurface trajectory of the crack and compare it to theoretical predictions. These cracks represent one of the most important failure mechanisms in advanced ceramic materials. The ability to map subsurface trajectories of cracks is a valuable tool in the evaluation of different existing theories. Better theoretical understanding of various properties of crack initiation and propagation can lead to engineering of improved ceramic materials.
C1 USN, Res Lab, Div Opt Sci, Washington, DC 20375 USA.
RP Bashkansky, M (reprint author), USN, Res Lab, Div Opt Sci, Code 5610, Washington, DC 20375 USA.
CR AMIN KE, 1995, AM CERAM SOC BULL, V74, P76
   Bashkansky M, 2001, NDT&E INT, V34, P547, DOI 10.1016/S0963-8695(01)00014-7
   Bashkansky M, 1997, OPT LETT, V22, P61, DOI 10.1364/OL.22.000061
   FRANK FC, 1967, PROC R SOC LON SER-A, V299, P291, DOI 10.1098/rspa.1967.0137
   Kamensky V, 1999, J BIOMED OPT, V4, P137, DOI 10.1117/1.429927
   Kocer C, 1998, J AM CERAM SOC, V81, P1736
   LAWN BR, 1967, PROC R SOC LON SER-A, V299, P307, DOI 10.1098/rspa.1967.0138
   PUJARI VK, DEV IMPROVED PROCESS
   PUJARI VK, 1995, AM CER SOC B, V74
   Rollins AM, 1999, OPT LETT, V24, P1484, DOI 10.1364/OL.24.001484
   SANDAY SC, 1999, P INTEGRATION MAT PR, P167
   SLOTWINSKI JA, 1993, NIST SPECIAL PUBLICA, V847, P117
   TONAKA T, 1990, J EUROPEAN CER SOC, V6, P9
   XU HHK, 1994, J AM CERAM SOC, V77, P1388, DOI 10.1111/j.1151-2916.1994.tb05424.x
NR 14
TC 4
Z9 4
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4451-0
J9 PROC SPIE
PY 2002
VL 4703
BP 46
EP 52
DI 10.1117/12.469630
PG 7
WC Materials Science, Characterization & Testing; Microscopy; Optics
SC Materials Science; Microscopy; Optics
GA BU98M
UT WOS:000177554000006
DA 2018-10-19
ER

PT S
AU Janotta, M
   Mizaikoff, A
AF Janotta, M
   Mizaikoff, A
BE Gannot, I
TI Recent developments in liquid phase mid-infrared sensor technology
SO OPTICAL FIBERS AND SENSORS FOR MEDICAL APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Optical Fibers and Sensors for Medical Applications II Conference
CY JAN 22-23, 2002
CL SAN JOSE, CA
SP SPIE
DE mid-infrared sensors; evanescent field sensors; chemical sensors;
   sol-gel coatings
ID MOLECULARLY IMPRINTED POLYMERS; OPTICAL CHEMICAL SENSORS;
   EVANESCENT-WAVE SENSORS; SOL-GEL COATINGS; CHLORINATED HYDROCARBONS;
   FIBEROPTIC SENSORS; FTIR SPECTROSCOPY; BIOSENSORS; WATER; PESTICIDES
AB The potential of mid-infrared optical sensing technology for liquid phase applications is tightly related to the implementation of appropriate chemical modifications of the sensing surface. Besides recognition and enrichment of analyte molecules, suppression of interfering water absorptions is of substantial interest. Utilizing the principle of evanescent wave spectroscopy for the signal generation is the basis for the realization of powerful spectroscopic sensing systems, which provide access to molecule specific vibrations of organic analytes. With the availability of mid-infrared transparent fiberoptic materials, access to the mid-infrared spectral region from 2-20 mum is gained enabling remote qualitative and quantitative analysis. Besides polymeric molecular recognition and enrichment layers, sol-gel films are among the most promising surface modification. This highly reproducible process allows detailed control on the surface properties of the sol-gel layer formed at the waveguide surface. Due to the inertness and robustness of sol-gel coatings they can be considered among the most promising surface modification materials for optical sensors applied in the biomedical and biological field.
C1 Georgia Inst Technol, Sch Chem & Biochem, Appl Sensors Lab, Atlanta, GA 30332 USA.
RP Janotta, M (reprint author), Georgia Inst Technol, Sch Chem & Biochem, Appl Sensors Lab, Atlanta, GA 30332 USA.
RI Mizaikoff, Boris/G-9959-2013
OI Mizaikoff, Boris/0000-0002-5583-7962
CR AVNIR D, 1992, P SOC PHOTO-OPT INS, V1758, P456, DOI 10.1117/12.132037
   Brinker C. J., 1990, SOL GEL SCI
   Dickert FL, 1999, TRAC-TREND ANAL CHEM, V18, P192, DOI 10.1016/S0165-9936(98)00123-X
   FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553
   Grant SA, 1997, SENSOR ACTUAT B-CHEM, V45, P35, DOI 10.1016/S0925-4005(97)00263-3
   Han L, 1999, APPL SPECTROSC, V53, P381, DOI 10.1366/0003702991946839
   Han L, 1998, APPL SPECTROSC, V52, P119, DOI 10.1366/0003702981942429
   Haupt K, 1998, TRENDS BIOTECHNOL, V16, P468, DOI 10.1016/S0167-7799(98)01222-0
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HOLST G, 2002, IN PRESS HDB FIBER O
   Hvozdara L, 2000, APPL OPTICS, V39, P6926, DOI 10.1364/AO.39.006926
   Ingersoll CM, 1997, CHEMTECH, V27, P26
   Jakusch M, 1997, P SOC PHOTO-OPT INS, V3105, P283, DOI 10.1117/12.276163
   Jakusch M, 1999, ANAL CHEM, V71, P4786, DOI 10.1021/ac990050q
   Jakusch M, 1997, SENSOR ACTUAT B-CHEM, V38, P83, DOI 10.1016/S0925-4005(97)80175-X
   Janata J, 2001, ANAL CHEM, V73, p150A, DOI 10.1021/ac012402a
   JANATA J, 1998, ANAL CHEM, V70, P179
   Janotta M, 2001, INT J ENVIRON AN CH, V80, P75, DOI 10.1080/03067310108044374
   Kraft M, 2000, INT J ENVIRON AN CH, V78, P367, DOI 10.1080/03067310008041354
   KRIZ D, 1995, ANAL CHIM ACTA, V300, P71, DOI 10.1016/0003-2670(94)00368-V
   Kriz D, 1997, ANAL CHEM, V69, pA345, DOI 10.1021/ac971657e
   KRIZ D, 1995, ANAL CHEM, V67, P2142, DOI 10.1021/ac00109a037
   Kron J, 1994, J SOL-GEL SCI TECHN, V2, P189, DOI 10.1007/BF00486239
   LEV O, 1995, ANAL CHEM, V67, pA22, DOI 10.1021/ac00097a001
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Lobnik A, 1998, ANAL CHIM ACTA, V367, P159, DOI 10.1016/S0003-2670(97)00708-3
   Lobnik A, 1998, SENSOR ACTUAT B-CHEM, V51, P203, DOI 10.1016/S0925-4005(98)00189-0
   MACCRAITH BD, 1995, SENSOR ACTUAT B-CHEM, V29, P51, DOI 10.1016/0925-4005(95)01662-7
   MacCraith BD, 1997, J SOL-GEL SCI TECHN, V8, P1053, DOI 10.1023/A:1018338426081
   MACCRAITH BD, 1993, SENSOR ACTUAT B-CHEM, V11, P29, DOI 10.1016/0925-4005(93)85235-3
   MACCRAITH BD, 1994, P SOC PHOTO-OPT INS, V2288, P518, DOI 10.1117/12.188986
   MACCRAITH BD, 1997, CRIT REV OPT SCI TEC, V68, P64
   McDonagh C, 1996, J NON-CRYST SOLIDS, V194, P72, DOI 10.1016/0022-3093(95)00488-2
   McDonagh C, 2001, SENSOR ACTUAT B-CHEM, V74, P124, DOI 10.1016/S0925-4005(00)00721-8
   Mendoza EA, 1997, P SOC PHOTO-OPT INS, V3136, P267, DOI 10.1117/12.290203
   Mizaikoff B, 1999, P SOC PHOTO-OPT INS, V3849, P7, DOI 10.1117/12.372799
   MIZAIKOFF B, 1995, SENSOR ACTUAT B-CHEM, V29, P58, DOI 10.1016/0925-4005(95)01663-5
   Mizaikoff B, 1999, MEAS SCI TECHNOL, V10, P1185, DOI 10.1088/0957-0233/10/12/310
   Mizaikoff B, 2001, PROC SPIE, V4253, P76, DOI 10.1117/12.427911
   MIZAIKOFF B, 2001, P SICON 01 IEEE C, P208
   Mizaikoff B., 2002, HDB VIBRATIONAL SPEC, V2, P1560
   MOLINELLI A, 2002, IN PRESS J AGR FOOD
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   Oehme I, 1997, MIKROCHIM ACTA, V126, P177, DOI 10.1007/BF01242319
   Pope EJA, 2000, P SOC PHOTO-OPT INS, V3943, P170, DOI 10.1117/12.384336
   POPE EJA, 1986, J NON-CRYST SOLIDS, V87, P185, DOI 10.1016/S0022-3093(86)80078-3
   Regan F, 1997, VIB SPECTROSC, V14, P239, DOI 10.1016/S0924-2031(96)00073-2
   Regan F, 1996, ANAL CHIM ACTA, V334, P85, DOI 10.1016/S0003-2670(96)00259-0
   SHAHRIARI MR, 1999, OPT FIBER SENS TECHN, V4, P47
   SHAHRIARI MR, 1994, SOL GEL OPTICS PROCE, P279
   WALSH JE, 1995, P SOC PHOTO-OPT INS, V2508, P233, DOI 10.1117/12.221736
   Walsh JE, 1996, ANALYST, V121, P789, DOI 10.1039/an9962100789
   WEISS R, 2002, IN PRESS BIOSEPARATI
   Wolfbeis OS, 2000, ANAL CHEM, V72, p81R
   Wulff G., 1995, ANGEW CHEM, V107, P1958
   Yano K, 1999, TRAC-TREND ANAL CHEM, V18, P199, DOI 10.1016/S0165-9936(98)00119-8
NR 56
TC 5
Z9 5
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4355-7
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4616
BP 1
EP 8
DI 10.1117/12.463796
PG 8
WC Engineering, Biomedical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BU44B
UT WOS:000175999200001
DA 2018-10-19
ER

PT S
AU Witte, R
   Herfurth, H
   Heinemann, S
AF Witte, R
   Herfurth, H
   Heinemann, S
BE Sugioka, K
   Gower, MC
   Haglund, RF
   Pique, A
   Dubowski, JJ
   Hoving, W
TI Laser joining of glass with silicon
SO PHOTON PROCESSING IN MICROELECTRONICS AND PHOTONICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Photon Processing in Microelectronics and Photonics
CY JAN 21-24, 2002
CL SAN JOSE, CA
SP SPIE, AIR Force Sci Res
DE selective bonding; glass; silicon; MEMS
AB New joining techniques are required for the variety of materials used in the manufacture of microsystems. Lasers are emerging as a useful tool for joining miniaturized devices. The beam can be focused to less than .001" allowing localized joining of very small geometries. There is minimal heat input into the part so distortion and change in material properties is minimal. The high quality of the laser welds and the precise process control enable hermetic scaling.
   Glass to silicon bonds are required in a vast array of opto-electronic components, including laser sources, sensors, switches and multiplexers. Typically, adhesives as well as direct and anodic bonding techniques are used to join the different materials. Adhesive residues, low bond strength, heating of entire parts during joining and poor long-term stability are disadvantages of these conventional techniques.
   Laser bonding is a promising alternative due to the increased bond strength and high repeatability. Compact and efficient diode lasers equipped with fiber beam delivery in the power range of <50W are applied to the sandwiched glass-silicon structure. During bonding, the laser beam penetrates the upper part and is absorbed at the surface of the bottom part. A clean environment and good part fit-up is required to ensure proper bonding, high bond strength, and hemietic sealing. The process eliminates adhesives; therefore reducing costs due to shorter cycle times, lower maintenance and less inventory. The process requires no handling of toxic liquids and creates no fumes. Furthermore, the bonded parts are free of any residue or contamination, reducing scrap rates. This study investigates the process parameter window and determines the impact on the parts and the stability of the process. The results will lead to the development of several applications in the areas of telecommunications, biomedical devices and MEMS. This includes the encapsulation of MEMS, the covering of sensors and the packaging of biomedical products. The selectivity of the process will be demonstrated on flat coupons.
C1 Fraunhofer USA, Ctr Laser Technol, Plymouth, MI 48170 USA.
RP Witte, R (reprint author), Fraunhofer USA, Ctr Laser Technol, Plymouth, MI 48170 USA.
CR *CORN, 1999, GLASS SIL CONSTR SUB
   *CORN INC, 2001, PROD INF
   HOFMANN K, 1986, APPL PHYS LETT, V49, P1525, DOI 10.1063/1.97322
   Mandle R. M., 1967, US patent, no, Patent No. 3298807
   NILSSON T, 1999, ACTA U LAPPEENRANTAE, V84, P472
   PAYNE CC, 1984, Patent No. 4462188
   PUETZ H, 1997, MODERN PLASTICS  SEP, P121
   SCHOTT AG, 2001, PRODUCT INFORMATION
   SCHOTT AG, 2001, BOROFLOAT 33 PRODUCT
   TAKAHAGI T, 1994, J APPL PHYS, V76, P3140, DOI 10.1063/1.357496
   Tong Q.-Y, 1999, SEMICONDUCTOR WAFER
NR 11
TC 7
Z9 8
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4376-X
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4637
BP 487
EP 495
DI 10.1117/12.470657
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BU94R
UT WOS:000177443500055
DA 2018-10-19
ER

PT J
AU Hirsch, SG
   Spontak, RJ
AF Hirsch, SG
   Spontak, RJ
TI Temperature-dependent property development in hydrogels derived from
   hydroxypropylcellulose
SO POLYMER
LA English
DT Article
DE hydrogels; hydroxypropylcellulose; temperature-induced phase separation
ID AQUEOUS-SOLUTIONS; PHASE-BEHAVIOR; GELS; DIAGRAM; POLYMER; SYSTEM
AB Hydrogels constitute an important class of responsive materials that are employed in numerous biomedical and personal-care applications, most notably of which are controlled drug delivery, separations and superabsorbency. Since aqueous hydroxypropylcellulose (HPC) solutions exhibit lower critical solution behavior, hydrogels produced from this cellulose ether are temperature-responsive, swelling at low temperatures and contracting at high temperatures. If HPC hydrogels are synthesized at temperatures in the single-phase regime, they remain nonporous, whereas those crosslinked in the biphasic regime become microporous. In this work, we employ the modified temperature-induced phase separation (TIPS) protocol to generate nonporous and microporous HPC hydrogels crosslinked at different temperatures. The dynamic mechanical properties and swelling capacities of these hydrogels are reported as functions of crosslinking temperature. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
EM rich_spontak@ncsu.edu
CR Alvarez-Lorenzo C, 1999, INT J PHARM, V180, P91, DOI 10.1016/S0378-5173(98)00409-8
   ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Brannon-Peppas L., 1990, ABSORBENT POLYM TECH
   Buchholz F., 1998, MODERN SUPERABSORBEN
   FISCHER H, 1995, J MATER SCI, V30, P4623, DOI 10.1007/BF01153071
   FORTIN S, 1989, MACROMOLECULES, V22, P2286, DOI 10.1021/ma00195a050
   Frey MW, 1996, J POLYM SCI POL PHYS, V34, P2049
   Gao J, 2001, MACROMOLECULES, V34, P2242, DOI 10.1021/ma001631g
   GEHRKE SH, 1992, POLYM INT, V29, P29, DOI 10.1002/pi.4990290107
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   GUIDO S, 1995, MACROMOLECULES, V28, P4530, DOI 10.1021/ma00117a023
   HARSH DC, 1991, J CONTROL RELEASE, V17, P175, DOI 10.1016/0168-3659(91)90057-K
   HARSH DC, 1993, ACS SYM SER, V520, P105
   Hirokawa Y, 1999, MACROMOLECULES, V32, P7093, DOI 10.1021/ma990437v
   Kabra BG, 1998, MACROMOLECULES, V31, P2166, DOI 10.1021/ma970418q
   KABRA BG, 1992, POLYMER, V33, P990, DOI 10.1016/0032-3861(92)90014-N
   KABRA BG, 1994, ACS SYM SER, V573, P76
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   OConnor SM, 1997, J APPL POLYM SCI, V66, P1279, DOI 10.1002/(SICI)1097-4628(19971114)66:7<1279::AID-APP7>3.0.CO;2-D
   Okano T., 1998, BIORELATED POLYM GEL
   OTTENBRITE RM, 1996, ACS SYM SER, P627
   SPONTAK RJ, 1992, STUD POLYM SCI, V11, P273
   Wang BC, 1997, LIQ CRYST, V22, P359, DOI 10.1080/026782997209432
   WERBOWYJ RS, 1980, MACROMOLECULES, V13, P69, DOI 10.1021/ma60073a014
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   WU XS, 1992, J POLYM SCI POL CHEM, V30, P2121, DOI 10.1002/pola.1992.080301005
NR 26
TC 28
Z9 28
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JAN
PY 2002
VL 43
IS 1
BP 123
EP 129
DI 10.1016/S0032-3861(01)00608-5
PG 7
WC Polymer Science
SC Polymer Science
GA 484TU
UT WOS:000171706300016
DA 2018-10-19
ER

PT B
AU Mano, JF
   Reis, RL
   Cunha, AM
AF Mano, JF
   Reis, RL
   Cunha, AM
BE Reis, RL
   Cohn, D
TI Dynamic mechanical analysis in polymers for medical applications
SO POLYMER BASED SYSTEMS ON TISSUE ENGINEERING, REPLACEMENT AND
   REGENERATION
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Polymer Based Systems
   on Tissue Engineering, Replacement and Regeneration
CY OCT 15-25, 2001
CL ALVOR, PORTUGAL
SP NATO, Adv Study Inst
ID ACRYLIC BONE-CEMENT; SOFT LINING MATERIALS; VISCOELASTIC PROPERTIES;
   DEGRADATION BEHAVIOR; THERMAL-PROPERTIES; TEMPERATURE; ACID);
   HYDROXYAPATITE; BIOMATERIALS; COMPOSITES
AB The Dynamic Mechanical Analysis (DMA) is a powerful thermal analysis technique, which allows to detect phase transitions and relaxation processes in a variety of materials. With this technique, the solid-state rheological properties of viscoelastic materials can be characterised over a wide range of temperature and frequencies. This chapter summarizes the principles and the capabilities of the DMA technique focusing on its uses on polymeric-based systems aimed to medical and environmental applications. The examples presented include the materials that have been investigated in our research group in the last few years, such as starch-based blends, proteins, polyethylenes, and composites thereof, among other materials. These newly developed biomaterials are being proposed for a range of biomedical applications that go from fracture replacement/fixation and tissue engineering scaffolding, to new partially degradable bone cements and hydrogels, carriers for controlled release of drugs and growth factors and new wound dressings and membranes.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RI Mano, Joao/A-4418-2009; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Mano, Joao/0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Group,
   3Bs/0000-0002-5195-3456
CR Alves NM, 2002, POLYMER, V43, P3627, DOI 10.1016/S0032-3861(02)00176-3
   Alves NM, 2001, MATER RES INNOV, V4, P170, DOI 10.1007/s100190000078
   Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BROWN AF, 1997, J PHARM PHARMACOL, V49, P26
   Butler MF, 2000, POLYMER, V41, P2249, DOI 10.1016/S0032-3861(99)00366-3
   Cascone MG, 1997, POLYM INT, V43, P55
   CauichRodriguez JV, 1996, J MATER SCI-MATER M, V7, P349, DOI 10.1007/BF00154547
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   Cerrada ML, 2000, POLYMER, V41, P6655, DOI 10.1016/S0032-3861(99)00868-X
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   ELVIRA C, 2001, 27 ANN M SOC BIOM ST, P271
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Frey MW, 1996, J POLYM SCI POL PHYS, V34, P2375, DOI 10.1002/(SICI)1099-0488(199610)34:14<2375::AID-POLB7>3.0.CO;2-V
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   HARRIS B, 1993, J MATER SCI, V28, P3353, DOI 10.1007/BF00354259
   JAUREGUI B, 1995, INT J BIOL MACROMOL, V17, P49, DOI 10.1016/0141-8130(95)93518-3
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   KALACHANDRA S, 1995, J MATER SCI-MATER M, V6, P218, DOI 10.1007/BF00146859
   Kalay G, 1999, J APPL POLYM SCI, V73, P2473, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2473::AID-APP16>3.3.CO;2-F
   Kim S., 1997, IPNS WORLD SCI ENG
   LEONOR IB, 2002, IN PRESS J MAT SCI M
   LEONOR IB, 2002, IN PRESS BIOMATERIAL
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Mano JF, 2000, J APPL POLYM SCI, V78, P2345, DOI 10.1002/1097-4628(20001220)78:13<2345::AID-APP110>3.0.CO;2-3
   Mano JF, 1999, J MATER SCI-MATER M, V10, P857, DOI 10.1023/A:1008916901009
   Mano JF, 2001, MACROMOLECULES, V34, P8825, DOI 10.1021/ma010855b
   Mano JF, 2002, J MATER SCI, V37, P257, DOI 10.1023/A:1013635809035
   Mano JF, 2001, POLYMER, V42, P6187, DOI 10.1016/S0032-3861(01)00090-8
   Mano JF, 2001, POLYM TEST, V20, P937
   MANO JF, 2002, IN PRESS J MAT SCI M
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   MARQUES AP, 2002, BIOMATERIALS, V6, P1471
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   McCrum N.G., 1991, ANELASTIC DIELECTRIC
   Menard K. P., 1999, DYNAMIC MECH ANAL PR
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Murata H, 2000, BIOMATERIALS, V21, P1421, DOI 10.1016/S0142-9612(00)00010-7
   Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   OLIVEIRA AL, 2001, EUR SOC BIOM 2001 C
   PAPADOGIANNIS Y, 1993, DENT MATER, V9, P118, DOI 10.1016/0109-5641(93)90087-7
   Pascual B, 1999, BIOMATERIALS, V20, P453, DOI 10.1016/S0142-9612(98)00191-4
   Penco M, 2000, EUR POLYM J, V36, P901, DOI 10.1016/S0014-3057(99)00155-X
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Reis RL, 2001, STARCH POLYM ENCY MA, P8810
   RICHERT R, 1994, DISORDERED EFFECTS R
   Rodriguez-Perez MA, 2001, POLYM TEST, V20, P253, DOI 10.1016/S0142-9418(00)00030-1
   Saber-Sheikh K, 1999, BIOMATERIALS, V20, P817, DOI 10.1016/S0142-9612(98)00236-1
   SABERSHEIKH K, 2000, BIOMATERIALS, V20, P2055
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   SILVA RM, 2002, ESB2002
   SKROVANEK DJ, 1990, PROG ORG COAT, V18, P89, DOI 10.1016/0033-0655(90)85004-H
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   SOUSA RA, 2002, BIOCERAMICS, V14, P469
   SOUSA RA, 2002, IN PRESS POLYM ENG S
   STARKWEATHER HW, 1993, MACROMOLECULES, V26, P5084, DOI 10.1021/ma00071a016
   STROBL GR, 1996, PHYSICS POLYM
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tsuji H, 1996, J APPL POLYM SCI, V60, P2367, DOI 10.1002/(SICI)1097-4628(19960627)60:13<2367::AID-APP8>3.0.CO;2-C
   VAIDYANATHAN J, 1995, J MATER SCI-MATER M, V6, P670, DOI 10.1007/BF00123449
   VASQUEZTORRES H, 1994, J APPL POLYM SCI, V54, P1141
   Vaz CA, 2002, J MACROMOL SCI PHYS, VB41, P33, DOI 10.1081/MB-120002344
   Vaz CM, 2001, MATER RES INNOV, V4, P375, DOI 10.1007/s100190000112
   VAZ CM, 2002, UNPUB J BIOMAT SCI P
   VAZ CM, 2000, 6 WORLD BIOM C HAW U, P429
   WATASE M, 1989, POLYM J, V21, P567, DOI 10.1295/polymj.21.567
   Waters M, 1996, BIOMATERIALS, V17, P1627, DOI 10.1016/0142-9612(95)00330-4
   WETTON RE, 1986, DEV POLYM CHARACTERI, V5, P179
   YAMASHITA, 2002, J BIOMED MAT RES APP, V63, P31
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
   Yang JM, 1999, J BIOMED MATER RES, V48, P52, DOI 10.1002/(SICI)1097-4636(1999)48:1<52::AID-JBM10>3.0.CO;2-Z
   Yang JM, 1997, J BIOMED MATER RES, V38, P361, DOI 10.1002/(SICI)1097-4636(199724)38:4<361::AID-JBM9>3.0.CO;2-M
   Yildiz ME, 2001, J RHEOL, V45, P903, DOI 10.1122/1.1380425
NR 79
TC 20
Z9 20
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1000-1
J9 NATO SCI SER II MATH
PY 2002
VL 86
BP 139
EP 164
PG 26
WC Engineering, Biomedical; Engineering, Chemical
SC Engineering
GA BV99N
UT WOS:000180622900010
DA 2018-10-19
ER

PT B
AU Aker, MN
   Lu, TF
   Li, Q
AF Aker, MN
   Lu, TF
   Li, Q
GP IEEE
   IEEE
TI Weight optimisation of brush-type wound-field direct current motors
SO PROCEEDINGS OF THE 2002 IEEE INTERNATIONAL SYMPOSIUM ON INTELLIGENT
   CONTROL
LA English
DT Proceedings Paper
CT IEEE International Symposium on Intelligent Control
CY OCT 27-30, 2002
CL VANCOUVER, CANADA
SP IEEE, IEEE Control Syst Soc
AB Weight optimised direct current motors have been used lately as actuators for micro-robotics and biomedical equipment. The evolution of these motors originated from the need for lightweight compact motors with good response and having cheap production cost in the industry. Many techniques have been used in developing permanent magnet and wound-field motors, such as numerical analysis, selecting adequate magnetic material, finite element analysis and optimisation models. Yet, published articles reveal the development of wound-field motors with problems; for example nonproportional geometry, saturated magnetic core, weak output torque and high temperature rise. A mathematical model is introduced in this paper for developing a new design method to overcome these problems. A 900-watts DC motor is optimised separately and in concurrent with a proportional, integral and derivative (PID) controller at the end of this paper, as an example for illustrating the proposed method.
C1 Univ Adelaide, Dept Mech Engn, Adelaide, SA 5005, Australia.
RP Aker, MN (reprint author), Univ Adelaide, Dept Mech Engn, Adelaide, SA 5005, Australia.
CR CHANGZHI A, 1996, IEEE CEFC 96 7 BIENN
   CORBETT AE, 1978, P INT C EL MACH KATH
   Frielich S. D., 1987, Robotics World, V5, P28
   Hamdi E.S., 1994, DESIGN SMALL ELECT M
   HANITSCH R, 1992, P INT C EL MACH MANC
   ITOH H, 1981, T I ELECT COMMUNIC E
   Jones D., 1990, Powerconversion & Intelligent Motion, V16, P25
   KAFTANATII VT, 1988, SOVIET ELECT ENG, V59, P66
   KOPP NL, 1994, P 1994 S AUT UND VEH
   MANDRYKA OR, 1985, SOVIET ELECT ENG, V56, P49
   Nelson R., 1992, Powerconversion & Intelligent Motion, V18, P36
   PAPALAMBROS P, 1999, P 1999 ASME DES ENG
   PIEN YP, 2000, ELECT MACHINES POWER, V28, P13
   SAVANI A, 1983, IEEE T MAGN, V19, P2088
   SEOL SS, 1995, T KOREAN I ELECT ENG, V44, P858
NR 15
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7620-X
PY 2002
BP 397
EP 402
DI 10.1109/ISIC.2002.1157796
PG 6
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Electrical & Electronic; Robotics
SC Automation & Control Systems; Computer Science; Engineering; Robotics
GA BV67V
UT WOS:000179732300067
DA 2018-10-19
ER

PT B
AU Kupp, D
   Claar, D
   Flemmig, K
   Waag, U
   Goehler, H
AF Kupp, D
   Claar, D
   Flemmig, K
   Waag, U
   Goehler, H
BE Ghosh, A
   Sanders, TH
   Claar, TD
TI Processing of controlled porosity titanium-based materials
SO PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES
LA English
DT Proceedings Paper
CT 3rd Global Symposium on Materials Processing and Manufacturing
CY FEB 17-21, 2002
CL Seattle, WA
SP ONR
ID METALLIC FOAMS; FIXATION; SURFACES
AB Alloys and intermetallic compounds based on titanium are used extensively in aerospace and biomedical applications, based on their high strength, light weight, and excellent corrosion resistance. To extend the range of applications, designers and engineers are now seeking titanium-based materials with controlled porosity. Ultra-lightweight, porous titanium alloys and intermetallics are being fabricated based on technologies being developed at the Fraunhofer Institute and Fraunhofer USA Center for Manufacturing and Advanced Materials, located in Dresden, Germany and Newark, DE, respectively. Powder metallurgy processing routes are being utilized to fabricate hollow metal spheres and open-celled foams in titanium, Ti-6Al-4V alloy and TiAl and TiAl(3) intermetallics. The processing, microstructures, and selected properties of these controlled-porosity materials will be presented, along with a discussion of potential applications in the aerospace, biotechnology, and other industries.
C1 Fraunhofer USA, Delaware Ctr Mfg & Adv Mat, Newark, DE 19716 USA.
RP Kupp, D (reprint author), Fraunhofer USA, Delaware Ctr Mfg & Adv Mat, 501 Wyoming Rd, Newark, DE 19716 USA.
CR ANDERSON O, 1999, P MET FOAM, P183
   Banhart J, 1998, MATER RES SOC SYMP P, V521, P121, DOI 10.1557/PROC-521-121
   BOBYN JD, 1982, CLIN ORTHOP RELAT R, P301
   Bohm A, 1998, Z METALLKD, V89, P90
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   GROESSNERSCHREI.B, 1991, SEMIN ARTHROP, V2, P260
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Heimke G., 1990, OSSEOINTEGRATED IMPL, V1
   Pilliar R. M., 1995, TISSUE IMPLANT INTER, P569
   Pilliar RM, 1998, INT J POWDER METALL, V34, P33
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   SIMMONS CA, 1998, POROUS COATED IMPLAN
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   STEPHANI G, 2000, P 2000 INT C POWD ME
   WANG KK, 1989, T SOC BIOM ANN M LAK, P154
   WOLFARTH D, 1994, J BIOMED MATER RES, V28, P417, DOI 10.1002/jbm.820280403
NR 18
TC 5
Z9 5
U1 1
U2 4
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-527-1
PY 2002
BP 61
EP 71
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BAW13
UT WOS:000223863600006
DA 2018-10-19
ER

PT J
AU Vekilov, PG
AF Vekilov, PG
TI Self-assembly of apoferritin molecules into crystals: thermodynamics and
   kinetics of molecular level processes
SO PROGRESS IN CRYSTAL GROWTH AND CHARACTERIZATION OF MATERIALS
LA English
DT Review
DE ferritin; self-assembly; molecular resolution; interaction energy;
   solvent entropy; interfacial supersaturation; solution non-ideality
ID ATOMIC-FORCE MICROSCOPY; TETRAGONAL LYSOZYME CRYSTALS; SITE-DIRECTED
   MUTAGENESIS; FACET MORPHOLOGY RESPONSE; YELLOW MOSAIC-VIRUS; PROTEIN
   CRYSTALLIZATION; ELECTRON-MICROSCOPY; SURFACE-MORPHOLOGY;
   GROWTH-MECHANISM; STEP DYNAMICS
AB Aside from the biological, biomedical and materials importance of ferritin and apoferritin, the self-assembly of these molecules into crystals is of interest because it is a suitable model for protein crystallization and aggregation that impact many fundamental and applied fields. We use the atomic force microscope in-situ, during the crystallization of apoferritin to visualize and quantify at the molecular level the processes responsible for crystal growth. We image the configuration of the incorporation sites, "kinks", on the surface of a growing crystal. We show that the kinks are due to thermal fluctuations of the molecules at the crystal-solution interface. This allows evaluation of the free energy of the intermolecular bond phi = 3.0 k(B)T = 7.3 kJ/mol. The crystallization free energy, extracted from the protein solubility, is - 42 kJ/mol. Thermodynamics analyses based on these two values suggest that the main component in the crystallization driving force is the entropy gain of the waters bound to the protein molecules in solution and released upon crystallization. Furthermore, we determine the characteristic frequency of attachment of individual molecules into the kinks at one set of conditions. We show that the macroscopic step growth velocity, scaled by the molecular size, equals the product of independently determined kink density and attachment frequency, i.e., these are the molecular-level parameters for crystallization. Finally, we show that although new crystal layers are generated by intrinsically stochastic surface nucleation, for crystals > 200 mum layer generation predominantly occurs at the crystal edges. Numerical simulations of the concentration fields in the solution allow us to assign this localization to higher interfacial concentration at the edges. As the steps propagate to cover the crystal face, step density waves, or bunches, develop and may lead to non-uniformity and-lower quality and utility of the growing crystal.
C1 Univ Houston, Dept Chem Engn, Houston, TX 77204 USA.
RP Vekilov, PG (reprint author), Univ Houston, Dept Chem Engn, Houston, TX 77204 USA.
CR ALFONSO C, 1992, SURF SCI, V262, P371, DOI 10.1016/0039-6028(92)90133-Q
   Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   BACHER A, 1992, J MOL BIOL, V225, P1065, DOI 10.1016/0022-2836(92)90105-S
   BARTELT NC, 1990, SURF SCI, V240, pL591, DOI 10.1016/0039-6028(90)90722-K
   BAUSER E, 1994, HDB CRYSTAL GROWTH B, V3, P879
   BERESFORDSMITH B, 1985, J COLLOID INTERF SCI, V105, P216, DOI 10.1016/0021-9797(85)90362-5
   BERLAND CR, 1992, P NATL ACAD SCI USA, V89, P1214, DOI 10.1073/pnas.89.4.1214
   Brange J., 1987, GALENICS INSULIN
   Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783
   BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006
   Carter DC, 1999, J CRYST GROWTH, V196, P602, DOI 10.1016/S0022-0248(98)00857-4
   CHAYEN NE, 1994, ACTA CRYSTALLOGR D, V50, P456, DOI 10.1107/S0907444993013320
   Chayen NE, 1996, Q REV BIOPHYS, V29, P227, DOI 10.1017/S0033583500005837
   Chernov A. A., 1995, SCI TECHNOLOGY CRYST, P67
   Chernov A.A., 1980, MODERN CRYSTALLOGRAP
   Chernov AA, 1999, J PHYS-CONDENS MAT, V11, P9969, DOI 10.1088/0953-8984/11/49/314
   CHERNOV AA, 1989, CONTEMP PHYS, V30, P251, DOI 10.1080/00107518908225517
   Crichton RR, 1997, BIOCHEMISTRY-US, V36, P15049, DOI 10.1021/bi9709147
   CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414
   Ducruix A, 1992, CRYSTALLIZATION NUCL
   DURBIN SD, 1992, J CRYST GROWTH, V122, P71, DOI 10.1016/0022-0248(92)90228-B
   Durbin SD, 1996, ANNU REV PHYS CHEM, V47, P171, DOI 10.1146/annurev.physchem.47.1.171
   Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9
   Eaton WA, 1997, CURR OPIN STRUC BIOL, V7, P10, DOI 10.1016/S0959-440X(97)80003-6
   EISENBERG D, 1979, PHYSICAL CHEM APPL L
   GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216
   GIDER S, 1995, SCIENCE, V268, P77, DOI 10.1126/science.7701343
   Giesen M, 1996, SURF SCI, V366, P229, DOI 10.1016/0039-6028(96)00823-0
   GIESENSEIBERT M, 1993, PHYS REV LETT, V71, P3521, DOI 10.1103/PhysRevLett.71.3521
   GIESENSEIBERT M, 1995, SURF SCI, V329, P47, DOI 10.1016/0039-6028(95)00055-0
   GILLILAND GL, 1994, ACTA CRYSTALLOGR D, V50, P408, DOI 10.1107/S0907444994002003
   GILMER GH, 1994, HDB CRYSTAL GROWTH, V1, P583
   Glaser SJ, 1998, SCIENCE, V280, P421, DOI 10.1126/science.280.5362.421
   Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2
   HAGEN MHJ, 1994, J CHEM PHYS, V101, P4093, DOI 10.1063/1.467526
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9
   Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970
   HIRSCH RE, 1985, ANAL BIOCHEM, V149, P415, DOI 10.1016/0003-2697(85)90592-5
   HOUSSMANDZADEH B, 1995, J PHYS I, V5, P685
   Ihle T, 1998, PHYS REV B, V58, P2289, DOI 10.1103/PhysRevB.58.2289
   Israelachvili J., 1995, INTERMOLECULAR SURFA
   Jackson K. A., 1958, GROWTH PERFECTION CR, P319
   KAISCHEW R, 1937, Z PHYS CHEM B LPZ, V35, P427
   Kim SH, 1998, NAT STRUCT BIOL, V5, P643, DOI 10.1038/1334
   KITAMURA N, 1993, PHYS REV LETT, V71, P2081
   KUIPERS L, 1993, PHYS REV LETT, V71, P3517, DOI 10.1103/PhysRevLett.71.3517
   KUIPERS L, 1995, PHYS REV B, V52, P11387, DOI 10.1103/PhysRevB.52.11387
   Kuyper LF, 1996, J CRYST GROWTH, V168, P155, DOI 10.1016/0022-0248(96)00349-1
   Kuznetsov YG, 1999, SURF SCI, V440, P69, DOI 10.1016/S0039-6028(99)00679-2
   Kuznetsov YG, 1997, BIOPHYS J, V72, P2357, DOI 10.1016/S0006-3495(97)78880-5
   KUZNETSOV YG, 1995, J STRUCT BIOL, V114, P184, DOI 10.1006/jsbi.1995.1018
   Land TA, 1997, SURF SCI, V384, P136, DOI 10.1016/S0039-6028(97)00187-8
   LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0
   LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325
   Li HY, 1999, ACTA CRYSTALLOGR D, V55, P1023, DOI 10.1107/S090744499900339X
   LI M, 1999, ACTA CRYSTALLOGR D, V55, P1036
   Li MR, 1999, ACTA CRYSTALLOGR D, V55, P1012, DOI 10.1107/S0907444999002905
   LIN H, 1995, J CRYST GROWTH, V151, P153, DOI 10.1016/0022-0248(95)00016-X
   Lin H, 1996, J CRYST GROWTH, V158, P552, DOI 10.1016/0022-0248(95)00426-2
   Lin H, 2001, CRYST GROWTH DES, V1, P73, DOI 10.1021/cg005515g
   LIN H, 2003, PHYS REV E, V67
   Long MM, 1996, J CRYST GROWTH, V168, P233, DOI 10.1016/0022-0248(96)00325-9
   Malkin AJ, 1999, J STRUCT BIOL, V127, P35, DOI 10.1006/jsbi.1999.4128
   Malkin AJ, 1996, J PHYS CHEM-US, V100, P11736, DOI 10.1021/jp960745k
   MALKIN AJ, 1995, NAT STRUCT BIOL, V75, P2778
   Marchenko V.I., 1980, SOV PHYS JETP, V52, P129
   MASSOVER WH, 1993, MICRON, V24, P389, DOI 10.1016/0968-4328(93)90005-L
   MATSUDA S, 1989, J BIOL CHEM, V264, P13381
   MCPHERSON A, 1995, STRUCTURE, V3, P759, DOI 10.1016/S0969-2126(01)00211-8
   McPherson A, 1999, CRYSTALLIZATION BIOL
   MEINING W, 1995, J MOL BIOL, V253, P208, DOI 10.1006/jmbi.1995.0545
   MILCHEV A, 1991, CONTEMP PHYS, V32, P321, DOI 10.1080/00107519108223705
   Nadarajah A, 1997, ACTA CRYSTALLOGR D, V53, P524, DOI 10.1107/S0907444997003041
   Nadarajah A, 1996, ACTA CRYSTALLOGR D, V52, P983, DOI 10.1107/S0907444996004532
   Nakada T, 1999, J CRYST GROWTH, V196, P503, DOI 10.1016/S0022-0248(98)00875-6
   Noy A, 1998, LANGMUIR, V14, P1508, DOI 10.1021/la970948f
   Pereira AS, 1997, BIOCHEMISTRY-US, V36, P7917, DOI 10.1021/bi970348f
   Peseta S., 1989, ANNU REV BIOCHEM, P727
   Petsev DN, 2000, BIOPHYS J, V78, P2060, DOI 10.1016/S0006-3495(00)76753-1
   Petsev DN, 2001, J CRYST GROWTH, V232, P21, DOI 10.1016/S0022-0248(01)01095-8
   POENSGEN M, 1992, SURF SCI, V274, P430, DOI 10.1016/0039-6028(92)90848-Z
   Prater BD, 1999, J CRYST GROWTH, V196, P674, DOI 10.1016/S0022-0248(98)00862-8
   PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x
   RASHKOVICH LN, 1998, CRYSTALLOG REPORTS, V43, P669
   REICHERT P, 1995, Patent No. 5441734
   Rosenbaum D, 1996, PHYS REV LETT, V76, P150, DOI 10.1103/PhysRevLett.76.150
   ROSENBERGER F, 1996, J CRYST GROWTH, V167, P1
   Sear RP, 1999, J CHEM PHYS, V111, P4800, DOI 10.1063/1.479243
   SEEGER A, 1953, PHILOS MAG, V44, P348
   Service RF, 1999, SCIENCE, V285, P1342, DOI 10.1126/science.285.5432.1342
   Stewart PDS, 1999, J CRYST GROWTH, V196, P665, DOI 10.1016/S0022-0248(98)00854-9
   Stranski IN, 1928, Z PHYS CHEM-STOCH VE, V136, P259
   Stranski IN, 1934, Z PHYS CHEM B-CHEM E, V26, P100
   STRANSKI IN, 1934, Z PHYS CHEM B LPZ, V26, P114
   Swartzentruber BS, 1998, J CRYST GROWTH, V188, P1, DOI 10.1016/S0022-0248(98)00039-6
   SWARTZENTRUBER BS, 1990, PHYS REV LETT, V65, P1913, DOI 10.1103/PhysRevLett.65.1913
   TAFT KL, 1993, SCIENCE, V259, P1302, DOI 10.1126/science.8446898
   Takeda S, 1995, PROTEINS, V23, P548, DOI 10.1002/prot.340230409
   Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724
   tenWolde PR, 1997, SCIENCE, V277, P1975
   THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289
   THOMAS BR, 1997, J CRYST GROWTH, V187, P499
   TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028
   Van der Eerden J. P., 1993, HANDB CRYST GROWTH, V1, P307
   VANDERHOEK B, 1982, J CRYST GROWTH, V58, P365, DOI 10.1016/0022-0248(82)90284-6
   VEKILOV PG, 1995, J CRYST GROWTH, V156, P267, DOI 10.1016/0022-0248(95)00240-5
   Vekilov PG, 1998, PHYS REV E, V57, P6979, DOI 10.1103/PhysRevE.57.6979
   Vekilov PG, 1996, J CRYST GROWTH, V158, P540, DOI 10.1016/0022-0248(95)00398-3
   Vekilov PG, 1996, PHYS REV E, V54, P6650, DOI 10.1103/PhysRevE.54.6650
   Vekilov PG, 1998, J PHYS CHEM B, V102, P5208, DOI 10.1021/jp973123n
   Vekilov PG, 2000, CHEM REV, V100, P2061, DOI 10.1021/cr9800558
   VEKILOV PG, 1993, STUDIES CONCEPTS CRY, P25
   Voigtlander B, 1998, PHYS REV LETT, V81, P858, DOI 10.1103/PhysRevLett.81.858
   VOLMER M, 1939, KINETIK PHASENBILDUN
   Warren WS, 1998, SCIENCE, V280, P398, DOI 10.1126/science.280.5362.398
   WEBER P, 1991, ADV PROTEIN CHEM, V41
   Weber PC, 1997, METHOD ENZYMOL, V276, P13, DOI 10.1016/S0076-6879(97)76048-8
   WEINKAUF S, 1991, J MOL BIOL, V221, P637, DOI 10.1016/0022-2836(91)80078-9
   WILLIAMS ED, 1991, SCIENCE, V251, P393, DOI 10.1126/science.251.4992.393
   WOLF D, 1992, SURF SCI, V277, P301, DOI 10.1016/0039-6028(92)90770-7
   Wutrich K., 1995, ACTA CRYSTALLOGR D, V51, P249
   YANG DW, 1995, BIOCHEM J, V307, P253, DOI 10.1042/bj3070253
   Yau ST, 2000, PHYS REV LETT, V85, P353, DOI 10.1103/PhysRevLett.85.353
   Yip CM, 1998, BIOPHYS J, V75, P1172, DOI 10.1016/S0006-3495(98)74036-6
   Yip CM, 1996, BIOPHYS J, V71, P1071, DOI 10.1016/S0006-3495(96)79307-4
NR 126
TC 11
Z9 11
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8974
J9 PROG CRYST GROWTH CH
JI Prog. Cryst. Growth Charact. Mater.
PY 2002
VL 45
IS 3
BP 175
EP 193
DI 10.1016/S0960-8974(03)00002-0
PG 19
WC Crystallography; Materials Science, Characterization & Testing
SC Crystallography; Materials Science
GA 689LW
UT WOS:000183495500001
DA 2018-10-19
ER

PT S
AU Janis, AD
   Lagerquist, KA
   Hinds, MT
AF Janis, AD
   Lagerquist, KA
   Hinds, MT
GP IEEE
   IEEE
   IEEE
TI Directional permeability in a porcine carotid elastin biomaterial
   vascular conduit - 2(nd) Joint Conference of the IEEE Engineering in
   Medicine and Biology Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE elastin; vascular; permeability
AB Purified porcine carotid elastin is under development as a substrate for a vascular conduit. The permeability of the graft may have implications in recellularlization. Light and scanning electron microscopy indicate that the lumen and adventitial surfaces have unique extracellular matrix morphology. This study investigates the permeability of the material, with consideration of the direction of the flow. The permeability of the adventitial surface was found to be approximately twice that of the lumenal surface. The mean permeability was 0.0123 +/- 0.005 mL/min*cm(2) for flow through from lumen surface to the adventitial surface and 0.0310 +/- 0.007 mL/min*cm(2) for flow through the adventitial surface to the lumen surface. The difference in elastin architecture can be taken advantage of to optimize recellularization in vitro and in vivo This is only the second biomaterial to have this described behavior.
C1 Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
RP Janis, AD (reprint author), Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
CR FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   WESOLOWSKI SA, 1962, EVALUATION TISSUE PR
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 413
EP 414
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800197
DA 2018-10-19
ER

PT S
AU Chiu, J
   Kim, K
   Zhong, S
   Hsiao, B
   Chu, B
   Hadjiargyrou, M
AF Chiu, J
   Kim, K
   Zhong, S
   Hsiao, B
   Chu, B
   Hadjiargyrou, M
GP IEEE
   IEEE
   IEEE
TI Development of a cell-delivery vehicle derived from electrospun
   non-woven nanostructured membranes
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE tissue engineering; electrospinning; nanostructures; cell-delivery
   vehicle; biodegradable scaffold
AB The construction and utilization of biodegradable and biocompatible scaffolds have long been practiced in tissue engineering. More recently, electrospinning has become increasingly popular as a means of manufacturing nanostructured scaffolds containing non-woven nanofibers for various biomedical applications. In this study, we expound on the prior art to potentially create a cell-delivery vehicle whose material and mechanical properties can be explicitly controlled by discriminating polymer compositions and concentrations. The introduction of a block copolymer (PLA 0.8 kD/PEG 3.4 kD/PLA 0.8 kD) as a bridging material to the hydrophobic PLA- and PLGA-based matrix has successfully inhibited in vitro conformational changes (i.e. shrinkage) while also improving cell affinity. The presence of this block copolymer in various concentrations has demonstrated characteristic degradation profiles in physiological medium - thus enabling us to specifically control breakdown rates. Furthermore, we successfully demonstrate that cells can migrate through a thin (10 gm) fibrous barrier and still remain viable for surface adhesion and proliferation. Taken together, these results indicate that a cell delivery vehicle composed of biodegradable polymers is indeed a viable option for tissue engineering.
C1 SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Chiu, J (reprint author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
OI Hadjiargyrou, Michael/0000-0001-8927-2333
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Kim KS, 1999, J APPL POLYM SCI, V72, P341, DOI 10.1002/(SICI)1097-4628(19990418)72:3<341::AID-APP4>3.0.CO;2-D
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 759
EP 760
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800364
DA 2018-10-19
ER

PT S
AU Deng, LH
   Karagiannoglou, SH
   Sakkas, WI
   Barbenel, JC
AF Deng, LH
   Karagiannoglou, SH
   Sakkas, WI
   Barbenel, JC
GP IEEE
   IEEE
   IEEE
TI Effects of geometrical factors of coplanar electrodes on biomedical
   measurements as exemplified by the electrical impedance measurement of
   saline and blood
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE coplanar electrode; geometrical configuration; biosensor; bioimpedance;
   saline; blood; hematocrit
AB In many biomedical measurements, particularly in biosensor applications, coplanar electrodes have to be used because the conventional parallel-plate configuration is either impossible or not preferred. Despite the wide use, the characteristics. of the coplanar electrodes have not been well studied, in particular the effects of the geometrical factors of the electrode on the measurement. In this report, we present our results of the effects of coplanar electrode's geometrical factors on the measurement of bioelectrical impedance, one of the most widely measured physical properties in biomedical applications. Coplanar electrodes of different shapes and sizes were used to measure the electrical impedance of saline at different concentration and blood reconstituted at different hematocrit in either plasma or serum. The results show that the impedance measurement by coplanar electrodes are sensitive-to the geometry-of the electrode as well as the sample boundary in addition to the universal determinants such as the ionic or cellular concentration of the material under test. This implies that all the geometrical parameters of a coplanar electrode ought to be taken into account collectively of-its design when it, is used in biomedical instrumentation. Thus the reliability of the instrument as well as the measurement may be assured.
C1 Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
RP Deng, LH (reprint author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
RI Deng, Linhong/C-1485-2009
OI Deng, Linhong/0000-0003-1970-8239
CR *ICSH, 1986, CLIN HEMORHEOL, V10, P436
   JACOBSON I, 1995, J OBJECT ORIENTED PR, V3, P10
   OKADA RH, 1960, IRE T MED ELECTRON, V7, P188, DOI 10.1109/IRET-ME.1960.5008044
NR 3
TC 3
Z9 3
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 1667
EP 1668
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800821
DA 2018-10-19
ER

PT S
AU Xu, JZ
   Ying, H
   Auner, G
AF Xu, JZ
   Ying, H
   Auner, G
GP IEEE
   IEEE
   IEEE
TI Development of aluminum nitride-based acoustic wave sensors #
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE acoustic wave sensor; biosensors; chemical sensors; surface acoustic
   wave; surface transverse wave; Aluminum Nitride thin films;
   immobilization
AB One of the most important applications of acoustic wave sensor systems is to detect chemical or biological agents because of their great potential for real-time and highly sensitive detection at low cost. We report preliminary experimental results on developing novel acoustic wave sensors for biomedical applications using Aluminum Nitride (AlN) thin films. Compared to conventional piezoelectric materials such as quartz, AlN is advantageous in terms of higher acoustic velocity, higher electromechanical coupling coefficient, and higher stability in harsh environment, translating to better sensor performance. We have designed, prototyped, and tested an AlN-based sensor. The center frequency is measured 174 MHz for its surface acoustic wave mode and 206 MHz for its surface transverse wave mode. The phase velocities are 5569 m/s and 6608 m/s, respectively. As expected, the frequency response of the surface transverse wave mode changed little when under water load. Immobilization was investigated using chemical compounds or magnetic microbeads. The result showed good affinity to AlN film. Finally, we found almost linear relationship between the resonant frequency of the sensor and temperature, with the temperature coefficient being about 90 PPMdegreesC.
C1 Wayne State Univ, Dept Elect & Comp Engn, Detroit, MI 48202 USA.
RP Auner, G (reprint author), Wayne State Univ, Dept Elect & Comp Engn, Detroit, MI 48202 USA.
CR Ballantine D., 1997, ACOUSTIC WAVE SENSOR
   CALIENDO C, 1992, P IEEE ULTR S, P219
   WHITE RM, 1970, PR INST ELECTR ELECT, V58, P1238, DOI 10.1109/PROC.1970.7900
   ZHAO Q, 2000, MARS INT J NITRID S1, V5
   ZHONG F, 2001, THESIS WAYNE STATE U
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 1716
EP 1717
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800845
DA 2018-10-19
ER

PT S
AU Cogan, SF
AF Cogan, SF
GP IEEE
   IEEE
   IEEE
TI Stability of electro-active materials and coatings for charge-injection
   electrodes - 2(nd) Joint Conference of the IEEE Engineering in Medicine
   and Biology Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE charge-injection; electrodes; coatings; iridium oxide; titanium nitride;
   noble metals; stability; electrochemistry
ID IRIDIUM OXIDE ELECTRODES; PACING LEAD; MICROSTIMULATION; STIMULATION;
   CAT; MICROELECTRODES; DISSOLUTION; SALINE; CORTEX
AB The stability of materials and coatings for charge injection in electrical stimulation with chronically implanted electrodes is reviewed. The focus of the review is iridium oxide, whose performance and charge-injection mechanisms are contrasted with other high-charge capacity materials such as high-surface-area titanium nitride and noble metal coatings, as well as traditional noble metals. The appropriateness of iridium oxide and these materials for applications in functional electrical stimulation is discussed with an emphasis on the stability of their electrochemical function in chronic implants. Gaps in our knowledge of the in vivo electrochemistry and chronic stability of iridium oxide are identified. The structure and electrochemical properties of iridium oxide that permit high charge injection capacities are described and thoughts on how these generally desirable features may also compromise the chronic in vivo stability of iridium oxide electrodes are presented.
C1 EIC Labs, Norwood, MA 02062 USA.
RP Cogan, SF (reprint author), EIC Labs, Norwood, MA 02062 USA.
CR BEEBE X, 1988, IEEE T BIO-MED ENG, V35, P494, DOI 10.1109/10.2122
   BOLZ A, 1993, MED PROG TECHNOL, V19, P129
   Breivik K, 1997, PACE, V20, P637, DOI 10.1111/j.1540-8159.1997.tb03882.x
   MCCREERY DB, 1994, HEARING RES, V77, P105, DOI 10.1016/0378-5955(94)90258-5
   McCreery DB, 1997, IEEE T BIO-MED ENG, V44, P931, DOI 10.1109/10.634645
   ROBBLEE LS, 1983, J NEUROSCI METH, V9, P301, DOI 10.1016/0165-0270(83)90062-6
   ROBBLEE LS, 1980, BIOMATERIALS, V1, P135, DOI 10.1016/0142-9612(80)90035-6
   ROBBLEE LS, 1983, J ELECTROCHEM SOC, V130, P731, DOI 10.1149/1.2119793
   ROBBLEE LS, 1990, NEURAL PROSTHESES FU, P25
   SCHALDACH M, 1995, MED PROG TECHNOL, V21, P1
   Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   Woodford BJ, 1996, J NEUROPATH EXP NEUR, V55, P982, DOI 10.1097/00005072-199609000-00005
NR 13
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2062
EP 2063
DI 10.1109/IEMBS.2002.1053168
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801011
DA 2018-10-19
ER

PT S
AU Torosyan, G
   Nerkararyan, K
   Beigang, R
AF Torosyan, G
   Nerkararyan, K
   Beigang, R
GP IEEE
   IEEE
   IEEE
TI Application of narrowband tunable THz-radiation for biomedical sensing -
   2(nd) Joint Conference of the IEEE Engineering in Medicine and Biology
   Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE THz radiation; biomedical sensor; waveguide
ID POLED LITHIUM-NIOBATE; TERAHERTZ RADIATION; GENERATION
AB The use of narrowband tunable THz radiation for biomedical sensing applications is discussed. The THz radiation is generated via optical rectification in periodically poled nonlinear materials in a frequency range from 100 GHz to 3 THz. Center frequency and bandwidth can easily be adjusted to the requirements of the application. Different THz sensors utilizing evanescent THz fields - are presented including waveguides and photonic bandgap structures.
C1 Univ Kaiserslautern, Fachbereich Phys, Kaiserslautern, Germany.
RP Torosyan, G (reprint author), Univ Kaiserslautern, Fachbereich Phys, Kaiserslautern, Germany.
CR Lee YS, 2000, APPL PHYS LETT, V76, P2505, DOI 10.1063/1.126390
   Nagel M, 2002, APPL PHYS LETT, V80, P154, DOI 10.1063/1.1428619
   QI ZM, 2002, OPT LETT, V27, P686
   Vollmer F, 2002, APPL PHYS LETT, V80, P4057, DOI 10.1063/1.1482797
   Weiss C, 2001, OPT LETT, V26, P563, DOI 10.1364/OL.26.000563
   WEISS C, 2001, OPT EXPRESS, V9, P497
NR 6
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2335
EP 2336
DI 10.1109/IEMBS.2002.1053309
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801144
DA 2018-10-19
ER

PT S
AU Schwartz, LB
AF Schwartz, LB
GP IEEE
   IEEE
   IEEE
TI The dilemma of bioengineering research on human subjects
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE human subject research
AB The increased scrutiny of human subject research is underscored by the recent suspension of authority of several prestigious medical centers by the federal Office of Human Research Protection (OHRP). Fueled in part by the well-publicized death of a young patient enrolled in a gene therapy trial in 1999, the OHRP's "reign of terror" has had far-reaching implications for all scientists, patients, and administrators engaged in human subject research.
   The first fundamental ethical standards for the conduct of research involving humans was the Nuremberg Code. Recognizing a need for a broader scope, The National Commission for the protection of Human Subjects of Biomedical and Behavioral Research was created in 1974 and charged to identify and expand the basic ethical principles that should underlie all human subject research. Its deliberations are summarized in The Belmont Report which establishes three fundamental ethical principles: respect for persons, beneficence, and justice. Title 45 Code of Federal Regulations, Part 46, Protection of Human Subjects (45 CFR Part 46) embraces the findings of The Belmont Report, and provides regulations for human research conducted or supported by the Intramural Research Program (IRP) of the National Institutes of Health (NIH).
   As defined by the NIH, a "human subject" is a living individual about whom an investigator obtains either (1) data through interaction or intervention with the individual or, (2) identifiable private information. "Research" is an systematic investigation designed to develop or contribute to generalizable knowledge. These definitions naturally require considerable interpretation on a case-by-case basis. For instance, specifically excluded are (1) samples from decreased individuals, (2) samples collected for diagnostic purposes only, (3) samples or data that are available from commercial or public repositories or registries, (4) established cell lines, and (5) cell-free genetic material such as viral isolates, closed DNA, or RNA. Obviously included are prospective studies testing the efficacy of a particular drug or intervention, and studies of new devices. Less obvious inclusions are (1) case reports, (2) retrospective case series, (3) studies that tabulate the results of laboratory tests from living subjects, (4) studies including any pathologic specimen from a living subject, (5) studies which include any x-ray or imaging study from any living individual, and (6) studies which include any hemodynamic or technical data from which an individual could be retrospectively identified. In short, all experiments and experimental protocols should be submitted for review by an institution's Internal Review Board, and the determination of exemption made by the board. This includes studies initiated at the home institution, as well as any collaborative activities, which are also rather broadly defined by the regulations.
   In summary, there are fundamental differences in the way that standards are generated for clinical medicine, bioengineering research, and human subject research. The standards for both clinical medicine and research have generally been set by the practitioners and scientists through peer review. This is. not the case. with human subject research, and any practitioner or scientist that merely follows his or her internal ethical standards does so at the institution's peril. The standards for human subject research are rightfully set by agencies of the international community and federal government and strict adherence is mandated by law. Whether or not the rigid ethical standards can ever reasonably be relaxed depends on the commitment of the scientific community to the consistent performance of human subject research with vigilant respect for persons, beneficence, and justice.
C1 Univ Chicago, Vasc Surg Sect, Chicago, IL 60637 USA.
RP Schwartz, LB (reprint author), Univ Chicago, Vasc Surg Sect, Chicago, IL 60637 USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2668
EP 2669
DI 10.1109/IEMBS.2002.1053483
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801307
DA 2018-10-19
ER

PT S
AU Lee, SK
   Lee, SJ
   An, HJ
   Cha, SE
   Chang, JK
   Kim, B
   Pak, JJ
AF Lee, SK
   Lee, SJ
   An, HJ
   Cha, SE
   Chang, JK
   Kim, B
   Pak, JJ
BE BarCohen, Y
TI Biomedical applications of electroactive polymers and shape memory
   alloys
SO SMART STRUCTURES AND MATERIALS 2002: ELECTROACTIVE POLYMER ACTUATORS AND
   DEVICES (EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2002 Conference
CY MAR 18-21, 2002
CL SAN DIEGO, CA
SP SPIE, Amer Soc Mech Engineers, Soc Exptl Mech, Boeing Co, Rhombus Consultants Grp, CSA Engn, ISIS Canada, USAF Off Sci Res, Def Adv Res Projects Agcy, Intelligent Mat Forum, USA Res OFf, Jet Propuls Lab, Natl Sci Fdn, Ceram Soc Japan, USN Off Naval Res, Nav Res Lab
DE polypyrrole; shape memory alloy; functional materials; actuator; drug
   delivery system
AB Among many kinds of polymer materials, electronic conductive material, that is polypyrrole, shows potential possibility for bio-related actuator materials. However, it may be an impediment for practical use of polypyrrole actuator that polypyrrole usually requires electrolyte solution for actuation. Our first research theme is focused on this problem solving. We have investigated many kinds of solid polymer electrolytes for the substitution of electrolyte solution. Our goals are to find the stable solid electrolyte in the air, to establish the reliable fabrication process of it and to apply it for micropump application. Besides actuators, the reduction and oxidation property of polypyrrole can be exploited for active drug delivery systems by the control of structural deformation of it. We have investigated this kind of new and bio-related possibility of polypyrrole. Shape memory alloy has another possibility in biomedical field. Due to its inherent excellent advantages as actuator materials, it can be used for micro active intravascular catheter. We have developed thin tube type bending actuator using shape memory alloy and characterized its performance by in-vivo test.
C1 Dankook Univ, Dept Elect Engn, Seoul 140714, South Korea.
RP Lee, SK (reprint author), Dankook Univ, Dept Elect Engn, Seoul 140714, South Korea.
CR BARCOHEN Y, 2000, KEYN PRES ROB 2000 S
   Barisci JN, 1997, PROC SPIE, V3241, P10, DOI 10.1117/12.293529
   Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5
   FUNAKUBO H, 1984, SHAPE MEMORY ALLOYS
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   GANDHI MR, 1995, SYNTHETIC MET, V73, P247, DOI 10.1016/0379-6779(95)80022-0
   Gardner JW, 1995, SENSOR ACTUAT A-PHYS, V51, P57, DOI 10.1016/0924-4247(96)80053-7
   Guo S., 1995, P INT S MICR MACH HU, P131
   KIM MS, 1997, T KIEE, V46, P445
   LEE SK, 2000, P SPIES 7 INT S SMAR, P291
   LIM AS, 1999, P 10 INT C SOL STAT, V2, P1894
   LIM G, 1995, P IEEE MEMS WORKSH, P116
   PEI QB, 1992, ADV MATER, V4, P277, DOI 10.1002/adma.19920040406
   Smela E., 1993, Journal of Micromechanics and Microengineering, V3, P203, DOI 10.1088/0960-1317/3/4/008
NR 14
TC 5
Z9 5
U1 0
U2 9
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4443-X
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4695
BP 17
EP 31
DI 10.1117/12.475196
PG 15
WC Engineering, Electrical & Electronic; Materials Science, Composites;
   Robotics; Optics; Polymer Science
SC Engineering; Materials Science; Robotics; Optics; Polymer Science
GA BV10E
UT WOS:000177817700003
DA 2018-10-19
ER

PT S
AU Gulch, RW
   Weible, A
   Wallmersperger, T
AF Gulch, RW
   Weible, A
   Wallmersperger, T
BE BarCohen, Y
TI Characterization of electroactive behavior and of progress in
   developments and applications of ionic polymer gels
SO SMART STRUCTURES AND MATERIALS 2002: ELECTROACTIVE POLYMER ACTUATORS AND
   DEVICES (EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2002 Conference
CY MAR 18-21, 2002
CL SAN DIEGO, CA
SP SPIE, Amer Soc Mech Engineers, Soc Exptl Mech, Boeing Co, Rhombus Consultants Grp, CSA Engn, ISIS Canada, USAF Off Sci Res, Def Adv Res Projects Agcy, Intelligent Mat Forum, USA Res OFf, Jet Propuls Lab, Natl Sci Fdn, Ceram Soc Japan, USN Off Naval Res, Nav Res Lab
DE polyacrylamide gel; polyacrylonitrile fibre; chitosan; biopolymer;
   anionic polyelectrolyte; cationic polyelectolyte; Donnan potential;
   chemical stimulation; electrical stimulation; electrolysis
ID ELECTRIC-FIELDS; POLYELECTROLYTE GELS; SWELLING BEHAVIOR; CHITOSAN;
   HYDROGELS; DEFORMATION
AB Polyelectrolyte gels are distinguished by enormous swelling capabilities under the influence of external physical or chemical stimuli. No other kind of material attains similar volume expansiveness., These properties make them most attractive candidates for a new generation of much greater thanpseudomuscularmuch less than actuators. In contrast to chemical stimulations which are able to trigger large in-toto deformations, weak electric fields can only induce considerable bending strains in ionic polymer gels when confined to direct electrical effects. This, of course, restricts their potential for technical applications. To characterize their chemo-mechanical and. electrical behavior and the underlying physico-chemical processes, experimental and theoretical findings are presented. Measurements of basic mechanical and electrical parameters on polyelectrolyte gels allow quantification of their electroactive responses, especially with respect to the direct effects of external electric fields on the Donnan potential inside the gels. Model calculations on the basis of a coupled chemo-electro-mechanical multi-field formulation are in good agreement with the experimental results. Although the emphasis of this study is given to various anionic and cationic gels of the polyacrylamide family, a new class of hydrogels based on the biopolymer chitosan is included. These natural polymers have excellent properties such as biocompatibility, biodegradability, non-toxicity etc. making them predestinate to biomedical. applications.
C1 Univ Tubingen, Inst Physiol 2, D-72076 Tubingen, Germany.
RP Weible, A (reprint author), Univ Tubingen, Inst Physiol 2, Gmelinstr 5, D-72076 Tubingen, Germany.
RI Wallmersperger, Thomas/S-4822-2016
OI Wallmersperger, Thomas/0000-0002-4720-5260
CR BARCOHEN Y, 2001, ELECTROACTIVE POLYM, V98, P3
   BUCHHOLZ FL, 1992, PLASTICS PROPERTIES, V21, P143
   Calvert P., 2001, ELECTROACTIVE POLYM, VPM98, P123
   DOI M, 1992, MACROMOLECULES, V25, P5504, DOI 10.1021/ma00046a058
   GREGOR HP, 1955, J PHYS CHEM-US, V59, P34, DOI 10.1021/j150523a011
   Gulch RW, 2001, P SOC PHOTO-OPT INS, V4329, P328, DOI 10.1117/12.432664
   Gulch RW, 2000, P SOC PHOTO-OPT INS, V3987, P193, DOI 10.1117/12.387778
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Nisato G, 1999, LANGMUIR, V15, P4236, DOI 10.1021/la981027n
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   Ramanathan S, 2001, J CONTROL RELEASE, V70, P109, DOI 10.1016/S0168-3659(00)00333-3
   Ravi Kumar M. N. V., 1999, B MATER SCI, V22, P905
   Shahinpoor M., 1994, Smart Materials and Structures, V3, P367, DOI 10.1088/0964-1726/3/3/012
   Shahinpoor M, 2000, P SOC PHOTO-OPT INS, V3987, P243, DOI 10.1117/12.387783
   SHIGA T, 1990, J APPL POLYM SCI, V39, P2305, DOI 10.1002/app.1990.070391110
   Smirnova LA, 2001, POLYM SCI SER B+, V43, P33
   Suzuki H, 1999, LANGMUIR, V15, P4283, DOI 10.1021/la981187z
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   UMEMOTO S, 1991, POLYMER GELS, P257
   Wallmersperger T, 2001, P SOC PHOTO-OPT INS, V4329, P264, DOI 10.1117/12.432655
   WALLMERSPERGER T, 2001, ELECTROACTIVE POLYM, V98, P285
   WEI YC, 1992, J POLYM SCI POL CHEM, V30, P2187, DOI 10.1002/pola.1992.080301013
   Yao KD, 1998, POLYM INT, V45, P191, DOI 10.1002/(SICI)1097-0126(199802)45:2<191::AID-PI892>3.0.CO;2-K
   YAO KD, 1993, J APPL POLYM SCI, V48, P343
NR 25
TC 4
Z9 4
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4443-X
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4695
BP 367
EP 377
DI 10.1117/12.475184
PG 11
WC Engineering, Electrical & Electronic; Materials Science, Composites;
   Robotics; Optics; Polymer Science
SC Engineering; Materials Science; Robotics; Optics; Polymer Science
GA BV10E
UT WOS:000177817700040
DA 2018-10-19
ER

PT S
AU Mandelis, A
AF Mandelis, A
BE Maldague, XP
   Rozlosnik, AE
TI Review of progress in theoretical, experimental, and computational
   investigations in turbid tissue phantoms and human teeth using laser
   infrared photothermal radiometry
SO THERMOSENSE XXIV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Thermosense XXIV Conference
CY APR 01-04, 2002
CL ORLANDO, FL
SP SPIE
DE frequency-domain; laser infrared photothermal radiometry; turbid media;
   diffuse-photon-density wave; thermal wave; dental enamel; tissue
   phantoms
ID LIGHT-SCATTERING; DENTAL ENAMEL; MEDIA; REFLECTION
AB This paper reviews and describes the state-of-the-art in the development of frequency-domain infrared photothermal radiometry (FD-PTR) for biomedical and dental applications. The emphasis is placed on the measurement of the optical and thermal properties of tissue-like materials using FD-PTR. A rigorous three-dimensional thermal-wave formulation with three-dimensional diffuse and coherent photon-density-wave sources is presented, and is applied to data from model tissue phantoms and dental enamel samples. The combined theoretical, experimental and computational methodology shows good promise with regard to its analytical ability to measure optical proper-ties of turbid media uniquely, as compared to PPTR, which exhibits uniqueness problems. From data sets obtained with calibrated test phantoms, the reduced optical scattering and absorption coefficients were found to be within 20% and 10%, respectively, from the independently derived values using Mie scattering theory and spectrophotometric measurements.
   Furthermore, the state-of-the-art and recent developments in applications of laser infrared FD-PTR to dental caries research is described, with examples and histological studies from carious dental tissue. The correlation of PTR signals with modulated dental luminescence is discussed as a very promising potential quantitative methodology for the clinical diagnosis of sub-surface incipient dental caries. The application of the turbid-medium thermal-wave model to the measurement of the optical absorption and scattering coefficients of enamel is also presented.
C1 Univ Toronto, Photothermal & Optoelect Diagnost Labs, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
RP Mandelis, A (reprint author), Univ Toronto, Photothermal & Optoelect Diagnost Labs, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
CR ANDERSON RR, 1989, APPL OPTICS, V28, P2256, DOI 10.1364/AO.28.002256
   Bohren C. F, 1983, ABSORPTION SCATTERIN
   BRADEN M, 1964, ARCH ORAL BIOL, V9, P479, DOI 10.1016/0003-9969(64)90033-0
   BUSSE G, 1992, PROGR PHOTOTHERMAL P, V1, P205
   FRIED D, 1995, APPL OPTICS, V34, P1278, DOI 10.1364/AO.34.001278
   Fried D, 1996, OPT ENG, V35, P1976, DOI 10.1117/1.600774
   Fried D, 1996, J Biomed Opt, V1, P455, DOI 10.1117/12.250668
   GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2456, DOI 10.1364/AO.22.002456
   Imhof R.E, 1994, PROGR PHOTOTHERMAL P, V2, P185
   ISHIMARU A, 1983, J OPT SOC AM, V73, P131, DOI 10.1364/JOSA.73.000131
   LEUNG WP, 1984, J APPL PHYS, V56, P153, DOI 10.1063/1.333739
   LONG FH, 1987, APPL PHYS LETT, V51, P2076, DOI 10.1063/1.98985
   MANDELIS A, 2001, DIFFUSION WAVE FIELD, pCH10
   MANDELIS A, IN PRESS PHYS REV E
   MUNIDASA M, 1992, MAT SCI ENG A-STRUCT, V159, P111, DOI 10.1016/0921-5093(92)90404-O
   Nicolaides L, 2000, J BIOMED OPT, V5, P31, DOI 10.1117/1.429965
   OSIZIK MN, 1968, BOUNARY VALUE PROBLE
   PRAHL SA, 1992, PHYS MED BIOL, V37, P1203, DOI 10.1088/0031-9155/37/6/001
   PRESS WH, 1987, NUMERICAL RECIPES C, V1, P149
   SPITZER D, 1975, Calcified Tissue Research, V17, P129
   STAR WM, IN PRESS APPL OPT
   VITKIN IA, 1995, OPTICAL THERMAL RESP, pCH16
   Welch J., 1995, OPTICAL THERMAL RESP
   Zijp JR, 1995, J DENT RES, V74, P1891, DOI 10.1177/00220345950740121301
NR 24
TC 12
Z9 12
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-4460-X
J9 PROC SPIE
PY 2002
VL 4710
BP 373
EP 383
DI 10.1117/12.459586
PG 5
WC Engineering, Mechanical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BU77V
UT WOS:000176994600041
DA 2018-10-19
ER

PT J
AU Ouchi, T
   Uchida, T
   Ohya, Y
AF Ouchi, T
   Uchida, T
   Ohya, Y
TI Synthesis of poly(L-lactide) with one terminal D-glucose residue and
   wettability of its film surface
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biodegradable; biopolymers; polyesters; surfaces; wettability
ID ACID-DEPSIPEPTIDE COPOLYMERS; DRUG-DELIVERY
AB Communication: To develop the new-type poly(L-lactide)- based biomedical material having a wettable surface, Synthesis of poly(L-lactide) with one terminal D-glucose residue was investigated. After the hydroxyl group at 1-C of alpha-tetrabenzyl glucose, alpha-Glc(Bzl)(4),was converted to the corresponding potassium alkoxide by using tert-butoxide, L-lactide (L-LA) was polymerized in the,presence of alpha-Glc(Bzl)(4)-OK as an initiator in tetrahydrofuran at room temperature to prepare alpha-Glc(Bzl)(4)-polyLA. Subsequently, the removal of O-protecting benzyl groups in the terminal alpha-Glc(Bzl)(4) residue was carried put by hydrogenolysis with Pd/C to obtain the objective D-glucose-end-capped polyLA, alpha-Glc-polyLA. The wettability of surface of the alpha-Glc-polyLA material is discussed using the difference of the dynamic contact angle between a alpha-Glc-polyLA/homopolyLA blend film and a film of the polyLA homopolymer.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
CR CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   Heller J, 1984, Crit Rev Ther Drug Carrier Syst, V1, P39
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEOUNG SY, 1986, ARCH PHARM RES, V9, P63
   Kricheldorf HR, 1996, MACROMOL SYMP, V103, P85
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P696, DOI 10.1021/ma9909915
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee SH, 2001, J POLYM SCI POL CHEM, V39, P973, DOI 10.1002/1099-0518(20010401)39:7<973::AID-POLA1073>3.0.CO;2-8
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Ouchi T, 1999, MACROMOL CHEM PHYSIC, V200, P436, DOI 10.1002/(SICI)1521-3935(19990201)200:2<436::AID-MACP436>3.0.CO;2-6
   Ouchi T, 1998, J POLYM SCI POL CHEM, V36, P1283, DOI 10.1002/(SICI)1099-0518(199806)36:8<1283::AID-POLA11>3.0.CO;2-2
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
   OUCHI T, UNPUB MACROMOLECULES
   SCHMIDT OT, 1960, CHEM BER-RECL, V93, P556, DOI 10.1002/cber.19600930247
   WOOD DA, 1980, INT J PHARM, V7, P1, DOI 10.1016/0378-5173(80)90094-0
NR 18
TC 27
Z9 29
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 28
PY 2001
VL 1
IS 9
BP 371
EP 375
DI 10.1002/1616-5195(20011201)1:9<371::AID-MABI371>3.3.CO;2-N
PG 5
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 513RZ
UT WOS:000173394100001
DA 2018-10-19
ER

PT J
AU Tang, YW
   Labow, RS
   Santerre, JP
AF Tang, YW
   Labow, RS
   Santerre, JP
TI Enzyme-induced biodegradation of polycarbonate-polyurethanes: Dependence
   on hard-segment chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polyurethanes; enzymes; esterase; hard segments; biodegradation; phase
   structure; hydrogen bonding
ID MONOCYTE-DERIVED MACROPHAGES; X-RAY-SCATTERING; CHOLESTEROL ESTERASE;
   BLOCK POLYMERS; MODEL SYSTEMS; BIOSTABILITY; STABILITY; POLYETHER;
   DEGRADATION; URETHANES
AB Polycarbonate urethanes (PCNUs) have been used as a replacement for traditional biomedical polyetherurethanes due to their reported resistance to oxidative biodegradation, However, relatively little is known about their hydrolytic stability in the presence of inflammatory derived enzymes. This has in part motivated the current study relating to the effect of hard segment chemistry and the microdomain structures generated by such chemistry, on the cholesterol esterase (CE) catalyzed hydrolysis of PCNUs. The bulk structures of the studied materials were characterized using gel permeation chromatography (GPC), differential scanning calorimetry (DSC), small-angle X-ray scattering (SAXS), Fourier transform infrared spectroscopy (FTIR) for their bulk structures, and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) for their subsurface structures. C-14-labeled PCNUs were incubated with CE (400 units/mL), for a period of 10 weeks (pH 7.0 at 37 degreesC), and radiolabel release was used to monitor the degradation. The results showed that all of the polymers synthesized in this study were susceptible to CE-catalvzed hydrolytic degradation, and that the extent of degradation was highly dependent on the nature of hard segment interactions within the polymer and at the surface. More specifically, the degree of phase separation and soft segment crystallinity were found to be less important in comparison to the hydrogen bonding among the carbonate and urethane linkages. The rank of the different chemical groups' susceptibility to hydrolysis was as follows: nonhydrogen bonded carbonate > nonhydrogen bonded urethane > hydrogen bonded carbonate > hydrogen bonded urethane. The findings suggest that the degree of hydrogen bonding, when processed into a polyurethane material could be an important parameter to consider in the design of new biostable polyurethane products. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON M5G 1G6, Canada.
   Univ Ottawa, Inst Heart, Cardiovasc Devices Div, Ottawa, ON K1Y 4W7, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR ADHIKARI R, 1998, J APPL POLYM SCI, V73, P573
   BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, P 8 ANN SOC BIOM, P24
   BRUNETTE CM, 1981, POLYM ENG SCI, V21, P163, DOI 10.1002/pen.760210309
   CHAPMAN TM, 1989, J POLYM SCI POL CHEM, V27, P1993, DOI 10.1002/pola.1989.080270620
   Culbertson BM, 1989, MULTIPHASE MACROMOLE
   Feigin L. A., 1987, STRUCTURAL ANAL SMAL
   Fukuda M, 1997, J POLYM SCI POL PHYS, V35, P1423, DOI 10.1002/(SICI)1099-0488(19970715)35:9<1423::AID-POLB12>3.0.CO;2-8
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HILL DJT, 1980, POLYM DEGRAD STABIL, V3, P83, DOI 10.1016/0141-3910(80)90010-5
   Hiltunen K, 1997, J APPL POLYM SCI, V64, P865, DOI 10.1002/(SICI)1097-4628(19970502)64:5<865::AID-APP6>3.0.CO;2-N
   Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X
   Kanapitsas A, 1999, J APPL POLYM SCI, V71, P1209, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1209::AID-APP1>3.0.CO;2-5
   Kim YD, 1998, POLYM DEGRAD STABIL, V62, P343, DOI 10.1016/S0141-3910(98)00017-2
   KOBERSTEIN JT, 1983, J POLYM SCI POL PHYS, V21, P1439, DOI 10.1002/pol.1983.180210814
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lelah M. D., 1986, POLYURETHANES MED
   LI YJ, 1994, MACROMOLECULES, V27, P612, DOI 10.1021/ma00080a043
   Lim LT, 1999, J APPL POLYM SCI, V71, P197, DOI 10.1002/(SICI)1097-4628(19990110)71:2<197::AID-APP2>3.0.CO;2-J
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MARCHANT RE, 1988, SURFACE CHARACTERIZA, P297
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   NG HN, 1973, POLYMER, V14, P255, DOI 10.1016/0032-3861(73)90085-2
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Saunders J.H., 1962, POLYURETHANES CHEM 2
   Saunders J. H., 1962, POLYURETHANES CHEM 1
   SEYMOUR RW, 1973, MACROMOLECULES, V6, P896, DOI 10.1021/ma60036a021
   Song YM, 1996, J APPL POLYM SCI, V62, P827, DOI 10.1002/(SICI)1097-4628(19961031)62:5<827::AID-APP15>3.3.CO;2-M
   SPATHIS G, 1994, J APPL POLYM SCI, V54, P831, DOI 10.1002/app.1994.070540701
   SPECKHARD TA, 1985, POLYMER, V26, P70, DOI 10.1016/0032-3861(85)90058-8
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STOKES KB, 1987, POLYM SCI TECHNOL, V35, P147
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   TAO HJ, 1994, MACROMOLECULES, V27, P1720, DOI 10.1021/ma00085a009
   Teo LS, 1997, MACROMOLECULES, V30, P1793, DOI 10.1021/ma961035f
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TINGEY KG, 1995, ACS SYM SER, V602, P66
   Vermette P, 1999, J BIOMAT SCI-POLYM E, V10, P729, DOI 10.1163/156856299X00612
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Yontz DJ, 1998, J POLYM SCI POL PHYS, V36, P3065, DOI 10.1002/(SICI)1099-0488(199812)36:17<3065::AID-POLB7>3.0.CO;2-G
   Yu HS, 1999, MACROMOLECULES, V32, P4365, DOI 10.1021/ma990106i
   ZHANG Z, 1994, BIOMATERIALS, V15, P483
NR 56
TC 99
Z9 103
U1 1
U2 27
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2001
VL 57
IS 4
BP 597
EP 611
DI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 478YQ
UT WOS:000171376800015
PM 11553891
DA 2018-10-19
ER

PT J
AU Fallen, CT
   Costello, J
   Crawford, G
   Schmidt, JA
AF Fallen, CT
   Costello, J
   Crawford, G
   Schmidt, JA
TI Measuring the elastic properties of fine wire
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE MP35N; 304 SS; Young's modulus; shear modulus; strain
AB The elastic moduli of fine wires made from MP35N and 304SS used in implantable biomedical devices are assumed to be the same as those published in the literature. However, the cold working required to manufacture the wire significantly alters the elastic moduli of the material. We describe three experiments performed on fine wire made from MP35N and 304SS. The experimentally determined Young's and shear modulus of both wire types were significantly less than the moduli reported in the literature. Young's modulus differed by as much as 26%, and the shear modulus differed by as much as 14% from reported values. (C) 2001 John Wiley & Sons, Inc.
C1 Quetzal Biomed Inc, Durango, CO 81301 USA.
   Ft Lewis Coll, Dept Phys, Durango, CO 81301 USA.
RP Schmidt, JA (reprint author), Quetzal Biomed Inc, 3455 Main Ave,Suite 4, Durango, CO 81301 USA.
CR Altman PA, 1998, J BIOMED MATER RES, V43, P21, DOI 10.1002/(SICI)1097-4636(199821)43:1<21::AID-JBM3>3.0.CO;2-O
   *AM SOC MET, 1980, MET HDB, V3
   BOLZE RE, 1973, CRC HDB TABLES APPL
   Dieter G. E., 1976, MECH METALLURGY
   Gere J. M., 1990, MECH MAT
   Landau L., 1970, THEORY ELASTICITY
   *LATR STEEL CO, 1980, MULT MP35N ALL TECHN
   LIPSON SG, 1995, OPTICAL PHYSICS
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   ZHAO Y, 2000, P ICCMB 11, P323
   ZHAO Y, 2000, P ICCMB 11, P325
NR 11
TC 13
Z9 15
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 58
IS 6
BP 694
EP 700
DI 10.1002/jbm.1071
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493WN
UT WOS:000172246600013
PM 11745523
DA 2018-10-19
ER

PT J
AU Lavos-Valereto, IC
   Wolynec, S
   Deboni, MCZ
   Konig, B
AF Lavos-Valereto, IC
   Wolynec, S
   Deboni, MCZ
   Konig, B
TI In vitro and in vivo biocompatibility testing of Ti-6Al-7Nb alloy with
   and without plasma-sprayed hydroxyapatite coating
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE osteoblastic-like cells; cell growth; Ti-6Al-7Nb dental implants; dog
   test; hydroxyapatite
ID IN-VITRO; METALLIC IMPLANTS; CALCIUM-PHOSPHATE; DENTAL IMPLANTS; RABBIT;
   BIOMATERIALS; OSSEOINTEGRATION; HYDROXYLAPATITE; MICROSCOPY
AB The Ti-6Al-7Nb alloy has been recently developed for biomedical use, particularly for orthopedics and dental applications. Osteosynthesis has been used to analyze biocompatibility and osseoconduction properties. The interaction of the implant with its biological environment, the formation of the implant material/tissue interface, and the long-term success or failure of integration in the human body is strongly connected with the surface properties of the implant device. This study was undertaken to evaluate the processes involved in biological responses of the Ti-6Al-7Nb alloy with and without hydroxyapatite coatings with both in vitro and in vivo tests. The results were analyzed by scanning electron microscopy (SEM) and energy-dispersive x-ray (EDX) microanalysis. The morphology of the in vitro and in vivo testing results with hydroxyapatite coating was similar to those obtained on the uncoated samples. A mineralized extracellular matrix was formed on all materials. Observation of the interface between the cell layer and substrata showed the presence of calcium and phosphorous-rich globular deposits associated with collagen fibers on all materials in vitro and in vivo. A higher density of these globular deposits was observed in all samples. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Sao Paulo, Polytech Sch, Dept Met & Mat Engn, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Dent, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Biomed Sci, Sao Paulo, Brazil.
RP Lavos-Valereto, IC (reprint author), Rua Pelotas,541 Apdo 1004, BR-04012000 Sao Paulo, Brazil.
RI Deboni, Maria Cristina/G-1859-2010
OI Deboni, Maria Cristina/0000-0002-2966-6039
CR Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   Baquey C, 1999, J MATER SCI-MATER M, V10, P695, DOI 10.1023/A:1008916601608
   BAUER G, 1987, Z ZAHNARZTL IMPLANTO, V5, P263
   BLACK J, 1992, BIOL PERFORMANCE MAT, P390
   Carr AB, 1997, INT J ORAL MAX IMPL, V12, P777
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CHUANXIAN D, 1987, P THERM SPRAY ADV CO, P407
   DEBONI MCZ, 1995, THESIS U SAO PAULO U, P62
   DEBONI MCZ, 1996, RPG, V3, P220
   Demri B, 1997, BIOMATERIALS, V18, P305, DOI 10.1016/S0142-9612(96)00130-5
   Donath K, 1991, Niedersachs Zahnarztebl, V26, P203
   DONATH K, 1995, JDZ, V12, P9
   Donath K., 1993, J HARD TISSUE BIOL, V2, P37
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   HING KA, 1995, P 12 EUR C BIOM PORT, P146
   KHUR KA, 1993, THERMAL SPRAY COATINGS: RESEARCH, DESIGN AND APPLICATIONS, P347
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Konig B, 1998, ANN ANAT, V180, P471
   LABAT B, 1995, J BIOMED MATER RES, V29, P1395
   Lavos-Valereto IC, 2001, J MATER SCI-MATER M, V12, P273, DOI 10.1023/A:1008975418453
   LAVOSVALERETO IC, 1998, THESIS U SAO PAULO U, P129
   LAVOSVALERTO IC, IN PRESS IN VITRO RE
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O, P201
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P129
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Park E, 1998, J MATER SCI-MATER M, V9, P643, DOI 10.1023/A:1008931508465
   Piattelli A, 1997, BIOMATERIALS, V18, P1191, DOI 10.1016/S0142-9612(97)00055-0
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   Tomas H, 1997, J MATER SCI-MATER M, V8, P233, DOI 10.1023/A:1018543808210
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wang SA, 1996, BIOMATERIALS, V17, P1965, DOI 10.1016/0142-9612(96)00020-8
   WILLIAMS DF, 1986, BIOMEDICAL MAT, V55, P117
NR 36
TC 46
Z9 47
U1 0
U2 22
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 58
IS 6
BP 727
EP 733
DI 10.1002/jbm.1072
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493WN
UT WOS:000172246600017
PM 11745527
DA 2018-10-19
ER

PT J
AU Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
AF Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
TI Impact of a nickel-reduced stainless steel implant on striated muscle
   microcirculation: A comparative in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE nickel; stainless steel; osteosynthesis materials; microcirculation;
   biocompatibility
ID MICROVASCULAR RESPONSE; ORTHOPEDIC IMPLANTS; METAL-IONS; TOXICITY;
   TISSUE; MICROSCOPY; LEUKOCYTES; PRODUCTS; TITANIUM; ADHESION
AB The impairment of skeletal muscle microcirculation by a biomaterial may have profound consequences. With moderately good physical and corrosion characteristics, implant-quality stainless steel is particularly popular in orthopedic surgery. However, due to the presence of a considerable amount of nickel in the alloy, concern has been voiced in respect to local tissue responses. More recently a stainless steel alloy with a significant reduction of nickel has become commercially available. We, therefore, studied bi vivo nutritive perfusion and leukocytic response of striated muscle to this nickel-reduced alloy, and compared these results with those of the materials conventional stainless steel and titanium. Using the hamster dorsal skinfold chamber preparation and intravital microscopy, we could demonstrate that reduction of the nickel quantity in a stainless steel implant has a positive effect on local microvascular parameters. Although the implantation of a conventional stainless steel sample led to a distinct and persistent activation of leukocytes combined with disruption of the microvascular endothelial integrity, marked leukocyte extravasation, and considerable venular dilation, animals with a nickel-reduced stainless steel implant showed only a moderate increase of these parameters, with a clear tendency of recuperation. Titanium implants merely caused a transient increase of leukocyte-endothelial cell interaction within the first 120 min, and no significant change in macromolecular leakage, leukocyte extravasation, or venular diameter. Pending biomechanical and corrosion testing, nickel-reduced stainless steel may be a viable alternative to conventional implant-quality stainless steel for biomedical applications. Concerning tolerance by the local vascular system, titanium currently remains unsurpassed, (C) 2001 John Wiley & Sons, Inc.
C1 Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
   Univ Regensburg, Dept Orthopaed Surg, D-93077 Bad Abbach, Germany.
   AO Res Inst, CH-7270 Davos, Switzerland.
RP Kraft, CN (reprint author), Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
CR Abreu A. M., 1995, Biomedical Letters, V52, P133
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   Brunner J, 2000, MICROCIRCULATION, V7, P103, DOI 10.1038/sj.mn.7300094
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   CIGADA A, 1994, COMPATIBILITY BIOMED, P185
   COTRAN RS, 1989, ROBBINS PATHOLOGIC B, P39
   DISEGI JA, 2000, P SOC BIOMATER, V6, P816
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FANTONE JC, 1982, AM J PATHOL, V107, P397
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   HIERHOLZER S, 1992, INTERNAL FIXATION ME
   Hosokawa Y, 1997, X-RAY SPECTROM, V26, P380
   Intergovernmental Oceanographic Commission, 1997, IARC HDB CANC PREV N, P1
   International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, P1
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, P256
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506
   MERRITT K, 1993, BRIS MYER Z, P147
   MERRITT K, 1993, TECHN ORTHOP, V8, P228
   MERRITT K, 1996, CLIN ORTHOP RELAT R, V329, P233
   NIEBOER E, 1980, NICKEL TOXICOLOGY, P359
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   Schaser KD, 1999, J ORTHOPAED RES, V17, P678, DOI 10.1002/jor.1100170509
   Shettlemore MG, 1999, J BIOMED MATER RES, V45, P395
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
   VOLLMAR B, 1993, ZBL CHIR, V118, P691
   WATAHA JC, 1993, J BIOMED MATER RES, V27, P227, DOI 10.1002/jbm.820270212
   WILLIAMS D, 1990, ENCY MED DENT MAT
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V2
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1
NR 42
TC 30
Z9 30
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 404
EP 412
DI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200010
PM 11523035
DA 2018-10-19
ER

PT J
AU Einmahl, S
   Capancioni, S
   Schwach-Abdellaoui, K
   Moeller, M
   Behar-Cohen, F
   Gurny, R
AF Einmahl, S
   Capancioni, S
   Schwach-Abdellaoui, K
   Moeller, M
   Behar-Cohen, F
   Gurny, R
TI Therapeutic applications of viscous and injectable poly(ortho esters)
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE poly(ortho esters); biodegradable polymers; drug delivery;
   ophthalmology; dentistry; veterinary medicine
ID CONTROLLED DRUG-RELEASE; GLAUCOMA FILTERING SURGERY; POLY ORTHO ESTERS;
   IN-VITRO; PROLIFERATIVE VITREORETINOPATHY; BIODEGRADABLE POLYMERS;
   BEAGLE DOGS; INTRAOPERATIVE 5-FLUOROURACIL; IRRADIATION STERILIZATION;
   MECHANICAL-PROPERTIES
AB Poly(ortho esters) (POE) are hydrophobic and bioerodible polymers that have been investigated for pharmaceutical use since the early 1970s. Among the four described generations of POE, the third (POE III) and fourth (POE IV) are promising viscous and injectable materials which have been investigated in numerous biomedical applications. POE III has been extensively studied for ophthalmic drug delivery, it presents an excellent biocompatibility and is currently being investigated as a vehicle for sustained drug delivery to treat diseases of the posterior segment of the eye. POE IV is distinguishable by a highly reproducible and controlled synthesis, a higher hydrophobicity, and an excellent biocompatibility. It is currently under development for a variety of applications, such as ocular delivery, periodontal disease treatment and applications in veterinary medicine. This review will also focus on new perspectives for this promising family of polymers, such as guided tissue regeneration, treatment of osteoarthritis, as well as peptide and protein delivery. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Geneva, Sch Pharm, Dept Pharmaceut & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   INSERM, Lab U450, F-75016 Paris, France.
RP Gurny, R (reprint author), Univ Geneva, Sch Pharm, Dept Pharmaceut & Biopharmaceut, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
OI Moller, Michael/0000-0002-5299-4436
CR Alward WLM, 1996, AM J OPHTHALMOL, V121, P349
   Andriano KP, 1999, J BIOMED MATER RES, V48, P528, DOI 10.1002/(SICI)1097-4636(1999)48:4<528::AID-JBM19>3.0.CO;2-F
   ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   ANDRIANO KP, 1993, J APPL BIOMATER, V4, P1, DOI 10.1002/jab.770040102
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   APPEL LE, 1993, J CONTROL RELEASE, V26, P77, DOI 10.1016/0168-3659(93)90107-G
   Baehni PC, 1997, CURR OPIN PERIODONT, V4, P151
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BECKETT AH, 1987, ARZNEIMITTEL-FORSCH, V37-1, P221
   BEHARCOHEN FF, 2001, EUR PHARM REV, V6, P35
   BERNATCHEZ SF, 1994, J BIOMED MATER RES, V28, P1037, DOI 10.1002/jbm.820280908
   BERNATCHEZ SF, 1993, J BIOMED MATER RES, V27, P677, DOI 10.1002/jbm.820270515
   BLUMENKRANZ MS, 1989, RETINA, P401
   BORA FW, 1987, J HAND SURG-AM, V12A, P685
   BRESSLER NM, 1995, OPHTHALMOLOGY, V102, P1206, DOI 10.1016/S0161-6420(95)30889-5
   BRUERA ED, 1994, CANCER, V74, P3204, DOI 10.1002/1097-0142(19941215)74:12<3204::AID-CNCR2820741220>3.0.CO;2-G
   Bryant DK, 1996, J CHROMATOGR A, V721, P41, DOI 10.1016/0021-9673(95)00766-0
   Burggraaf S., 1997, ADV DRUG DELIV REV, V28, P363
   Busch O, 1996, Int J Oral Maxillofac Implants, V11, P498
   CAPANCIONI S, 2001, EUR J PHARM BIOPHARM
   CAPANCIONI S, 2001, UNPUB EUR J PHARM BI
   CAPOZZA R C, 1976, National Institute on Drug Abuse Research Monograph, V4, P39
   CAPOZZA RC, 1978, POLYM DELIVERY SYSTE, P59
   CARGILL R, 1989, PHARMACEUT RES, V6, P506, DOI 10.1023/A:1015976709043
   Chang MR, 1998, J OCUL PHARMACOL TH, V14, P75, DOI 10.1089/jop.1998.14.75
   Choi NS, 1978, Patent No. [4093709, US4093709]
   CHOI NS, 1978, Patent No. 4079038
   CHOI NS, 1979, Patent No. 4180646
   CHOI NS, 1979, Patent No. 4138344
   CHOI NS, 1978, Patent No. 4131648
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   Clem D S 3rd, 1991, J Calif Dent Assoc, V19, P67
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DAVIES MC, 1991, BIOMATERIALS, V12, P305, DOI 10.1016/0142-9612(91)90038-C
   DAVIES MC, 1992, POLYM ADVAN TECHNOL, V3, P293
   Deshpande AA, 1998, CRIT REV THER DRUG, V15, P381
   DIEHL P, 1989, NMR, V21
   DOYLE JW, 1993, INVEST OPHTH VIS SCI, V34, P3313
   Du J, 1997, J CONTROL RELEASE, V43, P223, DOI 10.1016/S0168-3659(96)01487-3
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   Einmahl S., 1999, ENCY CONTROLLED DRUG, P564
   EINMAHL S, 2001, CHIMIA, V55, P142
   EINMAHL S, 2001, POLYM MED MACROMOLEC, V172, P72
   EINMAHL S, 1907, UNPUB INVEST OPHTHAL
   Ekholm M, 1997, J MATER SCI-MATER M, V8, P265, DOI 10.1023/A:1018552010027
   ELSAYED YM, 1995, INT J PHARM, V123, P113, DOI 10.1016/0378-5173(95)00054-M
   FIX J A, 1986, Journal of Controlled Release, V4, P87, DOI 10.1016/0168-3659(86)90044-1
   Frenzel EM, 1998, INVEST OPHTH VIS SCI, V39, P2157
   GURNY R, 1997, Patent No. 0885014
   HACKETT RP, 1982, J AM VET MED ASSOC, V181, P292
   HARRISON FJJ, 1994, ARZNEIMITTEL-FORSCH, V44-1, P519
   HELLER J, 1987, Journal of Controlled Release, V6, P217, DOI 10.1016/0168-3659(87)90078-2
   Heller J, 2000, EUR J PHARM BIOPHARM, V50, P121, DOI 10.1016/S0939-6411(00)00085-0
   HELLER J, 1991, J CONTROL RELEASE, V16, P3, DOI 10.1016/0168-3659(91)90026-A
   HELLER J, 1993, ADV POLYM SCI, V107, P41
   HELLER J, 1990, J CONTROL RELEASE, V13, P295, DOI 10.1016/0168-3659(90)90019-P
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HELLER J, 1987, Journal of Controlled Release, V5, P173, DOI 10.1016/0168-3659(87)90008-3
   Heller J, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P106
   HELLER J, 1981, POLYM ENG SCI, V21, P727, DOI 10.1002/pen.760211117
   HELLER J, 1990, BIOMATERIALS, V11, P235, DOI 10.1016/0142-9612(90)90003-9
   HELLER J, 1999, ENCY CONTROLLED DRUG, P852
   HELLER J, 1990, BIODEGRADABLE POLYM, P121
   HELLER J, 1981, Patent No. 4304767
   HELLER J, 1981, AICHE S SER, V77, P28
   HELLER J, 1985, J CONTROL RELEASE, V1, P225
   HELLER J, 1997, TRENDS FUTURE PERSPE, P39
   HELLER J, 1985, J CONTROL RELEASE, V1, P233
   Hellstrom I, 1998, CRIT REV IMMUNOL, V18, P1
   HSU SL, 1989, COMPREHENSIVE POLYM, P429
   Hui YN, 1999, GRAEF ARCH CLIN EXP, V237, P601, DOI 10.1007/s004170050284
   KALDAHL WB, 1993, J PERIODONTOL, V64, P243, DOI 10.1902/jop.1993.64.4.243
   Kawcak CE, 1997, AM J VET RES, V58, P1132
   Kramer G M, 1992, Int J Periodontics Restorative Dent, V12, P10
   Leadley SR, 1998, BIOMATERIALS, V19, P1353, DOI 10.1016/S0142-9612(97)00239-1
   LEWIS H, 1991, AM J OPHTHALMOL, V111, P15, DOI 10.1016/S0002-9394(14)76890-4
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   Lin YHE, 2000, J MICROENCAPSUL, V17, P1
   MAA YF, 1990, J CONTROL RELEASE, V14, P21, DOI 10.1016/0168-3659(90)90057-Z
   MAA YF, 1990, J CONTROL RELEASE, V13, P11, DOI 10.1016/0168-3659(90)90070-A
   MADEJ TH, 1988, BRIT J CLIN PHARMACO, V26, P747, DOI 10.1111/j.1365-2125.1988.tb05314.x
   Mader K, 1998, PHARMACEUT RES, V15, P787, DOI 10.1023/A:1011939607573
   MANNIS MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P816
   MCILWRAITH CW, 1988, EQUINE VET J S, V1, P3
   MERKLI A, 1994, J CONTROL RELEASE, V29, P105, DOI 10.1016/0168-3659(94)90126-0
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   Merkli A, 1996, BIOMATERIALS, V17, P897, DOI 10.1016/0142-9612(96)83285-6
   MERKLI A, 1995, EUR J PHARM BIOPHARM, V41, P271
   MERKLI A, 1994, PHARMACEUT RES, V11, P1485, DOI 10.1023/A:1018964511053
   Merkli A, 1998, PROG POLYM SCI, V23, P563, DOI 10.1016/S0079-6700(97)00048-8
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   MITRUKA BM, 1977, CLIN BIOCH HEMATOLOG, P71
   Moses VS, 2001, AM J VET RES, V62, P54, DOI 10.2460/ajvr.2001.62.54
   NEEDLEMAN IG, 1991, BRIT DENT J, V170, P405, DOI 10.1038/sj.bdj.4807569
   Ng SY, 1997, MACROMOLECULES, V30, P770, DOI 10.1021/ma9610626
   Ng SY, 2000, J CONTROL RELEASE, V65, P367, DOI 10.1016/S0168-3659(99)00218-7
   NG SY, 1985, Patent No. 4513143
   NYMAN S, 1991, J CLIN PERIODONTOL, V18, P494, DOI 10.1111/j.1600-051X.1991.tb02322.x
   PEYRON JG, 1993, J RHEUMATOL, V20, P10
   PHARRISS BB, 1976, J REPROD MED, V17, P91
   PINHOLT EM, 1991, ACTA ORTHOP SCAND, V62, P466
   Polson AM, 1996, J PERIODONTOL, V67, P1176, DOI 10.1902/jop.1996.67.11.1176
   Rathbone MJ, 1998, J CONTROL RELEASE, V54, P117, DOI 10.1016/S0168-3659(98)00003-0
   Rathbone MJ, 1998, CRIT REV THER DRUG, V15, P285
   Rathbone MJ, 2000, CONTROLLED RELEASE V
   Rathbone MJ, 1999, ENCY CONTROLLED DRUG, P1007
   Robinson T.J., 1967, CONTROL OVARIAN CYCL
   ROBINSON TJ, 1965, NATURE, V206, P39, DOI 10.1038/206039a0
   ROSKOS KV, 1995, BIOMATERIALS, V16, P313, DOI 10.1016/0142-9612(95)93259-G
   Rothen-Weinhold A, 1998, J CONTROL RELEASE, V52, P205, DOI 10.1016/S0168-3659(97)00216-2
   Rothen-Weinhold A, 2001, J CONTROL RELEASE, V71, P31, DOI 10.1016/S0168-3659(00)00348-5
   Schwach-Abdellaoui K, 2000, EUR J PHARM BIOPHARM, V50, P83, DOI 10.1016/S0939-6411(00)00086-2
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Schwach-Abdellaoui K, 1999, MACROMOLECULES, V32, P301, DOI 10.1021/ma981517m
   Schwach-Abdellaoui K, 2001, BIOMATERIALS, V22, P1659, DOI 10.1016/S0142-9612(00)00327-6
   SCHWACHABDELLAO.K, 2001, UNPUB INT J PHARM
   SCHWACHABDELLAO.K, 2001, UNPUB BIOERODIBLE IN
   SCHWACHABDELLAO.K, 2001, IN PRESS INT J POLYM
   SCHWACHABDELLAO.K, 2001, P INT S CONTR REL BI, V28, P305
   SCHWACHABDELLAO.K, 2001, P INT S CONTR REL BI, V28, P1245
   SEYMOUR LW, 1994, J CONTROL RELEASE, V31, P201, DOI 10.1016/0168-3659(94)00046-8
   SEYMOUR RA, 1995, J CLIN PERIODONTOL, V22, P22
   SHIH C, 1984, BIOMATERIALS, V5, P237, DOI 10.1016/0142-9612(84)90022-X
   SHIH C, 1991, J CONTROL RELEASE, V15, P55, DOI 10.1016/0168-3659(91)90103-K
   SHIH C, 1993, J CONTROL RELEASE, V25, P155, DOI 10.1016/0168-3659(93)90104-D
   Singh K, 1997, AM J OPHTHALMOL, V123, P48, DOI 10.1016/S0002-9394(14)70991-2
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sintzel MB, 1998, BIOMATERIALS, V19, P791, DOI 10.1016/S0142-9612(97)00229-9
   Sintzel MB, 1998, INT J PHARM, V175, P165, DOI 10.1016/S0378-5173(98)00274-9
   Sintzel MB, 1998, J CONTROL RELEASE, V55, P213, DOI 10.1016/S0168-3659(98)00051-0
   Sintzel MB, 1997, INT J PHARM, V155, P263, DOI 10.1016/S0378-5173(97)00169-5
   SOLHEIM E, 1995, J BIOMED MATER RES, V29, P1141, DOI 10.1002/jbm.820290914
   SOLHEIM E, 1992, J BONE JOINT SURG AM, V74A, P705, DOI 10.2106/00004623-199274050-00009
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   SOLHEIM E, 1991, EUR SURG RES, V23, P45, DOI 10.1159/000129135
   SOLHEIM E, 1992, J BONE JOINT SURG AM, V74A, P1456, DOI 10.2106/00004623-199274100-00004
   SOLHEIM E, 1992, J BIOMED MATER RES, V26, P791, DOI 10.1002/jbm.820260608
   SPASSKY N, 1991, MAKROMOL CHEM-M SYMP, V42-3, P15, DOI 10.1002/masy.19910420104
   SUDMANN B, 1993, ACTA ORTHOP SCAND, V64, P336, DOI 10.3109/17453679308993639
   TAMARGO RJ, 1991, CANCER RES, V51, P672
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   TODHUNTER RJ, 1993, J ORTHOPAED RES, V11, P782, DOI 10.1002/jor.1100110603
   Tolentino MJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P78
   TONETTI M, 1990, J PERIODONTAL RES, V25, P243, DOI 10.1111/j.1600-0765.1990.tb00911.x
   VANDAMME TF, 1995, J CONTROL RELEASE, V36, P209, DOI 10.1016/0168-3659(95)00012-W
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Vernino A R, 1999, Int J Periodontics Restorative Dent, V19, P56
   VISTNES LM, 1976, SURGERY, V79, P690
   WIEDEMANN P, 1992, CURR OPIN OPHTHALMOL, V3, P357, DOI 10.1097/00055735-199206000-00010
   WUTHRICH P, 1992, J CONTROL RELEASE, V21, P191, DOI 10.1016/0168-3659(92)90021-I
   YU Z, 1993, J PERIODONTAL RES, V28, P420
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 159
TC 39
Z9 42
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 3
PY 2001
VL 53
IS 1
BP 45
EP 73
DI 10.1016/S0169-409X(01)00220-4
PG 29
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 501XZ
UT WOS:000172712500004
PM 11733117
DA 2018-10-19
ER

PT J
AU Brocchini, S
AF Brocchini, S
TI Combinatorial chemistry and biomedical polymer development
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE combinatorial chemistry; polymer synthesis; biomedical polymers
ID SYNTHETIC-POLYMERS; MASS-SPECTROMETRY; DRUG CARRIERS; SIDE-CHAINS;
   BIOMATERIALS; HEMAGGLUTINATION; INHIBITORS; LIBRARIES; PROTEIN;
   CATALYSIS
AB Polymers are ubiquitous components of products manufactured for medical and pharmaceutical applications. Widely used commodity polymers were the first polymers to be utilised in biomedical applications. These polymers were not developed with biocompatibility established at the onset and many speciality polymers have been developed in recent years to begin to meet the multifaceted demands for medical development, the optimisation of structure-property correlations and ultimately, clinical use. In the broader area of materials research, combinatorial or high throughput strategies used for drug development are recognised to have potential for discovery and process development. Much of the application of combinatorial chemistry in drugs research has been dependent on the use of polymeric reagents, substrates and supports. The chemistry of the reactions on polymers in solid and liquid phases have also played a major role in combinatorial drugs research. There is considerable interest in combinatorial materials research and this review outlines how this research may be applied for biomedical polymer development. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ London, Sch Pharm, Biomed Polymers Grp, Dept Pharmaceut, London WC1N 1AX, England.
RP Brocchini, S (reprint author), Univ London, Sch Pharm, Biomed Polymers Grp, Dept Pharmaceut, 29 Brunswick Sq, London WC1N 1AX, England.
CR ADV MED INC, 2001, Patent No. 0142243
   ALAKHOV V, 1999, COLLOID SURFACE B, V16, P114
   Alakhov V Y, 1998, Expert Opin Investig Drugs, V7, P1453, DOI 10.1517/13543784.7.9.1453
   AVILA LZ, 1993, J MED CHEM, V36, P126, DOI 10.1021/jm00053a016
   Belu AM, 2000, RAPID COMMUN MASS SP, V14, P564, DOI 10.1002/(SICI)1097-0231(20000415)14:7<564::AID-RCM910>3.0.CO;2-0
   Boal AK, 2000, NATURE, V404, P746
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   BROCCHINI S, 2000, DRUG DELIVERY CO REP, P66
   Cawse JN, 2001, ACCOUNTS CHEM RES, V34, P213, DOI 10.1021/ar000117s
   Chen TH, 2001, BIOMACROMOLECULES, V2, P456, DOI 10.1021/bm000125w
   CHOI S, 1998, Patent No. 9847002
   Choi SK, 1997, J AM CHEM SOC, V119, P4103, DOI 10.1021/ja963519x
   Chytry V, 1997, J BIOMAT SCI-POLYM E, V8, P817, DOI 10.1163/156856297X00010
   CRABTREE G, 1999, Patent No. 5869337
   Dickinson TA, 1997, ANAL CHEM, V69, P3413, DOI 10.1021/ac970501b
   Domb A.J., 1997, DRUG TARGETING DELIV
   DUNCAN R, 1984, ADV POLYM SCI, V57, P51
   DUNCAN R, 1992, ANTI-CANCER DRUG, V3, P175, DOI 10.1097/00001813-199206000-00001
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Fu K, 1999, J CONTROL RELEASE, V58, P357, DOI 10.1016/S0168-3659(98)00192-8
   GALAKATOS N, 2000, Patent No. 0059627
   Godwin A., 2001, ANGEW CHEM INT EDIT, V113, P614
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hem DL, 1998, J BIOMED MATER RES, V39, P266
   Hewes JD, 2000, CHIM OGGI, V18, P20
   Hodge P, 2001, REACT FUNCT POLYM, V48, P15, DOI 10.1016/S1381-5148(01)00037-2
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   JAMES K, 1997, EXAMPLES SYNTHETIC M, P389
   Jandeleit B., 1999, ANGEW CHEM INT EDIT, V38, P2494
   JI Y, 1999, Patent No. 9963992
   JOSEPHMCCARTHY D, 1999, Patent No. 9929280
   KABANOV A, 1999, Patent No. 9939731
   KAPLAN AM, 1980, ANIONIC POLYM DRUGS, P227
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1996, POLYM MAT ENCY, V9, P7279
   KOHN J, 2001, Patent No. 0149249
   Langer R, 1998, NATURE, V392, P5
   Lemieux P, 2000, GENE THER, V7, P986, DOI 10.1038/sj.gt.3301189
   LINTON B, 1999, CURR OPIN CHEM BIOL, P307
   Lowe CR, 2001, CURR OPIN CHEM BIOL, V5, P248, DOI 10.1016/S1367-5931(00)00199-X
   Lundquist JJ, 2000, J ORG CHEM, V65, P8245, DOI 10.1021/jo000943e
   MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   MANDEVILLE H, 1999, CURR OPIN CARDIOVASC, V1, P241
   MARQUESS D, 1999, Patent No. 9966944
   MCFARLAND E, 1999, TIB TECH, V17, P115
   MENGER FM, 1995, J ORG CHEM, V60, P6666, DOI 10.1021/jo00126a008
   Menger FM, 1998, J ORG CHEM, V63, P7578, DOI 10.1021/jo9812431
   Menger FM, 1997, J ORG CHEM, V62, P9083, DOI 10.1021/jo971076p
   Motherwell WB, 2001, TETRAHEDRON, V57, P4663, DOI 10.1016/S0040-4020(01)00288-5
   Nathan A., 1994, BIOMEDICAL POLYM DES, P117
   Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o
   Patel N, 2000, J BIOMAT SCI-POLYM E, V11, P319, DOI 10.1163/156856200743724
   Patterson S, 1998, TETRAHEDRON LETT, V39, P3111, DOI 10.1016/S0040-4039(98)00514-0
   PHARM FORMULATION CO, 2001, Patent No. 0149311
   Rader HJ, 1998, ACTA POLYM, V49, P272
   Ramstrom O, 1998, ANAL COMMUN, V35, P9, DOI 10.1039/a707876e
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REECE PA, 1998, Patent No. 9821243
   REGELSON W, 1973, WATER SOLUBLE POLYME, V2, P161
   Reynolds CH, 1999, J COMB CHEM, V1, P297, DOI 10.1021/cc9900044
   Sabourin L, 1998, ANAL COMMUN, V35, P285, DOI 10.1039/a806195e
   SCHREIBER S, 1996, Patent No. 9613613
   Schultz PG, 1998, CURR OPIN SOLID ST M, V3, P153, DOI 10.1016/S1359-0286(98)80081-8
   SPARKS MA, 1993, J MED CHEM, V36, P778, DOI 10.1021/jm00058a016
   Stevens RC, 2000, CURR OPIN STRUC BIOL, V10, P558, DOI 10.1016/S0959-440X(00)00131-7
   Stockwell BR, 1998, CURR BIOL, V8, P761, DOI 10.1016/S0960-9822(98)70299-4
   Strong LE, 1999, J AM CHEM SOC, V121, P6193, DOI 10.1021/ja990223t
   Suarez N, 1998, BIOMATERIALS, V19, P2347, DOI 10.1016/S0142-9612(98)00151-3
   THAO J, 2001, J MATER RES, P1565
   TOONE E, 2000, CARBOHYDR CHEM BIOL, V2, P863
   UCHEGBU F, 1996, P INT S CONTR REL BI
   ULBRICH K, 1987, MAKROMOL CHEM, V188, P1261
   WHITESIDES G, 1998, Patent No. 9846270
NR 77
TC 34
Z9 38
U1 6
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 3
PY 2001
VL 53
IS 1
BP 123
EP 130
DI 10.1016/S0169-409X(01)00224-1
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 501XZ
UT WOS:000172712500008
PM 11733121
DA 2018-10-19
ER

PT J
AU Probst, J
   Gbureck, U
   Thull, R
AF Probst, J
   Gbureck, U
   Thull, R
TI Binary nitride and oxynitride PVD coatings on titanium for biomedical
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE biomedical coatings; vacuum evaporation; X-ray diffraction; titanium;
   refractory metals; steered arc technique
ID ARC-EVAPORATION; HARD COATINGS; TIN; TEMPERATURE
AB The aim of this study was the development and characterization of wear resistant and adhesive (oxy-)nitride refractory metal PVD coatings for biomedical applications. The steered are technique with a special sector target was used to vaporize two different metal components. The subjects of investigations were layers of (Ti,Zr)N, (Ti, NON and (Ti, Nb)ON with an average thickness of approximately 3-4 mum. By means of the sector target. the zirconium content of the (Ti,Zr)N layers could be varied between 50% and 70%, and the niobium content of the (Ti,Nb)N layers between 30% and 40%. X-Ray diffraction analysis showed for all materials that the cubic TiN lattice structure still dominates while a part of the titanium atoms are successively substituted by the second metal component. Zr and Nb, respectively. An excessive insertion of oxygen at interstitial sites leads to an embrittlement of the resulting coatings. All investigated coatings showed a preferred growth in the (111) direction of the cubic lattice. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Wurzburg, Dept Funct Mat Med & Dent, ZMK Clin, D-97070 Wurzburg, Germany.
RP Probst, J (reprint author), Univ Wurzburg, Dept Funct Mat Med & Dent, ZMK Clin, Pleicherwall 2, D-97070 Wurzburg, Germany.
RI Gbureck, Uwe/G-1430-2012
CR BOELENS S, 1987, SURF COAT TECH, V33, P63, DOI 10.1016/0257-8972(87)90177-0
   BRADING HJ, 1992, NUCL INSTRUM METH B, V66, P230, DOI 10.1016/0168-583X(92)96156-S
   CHRISTENSEN A, 1953, T AM SOC MET, V45, P397
   EUFINGER H, 1997, DT ARZTEBLATT, V94, P1962
   Gahlin R, 1995, SURF COAT TECH, V76, P174, DOI 10.1016/02578-9729(50)25979-
   GASSER B, 1997, MO, V51, P88
   HAKANSSON G, 1991, SURF COAT TECH, V48, P51, DOI 10.1016/0257-8972(91)90128-J
   JEROSCH J, 1997, DTSCH ARZTEBLATT, V94, P372
   KNOTEK O, 1989, PLASMA SURF ENG, V2, P643
   *NATL BUR STAND US, 1987, NATL BUR STAND US MO, V21
   *NATL BUR STAND US, 1987, NATL BUR STAND US MO, V136
   *NATL BUR STAND US, 1987, NATL BUR STAND US MO, V25
   POLO MC, 1991, SURF COAT TECH, V45, P67, DOI 10.1016/0257-8972(91)90207-D
   PROBST J, 1998, THESIS U WUERZBURG
   Rocca M, 1998, INT J ARTIF ORGANS, V21, P553
   SCHMIDBAUER SB, 1997, FRONT BIOSCI, V2, P6
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P830, DOI 10.1116/1.568682
   THULL R, 1990, MED PROG TECHNOL, V16, P225
   THULL R, 1994, BONELOCK
NR 19
TC 85
Z9 85
U1 1
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 3
PY 2001
VL 148
IS 2-3
BP 226
EP 233
DI 10.1016/S0257-8972(01)01357-3
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 504UZ
UT WOS:000172875400017
DA 2018-10-19
ER

PT J
AU Bumrerraj, S
   Katz, JL
AF Bumrerraj, S
   Katz, JL
TI Scanning acoustic microscopy study of human cortical and trabecular bone
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE scanning acoustic microscopy; cortical bone; trabecular bone; acoustic
   impedance; elastic moduli
ID ELASTIC PROPERTIES
AB Scanning acoustic microscopy (SAM) has been used in the burst mode to study the properties of human cortical and trabecular bone. An Olympus UH3 SAM (Olympus Co., Tokyo, Japan) was used with a 400 MHz burst mode lens (120degrees aperture, nominal lateral resolution 2.5 mum). The human cortical bone was from the midshaft of a femur from a 60+ male cadaver; the trabecular bone specimens were obtained from the distal femoral condyles of another 60+ human male cadaver. Elastic moduli for both trabecular and cortical bone were obtained by means of a series of calibration curves correlating SAM gray levels of known materials with their elastic moduli, specimens included: polypropylene, PMMA, Teflon, aluminum, Pyrex glass, titanium, and stainless steel. Values obtained by this method are in good agreement with those obtained by nanoindentation techniques. The three critical findings earlier by Katz and Meunier were observed here as well in both the cortical and trabecular bone samples. (C) 2001 Biomedical Engineering Society.
C1 Case Western Reserve Univ, Dept Biomed Engn, Case Sch Engn, Cleveland, OH 44106 USA.
   Khon Kaen Univ, Sch Med, Dept Biochem, Khon Kaen 40002, Thailand.
   Univ Texas, Sch Med, Dept Orthopaed, Houston, TX USA.
RP Katz, JL (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Case Sch Engn, Cleveland, OH 44106 USA.
OI Bumrerraj, Sauwanan/0000-0001-6704-5420
CR Biro L., 1983, Ultrasonics International 83. Conference Proceedings, P79
   BRIGGS GAD, 1992, ACOUSTIC MICROSCOPY
   BUMRERRAJ S, 1999, SCANNING ACOUSTIC MI
   DAS P, 1982, ULTRASON S P IEEE, P718
   Eckardt I, 2001, ANN BIOMED ENG, V29, P1043, DOI 10.1114/1.1424909
   HEIN HJ, 1995, ANN ANAT, V177, P427, DOI 10.1016/S0940-9602(11)80149-4
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   LEE S, HDB ELASTIC PROPERTI, V3, P148
   LEMONS RA, 1974, APPL PHYS LETT, V24, P163, DOI 10.1063/1.1655136
   LEMONS RA, 1979, PHYS ACOUSTICS, V14, P1
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
NR 14
TC 33
Z9 34
U1 0
U2 9
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1034
EP 1042
DI 10.1114/1.1424908
PG 9
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600002
PM 11853252
DA 2018-10-19
ER

PT J
AU Kreuz, P
   Arnold, W
   Kesel, AB
AF Kreuz, P
   Arnold, W
   Kesel, AB
TI Acoustic microscopic analysis of the biological structure of insect wing
   membranes with emphasis on their waxy surface
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE dragonfly; locust; aeshna cyanea; locusta migratoria; cuticle; ultrathin
   membranes
ID CHITIN
AB The mechanical performance of natural materials depends on the type, and especially the composition of the molecular constituents. They are almost without exception composite materials, whose characteristics are determined by the characteristics of the individual constituents, their shape, their interaction, and in particular their orientation within the natural material. One of the most impressive natural composites is the insect cuticle. This lightweight building material impresses one with its ability to withstand extremely heavy loading. Even the ultrathin (3-10 mum) membranes of insect wings add greatly to the structural stability of the wings. By means of acoustic microscopy, the present study also shows that the thin covering of wax on the membrane is not an accidental material arrangement. Contrary to that of locust wings, dragonfly wing membranes were found to have a criss-cross fiber-like density gradient within to the waxy layer. This density gradient proved to be mechanically relevant in stabilizing the wings. (C) 2001 Biomedical Engineering Society.
C1 Univ Saarland, Dept Zool Tech Biol & Bion, D-66041 Saarbrucken, Germany.
   Univ Saarland, Fraunhofer Inst Nondestruct Testing, IZFP, D-66041 Saarbrucken, Germany.
RP Kesel, AB (reprint author), Univ Saarland, Dept Zool Tech Biol & Bion, D-66041 Saarbrucken, Germany.
EM a.kesel@rz.uni-sb.de
RI Arnold, Walter/G-4717-2011
OI Arnold, Walter/0000-0003-3588-8719
CR BLACKWELL J, 1980, J MOL BIOL, V137, P49, DOI 10.1016/0022-2836(80)90156-4
   BRIGGS GAD, 1992, ACOUSTIC MICROSCOPY
   Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f
   DANG VL, 1995, POLYM MAT ENCY SYNTH
   Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7
   GORDON JE, 1998, SCI STRUCTURE MAT
   Hirsekorn S, 1996, APPL PHYS LETT, V69, P2138, DOI 10.1063/1.118156
   Kesel AB, 1998, COMPUT BIOL MED, V28, P423, DOI 10.1016/S0010-4825(98)00018-3
   Kesel AB, 2001, ZOOL-ANAL COMPLEX SY, V103, P222
   KESEL AB, 1998, 12 BION, P107
   KESEL AB, 1996, P 9 INT C MECH MED B, P395
   KESEL AB, 2001, 15 BION, P164
   KREUZ P, THESIS
   KREUZ P, 1998, 12 BION, P327
   KREUZ P, 2000, 14 BION, P16
   NEVILLE AC, 1975, BIOL ARTHROPOD CUTIC, P448
   NEVILLE AC, 1993, BIOL FIBROUS COMPOSI, P214
   Vincent J.F.V., 1980, Symposia of the Society for Experimental Biology, P183
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
   Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x
   Waterhouse D.F., 1980, P19
   WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553
NR 22
TC 27
Z9 32
U1 2
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1054
EP 1058
DI 10.1114/1.1424921
PG 5
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600005
PM 11853255
DA 2018-10-19
ER

PT J
AU Reilly, GC
   Knapp, HF
   Stemmer, A
   Niederer, P
   Tate, MLK
AF Reilly, GC
   Knapp, HF
   Stemmer, A
   Niederer, P
   Tate, MLK
TI Investigation of the morphology of the lacunocanalicular system of
   cortical bone using atomic force microscopy
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE fluid flow; osteocyte; lacunae; canaliculi; collagen; corrosion casting;
   bone morphology; ultrastructure
ID ELECTRON-MICROSCOPY; FLUID-FLOW; RAT; PROTEOGLYCANS; COLLAGEN; MATRIX;
   CASTS; MODEL
AB Mechanical loading has been implicated as a powerful driving mechanism for interstitial fluid flow through bone. However, little information is available with regard to the morphology of bone fluid spaces, e.g., the canalicular wall, which would be expected to dictate the type of flow regime developing in the lacunocanalicular system under mechanical loads. The purpose of this study was to examine the fine structure of the lacumocanalicular system in cortical bone using atomic force microscopy (AFM), resin casting methods, and selective etching of the specimen surface. A resin-cast replica of the canalicular wall was produced and surface morphology and dimensions were observed using AFTVI in tapping mode. Material contrast was obtained using surface potential measurements. A striped pattern perpendicular to the canaliculus long axis with a periodicity of 125 nm dominated the structure of the canalicular wall; it is likely that this was caused by the imprint of collagen fibrils arranged in parallel, lining the canaliculus wall. The largest dimension measured for canalicular diameter was on the order of 500 nm. The regular dips and ridges caused by the collagen that lines the wall are a source of roughness which may influence shear stresses imparted by the fluid on the cell surface as well as mixing of solutes within the lacunocanalicular system. In addition, the lacunocanalicular wall lining is likely to affect physicochemical interactions between the fluid and bone matrix. This has important implications for modeling and understanding the microfluid mechanics and theology of the fluid-filled lacunocanalicular network. (C) 2001 Biomedical Engineering Society.
C1 Univ Zurich, Inst Biomed Engn & Med Informat, CH-8092 Zurich, Switzerland.
   Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland.
   Swiss Fed Inst Technol, Nanotechnol Grp, ETH Ctr CLA, CH-8092 Zurich, Switzerland.
   AO Res Inst, Davos, Switzerland.
RP Tate, MLK (reprint author), Cleveland Clin Fdn, Dept Bioengn, Lerner Res Inst ND20, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM tatem@bme.ri.ccf.org
RI Knothe Tate, Melissa L./O-2086-2015; Reilly, Gwendolen/C-3456-2009
OI Knothe Tate, Melissa L./0000-0002-3552-2525; Reilly,
   Gwendolen/0000-0003-1456-1071
CR ATKINSON PJ, 1982, PROGR ANATOMY, V2, P179
   Bigi A, 1997, BIOMATERIALS, V18, P657, DOI 10.1016/S0142-9612(96)00156-1
   BONUCCI E, 1977, VIRCHOWS ARCH A, V373, P213, DOI 10.1007/BF00432238
   Burger EH, 1999, FASEB J, V13, pS101
   CASTENHOLZ A, 1989, SCANNING MICROSCOPY, V3, P315
   CASTENHOLZ A, 1983, SCANNING ELECTRON MI, V4, P1955
   COOPER RR, 1966, J BONE JOINT SURG AM, VA 48, P1239, DOI 10.2106/00004623-196648070-00001
   COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P
   CURTIS TA, 1985, ANAT RECORD, V212, P336, DOI 10.1002/ar.1092120403
   GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330
   GUZELSU N, 1990, J BIOMECH, V23, P673, DOI 10.1016/0021-9290(90)90167-2
   HEIN HJ, 1998, J BIOMECH, V31, P22
   ISMAIL OS, 1988, ANAT REC, V222, P121, DOI 10.1002/ar.1092220203
   Jacobs HO, 1999, REV SCI INSTRUM, V70, P1756, DOI 10.1063/1.1149664
   Jacobs HO, 1997, ULTRAMICROSCOPY, V69, P39, DOI 10.1016/S0304-3991(97)00027-2
   KNAPP HF, IN PRESS SCANNING
   KRATKY RG, 1989, SCANNING MICROSCOPY, V3, P937
   LEES S, 1994, CALCIFIED TISSUE INT, V55, P180, DOI 10.1007/BF00425873
   LUK SC, 1974, J ULTRA MOL STRUCT R, V46, P184, DOI 10.1016/S0022-5320(74)80055-9
   MARTI O, 1998, P SCANN PROB MICR, P105
   MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x
   NICOLELLA DP, 1999, P BIOENG C BED, V42, P319
   RALIS ZA, 1981, MICROSC ACTA, V84, P385
   Raspanti M, 1997, J STRUCT BIOL, V119, P118, DOI 10.1006/jsbi.1997.3865
   SAUREN YMHF, 1992, ANAT REC, V232, P36, DOI 10.1002/ar.1092320105
   SCHERFT JP, 1972, J ULTRA MOL STRUCT R, V38, P318, DOI 10.1016/S0022-5320(72)90008-1
   Sims PA, 1999, MICROSC MICROANAL, V5, P99, DOI 10.1017/S1431927699000070
   SKERRY TM, 1990, CALCIFIED TISSUE INT, V46, P318, DOI 10.1007/BF02563823
   TAKAGI M, 1991, J HISTOCHEM CYTOCHEM, V39, P41, DOI 10.1177/39.1.1898498
   TAO NJ, 1992, BIOPHYS J, V63, P1165, DOI 10.1016/S0006-3495(92)81692-2
   Tate MLK, 2000, J EXP BIOL, V203, P2737
   Tate MLK, 1998, BONE, V22, P107
   Tate MLK, 2000, J BIOMECH, V33, P247, DOI 10.1016/S0021-9290(99)00143-8
   TATE MLK, 2001, BONE BIOMECHANICS HD
   TATE MLK, 2001, T ORTHOPAED RES SOC, V26, P138
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Wiesmann HP, 1998, CELL TISSUE RES, V294, P93, DOI 10.1007/s004410051159
   You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161
   YOU L, 1999, ADV BIOENGINEERING B, V43, P171
NR 39
TC 32
Z9 38
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1074
EP 1081
DI 10.1114/1.1424910
PG 8
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600008
PM 11853258
DA 2018-10-19
ER

PT J
AU Hildebrand, G
   Kunze, S
   Driver, M
AF Hildebrand, G
   Kunze, S
   Driver, M
TI Blood cell adhesion on sensor materials studied by light, scanning
   electron, and atomic-force microscopy
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE haemocompatibility; cell substrate interaction; bioreactor; flow through
   chamber; on-line adhesion kinetic; PC-polymer coatings
ID COPOLYMER; SURFACES
AB Unwanted interactions of biomedical sensors with surrounding tissues, body fluids, and cells are one of the most crucial problems affecting their long-term stability. In vivo processes were simulated in a computer-controlled bioreactor connected to a flow chamber system. Optical sensor materials were inserted into a parallel-plate chamber and monitored by light microscopy in order to get information about the number of adhered cells. Tests with thrombocyte-enriched plasma show that novel phosphorylcholine (PC)-polymer-coated sensors appear to be more bioinert, and thus demonstrate better haemo-copatibility in comparison with untreated ass sensors. The influence of different materials on the morphology of adhered cells was investigated by off-line methods such as scanning electron microscopy (SEM) and atomic-force microscopy (AFM). SEM showed a reduction in the number of adhered thrombocytes and the lack of any fibrin network on the PC-polymer-modified glass surface, in contrast to the pure glass surface. AFM gives topographical information, and the calculated contact areas and cell volumes indicate smaller interactions between cells and sensor material in the case of PC-polymer-coated sensors. (C) 2001 Biomedical Engineering Society.
C1 Inst Bioproc & Analyt Measurement Tech EV, D-37308 Heilbad, Heiligenstadt, Germany.
   Biocompatibles Ltd, Farnham GU9 8QL, Surrey, England.
RP Hildebrand, G (reprint author), Inst Bioproc & Analyt Measurement Tech EV, D-37308 Heilbad, Heiligenstadt, Germany.
CR Friedbacher G, 1999, PURE APPL CHEM, V71, P1337, DOI 10.1046/j.1365-3075.1999.00266.x
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HILDEBRAND G, 2000, OPTO 2000 P WUNST GE, P199
   IP WF, 1985, J BIOMED MATER RES, V19, P161, DOI 10.1002/jbm.820190206
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1990, POLYM J, V22, P255
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   LIEFEITH K, 2000, UNPUB P 10 HEIL KOLL
   LIEFEITH K, 1995, MATER CORROS, V46, P157
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   SCHMIDT R, 1994, WERKSTOFFVERHALTEN B, P269
   Sjollema J., 1988, Biofouling, V1, P101
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
   Zhang SF, 1996, BIOSENS BIOELECTRON, V11, P1019, DOI 10.1016/0956-5663(96)87661-5
   ZHANG SF, 1996, CELL ENG, V1, P103
NR 17
TC 4
Z9 4
U1 0
U2 3
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1100
EP 1105
DI 10.1114/1.1424919
PG 6
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600012
PM 11853262
DA 2018-10-19
ER

PT J
AU Grant, GGS
   Koktysh, DS
   Yun, BG
   Matts, RL
   Kotov, NA
AF Grant, Gregory G. S.
   Koktysh, Dmitry S.
   Yun, BoGeon
   Matts, Robert L.
   Kotov, Nicholas A.
TI Layer-By-Layer Assembly of Collagen Thin Films: Controlled Thickness and
   Biocompatibility
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE layer-by-layer assembly; thin films; polyelectrolytes; collagen;
   biocompatibility
AB The extracellular matrix molecular collagen is the one of the most widely utilized scaffolding materials in tissue engineering. However, obtaining uniform bioactive collagen films in the nanoscale range and precisely controlling the physical and chemical properties of these biological films is still a challenge for biomedical engineering. Layer-by-layer assembly, i.e., sequential adsorption of oppositely charged macromolecular species, is a powerful new film preparation technique that can be applied to the design of versatile biomaterials, with well-controlled interfacial, mechanical and biological functions. To demonstrate the feasibility of biomaterial design by means of layer-by-layer assembly, type-I collagen thin films were prepared by using this technique with poly(styrene) sulfonate as a partner polyelectrolyte. The gradual build-up of the collagen films was confirmed by UV-vis spectroscopy and ellipsometry, while their surface morphology was assessed by atomic force microscopy. The thickness of the collagen layers can be changed by increasing the number of bilayers adsorbed with an increment of 13 nm. It was found that the layer-by-layer assembled collagen scaffolds can support the attachment and growth of C2C12 myoblast cells and PC12 pheochromocytoma cells. Accurate thickness control and compatibility with nerve cell precursors indicate the utility of layer-by-layer assembled films in neuroprosthesis.
C1 [Grant, Gregory G. S.; Koktysh, Dmitry S.; Kotov, Nicholas A.] Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA.
   [Yun, BoGeon; Matts, Robert L.] Oklahoma State Univ, Noble Res Ctr, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
RP Kotov, NA (reprint author), Oklahoma State Univ, Dept Chem, 107 PS I, Stillwater, OK 74078 USA.
OI Kotov, Nicholas/0000-0002-6864-5804
FU NSF [CHE-9876265]; AFOSR [F49620-99-C-0072]; OCAST, NSF/NATO (NSF-NATO)
   OSU Sensor Center [DGE-9902637]; NSF/NATO (NSF-NATO) [DGE-9902637]
FX N.A.K. thanks NSF CAREER (CHE-9876265), AFOSR (F49620-99-C-0072), and
   OCAST, NSF/NATO (NSF-NATO Grant # DGE-9902637) OSU Sensor Center, for
   partial financial support of this research. D.S.K. acknowledges support
   from the NSF/NATO (NSF-NATO Grant # DGE-9902637) for the postdoctoral
   fellowship.
CR Aliev FG, 1999, ADV MATER, V11, P1006, DOI 10.1002/(SICI)1521-4095(199908)11:12<1006::AID-ADMA1006>3.0.CO;2-2
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Falini G, 1998, CHEM-EUR J, V4, P1048, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1048::AID-CHEM1048>3.0.CO;2-U
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Koktysh D.S., 2001, UNPUB
   Mamedov A, 2000, LANGMUIR, V16, P3941, DOI 10.1021/la990957j
   Nakamura O., 1994, J BONE MINER METAB, V12, P17
   Ngankam PA, 2000, J AM CHEM SOC, V122, P8998, DOI 10.1021/ja000783o
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Silver F.H., 1997, HDB BIODEGRADABLE PO, V7, P319
   Uemura T, 1997, MAT SCI ENG C-BIO S, V4, P303, DOI 10.1016/S0928-4931(97)00015-5
NR 18
TC 51
Z9 53
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2001
VL 3
IS 4
BP 301
EP 306
DI 10.1023/A:1012456714628
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KX
UT WOS:000209018800006
DA 2018-10-19
ER

PT J
AU Bower, CK
   Bothwell, MK
   McGuire, J
AF Bower, CK
   Bothwell, MK
   McGuire, J
TI Lantibiotics as surface active agents for biomedical applications
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Review
DE antimicrobial coating; drug absorption; lantibiotic; nisin
ID COLLOIDAL SILICA; DRUG-DELIVERY; T4 LYSOZYME; NISIN; ADSORPTION;
   PEPTIDE; WATER; RESISTANCE; ABSORPTION; PROTEINS
AB The unique physical structure of lantibiotics, (e.g. double bonds. thioethers rings, and unusual amino acid residues), makes these antimicrobial peptides highly reactive, and thus different in mode-of-action from clinical antibiotics. Members of the lantibiotic group have been successfully tested against pathogenic organisms for decades. Some lantibiotics have been studied for use in treating skin infections, and several have been characterized for their anti-viral activity. In addition to their antimicrobial capabilities, lantibiotics possess amphiphilic characteristics, making them potentially valuable as emulsifiers in drug formulations. The small size and surface activity of these peptides also may allow them to enhance the transport of therapeutic compounds across cell membranes. Over 30 lantibiotics are presently known, and more are being discovered each year. With the rising incidence of resistant bacteria, lantibiotics offer considerable potential as safe, antimicrobial barriers for use on synthetic material surfaces, as emulsifiers in formulation of hydrophobic drugs, and as absorption promoters for selected compounds across mucosal membranes. The major hindrance to research in this area is that lantibiotics are difficult to obtain. But with improved methods for production and purification of these unusual antimicrobial agents, the promise of cost-effective application of lantibiotics may eventually be realized. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Oregon State Univ, Corvallis, OR 97331 USA.
CR AMSELEM S, 1993, LIPOSOME TECHNOLOGY, V1, pCH28
   ANDRADE JD, 1996, INTERFACIAL PHENOMEN, pCH2
   Bani-Jaber A, 2000, J FOOD SCI, V65, P502, DOI 10.1111/j.1365-2621.2000.tb16036.x
   Bower CK, 1998, BIOTECHNOL BIOENG, V58, P658, DOI 10.1002/(SICI)1097-0290(19980620)58:6<658::AID-BIT13>3.0.CO;2-3
   BOWER CK, 1995, APPL ENVIRON MICROB, V61, P992
   BOWER CK, UNPUB COLL SURF B
   BRASH J, 1995, PROTEINS INTERFACE 2, V602, pCH1
   COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050
   DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006
   Elliott TSJ, 1998, J HOSP INFECT, V40, P193, DOI 10.1016/S0195-6701(98)90137-2
   ENNIS RD, 1990, PHARMACEUT RES, V7, P468, DOI 10.1023/A:1015856430657
   FIELDING RM, 1991, CLIN PHARMACOKINET, V21, P155, DOI 10.2165/00003088-199121030-00001
   FLIER JS, 1985, TRANSNASAL SYSTEMIC, P217
   FUKASE K, 1988, TETRAHEDRON LETT, V29, P795, DOI 10.1016/S0040-4039(00)80212-9
   GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x
   GLASBY JS, 1992, DICT ANTIBIOTIC PROD
   Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P
   HANSEN JN, 1993, ANNU REV MICROBIOL, V47, P535, DOI 10.1146/annurev.mi.47.100193.002535
   Jung G., 1991, NISIN NOVEL LANTIBIO, P1
   KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x
   KIDO Y, 1983, J ANTIBIOT, V36, P1295, DOI 10.7164/antibiotics.36.1295
   KIM S, 1993, DRUGS, V46, P618, DOI 10.2165/00003495-199346040-00004
   KLEINKAUF H, 1982, P INT C TRENDS ANT R, P220
   Kupke T, 1996, ANTON LEEUW INT J G, V69, P139, DOI 10.1007/BF00399419
   Lakamraju M, 1996, J COLLOID INTERF SCI, V178, P495, DOI 10.1006/jcis.1996.0144
   LEE WA, 1992, DRUG TARGETING DELIV, pCH16
   Lee WK, 1999, J COLLOID INTERF SCI, V213, P265, DOI 10.1006/jcis.1999.6135
   LIAN LY, 1991, P 1 INT WORKSH LANT, P43
   LIU W, 1990, APPL ENVIRON MICROB, V56, P2551
   MCGUIRE J, 1995, PROTEINS INTERFACE 2, V602, pCH4
   MCMARTIN C, 1987, J PHARM SCI, V76, P535, DOI 10.1002/jps.2600760709
   NARUSE N, 1989, J ANTIBIOT, V42, P837, DOI 10.7164/antibiotics.42.837
   Natsume H, 1999, INT J PHARM, V185, P1, DOI 10.1016/S0378-5173(99)00100-3
   Nes IF, 1996, ANTON LEEUW INT J G, V69, P89, DOI 10.1007/BF00399414
   NIU WW, 1991, ANTIMICROB AGENTS CH, V35, P998, DOI 10.1128/AAC.35.5.998
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   RAUCH PJG, 1994, BACTERIOCINS LACTIC, pCH6
   REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F
   Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41
   SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0
   Shiba T., 1991, NISIN NOVEL LANTIBIO, P113
   STURZEL W, 1997, SURFACTANTS COSMETIC, pCH25
   SUTTIPRASIT P, 1993, FOOD HYDROCOLLOID, V7, P241, DOI 10.1016/S0268-005X(09)80175-6
   Tian MH, 1998, J COLLOID INTERF SCI, V200, P146, DOI 10.1006/jcis.1997.5348
   Wang J, 1997, J COLLOID INTERF SCI, V185, P317, DOI 10.1006/jcis.1996.4619
   WOOLLINS JD, 1996, BIOL INTERACTIONS SU, pCH1
NR 46
TC 15
Z9 15
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC
PY 2001
VL 22
IS 4
BP 259
EP 265
DI 10.1016/S0927-7765(01)00199-0
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 479NE
UT WOS:000171409800001
DA 2018-10-19
ER

PT J
AU Gotz, A
   Gracia, I
   Cane, C
   Morrissey, A
   Alderman, J
AF Gotz, A
   Gracia, I
   Cane, C
   Morrissey, A
   Alderman, J
TI Manufacturing and packaging of sensors for their integration in a
   vertical MCM microsystem for biomedical applications
SO JOURNAL OF MICROELECTROMECHANICAL SYSTEMS
LA English
DT Article
DE ion sensitive field-effect transistor (ISFET); microsystem; monolithic
   integration; pressure sensor; sensor packaging; vertical multichip
   module (MCM-V)
AB The goal of this work is to demonstrate the feasibility of integrating fragile micromachined chips into a complex three-dimensional (3-D) multichip module (MCM) microsystem for a biomedical application. The system is based on the vertical integration of the different parts: micropumps and valves, a multisensor chip for on-line control of the system and a signal-processing chip. In this paper, packaging of the microsystem is studied in order to minimize the induced stress that can affect the integrity of the different micromachined parts of the system. Standard commercially available components and materials were used so as to minimize costs for the case of high volume packaging. For testing the approach, a multisensor chip which includes thin silicon membrane-based devices has been used as the main test structure to compare different packaging materials. In addition, for the fabrication of such a sensor chip in an efficient mode, technological modules needed to fabricate sensors on complementary metal-oxide-semiconductor (CMOS) wafers are discussed. The definition of standardized "add-on" sensor modules to the CMOS process of a foundry is intended to limit the development cost of smart sensors.
C1 CSIC, CNM, E-08193 Bellaterra, Spain.
   NMRC, Cork, Ireland.
RP Gotz, A (reprint author), CSIC, CNM, Campus UAB, E-08193 Bellaterra, Spain.
RI Gracia, Isabel/P-7208-2015; Cane, Carles/O-5927-2016
OI Gracia, Isabel/0000-0001-8563-9468; Cane, Carles/0000-0003-0676-9294
CR BRYZEK J, 1996, SENSORS, V13, P4
   BRZOZKA Z, 1994, SENSOR ACTUAT B-CHEM, V18, P38, DOI 10.1016/0925-4005(94)87052-7
   ESTEVE D, 1997, BARMINT BASIC RES MI
   Gotz A, 1998, P SOC PHOTO-OPT INS, V3514, P112, DOI 10.1117/12.323924
   KELLY G, 1992, P ELECTR C, P467, DOI 10.1109/ECTC.1992.204247
   KO WH, 1994, P 4 INT C EXH MICR E, P545
   Martensson L, 1996, INT J HUM FACTOR MAN, V6, P29
   Morrissey A, 1997, P SOC PHOTO-OPT INS, V3224, P161, DOI 10.1117/12.284511
   REINHOUDT DN, 1995, SENSOR ACTUAT B-CHEM, V24, P197, DOI 10.1016/0925-4005(95)85042-2
   Senturia SD, 1998, SENSOR ACTUAT A-PHYS, V67, P1, DOI 10.1016/S0924-4247(97)01754-8
   van den Berg A., 1994, Sensors and Materials, V6, P23
   VANDERSHOOT BH, 1993, SENSOR ACTUAT B-CHEM, V13, P66
   WALSH S, 1999, P 4 INT C COMM MICR
   WONG HS, 1989, IEEE T ELECTRON DEV, V36, P479, DOI 10.1109/16.19957
NR 14
TC 4
Z9 4
U1 0
U2 5
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1057-7157
J9 J MICROELECTROMECH S
JI J. Microelectromech. Syst.
PD DEC
PY 2001
VL 10
IS 4
BP 569
EP 579
DI 10.1109/84.967380
PG 11
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 496GM
UT WOS:000172387900012
DA 2018-10-19
ER

PT J
AU Brovarone, CV
   Verne, E
   Krajewski, A
   Ravaglioli, A
AF Brovarone, CV
   Verne, E
   Krajewski, A
   Ravaglioli, A
TI Graded coatings on ceramic substrates for biomedical applications
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Al(2)O(3)-substrate; bioactivity; coatings; glass matrix; thermal
   expansion; ZrO(2)
ID PLASMA SPRAY DEPOSITION; MEDICAL APPLICATIONS
AB Bioactive glasses and particles reinforced composites were used to coat alumina substrates, in order to combine the mechanical properties of the high-strength alumina with the bioactivity of the coatings. The coatings were either monolithic glass or glass-matrix, zirconia particle composite and were prepared by a low-cost firing method. A multilayer approach was applied to minimize crack propagation at the interface between the coating and the substrate. Functionally graded structures were developed to achieve a compliant material to withstand the stresses due to the expansion coefficient mismatch between the substrate and the coatings. The sequential coating of the alumina with glass-matrix/zirconia particle composite layers produced a structurally stable composite structure. A systematic study revealed that multiple layers were necessary to provide a gradual compliance of the thermal expansion coefficient. The glass-matrix/zirconia particles composites layers were also essential for the control of the Al(3) diffusion from the substrate through the glass. This is in accordance with the experimental results of previous works. Thus, the alumina content in the coating should be maintained as low as possible in order to preserve its bioactivity. The composite layers were further coated by a glass belonging to the system SiO(2)-CaO-P(2)O(5)-Na(2)O- MGO-F(-), known for its bioactivity. The experimental results were substantiated by optical and scanning electron microscopy (SEM) with compositional analysis (EDS) and by a mechanical characterization. The in vitro behavior of the coated samples was investigated by means of soaking in simulated body fluid (SBF) followed by SEM observation and XRD analysis. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Politecn Torino, Mat Sci & Chem Engn Dept, I-10129 Turin, Italy.
   CNR, IRTEC, I-48018 Faenza, Italy.
RP Brovarone, CV (reprint author), Politecn Torino, Mat Sci & Chem Engn Dept, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM vitale@athena.polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Verne,
   Enrica/0000-0002-8649-4739
CR Berger G, 1992, 4 WORLD BIOM C APR 2, P33
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1996, J AM CERAM SOC, V79, P1515, DOI 10.1111/j.1151-2916.1996.tb08759.x
   FERRARIS M, 1996, BIOCERAMIC COATINGS, P31
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HULBERT SF, 1983, INTRO CERAMICS, V1, P25
   RAVAGLIOLI A, 1992, INTERCERAM, V41, P69
   SHELBY JE, 1979, J APPL PHYS, V50, P8010, DOI 10.1063/1.325986
   TORRICELLI P, BIOL GLASS COATING C
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
NR 11
TC 25
Z9 28
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD DEC
PY 2001
VL 21
IS 16
BP 2855
EP 2862
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 499XD
UT WOS:000172595200008
DA 2018-10-19
ER

PT J
AU Gitter, DM
AF Gitter, DM
TI International conflicts over patenting human DNA sequences in the United
   States and the European Union: An argument for compulsory licensing and
   a fair-use exemption
SO NEW YORK UNIVERSITY LAW REVIEW
LA English
DT Review
ID INTELLECTUAL PROPERTY-RIGHTS; GENE PATENTS; HUMAN-GENOME;
   BIOMEDICAL-RESEARCH; BIOTECHNOLOGY; SCIENCE; LAW; DISCRIMINATION;
   INFRINGEMENT; INVENTIONS
AB The thought of a large biotech company holding an exclusive right to research and manipulate human genetic material provokes many reactions-from moral revulsion to enthusiasm about the possibilities for therapeutic advancement. While most agree that such a right must exist, debate continues over the appropriate extent of its entitlements and preclusive effects. In this Article, Professor Donna Gitter addresses this multidimensional problem of patents on human deoxyribonucleic acid (DNA) sequences in the United States and the European Union. Professor Gitter chronicles not only the development of the law in this area, but also the array of policy, and moral arguments that proponents and detractors of such patents raise. She emphasizes the specific issue of patents on DNA sequences whose function has not filly been identified, and the chilling effect these patents may, have on beneficial research. From this discussion emerges a troubling realization: While the legal framework governing "life patents" may be similar in the United States and the European Union, the public perceptions and attitudes toward them are not, Professor Gitter thus proposes a dual reform: a compulsory licensing regime requiring holders of DNA sequence patents to license them to commercial researchers, in return for a royalty keyed to the financial success of the product that the licensee develops; and an experimental-use exemption from this regime for government and nonprofit researchers.
C1 Fordham Univ, Sch Business, Bronx, NY 10458 USA.
RP Gitter, DM (reprint author), Fordham Univ, Sch Business, Bronx, NY 10458 USA.
CR Abbott A, 2000, NATURE, V404, P802
   ADLER R, 1988, HARVARD J LAW TECH, V1, P1
   ADLER RG, 1992, SCIENCE, V257, P908, DOI 10.1126/science.1502557
   ADLER RG, 1988, HARV JL TECH, V1, P11
   Alberts B, 2000, NATURE, V404, P325, DOI 10.1038/35006245
   ANDERSON A, 1988, NATURE, V336, P300
   ANDERSON C, 1991, NATURE, V353, P486
   ANDERSON C, 1991, NATURE, V353, P485
   Angier Natalie, 2000, NY TIMES        0627, pA1
   ARNOLD BE, 2001, BIOTECHNOLOGY LAW  S, P2
   ARTHUR C, 1995, INDEPENDENT LON 1120, P2
   ARTHUR C, 2000, INDEPENDENT LON 0316, P21
   ATKINS R, 2000, FIN TIMES LONDO 0811, P6
   Ball H, 1944, LAW COPYRIGHT LIT PR, P260
   BAUMGARDT D, 1952, BENTHAM ETHICS TODAY, P171
   BELSIE L, 1999, CHRISTIAN SCI M 0819, P18
   Belsie Laurent, 1999, Christ Sci Monitor, P18
   BENDER GA, 2000, IDEA, V40, P52
   Bender Gretchen Ann, 2000, IDEA, V40, P49
   BERNSON A, 2000, NY TIMES        0315, pA1
   BLAKENEY M, 1996, TRADE RELATED ASPECT, P87
   BLOUNT S, 1997, SCIENCE, V276, P187
   Blount Steve, 1999, J PAT TRADEMARK OFF, V81, P13
   Blount Steve, 1999, J PAT TRADEMARK OFF, V81, P11
   Bobrow M, 2001, NATURE, V409, P763, DOI 10.1038/35057480
   BOBROW M, 2001, NATURE, V409, P764
   BORSON DB, 1995, IDEA, V35, P461
   BORSON DB, 1995, IDEA, V35, P483
   BOSTYN SJR, 1999, INTELL PROP Q, V3, P14
   BOYCE N, 2000, NEW SCI         0520, P15
   BROWN P, 1994, NEW SCI         1112, P4
   Burk Dan L., 1998, SECTON HALL CONST LJ, V8, P683
   Burk DL, 2000, TEX LAW REV, V79, P99
   BURK DL, 1998, SECTON HALL CONST LJ, V8, P690
   BURK DL, 2000, TEX LAW REV, V79, P153
   Butler D, 2000, NATURE, V404, P324
   BUTLER D, 1992, INDEPENDENT LON 1102, P14
   Carey J, 2000, BUS WEEK, P147
   CAREY J, 2000, BUS WK          0612, P152
   CELERA, 2001, SCIENCE, V291, P1191
   CHAPMAN J, 2000, EXPRESS         0222
   CHARTRAND S, 2000, NY TIMES        0306, pC9
   COLETURNER R, 1995, SCIENCE, V270, P52, DOI 10.1126/science.270.5233.52
   CONNOR S, 2000, INDEPENDENT LON 1115, P11
   COOKSON C, 1993, FIN TIMES LONDO 1220, P12
   Cornish WR, 1998, IIC-INT REV IND PROP, V29, P735
   CORNISH WR, 1996, INTELLECTUAL PROPERT, P20
   CORREA CM, 1998, INTELLECTUAL PROPERT, P189
   Crespi RS, 1997, BIOTECHNOLOGY, PATENTS AND MORALITY, P219
   CURIEN H, 1991, SCIENCE, V254, P1710
   DAVIES K, 2001, CRACKING GENOME
   Dickson D, 2000, NATURE, V405, P3
   Dickson D, 1998, NATURE, V392, P423, DOI 10.1038/32964
   Doll JJ, 1998, SCIENCE, V280, P689, DOI 10.1126/science.280.5364.689
   DRAHOS P, 1999, EUR INTELL PROP REV, V21, P442
   Drahos P., 1999, EUROPEAN INTELLECTUA, V21, P441
   DRONAMRAJU KR, 1998, BIOL SOCIAL ISSUES B, P112
   DUCOR P, 1995, J PAT TRADEMARK OFF, V77, P871
   DUCOR P, 1995, J PAT TRADEMARK OFF, V77, P888
   DUCOR PG, 1998, PATENTING RECOMBINAN, P10
   DUNLEAVY KJ, 1999, NATL LJ         0524, pC11
   Eisenberg Rebecca S, 1990, Emory Law J, V39, P721
   EISENBERG RS, 1987, YALE LAW J, V97, P177, DOI 10.2307/796481
   EISENBERG RS, 1995, AM INTELL PROP L ASS, V23, P3
   EISENBERG RS, 1987, YALE LAW J, V97, P217
   EISENBERG RS, 1990, EMORY LJ, V39, P722
   Enserink M, 2000, SCIENCE, V287, P1196, DOI 10.1126/science.287.5456.1196
   ENSERINK M, 2000, SCIENCE, V287, P1197
   Erramouspe M, 1996, UCLA LAW REV, V43, P961
   ERRAMOUSPE M, 1996, UCLA LAW REV, V43, P966
   FARRANT P, 1999, IP WORLDWIDE     JUL
   Ford R, 1997, Eur Intellect Prop Rev, V19, P315
   Gavaghan H, 1998, SCIENCE, V280, P1188, DOI 10.1126/science.280.5367.1188
   Gitter D., 2001, BERKELEY J INT L, V19, P1
   GITTER DM, 2001, BERKELEY J INT L, V19, P7
   GOLDSTEIN P, 1993, COPYRIGHT PATENT TRA, P402
   GOSTIN L, 1991, AM J LAW MED, V17, P109
   Gostin Larry, 1991, AM JL MED, V17, p[109, 110]
   HANTMAN RD, 1985, J PATENT TRADEMARK, V67, P617
   HANTMAN RD, 1985, J PAT TRADEMARK OFF, V67, P639
   HARMON A, 2001, NY TIMES        1019, pA1
   HAWLEY RS, 1999, HUMAN GENOME USERS G, P8
   Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698
   HERMAN R, 1992, WASH POST       0616, P11
   Holman MA, 2000, IOWA LAW REV, V85, P735
   HOLMAN MA, 2000, IOWA LAW REV, V85, P750
   HOWARTH A, 1992, SCIENCE, V256, P11, DOI 10.1126/science.1566049
   HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391
   ISRAELSEN N, 1988, AM INTELECT PROP L A, V16, P457
   JAENICHEN HR, 1997, EUROPEAN PATENT OFFI, P243
   KRIMSKY S, 1999, CHICAGO KENT LAW REV, V75, P15
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   LANGRETH R, 2000, WALL ST J       0316, pA18
   LANGRETH R, 2000, WALL ST J       0316, pA19
   LEAKE J, 2001, SUN TIMES LONDO 0225, P5
   LEDANTAM S, 2001, WASH POST       1021, pA4
   LEDER P, 1988, Patent No. 4736866
   Licking E, 2000, BUS WEEK, P152
   LLEWELYN M, 1994, EUR INTELL PROP REV, V16, P476
   LLEWELYN M, 1994, EUR INTELL PROP REV, V16, P473
   LOREN LP, 1997, J INTELL PROP L, V5, P15
   Loren Lydia Pallas, 1997, J INTELL PROP L, V5, P1
   Machin N, 1999, CALIF LAW REV, V87, P421, DOI 10.2307/3481089
   MACHIN N, 1999, CAL L, V87, P423
   Magnani T A, 1999, Berkeley Technol Law J, V14, P443
   MAGNANI TA, 1999, BERKELEY TECH LJ, V14, P448
   MARSHALL E, 2000, SCI NOW         0223
   MARTIN E, 2000, OXFORD DICT BIOL, P62
   MCCOY J, 1993, FORDHAM INTELL PROP, V4, P501
   MCCOY J, 1993, FORDHAM INTELL PROP, V4, P509
   MCGOURTY C, 2000, DAILY TELEGRAPH 0607
   MEEK J, 2000, GUARDIAN LONDON 0626, P8
   MEEK J, 2000, GUARDIAN LONDON 0126, P6
   MEEK J, 2000, GUARDIAN LONDON 1115
   Merges Robert P., 1995, AIPLA Q J, V23, P1
   Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996
   Mueller JM, 2001, WASH LAW REV, V76, P1
   MUELLER JM, 2001, WASH L REV, V76, P51
   MURRAY J, 1999, CHI KENT L REV, V75, P234
   Murray J., 1999, CHI KENT L REV, V75, P231
   NAYSMITH S, 2000, SUNDAY HERALD   0723, P4
   Newby TG, 1999, STANFORD LAW REV, V51, P1633, DOI 10.2307/1229532
   NEWBY TG, 1999, STANFORD LAW REV, V51, P1648
   O'Rourke MA, 2000, COLUMBIA LAW REV, V100, P1177, DOI 10.2307/1123488
   OROURKE MA, 2000, COLUMBIA LAW REV, V100, P1191
   Oser A, 1999, IIC-INT REV IND PROP, V30, P1
   OSER A, 1999, INT REV IND PROP COP, V30, P8
   Pelias M Z, 2000, Emory Law J, V49, P837
   PELIAS MZ, 2000, EMORY LJ, V49, P849
   POLLACK A, 2000, NY TIMES        1023, pC1
   PRESTON R, 2000, NEW YORKER      0612, P66
   QUINN B, 2001, COMMUNICATION   0711
   RADFORD T, 2000, GUARDIAN UK     1115, P4
   RAI A, 2000, WASH U JL POLY, V2, P205
   Rai A. K., 2000, WASH U JL POLY, V2, P199
   Rai AK, 1999, NORTHWEST U LAW REV, V94, P77
   RAI AK, 1999, NORTHWEST U LAW REV, V94, P110
   RAM NS, 1998, BIOSCI L REV, V2, P43
   REGALADO A, 2000, TECHNOLOGY REV   SEP, P50
   Reichhardt T, 1998, NATURE, V396, P499, DOI 10.1038/24929
   Reynolds T, 2000, J NATL CANCER I, V92, P596, DOI 10.1093/jnci/92.8.596
   Reynolds T, 2000, J NATL CANCER I, V92, P184, DOI 10.1093/jnci/92.3.184
   RIDLEY M, 1999, GENOME, P6
   RIFKIN J, 2001, HOUSTON CHRON   0702, pC5
   RIFKIN J, 1998, BIOTECH CENTURY, P160
   ROBERTS L, 1992, SCIENCE, V255, P912, DOI 10.1126/science.1546285
   ROBERTS L, 1991, SCIENCE, V252, P498, DOI 10.1126/science.2020849
   ROSENBERG PD, 1999, PATENT LAW FUNDAMENT, V3, P19
   RUBERTI A, 1992, SCIENCE, V256, P11, DOI 10.1126/science.1566050
   SCALISE DG, 1993, FORDHAM INT LJ, V16, P990
   SCALISE DG, 1993, FORDHAM INT LJ, V16, P999
   SCHAFFER R, 1999, INT BUSINESS LAW ITS, P88
   Schapira R, 1997, BIOTECHNOLOGY, PATENTS AND MORALITY, P171
   Schatz U, 1998, IIC-INT REV IND PROP, V29, P2
   Schiermeier Q, 2000, NATURE, V406, P111, DOI 10.1038/35018230
   Scott A, 1999, EUROPEAN INTELLECTUA, V21, P212
   SELLERS ME, 1994, ARK L REV, V47, P290
   SELLERS ME, 1994, ARK L REV, V47, P269
   SHULMAN S, 2000, TECH REV         SEP, P67
   Smaglik P, 2000, NATURE, V404, P322
   Sterckx S, 1997, BIOTECHNOLOGY, PATENTS AND MORALITY, P1
   STONE R, 1995, SCIENCE, V268, P1126, DOI 10.1126/science.7761825
   Straus J, 1995, IIC-INT REV IND PROP, V26, P920
   STRAUS J, 1994, PATENTING HUMAN GENE, P12
   STRAUS J, 1995, INT REV IND PROP COP, V26, P926
   TSEVDOS EJ, 1997, NATL LJ         0616, pC1
   VANDEKAMP GJ, 1998, EUR ENV L REV, V7, P235
   VANDEKAMP GJ, 1998, EUR ENV L REV, V7, P234
   Venter J. C., 2001, SCIENCE, V291, P1305
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   VINJE TC, 1995, EUR INTELL PROP REV, V17, P361
   VONMEIBOM W, 1997, PAT WORLD        JUN, P29
   VONMEIBOM W, 1997, PATENT WORLD     JUN, P27
   Wade N, 2000, N Y Times Web, pA18
   Wade Nicolas, 2000, NY TIMES        0407, pA20
   WALDHOLZ M, 1994, WALL ST J       0211, pB1
   Waldholz Michael, 2000, WALL ST J       0316, pA1
   Walter CF, 1998, INDIANA LAW J, V73, P1025
   WALTER CF, 1998, IND LJ, V73, P1029
   1995, FED REG         0714, V60, P36264
   FED REG, V66, P1095
   2000, GLOBAL NEWS WIR 0307
   2000, INSTRUMENT BUS  0915
   FED REG, V66, P1096
   2001, FED REG         0105, V62, P1098
   1997, NATURE, V385, P670
   1997, NATURE, V385, P671
   2001, FED REG         0105, V66, P1098
   1995, FED REG         0714, V60, P36263
   2001, FED REG         0105, V66, P1092
   2001, NY TIMES        0106, pC3
   2001, LANCET, V357, P81
NR 192
TC 37
Z9 38
U1 3
U2 8
PU NEW YORK UNIV SCHOOL LAW
PI NEW YORK
PA 110 WEST THIRD ST, NEW YORK, NY 10012 USA
SN 0028-7881
J9 NEW YORK U LAW REV
JI N. Y. Univ. Law Rev.
PD DEC
PY 2001
VL 76
IS 6
BP 1623
EP 1691
PG 69
WC Law
SC Government & Law
GA 499UF
UT WOS:000172588200003
PM 12741387
DA 2018-10-19
ER

PT J
AU Seliktar, D
   Nerem, RM
   Galis, ZS
AF Seliktar, D
   Nerem, RM
   Galis, ZS
TI The role of matrix metalloproteinase-2 in the remodeling of cell-seeded
   vascular constructs subjected to cyclic strain
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE tissue engineering; matrix metalloproteinases; mechanical properties;
   cyclic strain; vascular remodeling
ID SMOOTH-MUSCLE CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; COLLAGEN LATTICES;
   GENE-EXPRESSION; FOAM CELLS; STROMELYSIN; TISSUE
AB Tissue engineering offers the opportunity to develop vascular substitutes that mimic the responsive nature of native arteries. A good blood vessel substitute should be able to remodel its matrix in response to mechanical stimulation, as imposed by the hemodynamic environment. We have developed a novel method of studying the influence of mechanical strain on the remodeling of cell-seeded collagen gel blood vessel analogs. We assessed the remodeling capacity by examining the effect of mechanical conditioning upon the expression of enzymes which remodel the extracellular matrix, called matrix metalloproteinases (MMPs), and upon the mechanical properties of the constructs. We found that subjecting collagen constructs to a 10% cyclic radial distention, over a course of 4 days, resulted in an overall increase in the production of MMP-2. Cyclic mechanical strain also stimulated enzymatic activation of latent MMP-2. We found that cyclic strain also significantly increased the mechanical strength and material modulus, as indicated by an increase in circumferential tensile properties of the constructs. These observations suggested that MMP-2-dependent remodeling affects the material properties of vascular tissue analogs. To further investigate this possible connection we examined the effects of dynamic conditioning in the presence of two nonspecific inhibitors of MMP activity. Interestingly, we found that nonspecific inhibition of MMP ablated the benefits of mechanical conditioning upon mechanical properties. Our observations suggest that a better understanding of the complex relation between mechanical stimulation and construct remodeling is key for the proper design of tissue-engineered blood vessel substitutes. (C) 2001 Biomedical Engineering Society.
C1 Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA.
RP Seliktar, D (reprint author), ETH Zurich, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
OI Seliktar, Dror/0000-0001-6964-8567
FU NIGMS NIH HHS [GM08433]
CR Bullard KM, 1999, J SURG RES, V84, P31, DOI 10.1006/jsre.1999.5599
   GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181
   GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619
   Galis ZS, 1999, FIBRINOLYSIS PROTEOL, V13, P54, DOI 10.1016/S0268-9499(99)90080-2
   Galis ZS, 1998, CIRCULATION, V97, P2445, DOI 10.1161/01.CIR.97.24.2445
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604
   Howard AB, 1997, AM J PHYSIOL-CELL PH, V272, pC421
   JAMES TW, 1993, J CELL PHYSIOL, V157, P426, DOI 10.1002/jcp.1041570227
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   KHAW PT, 1995, Patent No. 9500576
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209
   MURPHY G, 1994, ANN NY ACAD SCI, V732, P31, DOI 10.1111/j.1749-6632.1994.tb24722.x
   Myers S A, 1998, Adv Dent Res, V12, P86
   NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Vorp DA, 1999, ANN BIOMED ENG, V27, P366, DOI 10.1114/1.158
   Yang JH, 1998, J BIOL CHEM, V273, P6550, DOI 10.1074/jbc.273.11.6550
NR 21
TC 107
Z9 109
U1 0
U2 1
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD NOV
PY 2001
VL 29
IS 11
BP 923
EP 934
DI 10.1114/1.1415522
PG 12
WC Engineering, Biomedical
SC Engineering
GA 502UE
UT WOS:000172760500001
PM 11791675
DA 2018-10-19
ER

PT J
AU Ji, J
   Feng, LX
   Barbosa, MA
AF Ji, J
   Feng, LX
   Barbosa, MA
TI Stearyl poly(ethylene oxide) grafted surfaces for preferential
   adsorption of albumin
SO BIOMATERIALS
LA English
DT Article
DE amphiphilic copolymer; biocompatible materials; albumin; fibrinogen;
   surface property; protein adsorption
ID BINDING SURFACES; LINEAR-POLYMERS; POLYETHYLENE; AFFINITY; BLENDS
AB An ideal surface for many biomedical applications would resist non-specific protein adsorption while at the same time triggering a specific biological pathway. Based on the approach of selectively binding albumin to free fatty acids, stearyl groups were immobilized onto poly(styrene) backbone via poly(ethylene oxide) side chains. X-ray photoelectron spectroscopy (XPS) analysis indicates substantial surface enrichment of the stearyl poly(ethylene oxide) (SPEO). In an aqueous environment, the surface rearrangement is limited, as proved by dynamic contact angle tests. The comb-like copolymer presents a special hydrophobic surface with high SPEO surface density, which may be due to the 'tail like' SPEO architecture at the copolymer/water interface. Protein adsorption tests confirm that the comb-like surfaces adsorb high levels of albumin and resist fibrinogen adsorption very significantly. The surfaces prepared in this research attract and reversibly bind albumin due to the synergistic action of the PEO chains and the stearyl end groups. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Zhejiang Univ, Dept Polymer Sci, Hangzhou 310027, Peoples R China.
   INEB, Inst Engn Biomed, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, Oporto, Portugal.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci, Hangzhou 310027, Peoples R China.
EM jija_99@yahoo.com
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Ji, Jian/0000-0001-9870-4038
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   BRASH JL, 1976, THROMB RES, V9, P249, DOI 10.1016/0049-3848(76)90214-0
   CAREL JVO, 1994, INTERFACIAL FORCES A, P170
   FRAUTSCHI JR, 1983, T AM SOC ART INT ORG, V29, P242
   GALLO BM, 1975, COPOLYMER POLYM COMP, P85
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   LIDE DR, 1996, SURFACE TENSION COMM, P6
   Mayes AM, 1998, MATER RES SOC SYMP P, V530, P73, DOI 10.1557/PROC-530-73
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   QIU YX, 1992, MAKROMOL CHEM, V173, P1377
   RANTER BD, 1996, J MOL RECOGNIT, V9, P617
   Walton DG, 1997, MACROMOLECULES, V30, P6947, DOI 10.1021/ma970698+
   Walton DG, 1996, PHYS REV E, V54, P2811, DOI 10.1103/PhysRevE.54.2811
   WU D, 1995, SCI CHINA SER B, V25, P1121
   WU D, 1995, SCI CHINA SER B, V26, P409
NR 22
TC 31
Z9 32
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2001
VL 22
IS 22
BP 3015
EP 3023
DI 10.1016/S0142-9612(01)00048-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 474FD
UT WOS:000171094900008
PM 11575476
DA 2018-10-19
ER

PT J
AU Long, MC
   Kisielewski, RW
   Richardson, DC
   Schroeder, LW
AF Long, MC
   Kisielewski, RW
   Richardson, DC
   Schroeder, LW
TI An experimental technique for determining biaxial fatigue lifetimes in
   biomedical elastomers
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Article
DE multiaxial fatigue; rubber; polymers; crack detection; fatigue test
   methods
ID LATEX
AB A novel test apparatus was developed to determine fatigue lifetimes of elastomeric materials. Thin elastomeric sheets (membranes) are biaxially fatigued while contained within a temperature controlled liquid environment. Membranes are displaced in a smooth sinusoidal motion by pumping the surrounding fluid through the equipment's inner cells. An electrical signal (AC) passes through the membrane during fatigue and is used to monitor changes in the elastomer's physical characteristics. In addition, the test cell is designed to allow optical observation of the membrane throughout the fatiguing process. Thus the design results in a test rig apparatus that permits failure determination by both material property changes and obvious fracture. Cyclic fatigue frequencies range from 0.2 to 1.2 Hz. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 US FDA, Div Mech & Mat Sci, Off Sci & Technol, Ctr Devices & Radiol Hlth, Rockville, MD 20850 USA.
RP Long, MC (reprint author), US FDA, Div Mech & Mat Sci, Off Sci & Technol, Ctr Devices & Radiol Hlth, 9200 Corp Blvd,HFZ-150, Rockville, MD 20850 USA.
CR Baumeister T, 1967, STANDARD HDB MECH EN
   Dillon JG, 1997, J APPL POLYM SCI, V64, P553, DOI 10.1002/(SICI)1097-4628(19970418)64:3<553::AID-APP12>3.0.CO;2-Z
   GOLDSTEIN A, 1992, LAT BARR MAT P JUL, P175
   KISIELEWSKI RW, 2000, J TESTING EVAL   MAR, P136
   KORNIEWICZ DM, 1990, J CLIN MICROBIOL, V28, P787
   Lytle CD, 1999, J TEST EVAL, V27, P231
   Moet A., 1986, FAILURE PLASTICS, P345
   VARGAS A, 1979, PLAST RECONSTR SURG, V64, P252, DOI 10.1097/00006534-197908000-00025
NR 8
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD NOV
PY 2001
VL 23
IS 10
BP 911
EP 916
DI 10.1016/S0142-1123(01)00046-9
PG 6
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 484JW
UT WOS:000171687300009
DA 2018-10-19
ER

PT J
AU Leng, YX
   Sun, H
   Yang, P
   Chen, JY
   Wang, J
   Wan, GJ
   Huang, N
   Tian, XB
   Wang, LP
   Chu, PK
AF Leng, YX
   Sun, H
   Yang, P
   Chen, JY
   Wang, J
   Wan, GJ
   Huang, N
   Tian, XB
   Wang, LP
   Chu, PK
TI Biomedical properties of tantalum nitride films synthesized by reactive
   magnetron sputtering
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CALIFORNIA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE tantalum nitride; blood compatibility; low-temperature isotropic
   pyrolytic carbon; platelet adhesion; artificial heart valve; mechanical
   properties
AB The biomedical properties of tantalum nitride thin films synthesized by reactive magnetron sputtering employing orthogonal design technology are investigated. The adhesion properties between the film and substrate can be enhanced by optimizing the sputtering gas pressure and substrate temperature. The hardness of the tantalum nitride films is greatly affected by the nitrogen partial pressure, and our results show that films deposited under the optimal conditions can achieve a hardness value of approximately 40 GPa. The blood compatibility of the tantalum nitride films, as evaluated by clotting time measurement and platelet adhesion tests, is compared to that of TiN, Ta and low-temperature isotropic pyrolytic carbon (LTIC). Our data reveal that the blood compatibility of our tantalum nitride films is better, and tantalum nitride is thus an excellent material for the fabrication of commercial artificial heart valves. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Sichuan, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Wan, GJ/A-3648-2009; Wan, Guojiang/A-6651-2013; Leng,
   Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013
OI Wan, Guojiang/0000-0002-1636-5405; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   BOLZ A, 1990, ARTIF ORGANS, V144, P260
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   Gutmann F, 1986, MODERN BIOELECTROCHE
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   LENG YX, 1998, J MAT ENG, V9, P18
   Mitamura Y, 1989, J Biomater Appl, V4, P33, DOI 10.1177/088532828900400103
   REN L, 1987, EXP OPTIMIZATION TEC, P263
   THROMSON A, 1991, BIOMATERIALS, V12, P37
   XI TF, 1988, T 3 WORLD BIOM C JAP, P32
   ZENG XL, 1998, J SW JIATONG U, V33, P263
NR 14
TC 91
Z9 98
U1 1
U2 31
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 1
PY 2001
VL 398
BP 471
EP 475
DI 10.1016/S0040-6090(01)01448-1
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 505GZ
UT WOS:000172906200080
DA 2018-10-19
ER

PT J
AU Silagy, CA
   Stead, LF
   Lancaster, T
AF Silagy, CA
   Stead, LF
   Lancaster, T
TI Use of systematic reviews in clinical practice guidelines: case study of
   smoking cessation
SO BRITISH MEDICAL JOURNAL
LA English
DT Article
ID BIOMEDICAL-RESEARCH; EVALUATING PAYBACK
AB Objective To examine the extent to which recommendations in the national guidelines for the cessation of smoking are based on evidence from systematic reviews of controlled trials.
   Design Retrospective analysis of recommendations for the national guidelines for the cessation of smoking.
   Materials National guidelines in clinical practice on smoking cessation published in English.
   Main outcome measures The type of evidence (systematic review of controlled trials, individual trials, other studies, expert opinion) used to support each recommendation. We also assessed whether a Cochrane systematic review was available and could have been used in formulating the recommendation.
   Results Four national smoking cessation guidelines (from Canada, New Zealand, the United Kingdom, and the United States) covering 105 recommendations were identified. An explicit evidence base for 100%, 89%, 68%, and 98% of recommendations, respectively, was detected, of which 60%, 56%, 59%, and 47% were based on systematic reviews of controlled studies. Cochrane systematic reviews could have been used to develop between 39% and 73% of recommendations but were actually used in 0% to 36% of recommendations. The UK guidelines had the highest proportion of recommendations based on Cochrane systematic reviews.
   Conclusions Use of systematic reviews in guidelines is a measure of the "payback" on investment in research synthesis. Systematic reviews commonly underpinned recommendations in guidelines on smoking cessation. The extent to which they were used varied by country and there was evidence of duplication of effort in some areas. Greater international collaboration in developing and maintaining an evidence base of systematic reviews can improve the efficiency of use of research resources.
C1 Monash Med Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia.
   Inst Hlth Sci, Dept Primary Hlth Care, Imperial Canc Res Fund Gen Practice Res Grp, Cochrane Tobacco Addict Grp, Oxford OX3 7LF, England.
RP Silagy, CA (reprint author), Monash Med Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia.
CR Chalmers I, 2000, BRIT MED J, V321, P566, DOI 10.1136/bmj.321.7260.566
   CHALMERS L, 1992, BRIT MED J, V340, P786
   Cohen D, 1998, SMOKING CESSATION ME
   FIORE MC, 1996, US DEP HHS PUBLICATI
   Fiore MC, 2000, TREATING TOBACCO USE
   Grant J, 2000, BRIT MED J, V321, P566
   Grant J, 2000, BRIT MED J, V320, P1107, DOI 10.1136/bmj.320.7242.1107
   Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858
   LANCASTER T, 2000, COCHRANE COLLABORATI
   MCDONALD S, 2000, SYSTEMATIC REV CITED
   *NAT HLTH COMM, 1999, GUID SMOK CESS LIT R
   *NAT HLTH COMM, 1999, GUID SMOK CESS
   Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1
   Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593
   TAYLOR MC, 1994, CANADIAN GUIDE CLIN, P500
   West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987
   Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527
NR 17
TC 32
Z9 33
U1 0
U2 2
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-535X
J9 BRIT MED J
JI Br. Med. J.
PD OCT 13
PY 2001
VL 323
IS 7317
BP 833
EP 836
DI 10.1136/bmj.323.7317.833
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 483RW
UT WOS:000171650500024
PM 11597966
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Sahoo, H
   Pavoor, T
   Vancheeswaran, S
AF Sahoo, H
   Pavoor, T
   Vancheeswaran, S
TI Actuators based on electroactive polymers
SO CURRENT SCIENCE
LA English
DT Article
ID ARTIFICIAL MUSCLES
AB Conducting polymers and ionic polymer-metal composites (IPMCs) are among those electro-active polymer materials that have shown tremendous potential to make efficient actuators. The volume change that a conducting polymer undergoes upon electrochemical oxidation and reduction is used to make microactuators, which find various biomedical applications and can be used for manipulation of particles of micrometre dimensions. IPMCs undergo strong bending on application of an electric field, Actuators using IPMCs have space applications. Further development of IPMCs is being done to make it overcome the present obstacles. Conducting polymers and IPMCs have gained recognition due to their low cost, low operating potential and high, efficiency.
C1 Univ Bombay, Dept Chem Technol, Dept Chem Engn, Bombay 400019, Maharashtra, India.
RP Pavoor, T (reprint author), Univ Bombay, Dept Chem Technol, Dept Chem Engn, Matunga, Bombay 400019, Maharashtra, India.
CR Bar-Cohen Y, 2001, P 42 AIAA STRUCT STR
   Bar-Cohen Y., 1999, MRS S FF EL POL, V31295
   BARCOHEN Y, 1998, ROBOTICS 98
   BARCOHEN Y, 2000, HDB BIOMIMETICS
   BARCOHEN Y, 1999, P SPIES 6 ANN INT S
   Jager EWH, 1999, P SOC PHOTO-OPT INS, V3669, P377, DOI 10.1117/12.349696
   Jager EWH, 2000, SCIENCE, V288, P2335, DOI 10.1126/science.288.5475.2335
   OTERO TF, 1995, BIOELECTROCH BIOENER, V38, P411, DOI 10.1016/0302-4598(95)01802-L
   Shahinpoor M, 2000, SMART MATER STRUCT, V9, P543, DOI 10.1088/0964-1726/9/4/318
   Shahinpoor M., 1998, P SPIES 5 ANN INT S
NR 10
TC 14
Z9 14
U1 0
U2 5
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD OCT 10
PY 2001
VL 81
IS 7
BP 743
EP 746
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 483KD
UT WOS:000171633800010
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU van Hest, JCM
   Tirrell, DA
AF van Hest, JCM
   Tirrell, DA
TI Protein-based materials, toward a new level of structural control
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID TRANSFER-RNA SYNTHETASE; UNNATURAL AMINO-ACIDS; SITE-SPECIFIC
   INCORPORATION; DRAGLINE SILK PROTEINS; IN-VIVO INCORPORATION; SPIDER
   SILK; ESCHERICHIA-COLI; MUSSEL BYSSUS; EFFICIENT INCORPORATION; PERIODIC
   POLYPEPTIDES
AB Through billions of years of evolution nature has created and refined structural proteins for a wide variety of specific purposes. Amino acid sequences and their associated folding patterns combine to create elastic, rigid or tough materials. In many respects, nature's intricately designed products provide challenging examples for materials scientists, but translation of natural structural concepts into bio-inspired materials requires a level of control of macromolecular architecture far higher than that afforded by conventional polymerization processes. An increasingly important approach to this problem has been to use biological systems for production of materials. Through protein engineering, artificial genes can be developed that encode protein-based materials with desired features. Structural elements found in nature, such as P-sheets and a-helices, can be combined with great flexibility, and can be outfitted with functional elements such as cell binding sites or enzymatic domains. The possibility of incorporating non-natural amino acids increases the versatility of protein engineering still further. It is expected that such methods will have large impact in the field of materials science, and especially in biomedical materials science, in the future.
C1 Catholic Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands.
   CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP van Hest, JCM (reprint author), Catholic Univ Nijmegen, Dept Organ Chem, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.
EM vanhest@sci.kun.nl; tirrell@Caltech.edu
RI Sanguansri, Luz/B-6630-2011; van Hest, Jan/D-5625-2012
OI Sanguansri, Luz/0000-0003-1908-7604; van Hest, Jan/0000-0001-7973-2404
CR Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 1999, MACROMOLECULES, V32, P4940, DOI 10.1021/ma990442z
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Coyne KJ, 2000, J EXP BIOL, V203, P1425
   Deming TJ, 1997, ADV MATER, V9, P299, DOI 10.1002/adma.19970090404
   Deming TJ, 1997, J MACROMOL SCI PURE, VA34, P2143, DOI 10.1080/10601329708010331
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Furter R, 1998, PROTEIN SCI, V7, P419
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   Hamano-Takaku F, 2000, J BIOL CHEM, V275, P40324, DOI 10.1074/jbc.M003696200
   He SJ, 1998, MACROMOLECULES, V31, P9387, DOI 10.1021/ma981286j
   Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q
   Jelinski LW, 1998, CURR OPIN SOLID ST M, V3, P237, DOI 10.1016/S1359-0286(98)80097-1
   Jelinski LW, 1996, SCIENCE, V273, P1481
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7
   Kiick KL, 2000, TETRAHEDRON, V56, P9487, DOI 10.1016/S0040-4020(00)00833-4
   Kitamura M, 1999, J POLYM SCI POL CHEM, V37, P729, DOI 10.1002/(SICI)1099-0518(19990315)37:6<729::AID-POLA8>3.3.CO;2-V
   KOTHAKOTA S, 1995, J AM CHEM SOC, V117, P536, DOI 10.1021/ja00106a064
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Krejchi MT, 1997, MACROMOLECULES, V30, P5012, DOI 10.1021/ma9614050
   Lee TAT, 2000, ADV MATER, V12, P1105, DOI 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Liu DR, 1997, P NATL ACAD SCI USA, V94, P10092, DOI 10.1073/pnas.94.19.10092
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Matyjaszewski K., 2000, ACS S SERIES, V768
   McGrath K. P., 1997, PROTEIN BASED MAT
   McMillan RA, 2000, ABSTR PAP AM CHEM S, V219, pU453
   Nicol A., 1994, BIOTECHNOLOGY BIOACT
   NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980
   O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.3.CO;2-K
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Panitch A, 1997, MACROMOLECULES, V30, P42, DOI 10.1021/ma961059m
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Qu Y, 2000, J AM CHEM SOC, V122, P5014, DOI 10.1021/ja9935761
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   RICHMOND MH, 1962, BACTERIOL REV, V26, P398
   Riekel C, 1999, MACROMOLECULES, V32, P4464, DOI 10.1021/ma990067a
   ROBINSON C, 1957, NATURE, V180, P1183, DOI 10.1038/1801183a0
   Rutjes FPJT, 2000, J CHEM SOC PERK T 1, P4197, DOI 10.1039/b001538p
   Sambrook J, 1986, MOL CLONING
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0
   Tang Y, 2001, BIOCHEMISTRY-US, V40, P2790, DOI 10.1021/bi0022588
   TIRRELL DA, 1991, MRS BULL, V16, P23
   Urry DW, 1998, BIOTECHNOL BIOENG, V58, P175, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<175::AID-BIT10>3.0.CO;2-C
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j
   van Hest JCM, 1998, FEBS LETT, V428, P68, DOI 10.1016/S0014-5793(98)00489-X
   VANDERREST M, 1990, BIOCHIMIE, V72, P473, DOI 10.1016/0300-9084(90)90071-N
   Waite JH, 1999, ANN NY ACAD SCI, V875, P301, DOI 10.1111/j.1749-6632.1999.tb08513.x
   Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077
   Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y
   Warner SB, 1999, J MACROMOL SCI R M C, VC39, P643
   Watt SW, 1999, MACROMOLECULES, V32, P8671, DOI 10.1021/ma991223g
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P14002, DOI 10.1021/bi005119z
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   YOSHIKAWA E, 1994, MACROMOLECULES, V27, P5471, DOI 10.1021/ma00097a029
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Yu SJM, 1997, NATURE, V389, P167
NR 74
TC 264
Z9 264
U1 6
U2 107
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD OCT 7
PY 2001
IS 19
BP 1897
EP 1904
DI 10.1039/b105185g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 482PJ
UT WOS:000171584200001
PM 12240211
DA 2018-10-19
ER

PT J
AU Banas, A
   Kwiatek, WM
   Zajac, W
AF Banas, A
   Kwiatek, WM
   Zajac, W
TI Trace element analysis of tissue section by means of synchrotron
   radiation: the use of GNUPLOT for SRIXE spectra analysis
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article; Proceedings Paper
CT 5th International School and Symposium on Synchrotron Radiation in
   Natural Science (ISSRNS)
CY JUN 12-17, 2000
CL POLAND
DE SRIXE; trace elements; GNUPLOT; prostate; kidney
AB Synchrotron Radiation Induced X-ray Emission (SRIXE) is a powerful technique for Trace Element (TE) analysis in biomedical samples. Recently, SRIXE technique has been applied to TE determination in 20 mum thick kidney and prostate tissue sections, taken from cancerous and healthy organs. Results obtained for the latter two are compared. Matrices of biomedical samples are mostly composed of low-Z elements, and trace elements are at low levels. This is why SRIXE data analysis in such materials may be quite a challenge. In order to solve analytical problems, sophisticated fitting procedures have to be applied since a proper spectra analysis requires additional information about the sample. This is usually carried out by dedicated computer software. We are showing that satisfactory results can be obtained by employing GNUPLOT, a public domain script-driven engine for data visualization and curve fitting. The results of GNUPLOT are compared with ones obtained from QXAS. an open domain software (obtained from IAEA). (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Jagiellonian Univ, Inst Phys, PL-30059 Krakow, Poland.
   H Niewodniczanski Inst Nucl Phys, PL-31342 Krakow, Poland.
RP Banas, A (reprint author), Jagiellonian Univ, Inst Phys, Reymonta 4, PL-30059 Krakow, Poland.
RI Zajac, Wojciech/R-1218-2017
OI Zajac, Wojciech/0000-0001-9957-1206; Kwiatek,
   Wojciech/0000-0002-2197-8572
CR BRANDENBURG T, 1992, THESIS HAMBURG U
   HALLIWELL B, 1984, BIOCHEM J, V219, P1
   Jones K. W., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V749, P37
   JONES KW, 1992, HDB XRAY SPECTROMETR, P411
   KWIATEK WM, 1994, ACTA PHYS POL A, V86, P695, DOI 10.12693/APhysPolA.86.695
   1970, NUCL DATA TABLES A, V7, P688
NR 6
TC 10
Z9 10
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD OCT 4
PY 2001
VL 328
IS 1-2
BP 135
EP 138
DI 10.1016/S0925-8388(01)01334-2
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 473RZ
UT WOS:000171063000024
DA 2018-10-19
ER

PT J
AU Righetti, PG
AF Righetti, PG
TI Capillary electrophoretic analysis of proteins and peptides of
   biomedical and pharmacological interest
SO BIOPHARMACEUTICS & DRUG DISPOSITION
LA English
DT Review
DE capillary electrophoresis; proteins; peptides; peptide maps; isoelectric
   buffers; protein folding/unfolding
ID INDUCED FLUORESCENCE DETECTION; RECOMBINANT-HUMAN-ERYTHROPOIETIN;
   ELECTROSPRAY MASS-SPECTROMETRY; BARE SILICA WALL; MICELLAR
   ELECTROKINETIC CHROMATOGRAPHY; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ZONE-ELECTROPHORESIS; ISOELECTRIC BUFFERS; GLOBIN CHAINS;
   DISSOCIATION-CONSTANTS
AB Capillary electrophoresis (CE) is an automated approach to electrokinetic separations that has had a deep impact in all fields of life sciences, including biomedical and biotechnological research and clinical and forensic practice. The present review highlights aspects of peptides and proteins separations, with particular emphasis on macromolecular analytes of biomedical interest. Among the various CE techniques available, a novel methodology is here illustrated consisting in separations in acidic, isoelectric buffers, which have the advantage of protonating the silica wall, thus minimizing interactions of proteinaceous material with the siliceous surface, while allowing delivery of high voltage gradients, due to their low conductivities. The review ends with applications of CE to the analysis of folding/unfolding/refolding/misfolding of proteins, a field which has deep implications in the biomedical arena, since it is connected to a host of disorders, such as prion protein diseases. Copyright (C) 2001 John Wiley Sons, Ltd.
C1 Univ Verona, Dept Agr & Ind Biotechnol, I-37134 Verona, Italy.
RP Righetti, PG (reprint author), Univ Verona, Dept Agr & Ind Biotechnol, Strada Le Grazie 15, I-37134 Verona, Italy.
OI Righetti, Pier Giorgio/0000-0001-8321-9187
CR Adamson NJ, 1997, J CHROMATOGR B, V699, P133, DOI 10.1016/S0378-4347(97)00202-8
   Asermely KE, 1997, J CHROMATOGR B, V695, P67, DOI 10.1016/S0378-4347(97)00172-2
   Baars MJ, 1999, ANAL CHEM, V71, P667, DOI 10.1021/ac980714g
   Ban EM, 1997, ANAL SCI, V13, P489, DOI 10.2116/analsci.13.Supplement_489
   Banks JF, 1997, ELECTROPHORESIS, V18, P2255, DOI 10.1002/elps.1150181216
   Bardelmeijer HA, 1997, ELECTROPHORESIS, V18, P2214, DOI 10.1002/elps.1150181212
   Bardelmeijer HA, 1998, J CHROMATOGR A, V807, P3, DOI 10.1016/S0021-9673(98)00230-1
   BECKERS JL, 1988, J CHROMATOGR, V452, P591, DOI 10.1016/S0021-9673(01)81482-5
   Bietlot HP, 1997, J CHROMATOGR A, V759, P177, DOI 10.1016/S0021-9673(96)00767-4
   Boss HJ, 1998, ELECTROPHORESIS, V19, P2654, DOI 10.1002/elps.1150191515
   Bossi A, 1997, ELECTROPHORESIS, V18, P2012, DOI 10.1002/elps.1150181122
   Bossi A, 1999, J CHROMATOGR A, V853, P71, DOI 10.1016/S0021-9673(99)00519-1
   Bossi A, 1999, J CHROMATOGR A, V840, P117, DOI 10.1016/S0021-9673(99)00215-0
   Boulis Y, 1998, J CHROMATOGR A, V805, P285, DOI 10.1016/S0021-9673(97)01303-4
   Capelli L, 1997, J CHROMATOGR A, V791, P313, DOI 10.1016/S0021-9673(97)00790-5
   Castagnola M, 1998, ELECTROPHORESIS, V19, P2273, DOI 10.1002/elps.1150191304
   CASTAGNOLA M, 1994, J CHROMATOGR B, V656, P87, DOI 10.1016/0378-4347(94)00082-4
   CASTAGNOLA M, 1991, J CHROMATOGR-BIOMED, V572, P51, DOI 10.1016/0378-4347(91)80472-O
   Castagnola M, 1996, CRC SER ANAL BIOTECH, P239
   Castelletti L, 2000, J CHROMATOGR A, V894, P281, DOI 10.1016/S0021-9673(00)00664-6
   Chen CP, 1997, J CHROMATOGR B, V697, P149, DOI 10.1016/S0378-4347(97)00062-5
   CHIARI M, 1996, CRC SER ANAL BIOTECH, P1
   CHIESA C, 1996, CAPILLARY ELECTROPHO, P155
   Cho BY, 1997, J CHROMATOGR B, V697, P163, DOI 10.1016/S0378-4347(97)00285-5
   Cifuentes A, 1997, ELECTROPHORESIS, V18, P2362, DOI 10.1002/elps.1150181227
   Cifuentes A, 1999, J CHROMATOGR A, V830, P453, DOI 10.1016/S0021-9673(98)00875-9
   Clarke NJ, 1997, J AM SOC MASS SPECTR, V8, P743, DOI 10.1016/S1044-0305(97)00084-6
   COMI P, 1979, BIOCHEM BIOPH RES CO, V87, P1, DOI 10.1016/0006-291X(79)91639-5
   COMPTON BJ, 1991, J CHROMATOGR, V559, P357, DOI 10.1016/0021-9673(91)80085-U
   COMPTON BJ, 1991, ANAL CHEM, V63, P2587
   Cousino MA, 1997, ANAL CHEM, V69, pA544, DOI 10.1021/ac9717651
   Dolnik V, 1997, ELECTROPHORESIS, V18, P2353, DOI 10.1002/elps.1150181226
   Farchaus JW, 1998, APPL ENVIRON MICROB, V64, P982
   GANZLER K, 1996, CRC SER ANAL BIOTECH, P183
   GAO J, 1998, HIGH PERFORMANCE CAP, P947
   Gelfi C, 2001, ANAL CHEM, V73, P3862, DOI 10.1021/ac001478o
   Gelfi C, 1998, ELECTROPHORESIS, V19, P1677, DOI 10.1002/elps.1150191026
   Goldman MH, 1998, BIOTECHNOL BIOENG, V60, P596, DOI 10.1002/(SICI)1097-0290(19981205)60:5<596::AID-BIT10>3.0.CO;2-5
   GROSSMAN PD, 1989, ANAL BIOCHEM, V179, P28, DOI 10.1016/0003-2697(89)90195-4
   Guijt-van Duijn RM, 2000, ELECTROPHORESIS, V21, P3905
   Hearn MTW, 2000, ANAL CHEM, V72, P1964, DOI 10.1021/ac990369a
   Heegaard NHH, 1999, ELECTROPHORESIS, V20, P3122, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3122::AID-ELPS3122>3.3.CO;2-D
   HILSER VJ, 1993, J CHROMATOGR, V630, P329, DOI 10.1016/0021-9673(93)80469-O
   HIROKAWA T, 1987, J CHROMATOGR, V408, P27, DOI 10.1016/S0021-9673(01)81788-X
   Hjerten S, 1967, Chromatogr Rev, V9, P122, DOI 10.1016/0009-5907(67)80003-6
   Hjerten S, 1992, CAPILLARY ELECTROPHO, P191
   Hoitink MA, 1997, J CHROMATOGR A, V776, P319, DOI 10.1016/S0021-9673(97)00349-X
   Jiskra J, 1997, J CHROMATOGR A, V761, P285, DOI 10.1016/S0021-9673(96)00831-X
   JORGENSON JW, 1981, ANAL CHEM, V53, P1298, DOI 10.1021/ac00231a037
   KAIJWARA H, 1998, ELECTROPHORESIS, V19, P1270
   KALMAN F, 1995, J CHROMATOGR A, V705, P135, DOI 10.1016/0021-9673(94)00549-O
   Kasicka V, 1999, ELECTROPHORESIS, V20, P3084, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3084::AID-ELPS3084>3.0.CO;2-4
   KELLY KA, 1998, HIGH PERFORMANCE CAP, P277
   Khaledi M. G, 1998, HIGH PERFORMANCE CAP, P77
   Klyushnichenko V, 1997, J BIOTECHNOL, V58, P187, DOI 10.1016/S0168-1656(97)00149-1
   Kopp K, 1996, ARZNEIMITTEL-FORSCH, V46, P1191
   KRIVANKOVA L, 1998, HIGH PERFORMANCE CAP, P251
   Kubota H, 1998, J CHROMATOGR A, V803, P315, DOI 10.1016/S0021-9673(97)01229-6
   Kundu S, 1997, J CAPILLARY ELECTROP, V4, P7
   Lagu AL, 1999, ELECTROPHORESIS, V20, P3145, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3145::AID-ELPS3145>3.0.CO;2-0
   Lai M, 1998, J PHARMACEUT BIOMED, V18, P421, DOI 10.1016/S0731-7085(98)00049-1
   LAUER HH, 1986, ANAL CHEM, V58, P166, DOI 10.1021/ac00292a041
   Matsubara N, 1996, CRC SER ANAL BIOTECH, P155
   MCCORMICK RM, 1988, ANAL CHEM, V60, P2322, DOI 10.1021/ac00172a003
   MCCORMICK RM, 1993, HDB CAPILLARY ELECTR, P287
   McLaughlin GM, 1998, HIGH PERFORMANCE CAP, P637
   McNerney TM, 1996, J CHROMATOGR A, V744, P223, DOI 10.1016/0021-9673(96)00421-9
   Messana I, 1997, J CHROMATOGR B, V699, P149, DOI 10.1016/S0378-4347(97)00198-9
   MEYER S, 1994, ELECTROPHORESIS, V15, P1151, DOI 10.1002/elps.11501501174
   Moorhouse KG, 1996, ELECTROPHORESIS, V17, P423, DOI 10.1002/elps.1150170223
   Moring S.E., 1996, CRC SER ANAL BIOTECH, P37
   Nieto O, 1996, ANAL COMMUN, V33, P425, DOI 10.1039/ac9963300425
   OFFORD RE, 1966, NATURE, V211, P591, DOI 10.1038/211591a0
   Olivieri E, 2000, J CHROMATOGR A, V894, P273, DOI 10.1016/S0021-9673(00)00665-8
   PALMIERI R, 1993, HDB CAPILLARY ELECTR, P325
   PARK SS, 1997, NEUROPEPTIDE PROTOCO, P101
   Pesek JJ, 1999, ELECTROPHORESIS, V20, P2343, DOI 10.1002/(SICI)1522-2683(19990801)20:12<2343::AID-ELPS2343>3.3.CO;2-0
   Pinto DM, 1997, ANAL CHEM, V69, P3015, DOI 10.1021/ac9611677
   POLASEK M, 1992, J CHROMATOGR, V596, P265, DOI 10.1016/0021-9673(92)85015-L
   POSPICHAL J, 1987, J CHROMATOGR, V390, P17, DOI 10.1016/S0021-9673(01)94356-0
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Regnier F. E., 1998, HIGH PERFORMANCE CAP, P683
   Reubsaet JLE, 1998, J PHARMACEUT BIOMED, V17, P979, DOI 10.1016/S0731-7085(98)00064-8
   Reubsaet JLE, 1998, J PHARMACEUT BIOMED, V17, P955, DOI 10.1016/S0731-7085(98)00063-6
   RICKARD EC, 1991, ANAL BIOCHEM, V197, P197, DOI 10.1016/0003-2697(91)90379-8
   Ridge S, 1998, J CHROMATOGR A, V817, P215, DOI 10.1016/S0021-9673(98)00313-6
   Righetti P. G., 1994, J CAP ELEC, V1, P27
   Righetti P. G., 1996, CAPILLARY ELECTROPHO
   Righetti P. G., 1993, CAPILLARY ELECTROPHO, P89
   Righetti P. G., 1996, CRC SER ANAL BIOTECH, P509
   Righetti P. G., 1979, J BIOCHEM BIOPH METH, V1, P47
   Righetti PG, 1997, ELECTROPHORESIS, V18, P2145, DOI 10.1002/elps.1150181205
   Righetti PG, 2000, ELECTROPHORESIS, V21, P4046, DOI 10.1002/1522-2683(200012)21:18<4046::AID-ELPS4046>3.0.CO;2-5
   Righetti PG, 2001, ELECTROPHORESIS, V22, P603, DOI 10.1002/1522-2683(200102)22:4<603::AID-ELPS603>3.0.CO;2-N
   Righetti PG, 1997, J CHROMATOGR A, V772, P203, DOI 10.1016/S0021-9673(97)00105-2
   Righetti PG, 1999, J BIOCHEM BIOPH METH, V40, P1, DOI 10.1016/S0165-022X(99)00010-X
   Righetti PG, 1990, IMMOBILIZED PH GRADI
   Roche ME, 1998, ANAL BIOCHEM, V258, P87, DOI 10.1006/abio.1997.2553
   Roddy TP, 1997, J CHROMATOGR B, V695, P49, DOI 10.1016/S0378-4347(97)00100-X
   Sabah S, 1998, J PHARMACEUT BIOMED, V16, P1089, DOI 10.1016/S0731-7085(97)00054-X
   Saccomani A, 1999, J CHROMATOGR A, V832, P225, DOI 10.1016/S0021-9673(98)00963-7
   Sanz-Nebot V, 2001, J CHROMATOGR A, V921, P69, DOI 10.1016/S0021-9673(01)00730-0
   SCHOMBURG G, 1998, HIGH PERFORMANCE CAP, P481
   Sebastiano R, 2001, J CHROMATOGR A, V924, P71, DOI 10.1016/S0021-9673(01)00804-4
   Sebastiano R, 2000, J CHROMATOGR A, V894, P53, DOI 10.1016/S0021-9673(00)00801-3
   Settlage RE, 1998, J MICROCOLUMN SEP, V10, P281, DOI 10.1002/(SICI)1520-667X(1998)10:3<281::AID-MCS7>3.0.CO;2-C
   SHIEH P, 1998, HIGH PERFORMANCE CAP, P185
   Shihabi ZK, 1998, J CHROMATOGR A, V807, P129, DOI 10.1016/S0021-9673(98)00055-7
   Strege MA, 1997, ELECTROPHORESIS, V18, P2343, DOI 10.1002/elps.1150181225
   SWEDBERG SA, 1993, HDB CAPILLARY ELECTR, P513
   Szoko E, 1997, ELECTROPHORESIS, V18, P74, DOI 10.1002/elps.1150180116
   TANFORD C, 1961, PHYSICAL CHEM MACROM, pCH3
   Thorne JM, 1996, J CHROMATOGR A, V744, P155, DOI 10.1016/0021-9673(96)00513-4
   TIMPERMAN AT, 1995, ANAL CHEM, V67, P3421, DOI 10.1021/ac00115a009
   TOMER KB, 1996, CRC SER ANAL BIOTECH, P123
   Tomlinson AJ, 1997, J AM SOC MASS SPECTR, V8, P15, DOI 10.1016/S1044-0305(96)00133-X
   TSUDA T, 1993, HDB CAPILLARY ELECTR, P563
   Verzola B, 2000, J CHROMATOGR A, V874, P293, DOI 10.1016/S0021-9673(00)00090-X
   Verzola B, 2000, J CHROMATOGR A, V868, P85, DOI 10.1016/S0021-9673(99)01207-8
   Verzola B, 2000, ANAL BIOCHEM, V282, P239, DOI 10.1006/abio.2000.4620
   Vessillier S, 1997, J CHROMATOGR A, V776, P133, DOI 10.1016/S0021-9673(97)00434-2
   Voelter W, 1998, J CHROMATOGR A, V807, P135, DOI 10.1016/S0021-9673(98)00178-2
   WIKTOROWICZ JE, 1998, HIGH PERFORMANCE CAP, P223
   Yang Q, 1999, J BIOCHEM BIOPH METH, V38, P103, DOI 10.1016/S0165-022X(98)00032-3
   Zhou GH, 1998, ELECTROPHORESIS, V19, P2348, DOI 10.1002/elps.1150191315
NR 125
TC 48
Z9 49
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2782
J9 BIOPHARM DRUG DISPOS
JI Biopharm. Drug Dispos.
PD OCT-NOV
PY 2001
VL 22
IS 7-8
BP 337
EP 351
DI 10.1002/bdd.276
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 524EM
UT WOS:000173999500005
PM 11835253
DA 2018-10-19
ER

PT J
AU Ananthanarayan, VT
   Shutov, F
AF Ananthanarayan, VT
   Shutov, F
TI Development of fabric sintering/compaction process to produce porous
   UHMW polyethylene composites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE porous Ultra High Molecular Weight (UHMW) polyethylene; biomedical
   implant; porous polymer composites; biomedical application
AB Implants based on solid (nonporous) Ultra High Molecular Weight (UHMW) polyethylene have serious disadvantages such as generation of fine polymer particles, because of the lack of internal natural lubricant inside the implant body. A novel family of porous multilayer composites based on Ultra High Molecular Weight (UHMW) polyethylene commercial fabrics has been developed. These composites are produced using a compaction/sintering process with a compression molding technique. The developed porous materials have much higher tensile strength than solid (nonporous) UHMW polyethylene materials.
C1 Tennessee Technol Univ, Dept Chem Engn, Cookeville, TN 38501 USA.
CR AGRAWAL MC, 1995, ENCY HDB BIOMATERIAL
   ANANTHANARAYAN VT, 2000, THESIS TENNESSEE TU
   FUREY MJ, 1993, BIOTR BUD HUNG 6 INT
   MILLER DA, 1995, ENCY HDB BIOMATERIAL
   SHUTOV FA, 1995, T 2 COMB M ORTH RES
NR 5
TC 3
Z9 5
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2001
VL 16
IS 2
BP 139
EP 148
DI 10.1106/LL58-TM8B-9PUD-X2X1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507TJ
UT WOS:000173045100004
PM 11794723
DA 2018-10-19
ER

PT J
AU Belanger, MC
   Marois, Y
AF Belanger, MC
   Marois, Y
TI Hemocompatibility, biocompatibility, inflammatory and in vivo studies of
   primary reference materials low-density polyethylene and
   polydimethylsiloxane: A review
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
DE primary reference materials; low-density polyethylene;
   polydimethylsiloxane; biocompatibility; hemocompatibility; inflammatory
   response; in vivo studies; tissue reactions
ID BIO-MEDICAL POLYMERS; BIOMEDICAL POLYMERS; MACROPHAGE ACTIVATION; BLOOD
   COMPATIBILITY; PROTEIN ADSORPTION; PLASMA-PROTEINS; FACTOR-XII;
   BIOMATERIALS; MODEL; VITRO
AB In 1984, low-density polyethylene (LDPE) and polymethylsiloxane (PDMS), two primary reference materials (PRM), were made available by the National Heart, Lung, and Blood Institute (NHLBI) as discriminatory tools for the validation of standardized and novel in vitro and in vivo tests in the evaluation of biomaterials. This article reviews the results and conclusions obtained by several studies investigating the hemocompatibility, in vitro biocompatibility, inflammatory response, and in vivo tissue reactions of these two reference materials. Variable results obtained with LDPE and PDMS in ex vivo hemocompatibility studies were attributed to the type of animal model used, the flow velocity of the circulating blood, the time of exposure, and the methodology used to measure blood cell adhesion or activation at the surface of the materials. In contrast, both the LDPE and PDMS appeared to be suitable reference materials when used in in vitro biocompatibility, inflammatory response, and in vivo studies. However, caution must be taken when interpreting the results, because gamma sterilization of these two materials as well as their origin (for example PDMS) are two critically important factors. In conclusion, we see a definite need for standardized hemocompatible parameters and better high-quality hemocompatibility studies on PRM. This review also suggests other materials as potential PRM candidates, namely, Biomer((R)) and Intra-medic (TM) polyethylene. (C) 2001 John Wiley & Sons.
C1 CHUQ, Quebec Biomat Inst, Hop St Francois Assise, Quebec City, PQ G1L 3L5, Canada.
   Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada.
RP Marois, Y (reprint author), CHUQ, Quebec Biomat Inst, Hop St Francois Assise, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
CR Akoum A, 1992, J Invest Surg, V5, P129, DOI 10.3109/08941939209012429
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1994, J BIOMED MATER RES, V28, P137, DOI 10.1002/jbm.820280118
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   CAIX J, 1994, J BIOMAT SCI-POLYM E, V5, P279, DOI 10.1163/156856294X00022
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Fages J, 1998, ASAIO J, V44, P278
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HUANG B, 1992, BIOMATERIALS, V13, P209, DOI 10.1016/0142-9612(92)90186-R
   IP WF, 1991, J BIOMED MATER RES, V25, P1321, DOI 10.1002/jbm.820251012
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KEOUGH EM, 1985, J BIOMED MATER RES, V19, P577, DOI 10.1002/jbm.820190509
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   MCCOY TJ, 1989, BIOMATERIALS, V10, P243, DOI 10.1016/0142-9612(89)90100-2
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   PELZER H, 1986, J BIOMED MATER RES, V20, P1401, DOI 10.1002/jbm.820200913
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   SCHMIDT JA, 1993, J APPL BIOMATER, V4, P73, DOI 10.1002/jab.770040110
   SEVASTIANOV VI, 1984, T AM SOC ART INT ORG, V30, P137
   SHINTANI H, 1995, J BIOMATER APPL, V10, P23, DOI 10.1177/088532829501000102
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   Stroman PW, 1999, MAGNET RESON MED, V42, P210, DOI 10.1002/(SICI)1522-2594(199907)42:1<210::AID-MRM29>3.0.CO;2-Q
   VANDERKAMP KWHJ, 1994, J BIOMED MATER RES, V28, P349, DOI 10.1002/jbm.820280309
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   1980, GUIDELINES BLOOD MAT
   1980, GUIDELINES PHYSIOCHE
   1985, GUIDELINES BLOOD MAT
NR 36
TC 227
Z9 229
U1 8
U2 98
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 58
IS 5
BP 467
EP 477
DI 10.1002/jbm.1043
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472VR
UT WOS:000171006100001
PM 11505420
DA 2018-10-19
ER

PT J
AU Furness, PN
AF Furness, PN
TI Research using human tissues - a crisis of supply?
SO JOURNAL OF PATHOLOGY
LA English
DT Review
DE human tissues; medical ethics; consent
ID ETHICS
AB It is a paradox that the pursuit of ethical practice can sometimes produce distinctly unethical results. Pathologists seek to study diseased human tissues for the benefit of mankind, but in the UK there has been a sudden restriction in the availability of this basic resource, supposedly on ethical grounds. This was triggered by adverse publicity about the inappropriate retention of whole organs at paediatric post-mortem, but the reaction has spread to influence the use of 'surgical waste' left over after routine analysis of therapeutic resections, diagnostic biopsies, and even blood samples. The use of such material for research is being restricted, and its use in teaching and laboratory quality control is being questioned. This has occurred despite the facts that public opinion favours using such 'waste' material for research; that the tissues would otherwise be incinerated; and that until very recently, such tissues were regarded as having been 'abandoned' by the patient. This review attempts to chart how this dramatic change has occurred. It then considers some of the ethical problems in using such 'surplus' tissues and proposes mechanisms by which this valuable resource can remain available for most biomedical research, while maintaining or enhancing the autonomy of individual patients. This crisis has shown a tendency for regulatory authorities to apply very restrictive, oversimplified rules, without due consideration of the character of each project. The motivation is to avoid the possibility of media criticism, even though such rules block ethically sound work which is of value to all, including the individuals whose protection is supposedly being sought. The moral need for logical ethical arguments instead of such 'one size fits all' regulations is emphasized. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Univ Leicester, Dept Pathol, Leicester, Leics, England.
RP Furness, PN (reprint author), Leicester Gen Hosp, Dept Pathol, Gwendolen Rd, Leicester LE5 4PW, Leics, England.
CR [Anonymous], 2000, INQUIRY MANAGEMENT C
   [Anonymous], 2001, REPORT ROYAL LIVERPO
   Ashcroft R, 2000, NEUROPATH APPL NEURO, V26, P408, DOI 10.1046/j.1365-2990.2000.00276.x
   Beauchamp T, 1994, PRINCIPLES BIOMEDICA, P4
   de Zulueta P, 2000, J MED ETHICS, V26, P16, DOI 10.1136/jme.26.1.16
   Department of Health, 2001, REF GUID CONS EX TRE
   DEZULUETA P, 2000, J MED ETHICS, V26, P22
   *HOUS LORDS, 2001, SEL COMM SCI TECHN 4
   Human Genetics Commission, 2001, WHOS HANDS YOUR GEN
   Hutton JL, 2000, HEALTH CARE ANAL, V8, P41, DOI 10.1023/A:1009421824028
   *MED RES COUNC, 1999, HUM TISS BIOL SAMPL
   *MED RES COUNC, 2001, HUM TISS BIOL SAMPL
   Medical Research Council, 2000, PERS INF MED RES
   Medical Research Council and Wellcome Trust, 2001, PUBL PERC COLL HUM B
   Nuffield Council on Bioethics, 1995, HUM TISS ETH LEG ISS
   Start RD, 1996, BRIT MED J, V313, P1366, DOI 10.1136/bmj.313.7069.1366
NR 16
TC 11
Z9 11
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0022-3417
J9 J PATHOL
JI J. Pathol.
PD OCT
PY 2001
VL 195
IS 3
BP 277
EP 284
PG 8
WC Oncology; Pathology
SC Oncology; Pathology
GA 481MK
UT WOS:000171522900002
PM 11673823
DA 2018-10-19
ER

PT J
AU Kunzi-Rapp, K
   Genze, F
   Kufer, R
   Reich, E
   Hautmann, RE
   Gschwend, JE
AF Kunzi-Rapp, K
   Genze, F
   Kufer, R
   Reich, E
   Hautmann, RE
   Gschwend, JE
TI Chorioallantoic membrane assay: Vascularized 3-dimensional cell culture
   system for human prostate cancer cells as an animal substitute model
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostatic neoplasms; chick embryo; chorion; membrane
ID CARCINOMA; ESTABLISHMENT; EMBRYO; GROWTH; LINES; DEATH
AB Purpose: Chorioallantoic membranes have been used as a reliable biomedical assay system for many years. Chicken eggs in the early phase of breeding are between in vitro and in vivo systems but may provide an immunodeficient, vascularized test environment. We tested this model as an in vivo system for prostate cancer research.
   Materials and Methods: Single cell suspensions of LNCaP, PC-3 and Tsu-Prl human prostatic cancer cell lines as well as 2 immortalized normal human prostate epithelial cell lines were inoculated on the chorioallantoic membrane of fertilized chicken eggs on day 5 or 6 of breeding. Tumor growth and viability of the embryo was evaluated by stereo microscopy. At day 10 the membranes were removed and embedded in paraffin. Cell morphology was assessed after hematoxylin and eosin staining. Cellular expression of cytokeratin, prostate specific antigen and androgen receptor as well as apoptosis induction was confirmed by immunohistochemistry.
   Results: Three days after tumor cell inoculation on the extraembryonic vascular system of the chorioallantoic membrane cell growth and formation of 3-dimensional tumors became apparent in 100% of inoculated membranes. Strong neo-angiogenesis was detected next to the established tumors and tumor cells invading the stroma of the chorioallantoic membrane. Cytokeratin expression as well as prostate specific antigen and androgen receptor in LNCaP cells confirmed the human prostate tumor origin. Assessment of quantitative in vivo apoptosis induction in LNCaP cells after intravenous injection of the phorbol ester 12-0-tetradecanoylphorbol-13-acetate confirmed the model as a versatile in vivo system.
   Conclusions: The well vascularized chorioallantoic membrane of bred chicken eggs is a suitable system for early in vivo cancer research. Reliable growth of prostate cancer cell lines is feasible and allows the evaluation of proliferation and apoptosis induction after intravascular or topic application of anticancer drugs. Exploitation of this assay enables a substantial reduction in or substitution for subsequent animal experiments.
C1 Univ Ulm, Dept Urol, D-89075 Ulm, Germany.
   Univ Ulm, Inst Laser Technol Med & Metrol, D-89075 Ulm, Germany.
RP Gschwend, JE (reprint author), Univ Ulm, Dept Urol, Prittwitz Str 43, D-89075 Ulm, Germany.
CR ARMSTRONG PB, 1982, CANCER RES, V42, P1826
   AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   AUSPRUNK DH, 1975, AM J PATHOL, V79, P597
   DAGG CP, 1956, CANCER RES, V16, P589
   DAY ML, 1994, CELL GROWTH DIFFER, V5, P735
   Garzotto M, 1997, PROSTATE, V33, P60, DOI 10.1002/(SICI)1097-0045(19970915)33:1<60::AID-PROS10>3.0.CO;2-J
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GLEAVE M, 1991, CANCER RES, V51, P3753
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809
   IIZUMI T, 1987, J UROLOGY, V137, P1304, DOI 10.1016/S0022-5347(17)44488-0
   ISAACS JT, 1992, J ANDROL, V13, P457
   ISAACS WB, 1991, CANCER RES, V51, P4716
   JANSE EM, 1991, IMMUNOBIOLOGY, V182, P472
   KAIGHN ME, 1979, INVEST UROL, V17, P16
   KAUFMAN N, 1956, AM J PATHOL, V32, P271
   KOOP S, 1995, CANCER RES, V55, P2520
   KunziRapp K, 1996, P SOC PHOTO-OPT INS, V2924, P176, DOI 10.1117/12.260754
   KUNZIRAPP K, 1992, IN VITRO CELL DEV-AN, V28A, P565
   Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8
   Murphy JB, 1912, J AMER MED ASSOC, V59, P874
   Webber MM, 1997, PROSTATE, V30, P136, DOI 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M
NR 22
TC 67
Z9 70
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2001
VL 166
IS 4
BP 1502
EP 1507
DI 10.1016/S0022-5347(05)65820-X
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 471VV
UT WOS:000170950100092
PM 11547121
DA 2018-10-19
ER

PT J
AU Hoyt, RF
   Clevenger, RR
   McGehee, JA
AF Hoyt, RF
   Clevenger, RR
   McGehee, JA
TI Introduction to microsurgery: An emerging discipline in biomedical
   research
SO LAB ANIMAL
LA English
DT Article
AB Using microsurgical techniques, biomedical researchers are able to perform procedures that would otherwise be impossible on small laboratory animals. The authors provide a primer on learning microsurgical technique, from correct posture and hand position, to understanding lenses and proper handling of surgical needles and suture material.
C1 NHLBI, LAMS, NIH, Bethesda, MD 20892 USA.
RP Hoyt, RF (reprint author), NHLBI, LAMS, NIH, Serv Rd S,Bldg 14E,105B, Bethesda, MD 20892 USA.
CR FORSTER B, 1985, MICROSURGERY UROLOGY, P2
   GILBERT BR, 1995, SURG MALE INFERTILIT
   GREEN C, 1987, BASIC MICROSURGICAL, P1
   GREEN CJ, 1987, LAB ANIM, V21, P1, DOI 10.1258/002367787780740734
   LANZ O, 1998, CURRENT TECHNIQUES S, P713
   LEE S, 1987, EXPT MICROSURGERY, P15
   LICHTMAN DM, 1987, PRINCIPLES SURG TECH, P113
   MILLER CW, 1990, VET CLIN N AM-SMALL, V20, P189, DOI 10.1016/S0195-5616(90)50010-8
   SERAFIN D, 1986, LAB MANUAL MICROSURG, P1
   WOODRUFF WE, 1992, ATLAS MICROVASCULAR, P1
NR 10
TC 3
Z9 3
U1 0
U2 0
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 0093-7355
J9 LAB ANIMAL
JI Lab Anim.
PD OCT
PY 2001
VL 30
IS 9
BP 26
EP 35
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 482NX
UT WOS:000171583100003
PM 11687781
DA 2018-10-19
ER

PT J
AU Sadoqi, M
   Riseborough, P
   Kumar, S
AF Sadoqi, M
   Riseborough, P
   Kumar, S
TI Analytical models for time resolved fluorescence spectroscopy in tissues
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID TURBID MEDIA; SPECTRA
AB Laser induced fluorescence is a rapidly growing technique for diagnostics and imaging in scattering material, most notably in in vivo biomedical testing. Most previous applications have relied on the measurements of the steady-state emission spectrum, with subsequent analysis of the spectrum for relative concentrations of potential fluorophores. Only recently a few investigators have explored the use of the fluorescence lifetimes as a diagnostic tool by taking advantage of the perturbation of the lifetime by multiple scattering of the excitation and emission light in the tissue.
   We have developed a model to study the fluorescence signal generated by fluorophores distributed in a scattering medium. This model is based on two coupled time-dependent photon migration phenomena: the transport of the pulsed source laser light and the transport of the induced fluorescent light excited by the source. The coupling of these two is through the source for the induced fluorescence where the strength of the local fluorescence emission depends on the absorption of the laser intensity at that location. Whereas previous research focused mainly on the fluorescence properties of various dyes, compounds and materials, transport phenomena have only recently been addressed by researchers. We have presented general analytical and numerical solutions for finite, infinite, cylindrical and spherical geometries.
C1 St Johns Univ, Dept Phys, Jamaica, NY 11439 USA.
   Temple Univ, Dept Phys, Philadelphia, PA 19122 USA.
   Polytech Univ, Dept Mech Engn, Brooklyn, NY 11201 USA.
RP Sadoqi, M (reprint author), St Johns Univ, Dept Phys, Jamaica, NY 11439 USA.
RI Riseborough, Peter/D-4689-2011; Kumar, Sunil/H-1082-2012
CR Avrillier S, 1998, APPL OPTICS, V37, P2781, DOI 10.1364/AO.37.002781
   BAKER KJ, 1966, P SOC EXP BIOL MED, V122, P957
   CERRUSI AE, 1997, P SOC PHOTO-OPT INS, V2979, P139
   DEMAS JN, 1971, J PHYS CHEM-US, V75, P991
   DURKIN AJ, 1994, APPL OPTICS, V33, P414, DOI 10.1364/AO.33.000414
   HAGLUND MM, 1994, NEUROSURGERY, V35, P930, DOI 10.1227/00006123-199411000-00019
   HASKELL RC, 1994, J OPT SOC AM A, V11, P2727, DOI 10.1364/JOSAA.11.002727
   HUTCHINSON CL, 1995, BIOPHYS J, V68, P1574, DOI 10.1016/S0006-3495(95)80330-9
   LI XD, 1996, OSA TOPS BIOMEDICAL, V3, P195
   PATTERSON MS, 1994, APPL OPTICS, V33, P1963, DOI 10.1364/AO.33.001963
   SEVICKMURACA EM, 1994, OPT LETT, V19, P1928, DOI 10.1364/OL.19.001928
   SEVICKMURACA EM, 1996, OSA TRENDS OPTICS PH, V3, P166
   Sheridan R. L., 1995, Journal of Burn Care and Rehabilitation, V16, P602, DOI 10.1097/00004630-199511000-00007
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   WEISS GH, 1989, J MOD OPTIC, V36, P348
   WU J, 1993, APPL OPTICS, V32, P3585, DOI 10.1364/AO.32.003585
NR 16
TC 26
Z9 26
U1 0
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD OCT
PY 2001
VL 46
IS 10
BP 2725
EP 2743
DI 10.1088/0031-9155/46/10/314
PG 19
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 487HA
UT WOS:000171866700014
PM 11686285
DA 2018-10-19
ER

PT J
AU Revenko, I
   Tang, Y
   Santerre, JP
AF Revenko, I
   Tang, Y
   Santerre, JP
TI Surface structure of polycarbonate urethanes visualized by atomic force
   microscopy
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE atomic force microscopy; surface structure, morphology, roughness, and
   topography
ID SOFT CONTACT-LENSES; ENERGY-DISSIPATION; POLYMER SURFACES; AFM;
   POLYURETHANES; BIOMATERIALS; BIOSTABILITY; STABILITY
AB Polycarbonate polyurethanes are utilized for the production of long-term biomedical implants. The thermodynamic incompatibility between the hard and soft segments that make up these materials induces a two-phase microstructure. This two-phase structure (i.e. hard and soft segment phases) has unique features which contribute to its mechanical stability and moderate biocompatibility at the surface. As AFM was used to study the structure of six different polyurethane elastomers, where the reagent stoichiometrics, as well as the chemistry of the hard segments, were changed. The results (especially phase-mode images) indicated that the microdomain structures depend on the hard segment chemistry and are relatively less dependent on the stoichiometry. This type of data could be used in the future to relate biological responses to the surface architecture and chemistry of polyurethanes. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Digital Instruments, Santa Barbara, CA 93117 USA.
   Univ Toronto, Fac Dent, Toronto, ON M5S 1A8, Canada.
RP Revenko, I (reprint author), Digital Instruments, 112 Robin Hill Rd, Santa Barbara, CA 93117 USA.
RI He, Yong/F-8752-2012
CR BAGUET J, 1995, BIOMATERIALS, V16, P3, DOI 10.1016/0142-9612(95)91089-H
   BAGUET J, 1993, BIOMATERIALS, V14, P279, DOI 10.1016/0142-9612(93)90118-L
   Bar G, 2000, SURF SCI, V444, pL11, DOI 10.1016/S0039-6028(99)00975-9
   Bhatia Sameer, 1997, CLAO Journal, V23, P264
   Bourauel C, 1998, EUR J ORTHODONT, V20, P79, DOI 10.1093/ejo/20.1.79
   CAMPBELL PA, 1998, APPL PHYS A, V66, pS1
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   Chen XQ, 1998, JPN J APPL PHYS 1, V37, P3834, DOI 10.1143/JJAP.37.3834
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   Czajkowsky DM, 1998, ULTRAMICROSCOPY, V74, P1, DOI 10.1016/S0304-3991(98)00024-2
   DUCHET J, 1997, LANGMUIR, V13, P2273
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   FRIEDBACHER G, 1991, SCIENCE, V253, P1261, DOI 10.1126/science.253.5025.1261
   Garrison MD, 1997, ANN NY ACAD SCI, V831, P101
   GLOMM BH, 1994, POLYMER, V35, P878, DOI 10.1016/0032-3861(94)90890-7
   Goldberg Eugene P., 1997, CLAO Journal, V23, P243
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Grobe GL, 1996, J BIOMED MATER RES, V32, P45, DOI 10.1002/(SICI)1097-4636(199609)32:1<45::AID-JBM6>3.0.CO;2-P
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   JAENCHEN G, 1999, SURF INTERFACE ANAL, V27, P44
   Ji GD, 1996, POLYMER, V37, P3255, DOI 10.1016/0032-3861(96)88470-9
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lelah M. D., 1986, POLYURETHANES MED
   Li TL, 1998, PHARMACEUT RES, V15, P1222, DOI 10.1023/A:1011939824353
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Magonov S. N., 2000, ENCY ANAL CHEM, P7432
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Magonov SN, 1997, SURF SCI, V375, P385
   MARTI O, 1988, SCIENCE, V239, P50, DOI 10.1126/science.3336773
   OLCHERO PJ, 2000, PHYS REV B, V61, P14179
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rebeix V, 2000, BIOMATERIALS, V21, P1197, DOI 10.1016/S0142-9612(99)00221-5
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   SPECKHARD TA, 1985, POLYMER, V26, P70, DOI 10.1016/0032-3861(85)90058-8
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   TANG YW, IN PRESS J BIOMED MA
   Thierry B, 2000, J BIOMED MATER RES, V49, P88, DOI 10.1002/(SICI)1097-4636(200001)49:1<88::AID-JBM11>3.0.CO;2-I
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TINGEY KG, 1995, ACS SYM SER, V602, P66
   VANBOGART JWC, 1980, J MACROMOL SCI PHYS, VB17, P267, DOI 10.1080/00222348008213125
   YU D, 2000, BIOMED SCI INSTRUM, V36, P1
   YUKA S, 1999, J CRYST GROWTH, V203, P244
   ZHONG O, 1993, SURF SCI LETT, V290, pL688
NR 50
TC 41
Z9 42
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 346
EP 354
DI 10.1016/S0039-6028(01)01298-5
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900004
DA 2018-10-19
ER

PT J
AU Harada, O
   Kadota, K
   Yamamoto, T
AF Harada, O
   Kadota, K
   Yamamoto, T
TI Collagen-based new biomedicial films: Synthesis, property, and cell
   adhesion
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE collagen; graft polymerization; biomedical films; cell adhesion; high
   wet-strength
ID COPOLYMERIZATION
AB Grafted-collagen films with poly(methyl methacrylate), poly(butyl methacrylate), and poly(styrene) were prepared by photoirradiation of the collagen films in the presence of respective monomers. Cell adhesion onto the films was investigated, and the amount of cells adhered onto every grafted films was almost the same as that onto the collagen film crosslinked with glutaraldehyde. Because the swollen grafted films are stronger than the collagen film, they are expected to be good biomedical materials. (C) 2001 John Wiley & Sons, Inc. J Appl Polym Sci 81: 2433-2438, 2001.
C1 Hyogo Prefectural Inst Ind Res, Tech Ctr Leather, Himeji, Hyogo 6700811, Japan.
   Himeji Inst Technol, Himeji, Hyogo 6712201, Japan.
RP Harada, O (reprint author), Hyogo Prefectural Inst Ind Res, Tech Ctr Leather, Himeji, Hyogo 6700811, Japan.
CR Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   HARADA O, 1993, KOBUNSHI RONBUNSHU, V50, P471, DOI 10.1295/koron.50.471
   Harada O, 1999, KOBUNSHI RONBUNSHU, V56, P307, DOI 10.1295/koron.56.307
   HARADA O, 1994, KOBUNSHI RONBUNSHU, V51, P710, DOI 10.1295/koron.51.710
   SHIMIZU Y, 1977, BIOMATER ARTIF CELL, V5, P49, DOI 10.3109/10731197709118665
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
NR 7
TC 0
Z9 1
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 6
PY 2001
VL 81
IS 10
BP 2433
EP 2438
DI 10.1002/app.1684
PG 6
WC Polymer Science
SC Polymer Science
GA 447HT
UT WOS:000169566400014
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Survey of biomedical materials
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB Biomedical materials must do no damage to the body, must sustain minimal damage from the body, and must provide required strength and toughness for joints and other implants.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD SEP
PY 2001
VL 159
IS 9
BP 26
EP 29
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 468GL
UT WOS:000170749700003
DA 2018-10-19
ER

PT J
AU Laguna, R
   Romo, J
   Read, BA
   Wahlund, TM
AF Laguna, R
   Romo, J
   Read, BA
   Wahlund, TM
TI Induction of phase variation events in the life cycle of the marine
   coccolithophorid Emiliania huxleyi
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID PHOTOSYNTHETIC BACTERIUM; RHODOSPIRILLUM-CENTENUM; SWARMING MOTILITY;
   CALCIUM-CARBONATE; FLOW-CYTOMETRY; CELL-CYCLE; DIATOM; BIOMATERIALS;
   LIGHT; BONE
AB Emiliania huxleyi is a unicellular marine alga that is considered to be the world's major producer of calcite. The life cycle of this alga is complex and is distinguished by its ability to synthesize exquisitely sculptured calcium carbonate cell coverings known as coccoliths. These structures have been targeted by materials scientists for applications relating to the chemistry of biomedical materials, robust membranes for high-temperature separation technology, lightweight ceramics, and semiconductor design. To date, however, the molecular and biochemical events controlling coccolith production have not been determined. In addition, little is known about the life cycle of E. huxleyi and the environmental and physiological signals triggering phase switching between the diploid and haploid life cycle stages. We have developed laboratory methods for inducing phase variation between the haploid (S-cell) and diploid (C-cell) life cycle stages of E. huxleyi. Plating E. huxleyi C cells on solid media was shown to induce phase switching from the C-cell to the S-cell life cycle stage, the latter of which has been maintained for over 2 years under these conditions. Pure cultures of S cells were obtained for the first time. Laboratory conditions for inducing phase switching from the haploid stage to the diploid stage were also established. Regeneration of the C-cell stage from pure cultures of S cells followed a predictable pattern involving formation of large aggregations of S cells and the subsequent production of cultures consisting predominantly of diploid C cells. These results demonstrate the ability to manipulate the life cycle of E. huxleyi under controlled laboratory conditions, providing us with powerful tools for the development of genetic techniques for analysis of coccolithogenesis and for investigating the complex life cycle of this important marine alga.
C1 Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.
RP Wahlund, TM (reprint author), Calif State Univ San Marcos, Dept Biol Sci, 333 S Twin Oaks Valley Rd, San Marcos, CA 92096 USA.
CR ARMBRUST EV, 1990, J PHYCOL, V26, P470, DOI 10.1111/j.0022-3646.1990.00470.x
   Arnaud E, 1994, Ann Chir Plast Esthet, V39, P491
   BHATTACHARYA D, 1992, EVOLUTION, V46, P1801, DOI 10.1111/j.1558-5646.1992.tb01170.x
   Billard C., 1994, HAPTOPHYTE ALGAE SYS, P167
   BROWN CW, 1994, J GEOPHYS RES-OCEANS, V99, P7467, DOI 10.1029/93JC02156
   COMPRASSE G, 1988, C R ACAD SCI 3, V307, P485
   Damien C J, 1993, Ann Chir Gynaecol Suppl, V207, P117
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Edlund MB, 1997, J PHYCOL, V33, P897, DOI 10.1111/j.0022-3646.1997.00897.x
   FABRY V, 1994, CARBON DIOXIDE CHEM, P301
   Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363
   FAVINGER J, 1989, A VAN LEEUW J MICROB, V55, P291, DOI 10.1007/BF00393857
   Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634
   FUJIWARA S, 1994, J PHYCOL, V30, P863, DOI 10.1111/j.0022-3646.1994.00863.x
   Green J.C., 1994, Systematics Association Special Volume Series, V51, P47
   Green JC, 1996, J MARINE SYST, V9, P33, DOI 10.1016/0924-7963(96)00014-0
   Guillard R. R. L, 1975, CULTURE MARINE INVER, P29, DOI DOI 10.1007/978-1-4615-8714-9_3
   HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731
   KLAVENESS D, 1972, Protistologica, V8, P335
   Lindum PW, 1998, J BACTERIOL, V180, P6384
   LINSCHOOTEN C, 1991, J PHYCOL, V27, P82, DOI 10.1111/j.0022-3646.1991.00082.x
   LUPORINI P, 1995, J EUKARYOT MICROBIOL, V42, P208, DOI 10.1111/j.1550-7408.1995.tb01567.x
   Marie D, 1997, APPL ENVIRON MICROB, V63, P186
   Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9
   MITCHELL AP, 1988, MEIOTIC INHIBITION M, P47
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   RAGATZ L, 1995, ARCH MICROBIOL, V163, P1
   RAGATZ L, 1994, NATURE, V370, P104, DOI 10.1038/370104a0
   REMES A, 1991, BIOMATERIALS, V12, P661, DOI 10.1016/0142-9612(91)90114-P
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   Sikes C. S., 1994, PHOTOSYNTHETIC CARBO, P217
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   VANBLEIJSWIJK JDL, 1995, MAR ECOL PROG SER, V121, P271, DOI 10.3354/meps121271
   WALSH D, 1995, NATURE, V377, P320, DOI 10.1038/377320a0
   WESTBROEK P, 1984, PHILOS T ROY SOC B, V304, P435, DOI 10.1098/rstb.1984.0037
   Young GM, 1999, J BACTERIOL, V181, P2823
   Young Jeremy R., 1996, P261
   YOUNG JR, 1994, SARSIA, V79, P417, DOI 10.1080/00364827.1994.10413573
NR 38
TC 11
Z9 14
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD SEP
PY 2001
VL 67
IS 9
BP 3824
EP 3831
DI 10.1128/AEM.67.9.3824-3831.2001
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 468FH
UT WOS:000170747100008
PM 11525973
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Li, YL
   Pfohl, T
   Kim, JH
   Yassa, M
   Wen, ZY
   Kim, MW
   Safinya, CR
AF Li, Youli
   Pfohl, Thomas
   Kim, Joon Heon
   Yassa, Mario
   Wen, Zhiyu
   Kim, Mahn Won
   Safinya, Cyrus R.
TI Selective Surface Modification in Silicon Microfluidic Channels for
   Micromanipulation of Biological Macromolecules
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE microchannel arrays; surface modification techniques; micromanipulation
   of biological macromolecules
AB Interactions between biological macromolecules and micrometer- and sub-micrometer-scale surface structures are directly influenced by the surface wettability, chemical reactivity and surface charge. Understanding these interactions is crucial for developing integrated microsystems for biological and biomedical processing and analysis. We report development of selective surface modification techniques based on microcontact printing and polyelectrolyte adsorption. These techniques were applied to lithographically patterned silicon microfluidic channels and flat silicon substrates to create surface microstructures with contrasting wetting properties and surface charges. These controls enabled us to devise various techniques for controlled loading and processing of biomaterials in the channels. Solutions containing long chain biological macromolecules DNA and microtubules were directly loaded into the microchannels by using a micromanipulator/microinjector system. Structural arrangements of these linear macromolecules, which were probed by using fluorescence and laser scanning confocal microscopy, were found to be quite different from bulk solutions. As expected, the filamentous molecules were observed to align linearly along the channels, with the degree of alignment dependent on channel width as well as the length of the molecule. This molecular alignment, which is induced by both the surface confinement effect and capillary flow during sample loading, may be used to enhance processing of biological materials in silicon biomedical microdevices. It also opens up the possibility of carrying out direct combinatorial structural characterization of proteins in the microchannels utilizing X-ray diffraction, which so far has not been possible.
C1 [Li, Youli; Pfohl, Thomas; Kim, Joon Heon; Yassa, Mario; Kim, Mahn Won; Safinya, Cyrus R.] Univ Calif Santa Barbara, Dept Mat, Dept Phys, Mat Res Lab, Santa Barbara, CA 93106 USA.
   [Li, Youli; Pfohl, Thomas; Kim, Joon Heon; Yassa, Mario; Kim, Mahn Won; Safinya, Cyrus R.] Univ Calif Santa Barbara, Biochem & Mol Biol Program, Santa Barbara, CA 93106 USA.
   [Wen, Zhiyu] Chongqing Univ, Coll Optoelect Engn, Chongqing 630044, Peoples R China.
   [Kim, Joon Heon; Kim, Mahn Won] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea.
RP Li, YL (reprint author), Univ Calif Santa Barbara, Dept Mat, Dept Phys, Mat Res Lab, Santa Barbara, CA 93106 USA.
EM youli@mrl.ucsb.edu
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216
FU NIH [GM59288]; University of California Biotech Research and Education
   training [99-14]; DFG [pf 375/1-1]; Chongqing University through the
   Ministry of Education of China; KISTEP [99-I-01-03-A-064]; 
   [NSF-DMR-9972246];  [NSF-DMR-0076357];  [ONR-N00014-00-1-0214]; 
   [NSF-DMR-0080034]
FX This work was supported by NSF-DMR-9972246, NSF-DMR-0076357,
   ONR-N00014-00-1-0214, NIH Grant GM59288, and the University of
   California Biotech Research and Education training grant 99-14. The
   Materials Research Laboratory at UC Santa Barbara is supported by
   NSF-DMR-0080034. In addition, T.P. acknowledges support by a DFG (pf
   375/1-1) scholarship, Y.L. acknowledges support by a visiting scientist
   grant from Chongqing University through the Ministry of Education of
   China and M.W.K. acknowledges partial support by KISTEP
   (99-I-01-03-A-064).
CR Abramowitz S., 1999, J BIOMEDICAL MICRODE, V1, P1
   Craighead HG, 1998, BIOMED MICRODEVICES, V1, P49, DOI 10.1023/A:1009982306118
   Feldstein M. J., 1999, J BIOMED MICRODEVICE, V1, P139
   Graf K, 1998, COLLOID SURFACE A, V131, P215, DOI 10.1016/S0927-7757(96)03923-4
   Koltover I, 1996, J PHYS II, V6, P893, DOI 10.1051/jp2:1996218
   Li YL, 1998, REV SCI INSTRUM, V69, P2844, DOI 10.1063/1.1149022
   Oda T, 1998, BIOPHYS J, V75, P2672, DOI 10.1016/S0006-3495(98)77712-4
   Pfohl T., LANGMUIR IN PRESS
   Pompe T, 1999, LANGMUIR, V15, P2398, DOI 10.1021/Ia980429s
   Wong GCL, 1998, APPL PHYS LETT, V73, P2042, DOI 10.1063/1.122361
NR 10
TC 18
Z9 18
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD SEP
PY 2001
VL 3
IS 3
BP 239
EP 244
DI 10.1023/A:1011467431506
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KW
UT WOS:000209018700009
DA 2018-10-19
ER

PT J
AU Hu, QL
   Fang, ZP
   Zhao, Y
   Xu, CW
AF Hu, QL
   Fang, ZP
   Zhao, Y
   Xu, CW
TI A new method to prepare chitosan membrane as a biomedical material
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE chitosan; membrane; sol-gel transformation; fixation agent
AB This paper reports a new method to prepare chitosan membrane which could be used as a biomedical material. Addition of a fixation agent composed of alcohol, glycerol and potassium hydroxide can accelerate the sol-gel transformation process and hence shorten the preparation period. The present method takes about 6 h to get a flexible membrane with fine appearance, The physical and biological properties of the membrane were also investigated and compared with the membrane prepared by conventional method.
C1 Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
RP Fang, ZP (reprint author), Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
RI Fang, Zhengping/D-6167-2011
CR LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   LU F, 1996, J BIOMED ENG, V13, P375
   MIYAZAKI S, 1985, CHEM PHARM BULL, V33, P2490
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Rao SB, 1995, J BIOMATER APPL, V10, P136, DOI 10.1177/088532829501000204
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
NR 9
TC 12
Z9 22
U1 0
U2 8
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD SEP
PY 2001
VL 19
IS 5
BP 467
EP 470
PG 4
WC Polymer Science
SC Polymer Science
GA 466ZH
UT WOS:000170675700005
DA 2018-10-19
ER

PT J
AU Zhitomirsky, I
   Petric, A
AF Zhitomirsky, I
   Petric, A
TI The electrodeposition of ceramic and organoceramic films for fuel cells
SO JOM-JOURNAL OF THE MINERALS METALS & MATERIALS SOCIETY
LA English
DT Article
ID ELECTROPHORETIC DEPOSITION; ELECTROLYTIC DEPOSITION; ELECTROCHEMICAL
   DEPOSITION; OXIDE; COATINGS; ZIRCONIA
AB The electrodeposition of metals from aqueous solutions is a longstanding technique, commonly known as electroplating. Now, electrodeposition is being used to produce ceramic coatings. Two such processes are known as electrolytic and electrophoretic deposition. They may be applied to protective coatings, biomedical implants, electronic devices, chemical sensors, piezoelectric transducers, displays, and electrode materials. Electrodeposition offers important processing advantages and allows new possibilities in the design of materials and devices. This paper describes recent developments in the application of electrodeposition for fabrication of fuel cell membranes.
C1 McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON L8S 4L7, Canada.
RP Zhitomirsky, I (reprint author), McMaster Univ, Dept Mat Sci & Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM zhitom@mcmaster.ca
CR Basu RN, 1999, ELEC SOC S, V99, P153
   ELSHERIK AM, 1998, IONIC MIXED CONDUCTI, P643
   ISHIHARA T, 1992, CHEM LETT, P943, DOI 10.1246/cl.1992.943
   Ishihara T, 2000, J AM CERAM SOC, V83, P1921
   Ishihara T, 1996, J AM CERAM SOC, V79, P913, DOI 10.1111/j.1151-2916.1996.tb08525.x
   KONNO H, 1990, J ELECTROCHEM SOC, V137, P361, DOI 10.1149/1.2086430
   KONNO H, 1992, ELECTROCHIM ACTA, V37, P2421, DOI 10.1016/0013-4686(92)87077-D
   MATSUMOTO Y, 1992, INORG CHEM, V31, P738, DOI 10.1021/ic00031a009
   Minh N. Q., 1995, SCI TECHNOLOGY CERAM
   Negishi H, 2000, J ELECTROCHEM SOC, V147, P1682, DOI 10.1149/1.1393418
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Therese GHA, 1998, CHEM MATER, V10, P3364, DOI 10.1021/cm980046f
   Zhitomirsky I, 2000, AM CERAM SOC BULL, V79, P57
   Zhitomirsky I, 1999, INTERMETALLIC AND CERAMIC COATINGS, P83
   Zhitomirsky I, 2000, MATER LETT, V46, P1, DOI 10.1016/S0167-577X(00)00133-6
   Zhitomirsky I, 2000, J MATER CHEM, V10, P1215, DOI 10.1039/b000311p
   Zhitomirsky I, 2001, CERAM INT, V27, P149, DOI 10.1016/S0272-8842(00)00054-7
   Zhitomirsky I, 2000, MATER LETT, V42, P273, DOI 10.1016/S0167-577X(99)00193-7
   Zhitomirsky I, 1998, J EUR CERAM SOC, V18, P849, DOI 10.1016/S0955-2219(97)00213-6
   Zhitomirsky I, 1999, ELEC SOC S, V99, P217
   Zhitomirsky I, 2000, MAT SCI ENG B-SOLID, V78, P125, DOI 10.1016/S0921-5107(00)00535-3
   Zhitomirsky I, 2000, J EUR CERAM SOC, V20, P2055, DOI 10.1016/S0955-2219(00)00098-4
   ZHITOMIRSKY I, IN PRESS MAT LETT
   ZHITOMIRSKY I, 2000, OXIDE FILMS
   ZHITOMIRSKY I, 2000, JOM E, V52
NR 25
TC 20
Z9 21
U1 1
U2 3
PU MINERALS METALS MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086 USA
SN 1047-4838
J9 JOM-J MIN MET MAT S
JI JOM-J. Miner. Met. Mater. Soc.
PD SEP
PY 2001
VL 53
IS 9
BP 48
EP 50
DI 10.1007/s11837-001-0071-2
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 470LE
UT WOS:000170872800012
DA 2018-10-19
ER

PT J
AU Bubb, DM
   Horwitz, JS
   Callahan, JH
   McGill, RA
   Houser, EJ
   Chrisey, DB
   Papantonakis, MR
   Haglund, RF
   Galicia, MC
   Vertes, A
AF Bubb, DM
   Horwitz, JS
   Callahan, JH
   McGill, RA
   Houser, EJ
   Chrisey, DB
   Papantonakis, MR
   Haglund, RF
   Galicia, MC
   Vertes, A
TI Resonant infrared pulsed-laser deposition of polymer films using a
   free-electron laser
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; MASS-SPECTROMETRY; FAR-ULTRAVIOLET; THIN-FILM;
   ABLATION; METHACRYLATE); DESORPTION; IONIZATION; ABSORPTION; SURFACES
AB Thin films of polyethylene glycol (MW 1500) have been prepared by pulsed-laser deposition (PLD) using both a tunable infrared (lambda =2.9 mum, 3.4 mum) and an ultraviolet laser (lambda =193 nm). A comparison of the physicochemical properties of the films by means of Fourier transform infrared spectroscopy, electrospray ionization mass spectrometry, and matrix-assisted laser desorption and ionization shows that when the IR laser is tuned to a resonant absorption in the polymer, the IR PLD thin films are identical to the starting material, whereas the UV PLD show significant structural modification. These results are important for several biomedical applications of organic and polymeric thin films. (C) 2001 American Vacuum Society.
C1 USN, Res Lab, Washington, DC 20375 USA.
   Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
   Vanderbilt Univ, WM Keck Fdn Free Electron Laser Ctr, Nashville, TN 37235 USA.
   George Washington Univ, Dept Chem, Washington, DC 20001 USA.
RP Bubb, DM (reprint author), Seton Hall Univ, Dept Phys, 400 S Orange Ave, S Orange, NJ 07079 USA.
EM bubbdani@shu.edu
RI Papantonakis, Michael/G-3888-2012; Vertes, Akos/B-7159-2008
OI Vertes, Akos/0000-0001-5186-5352
CR BLANCHET GB, 1995, MACROMOLECULES, V28, P4603, DOI 10.1021/ma00117a034
   Blanchet GB, 1996, J APPL PHYS, V80, P4082, DOI 10.1063/1.363278
   BLANCHET GB, 1993, APPL PHYS LETT, V62, P1026, DOI 10.1063/1.108514
   BLANCHET GB, 1993, SCIENCE, V262, P719, DOI 10.1126/science.262.5134.719
   BLANCHET GB, 1994, APPL PHYS LETT, V65, P1311, DOI 10.1063/1.112038
   Blanchet GB, 2000, J APPL PHYS, V88, P2975, DOI 10.1063/1.1288501
   BRANNON JH, 1985, J APPL PHYS, V58, P2036, DOI 10.1063/1.336012
   Bubb DM, 2001, APPL PHYS A-MATER, V73, P121, DOI 10.1007/s003390100884
   Bubb DM, 2001, J APPL PHYS, V89, P5739, DOI 10.1063/1.1362405
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Cramer R, 1997, INT J MASS SPECTROM, V169, P51, DOI 10.1016/S0168-1176(97)00223-1
   EDWARDS G, 1999, LASER ABLATION MECH, P457
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fuson MM, 1997, MACROMOLECULES, V30, P5704, DOI 10.1021/ma9700340
   HANSEN SG, 1988, J APPL PHYS, V64, P2122, DOI 10.1063/1.341722
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   JELLINEK HHG, 1984, J PHYS CHEM-US, V88, P3048, DOI 10.1021/j150658a024
   KACZMAREK H, 1995, EUR POLYM J, V31, P1037, DOI 10.1016/0014-3057(95)00094-1
   KANEKO Y, 1998, BIORELATED POLYM GEL, P29
   Manoravi P, 1998, J PHYS CHEM SOLIDS, V59, P1271, DOI 10.1016/S0022-3697(98)00059-6
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   NOHMI T, 1992, J AM CHEM SOC, V114, P3241, DOI 10.1021/ja00035a012
   Owrutsky JC, 1999, J CHEM PHYS, V111, P7329, DOI 10.1063/1.480056
   Patel N, 1998, FASEB J, V12, P1447
   PHILIPP HR, 1986, APPL PHYS LETT, V48, P192, DOI 10.1063/1.96940
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Smith BC, 1999, INFRARED SPECTRAL IN
   SRINIVASAN R, 1993, J APPL PHYS, V73, P2743, DOI 10.1063/1.353048
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   SUMPTER BG, 1999, LASER ABLATION MECH, P334
   Tsuboi Y, 1999, APPL PHYS LETT, V74, P3896, DOI 10.1063/1.124216
   TURRO NJ, 1991, MODERN MOL PHOTOCHEM, P174
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Yokoyama M, 1998, BIORELATED POLYM GEL, P193
NR 38
TC 70
Z9 70
U1 2
U2 14
PU A V S AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0734-2101
EI 1520-8559
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A
PD SEP-OCT
PY 2001
VL 19
IS 5
BP 2698
EP 2702
DI 10.1116/1.1387052
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 478YP
UT WOS:000171376700101
DA 2018-10-19
ER

PT J
AU Sivakumar, M
   Manjubala, I
AF Sivakumar, M
   Manjubala, I
TI Preparation of hydroxyapatite/fluoroapatite-zirconia composites using
   Indian corals for biomedical applications
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite; fluoroapatite; zirconia composite; decomposition;
   tricalcium phosphate
ID MECHANICAL-PROPERTIES
AB Hydroxyapatite (HA) has been widely used in the field of orthopaedics and dentistry. Due to HA's lack of mechanical properties, composites containing hydroxyapatite and zirconia have been suggested for the purpose of increasing strength and fracture toughness. This paper reports the preparation of fluorine-doped hydroxyapatite from Indian coast corals and zirconia composites using coralline hydroxyapatite and coralline fluoroapatite. The fluoroapatite and composites were prepared by two methods: (i) low temperature (LT) or hydrothermal method and (ii) high temperature (HT) or solid state reaction method. These materials were characterized by X-ray diffraction (XRD) analysis, Fourier-transform. infrared spectroscopy (FT-IR) and thermal analysis. Decrease in the a-axis of HA lattice was observed in the fluoroapatite, suggesting partial fluorination of hydroxyapatite resulting in hydroxy/fluoroapatite solid solution. The analysis of the composites shows the formation of beta -tricalcium phosphate due to the decomposition of hydroxyapatite. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Cent Leather Res Inst, Biomat Div, Chennai 600020, Tamil Nadu, India.
   Univ Madras, Ctr Mat Sci, Dept Nucl Phys, Chennai 600025, Tamil Nadu, India.
RP Sivakumar, M (reprint author), Cent Leather Res Inst, Biomat Div, Chennai 600020, Tamil Nadu, India.
EM msivaclri@hotmail.com
RI Inderchand, Manjubala/B-9020-2012
OI Manjubala, I/0000-0003-4873-2377
CR AOKI H, 1991, J ANAL AT SPECTROM
   DeGroot K., 1981, SCI CERAM, V11, P433
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   *JCPDS, 1988, 9169 JCPDS
   *JCPDS, 1988, 9432 JCPDS
   *JCPDS, 1988, 15876 JCPDS
   KASUGA T, 1993, J MATER SCI-MATER M, V4, P36, DOI 10.1007/BF00122975
   LI J, 1993, J MATER SCI-MATER M, V4, P50, DOI 10.1007/BF00122977
   MAGER C, 1998, P MRS FALL M
   PARTENFELDER U, 1993, J MATER SCI-MATER M, V4, P292, DOI 10.1007/BF00122283
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   TAMARI N, 1987, NIPPON SERAM KYO GAK, V95, P806
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
NR 15
TC 39
Z9 40
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD SEP
PY 2001
VL 50
IS 4
BP 199
EP 205
DI 10.1016/S0167-577X(01)00225-7
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 473ZU
UT WOS:000171080400003
DA 2018-10-19
ER

PT J
AU Wei, Q
   Sankar, J
   Narayan, J
AF Wei, Q
   Sankar, J
   Narayan, J
TI Structure and properties of novel functional diamond-like carbon
   coatings produced by laser ablation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CALIFORNIA
DE diamond-like carbon; pulsed laser deposition; functional materials
ID TETRAHEDRAL AMORPHOUS-CARBON; THIN-FILMS; ELASTIC PROPERTIES; STRESS
   REDUCTION; WEAR-RESISTANCE; DEPOSITION; GRADIENT
AB Diamond-like carbon (DLC) mainly consists of sp(3) bonded carbon atoms. It can have properties that rival those of crystalline diamond. Its beneficial properties stem from the continuous rigid random networks of sp(3) carbon atoms, and the properties can essentially be tailored by the sp(3)/sp(2) ratio. DLC coatings or thin films can be prepared by pulsed laser ablation (PLA), filtered cathodic vacuum arc (FCVA) deposition and mass selected ion beam (MSIB) deposition. In the past decade, tremendous progress has been made in experimental and theoretical investigations of hydrogen-free DLC. Experimental and commercial applications in microelectronics, micro- tribology, biomedical technologies, etc., have been demonstrated. Potential applications include sensors, flat panel displays (field emitters), photodiode, etc. In this paper, we report comprehensively the past and recent efforts in the research of functional diamond-like carbon coatings prepared by pulsed laser ablation in our group. In order to alleviate the internal compressive stress problem associated with high quality DLC coatings, we have adopted a novel and simple target design. The films were characterized by Raman spectroscopy, transmission electron microscopy, IR range optical measurements, tribological measurement. etc. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 N Carolina Agr & Tech State Univ, Dept Mech Engn, NSF Ctr Adv Mat & Smart Struct, Greensboro, NC 27411 USA.
   N Carolina State Univ, Burlington Labs, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
RP Wei, Q (reprint author), Johns Hopkins Univ, Dept Engn Mech, N Charles St, Baltimore, MD 21218 USA.
RI Wei, Qiuming/B-7579-2008; Narayan, Jagdish/D-1874-2009
CR Achard J.F., 1953, J APPL PHYS, V24, P981
   ATKINS P, 1994, PHYSICAL CHEM
   BENTZON MD, 1994, SURF COAT TECH, V68, P651, DOI 10.1016/0257-8972(94)90232-1
   Chhowalla M, 1997, DIAM RELAT MATER, V6, P207, DOI 10.1016/S0925-9635(96)00760-1
   COCKAYNE DJH, 1988, ACTA CRYSTALLOGR A, V44, P870, DOI 10.1107/S0108767388004957
   CRISCHKE M, 1995, SURF COAT TECH, V74, P739
   Dikshit SJ, 1996, J MATER RES, V11, P2236, DOI 10.1557/JMR.1996.0284
   EFROS AL, 1975, J PHYS C SOLID STATE, V8, P49
   ENKE K, 1990, MATER SCI FORUM, V52, P559
   Ferrari AC, 1999, APPL PHYS LETT, V75, P1893, DOI 10.1063/1.124863
   Ferrari AC, 1999, J APPL PHYS, V85, P7191, DOI 10.1063/1.370531
   Friedmann TA, 1997, APPL PHYS LETT, V71, P3820, DOI 10.1063/1.120515
   HE H, 1985, PHYS REV LETT, V54, P2107, DOI 10.1103/PhysRevLett.54.2107
   KELIRES PC, 1994, PHYS REV LETT, V73, P2460, DOI 10.1103/PhysRevLett.73.2460
   Koidl P., 1989, MATER SCI FORUM, V52 & 53, P41
   KRISHNASWAMY J, 1989, APPL PHYS LETT, V54, P2455, DOI 10.1063/1.101070
   KULIK J, 1994, J APPL PHYS, V76, P5063, DOI 10.1063/1.357218
   Madelung O., 1996, INTRO SOLID STATE TH
   MCKENZIE DR, 1991, PHYS REV LETT, V67, P773, DOI 10.1103/PhysRevLett.67.773
   Milne WI, 1996, J NON-CRYST SOLIDS, V198, P605, DOI 10.1016/0022-3093(95)00773-3
   Milnes A. G., 1973, DEEP IMPURITIES SEMI
   Mott N. F., 1979, ELECT PROCESSES NONC
   NARAYAN J, 1995, J ADHES SCI TECHNOL, V9, P753, DOI 10.1163/156856195X00653
   NIR D, 1987, THIN SOLID FILMS, V146, P27, DOI 10.1016/0040-6090(87)90337-3
   PAPPAS DL, 1992, J APPL PHYS, V71, P5672
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   ROHLFING EA, 1988, J CHEM PHYS, V89, P6013
   SATO T, 1987, JPN J APPL PHYS 2, V26, pL1487, DOI 10.1143/JJAP.26.L1487
   SIEGAL MP, 1998, COVALENTLY BONDED DI, V498
   SULLIVAN JP, 1997, J ELECT MAT, V26, P102
   Voevodin AA, 1996, SURF COAT TECH, V82, P199, DOI 10.1016/0257-8972(95)02734-3
   Voevodin AA, 1998, DIAM RELAT MATER, V7, P463, DOI 10.1016/S0925-9635(97)00214-8
   Voevodin AA, 1997, THIN SOLID FILMS, V298, P107, DOI 10.1016/S0040-6090(96)09145-6
   Wei Q, 1998, MAT SCI ENG B-SOLID, V53, P262, DOI 10.1016/S0921-5107(98)00150-0
   Wei Q, 1999, J VAC SCI TECHNOL A, V17, P3406, DOI 10.1116/1.582074
   Wei Q, 1998, MATER RES SOC SYMP P, V498, P61
   Wei Q, 1998, MATER RES SOC SYMP P, V505, P331
   Wei Q, 1999, MATER RES SOC SYMP P, V555, P303
   Wei Q, 2000, INT MATER REV, V45, P133, DOI 10.1179/095066000101528340
   Wei Q, 2001, J VAC SCI TECHNOL A, V19, P311, DOI 10.1116/1.1322641
   Wei Q, 2000, J MATER RES, V15, P633, DOI 10.1557/JMR.2000.0094
   Weiler M, 1996, PHYS REV B, V53, P1594, DOI 10.1103/PhysRevB.53.1594
NR 42
TC 41
Z9 45
U1 0
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP-OCT
PY 2001
VL 146
BP 250
EP 257
DI 10.1016/S0257-8972(01)01394-9
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 500DY
UT WOS:000172611700037
DA 2018-10-19
ER

PT J
AU Glocker, DA
   Romach, MM
   Lindberg, VW
AF Glocker, DA
   Romach, MM
   Lindberg, VW
TI Recent developments in inverted cylindrical magnetron sputtering
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CALIFORNIA
DE sputtering; cylindrical magnetron; Dielectric material
AB Inverted cylindrical magnetron cathodes sputter from the interior surfaces of cylindrical targets and simultaneously deposit material on all sides of three-dimensional substrates. Since their invention in the 1970s, they have been widely used to coat wires, fibers and ribbons. As the use of coatings on complex shapes has increased, cylindrical magnetrons have been adopted for a variety of applications, ranging from X-ray telescope mirrors to biomedical implants. This paper describes the features of these devices and compares their operation and coating characteristics to those of planar magnetrons. Recent developments in sputtering dielectric materials are described and new methods that take advantage of cylindrical magnetron designs to produce high ionization densities at the substrates are discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Isoflux Inc, Henrietta, NY 14467 USA.
   Rochester Inst Technol, Dept Phys, Rochester, NY 14623 USA.
RP Glocker, DA (reprint author), Isoflux Inc, 245 Summit Point Dr,Suite 2A, Henrietta, NY 14467 USA.
CR GLOCKER DA, 1993, J VAC SCI TECHNOL A, V11, P2989, DOI 10.1116/1.578286
   GLOCKER DA, 1999, SOC VAC COAT ANN TEC, P97
   GLOCKER DA, 1999, SOC VAC COAT ANN TEC, P517
   Lindberg VW, 2000, SURF COAT TECH, V133, P484, DOI 10.1016/S0257-8972(00)00920-8
   PETROV I, 1993, APPL PHYS LETT, V63, P36, DOI 10.1063/1.109742
   SIEGFRIED DE, 1996, SOC VACC COAT ANN TE, P97
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P93, DOI 10.1116/1.568631
   THORNTON JA, 1978, THIN FILM PROCESSES, P76
NR 8
TC 20
Z9 20
U1 1
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP-OCT
PY 2001
VL 146
BP 457
EP 462
DI 10.1016/S0257-8972(01)01487-6
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 500DY
UT WOS:000172611700069
DA 2018-10-19
ER

PT J
AU Wu, JR
AF Wu, JR
TI Tofu as a tissue-mimicking material
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article
DE acoustic properties; tofu; tissue-mimicking material
ID TEMPERATURE RISE; ATTENUATION; ULTRASOUND; WAVES
AB The acoustic properties of one kind of tofu (soft, firm and extra-firm types) commercially available in grocery markets were measured. It was found that density, speed of sound and attenuation coefficient of tofu were close to those of some soft tissues. It is suggested that tofu may serve as a tissue-mimicking material for some biomedical ultrasound (US) through transmission applications in vitro.
C1 Univ Vermont, Dept Phys, Burlington, VT 05405 USA.
RP Wu, JR (reprint author), Univ Vermont, Dept Phys, Cook Phys Sci Bldg, Burlington, VT 05405 USA.
CR BURLEW MM, 1980, RADIOLOGY, V134, P517, DOI 10.1148/radiology.134.2.7352242
   CARSTENSEN EL, 1986, TISSUE CHARACTERIZAT, V1, P57
   DUCK FA, 1990, PHYSICAL PROPERTIES
   Madsen EL, 1998, ULTRASOUND MED BIOL, V24, P535, DOI 10.1016/S0301-5629(98)00013-1
   MADSEN EL, 1982, ULTRASOUND MED BIOL, V8, P277, DOI 10.1016/0301-5629(82)90034-5
   *NCRP, 1992, EXP CRIT MED DIAN UL, V1, P20814
   ROGERS PH, 1974, J ACOUST SOC AM, V55, P724, DOI 10.1121/1.1914589
   SACHSE W, 1978, J APPL PHYS, V49, P4320, DOI 10.1063/1.325484
   Szabo TL, 2000, J ACOUST SOC AM, V107, P2437, DOI 10.1121/1.428630
   SZABO TL, 1999, J ACOUST SOC AM, V2, P2255
   Wu JR, 1996, J ACOUST SOC AM, V99, P2871, DOI 10.1121/1.414880
   Wu JR, 1996, J ACOUST SOC AM, V99, P3380, DOI 10.1121/1.414894
   WU JR, 1992, ULTRASOUND MED BIOL, V18, P495, DOI 10.1016/0301-5629(92)90089-S
   WU JR, 1995, ULTRASOUND MED BIOL, V21, P561, DOI 10.1016/0301-5629(94)00151-3
NR 14
TC 22
Z9 22
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PD SEP
PY 2001
VL 27
IS 9
BP 1297
EP 1300
DI 10.1016/S0301-5629(01)00424-0
PG 4
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 481JF
UT WOS:000171515600018
PM 11597372
DA 2018-10-19
ER

PT J
AU Stern, T
   Cohn, D
AF Stern, T
   Cohn, D
TI Surface tailoring of biomedical polymers: An FTIR study
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE surface modification; plasma; biostability; biocompatibility; vascular
   grafts
ID DERIVATIZATION
AB A multistep, surface-tailoring process of polymeric materials was developed with two consecutive plasma treatments and followed by derivatization reactions. In the first step, tetrafluoroethylene was plasma-polymerized, generating a highly crosslinked perfluoric surface layer. The next step introduced amine groups into the plasma polymer through exposure of the surface to plasma of ammonia. The reactive amine moieties were then used as anchoring sites for further derivatization. Finally, poly(ethylene glycol) chains were grafted onto the surface via a hexamethylene diisocyanate spacer. This method, aimed at the chemical modification of polymers for biomedical applications, was first demonstrated with poly(ethylene terephthalate) (PET) as a substrate in a previously published study (Cohn, D.; Stern, T. Macromolecules 2000, 33, 137). The aim of this study was to demonstrate the applicability of the method described previously to different polymers: poly(lactic acid), poly(ethylene) (PE), polystyrene (PST), poly(methyl methacrylate), a polybutadiene-based polyurethane (PEUOXAB-20), and Lycra. Fourier transform infrared (FTIR) spectroscopy was used to characterize the surface-modified substrates and the various control treatments. The results obtained were consistent with the derivatization scheme and in full agreement with the FTIR and ESCA results previously obtained for PET. (C) 2001 John Wiley & Sons, Inc.
C1 Hebrew Univ Jerusalem, Casali Inst Appl Sci, IL-91904 Jerusalem, Israel.
RP Cohn, D (reprint author), Hebrew Univ Jerusalem, Casali Inst Appl Sci, IL-91904 Jerusalem, Israel.
EM danielc@vms.huji.ac.il
CR Cohn D, 2000, POLYMER, V41, P6519, DOI 10.1016/S0032-3861(99)00835-6
   Cohn D, 2000, MACROMOLECULES, V33, P137, DOI 10.1021/ma9900784
   STERN T, 1995, BIOMATERIALS, V16, P17, DOI 10.1016/0142-9612(95)91091-C
NR 3
TC 9
Z9 9
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 29
PY 2001
VL 81
IS 9
BP 2203
EP 2209
DI 10.1002/app.1657.abs
PG 7
WC Polymer Science
SC Polymer Science
GA 442XD
UT WOS:000169309500021
DA 2018-10-19
ER

PT J
AU Kowalski, ZW
AF Kowalski, ZW
TI Ion sputter induced surface morphology - biomedical implications
SO VACUUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Ion Implantation and Other Applications of
   IOns and Electrons (ION 2000)
CY JUN 12-15, 2000
CL KAZIMIERS DOLNY, POLAND
SP Inst Phys, Maria Curie Sklodowska Univ, Tech Univ Lublin, Tech Univ Wroclaw
DE ion sputtering; ion etching; surface morphology; surface topography;
   surface roughness; biocompatible materials; biomaterials; implants;
   biological response
ID LINE-EDGE ROUGHNESS; CELL-ADHESION; BOMBARDMENT; BIOMATERIALS; IMPLANTS;
   PROTEIN; BONE; SI
AB This is a short review of surface morphological changes induced by ion sputtering of solids (mainly biocompatible materials) as well as potential and practical biomedical applications of the sputtering process. Usually changes of two aspects of surface morphology are studied, i.e. surface topography and roughness. It can be generally accepted that, among other factors which affect the so-called biological response to biomaterial, surface morphology is one of the more important. Depending on surface topography and/or roughness various biological responses could be expected, generally, changes in: (a) attachment of the surrounding tissue or thrombus to the material in question and (b) cell attachment kinetics that can influence the heating process resulting from the presence of the sputtered implant and/or tissue inflammatory in the tissue surrounding the implanted material. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Wroclaw Univ Technol, Inst Microsyst Technol, PL-50372 Wroclaw, Poland.
RP Kowalski, ZW (reprint author), Wroclaw Univ Technol, Inst Microsyst Technol, Z Janiszewskiego 11-17, PL-50372 Wroclaw, Poland.
EM zwkoval@wtm.ite.pwr.wroc.pl
CR Auciello O., 1984, ION BOMBARDMENT MODI
   BEHRISCH R, 1983, TOPICS APPL PHYSICS, V52
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Carter G, 1996, VACUUM, V47, P409, DOI 10.1016/0042-207X(95)00239-1
   CHASON E, 1994, PHYS REV LETT, V72, P3040, DOI 10.1103/PhysRevLett.72.3040
   EKLUND EA, 1991, PHYS REV LETT, V67, P1759, DOI 10.1103/PhysRevLett.67.1759
   EKLUND EA, 1993, SURF SCI, V285, P157, DOI 10.1016/0039-6028(93)90427-L
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HAUFFE W, 1991, TOP APPL PHYS, V64, P305
   Henry S, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P494, DOI 10.1109/MEMSYS.1998.659807
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Ivanova OP, 1996, VACUUM, V47, P67, DOI 10.1016/0042-207X(95)00180-8
   Iwaki M, 1995, NUCL INSTRUM METH B, V106, P618, DOI 10.1016/0168-583X(96)80035-8
   Kowalski Z. W., 1998, Electron Technology, V31, P477
   KOWALSKI ZW, 1985, J MATER SCI, V20, P1521, DOI 10.1007/BF00555259
   KOWALSKI ZW, 1989, MONOGRAPHS TU WOCL, V13
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Lhoest JB, 1995, NUCL INSTRUM METH B, V105, P322, DOI 10.1016/0168-583X(95)00524-2
   Loesing R, 2000, J VAC SCI TECHNOL B, V18, P509, DOI 10.1116/1.591222
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MAZOLDI P, 1987, ION BEAM MODIFICATIO
   Namatsu H, 1998, J VAC SCI TECHNOL B, V16, P3315, DOI 10.1116/1.590375
   Nelson C, 1999, J VAC SCI TECHNOL B, V17, P2488, DOI 10.1116/1.591117
   NOWICKI B, 1991, STRUKTURA GEOMETRYCZ
   Otte K, 1999, J VAC SCI TECHNOL A, V17, P19, DOI 10.1116/1.581548
   Reynolds GW, 1999, J VAC SCI TECHNOL B, V17, P2723, DOI 10.1116/1.591053
   Saitoh H, 1996, J MATER SCI, V31, P603, DOI 10.1007/BF00367874
   SIGMUND P, 1995, APPL PHYS LETT, V66, P433, DOI 10.1063/1.114047
   Verdonschot N, 1998, J BIOMED MATER RES, V42, P554, DOI 10.1002/(SICI)1097-4636(19981215)42:4<554::AID-JBM11>3.3.CO;2-B
   VISHNYAKOV V, 1995, VACUUM, V46, P637, DOI 10.1016/0042-207X(95)00003-8
   WILK J, 1997, 27 ITE TUW
   Wittmaack K, 2000, J VAC SCI TECHNOL B, V18, P524, DOI 10.1116/1.591225
NR 33
TC 11
Z9 11
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD AUG 16
PY 2001
VL 63
IS 4
BP 603
EP 608
DI 10.1016/S0042-207X(01)00247-0
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 470TH
UT WOS:000170886900028
DA 2018-10-19
ER

PT J
AU Serafetinides, AA
   Makropoulou, MI
   Skordoulis, CD
   Kar, AK
AF Serafetinides, AA
   Makropoulou, MI
   Skordoulis, CD
   Kar, AK
TI Ultra-short pulsed laser ablation of polymers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE polymer ablation; picosecond laser ablation; ultra-short laser ablation
ID INDUCED DAMAGE; PICOSECOND; UV; FILMS; NITROCELLULOSE; POLYIMIDE;
   RADIATION; VIOLET
AB We report the experimental results of the ablation rate per pulse as a function of the laser fluence and images of the surface morphology, as examined by atomic force microscopy, for a number of organic polymer materials of special interest in microelectronics and biomedical applications. The ablation parameters and the surface modifications are examined under various irradiation conditions using laser wavelengths ranging from the ultraviolet through the visible to the infrared and pulse widths ranging from nanoseconds to femtoseconds. Our results are discussed in the view of interplay between the material properties and the radiation dependent parameters governing the ablation process. Visible and infrared ultra-short pulsed laser ablation of the polymer samples was performed with a very low threshold fluence of approximately 0.2 mJ/mm(2). The irradiated polymers exhibit different optical transmission properties in the corresponding spectral regions. The quantitative results on ablation rate versus laser energy fluence show that the picosecond laser ablation is more efficient than the subpicosecond and nanosecond ablation, i.e., it exhibits higher etch rates before the onset of any saturation. (C) 2001 Elsevier Science B.V All rights reserved.
C1 Natl Tech Univ Athens, Dept Phys, Athens 15780, Greece.
   Univ Ioannina, Dept Phys, Atom & Mol Phys Lab, GR-45110 Ioannina, Greece.
   Heriot Watt Univ, Dept Phys, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Makropoulou, MI (reprint author), Natl Tech Univ Athens, Dept Phys, Zografou Campus, Athens 15780, Greece.
OI Serafetinides, Alexandros/0000-0001-5284-0050
CR BOR Z, 1995, APPL PHYS A-MATER, V60, P365, DOI 10.1007/BF01538335
   DAVIS CR, 1992, APPL PHYS B-PHOTO, V54, P227, DOI 10.1007/BF00325507
   DICKINSON JT, 1993, J APPL PHYS, V74, P4729, DOI 10.1063/1.354341
   Himmelbauer M, 1996, APPL PHYS A-MATER, V63, P337, DOI 10.1007/BF01567323
   Jandeleit J, 1996, APPL PHYS A-MATER, V63, P117, DOI 10.1007/BF01567638
   KOSMIDIS CE, 1993, APPL PHYS A-MATER, V56, P64, DOI 10.1007/BF00351904
   Kruger J, 1996, APPL SURF SCI, V96-8, P430, DOI 10.1016/0169-4332(95)00446-7
   KUMAGAI H, 1994, APPL PHYS LETT, V65, P1850, DOI 10.1063/1.112863
   KUPER S, 1987, APPL PHYS B-PHOTO, V44, P199, DOI 10.1007/BF00692122
   Makropoulou M, 1995, LASER MED SCI, V10, P201, DOI 10.1007/BF02133332
   MAKROPOULOU MI, 1997, SPIE, V3423, P384
   Serafetinides AA, 1999, LASER MED SCI, V14, P168, DOI 10.1007/s101030050080
   Serafetinides AA, 1998, APPL SURF SCI, V135, P276, DOI 10.1016/S0169-4332(98)00276-1
   SKORDOULIS CD, 1995, OPT LASER TECHNOL, V27, P185, DOI 10.1016/0030-3992(95)93639-9
   SKORDOULIS CD, 1995, APPL SURF SCI, V86, P239, DOI 10.1016/0169-4332(94)00413-7
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   SRINIVASAN R, 1987, APPL PHYS LETT, V51, P1285, DOI 10.1063/1.99001
   STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248
   Varel H, 1996, APPL PHYS A-MATER, V62, P293, DOI 10.1007/BF01575098
   ZWEIG AD, 1992, APPL PHYS B-PHOTO, V54, P76, DOI 10.1007/BF00331737
   1990, LAMBDA HIGHLIGHTS, V25, P1
NR 21
TC 42
Z9 43
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 1
PY 2001
VL 180
IS 1-2
BP 42
EP 56
DI 10.1016/S0169-4332(01)00324-5
PG 15
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 462LL
UT WOS:000170421500006
DA 2018-10-19
ER

PT J
AU Huang, LY
   Xu, KW
   Lu, J
   Guelorget, B
   Chen, H
AF Huang, LY
   Xu, KW
   Lu, J
   Guelorget, B
   Chen, H
TI Nano-scratch and fretting wear study of DLC coatings for biomedical
   application
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE diamond-like carbon (DLC); nanoindentation; nano-scratch; biomaterials
ID DIAMOND-LIKE-CARBON; A-C-H; FILMS; DEPOSITION; RESISTANCE; SI;
   NANOINDENTATION; POLYETHYLENE; TI-6AL-4V; ALLOY
AB The generation of wear particles is now considered one of the most important failures in total arthroplasty. It is especially needed to study damage process of the particles at slight movement and lower load for long-term service of implanted materials. The wear and abrasion behavior of particles on Ti-6Al-4V coated with diamond-like carbon (DLC) were appropriately simulated in the present paper by fretting wear and nano-scratch test. The coatings with a thickness of 2.5 mum were deposited with an r.f.-plasma enhanced chemical vapor deposition method. The analytic techniques employed to assess DLC coatings characterization include SEM, ATM, Raman and IR spectroscopy. Assessment of hardness, elastic modulus, abrasion and adhesion of the coatings were performed using a Nano Indenter XP system with attachments of continuous stiffness measurements (CSM) and lateral force measurements (LFM). Tribological properties of the coatings were evaluated by a fretting wear test. It was concluded that the DLC coatings had a smooth surface morphology with a rms of 6.8 nm and possessed good adhesion to the substrate, they recovered fully elastic at lower load (60 mN) and were ploughed and delaminated only partially at higher load (400 mN). Nevertheless, there was wear debris concurrently generated during the nano-scratch and fretting test, which was more evident at high loads for a definite coatings, indicating an essential necessity of the work to improve the wear resistant of the coatings to avoid the generation of wear debris. The friction coefficient of DLC coatings against corundum obtained by fretting test decreased with the increase of relative humidity, it was below 0.1 in an aqueous condition, this may be beneficial to their biomedical applications in body fluids. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Xian Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   Univ Technol Troyes, LASMIS, F-10010 Troyes, France.
RP Xu, KW (reprint author), Xian Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
RI LU, JIAN/C-6044-2013
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   ALLOUARD M, 1995, MATER MANUF PROCESS, V10, P1093, DOI 10.1080/10426919508935091
   BEEMAN D, 1984, PHYS REV B, V30, P870, DOI 10.1103/PhysRevB.30.870
   Bell T., 1986, Surface Engineering, V2, P133
   Besong AA, 1997, BIO-MED MATER ENG, V7, P59
   BHATTACHARYA AK, 1988, INT J SOLIDS STRUCT, V24, P1287, DOI 10.1016/0020-7683(88)90091-1
   BOS I, 1991, Z ORTHOP GRENZGEB, V129, P507, DOI 10.1055/s-2008-1040281
   CHANDRA L, 1995, J MATER SCI-MATER M, V6, P581, DOI 10.1007/BF00121282
   Charitidis C, 2000, SURF COAT TECH, V125, P201, DOI 10.1016/S0257-8972(99)00546-0
   Charitidis C, 1999, DIAM RELAT MATER, V8, P558, DOI 10.1016/S0925-9635(98)00285-4
   DEMARTINO C, 1995, DIAM RELAT MATER, V4, P1215
   Fisher J, 1995, Proc Inst Mech Eng H, V209, P263, DOI 10.1243/PIME_PROC_1995_209_353_02
   Fu YQ, 1998, SURF COAT TECH, V106, P193, DOI 10.1016/S0257-8972(98)00528-3
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   Grill A, 1997, SURF COAT TECH, V94-5, P507, DOI 10.1016/S0257-8972(97)00458-1
   Grill A., 1994, SYNTHETIC DIAMOND EM, P91
   Hauert R, 1997, THIN SOLID FILMS, V308, P191, DOI 10.1016/S0040-6090(97)00422-7
   Heinrich G, 1997, SURF COAT TECH, V94-5, P514, DOI 10.1016/S0257-8972(97)00459-3
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   Johns SM, 1996, SURF COAT TECH, V85, P7, DOI 10.1016/0257-8972(96)02884-8
   LAPPALAINEN R, 1991, DIAM RELAT MATER, V29, P462
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   LI X, 1999, J MATER RES, V14, P2
   Liu DX, 1999, SURF COAT TECH, V116, P234, DOI 10.1016/S0257-8972(99)00279-0
   Liu E, 1999, SURF COAT TECH, V120, P601, DOI 10.1016/S0257-8972(99)00442-9
   Liu Y, 1997, SURF COAT TECH, V94-5, P463, DOI 10.1016/S0257-8972(97)00450-7
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
   Michler T, 1999, SURF COAT TECH, V111, P41, DOI 10.1016/S0257-8972(98)00701-4
   NARYAN J, 1994, MAT SCI ENG B-FLUID, V25, P5
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   Peng XL, 1998, THIN SOLID FILMS, V312, P207, DOI 10.1016/S0040-6090(97)00588-9
   PILIAR RM, 1986, CLIN ORTHOP RELAT R, V206, P108
   QIU X, 1989, WEAR CORROSION INTER, P109
   Scharf TW, 1997, THIN SOLID FILMS, V308, P340, DOI 10.1016/S0040-6090(97)00568-3
   SUSHANSI P, 1996, SURF COAT TECH, V83, P175
   TAKADOUM J, 1996, SURF COAT TECH, V88, P231
   Voevodin AA, 1995, SURF COAT TECH, V76-77, P534, DOI 10.1016/0257-8972(95)02521-9
   WILLIAMS JM, 1985, MATER SCI ENG, V69, P237, DOI 10.1016/0025-5416(85)90398-2
NR 40
TC 66
Z9 71
U1 1
U2 33
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD AUG
PY 2001
VL 10
IS 8
BP 1448
EP 1456
DI 10.1016/S0925-9635(00)00501-X
PG 9
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 456HG
UT WOS:000170076600002
DA 2018-10-19
ER

PT J
AU Freund, P
AF Freund, P
TI Bodies, disability and spaces: the social model and disabling spatial
   organisations
SO DISABILITY & SOCIETY
LA English
DT Article
ID CHRONIC ILLNESS; PLACE; GEOGRAPHY; POLITICS; HEALTH; PEOPLE; BODY
AB This essay examines the relevance of socio-material space to the social model. The social model has been criticised as being disembodied. While there is some basis for this critique, the social model, in fact, has 'bodies in space' as a central concern. A distinction is made between disability as a sociocultural and biomedical category, and as a state of 'not being able to'. The latter usage is not just relevant to people with disabilities. In order to illustrate the strength of the social model, disabling social organisations of space-time practises are examined with a special emphasis on transport-public space. It is concluded that the social model offers insights into relationships between bodies, embodied agency and the social organisation of space-time.
C1 Montclair State Univ, Dept Sociol, Montclair, NJ 07043 USA.
RP Freund, P (reprint author), Montclair State Univ, Dept Sociol, Montclair, NJ 07043 USA.
CR BARNES C, 1998, DISABILITY READER
   Bourdieu P., 1977, OUTLINE THEORY PRACT
   COCKBURN A, 1988, ZETA MAGAZINE, V1, P5
   Corker M., 1999, DISABILITY DISCOURSE
   Curtis S, 1998, SOCIOL HEALTH ILL, V20, P645, DOI 10.1111/1467-9566.00123
   ELIAS N, 1995, THEOR CULT SOC, V12, P7, DOI 10.1177/026327695012003002
   Elias N, 1982, CIVILIZING PROCESS, V2
   Elias N, 1996, GERMANS POWER STRUGG
   FREUND P, 1999, HLTH ILLNESS SOCIAL
   Freund P. E. S., 1993, ECOLOGY AUTOMOBILE
   Gleeson B., 1999, GEOGRAPHIES DISABILI
   Hahn H., 1994, RES SOCIOLOGY HLTH C, V11, P3
   Harvey D., 1996, JUSTICE NATURE GEOGR
   Hillier B., 1996, SPACE IS MACHINE
   HOXIE RE, 1994, J AM GERIATR SOC, V42, P241, DOI 10.1111/j.1532-5415.1994.tb01745.x
   Hughes B, 1997, DISABIL SOC, V12, P325, DOI 10.1080/09687599727209
   Humphrey JC, 2000, DISABIL SOC, V15, P63, DOI 10.1080/09687590025775
   Imrie R, 2000, DISABIL SOC, V15, P5, DOI 10.1080/09687590025748
   IMRIE R, 1998, DISABILITY READER
   Kitchin R, 1998, DISABIL SOC, V13, P343, DOI 10.1080/09687599826678
   LINDEMANN G, 1996, IDENTITAT LEIBLICHKE
   Oliver M., 1996, UNDERSTANDING DISABI
   Paterson K, 1999, DISABIL SOC, V14, P597, DOI 10.1080/09687599925966
   PINDER R, 1995, SOCIOL HEALTH ILL, V17, P605, DOI 10.1111/1467-9566.ep10932129
   Pinder R, 1997, DISABIL SOC, V12, P301, DOI 10.1080/09687599727399
   Popay J, 1998, SOCIOL HEALTH ILL, V20, P619, DOI 10.1111/1467-9566.00122
   Radley A, 1996, THEOR PSYCHOL, V6, P559, DOI 10.1177/0959354396064002
   RADLEY A, 1995, BODY SOC, V1, P3
   Relph E, 1981, RATIONAL LANDSCAPES
   Shakespeare T, 1997, DISABIL SOC, V12, P293, DOI 10.1080/09687599727380
   Shakespeare T., 1999, DISABILITY DIVERS AB
   SMITH RG, 1999, DISABILITY DIVERS AB
   Wendell Susan, 1996, REJECTED BODY
   Williams G, 1998, DISABILITY READER
   Williams G, 2000, HLTH MED SOC
   Williams SJ, 1999, SOCIOL HEALTH ILL, V21, P797, DOI 10.1111/1467-9566.00184
   Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191
   Wolf W., 1996, CAR MANIA CRITICAL H
   Zarb G., 1995, CRITICAL PUBLIC HLTH, V6, P21
   ZOLA IK, 1989, MILBANK Q, V67, P401, DOI 10.2307/3350151
   Zola Irving. K., 1982, MISSING PIECES CHRON
   1992, DISABILITY RAG, V12, P4
NR 42
TC 66
Z9 71
U1 3
U2 14
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0968-7599
J9 DISABIL SOC
JI Disabil. Soc.
PD AUG
PY 2001
VL 16
IS 5
BP 689
EP 706
DI 10.1080/09687590120070079
PG 18
WC Rehabilitation; Social Sciences, Interdisciplinary
SC Rehabilitation; Social Sciences - Other Topics
GA 459UC
UT WOS:000170269000004
DA 2018-10-19
ER

PT J
AU Liu, HF
   Lussier, YA
   Friedman, C
AF Liu, HF
   Lussier, YA
   Friedman, C
TI Disambiguating ambiguous biomedical terms in biomedical narrative text:
   An unsupervised method
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE natural language processing; word sense disambiguation; corpus-based
   machine learning; MedLEE; UMLS; MEDLINE
ID SPECIAL ISSUE; LANGUAGE
AB With the growing use of Natural Language Processing (NLP) techniques for information extraction and concept indexing in the biomedical domain, a method that quickly and efficiently assigns the correct sense of an ambiguous biomedical term in a given context is needed concurrently. The current status of word sense disambiguation (WSD) in the biomedical domain is that handcrafted rules are used based on contextual material. The disadvantages of this approach are (i) generating WSD rules manually is a time-consuming and tedious task, (ii) maintenance of rule sets becomes increasingly difficult over time, and (iii) handcrafted rules are often incomplete and perform poorly in new domains comprised of specialized vocabularies and different genres of text. This paper presents a two-phase unsupervised method to build a WSD classifier for an ambiguous biomedical term W The first phase automatically creates a sense-tagged corpus for W, and the second phase derives a classifier for W using the derived sense-tagged corpus as a training set. A formative experiment was performed, which demonstrated that classifiers trained on the derived sense-tagged corpora achieved an overall accuracy of about 97%, with greater than 90% accuracy for each individual ambiguous term. (C) 2001 Elsevier Science (USA).
C1 CUNY Grad Sch & Univ Ctr, Div Comp Sci, New York, NY 10016 USA.
   CUNY Queens Coll, Dept Comp Sci, New York, NY USA.
   Columbia Univ Coll Phys & Surg, Dept Med Informat, New York, NY 10032 USA.
RP Liu, HF (reprint author), CUNY Grad Sch & Univ Ctr, Div Comp Sci, New York, NY 10016 USA.
RI Lussier, Yves/N-4891-2017
OI Lussier, Yves/0000-0001-9854-1005
FU NLM NIH HHS [LM06274, K22 LM008308, K22 LM008308-01]
CR ARONSON AR, 1994, P RIAO, P197
   BLOOM D, 2000, BJU INT, P1
   BRUCE R, P ACL, V32, P139
   BRUCE R, 1994, P ACL, V32, P139
   Campbell D A, 2001, Proc AMIA Symp, P90
   CARDIE C, P NAT C AI, V11, P798
   CHEUNG T, 1999, AM HEART J, V134, P726
   COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964
   Dreiseitl S, 2001, J BIOMED INFORM, V34, P28, DOI 10.1006/jbin.2001.10004
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Escudero G., 2000, P 14 EUR C ART INT E, P421
   Fellbaum Christiane, 1998, WORDNET ELECT LEXICA
   Friedman C, 2000, Proc AMIA Symp, P270
   Friedman C, 2001, Proc AMIA Symp, P189
   Friedman C, 1998, METHOD INFORM MED, V37, P334
   FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146
   GALE WA, 1992, P 4 INT C THEOR METH, P101
   HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007
   Ide N, 1998, COMPUT LINGUIST, V24, P1
   Johnson SB, 1999, J AM MED INFORM ASSN, V6, P205, DOI 10.1136/jamia.1999.0060205
   Kilgarriff A, 2000, COMPUT HUMANITIES, V34, P1, DOI 10.1023/A:1002619001915
   Knirsch CA, 1998, INFECT CONT HOSP EP, V19, P94
   Leacock C, 1998, COMPUT LINGUIST, V24, P147
   LEACOCK C, 1993, P ARPA WORKSH HUM LU
   LI M, T NEURAL NETW, V11, P647
   Liu H, 2001, Proc AMIA Symp, P393
   MOONEY RJ, 1996, P EMNLP, V1, P82
   NADKAMI P, 2001, J AM MED INFORM ASSN, V80, P80
   NG HT, 1996, P ACL, V34, P40
   NG HT, 1997, P EMNLP2
   NG HT, 1997, AI MAGAZINE      WIN, P45
   Reis BY, 2001, J BIOMED INFORM, V34, P15, DOI 10.1006/jbin.2001.1005
   Rindflesch T C, 1994, Proc Annu Symp Comput Appl Med Care, P240
   Rivest R. L., 1987, Machine Learning, V2, P229, DOI 10.1007/BF00058680
   ROTH L, 2000, P AMIA ANN FALL S 20, P1124
   STEVENSON M, 1999, P INT JOINT C AI
   *US DHHS NIH NAT L, UMLS KNOWL SOURC
   YAROWSKY D, 1994, P ACL, V32, P88
   YAROWSKY D, P ACL, V32, P88
NR 39
TC 37
Z9 38
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD AUG
PY 2001
VL 34
IS 4
BP 249
EP 261
DI 10.1006/jbin.2001.1023
PG 13
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA 541RX
UT WOS:000174998900002
PM 11977807
OA Bronze
DA 2018-10-19
ER

PT J
AU Yan, XL
   Khor, E
   Lim, LY
AF Yan, XL
   Khor, E
   Lim, LY
TI Chitosan-alginate films prepared with chitosans of different molecular
   weights
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE chitosan-alginate PEC film; molecular weight; surface morphology; water
   vapor transmission; X-ray diffraction; cytotoxicity
ID MICROSPHERES; MICROCAPSULES
AB Chitosan-alginate polyelectrolyte complex (CS-AL PEG) is water insoluble and more effective in limiting the release of encapsulated materials compared to chitosan or alginate, Coherent CS-AL PEC films have been prepared in our laboratory hy casting and drying suspensions of chitosan-alginate coacervates. The objective of this study was to evaluate the properties of the CS-AL PEC films prepared with chitosans of different molecular weights. Films prepared with low-molecular-weight chitosan (M-v 1.30 x 10(5)) were twice as thin and transparent, as well as 55% less permeable to water vapor, compared to films prepared with high-molecular-weight chitosan (M-v 10.0 x 10(5)), It may be inferred that the low-molecular-weight chitosan reacted more completely with the sodium alginate (M-v 1.04 x 10(5)) than chitosan of higher molecular weight. A threshold molecular weight may be required, because chitosans of M-v 10.0 x 10(5) and 5.33 x 10(5) yielded films with similar physical properties. The PEC films exhibited different surface properties from the parent films, and contained a higher degree of chain alignment with the possible formation of new crystal types. The PEC films exhibited good in vitro biocompatibility with mouse and human fibroblasts, suggesting that they can be further explored for biomedical applications. (C) 2001 John Wiley & Sons. Inc.
C1 Natl Univ Singapore, Dept Pharm, Singapore 119260, Singapore.
   Natl Univ Singapore, Dept Chem, Singapore 119260, Singapore.
RP Lim, LY (reprint author), Natl Univ Singapore, Dept Pharm, 10 Lower Kent Ridge Rd, Singapore 119260, Singapore.
EM phalimly@nus.edu.sg
RI Lim, Lee Yong/C-6144-2013; Yan, Xiaoliang/D-3640-2009
OI Lim, Lee Yong/0000-0002-7307-0742; 
CR ALEXAKIS T, 1995, APPL BIOCHEM BIOTECH, V50, P93, DOI 10.1007/BF02788043
   *ASTM, E9695 ASTM
   Bartkowiak A, 1999, CHEM MATER, V11, P2486, DOI 10.1021/cm9910456
   BOHDANECKY M, 1982, VISCOSITY POLYM SOLU, P108
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   FILIPOVICGRCIC J, 1995, INT J PHARMACEUT, V116, P39, DOI 10.1016/0378-5173(94)00269-B
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Liu LS, 1997, J CONTROL RELEASE, V43, P65, DOI 10.1016/S0168-3659(96)01471-X
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7
   OVERGAARD S, 1991, CAN J CHEM ENG, V69, P439, DOI 10.1002/cjce.5450690206
   RemunanLopez C, 1997, J CONTROL RELEASE, V44, P215, DOI 10.1016/S0168-3659(96)01525-8
   Tan SC, 1998, TALANTA, V45, P713, DOI 10.1016/S0039-9140(97)00288-9
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Yamamoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1230, DOI 10.1271/bbb.61.1230
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
   Yao K. D., 1996, J APPL POLYM SCI, V60, P279
NR 16
TC 119
Z9 123
U1 2
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 58
IS 4
BP 358
EP 365
DI 10.1002/jbm.1029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452CL
UT WOS:000169839500004
PM 11410893
DA 2018-10-19
ER

PT J
AU Mujat, M
   Dogariu, A
AF Mujat, M
   Dogariu, A
TI Measurements of structure-induced polarization features in forward
   scattering from collections of cylindrical fibers
SO JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER
LA English
DT Article; Proceedings Paper
CT 5th Conference on Light Scattering by Nonspherical Particles
CY AUG 28-SEP 01, 2000
CL DALHOUSIE UNIV, HALIFAX, CANADA
SP USA Res Lab, Opt Soc Amer
HO DALHOUSIE UNIV
AB Many applications in remote sensing, material sciences and biomedical field are characterized by a transition domain between single scattering and multiple-scattering regimes. This regime is described by typical polarization features which can be used to retrieve structural information. An electronically agile technique was used for measuring in real time the Stokes vectors of light incident on and emerging from an inhomogeneous medium. Subsequently. the Mueller matrix associated with the scattering medium is determined. We focus our attention on forward scattering from systems consisting of random as well as partially oriented long cylindrical fibers. We discuss the effects of: (1) shape of individual scattering centers, (2) structure parameter, and (3) optical density of the scattering medium. The anisotropic behavior of the structure function at different packing fractions determines nontrivial characteristics of the polarization transfer. The complex effective index of refraction can be polarization dependent as a result of the optical anisotropy due to both the shape of the individual scatterers and the structure characteristics of the scattering system. Some of the Mueller matrix elements are shown to be related to the optical anisotropy of the system for the case of long cylindrical fibers. The polarization efficiency, the structure parameter, and the packing fraction are used to quantify this relationship. We also found that some of the matrix elements are more sensitive to the degree of structural anisotropy and the packing fraction, while other elements are sensitive to structural non-uniformities across the investigated area. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Cent Florida, CREOL, Sch Opt, Orlando, FL 32816 USA.
RP Dogariu, A (reprint author), Univ Cent Florida, CREOL, Sch Opt, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
CR Bickel W. S., 1980, Light Scattering by Irregularly Shaped Particles, Proceedings of the International Workshop, P299
   BICOUT D, 1994, PHYS REV E, V49, P1767, DOI 10.1103/PhysRevE.49.1767
   Bohren C. F, 1983, ABSORPTION SCATTERIN
   CARIOU J, 1990, APPL OPTICS, V29, P1689, DOI 10.1364/AO.29.001689
   Fuller G.G., 1995, OPTICAL RHEOMETRY CO
   Hovenier JW, 1998, J QUANT SPECTROSC RA, V60, P483, DOI 10.1016/S0022-4073(98)00022-3
   Kadyshevich Y. A., 1971, IZV AS USSR ATMOS OC, V7, P367
   MISHCHENKO MI, 2000, LIGHT SCATTERING NON, P147
   Mujat M, 2000, P SOC PHOTO-OPT INS, V4035, P390, DOI 10.1117/12.397810
   Mujat M, 2001, APPL OPTICS, V40, P34, DOI 10.1364/AO.40.000034
   ONUKI A, 1986, J CHEM PHYS, V85, P1190, DOI 10.1063/1.451315
   Perrin F, 1942, J CHEM PHYS, V10, P415, DOI 10.1063/1.1723743
   VANDEHULST HC, 1981, LIGHT SCATTERING SMA, pCH9
   VANDEHULST HC, 1981, LIGHT SCATTERING SMA
NR 14
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-4073
J9 J QUANT SPECTROSC RA
JI J. Quant. Spectrosc. Radiat. Transf.
PD AUG-SEP
PY 2001
VL 70
IS 4-6
BP 555
EP 567
DI 10.1016/S0022-4073(01)00029-2
PG 13
WC Optics; Spectroscopy
SC Optics; Spectroscopy
GA 454ME
UT WOS:000169975700014
DA 2018-10-19
ER

PT J
AU Taddei, P
   Tinti, A
   Fini, G
AF Taddei, P
   Tinti, A
   Fini, G
TI Vibrational spectroscopy of polymeric biomaterials
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Review
ID MOLECULAR-WEIGHT POLYETHYLENE; INFRARED CORRELATION SPECTROSCOPY;
   PLA/PEO/PLA TRIBLOCK COPOLYMERS; PEO/PLA BLOCK COPOLYMERS;
   FOURIER-TRANSFORM-RAMAN; HYDROLYTIC DEGRADATION; POLY(L-LACTIC ACID);
   L-LACTIDE; POLY(ETHYLENE GLYCOL); IN-VIVO
AB This review highlights the potential of vibrational spectroscopy for investigating the molecular structure of some polymeric materials used in biomedical applications in relation to their biocompatibility. Many types of polymers are used for biomedical purposes; depending on the application, bioresorbable or non-bioresorbable (semi-crystalline or amorphous) polymers are used. Among bioresorbable polymers, we focused on homopolymers and copolymers based on poly(lactic acid), poly(glycolic acid) and poly(epsilon -caprolactone). Being a nondestructive technique, Raman spectroscopy proved particularly suitable for evaluating the molecular structure and crystallinity of bioresorbable polymers and their degradation products. For various biomedical applications, non-degradable semi-crystalline polymers have been widely employed; in this class of polymers, we concentrated on ultra-high molecular weight polyethylene (UHMWPE) used in orthopaedic implants (total hip and knee joints). Vibrational spectroscopy appeared particularly suitable in studying the oxidation and crystallinity of UHMWPE. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, Sez Chim & Propedeut Biochim, I-40126 Bologna, Italy.
RP Fini, G (reprint author), Univ Bologna, Dipartimento Biochim G Moruzzi, Sez Chim & Propedeut Biochim, Via Belmeloro 8-2, I-40126 Bologna, Italy.
OI TADDEI, PAOLA/0000-0001-8478-4508; TINTI, ANNA/0000-0001-8452-815X
CR AFFATATO S, IN PRESS BIOMATERIAL
   Agarwal M, 1998, BIOTECHNOL PROGR, V14, P517, DOI 10.1021/bp980015p
   Berrill SA, 1999, J MATER CHEM, V9, P1059, DOI 10.1039/a808718k
   Bertoluzza A, 1997, SPECTROSCOPY OF BIOLOGICAL MOLECULES: MODERN TRENDS, P431
   Bertoluzza A, 1997, SPECTROSCOPY OF BIOLOGICAL MOLECULES: MODERN TRENDS, P507
   Bertoluzza A, 1999, SPECTROSCOPY OF BIOLOGICAL MOLECULES: NEW DIRECTIONS, P603
   BERTOLUZZA A, 1992, Clinical Materials, V9, P49, DOI 10.1016/0267-6605(92)90010-Q
   Bertoluzza A, 1998, BIOM HLTH R, V16, P45
   BERTOLUZZA A, 1997, CERAMICS CELLS TISSU, V4, P7
   BERTOLUZZA A, 2000, J MOL STRUCT, V251, P89
   Blazewicz M, 1999, J MOL STRUCT, V482, P519, DOI 10.1016/S0022-2860(98)00695-4
   Buchanan FJ, 1999, BIOMATERIALS, V20, P823, DOI 10.1016/S0142-9612(98)00237-3
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   Cai Q, 2000, POLYM ADVAN TECHNOL, V11, P159, DOI 10.1002/1099-1581(200004)11:4<159::AID-PAT956>3.0.CO;2-N
   CASSANAS G, 1991, J RAMAN SPECTROSC, V22, P409, DOI 10.1002/jrs.1250220709
   CASSANAS G, 1991, J RAMAN SPECTROSC, V22, P11, DOI 10.1002/jrs.1250220103
   CASSANAS G, 1993, SPECTROCHIM ACTA A, V49, P271, DOI 10.1016/0584-8539(93)80181-9
   CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   CERRAI P, 1993, MAKROMOL CHEM-RAPID, V14, P529
   Cerrai P, 1999, J MATER SCI-MATER M, V10, P283, DOI 10.1023/A:1008905529461
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Chenery DH, 1997, BIOMATERIALS, V18, P415, DOI 10.1016/S0142-9612(96)00149-4
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   Costa L, 1998, BIOMATERIALS, V19, P1371, DOI 10.1016/S0142-9612(98)00013-1
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   delPrever EB, 1996, BIOMATERIALS, V17, P873, DOI 10.1016/0142-9612(96)83282-0
   Edidin AA, 2000, BIOMATERIALS, V21, P1451, DOI 10.1016/S0142-9612(00)00021-1
   ElBaseir MM, 1997, INT J PHARM, V151, P145, DOI 10.1016/S0378-5173(96)04873-9
   Elkheshen SA, 2000, J MICROENCAPSUL, V17, P425
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   EYERER P, 1987, J BIOMED MATER RES, V21, P275, DOI 10.1002/jbm.820210302
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   Goldman M, 1997, J BIOMED MATER RES, V37, P43, DOI 10.1002/(SICI)1097-4636(199710)37:1<43::AID-JBM6>3.0.CO;2-J
   Gonsalves KE, 1998, BIOMATERIALS, V19, P1501, DOI 10.1016/S0142-9612(98)00066-0
   HANH DW, 1997, J BIOMED MATER RES, V35, P31
   He Y, 2000, POLYM INT, V49, P623, DOI 10.1002/1097-0126(200006)49:6<623::AID-PI435>3.0.CO;2-8
   IZUMIKAWA S, 1991, J CONTROL RELEASE, V15, P133, DOI 10.1016/0168-3659(91)90071-K
   JAMES SP, 1993, BIOMATERIALS, V14, P643, DOI 10.1016/0142-9612(93)90062-7
   JIN S, 1998, ACS SYM SER, V704, P276
   Kader A, 1998, DRUG DEV IND PHARM, V24, P535, DOI 10.3109/03639049809085654
   KAHN J, 1996, BIOMATERIALS SCI INT, P64
   KERESZTURY G, 1990, POLYM TEST, V9, P329, DOI 10.1016/0142-9418(90)90004-W
   KISTER G, 1992, EUR POLYM J, V28, P1273, DOI 10.1016/0014-3057(92)90218-Q
   KISTER G, 1995, J RAMAN SPECTROSC, V26, P307, DOI 10.1002/jrs.1250260409
   Kister G, 1998, POLYMER, V39, P3335, DOI 10.1016/S0032-3861(97)10057-X
   Kister G, 1997, SPECTROCHIM ACTA A, V53, P1399, DOI 10.1016/S0584-8539(97)00039-1
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Kister G, 2000, POLYMER, V41, P925, DOI 10.1016/S0032-3861(99)00223-2
   Lang MD, 1999, J BIOMAT SCI-POLYM E, V10, P501
   LI S, 1994, J BONE JOINT SURG AM, V76A, P1080, DOI 10.2106/00004623-199407000-00020
   Li SM, 1998, POLYMER, V39, P5421, DOI 10.1016/S0032-3861(97)10272-5
   Li SM, 1998, J APPL POLYM SCI, V68, P989, DOI 10.1002/(SICI)1097-4628(19980509)68:6<989::AID-APP12>3.0.CO;2-J
   LUU DV, 1980, J RAMAN SPECTROSC, V9, P172, DOI 10.1002/jrs.1250090309
   Matsushita A, 2000, VIB SPECTROSC, V24, P171, DOI 10.1016/S0924-2031(00)00062-X
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nelson DGA, 1982, CALCIFIED TISSUE INT, V34, P69
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Petrova T, 1998, POLYM INT, V45, P419
   Qin D, 1998, APPL SPECTROSC, V52, P488, DOI 10.1366/0003702981943950
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   Ren Y, 2000, VIB SPECTROSC, V23, P207, DOI 10.1016/S0924-2031(00)00063-1
   RULL F, 1993, J RAMAN SPECTROSC, V24, P545, DOI 10.1002/jrs.1250240813
   Shen FW, 1999, J BIOMED MATER RES, V48, P203, DOI 10.1002/(SICI)1097-4636(1999)48:3<203::AID-JBM1>3.0.CO;2-R
   STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704
   TADDEI P, IN PRESS J MAT SCI M
   TADDEI P, J MOL STRUCT, V317, P565
   Thosar SS, 1999, J PHARMACEUT BIOMED, V20, P107, DOI 10.1016/S0731-7085(99)00002-3
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Williams DF, 1986, P CONS C EUR SOC BIO
   WILLIAMS KPJ, 1995, J RAMAN SPECTROSC, V26, P427, DOI 10.1002/jrs.1250260606
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 73
TC 32
Z9 32
U1 3
U2 27
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD AUG
PY 2001
VL 32
IS 8
BP 619
EP 629
DI 10.1002/jrs.723
PG 11
WC Spectroscopy
SC Spectroscopy
GA 465KN
UT WOS:000170588300001
DA 2018-10-19
ER

PT J
AU Jones, JR
   Hench, LL
AF Jones, JR
   Hench, LL
TI Materials perspective - Biomedical materials for new millennium:
   perspective on the future
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
ID SOL-GEL GLASSES; IN-VITRO; BIOACTIVE GLASS; HYDROXYAPATITE FORMATION;
   BONE-FORMATION; SURFACE; PHOSPHATE; SILICA; DISSOLUTION; BIOMATERIALS
AB Millions of orthopaedic prostheses made of bioinert materials have been implanted with an excellent 15 year survivability of 75-85%. Improved metal alloys, special polymers, and medical grade ceramics are the basis for this success, which has enhanced the quality of life for millions of patients. However, an increasing percentage of our aging population require greater than 30 years survivability of the devices. It is proposed that to satisfy this growing need for very long term orthopaedic repair a paradigm shift is needed; a shift in emphasis from the replacement of tissues to the regeneration of tissues. Such a shift from a materials and mechanics approach to tissue repair requires an increase in the understanding and utilisation of biologically approaches. Two new biologically orientated alternatives in biomaterials for orthopaedics in the new millennium are discussed: tissue regeneration, where in situ repair is initiated in the host tissue, and tissue engineering, where repair is initiated in vitro on cellularly seeded scaffolds and then transplanted to the recipient. The concept of the use of class A bioactive materials to stimulate the regeneration of trabecular bone is described along with clinical applications. Eleven reaction stages lead to the enhanced proliferation and differentiation of osteoblasts and the recreation of trabecular bone architecture. Recent results showing the effects of microchemical gradients on the genetic activation of bone cells are related to the molecular design of hierarchical bioactive resorbable scaffolds for the tissue engineering of bone constructs. (C) 2001 IoM Communications Ltd.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP Jones, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RI Jones, Julian/B-1007-2012
OI Jones, Julian/0000-0002-2647-8024
CR Aksay IA, 1998, CURR OPIN SOLID ST M, V3, P219, DOI 10.1016/S1359-0286(98)80093-4
   ALBAZIE S, 1998, J DENT RES, V77, P1664
   Andersson OH, 1999, J NON-CRYST SOLIDS, V246, P9, DOI 10.1016/S0022-3093(99)00072-1
   Bonfield W., 1998, BIOCERAMICS, V11, P37
   BRADLEY JG, 2000, P 13 C BIOC, P1013
   BRONZINO JD, 1995, BIOMEDICAL ENG HDB, P532
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CLARK AE, 1979, CORROSION GLASS, P1
   COSTA JM, 1996, J SOLGEL SCI TECHNOL, V7, P45
   DOREMUS RH, 1983, J MATER SCI, V18, P612, DOI 10.1007/BF00560651
   DOUGLAS RW, 1967, J AM CERAM SOC, V50, P1, DOI 10.1111/j.1151-2916.1967.tb14960.x
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   ELSBERG LL, UNPUB
   GREENSPAN DC, 1998, P 11 C BIOC, P345
   GREENSPAN DC, 1997, P 19 C BIOC, P391
   GREENSPAN DC, 1994, P M C BIOC, P28
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1993, INTRO BIOCERAMICS
   HENCH LL, 1997, KIRK OTHMER ENCY CHE, V22, P497
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1996, CLIN PERFORMANCE SKE
   HILL RG, 1996, J MATER SCI LETT, V15, P112
   Ishizaki K, 1998, POROUS MAT PROCESS T, P67
   Kirkwood T, 1999, TIME OUR LIVES
   Kuijer R, 1998, J MATER SCI-MATER M, V9, P449, DOI 10.1023/A:1008867300634
   LEFANU J, 1999, FALL RISE MODERN MED, P104
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   LI RN, 1992, CHEMICAL PROCESSING OF ADVANCED MATERIALS, P627
   LIVAGE J, 1992, J NON-CRYST SOLIDS, V145, P11, DOI 10.1016/S0022-3093(05)80422-3
   Livage J, 1997, CURR OPIN SOLID ST M, V2, P132, DOI 10.1016/S1359-0286(97)80057-5
   MAZER JJ, 1994, J NON-CRYST SOLIDS, V170, P32, DOI 10.1016/0022-3093(94)90100-7
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Padrines M, 2000, CONNECT TISSUE RES, V41, P101, DOI 10.3109/03008200009067662
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   RATNER BD, 1996, INTRO MAT MED BIOMAT, V484
   Rinehart JD, 1999, J BIOMED MATER RES, V48, P833, DOI 10.1002/(SICI)1097-4636(1999)48:6<833::AID-JBM11>3.0.CO;2-#
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.3.CO;2-Y
   SCHEPERS E, 1993, IMPLANT DENTISTRY, V2, P156
   SEPULVEDA P, 2000, P 13 C BIOC, P629
   SIMON SR, 1994, ORTHOPAEDIC BASIC SC
   STAMBOULIS A, 2000, P 13 C BIOC, P729
   THOMPSON I, 2000, COMPREHENSIVE COMPOS, P727
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   *US BIOM INC, DET CLIN CAS
   VIDUEAU JJ, 1991, EUR J SOL STATE INOR, V28, P303
   Wallace KE, 1999, J MATER SCI-MATER M, V10, P697, DOI 10.1023/A:1008910718446
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   WHEELER DL, 1997, P 10 C BOIC, P349
   WHEELER DL, 1997, P 23 ANN M SOC BIOM
   WILSON J, 1990, P 3 C BIOC, P283
   WIRTH GS, 1979, J COLLOID INTERF SCI, V68, P492, DOI 10.1016/0021-9797(79)90307-2
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   XYNOS ID, 2000, BIOCHEM BIOPH RES CO, V277, P604
   ZHONG JP, 1994, P 7 C BIOC, P61
   ZHONG JP, 1997, P 10 C BIOC, P391
NR 66
TC 66
Z9 66
U1 0
U2 22
PU I O M COMMUNICATIONS LTD INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0267-0836
J9 MATER SCI TECH SER
JI Mater. Sci. Technol.
PD AUG
PY 2001
VL 17
IS 8
BP 891
EP 900
DI 10.1179/026708301101510762
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 466XC
UT WOS:000170670600001
DA 2018-10-19
ER

PT J
AU Liang, CH
   Mou, ZQ
AF Liang, CH
   Mou, ZQ
TI Effects of different simulated fluids on anticorrosion biometallic
   materials
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE simulated body fluids; biomedical material; corrosion; corrosion
   inhibition
ID CORROSION
AB The corrosion behaviors of SUS316L stainless steel, Co-Cr alloy and Ti-6Al-4V alloy in Ringer's, PBS(-) and Hank's solutions have been investigated. The results indicate that the corrosion of Ringer's solution is the strongest, then followed by PBS(-) and Hank's solution. The presence of HPO42-, H2PO4-, SO42- and glucose in the PBS(-)and Hank's solution probably reduces the corrosion inhibitor and corrosion current. The decrease of the solution's pH significantly increases the corrosion rate and susceptibility to localized corrosion of SUS316L SS and Co-Cr alloy. However, Ti-6Al-4V alloy exhibits an exceptional stability and has only a slight increase of corrosion rate with decreasing pH.
C1 Dalian Univ Technol, Sch Chem Engn, Dalian 116012, Peoples R China.
CR BROWN SA, 1980, J BIOMED MATER RES, V14, P173, DOI 10.1002/jbm.820140208
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   DAISUKE K, 2000, JAPAN TETSU TO HAGAN, V66, P610
   GUO L, 2000, ELECTROCHEMISTRY, V6, P208
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   TOSHIHIRO K, 2000, MAT JAPAN, V39, P250
   TOSHIKAZU A, 2000, J JAPAN I METALS, V64, P895
   UHLIG HH, 1985, CORROSION CORROSION, P291
   Wang Guisheng, 1996, CHINESE J NONFERROUS, V6, P147
   YOSHIMITSU O, 1993, J JAPAN I METALS, V57, P338
   YOSHIMITSU O, 1996, J JAPAN I METALS, V60, P890
NR 12
TC 6
Z9 9
U1 0
U2 1
PU ALLERTON PRESS INC
PI NEW YORK
PA 18 WEST 27TH ST, NEW YORK, NY 10001 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD AUG
PY 2001
VL 11
IS 4
BP 579
EP 582
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 461PX
UT WOS:000170373600026
DA 2018-10-19
ER

PT J
AU Tasaka, F
   Ohya, Y
   Ouchi, T
AF Tasaka, F
   Ohya, Y
   Ouchi, T
TI One-pot synthesis of novel branched polylactide through the
   copolymerization of lactide with mevalonolactone
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
ID TRIMETHYLSILYL PROTECTION METHOD; RING-OPENING COPOLYMERIZATION;
   HYPERBRANCHED POLYESTERS; BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES;
   BLOCK-COPOLYMERS; POLY(L-LACTIDE); POLYMERIZATION; DEGRADATION; BACKBONE
AB Polylactide, which is a biodegradable and bio-absorbable polymer having low immunogenicity and good biocompatibility, has been mainly studied for biomedical applications. Branched polymers have different rheological and mechanical properties compared with their linear counterparts owing to their molecular architectures. we synthesized novel biodegradable polylactide having a branched structure composed of metabolically degradable and/or absorbable materials only. The branched polylactide was obtained from a one-pot copolymerization of L-lactide using metabolic intermediate DL-mevalonolactone as a bifunctional comonomer having both lactone ring and pendant hydroxy group. The glass transition point, melting point and crystallinity of the branched polylactide are lower than those of linear polylactide.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
CR ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   Atthoff B, 1999, MACROMOL CHEM PHYS, V200, P1333
   Breitenbach A, 1998, POLYMER, V39, P3261, DOI 10.1016/S0032-3861(97)10077-5
   Chasin M., 1990, BIODEGRADABLE POLYM
   Cho KY, 1999, MACROMOL RAPID COMM, V20, P598, DOI 10.1002/(SICI)1521-3927(19991101)20:11<598::AID-MARC598>3.0.CO;2-1
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   HOLLINGER JO, 1995, BIOCH APPL SYNTHETIC
   Hori Y, 1999, MACROMOLECULES, V32, P3537, DOI 10.1021/ma981846e
   HORI Y, 1993, MACROMOLECULES, V26, P4388, DOI 10.1021/ma00068a053
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Joziasse CAP, 2000, MACROMOL CHEM PHYSIC, V201, P107, DOI 10.1002/(SICI)1521-3935(20000101)201:1<107::AID-MACP107>3.0.CO;2-W
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   LEENSLAG JW, 1984, J APPL POLYM SCI, V29, P2829, DOI 10.1002/app.1984.070290913
   LI TY, 1998, BEITRAGE ALGEBRA GEO, V39, P1
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   LIU HJ, 1994, POLYM BULL, V32, P463, DOI 10.1007/BF00587889
   Liu MJ, 1999, MACROMOLECULES, V32, P6881, DOI 10.1021/ma990785x
   Nguyen C, 2000, MACROMOLECULES, V33, P4281, DOI 10.1021/ma991407v
   Nijenhuis AJ, 1996, POLYMER, V37, P2783, DOI 10.1016/0032-3861(96)87642-7
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   PITT CG, 1987, J POLYM SCI POL CHEM, V25, P955, DOI 10.1002/pola.1987.080250402
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   TASAKA F, 2000, POLYM PREPR AM CHEM, V41, P1552
   Trollsas M, 1999, MACROMOLECULES, V32, P9062, DOI 10.1021/ma991039v
NR 28
TC 48
Z9 50
U1 0
U2 27
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD JUL 30
PY 2001
VL 22
IS 11
BP 820
EP 824
DI 10.1002/1521-3927(20010701)22:11<820::AID-MARC820>3.0.CO;2-7
PG 5
WC Polymer Science
SC Polymer Science
GA 461KB
UT WOS:000170362500003
DA 2018-10-19
ER

PT J
AU Li, YH
   Rong, LJ
   Li, YY
AF Li, YH
   Rong, LJ
   Li, YY
TI Pore characteristics of porous NiTi alloy fabricated by combustion
   synthesis
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE porous NiTi alloy; pure morphology; mean pore size; porosity; combustion
   synthesis
ID NICKEL-TITANIUM; TISSUE; HARD
AB Biomedical porous NiTi shape memory alloy (SMA) is a promising implant material. The pore characteristics, such as pore morphology and distribution, mean pore size and porosity of porous NiTi SMA fabricated by combustion synthesis were investigated in this paper by optical microscopy, scanning electron microscopy (SEM), image processing and density determination and the mechanism of pore formation was proposed. The result indicated that pore morphology and distribution of porous NiTi SMA exhibited features of isotropy or anisotropy, depending upon preheating temperature during synthesis. Mean pore size and porosity range was 300-600 mum and 60-64% respectively, and open porosity ratio was bigger than 90% which indicates that porous NiTi SMA. is suitable for biomedical application. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Met Res Inst, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
OI Li, Yong-Hua/0000-0003-0005-3789
CR HIRANO K, 1968, J JAPAN I METALS, V32, P613
   Ishizaki K., 1998, POROUS MAT PROCESS T, P202
   ISHIZAKI K, 1998, POROUS MAT PROCESS T, P198
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   MUNIR ZA, 1988, AM CERAM SOC BULL, V67, P342
   RATNER BD, 1996, BIOMATERIALS SCI INT, P37
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
NR 10
TC 52
Z9 53
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD JUL 26
PY 2001
VL 325
IS 1-2
BP 259
EP 262
DI 10.1016/S0925-8388(01)01382-2
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 455YF
UT WOS:000170054800046
DA 2018-10-19
ER

PT J
AU Mandelis, A
   Nicolaides, L
   Chen, Y
AF Mandelis, A
   Nicolaides, L
   Chen, Y
TI Structure and the reflectionless/refractionless nature of parabolic
   diffusion-wave fields
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID PHOTON DENSITY WAVES; REFRACTION
AB We show the impossibility of reflection and refraction phenomena at linear diffusion-wave-field (DWF) interfaces. Instead, interfacial flux expressions are derived which involve coherent accumulation or depletion phenomena subject to an interface flux conservation principle. The conditions for reflectionless and refractionless interfaces are the parabolic nature and the concomitant Fickian constitutive relations satisfied by DWFs. Simulations show that the reflection and Snell's laws can be adequate approximations only under near-normal incidence conditions, in agreement with published experimental evidence in wide areas of biomedical, electronic, and materials physics.
C1 Univ Toronto, Dept Mech & Ind Engn, Photothermal & Optoelect Diagnost Labs, Toronto, ON M5S 3G8, Canada.
RP Mandelis, A (reprint author), Univ Toronto, Dept Mech & Ind Engn, Photothermal & Optoelect Diagnost Labs, Toronto, ON M5S 3G8, Canada.
CR BENNETT CA, 1982, APPL OPTICS, V21, P49, DOI 10.1364/AO.21.000049
   Bertolotti M, 1999, J APPL PHYS, V85, P3540, DOI 10.1063/1.369713
   BOAS DA, 1993, PHYS REV E, V47, pR2999, DOI 10.1103/PhysRevE.47.R2999
   BURT JA, 1986, CAN J PHYS, V64, P1053, DOI 10.1139/p86-179
   Mandelis A, 2001, PHYS TODAY, V54, P100, DOI 10.1063/1.4796266
   Mandelis A, 2000, PHYS TODAY, V53, P29, DOI 10.1063/1.1310118
   Mandelis A, 1994, PROGR PHOTOTHERMAL P, VII
   Mandelis A., 2000, PROGR PHOTOTHERMAL P, V4
   MANDELIS A, 2000, PROGR PHOTOTHERMAL P, V3
   Mandelis A., 2001, DIFFUSION WAVE FIELD
   Mandelis A., 1992, PROGR PHOTOTHERMAL P, VI
   Morse P. M., 1968, THEORETICAL ACOUSTIC
   OLEARY MA, 1992, PHYS REV LETT, V69, P2658, DOI 10.1103/PhysRevLett.69.2658
   Patel PM, 1996, PHOTOTHERMAL SCI TEC
NR 14
TC 52
Z9 52
U1 0
U2 3
PU AMERICAN PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD JUL 9
PY 2001
VL 87
IS 2
AR 020801
DI 10.1103/PhysRevLett.87.020801
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 451VM
UT WOS:000169823100002
DA 2018-10-19
ER

PT J
AU Gao, W
   Lui, ZY
   Li, ZW
AF Gao, W
   Lui, ZY
   Li, ZW
TI Nano- and microcrystal coatings and their high-temperature applications
SO ADVANCED MATERIALS
LA English
DT Article
ID CR-AL ALLOY; OXIDATION BEHAVIOR; SELECTIVE OXIDATION; DEPOSITION;
   RESISTANCE
AB Nano- and microcrystal materials often possess special properties that materials with identical compositions but ordinary crystal size do not have, These materials are finding wide applications especially as electronic, photonic, magnetic and biomedical materials.([1]) Nano- and microcrystal materials are also known to have superior mechanical properties due to the extremely fine grain size.([2]) However, it has not been well known that alloy and alloy-oxide coatings with nano- and microcrystal grains have special properties at high temperatures. Nanocrystal structures promote selective oxidation, forming protective oxidation scales with superior adhesion to the substrate. Progress has been made in this area as micro- and nanocrystal alloy and oxide dispersive alloy coatings show superior high-temperature corrosion resistance.([3])
C1 Univ Auckland, Sch Engn, Auckland 1, New Zealand.
RP Gao, W (reprint author), Univ Auckland, Sch Engn, Private Bag 92019, Auckland 1, New Zealand.
OI Gao, Wei/0000-0002-5064-0917
CR ARNELL RD, 1993, SURF COAT TECH, V59, P105, DOI 10.1016/0257-8972(93)90063-T
   GAO W, 2000, CORROS ENG JPN, V49, P592
   Goldstein A., 1997, HDB NANOPHASE MAT
   He K, 2000, MATER LETT, V46, P53, DOI 10.1016/S0167-577X(00)00142-7
   He Y, 2000, MATER LETT, V45, P79, DOI 10.1016/S0167-577X(00)00080-X
   He Y, 2000, HIGH TEMP MATER PROC, V19, P71
   JOHNSON RN, 1995, ELEVATED TEMPERATURE, V1, P265
   Li ZW, 2000, HIGH TEMP MATER PROC, V19, P443
   LIANG J, 2000, P HIGH TEMP CORR PRO, P383
   Liu ZY, 1998, SCRIPTA MATER, V39, P1497, DOI 10.1016/S1359-6462(98)00360-1
   Liu ZY, 1997, SCRIPTA MATER, V37, P1551, DOI 10.1016/S1359-6462(97)00291-1
   Liu ZY, 2000, OXID MET, V53, P341, DOI 10.1023/A:1004545421739
   Liu ZY, 1997, HIGH TEMP MATER PROC, V16, P159
   Liu ZY, 1998, OXID MET, V50, P51, DOI 10.1023/A:1018871817578
   Liu ZY, 1998, SCRIPTA MATER, V38, P877, DOI 10.1016/S1359-6462(97)00576-9
   Liu ZY, 1998, ACTA MATER, V46, P1691, DOI 10.1016/S1359-6454(97)00346-7
   Morris D. G., 1998, MECH BEHAV NANOSTRUC
   NICHOLLS J, 1986, MAT SCI TECH, V5, P799
   SIEGEL RW, 1998, PHYSICS NEW MAT, P66
   WALLWORK GR, 1971, OXID MET, V3, P171, DOI 10.1007/BF00603485
NR 20
TC 44
Z9 45
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUL 4
PY 2001
VL 13
IS 12-13
BP 1001
EP +
DI 10.1002/1521-4095(200107)13:12/13<1001::AID-ADMA1001>3.0.CO;2-V
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 451XA
UT WOS:000169826800030
DA 2018-10-19
ER

PT J
AU Bubb, DM
   Ringeisen, BR
   Callahan, JH
   Galicia, M
   Vertes, A
   Horwitz, JS
   McGill, RA
   Houser, EJ
   Wu, PK
   Pique, A
   Chrisey, DB
AF Bubb, DM
   Ringeisen, BR
   Callahan, JH
   Galicia, M
   Vertes, A
   Horwitz, JS
   McGill, RA
   Houser, EJ
   Wu, PK
   Pique, A
   Chrisey, DB
TI Vapor deposition of intact polyethylene glycol thin films
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID MASS-SPECTROMETRY; LASER-ABLATION; BIOMEDICAL APPLICATIONS; POLYMER;
   SURFACES
AB Thin films of polyethylene glycol (PEG) of average molecular weight, 1400 amu, were deposited by both matrix-assisted pulsed laser evaporation (MAPLE) and pulsed laser deposition (PLD). The deposition was carried out in vacuum (similar to 10(-6) Torr) with an ArF (lambda = 193 nm) laser at a fluence between 150 and 300 mJ/cm(2). Films were deposited on NaCl plates, Si(lll) wafers, and glass slides. The physiochemical properties of the films are compared via Fourier transform infrared spectroscopy (FTIR), electrospray ionization (ESI) mass spectrometry, and matrix-assisted laser desorption and ionization (MALDI) time-of-flight mass spectrometry. The results show that the MAPLE films nearly identically resemble the starting material, whereas the PLD films do not. These results are discussed within the context of biomedical applications such as drug delivery coatings and in vivo applications where there is a need for transfer of polymeric coatings of PEG without significant chemical modification.
C1 USN, Res Lab, Surface Modificat Lab, Washington, DC 20375 USA.
   USN, Res Lab, Chem Dynam & Diagnost Branch, Washington, DC 20375 USA.
   George Washington Univ, Dept Chem, Washington, DC 20001 USA.
   So Oregon State Univ, Ashland, OR 97520 USA.
RP Bubb, DM (reprint author), USN, Res Lab, Surface Modificat Lab, Code 6370,4555 Overlook Ave SW, Washington, DC 20375 USA.
EM dbubb@nrl.navy.mil
RI Vertes, Akos/B-7159-2008
OI Vertes, Akos/0000-0001-5186-5352
CR Blanchet GB, 1996, J APPL PHYS, V80, P4082, DOI 10.1063/1.363278
   BLANCHET GB, 1993, SCIENCE, V262, P719, DOI 10.1126/science.262.5134.719
   BLANCHET GB, 1994, APPL PHYS LETT, V65, P1311, DOI 10.1063/1.112038
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fei X, 1996, ANAL CHEM, V68, P3555, DOI 10.1021/ac960352h
   HANSEN SG, 1990, J APPL PHYS, V68, P1878, DOI 10.1063/1.346577
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   KANEKO Y, 1998, BIORELATED POLYM GEL, P29
   Manoravi P, 1998, J PHYS CHEM SOLIDS, V59, P1271, DOI 10.1016/S0022-3697(98)00059-6
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   NOHMI T, 1992, J AM CHEM SOC, V114, P3241, DOI 10.1021/ja00035a012
   Patel N, 1998, FASEB J, V12, P1447
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   RINGEISEN BR, IN PRESS LANGMUIR
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Yokoyama M, 1998, BIORELATED POLYM GEL, P193
NR 20
TC 46
Z9 46
U1 2
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUL
PY 2001
VL 73
IS 1
BP 121
EP 123
DI 10.1007/s003390100884
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 447QN
UT WOS:000169584100018
DA 2018-10-19
ER

PT J
AU Gomes, ME
   Reis, RL
   Cunha, AM
   Blitterswijk, CA
   de Bruijn, JD
AF Gomes, ME
   Reis, RL
   Cunha, AM
   Blitterswijk, CA
   de Bruijn, JD
TI Cytocompatibility and response of osteoblastic-like cells to
   starch-based polymers: effect of several additives and processing
   conditions
SO BIOMATERIALS
LA English
DT Article
DE starch-based polymers biodegradable; polymers; cytotoxicity;
   orthopaedics
ID IN-VITRO; BIOCOMPATIBILITY; BIOMATERIALS; SCAFFOLDS; BEHAVIOR
AB This work reports on the biocompatibility evaluation of new biodegradable starch-based polymers that are under consideration for use in orthopaedic temporary applications and as tissue engineering scaffolds. It has been shown in previous works that by using these polymers it is both possible to produce polymer/hydroxyapatite (HA) composites (with or without the use of coupling agents) with mechanical properties matching those of the human bone, and to obtain 3D structures generated by solid blowing agents, that are suitable for tissue engineering applications. This study was focused on establishing the influence of several additives (ceramic fillers, blowing agents and coupling agents) and processing methods/conditions on the biocompatibility of the materials described above. The cytotoxicity of the materials was evaluated using cell culture methods, according to ISO/EN 109935 guidelines. A cell suspension of human osteosarcoma cells (HOS) was also seeded on a blend of corn starch with ethylene vinyl alcohol (SEVA-C) and on SEVA-C/HA composites, in order to have a preliminary indication on cell adhesion and proliferation on the materials surface. In general, the obtained results show that all tile different materials based on SEVA-C, (which are being investigated for use in several biomedical applications), as well as all the additives (including the novel coupling agents) and different processing methods required to obtain the different properties/products, can be used without inducing a cytotoxic behaviour to the developed biomaterials. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Minho, Dept Polymer Engn, P-4710057 Braga, Portugal.
   IsoTis Bv, NL-3723 MB Bilthoven, Netherlands.
RP Gomes, ME (reprint author), Univ Minho, Dept Polymer Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM megomes@eng.uminho.pt
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Gomes,
   Manuela/B-6282-2009
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Gomes,
   Manuela/0000-0002-2036-6291; Cunha M., Antonio/0000-0003-3860-7732; van
   Blitterswijk, Clemens/0000-0003-2371-4615
CR [Anonymous], 109935 ISO EN
   DEKKER A, 1994, CELL MATER, V4, P101
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   KOOTEN TG, 1997, J MATER SCI-MATER M, V8, P835
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MENDES S, 2001, IN PRESS BIOMATERIAL
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Pachence J. M., 1997, PRINCIPLES TISSUE EN, P263
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Ratner BD, 1997, NATO ADV SCI I E-APP, V346, P453
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   VAZ CM, 2001, IN PRESS MAT RES INN
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
NR 19
TC 143
Z9 155
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1911
EP 1917
DI 10.1016/S0142-9612(00)00377-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100026
PM 11396897
DA 2018-10-19
ER

PT J
AU Ramakrishna, S
   Mayer, J
   Wintermantel, E
   Leong, KW
AF Ramakrishna, S
   Mayer, J
   Wintermantel, E
   Leong, KW
TI Biomedical applications of polymer-composite materials: a review
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Review
DE biomaterials; biocomposites; polymer composites; implants; prosthesis;
   medical devices; biomedical engineering; bioengineering
ID MOLECULAR-WEIGHT POLYETHYLENE; FIBER-REINFORCED PEEK; HYDROXYLAPATITE
   POLY(L-LACTIDE) COMPOSITES; ANTERIOR CRUCIATE LIGAMENT; VERTEBRAL BODY
   REPLACEMENT; INTERNAL-FIXATION PLATES; MATRIX INTERFACIAL BOND;
   HIP-PROSTHESIS DESIGN; FINITE-ELEMENT METHOD; CARBON-FIBER
AB An overview of various biomedical applications of polymer-composite materials reported in the literature over the last 30 years is presented in this paper. For the benefit of the readers, general information regarding structure and function of tissues, types and purpose of implants/medical devices, and various other materials used, are also briefly presented. Different types of polymer composite that are already in use or are investigated for various biomedical applications are presented. Specific advantages of using polymer-composite biomaterials in selected applications are also highlighted. The paper also examines the critical issues and scientific challenges that require further research and development of polymer composite materials for their increased acceptance in the biomedical industry. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   Swiss Fed Inst Technol ETH, Chair Biocompatible Mat Sci & Engn, Dept Mat, CH-8952 Schlieren, Switzerland.
   Tech Univ Munich, Cent Inst Biomed Engn, D-85748 Garching, Germany.
   Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM engsr@nus.edu.sg
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   Akay M, 1996, J BIOMED MATER RES, V31, P167
   ALI MS, 1990, J BONE JOINT SURG BR, V72, P586
   Ambrosio L, 1998, J BIOMED MATER RES, V42, P6, DOI 10.1002/(SICI)1097-4636(199810)42:1<6::AID-JBM2>3.0.CO;2-U
   Ambrosio L, 1996, J MATER SCI-MATER M, V7, P251, DOI 10.1007/BF00058561
   AMBROSIO L, 1998, HDB BIOMATERIAL PROP, P214
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   ANDERSSON BJG, 1993, MECH HUMAN JOINTS PH, P293
   Andreopoulos AG, 1998, J BIOMATER APPL, V13, P66, DOI 10.1177/088532829801300104
   ARNOCZKY SP, 1988, AM J SPORT MED, V16, P106, DOI 10.1177/036354658801600204
   Baidya K. P., 2001, J ENG MED, V215, P11
   Baidya KP, 2001, J BIOMATER APPL, V15, P279, DOI 10.1106/BKLQ-E2YG-D2LA-RG3R
   BAIDYA KP, P ICCM 12 PAR FRANC, P496
   Bao QB, 1996, BIOMATERIALS, V17, P1157, DOI 10.1016/0142-9612(96)84936-2
   BERRY JL, 1988, CLIN ORTHOP RELAT R, P270
   BJORK N, 1986, BIOMATERIALS, V7, P73, DOI 10.1016/0142-9612(86)90093-1
   Black J., 1998, HDB BIOMATERIALS PRO
   Black J., 1988, ORTHOPAEDIC BIOMATER, P197
   Black J., 1992, BIOL PERFORMANCE MAT
   Blazewicz S, 1997, BIOMATERIALS, V18, P437, DOI 10.1016/S0142-9612(96)00067-1
   BLUMENTHAL NC, 1994, J APPL BIOMATER, V5, P191, DOI 10.1002/jab.770050303
   BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   BRADLEY JS, 1981, BIOMATERIALS, V2, P124, DOI 10.1016/0142-9612(81)90011-9
   BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   BRADLEY JS, MECH PROPERTIES BIOM, P379
   Bragdon C. R., 1995, DEFECTS CEMENT MANTL
   BRANTIGAN JW, 1991, SPINE, V16, pS277, DOI 10.1097/00007632-199106001-00020
   BRIDWELL KH, 1991, TXB SPINAL SURG
   BROWN SA, 1990, BIOMATERIALS, V11, P541, DOI 10.1016/0142-9612(90)90075-2
   BRUCKMANN H, 1980, BIOMATERIALS, V1, P67, DOI 10.1016/0142-9612(80)90002-2
   BRUCKMANN H, 1980, BIOMATERIALS, V1, P73, DOI 10.1016/0142-9612(80)90003-4
   BUCHERT PK, 1986, J BONE JOINT SURG AM, V68A, P606, DOI 10.2106/00004623-198668040-00020
   CAILLETEAU JG, 1992, J ENDODONT, V18, P540, DOI 10.1016/S0099-2399(06)81210-0
   Cao Y, 1995, MATER RES SOC SYMP P, V394, P83
   CHALIAN VA, 1974, J BIOMEDICAL MAT RES, V5, P349
   CHANG FK, 1990, J BIOMED MATER RES, V24, P873, DOI 10.1002/jbm.820240707
   Chao Edmund Y. S., 1997, P317
   CHOUEKA A, 1995, J BIOMED MATER RES, V29, P1309
   CHRISTEL P, 1987, J BIOMED MATER RES-A, V21, P191
   Christel P., 1991, HIGH PERFORMANCE BIO, P499
   CHRISTEL PS, 1980, MECHANICAL PROPERTIE, P367
   Ciappetta P, 1997, NEUROSURGERY, V41, P1203, DOI 10.1097/00006123-199711000-00040
   Claes L, 1999, J BIOMED MATER RES, V48, P82, DOI 10.1002/(SICI)1097-4636(199921)48:1<82::AID-JBM14>3.3.CO;2-Z
   Claes L., 1997, BIOL BIOMECHANICAL P, P81
   CLAES L E, 1992, Clinical Materials, V10, P41, DOI 10.1016/0267-6605(92)90083-6
   COGSWELL FN, 1992, THERMOPLASTIC AROMAT
   Coombes Allan G. A., 1996, P215
   Culleton T. P., 1993, Clinical Materials, V12, P95, DOI 10.1016/0267-6605(93)90056-D
   DARENDELILER S, 1992, J ORAL REHABIL, V19, P371, DOI 10.1111/j.1365-2842.1992.tb01579.x
   Dauner M, 1998, J MATER SCI-MATER M, V9, P173, DOI 10.1023/A:1008823804460
   DAVY KWM, 1998, BIOMATERIALS, V13, P17
   Deb S, 1996, J MATER SCI-MATER M, V7, P191, DOI 10.1007/BF00119729
   DEHAAN J, 1996, P ECCM 7 LOND, P421
   DEHL RE, 1982, J BIOMED MATER RES, V16, P715, DOI 10.1002/jbm.820160517
   DELUCA PA, 1988, J BONE JOINT SURG AM, V70A, P1372, DOI 10.2106/00004623-198870090-00015
   Deng M, 1997, BIOMATERIALS, V18, P645, DOI 10.1016/S0142-9612(96)00194-9
   Durselen L, 1996, BIOMATERIALS, V17, P977, DOI 10.1016/0142-9612(96)84671-0
   ESSLINGER JO, 1973, J BIOMEDICAL MAT RES, V4, P187
   FEITH R, 1975, ACTA ORTHOP SCAND S, P161
   Flahiff CM, 1996, J BIOMED MATER RES, V32, P419
   Forster I. W., 1980, EVALUATION BIOMATERI, P367
   Freilich MA, 2000, FIBER REINFORCED COM
   Fujihara K, 2001, ADV COMPOS LETT, V10, P13
   GALLETTI PM, 1988, SURGERY, V103, P231
   Ganesh V. K., 1998, Q MAGAZINE, V29, P56
   Ganesh VK, 1998, ADV COMPOS LETT, V7, P111
   GERHART TN, 1988, J BIOMED MATER RES, V22, P1071, DOI 10.1002/jbm.820221110
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   GERSHON B, 1992, BIOMATERIALS, V13, P38, DOI 10.1016/0142-9612(92)90093-4
   GESE H, ZEMENTLOSE HUFTPROTH, P75
   Giardino R., 1993, BIODEGRADABLE IMPLAN, P143
   GILBERT JL, 1995, BIOMATERIALS, V16, P1043, DOI 10.1016/0142-9612(95)98900-Y
   GILLETT N, 1985, BIOMATERIALS, V6, P113, DOI 10.1016/0142-9612(85)90074-2
   GOH JCH, 1994, GAIT POSTURE, V2, P95
   GOLDNER JL, 1973, J BIOMEDICAL MAT RES, V4, P137
   HA SW, 1994, J MATER SCI-MATER M, V5, P481, DOI 10.1007/BF00058987
   Ha SW, 1997, J MATER SCI-MATER M, V8, P881, DOI 10.1023/A:1018557922690
   HA SW, 1997, THESIS ETH ZURICH SW
   HAKE U, 1991, LANGENBECK ARCH CHIR, V376, P323
   HALSTEAD A, 1979, J BIOMED MATER RES, V13, P121, DOI 10.1002/jbm.820130113
   HARRIS B, 1980, MECH PROPERTIES BIOL, P37
   HASTINGS GW, CARBON FIBRE THEIR C, P261
   HASTINGS GW, 1993, BIODEGRADABLE IMPLAN, P19
   Heiner AD, 1996, BIOMATERIALS, V17, P2211, DOI 10.1016/0142-9612(96)00070-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1995, ADV CHEM SER, V245, P523
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HENDERSON JD, 1987, J BIOMED MATER RES, V21, P59, DOI 10.1002/jbm.820210110
   HIDAKA S, 1984, J BONE JOINT SURG AM, V66A, P1241, DOI 10.2106/00004623-198466080-00012
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HIRT SW, 1993, J VASC SURG, V17, P538
   HIRT SW, 1991, THORAC CARDIOV SURG, V39, P365, DOI 10.1055/s-2007-1020001
   HO MH, 1994, J PROSTHET DENT, V72, P367, DOI 10.1016/0022-3913(94)90555-X
   HOAG EP, 1982, J PROSTHET DENT, V47, P177, DOI 10.1016/0022-3913(82)90183-4
   Huang ZM, 1999, ADV COMPOS LETT, V8, P289
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   HUISKES R, 1980, ACTA ORTHOP SCAND S, P185
   Hunt M. S., 1987, MAT DESIGN, V8, P113
   Huttner W., 1984, BIOMATERIALS BIOMECH, P167
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   Ignatius A, 1997, J MATER SCI-MATER M, V8, P753, DOI 10.1023/A:1018508511787
   IMAI T, 1999, AM J ORTHOD DENTOFAC, P533
   Inoue N., 1994, MAT TECHNIQUES, V4, P23
   ISSIDOR F, 1996, INT J PROSTHODONT, V9, P131
   ISSIDOR F, 1992, INT J PROSTHODONT, V5, P257
   JAMES SP, 1992, J BIOMED MATER RES, V26, P651, DOI 10.1002/jbm.820260507
   JANCAR J, 1993, J MATER SCI-MATER M, V4, P555, DOI 10.1007/BF00125593
   JANCAR J, 1993, J MATER SCI-MATER M, V4, P562, DOI 10.1007/BF00125594
   JENKINS DHR, 1977, J BONE JOINT SURG BR, V59, P501
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   KAHL S, 1993, BIOMED TECH, V38, P298, DOI 10.1515/bmte.1993.38.12.298
   KAJIWARA H, 1995, ARTIF ORGANS, V19, P64, DOI 10.1111/j.1525-1594.1995.tb02246.x
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   Kennedy KC, 1998, J MATER SCI-MATER M, V9, P243, DOI 10.1023/A:1008896425841
   Kettunen J, 1999, J BIOMAT SCI-POLYM E, V10, P33, DOI 10.1163/156856299X00261
   King M. W., 1996, CAN TEXT J, V113, P53
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P308
   KLEIN N, 1993, J MATER SCI-MATER M, V4, P285, DOI 10.1007/BF00122282
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   KO FK, 1999, LECT TEXTILE STRUCTU
   KOCVARA S., 1967, J BIOMED MAT RES, V1, P325, DOI 10.1002/jbm.820010304
   KRAUSE W, 1988, J BIOMED MATER RES-A, V22, P37
   KRAUSE WR, 1989, J BIOMED MATER RES, V23, P1195, DOI 10.1002/jbm.820231008
   KREBS J, 1997, P ICCM 11, P509
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   KWARTENG KB, 1990, SAMPE QUART, V22, P10
   LACROIX H, 1995, ANN VASC SURG, V9, P152, DOI 10.1007/BF02139657
   LAKES R, 1995, BIOMEDICAL ENG HDB, P598
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGER R, 1995, SCI AM           SEP, P100
   LATOUR RA, 1992, J BIOMED MATER RES, V26, P593, DOI 10.1002/jbm.820260504
   LATOUR RA, 1993, J BIOMED MATER RES, V27, P1281, DOI 10.1002/jbm.820271008
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   LEE IY, 1994, J BIOMED MATER RES, V28, P1055, DOI 10.1002/jbm.820280910
   LEE SM, 1991, INT ENCY COMPOSITES, V4, P74
   LEONG KW, IN PRESS ANN REV BIO
   Lin TW, 1997, J BIOMEDICAL MAT RES, V36, P37
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Loh PL, 2000, J DENT RES, V79, P1317
   LOHER U, 1993, 7 INT C POL MED SURG, P88
   LOUIS JP, 1990, BIOMATERIALS, V11, P525, DOI 10.1016/0142-9612(90)90071-W
   LOVDAHL PE, 1977, J PROSTHET DENT, V38, P507, DOI 10.1016/0022-3913(77)90025-7
   MAJOLA A, 1991, CLIN ORTHOP RELAT R, P260
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   MATSUMOTO A, 1995, ARTIF ORGANS, V19, P51, DOI 10.1111/j.1525-1594.1995.tb02244.x
   Mayer J., 1994, THESIS ETH ZURICH SW
   Mayer J., 1997, COMPOSITE SHEET FORM, P403
   MAYER J, 1993, BIOMED ENG-APP BAS C, V5, P778
   MCGRATH MH, 1992, TXB PLASTIC MAXILLOF, P93
   MCKENNA GB, 1979, J BIOMED MATER RES, V13, P783, DOI 10.1002/jbm.820130509
   MCKENNA GB, 1980, BIOMATERIALS, V1, P189, DOI 10.1016/0142-9612(80)90015-0
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   MESSNER K, 1993, J BIOMED MATER RES, V27, P1165, DOI 10.1002/jbm.820270907
   Miettinen VM, 1997, BIOMATERIALS, V18, P181, DOI 10.1016/S0142-9612(96)00123-8
   MJOBERG B, 1991, ACTA ORTHOP SCAND, V62, P500, DOI 10.3109/17453679108996658
   MORE N, 1988, BIOMATERIALS, V9, P328, DOI 10.1016/0142-9612(88)90028-2
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   NAZRE A, 1994, AM SOC TEST MATER, V1217, P53, DOI 10.1520/STP12221S
   NEUGEBAUER R, 1981, BIOMATERIALS, V2, P182, DOI 10.1016/0142-9612(81)90049-1
   Noishiki Y, 1993, J Invest Surg, V6, P231, DOI 10.3109/08941939309141614
   NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770
   Noishiki Y, 1994, ASAIO J, V40, pM267, DOI 10.1097/00002480-199407000-00006
   OKAZAKI M, 1988, BIOMATERIALS, V9, P345, DOI 10.1016/0142-9612(88)90031-2
   Paganetto G., 1991, BIOMATERIALI, V2, P179
   Park JB, 1984, BIOMATERIALS SCI ENG
   Park JB, 1992, BIOMATERIALS INTRO, P169
   Parson J. R., 1983, BIOCOMPATIBLE POLYM, P873
   Pascaud RS, 1997, BIOMATERIALS, V18, P727, DOI 10.1016/S0142-9612(96)00207-4
   Patel M, 1992, Ann Vasc Surg, V6, P244, DOI 10.1007/BF02000270
   PELUSO G, 1991, BIOMATERIALS, V12, P231, DOI 10.1016/0142-9612(91)90205-O
   Peter T., 1997, P 9 C BIOM ENG SING, P317
   PETERSON CJ, 1985, J BIOMED MATER RES, V19, P589, DOI 10.1002/jbm.820190510
   Philips D., 1999, THESIS KATHOLIEKE U
   PIETRUCHA K, 1991, BIOMATERIALS, V12, P320, DOI 10.1016/0142-9612(91)90041-8
   PILLIAR RM, 1976, J BIOMED MATER RES, V10, P893, DOI 10.1002/jbm.820100608
   PONGOR P, 1992, BIOMATERIALS, V13, P1070, DOI 10.1016/0142-9612(92)90139-F
   Poss R, 1987, J Arthroplasty, V2, P259, DOI 10.1016/S0883-5403(87)80057-8
   POURDEYHIMI B, 1989, J BIOMED MATER RES, V23, P63, DOI 10.1002/jbm.820230106
   Profio A.E., 1993, BIOMEDICAL ENG
   Purton D G, 1996, Quintessence Int, V27, P93
   Ramakrishna S, 1998, Singapore Patent Application, Patent No. [9800874-1, 98008741]
   Ramakrishna S., 2000, P 2 AS AUSTR C COMP, pA431
   RAMAKRISHNA S, 2000, TEXTILE SCAFFOLDS TI
   RAMAKRISHNA S, 2000, 29 FRP S JAP SOC MAT, P11
   RAMAKRISHNA S, 1996, INT C NEW TEXT COMP, P27
   Ramakrishna S., 1997, P 11 INT C COMP MAT, V1, P458
   RAMAKRISHNA S, 1997, JAPANESE J ARTIFICIA, V26, pS61
   RATNEV BD, 1996, INTRO MAT MED, P308
   Robin G. C., 1981, BIOMECHANICS MED DEV, P535
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   ROMAN JS, 1991, BIOMATERIALS, V12, P236, DOI 10.1016/0142-9612(91)90206-P
   RUBIN P, 1983, BIOCOMPATBILE POLYM, P941
   RUBIN P, 1992, HIP JOINT REPLACEMEN, P189
   RUSHTON N, 1984, BIOMATERIALS, V5, P352, DOI 10.1016/0142-9612(84)90034-6
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   SBARBATI R, INT J ARTIFICIAL ORG, V491, P14
   Schmitt-Thomas K. H. G., 1997, P ICCM 11 GOLD COAST, pV277
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   Scholz C., 1993, BIODEGRADABLE IMPLAN, P67
   SCLIPPA E, 1973, J BIOMED MATER RES, V7, P59, DOI 10.1002/jbm.820070105
   SEEDHAM BB, 1993, PHYSL PATHOPHYSIOLOG, P163
   Silverton C, 1996, J BONE JOINT SURG AM, V78A, P340, DOI 10.2106/00004623-199603000-00004
   Simoes JA, 2000, COMPOS SCI TECHNOL, V60, P559, DOI 10.1016/S0266-3538(99)00155-4
   SPEIDEL MO, 1998, MAT MED, P191
   Suwanprateeb J, 1997, J MATER SCI-MATER M, V8, P469, DOI 10.1023/A:1018522025474
   Szycher M., 1991, HIGH PERFORMANCE BIO, P519
   Szycher M., 1983, BIOCOMPATIBLE POLYM, P861
   TALLENT MA, 1990, INT ENCY COMPOSITES, V2, P466
   TAMURA J, 1995, J BIOMED MATER RES, V29, P551, DOI 10.1002/jbm.820290502
   TAYTON K, 1983, J BONE JOINT SURG BR, V65, P312
   TAYTON K, 1982, J BONE JOINT SURG BR, V64, P105
   TAYTON K, 1982, J BONE JT SURG B, V64, P112
   TAYTON KJJ, 1983, J MED ENG TECHNOL, V7, P271, DOI 10.3109/03091908309018173
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   TOH SL, 1993, PROSTHET ORTHOT INT, V17, P180
   TONINO AJ, 1976, J BONE JOINT SURG BR, V58, P107
   TOPOLESKI LDT, 1992, J BIOMED MATER RES, V26, P1599, DOI 10.1002/jbm.820261206
   Torbjorner A, 1996, EUR J ORAL SCI, V104, P605, DOI 10.1111/j.1600-0722.1996.tb00149.x
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   TORMALA P, 1987, BIOMATERIALS, V8, P42, DOI 10.1016/0142-9612(87)90027-5
   TRABERT KC, 1984, DENT CLIN N AM, V28, P923
   UHTHOFF HK, 1983, J BONE JOINT SURG BR, V65, P66
   URBANIAK JR, 1973, J BIOMED MATER RES, V7, P165, DOI 10.1002/jbm.820070311
   Valdevit A. D. C., 1996, SPINE, V10, P231
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   WAGNER HD, 1989, BIOMATERIALS, V10, P139, DOI 10.1016/0142-9612(89)90049-5
   Walker Peter S., 1997, P461
   WALKER PS, 1987, J BIOMECH, V20, P693, DOI 10.1016/0021-9290(87)90035-2
   WARD R, 1989, BIOMATERIALS, V20, P425
   Weinans H., 1991, THESIS U NIJMEGEN NE
   WENING JV, 1995, BIOMATERIALS, V16, P337, DOI 10.1016/0142-9612(95)93262-C
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   Werkmeister JA, 1998, J BIOMED MATER RES, V39, P429, DOI 10.1002/(SICI)1097-4636(19980305)39:3<429::AID-JBM12>3.0.CO;2-5
   WHITESIDE LA, 1989, CLIN ORTHOP RELAT R, P138
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   Williams D., 1990, CONCISE ENCY MED DEN
   Williams D.F., 1988, ADV BIOMATER, P11
   WILLIAMS DF, 1987, J MATER SCI LETT, V6, P188, DOI 10.1007/BF01728981
   Williams DF, 1979, MAT CLIN DENT
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   WINTERMANTEL E, 1994, J BIOMEDICAL ENG APP, V6, P18
   Wintermantel E., 1998, MAT MED, P1
   Wintermantel E, 1998, BIOKOMPATIBLE WERKST, V2
   Wintermantel Erich, 1995, P3
   WOO SLY, 1974, J BIOMED MATER RES, V8, P321, DOI 10.1002/jbm.820080513
   WOO SLY, 1976, J BONE JOINT SURG AM, V58, P190, DOI 10.2106/00004623-197658020-00005
   WRIGHT TM, 1981, J BIOMED MATER RES, V15, P719, DOI 10.1002/jbm.820150508
   WROBLEWSKI BM, 1988, ORTHOP CLIN N AM, V19, P627
   Yang JM, 1997, J BIOMED MATER RES, V38, P361, DOI 10.1002/(SICI)1097-4636(199724)38:4<361::AID-JBM9>3.0.CO;2-M
   Yildiz H, 1998, J BIOMED MATER RES, V39, P92, DOI 10.1002/(SICI)1097-4636(199801)39:1<92::AID-JBM12>3.0.CO;2-Q
   Yildiz H, 1998, J BIOMED MATER RES, V39, P102, DOI 10.1002/(SICI)1097-4636(199801)39:1<102::AID-JBM13>3.0.CO;2-H
   Yu T J, 1994, J Invest Surg, V7, P195, DOI 10.3109/08941939409018286
   YU TJ, 1993, J BIOMED MATER RES, V27, P1329, DOI 10.1002/jbm.820271013
   ZIMMERMAN M, 1987, J BIOMED MATER RES-A, V21, P345
   Zufall SW, 1998, J MATER SCI-MATER M, V9, P611, DOI 10.1023/A:1008977106648
NR 263
TC 686
Z9 697
U1 22
U2 356
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD JUL
PY 2001
VL 61
IS 9
BP 1189
EP 1224
DI 10.1016/S0266-3538(00)00241-4
PG 36
WC Materials Science, Composites
SC Materials Science
GA 454YF
UT WOS:000169998800002
DA 2018-10-19
ER

PT J
AU Miller, DL
   Spooner, GJR
   Williams, AR
AF Miller, DL
   Spooner, GJR
   Williams, AR
TI Photodisruptive laser nucleation of ultrasonic cavitation for biomedical
   applications
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE laser photodisruption; ultrasonic cavitation; hemolysis; biological
   effect
ID IN-VITRO; OPTICAL-BREAKDOWN; EXPOSURE CHAMBER; PULSE DURATION;
   SHOCK-WAVES; LITHOTRIPTER; WATER; ERYTHROCYTES; DEPENDENCE; PICOSECOND
AB Pulses of high intensity laser light, when focused into transparent materials, may produce localized electron-ion plasmas through optical breakdown. By simultaneously incorporating the resulting volume of vaporized material within the focal volume of a high intensity ultrasound source, the photodisruption (1.05 mum wavelength) void served as a nucleation site for ultrasonic cavitation. Dilute suspensions of canine erythrocytes in phosphate buffered saline were exposed in a flow-through exposure chamber and the percentage of lysed cells was used as a measure of the biologically effective cavitation activity produced in the chamber. Brief (about 30 mus) acoustic emissions were detected from the photodisruption alone (indicating laser nucleation of bubbles), but the cell lysis produced was undetectable against the background. However, combined exposure greatly increased both the duration of the acoustic emissions (up to 1.5 ms) and the amount of cell lysis above an ultrasonic pressure amplitude threshold of about 4.3 MPa at 2.5 MHz. The amount of cell lysis (sometimes approaching 100%) increased with increasing ultrasonic intensity, laser pulse energy and laser PRF Addition of 5% serum albumin enhanced the effect, apparently by stabilizing bubbles and nuclei. Photodisruptive laser nucleation of ultrasonic cavitation can provide controlled and synergistic enhancement of bioeffects. (C) 2001 Society of Photo-Optical Instrumentation Engineers.
C1 Univ Michigan, Med Ctr, Dept Radiol, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Elect Engn & Comp Sci, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA.
   Haemacoust Ltd, Swansea SA9 1EX, W Glam, Wales.
RP Miller, DL (reprint author), Univ Michigan, Med Ctr, Dept Radiol, 3315 Kresge III,200 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
FU NCI NIH HHS [CA42947]
CR Bao SP, 1998, CANCER RES, V58, P219
   BILLE JF, 1993, PHYS UNSERER Z, V24, P280
   Brayman AA, 1996, ULTRASOUND MED BIOL, V22, P927, DOI 10.1016/0301-5629(96)00108-1
   CHURCH CC, 1989, J ACOUST SOC AM, V86, P215, DOI 10.1121/1.398328
   Dierickx C, 1999, DERMATOL CLIN, V17, P357, DOI 10.1016/S0733-8635(05)70092-9
   FISCHER JP, 1994, APPL PHYS B-LASERS O, V58, P493, DOI 10.1007/BF01081080
   HOLST A, 1993, CURR EYE RES, V12, P359, DOI 10.3109/02713689308999460
   HYNYNEN K, 1991, ULTRASOUND MED BIOL, V17, P157, DOI 10.1016/0301-5629(91)90123-E
   Jochle K, 1996, ULTRASOUND MED BIOL, V22, P329, DOI 10.1016/0301-5629(96)00031-2
   Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.0.CO;2-S
   LAUTERBORN W, 1977, APPL PHYS LETT, V31, P663, DOI 10.1063/1.89495
   Lawrence N, 1997, DERMATOL SURG, V23, P1197, DOI 10.1111/j.1524-4725.1997.tb00474.x
   Loesel FH, 1996, IEEE J QUANTUM ELECT, V32, P1717, DOI 10.1109/3.538774
   Miller DL, 1998, ULTRASONICS, V36, P947, DOI 10.1016/S0041-624X(98)00017-1
   MILLER DL, 1995, ULTRASOUND MED BIOL, V21, P1059, DOI 10.1016/0301-5629(95)93252-U
   Miller DL, 1997, ULTRASOUND MED BIOL, V23, P625, DOI 10.1016/S0301-5629(97)00042-2
   MILLER DL, 1992, J ULTRAS MED, V11, P407
   Miller DL, 2000, J ACOUST SOC AM, V107, P3480, DOI 10.1121/1.429418
   NEPPIRAS EA, 1980, PHYS REP, V61, P159, DOI 10.1016/0370-1573(80)90115-5
   Noack J, 1998, J APPL PHYS, V83, P7488, DOI 10.1063/1.367512
   PRAT F, 1993, BRIT J CANCER, V68, P13, DOI 10.1038/bjc.1993.279
   Sacks ZS, 2000, PROC SPIE, V4162, P20, DOI 10.1117/12.405935
   Sliney DH, 1993, MED LASERS THEIR SAF
   Steinert RF, 1985, ND YAG LASER OPHTHAL
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
   Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878
   WILLARD GW, 1953, J ACOUST SOC AM, V25, P669, DOI 10.1121/1.1907161
   ZELICKSON BD, 1994, LASER SURG MED, V15, P364, DOI 10.1002/lsm.1900150406
NR 28
TC 9
Z9 10
U1 0
U2 6
PU SPIE-INT SOCIETY OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL
PY 2001
VL 6
IS 3
BP 351
EP 358
DI 10.1117/1.1380669
PG 8
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 462DR
UT WOS:000170405900013
PM 11516327
DA 2018-10-19
ER

PT J
AU Erckens, RJ
   March, WF
   Jongsma, FH
   Wicksted, JP
   Hendrikse, F
   Smit, EE
   Motamedi, M
AF Erckens, RJ
   March, WF
   Jongsma, FH
   Wicksted, JP
   Hendrikse, F
   Smit, EE
   Motamedi, M
TI Noninvasive Raman spectroscopic identification of intraocular lens
   material in the living human eye
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY APR 30-MAY 05, 2000
CL FT LAUDERDALE, FLORIDA
SP Assoc Res Vis & Ophthalmol
ID SILICONE OIL; POLY(METHYL METHACRYLATE); IN-VITRO; SURFACE;
   BIOCOMPATIBILITY
AB Purpose: To develop a safe noninvasive technique for identifying the material of intraocular lenses (IOLs) implanted in patients.
   Setting: Center for Biomedical Engineering and the Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, USA. Methods: Raman spectroscopy was used to noninvasively identify the type of IOL implanted after previous cataract surgery in 9 eyes of 6 patients who were legally blind as a result of eye disease. Three IOLs were characterized: poly(methyl methacrylate) (PMMA) (n = 5), acrylic (n = 3), and silicone (n = 1). Confocal Raman spectroscopy was used with a laser power of 95 muW and exposure time of 1 second.
   Results: Distinct spectral peaks associated with each type of IOL were obtained. These included spectra peaks at 2840 cm(-1), 2946 cm(-1), and 3000 cm(-1) for PMMA; 2917 cm(-1), 2939 cm(-1), and 3055 cm(-1) for acrylic; and 2900 cm-1, 2961 cm(-1), and 3048 cm(-1) for silicone. The procedure was well accepted by patients, and there were no complications.
   Conclusions: The specific Raman spectra of the IOLs allowed for noninvasive determination of IOL material with the use of a safe light dose and an exposure time of 1 second.
C1 Univ Texas, Med Branch, Laser & Spect Program, Ctr Biomed Engn, Galveston, TX 77555 USA.
   Univ Texas, Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA.
   Oklahoma State Univ, Ctr Sensors & Sensor Technol, Dept Phys, Stillwater, OK 74078 USA.
   Acad Hosp Maastricht, Dept Ophthalmol, Maastricht, Netherlands.
RP March, WF (reprint author), Univ Texas, Med Branch, Dept Ophthalmol, 700 Univ Blvd,Suite 400, Galveston, TX 77555 USA.
CR *ANSI, 1993, 13611986 ANSI
   Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   BARTZSCHMIDT KU, 1995, KLIN MONATSBL AUGENH, V207, P162, DOI 10.1055/s-2008-1035362
   Bauer NJC, 1998, INVEST OPHTH VIS SCI, V39, P831
   BAUER NJC, 1999, THESIS U MAASTRICHT
   BERTOLUZZA A, 1987, J RAMAN SPECTROSC, V18, P151, DOI 10.1002/jrs.1250180218
   BRADNAM MS, 1995, OPHTHALMOLOGY, V102, P799, DOI 10.1016/S0161-6420(95)30954-2
   Carey P R, 1982, BIOMEDICAL APPL RAMA
   Chehade M, 1997, AUST NZ J OPHTHALMOL, V25, P255, DOI 10.1111/j.1442-9071.1997.tb01512.x
   Erckens RJ, 1997, J RAMAN SPECTROSC, V28, P293
   Fyodorov S, 1991, OPHTHALMOSURGERY, V3, P57
   GERRARD DL, 1994, ANAL CHEM, V66, pR547, DOI 10.1021/ac00084a020
   Gills JP, 1998, CATARACT SURG STATE
   Hoerauf H, 2000, GRAEF ARCH CLIN EXP, V238, P8, DOI 10.1007/s004170050002
   Hoerauf H, 1999, KLIN MONATSBL AUGENH, V214, P71, DOI 10.1055/s-2008-1034752
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Jongsma FHM, 1997, OPT ENG, V36, P3193, DOI 10.1117/1.601529
   Kusaka S, 1996, AM J OPHTHALMOL, V121, P574, DOI 10.1016/S0002-9394(14)75436-4
   Langefeld S, 1999, GRAEF ARCH CLIN EXP, V237, P201, DOI 10.1007/s004170050219
   Legeais JM, 1998, J CATARACT REFR SURG, V24, P371, DOI 10.1016/S0886-3350(98)80326-X
   Lyon LA, 1998, ANAL CHEM, V70, p341R
   Newland TJ, 1999, J CATARACT REFR SURG, V25, P72, DOI 10.1016/S0886-3350(99)80014-5
   Nishi O, 1998, J CATARACT REFR SURG, V24, P975, DOI 10.1016/S0886-3350(98)80054-0
   RIDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   Senn P, 1997, OPHTHALMIC SURG LAS, V28, P776
   Smit EE, 1999, J CATARACT REFR SURG, V25, P1498, DOI 10.1016/S0886-3350(99)00239-4
   Tosch U, 1994, Aktuelle Radiol, V4, P218
   TU AT, 1984, RAMAN SPECTROSCOPY B
NR 28
TC 6
Z9 6
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JUL
PY 2001
VL 27
IS 7
BP 1065
EP 1070
DI 10.1016/S0886-3350(00)00828-2
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 459VK
UT WOS:000170272000029
PM 11489577
DA 2018-10-19
ER

PT J
AU Gonnella, JS
   Hojat, M
AF Gonnella, JS
   Hojat, M
TI Biotechnology and ethics in medical education of the new millennium:
   physician roles and responsibilities
SO MEDICAL TEACHER
LA English
DT Article; Proceedings Paper
CT Conference on Biomedicine and Ethics in the New Millennium
CY SEP, 2000
CL ROME, ITALY
ID HUMAN-GENOME-PROJECT; HUMAN CLONING; CARE; CANCER
AB Although the medical education curriculum varies internationally, we suggest that it is desirable for medical educators to share a universal responsibility to prepare physicians to perform three distinct, yet interrelated professional roles. The first is that of a clinician who has the knowledge and technical skills to care for individual patients, as well as the public. The second role can be viewed as that of an educator, a teacher, or a consultant who has the interpersonal skills and personal qualities to teach, advise and counsel patients and the public about their health and illness, risk factors and healthy lifestyle. The third role is that of a resource manager to enable physicians to care for patients and serve the public not only by drawing on available material assets but also by prudent use of the resources for better serving the most number of people at the least expense without compromising the quality of care. The very nature of the medical profession also obligates medical educators through the world to sensitize medical students and physicians to the ethical responsibilities that are implicit to each of the three aforementioned roles. Although the basic ethical responsibilities of do no harm and confidentiality are universal, certain global changes, such as rapid advancements in biotechnology and resource allocation, are now reshaping medical ethics on every continent. Spawned by the rapid advances in the biomedical sciences, biotechnology is revolutionizing human reproduction, sustaining human life, cloning human beings, and mapping the entire human genetic terrain. These advances imply changes in medical education and formal preparation of physicians in performing their roles as clinicians, educators and resource managers. These biotechnological developments, coupled with the increasing cost of healthcare and maldistribution of resources worldwide, present unprecedented ethical-social challenges that need to be addressed in the education of the physician in the new millennium.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, Philadelphia, PA 19107 USA.
RP Gonnella, JS (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, 1025 Walnut St, Philadelphia, PA 19107 USA.
CR ANNAS GI, 1998, NEW ENGL J MED, V339, P118
   CALMAN K, 1994, BRIT MED J, V309, P1140, DOI 10.1136/bmj.309.6962.1140
   Chao T. C., 1995, Annals Academy of Medicine Singapore, V24, P919
   Clever LH, 2000, ANN INTERN MED, V132, P85, DOI 10.7326/0003-4819-132-1-200001040-00014
   Cohen MM, 1998, JAMA-J AM MED ASSOC, V279, P748, DOI 10.1001/jama.279.10.748
   Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106
   Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682
   CRAWSHAW R, 1995, JAMA-J AM MED ASSOC, V273, P1553, DOI 10.1001/jama.273.19.1553
   FAGELL PL, 2000, HARVARD MED ALUM WIN, P12
   Fins JJ, 2000, ACAD MED, V75, P662, DOI 10.1097/00001888-200006000-00021
   Ganske G, 1999, PLAST RECONSTR SURG, V103, P1280
   Glass RM, 1996, JAMA-J AM MED ASSOC, V275, P147, DOI 10.1001/jama.275.2.147
   Gonnella J.S., 1993, ASSESSMENT MEASURES, P155
   GONNELLA JS, 1984, JAMA-J AM MED ASSOC, V251, P637
   GONNELLA JS, 1993, ASSESSMENT MEASURES
   GONNELLA JS, 1983, P 22 ANN C RES MED E, P3
   Hojat M, 2000, J COMMUN HEALTH, V25, P455, DOI 10.1023/A:1005192613992
   Hojat M, 1997, ACAD MED S, V72, P1
   Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210
   Kassirer JP, 1998, NEW ENGL J MED, V338, P905, DOI 10.1056/NEJM199803263381309
   LEWONTIN RC, 1997, NEW YORK REV BO 1023, P146
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   Lupton M L, 1999, Med Law, V18, P107
   NELSON AR, 1999, AM J OBSTET GYNECOL, V178, P755
   Novielli KD, 2000, ACAD MED, V75, pS53, DOI 10.1097/00001888-200010001-00017
   Obermann K, 1999, LANCET, V353, P1103, DOI 10.1016/S0140-6736(05)76465-5
   Plows CW, 1999, JAMA-J AM MED ASSOC, V281, P937
   Robertson JA, 1998, NEW ENGL J MED, V339, P119, DOI 10.1056/NEJM199807093390212
   Shapiro HT, 1997, SCIENCE, V277, P195, DOI 10.1126/science.277.5323.195
   Singer PA, 1998, CAN MED ASSOC J, V159, P159
   Verrees M, 1996, JAMA-J AM MED ASSOC, V276, P1285, DOI 10.1001/jama.276.16.1285
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
NR 32
TC 12
Z9 12
U1 1
U2 5
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0142-159X
J9 MED TEACH
JI Med. Teach.
PD JUL
PY 2001
VL 23
IS 4
BP 371
EP 377
DI 10.1080/01421590120042982
PG 7
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA 453CH
UT WOS:000169898700008
DA 2018-10-19
ER

PT J
AU Moretto, P
   Michelet, C
   Le Gallet, S
   Rebillat, F
   Guette, A
   Vignoles, G
AF Moretto, P
   Michelet, C
   Le Gallet, S
   Rebillat, F
   Guette, A
   Vignoles, G
TI STIM tomography: A potential tool for the non-destructive
   characterisation of SiC microcomposite materials
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Nuclear Microprobe Technology and
   Applications
CY SEP 10-15, 2000
CL BORDEAUX, FRANCE
SP CNRS, CEA, CNRS Univ Bordeaux, CNRS Minist Culture & Commun
DE scanning transmission ion microscopy; computed tomography; ceramic
   matrix microcomposites; interphase; non-destructive characterisation
ID MICROPROBE; MICROBEAM; IONS
AB Despite the fact that ion micro-tomography techniques were initiated several years ago, useful applications are still rare in material sciences. This work is a preliminary study on the non-destructive characterisation of a thin BN interphase in a ceramic matrix composite material by scanning transmission ion microscopy (STIM) tomography. The technique, initially developed at CENBG for applications in the biomedical field, was used here to investigate several model composites as processed and after oxidation tests at high temperature.
   The data reduction codes, based on analytic reconstruction methods, made it possible to determine the spatial extension of the BN interphase in transversal planes at different positions along the microcomposites (25 mum in diameter). This measurement was performed taking advantage of the density contrast between SiC and BN even for a layer thickness down to 3 mum. A first attempt was also made to separate the initial BN interphase from the B2O3 layer formed on its surface during oxidation, (C) 2001 Elsevier Science B.V. All rights reserved.
C1 CEN Bordeaux Gradignan, F-33175 Gradignan, France.
   UB1, UMR 5801, Lab Composites Thermostruct, CNRS,SNECMA,CEA, F-33600 Pessac, France.
RP Moretto, P (reprint author), CEN Bordeaux Gradignan, BP 120, Le Haut Vigneau, F-33175 Gradignan, France.
RI VIGNOLES, Gerard/A-2406-2013
OI VIGNOLES, Gerard/0000-0003-1606-6867
CR ANDERSEN HH, 1977, STOPPING POWERS RANG, V3
   ANTOLAK AJ, 1994, NUCL INSTRUM METH A, V353, P568, DOI 10.1016/0168-9002(94)91725-6
   AZEVEDO SG, 1990, IEEE T NUCL SCI, V37, P1525, DOI 10.1109/23.55866
   CHOLEWA M, 1994, NUCL INSTRUM METH B, V89, P157, DOI 10.1016/0168-583X(94)95164-0
   DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1
   FISCHER BE, 1990, NUCL INSTRUM METH B, V47, P271, DOI 10.1016/0168-583X(90)90757-L
   HUESMAN RH, 1977, PUB L BERKELEY LAB, V214
   LEFEVRE HW, 1991, NUCL INSTRUM METH B, V54, P363, DOI 10.1016/0168-583X(91)95538-O
   LLABADOR Y, 1990, NUCL INSTRUM METH B, V49, P435, DOI 10.1016/0168-583X(90)90289-7
   Michelet C, 1999, NUCL INSTRUM METH B, V150, P173, DOI 10.1016/S0168-583X(98)01015-5
   Michelet C, 1999, NUCL INSTRUM METH B, V158, P361, DOI 10.1016/S0168-583X(99)00348-1
   MICHELET C, 1998, THESIS U BORDEAUX FR
   Morse DH, 1997, NUCL INSTRUM METH B, V130, P740, DOI 10.1016/S0168-583X(97)00180-8
   NASLAIN R, 1996, PROGR ADV MAT MECH, P198
   PONTAU AE, 1989, NUCL INSTRUM METH B, V40-1, P646, DOI 10.1016/0168-583X(89)91067-7
   Rebillat F, 1998, J EUR CERAM SOC, V18, P1809, DOI 10.1016/S0955-2219(98)00120-4
NR 16
TC 7
Z9 7
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUL
PY 2001
VL 181
BP 238
EP 243
DI 10.1016/S0168-583X(01)00461-X
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 470RR
UT WOS:000170885400039
DA 2018-10-19
ER

PT J
AU Lugscheider, E
   Bobzin, K
   Lake, MK
AF Lugscheider, E
   Bobzin, K
   Lake, MK
TI Deposition of solder for micro-joining on MEMS components by means of
   magnetron sputtering
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Plasma Surface Engineering (PSE 2000)
CY SEP 17-21, 2000
CL PARTENKIRCHEN, GERMANY
DE MSIP PVD process; MEMS; micro-joining; solder application; TLP process
AB Micro electro-mechanical systems (M.E.M.S.) are used in many different technical areas, e.g. automotive control, information technology, biomedical or environmental application. Due to an increasing miniaturisation of components and devices and a great variety of materials, the M.E.M.S. has become very interesting. To mount different materials like ceramics, plastics or metals to hybrid M.E.M.S., sophisticated joining technologies have to be developed. The assembly and mounting of micro-components can be performed by a low temperature joining process, e.g. transient liquid phase bonding (TLP) or low temperature active compound joining. For these joining techniques, a solder system has to be deposited on the M.E.M.S. components locally. The TLP solder system is a composition of a thin film layer with a high melting point (e.g. Cu, Ni and Ag) and a second thin film with a low melting point (e.g. Sn, In and In-Bi). The deposition of a low temperature active compound solder system recommends an ingenious field of process parameters because of the multiplicity of solder elements, their stoichiometry and distribution within the deposited film. The deposition process can be carried out by the magnetron sputter ion plating (MSIP) PVD technique by adapting process parameters like discharge power, total gas pressure, substrate bias, or substrate heating, to obtain a defined film constitution. This paper presents the first results of solder deposition on different M.E.M.S. materials like silicon and glass, for the TLP joining process. The microstructure, morphology, and bond strength of the deposited solder layers are discussed in the context of deposition parameters. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Rhein Westfal TH Aachen, Inst Mat Sci, Aachen, Germany.
RP Lake, MK (reprint author), Rhein Westfal TH Aachen, Inst Mat Sci, Aachen, Germany.
CR BADER S, 1989, BILDUNG INTERMETALLI, P16
   JACOBSON DM, 1996, NOVEL APPL 13DIFFUSI, V23, P12
   JACOBSON DM, 1992, DIFFUS SOLDER SOLDER, V10, P27
   Lugscheider E, 1996, SURF COAT TECH, V86, P177, DOI 10.1016/S0257-8972(96)03041-1
   LUGSCHEIDER E, 1999, LOTEN MIKROSYSTEMTEC, V1
   Thornton J.A., 1974, J VAC SCI TECHNOL, V11, P660
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P830, DOI 10.1116/1.568682
   1994, 2409 EN ISO
NR 8
TC 14
Z9 14
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL
PY 2001
VL 142
BP 813
EP 816
DI 10.1016/S0257-8972(01)01182-3
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 474KA
UT WOS:000171104600136
DA 2018-10-19
ER

PT J
AU Min, SK
   Kim, JH
   Chung, DJ
AF Min, SK
   Kim, JH
   Chung, DJ
TI Swelling behavior of biodegradable crosslinked gel based on
   poly(aspartic acid) and PEG-diepoxide
SO KOREA POLYMER JOURNAL
LA English
DT Article
ID L-ASPARTIC ACID; THERMAL POLYCONDENSATION; POLY(SUCCINIMIDE)
AB Poly(aspartic acid), PASP, is a biodegradable water-soluble polymer and offers a biodegradable alternative to polycarboxylates and other non-degradable water-soluble polymers. PASP, one of poly (amino acid)s, possesses carboxylic acid pendant group in its repeating unit. which can be used for various further modification put-poses. In this study we prepared high molecular weight polysuccinimide, as the precursor polymer for PASP by thermal polycondensation of L-aspartic acid in the presence of phosphoric acid. The polysuccinimide was hydrolyzed with 0.1 N sodium hydroxide, and then acidified to give PASP. High water-absorbent gels were produced by thermal crosslinking of freeze-dried mixture of partially-neutralized PASP and different amount of low mel. wt. PEG-diepoxide compounds in aqueous medium. The swelling behavior of the prepared gels from different size and composition of crosslinking reagent in different media was investigated and the results were discussed. This PASP-based hydrogel materials possessing inherent biodegradability, potential non-toxicity and biocompatibility, is expected to be used as a substrate for various biomedical applications as well as a general purpose super-absorbent polymer.
C1 Sungkyunkwan Univ, Polymer Technol Inst, Dept Chem Engn, Suwon 440746, Kyunggi, South Korea.
   Sungkyunkwan Univ, Polymer Technol Inst, Dept Polymer Sci & Engn, Suwon 440746, Kyunggi, South Korea.
EM kimjh@skku.ac.kr
CR Allen DS, 1998, MODERN SUPERABSORBEN
   Andrade JD, 1996, ACS S SERIES, V31
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Giammona G., 1994, COLLOID POLYM SCI, V272, P12
   Matsubara K, 1997, MACROMOLECULES, V30, P2305, DOI 10.1021/ma961579h
   Min SK, 2000, J IND ENG CHEM, V6, P276
   Mosig J, 1997, IND ENG CHEM RES, V36, P2163, DOI 10.1021/ie960678g
   Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y
   Nakato T, 2000, J POLYM SCI POL CHEM, V38, P117, DOI 10.1002/(SICI)1099-0518(20000101)38:1<117::AID-POLA15>3.0.CO;2-F
   NAKATO T, 1996, ACS POLYM PREPRINT, V31, P555
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   Sung YK, 2000, KOREA POLYM J, V8, P199
   TAMATAI H, 1995, ANTEC, P1511
   Tomida M, 1997, POLYMER, V38, P2791, DOI 10.1016/S0032-3861(97)85616-9
   WHEELER AP, 1993, MATER RES SOC S P, V292, P279
   WOLK SK, 1994, MACROMOLECULES, V27, P7613, DOI 10.1021/ma00104a016
   WONG WH, 1997, SYNTHETIC BIODEGRADA, pCH4
NR 17
TC 14
Z9 14
U1 0
U2 2
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1225-5947
J9 KOREA POLYM J
JI Korea Polym. J.
PD JUN 30
PY 2001
VL 9
IS 3
BP 143
EP 149
PG 7
WC Polymer Science
SC Polymer Science
GA 449LM
UT WOS:000169686100002
DA 2018-10-19
ER

PT J
AU Lee, CH
   Singla, A
   Lee, Y
AF Lee, CH
   Singla, A
   Lee, Y
TI Biomedical applications of collagen
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Review
DE collagen; biomaterial; drug/protein/gene delivery; tissue engineering
ID DRUG-DELIVERY SYSTEM; CROSS-LINKED COLLAGEN; BIOPROSTHETIC HEART-VALVES;
   CULTURED SKIN SUBSTITUTES; SOLID LIPID NANOPARTICLES; FIBROBLAST
   GROWTH-FACTOR; RECOMBINANT HUMAN BMP-2; SOFT CONTACT-LENSES; IN-VITRO;
   CORNEAL SHIELDS
AB Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics. such as biodegradability and weak antigenecity, made collagen the primary resource in medical applications. The main applications of collagen as drug delivery systems are collagen shields in ophthalmology, sponges for burns/wounds, mini-pellets and tablets for protein delivery, gel formulation in combination with liposomes for sustained drug delivery, as controlling material for transdermal delivery, and nanoparticles for gene delivery and basic matrices for cell culture systems. wt was also used for tissue engineering including skin replacement, bone substitutes, and artificial blood vessels and valves. This article reviews biomedical applications of collagen including the collagen film, which we have developed as a matrix system fur evaluation of tissue calcification and for the embedding of a single cell suspension for tumorigenic study. The advantages and disadvantages of each system are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Missouri, Coll Pharm, Dept Pharmaceut, Kansas City, MO 64110 USA.
   Univ Missouri, Sch Interdisciplinary Comp & Engn, Kansas City, MO 64110 USA.
RP Lee, CH (reprint author), Univ Missouri, Coll Pharm, Dept Pharmaceut, 5005 Rockhill Rd Katz Bdg 108, Kansas City, MO 64110 USA.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   ALHENDY A, 1995, HUM GENE THER, V6, P165, DOI 10.1089/hum.1995.6.2-165
   Angella GJ, 2000, INVEST OPHTH VIS SCI, V41, P4158
   AQUAVELLA JV, 1988, J CATARACT REFR SURG, V14, P492, DOI 10.1016/S0886-3350(88)80004-X
   ASSIL KK, 1992, AM J OPHTHALMOL, V113, P418, DOI 10.1016/S0002-9394(14)76165-3
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E
   BARBANI N, 1995, J BIOMAT SCI-POLYM E, V7, P461
   BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212
   BAZIUK N, 1992, INT OPHTHALMOL, V16, P101, DOI 10.1007/BF00918940
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Bender AR, 1996, ANTIMICROB AGENTS CH, V40, P1467, DOI 10.1128/AAC.40.6.1467
   Bergeon M T, 1967, J Okla State Med Assoc, V60, P330
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885
   BOYCE ST, 1993, ANTIMICROB AGENTS CH, V37, P1890, DOI 10.1128/AAC.37.9.1890
   BOYCE ST, 1992, J BIOMED MATER RES, V26, P547, DOI 10.1002/jbm.820260410
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886
   BRADLEY WG, 1977, BIOMATER ARTIF CELL, V5, P159, DOI 10.3109/10731197709118671
   BRAUKER J, 1995, J CELL BIOCH B, V21, pD1
   BROWDER IW, 1986, AM SURGEON, V52, P492
   BURGE RE, 1964, P NATO ADV STUDY GRO, P2
   CAMERON WJ, 1978, OBSTET GYNECOL, V51, P118
   CARROLL RE, 1989, J HAND SURG-BRIT EUR, V14B, P218, DOI 10.1016/0266-7681(89)90131-9
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   CHEN JM, 1995, J BIOMOL STRUCT DYN, V12, P1129, DOI 10.1080/07391102.1995.10508804
   CHEN YF, 1990, AM J OPHTHALMOL, V109, P132, DOI 10.1016/S0002-9394(14)75976-8
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   CHVAPIL M, 1985, AM J OBSTET GYNECOL, V151, P325, DOI 10.1016/0002-9378(85)90296-0
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   DANIELSEN CC, 1990, BIOCHEM J, V272, P697, DOI 10.1042/bj2720697
   DEATHERAGE JR, 1987, COLLAGEN REL RES, V7, P225
   Desgrandchamps F, 2000, Curr Opin Urol, V10, P201, DOI 10.1097/00042307-200005000-00003
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DORIGO MT, 1995, CHEMOTHERAPY, V41, P1, DOI 10.1159/000239317
   DORR RT, 1982, J BIOMED MATER RES, V16, P839, DOI 10.1002/jbm.820160609
   ELSAMALIGY MS, 1983, J PHARM PHARMACOL, V35, P537, DOI 10.1111/j.2042-7158.1983.tb04831.x
   Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925
   FELL JT, 1970, J PHARM SCI, V59, P688, DOI 10.1002/jps.2600590523
   FERKOL T, 1993, J CLIN INVEST, V92, P2394, DOI 10.1172/JCI116845
   FINKELSTEIN I, 1991, CAN J OPHTHALMOL, V26, P129
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   FRIEDBERG ML, 1991, OPHTHALMOLOGY, V98, P725
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   GEBHARDT BM, 1995, J OCUL PHARMACOL TH, V11, P319, DOI 10.1089/jop.1995.11.319
   Geesin JC, 1996, J BIOMED MATER RES, V33, P1
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   GLOECKNER DC, 2000, BIOMATERIALS, V52, P365
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Grammer JB, 1996, CURR EYE RES, V15, P815, DOI 10.3109/02713689609017622
   GROSS J., 1963, COMP BIOCHEM, V5, P307
   GUSSLER JR, 1990, J CATARACT REFR SURG, V16, P719, DOI 10.1016/S0886-3350(13)81013-9
   HARKNESS RD, 1966, SCI PROGRESS-UK, V54, P257
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   HARRIS PT, 1989, CORAL REEFS, V8, P97
   HEARTLEIN MW, 1994, P NATL ACAD SCI USA, V91, P10967, DOI 10.1073/pnas.91.23.10967
   HOBDEN JA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1605, DOI 10.1001/archopht.1988.01060140773053
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   HWANG DG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1375, DOI 10.1001/archopht.1989.01070020445052
   Jerome A., 1992, BIOMATERIALS, V9, P137
   JEYANTHI R, 1991, J PHARM PHARMACOL, V43, P60, DOI 10.1111/j.2042-7158.1991.tb05453.x
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KAUFMAN HE, 1994, J OCUL PHARMACOL, V10, P17, DOI 10.1089/jop.1994.10.17
   KAUFMAN HE, 1988, J CATARACT REFR SURG, V14, P487, DOI 10.1016/S0886-3350(88)80002-6
   Kemp PD, 2000, METH MOL B, V139, P287
   KIMURA M, 2000, J PLAST RECONSTR SUR, V34, P289
   Kobayashi Y, 2000, Hinyokika Kiyo, V46, P869
   Kohmura E, 1999, BRAIN RES, V849, P235, DOI 10.1016/S0006-8993(99)02163-0
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kuwano M, 1997, J OCUL PHARMACOL TH, V13, P31, DOI 10.1089/jop.1997.13.31
   KUZUYA M, 1994, EXP CELL RES, V215, P310, DOI 10.1006/excr.1994.1347
   Lam PK, 1999, ANN PLAS SURG, V43, P523, DOI 10.1097/00000637-199911000-00010
   LEADERS F E, 1973, Annals of Ophthalmology, V5, P513
   Lee CH, 1998, J BIOMED MATER RES, V42, P30, DOI 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P
   LEE VHL, 1990, J OCUL PHARMACOL, V6, P157, DOI 10.1089/jop.1990.6.157
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   LIANG FQ, 1992, INVEST OPHTH VIS SCI, V33, P2194
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MARMER RH, 1988, J CATARACT REFR SURG, V14, P496, DOI 10.1016/S0886-3350(88)80005-1
   MARTY JJ, 1978, PHARM ACTA HELV, V53, P17
   MATINCHOULY CA, 1999, INVEST RADIOL, V34, P663
   Matsuoka J, 1988, T AM SOC ART INT ORG, V34, P729
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   Mendicute Javier, 1995, CLAO Journal, V21, P252
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   MILLER JM, 1964, ARCH SURG-CHICAGO, V88, P167, DOI 10.1001/archsurg.1964.01310200005002
   MINABE M, 1989, J PERIODONTOL, V60, P113, DOI 10.1902/jop.1989.60.2.113
   MINABE M, 1989, J PERIODONTOL, V60, P552, DOI 10.1902/jop.1989.60.10.552
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   MONDINO BJ, 1991, AM J OPHTHALMOL, V112, P587, DOI 10.1016/S0002-9394(14)76863-1
   MOULLIER P, 1993, NAT GENET, V4, P154, DOI 10.1038/ng0693-154
   MOULLIER P, 1995, NAT MED, V1, P353, DOI 10.1038/nm0495-353
   MOULLIER P, 1993, TRANSPLANTATION, V56, P427, DOI 10.1097/00007890-199308000-00034
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Mullins RJ, 1996, AUST NZ J OPHTHALMOL, V24, P257, DOI 10.1111/j.1442-9071.1996.tb01589.x
   Muniruzzaman M, 1998, J BIOMAT SCI-POLYM E, V9, P459, DOI 10.1163/156856298X00569
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   MURRAY TG, 1990, ARCH OPHTHALMOL-CHIC, V108, P104, DOI 10.1001/archopht.1990.01070030110039
   Nakagawa T, 2000, ORAL DIS, V6, P172
   NARAZAKI H, 1994, INT J APPROX REASON, V11, P1, DOI 10.1016/0888-613X(94)90017-5
   NICHOLAS FL, 1997, BIOMATERIALS, V18, P815
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   OBRIEN TP, 1988, J CATARACT REFR SURG, V14, P505, DOI 10.1016/S0886-3350(88)80007-5
   Ochiya T, 1999, NAT MED, V5, P707
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   PAJEAN M, 1993, INT J PHARM, V91, P209, DOI 10.1016/0378-5173(93)90340-L
   PALMER RM, 1995, J CATARACT REFR SURG, V21, P125, DOI 10.1016/S0886-3350(13)80497-X
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PENG YM, 1986, INVEST NEW DRUG, V4, P245
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PHINNEY RB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1599, DOI 10.1001/archopht.1988.01060140767052
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PLEYER U, 1994, CURR EYE RES, V13, P177, DOI 10.3109/02713689408995775
   PODOS SM, 1972, AM J OPHTHALMOL, V73, P336, DOI 10.1016/0002-9394(72)90062-1
   POLAND DE, 1988, J CATARACT REFR SURG, V14, P489, DOI 10.1016/S0886-3350(88)80003-8
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P226, DOI 10.1046/j.1524-475x.2000.00226.x
   RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   RAO KP, 1992, J MEMBRANE SCI, V71, P161, DOI 10.1016/0376-7388(92)85015-B
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REIDY JJ, 1990, CORNEA, V9, P196
   REMACLE M, 1995, ANN OTO RHINOL LARYN, V104, P437, DOI 10.1177/000348949510400604
   ROBIN JB, 1990, INVEST OPHTH VIS SCI, V31, P1294
   Rosenthal FM, 1997, ANTICANCER RES, V17, P1179
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   ROSSLER B, 1994, PHARMAZIE, V49, P175
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   RUBIN AL, 1973, J CLIN PHARMACOL, V13, P309, DOI 10.1002/j.1552-4604.1973.tb00217.x
   RUDERMAN RJ, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070213
   Sahai A., 1995, Pharmaceutical Research (New York), V12, pS227
   Samuel CS, 1998, J ENDOCRINOL, V159, P117, DOI 10.1677/joe.0.1590117
   SASTRY TP, 1991, COMPREHENSIVE GUIDE, P171
   Sato H, 1996, PHARMACEUT RES, V13, P1565, DOI 10.1023/A:1016096016642
   SAWUSCH MR, 1988, AM J OPHTHALMOL, V106, P279, DOI 10.1016/0002-9394(88)90361-3
   SAWUSCH MR, 1988, J CATARACT REFR SURG, V14, P625
   SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   SCHWARTZ SD, 1990, AM J OPHTHALMOL, V109, P701, DOI 10.1016/S0002-9394(14)72439-0
   Sekine T, 2001, J BIOMED MATER RES, V54, P305, DOI 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B
   Sela J, 2000, INFLAMM RES, V49, P679, DOI 10.1007/s000110050646
   SHAKER GJ, 1989, INVEST OPHTH VIS SCI, V30, P1565
   SHANTHA KL, 1993, J BIOACT COMPAT POL, V8, P142, DOI 10.1177/088391159300800204
   SHORTLIFFE LMD, 1989, J UROLOGY, V141, P538
   SOBOLEWSKI K, 1995, ACTA BIOCHIM POL, V42, P301
   Stemberger A, 1997, EUR J SURG, V163, P17
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Supp AP, 1999, WOUND REPAIR REGEN, V7, P226, DOI 10.1046/j.1524-475X.1999.00226.x
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKENAKA H, 1986, PHARM TECH JAPAN, V2, P1083
   TANI K, 1989, BLOOD, V74, P1274
   Taravella MJ, 1999, J CATARACT REFR SURG, V25, P562, DOI 10.1016/S0886-3350(99)80056-X
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Trasciatti S, 1998, BIOMATERIALS, V19, P897, DOI 10.1016/S0142-9612(97)00175-0
   Traub W, 1971, ADV PROTEIN CHEM, V25, P245
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379
   Ulrich U, 2001, ARCH GYNECOL OBSTET, V264, P186, DOI 10.1007/s004040000105
   UNTERMAN SR, 1988, J CATARACT REFR SURG, V14, P500, DOI 10.1016/S0886-3350(88)80006-3
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   Vaneerdeweg W, 1998, EUR J SURG, V164, P617
   Vaneerdeweg W, 2000, EUR J SURG, V166, P959
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   WALTMAN SR, 1970, INVEST OPHTH VISUAL, V9, P250
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WEBSTER RC, 1984, ARCH OTOLARYNGOL, V110, P652
   WEDGE CI, 1992, CAN J OPHTHALMOL, V27, P295
   WEINER AL, 1985, J PHARM SCI, V74, P922, DOI 10.1002/jps.2600740903
   WILLEY DE, 1991, CURR EYE RES, V10, P167, DOI 10.3109/02713689109020374
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   Yamada N, 1999, SCAND J PLAST RECONS, V33, P147
   YAMAHIRA Y, 1991, Patent No. 841123136
   Yang SC, 1999, J CONTROL RELEASE, V59, P299, DOI 10.1016/S0168-3659(99)00007-3
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 202
TC 969
Z9 1045
U1 25
U2 460
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD JUN 19
PY 2001
VL 221
IS 1-2
BP 1
EP 22
DI 10.1016/S0378-5173(01)00691-3
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 443XJ
UT WOS:000169368300001
PM 11397563
DA 2018-10-19
ER

PT J
AU Kumar, R
   Cheang, P
   Khor, KA
AF Kumar, R
   Cheang, P
   Khor, KA
TI RF plasma processing of ultra-fine hydroxyaptite powders
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 5th Asia-Pacific Conference on Materials Processing
CY JUN 25-27, 2001
CL SEOUL, SOUTH KOREA
DE hydroxyaptite; tricalcium phosphate; calcium oxide; RF plasma
   processing; bioactive material
ID HYDROXYLAPATITE; COATINGS
AB The study of biocompatible materials has intensified over the last decade driven by the growing awareness of an aging population. The need for alternative medical solutions has not only extended the requirement for biomedical devices to offer more than just functionality but also bioactivity. A new generation of bioactive materials has emerged promising better properties over existing biomaterials because of their ability-to promote intimate bone growth and rapid fixation. In particular, hydroxyapatite (HA) has been recognised as one bioactive material having the potential and opportunity for development as bone substitutes. Although HA has a similar chemical composition to that of natural bone, it lacks sufficient strength and toughness for use in load bearing applications. Very often it requires blending with a low modulus polymer to achieve adequate toughness. However, the properties of HA composites is highly dependent on the particle size and morphology of the HA filler. Much has been suggested on the benefit of nano particulate materials in achieving higher mechanical properties. The need now arises in developing and processing HA of sufficient fineness for this purpose. As such the synthesis of ultra-fine HA was initiated using RF induction suspension plasma spraying with a wet suspension of HA as feedstock. This was axially injected into the RF plasma at various plate powers (plasma energies), chamber pressures, probe distances and plasma gas flow rates. The processed powders varied in size according to the cyclones designed to collect the powders from medium to ultra-fine. The chamber collecting ultrafine powder contained particles ranging from 10 nm to 4 mum. The particle size, morphology and phase concentration of the powders were characterised using SEM, TEM, XRD and FTIR. In general, the particle size decreased with increasing plate power, while the reverse was observed for the volume of nano-sized particles produced. Decomposition into other phases such as tricalcium phosphate (TCP), tetracalcium phosphate (TTCP) and calcium oxide (CaO) increased with increasing plate power. This study suggests that the processing parameters associated with the production of the ultra-fine powders interact in a complex manner but can be rationalised by considering the overall thermal treatment experienced by the particulates during plasma treatment. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Nanyang Technol Univ, Adv Mat Res Ctr, Sch Mat Engn, Singapore 639789, Singapore.
RP Cheang, P (reprint author), Nanyang Technol Univ, Adv Mat Res Ctr, Sch Mat Engn, Nanyang Ave, Singapore 639789, Singapore.
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423
CR Babat G.I., 1947, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V94, P27
   Bouyer E, 1997, IEEE T PLASMA SCI, V25, P1066, DOI 10.1109/27.649627
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KHON DH, 1992, MAT SCI TECHNOLOGY, V14, P66
   Khor KA, 1997, JOM-J MIN MET MAT S, V49, P51, DOI 10.1007/BF02915482
   KNOWLES JC, BIOCERAMICS, V8, P311
   KUMAR R, 2000, P 14 INT C SURF MOD
   MATEJKA D, 1989, PLASMA SPRAYING META, P15
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   REED TB, 1961, J APPL PHYS, V32, P821, DOI 10.1063/1.1736112
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Ye R, 1999, INT J HEAT MASS TRAN, V42, P1585, DOI 10.1016/S0017-9310(98)00260-9
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
NR 16
TC 52
Z9 53
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD JUN 15
PY 2001
VL 113
IS 1-3
BP 456
EP 462
DI 10.1016/S0924-0136(01)00611-2
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 444TA
UT WOS:000169415000078
DA 2018-10-19
ER

PT J
AU Golosio, B
   Brunetti, A
   Cesareo, R
   Amendolia, SR
   Rao, DV
   Seltzer, SM
AF Golosio, B
   Brunetti, A
   Cesareo, R
   Amendolia, SR
   Rao, DV
   Seltzer, SM
TI Images of soft materials: a 3D visualization of interior of the sample
   in terms of attenuation coefficient
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
DE X-ray computed tomography; 3D graphics; non-destructive evaluation;
   imaging
ID MICROTOMOGRAPHY; TOMOGRAPHY
AB Images of soft materials are obtained using image intensifier based X-ray system (Rao et al., Nucl. Instr. and Meth. A 437 (1999) 141). The interior of the soft material is visualized using the novel software in order to know the distribution of attenuation coefficient in terms of density. The novel software is based mainly on graphical library and applicable to several operating systems without any change. It can be applied to several applications starting from biomedical to industries, for example, quality control. The results for walnut and brew tooth are presented as a set of images from the internal parts of the sample. A description of the principal parameters required for tomographic visualization is given and some results based on this technique are reported and discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Sir CRR Autonomous Coll, Dept Phys, Eluru 534007, AP, India.
   Univ Sassari, Ist Matemat Fis, I-07100 Sassari, Italy.
   Natl Inst Stand & Technol, Ionizing Radiat Div, Photon & Charged Particle Data Ctr, Gaithersburg, MD 20899 USA.
RP Rao, DV (reprint author), Sir CRR Autonomous Coll, Dept Phys, Eluru 534007, AP, India.
RI brunetti, antonio/F-3370-2011
OI brunetti, antonio/0000-0002-0116-1899; Golosio,
   Bruno/0000-0001-5144-6932
CR CESAREO R, 1994, APPL RADIAT ISOTOPES, V45, P613, DOI 10.1016/0969-8043(94)90205-4
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   FLANNERY BP, 1987, SCIENCE, V237, P1439, DOI 10.1126/science.237.4821.1439
   HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016
   Jain A. K, 1989, FUNDAMENTALS DIGITAL
   JONES KW, HDB XRAY SPECTROMETR, V192, P443
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   MARTZ HE, 1990, APPL RADIAT ISOTOPES, V41, P943
   NEIDER J, 1992, OPENGL ARCHITECTURE
   Rao DV, 2000, J TRACE MICROPROBE T, V18, P257
   RAO DV, 1999, NUCL INSTRUM METH A, V437, P437
   SPANNE P, 1994, PHYS REV LETT, V73, P2001, DOI 10.1103/PhysRevLett.73.2001
   WEBB S, 1987, IEE PROC-A, V134, P126, DOI 10.1049/ip-a-1.1987.0019
   1992, OPENGL ARCHITECTURE
NR 14
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD JUN 11
PY 2001
VL 465
IS 2-3
BP 577
EP 583
DI 10.1016/S0168-9002(01)00674-X
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 445GD
UT WOS:000169449000026
DA 2018-10-19
ER

PT J
AU Ritter, SK
AF Ritter, SK
TI The changing face of chemical engineering
SO CHEMICAL & ENGINEERING NEWS
LA English
DT Article
AB Century-old discipline is ripe for expansion into materials and biomedical product development.
NR 0
TC 10
Z9 10
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 4
PY 2001
VL 79
IS 23
BP 63
EP 66
DI 10.1021/cen-v079n040.p063
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 439YD
UT WOS:000169144400043
DA 2018-10-19
ER

PT J
AU Abraham, GA
   Gallardo, A
   Roman, JS
   Olivera, ER
   Jodra, R
   Garcia, B
   Minambres, B
   Garcia, JL
   Luengo, JM
AF Abraham, GA
   Gallardo, A
   Roman, JS
   Olivera, ER
   Jodra, R
   Garcia, B
   Minambres, B
   Garcia, JL
   Luengo, JM
TI Microbial synthesis of poly(beta-hydroxyalkanoates) bearing phenyl
   groups from Pseudomonas putida: Chemical structure and characterization
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYHYDROXYALKANOIC ACIDS; BACTERIAL PRODUCTION; ALKANOIC ACIDS; COA
   CATABOLON; OLEOVORANS; POLY(3-HYDROXYALKANOATES);
   POLY-3-HYDROXYALKANOATES; BIOSYNTHESIS; PURIFICATION; DEGRADATION
AB New poly(beta-hydroxyalkanoates) having aromatics groups (so-called PHPhAs) from a microbial origin have been characterized. These polymers were produced and accumulated as reserve materials when a beta-oxidation mutant of Pseudomonas putida U, disrupted in the gene that encodes the 3-ketoacyl-CoA thiolase (fadA), was cultured in a chemically defined medium containing different aromatic fatty acids (6-phenylhexanoic acid, 7-phenylheptanoic acid, a mixture of them, or 8-phenyloctanoic acid) as carbon sources. The polymers were extracted from the bacteria, purified and characterized by using C-13 nuclear magnetic resonance spectroscopy (NMR), gel permeation chromatography (GPC), and differential scanning calorimetry (DSC). Structural studies revealed that when 6-phenylhexanoic acid was added to the cultures, an homopolymer (poly-3-hydroxy-6-phenylhexanoate) was accumulated. The feeding with 8-phenyloctanoic acid and 7-phenylheptanoic acid leads to the formation of copolymers of the corresponding units with the n - 2 carbons formed after deacetylation, copoly(3-hydroxy-8-phenyloctanoate-3-hydroxy-6-phenylhexanoate) and copoly(3-hydroxy-7-phenytheptanoate-3-hydroxy-5-phenylvalerate), respectively. The mixture of 6-phenylhexanoic acid and 7-phenylheptanoic acid gave rise to the corresponding terpolymer, copoly(3-hydroxy-7-phenylheptanoate-3-hydroxy-6-phenylhexanoate-3-hydroxy-5,phenylvalerate). Studies on the chemical structure of these three polyesters revealed that they were true copolymers but not a mixture of homopolymers and that the different monomeric units were randomly incorporated in the macromolecular chains. Thermal behavior and molecular weight distribution were also discussed. These compounds had a dual attractive interest in function of (i) their broad use as biodegradable polymers and (ii) their possible biomedical applications.
C1 CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
   Univ Leon, Dept Bioquim & Biol Mol, E-24007 Leon, Spain.
   CSIC, Ctr Invest Biol, Dept Mol Microbiol, Madrid, Spain.
   UNMdP, CONICET, Inst Invest Ciencia & Tecnol Mat, RA-7600 Mar Del Plata, Argentina.
RP Roman, JS (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Juan de la Cierva 3, E-28006 Madrid, Spain.
RI Abraham, Gustavo/E-2820-2014; RODRIGUEZ OLIVERA, ELIAS/H-6385-2016;
   Gallardo, Alberto/B-4794-2011
OI Abraham, Gustavo/0000-0001-7094-1031; RODRIGUEZ OLIVERA,
   ELIAS/0000-0003-2315-8524; Gallardo, Alberto/0000-0003-4614-4299;
   Luengo, Jose M./0000-0002-4984-6256; Garcia Lopez, Jose
   Luis/0000-0002-9238-2485; Minambres Rodriguez,
   Baltasar/0000-0003-4590-4911
CR BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4
   Byrom D., 1994, PLASTICS MICROBES MI, P5
   Curley JM, 1996, MACROMOLECULES, V29, P1762, DOI 10.1021/ma951185a
   FERNANDEZ A, 1998, J BIOL CHEM, V273, P25974
   FRITZSCHE K, 1990, MAKROMOL CHEM, V191, P1957
   Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   Hazer B, 1996, POLYMER, V37, P5951, DOI 10.1016/S0032-3861(96)00570-8
   HUISMAN GW, 1991, J BIOL CHEM, V266, P2191
   KAMIYA N, 1989, MACROMOLECULES, V22, P1676, DOI 10.1021/ma00194a030
   Kim YB, 1999, MACROMOLECULES, V32, P6058
   KIM YB, 1992, MACROMOLECULES, V25, P1852, DOI 10.1021/ma00033a002
   Kim YB, 1996, MACROMOLECULES, V29, P3432
   KIM YB, 1991, MACROMOLECULES, V24, P5256, DOI 10.1021/ma00019a004
   LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924
   LENZ RW, 1993, ADV POLYM SCI, V107, P1
   LUENGO JM, 2001, IN PRESS MOL MICROBI
   MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419
   RITTER H, 1994, MACROMOL CHEM PHYSIC, V195, P1665, DOI 10.1002/macp.1994.021950517
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SCHIRMER A, 1993, APPL ENVIRON MICROB, V59, P1220
   STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1111/j.1574-6968.1992.tb05841.x
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   STEINBUCHEL A, 1991, BIOMATERIALS
   STEINBUECHEL A, 1992, Current Opinion in Biotechnology, V3, P291, DOI 10.1016/0958-1669(92)90107-T
NR 28
TC 30
Z9 30
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SUM
PY 2001
VL 2
IS 2
BP 562
EP 567
DI 10.1021/bm010018h
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RF
UT WOS:000174256200033
PM 11749221
DA 2018-10-19
ER

PT J
AU Menard, C
   Smith, ICP
   Somorjai, RL
   Leboldus, L
   Patel, R
   Littman, C
   Robertson, SJ
   Bezabeh, T
AF Menard, C
   Smith, ICP
   Somorjai, RL
   Leboldus, L
   Patel, R
   Littman, C
   Robertson, SJ
   Bezabeh, T
TI Magnetic resonance spectroscopy of the malignant prostate gland after
   radiotherapy: A histopathologic study of diagnostic validity
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 42nd Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO)
CY OCT 22-26, 2000
CL BOSTON, MASSACHUSETTS
SP Amer Soc Therapeut Radiol & Oncol
DE classifier; magnetic resonance spectroscopy; multivariate analysis;
   prostate cancer; radiotherapy
ID RADIATION-THERAPY; NEOPLASTIC PROSTATE; LOCAL-CONTROL; MR SPECTRA;
   CANCER; H-1; BIOPSY; CARCINOMA; BENIGN; ADENOCARCINOMA
AB Purpose: Accurate spatial representation of tumor clearance after conformal radiotherapy is an endpoint of clinical importance. Magnetic resonance spectroscopy (MRS) can diagnose malignancy in the untreated prostate gland through measurements of cellular metabolites, In this study we sought to describe spectral metabolic changes in prostatic tissue after radiotherapy and validate a multivariate analytic strategy (based on MRS) that could identify viable tumor.
   Methods and Materials: Transrectal ultrasound-guided prostate biopsies from 35 patients were obtained 18-36 months after external beam radiotherapy. One hundred sixteen tissue specimens were subjected to H-1 MRS, submitted to histopathology, and analyzed for correlation with a multivariate strategy specifically developed for biomedical spectra,
   Results: The sensitivity and specificity of MRS in identifying a malignant biopsy were 88.9% and 92% respectively, with an overall classification accuracy of 91.4%, The diagnostic spectral regions identified by our algorithm included those due to choline, creatine, glutamine, and lipid. Citrate, an important discriminating resonance in the untreated prostate gland, was invisible in all spectra, regardless of histology,
   Conclusions: Although the spectral features of prostate tissue markedly change after radiotherapy, MRS combined with multivariate methods of analysis can accurately identify histologically malignant biopsies. MRS shows promise as a modality that could integrate three-dimensional measures of tumor response. (C) 2001 Elsevier Science Inc.
C1 Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada.
   Univ Manitoba, Dept Radiat Oncol, Winnipeg, MB, Canada.
   Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada.
   Winnipeg Clin, Winnipeg, MB, Canada.
   Ottawa Hosp, Dept Pathol, Ottawa, ON, Canada.
RP Bezabeh, T (reprint author), Natl Res Council Canada, Inst Biodiagnost, 435 Ellice Ave, Winnipeg, MB R3B 1Y6, Canada.
CR Bezabeh T, 2001, AM J GASTROENTEROL, V96, P442
   BOCKING A, 1987, DIAGN CYTOPATHOL, V3, P108, DOI 10.1002/dc.2840030204
   BOSTWICK DG, 1982, AM J SURG PATHOL, V6, P541, DOI 10.1097/00000478-198209000-00006
   BRAWER MK, 1989, CANCER, V63, P454, DOI 10.1002/1097-0142(19890201)63:3<454::AID-CNCR2820630311>3.0.CO;2-E
   CORNEL EB, 1993, J UROLOGY, V150, P2019, DOI 10.1016/S0022-5347(17)35957-8
   COSTELLO LC, 1991, PROSTATE, V19, P181, DOI 10.1002/pros.2990190302
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   CROOK JM, 1995, UROLOGY, V45, P524
   DALY PF, 1987, J BIOL CHEM, V262, P14875
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537, DOI 10.1016/0360-3016(91)90668-T
   Garcia-Segura JM, 1999, MAGN RESON IMAGING, V17, P755, DOI 10.1016/S0730-725X(99)00006-5
   GRIGNON DJ, 1995, CANCER, V75, P1837, DOI 10.1002/1097-0142(19950401)75:7+<1837::AID-CNCR2820751613>3.0.CO;2-S
   Hahn P, 1997, CANCER RES, V57, P3398
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   KAPLAN ID, 1992, J UROLOGY, V147, P917, DOI 10.1016/S0022-5347(17)37422-0
   Kotzerke J, 2000, EUR J NUCL MED, V27, P1415, DOI 10.1007/s002590000309
   KUBAN DA, 1987, UROLOGY, V30, P420, DOI 10.1016/0090-4295(87)90372-4
   KUBAN DA, 1992, INT J RADIAT ONCOL, V24, P409, DOI 10.1016/0360-3016(92)91053-P
   KUESEL AC, 1992, MAGNET RESON MED, V27, P340
   Kurhanewicz J, 1996, RADIOLOGY, V198, P795, DOI 10.1148/radiology.198.3.8628874
   Kurhanewicz J, 1996, RADIOLOGY, V200, P489, DOI 10.1148/radiology.200.2.8685346
   KURHANEWICZ J, 1993, MAGN RESON MED, V29, P149, DOI 10.1002/mrm.1910290202
   NEGANDANK WG, 1992, RADIOLOGY, V185, P875
   Nikulin AE, 1998, NMR BIOMED, V11, P209, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<209::AID-NBM510>3.0.CO;2-5
   PEREZ CA, 1993, INT J RADIAT ONCOL, V26, P581, DOI 10.1016/0360-3016(93)90273-X
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
   PRESTIDGE BR, 1992, INT J RADIAT ONCOL, V24, P403, DOI 10.1016/0360-3016(92)91052-O
   Scardino P T, 1988, NCI Monogr, P95
   Scheidler J, 1999, RADIOLOGY, V213, P473, DOI 10.1148/radiology.213.2.r99nv23473
   SCHELLHAMMER PF, 1987, J UROLOGY, V137, P897, DOI 10.1016/S0022-5347(17)44289-3
   Siegelman ES, 1999, SEMIN ROENTGENOL, V34, P295, DOI 10.1016/S0037-198X(99)80007-8
   SMITH ICP, 2000, METHODS BIOMEDICAL M, P891
   SOMORJAI RL, 1995, MAGN RESON MED, V33, P257, DOI 10.1002/mrm.1910330217
   SOMORJAI RL, 1999, J MED BIOCH, V3, P17
   SOMORJAI RL, IN PRESS VIBRATIONAL
   Speck O, 1996, ANTICANCER RES, V16, P1581
   Speight JL, 2000, RADIOL CLIN N AM, V38, P159, DOI 10.1016/S0033-8389(05)70154-8
   Tedeschi G, 1997, J NEUROSURG, V87, P516, DOI 10.3171/jns.1997.87.4.0516
   Valicenti R, 2000, J CLIN ONCOL, V18, P2740, DOI 10.1200/JCO.2000.18.14.2740
   Wald LL, 1997, J NEUROSURG, V87, P525, DOI 10.3171/jns.1997.87.4.0525
   Yu KK, 1999, RADIOLOGY, V213, P481, DOI 10.1148/radiology.213.2.r99nv26481
   Zaider M, 2000, INT J RADIAT ONCOL, V47, P1085, DOI 10.1016/S0360-3016(00)00557-5
NR 44
TC 54
Z9 60
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 2001
VL 50
IS 2
BP 317
EP 323
DI 10.1016/S0360-3016(01)01480-8
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 433VG
UT WOS:000168781000005
PM 11380217
DA 2018-10-19
ER

PT J
AU Buczkowski, M
   Sartowska, B
   Wawszczak, D
   Starosta, W
AF Buczkowski, M
   Sartowska, B
   Wawszczak, D
   Starosta, W
TI Radiation resistance of track etched membranes
SO RADIATION MEASUREMENTS
LA English
DT Article; Proceedings Paper
CT 20th International Conference on Nuclear Tracks in Solids
CY AUG 28-SEP 01, 2000
CL PORTOROZ, SLOVENIA
SP Minist Sci & Technol Slovenia, European Nucl Soc
DE track etched membrane; heavy ion beam; radiation sterilization; strength
   properties of polymer films and membranes
AB Track etched membranes (TEMs) obtained by irradiation of polymer films with heavy ions and subsequent etching of latent tracks can be applied in many fields and among others in biomedicine as well. It is important to know radiation resistance of TEMs because of Aide use of radiation sterilization in the case of biomedical devices.
   Tensile properties of TEMs made of PET and PC films with the thickness of 10 mum after electron irradiation at different doses are known from literature. Nowadays TEMs are being manufactured from thicker (20 mum) PET and PC films as well as polyethylene naphthalate (PEN) films are proposed for TEMs. It seems to be important to get data about radiation resistance of new kinds of TEMs.
   Samples of polymer films made of PET and PEN with the thickness of 19-25 mum and TEMs made of such materials have been irradiated using 10 MeV electron beam with doses up to 990 kGy. Tensile properties and SEM photographs of the samples after irradiation are given in the paper. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Inst Nucl Chem & Technol, PL-03195 Warsaw, Poland.
RP Buczkowski, M (reprint author), Inst Nucl Chem & Technol, Dorodna 16, PL-03195 Warsaw, Poland.
CR APEL PY, 1995, RADIAT MEAS, V25, P667, DOI 10.1016/1350-4487(95)00219-5
   BUCZKOWSKI M, 1997, P 6 INT SCH SEM HEAV, P761
   SPOHR R, 1990, ION TRACK MICROTECHN
   Starosta W, 1999, RADIAT MEAS, V31, P149, DOI 10.1016/S1350-4487(99)00184-5
   Zhitariuk NI, 1996, EUR POLYM J, V32, P391, DOI 10.1016/0014-3057(95)00199-9
NR 5
TC 9
Z9 11
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-4487
J9 RADIAT MEAS
JI Radiat. Meas.
PD JUN
PY 2001
VL 34
IS 1-6
BP 597
EP 599
DI 10.1016/S1350-4487(01)00236-0
PG 3
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 471EW
UT WOS:000170916200122
DA 2018-10-19
ER

PT J
AU Hennemeyer, CT
   Wicklow, K
   Feinberg, DA
   Derdeyn, CP
AF Hennemeyer, CT
   Wicklow, K
   Feinberg, DA
   Derdeyn, CP
TI In vitro evaluation of platinum Guglielmi detachable coils at 3 T with a
   porcine model: Safety issues and artifacts
SO RADIOLOGY
LA English
DT Article
DE aneurysm, cerebral; head, MR; magnetic resonance (MR), safety; radiology
   and radiologists, iatrogenic injury
ID MR-ANGIOGRAPHY; BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS; METALLIC
   IMPLANTS; FERROMAGNETISM; ANEURYSMS; DEVICES; TIME
AB PURPOSE: To evaluate safety-related issues and imaging artifacts of Guglielmi detachable coils in vitro with 3-T magnetic resonance (MR) imaging.
   MATERIALS AND METHODS: Two aneurysm models were constructed: one from porcine carotid artery and the other from a pharmaceutical capsule. Both were filled with Guglielmi detachable coils. The models were tested with a 3-T MR imager for :heating, deflection, and imaging artifact. Testing for heating and deflection was performed (a) at static points both inside and outside the bore, (b) during movement into the imager, and (c) during clinical imaging sequences.
   RESULTS: No change in temperature was measured during movement into the imager bore or at different points within the bore. No differences in heating from radio-frequency energy were found between aneurysm models and controls. Similarly, no evidence of deflection of the coil mass (capsule model) was found. Minor susceptibility artifacts were found in the readout direction during gradient-echo sequences. Magnetic field mapping showed no induced field inhomogeneity.
   CONCLUSION: MR imaging at field strengths of 3 T in patients with aneurysms treated with Guglielmi detachable coils is safe. Imaging artifacts are likely to be minimal.
C1 Washington Univ, Sch Med, Neuroradiol Sect, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Neuroimaging Lab, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
RP Derdeyn, CP (reprint author), Washington Univ, Sch Med, Neuroradiol Sect, Edward Mallinckrodt Inst Radiol, 510 S Kingshighway Blvd, St Louis, MO 63110 USA.
CR DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   Derdeyn CP, 1997, AM J NEURORADIOL, V18, P279
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   Gonner F, 1998, AM J NEURORADIOL, V19, P1324
   Hartman J, 1997, AM J NEURORADIOL, V18, P497
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   Kahara VJ, 1999, AM J NEURORADIOL, V20, P1470
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   MARSHALL MW, 1991, CARDIOVASC INTER RAD, V14, P163, DOI 10.1007/BF02577720
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
NR 15
TC 37
Z9 41
U1 0
U2 1
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JUN
PY 2001
VL 219
IS 3
BP 732
EP 737
DI 10.1148/radiology.219.3.r01jn33732
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 435EQ
UT WOS:000168864800022
PM 11376262
DA 2018-10-19
ER

PT J
AU Ringeisen, BR
   Callahan, J
   Wu, PK
   Pique, A
   Spargo, B
   McGill, RA
   Bucaro, M
   Kim, H
   Bubb, DM
   Chrisey, DB
AF Ringeisen, BR
   Callahan, J
   Wu, PK
   Pique, A
   Spargo, B
   McGill, RA
   Bucaro, M
   Kim, H
   Bubb, DM
   Chrisey, DB
TI Novel laser-based deposition of active protein thin films
SO LANGMUIR
LA English
DT Article
ID LANGMUIR-BLODGETT-FILMS; MICROFLUIDIC NETWORKS; BIOMEDICAL APPLICATIONS;
   MASS-SPECTROMETRY; SOFT LITHOGRAPHY; BIOSENSORS; SURFACES;
   OLIGONUCLEOTIDE; FABRICATION; GLUCOSE
AB This paper reports the deposition of active protein thin films by a novel laser-based approach termed matrix-assisted pulsed laser evaporation (MAPLE). We have deposited uniform 10 nm to nearly 1 mum thin films of insulin and horseradish peroxidase (HRP). We performed several experiments to characterize the chemical integrity of the deposited films. Matrix assisted laser desorption/ionization and liquid chromatography/electrospray ionization mass spectrometry experiments performed on MAPLE-deposited insulin films indicate that the laser-material interaction involved in this deposition technique does not modify the protein's mass. Fourier transform infrared spectroscopy experiments show that the chemical functionality and secondary structure of MAPLE-deposited HRP are nearly identical to those of the native protein. We also find that deposited HRP films retain their ability to catalyze the reduction of 3,3'-diaminobenzidine (DAB), suggesting that the active site of transferred proteins is unaffected by the MAPLE process. We also produced patterns and multilayers with feature sizes from 20 to 250 mum by depositing different biomaterials through a shadow mask. Patterns of physisorbed HRP were then protected from dissolution in an aqueous environment by a semipermeable polymer overlayer that was deposited in situ using pulsed laser deposition. This polymer membrane protects the protein pattern when it is exposed to DAB solution and enables the optical observation of HRP activity for spots as small as 2000 mum(2). These results demonstrate that MAPLE is a preferred technique for depositing active biomolecules for applications ranging from microfluidic sensor devices to gene and protein recognition microarrays.
C1 USN, Res Lab, Washington, DC 20375 USA.
   So Oregon Univ, Dept Phys, Ashland, OR 97520 USA.
RP Ringeisen, BR (reprint author), USN, Res Lab, Code 6372, Washington, DC 20375 USA.
CR Albareda-Sirvent M, 2000, SENSOR ACTUAT B-CHEM, V69, P153, DOI 10.1016/S0925-4005(00)00536-0
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Borman S, 2000, CHEM ENG NEWS, V78, P31, DOI 10.1021/cen-v078n031.p031
   Brooks SA, 2000, ANAL CHEM, V72, P3253, DOI 10.1021/ac9914531
   BUBB DM, UNPUB
   BUBB DM, IN PRESS APPL PHYS A
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chrisey D, 2000, LASER FOCUS WORLD, V36, P113
   Chrisey D., 1994, PULSED LASER DEPOSIT
   CHUARD C, 1993, ANTIMICROB AGENTS CH, V37, P625, DOI 10.1128/AAC.37.4.625
   COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   FUJIWARA I, 1992, LANGMUIR, V8, P2219, DOI 10.1021/la00045a025
   Gooding JJ, 1998, ELECTROANAL, V10, P1130, DOI 10.1002/(SICI)1521-4109(199811)10:16<1130::AID-ELAN1130>3.3.CO;2-Y
   Graves DJ, 1998, ANAL CHEM, V70, P5085, DOI 10.1021/ac980456n
   Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kimura J., 1998, BIOSENSORS, V4, P41
   Konig S, 1998, ANAL CHEM, V70, P4453, DOI 10.1021/ac980169j
   Kumar CV, 2000, J AM CHEM SOC, V122, P830, DOI 10.1021/ja993310u
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Li TS, 2000, CHEM LETT, P608, DOI 10.1246/cl.2000.608
   McGill RA, 1998, IEEE T ULTRASON FERR, V45, P1370, DOI 10.1109/58.726464
   MCGILL RA, 1998, P SPIE LASER APPL MI, V3, P255
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Mulchandani A, 1999, ANAL CHEM, V71, P2246, DOI 10.1021/ac9813179
   NELSON RW, 1990, RAPID COMMUN MASS SP, V4, P348, DOI 10.1002/rcm.1290040911
   NEWMAN JD, 1995, ANAL CHEM, V67, P4594, DOI 10.1021/ac00120a027
   NEWMAN JD, 1992, ANAL CHIM ACTA, V262, P13, DOI 10.1016/0003-2670(92)80002-O
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   Panick G, 2000, BIOCHEMISTRY-US, V39, P1862, DOI 10.1021/bi992176n
   Patel N, 1999, LANGMUIR, V15, P7252, DOI 10.1021/la981268v
   Phadke RS, 1998, MAT SCI ENG C-BIOMIM, V5, P237, DOI 10.1016/S0928-4931(97)00051-9
   PIQUE A, 1999, THIN SOLID FILMS, V356, P536
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   Sirkar K, 2000, ANAL CHEM, V72, P2930, DOI 10.1021/ac991041k
   SUN SC, 1991, LANGMUIR, V7, P727, DOI 10.1021/la00052a022
   TANG XD, 1995, ANAL CHEM, V67, P4542, DOI 10.1021/ac00120a018
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   Tsuboi Y, 1998, CHEM LETT, P521, DOI 10.1246/cl.1998.521
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
   Zhang SQ, 2000, ANAL CHIM ACTA, V421, P175, DOI 10.1016/S0003-2670(00)01043-6
NR 52
TC 101
Z9 101
U1 0
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 29
PY 2001
VL 17
IS 11
BP 3472
EP 3479
DI 10.1021/la0016874
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 436UY
UT WOS:000168955300048
DA 2018-10-19
ER

PT J
AU Kweon, H
   Ha, HC
   Um, IC
   Park, YH
AF Kweon, H
   Ha, HC
   Um, IC
   Park, YH
TI Physical properties of silk fibroin/chitosan blend films
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE silk fibroin; chitosan; blend film; mechanical properties; permeability
ID FIBROIN MEMBRANES; COMPATIBILITY; PERMEABILITY; CHITOSAN; METHANOL;
   ALCOHOL)
AB Silk fibroin/chitosan blend films were examined through IR spectroscopy to determine the conformational changes of silk fibroin. The effects of the fibroin/chitosan blend ratios (chitosan content) on the physical and mechanical properties were investigated to discover the feasibility of using these films as biomedical materials such as artificial skin and wound dressing. The mechanical properties of the blend films containing 10-40% chitosan were found to be excellent. The tensile strength, breaking elongation, and Young's modulus were affected by the chitosan contents of the blend films, which were also related to the density and degree of swelling. The coefficient of water vapor permeability of the blend films increased linearly with the chitosan content, and the values of 1000-2000 g m(-2) day(-1) were comparable to those of commercial wound dressings. Silk fibroin/chitosan blend films had good oxygen and water vapor permeabilities, making them useful as biomaterials. In particular, the blend film containing 40-50% chitosan showed very high oxygen permeability. (C) 2001 John Wiley & Sons, Inc.
C1 Seoul Natl Univ, Dept Nat Fiber Sci, Suwon 441744, South Korea.
RP Park, YH (reprint author), Seoul Natl Univ, Dept Nat Fiber Sci, Suwon 441744, South Korea.
CR CANETTI M, 1989, BIOPOLYMERS, V28, P1613, DOI 10.1002/bip.360280910
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chen X, 1999, J APPL POLYM SCI, V73, P975, DOI 10.1002/(SICI)1097-4628(19990808)73:6<975::AID-APP15>3.0.CO;2-#
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   KANE JB, 1996, BIOMATERIALS SCI, pCH7
   Ketelaars AAJ, 1997, J APPL POLYM SCI, V66, P921, DOI 10.1002/(SICI)1097-4628(19971031)66:5<921::AID-APP12>3.0.CO;2-Q
   LAMKE LO, 1977, BURNS, V3, P159, DOI 10.1016/0305-4179(77)90004-3
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIANG CX, 1991, SEN-I GAKKAISHI, V47, P334
   MAGOSHI J, 1985, J APPL POLYM SCI, V41, P189
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   Nakamura T, 1999, SEN-I GAKKAISHI, V55, P369, DOI 10.2115/fiber.55.8_369
   SANNAN T, 1978, POLYMER, V19, P4789
   Tanaka T, 1997, POLYM INT, V42, P107, DOI 10.1002/(SICI)1097-0126(199701)42:1<107::AID-PI686>3.0.CO;2-9
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um I.C., 1998, KOREAN J SERIC SCI, V40, P169
   WARNER SB, 1995, FIBER SCI, P40
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   YANNAS IV, 1982, BIOMATERIALS INTERFA, P474
   YOSHIKAWA A, 1990, SEN L KAKO, V42, P351
NR 25
TC 122
Z9 128
U1 5
U2 58
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 16
PY 2001
VL 80
IS 7
BP 928
EP 934
DI 10.1002/app.1172
PG 7
WC Polymer Science
SC Polymer Science
GA 410KG
UT WOS:000167438700004
DA 2018-10-19
ER

PT J
AU Bosetti, M
   Verne, E
   Ferraris, M
   Ravaglioli, A
   Cannas, M
AF Bosetti, M
   Verne, E
   Ferraris, M
   Ravaglioli, A
   Cannas, M
TI In vitro characterisation of zirconia coated by bioactive glass
SO BIOMATERIALS
LA English
DT Article
DE zirconia; in vitro biocompatibility; osteoblast-like cells; glass
   coating
ID MEDICAL APPLICATIONS
AB An in vitro evaluation of a biomedical device, which combines the mechanical properties of zirconia substrates with the bioactivity of two different glass layers (AP40 and RKKP), was performed. In this work, data on different kinds of analysis were reported both on as-sintered zirconia samples and on RKKP- and AP40-coated zirconia substrates. Structure, composition and morphology of the apatite layer growth on the coated samples after 30 days of soaking in an acellular simulated body fluid, serum protein adsorption, fibroblasts and human osteoblast-like cells adhesion, growth, morphology and biochemical aspects were studied. Results of soaking test in SBF, revealed the growth of an apatite layer on the surface of the glass-coated samples. Proteins adsorbed to the materials were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and results evidenced that the two glass-coated materials bound a higher amount of total protein than did the zirconia substrate. Fibroblasts and osteoblast-like cells cultured on RKKP- and AP40-coated zirconia showed a higher proliferation rate, leading to confluent cultures with higher cell density and a generally better expression of osteoblast alkaline phosphatase activity in comparison with zirconia substrate. In conclusion, our results indicate that the surface chemical characteristics of the two glass coatings AP40 and RKKP, with no great differences between them, substantially enhance zirconia integration with bone cells at least in vitro. This effect may be of significance in the stability of glass-coated zirconia orthopaedic and dental implants. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Eastern Piemont A Avogadro, Dept Med Sci Human Anat, I-28100 Novara, Italy.
   Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
RP Cannas, M (reprint author), Univ Eastern Piemont A Avogadro, Dept Med Sci Human Anat, Via Solaroli 17, I-28100 Novara, Italy.
EM cannas@med.unipmn.it
OI Verne, Enrica/0000-0002-8649-4739
CR Berger G, 1992, 4 WORLD BIOM C APR 2, P33
   Bosetti M, 1998, J BIOMED MATER RES, V40, P307, DOI 10.1002/(SICI)1097-4636(199805)40:2<307::AID-JBM16>3.0.CO;2-I
   CANNAS M, 1999, TISSUE RESPONSE IMPL, P95
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   FERRARIS M, 1996, BIOCERAMIC COATINGS, P31
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   KEPNER RL, 1994, MICROBIOL REV, V58, P603
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   KOKUBO T, 1993, ADV SERIES CERAMICS, V175, P889
   Krajewski A, 1998, J MATER SCI-MATER M, V9, P309, DOI 10.1023/A:1008846728859
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   WILSON J, 1993, ADV SERIES CERAMICS, V175, P63
NR 21
TC 51
Z9 52
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2001
VL 22
IS 9
BP 987
EP 994
DI 10.1016/S0142-9612(00)00264-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 418NU
UT WOS:000167898900014
PM 11311018
DA 2018-10-19
ER

PT J
AU Gross, M
   Cramton, SE
   Gotz, F
   Peschel, A
AF Gross, M
   Cramton, SE
   Gotz, F
   Peschel, A
TI Key role of teichoic acid net charge in Staphylococcus aureus
   colonization of artificial surfaces
SO INFECTION AND IMMUNITY
LA English
DT Article
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; BIOFILM FORMATION; BACTERIAL
   ADHESION; MOLECULAR-BASIS; EPIDERMIDIS; INFECTIONS; INSERTION; MECHANISM
AB Staphylococcus aureus is responsible for a large percentage of infections associated with implanted biomedical devices. The molecular basis of primary adhesion to artificial surfaces is not yet understood. Here, we demonstrate that teichoic acids, highly charged cell wall polymers, play a key role in the first step of biofilm formation. An S. aureus mutant bearing a stronger negative surface charge due to the lack of D-alanine esters in its teichoic acids can no longer colonize polystyrene or glass. The mutation abrogates primary adhesion to plastic while production of the glucosamine-based polymer involved in later steps of biofilm formation is not affected. Our data suggest that repulsive electrostatic forces can lead to reduced staphylococcal biofilm formation, which could have considerable impact on the design of novel implanted materials.
C1 Univ Tubingen, D-72076 Tubingen, Germany.
RP Peschel, A (reprint author), Univ Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany.
CR Ausubel FM, 1990, CURRENT PROTOCOLS MO
   Biedlingmaier JF, 1998, OTOLARYNG HEAD NECK, V118, P444, DOI 10.1177/019459989811800403
   Bierbaum G., 1991, NISIN NOVEL LANTIBIO, P386
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   FISCHER W, 1997, NEW TARGETS NEW ANTI, P47
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Homma H, 1996, J GASTROENTEROL, V31, P836, DOI 10.1007/BF02358611
   Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696
   ING BM, 1997, STAPHYLOCOCCI HUMAN, P331
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   Jenni R, 1998, ARCH MICROBIOL, V170, P171, DOI 10.1007/s002030050630
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Loosdrecht M. C. M. V., 1987, APPL ENVIRON MICROB, V53, P1898
   Loosdrecht MCV, 1987, APPL ENVIRON MICROB, V53, P1893
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000
   Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405
   Proctor RA, 2000, J LAB CLIN MED, V135, P14, DOI 10.1016/S0022-2143(00)70015-1
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379
   SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
NR 29
TC 296
Z9 304
U1 1
U2 34
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAY
PY 2001
VL 69
IS 5
BP 3423
EP 3426
DI 10.1128/IAI.69.5.3423-3426.2001
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 423CT
UT WOS:000168158400080
PM 11292767
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Moszner, N
   Salz, U
AF Moszner, N
   Salz, U
TI New developments of polymeric dental composites
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE dental monomers; restorative composite; ring-opening polymerization;
   liquid-crystalline monomers; dendrimers; ormocers; radiopacity;
   nanoparticles; polymerization shrinkage; bioactivity; composite
   reinforcement
ID RING-OPENING POLYMERIZATION; CALCIUM PHOSPHATE/METHACRYLATE COMPOSITES;
   GLASS-IONOMER CEMENTS; SOL-GEL-PROCESS; RADICAL POLYMERIZATION; CYCLIC
   MONOMERS; FLUORIDE RELEASE; MECHANICAL-PROPERTIES; CATIONIC
   POLYMERIZATION; BIOMEDICAL APPLICATIONS
AB The currently used commercial restorative composites contain a mixture of various cross-linking dimethacrylates, glass- and/or silicon dioxide fillers, and a photoinitiator system. They are cured by irradiation with visible light. New developments of polymeric composites for restorative filling materials are mainly focused on the reduction of polymerization shrinkage, and improvement of biocompatibility, wear resistance and processing properties. This can be partially achieved by using new tailor-made monomers and optimized filler particles.
   This review describes the polymeric chemical aspects of the application of new monomers, e.g. cyclic monomers, liquid-crystalline monomers, ormocers, branched monomers, compomers or Bis-GMA analogues or substitutes for restorative composites. In addition, the contribution of new filler-technologies for the improvement of restorative composites is discussed. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Ivoclar AG, Res & Dev, FL-9494 Schaan, Liechtenstein.
RP Moszner, N (reprint author), Ivoclar AG, Res & Dev, FL-9494 Schaan, Liechtenstein.
CR ALSTER D, 1992, J DENT RES, V71, P1619, DOI 10.1177/00220345920710091401
   ANTONUCCI JM, 1997, POLYM PREPR, V38, P118
   ANZAI M, 1992, J NIHON U SCH DENT, V34, P120
   ATTIN T, 1998, DTSCH ZAHNARZTL Z, V53, P766
   BAILEY WJ, 1990, MAT SCI ENG A-STRUCT, V126, P271, DOI 10.1016/0921-5093(90)90133-N
   BAILEY WJ, 1972, POLYM PREPR AM CHEM, V13, P281
   BAILEY WJ, 1983, Patent No. 438215
   BAILEY WJ, 1989, COMPREHENSIVE POLYM, V3, P283
   BAUER CM, 1995, DTSCH ZAHNARZTL Z, V50, P335
   Bayne SC, 1998, J AM DENT ASSOC, V129, P567, DOI 10.14219/jada.archive.1998.0274
   Belfield KD, 1997, MACROMOLECULES, V30, P6985, DOI 10.1021/ma9613446
   BLACKWELL GB, 1993, Patent No. 5218070
   BOLLN C, 1995, J POLYM SCI POL CHEM, V33, P587, DOI 10.1002/pola.1995.080330326
   Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y
   Bouschlicher MR, 1999, OPER DENT, V24, P20
   Bowen R.L., 1962, USPatent, Patent No. [US3066112A, 3066112, 3, 066, 112]
   BRADY RF, 1992, J MACROMOL SCI R M C, VC32, P135, DOI 10.1080/15321799208021424
   BRAUER GM, 1981, J AM DENT ASSOC, V101, P347
   Burke FJT, 1999, QUINTESSENCE INT, V30, P234
   BYERLEY TJ, 1992, DENT MATER, V8, P345, DOI 10.1016/0109-5641(92)90016-6
   Carvalho AS, 1999, OPER DENT, V24, P14
   Chan DCN, 1999, DENT MATER, V15, P219, DOI 10.1016/S0109-5641(99)00039-1
   CHAPPELOW CC, 1998, Patent No. 5808215
   CHAPPELOW CC, 1997, J DENT RES, V76, P40
   CHO I, 1991, MAKROMOL CHEM-RAPID, V12, P141
   Choi KM, 1996, CHEM MATER, V8, P2704, DOI 10.1021/cm9603260
   Condon JR, 1998, DENT MATER, V14, P256, DOI 10.1016/S0109-5641(98)00036-0
   Condon JR, 2000, J AM DENT ASSOC, V131, P497, DOI 10.14219/jada.archive.2000.0207
   Culbertson BM, 1999, POLYM ADVAN TECHNOL, V10, P206, DOI 10.1002/(SICI)1099-1581(199904)10:4<206::AID-PAT861>3.0.CO;2-C
   Culbertson BM, 1997, J MACROMOL SCI PURE, VA34, P2405, DOI 10.1080/10601329708010056
   Culbertson BM, 1999, POLYM ADVAN TECHNOL, V10, P275, DOI 10.1002/(SICI)1099-1581(199905)10:5<275::AID-PAT874>3.0.CO;2-V
   CULBERTSON BM, 1997, POLYM PREPR, V38, P100
   DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DAVY KWM, 1982, J DENT, V10, P254, DOI 10.1016/0300-5712(82)90058-6
   DONLY KJ, 1999, J AM DENT ASSOC, V130, P497
   DOORNKAMP AT, 1992, POLYMER, V33, P2863, DOI 10.1016/0032-3861(92)90468-C
   EBENHOCH J, 1999, Patent No. 19816148
   EICK JD, 1993, DENT MATER, V9, P123, DOI 10.1016/0109-5641(93)90088-8
   Eliades G, 1998, DENT MATER, V14, P57, DOI 10.1016/S0109-5641(98)00010-4
   ELLSWORTH MW, 1993, CHEM MATER, V5, P839, DOI 10.1021/cm00030a020
   ERICSON D, 1990, Patent No. 8910736
   EVANS EA, 1996, Patent No. 9619471
   Evans RA, 1996, MACROMOLECULES, V29, P6983, DOI 10.1021/ma960573p
   FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601
   FIFE WK, 1996, Patent No. 9622761
   FISCHER U, 1995, THESIS HTL CHUR
   FONTANA M, 1999, AM J DENT, V12, P8
   Francci C, 1999, J DENT RES, V78, P1647, DOI 10.1177/00220345990780101001
   FURMAN BR, 2000, J DENT RES, V246, P824
   Gasser O., 1998, Patent No. [DE 19648283 A1, 19648283]
   Geurtsen W, 1999, DENT MATER, V15, P196, DOI 10.1016/S0109-5641(99)00034-2
   HALLER B, 2000, DTSCH ZAHNARZTL Z, V55, P331
   HAMMERSFAHR PD, 1997, POLYM PREPR, V38, P131
   HEINDL D, 1997, Patent No. 19615763
   Herrera M, 1999, OPER DENT, V24, P286
   Hickel R, 1998, INT DENT J, V48, P3, DOI 10.1111/j.1875-595X.1998.tb00688.x
   HICKEL R, 1997, DTSCH ZAHNARZTL Z, V52, P572
   HIKMET RAM, 1992, POLYMER, V33, P89, DOI 10.1016/0032-3861(92)90564-D
   Holter D, 1996, MACROMOLECULES, V29, P7003, DOI 10.1021/ma960327d
   Holter D, 1998, ADV MATER, V10, P864, DOI 10.1002/(SICI)1521-4095(199808)10:11<864::AID-ADMA864>3.0.CO;2-H
   Imazato S, 1999, BIOMATERIALS, V20, P899, DOI 10.1016/S0142-9612(98)00247-6
   Jackson RD, 2000, J AM DENT ASSOC, V131, P375, DOI 10.14219/jada.archive.2000.0182
   JACOBINE AF, 1990, ACS SYM SER, V417, P160
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Kaisaki D, 1996, Int Pat Appl PCT, Patent No. [WO 96/13538, 9613538]
   Kakaboura A, 1998, J DENT RES, V77, P658
   Karantakis P, 2000, OPER DENT, V25, P20
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Klee JE, 1998, ANGEW MAKROMOL CHEM, V260, P71
   Klee JE, 1999, MACROMOL CHEM PHYSIC, V200, P517, DOI 10.1002/(SICI)1521-3935(19990301)200:3<517::AID-MACP517>3.0.CO;2-4
   KLEE JE, 1998, Patent No. 9836729
   KRAUSE WR, 1989, J BIOMED MATER RES, V23, P1195, DOI 10.1002/jbm.820231008
   Krejci I, 1993, Schweiz Monatsschr Zahnmed, V103, P614
   Labella R, 1999, DENT MATER, V15, P128, DOI 10.1016/S0109-5641(99)00022-6
   Leinfelder K F, 1999, J Esthet Dent, V11, P234, DOI 10.1111/j.1708-8240.1999.tb00405.x
   Liu C F, 1990, Am J Dent, V3, P44
   LU K, 1994, Patent No. 5338773
   Luo JH, 1998, DENT MATER, V14, P29, DOI 10.1016/S0109-5641(98)00006-2
   Lutz F, 1983, SSO Schweiz Monatsschr Zahnheilkd, V93, P914
   Manhart J, 2000, DENT MATER, V16, P33, DOI 10.1016/S0109-5641(99)00082-2
   MANHART J, 1999, DTSCH ZAHNARZTL Z, V54, P89
   MARRITTI A, 1998, EUR J ORAL SCI, V106, P1022
   MASUHARA E, 1982, Patent No. 8201708
   MATSUMURA H, 1992, J DENT RES, V71, P2, DOI 10.1177/00220345920710010201
   McLean J W, 1994, Quintessence Int, V25, P587
   Meyer JM, 1998, BIOMATERIALS, V19, P529, DOI 10.1016/S0142-9612(97)00133-6
   MICHL RJ, 1986, Patent No. 3502594
   MILLICH F, 1993, J POLYM SCI POL PHYS, V31, P729, DOI 10.1002/polb.1993.090310613
   MINNS RA, 1992, J MACROMOL SCI PURE, V29, P19, DOI 10.1080/10101329208054104
   Moszner N, 1997, MACROMOL CHEM PHYSIC, V198, P749, DOI 10.1002/macp.1997.021980307
   Moszner N, 1999, J APPL POLYM SCI, V72, P1775, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1775::AID-APP13>3.0.CO;2-F
   Moszner N, 1999, ANGEW MAKROMOL CHEM, V265, P31
   Moszner N, 1999, MACROMOL CHEM PHYSIC, V200, P2173, DOI 10.1002/(SICI)1521-3935(19991001)200:10<2173::AID-MACP2173>3.3.CO;2-1
   Moszner N, 1996, MACROMOL CHEM PHYSIC, V197, P621, DOI 10.1002/macp.1996.021970217
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Moszner N, 1998, POLYM BULL, V40, P447, DOI 10.1007/s002890050275
   MOSZNER N, 1995, MACROMOL RAPID COMM, V16, P667, DOI 10.1002/marc.1995.030160906
   Moszner N, 1997, MACROMOL RAPID COMM, V18, P775, DOI 10.1002/marc.1997.030180904
   MOSZNER N, 1997, POLYM PREPR, V38, P86
   MOSZNER N, UNPUB
   MOSZNER N, 1996, POLYM B, V73, P289
   MOSZNER N, 1998, MACROMOL RAPID COMM, V20, P33
   MOSZNER N, 1998, Patent No. 19714324
   MUELHAUPT R, 2000, 219 ACS NAT M, P26
   Murchison DF, 1999, QUINTESSENCE INT, V30, P179
   NICHOLSON J, 1994, TRENDS POLYM SCI, V2, P272
   NOACK MJ, 1993, J DENT RES, V72, P178
   NOWAK R, 1996, Patent No. 0717977
   Nuyken O, 1996, MACROMOL SYMP, V107, P125, DOI 10.1002/masy.19961070113
   Oguri M., 2004, US Patent, Patent No. [6 815 470, 9714674]
   OXMAN J, 1998, Patent No. 9847046
   Park MS, 1998, DENT MATER, V14, P137, DOI 10.1016/S0109-5641(98)00020-7
   PARTHA PP, 1999, Patent No. 600502
   RAWLS HR, 1997, POLYM PREPR, V38, P167
   REED B, 1972, POLYM PREPR, V33, P520
   RHEINBERGER  V, 1999, Patent No. 5886212
   Rheinberger V, 1999, Dental material, Patent No. [US 1999; 5889132, 5889132]
   RHEINBERGER V, Patent No. 19619046
   RHEINBERGER V, 1991, Patent No. 3939998
   RHEINBERGER V, 1999, Patent No. 5886064
   RHEINBERGER V, 1992, Patent No. 4029230
   RHEINBERRGER V, 1997, Patent No. 5703249
   RITTER H, 2000, Patent No. 6031015
   RITTER H, 1997, Patent No. 19525941
   RUMPHORST A, 1999, Patent No. 19818210
   RUYTER IE, 1987, J BIOMED MATER RES, V21, P11, DOI 10.1002/jbm.820210107
   SALZ U, 1996, Patent No. 19520016
   SANDA F, 1994, J POLYM SCI POL CHEM, V32, P323, DOI 10.1002/pola.1994.080320214
   Sankarapandian M, 1997, J MATER SCI-MATER M, V8, P465, DOI 10.1023/A:1018569908635
   SANKARAPANDIAN M, 1997, POLYM PREPR, V38, P92
   SASAKI H, 1995, POLYM MAT SCI ENG, V72, P475
   SCHAEFER R, 1998, Patent No. 5750590
   SELLINGER A, 1994, J POLYM SCI POL CHEM, V32, P3069, DOI 10.1002/pola.1994.080321608
   SELLINGER A, 1994, POLYM PREPR, V35, P665
   Sellinger A., 1995, POLYM PREPR, V36, P282
   Shah PMM, 1996, ORAL SURG ORAL MED O, V81, P476, DOI 10.1016/S1079-2104(96)80028-X
   Skrtic D, 1996, J DENT RES, V75, P1679, DOI 10.1177/00220345960750091001
   SOLTEZ U, 1998, ZAHNARZTL MITTEIL, V88, P52
   Stansbury JW, 1999, DENT MATER, V15, P166, DOI 10.1016/S0109-5641(99)00028-7
   STANSBURY JW, 1992, J DENT RES, V71, P1408, DOI 10.1177/00220345920710070901
   STANSBURY JW, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P133
   STANSBURY JW, 1995, POLYM PREPR, V36, P831
   STANSBURY JW, 1997, POLYM PREPR, V38, P96
   Stansbury JW, 1992, POLYM PREPR, V33, P518
   Stein S, 1998, MATER RES SOC SYMP P, V519, P357, DOI 10.1557/PROC-519-357
   SUGIYAMA J, 1994, MACROMOLECULES, V27, P5543, DOI 10.1021/ma00098a005
   TAIRA M, 1993, DENT MATER, V9, P167, DOI 10.1016/0109-5641(93)90115-7
   TAKATA T, 1992, EXPANDING MONOMERS S, P63
   ten Cate JM, 1999, ACTA ODONTOL SCAND, V57, P325, DOI 10.1080/000163599428562
   THOMPSON VP, 1979, J DENT RES, V58, P1522, DOI 10.1177/00220345790580051701
   TIBA A, 1997, J MACROMOL SCI PURE, V36, P489
   TIBA A, 1998, J MACROMOL SCI PURE, V39, P1445
   Vieira AR, 1999, AM J DENT, V12, P14
   WAN Q, 2000, POLYM PREPR, V41, P155
   WAN Q, 2000, POLYM PREPR, V41, P101
   Wang G, 1999, J MACROMOL SCI PURE, VA36, P225, DOI 10.1081/MA-100101527
   Wang G, 1999, J MACROMOL SCI PURE, VA36, P373, DOI 10.1081/MA-100101536
   WEI Y, 1990, CHEM MATER, V2, P337, DOI 10.1021/cm00010a001
   WEI Y, 1997, POLYM PREPR AM CHEM, V38, P122
   WELLINGHOFF VT, 1997, J DENT RES, V76, P279
   WICTORIN L, 1995, Patent No. 9530402
   WILSON AD, 1988, GLASS IONOMER CEMENT
   Wilson N H, 1997, Quintessence Int, V28, P245
   Wolter H, 1996, MATER RES SOC SYMP P, V435, P67, DOI 10.1557/PROC-435-67
   WOLTER H, 1992, MATER RES SOC SYMP P, V271, P719, DOI 10.1557/PROC-271-719
   WOLTER H, 1994, MATER RES SOC SYMP P, V346, P143
   WOLTER H, 1996, Patent No. 4133494
   Xu HHK, 1999, J DENT RES, V78, P1304, DOI 10.1177/00220345990780070401
   Yamamoto H, 2000, OPER DENT, V25, P104
   Zeuner F, 1996, MACROMOL CHEM PHYSIC, V197, P2745, DOI 10.1002/macp.1996.021970912
NR 171
TC 390
Z9 401
U1 10
U2 138
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD MAY
PY 2001
VL 26
IS 4
BP 535
EP 576
DI 10.1016/S0079-6700(01)00005-3
PG 42
WC Polymer Science
SC Polymer Science
GA 445LU
UT WOS:000169459600001
DA 2018-10-19
ER

PT J
AU Wilson, DJ
   Williams, RL
   Pond, RC
AF Wilson, DJ
   Williams, RL
   Pond, RC
TI Plasma modification of PTFE surfaces Part II: Plasma-treated surfaces
   following storage in air or PBS
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE plasma modification; PTFE; XPS; SIMS; DCA; AFM; ageing
AB The mechanisms and kinetics of the ageing process of polytetrafluoroethylene (PTFE) samples stored in either phosphate-buffered saline (PBS) or air for periods of up to 1 month have been investigated. Changes of surface chemistry and wettability were studied as a function of ageing time using the complementary techniques of x-ray photoelectron spectroscopy, static secondary ion mass spectroscopy and dynamic contact angle measurements. Specimens were aged either in the as-received condition or after treatment by O-2, Ar, N-2 and NH3 plasma as described in Part I. Evidence was obtained for two ageing mechanisms, namely chemical reaction with the storage medium and relaxation in the surface region of the polymer. The extent of these mechanisms depended on the initial plasma treatment and the nature of the storage medium. These issues are discussed in a framework that correlates wettability with surface chemistry in a semiquantitative manner. This analysis facilitates comparison of the changes induced on virgin material by plasma treatment and ageing in storage environments relevant to the biomedical application of PTFE. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Univ Liverpool, Dept Clin Engn, Liverpool L69 3GA, Merseyside, England.
   Univ Liverpool, Dept Engn, Liverpool L69 3GH, Merseyside, England.
RP Williams, RL (reprint author), Univ Liverpool, Dept Clin Engn, Liverpool L69 39A, Merseyside, England.
OI Williams, Rachel/0000-0002-1954-0256
CR CHATELIER RC, 1995, LANGMUIR, V11, P2576, DOI 10.1021/la00007a042
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   FOERCH R, 1990, J APPL POLYM SCI, V40, P1903, DOI 10.1002/app.1990.070401109
   GERENSER LJ, 1987, J ADHES SCI TECHNOL, V1, P303
   GRIESSER HJ, 1990, PAP AM CHEM S 2, V199
   ISRAELACHVILI JN, 1989, LANGMUIR, V5, P288, DOI 10.1021/la00085a059
   JOHANNES G, 1995, J APPL POLYM SCI, V57, P969
   MORRA M, 1990, SURF INTERFACE ANAL, V16, P412, DOI 10.1002/sia.740160186
   OCCHIELLO E, 1991, J APPL POLYM SCI, V42, P551, DOI 10.1002/app.1991.070420228
   OKELL S, 1995, SURF INTERFACE ANAL, V23, P319, DOI 10.1002/sia.740230508
   Pringle SD, 1996, SURF INTERFACE ANAL, V24, P821, DOI 10.1002/(SICI)1096-9918(199611)24:12<821::AID-SIA189>3.0.CO;2-B
   WILSON DJ, 2000, THESIS U LIVERPOOL L
   WITTENBECK P, 1993, J APPL POLYM SCI, V50, P187, DOI 10.1002/app.1993.070500201
   XIE X, 1993, CONTACT ANGLE WETTAB, P509
   YASUDA H, 1981, J POLYM SCI POL PHYS, V19, P1255
NR 15
TC 44
Z9 46
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD MAY
PY 2001
VL 31
IS 5
BP 397
EP 408
DI 10.1002/sia.1066
PG 12
WC Chemistry, Physical
SC Chemistry
GA 437VR
UT WOS:000169014700007
DA 2018-10-19
ER

PT J
AU Leng, YX
   Yang, P
   Chen, JY
   Sun, H
   Wang, J
   Wang, GJ
   Huang, N
   Tian, XB
   Chu, PK
AF Leng, YX
   Yang, P
   Chen, JY
   Sun, H
   Wang, J
   Wang, GJ
   Huang, N
   Tian, XB
   Chu, PK
TI Fabrication of Ti-O/Ti-N duplex coatings on biomedical titanium alloys
   by metal plasma immersion ion implantation and reactive plasma
   nitriding/oxidation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE titanium oxide and nitride; biomedical materials; plasma implantation;
   plasma nitriding; plasma oxidation
ID SURFACE MODIFICATION; DEPOSITION; BEAM
AB Ti-O/Ti-N duplex coatings were fabricated on titanium alloys by metal plasma immersion ion implantation and reactive plasma nitriding/oxidation. The purpose of Ti-O is to improve the blood compatibility, and that of Ti-N is to improve the mechanical properties. X-Ray diffraction (XRD), microhardness tests, pin-on-disk wear experiments, and platelet adhesion investigation were conducted to evaluate the properties and blood compatibility of the coatings. The results reveal that the blood compatibility of the Ti-O/Ti-N duplex coatings is better than that of low temperature isotropic pyrolytic carbon (LTIC). The microhardness of Ti-O/Ti-N duplex coatings can reach 14 GPa. The wear resistance is also much better than that of Ti6Al4V alloy.,The semiconductor nature of non-stoichiometric titanium oxide may be responsible for the observed improvement in the blood compatibility. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Sichuan, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013; Leng, Yongxiang/G-5488-2010
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   EBERT R, 1982, P WORLD C MED PHYS B, P307
   FENG Z, 1997, CHINESE J FUNCT MAT, V3, P47
   Gutmann F, 1986, MODERN BIOELECTROCHE
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Jarzebski ZM, 1973, OXIDE SEMICONDUCTORS
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Staia MH, 1995, SURF COAT TECH, V76, P231
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
NR 14
TC 61
Z9 66
U1 1
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 16
PY 2001
VL 138
IS 2-3
BP 296
EP 300
DI 10.1016/S0257-8972(00)01172-5
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 410QG
UT WOS:000167450200024
DA 2018-10-19
ER

PT J
AU Langer, RS
AF Langer, RS
TI Novel biomedical materials.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 1
PY 2001
VL 221
MA 143-POLY
BP U315
EP U315
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 434PJ
UT WOS:000168824801865
DA 2018-10-19
ER

PT J
AU Bigi, A
   Cojazzi, G
   Panzavolta, S
   Rubini, K
   Roveri, N
AF Bigi, A
   Cojazzi, G
   Panzavolta, S
   Rubini, K
   Roveri, N
TI Mechanical and thermal properties of gelatin films at different degrees
   of glutaraldehyde crosslinking
SO BIOMATERIALS
LA English
DT Article
DE gelatin; glutaraldehyde; crosslinking; mechanical properties; d.s.c.;
   swelling
ID CROSS-LINKING; IN-VITRO; COLLAGEN; BIOCOMPATIBILITY; BIOPROSTHESES;
   BIOMATERIALS; CARBODIIMIDE; MATRICES; GELS
AB The mechanical, thermal, swelling and release properties of glutaraldehyde (GTA) crosslinked gelatin films have been investigated in order to verify the influence of GTA concentration on the stability of the films. Air-dried films were submitted to treatment with GTA solutions at concentrations ranging from 0.05 to 2.5 wt%. At the smallest GTA concentration, the crosslinking degree, determined by trinitrobenzensulfonic acid assay, amounts to about 60% and increases up to values near 100%, obtained with GTA concentrations greater than or equal to 1 wt%. Simultaneously, the deformability of the films decreases, whereas the stress at break, sigma (b), and the Young's modulus, E, increase. A crosslinking degree of about 85%, obtained using 0.25% GTA, is enough to prevent gelatin release in buffer solution and to provoke a significant reduction of the swelling in physiological solution. Furthermore, crosslinking greatly affects the thermal stability of the samples, as indicated by the results of differential scanning calorimetry (d.s.c.) investigation carried out on wet and air-dried films. The data suggest that the use of GTA at low concentration, which is desiderable to prevent toxicity, allows to modulate the physico-chemical properties of gelatin films, in order to obtain stable materials with a wide range of possible biomedical applications. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Bologna, Dipartimento Chim G Ciamician, CNR, Ctr Study Macromol Phys, I-40126 Bologna, Italy.
RP Bigi, A (reprint author), Univ Bologna, Dipartimento Chim G Ciamician, CNR, Ctr Study Macromol Phys, Via Selmi 2, I-40126 Bologna, Italy.
RI Bigi, adriana/R-6341-2016
OI Bigi, adriana/0000-0003-2668-8627; Panzavolta,
   Silvia/0000-0002-2937-2284
CR ACHET D, 1995, POLYMER, V36, P787, DOI 10.1016/0032-3861(95)93109-Y
   Bailey AJ, 1999, P INDIAN AS-CHEM SCI, V111, P57
   Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Bigi A, 2000, J THERM ANAL CALORIM, V61, P451, DOI 10.1023/A:1010117401098
   BIGI A, 1987, INT J BIOL MACROMOL, V9, P363, DOI 10.1016/0141-8130(87)90010-9
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   ESPOSITO E, 1995, BIOMATERIALS, V20, P2009
   FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7
   FRAGA AN, 1985, POLYMER, V26, P113, DOI 10.1016/0032-3861(85)90066-7
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   Hataka T, 1994, CHEM PHARM BULL, V42, P1138
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KOPP J, 1989, Matrix, V9, P443
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Otani Y, 1998, BIOMATERIALS, V19, P2091, DOI 10.1016/S0142-9612(98)00121-5
   PEZRON I, 1991, POLYMER, V32, P3201, DOI 10.1016/0032-3861(91)90143-7
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Rose P. J., 1987, ENCY POLYM SCI ENG, V7
   ROSSMURPHY SB, 1992, POLYMER, V33, P2622, DOI 10.1016/0032-3861(92)91146-S
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   TANIOKA A, 1976, BIOPOLYMERS, V15, P1505, DOI 10.1002/bip.1976.360150806
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   Veis A., 1964, MACROMOLECULAR CHEM
   WISSEMANN KW, 1985, IN VITRO CELL DEV B, V21, P391
NR 29
TC 424
Z9 443
U1 17
U2 201
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 763
EP 768
DI 10.1016/S0142-9612(00)00236-2
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000002
PM 11246944
DA 2018-10-19
ER

PT J
AU Lloyd, AW
   Faragher, RGA
   Denyer, SP
AF Lloyd, AW
   Faragher, RGA
   Denyer, SP
TI Ocular biomaterials and implants
SO BIOMATERIALS
LA English
DT Article
DE ocular biomaterials; ophthalmic implants and devices
ID INTRAOCULAR-LENS MATERIALS; GLAUCOMA DRAINAGE DEVICES; IN-VITRO
   EVALUATION; SURFACE MODIFICATION; CELL-PROLIFERATION; BACTERIAL
   ADHESION; ORBITAL IMPLANTS; CONTACT-LENSES; KERATOPROSTHESIS;
   HYDROXYAPATITE
AB The maintenance of vision is a key determinant of healthy ageing. This has been facilitated over recent decades by the development of a wide range of implants and biomedical devices to correct the functional deficiencies of disease, age and ocular trauma. This brief overview provides an insight into the structure of this unique organ, the major physiological functions of the component tissues and the present state of the art with respect to modern ocular implants. The review focuses primarily on the existing limitations of existing ocular biomaterials used in the fabrication of contact lenses, intraocular lenses, glaucoma filtration implants, keratoprostheses, intracorneal implants, scleral buckles and viscoelastic replacement agents. The challenge of improving ocular compatibility and ensuring the longevity of indwelling ocular devices is addressed along with the need to improve the physicochemical and mechanical properties of existing ocular biomaterials. (C) 2001 Published by Elsevier Science Ltd.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
RP Lloyd, AW (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
EM a.w.lloyd@brighton.ac.uk
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR ARIAZ JJ, 1993, INVEST OPHTH VIS SCI, V34, P522
   ARROYO MH, 1993, RETINA-J RET VIT DIS, V13, P245, DOI 10.1097/00006982-199313030-00011
   BARBER JC, 1980, INVEST OPHTH VIS SCI, V19, P182
   BAYLISS J, 1981, OPHTHALMIC SURG, P313
   BILYK JR, 1992, INT OPHTHALMOL CLIN, V32, P151, DOI 10.1097/00004397-199203230-00011
   Bours J, 1990, Lens Eye Toxic Res, V7, P491
   Capone A Jr, 1995, Curr Opin Ophthalmol, V6, P33
   CARDONA H, 1969, AM J OPHTHALMOL, V68, P604, DOI 10.1016/0002-9394(69)91239-2
   CATROVEIJO R, 1969, AM J OPHTHALMOL, V68, P613
   CHIRILA TV, 1994, TRENDS POLYM SCI, V2, P296
   CHIRILA TV, 1998, TRIP, V5, P346
   CUMMINGS SJ, 1997, Patent No. 1997439651
   Ding SL, 1998, PHARM SCI TECHNOL TO, V1, P328, DOI 10.1016/S1461-5347(98)00087-X
   Doane MG, 1996, CORNEA, V15, P179, DOI 10.1097/00003226-199603000-00011
   Drubaix I, 1996, EXP EYE RES, V62, P367, DOI 10.1006/exer.1996.0042
   DUTTON JJ, 1991, OPHTHALMOLOGY, V98, P370
   Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814
   Filipec M, 1997, INVEST OPHTH VIS SCI, V38, P883
   FINI ME, 1990, J CELL SCI, V97, P373
   Fleming J F, 1989, CLAO J, V15, P146
   Flowers C W Jr, 1994, Curr Opin Ophthalmol, V5, P81, DOI 10.1097/00055735-199408000-00012
   GEROSHI DH, 1995, OPHTHALMOLOGY, V92, P1
   Girard L J, 1977, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol, V83, P252
   GIRARD LJ, 1983, CORNEA, V2, P207
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Hanlon GW, 1997, INVEST OPHTH VIS SCI, V38, P885
   HIGHTOWER KR, 1995, CURR EYE RES, V14, P71, DOI 10.3109/02713689508999916
   HOFFMANN F, 1993, CURR OPIN OPHTHALMOL, V4, P84, DOI 10.1097/00055735-199308000-00013
   JONGEBLOED WL, 1994, BIOMATERIALS, V15, P766, DOI 10.1016/0142-9612(94)90030-2
   Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566
   KIRKHAM SM, 1991, OPHTHALMIC SURG LAS, V22, P455
   Kohnen T, 1996, J CATARACT REFR SURG, V22, P1255, DOI 10.1016/S0886-3350(96)80079-4
   KRAUSE U, 1969, OPHTHALMOLOGICA, V159, P178, DOI 10.1159/000305901
   Kunzler J. F., 1995, CHEM IND, V16, P651
   LANE SS, 1991, INT OPHTHALMOL CLIN, V31, P37, DOI 10.1097/00004397-199103110-00007
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   LEGEAIS JM, 1994, EXP EYE RES, V58, P41, DOI 10.1006/exer.1994.1193
   LEGEAIS JM, 1992, CORNEA, V11, P538, DOI 10.1097/00003226-199211000-00010
   Lehrer MS, 1998, J CELL SCI, V111, P2867
   LIESEGANG TJ, 1990, SURV OPHTHALMOL, V34, P268, DOI 10.1016/0039-6257(90)90027-S
   Lim KS, 1998, BRIT J OPHTHALMOL, V82, P1083, DOI 10.1136/bjo.82.9.1083
   LIPMAN RD, 1987, CURR EYE RES, V6, P1453, DOI 10.3109/02713688709044509
   Lloyd AW, 1997, INVEST OPHTH VIS SCI, V38, P884
   Lloyd AW, 1996, VISION RES, V36, P73
   MCDONALD MB, 1993, J CATARACT REFR SURG, V19, P213, DOI 10.1016/S0886-3350(13)80945-5
   MCDONALD MB, 1993, EXIMER LASER SURG, P43
   MOLTENO ACB, 1969, BRIT J OPHTHALMOL, V53, P161, DOI 10.1136/bjo.53.3.161
   MOSHYEDI P, 1995, CURR EYE RES, V14, P555, DOI 10.3109/02713689508998402
   NOSE W, 1993, REFRACT CORNEAL SURG, V19, P182
   OBSTBAUM SA, 1992, J CATARACT REFR SURG, V18, P219, DOI 10.1016/S0886-3350(13)80897-8
   Pande MV, 1996, BRIT J OPHTHALMOL, V80, P469, DOI 10.1136/bjo.80.5.469
   Perry A C, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P75
   PERRY AC, 1991, OPHTHALMOL CLIN N AM, V4, P173
   Porter JM, 1997, OPHTHALMOLOGY, V104, P1701, DOI 10.1016/S0161-6420(97)30077-3
   Ravi N, 1996, INVEST OPHTH VIS SCI, V37, P3539
   REMULLA HD, 1995, OPHTHALMOLOGY, V102, P586
   RUBIN PAD, 1993, CURR OPIN OPHTHALMOL, V4, P39, DOI 10.1097/00055735-199310000-00009
   RUBIN PAD, 1994, OPHTHALMIC PLAST REC, V10, P96, DOI 10.1097/00002341-199406000-00005
   SCHEPENS CL, 1991, SURV OPHTHALMOL, V35, P447, DOI 10.1016/0039-6257(91)90108-R
   SHARMA A, 1993, BIOPHYS CHEM, V47, P87, DOI 10.1016/0301-4622(93)80036-I
   SHIELDS CL, 1992, ARCH OPHTHALMOL-CHIC, V110, P333, DOI 10.1001/archopht.1992.01080150031022
   SMITH SG, 1989, Patent No. 198950782
   Soll D B, 1986, Ophthalmic Plast Reconstr Surg, V2, P163, DOI 10.1097/00002341-198601060-00009
   STRAMPELLI B, 1963, Ann Ottalmol Clin Ocul, V89, P1039
   SUTULA FC, 1991, OPHTHALMOL CLIN N AM, V4, P183
   Taylor RL, 1998, OPTOMETRY VISION SCI, V75, P23, DOI 10.1097/00006324-199801000-00021
   Trinkaus-Randall VCJ, 1988, INVEST OPHTH VIS SCI, V29, P293
   Werblin T P, 1992, Refract Corneal Surg, V8, P12
   Williams TJ, 1998, OPTOMETRY VISION SCI, V75, P266, DOI 10.1097/00006324-199804000-00023
   Wilson SE, 1997, J REFRACT SURG, V13, P171
   ZIGMAN S, 1985, OCULA LENS STRUCTURE, P117
   1979, INTRAOCULAR LENS IMP, V2, P37
NR 72
TC 168
Z9 170
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 769
EP 785
DI 10.1016/S0142-9612(00)00237-4
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000003
PM 11246945
DA 2018-10-19
ER

PT J
AU Williams, MD
   Gish, KW
   Giuse, NB
   Sathe, NA
   Carrell, DL
AF Williams, MD
   Gish, KW
   Giuse, NB
   Sathe, NA
   Carrell, DL
TI The Patient Informatics Consult Service (PICS): an approach for a
   patient-centered service
SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
ID HEALTH INFORMATION
AB The Patient Informatics Consult Service (PICS) at the Eskind Biomedical Library at Vanderbilt University Medical Center (VUMC) provides patients with consumer-friendly information by using an information prescription mechanism. Clinicians refer patients to the PICS by completing the prescription and noting the patients condition and any relevant factors. In response, PICS librarians critically appraise and summarize consumer-friendly materials into a targeted information report. Copies of the report are given to both patient and clinician, thus facilitating doctor-patient communication and closing the clinician-librarian feedback loop. Moreover, the prescription form also circumvents many of the usual barriers for patients in locating information, namely, patients' unfamiliarity with medical terminology and lack of knowledge of authoritative sources. PICS librarians capture the time and expertise put into these reports by creating Web-based pathfinders on prescription topics. Pathfinders contain Librarian-created disease overviews and links to authoritative resources and seek to minimize the consumer's exposure to unreliable information. Pathfinders also adhere to strict guidelines that act as a model for locating, appraising, and summarizing information for consumers. These mechanisms-the information prescription, research reports, and pathfinders - serve as steps toward the long-term goal of full integration of consumer health information into patient care at VUMC.
C1 Vanderbilt Univ, Ctr Med, Annette & Irwin Eskind Biomed Lib, Nashville, TN 37232 USA.
RP Williams, MD (reprint author), Vanderbilt Univ, Ctr Med, Annette & Irwin Eskind Biomed Lib, Nashville, TN 37232 USA.
RI Giuse, Nunzia/N-2032-2016
OI Giuse, Nunzia/0000-0002-7644-9803
CR BARTLETT EE, 1995, PATIENT EDUC COUNS, V26, P87, DOI 10.1016/0738-3991(95)00723-D
   BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004
   COSGROVE TL, 1994, B MED LIBR ASSOC, V82, P57
   Earl M., 1998, AM LIB, V29, P44
   Giuse N B, 1998, Bull Med Libr Assoc, V86, P412
   Giuse NB, 1997, B MED LIBR ASSOC, V85, P437
   GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921
   HUMPHRIES AW, 1994, B MED LIBR ASSOC, V82, P52
   Ley P, 1982, SOCIAL PSYCHOL BEHAV, P339
   MCLELLAN F, 1998, LANCET S, V2, P39
   Morris TA, 1997, J AM MED INFORM ASSN, V4, P6, DOI 10.1136/jamia.1997.0040006
   *NAT LIB MED, 1998, NLM NEWSLINE
   NOTKIN H, 1994, WESTERN J MED, V161, P184
   Scheitel SM, 1996, MAYO CLIN PROC, V71, P1131, DOI 10.4065/71.12.1131
   TYSON TR, 2000, J AMBULATORY CARE MA, V53, P1
NR 15
TC 25
Z9 25
U1 0
U2 3
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 0025-7338
J9 B MED LIBR ASSOC
JI Bull. Med. Libr. Assoc.
PD APR
PY 2001
VL 89
IS 2
BP 185
EP 193
PG 9
WC Information Science & Library Science
SC Information Science & Library Science
GA 544DE
UT WOS:000175142300006
PM 11337950
DA 2018-10-19
ER

PT J
AU He, BL
   Guo, XQ
   Chen, Y
AF He, BL
   Guo, XQ
   Chen, Y
TI Blood purification and hemoperfusion
SO CHINESE SCIENCE BULLETIN
LA English
DT Review
DE biomedical materials; blood purification; hemoperfusion; adsorption
AB The method of blood purification is a new overlapping frontier discipline which develops quickly in recent years, It helps overcoming many serious and complicated diseases, even including some incurable illnesses.
C1 Nankai Univ, State Key Lab Funct Polymer Mat Adsorpt & Separat, Inst Polymer Chem, Tianjin 300071, Peoples R China.
RP He, BL (reprint author), Nankai Univ, State Key Lab Funct Polymer Mat Adsorpt & Separat, Inst Polymer Chem, Tianjin 300071, Peoples R China.
CR AN M, 1994, ION EXCHANGE ADSORPT, V10, P97
   BABB AL, 1971, T AM SOC ART INT ORG, V17, P81
   CHEN Y, 1996, ION EXCHANGE ADSORPT, V12, P304
   FURST P, 1976, CLIN NEPHROL, V5, P178
   GUO X, 1991, CHEM J CHINESE U, V12, P1130
   GUO X, 1997, MED SOC, V10, P51
   GUO X, 1997, ION EXCHANGE ADSORPT, V13, P203
   GUO X, 1993, ION EXCHANGE ADSORPT, V9, P352
   GUO X, 1995, ION EXCHANGE ADSORPT, V11, P289
   GUO X, 1997, ION EXCHANGE ADSORPT, V13, P9
   HE B, 1990, CHEM J CHINESE U, V11, P739
   HE B, 1990, CHEM J CHINESE U, V11, P873
   HE B, 1987, 3 C ION EXCH ADS NIN, P1
   MA T, 1991, 4 NAT AC EXCH C SHEN, P1
   ROSENBAUM J, 1970, KIDNEY INT S10, V18, P106
   WANG Z, 1992, BLOOD PURIFICATION
   XI Y, 1995, CHINESE J INFECT DIS, V13, P152
   YANG Y, 1988, ARTIF ORGANS, V12, P444
   YANG Y, 1991, ACTA POLYM SINICA, P169
   YANG Y, 1990, ION EXCHANGE ADSORPT, V11, P739
   YANG Y, 1985, CHEM J CHINESE U, V6, P843
   YANG Y, 1986, CHINESE J MICROBIOLO, V6, P353
   Yatzidis H., 1964, P EUROP DIALYSIS TRA, V1, P83
   YU S, 1998, FDN CLIN APPL BIOMED, P159
   YU Z, 1986, MODERN THERAPEUTICS
NR 25
TC 0
Z9 0
U1 2
U2 21
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD APR
PY 2001
VL 46
IS 8
BP 617
EP 621
DI 10.1007/BF03182818
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 433CN
UT WOS:000168737900001
DA 2018-10-19
ER

PT J
AU Thomsen, P
   Gretzer, C
AF Thomsen, P
   Gretzer, C
TI Macrophage interactions with modified material surfaces
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; BODY GIANT-CELLS; ACUTE
   INFLAMMATORY RESPONSES; PERIPHERAL-BLOOD MONOCYTES; ADHERENT
   HUMAN-NEUTROPHILS; INDUCED PULMONARY-FIBROSIS; MESSENGER-RNA EXPRESSION;
   SOFT-TISSUE RESPONSE; IN-VITRO
AB An understanding of the biological response at material surfaces is a key biomaterials research area. Inflammation, tissue repair and regeneration are hallmarks of this response. Macrophages are long-lived and versatile cells and have a pivotal role at surfaces of implanted medical devices. The present review provides an update on macrophage behaviour at material surfaces. The interactions between cells and material surfaces are dynamic processes which require additional experimental models with different degrees of environmental complexity. It is concluded that both modifications of material surface properties and cellular signalling pathways will provide strategies for optimising the performance of biomedical devices. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Gothenburg Univ, Inst Anat & Cell Biol, S-40530 Gothenburg, Sweden.
RP Thomsen, P (reprint author), Gothenburg Univ, Inst Anat & Cell Biol, Box 420, S-40530 Gothenburg, Sweden.
EM peter.thomsen@dof.se
OI Thomsen, Peter/0000-0003-3910-6665
CR ABRAMSON SL, 1990, J IMMUNOL, V144, P625
   Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1991, J VASC SURG, V13, P750, DOI 10.1016/0741-5214(91)90375-5
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BABIOR BM, 1984, BLOOD, V64, P959
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   Baran J, 1996, INFECT IMMUN, V64, P4242
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
   Blaine TA, 1996, J BONE JOINT SURG AM, V78A, P1181, DOI 10.2106/00004623-199608000-00008
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   BOLK HD, 2000, CD14 INFLAMMAOTRY RE, P162
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BROHIM RM, 1992, ANN PLAS SURG, V28, P354, DOI 10.1097/00000637-199204000-00010
   Burdon RH, 1996, FEBS LETT, V383, P150, DOI 10.1016/0014-5793(96)00230-X
   BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3
   CAMARERO VCPC, 1990, J CELL PHYSIOL, V145, P481, DOI 10.1002/jcp.1041450313
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   Champaiboon C, 2000, J PERIODONTOL, V71, P468, DOI 10.1902/jop.2000.71.3.468
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou LS, 1996, J BIOMED MATER RES, V31, P209
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   Cornelissen AMH, 2000, J DENT RES, V79, P1782, DOI 10.1177/00220345000790100901
   Dalu A, 2000, BIOMATERIALS, V21, P1947, DOI 10.1016/S0142-9612(00)00078-8
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   DE WMR, 1991, J EXP MED, V174, P1209
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Dinarello Charles A., 1997, Cytokine and Growth Factor Reviews, V8, P253, DOI 10.1016/S1359-6101(97)00023-3
   DONOFRIO C, 1984, IMMUNOBIOLOGY, V167, P414, DOI 10.1016/S0171-2985(84)80074-1
   ENK AH, 1992, J IMMUNOL, V149, P92
   Eriksson AS, 1996, J CELL PHYSIOL, V166, P138, DOI 10.1002/(SICI)1097-4652(199601)166:1<138::AID-JCP16>3.0.CO;2-B
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   ESSNER R, 1989, J IMMUNOL, V142, P3857
   Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404
   FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Flad HD, 1998, RES IMMUNOL, V149, P733, DOI 10.1016/S0923-2494(99)80048-0
   GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792
   GINIS I, 1990, BLOOD, V76, P1233
   GINIS I, 1997, AM J PHYSIOL, V41, pC295
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   GRANSTEIN RD, 1987, CLIN INVESTIGATOR, V4, P1254
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gretzer C, 2000, CYTOKINE, V12, P32, DOI 10.1006/cyto.1999.0523
   Gretzer C, 2000, BIOMATERIALS, V21, P1047, DOI 10.1016/S0142-9612(99)00279-3
   GRETZER C, 2000, THESIS GOTEBORG U
   GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226
   HANSSON HA, 1988, ACTA PHYSIOL SCAND, V134, P199, DOI 10.1111/j.1748-1716.1988.tb08480.x
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   HART PH, 1990, LYMPHOKINE RES, V9, P147
   HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Heidenreich S, 1999, J LEUKOCYTE BIOL, V65, P737
   HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861
   HIGAZI AA, 1994, INFLAMMATION, V18, P525, DOI 10.1007/BF01560699
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   HOGQUIST KA, 1991, J IMMUNOL, V147, P2181
   HONG HL, 1987, J CELL SCI, V87, P259
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   Horowitz SM, 1998, J BIOMED MATER RES, V41, P468, DOI 10.1002/(SICI)1097-4636(19980905)41:3<468::AID-JBM17>3.3.CO;2-7
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   HURME M, 1991, SCAND J IMMUNOL, V33, P713, DOI 10.1111/j.1365-3083.1991.tb02545.x
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Ingham E, 2000, BIOMATERIALS, V21, P1005, DOI 10.1016/S0142-9612(99)00261-6
   Ishiguro N, 1996, J BIOMED MATER RES, V32, P611, DOI 10.1002/(SICI)1097-4636(199612)32:4<611::AID-JBM14>3.3.CO;2-4
   Iwaki K, 1997, J BIOL CHEM, V272, P20665, DOI 10.1074/jbc.272.33.20665
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   JIRANEK W, 1995, J BONE JOINT SURG AM, V77A, P1650, DOI 10.2106/00004623-199511000-00003
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   KALLTORP M, 2000, UNPOUB MORPHOMETRIC
   KAO WJ, 1995, J BIOMED MATER RES, V19, P1267
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   KAPLAN G, 1982, J EXP MED, V156, P1101, DOI 10.1084/jem.156.4.1101
   KEHRL JH, 1991, INT J CELL CLONING, V9, P438, DOI 10.1002/stem.1991.5530090502
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kohilas K, 1999, J BIOMED MATER RES, V47, P95, DOI 10.1002/(SICI)1097-4636(199910)47:1<95::AID-JBM14>3.0.CO;2-8
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   KREIPE H, 1988, AM J PATHOL, V130, P232
   Kremer EA, 1998, J BONE MINER RES, V13, P1890, DOI 10.1359/jbmr.1998.13.12.1890
   Kuhn A, 2000, ANN PLAS SURG, V44, P387, DOI 10.1097/00000637-200044040-00006
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LARSSON C, 2001, TITANIUM MED, pCH18
   LEHN M, 1989, J IMMUNOL, V143, P3020
   LOSSING C, 1993, PLAST RECONSTR SURG, V91, P1277, DOI 10.1097/00006534-199306000-00014
   LOSSING C, 2000, UNPUB SCAND J PLAST
   MALEFYT RD, 1991, J EXP MED, V174, P915
   MANGAN DF, 1991, J IMMUNOL, V146, P1541
   Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894
   MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121
   Moulin V, 1998, EXP CELL RES, V238, P283, DOI 10.1006/excr.1997.3827
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NATHAN CF, 1989, BLOOD, V73, P301
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314
   OLDHAM KT, 1988, FREE RADICAL BIO MED, V4, P387, DOI 10.1016/0891-5849(88)90090-1
   PAPADIMITRIOU JM, 1975, AM J PATHOL, V78, P343
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   RICH A, 1981, J CELL SCI, V50, P1
   ROOS D, 1991, KLIN WOCHENSCHR, V69, P975, DOI 10.1007/BF01645142
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   ROSENGREN A, 1994, BIOMATERIALS, V15, P17, DOI 10.1016/0142-9612(94)90190-2
   Rosengren A, 1999, J MATER SCI-MATER M, V10, P75, DOI 10.1023/A:1008964819101
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Rubin E, 1994, PATHOLOGY
   Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304
   Sandhu J, 1998, J RHEUMATOL, V25, P1794
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SAVIDGE RA, 1993, IAWA J, V14, P3
   Savio J. A. Iii, 1994, Clinical Materials, V15, P101, DOI 10.1016/0267-6605(94)90076-0
   Schmidt M, 2000, EUR J IMMUNOL, V30, P1769, DOI 10.1002/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5
   SIMON DI, 1993, BLOOD, V82, P2414
   SMETANA K, 1989, J BIOMED MATER RES, V23, P947, DOI 10.1002/jbm.820230810
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   SPORN MB, 1989, JAMA-J AM MED ASSOC, V262, P938, DOI 10.1001/jama.262.7.938
   Stea S, 2000, BIOMATERIALS, V21, P1393, DOI 10.1016/S0142-9612(00)00041-7
   TAKAGI M, 1995, J RHEUMATOL, V22, P2285
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1994, CELL MATER, V4, P429
   THERIN M, 1994, J BIOMED MATER RES, V28, P1267, DOI 10.1002/jbm.820281104
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   VANFURTH R, 1992, INFLAMMATION BASIC P, P325
   VIGNERY A, 1989, AM J PATHOL, V135, P565
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   WALLIWAARA B, 1994, BIOMATERIALS, V15, P827
   WEBSTER NR, 1988, BRIT J ANAESTH, V60, P98, DOI 10.1093/bja/60.1.98
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Wolk K, 2000, BLOOD, V96, P218
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zambonin G, 2000, J BONE JOINT SURG BR, V82B, P457, DOI 10.1302/0301-620X.82B3.9310
   Zhang XS, 1999, J MATER SCI-MATER M, V10, P879, DOI 10.1023/A:1008937419664
   Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 167
TC 92
Z9 93
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD APR-JUN
PY 2001
VL 5
IS 2-3
BP 163
EP 176
DI 10.1016/S1359-0286(01)00004-3
PG 14
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 451CJ
UT WOS:000169783300009
DA 2018-10-19
ER

PT J
AU Lazzi, G
AF Lazzi, G
TI Unconditionally stable D-H FDTD formulation with anisotropic PML
   boundary conditions
SO IEEE MICROWAVE AND WIRELESS COMPONENTS LETTERS
LA English
DT Article
DE ADI; FDTD methods; PML
ID TIME-DOMAIN METHOD; ALGORITHM; MEDIA
AB An unconditionally stable finite difference time domain (FDTD) method based on a D-H formulation and the recently proposed alternating-direction-implicit (ADI) marching scheme is presented, The advantage of the D-H algorithm over the conventional E-W is the possibility to easily implement an unsplit field components formulation of the PML absorbing boundary condition that is independent from the background material used in the FDTD grid. The method allows therefore immersing any dielectric in the PML layers without any special consideration, and is amenahle for models truncation often used in biomedical simulations. Furthermore, the proposed scheme can be extended to account for frequency dispersive dielectrics.
C1 N Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.
RP Lazzi, G (reprint author), N Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.
CR LAZZI G, 2000, IEEE T MICROWAVE NOV
   Liu G, 2000, IEEE MICROW GUIDED W, V10, P261, DOI 10.1109/75.856982
   Namiki T, 1999, IEEE T MICROW THEORY, V47, P2003, DOI 10.1109/22.795075
   Namiki T, 2000, IEEE T MICROW THEORY, V48, P1743, DOI 10.1109/22.873904
   Sullivan D. M., 2000, ELECTROMAGNETIC SIMU
   Sullivan DM, 1997, IEEE MICROW GUIDED W, V7, P184, DOI 10.1109/75.594858
   Taflove A., 2000, COMPUTATIONAL ELECTR
   Zhao AP, 1998, IEEE MICROW GUIDED W, V8, P52, DOI 10.1109/75.658638
   Zheng FH, 2000, IEEE T MICROW THEORY, V48, P1550, DOI 10.1109/22.869007
   Zheng FH, 1999, IEEE MICROW GUIDED W, V9, P441, DOI 10.1109/75.808026
NR 10
TC 10
Z9 13
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1531-1309
J9 IEEE MICROW WIREL CO
JI IEEE Microw. Wirel. Compon. Lett.
PD APR
PY 2001
VL 11
IS 4
BP 149
EP 151
DI 10.1109/7260.916326
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA 435RJ
UT WOS:000168894700001
OA Green Published
DA 2018-10-19
ER

PT J
AU Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
AF Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
TI Human monocyte-derived macrophages and dendritic cells as targets for
   biomaterial cytocompatibility studies using an improved in vitro culture
   system
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; INTERLEUKIN-1 GENERATION; BIOMEDICAL POLYMERS;
   MONONUCLEAR-CELLS; BLOOD MONOCYTES; BONE-RESORPTION; INVITRO;
   IMMUNOTHERAPY; REPLACEMENTS; DEGRADATION
AB Since macrophage plays a key role in the biocompatibility process, neoplastic macrophage cell lines and human blood monocytes are commonly used as target cells for in vitro biomaterial tolerance evaluation. However, tumor cells profoundly differ from normal tissue cells and monocytes are only precursors of macrophages. It has become possible to generate recently, under adherent-free conditions, fully mature macrophages and dendritic cells from human blood monocytes in the presence of GM-CSF and GM-CSF + IL4 respectively. In the present work, we examined the effects of titanium-alloy on morphology, adhesion, cell phenotype and TNF-alpha release activity of such differentiated cells grown in hydrophobic teflon bags. Scanning electron microscopy showed that macrophages substantially adhered and spread on titanium-alloy surface throughout the culture period, whereas only a few dendritic cells were adherent. The phenotype of both cell types remained unchanged in the presence of the tested material. However, titanium-alloy stimulated the secretion of TNF-alpha by the macrophages of some donors. This model of culture may offer new insights into the biomaterial evaluation and may be useful for studying individual responses induced by biomaterials. (C) 2001 Kluwer Academic Publishers.
C1 UFR Med, Lab Histol Embryol Cytogenet, F-51095 Reims, France.
   Inst Jean Godinot, Immunol Lab, F-51100 Reims, France.
   Ctr Etud Biomat & Interfaces, EA 2068, F-51095 Reims, France.
   CHU, Hematol Lab, F-51092 Reims, France.
   UFR Pharm, Immunol Lab, F-51095 Reims, France.
RP Mebouta-Nkamgueu, E (reprint author), UFR Med, Lab Histol Embryol Cytogenet, 51 Rue Cognacq Jay, F-51095 Reims, France.
CR ADAMS DO, 1979, METHOD ENZYMOL, V58, P4
   ANDREESEN R, 1990, CANCER RES, V50, P7450
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bernard J, 1998, HEMATOL CELL THER, V40, P17
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BHARDWAJ N, 1988, CELL IMMUNOL, V114, P405, DOI 10.1016/0008-8749(88)90332-2
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Caux C, 1996, HEMATOL CELL THER, V38, P463, DOI 10.1007/s00282-996-0463-4
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   FREUNDLICH B, 1984, J IMMUNOL, V132, P1255
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GLANT TT, 1994, T ORTHOP RES SOC, V19, P152
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   HELFGOTT DC, 1989, J IMMUNOL, V142, P948
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Koerten H. K., 1997, Cells and Materials, V7, P191
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   LOPEZ M, 1992, J IMMUNOTHER, V11, P209, DOI 10.1097/00002371-199204000-00008
   LOPEZ M, 1993, J IMMUNOL METHODS, V159, P29, DOI 10.1016/0022-1759(93)90138-W
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NAVARRO S, 1989, J IMMUNOL, V142, P4339
   Nivbrant B, 1999, J BONE JOINT SURG BR, V81B, P163, DOI 10.1302/0301-620X.81B1.8664
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   ROSENSTREICH DL, 1978, IMMUNOL REV, V40, P102, DOI 10.1111/j.1600-065X.1978.tb00403.x
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1996, J BIOMED MATER RES, V30, P429, DOI 10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.3.CO;2-D
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SNYDERMAN R, 1971, J IMMUNOL, V119, P926
   THOMAS R, 1994, J IMMUNOL, V152, P2613
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P76
NR 46
TC 4
Z9 5
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2001
VL 12
IS 4
BP 351
EP 357
DI 10.1023/A:1011255406438
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 419DN
UT WOS:000167934200011
PM 15348298
DA 2018-10-19
ER

PT J
AU Gore, JC
   Anderson, AW
   Does, MD
   Gochberg, DF
   Joers, JM
   Kennan, RP
   Parsons, EC
   Schachter, M
AF Gore, JC
   Anderson, AW
   Does, MD
   Gochberg, DF
   Joers, JM
   Kennan, RP
   Parsons, EC
   Schachter, M
TI The relationship of problems in biomedical MRI to the study of porous
   media
SO MAGNETIC RESONANCE IMAGING
LA English
DT Editorial Material
ID MAGNETIZATION-TRANSFER; DIFFUSION; RELAXATION
AB The NMR methods that are used to characterize inanimate porous media measure relaxation times and related phenomena and material transport, fluid displacement and flow. Biological tissues are comprised of multiple small, fluid-filled compartments, such as cells, that restrict the movement of the bulk solvent water and whose constituents influence water proton relaxation times via numerous interactions with macromolecular surfaces. Several of the methods and concepts that have been developed in one field of application are also of great value in the Ether, and it may be expected that technical developments that have been spurred by biomedical applications of MR imaging will be used in the continuing study of porous media. Some recent specific studies from our laboratory include the development of multiple quantum coherence methods for studies of ordered water in anisotropic macromolecular assemblies, studies of the degree of restriction of water diffusion in cellular systems, multiple selective inversion imaging to depict the ratios of proton pool sizes and rates of magnetization transfer between proton populations, and diffusion tensor imaging to depict tissue anisotropies. These illustrate how approaches to obtain structural information from biological media are also relevant to porous media. For example, the recent development of oscillating gradient spin echo techniques (OGSE), an approach that extends our ability to resolve apparent diffusion changes over different time scales in tissues, has also been used to compute surface to volume measurements in assemblies of pores. Each of the new methods can be adapted to provide spatially resolved quantitative measurements of properties of interest, and these can be efficiently acquired with good accuracy using fast imaging methods such as echo planar imaging. The community of NMR scientists focused on applications to porous media should remain in close communication with those who use MRI to study problems in biomedicine, to their mutual benefits. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA.
   Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.
RP Gore, JC (reprint author), Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA.
RI Does, Mark/G-8975-2011
CR Bear J, 1988, DYNAMICS FLUIDS PORO
   Callaghan P.T., 1991, PRINCIPLES NUCL MAGN
   Does MD, 2000, MAGNET RESON MED, V43, P837, DOI 10.1002/1522-2594(200006)43:6<837::AID-MRM9>3.0.CO;2-O
   EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0
   Gochberg DF, 1999, MAGNET RESON MED, V41, P1065, DOI 10.1002/(SICI)1522-2594(199905)41:5<1065::AID-MRM27>3.0.CO;2-9
   Gochberg DF, 1998, J MAGN RESON, V131, P191, DOI 10.1006/jmre.1998.1371
   HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607
   Kennan RP, 1996, J MAGN RESON SER B, V110, P267, DOI 10.1006/jmrb.1996.0042
   LATOUR LL, 1993, J MAGN RESON SER A, V101, P342, DOI 10.1006/jmra.1993.1056
   SCHACHTER M, 2000, J MAGN RESON, V174, P232
   SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516
NR 11
TC 14
Z9 14
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0730-725X
J9 MAGN RESON IMAGING
JI Magn. Reson. Imaging
PD APR-MAY
PY 2001
VL 19
IS 3-4
BP 295
EP 300
DI 10.1016/S0730-725X(01)00239-9
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 455YU
UT WOS:000170056000003
PM 11445302
DA 2018-10-19
ER

PT J
AU Vaz, CM
   Reis, RL
   Cunha, AM
AF Vaz, CM
   Reis, RL
   Cunha, AM
TI Degradation model of starch-EVOH plus HA composites
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE in-vitro degradation; composites; starch/ethylene-vinyl alcohol;
   biodegradable; enzymes; coupling agents
ID POLYMERS
AB Composites of starch based blends (starch-EVOH) reinforced with bioactive bone-like hydroxyapatite (HA) have been recently proposed for temporary biomedical implants. Very promising mechanical results were obtained so far, both by the introduction of coupling agents (titanates, zirconates and silanes) or by optimizing the respective processing route. In this study coupled and non-coupled composites were aged up to 30 days in two types of simulated physiological solutions (with and without added proteins/enzymes) and the respective property variation was evaluated by means of: weight loss, water-uptake and mechanical performance (strength, stiffness and ductility). The interfacial attack generated by the solutions was observed by scanning electron microscopy (SEM) and quantified (calcium and phosphorous amounts in the solution) by atomic emission spectrometry (ICP). The in-vitro degradation process of starch-EVOH+HA composites consists apparently of three main stages: i) for short periods (0-6 days) it is characterized by a high degradation rate due to the leaching of plasticizers, low molecular weight polymeric chains and some dissolution of HA; ii) for longer periods (7-15 days), the major extraction of the plasticizers oc curs and the material becomes brittle and; iii) from the 15th immersion day on, the degradation rate is lower and, eventually chemical attack on the polymer structure takes place, mainly in the presence of enzymes/proteins.
   The confirmation of this type of behavior will support the potential use of these composites, already tested for their non-cytotoxic character, in temporary applications where the retention of mechanical properties for 3 to 6 weeks is required.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Vaz, CM (reprint author), Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Cunha
   M., Antonio/0000-0003-3860-7732
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   BASTIOLI C, 1995, Patent No. 9102025
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P210
   GOMES ME, 1999, 15 EUR C BIOM BORD F
   Hench LL, 1996, BIOMATERIALS SCI INT, P73
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   KLEMCHUK PP, 1990, POLYM DEGRAD STABIL, V27, P183, DOI 10.1016/0141-3910(90)90108-J
   KNOWLES JC, 1992, J MATER SCI-MATER M, V3, P352, DOI 10.1007/BF00705367
   MENDES SC, 2000, UNPUB BIOMATERIALS
   MIDDLETON JC, 1998, MED PLAST BIOMATER, V2, P30
   MONTE SJ, 1993, KEN REACTRO REFERENC
   PISKIN E, 1992, Clinical Materials, V11, P3, DOI 10.1016/0267-6605(92)90023-M
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   SCOTT G, 1995, POLYM DEGRAD STABIL, V48, P315, DOI 10.1016/0141-3910(95)00090-9
   TORMALA P, 1993, CLIN MATER, V13, P35, DOI 10.1016/0267-6605(93)90087-N
   VAZ CM, 1999, 15 EUR C BIOM BORD F
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   ZAIKOV GE, 1989, DEGRADATION STABILIS, P469
NR 22
TC 31
Z9 31
U1 0
U2 3
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD APR
PY 2001
VL 4
IS 5-6
BP 375
EP 380
DI 10.1007/s100190000112
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 431DX
UT WOS:000168617500017
DA 2018-10-19
ER

PT J
AU Iwaki, M
AF Iwaki, M
TI Ion surface treatments on organic materials
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Ion Beam Modification of Materials
   (IBMM2000)
CY SEP 03-08, 2000
CL CANELA, BRAZIL
SP Inst Fis UFRGS, Ion Implantat Lab
DE ion implantation; polymer; surface analysis; cell adhesion
ID IMPLANTED POLYIMIDE FILMS; CELL-ADHESION
AB A study has been made of surface modification of various organic materials by ion bombardment or implantation to make the surface properties of high and multiple functions in RIKEN. Substrates used were polyimide (PI), polyacetylene, polytetrafluoroethylene (PTFE), polystyrene (PS), silicone rubber, various kinds of proteins and so on. Bombarded or implanted ions were inert gas elements, chemically active gaseous elements and metallic elements. Surface properties such as electrical conductivity, wettability and cell adhesion of implanted layers have been investigated. Surface characterization of implanted materials has been carried out by means of transmission electron microscopy, laser Raman spectroscopy, X-ray photoelectron spectroscopy and Rutherford backscattering spectroscopy. In this paper, studies in RIKEN are reviewed of electrical conductivity, optical absorbance, wettability and cell adhesion depending on current densities and doping elements. Applications of ion bombardment to biomedical materials are introduced using cell adhesion control. It is concluded that ion bombardment or implantation is useful to change and control surface properties of various organic materials. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 RIKEN, Surface Characterizat Div, Wako, Saitama 3510198, Japan.
RP Iwaki, M (reprint author), RIKEN, Surface Characterizat Div, Hirosawa 2-1, Wako, Saitama 3510198, Japan.
CR DAVENAS J, 1993, NUCL INSTRUM METH B, V80-1, P1021, DOI 10.1016/0168-583X(93)90729-P
   FISCHER BE, 1990, NUCL INSTRUM METH B, V30, P284
   HOLMAN R, 1984, UV EB CURING FORMULA
   INOUE Y, 2000, COLLOID SURFACE B, V19, P263
   IWAKI M, 1993, NUCL INSTRUM METH B, V80-1, P1080, DOI 10.1016/0168-583X(93)90741-N
   IWAKI M, 1999, P 1998 INT C ION IMP, P824
   Kobayaski T, 2001, NUCL INSTRUM METH B, V175, P548, DOI 10.1016/S0168-583X(01)00342-1
   Murayama Y, 1999, AM J NEURORADIOL, V20, P1992
   Nakao A, 1998, J COLLOID INTERF SCI, V197, P257, DOI 10.1006/jcis.1997.5289
   SAKAMOTO K, 1996, J MATER RES, V11, P1656
   SUZUKI Y, 1992, NUCL INSTRUM METH B, V65, P142, DOI 10.1016/0168-583X(92)95027-O
   Suzuki Y, 1997, NUCL INSTRUM METH B, V127, P1019, DOI 10.1016/S0168-583X(97)00050-5
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   Watanabe H, 1995, MATER RES SOC SYMP P, V354, P369
   YOSHIDA K, 1987, NUCL INSTRUM METH B, V19-20, P878, DOI 10.1016/S0168-583X(87)80175-1
NR 15
TC 34
Z9 34
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 2001
VL 175
BP 368
EP 374
DI 10.1016/S0168-583X(00)00543-7
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 444FH
UT WOS:000169389100067
DA 2018-10-19
ER

PT J
AU Helminen, A
   Korhonen, H
   Seppala, JV
AF Helminen, A
   Korhonen, H
   Seppala, JV
TI Biodegradable crosslinked polymers based on triethoxysilane terminated
   polylactide oligomers
SO POLYMER
LA English
DT Article
DE silane; lactide; crosslinking
ID MOLAR-MASS POLYBUTADIENE; ORGANIC HYBRID MATERIALS; SOL-GEL PROCESS;
   SILANE MOIETIES; URETHANE LINKAGE; COMPOSITES; DEGRADATION; BEHAVIOR
AB Lactic acid based polymers and their copolymers are widely used in biomedical applications. Different properties are introduced by modifying the composition. In this study, crosslinked polymers were produced from DL-lactide oligomers, which were functionalised with (3-isocyanatopropyl)triethaxysilane (IPTS) and crosslinked by acid catalysis in the presence of water without the use of solvent. The polymers were characterised by fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC), and their crosslinking density and compressive properties were measured. Functionalised linear and star-shaped oligomers were characterised by FTIR and DSC and also by H-1 NMR and size exclusion chromatography (SEC). According to H-1 NMR, 79-95% of the hydroxyl groups were functionalised by IPTS during the early part of the synthesis. The formation of a strong polymer network was found to require a curing temperature of at least 90 degreesC. The best mechanical properties were achieved with the oligomer initiated with 5% pentaerythritol. The properties of the polymer were then compressive yield strength 81 MPa, modulus 2260 MPa and 4.4% strain at yield point. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Helsinki Univ Technol, Dept Chem Technol, Lab Polymer Technol, FIN-02015 Helsinki, Finland.
RP Seppala, JV (reprint author), Helsinki Univ Technol, Dept Chem Technol, Lab Polymer Technol, POB 6100, FIN-02015 Helsinki, Finland.
RI Seppala, Jukka/G-7698-2012
CR ALGER MSM, 1989, POLYM SCI DICT, P93
   Colthup N.B., 1975, INTRO INFRARED RAMAN
   Gresser Joseph D., 1996, P169
   GRIJPMA DW, 1994, MACROMOL CHEM PHYSIC, V195, P1633, DOI 10.1002/macp.1994.021950515
   HAN YK, 1988, J MACROMOL SCI CHEM, VA25, P847, DOI 10.1080/00222338808053402
   Hiltunen K, 1997, J APPL POLYM SCI, V63, P1091
   HUANG HH, 1989, POLYMER, V30, P2001, DOI 10.1016/0032-3861(89)90286-3
   Jokinen M, 2000, J EUR CERAM SOC, V20, P1739, DOI 10.1016/S0955-2219(00)00036-4
   Kharas GB, 1997, J APPL POLYM SCI, V66, P1123
   KIOUL A, 1994, J NON-CRYST SOLIDS, V175, P169, DOI 10.1016/0022-3093(94)90009-4
   KORHONEN H, 2000, UNPUB J APPL POLYM S
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Mascia L, 1998, POLYMER, V39, P3045, DOI 10.1016/S0032-3861(97)10088-X
   MATTSON B, 1996, COMPOS INTERFACE, V4, P57
   MATTSON B, 1996, COMPOS INTERFACE, V4, P77
   Park J. B., 1992, BIOMATERIALS INTRO, V2nd, P141
   Schapman F, 2000, POLYMER, V41, P17, DOI 10.1016/S0032-3861(99)00133-0
   Schapman F, 1998, POLYMER, V39, P965, DOI 10.1016/S0032-3861(97)00354-6
   Schapman F, 1998, POLYMER, V39, P973, DOI 10.1016/S0032-3861(97)00355-8
   Schapman F, 1998, POLYMER, V39, P4955, DOI 10.1016/S0032-3861(97)10244-0
   STOREY RF, 1993, POLYM COMPOSITE, V14, P7, DOI 10.1002/pc.750140103
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Tian D, 1996, POLYMER, V37, P3983, DOI 10.1016/0032-3861(96)00199-1
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   VERT M, 1995, J MACROMOL SCI PURE, VA32, P787, DOI 10.1080/10601329508010289
   WILLIAMS DH, 1989, SPECTROSCOPIC METHOD, P29
NR 28
TC 54
Z9 58
U1 4
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR
PY 2001
VL 42
IS 8
BP 3345
EP 3353
DI 10.1016/S0032-3861(00)00708-4
PG 9
WC Polymer Science
SC Polymer Science
GA 396CX
UT WOS:000166619700005
DA 2018-10-19
ER

PT J
AU Hao, JY
   Deng, XM
AF Hao, JY
   Deng, XM
TI Semi-interpenetrating networks of bacterial poly(3-hydroxybutyrate) with
   net-poly(ethylene glycol)
SO POLYMER
LA English
DT Article
DE semi-interpenetrating network; poly(3-hydroxybutyrate);
   net-poly(ethylene glycol)
ID POLY(ETHYLENE GLYCOL); BETA-CHITIN; HYDROGELS; MACROMER; BLENDS
AB Semi-interpenetrating network (IPN) hydrogels based on bacterial poly(3-hydroxybutyrate) (PHB) and net-poly(ethylene glycol) (net-PEG) were prepared by the UV irradiation technique. The swelling and thermal behavior of the hydrogels, os well as their mechanical properties were studied by means of swelling tests, differential scanning calorimetry and tensile experiments. Net-PEG-based hydrogels all show higher equilibrium water contents (EWCs), while a remarkably decreased EWC is observed for the hydrogel containing 75% PHB. The thermal behavior of PHB in the semi-IPNs is not greatly affected by hydrogel composition. However, the crystallinity of PEG segments is noticeably decreased by crosslinking and would further drop with increasing amount of PHB. Incorporation of semi-IPN structure with PHB could significantly improve the mechanical properties of hydrogels when compared with that of pure net-PEG. The PHB/net-PEG 150/50) semi-IPN2. ranking as that possessing the best mechanical properties in the wet state, is expected to be useful as a biomedical material. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Acad Sinica, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
RP Hao, JY (reprint author), Acad Sinica, Chengdu Inst Organ Chem, POB 415, Chengdu 610041, Peoples R China.
CR AKHTAR S, 1987, J PHARM PHARMACOL, V39, P43
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   AVELLA M, 1988, POLYMER, V29, P1731, DOI 10.1016/0032-3861(88)90384-9
   CORKHILL PH, 1990, POLYMER, V31, P1526, DOI 10.1016/0032-3861(90)90161-Q
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   Doi Y., 1990, MICROBIAL POLYESTERS
   ESCHBACH FO, 1994, ADV CHEM SER, P239
   GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P47, DOI 10.1016/0141-3910(84)90016-8
   KIM SS, 1995, POLYMER, V36, P4497, DOI 10.1016/0032-3861(95)96859-7
   KIM SS, 1995, J POLYM SCI POL CHEM, V33, P2285, DOI 10.1002/pola.1995.080331324
   Lee YM, 1997, POLYMER, V38, P2415, DOI 10.1016/S0032-3861(96)00789-6
   PEARCE R, 1994, POLYMER, V35, P3990, DOI 10.1016/0032-3861(94)90285-2
   REHBERG CE, 1945, J AM CHEM SOC, V67, P208, DOI 10.1021/ja01218a019
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
NR 14
TC 21
Z9 25
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR
PY 2001
VL 42
IS 9
BP 4091
EP 4097
DI 10.1016/S0032-3861(00)00465-1
PG 7
WC Polymer Science
SC Polymer Science
GA 403NY
UT WOS:000167050400018
DA 2018-10-19
ER

PT J
AU Hasirci, V
   Lewandrowski, K
   Gresser, JD
   Wise, DL
   Trantolo, DJ
AF Hasirci, V
   Lewandrowski, K
   Gresser, JD
   Wise, DL
   Trantolo, DJ
TI Versatility of biodegradable biopolymers: degradability and an in vivo
   application
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Interim Meeting of the
   International-Society-of-Environmental-Biotechnology (ISEB)
CY MAR 02-05, 1999
CL LEIPZIG, GERMANY
SP Int Soc Environm Biotechnol
DE biodegradation; interpenetrating networks; molecular reinforcement;
   osteointegration; polypropylene fumarate
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; STRUCTURE PROPERTY
   RELATIONSHIPS; GUIDED TISSUE REGENERATION; ETHYLENE GLYCOL) HYDROGELS;
   IN-VITRO; FRACTURE FIXATION; BONE REGENERATION; MEDICAL DEVICES;
   AQUEOUS-MEDIA; DEGRADATION
AB Biodegradable materials have various important applications in the biomedical field. There are basically two groups of polyesters which have significant importance in this field. These are polylactides and polyhydroxybutyrates. Both groups degrade via hydrolysis with the rates of degradation depending on medium properties such as pH, temperature, solvent and presence of biocatalysts, as well as on chemical compositions. In order for these biomaterials to be suitable for use in load bearing applications without deformation or warping their strengths and their capability to maintain their form must be improved. To insure dimensional stability during degradation and to match modulus and strength to that of bone, introduction of a reinforcing structure for those applications to plate fixation through the creation of an interpenetrating network might be a feasible approach. In this study, poly(lactide-co-glycolide) (PLGA), was the major structural element to be strengthened by a three-dimensional network or 'scaffold' of another biodegradable polymer, poly(propylene fumarate) (PPF). PPF would be crosslinked with a biocompatible vinyl monomer, vinylpyrrolidone (VP). Three different approaches were tested to create dimensionally stable bone plates. First, via in situ crosslinking of PPF in the presence of PLGA. Secondly, by blending of precrosslinked PPF with PLGA. Finally, by simultaneous crosslinking and molding of the PLGA, PPF and VP. These were compared against extruded or compression molded PLGA controls. Results showed that compression molding at room temperature followed by crosslinking under pressure at elevated temperature and subsequently by gamma -irradiation appeared to yield the most favorable product as judged by swelling, hardness and flexural strength data. The composition of the implant material, PLGA(3):PPF(1):VP(0.7), appeared to be suitable and formed the compositional and procedural basis for in vivo biocompatibility studies. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   Massachusetts Gen Hosp, Orthopaed Res Labs, Boston, MA 02114 USA.
   Cambridge Sci Inc, Belmont, MA 02478 USA.
RP Hasirci, V (reprint author), Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
FU NIAMS NIH HHS [1 R43 AR44317-01]
CR BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   CHRISTEL P, 1982, BIOMATERIALS 1980, P271
   Ferguson SJ, 1996, MED ENG PHYS, V18, P241, DOI 10.1016/1350-4533(95)00041-0
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   GALGUT P, 1991, J CLIN PERIODONTOL, V18, P581, DOI 10.1111/j.1600-051X.1991.tb00093.x
   GERHART TN, 1989, J BIOMED MATER RES, V23, P1, DOI 10.1002/jbm.820230102
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GOTFREDSEN K, 1994, CLIN ORAL IMPLAN RES, V5, P83, DOI 10.1034/j.1600-0501.1994.050204.x
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   MALM T, 1992, SCAND J THORACIC CAR, V1, P9
   Matsusue Y, 1996, CLIN ORTHOP RELAT R, P166
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Parsons J. R., 1979, Proceedings of the Seventh New England (Northeast) Bioengineering Conference, P162
   Partidos CD, 1996, MOL IMMUNOL, V33, P485, DOI 10.1016/0161-5890(96)00032-6
   PETER SJ, 1988, J BIOMED MATER RES, V41, P1
   POLSON AM, 1995, J PERIODONTOL, V66, P377
   ROBINSON BP, 1995, OTOLARYNG HEAD NECK, V112, P707
   SHIH C, 1995, J CONTROL RELEASE, V34, P9, DOI 10.1016/0168-3659(94)00100-9
   SKIRVING AP, 1987, CLIN ORTHOP RELAT R, P117
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Timmins M. R., 1994, Trends in Polymer Science, V2, P15
   WILLIAMS DF, 1997, MED DEVICE TECHNOL, P8
   WISE DL, 1984, BIOPOLYMERIC CONTROL, V2, pCH11
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
NR 38
TC 88
Z9 98
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD MAR 30
PY 2001
VL 86
IS 2
SI SI
BP 135
EP 150
DI 10.1016/S0168-1656(00)00409-0
PG 16
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 415XU
UT WOS:000167749500007
PM 11245902
DA 2018-10-19
ER

PT J
AU Seal, S
   Barr, TL
   Krezoski, S
   Petering, D
AF Seal, S
   Barr, TL
   Krezoski, S
   Petering, D
TI Surface modification of silicon and silica in biological environment: an
   X-ray photoelectron spectroscopy study
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE silicon; silica; XPS or ESCA; biocells; pathogenesis; surface analysis
ID TOXICITY; HEMOLYSIS; PARTICLES; CHEMISTRY; CELLS
AB The Earth's crust is primarily made of various silicate materials upon which we successfully dwell everyday. Numerous biomedical studies, however, have documented the toxicity of some of these materials when interacted with biological cells. It has become apparent that the surface chemistry of these silicates plays a key role in the cell pathogenesis, thus enhancing the value of the use of electron spectroscopy for chemical analysis (ESCA) or X-ray photoelectron spectroscopy (XPS) as a key method for analysis. Recent studies suggest that many common silicates, including silica itself, may not be innocuous to cell pathogenecity, thus suggesting their inclusion in these XPS studies. This paper presents a detailed study of the surface chemical modification of silicon and silica when interacting with Ehrlich cells. XPS studies at selected stages of cell treatment reveal cell-induced alteration in the carbon, silicon, and oxygen of these silicon-based materials as well as changes in the carbon, iron, and nitrogen of the cell chemistry. Supporting results from the atomic absorption spectroscopy show similar changes. (C) 2001 Published by Elsevier Science B.V.
C1 Univ Cent Florida, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA.
   Univ Cent Florida, Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
   Univ Wisconsin, Dept Mat Engn, Milwaukee, WI 53201 USA.
   Univ Wisconsin, Surface Studies Lab, Milwaukee, WI 53201 USA.
   Univ Wisconsin, Dept Chem, Milwaukee, WI 53201 USA.
RP Seal, S (reprint author), Univ Cent Florida, Adv Mat Proc Anal Ctr, Eng 381,4000 Univ Blvd, Orlando, FL 32816 USA.
CR ALLISON AC, 1966, J EXP MED, V124, P141, DOI 10.1084/jem.124.2.141
   ALLISON AC, 1971, ARCH INTERN MED, V128, P131, DOI 10.1001/archinte.128.1.131
   Barr T L, 1994, MODERN ESCA PRINCIPL
   BARR TL, 1995, J VAC SCI TECHNOL A, V13, P1239, DOI 10.1116/1.579868
   BARR TL, 1995, VACUUM, V46, P1391, DOI 10.1016/0042-207X(95)00159-X
   Barr TL, 1996, SURF INTERFACE ANAL, V24, P99, DOI 10.1002/(SICI)1096-9918(199602)24:2<99::AID-SIA98>3.0.CO;2-I
   BATEMAN ED, 1982, BRIT J EXP PATHOL, V63, P414
   Beamson G., 1992, HIGH RESOLUTION XPS
   BRIGGS D, 1990, PRACTICAL SURFACE AN, P6355
   DUMITRUSTANESCU R, 1994, ANALYST, V119, P689, DOI 10.1039/an9941900689
   GOODGLICK LA, 1986, CANCER RES, V46, P5558
   KAW JL, 1975, ACTA PHARMACOL TOX, V36, P225
   KESSLER DA, 1992, NEW ENGL J MED, V326, P1713, DOI 10.1056/NEJM199206183262525
   KOSKINEN H, 1983, CHEST, V83, P848, DOI 10.1378/chest.83.6.848
   KOZIN F, 1982, J COLLOID INTERF SCI, V88, P326, DOI 10.1016/0021-9797(82)90262-4
   MARKS J, 1957, Br J Ind Med, V14, P81
   MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C
   MILLER K, 1972, BRIT J EXP PATHOL, V53, P397
   MOSSMAN BT, 1985, INVITRO EFFECTS MINE, P66
   NOLAN RP, 1981, ENVIRON RES, V26, P503, DOI 10.1016/0013-9351(81)90226-7
   NOWEIR MH, 1980, BRIT J IND MED, V37, P399
   PARAZZI E, 1968, ARCH ENVIRON HEALTH, V17, P850, DOI 10.1080/00039896.1968.10665341
   RAASK E, 1980, ANN OCCUP HYG, V23, P147, DOI 10.1093/annhyg/23.2.147
   REISER KM, 1979, TOXICOLOGY, V13, P51, DOI 10.1016/0300-483X(79)90055-6
   SCHEPERS G W, 1960, Ind Med Surg, V29, P326
   Seal S, 1997, J VAC SCI TECHNOL A, V15, P1235, DOI 10.1116/1.580601
   Seal S, 1996, J VAC SCI TECHNOL A, V14, P1770, DOI 10.1116/1.580335
   SEAL S, 1995, J VAC SCI TECHNOL A, V13, P1260, DOI 10.1116/1.579871
   Seal S, 1996, P ROY SOC B-BIOL SCI, V263, P943, DOI 10.1098/rspb.1996.0140
   SEAL S, 1997, J HAZARD MATER, V53, P55
   Sherwood P. M. A., 1983, PRACTICAL SURFACE AN, P445
   SHERWOOD PMA, 1990, DATA ANAL XPS AES PR, P555
   SHI XL, 1989, J TOXICOL ENV HEALTH, V27, P435, DOI 10.1080/15287398909531314
   SUMMERTON J, 1977, EXP MOL PATHOL, V26, P113, DOI 10.1016/0014-4800(77)90071-5
   THORNE PS, 1985, ENVIRON RES, V36, P89, DOI 10.1016/0013-9351(85)90010-6
   WOLFF RK, 1981, J AEROSOL SCI, V12, P119, DOI 10.1016/0021-8502(81)90044-6
   ZISKIND M, 1976, AM REV RESPIR DIS, V113, P643
NR 37
TC 14
Z9 16
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 29
PY 2001
VL 173
IS 3-4
BP 339
EP 351
DI 10.1016/S0169-4332(01)00018-6
PG 13
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 411CD
UT WOS:000167479800020
DA 2018-10-19
ER

PT J
AU Kraft, O
   Volkert, CA
AF Kraft, O
   Volkert, CA
TI Mechanical testing of thin films and small structures
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID SENSING INDENTATION EXPERIMENTS; X-RAY-DIFFRACTION; YOUNGS MODULUS;
   BULGE TEST; MICROBEAM DEFLECTION; FRACTURE STRENGTH; HIGH-TEMPERATURE;
   SILICON-NITRIDE; THERMAL HISTORY; ALUMINUM FILMS
AB Thin films, as well as small structures, are used in many technical applications, such as semiconductor devices, information storage media, microelectromechanical systems (MEMS), and biomedical devices. The knowledge of materials properties is essential for the design and fabrication of these devices, particularly since small structures often have different properties than their bulk counterparts. This article describes the most common experimental techniques used to measure mechanical properties in small dimensions.
C1 Max Planck Inst Met Forsch, D-70174 Stuttgart, Germany.
RP Kraft, O (reprint author), Max Planck Inst Met Forsch, Seestr 92, D-70174 Stuttgart, Germany.
CR ACOSTA RE, 1992, MICROELECTRON ENG, V17, P189, DOI 10.1016/0167-9317(92)90039-T
   ALLEN MG, 1987, APPL PHYS LETT, V51, P241, DOI 10.1063/1.98460
   Arzt E, 1998, ACTA MATER, V46, P5611, DOI 10.1016/S1359-6454(98)00231-6
   Attia P, 1998, MATER RES SOC SYMP P, V518, P3, DOI 10.1557/PROC-518-3
   BADER S, 1995, MATER RES SOC SYMP P, V356, P435
   BADER S, 1995, THIN SOLID FILMS, V263, P175, DOI 10.1016/0040-6090(95)06556-3
   BADER S, 1994, J MATER RES, V9, P318, DOI 10.1557/JMR.1994.0318
   Baker SP, 1997, THIN SOLID FILMS, V308, P289, DOI 10.1016/S0040-6090(97)00556-7
   BAKER SP, 1994, J MATER RES, V9, P3145, DOI 10.1557/JMR.1994.3145
   Baker SP, 1998, MATER RES SOC SYMP P, V505, P605
   BAKER SP, 1994, J MATER RES, V9, P3131, DOI 10.1557/JMR.1994.3131
   BEAMS JW, 1959, STRUCTURE PROPERTIES, P183
   BESSER PR, 1994, J MATER RES, V9, P13, DOI 10.1557/JMR.1994.0013
   BHATTACHARYA AK, 1988, INT J SOLIDS STRUCT, V24, P1287, DOI 10.1016/0020-7683(88)90091-1
   BLEVINS RD, 1987, FORMULAS NATURAL FRE
   BROMLEY EI, 1983, J VAC SCI TECHNOL B, V1, P1364, DOI 10.1116/1.582744
   BROTZEN FR, 1994, INT MATER REV, V39, P24, DOI 10.1179/imr.1994.39.1.24
   BROTZEN FR, 1990, VACUUM, V41, P1287, DOI 10.1016/0042-207X(90)93935-C
   Buckle H., 1971, SCI HARDNESS TESTING, P453
   CARDINALE GF, 1992, THIN SOLID FILMS, V207, P126, DOI 10.1016/0040-6090(92)90112-O
   CLEMENS BM, 1992, MRS BULL, V17, P46, DOI 10.1557/S0883769400041658
   Cornella G, 1998, MATER RES SOC SYMP P, V518, P81, DOI 10.1557/PROC-518-81
   *CSEM INSTR, NAN HARDN TEST
   *CSIRO, UMIS 2000
   *DIN, 50359 DIN
   Emery R, 1998, MATER RES SOC SYMP P, V505, P57
   FLINN PA, 1991, J MATER RES, V6, P1498, DOI 10.1557/JMR.1991.1498
   FLINN PA, 1987, IEEE T ELECTRON DEV, V34, P689, DOI 10.1109/T-ED.1987.22981
   Florando J, 1999, MATER RES SOC SYMP P, V563, P231, DOI 10.1557/PROC-563-231
   GARDNER DS, 1988, MATER RES SOC S P, V130, P69
   Gerberich WW, 1996, ACTA MATER, V44, P3585, DOI 10.1016/1359-6454(96)00010-9
   Gouldstone A, 1998, J MATER RES, V13, P1956, DOI 10.1557/JMR.1998.0275
   Gudmundson P, 1999, AIP CONF PROC, V491, P217
   *HELM FISCH GMBH, FISCH
   *HELM FISCH GMBH, NAN HARDN TEST
   Hommel M, 1999, J MATER RES, V14, P2373, DOI 10.1557/JMR.1999.0317
   HOMMEL M, 1999, THESIS U STUTTGART
   *HYS INC, TRIB
   *ISO DIS, 14577 ISODIS
   Josell D, 1998, J MATER RES, V13, P2902, DOI 10.1557/JMR.1998.0397
   Kang YS, 1997, J ELECTRON MATER, V26, P805, DOI 10.1007/s11664-997-0255-9
   Keller RM, 1999, ACTA MATER, V47, P415, DOI 10.1016/S1359-6454(98)00387-5
   Keller RM, 1998, J MATER RES, V13, P1307, DOI 10.1557/JMR.1998.0186
   KING RB, 1987, INT J SOLIDS STRUCT, V23, P1657, DOI 10.1016/0020-7683(87)90116-8
   KNAUSS M, 1996, THESIS U STUTTGART
   KOLA RR, 1989, J VAC SCI TECHNOL B, V9, P3297
   Kraft O, 1998, MATER RES SOC SYMP P, V518, P39, DOI 10.1557/PROC-518-39
   Kraft O, 1998, MATER RES SOC SYMP P, V516, P201, DOI 10.1557/PROC-516-201
   KRETSCHMANN A, 1997, THESIS U STUTTGART
   Kretschmann A., 1996, MAT RES SOC P, V436, P59
   KUNERT M, 2000, THESIS U STUTTGART
   KUSCHKE WM, 1994, APPL PHYS LETT, V64, P1097, DOI 10.1063/1.110944
   LAHAV A, 1990, J APPL PHYS, V67, P734, DOI 10.1063/1.345779
   LAURSEN TA, 1992, J MATER RES, V7, P618, DOI 10.1557/JMR.1992.0618
   LIDDLE JA, 1994, MATER RES SOC SYMP P, V338, P501
   Lucas BN, 1999, METALL MATER TRANS A, V30, P601, DOI 10.1007/s11661-999-0051-7
   Macionczyk F, 1998, J MATER RES, V13, P2852, DOI 10.1557/JMR.1998.0390
   Maier-Schneider D., 1995, Sensors and Materials, V7, P121
   Mann AB, 1999, J MATER RES, V14, P2195, DOI 10.1557/JMR.1999.0643
   McElhaney KW, 1998, J MATER RES, V13, P1300, DOI 10.1557/JMR.1998.0185
   MOODY NR, 1998, MATER RES SOC S P, P522
   MOSKE M, 1988, REV SCI INSTRUM, V59, P2012, DOI 10.1063/1.1140017
   MOSKE MA, 1993, J APPL PHYS, V74, P1716, DOI 10.1063/1.354826
   *MTS SYST CORP, NANOXP
   Nakladal A, 1998, MATER RES SOC SYMP P, V518, P105, DOI 10.1557/PROC-518-105
   NIX WD, 1989, METALL TRANS A, V20, P2217, DOI 10.1007/BF02666659
   NIX WD, UNPUB
   NOYAN IC, 1987, RESIDUAL STRESS MEAS
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PAVIOT VM, 1995, MATER RES SOC SYMP P, V356, P579
   PETERSEN KE, 1979, J APPL PHYS, V50, P6761, DOI 10.1063/1.325870
   READ DT, 1993, J MATER RES, V8, P1542, DOI 10.1557/JMR.1993.1542
   Read DT, 1998, INT J FATIGUE, V20, P203, DOI 10.1016/S0142-1123(97)00080-7
   RUUD JA, 1993, J MATER RES, V8, P112, DOI 10.1557/JMR.1993.0112
   SANCHEZ JE, 1992, SCRIPTA METALL MATER, V27, P285, DOI 10.1016/0956-716X(92)90513-E
   SCHADLER L, 1995, APPL PHYS LETT, V66, P22, DOI 10.1063/1.114168
   Schlax MP, 1999, J VAC SCI TECHNOL B, V17, P2714, DOI 10.1116/1.591051
   SCHLAX MP, 1999, S EM LIGH TECHN 3 SP, V3676, P556
   Schwaiger R, 1999, SCRIPTA MATER, V41, P823, DOI 10.1016/S1359-6462(99)00231-6
   Schwaiger R., UNPUB
   SCHWEITZ JA, 1992, MRS BULL, V17, P34, DOI 10.1557/S0883769400041646
   Sharpe WN, 1997, J MICROELECTROMECH S, V6, P193, DOI 10.1109/84.623107
   Shojaei OR, 1998, THIN SOLID FILMS, V332, P202, DOI 10.1016/S0040-6090(98)01057-8
   STEWART RA, 1991, SENS MATER, V2, P285
   Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021
   Suresh S, 1998, ACTA MATER, V46, P5755, DOI 10.1016/S1359-6454(98)00226-2
   TABATA O, 1990, APPL PHYS LETT, V56, P1314, DOI 10.1063/1.103199
   TOWNSEND PH, 1992, MATER RES SOC SYMP P, V239, P37
   Tsui TY, 1996, J MATER RES, V11, P752, DOI 10.1557/JMR.1996.0091
   van Leeuwen M, 1999, J APPL PHYS, V86, P1904, DOI 10.1063/1.370986
   VENKATRAMAN R, 1992, J MATER RES, V7, P2040, DOI 10.1557/JMR.1992.2040
   VINCI RP, 1995, MATER RES SOC SYMP P, V356, P459
   VLASSAK JJ, 1992, J MATER RES, V7, P3242, DOI 10.1557/JMR.1992.3242
   VOLKERT CA, 1994, J MATER RES, V9, P1147, DOI 10.1557/JMR.1994.1147
   von Preissig FJ, 1998, MATER RES SOC SYMP P, V518, P117, DOI 10.1557/PROC-518-117
   WEIHS TP, 1988, J MATER RES, V3, P931, DOI 10.1557/JMR.1988.0931
   Yu CL, 1997, MATER RES SOC SYMP P, V446, P261
   Ziebart V, 1998, J MICROELECTROMECH S, V7, P320, DOI 10.1109/84.709651
NR 98
TC 102
Z9 102
U1 2
U2 60
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAR
PY 2001
VL 3
IS 3
BP 99
EP 110
DI 10.1002/1527-2648(200103)3:3<99::AID-ADEM99>3.0.CO;2-2
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 416AW
UT WOS:000167756600002
DA 2018-10-19
ER

PT J
AU Anderson, R
   Balls, M
   Burke, MD
   Cummins, M
   Fehily, D
   Gray, N
   de Groot, MG
   Helin, H
   Hunt, C
   Jones, D
   Price, D
   Richert, L
   Ravid, R
   Shute, D
   Sladowski, D
   Stone, H
   Thasler, W
   Trafford, J
   van der Valk, J
   Weiss, T
   Womack, C
   Ylikomi, T
AF Anderson, R
   Balls, M
   Burke, MD
   Cummins, M
   Fehily, D
   Gray, N
   de Groot, MG
   Helin, H
   Hunt, C
   Jones, D
   Price, D
   Richert, L
   Ravid, R
   Shute, D
   Sladowski, D
   Stone, H
   Thasler, W
   Trafford, J
   van der Valk, J
   Weiss, T
   Womack, C
   Ylikomi, T
TI The establishment of human research tissue banking in the UK and several
   western European countries - The report and recommendations of ECVAM
   Workshop 44
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
AB This is the report of the forty-fourth of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM's main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well-informed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of in vitro tests and their potential uses, and make recommendations about the best ways forward (1). In addition, other topics relevant to the Three Rs concept of alternatives to animal experiments have been considered in several ECVAM workshops.
   A workshop on the establishment of human research tissue banking in the UK and several western European countries was held at The Belfry, Birmingham. UK, on 8-10 September 2000, under the chairmanship of Robert Anderson (UK Human Tissue Bank [UK HTB]). There were 22 participants from six western European countries.
   The principal aim of the workshop was to explore the feasibility of establishing research tissue banks (RTBs) in the countries represented, in order to facilitate programmes of medical and pharmacotoxicological research. This report builds upon the conclusions and recommendations of ECVAM Workshop 32 on the availability of human tissue for biomedical research (2) and summarises discussions and progress made since the publication of that report, toward the provision of tissue banking services in European countries. A number of recommendations are proposed for improving the availability of human material for research through the formation of a European Network of Research Tissue Banks (ENRTB).
C1 De Montfort Univ, UK Human Tissue Bank, Leicester LE1 5XY, Leics, England.
RP Anderson, R (reprint author), De Montfort Univ, UK Human Tissue Bank, Innovat Ctr, Leicester LE1 5XY, Leics, England.
RI Weiss, Thomas/G-3989-2012; van der Valk, Jan/A-8529-2008
OI Weiss, Thomas/0000-0003-0336-0581; Sladowski,
   Dariusz/0000-0002-2453-5160
CR Anderson R, 1998, ATLA-ALTERN LAB ANIM, V26, P763
   GURNEY J, 1993, HUMAN CELLS IN IN VITRO PHARMACO-TOXICOLOGY, P315
   *NUFF COUNC BIOETH, 1995, HUM TISS ETH LEG ISS, P113
   1997, ATLA, V22, P7
NR 4
TC 20
Z9 21
U1 0
U2 2
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD MAR-APR
PY 2001
VL 29
IS 2
BP 125
EP 134
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 420VN
UT WOS:000168026100010
PM 11262758
DA 2018-10-19
ER

PT J
AU Kleps, I
   Angelescu, A
   Vasilco, R
   Dascalu, D
AF Kleps, Irina
   Angelescu, Anca
   Vasilco, Roxana
   Dascalu, Dan
TI New Micro- and Nanoelectrode Arrays for Biomedical Applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE nanoelectrode array technology; biotechnology; nano-tools
AB A very simple fabrication technology for a new electrode array architecture with pyramidal micro- or nano-electrodes (ultramicroelectrodes, or UME) is described in this paper. This technology is based on standard processes used in silicon device fabrication such as: silicon etching, metallic and dielectric film deposition. In order to release the dielectric material from the top of the pyramidal electrode, the photolithographic exposure takes place on the whole silicon surface without photolithographic mask. Different applications of these micro- and nano-electrode array in bio-medical field are presented.
C1 [Kleps, Irina; Angelescu, Anca; Vasilco, Roxana; Dascalu, Dan] Natl Inst Res & Dev Microtechnol IMT Bucharest, Bucharest, Romania.
RP Kleps, I (reprint author), Natl Inst Res & Dev Microtechnol IMT Bucharest, POB 38-160, Bucharest, Romania.
EM irinak@imt.ro
CR [Anonymous], 1997, P WTEC WORKSH ROSSL
   BIRGE RR, 1995, SCI AM, V272, P90, DOI 10.1038/scientificamerican0395-90
   Borkholder D. A., 1998, THESIS
   Dabrowski MJ, 1995, ADV MATER, V7, P1015, DOI 10.1002/adma.19950071209
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
NR 5
TC 10
Z9 10
U1 9
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD MAR
PY 2001
VL 3
IS 1
BP 29
EP 33
DI 10.1023/A:1011469102224
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KU
UT WOS:000209018500004
DA 2018-10-19
ER

PT J
AU Gurrappa, I
AF Gurrappa, I
TI Corrosion and its importance in selection of materials for biomedical
   applications
SO CORROSION PREVENTION & CONTROL
LA English
DT Article
ID ALLOYING ELEMENTS; ION-IMPLANTATION; TITANIUM-ALLOYS; WEAR BEHAVIOR;
   HYDROXYAPATITE; ADHESION; CELLS
AB BIOMEDICAL PROSTHETIC devices are artificial replacements that are used in the human body to function as original parts. Corrosion is one of the major processes that cause failures of the implant devices. In this paper, the factors responsible for causing corrosion, and the importance of corrosion in selecting suitable materials, are emphasized. The different biomaterials that have been used are reviewed, and the advantages and disadvantages of each type of alloy are reviewed. The paper also describes various laboratory-testing solutions for evaluating the performance of newer materials and coatings, to improve their properties. The role of surface engineering techniques in enhancing the biocompatibility of a variety of biomaterials is highlighted, and the results in improving corrosion resistance are presented. Finally, the necessity for innovation and development of smart materials/coatings with improved functional and biocompatible properties, either by employing surface engineering or through improving process parameters is discussed.
C1 Def Met Res Lab, Hyderabad 500258, Andhra Pradesh, India.
RP Gurrappa, I (reprint author), Def Met Res Lab, PO Kanchanbagh, Hyderabad 500258, Andhra Pradesh, India.
CR Acharya A., 1979, ASTM STP, V684, P229
   ARNAUD Y, 1986, APPL SURF SCI, V26, P12, DOI 10.1016/0169-4332(86)90049-8
   BAILEY OT, 1952, J NEUROSURG, V9, P83, DOI 10.3171/jns.1952.9.1.0083
   Bechtol CO., 1959, METALS ENG BONE JOIN
   BOROWY KH, TITANIUM BIOMEDICAL, P1381
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BRIGHTON CT, 1984, ORTHOP CLIN N AM, V15, P1
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CLINARD K, 1981, J DENT RES, V60, P682
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DFARNALFY G, 1986, SURF ENG, V2, P213
   Donachie M., 1998, ADV MATER PROCESS, V7, P63
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   FRAKER AC, 1985, 853166 NBSIR
   Fu L, 2000, SURF COAT TECH, V127, P66, DOI 10.1016/S0257-8972(00)00559-4
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Genkins G. N., 1978, PHYSL BIOCH MOUTH, P284
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GURRAPPA I, IN PRESS
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   HANSMANN H, 1993, VEREIN DTSCH GESELLS, V15, P134
   HARUYUKI K, 1992, B JAPAN I METALS, V31, P1033
   HILLE GH, 1966, J MATER, V1, P373
   Hirschhorn J.S., 1969, RES DENTAL MED MATER, P137
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   Hubler R, 1999, SURF COAT TECH, V116, P1111, DOI 10.1016/S0257-8972(99)00221-2
   ICART, 1775, J MED CHIR PHARM, V44, P169
   JERGESEN FH, 1951, STUDIES VARIOUS FACT
   JI HX, 1991, SURF COAT TECH, V45, P121, DOI 10.1016/0257-8972(91)90214-H
   JOHNSSON CB, 1993, J MAT SCI MAT MED, V4, P132
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, CELL MATER, V2, P169
   KRIGMAN MR, 1984, NEUROTOXICOLOGY, V5, P129
   KUMAR MK, 2000, P GLOB 2000 CORR M N, V1, P561
   KUMAR P, 1985, ASTM STP, V859, P30
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LAING PG, 1977, P RETR AN ORTH IMP G, P31
   LEVENTHAL GC, 1951, J BONE JOINT SURG, V33, P573
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Lister J, 1883, Br Med J, V2, P855
   LUDWIGSO.DC, 1965, MET ENG QUART, V5, P1
   MARTINELLA R, 1984, MATER RES SOC S P, V27, P711
   MASMONTEIL F, 1935, PRESSE MED, V43, P1915
   MEYER M, 1999, Z METALLKD, V90, P12
   MIROWSKY AM, 1950, J NEUROSURG, V7, P485
   Moffa J P, 1984, CDA J, V12, P45
   MORISHITA M, 1990, J JPN I MET, V54, P568, DOI 10.2320/jinstmet1952.54.5_568
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   PARGES G, 1988, SURF COAT TECH, V35, P611
   RAVASINI G, 1985, ATLAS, P136
   RHINELANDER FW, 1967, J BIOMED MATER RES, V1, P235
   RIFU J, 1991, BIOMATER, V12, P39
   ROSTOKER W, 1976, J BIOMED MATER RES, V10, P303, DOI 10.1002/jbm.820100211
   Salman N. N., 1980, THESIS CLEMSON U
   SARKAR N, 1980, J DENT RES, V59, P28
   SARKAR NK, 1983, J ORAL REHABIL, V10, P121, DOI 10.1111/j.1365-2842.1983.tb00106.x
   SELLA C, 1991, SURF COAT TECH, V45, P145
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
   SOLAR RJ, 1985, ASTM STP, V859, P161
   SOLAR RJ, 1985, ASTM STP, V859, P253
   Solar RJ, 1979, ASTM STP, P259
   STEWART KL, 1983, CLIN REMOVABLE PARTI, P31
   Venable CS, 1937, ANN SURG, V105, P917, DOI 10.1097/00000658-193706000-00006
   VENABLE CS, INTERNAL FIXATION FR
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WILLIAMS DF, 1973, IMPLANTS SURG
   WILLIS AL, 1974, PROSTAGLANDINS, V5, P1, DOI 10.1016/S0090-6980(74)80126-7
   WINSHIP KA, 1988, ADVERSE DRUG REACT, V1, P19
NR 73
TC 11
Z9 18
U1 0
U2 1
PU SCIENTIFIC SURVEYS LTD
PI BEACONSFIELD
PA PO BOX 21, BEACONSFIELD, BUCKS, ENGLAND HP9 1NS
SN 0010-9371
J9 CORROS PREVENT CONTR
JI Corrosion Prev. Control
PD MAR
PY 2001
VL 48
IS 1
BP 23
EP 37
PG 15
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 421FU
UT WOS:000168054800005
DA 2018-10-19
ER

PT J
AU Sunday, J
   Eyles, J
   Upshur, R
AF Sunday, J
   Eyles, J
   Upshur, R
TI Applying Aristotle's doctrine of causation to Aboriginal and biomedical
   understandings of diabetes
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
DE aboriginal; Aristotle; Canada; cause; diabetes
ID EXPLANATIONS; DISEASE
AB Aristotle's doctrine on causation identifies four distinct types of cause: formal, efficient, material, and final. Science is said to have differentiated itself from philosophy by concentrating solely on efficient causes. Nonetheless, when applied to narratives of causation, Aristotle's doctrine provides a useful heuristic to explore the issues such as Aboriginal and biomedical perceptions of causal factors for non-insulin dependent diabetes mellitus (NIDDM) on Manitoulin Island, Ontario. This paper also outlines two divergent causal stories for NIDDM and the associated moral positions regarding the `righteous' pursuit of health. Biomedical narratives emphasize the role of lifestyle factors, particularly the impact of obesity, in causation. In the case of diabetes, the moral course of action is pursued through lifestyle choices. In contrast, Aboriginal narratives emphasize the role of genetics in causation. These narratives describe diabetes as collectively affecting Aboriginal people - thus identifying Aboriginal people as different. Aboriginal frameworks for health venture beyond the 'efficient' cause of biomedicine and thus the moral pursuit of health within this framework involves returning to an initial state of health and purity through traditional knowledge.
C1 McMaster Univ, Hamilton, ON L8S 4K1, Canada.
RP Sunday, J (reprint author), McMaster Univ, BSB B150,1280 Main St W, Hamilton, ON L8S 4K1, Canada.
OI Upshur, Ross/0000-0003-1128-0557
CR Aristotle, 1998, METAPHYSICS
   Bernard H.R., 1995, RES METHODS ANTHR QU
   BLAXTER M, 1983, SOC SCI MED, V17, P59, DOI 10.1016/0277-9536(83)90356-8
   Boston P, 1997, Chronic Dis Can, V18, P5
   BROWN P, 1992, J HEALTH SOC BEHAV, V33, P267, DOI 10.2307/2137356
   Doyal L., 1986, EMPIRICISM EXPLANATI
   ELLIOTT S, 1994, U VICTORIA W GEOGRAP, V29, P135
   FIFE BL, 1994, SOC SCI MED, V38, P309, DOI 10.1016/0277-9536(94)90400-6
   Garro L C, 1995, Soc Sci Med, V40, P37, DOI 10.1016/0277-9536(94)00125-D
   Garro LC, 1996, CULT MED PSYCHIAT, V20, P381, DOI 10.1007/BF00117086
   GARRO LC, 1993, DIABETES DIS CIVILIZ
   GOOD B, 1994, MED RATIONALITY EXPE
   Hage J., 1988, SOCIAL CAUSALITY
   HAGEY R, 1984, SOC SCI MED, V18, P265, DOI 10.1016/0277-9536(84)90089-3
   HEFFERNAN MC, 1995, PERSISTENT SPIRIT UN
   HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064
   Hollis Martin, 1982, RATIONALITY RELATIVI
   Horton R., 1973, MODES THOUGHT ESSAYS
   HORTON R, 1970, RATIONALITY
   JOE JR, 1995, DIABETES DIS CIVILIZ
   Kleinman A., 1988, ILLNESS NARRATIVES S
   Leplin J, 1984, SCI REALISM
   LITVA A, 1994, SOC SCI MED, V39, P1083, DOI 10.1016/0277-9536(94)90380-8
   *QUAL SOL RES PTY, 1994, NUD IST VERS 4 0
   Russell B, 1984, HIST W PHILOS
   Shweder R, 1984, CULTURE THEORY ESSAY
   SMITH BE, 1981, INT J HEALTH SERV, V11, P343, DOI 10.2190/LMPT-4G1J-15VQ-KWEK
   Sontag S, 1989, ILLNESS METAPHOR AID
   Sperber D., 1985, ANTHR KNOWLEDGE
   Stacey M, 1988, SOCIOLOGY HLTH HEALI
   SZATHMARY EJE, 1994, ANNU REV ANTHROPOL, V23, P457
   Tambiah S.J, 1990, MAGIC SCI RELIG SCOP
   Taylor Charles, 1985, PHILOS HUMAN SCI
   WAKEFIELD S, 1998, QUALITATIVE ANAL PRO, P111
   Warry W., 1998, UNFINISHED DREAMS CO
   Wilson B. R, 1970, RATIONALITY
   Wilson J. D., 1991, HARRISONS PRINCIPLES
   YOUNG TK, 1990, SOC SCI MED, V31, P129, DOI 10.1016/0277-9536(90)90054-V
   YOUNG TK, 1987, DIABETES CANADIAN NA
   YOUNG TK, 1994, DIABETES DIS CIVILIZ, P21
NR 40
TC 23
Z9 23
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD MAR
PY 2001
VL 25
IS 1
BP 63
EP 85
DI 10.1023/A:1005638900581
PG 23
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA 397BU
UT WOS:000166674100003
PM 11270666
DA 2018-10-19
ER

PT J
AU White, MJ
   Yun, ZQ
   Iskander, MF
AF White, MJ
   Yun, ZQ
   Iskander, MF
TI A new 3-D FDTD multigrid technique with dielectric traverse capabilities
SO IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
LA English
DT Article
DE complex structures; dielectric traverse; electrically large;
   finite-difference time-domain method; multigrid; sub-gridding
ID SIMULATION
AB The finite-difference time-domain (FDTD) technique has become increasingly popular and is being used to model extremely complex and electrically large structures, These simulations are computationally demanding and often exceed available limits on computer resources, In this paper, we present an FDTD sub-gridding technique that allows for increased resolution in regions of interest without increasing the overall computational requirements beyond the available resources. Furthermore, the formulation presented here allows for traversing dielectric boundaries using any integer refinement factor and the maximum Courant number By allowing the coarse-/fine-grid boundary to traverse dielectric boundaries, numerical simulations that were previously either extremely difficult or impossible to perform are now possible. The technique presented here uses a weighted current value from the coarse region at the boundary between the fine- and coarse-grid regions to update the fine-region tangential fields on that boundary, The weighting function depends on the material properties and the relative position of the fine-region electric field within the current contour at the boundary. The complete formulation of this new technique is described and some results of simulation cases are presented to validate the accuracy and stability of the newly developed FDTD code. Simulations include simple cases where the analytical solution exists and more complex cases, which were impossible to model using a uniform-grid FDTD code, In some simulation examples, computer memory savings as high as 70 times what would have been necessary with a uniform-grid code were achieved, It is shown that errors of less than 2% are achievable with ratios of coarse-to-fine grid sizes exceeding ten, The new technique is expected to be used in simulating many electrically large and complex structures in the biomedical microwave processing of materials and the wireless communications areas.
C1 Univ Utah, Dept Elect Engn, Salt Lake City, UT 84112 USA.
RP White, MJ (reprint author), Univ Utah, Dept Elect Engn, Salt Lake City, UT 84112 USA.
CR BRINGHURST S, 1996, P MAT RES SOC S DIG, V430, P487
   Chevalier MW, 1997, IEEE T ANTENN PROPAG, V45, P411, DOI 10.1109/8.558656
   CHOI DH, 1986, IEEE T MICROW THEORY, V34, P1464
   Okoniewski M, 1997, IEEE T ANTENN PROPAG, V45, P422, DOI 10.1109/8.558657
   Prescott D. T., 1992, IEEE Microwave and Guided Wave Letters, V2, P434, DOI 10.1109/75.165634
   Subirats M, 1996, MATER RES SOC SYMP P, V430, P29, DOI 10.1557/PROC-430-29
   White MJ, 1997, IEEE T ANTENN PROPAG, V45, P1512, DOI 10.1109/8.633859
   White MJ, 1996, MATER RES SOC SYMP P, V430, P487, DOI 10.1557/PROC-430-487
   ZIVANOVIC SS, 1991, IEEE T MICROW THEORY, V39, P471, DOI 10.1109/22.75289
NR 9
TC 35
Z9 36
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9480
J9 IEEE T MICROW THEORY
JI IEEE Trans. Microw. Theory Tech.
PD MAR
PY 2001
VL 49
IS 3
BP 422
EP 430
DI 10.1109/22.910545
PG 9
WC Engineering, Electrical & Electronic
SC Engineering
GA 410WF
UT WOS:000167463500002
DA 2018-10-19
ER

PT J
AU Lavos-Valereto, IC
   Konig, B
   Rossa, C
   Marcantonio, E
   Zavaglia, AC
AF Lavos-Valereto, IC
   Konig, B
   Rossa, C
   Marcantonio, E
   Zavaglia, AC
TI A study of histological responses from Ti-6Al-7Nb alloy dental implants
   with and without plasma-sprayed hydroxyapatite coating in dogs
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SURFACE MODIFICATION
AB Titanium alloys are hoped to be used much more for applications as implant materials in the medical and dental fields because of their basic properties, such as biocompatibility, corrosion resistance and specific strength compared with other metallic implant materials. Thus, the Ti-6Al-7Nb alloy that has recently been developed for biomedical use, that is, primarily developed for orthopaedic use, is to be studied in this paper, for application in dental implants. The biocompatibility test in vivo was carried out in dogs and the osseointegration was verified through histological analysis of the samples of the Ti-6Al-7Nb alloy with and without hydroxyapatite coating that were inserted in the alveoli. Within the controlled conditions the samples did not show any toxic effects on the cells. (C) 2001 Kluwer Academic Publishers.
C1 Univ Sao Paulo, IPEN CNEN SP, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Biomed Sci, BR-05508 Sao Paulo, Brazil.
   State Univ Sao Paulo, Fac Dent Araraquara, Sao Paulo, Brazil.
   Univ Estadual Campinas, Dept Mat, Campinas, Brazil.
RP Lavos-Valereto, IC (reprint author), Univ Sao Paulo, IPEN CNEN SP, BR-05508 Sao Paulo, Brazil.
EM iclvaler@usp.br
RI Marcantonio, Elcio/A-4784-2008; Rossa Jr, Carlos/D-8328-2012
OI Marcantonio, Elcio/0000-0003-1294-2305; Rossa Jr,
   Carlos/0000-0003-1705-5481
CR Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   KHUR KA, 1993, P NTSC, P347
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   STREICHER RM, 1991, BIOMATERIALS, V12, P125, DOI 10.1016/0142-9612(91)90190-L
   WILLIAMS D F, 1991, Mammalian Species, P1
   WILLIAMS DF, 1987, DEFINITIONS BIOMATER, P9
NR 11
TC 22
Z9 25
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2001
VL 12
IS 3
BP 273
EP 276
DI 10.1023/A:1008975418453
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403LW
UT WOS:000167045100012
PM 15348312
DA 2018-10-19
ER

PT J
AU Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
   Sabina, FJ
   Martinez-Rosado, R
AF Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
   Sabina, FJ
   Martinez-Rosado, R
TI Overall properties of piezocomposite materials 1-3
SO MATERIALS LETTERS
LA English
DT Article
DE piezocomposite; effective properties; asymptotic homogenization;
   biomedical application
ID ULTRASONIC TRANSDUCER APPLICATIONS; COMPOSITES
AB The purpose of this paper is to present analytical expressions of the effective constants of reinforced piezoelectric composite materials with periodically distributed unidirectional cylindrical fibers for transducer applications. Each periodic cell of the medium is a binary piezoelectric composite wherein both constituents are homogeneous piezoelectric materials with hexagonal symmetry. The general formulae obtained allow the prediction of global properties of an important class of piezocomposites. Numerical calculations show an adequate concordance with other theoretical models. In the analysis, the periodicity of the structure is assumed to be much smaller than the elastic wavelength. Finally, we apply these results to a 1-3 material and obtain new piezocomposites with better global properties for biomedical imaging and hydrophone applications, (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ La Habana, Fac Matemat & Computac, Havana 10400, Cuba.
   Inst Tecnol Estudios Super Monterrey, Div Arquitectura & Ingn, Atizapan 52926, Mexico.
   Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Mexico City 01000, DF, Mexico.
RP Guinovart-Diaz, R (reprint author), Univ La Habana, Fac Matemat & Computac, Havana 10400, Cuba.
RI Sabina, Federico/A-1974-2008
OI Martinez-Rosado, Raul /0000-0001-9952-2519; Bravo-Castillero,
   Julian/0000-0002-7499-3821; Guinovart-Sanjuan, David/0000-0002-0687-0993
CR BRAVOCASTILLERO J, 1998, INT J SOLIDS STRUCT, V35, P527
   BRAVOCASTILLERO R, 1997, MECH COMPOS MATER, V33, P670
   CHAN HLW, 1989, IEEE T ULTRASON FERR, V36, P434, DOI 10.1109/58.31780
   Galka A, 1996, COMPUT ASSISTED MECH, V3, P133
   Geng XC, 1999, J APPL PHYS, V85, P1342, DOI 10.1063/1.369265
   Geng XC, 1997, IEEE T ULTRASON FERR, V44, P857, DOI 10.1109/58.655201
   Hashimoto K. Y., 1986, IEEE 1986 Ultrasonics Symposium Proceedings (Cat. No.86CH2375-4), P697
   NEWNHAM RE, 1978, MATER RES BULL, V13, P525, DOI 10.1016/0025-5408(78)90161-7
   Pastor J, 1997, MECH RES COMMUN, V24, P145, DOI 10.1016/S0093-6413(97)00006-2
   Rodriguez-Ramos R., 1996, MECH COMPOS MATER, V32, P410
   SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833
NR 11
TC 33
Z9 33
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAR
PY 2001
VL 48
IS 2
BP 93
EP 98
DI 10.1016/S0167-577X(00)00285-8
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 415ZC
UT WOS:000167752600006
DA 2018-10-19
ER

PT J
AU Samset, E
   Mala, T
   Ellingsen, R
   Gladhaug, I
   Soreide, O
   Fosse, E
AF Samset, E
   Mala, T
   Ellingsen, R
   Gladhaug, I
   Soreide, O
   Fosse, E
TI Temperature measurement in soft tissue using a distributed fibre
   Bragg-grating sensor system
SO MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
LA English
DT Article
DE biomedical engineering; fibreoptics; thermometers; magnetic resonance
   imaging; freezing; cryosurgery
ID THERMOMETRY; PROBE
AB Currently used temperature sensor systems do not provide sufficient spatial resolution and can not be used as an integrated part of minimally invasive treatment. Few magnetic resonance (MR) compatible sensor systems are available. A distributed fibre Bragg-grating sensor system for use in biological tissue was constructed. Ten Bragg gratings were inscribed in the core of an optical fibre. The fibre was mounted into tubes made of MR-compatible materials. An opto-electronic unit connected to the fibre was used for signal generation and detection. Communication with a PC allowed presentation and logging of temperature data. The system was calibrated to the temperature range -195.8 degreesC to 100 degreesC. Experiments were conducted during freezing (cryoablation) of porcine liver in vivo. The system yielded a temperature profile with 6.5 mm spatial resolution and 5 s temporal resolution. Both mechanical stability and MR compatibility were acceptable and will allow routine use.
C1 Natl Hosp Norway, Intervent Ctr, Oslo, Norway.
RP Samset, E (reprint author), Rikshosp, Intervensjonssenteret, N-0027 Oslo, Norway.
CR Daniel BL, 1999, MAGNET RESON MED, V41, P627, DOI 10.1002/(SICI)1522-2594(199903)41:3<627::AID-MRM28>3.3.CO;2-H
   DEPOORTER J, 1995, MAGNET RESON MED, V33, P74
   ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606
   LINDE DR, 1998, CRC HDB CHEM PHYSICS
   Morey W. W., 1989, P SOC PHOTO-OPT INS, V1169, P98
   Rao YJ, 1997, J LIGHTWAVE TECHNOL, V15, P779, DOI 10.1109/50.580812
   RYAN TP, 1991, J BIOMED ENG, V13, P348, DOI 10.1016/0141-5425(91)90118-Q
   Shankaranarayanan A, 1998, JMRI-J MAGN RESON IM, V8, P197, DOI 10.1002/jmri.1880080133
   Stone JG, 1997, NEUROSURGERY, V41, P20, DOI 10.1097/00006123-199707000-00007
   WANG DJ, 1994, J MAGN RESON SER B, V105, P25, DOI 10.1006/jmrb.1994.1095
   WICKERSHEIM KA, 1987, J MICROWAVE POWER EE, V22, P85
NR 11
TC 14
Z9 14
U1 0
U2 2
PU MARTIN DUNITZ LTD
PI LONDON
PA LIVERY HOUSE, 7-9 PRATT ST, LONDON NW1 0AE, ENGLAND
SN 1364-5706
J9 MINIM INVASIV THER
JI Minim. Invasive Ther. Allied Technol.
PD MAR
PY 2001
VL 10
IS 2
BP 89
EP 93
DI 10.1080/13645700152601379
PG 5
WC Surgery
SC Surgery
GA 477DP
UT WOS:000171268100004
DA 2018-10-19
ER

PT J
AU Chu, PK
   Tang, BY
   Wang, LP
   Wang, XF
   Wang, SY
   Huang, N
AF Chu, PK
   Tang, BY
   Wang, LP
   Wang, XF
   Wang, SY
   Huang, N
TI Third-generation plasma immersion ion implanter for biomedical materials
   and research
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID TITANIUM-OXIDE FILMS; DOSE UNIFORMITY; CATHODIC ARC; SURFACE
   MODIFICATION; AUXILIARY ELECTRODE; BALL-BEARINGS; SILICON;
   CONFIGURATION; DEPOSITION; METAL
AB A third generation plasma immersion ion implanter dedicated to biomedical materials and research has been designed and constructed. The distinct improvement over first and second generation multipurpose plasma immersion ion implantation equipment is that hybrid and combination techniques utilizing metal and gas plasmas, sputter deposition, and ion beam enhanced deposition can be effectively conducted in the same machine. The machine consists of four sets of high-efficiency metal arc plasma sources with magnetic filters, a custom designed high voltage modulator for operation up to 60 kV, a separate high-frequency, low-voltage power supply for hybrid treatment processes, special rotating sample stage for samples with an irregular shape, and other advanced features. The machine has been installed at Southwest Jiaotong University and operated reliably for 6 months. This article describes the design principles and performances of the machine as well as pertinent biomedical applications. (C) 2001 American Institute of Physics.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Harbin Inst Technol, Natl Key Lab, Harbin 150001, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Aksenov I. I., 1980, Soviet Physics - Technical Physics, V25, P1164
   Anders A, 2000, HDB PLASMA IMMERSION, P2
   Anders S, 1997, IEEE T PLASMA SCI, V25, P670, DOI 10.1109/27.640683
   Bilek MMM, 1996, IEEE T PLASMA SCI, V24, P1291, DOI 10.1109/27.538803
   Chu PK, 1998, IEEE T PLASMA SCI, V26, P79, DOI 10.1109/27.659535
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   DILLON RO, 1984, PHYS REV B, V29, P3482, DOI 10.1103/PhysRevB.29.3482
   EBERT R, 1982, UNP P WORLD C MED PH, P307
   Fan ZN, 1999, IEEE T PLASMA SCI, V27, P633, DOI 10.1109/27.772296
   Fan ZN, 1998, APPL PHYS LETT, V73, P202, DOI 10.1063/1.121755
   GUENZEL R, 1998, UNP 6 INT C PLASM SU
   GUENZEL R, 1999, UNP P 2 AS EUR INT C, P58
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   HUANG N, 1999, UNP 8 INT C SURF MOD
   HUANG N, 1999, UNP 5 IUMRS INT C AD
   HUANG N, UNPUB J VAC SCI TE A
   HUANG N, 2000, UNP 2 INT C IN MATT
   KOWK TK, 1999, J APPL PHYS, V85, P1
   Kwok DTK, 1999, IEEE T PLASMA SCI, V27, P225, DOI 10.1109/27.763123
   Kwok DTK, 1998, IEEE T PLASMA SCI, V26, P1669, DOI 10.1109/27.747885
   Lee BH, 1999, APPL PHYS LETT, V74, P3143, DOI 10.1063/1.124089
   LENG Y, 2000, UNP 2000 WORLD BIOM
   LENG YX, 2000, UNP 2 INT C IN MAT S
   LENG YX, IN PRESS THIN SOLID
   LI JG, 1993, BIOMATERIALS, V14, P229, DOI 10.1016/0142-9612(93)90028-Z
   Liu AG, 1999, J VAC SCI TECHNOL B, V17, P875, DOI 10.1116/1.590667
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Mantese JV, 1996, MRS BULL, V21, P52
   Martin N, 1998, SURF COAT TECH, V107, P172, DOI 10.1016/S0257-8972(98)00647-1
   Tang BY, 1998, SURF COAT TECH, V104, P248, DOI 10.1016/S0257-8972(98)00403-4
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   Tian XB, 1999, J VAC SCI TECHNOL A, V17, P3255, DOI 10.1116/1.582051
   Tian XB, 2000, SURF COAT TECH, V128, P226, DOI 10.1016/S0257-8972(00)00652-6
   Tian XB, 2000, J APPL PHYS, V88, P2221, DOI 10.1063/1.1287221
   Tian XB, 2000, SCRIPTA MATER, V43, P417, DOI 10.1016/S1359-6462(00)00436-X
   Wang SY, 1997, SURF COAT TECH, V93, P309, DOI 10.1016/S0257-8972(97)00066-2
   Wiggins MD, 1996, J VAC SCI TECHNOL A, V14, P772, DOI 10.1116/1.580387
   ZANG T, 1999, J VAC SCI TECHNOL A, V17, P3074
   Zeng XC, 1998, J APPL PHYS, V83, P44, DOI 10.1063/1.366699
   Zeng ZM, 2000, IEEE T PLASMA SCI, V28, P394, DOI 10.1109/27.848098
   Zeng ZM, 1999, J APPL PHYS, V86, P120, DOI 10.1063/1.370708
   Zeng ZM, 1999, IEEE T PLASMA SCI, V27, P1203, DOI 10.1109/27.782301
   Zhang T, 1999, REV SCI INSTRUM, V70, P3329, DOI 10.1063/1.1149913
   Zhang T, 1999, IEEE T PLASMA SCI, V27, P786, DOI 10.1109/27.774684
   Zhang T, 1999, REV SCI INSTRUM, V70, P4359, DOI 10.1063/1.1150094
   Zhang T, 2000, SURF COAT TECH, V128, P231, DOI 10.1016/S0257-8972(00)00653-8
NR 49
TC 96
Z9 105
U1 3
U2 19
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD MAR
PY 2001
VL 72
IS 3
BP 1660
EP 1665
DI 10.1063/1.1340029
PG 6
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 406BK
UT WOS:000167194900009
DA 2018-10-19
ER

PT J
AU Bobbitt, DR
   Linder, SW
AF Bobbitt, DR
   Linder, SW
TI Recent advances in chiral detection for high performance liquid
   chromatography
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Article
DE polarimeter; optical rotatory dispersion; circular dichroism; chirality;
   optical activity; enantiomer
ID POLARIMETRIC DETECTION; CIRCULAR-DICHROISM; CAPILLARY-ELECTROPHORESIS;
   ENANTIOMERIC PURITY; HPLC SEPARATION; QUANTITATION; IDENTIFICATION;
   MODEL
AB The unique response characteristics of optical activity detectors make them an important adjunct to high performance liquid chromatography (HPLC) for the analysis of biologically active molecules. The recent commercial introduction of turnkey, circular dichroism (CD) and polarimetric detection systems compatible with the sensitivity and volume requirements of HPLC will allow these detection approaches to be applied to measurement problems in a number of areas including biomedical research and diagnosis, biotechnology, as well as pharmaceutical science. The CD and polarimetric detectors respond directly to the intrinsic optical activity of the analyte, and both the magnitude and sign of the response can be used for quantitative and qualitative determinations. The information available from these detectors is difficult or impossible to obtain by other methods. In this article, the instrumental basis for both the CD and laser-based polarimetric detectors will be reviewed. Several applications will be described in which the unique response characteristics of these detection systems, either alone or in tandem with other detectors, can be used to identify chiral materials, and determine enantiomeric excess. It will be shown that this methodology is effective either without enantiomeric separation, or under conditions of low enantio-selective resolution. With this technology, a real-time assessment of enantiomeric excess can be obtained as a means to optimize and guide enantio-selective separation processes. (C)2001 Elsevier Science B.V. All rights reserved.
C1 Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
RP Bobbitt, DR (reprint author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
CR ARMSTRONG DW, 1987, ANAL CHEM, V59, P84
   Bertucci C, 2000, CHIRALITY, V12, P84, DOI 10.1002/(SICI)1520-636X(2000)12:2<84::AID-CHIR5>3.0.CO;2-G
   BOBBITT DR, 1994, ANAL APPL CIRCULAR D, pCH2
   Charney E., 1979, MOL BASIS OPTICAL AC
   de Boer T, 2000, ELECTROPHORESIS, V21, P3220, DOI 10.1002/1522-2683(20000901)21:15<3220::AID-ELPS3220>3.0.CO;2-X
   Desiderio C, 1998, J CHROMATOGR A, V807, P37, DOI 10.1016/S0021-9673(98)00061-2
   Edkins TJ, 1996, ENANTIOMER, V1, P97
   GOODALL DM, 1988, Patent No. 2197467
   Hoglund P, 1998, J PHARMACOKINET BIOP, V26, P363, DOI 10.1023/A:1021008016719
   KUDO K, 1999, J CHROMATOGR, V20, P59
   Lodevico RG, 1997, TALANTA, V44, P1353, DOI 10.1016/S0039-9140(96)02082-6
   Lodevico RG, 1998, TALANTA, V46, P907, DOI 10.1016/S0039-9140(97)00329-9
   MANNSCHRECK A, 1980, ANGEW CHEM INT EDIT, V19, P469, DOI 10.1002/anie.198004691
   MEINARD C, 1985, J CHROMATOGR, V349, P109, DOI 10.1016/S0021-9673(00)90640-X
   NG K, 1991, MICROCHEM J, V44, P25, DOI 10.1016/0026-265X(91)90071-V
   NOVOTNY M, 1994, ANAL CHEM, V66, pA646, DOI 10.1021/ac00083a002
   Pasteur L., 1848, CR HEBD ACAD SCI, V26, P535
   PURDIE N, 1989, ANAL CHEM, V61, pA77, DOI 10.1021/ac00177a001
   RICE PD, 1989, TALANTA, V36, P985, DOI 10.1016/0039-9140(89)80179-1
   RICE PD, 1989, TALANTA, V36, P473, DOI 10.1016/0039-9140(89)80231-0
   SALVADORI P, 1991, CHIRALITY, V3, P376, DOI 10.1002/chir.530030424
   Salvadori P., 1994, CIRCULAR DICHROISM P, P541
   SOLOMONS TWG, 1992, SOLOMONS ORGANIC CHE, P186
   WELCH CJ, 1995, ADV CHROMATOGR, V35, P171
   WU ZC, 1990, J CHROMATOGR, V513, P209, DOI 10.1016/S0021-9673(01)89437-1
   YEUNG ES, 1986, ANAL CHEM, V58, P1237
   YEUNG ES, 1980, ANAL CHEM, V52, P1399, DOI 10.1021/ac50059a006
NR 27
TC 46
Z9 47
U1 2
U2 11
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0165-9936
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD MAR
PY 2001
VL 20
IS 3
BP 111
EP 123
DI 10.1016/S0165-9936(00)00083-2
PG 13
WC Chemistry, Analytical
SC Chemistry
GA 407JM
UT WOS:000167268500004
DA 2018-10-19
ER

PT J
AU Griffith, LG
   Grodzinsky, AJ
AF Griffith, LG
   Grodzinsky, AJ
TI Advances in biomedical engineering
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID PROTEIN; FUTURE
AB The most visible contributions of biomedical engineering to clinical practice involve instrumentation for diagnosis, therapy, and rehabilitation. Cell and tissue engineering also have emerged as clinical realities. In the next 25 years, advances in electronics, optics, materials, and miniaturization will accelerate development of more sophisticated devices for diagnosis and therapy, such as imaging and virtual surgery. The emerging new field of bioengineering-engineering based in the science of molecular cell biology-will greatly expand the scope of biomedical engineering to tackle challenges in molecular and genomic medicine.
C1 MIT, Ctr Biomed Engn, Dept Chem Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Dept Mech Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Dept Elect Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
RP Griffith, LG (reprint author), MIT, Ctr Biomed Engn, Dept Chem Engn, Div Bioengn & Environm Hlth, 77 Mass Ave,Room 66-466, Cambridge, MA 02139 USA.
CR Bronzino J D, 2000, BIOMEDICAL ENG HDB
   BROWN CS, IN PRESS P NATL ACAD
   CORMACK AM, 1980, MED PHYS, V7, P277, DOI 10.1118/1.594708
   COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Fagette P, 1997, IEEE ENG MED BIOL, V16, P164, DOI 10.1109/51.620510
   GEDDES LA, 1983, AM J CARDIOL, V52, P403, DOI 10.1016/0002-9149(83)90147-9
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720
   HOUNSFIELD GN, 1980, MED PHYS, V7, P283, DOI 10.1118/1.594709
   KISIDAY J, 2001, SELF ASSEMBLING PEPT, V26
   LANZA RP, 2000, PRINCIPLES TISSUE EN
   Lardo AC, 2000, PEDIATR CARDIOL, V21, P80, DOI 10.1007/s002469910010
   Lauffenburger DA, 1998, CHEM BIOL, V5, pR257, DOI 10.1016/S1074-5521(98)90110-7
   LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0
   Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709
   Riccobene TA, 1999, J THEOR BIOL, V200, P207, DOI 10.1006/jtbi.1999.0988
   SCHWAN HP, 1991, IEEE ENG MED BIOL, V10, P25, DOI 10.1109/51.84182
   SEVERINGHAUS JW, 1992, ANESTHESIOLOGY, V76, P1018
   Spelman FA, 1999, IEEE ENG MED BIOL, V18, P27, DOI 10.1109/51.765186
   Stokes CL, 2000, AICHE J, V46, P430, DOI 10.1002/aic.690460302
   WELLS PNT, 1969, PHYSICAL PRINCIPLES, P282
   Yang GZ, 2000, IEEE ENG MED BIOL, V19, P120, DOI 10.1109/51.816253
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   ZOLLIKOFER CL, 1992, CARDIOVASC INTER RAD, V15, P272, DOI 10.1007/BF02733950
NR 28
TC 18
Z9 19
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0098-7484
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD FEB 7
PY 2001
VL 285
IS 5
BP 556
EP 561
DI 10.1001/jama.285.5.556
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 397TV
UT WOS:000166714200011
PM 11176858
OA Bronze
DA 2018-10-19
ER

PT J
AU Geddes, LA
   Roeder, R
AF Geddes, LA
   Roeder, R
TI Measurement of the direct-current (Faradic) resistance of the
   electrode-electrolyte interface for commonly used electrode materials
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
ID IMPEDANCE
AB The direct-current (Faradic) resistance is important because it is the highest impedance that an electrode-electrolyte interface can attain. In this study, the Faradic resistance (Rf) of identical pairs of 0.5 cm(2) electrodes of bare and chlorided silver, tin and chlorided tin, nickel-silver, copper, and carbon was measured in contact with 0.9% saline at room temperature. It was found that for positive and negative current flow, the data fit the expression R-f=R(f0)e(-alphai) (with a high coefficient of determination), where R-f0 is the zero-current Faradic resistance and alpha is a constant that describes the manner in which R-f decreases with increasing current (i). It was found that chlorided silver exhibited the lowest R-f0; removing the chloride deposit increased R-f0 by more than sixfold. Likewise, chloriding tin reduced R-f0 by a factor of about 2. Electrolytically cleaning an electrode reduced R-f0. The highest value for R-f0 was for carbon. This paper concludes with a summary of the data for R-f0 scaled to 1 cm2 electrode area for the electrode materials measured in the present study and data from the published literature. (C) 2001 Biomedical Engineering Society.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Geddes, LA (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR *AAMI ANSI, 1991, 3330 AAMI
   Artz W, 1970, Biomed Eng, V5, P300
   DARSONVAL A, 1986, COMPTES RENDUS, V38, P288
   Faraday M., 1834, PHILOS T ROY SOC LON, V124, P77
   FERRARI RK, Patent No. 5571165
   Geddes L. A., 1975, PRINCIPLES APPL BIOM
   GEDDES LA, 1969, MED BIOL ENG, V7, P49, DOI 10.1007/BF02474669
   Geddes LA, 1997, ANN BIOMED ENG, V25, P1, DOI 10.1007/BF02738534
   GETZEL WA, 1976, IEEE T BIO-MED ENG, V23, P87, DOI 10.1109/TBME.1976.324626
   GRUBBS DS, 1983, MED BIOL ENG COMPUT, V21, P232, DOI 10.1007/BF02441545
   HEATH R, 1989, Patent No. 4852585
   James WB, 1910, AM J MED SCI, V140, P408
   JENKNER FL, 1967, ELECTROEN CLIN NEURO, V23, P570, DOI 10.1016/0013-4694(67)90026-0
   KADO RT, 1964, P ANN C ENG MED BIOL, V6, P1
   MARMONT G, 1949, J CELL COMPAR PHYSL, V34, P351, DOI 10.1002/jcp.1030340303
   Mayer S, 1992, Australas Phys Eng Sci Med, V15, P38
   MAYER S, 1992, MED BIOL ENG COMPUT, V30, P538, DOI 10.1007/BF02457834
   MONTER RP, 1976, Patent No. 3976055
   RAGHEB T, 1991, ANN BIOMED ENG, V19, P151, DOI 10.1007/BF02368466
   SCHWAN HP, 1968, PHYSICAL TECHNIQ V B, V1
   Volta A., 1800, PHILOS T ROY SOC LON, V90, P403
   Warburg E, 1901, ANN PHYS-BERLIN, V6, P125
   Warburg E., 1899, Annalen der Physik und Chemie, V67, P493
NR 23
TC 20
Z9 22
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2001
VL 29
IS 2
BP 181
EP 186
DI 10.1114/1.1349699
PG 6
WC Engineering, Biomedical
SC Engineering
GA 413EA
UT WOS:000167595900009
PM 11284673
DA 2018-10-19
ER

PT J
AU Miller, KL
   Erdman, MC
   King, SH
AF Miller, KL
   Erdman, MC
   King, SH
TI Contaminating incident investigation in medicine and biomedical research
SO HEALTH PHYSICS
LA English
DT Article
DE operational topic; radioactive materials; contamination; radiation
   protection
AB Regardless of how well trained, experienced and careful individuals are, if they handle radioactive materials often enough they will eventually have a contaminating incident. When the incident occurs it is imperative that the proper actions are taken to control the incident, minimize contamination and exposure, assure that proper remediation is implemented, assure that the incident remains confined, that no others become contaminated or exposed and that effective remediation is documented. This paper discusses our approach to such incidents and discusses the incident report form and our philosophy of information recording.
C1 Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA.
EM kmiller@psu.edu
CR U. S. Nuclear Regulatory Commission, 1987, REG GUID 10 8 REV 2
NR 1
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 2001
VL 80
IS 2
SU S
BP S9
EP S11
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 392PN
UT WOS:000166420200004
PM 11197516
DA 2018-10-19
ER

PT J
AU Young, FW
AF Young, FW
TI An explanation of the persistent doctor-mortality association
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID INFANT-MORTALITY; DEVELOPED-COUNTRIES; DETERMINANTS
AB Study objective-The aim of the study is to explain the persistent but puzzling positive correlation of physicians per capita and mortality rates, when income is controlled, which has been reported many times since it was first observed in 1978. The explanation that is proposed and tested is that expanding urban-industrial regions attract an oversupply of doctors. Also, but independently, rural people migrate to urban-industrial areas where they suffer from the stress of adapting to urban-industrial life. Consequently, their death rates rise.
   Source material-Using data from the 47 Japanese prefectures, the 3000+ counties of the USA and a set of 29 mostly European countries, the explanation was examined by adding the appropriate test variable to a basic equation linking physicians per capita to mortality, net of income.
   Results-The test variables dissolved or reduced the original correlation in two of the three samples, but the signs did not change from positive to negative, as would be expected on the basis of conventional biomedical theory. The available test variable (refugees) did not reduce the correlation for the 29 countries but a particular subset of countries was identified that did.
   Conclusion-The conceptual and empirical analysis exposed the positive correlation as spurious, but the availability of medical specialists had little impact on mortality rates in competition with the social and economic variables that were used as controls.
C1 Cornell Univ, Dept Rural Sociol, Ithaca, NY 14853 USA.
RP Young, FW (reprint author), Cornell Univ, Dept Rural Sociol, Ithaca, NY 14853 USA.
CR ALVAREZDARDET C, 1993, BRIT MED J, V306, P1252, DOI 10.1136/bmj.306.6887.1252
   CHEN MK, 1985, INT J EPIDEMIOL, V14, P300, DOI 10.1093/ije/14.2.300
   CLARKE LL, 1994, RURAL SOCIOL, V59, P84
   COCHRANE AL, 1978, J EPIDEMIOL COMMUN H, V32, P200, DOI 10.1136/jech.32.3.200
   Cochrane AL, 1972, EFFECTIVENESS EFFICI
   JAYACHANDRAN J, 1986, SOC BIOL, V33, P301
   KORNHAUSER DH, 1982, JAPAN GEOGRAPHIC BAC
   MACKENBACH JP, 1990, J EPIDEMIOL COMMUN H, V44, P106, DOI 10.1136/jech.44.2.106
   Matteson DW, 1998, SOC SCI MED, V47, P1841, DOI 10.1016/S0277-9536(98)00229-9
   MCKEOWN T., 1976, ROLE MED DREAM MIRAG
   MCKINLAY JB, 1977, MILBANK FUND Q, V55, P405, DOI 10.2307/3349539
   SANKRITHI U, 1991, INT J EPIDEMIOL, V20, P565, DOI 10.1093/ije/20.2.565
   STLEGER AS, 1978, LANCET, V2, P1153
   United Nations Development Programme, 1999, HUM DEV REP 1999
   WILLIAMS R, 1993, LOCATING HLTH SOCIOL, P179
   WIMBERLEY DW, 1990, AM SOCIOL REV, V55, P75, DOI 10.2307/2095704
   YOUNG FW, IN PRESS AM J PUBLIC
NR 17
TC 14
Z9 15
U1 0
U2 0
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD FEB
PY 2001
VL 55
IS 2
BP 80
EP 84
DI 10.1136/jech.55.2.80
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 393WX
UT WOS:000166493600005
PM 11154245
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Hellberg, A
   Ulus, AT
   Christiansson, L
   Westman, J
   Leppanen, O
   Bergqvist, D
   Karacagil, S
AF Hellberg, A
   Ulus, AT
   Christiansson, L
   Westman, J
   Leppanen, O
   Bergqvist, D
   Karacagil, S
TI Monitoring of intrathecal oxygen tension during experimental aortic
   occlusion predicts ultrastructural changes in the spinal cord
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID SOMATOSENSORY EVOKED-POTENTIALS; BLOOD-FLOW; THORACOABDOMINAL AORTA;
   SURGICAL-PROCEDURES; ISCHEMIA; PERFUSION; ANEURYSM; INJURY;
   IDENTIFICATION; REPLACEMENT
AB Objective: To study the correlation between intrathecal PO2 and ultrastructural changes in the spinal cord during thoracic aortic occlusion in pigs.
   Material and methods: In 18 pigs, online intrathecal oxygenation was monitored by a multiparameter Paratrend catheter (Biomedical Sensors, High Wycombe, United Kingdom) during 60 minutes' clamping of the proximal and distal descending thoracic aorta. The animals were randomly divided into 2 groups (A and B) depending on the level of distal aortic clamping. Distal aortic perfusion was restored through an aorto-iliac shunt, which also maintained low thoracic segmental perfusion of the spinal cord in group B. Perfusion-fixation technique was used before harvesting the spinal cord specimens, which later were evaluated with light and electron microscopy by an independent observer. Intrathecal parameters were interpreted as normal if PO2 was more than 0.8 kPa and PCO2 was less than 12 kPa, as intermediate ischemia if PO2 was 0.8 or less or PCO2 was more than 12 kPa, and as absolute ischemia if PO2 was 0.8 or less and PCO2 was more than 12 kPa.
   Results: Among 6 animals with ultrastructural changes of absolute spinal cord ischemia-reperfusion injury, 5 also had absolute ischemia according to variables derived by the Paratrend catheter, The 2 methods were in agreement in 3 of 5 animals with intermediate ischemia-reperfusion changes and in 5 of 6 animals with normal findings. The accuracy of cerebrospinal fluid PO2 and PCO2 to predict electron microscopy-verified intermediate or absolute ischemia-reperfusion injury was 94%.
   Conclusions: Monitoring of intrathecal PO2 after clamping of the descending aorta correlated with ultrastructural changes in the spinal cord in this pig model.
C1 Univ Hosp, Dept Surg, SE-75185 Uppsala, Sweden.
   Univ Hosp, Dept Anesthesiol, Uppsala, Sweden.
   Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.
RP Hellberg, A (reprint author), Univ Hosp, Dept Surg, SE-75185 Uppsala, Sweden.
CR BALENTINE JD, 1978, LAB INVEST, V39, P254
   BLISARD KS, 1995, PARAPLEGIA, V33, P136, DOI 10.1038/sc.1995.30
   Christiansson L, 1998, EUR J VASC ENDOVASC, V15, P78, DOI 10.1016/S1078-5884(98)80076-2
   Christiansson L, 2000, SURGERY, V127, P571, DOI 10.1067/msy.2000.105036
   CRAWFORD ES, 1988, J THORAC CARDIOV SUR, V95, P357
   CUNNINGHAM JN, 1987, J THORAC CARDIOV SUR, V94, P275
   de Haan P, 1998, Semin Thorac Cardiovasc Surg, V10, P19
   DUCKER TB, 1978, SURG NEUROL, V10, P64
   ELMORE JR, 1991, J VASC SURG, V14, P131
   GALLA JD, 1994, J CARDIAC SURG, V9, P662, DOI 10.1111/j.1540-8191.1994.tb00900.x
   Grabitz K, 1996, J VASC SURG, V23, P230, DOI 10.1016/S0741-5214(96)70267-7
   GRUBBS PE, 1988, SURGERY, V104, P216
   Hellberg A, 2000, J VASC SURG, V31, P164, DOI 10.1016/S0741-5214(00)70078-4
   Hellberg A, 2000, EUR J VASC ENDOVASC, V19, P318, DOI 10.1053/ejvs.1999.1027
   Ishizaki M, 1999, EUR J VASC ENDOVASC, V18, P17, DOI 10.1053/ejvs.1999.0845
   Laschinger J C, 1988, J Vasc Surg, V7, P161
   LASCHINGER JC, 1987, J THORAC CARDIOV SUR, V94, P271
   LESSER RP, 1986, ANN NEUROL, V19, P22, DOI 10.1002/ana.410190105
   Mackey ME, 1997, STROKE, V28, P2012, DOI 10.1161/01.STR.28.10.2012
   MARSALA M, 1994, STROKE, V25, P2038, DOI 10.1161/01.STR.25.10.2038
   MONGAN PD, 1994, ANESTH ANALG, V78, P257, DOI 10.1213/00000539-199402000-00011
   NASLUND TC, 1992, ANN SURG, V215, P409, DOI 10.1097/00000658-199205000-00002
   Prough DS, 1998, CRIT CARE MED, V26, P1482, DOI 10.1097/00003246-199809000-00010
   Rhee RY, 1996, INT ANGIOL, V15, P153
   SHIIYA N, 1995, J VASC SURG, V21, P970, DOI 10.1016/S0741-5214(95)70225-3
   Tonnessen TI, 1997, ACTA ANAESTH SCAND, V41, P659
   TURREN LL, 1936, ARCH NEUROL PSYCHOL, V35, P789
   Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029
   Yamada T, 1998, NEUROSURGERY, V42, P626, DOI 10.1097/00006123-199803000-00033
   YAMAMOTO N, 1994, J SPINAL DISORD, V7, P285
NR 30
TC 8
Z9 8
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2001
VL 121
IS 2
BP 316
EP 323
DI 10.1067/mtc.2001.112204
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 402XW
UT WOS:000167014300017
PM 11174737
OA Bronze
DA 2018-10-19
ER

PT J
AU Mischie, A
   Maior, O
   Badea, F
   Vasilescu, M
   Caragheorgheopol, A
   Caldararu, H
   Socoteanu, R
   Pencu, G
   Constantinescu, A
AF Mischie, A
   Maior, O
   Badea, F
   Vasilescu, M
   Caragheorgheopol, A
   Caldararu, H
   Socoteanu, R
   Pencu, G
   Constantinescu, A
TI Advanced organic materials. Esters of the free stable radical
   3-carboxy-proxyl having fluorescent or complexing properties
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article
ID INSULIN MIMETIC AGENT; NITROXIDE RADICALS; DERIVATIVES; CHEMISTRY;
   BIS(MALTOLATO)OXOVANADIUM(IV); LABELS; BMOV; IONS
AB In order to design new advanced organic structures, possessing prestablished hybrid properties, the stable free radical the esters 3a-c (where: a 3-(2-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy; b 3-(3-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy; c 3-(3-hydroxy-6-methylcarbonyloxy-4H-pyran-4-one)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy) were synthesized, starting from the persistent and stable nitroxide free radical 3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxy, 1, (3-CARBOXY-PROXYL) and the bromoderivatives 2a-c (where: a 2-(alpha-bromoacetyl)-phenoxathiin; b 3-(alpha-bromoacetyl) phenoxathiin; c 6-bromomethyl-3-hydroxy-4H-pyran-4-one) in the presence of 18C6 and potassium hydroxide. The new compounds, bearing the phenoxathiin fluorescent fragment (3a,b) or the 3--hydroxy-4pyrone chelating structure (3c) linked to the proxy I-paramagnetic unit may be suitable labels in physico-chemical or biomedical processes. The spectral characteristics (IR, UV-VIS, fluorescence and EPR), the lipophilicities (determined by the RPTLC method) and the purities (from TLC densitometric analysis) of the synthesized compounds 3a-c are presented. The nitroxide free radical esters 3a-c were reduced, using ascorbic acid, cysteine, or glutathione, to the corresponding diamagnetic hydroxylamines 4a-c (where: a 3-(2-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-hydroxypyrrolidine; b 3-(3-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-hydroxypyrrolidine; c 3-(3-hydroxy-6-methylcarbonyloxy-4H-pyran-4-one)-2,2,5 5-tetramethyl-1-hydroxypyrrolidine). This process is reversible, the compounds 4a-c undergoing rapid reoxidation to the initial nitroxides 3a-c by air exposure. The hydroxylamines 4a-c were found to exhibit a greater fluorescence than the nitroxide radicalic species 3a-c.
C1 Romanian Acad, IG Murgulescu Inst Phys Chem, Bucharest 77208, Romania.
   Univ Bucharest, Dept Organ Chem, Bucharest, Romania.
   Politehn Univ, Dept Organ Chem, Bucharest, Romania.
   Inst Drugs Control & Pharmaceut Res, Bucharest, Romania.
RP Mischie, A (reprint author), Romanian Acad, IG Murgulescu Inst Phys Chem, 202 Splaiul Independentei, Bucharest 77208, Romania.
RI Vasilescu, Marilena/A-5275-2012
OI Radu, Socoteanu/0000-0003-1529-3603
CR Badea F, 1997, REV ROUM CHIM, V42, P3
   Caravan P, 1995, J AM CHEM SOC, V117, P12759
   CHIACCHIERINI E, 1968, COLLECT CHZECH CHEM, V33, P4125
   Cires L, 1998, J LUMIN, V79, P91, DOI 10.1016/S0022-2313(98)00023-4
   Constantinescu T, 2000, REV ROUM CHIM, V45, P1009
   DARWISH Y, 1994, J CHROMATOGR A, V668, P485, DOI 10.1016/0021-9673(94)80144-4
   DEGRAND C, 1993, J ORG CHEM, V58, P2573, DOI 10.1021/jo00061a037
   FORRESTER AR, 1968, ORGANIC CHEM STABLE, P180
   Hanson GR, 1996, INORG CHEM, V35, P6507, DOI 10.1021/ic960490p
   HEDLUND T, 1988, ACTA CHEM SCAND A, V42, P702, DOI 10.3891/acta.chem.scand.42a-0702
   HEWITT SD, 1989, ANN RHEUM DIS, V48, P382, DOI 10.1136/ard.48.5.382
   HIDAG K, 1986, CAN J CHEM, V64, P1482
   HIDER RC, 1990, ANN NY ACAD SCI, P237
   HILLEBRAND M, 1969, J CHEM SOC B, P755, DOI 10.1039/j29690000755
   Ionita G, 1998, JPC-J PLANAR CHROMAT, V11, P141
   KEANA JFW, 1978, CHEM REV, V78, P37, DOI 10.1021/cr60311a004
   KONTOGHIORGHES NT, 1987, CLIN CHIM ACTA, V163, P137
   LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003
   LEE TD, 1978, J ORG CHEM, V43, P4266
   LEHN JM, 1995, SUPRAMOL CHEM, P57
   LIKHTENSTEIN GI, 1990, PURE APPL CHEM, V62, P281, DOI 10.1351/pac199062020281
   LIOTTA CL, 1974, J AM CHEM SOC, V96, P2250, DOI 10.1021/ja00814a044
   LUCA C, 1993, REV ROUM CHIM, V38, P123
   MEHLHORN A, 1977, TETRAHEDRON, V33, P1489, DOI 10.1016/0040-4020(77)88010-1
   MUKKALA VM, 1989, ANAL BIOCHEM, V176, P319, DOI 10.1016/0003-2697(89)90316-3
   NELHMISH VH, 1961, J PHYS CHEM-US, V65, P229
   NICOLAE A, 1998, S BRAZ J CHEM, V6, P33
   PETROLA R, 1986, FINN CHEM LETT, V13, P129
   PETROLA R, 1985, FINN CHEM LETT, P219
   PETROLA R, 1985, FINN CHEM LETT, P207
   POU S, 1993, ANAL BIOCHEM, V212, P85, DOI 10.1006/abio.1993.1295
   REWCASTLE GW, 1991, J MED CHEM, V34, P491, DOI 10.1021/jm00106a003
   ROZANTZE.EG, 1965, TETRAHEDRON, V21, P491, DOI 10.1016/S0040-4020(01)82219-5
   SCHMILLER A, 1967, LANDOLTBORNSTEIN, V3, P300
   SHINE J, 1965, J ORG CHEM, V30, P2140
   STARKS CM, 1973, J AM CHEM SOC, V95, P3613, DOI 10.1021/ja00792a025
   STREATER M, 1990, J MED CHEM, V33, P1749, DOI 10.1021/jm00168a033
   SzajdzinskaPietek E, 1997, CHEM PHYS LETT, V270, P527, DOI 10.1016/S0009-2614(97)00395-3
   TAMURA R, 1994, ANGEW CHEM INT EDIT, V33, P878, DOI 10.1002/anie.199408781
   Vasilescu M, 1998, J PHYS CHEM B, V102, P7740, DOI 10.1021/jp981932g
   Vasiliu G., 1964, ANAL U BUC, V13, P103
   WHITE HL, 1992, DRUG DEVELOP RES, V25, P191, DOI 10.1002/ddr.430250303
   YAMAGUCHI M, 1990, PURE APPL CHEM, V62, P217, DOI 10.1351/pac199062020217
NR 43
TC 7
Z9 7
U1 1
U2 5
PU EDITURA ACADEMIEI ROMANE
PI BUCHAREST
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCHAREST RO-76117, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD FEB
PY 2001
VL 46
IS 2
BP 107
EP 113
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 521PQ
UT WOS:000173850000005
DA 2018-10-19
ER

PT J
AU Hanada, T
   Li, YJ
   Nakaya, T
AF Hanada, T
   Li, YJ
   Nakaya, T
TI Synthesis and hemocompatibilities of cellulose-containing segmented
   polyurethanes
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID CHAIN ALKYL-GROUPS; PHOSPHATIDYLCHOLINE ANALOGOUS MOIETIES;
   BLOOD-COMPATIBLE POLYURETHANES; POLY(BUTADIENE) SOFT SEGMENTS; MAIN
   CHAINS; SIDE-CHAINS; PHOSPHOLIPID POLYURETHANES; BIOMEDICAL
   APPLICATIONS; POLAR HEADGROUPS; SURFACE
AB Novel segmented polyurethanes (SPUs) have been synthesized using hydrolyzed cellulose triacetate (HCTA) and 1,4-butanediol (BD) as diol component. By altering the molar ratio of HCTA to diphenylmethane diisocyanate (MDI), a series of polymers having poly(butadiene) (PBD) diol soft segments and varying content of HCTA was prepared. Then the polymers were further deacetylated with NaOCH3/CH3OH. Viscosity measurements showed the polymers had the viscosity behavior of common polyelectrolytes. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) and water contact angle measurements revealed that the cellulose is oriented on the surface of these materials. The hemocompatibility in vitro was evaluated with platelet-rich plasma (PRP) contact tests and viewed by scanning electron microscopy (SEM) using commercial BioSpan(R) and cellulose-free SPU as control samples. platelet adhesion to cellulose-containing SPUs was inhibited by 30-75% compared with cellulose-free polyurethanes, Cell spreading was observed on the control SPUs but not on any of the other surfaces. The incorporation of cellulose into the SPUs backbone effectively reduced platelet adhesion and thus potentially could result in better hemocompatibility.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR Chen TM, 1996, MACROMOL CHEM PHYSIC, V197, P1587, DOI 10.1002/macp.1996.021970501
   Huang SL, 1999, J MEMBRANE SCI, V161, P21, DOI 10.1016/S0376-7388(99)00096-4
   Jo NJ, 1999, POLYM-KOREA, V23, P552
   Korematsu A, 1999, J MATER CHEM, V9, P647, DOI 10.1039/a806279j
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Li YJ, 1997, MACROMOL SYMP, V122, P363, DOI 10.1002/masy.19971220156
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1999, CHEM MATER, V11, P763, DOI 10.1021/cm9806432
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, EUR J PHARMACOL, V311, P163, DOI 10.1016/0014-2999(96)00426-8
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Li YJ, 1996, J BIOMAT SCI-POLYM E, V7, P893, DOI 10.1163/156856296X00066
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NAKAYA T, 1993, MAKROMOL CHEM-RAPID, V14, P77
   NAKAYA T, 1993, MACROMOL REPORTS A, V30, P349
   NISHIO K, 1978, MAKROMOL CHEM, V179, P1117
   NISHIO K, 1974, MAKROMOL CHEM, V175, P3319
   Ramesh S, 1998, J MACROMOL SCI R M C, VC38, P481
   Saunders J.H., 1962, POLYURETHANE CHEM 1
   SHIGEMASA Y, 1992, INT J BIOL MACROMOL, V14, P274, DOI 10.1016/S0141-8130(05)80040-6
   STEINMANN HW, 1970, POLYMER PREPRINTS, V11, P285
   Sugiyama K, 1997, NIPPON KAGAKU KAISHI, P816, DOI 10.1246/nikkashi.1997.816
   Sugiyama K, 1996, KOBUNSHI RONBUNSHU, V53, P115, DOI 10.1295/koron.53.115
   Sugiyama K, 1996, KOBUNSHI RONBUNSHU, V53, P496, DOI 10.1295/koron.53.496
   Tomita T, 1999, CHEM MATER, V11, P2155, DOI 10.1021/cm9901257
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   YASUZAWA M, 1986, J MACROMOL SCI CHEM, VA23, P963, DOI 10.1080/00222338608081104
NR 35
TC 17
Z9 17
U1 0
U2 10
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JAN 24
PY 2001
VL 202
IS 1
BP 97
EP 104
DI 10.1002/1521-3935(20010101)202:1<97::AID-MACP97>3.0.CO;2-C
PG 8
WC Polymer Science
SC Polymer Science
GA 398QR
UT WOS:000166767600013
DA 2018-10-19
ER

PT S
AU Dhamdhere, AR
   Malshe, AP
   Yedave, SN
   Schmidt, WF
   Brown, WD
AF Dhamdhere, AR
   Malshe, AP
   Yedave, SN
   Schmidt, WF
   Brown, WD
GP SPIE
   SPIE
TI Failure mechanisms in high power optical device packaging: Semiconductor
   laser diodes - A case study
SO 2001 INTERNATIONAL SYMPOSIUM ON MICROELECTRONICS, PROCEEDINGS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT International Symposium on Microelectronics
CY OCT 09-11, 2001
CL BALTIMORE, MD
SP Int Microelectr & Packaging Soc, SPIE
DE semiconductor laser diode; die attach; solder; reliability; optical
   packaging
AB High power semiconductor laser diodes are finding increasing applications in diverse areas like the biomedical field, cosmetics, etc. Dissimilar materials integration and thermal management are some of the primary challenges in the fabrication and packaging of reliable laser diode systems. For example, in a specific case, a high power diode needs to be mounted in a certain configuration, with the epitaxy-side down, so as to achieve efficient heat transfer. The device and package junction, particularly the die attach interface, is required to he void (micro defect)-free, stress-free, and contamination-free for uniform optical delivery and reliable optical alignment. Soft solders used in optoelectronic applications are typically subjected to extreme service conditions that may exceed temperatures in excess of two-thirds of the melting point. As a result, it is expected that the solder microstructure is metastable and subjected to nearly constant modification during processing and device operation. In this study, we investigated high power laser diode packages aged under different conditions. Analyses of the die attach interface and microscopic defects were carried out primarily using metallography, scanning electron microscopy (SEM), and scanning acoustic microscopy (SAM). It was observed that intermetallic compounds and microscopic physical defects at the die attach interface are detrimental to the transient heat transfer, and thus, to the overall package reliability.
C1 Univ Arkansas, Dept Mech Engn, Fayetteville, AR 72701 USA.
RP Dhamdhere, AR (reprint author), Univ Arkansas, Dept Mech Engn, Fayetteville, AR 72701 USA.
EM apm2@engr.uark.edu
CR ANTLER M, 1970, PLATING, V6, P615
   CINQUE RB, 1994, J ELECTRON MATER, V23, P533, DOI 10.1007/BF02670656
   GOLDSTEIN JLF, 1994, J ELECTRON MATER, V23, P477, DOI 10.1007/BF02671233
   Lee C. C., 1997, Proceedings of the Technical Program. NEPCON West '97. Conference, P1395
   Liu YM, 2000, J ELECTRON MATER, V29, P405, DOI 10.1007/s11664-000-0152-y
   Merritt SA, 1997, IEEE T COMPON PACK B, V20, P141, DOI 10.1109/96.575565
   MORRIS JW, 1997, C P INT INT EL PHOT, V2, P1529
   Nakwaski W., 1990, Electron Technology, V23, P33
   PARSEY JM, 1999, J MAT, V31, P28
   PLOTNER M, 1991, P INT C MICR EL OPT, P358
   VIANCO PT, 1994, J ELECTRON MATER, V23, P583, DOI 10.1007/BF02653343
   WEN L, 1997, S P TMS ANN M, P219
NR 12
TC 1
Z9 1
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4317-4
J9 PROC SPIE
PY 2001
VL 4587
BP 212
EP 217
PG 2
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BT85F
UT WOS:000174225600035
DA 2018-10-19
ER

PT B
AU Drozd, Z
   Hackiewicz, H
   Jezior, R
   Lasocki, J
   Lukasik, W
   Orzechowski, J
   Szwech, M
AF Drozd, Z
   Hackiewicz, H
   Jezior, R
   Lasocki, J
   Lukasik, W
   Orzechowski, J
   Szwech, M
BE Dumitrache, I
   Svasta, P
TI New flip-chip assembly system for prototyping and process investigations
SO 24TH INTERNATIONAL SPRING SEMINAR ON ELECTRONICS TECHNOLOGY: CONCURRENT
   ENGINEERING IN ELECTRONIC PACKAGING, CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 24th International Spring Seminar on Electronics Technology (ISSE 2001)
CY MAY 05-09, 2001
CL POLITEHNICA UNIV BUCHAREST, CALIMANESTI, ROMANIA
SP Hydraul & Pneumat Res Inst, Chamber Commerce & Ind Valcea, Minist Educ & Res, IEEE Romania Sect, Romanian Assoc Electr & Software Ind, Elma Trenew Electr SRL, RondElectr SRL, Diana SRL, Bere Alutus SA, Boromir SA
HO POLITEHNICA UNIV BUCHAREST
DE FC packaging; assembly system; interconnection process
AB The Flip - Chip assembly technology and new laboratory stand for investigation of FC bonding processes are presented. The prototype system was developed by Division of Precision and Electronic Product Technology in Institute of Precision and Biomedical Engineering of Warsaw University of Technology, in cooperation with Tele & Radio Research Institute in Warsaw. New idea of the system consist in application of unique measuring and positioning subsystem assuring high precision of the chip position on the substrate. Simplicity, high precision and versatility are main advantages of presented system. The assembly processes are realized in prototype scale, however the principles and physical parameters of the process are comparable with mass production processes.
   The stand will be applied for essential tests and investigations of FC technology and materials, especially for SME. It will be also useful for didactic applications.
C1 Warsaw Univ Technol, Inst Precis & Biomed Engn, Div Precis & Elect Prod Technol, PL-03922 Warsaw, Poland.
RP Drozd, Z (reprint author), Warsaw Univ Technol, Inst Precis & Biomed Engn, Div Precis & Elect Prod Technol, Ul Chodkiewicza 8, PL-03922 Warsaw, Poland.
CR ASCHENBRENNER R, 1995, KLEBETECHNOLOGIEN FL
   DROZD Z, 1999, T PRECISION ELECT TE, V4, P191
   DROZD Z, 2001, NEW LAB STAND FLIP C, P555
   DROZD Z, NEW LAB STAND INVEST
   DROZD Z, 2000, P ISSE 2000, P253
   OPPERMANN H, 1999, T PRECISION ELECTRON, V4
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7111-9
PY 2001
BP 68
EP 72
DI 10.1109/ISSE.2001.931014
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BS68V
UT WOS:000170861900015
DA 2018-10-19
ER

PT S
AU Gesualdi, MRR
   Soga, D
   Muramatsu, M
AF Gesualdi, MRR
   Soga, D
   Muramatsu, M
BE Kaufmann, GH
TI Holographic interferometry techniques using photorefractives crystals of
   sillenite family Bi12SiO20 (BSO) and their applications in analysis of
   surfaces
SO 4TH IBEROAMERICAN MEETING ON OPTICS AND 7TH LATIN AMERICAN MEETING ON
   OPTICS, LASERS, AND THEIR APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th Iberoamerican Meeting on Optics and 7th Latin American Meeting on
   Optics, Lasers, and Their Applications
CY SEP 03-07, 2001
CL TANDIL, ARGENTINA
SP Agcy Nacl Promoc Cient & Technol, Cent Latinamer Fis, Consejo Nacl Investi Cient & Tecn, Filial Buenos Aires Asociac Fis Argentina, Int Commiss Opt, Laseroptics SA, Opt Soc Amer, Spectra Phys GmbH, Abdus Salam Int Ctr Theoret Phys, SPIE, Univ Nacl Cent Provincia Buenos Aires
DE holographic interferometry; photorefractives crystals; surfaces analysis
AB The Holographic Interferometry is a Non-Destrutive Testing of analysis on surfaces in basic research, technological and biomedical fields. However, the holographic interferometry techniques in real-time with conventional materials (silver halide emulsions, photothermoplastics...) present serious difficulties. The photorefractives crystals are presenting as a attractive holographic recording medium. The phenomenon that characterizes these crystals is the photorefractive effect, consists of the refractive index modulation through photo-induced and linear electro-optic effect, allows the register of holograms of phase. Also it presents advantages as in situ self-proceeding of the recording medium and its indefinite reusability, i.e., it does not present fatigue. Thus, the objective of this work is the development of a Holographic Interferometer that uses the Photorefractive Crystal of the Sillenite Family Bi12SiO20(BSO) as holographic recording medium. Iri this direction, we search to characterize BSO crystal determining some figures of merit in diffusive regime (without applied external electric field) and drift regime (with applied external electric field). The holographic techniques of metrology axe presented in three methods: Real-Time Holographic Interferometry (RTM), Double-Exposure Holographic Interferometry (2EHI), and Time-Average Holographic Interferometry (TAM) had been studied with some applications in analisys of statics and dynamics processes on surfaces.
C1 Univ Sao Paulo, Inst Fis, Depto Fis Geral, Lab Opt, BR-05315970 Sao Paulo, Brazil.
RP Gesualdi, MRR (reprint author), Univ Sao Paulo, Inst Fis, Depto Fis Geral, Lab Opt, CP 66318, BR-05315970 Sao Paulo, Brazil.
RI Institute of Physics, USP/H-5191-2017; Gesualdi, Marcos/A-6348-2008
OI Gesualdi, Marcos/0000-0001-6839-4374; Soga, Diogo/0000-0002-4267-4244
CR Barbosa EA, 1997, OPT LASER TECHNOL, V29, P359, DOI 10.1016/S0030-3992(97)00041-8
   Georges MP, 1999, APPL PHYS B-LASERS O, V68, P1073, DOI 10.1007/s003400050749
   GUNTER P, 1988, SPRINGER TOPICS APPL, V61, P62
   KAMSHILIN AA, 1985, OPT COMMUN, V53, P23, DOI 10.1016/0030-4018(85)90254-8
   Rickermann F, 1998, OPT COMMUN, V155, P91, DOI 10.1016/S0030-4018(98)00357-5
   Yeh P., 1993, INTRO PHOTOREFRACTIV
NR 6
TC 0
Z9 0
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4126-0
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4419
BP 256
EP 260
DI 10.1117/12.437068
PG 3
WC Optics; Physics, Applied
SC Optics; Physics
GA BT28M
UT WOS:000172533500064
DA 2018-10-19
ER

PT J
AU Klajnert, B
   Bryszewska, M
AF Klajnert, B
   Bryszewska, M
TI Dendrimers: properties and applications
SO ACTA BIOCHIMICA POLONICA
LA English
DT Review
DE dendrimers; cascade molecules; PAMAM dendrimers
ID NEUTRON-CAPTURE THERAPY; DENDRITIC MACROMOLECULES; IN-VITRO; MOLECULAR
   ARCHITECTURE; STARBURST DENDRIMERS; ENERGY-TRANSFER; DELIVERY; POLYMERS;
   CHEMISTRY; WATER
AB Dendrimers are a new class of polymeric materials. They are highly branched, monodisperse macromolecules. The structure of these materials has a great impact on their physical and chemical properties. As a result of their unique behaviour dendrimers are suitable for a wide range of biomedical and industrial applications. The paper gives a concise review of dendrimers' physico-chemical properties and their possible use in various areas of research, technology and treatment.
C1 Univ Lodz, Dept Gen Biophys, PL-90237 Lodz, Poland.
RP Klajnert, B (reprint author), Univ Lodz, Dept Gen Biophys, St Banacha 12-16, PL-90237 Lodz, Poland.
RI Klajnert-Maculewicz, Barbara/J-4574-2014; Kapczynski, Marcin/K-9682-2018
OI Klajnert-Maculewicz, Barbara/0000-0003-3459-8947; Kapczynski,
   Marcin/0000-0003-3334-2835; Bryszewska, Maria/0000-0003-4676-3743
CR Adronov A, 2000, J AM CHEM SOC, V122, P1175, DOI 10.1021/ja993272e
   ALPER J, 1991, SCIENCE, V251, P1562, DOI 10.1126/science.2011736
   Archut A, 1998, J AM CHEM SOC, V120, P12187, DOI 10.1021/ja9822409
   BARTH RF, 1994, BIOCONJUGATE CHEM, V5, P58, DOI 10.1021/bc00025a008
   Bielinska A, 1996, NUCLEIC ACIDS RES, V24, P2176, DOI 10.1093/nar/24.11.2176
   Bourne MW, 1996, JMRI-J MAGN RESON IM, V6, P305, DOI 10.1002/jmri.1880060209
   Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J
   CAMINATI G, 1990, J AM CHEM SOC, V112, P8515, DOI 10.1021/ja00179a041
   Capala J, 1996, BIOCONJUGATE CHEM, V7, P7, DOI 10.1021/bc950077q
   Cooper AI, 1997, NATURE, V389, P368, DOI 10.1038/38706
   FISCHER M, 1999, ANGEW CHEM INT EDIT, V38, P884, DOI DOI 10.1002/SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO
   FRECHET JMJ, 1994, SCIENCE, V263, P1710, DOI 10.1126/science.8134834
   Gilat SL, 1999, ANGEW CHEM INT EDIT, V38, P1422, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1422::AID-ANIE1422>3.0.CO;2-V
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   HAWKER CJ, 1992, J AM CHEM SOC, V114, P8405, DOI 10.1021/ja00048a009
   HAWTHORNE MF, 1993, ANGEW CHEM INT EDIT, V32, P950, DOI 10.1002/anie.199309501
   HODGE P, 1993, NATURE, V362, P18, DOI 10.1038/362018a0
   JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226
   JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032
   KNAPEN JWJ, 1994, NATURE, V372, P659, DOI 10.1038/372659a0
   Kukowska-Latallo JF, 2000, HUM GENE THER, V11, P1385, DOI 10.1089/10430340050057468
   Liu L, 1995, J Hematother, V4, P477, DOI 10.1089/scd.1.1995.4.477
   Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   MOUREY TH, 1992, MACROMOLECULES, V25, P2401, DOI 10.1021/ma00035a017
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   ROY R, 1993, J CHEM SOC CHEM COMM, P1869, DOI 10.1039/c39930001869
   Sigal GB, 1996, J AM CHEM SOC, V118, P3789, DOI 10.1021/ja953729u
   TOMALIA D, 1994, NATURE, V372, P617, DOI 10.1038/372617a0
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X
   Weener JW, 1999, J AM CHEM SOC, V121, P10346, DOI 10.1021/ja984432+
   Wiener EC, 1996, J AM CHEM SOC, V118, P7774, DOI 10.1021/ja9536126
   Zanini D, 1998, J ORG CHEM, V63, P3486, DOI 10.1021/jo972061u
   Zhuo RX, 1999, J CONTROL RELEASE, V57, P249, DOI 10.1016/S0168-3659(98)00120-5
   Zimmerman SC, 1996, SCIENCE, V271, P1095, DOI 10.1126/science.271.5252.1095
NR 39
TC 233
Z9 237
U1 2
U2 50
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PY 2001
VL 48
IS 1
BP 199
EP 208
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 417ZQ
UT WOS:000167865700021
PM 11440170
DA 2018-10-19
ER

PT S
AU Henriques, VAR
   da Silva, CRM
AF Henriques, VAR
   da Silva, CRM
BE Salgado, L
   Filho, FA
   Muccilo, R
TI Production of titanium alloys for medical implants by powder metallurgy
SO ADVANCED POWDER TECHNOLOGY II
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 2nd International Latin-American Conference on Power Technology
CY NOV, 1999
CL FOZ DO IGUACU, BRAZIL
SP Air Liquide, Belgo Brasileira, brassinter, CCDM, Cofap, Combusto Metalpo, CCP, Degussa Huls, Forjisnter, Gasbarre Sinterite, Hoeganaes, Hoganas, Mahle Metal Leve Miba, OMG Amer, Osterwalder, Penn Team, Zoz
DE powder metallurgy; surgical implants; titanium alloy
AB Titanium alloys are expected to be much more widely used for implant materials in the medical and dental fields because of their superior biocompatibillity, corrosion resistance and specific strength compared with other metallic implant materials. Vanadium free alloys like Ti-6Al-7Nb and Ti-5Al-2,5Fe have been recently developed for biomedical use. More recently vanadium and aluminum free alloys composed of non-toxic elements like Nb, Ta, Zr and so on with lower modulus have been started to be developed. The beta type alloys like Ti-15Mo are now the main target for medical materials. A blended elemental titanium powder metallurgy process has been developed to offer low cost products. The process employs hydride-dehydride (HDH) powders and near-net shape techniques. In this work, the influence of the processing parameters and chemical composition of the elementary powders on the final microstructure was investigated. The alloys were characterized by means of scanning electron microscopy, X-ray diffraction, Vickers microhardness measurements, chemical analysis and density. The results indicate that the samples presented high densification, homogeneous chemical composition and coherent microstructures. The process parameters were defined aiming to reduce the interstitial pick-up (O, N) and to avoid the grain growth.
C1 Fac Engn Quim Lorena FAENQUIL, Dept Engn Mat DEMAR, BR-12600000 Lorena, SP, Brazil.
   AMR, IAE, CTA, Div Mat, BR-12228904 Sao Jose Dos Campos, Brazil.
RP Henriques, VAR (reprint author), Fac Engn Quim Lorena FAENQUIL, Dept Engn Mat DEMAR, Caixa Postal 116, BR-12600000 Lorena, SP, Brazil.
RI da Silva, Cosme/J-1394-2018; Henriques, Vinicius/G-2465-2012
OI da Silva, Cosme/0000-0001-6301-6446; 
CR Andersen P. J., 1980, PRECIS MET, V104, P34
   BOBROVA E, 1994, POWDER METALLURGY
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BULLY RL, 1992, J ARTHOPLASTY, V7, P315
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Froes F.H., 1998, J MET, V9, P41
   Froes F.H., 1985, POWDER METALLURGY IN, V17, P47
   German R. M., 1996, SINTERING THEORY PRA
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Mitkov M, 1996, MATER CHARACT, V37, P53, DOI 10.1016/S1044-5803(96)00061-7
   PRENDERGAST P, 1990, J BIOMED ENG, V1295, P370
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   SLANINA P, 1985, ACTA PHARMACOL TOX, V56, P3331
   VANDERVOET GB, 1991, ALUMINUM NEROTOXITY, P235
   ZWICKER R, 1980, MET SOC AIME, P505
NR 17
TC 9
Z9 9
U1 2
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-864-8
J9 KEY ENG MAT
PY 2001
VL 189-1
BP 443
EP 448
DI 10.4028/www.scientific.net/KEM.189-191.443
PG 6
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering;
   Materials Science, Composites
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BS01C
UT WOS:000168303300070
DA 2018-10-19
ER

PT J
AU Pena-Rodriguez, G
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
AF Pena-Rodriguez, G
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
TI Measurement of thermal diffusivity of bone, hydroxyapatite and metals
   for biomedical application
SO ANALYTICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Photoacoustic and Photothermal
   Phenomena
CY JUN 06-09, 2000
CL KYOTO, JAPAN
SP Japan Soc Analyt Chem, Spectroscop Soc Japan, Japan Soc Promot Sci, Commemorat Assoc Japan World Exposit (1970), Inoue Fdn Sci, Tokyo Ohka Fdn Promot Sci & Technol Japan, Asahi Glass Fdn, Kao Fdn Arts & Sci, Fdn Promot Mat Sci & Technol Japan
ID SILICON; SOLIDS
AB We present a microstructural study and thermal diffusivity measurements at room temperature in two different sections of bull dense bone, bull bone and commercial hydroxyapatite, the last two in powder form. A comparison tvas made between these measured values and those obtained from metallic samples frequently used in implants such as high purity titanium and 316L stainless steel. Our results show that the porosity and its orientation in the bone are two important factors for the heat flux through the bone. The hydroxyapatite, in compact powder form, presents a thermal diffusivity value very near to those obtained for the bone samples which gives a good thermal agreement between these materials. Finally, one order of magnitude of difference among the thermal diffusivity values of metallic samples and those corresponding values to bone and hydroxyapatite was obtained, this difference being greater in titanium than in stainless steel.
C1 IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Phys Lab, Mexico City 11500, DF, Mexico.
   Univ Francisco de Paula Santander, Cucuta, Colombia.
   Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07000, DF, Mexico.
RP Arenas, AC (reprint author), IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Phys Lab, Legaria 694,Colonia Irrigac, Mexico City 11500, DF, Mexico.
CR Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1998, J APPL PHYS, V84, P6327, DOI 10.1063/1.368957
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   LOPEZ CV, 2000, J MATER RES, V15, P85
   MARQUEZINI MV, 1991, MEAS SCI TECHNOL, V2, P396, DOI 10.1088/0957-0233/2/4/020
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Rosencwaig A., 1980, PHOTOACOUSTICS PHOTO
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 11
TC 0
Z9 0
U1 0
U2 1
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PY 2001
VL 17
SI SI
BP S378
EP S381
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 428UZ
UT WOS:000168481200108
DA 2018-10-19
ER

PT J
AU Rodriguez, GP
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
AF Rodriguez, GP
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
TI Measurement of thermal diffusivity of bone, hydroxyapatite and metals
   for biomedical application
SO ANALYTICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Photoacoustic and Photothermal
   Phenomena
CY JUN 06-09, 2000
CL KYOTO, JAPAN
SP Japan Soc Analyt Chem, Spectroscop Soc Japan, Japan Soc Promot Sci, Commemorat Assoc Japan World Exposit (1970), Inoue Fdn Sci, Tokyo Ohka Fdn Promot Sci & Technol Japan, Asahi Glass Fdn, Kao Fdn Arts & Sci, Fdn Promot Mat Sci & Technol Japan
ID SILICON; SOLIDS
AB We present a microstructural study and thermal diffusivity measurements at room temperature in two different sections of bull dense bone, bull bone and commercial hydroxyapatite, the last two in powder form. A comparison was made between these measured values and those obtained from metallic samples frequently used in implants such as high purity titanium and 316L stainless steel. Our results show that the porosity and its orientation in the bone are two important factors for the heat flux through the bone. The hydroxyapatite, in compact powder form, presents a thermal diffusivity value very near to those obtained for the bone samples which give a good thermal agreement between these materials. Finally, one order of magnitude of difference among the thermal diffusivity values of metallic samples and those corresponding values to bone and hydroxyapatite was obtained, this difference being greater in titanium than in stainless steel.
C1 IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Mexico City 11500, DF, Mexico.
   Univ Francisco de Paula Santander, Cucuta, Colombia.
   Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Phys, Mexico City 07000, DF, Mexico.
RP Arenas, AC (reprint author), IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Legaria 694,Colonia Irrigac, Mexico City 11500, DF, Mexico.
CR Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1998, J APPL PHYS, V84, P6327, DOI 10.1063/1.368957
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   LOPEZ CV, 2000, J MATER RES, V15, P85
   MARQUEZINI MV, 1991, MEAS SCI TECHNOL, V2, P396, DOI 10.1088/0957-0233/2/4/020
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Rosencwaig A., 1980, PHOTOACOUSTICS PHOTO
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 11
TC 8
Z9 8
U1 0
U2 3
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PY 2001
VL 17
SI SI
BP S357
EP S360
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 428UZ
UT WOS:000168481200102
DA 2018-10-19
ER

PT J
AU Risbud, M
AF Risbud, M
TI Tissue engineering: implications in the treatment of organ and tissue
   defects
SO BIOGERONTOLOGY
LA English
DT Article
DE artificial organs; biomaterials; cell culture; tissue engineering
ID POLYVINYL PYRROLIDONE HYDROGELS; IN-VITRO; ARTICULAR-CARTILAGE;
   CELL-CULTURE; BIOARTIFICIAL PANCREAS; ISLET TRANSPLANTATION; SURFACE
   MODIFICATION; ENDOCRINE PANCREAS; ARTIFICIAL CORNEA; HOLLOW FIBERS
AB The loss or failure of organs and tissues due to injury/trauma or ageing is one of the major causes for concern in human health care. Tissue engineering, a new emerging field in modem biomedical sciences, promises a new ray of hope for transplantation biology by creating viable substitutes for such failing organs or tissues. Tissue engineering is rapidly growing in both scope and importance within biomedical engineering. It represents the marriage of rapid developments in cellular and molecular biology on the one hand and materials, chemical and mechanical engineering on the other. The ability to manipulate and reconstitute tissue function has tremendous clinical implications and is likely to play a key role in cell and gene therapies in the coming years. This article discusses the basic principles of tissue engineering and some of the attempts made to provide solutions by engineering tissues in vitro.
C1 Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
RP Risbud, M (reprint author), Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
EM mrisbud@hotmail.com
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   *AM LIV FDN, 1988, VIT STAT US A, V2
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   BUTOR C, 1992, EXP CELL RES, V203, P115, DOI 10.1016/0014-4827(92)90046-B
   Campbell JH, 1999, CIRC RES, V85, P1173
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CHICK WL, 1975, SCIENCE, V187, P847, DOI 10.1126/science.187.4179.847
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   GALLETTI PM, 1981, T AM SOC ART INT ORG, V27, P185
   GATES RJ, 1977, LANCET, V2, P1257
   Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRIFFITH M, 1998, INVEST OPHTH VIS SCI, V38, P3948
   Gruessner R W, 1996, Transpl Int, V9 Suppl 1, pS251, DOI 10.1111/j.1432-2277.1996.tb01624.x
   Hardikar AA, 2000, TRANSPLANT P, V32, P824, DOI 10.1016/S0041-1345(00)00995-7
   Hardikar AA, 1999, J BIOSCIENCE, V24, P371, DOI 10.1007/BF02941251
   Hickey DP, 1997, J UROLOGY, V157, P2042, DOI 10.1016/S0022-5347(01)64670-6
   Hicks CR, 1997, SURV OPHTHALMOL, V42, P175, DOI 10.1016/S0039-6257(97)00024-6
   Honda M, 2000, J ORAL MAXIL SURG, V58, P767, DOI 10.1053/joms.2000.7262
   Hou QP, 1999, ADV DRUG DELIVER REV, V35, P271, DOI 10.1016/S0169-409X(98)00077-5
   HYMER WC, 1981, NEUROENDOCRINOLOGY, V32, P339, DOI 10.1159/000123184
   IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711
   Kawakami Y, 1997, CELL TRANSPLANT, V6, P541, DOI 10.1016/S0963-6897(97)00074-2
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Klapperich C, 1999, J ARTHROPLASTY, V14, P877, DOI 10.1016/S0883-5403(99)90042-6
   KOECHLIN N, 1991, EUR J CELL BIOL, V54, P224
   KOO J, 1993, INT J ARTIF ORGANS, V16, P557
   L'Heureux N, 1998, FASEB J, V12, P47
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza RP, 1999, TRANSPLANTATION, V67, P1105, DOI 10.1097/00007890-199904270-00004
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Legeais JM, 1998, BIOMATERIALS, V19, P1517, DOI 10.1016/S0142-9612(98)00069-6
   Lhommeau C, 1997, J MATER SCI-MATER M, V8, P163, DOI 10.1023/A:1018575220505
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lindner MD, 1998, CELL TRANSPLANT, V7, P165, DOI 10.1016/S0963-6897(97)00169-3
   LIU CM, 1993, PLANT J, V3, P291, DOI 10.1111/j.1365-313X.1993.tb00179.x
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   Nagamori S, 2000, J GASTROENTEROL, V35, P493, DOI 10.1007/s005350070071
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Prevost P, 1997, ANN NY ACAD SCI, V831, P344
   Risbud H, 2000, CELL TRANSPLANT, V9, P25
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   RISBUD MV, 2000, IN PRESS CELL TRANSP
   Ritter EF, 1997, SURGERY, V122, P888, DOI 10.1016/S0039-6060(97)90329-9
   Robert L, 2000, BIOGERONTOLOGY, V1, P123, DOI 10.1023/A:1010048014925
   Saito A, 1997, SURG TODAY, V27, P907, DOI 10.1007/BF02388137
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SOLDANI G, 1992, J MATER SCI-MATER M, V3, P371, DOI 10.1007/BF00705370
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Stegall MD, 1996, TRANSPLANTATION, V61, P1272, DOI 10.1097/00007890-199604270-00027
   Stockley TL, 2000, J LAB CLIN MED, V135, P484, DOI 10.1067/mlc.2000.106804
   Tatarkiewicz K, 1999, TRANSPLANTATION, V67, P665, DOI 10.1097/00007890-199903150-00005
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WALSHREITZ MM, 1984, AM J PHYSIOL, V247, pC321
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   YANG MB, 1994, CELL TRANSPLANT, V3, P373, DOI 10.1177/096368979400300504
   ZEKORN T, 1989, TRANSPLANT P, V21, P2748
NR 86
TC 32
Z9 34
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2001
VL 2
IS 2
BP 117
EP 125
DI 10.1023/A:1011585117310
PG 9
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 448EF
UT WOS:000169613400006
PM 11708378
DA 2018-10-19
ER

PT S
AU Shaw, MA
   Spillman, WB
   Meissner, KE
   Gabbard, J
AF Shaw, MA
   Spillman, WB
   Meissner, KE
   Gabbard, J
BE Bearman, GH
   Bornhop, DJ
   Levenson, RM
TI Virtual reality techniques for the visualization of biomedical imaging
   data
SO BIOMARKERS AND BIOLOGICAL SPECTRAL IMAGING
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biomarkers and Biological Spectral Imaging
CY JAN 23, 2001
CL SAN JOSE, CA
SP USAF Off Sci Res, SPIE
AB The Optical Sciences & Engineering Research Center (OSER) at Virginia Polytechnic and State University investigates advanced laser surgery optics, biocompatible material for implants, and diagnostic patches and other diagnostic and drug delivery tools. The Center employs optics to provide new biological research tools for visualization, measurement, analysis and manipulation. The Center's Research into Multispectral Medical Analysis and Visualization techniques will allow human and veterinary medical professionals to diagnose various conditions of the body in much the same way that satellite information is used to study earth resources. Each pixel in the image has an associated spectra. Advanced image analysis techniques are combined with cross-correlation of the spectra with signatures of known conditions, allowing automated diagnostic assistance to physicians. The analysis and visualization system consists of five components: data acquisition, data storage, data standardization, data analysis, and data visualization. OSER research efforts will be directed toward investigations of these system components as an integrated tool for next generation medical diagnosis. OSER will research critical data quality and data storage issues, mult-spectral sensor technologies, data analysis techniques, and diagnostic visualization systems including the V-T-CAVE,(www.cave.vt.edu). The VT-CAVE is Virginia Tech's configuration of Fakespace Systems, Inc Virtual Reality system.
C1 Virginia Polytech Inst & State Univ, Opt Sci & Engn Res Ctr, Blacksburg, VA 24061 USA.
RP Shaw, MA (reprint author), Virginia Polytech Inst & State Univ, Opt Sci & Engn Res Ctr, Blacksburg, VA 24061 USA.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3937-1
J9 PROC SPIE
PY 2001
VL 4259
BP 24
EP 28
DI 10.1117/12.432497
PG 5
WC Engineering, Biomedical; Optics; Imaging Science & Photographic
   Technology
SC Engineering; Optics; Imaging Science & Photographic Technology
GA BT01W
UT WOS:000171643400005
DA 2018-10-19
ER

PT J
AU Coombes, AGA
   Breeze, V
   Wu, LL
   Gray, T
   Parker, KG
   Parker, T
AF Coombes, AGA
   Breeze, V
   Wu, LL
   Gray, T
   Parker, KG
   Parker, T
TI Lactic acid-stabilised albumin for microsphere formulation and
   biomedical coatings
SO BIOMATERIALS
LA English
DT Article
DE albumin stabilisation; microspheres; coatings; vascular grafts
ID VASCULAR PROSTHESES; SERUM-ALBUMIN; PROTEIN; GRAFT; COMPATIBILITY;
   POLYURETHANE; DELIVERY; INVIVO
AB Microspheres of ovalbumin (OVA) ranging from 1 to 15 mum were prepared by emulsifying an aqueous solution of albumin in soya oil at room temperature then raising the temperature to 45 degreesC for 30 min, prior to harvesting of the microspheres. Production of OVA nanospheres with size less than 500 nm was achieved by desolvation from aqueous albumin solutions using acetone. In both cases, lactic acid was added to the starting albumin solution to stabilise the resulting particles. Utilisation of an endogenous substance avoids the use of chemical crosslinking agents such as glutaraldehyde and associated toxicological concerns. Protein coating of knitted Dacron vascular grafts was performed by impregnation of the textile structure with lactic acid-stabilised ovalbumin nanospheres thereby providing a surface potentially resistant to blood platelet adhesion but conducive to endothelialisation, Protein release testing carried out in PBS at 37 degreesC revealed that approximately 60% of the original albumin coating was retained by the Dacron graft material after 4 days and remained at this level for upto 4 weeks. Apart from the formulation of albumin microspheres for drug delivery, diagnostic applications and coating of biomedical textiles, the process of albumin stabilisation using lactic acid may be usefully applied to improve protein immobilisation on a wide range of biomaterial surfaces. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England.
   Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Sch Med, Nottingham NG2 7FP, England.
   Univ Hosp, Queens Med Ctr, Dept Histopathol, Nottingham NG2 7FP, England.
RP Coombes, AGA (reprint author), Aston Univ, Aston Pharm Sch, Aston Triangle, Birmingham B4 7ET, W Midlands, England.
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   ARSHADY R, 1990, J CONTROL RELEASE, V14, P111, DOI 10.1016/0168-3659(90)90149-N
   BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   CAPPELLO J, 1997, CONTROLLED DRUG DELI, P439
   CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
   Coombes AGA, 1996, VACCINE, V14, P1429, DOI 10.1016/S0264-410X(96)00077-1
   CZIPERLE DJ, 1992, J CARDIOVASC SURG, V33, P407
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   HAKE U, 1991, THORAC CARDIOV SURG, V39, P208, DOI 10.1055/s-2007-1022711
   HIRT SW, 1993, J VASC SURG, V17, P538
   HORA MS, 1990, PHARMACEUT RES, V7, P1190, DOI 10.1023/A:1015948829632
   Lin W, 1993, J DRUG TARGET, V1, P237, DOI 10.3109/10611869308996081
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   PAVANETTO F, 1994, J MICROENCAPSUL, V11, P445, DOI 10.3109/02652049409034262
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   REMY M, 1994, J MATER SCI-MATER M, V5, P808, DOI 10.1007/BF00213139
   RUMISEK JD, 1986, J VASC SURG, V4, P136, DOI 10.1067/mva.1986.avs0040136
   RYU G, 1992, T AM SOC ART INT ORG, V38, pM644
   SCHWENDEMAN SP, 1997, CONTROLLED DRUG DELI, P229
   STANSBY G, 1994, BRIT J SURG, V81, P1286, DOI 10.1002/bjs.1800810908
   Takahata H, 1998, J CONTROL RELEASE, V50, P237, DOI 10.1016/S0168-3659(97)00145-4
   TOMLINSON E, 1987, POLYM CONTROLLED DRU, P25
   ZDANOWSKI Z, 1993, APMIS, V101, P926, DOI 10.1111/j.1699-0463.1993.tb00203.x
NR 24
TC 12
Z9 24
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2001
VL 22
IS 1
BP 1
EP 8
DI 10.1016/S0142-9612(00)00074-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 367BG
UT WOS:000090041200001
PM 11085377
DA 2018-10-19
ER

PT S
AU Lechna-Marczynska, MA
   Podbielska, H
   Ulatowska-Jarza, A
   Holowacz, I
   Andrzejewski, D
AF Lechna-Marczynska, MA
   Podbielska, H
   Ulatowska-Jarza, A
   Holowacz, I
   Andrzejewski, D
BE Chiou, AET
   Podbielska, H
   Jacques, SL
TI Sol-gel optics for biomeasurements
SO BIOPHOTONICS INSTRUMENTATION AND ANALYSIS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biophotonics Instrumentation and Analysis
CY NOV 28-29, 2001
CL SINGAPORE, SINGAPORE
SP SPIE, Nanyang Technol Univ
DE sol-gel bulks; films; optodes; biomeasurements
ID BIOSENSOR; SENSOR
AB Sol-gel technique is a method for producing of glass-like materials without involving a melting process. Organic compounds such as alcoholates of silicon, sodium or calcium can be used. The irregular noncrystalline network forms a gel structure where the metallic atoms are bonded to oxygen atoms. Low-temperature treatment turns this gel into an inorganic glass-like structure. There are numbers of applications C of these materials that can be produced in various forms and shapes. Here, silica based sol-gel bulks and thin films optodes for biomedical applications will be presented.
C1 Wroclaw Univ Technol, Inst Phys, Bioopt Grp, Wroclaw, Poland.
RP Lechna-Marczynska, MA (reprint author), Wroclaw Univ Technol, Inst Phys, Bioopt Grp, Wybrzeze Wyspianskiego 27, Wroclaw, Poland.
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530
CR Andrzejewski D, 2001, OPTIK, V112, P158, DOI 10.1078/0030-4026-00029
   Andrzejewski D, 2000, OPT APPL, V30, P503
   BALDINI F, 1993, Patent No. 93A125
   Blyth DJ, 1996, ANALYST, V121, P1975, DOI 10.1039/an9962101975
   Bottcher H, 1998, J SOL-GEL SCI TECHN, V13, P277, DOI 10.1023/A:1008603622543
   BRAUN S, 1992, J NON-CRYST SOLIDS, V147, P739, DOI 10.1016/S0022-3093(05)80708-2
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   EBELMEN M, 1845, CR HEBD ACAD SCI, V21, P502
   GLEZER V, 1993, J AM CHEM SOC, V115, P2533, DOI 10.1021/ja00059a072
   KONCKI R, 1995, BIOSENS BIOELECTRON, V10, P653, DOI 10.1016/0956-5663(95)96955-X
   LOBNIK A, 1997, 9 INT WORKSH GLASS C
   Maruszewski K, 1998, J MOL STRUCT, V450, P193, DOI 10.1016/S0022-2860(98)00428-1
   POPE EJA, 1997, 9 INT WORKSH GLASS C
   PREININGER C, 1994, ANAL CHEM, V66, P1841, DOI 10.1021/ac00083a011
   SCHAEFER DW, 1994, MRS BULL, V19, P14
   Sieminska L, 1996, J PHYS CHEM-US, V100, P4591, DOI 10.1021/jp952759g
   Stachs O, 1999, J SOL-GEL SCI TECHN, V15, P23, DOI 10.1023/A:1008767720995
   Trinkel M, 1996, ANAL CHIM ACTA, V320, P235, DOI 10.1016/0003-2670(95)00540-4
   ULATOWSKAJARZA A, 2001, THESIS WROCLAW U TEC
   WOLFBEIS OS, 1993, SPIE P, V2085
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN
   ZUSMAN R, 1990, J NON-CRYST SOLIDS, V122, P107, DOI 10.1016/0022-3093(90)90232-B
NR 22
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4327-1
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4597
BP 75
EP 80
DI 10.1117/12.446640
PG 6
WC Engineering, Biomedical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BT92Z
UT WOS:000174463700011
DA 2018-10-19
ER

PT J
AU Heras, A
   Rodriguez, NM
   Ramos, VM
   Agullo, E
AF Heras, A
   Rodriguez, NM
   Ramos, VM
   Agullo, E
TI N-methylene phosphonic chitosan: A novel soluble derivative
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE N-methylene phosphonic chitosan; phosphonomethylation; chitosan soluble
   derivative; H-1 NMR; C-13 NMR
ID SOLUBILITY; H-1-NMR
AB A novel water-soluble chitosan derivative carrying phosphonic groups was synthesized using a one-step reaction that allowed homogeneous modifications without any sharp decrease in its properties, such as filmogenic capacity (this compound and its synthesis have been protected with a patent). The H-1 NMR, C-13 NMR assignments and H-1-C-13 NMR correlation permitted the identification of the structure by the subtituent distribution of the product, which is partly N-monophosphonomethylated (0.24) and N,N-diphosphonomethylated (0.14) and N-acetylated (0.16) without modification of the initial degree of acetylation. The identity of the N-methylene phosphonic chitosan was confirmed by FT-IR spectrometry, X-ray diffraction and elemental analysis. Taking advantage of the known chelating ability of the phosphonic groups, especially for calcium, this new derivative opens new perspectives as biomedical material. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Nacl Sur, Dept Quim & Ingn Quim, Catedra Bromatol, RA-8000 Bahia Blanca, Argentina.
   Univ Complutense Madrid, Fac Farm, Dept Quim Fis 2, Unidad RMN, E-28040 Madrid, Spain.
   Univ Nacl Sur, Dept Quim & Ingn Quim, Inst Invest Quim Organ, RA-8000 Bahia Blanca, Argentina.
RP Agullo, E (reprint author), Univ Nacl Sur, Dept Quim & Ingn Quim, Catedra Bromatol, Avenida Alem 1253, RA-8000 Bahia Blanca, Argentina.
RI Ramos, Viviana/A-1905-2009; Heras, Angeles/H-7421-2015
OI Heras, Angeles/0000-0002-7209-6190
CR DUNG P, 1994, CARBOHYD POLYM, V24, P209
   FLEISCH H, 1969, SCIENCE, V165, P1262, DOI 10.1126/science.165.3899.1262
   HENDRICKSON HS, 1967, ANAL CHEM, V39, P998, DOI 10.1021/ac60252a022
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   JUNG A, 1973, CALC TISS RES, V11, P269, DOI 10.1007/BF02547227
   MOEDRITZ.K, 1966, J ORG CHEM, V31, P1603, DOI 10.1021/jo01343a067
   Muzzarelli R. A. A., 1997, CHITIN HDB, P109
   MUZZARELLI RA, 1969, TALANTA, V16, P1571, DOI 10.1016/0039-9140(69)80218-3
   MUZZARELLI RAA, 1986, INT J BIOL MACROMOL, V8, P137, DOI 10.1016/0141-8130(86)90014-0
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P99, DOI 10.1016/0144-8617(93)90084-H
   MUZZARELLI RAA, 1992, CARBOHYD POLYM, V19, P231, DOI 10.1016/0144-8617(92)90074-Z
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   MUZZARELLI RAA, 1994, INT J BIOL MACROMOL, V16, P177, DOI 10.1016/0141-8130(94)90048-5
   MUZZARELLI RAA, 1985, CHITIN ENCY POLYM SC, V3, P430
   MUZZARELLI RAA, 1977, CHITIN
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   RINAUDO M, 1992, INT J BIOL MACROMOL, V14, P122, DOI 10.1016/S0141-8130(05)80001-7
   Roberts G. A. F., 1992, CHITIN CHEM, P106
   Roberts G.A.F., 1992, CHITIN CHEM, P274
   SCHWARZENBACH G, 1949, HELV CHIM ACTA, V32, P1175, DOI 10.1002/hlca.19490320403
   WESTERBACK S, 1965, J AM CHEM SOC, V87, P2567, DOI 10.1021/ja01090a008
   WESTERBACK SJ, 1956, NATURE, V178, P321, DOI 10.1038/178321a0
   Wojtasz-Pajak A, 1994, CHITIN WORLD, P435
   1980, Patent No. 2942898A1
NR 26
TC 135
Z9 145
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN
PY 2001
VL 44
IS 1
BP 1
EP 8
DI 10.1016/S0144-8617(00)00195-8
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 367RC
UT WOS:000090074400001
DA 2018-10-19
ER

PT J
AU Einmahl, S
   Schwach-Abdellaoui, K
   Heller, J
   Gurny, R
AF Einmahl, S
   Schwach-Abdellaoui, K
   Heller, J
   Gurny, R
TI Poly(ortho esters): Recent developments for biomedical applications
SO CHIMIA
LA English
DT Article; Proceedings Paper
CT Meeting of the Polymer-Group-of-Switzerland
CY OCT   20, 2000
CL ETH ZURICH, ZURICH, SWITZERLAND
SP Polymer Grp Switzerland
HO ETH ZURICH
DE biodegradable polymers; dentistry; drug delivery; ophthalmology;
   poly(ortho esters)
ID GLAUCOMA FILTERING SURGERY; CONTROLLED DRUG-RELEASE; IRRADIATION
   STERILIZATION; DELIVERY SYSTEMS; OCULAR DELIVERY; LOCAL-DELIVERY;
   5-FLUOROURACIL; BIOCOMPATIBILITY; DEXAMETHASONE; ACID
AB Poly(ortho esters) (POE) are hydrophobic and bioerodible polymers that have been under development since the early 1970s. Up to now, four generations of such polymers have been described. Of most interest are poly(ortho esters) III and poly(ortho esters) IV. POE III is a semi-solid material that has been shown to be highly biocompatible and is currently being investigated as a carrier for sustained drug delivery to treat diseases of the posterior segment of the eye. However, the polymerization is difficult to control and is not readily scaled up. POE IV can be easily prepared in a highly reproducible manner, is very stable provided moisture is rigorously excluded and has also been shown to be biocompatible. It is currently under development for a variety of applications, such as ocular delivery, protein release, and periodontal disease treatment.
C1 Univ Geneva, Sch Pharm, Dept Pharmaceut Technol & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   Adv Polymer Syst, Redwood City, CA 94063 USA.
RP Einmahl, S (reprint author), Univ Geneva, Sch Pharm, Dept Pharmaceut Technol & Biopharmaceut, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
CR APPEL LE, 1993, J CONTROL RELEASE, V26, P77, DOI 10.1016/0168-3659(93)90107-G
   BENAGIANO G, 1979, J STEROID BIOCHEM, V11, P449, DOI 10.1016/0022-4731(79)90066-9
   BERNATCHEZ SF, 1994, J BIOMED MATER RES, V28, P1037, DOI 10.1002/jbm.820280908
   CAPOZZA RC, 1978, POLYM DELIVERY SYSTE, P59
   Chang MR, 1998, J OCUL PHARMACOL TH, V14, P75, DOI 10.1089/jop.1998.14.75
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   EINHAMHL S, 1999, ENCY CONTROLLED DRUG, P564
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   EINMAHL S, 2001, UNPUB INVEST OPHTHAL
   Einmahl SC, 2000, INVEST OPHTH VIS SCI, V41, pS81
   HELLER J, 1985, Journal of Controlled Release, V2, P167, DOI 10.1016/0168-3659(85)90042-2
   Heller J, 2000, EUR J PHARM BIOPHARM, V50, P121, DOI 10.1016/S0939-6411(00)00085-0
   HELLER J, 1990, J CONTROL RELEASE, V13, P295, DOI 10.1016/0168-3659(90)90019-P
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HELLER J, 1990, BIOMATERIALS, V11, P235, DOI 10.1016/0142-9612(90)90003-9
   HELLER J, 1999, ENCY CONTROLLED DRUG, P852
   HELLER J, 1988, J BIOACT COMPAT POLY, V3, P97
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   MAA YF, 1990, J CONTROL RELEASE, V13, P11, DOI 10.1016/0168-3659(90)90070-A
   MERKLI A, 1994, J CONTROL RELEASE, V29, P105, DOI 10.1016/0168-3659(94)90126-0
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   Merkli A, 1996, BIOMATERIALS, V17, P897, DOI 10.1016/0142-9612(96)83285-6
   MERKLI A, 1994, PHARMACEUT RES, V11, P1485, DOI 10.1023/A:1018964511053
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   Ng SY, 2000, J CONTROL RELEASE, V65, P367, DOI 10.1016/S0168-3659(99)00218-7
   ROTHENWEINHOLD A, 2001, IN PRESS J CONTROLLE
   Schwach-Abdellaoui K, 2000, EUR J PHARM BIOPHARM, V50, P83, DOI 10.1016/S0939-6411(00)00086-2
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Schwach-Abdellaoui K, 1999, MACROMOLECULES, V32, P301, DOI 10.1021/ma981517m
   SCHWACHABDELLAO.K, 2001, IN PRESS BIOMATERIAL
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sintzel MB, 1998, BIOMATERIALS, V19, P791, DOI 10.1016/S0142-9612(97)00229-9
   Sintzel MB, 1998, INT J PHARM, V175, P165, DOI 10.1016/S0378-5173(98)00274-9
   Sintzel MB, 1998, J CONTROL RELEASE, V55, P213, DOI 10.1016/S0168-3659(98)00051-0
   Sintzel MB, 1997, INT J PHARM, V155, P263, DOI 10.1016/S0378-5173(97)00169-5
   SOLHEIM E, 1995, J BIOMED MATER RES, V29, P1141, DOI 10.1002/jbm.820290914
   SPARER RV, 1984, J CONTROL RELEASE, V1, P23
   VISTNES LM, 1976, SURGERY, V79, P690
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 44
TC 1
Z9 1
U1 2
U2 3
PU NEW SWISS CHEMICAL SOC
PI BASEL
PA C/O NOVARTIS AG, K-25 1 45, CH-4002 BASEL, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2001
VL 55
IS 3
BP 218
EP 222
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 419PE
UT WOS:000167956900025
DA 2018-10-19
ER

PT J
AU Brandstatter, B
   Scharfetter, H
   Magele, C
AF Brandstatter, B
   Scharfetter, H
   Magele, C
TI Multi frequency electrical impedance tomography
SO COMPEL-THE INTERNATIONAL JOURNAL FOR COMPUTATION AND MATHEMATICS IN
   ELECTRICAL AND ELECTRONIC ENGINEERING
LA English
DT Article
DE biomedical; impedance; conductivity profile
ID TISSUE CHARACTERIZATION
AB Electrical impedance tomography (EIT) is a non-invasive method to monitor conductivity changes in regions of the human body. Its robust, miniaturizable instrumentation makes EIT particularly suitable for online-monitoring without too much inconvenience for the patient. A major methodological problem is the poor quality of the conductivity images, which is due to the low spatial resolution and low sensitivity for structures far away from the object's surface as well as large qualitative errors in the reconstructed conductivity values. This paper outlines the advantages of multi-frequency EIT for a simple two-dimensional model In the first Part of the paper we assume that some a priori information from MR images is at hand, providing good starting values for the reconstruction process, while in the second part it is assumed that no a priori information about regions of different material values is available.
C1 Inst Fundamentals & Theory Elect Engn, Graz, Austria.
   Inst Biomed Engn, Graz, Austria.
RP Brandstatter, B (reprint author), Inst Fundamentals & Theory Elect Engn, Graz, Austria.
CR Chang AM, 1999, INT J ELECTRON COMM, V4, P85, DOI 10.1080/10864415.1999.11518358
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   FLETCHER M, 1987, PRACTICAL METHODS OP
   KUSHNER RF, 1992, J AM COLL NUTR, V11, P199
   RIGAUD B, 1994, PHYSIOL MEAS, V15, pA13, DOI 10.1088/0967-3334/15/2A/002
   RIGAUD B, 1995, PHYSIOL MEAS, V16, pA15, DOI 10.1088/0967-3334/16/3A/002
   SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147
   Vauhkonen M, 1997, THESIS U KUOPIO FINL
   Webster JG, 1990, ELECT IMPEDANCE TOMO
NR 9
TC 1
Z9 1
U1 0
U2 3
PU MCB U P LIMITED
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD BD8 9BY, W YORKSHIRE, ENGLAND
SN 0332-1649
J9 COMPEL
JI Compel-Int. J. Comp. Math. Electr. Electron. Eng.
PY 2001
VL 20
IS 3
BP 828
EP 847
DI 10.1108/03321640110394003
PG 20
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic; Mathematics, Applied
SC Computer Science; Engineering; Mathematics
GA 473UH
UT WOS:000171066100015
DA 2018-10-19
ER

PT J
AU Silva, VV
   Lameiras, FS
   Domingues, RZ
AF Silva, VV
   Lameiras, FS
   Domingues, RZ
TI Microstructural and mechanical study of zirconia-hydroxyapatite (ZH)
   composite ceramics for biomedical applications
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; zirconia; composite; microstructure; mechanical
   properties
ID PARTIALLY-STABILIZED ZIRCONIA; BONE; PSZ; INTERFACE; IMPLANTS
AB Hydroxyapatite is the mineral component of natural hard tissues and, as such, it has been studied extensively as a candidate biomaterial for its use in prosthetic applications. However. the main weakness of this material lies in its poor mechanical strength which makes it unsuitable for load-bearing applications. On the other hand, partially stabilized zirconia has been widely studied on account of its high strength and fracture toughness, and good biocompatibility. Therefore, it is believed that the addition of a particulate zirconia phase to a hydroxyapatite one may lead to an improvement of the mechanical properties of this kind of composite and will not affect its biocompatibility. In this study, two series of zirconia- hydroxyapatite composites, Z4H6 and Z6H4 with 40 and 60 vol.% of zirconia content respectively, were prepared by powder uniaxial pressing at 700 MPa and sintering in air at 120-1500 degreesC for 3 h. The sintering behavior. microstructural characteristics and mechanical properties were evaluated. Variation of average grain size for the zirconia and hydroxyapatite phases with sintering temperature was observed. Relative densities ranging from 89 to 91% of the theoretical values were reached for the Z6H4 ceramic series and for the Z4H6 sample sintered at 1400 degreesC, although microcracks were present in all specimens sintered at 1400 and 1500 degreesC. Values of ultimate compressive strength, Young's modulus. micro-Vickers hardness and Poisson's ratio near to those for human cortical bone and human tooth (dentine and enamel) were found for almost all samples investigated suggesting that these materials present potential applications as structural implants. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 CNEC, CDTN, BR-30123970 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, ICEx, Dept Quim, Mat Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Silva, VV (reprint author), CNEC, CDTN, R Prof Mario Werneck S-N,Pampulha,CP 941, BR-30123970 Belo Horizonte, MG, Brazil.
RI Domingues, Rosana/P-2017-2014; Domingues, Rosana/C-3174-2013
OI Domingues, Rosana/0000-0001-5667-2031; Domingues,
   Rosana/0000-0001-5667-2031
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Gregorie M., 1990, J BIOMED MATER RES, V24, P163
   GROSS V, 1987, BIOCERAMICS MAT CHAR
   HEALY KE, 1998, HDB BIOMATERIALS PRO
   HOLMES RE, 1987, INT J ORAL MAX SURG, V16, P718, DOI 10.1016/S0901-5027(87)80059-0
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   KROON PO, 1992, J BONE JOINT SURG BR, V74, P518
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Legeros R. Z., 1991, ADV SERIES CERAMICS, V1
   Legeros RZ, 1988, J DENT RES, V67, P177
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   MattioliBelmonte M, 1997, J MATER SCI-MATER M, V8, P85, DOI 10.1023/A:1018554715962
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   Park K, 1997, MATER LETT, V32, P229, DOI 10.1016/S0167-577X(97)00041-4
   PINTO LCM, 1996, ACTA MICROSCOPIA B, V5, P168
   PORTER DL, 1977, J AM CERAM SOC, V60, P183, DOI 10.1111/j.1151-2916.1977.tb15509.x
   RAVAGLIOLI A, BIOCERAMICS MAT PROP, P292
   SEDEL L, 1991, BIOCERAMICS, V4
   Silva VV, 1997, J MATER SCI-MATER M, V8, P907, DOI 10.1023/A:1018566124507
   Silva VV, 2000, MATER CHARACT, V45, P51, DOI 10.1016/S1044-5803(00)00048-6
   SILVA VV, P MAT SOC RES 1998 F, P261
   SUBBARAO EC, 1981, ADV CERAMICS SCI TEC, V3
NR 33
TC 96
Z9 104
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PY 2001
VL 61
IS 2
BP 301
EP 310
DI 10.1016/S0266-3538(00)00222-0
PG 10
WC Materials Science, Composites
SC Materials Science
GA 398HF
UT WOS:000166750300012
DA 2018-10-19
ER

PT J
AU Tang, ZG
   Teoh, SH
AF Tang, ZG
   Teoh, SH
TI Mechanical properties of elastomeric composite membranes made from the
   porous biaxially drawn ultrahigh-molecular-weight polyethylene film and
   polyether polyurethane materials
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE fibrous composites; mechanical properties; microstructure
ID BIOMEDICAL APPLICATIONS
AB Fibrous composites are commonly found in soft tissue but few man-made composites are used for soft tissue replacement. In this study, fibrous composites, made from biaxially drawn ultra-high molecular-weight polyethylene (BD-UHMWPE) and polyether polyurethane materials, were fabricated by solution casting and heat compaction. The effects of processing conditions on tensile properties of the composites were evaluated, in terms of the molecular structures of the polyurethane materials, thermal behavior of the UHMWPE, and the microstructures of the as-made composites. The results indicated that composites of improved tensile properties were constructed in the form of interpenetration of polyurethane through the stacks of the BD-UHMWPE. The tensile strength and modulus of the composites (made from Toyobo TM5 and Solupor (TM) 7PO3) are approximately 69 and 210 MPa. The as-made composite has a significant improvement on its toughness, about 5 times increase in the tensile toughness if compared to that of the BD-UHMWPE. A possible interlocking structure was suggested for those polyurethane materials (Toyobo TM5) that might be recrystallized during heat compaction. The polyurethane like Tecoflex 80A, not indicating a symptom of annealing crystallization, has no impact on increasing the tensile properties but a decrease with plasticizing the materials. (C) 2001 Published by Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Ctr Biomed Mat Applicat & Technol, Singapore 117548, Singapore.
RP Tang, ZG (reprint author), Blk 359,10-311,Clementi Ave 2, Singapore 120359, Singapore.
EM zgtang@gintic.gov.sg
CR Carlsson LA, 1987, EXPT CHARACTERIZATIO
   GERRITS NSJA, 1991, POLYMER, V32, P1770, DOI 10.1016/0032-3861(91)90361-L
   HOW TV, 1992, CARDIOVASCULAR BIOMA, P1
   LEEPER HM, 1983, RUBBER CHEM TECHNOL, V56, P523, DOI 10.5254/1.3538140
   LIU SH, 1985, J BIOMED ENG, V2, P157
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Montagna W., 1992, ATLAS NORMAL HUMAN S
   Nimni M., 1992, CARDIOVASCULAR BIOMA, P81
   PIENKOWSKI D, 1995, J BIOMED MATER RES, V29, P1167, DOI 10.1002/jbm.820291002
   PLUYTER PB, 1997, Patent No. 5643511
   PLUYTER PB, 1993, Patent No. 5248461
   PORTER RS, 1994, POLYMER, V35, P4979, DOI 10.1016/0032-3861(94)90652-1
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT
   Tang ZG, 2000, COLLOID SURFACE B, V19, P19, DOI 10.1016/S0927-7765(00)00134-X
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P270
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
NR 18
TC 7
Z9 7
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
EI 1879-1050
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PY 2001
VL 61
IS 16
BP 2371
EP 2380
DI 10.1016/S0266-3538(01)00175-0
PG 10
WC Materials Science, Composites
SC Materials Science
GA 502RL
UT WOS:000172756500003
DA 2018-10-19
ER

PT S
AU Ferguson, B
   Mickan, S
   Hubbard, S
   Pavlidis, D
   Abbott, D
AF Ferguson, B
   Mickan, S
   Hubbard, S
   Pavlidis, D
   Abbott, D
BE Bergmann, NW
   Abbott, D
   Hariz, AJ
   Varadan, VK
TI Investigation of gallium nitride T-ray transmission characteristics
SO ELECTRONICS AND STRUCTURES FOR MEMS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Electronics and Structures for MEMS II
CY DEC 17-19, 2001
CL ADELAIDE, AUSTRALIA
SP SPIE, USAF, Off Sci Res, Asian Off Aerosp Res & Dev, Ctr Biomed Engn, Def Sci & Technol Org, Dept Ind & Trade
DE terahertz; gallium nitride; T-rays; photoconductive antenna
ID GENERATION; PULSES; SPECTROSCOPY; THZ
AB T-ray imaging and spectroscopy both exploit the terahertz (THz) region of the spectrum. This gives rise to very promising industrial and biomedical applications, where non-invasive and sensitive identification of a substance is achievable, through a material's distinct absorption features in the THz band. Present T-ray systems are limited by low output power, and the race is now on to find more efficient THz emitters. We discuss the feasibility of a novel high-power gallium nitride emitter for terahertz generation. This paper details the advantages of such an emitter, primarily by virtue of its high-voltage capability, and evaluates the benefits of sapphire and silicon carbide substrates. The far-infrared transmission spectra for thin samples of GaN, sapphire and SiC are reported. A high-power THz emitter, that operates at room temperature and is potentially low-cost will open up a host of new possibilities and applications. The central result in this paper demonstrates that sapphire is the better choice over SiC, for the GaN supporting substrate, as we show that it has superior THz transmission characteristics.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Ferguson, B (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RI Abbott, Derek/E-8352-2011
OI Abbott, Derek/0000-0002-0945-2674
CR ARNONE D, 2000, PHYSICS WORLD, P35
   Arnone DD, 1999, P SOC PHOTO-OPT INS, V3828, P209, DOI 10.1117/12.361037
   AUSTON DH, 1983, APPL PHYS LETT, V43, P631, DOI 10.1063/1.94468
   BUDIARTO E, 1997, P C QELS BALT, V12, P41
   Cole BE, 2001, NATURE, V410, P60, DOI 10.1038/35065032
   FERGUSON B, 2001, SPIE, V4236, P157
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   GUNZUN D, 2000, OPT COMMUN, V180, P367
   Kawase K, 1999, OPT LETT, V24, P1065, DOI 10.1364/OL.24.001065
   Kim HM, 2001, MATER LETT, V47, P276, DOI 10.1016/S0167-577X(00)00249-4
   Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X
   McLaughlin R, 2000, J MOD OPTIC, V47, P1847, DOI 10.1080/095003400417007
   Melnik YV, 1997, MRS INTERNET J N S R, V2
   MICKAN S, 2001, SMART STRUCTURES D 2, V4235, P434
   Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   Morris J. R., 1971, Optics Communications, V3, P81, DOI 10.1016/0030-4018(71)90182-9
   MOUROU G, 1981, APPL PHYS LETT, V39, P295, DOI 10.1063/1.92719
   MOUROU G, 1981, APPL PHYS LETT, V38, P470, DOI 10.1063/1.92407
   Nuss MC, 1996, IEEE CIRCUIT DEVIC, V12, P25, DOI 10.1109/101.485909
   Proakis JG, 1996, DIGITAL SIGNAL PROCE
   Shen Y. R., 1976, PROG QUANT ELECTRON, V4, P207
   Steinbach D, 1998, J OPT SOC AM B, V15, P1231, DOI 10.1364/JOSAB.15.001231
   Weiner AM, 1998, OPT LETT, V23, P1441, DOI 10.1364/OL.23.001441
   Woodward R. M., 2001, C LAS EL 2001, P329
   YANG KH, 1971, APPL PHYS LETT, V19, P320, DOI 10.1063/1.1653935
   YOU D, 1993, OPT LETT, V18, P290, DOI 10.1364/OL.18.000290
NR 27
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4321-2
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4591
BP 210
EP 220
DI 10.1117/12.449150
PG 3
WC Computer Science, Hardware & Architecture; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BT92X
UT WOS:000174463500022
DA 2018-10-19
ER

PT B
AU Kancharla, VV
   Chen, SC
AF Kancharla, VV
   Chen, SC
BE Zhu, GM
   Peng, SQ
   Li, QP
TI UV laser micromachining of biodegradable polymers
SO ENERGY CONVERSION AND APPLICATION, VOL I AND II
LA English
DT Proceedings Paper
CT International Conference on Energy Conversion and Application (ICECA
   2001)
CY JUN 17-20, 2001
CL WUHAN, PEOPLES R CHINA
SP Huazhong Univ Sci & Technol, Univ Calif Los Angeles, Univ Nottingham, Nippon Inst Technol, Hong Kong Univ Sci & Technol, Univ Otago
ID EXCIMER
AB This paper reports on Ultra-Violet (UV) laser micromachining or two biodegradable polymeric materials for applications in biomedical engineering. Parametric studies have been conducted on Poly-vinyl Alcohol (PVA) and Poly-D-Lactic acid (PDLA) to produce microchannels and microholes. Laser micromachining of microchannels is studied usinga XeCl excimer laser at 308 nm wavelength and laser microdrilling is studied using a Q-switched Nd: YAG laser at 266 nm wave length. Feature sizes ranging from 4 to 10 mum were obtained for the microholes and the features of microchannels were 20 mum and 10 mum deep. This work demonstrated that UV laser micromachining is a well-suited technique for patterning of biodegradable polymers with minimum thermal damage to the surrounding material.
C1 Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
RP Kancharla, VV (reprint author), Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
CR Chen SC, 2000, J HEAT TRANS-T ASME, V122, P107, DOI 10.1115/1.521441
   CHEN YH, 1995, P SOC PHOTO-OPT INS, V3184, P202
   GANNEPALLI A, 1998, POLYM MAT SCI ENG P, V78, P3
   Gower MC, 1999, P SOC PHOTO-OPT INS, V3618, P251, DOI 10.1117/12.352688
   KUMAR GS, 1986, BIODEGRADABLE POLYM
   Lin LW, 1999, J MICROELECTROMECH S, V8, P78, DOI 10.1109/84.749406
   Matsui S, 1995, MATER RES SOC SYMP P, V380, P49, DOI 10.1557/PROC-380-49
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
NR 8
TC 0
Z9 0
U1 0
U2 0
PU HUAZHONG UNIVERSITY SCIENCE & TECHNOLOGY PRESS
PI WUHAN
PA YUJIASHAN, WUHAN, HUPEI, PEOPLES R CHINA
BN 7-5609-2420-4
PY 2001
BP 1274
EP 1277
PG 4
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA BS85M
UT WOS:000171232700274
DA 2018-10-19
ER

PT S
AU Soboyejo, WO
   Mercer, C
   Allameh, S
   Nemetski, B
   Marcantonio, N
   Ricci, JL
AF Soboyejo, WO
   Mercer, C
   Allameh, S
   Nemetski, B
   Marcantonio, N
   Ricci, JL
BE Katsube, N
   Soboyejo, WO
   Sacks, M
TI Multi-scale microstructural characterization of micro-textured Ti-6Al-4V
   surfaces
SO FUNCTIONAL BIOMATERIALS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT Symposium on Functional Biomaterials held at the ASME Winter Annual
   Meeting
CY NOV, 2000
CL ORLANDO, FLORIDA
SP ASME
DE microstructural characterization; micro-textured surfaces; Ti-6Al-4V
ID CELL BEHAVIOR; TOPOGRAPHICAL CONTROL; CONTACT GUIDANCE; TITANIUM
   SUBSTRATA; IMPLANT MATERIALS; IN-VITRO; FIBROBLASTS; INVITRO;
   TRANSMISSION; GROWTH
AB This paper presents the results of a multi-scale microstructural characterization of microtextured Ti-6Al-4V surfaces that are used in biomedical implants. The hierarchies of substructural and microstructural features associated with laser micro-texturing, mechanical polishing and surface blasting with alumina pellets are elucidated via atomic force microscopy (AFM), transmission electron microscopy (TEM), scanning electron microscopy (SEM) and optical microscopy (OM). The nano-scale roughness profiles for the different surface textures are characterized via AFM. Sub-micron precipitates and dislocation substructures associated with wrought processing and laser processing are revealed by TEM. OM and SEM micro- and mesoscale images of the groove structures and then described before discussing the implications of the result for the optimization of laser processing schemes. The implications of the results are examined for the fabrication of micro-textured surfaces that will facilitate the self organization of proteins, and the attachment of mammalian cells to the Ti-6Al-4V surfaces in biomedical implants.
C1 Princeton Mat Inst, Princeton, NJ 08544 USA.
   Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.
   Brown Univ, Div Engn, Providence, RI 02912 USA.
   Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Orthodont, Newark, NJ 07103 USA.
RP Soboyejo, WO (reprint author), Princeton Mat Inst, Olden St, Princeton, NJ 08544 USA.
RI MERCER, Christopher/H-2654-2011
OI Allameh, Seyed/0000-0001-7726-415X
CR BAESLACK WA, 1990, J MATER SCI, V21, P698
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brunette D., 1996, NANOFABRICATION BIOS, P335
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   Chehroudi B., 1990, J BIOMED MATER RES, V24, P1067
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1987, DEVELOPMENT, V99, P439
   COEN MC, 2000, P 6 WORLD C BIOM BIO, P665
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Davidon WC, 1991, SIAM J OPTIMIZ, V1, P1, DOI 10.1137/0801001
   DECUPERE VM, 2000, P 6 WORLD C BIOM BIO, P635
   Dee KC, 2000, MATER TODAY, V3, P7
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   DOBBS HS, 1983, STP, V796, P174
   DOSERRO APV, 2000, P 6 WORLD C BIOM BIO, P376
   DUCHEYNE WD, J BIOMEDICAL MAT RES, V28, P417
   ECKERDAL J, 2000, P 6 WORLD C BIOM BIO, P1184
   HADDAD RJ, 1987, J BONE JOINT SURG AM, V69A, P1459
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   KANE RS, 1999, BIOMATERIALS, V20, P2353
   LEDUNG G, 2000, P 6 WORLD C BIOM BIO, P676
   Lu LC, 1999, BIOMATERIALS, V20, P2351, DOI 10.1016/S0142-9612(99)00164-7
   LU W, 2000, UNPUB J MECH PHYSICS
   Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT
   MEAGHER L, 2000, P 6 WORLD C BIOM BIO, P24
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Recum A F, 1996, Tissue Eng, V2, P241, DOI 10.1089/ten.1996.2.241
   Ricci J.L., 2000, BONE ENG, P1
   RICCI JL, 1991, MODULATION BONE INGR, P334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   TZIAMPAZIS E, 2000, P 6 WORLD C BIOM BIO, P166
   UNDERWOOD EE, 1987, METALS HDB, V12, P211
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WAGNER MS, 2000, P 6 WORLD C BIOM BIO, P22
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
NR 48
TC 23
Z9 23
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-871-0
J9 KEY ENG MAT
PY 2001
VL 198-1
BP 203
EP 227
DI 10.4028/www.scientific.net/KEM.198-199.203
PG 25
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BS10M
UT WOS:000168666500008
DA 2018-10-19
ER

PT S
AU Barnes, AS
   Pantano, CG
   Conzone, SD
AF Barnes, AS
   Pantano, CG
   Conzone, SD
BE Marker, AJ
   Davis, MJ
TI Surface cleaning and etching of rare-earth doped phosphate glass
SO INORGANIC OPTICAL MATERIALS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Inorganic Optical Materials III
CY AUG 02, 2001
CL SAN DIEGO, CA
SP SPIE
DE phosphate glasses; surface preparation; cleaning; etching; surface
   finishing
ID SOLUBILITIES; SILICA
AB The surface reactions of phosphate glasses are important for the processing and application of photonic devices. biomedical materials and conventional optical components. Of particular concern are the leaching of optically-active dopant species. surface layer formation and roughening during polishing, cleaning and other fabrication processes. In this study. the effects of various cleaning treatments, and both acid and base etching, were evaluated using surface analytical techniques (XPS, AFM). It is shown that in these phosphate glasses, the aluminum and rare-earth oxides have limited aqueous solubility. whereas the phosphate network is soluble over a wider range of pH. Thus. under those conditions where polishing damage can be removed by etching the surface, a localized precipitation of rare-earth oxides occurs which influences the final roughness and surface composition. Conversely, under conditions where this precipitation can be eliminated. an in-depth leaching of the surface occurs. These aqueous surface reactions were similar for both the optically-active and passive IOG-1 glasses. An optimized surface preparation method is described.
C1 Penn State Univ, Mat Res Inst, Dept Mat Sci & Engn, University Pk, PA 16801 USA.
RP Barnes, AS (reprint author), Penn State Univ, Mat Res Inst, Dept Mat Sci & Engn, 198 MRI Bldg, University Pk, PA 16801 USA.
EM asb6@psu.edu; pantano@ems.psu.edu; sconzone@schottglasstech.com
CR Affatigato M, 1996, J AM CERAM SOC, V79, P688
   ALEKSEEV NE, 1983, GLASS CERAM+, V40, P344, DOI 10.1007/BF00701918
   BROW RK, 1993, J AM CERAM SOC, V76, P913, DOI 10.1111/j.1151-2916.1993.tb05315.x
   BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   Carr JW, 1999, CERAM TRANS, V102, P163
   Deberdt S, 1998, CHEM GEOL, V151, P349, DOI 10.1016/S0009-2541(98)00089-8
   Hao Sun, 1997, Chemosphere, V34, P1753
   HAYDEN JS, 1990, P SOC PHOTO-OPT INS, V1277, P121, DOI 10.1117/12.20590
   JONASSON RG, 1985, GEOCHIM COSMOCHIM AC, V49, P2133, DOI 10.1016/0016-7037(85)90071-7
   Mellott NP, 2001, SURF INTERFACE ANAL, V31, P362, DOI 10.1002/sia.971.abs
   SANDERS DM, 1973, AM CERAM SOC BULL, V52, P666
   SPRENGER D, 1993, SURF INTERFACE ANAL, V20, P796, DOI 10.1002/sia.740200908
NR 12
TC 10
Z9 10
U1 0
U2 9
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4166-X
J9 PROC SPIE
PY 2001
VL 4452
BP 115
EP 125
DI 10.1117/12.446886
PG 11
WC Materials Science, Ceramics; Optics
SC Materials Science; Optics
GA BT90P
UT WOS:000174396000014
DA 2018-10-19
ER

PT J
AU Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
AF Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
TI Dual material rapid prototyping techniques for the development of
   biomedical devices. Part 1: Space creation
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE drug delivery devices (DDD); dual material RP; electrography; rapid
   prototyping (RP); selective laser sintering (SLS)
AB Polymeric drug delivery devices play an important role in drug administration. However, the current polymeric drug delivery device fabrication methods lack precision. This impairs the quality of the devices, resulting in a decrease in the efficiency and effectiveness of drug delivery. The concept of building parts laver by layer out of powdered raw materials makes selective laser sintering (SLS) a suitable process for fabricating polymeric matrix drug delivery devices. The current SLS process is not capable of processing two or more materials separately. This work explores the possibilities of SLS performing a dual material operation by developing two process models. These two processes can then be integrated to form a dual or expanded multimaterial fabrication technique and act as a foundation for future work in multimaterial applications such as polymeric drug delivery device fabrication. Accordingly, two papers are presented.
   In this paper, Part 1, the focus is on the first process, which is a "space" creation technique in which a "space" is created by varying the density of a first representative material using heat during sintering. Three methods - one based on a vacuum and a place method, and the other two based on two variations of a laser compacting method - were tested. Results have shown that by varying the laser power during sintering, it is possible to create channels in which a second material can be deposited.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Leong, Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR BEAMAN JJ, 1997, INDIRECT METHODS MET, V1
   CARDINAL JR, 1980, CONTROLLED RELEASE B
   CHUA CK, 1997, RAPID PROTOTYPING J
   Cima L. G, 1996, U. S. Patent, Patent No. [5,490,962, 5490962]
   COLTER KD, 1997, BIOMATERIALS MEDICAL
   De Rossi D, 1991, POLYM GELS
   GOLDBERG EP, 1979, BIOMEDICAL POLYM
   GOOD WR, 1981, AICHE S SERV, V206
   LEE ES, 1980, J MEMBRANE SCI, V7, P293, DOI 10.1016/S0376-7388(00)80474-3
   Sachs E. M., 1993, U. S. Patent, Patent No. [U. S. 5204055, 5204055]
NR 10
TC 32
Z9 34
U1 0
U2 7
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2001
VL 18
IS 10
BP 717
EP 723
DI 10.1007/s001700170014
PG 7
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 503XL
UT WOS:000172826900004
DA 2018-10-19
ER

PT J
AU Hisao, FK
   Yang, W
   Morita, A
   Hayashi, S
   Niinomi, M
   Hasegawa, J
AF Hisao, FK
   Yang, W
   Morita, A
   Hayashi, S
   Niinomi, M
   Hasegawa, J
TI Study of biocompatible and high melting point Ti-Ta-Nb ternary alloys:
   development of a non-contaminating melting process
SO INTERNATIONAL JOURNAL OF MATERIALS & PRODUCT TECHNOLOGY
LA English
DT Article
DE biomedical materials; Ti-Ta-Nb alloys; cold crucible levitation melting
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS
AB A one-coil type Cold Crucible Levitation Melting furnace, with capacity of 100g and supplied by a frequency inverter power system, is used successfully for melting Ti-10Ta-20Nb, Ti-20Ta-30Nb and Ti-30Nb alloys under argon atmosphere of 7.4x 10(4) Pa, adopting supply conditions of 60kHz, 50kw/30sec for fusing the raw materials and 30kw/5min for homogenization. 70g ingots were gained, and then were analyzed by EPMA. The cast microstructure of all alloys presents dendrite-type. Elements almost distribute uniformly in ingots, only a Ta-rich bond is found in the lower part of some Ti-20Ta-30Nb and Ti-30Ta ingots. The real contents of Nb in all the samples are smaller than the nominal. Improving measures are also pointed out.
C1 Aichi Gakuin Univ, Sch Dent, Dept Dent Mat Sci, Chikusa Ku, Nagoya, Aichi 4648650, Japan.
   Fuji Elect Furnace Co, Suzuka 5138633, Japan.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR FUKUI H, 2000, J JAPAN SOC DENT MAT, V19, P49
   FUKUZAWA A, 1994, P INT S ELECTROMAGNE, P172
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MORITA A, 1999, P 1 IUMRS INT C ADV
   MORITA A, 2000, P 3 INT S EL PROC MA, P358
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OKUNO I, 1991, QDT, V16, P5
   SAKURAYA K, 1994, P INT S SIM DES APPL, P483
   TADANO H, 1997, P EPM FRANC, P377
   WINTER GD, 1980, EVALUATION BIOMATERI
NR 10
TC 0
Z9 0
U1 0
U2 2
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0268-1900
J9 INT J MATER PROD TEC
JI Int. J. Mater. Prod. Technol.
PY 2001
SU 2
BP 461
EP 467
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 534UG
UT WOS:000174604900005
DA 2018-10-19
ER

PT J
AU Costello, J
AF Costello, J
TI Nursing older dying patients: findings from an ethnographic study of
   death and dying in elderly care wards
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE older patients; terminal care; death and dying; nursing; biomedicine;
   nurses; physicians
ID HOSPITAL-CARE; PALLIATIVE CARE; NURSES; COMMUNICATION; PROFESSIONALS;
   RESPONSES; AWARENESS; PEOPLE
AB Background and aim. The aim of the study was to explore the experiences of dying patients and nurses working in three elderly care wards focusing on the management of care for dying patients. The majority of patients who die in hospital are over the age of 65 and evidence suggests that three fifths are over the age of 75. Older patients pose tremendous problems and challenges to nurses and doctors regarding the provision of good terminal care, particularly in relation to developing effective communication.
   Method. An ethnographic research design was chosen. The research sample consisted of 74 patients, 29 nurses and 8 physicians. The principle data collection methods were participant observation and semi-structured interviews. All respondents were interviewed following a period of observation on each of the ward areas. The data obtained from participant observation were then used to structure the interview questions. The purpose of asking questions about meanings associated with observational material was to evaluate the extent to which convergence or divergence of the data was taking place.
   Findings. The findings demonstrate that the care of older dying patients was defined by a lack of 'emotional engagement' with the patient and the institutionalized nondisclosure of information about death and dying. The study raises issues concerning the lack of effective communication about terminal diagnosis and the strategies used by nurses and doctors for disclosing information about death and dying. The findings suggest that although nurses provide individual care to dying patients, much of this was aimed at meeting patients' physical needs. Nurses reported psychosocial aspects including spiritual and emotional care to be important, although there was little evidence of them being orientated towards this in practice.
   Conclusion. The indicative conclusions from this study suggest that terminal care for some elderly patients remains hampered by a reluctance of nurses and doctors to be more open in their communication about death. It would appear that hospital culture and the mores, beliefs and ideologies that emanate from the biomedical model, significantly shape the experiences of older dying patients.
C1 Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M60 7LP, Lancs, England.
RP Costello, J (reprint author), Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Gateway House, Manchester M60 7LP, Lancs, England.
CR AHMEDZAI S, 1982, BRIT MED J, V285, P712, DOI 10.1136/bmj.285.6343.712
   Bartlett D., 1997, UNDERSTANDING SOCIAL, P173
   BLACKBURN A, 1994, BRIT MED J, V309, P1579, DOI 10.1136/bmj.309.6968.1579b
   BLACKBURN AM, 1989, PALLIATIVE MED, V3, P203
   BLUMER H, 1956, AM SOCIOL REV, V21, P683, DOI 10.2307/2088418
   CANDY CE, 1991, J ADV NURS, V16, P138, DOI 10.1111/j.1365-2648.1991.tb01617.x
   Cartwright A, 1973, LIFE BEFORE DEATH
   CLARK D., 1999, REFLECTIONS PALLIATI
   COPP G, 1999, EXPERIENCES NURSES T
   COSTELLO J, 2000, INT J PALLIATIVE NUR, V6, P152
   COSTELLO J, 1994, REV CLIN GERONTOLOGY, V4, P169
   COSTELLO J, 2000, THESIS MANCHESTER ME
   DAVEY B, 2000, DEATH DYING BEREAVEM, P250
   EMERSON RM, 1988, HUM ORGAN, V47, P189, DOI 10.17730/humo.47.3.8tm323u28p760863
   Eve A, 1997, PALLIATIVE MED, V11, P31, DOI 10.1177/026921639701100104
   Field D, 1999, PALLIATIVE MED, V13, P459, DOI 10.1191/026921699668763479
   FIELD D, 1987, THESIS U LEICESTER
   FIELD D, 1994, EUROPEAN J CANC CARE, V3, P358
   Field D., 2000, DEATH DYING BEREAVEM, P91
   Field D, 1989, NURSING DYING
   Glaser BG, 1965, AWARENESS DYING
   HIGGINSON I, 1997, EPIDEMIOLOGICALLY BA
   HINTON JM, 1967, DYING
   JAMES N, 1992, SOC SCI MED, V34, P1363, DOI 10.1016/0277-9536(92)90145-G
   JAMES V, 1986, THESIS U ABERDEEN
   KELNER MJ, 1993, SOC SCI MED, V36, P757, DOI 10.1016/0277-9536(93)90036-4
   Lawler J., 1991, SCREENS NURSING SOMO
   Maeve MK, 1998, J ADV NURS, V27, P1136
   Magnusson S, 1996, BRIT MED J, V313, P1601, DOI 10.1136/bmj.313.7072.1601
   Mallik M, 1997, J ADV NURS, V25, P130, DOI 10.1046/j.1365-2648.1997.1997025130.x
   MAY C, 1993, INT J NURS STUD, V30, P181, DOI 10.1016/0020-7489(93)90067-5
   MILLS M, 1994, BRIT MED J, V309, P583, DOI 10.1136/bmj.309.6954.583
   MOORE LW, 1999, J ADV NURS, V35, P1034
   MOUNT BM, 1995, PALLIATIVE MED, V9, P165, DOI 10.1177/026921639500900207
   PARKES CM, 1984, POSTGRAD MED J, V60, P120, DOI 10.1136/pgmj.60.700.120
   PARKES CM, 1985, LANCET, V1, P155
   Payne S, 2000, J ADV NURS, V32, P277, DOI 10.1046/j.1365-2648.2000.01474.x
   Payne S, 1996, SOC SCI MED, V43, P1785, DOI 10.1016/S0277-9536(96)00077-9
   PEARSALL M, 1965, NURS RES, V14, P37, DOI 10.1097/00006199-196501410-00011
   PINE VR, 1975, J THANATOL, V3, P1
   PORTER S, 1991, J ADV NURS, V16, P728, DOI 10.1111/j.1365-2648.1991.tb01731.x
   Quint J. C., 1967, NURSE DYING PATIENT
   Randall F, 1996, PALLIATIVE CARE ETHI
   REVANS RW, 1964, STANDARDS MORALE
   Rogers A, 2000, J ADV NURS, V31, P768, DOI 10.1046/j.1365-2648.2000.01347.x
   SAUNDERS C, 1963, P ROY SOC MED, V56, P195
   Scottish Health Advisory Council, 1991, EV DEATH SHOULD MATT
   SEALE C, 1991, SOC SCI MED, V32, P943, DOI 10.1016/0277-9536(91)90249-C
   Seale C, 1997, PALLIATIVE MED, V11, P93, DOI 10.1177/026921639701100202
   Sheldon F, 1997, PSYCHOSOCIAL PALLIAT
   SHELDON JH, 1961, REPORT BIRMINGHAM RE
   SIDELL M, 1995, HLTH OLD AGE
   SMITH P, 1992, EMOTIONAL LABOUR NUR
   Strauss A, 1982, Sociol Health Illn, V4, P254, DOI 10.1111/1467-9566.ep10487954
   Strauss A. L., 1990, BASICS QUALITATIVE R
   Thompson S., 1999, ILLNESS CRISIS LOSS, V7, P122
   Townsend P., 1962, LAST REFUGE
   Tuckett A, 1998, INT J NURS STUD, V35, P292, DOI 10.1016/S0020-7489(98)00043-1
   TURNER BA, 1981, QUAL QUANT, V15, P225
   VACHON MLS, 1987, OCCUPATIONAL STRESS, P51
   WIDGERY D, 1988, NATL HLTH SERVICE RA
   WILKES E, 1984, LANCET, V1, P950
   WILKES E, 1965, LANCET, V1, P799
   WILKINSON S, 1991, J ADV NURS, V16, P677, DOI 10.1111/j.1365-2648.1991.tb01726.x
   Willard C, 1996, J ADV NURS, V24, P60, DOI 10.1046/j.1365-2648.1996.01698.x
   WILLIAMS A, 1989, THESIS U MANCHESTER
NR 66
TC 80
Z9 81
U1 1
U2 7
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0309-2402
J9 J ADV NURS
JI J. Adv. Nurs.
PY 2001
VL 35
IS 1
BP 59
EP 68
DI 10.1046/j.1365-2648.2001.01822.x
PG 10
WC Nursing
SC Nursing
GA 452YW
UT WOS:000169888100015
PM 11442683
DA 2018-10-19
ER

PT J
AU Gimenez, S
   Ponsart, S
   Coudane, J
   Vert, M
AF Gimenez, S
   Ponsart, S
   Coudane, J
   Vert, M
TI Synthesis, properties and in vitro degradation of carboxyl-bearing PCL
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID DRUG DELIVERY SYSTEMS; POLY(DL-LACTIC ACID); SUSTAINED-RELEASE;
   HYDROLYTIC DEGRADATION; MULTIBLOCK COPOLYMERS; POLY(L-LACTIC ACID);
   GENTAMICIN SULFATE; AQUEOUS-MEDIA; POLY(EPSILON-CAPROLACTONE); POLYMERS
AB Aliphatic polyesters derived from lactic and glycolic acids (PLAGA) are the most attractive degradable polymers with respect to biomedical and environmental applications.Poly(-epsilon -caprolactone), PCL, is a hydrophobic highly crystalline aliphatic polyester that is more resistant to hydrolytic degradation than PLA. It is not biodegradable in animal body but is rapidly degraded by outdoor microorganisms. In order to increase the rate of hydrolysis of the material, carboxyl-bearing PCL copolymers (PCLCOOH) were synthesized by anionic activation with LDA and reaction of CO2 on the polycarbanion. Variations in crystallinity, thermal properties and hydrophilicity caused by the presence of the pendent carboxyl groups were investigated. The degradation behavior of PCLCOOH was assessed by the evaluation of water uptake, mass loss, molecular masses and ESEM microphotographs. A dramatic increase in the hydrolytic degradation rate was observed compared with pure PCL, thus PCLCOOH can now be considered as a hydrolytically degradable polymer.
C1 Fac Pharm, Ctr Rech Biopolymers Artificiels, F-34060 Montpellier 2, France.
RP Coudane, J (reprint author), Fac Pharm, Ctr Rech Biopolymers Artificiels, 15 Ave Charles Flahault, F-34060 Montpellier 2, France.
CR Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   DOMB AJ, 1994, POLYM BIOMATERIALS
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   HECQUET B, 1986, ANTICANCER RES, V6, P1251
   HUTCHINSON FG, 1985, BIOCHEM SOC T, V13, P520, DOI 10.1042/bst0130520
   Li SM, 1998, J APPL POLYM SCI, V68, P989, DOI 10.1002/(SICI)1097-4628(19980509)68:6<989::AID-APP12>3.0.CO;2-J
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Li SM, 1996, J BIOMAT SCI-POLYM E, V8, P165, DOI 10.1163/156856296X00237
   MAUDUIT J, 1993, J CONTROL RELEASE, V23, P221, DOI 10.1016/0168-3659(93)90003-N
   MAUDUIT J, 1993, J CONTROL RELEASE, V23, P209, DOI 10.1016/0168-3659(93)90002-M
   MAUDUIT J, 1995, J BIOMAT SCI-POLYM E, V7, P207
   NAKAMURA T, 1987, BIOMATERIALS CLIN AP
   Petrova T, 1998, POLYM INT, V45, P419
   Pitt C. G., 1984, LONG ACTING CONTRACE
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   PITT CG, 1992, BIODEGRADABLE POLYM
   Ponsart S, 2000, BIOMACROMOLECULES, V1, P275, DOI 10.1021/bm005521t
   VERT M, 1989, ANGEW MAKROMOL CHEM, V166, P155, DOI 10.1002/apmc.1989.051660111
   ZHANG XC, 1993, J MACROMOL SCI PURE, VA30, P933, DOI 10.1080/10601329308009437
   ZIMMERMAN M, 1987, J BIOMED MATER RES-A, V21, P345
NR 23
TC 25
Z9 25
U1 0
U2 16
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2001
VL 16
IS 1
BP 32
EP 46
DI 10.1106/MF92-TCJC-KC2X-J0FB
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 413NZ
UT WOS:000167619800003
DA 2018-10-19
ER

PT J
AU Baidya, KP
   Ramakrishna, S
   Rahman, M
   Ritchie, A
AF Baidya, KP
   Ramakrishna, S
   Rahman, M
   Ritchie, A
TI Quantitative radiographic analysis of fiber reinforced polymer
   composites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE radiolucency; fiber reinforced polymer composite material; total mass
   attenuation coefficient (TMAC)
ID VERTEBRAL BODY REPLACEMENT; RADIOLUCENT
AB X-ray radiographic examination of the bone fracture healing process is a widely used method in the treatment and management of patients. Medical devices made of metallic alloys reportedly produce considerable artifacts that make the interpretation of radiographs difficult. Fiber reinforced polymer composite materials have been proposed to replace metallic alloys in certain medical devices because of their radiolucency, light weight, and tailorable mechanical properties. The primary objective of this paper is to provide a comparable radiographic analysis of different fiber reinforced polymer composites that are considered suitable for biomedical applications. Composite materials investigated consist of glass, aramid (Kevlar-29), and carbon reinforcement fibers, and epoxy and polyether-ether-ketone (PEEK) matrices. The total mass attenuation coefficient of each material was measured using clinical X-rays (50 kev). The carbon fiber reinforced composites were found to be more radiolucent than the glass and kevlar fiber reinforced composites.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Singapore 119260, Singapore.
   Nanyang Technol Univ, Dept Mech & Prod Engn, Singapore 639798, Singapore.
RI Rahman, Mustafizur/G-1998-2012
CR Ciappetta P, 1997, NEUROSURGERY, V41, P1203, DOI 10.1097/00006123-199711000-00040
   Claes L, 1999, J BIOMED MATER RES, V48, P82, DOI 10.1002/(SICI)1097-4636(199921)48:1<82::AID-JBM14>3.3.CO;2-Z
   COMPTON, 1935, XRAYS THEORY EXPT
   GOLVAKOVSKY V, 1993, OPERATIVE MANUAL ILI
   *NUS, MASS ATT XDB SOFTW
   OKUDERA H, 1994, ACTA NEUROCHIR, V127, P121, DOI 10.1007/BF01808559
   ROWLEY DI, 1985, ARCH ORTHOP TRAUMA S, V103, P40
   Skalak R., 1987, HDB BIOENGINEERING
   WYTCH R, 1991, INJURY, V22, P41, DOI 10.1016/0020-1383(91)90160-G
NR 9
TC 29
Z9 33
U1 2
U2 12
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2001
VL 15
IS 3
BP 279
EP 289
DI 10.1106/BKLQ-E2YG-D2LA-RG3R
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 413NN
UT WOS:000167618400005
PM 11261603
DA 2018-10-19
ER

PT J
AU Skarja, GA
   Woodhouse, KA
AF Skarja, GA
   Woodhouse, KA
TI In vitro degradation and erosion of degradable, segmented polyurethanes
   containing an amino acid-based chain extender
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethane; enzyme; degradation; in vitro
ID BIS(L-PHENYLALANINE) ALPHA,OMEGA-ALKYLENE DIESTERS; BIOANALOGOUS
   POLYMERS; POLY(ESTER-URETHANE) ELASTOMER; COMPARATIVE REACTIVITIES;
   BIODEGRADABLE POLYMERS; PEPTIDE 4-NITROANILIDE; ENZYMATIC DEGRADATION;
   EPSILON-CAPROLACTONE; LYSINE DIISOCYANATE; L-ALANINE
AB In vitro degradation and erosion of novel, degradable segmented polyurethanes containing a phenylalanine diester chain extender were investigated by exposing the polymers to buffer, chymotrypsin, and trypsin solutions for up to 28 days. Polyurethane degradation and erosion were monitored by gravimetry, scanning electron microscopy (SEM), and gel permeation chromatography (GPC) and compared to a control polyurethane. Polyurethanes were synthesized using two different soft segments (polycaprolactone diol and polyethylene oxide) of variable molecular weight. Inclusion of the phenylalanine-based chain extender resulted in an increased susceptibility to enzyme-mediated, but not buffer-mediated, erosion in comparison to the control polyurethane. SEM analysis indicated that enzyme-mediated erosion proceeded via a surface-limited mechanism resulting in a progressive removal of material from the surface inwards with time. The magnitude of degradation and erosion was highly variable and was dependent on soft segment type and molecular weight. The range of degradation rates, as well as physicochemical properties, makes these polyurethanes potentially useful for a wide range of biomedical applications.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Woodhouse, KA (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
CR Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   ARABULI N, 1994, MACROMOL CHEM PHYSIC, V195, P2279, DOI 10.1002/macp.1994.021950633
   BARRETT AJ, 1980, MAMMALIAN PROTEASES, V1
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Coury A, 1987, PROGR RUBBER PLASTIC, V3, P24
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Darwis D, 1998, POLYM DEGRAD STABIL, V62, P259, DOI 10.1016/S0141-3910(98)00005-6
   Deslandes Y, 1998, POLYMER, V39, P2361, DOI 10.1016/S0032-3861(97)00533-8
   Doi Y, 1992, BIODEGRADABLE POLYM, P139
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HANSCH C, 1972, J ORG CHEM, V37, P92, DOI 10.1021/jo00966a025
   Hettrich W, 1997, POLYMER, V38, P2437, DOI 10.1016/S0032-3861(96)00798-7
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   Kartvelishvili T, 1997, MACROMOL CHEM PHYSIC, V198, P1921, DOI 10.1002/macp.1997.021980620
   Kartvelishvili T, 1996, MACROMOL CHEM PHYSIC, V197, P249, DOI 10.1002/macp.1996.021970119
   Katsarava R, 1999, J POLYM SCI POL CHEM, V37, P391, DOI 10.1002/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   LIPATOVA TE, 1983, BIOMATERIALS, V4, P201, DOI 10.1016/0142-9612(83)90011-X
   Paredes N, 1998, J APPL POLYM SCI, V69, P1537, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1537::AID-APP8>3.0.CO;2-D
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037
   Rodriguez-Galan A, 2000, POLYMER, V41, P5967, DOI 10.1016/S0032-3861(99)00756-9
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   SILVER JH, 1993, J BIOMED MATER RES, V27, P735, DOI 10.1002/jbm.820270606
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spyros A, 1997, MACROMOLECULES, V30, P8218, DOI 10.1021/ma971193m
   STOREY RF, 1994, J POLYM SCI POL CHEM, V32, P2345, DOI 10.1002/pola.1994.080321216
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TANAKA T, 1983, J BIOL CHEM, V258, P3552
   WADE LG, 1987, ORGANIC CHEM
   Wang GB, 1997, J BIOMED MATER RES, V36, P407, DOI 10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.3.CO;2-U
NR 43
TC 84
Z9 88
U1 1
U2 28
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 8
BP 851
EP 873
DI 10.1163/156856201753113060
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 490TE
UT WOS:000172066500002
PM 11718481
DA 2018-10-19
ER

PT J
AU Shen, MC
   Pan, YV
   Wagner, MS
   Hauch, KD
   Castner, DG
   Ratner, BD
   Horbett, TA
AF Shen, MC
   Pan, YV
   Wagner, MS
   Hauch, KD
   Castner, DG
   Ratner, BD
   Horbett, TA
TI Inhibition of monocyte adhesion and fibrinogen adsorption on glow
   discharge plasma deposited tetraethylene glycol dimethyl ether
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE monocyte adhesion; fibrinogen adsorption; glow discharge plasma
   deposited tetraglyme; polyethylene oxide (PEO); time of flight secondary
   ion mass spectrometry (ToF-SIMS)
ID POLY(ETHYLENE OXIDE); INFLAMMATORY RESPONSES; RESISTANT SURFACES;
   POLYETHYLENE OXIDE; CELL-ADHESION; IN-VITRO; PROTEINS; PEO;
   BIOMATERIALS; COPOLYMERS
AB Monocytes and macrophages play important roles in host responses to implanted biomedical devices. Monocyte and macrophage interactions with biomaterial surfaces are thought to be mediated by adsorbed adhesive proteins such as fibrinogen and fibronectin. Non-fouling surfaces that minimize protein adsorption may therefore minimize monocyte adhesion, activation, and the foreign body response. Radio-frequency glow discharge plasma deposition (RF-GDPD) of tetraethylene glycol dimethyl ether (tetraglyme) was used to produce polyethylene oxide (PEO)-like coatings on a fluorinated ethylene-propylene (FEP) surface. Electron spectroscopy for chemical analysis (ESCA) and static time of flight secondary ion mass spectrometry (ToF-SIMS) were used to characterize the surface chemistry of tetraglyme coating. Fibrinogen adsorption to the tetraglyme surface was measured with I-125-labeled fibrinogen and ToF-SIMS. Adsorption of fibrinogen to plasma deposited tetraglyme was less than 10 ng cm(-2), a 20-fold decrease compared to untreated FEP or tissue culture polystyrene (TCPS). Monocyte adhesion to plasma deposited tetraglyme was significantly lower than adhesion to FEP or TCPS. In addition, when the surfaces were preadsorbed with fibrinogen, fibronectin, or blood plasma, monocyte adhesion to plasma deposited tetraglyme after 2 h or 1 day was much lower than adhesion to FEP. RF-GDPD tetraglyme coating provides a promising approach to make non-fouling biomaterials that can inhibit non-specific material-host interactions and reduce the foreign body response.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR01296]
CR ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   CHILKOTI A, 1991, THESIS U WASHINGTON
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   GNANOU Y, 1984, MACROMOLECULES, V17, P945, DOI 10.1021/ma00134a069
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, V2, P214
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JOHNSTON EE, 1997, THESIS U WASHINGTON
   Kidane A, 1999, J BIOMAT SCI-POLYM E, V10, P1089, DOI 10.1163/156856299X00702
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Litauszki L, 1997, J BIOMED MATER RES, V35, P1
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   McCarthy JB, 1997, J IMMUNOL, V159, P2424
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   O'Connor SM, 1997, ANN NY ACAD SCI, V831, P138
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OWEN CA, 1992, J LEUKOCYTE BIOL, V51, P400
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   SCHMIERER AS, 1998, THESIS U WASHINGTON
   SHAN J, 1999, THESIS U WASHINGTON
   SHEN M, 2001, UNPUB
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   VICKERMAN JC, 1999, STATIC SIMS LIB
NR 51
TC 64
Z9 68
U1 1
U2 11
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 9
BP 961
EP 978
DI 10.1163/156856201753252507
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 506TL
UT WOS:000172987800002
PM 11787523
DA 2018-10-19
ER

PT J
AU Smeds, KA
   Grinstaff, MW
AF Smeds, KA
   Grinstaff, MW
TI Photocrosslinkable polysaccharides for in situ hydrogel formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE in situ polymerization; hydrogels; hyaluronan; photocrosslinkable
   polysaccharides; sutureless surgery
ID TISSUE; PHOTOPOLYMERIZATION; BIOMATERIALS; BEHAVIOR; ALGINATE; MATRIX;
   CELLS; GELS
AB In situ photopolymerization is an exciting new technique for tissue engineering. Two photocrosslinkable polysaccharides composed of alginate and hyaluronan are described that upon photolysis form soft, flexible, and viscoelastic hydrogels. The degree of methacrylate modification and thus covalent affects mechanical properties such as swelling, compression, and creep compliance. Significant swelling is observed in aqueous solution; these hydrogels can swell up to 14 times their dry weight. Both hydrogels exhibit low phase angles and I G* I values indicative of viscoelastic materials. The hyaluronan based hydrogel is stronger and more resilient than the corresponding alginate gel. SEM and AFM studies on both hydrogels show smooth and uniform surfaces at the macroscopic level with salient features observed only on the nanometer scale. Rapid polymerization by an optical trigger allows for controlled in situ photopolymerization in a minimally invasive manner, indicating that these hydrogels are relevant for biomedical applications such as sealing wounds and reconstructing soft tissues. (C) 2000 John Wiley & Sons, Inc.
C1 Duke Univ, Dept Chem, Paul M Gross Chem Lab, Durham, NC 27708 USA.
   Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.
   Duke Univ, Med Ctr, Durham, NC 27708 USA.
RP Grinstaff, MW (reprint author), Duke Univ, Dept Chem, Paul M Gross Chem Lab, Durham, NC 27708 USA.
EM mwg@chem.duke.edu
OI Grinstaff, Mark/0000-0002-5453-3668
CR Aharoni S. M., 1992, SYNTHESIS CHARACTERI
   ANDRADE JD, 1976, S AM CHEM SOC, V31
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Christenson L, 1997, TISSUE ENG, V3, P71, DOI 10.1089/ten.1997.3.71
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   Holzman S, 1994, J Invest Surg, V7, P431, DOI 10.3109/08941939409016509
   HONG GL, 1994, ANAL BIOCHEM, V219, P278
   Honig MA, 1997, CORNEA, V3, P1815
   Hubbell JA, 1996, MRS BULL, V21, P33
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Keys KB, 1998, MACROMOLECULES, V31, P8149, DOI 10.1021/ma980999z
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   LARSEN NE, 1991, ADV DRUG DELIVER REV, V7, P279, DOI 10.1016/0169-409X(91)90007-Y
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   LYNMAN MD, 1996, BIOMATER, V17, P359
   MIKI D, 2000, UNPUB INVEST OPHTHAL
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   Mulder G T, 1999, J Wound Care, V8, P21
   OTTENBRITE RM, 1994, ACS S SER
   PARK K, 1993, BIODEGRADABLE HYDROG
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317
   SCHOICHET MS, 1996, BIOTECHNOL BIOENG, V50, P374
   SEFTON MV, 1998, J CUTAN MED SURG, V3, P18
   Smeds KA, 1999, J MACROMOL SCI PURE, VA36, P981, DOI 10.1081/MA-100101577
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P4639, DOI 10.1021/ma9704018
   WATTS DC, 1991, MAT SCI TECHNOLOGY C, P14
   WEISS JL, 1983, OPHTHALMOLOGY, V90, P610
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   1994, SCI AM, P4
NR 40
TC 254
Z9 259
U1 17
U2 154
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2001
VL 54
IS 1
BP 115
EP 121
DI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378MW
UT WOS:000165589000014
PM 11077410
DA 2018-10-19
ER

PT J
AU Bouhadir, KH
   Mooney, DJ
AF Bouhadir, KH
   Mooney, DJ
TI Promoting angiogenesis in engineered tissues
SO JOURNAL OF DRUG TARGETING
LA English
DT Article
DE endothelial cells; blood vessels; growth factors; plasmid DNA
ID ENDOTHELIAL GROWTH-FACTOR; POLY(ALDEHYDE GULURONATE) HYDROGELS;
   CALCIUM-ALGINATE BEADS; IN-VIVO; INCREASED VASCULARIZATION; BIOMEDICAL
   APPLICATIONS; COLLATERAL DEVELOPMENT; DELIVERY SYSTEMS; MATRICES;
   RELEASE
AB There is a tremendous need for organs and tissues to replace those lost due to diseases or trauma. In theory, transplanting cells on biomaterial matrices can create functional tissue. A critical question, however, is how to supply cells embedded within large cell-polymer constructs with sufficient oxygen and nutrients to sustain their survival and proliferation, and allow for the integration of the developing tissue with the surrounding tissue. A rapid and high level of vascularization of transplanted polymer-cell matrices is essential in tissue engineering approaches to meet these challenges. This review summarizes the current approaches and materials under development in our laboratory to promote angiogenesis in engineered tissues.
C1 Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Amer Univ Beirut, Dept Chem, Beirut, Lebanon.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, 2300 Hayward St,3074 HH Dow Bldg, Ann Arbor, MI 48109 USA.
CR Ahrendt G, 1998, TISSUE ENG, V4, P117, DOI 10.1089/ten.1998.4.117
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COOK W, 1986, J BIOMED MATER RES, V20, P1, DOI 10.1002/jbm.820200103
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225
   DVORAK HF, 1995, AM J PATHOL, V146, P1029
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KING K, 1994, FOOD HYDROCOLLOID, V8, P83, DOI 10.1016/S0268-005X(09)80035-0
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOTECHNOL BIOENG, V50, P422, DOI 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   MOONEY DJ, 1994, TRANSP P, V26, P4025
   MUMPER RJ, 1994, J CONTROL RELEASE, V30, P241, DOI 10.1016/0168-3659(94)90030-2
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   MURPHY WL, 1999, MINERALIZATION NATUR, V599, P347
   MURPHY WL, 2001, BIOMATERIALS
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342
   Peters M. C., 1999, POLYM PREPRINTS, V40, P273
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   REDDI AH, 2000, PRINCIPLES TISSUE EN, P81
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
   Thirumurti V, 1998, J AM COLL CARDIOL, V31, p54A, DOI 10.1016/S0735-1097(97)83941-1
   Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 56
TC 50
Z9 55
U1 3
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1061-186X
J9 J DRUG TARGET
JI J. Drug Target.
PY 2001
VL 9
IS 6
BP 397
EP 406
DI 10.3109/10611860108998775
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 513ZC
UT WOS:000173397300002
PM 11822813
DA 2018-10-19
ER

PT J
AU Bosetti, M
   Masse, A
   Tobin, E
   Cannas, M
AF Bosetti, M
   Masse, A
   Tobin, E
   Cannas, M
TI In vivo evaluation of bone tissue behavior on ion implanted surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID JOINT PROSTHESIS MATERIALS; WEAR; IMPROVEMENT; MECHANISMS; TI-6AL-4V
AB The ion implantation process offers several unique advantages over other surfaces modifications techniques, in regard to ion release and material mechanical characteristics. The aim of this study was to evaluate the in vivo bone tissue response to ion implanted surfaces. Untreated and nitrogen-ion-implanted stainless steel implants were inserted in the tibia diaphysis (cortical bone) and proximal tibia epiphysis (trabecular bone) of 12 New Zealand White rabbits. The animals were divided into three groups of four animals each, which were maintained for 4, 12 and 24 weeks according to internationally accepted and standardized procedures. At sacrifice, the implants were retrieved with surrounding bone and fixed in 4% neutral buffered formaldehyde and embedded in polymethylmethacrylate (PMMA). The samples were reducted in slices and stained with hematoxylin-eosin, light-green, fuchsin acid and giemsa solution for histological evaluation; fluorescent markers were also used to assess bone apposition. Histomorphometric evaluation was used to determine the extent of bone-material contact. Results from histological and morphometrical analyses revealed active remodeling of bone around both types of implants (control and ion implanted). However, faster bone deposition was observed around the treated material (12 weeks). Both materials reached similar endpoints, as no significant differences between them were evident at 24 weeks. The results demonstrate that ion implanted stainless steel has similar, or slightly enhanced, biological compatibility in contact with bone compared to untreated material; thus it may be a useful material in biomedical applications where reduced ion release or enhanced mechanical properties (as provided by ion implantation) are required. (C) 2001 Kluwer Academic Publishers.
C1 Univ Eastern Piedmont, Dept Med Sci, Novara, Italy.
   Univ Turin, Orthopaed Clin CTO 1, I-10124 Turin, Italy.
   Spire Corp, Bedford, MA 01730 USA.
RP Cannas, M (reprint author), Univ Eastern Piedmont, Dept Med Sci, Novara, Italy.
OI MASSE', Alessandro/0000-0003-3999-4121
CR BIANCHI V, 1980, TOXICOLOGY, V17, P219, DOI 10.1016/0300-483X(80)90097-9
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   DAVIDSON JA, 1993, CLIN ORTHOP RELAT R, P361
   DEARNALEY G, 1982, J MET, P18
   HEATH JC, 1967, BRIT J CANCER, V21, P768, DOI 10.1038/bjc.1967.90
   JOHNSTON RC, 1990, J BONE JOINT SURG AM, V72A, P161, DOI 10.2106/00004623-199072020-00002
   KOVACS P, 1990, P 16 ANN M SOC BIOM, P20
   LIU YK, 1990, SPINE, V15, P311, DOI 10.1097/00007632-199004000-00012
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Picraux S. T., 1985, Scientific American, V252, P84
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   RIEU J, 1990, BIOMATERIALS, V11, P51
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
   WELSCH G, 1983, P INT C MET COAT SAN, P305
   WILLIAMS JM, 1984, MATERIALS RES SOC S, V27, P735
NR 16
TC 11
Z9 11
U1 1
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 5
BP 431
EP 435
DI 10.1023/A:1011253121063
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 427YP
UT WOS:000168434600010
PM 15348283
DA 2018-10-19
ER

PT J
AU Mohammadi, S
   Esposito, M
   Cucu, M
   Ericson, LE
   Thomsen, P
AF Mohammadi, S
   Esposito, M
   Cucu, M
   Ericson, LE
   Thomsen, P
TI Tissue response to hafnium
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NODULAR LYMPHATIC CELLS; ABDOMINAL-WALL; ELECTRON-MICROPROBE;
   SOFT-TISSUE; TITANIUM; IMPLANTS; RAT; INTERFACE; ZIRCONIUM; PTFE
AB The aim of the present experimental study was to evaluate the tissue response to hafnium (Hf) a reactive metal closely related to titanium (Ti) and zirconium (Zr). Hf has not been previously evaluated as implant material in a biologic environment. In a first experiment, 21 machined Hf non-threaded implants (test) and 21 similar Ti implants (control) were inserted in the abdominal wall of 21 rats. Animals were sacrificed after 8 days (6 rats), 6 (7 rats) and 12 weeks (8 rats). In a second experiment, 18 rabbits received 18 Hf and 18 Ti threaded implants in their tibiae, one implant in each tibia. The rabbits were sacrificed after 6, 12 and 24 weeks (6 animals/time interval). The bulk metal of the abdominal wall implants, embedded together with the surrounding tissue, was electrolytically dissolved and semithin (1 mum) sections of the intact tissue-implant interface were evaluated by light microscopy (morphometry). Bone-implant contact and bone area within threads were evaluated in ground sections. In soft tissues, a fluid space containing predominantly monocytes/macrophages surrounded the abdominal implants at 8 days. At 6 and 12 weeks, a fibrous capsule, consisting of layers of macrophages and fibroblasts, surrounded the implants. Macrophages, including multinuclear giant cells, always formed the innermost layer in contact with the implant surface. No quantitative or qualitative difference in the tissue organization was detected between Ti and Hf implants. In rabbits, 6 weeks after insertion, the proximal two threads located within the cortical bone were filled with bone in contact with Hf and Ti. The distal threads contained bone marrow. After 12 and 24 weeks, mature bone was present in the proximal 3-4 implant threads. No statistically significant difference was found between Hf and Ti implants at any time periods. It is concluded that Hf is an interesting metal for biomedical applications in bone and soft tissue. (C) 2001 Kluwer Academic Publishers.
C1 Univ Gothenburg, Inst Anat & Cell Biol, Gothenburg, Sweden.
   Univ Gothenburg, Dept Orthodont, Gothenburg, Sweden.
RP Mohammadi, S (reprint author), Univ Gothenburg, Inst Anat & Cell Biol, Gothenburg, Sweden.
OI Thomsen, Peter/0000-0003-3910-6665
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   ANDERSON JM, 2000, BONE ENG
   BERRY JP, 1990, TOXICOLOGY, V62, P239, DOI 10.1016/0300-483X(90)90113-U
   BERRY JP, 1992, J SUBMICR CYTOL PATH, V24, P15
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P569
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   BRUNETTE D, 2000, TITANIUM MED
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   GALANTE J, 1972, CLIN ORTHOP RELAT R, P237
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   HUGGINS CB, 1966, J EXP MED, V124, P1099, DOI 10.1084/jem.124.6.1099
   KALLTORP M, 1999, THESIS GOTEBORG U GO
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LIDE DR, 1999, CRC HDB CHEM PHYSICS
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   Rosengren A, 1998, J MATER SCI-MATER M, V9, P415, DOI 10.1023/A:1013239731256
   ROSENGREN A, 1997, THESIS LUND U LUND
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SHELLEY WB, 1973, CANCER RES, V33, P287
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
   THOMSEN P, 2000, IN PRESS BONE ENG, P117
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
NR 27
TC 12
Z9 13
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 7
BP 603
EP 611
DI 10.1023/A:1011237610299
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 446KL
UT WOS:000169512400006
PM 15348253
DA 2018-10-19
ER

PT J
AU Borzacchiello, A
   Ambrosio, L
   Netti, PA
   Nicolais, L
   Peniche, C
   Gallardo, A
   San Roman, J
AF Borzacchiello, A
   Ambrosio, L
   Netti, PA
   Nicolais, L
   Peniche, C
   Gallardo, A
   San Roman, J
TI Chitosan-based hydrogels: Synthesis and characterization
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 16th Conference of the European-Society-for-Biomaterials
CY SEP 12-14, 2001
CL LONDON, ENGLAND
SP European Soc Biomat
ID ACID) INTERPOLYMER COMPLEX; POLY(ACRYLIC ACID); SOLUBLE CHITOSAN;
   BRANCHED-CHAIN; DERIVATIVES; NETWORK
AB Chitosan (CHI) is a polysaccharide of beta -1,4-linked 2-amino-2-deoxy-D-glucopyranose derived by N-deacetylation of chitin in aqueous alkaline medium. The shells of crustaceans such as crabs, shrimp, and lobster are the current source of chitosan. It is known to be non-toxic, odourless, biocompatible in animal tissues and enzymatically biodegradable. For these reasons much research interest has been paid to its biomedical, ecological, and industrial applications over the past decade. However, its rigid crystalline structure, poor solubility in organic solvents and poor processability have limited its use. To broadening its range of applications, a growth research effort has been devoted to explore ways of modifying Chitosan. Here it has been reported on the synthesis of new hydrogels, obtained by self-curing chitosan with acrylic acid (AA) and methyl acrylate (MA). The hydrogels were characterized by FTIR, swelling and rheological analysis. The results of this study showed that the swelling and mechanical properties of chitosan are highly improved by the presence of poly acrylate. The swelling degree of these materials does not depend upon the ratio MA/AA. It is possible to improve and modulate the mechanical properties of the hydrogels by changing the relative MA/AA ratio. (C) 2001 Kluwer Academic Publishers.
C1 Univ Naples Federico II, CNR, Inst Composite Mat Technol, I-80125 Naples, Italy.
   Univ Naples Federico II, CRIB, I-80125 Naples, Italy.
   CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
RP Borzacchiello, A (reprint author), Univ Naples Federico II, CNR, Inst Composite Mat Technol, Ple Tecchio 80, I-80125 Naples, Italy.
RI Gallardo, Alberto/B-4794-2011
OI Gallardo, Alberto/0000-0003-4614-4299; AMBROSIO,
   LUIGI/0000-0002-8367-2405; Peniche Covas, Carlos
   Andres/0000-0003-2563-0132; NETTI, PAOLO/0000-0002-2435-7181
CR ARGUELLESMONAL W, 1988, MAKROMOL CHEM-RAPID, V9, P693
   CLARK AH, 1987, ADV POLYM SCI, V83, P61
   DEUCHI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1613, DOI 10.1271/bbb.58.1613
   Ferry J. D., 1970, VISCOELASTIC PROPERT
   HALL LD, 1980, J CHEM SOC CHEM COMM, P1153, DOI 10.1039/c39800001153
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   Jiang H, 1999, POLYMER, V40, P4593, DOI 10.1016/S0032-3861(99)00070-1
   Lee YM, 1997, J MATER SCI-MATER M, V8, P537, DOI 10.1023/A:1018594614087
   MOORE GK, 1981, INT J BIOL MACROMOL, V3, P292, DOI 10.1016/0141-8130(81)90045-3
   MUZZARELLI RAA, 1982, PURE APPL CHEM, V54, P2141, DOI 10.1351/pac198254112141
   Peniche C, 1998, POLYMER, V39, P6549, DOI 10.1016/S0032-3861(98)00059-7
   Peniche C, 1999, BIOMATERIALS, V20, P1869, DOI 10.1016/S0142-9612(99)00048-4
   ROSSMURPHY SB, 1993, BIORHEOLOGY, V30, P217
   ROSSMURPHY SB, 1991, POLYMER GELS, P21
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Wang HF, 1997, J APPL POLYM SCI, V65, P1445
   Wang HF, 1996, J APPL POLYM SCI, V61, P2221, DOI 10.1002/(SICI)1097-4628(19960919)61:12<2221::AID-APP22>3.0.CO;2-8
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
   Zong Z, 2000, POLYMER, V41, P899, DOI 10.1016/S0032-3861(99)00270-0
NR 21
TC 51
Z9 53
U1 0
U2 21
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 10-12
BP 861
EP 864
DI 10.1023/A:1012851402759
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 494KB
UT WOS:000172280300004
PM 15348330
DA 2018-10-19
ER

PT J
AU Rodriguez, D
   Manero, JM
   Gil, FJ
   Planell, JA
AF Rodriguez, D
   Manero, JM
   Gil, FJ
   Planell, JA
TI Low cycle fatigue behavior of Ti6Al4V thermochemically nitrided for its
   use in hip prostheses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 16th Conference of the European-Society-for-Biomaterials
CY SEP 12-14, 2001
CL LONDON, ENGLAND
SP European Soc Biomat
AB Titanium and its alloys have many attractive properties including high specific strength, low density, and excellent corrosion resistance. Besides, titanium and the Ti6Al4V alloy have long been recognized as materials with high biocompatibility. These properties have led to the use of these materials in biomedical applications. Despite these advantages, the lack of good wear resistance makes difficult the use of titanium and Ti6Al4V in some biomedical applications, like articulating components of prostheses.
   Some surface treatments are available in order to correct these problems, like thermal surface treatment by means of nitrogen gaseous diffusion at high temperature. Nitrogen enters into the material by diffusion, creating a surface layer of increased hardness.
   Low cycle fatigue behavior in air of Ti6Al4V alloy has been studied. Results show a reduction of low cycle fatigue life up to 10% compared to the not-treated material. Studies suggest it is not related to the titanium nitride surface layer, but to microstructural changes caused by the high temperature treatment. (C) 2001 Kluwer Academic Publishers.
C1 ETSEIB, CREB, Dept Ciencia Mat & Engn Met, Barcelona 08028, Spain.
RP Rodriguez, D (reprint author), ETSEIB, CREB, Dept Ciencia Mat & Engn Met, Av Diagonal 647, Barcelona 08028, Spain.
RI Manero, Jose Maria/B-4169-2015
OI Manero, Jose Maria/0000-0002-1673-4389
CR BLOYCE A, 1997, WEAR PROTECTION TITA, P155
   GIL FJ, 1996, P 5 WORLD BIOM C CAN, V2, P477
   MANERO JM, 1997, THESIS U POLITECNICA
   Morton P. H., 1988, P 6 WORLD C TIT, P1705
   RODRIGUEZ D, 2000, THESIS U POLITECNICA
   SHIBATA H, 1994, INT J FATIGUE, V16, P370, DOI 10.1016/0142-1123(94)90448-0
   WELSH G, 1994, HDB MAT PROPERTIES T
NR 7
TC 5
Z9 5
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 10-12
BP 935
EP 937
DI 10.1023/A:1012892511845
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 494KB
UT WOS:000172280300017
PM 15348343
DA 2018-10-19
ER

PT J
AU Tolmachev, V
   Lundqvist, H
AF Tolmachev, V
   Lundqvist, H
TI Separation of arsenic from germanium oxide targets by dry distillation
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
AB Positron-emitting isotopes of arsenic, As-70 (T-1/2 = 53 min), As-71 (T-1/2 = 64 h), (72)AS (T-1/2 = 26 h), and As-73 (T-1/2 = 17.8 d) are of interest in biomedical investigations using PET. A fast and simple method for their production using low-energy proton and deuteron reactions on enriched Ge-targets is presented. Dry distillation of GeO2 at 1105 degreesC during 2 hours provides a separation efficiency of more than 60%. The loss of target material is less than one per cent and the irradiated targets can be used several times. The method allows production of diagnostically useful amounts of positron-emitting arsenic isotopes using accelerators commonly available at PET-centres.
C1 Univ Uppsala, Sect Biomed Radiat Sci, Dept Oncol Radiol & Clin Immunol, Rudbecklaboratoriet, S-75185 Uppsala, Sweden.
RP Tolmachev, V (reprint author), Univ Uppsala, Sect Biomed Radiat Sci, Dept Oncol Radiol & Clin Immunol, Rudbecklaboratoriet, S-75185 Uppsala, Sweden.
RI Tolmachev, Vladimir/I-3076-2012; Tolmachev, Vladimir/T-3722-2017
OI Tolmachev, Vladimir/0000-0002-6122-1734
CR ALKOURAISHI SH, 1978, INT J APPL RADIAT IS, V29, P607, DOI 10.1016/0020-708X(78)90093-5
   BASILE D, 1981, INT J APPL RADIAT IS, V32, P403, DOI 10.1016/S0020-708X(81)81007-1
   Browne E., 1986, TABLE RADIOACTIVE IS
   BROWNELL GL, 1953, NUCLEONICS, V11, P40
   DMITRIEV PP, 1986, EHNERGOATOMIZDAT, P144
   EMRAN A, 1982, J LABELLED COMPD RAD, V19, P1505
   EMRAN AM, 1991, NEW TRENDS IN RADIOPHARMACEUTICAL SYNTHESIS, QUALITY ASSURANCE, AND REGULATORY CONTROL, P153
   EMRAN AM, 1986, APPL RADIAT ISOTOPES, V37, P545
   GANDARIASCRUZ D, 1988, P IAEA CONS M DAT RE, P145
   GRUVERMAN I J, 1959, Int J Appl Radiat Isot, V5, P21, DOI 10.1016/0020-708X(59)90347-3
   HOSAIN F, 1982, INT J APPL RADIAT IS, V33, P477
   KELLER KA, 1974, NUCL PARTICLE PHYS C, V5
   Leonard A., 1991, METALS THEIR COMPOUN, P751
   MORRISON GH, 1957, SOLVENT EXTRACTION A, P193
   NOZAKI T, 1979, INT J APPL RADIAT IS, V30, P595, DOI 10.1016/0020-708X(79)90076-0
   WEINREICH R, 1989, J LAB COMP RADIOPHAR, V27, P146
   Zweit J, 1996, PHYS MED BIOL, V41, P1905, DOI 10.1088/0031-9155/41/10/004
NR 17
TC 12
Z9 12
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0236-5731
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD JAN
PY 2001
VL 247
IS 1
BP 61
EP 66
DI 10.1023/A:1006706913108
PG 6
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA 412RC
UT WOS:000167567300010
DA 2018-10-19
ER

PT J
AU Vallet-Regi, M
AF Vallet-Regi, M
TI Ceramics for medical applications
SO JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
LA English
DT Article
ID SOL-GEL GLASSES; CALCIUM-PHOSPHATE FORMATION; IN-VITRO BIOACTIVITY;
   BIOMEDICAL APPLICATIONS; MINERAL PHASE; SURFACE; BONE; SYSTEM;
   DEPENDENCE; COMPOSITE
AB Ceramics, glasses and glass ceramics include a broad range of inorganic non-metallic compositions. The apatite and related calcium phosphates have been of remarkable interest to biologists, mineralogists, inorganic and industrial chemists for many years. Calcium phosphate biomaterials, mainly hydroxyapatite, find many clinical applications in the repair of bone defects, bone augmentation and coatings for metal implants. Certain compositions of ceramics, glasses, glass ceramics and composites have shown bone bonding behaviour. These materials have become known as bioactive ceramics. A common characteristic of bioactive ceramics is a time-dependent, kinetic modification of the surface that occurs upon implantation. The surface forms a biologically active carbonate hydroxyapatite layer that provides the bonding interface with living tissues. The aim of this perspective is to present an overview of the different types of ceramics available for medical applications, focused mainly on bioactive glasses.
C1 Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RI Vallet-Regi, Maria/M-3378-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889
CR ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   AOKI H, 1977, J DENT OUTLOOK, V49, P567
   Aoki H, 1994, MED APPL HYDROXYAPAT
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   BARRALET JE, 1993, BIOCERAMICS, V6, P179
   Brink M, 1997, J BIOMED MATER RES, V36, P109, DOI 10.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.3.CO;2-Q
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   CHOW LC, 1998, CEMENTS RES PROGR
   CONSTANTINO PD, 1996, CLIN N AM, V27, P1037
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Driessens FCM, 1995, ENCY HDB BIOMATERIAL
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Dupraz A, 1999, BIOMATERIALS, V20, P663, DOI 10.1016/S0142-9612(98)00222-1
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   ELLIOTT JC, 1980, J APPL CRYSTALLOGR, V13, P618, DOI 10.1107/S0021889880012927
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Falaize S, 1999, J AM CERAM SOC, V82, P969, DOI 10.1111/j.1151-2916.1999.tb01861.x
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   GREENSPAN DC, 1999, T 25 ANN M SOC BIOM, V22, P346
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HEIMKE G, 1986, HDB BIOMATERIALS EVA
   Hench L. L., 1996, BIOMATERIALS SCI INT
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hulbert S. F., 1993, INTRO BIOCERAMICS
   HULBERT SF, 1982, CERAM INT, V8, P121
   Izquierdo-Barba I, 1999, J BIOMED MATER RES, V47, P243, DOI 10.1002/(SICI)1097-4636(199911)47:2<243::AID-JBM15>3.0.CO;2-S
   Izquierdo-Barba I, 2000, J BIOMED MATER RES, V51, P191, DOI 10.1002/(SICI)1097-4636(200008)51:2<191::AID-JBM7>3.0.CO;2-T
   JANSEN JA, 2000, T 6 WORLD BIOM C MAY, P337
   Karatzas S, 1999, INT J PERIODONT REST, V19, P489
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   KIKUCHI M, 1998, BIOCERAMICS, V11, P153
   KNAACK D, 1998, BIOCERAMICS, V11, P357
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kokubo T., 1993, ADV SERIES CERAMICS, V1
   Laczka M, 1997, J ALLOY COMPD, V248, P42, DOI 10.1016/S0925-8388(96)02648-5
   LeGeros R. Z., 1970, DEV APPL SPECTROSC B, V7B, P13
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   Lemaitre J, 1987, SIL IND CERAM SCI TE, V52, P141
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   NAINWRIGHT SA, 1976, MECH DESIGN ORGANISM
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Okazaki M., 1998, BIOCERAMICS, V11, P85
   PANTANO CG, 1974, J AM CERAM SOC, V57, P412, DOI 10.1111/j.1151-2916.1974.tb11429.x
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   Pena J, 1997, J BIOMED MATER RES, V35, P129, DOI 10.1002/(SICI)1097-4636(199704)35:1<129::AID-JBM13>3.0.CO;2-E
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1996, J SOL-GEL SCI TECHN, V7, P231
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   Perez-Pariente J, 2000, CHEM MATER, V12, P750, DOI 10.1021/cm9911114
   Radin S, 1997, J BIOMED MATER RES, V37, P363, DOI 10.1002/(SICI)1097-4636(19971205)37:3<363::AID-JBM7>3.0.CO;2-J
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   RODRIGUEZLORENZ.M, 2001, BIOMATERIALS, V22, P583
   RODRIGUEZLORENZ.M, 2000, IN PRESS BIOMATERIAL
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   SALINAS AJ, IN PRESS J SOL GEL S
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b
   Vallet-Regi M, 1999, J MATER CHEM, V9, P515, DOI 10.1039/a808679f
   Vallet-Regi M, 1999, J BIOMED MATER RES, V46, P560
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   VALLETREGI M, 1998, NONCRYSTALLINE NANOS, P55
   VOGEL W, 1986, J NON-CRYST SOLIDS, V80, P34, DOI 10.1016/0022-3093(86)90377-7
   Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C
   Wang M., 1996, BIOCERAMICS, V9, P387
   WANG PE, 1995, J MATER SCI-MATER M, V6, P94, DOI 10.1007/BF00120415
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Zhong J. P., 1998, BIOCERAMICS, V11, P415
NR 82
TC 238
Z9 247
U1 1
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1472-7773
J9 J CHEM SOC DALTON
JI J. Chem. Soc.-Dalton Trans.
PY 2001
IS 2
BP 97
EP 108
DI 10.1039/b007852m
PG 12
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 396AC
UT WOS:000166613300001
DA 2018-10-19
ER

PT S
AU Rechmann, P
   Pilgrim, C
   Hennig, T
AF Rechmann, P
   Pilgrim, C
   Hennig, T
BE Rechmann, P
   Fried, D
   Hennig, T
TI Laser treatment of first degree carious lesions.
SO LASERS IN DENTISTRY VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Lasers in Dentistry VII Conference
CY JAN 21-22, 2001
CL SAN JOSE, CA
SP SPIE
DE Er : YAG laser; non contact or contact mode delivered; effect in enamel;
   clinical rating; light microscopy; caries diagnosis; laser fluorescence
   measurements
ID ER-YAG LASER; ABLATION; ENAMEL
AB The therapy of initial carious lesions aims in a minimal invasive removal of infected dental hard tissues. Typically standard preparation instruments bear the risk of removing a big amount of sound structures as a result of access. On the other hand the competence of Er:YAG lasers for caries removal has been repeatedly proven.
   Aim of this study was to compare cavity preparations at simulated clinical conditions performed by two different Er:YAG laser systems, one working in non-contact mode (KaVo Key Laser; Biberach, Germany) the other working in contact mode (Continuum Biomedical DELight Er:YAG Laser System, Santa Clara, CA).
   The sample material consisted of 15 randomized selected extracted human molars clinically presenting initial carious lesions located in the occlusal fissure area. In the first part of the study each lesion passed standard clinical examinations. Visual examination, probing, x-rays and Fluorescence measurements (DIAGNOdent 2095; KaVo, Biberach, Germany) were performed. A clinical diagnosis for each lesion was given. Finally, the percentage of correct caries diagnosis obtained from the different diagnostic aids was calculated. The fluorescence measurement tool showed an extremely high success rate in the diagnosis of depth of caries.
   In the second part of the study the sample material was split into two groups showing equivalent clinical extension of the assumed first degree caries in horizontal direction. Each group was randomized assigned to a single laser system and laser caries removal was performed until no residual caries was clinically detectable. Afterwards a blinded evaluation on the treated samples was performed. They were judged by the quality and completeness of caries removal, the quality and extension of the cavity outline, quality of cavity walls, bevels and surface of the cavity floor. Additionally macroscopical and histological evaluations were performed.
   The results support initial caries therapy with Er:YAG lasers. Differences between the use of a contact mode or a non contact Er:YAG laser delivery mode came to light. In case of tiny carious fissures the contact mode delivered Er:YAG laser seems to have advantages over the non contact mode laser. The overall rating for the quality of the cavity preparation is better using the contact mode delivered Er:YAG laser than engaging the non contact mode laser at the same parameter settings.
C1 Univ Dusseldorf, Sch Dent, Dept Oral Surg, Dusseldorf, Germany.
RP Rechmann, P (reprint author), Univ Dusseldorf, Sch Dent, Dept Oral Surg, Dusseldorf, Germany.
CR BURKES EJ, 1992, J PROSTHET DENT, V67, P847, DOI 10.1016/0022-3913(92)90599-6
   Cozean CD, 1998, P SOC PHOTO-OPT INS, V3248, P14, DOI 10.1117/12.306018
   DENBESTEN PK, 2000, SPIE P LASER DENT 6, V3910, P171
   FREID D, 2000, SPIE P LASER DENT 6, V3910, P136
   HARRIS DM, 2000, SPIE P LASER DENT 6, V3910, P184
   HENNIG T, 1991, SPIE, V1424, P99
   Hibst R, 1999, P SOC PHOTO-OPT INS, V3593, P141, DOI 10.1117/12.348341
   HIBST R, 1989, LASER SURG MED, V9, P338, DOI 10.1002/lsm.1900090405
   Keller U, 1997, LASER SURG MED, V20, P32, DOI 10.1002/(SICI)1096-9101(1997)20:1<32::AID-LSM5>3.0.CO;2-#
   KELLER U, 1994, SPIE ADV LASER DENT, V1984, P85
   Lussi A, 1999, CARIES RES, V33, P261, DOI 10.1159/000016527
   Rechmann P, 1998, P SOC PHOTO-OPT INS, V3248, P62, DOI 10.1117/12.306038
   Rechmann P, 1998, P SOC PHOTO-OPT INS, V3248, P2, DOI 10.1117/12.306009
NR 13
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3927-4
J9 PROC SPIE
PY 2001
VL 4249
BP 104
EP 114
DI 10.1117/12.424502
PG 11
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical; Optics;
   Physics, Applied
SC Dentistry, Oral Surgery & Medicine; Engineering; Optics; Physics
GA BS31X
UT WOS:000169435600016
DA 2018-10-19
ER

PT S
AU Duarte, J
   Tadeu, M
   Pacheco, T
   Silveira, L
   Machado, RZ
   Martins, RA
   Zangaro, RA
   Villaverde, AB
AF Duarte, J
   Tadeu, M
   Pacheco, T
   Silveira, L
   Machado, RZ
   Martins, RA
   Zangaro, RA
   Villaverde, AB
BE Anderson, RR
   Bartels, KE
   Bass, LS
   Garrett, CG
   Gregory, KW
   Katzir, A
   Kollias, N
   Lucroy, MD
   Malek, RS
   Nelson, JS
   Peavy, GM
   Reidenbach, HD
   Reinisch, L
   Robinson, DS
   Tate, LP
   Trowers, EA
   Woodward, TA
TI Near-infrared Raman spectroscopy to detect anti-Toxoplasma gondii
   antibodies in blood sera of domestic cats
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION THERAPEUTICS, AND SYSTEMS
   XI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery - Advanced Characterization,
   Therapeutics, and Systems XI
CY JAN 20-23, 2001
CL SAN JOSE, CA
SP SPIE
DE toxoplasmosis; serological analysis; disease diagnosis; NIR Raman
   spectroscopy; PCA method
ID LASER; THERAPY
AB Near Infrared (NIR) Raman Spectroscopy has been study for the last years for many biomedical applications. It is a powerful tool for biological materials analysis. Toxoplasmosis is an important zoonosis in public health, being the cats the principal responsible for the transmission of the disease in Brazil. The objective of this work is to investigate a new method of diagnosis of this disease. NIR Raman Spectroscopy was used to detect anti Toxoplasma gondii antibodies in blood sera from domestic cats, without sample preparation. In all, six blood serum samples were used for this study. A previous serological test was done by the Indirect Immunoenzymatic Assay (ELISA) to permit a comparative study between both techniques and it showed that three serum samples were positive and the other three were negative to toxoplasmosis. Raman spectra were taken for all the samples and analyzed by using the Principal Components Analysis (PCA). A diagnosis parameter was defined from the analysis of the second and third principal components of the Raman spectra. It was found that this parameter can detect the infection level of the animal. The results have indicated that NIR Raman Spectroscopy, associated to the PCA can be a promising technique for serological analysis, such as toxoplasmosis, allowing a fast and sensitive method of diagnosis.
C1 Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RP Duarte, J (reprint author), Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RI Silveira, Landulfo/I-2474-2012; Machado, Rosangela/C-4850-2012
OI Silveira, Landulfo/0000-0002-6616-3334; 
CR Barnett SM, 1999, P SOC PHOTO-OPT INS, V3608, P124, DOI 10.1117/12.345393
   Berger AJ, 1996, APPL OPTICS, V35, P209, DOI 10.1364/AO.35.000209
   DENIUM G, 1999, APPL SPECTROSC, V53, P938
   ELLISON GW, 1995, VET SURG, V24, P140, DOI 10.1111/j.1532-950X.1995.tb01308.x
   GANESH DS, 1999, SPIE C BIOM APPL RAM, V3608, P185
   Ghamsari SM, 1997, VET SURG, V26, P114, DOI 10.1111/j.1532-950X.1997.tb01473.x
   GOODMAN JW, 1992, IMUNOLOGIA BASICA, P85
   Hahn KA, 1998, VET DERMATOL, V9, P3, DOI 10.1046/j.1365-3164.1998.00071.x
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Harlow E, 1988, ANTIBODIES LAB MANUA, P726
   Hayden CA, 1996, APPL SPECTROSC, V50, P708, DOI 10.1366/0003702963905772
   Lindsay DS, 1997, COMP CONT EDUC PRACT, V19, P448
   Lucroy MD, 1999, VET SURG, V28, P292, DOI 10.1053/jvet.1999.0292
   PUPPELS GJ, 1996, 15 INT C RAM SPECTR, V15, P522
   QU YJ, 1999, APPL OPTICS, V38, P5491
   Sullivan TC, 1997, VET CLIN N AM-SMALL, V27, P1193, DOI 10.1016/S0195-5616(97)50109-4
   Svobodova V, 1998, VET PARASITOL, V80, P173, DOI 10.1016/S0304-4017(98)00201-5
   Torreggiani A, 1998, J RAMAN SPECTROSC, V29, P229, DOI 10.1002/(SICI)1097-4555(199803)29:3<229::AID-JRS229>3.3.CO;2-O
   WOLLMAN ST, 1993, APPL SPECTROSC, V47, P125, DOI 10.1366/0003702934048479
NR 19
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3922-3
J9 PROC SPIE
PY 2001
VL 4244
BP 536
EP 543
DI 10.1117/12.427767
PG 8
WC Engineering, Biomedical; Optics; Physics, Applied; Surgery
SC Engineering; Optics; Physics; Surgery
GA BS36N
UT WOS:000169641700072
DA 2018-10-19
ER

PT J
AU Anastassopoulou, N
   Arapoglou, B
   Demakakos, P
   Makropoulou, MI
   Paphiti, A
   Serafetinides, AA
AF Anastassopoulou, N
   Arapoglou, B
   Demakakos, P
   Makropoulou, MI
   Paphiti, A
   Serafetinides, AA
TI Spectroscopic characterisation of carotid atherosclerotic plaque by
   laser induced fluorescence
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE laser biomedical applications; optical spectroscopy
ID TISSUE ABLATION; WALL FLUORESCENCE; HUMAN AORTA; ANGIOPLASTY;
   AUTOFLUORESCENCE; DIAGNOSIS; DEPOSITS; DESIGN
AB Background and Objective: An effort has been made to distinguish the composition of carotid atherosclerotic plaques (CAP) from patients undergoing carotid endarterectomy, by laser induced fluorescence spectroscopy.
   Study Design/Materials and Methods: Different excitation wavelengths were used: 476, 488, and 458 nm of a continuous wave krypton/argon ion laser, and 337 nm of a pulsed nitrogen laser. Twenty-three CAP samples from different patients were investigated and several spectra from each plaque were obtained.
   Results: Results were crossed-examined with conventional histologic techniques, which showed three areas of different composition on the pathologic samples: fibrous tissue, lipid constituents, and calcified plaque. Gaussian fittings were performed to reproduce the fluorescence spectra as a correlation of multiple Gaussian curves.
   Conclusion: The accuracy for discrimination of the heterogeneous composition of the atherosclerotic plaque is still limited, due to superposition of the fluorescence emission of various plaque components. Lasers Surg. Med. 28: 67-73, 2001. (C) 2001 Wiley-Liss, Inc.
C1 Natl Tech Univ Athens, Dept Phys, Athens 15780, Greece.
   Univ Athens, Areteion Hosp, Sch Med, Dept Surg, Athens, Greece.
RP Makropoulou, MI (reprint author), Natl Tech Univ Athens, Dept Phys, Zografou Campus, Athens 15780, Greece.
OI Serafetinides, Alexandros/0000-0001-5284-0050
CR ALEXANDER AL, 1994, OPT ENG, V33, P167, DOI 10.1117/12.152018
   ALFANO RR, 1984, IEEE J QUANTUM ELECT, V20, P1507, DOI 10.1109/JQE.1984.1072322
   Anastassopoulou N, 1996, P SOC PHOTO-OPT INS, V3052, P394, DOI 10.1117/12.262964
   ANDERSSON P S, 1987, Lasers in Medical Science, V2, P261, DOI 10.1007/BF02594170
   ANDERSSONENGELS S, 1988, LASER MED SCI, V4, P71
   BARAGA JJ, 1989, SPECTROCHIM ACTA A, V45, P95, DOI 10.1016/0584-8539(89)80032-7
   BARAGA JJ, 1991, ATHEROSCLEROSIS, V88, P1, DOI 10.1016/0021-9150(91)90251-W
   BARAGA JJ, 1990, LASER SURG MED, V10, P245, DOI 10.1002/lsm.1900100305
   CLARKE RH, 1988, LASER SURG MED, V8, P45, DOI 10.1002/lsm.1900080110
   DECKELBAUM LI, 1989, LASER SURG MED, V9, P205, DOI 10.1002/lsm.1900090303
   FURZIKOV NP, 1988, P INT SCH QUANT EL L, P243
   Gardner CM, 1996, APPL OPTICS, V35, P1780, DOI 10.1364/AO.35.001780
   GARRAND TJ, 1991, LASER SURG MED, V11, P106, DOI 10.1002/lsm.1900110204
   GINDI GR, 1991, IEEE T BIO-MED ENG, V38, P246, DOI 10.1109/10.133205
   GMITRO AF, 1988, APPL OPTICS, V27, P1844, DOI 10.1364/AO.27.001844
   KITTRELL C, 1985, APPL OPTICS, V24, P2280, DOI 10.1364/AO.24.002280
   LAIFER LI, 1989, CIRCULATION, V80, P1893, DOI 10.1161/01.CIR.80.6.1893
   LAUFER G, 1988, CIRCULATION, V78, P1031, DOI 10.1161/01.CIR.78.4.1031
   Lee DJ, 1998, ULTRASOUND MED BIOL, V24, P1291, DOI 10.1016/S0301-5629(98)00125-2
   Makropoulou M, 2000, OPT WITHIN LIFE SCI, V5, P328
   MAKROPOULOU M, 1998, P SOC PHOTO-OPT INS, V3564, P68
   MORQUET A, 1994, LASER SURG MED, V14, P238
   OBRIEN KM, 1989, IEEE T BIO-MED ENG, V36, P424, DOI 10.1109/10.18748
   PAPAZOGLOU TG, 1994, J PHOTOCH PHOTOBIO B, V22, P139, DOI 10.1016/1011-1344(93)06960-B
   PAPAZOGLOU TG, 1990, APPL OPTICS, V29, P4950, DOI 10.1364/AO.29.004950
   PASCU ML, 1994, P SOC PHOTO-OPT INS, V2630, P120
   RICHARDSKORTUM R, 1989, SPECTROCHIM ACTA A, V45, P87, DOI 10.1016/0584-8539(89)80031-5
   RICHARDSKORTUM R, 1989, AM HEART J, V118, P381, DOI 10.1016/0002-8703(89)90199-3
   SARTORI M, 1987, IEEE J QUANTUM ELECT, V23, P1794, DOI 10.1109/JQE.1987.1073221
   SERAFETINIDES AA, 1998, P SOC PHOTO-OPT INS, V3570, P28
   SERAFETINIDES AA, 1994, P SOC PHOTO-OPT INS, V2328, P244
   SERAFETINIDES AA, 1998, P SOC PHOTO-OPT INS, V3570, P12
   STAVRIDI M, 1995, MED ENG PHYS, V17, P595, DOI 10.1016/1350-4533(95)00016-G
   Strebel RT, 1998, J LASER APPL, V10, P34, DOI 10.2351/1.521831
   TAYLOR RS, 1990, LASER SURG MED, V10, P414, DOI 10.1002/lsm.1900100503
   VERBUNT RJAM, 1992, AM HEART J, V123, P208, DOI 10.1016/0002-8703(92)90767-P
   YAN WD, 1995, LASER SURG MED, V16, P164, DOI 10.1002/lsm.1900160206
   ZANG JY, 1990, LASER MED SCI, V5, P303
NR 38
TC 8
Z9 10
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2001
VL 28
IS 1
BP 67
EP 73
DI 10.1002/1096-9101(2001)28:1<67::AID-LSM1018>3.0.CO;2-E
PG 7
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 388WW
UT WOS:000166206900010
PM 11430445
DA 2018-10-19
ER

PT B
AU Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
   Braz, D
AF Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
   Braz, D
BE Magjarevic, R
   Tonkovic, S
   Bilas, V
   Lackovic, I
TI X-ray synchrotron diffraction tomography for using in biomedical
   applications
SO MEDICON 2001: PROCEEDINGS OF THE INTERNATIONAL FEDERATION FOR MEDICAL &
   BIOLOGICAL ENGINEERING, PTS 1 AND 2
LA English
DT Proceedings Paper
CT 9th Mediterranean Conference on Medical and Biological Engineering and
   Computing
CY JUN 12-15, 2001
CL PULA, CROATIA
SP Croatian Med & Biol Engn Soc, Int Federat Med & Biol Engn, Minist Sci & Technol Republ Croatia, Univ Zagreb, Croatian Med Assoc, Assoc Italiana Ingegner Med & Biol, Cyprus Assoc Med Phys & Biomed Engn, Greek Soc Biomed Engn, Israel Soc Med & Biol Engn, Slovenian Soc Med & Biol Engn, Soc Electriciens & Electroniciens Francais, Spanish Soc Biomed Engn
AB This work reports the feasibility of a nondestructive synchrotron radiation X-ray diffraction imaging technique. This research was performed at the X-ray Diffraction beam line of the National Synchrotron Light Laboratory (LNLS) in Brazil. The X-ray diffraction measurements were carried out with an 11.101 keV and the diffracted beam was detected by a fast scintillation detector. The obtained diffraction patterns form the basis of a method of characterizing tissue samples according to their atomic structure rather than X-ray attenuation properties. Two different samples were constructed in order to evaluate the capability of the technique in distinguish between two polycrystalline solids of very similar attenuation coefficients and discriminate powder materials. Each sample was scanned at both Bragg scattering angles characteristic of each scatter and at zero degree. In this way, it was possible to obtain a transmission CT image with which to compare the diffraction CT images. All the tomographic images presented have been reconstructed by using a back-projection reconstruction technique. The results encourage us to examine further the application of the two-dimensional selective method to biomedical imaging.
C1 Univ Estado Rio de Janeiro, Inst Fis, BR-20550900 Rio De Janeiro, Brazil.
RP Barroso, RC (reprint author), Univ Estado Rio de Janeiro, Inst Fis, Rua Sao Francisco Xavier 524 Sala 3001A, BR-20550900 Rio De Janeiro, Brazil.
RI Braz, Delson/C-4971-2013
CR Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   Barroso RC, 1999, NUCL INSTRUM METH A, V422, P718, DOI 10.1016/S0168-9002(98)01024-9
   Cusatis C, 1998, J SYNCHROTRON RADIAT, V5, P491, DOI 10.1107/S0909049598000685
   EVANS SH, 1991, PHYS MED BIOL, V36, P7, DOI 10.1088/0031-9155/36/1/002
   FOWLER BA, 1993, ENVIRON HEALTH PERSP, V100, P57, DOI 10.2307/3431521
   HARDING G, 1987, J OPT SOC AM A, V4, P933, DOI 10.1364/JOSAA.4.000933
   Shimojo N, 1997, LIFE SCI, V60, P2129, DOI 10.1016/S0024-3205(97)00222-1
   Westmore MS, 1996, MED PHYS, V23, P723, DOI 10.1118/1.597720
NR 8
TC 0
Z9 0
U1 0
U2 1
PU UNIV ZAGREB
PI ZAGREB
PA P O BOX 327, 41001 ZAGREB, CROATIA
BN 953-184-023-7
PY 2001
BP 508
EP 511
PG 2
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BU46P
UT WOS:000176065600145
DA 2018-10-19
ER

PT J
AU Shih, A
   Wang, G
   Cheng, PC
AF Shih, A
   Wang, G
   Cheng, PC
TI Fast algorithm for X-ray cone-beam microtomography
SO MICROSCOPY AND MICROANALYSIS
LA English
DT Article
DE X-ray computed tomography; cone-beam; microtomography; image
   reconstruction; real-time; nondestructive evaluation
ID RECONSTRUCTION ALGORITHM; PROJECTION
AB Cone-beam X-ray microtomography attracts increasing attention due to its applications in biomedical sciences, material engineering, and industrial nondestructive evaluation. Rapid volumetric image reconstruction is highly desirable in all these areas for prompt visualization and analysis of complex structures of interest. In this article, we reformulate a generalized Feldkamp cone-beam image reconstruction algorithm, utilize curved voxels and mapping tables, improve the reconstruction efficiency by an order of magnitude relative to a direct implementation of the standard algorithm, and demonstrate the feasibility with numerical simulation and experiments using a prototype cone-beam X-ray microtomographic system. Our fast algorithm reconstructs a 256-voxel cube from 100 projections within 2 min on an Intel Pentium II(R) 233 MHz personal computer, produces satisfactory image quality, and can be further accelerated using special hardware and/or parallel processing techniques.
C1 SUNY Buffalo, Dept Elect Engn, Adv Microscopy & Imaging Lab, Buffalo, NY 14260 USA.
   Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA.
RP Cheng, PC (reprint author), SUNY Buffalo, Dept Elect Engn, Adv Microscopy & Imaging Lab, Buffalo, NY 14260 USA.
CR Cheng P. C., 1991, J SCANNING MICROSCOP, V13, P10
   Cheng PC, 1999, FOCUS MULTIDIMENSION, P233
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Gullberg GT, 1996, IEEE T NUCL SCI, V43, P295, DOI 10.1109/23.485969
   HE YJ, 1993, IEEE T MED IMAGING, V12, P555, DOI 10.1109/42.241883
   Kak AC, 1988, PRINCIPLE COMPUTERIZ, P99
   KINNEY JH, 1989, REV SCI INSTRUM, V60, P2471, DOI 10.1063/1.1140702
   KRIETE A, 1994, MULTIDIMENSIONAL MICROSCOPY, P209
   PAN SJ, 1997, J ANAL MORPHOL, V4, P16
   PETERS TM, 1981, IEEE T NUCL SCI, V28, P3641, DOI 10.1109/TNS.1981.4331812
   RUSS JC, 1988, T AM NUCL SOC, V56, P14
   SHEPP LA, 1974, IEEE T NUCL SCI, VNS21, P21, DOI 10.1109/TNS.1974.6499235
   Wang G, 1996, IEEE T MED IMAGING, V15, P657, DOI 10.1109/42.538943
   WANG G, 1993, IEEE T MED IMAGING, V12, P486, DOI 10.1109/42.241876
   WANG G, 1992, SCANNING, V14, P350, DOI 10.1002/sca.4950140607
NR 15
TC 15
Z9 15
U1 0
U2 1
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1431-9276
J9 MICROSC MICROANAL
JI Microsc. microanal.
PD JAN-FEB
PY 2001
VL 7
IS 1
BP 13
EP 23
PG 11
WC Materials Science, Multidisciplinary; Microscopy
SC Materials Science; Microscopy
GA 409KF
UT WOS:000167382300001
DA 2018-10-19
ER

PT S
AU Girkin, JM
   Wokosin, DL
AF Girkin, JM
   Wokosin, DL
BE Periasamy, A
   So, PTC
TI Novel compact sources for multiphoton microscopy
SO MULTIPHOTON MICROSCOPY IN THE BIOMEDICAL SCIENCES
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Multiphoton Microscopy in the Biomedical Sciences
CY JAN 21-23, 2001
CL SAN JOSE, CA
SP SPIE, Bio Rad Labs Inc, Carl Zeiss Inc, Coherent Laser Grp, Chroma Technol Corp, Nikon Instruments Inc, Omega Opt Inc, Spectra Phys Lasers
DE femtosecond lasers; multiphoton microscopy; biomedical imaging
ID FLUORESCENCE; LASERS
AB Most multiphoton imaging has been undertaken using tuneable femtosecond Ti:Sapphire lasers which are large, expensive and require a level of laser expertise to operate. Although new commercial, computer controlled systems are becoming available they are still complex instruments. We report on the development of a range of novel laser sources for multiphoton microscopy based upon optically pumped semiconductor materials.
C1 Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
RP Girkin, JM (reprint author), Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
OI Girkin, John/0000-0003-2568-3576
CR CURLEY PF, 1992, OPT QUANT ELECTRON, V24, P851, DOI 10.1007/BF00620198
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Guild JB, 1997, APPL OPTICS, V36, P397, DOI 10.1364/AO.36.000397
   Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x
   Kuznetsov M, 1997, IEEE PHOTONIC TECH L, V9, P1063, DOI 10.1109/68.605500
   STRADLING RA, GROWTH CHARACTERISAT
   Wokosin DL, 1996, IEEE J SEL TOP QUANT, V2, P1051, DOI 10.1109/2944.577337
NR 7
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3940-1
J9 PROC SPIE
PY 2001
VL 4262
BP 186
EP 191
DI 10.1117/12.424553
PG 6
WC Engineering, Biomedical; Microscopy; Optics
SC Engineering; Microscopy; Optics
GA BS31Y
UT WOS:000169435900023
DA 2018-10-19
ER

PT S
AU Seo, JW
   Park, SL
   Hee, LJ
   Yoon, HK
   Gweon, DG
AF Seo, JW
   Park, SL
   Hee, LJ
   Yoon, HK
   Gweon, DG
BE Cho, H
   Knopf, GK
TI Optimal rejection of the image extinction in confocal scanning
   microscopy
SO OPTOMECHATRONIC SYSTEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optomechatronic Systems
CY NOV 05-06, 2000
CL BOSTON, MA
SP SPIE, Inst Control, Automat & Syst Engineers
DE confocal scanning microscopy (CSM); image extinction; AO deflector;
   optical fields; unitary lens
AB Confocal scanning microscopy(CSM) has been used in biomedical application, materials science, semiconductor quality measurement and forensic application. CSM consists of a beam projector with which a small spot is formed on a specimen, a point detector with a pinhole or slit [I], and a mechanism for two-dimensional beam scanning. An image distribution can be reconstructed by a correlation of spots with many advantages of non-contact, high speed, high resolution of thick specimen comparatively But it is a serious problem for the high performance to align pinhole and other optical components. Especially, the parasitic motion of focus on the point detector gives rise to the fatal distortion of an image profile named the image extinction while the beam is scanned. The intensity of detecting signal truncated by the finite aperture of detector diminishes by the order of two or more when the spot is focused with more than a half aperture.
   This paper shows the mathematical expression of the Light such as the extinction curve in the optical fields [2] of system using AO deflector, and the axial/lateral response experimentally when the error sources change. We propose the progressive methods for the rejection of image extinction as the following. At first for having the corrected image, small spot and long scan range, this paper shows that the optimal design having the multi-objects can be used by choosing the unitary lens [3] device in CSM. At second, in order to compensate for the intensity cancellation at the end profile that may be the cause of waviness for the optical image, this paper shows that it is efficient to schedule the frequency of scan. According to characteristics of the extinction curve and axial/lateral response having the error property, we can define the frequency and sensitivity of as their robustness.
C1 Korea Adv Inst Sci & Technol, Dept Mech Engn, Yusong Gu, Taejon 305701, South Korea.
RP Seo, JW (reprint author), Korea Adv Inst Sci & Technol, Dept Mech Engn, Yusong Gu, 373-1 Kusung Dong,ME3265, Taejon 305701, South Korea.
CR Boddeke FR, 1997, J MICROSC-OXFORD, V186, P270, DOI 10.1046/j.1365-2818.1997.2060766.x
   Born M, 1980, PRINCIPLES OPTICS
   BRACEWELL BR, 1965, FOURIER TRANSFORM IT
   Goodman J.W., 1968, INTRO FOURIER OPTICS
   GU M, PRINCIPLES 3 DIMENSI
   SHEPPARD CJR, 1997, CONFOCAL LASER SCANN
   SHEPPARD CJR, CONFOCAL LASER SCANN
   STARK H, 1982, APPL OPTICAL FOURIER
   WILSON T, THEORY PRACTICE SCAN
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3855-3
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4190
BP 62
EP 70
DI 10.1117/12.417234
PG 9
WC Automation & Control Systems; Engineering, Mechanical; Robotics; Optics
SC Automation & Control Systems; Engineering; Robotics; Optics
GA BS18U
UT WOS:000169001400007
DA 2018-10-19
ER

PT B
AU Mondelaers, W
   Lahorte, P
AF Mondelaers, W
   Lahorte, P
BE DeCuyper, M
   Bulte, JWM
TI Radiation-induced bioradicals: Physical, chemical and biological aspects
SO PHYSICS AND CHEMISTRY BASIS OF BIOTECHNOLOGY, VOL 7
SE FOCUS ON BIOTECHNOLOGY
LA English
DT Proceedings Paper
CT 9th European Congress on Biotechnology (ECB9)
CY JUL 11-15, 1999
CL BRUSSELS, BELGIUM
SP Commiss European Comm, Gen Director Technol, Res & Energy Wallonia Reg, J Chabert, Minist Econ Brussels Capit Reg
ID HYPERFINE COUPLING-CONSTANTS; MONTE-CARLO SIMULATION; TUMOR-SUPPRESSOR
   GENE; STRAND BREAK REPAIR; CELL-CYCLE CHECKPOINTS; DNA-DAMAGE;
   IONIZING-RADIATION; AQUEOUS-SOLUTION; TRACK STRUCTURE;
   CHROMOSOMAL-ABERRATIONS
AB This chapter is part one of a review in which the production and application of radiation-induced bioradicals is discussed. Bioradicals play a pivotal role in the complex chain of processes starting with the absorption of radiation in biological materials and ending with the radiation-induced biological after-effects. The general aspects of the four consecutive stages (physical, physicochemical, chemical and biological) are discussed from an interdisciplinary point of view. The close relationship between radiation dose and track structure, induced DNA damage and cell survival or killing is treated in detail. The repair mechanisms that cells employ, to insure DNA stability following irradiation, are described. Because of their great biomedical importance tumour suppressor genes involved in radiation-induced DNA repair and in checkpoint activation will be treated briefly, together with the molecular genetics of radiosensitivity. Part two of this review will deal with modem theoretical methods and experimental instrumentation for quantitative studies in this research field. Also an extensive overview of the applications of radiation-induced bioradicals will be given. A comprehensive list of references allows further exploration of this research field, characterised in the last decade by a substantial advance, both in fundamental knowledge and in range of applications.
C1 State Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, B-9000 Ghent, Belgium.
RP Mondelaers, W (reprint author), State Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, Proeftuinstr 86, B-9000 Ghent, Belgium.
RI Bulte, Jeff/A-3240-2008
OI Bulte, Jeff/0000-0003-1202-1610
CR ADAMS GE, 1991, RADIOTHER ONCOL, V20, P85, DOI 10.1016/0167-8140(91)90194-L
   Alberts B, 1994, MOL BIOL CELL
   ALPER T, 1980, RAD BIOL CANCER RES, P3
   ANDREO P, 1991, PHYS MED BIOL, V36, P861, DOI 10.1088/0031-9155/36/7/001
   Attix F. H., 1986, INTRO RADIOLOGICAL P
   Ballarini F, 1999, INT J RADIAT BIOL, V75, P35, DOI 10.1080/095530099140780
   BECKER D, 1993, ADV RADIAT BIOL, V17, P121
   BEDFORD JS, 1991, INT J RADIAT ONCOL, V21, P1457, DOI 10.1016/0360-3016(91)90320-4
   Begusova M, 1999, INT J RADIAT BIOL, V75, P913, DOI 10.1080/095530099139971
   BIAGLOW JE, 1987, RAD CHEM PRINCIPLES, P527
   BOX HC, 1995, RADIAT RES, V141, P91, DOI 10.2307/3579095
   BRENNER D, 1990, RADIAT RES, V124, P29
   Briesmeister J. F, 1993, LA12625 LOS AL NAT L
   Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75
   Brown JM, 1999, CANCER RES, V59, P1391
   BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805
   Cadet J, 1999, NUCL INSTRUM METH B, V151, P1, DOI 10.1016/S0168-583X(99)00117-2
   Callens F, 1996, APPL RADIAT ISOTOPES, V47, P1241, DOI 10.1016/S0969-8043(96)00166-2
   CARTWRIGHT R, 1993, MOL BIOL ONCOLOGISTS
   CASSONI AM, 1992, EUR J CANCER, V28A, P1610, DOI 10.1016/0959-8049(92)90052-4
   COLSON AO, 1995, INT J RADIAT BIOL, V67, P627, DOI 10.1080/09553009514550751
   COOPER M, 1997, RADIAT PHYS CHEM, V50, P102
   COURDI A, 1993, PATHOL BIOL, V41, P117
   CURTIS SB, 1986, RADIAT RES, V106, P252, DOI 10.2307/3576798
   Dahm-Daphi J, 1998, STRAHLENTHER ONKOL, V174, P8
   Dasika GK, 1999, ONCOGENE, V18, P7883
   DEACON J, 1984, RADIOTHER ONCOL, V2, P317, DOI 10.1016/S0167-8140(84)80074-2
   DEALMODOVAR JMR, 1994, BRIT J CANCER, V69, P457
   DEMARCO J, 1998, MED PHYS, V21, P1943
   DIEHL J, 1981, RADIOLYTIC EFFECTS F
   Diehl J.F., 1995, SAFETY IRRADIATED FO
   EVANS HH, 1994, RADIAT RES, V137, P131, DOI 10.2307/3578804
   *FAO IAEA, 1996, FOOD IRR NEWSL
   Ferradini C, 1999, CAN J CHEM, V77, P1542, DOI 10.1139/v99-162
   FERTIL B, 1981, INT J RADIAT ONCOL, V7, P621, DOI 10.1016/0360-3016(81)90377-1
   FRANKENBURGSCHWAGER M, 1994, INT J RADIAT BIOL, V66, P543, DOI 10.1080/09553009414551591
   Fulford J, 1999, J PHYS CHEM A, V103, P11345, DOI 10.1021/jp993087n
   Gallagher WM, 1999, ANN ONCOL, V10, P139, DOI 10.1023/A:1008368500557
   GERWARD L, 1993, RADIAT PHYS CHEM, V41, P783, DOI 10.1016/0969-806X(93)90326-P
   GLASS WA, 1991, PHYSICAL CHEM MECH M
   GOODHEAD DT, 1989, INT J RADIAT BIOL, V55, P513, DOI 10.1080/09553008914550571
   GOODHEAD DT, 1988, HEALTH PHYS, V55, P231, DOI 10.1097/00004032-198808000-00015
   HALBEIB JA, 1984, SAND840573 SAND NAT
   HALL EJ, 1994, RADIOBIOLOGY RADIOBI
   HALL PA, 1994, EUR J CANCER, V30A, P2001, DOI 10.1016/0959-8049(94)00394-K
   Hardy CJ, 1997, J APPL SPORT PSYCHOL, V9, P1, DOI 10.1080/10413209708415381
   HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013
   HILDENBRAND K, 1990, FREE RADICAL RES COM, V11, P195, DOI 10.3109/10715769009088916
   Hill MA, 1999, RADIAT MEAS, V31, P15, DOI 10.1016/S1350-4487(99)00090-6
   HOUEELEVIN C, 1994, J CHIM PHYS PCB, V91, P1107, DOI 10.1051/jcp/1994911107
   Hubbell J. H., 1999, PHYS MED BIOL, V44, P1
   *ICRU, 1992, 46 ICRU
   ICRU, 1984, 37 ICRU
   ICRU, 1993, 49 ICRU
   ISABELLE V, 1995, INT J RADIAT BIOL, V67, P169, DOI 10.1080/09553009514550211
   ISABELLE V, 1993, INT J RADIAT BIOL, V63, P749, DOI 10.1080/09553009314552151
   Joiner MC, 1993, BASIC CLIN RADIOBIOL, P40
   KATZ R, 1994, RADIAT RES, V140, P356, DOI 10.2307/3579113
   Kiefer J., 1990, BIOL RAD EFFECTS
   KLASSEN NV, 1987, RAD CHEM PRINCIPLES, P29
   Knoll G, 1989, RAD DETECTION MEASUR
   Lahorte P, 1999, J PHYS CHEM A, V103, P6650, DOI 10.1021/jp990942u
   Lahorte P, 1999, J PHYS CHEM A, V103, P11130, DOI 10.1021/jp992489s
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   LAVERNE JA, 1993, RADIAT RES, V135, P16, DOI 10.2307/3578391
   LEE JM, 1994, MUTAT RES, V307, P573, DOI 10.1016/0027-5107(94)90267-4
   LEE JM, 1995, CANCER METAST REV, V14, P149, DOI 10.1007/BF00665797
   LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6
   Ma C-M, 1999, PHYS MED BIOL, V44, P157
   MCKENNA W, 1992, RAD RES 20 CENTURY P, P392
   MCLAUGHLIN WL, 1993, RADIAT PHYS CHEM, V41, P45, DOI 10.1016/0969-806X(93)90041-R
   MCMILLAN TJ, 1990, INT J RADIAT BIOL, V58, P427, DOI 10.1080/09553009014551781
   MCMILLAN TJ, 1993, BASIC CLIN RADIOBIOL, P211
   Mee L. K., 1987, RAD CHEM PRINCIPLES, P477
   MEEK D, 1999, ONCOGENE, V13, P7666
   Michalik V, 1995, J BIOMOL STRUCT DYN, V13, P565, DOI 10.1080/07391102.1995.10508867
   Michalik V, 1995, NUCL INSTRUM METH B, V105, P328, DOI 10.1016/0168-583X(95)00635-4
   MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0
   NIEMANN EG, 1982, BIOPHYSIK, P300
   Nikjoo H, 1998, INT J RADIAT BIOL, V73, P355, DOI 10.1080/095530098142176
   Nunez MI, 1996, RADIOTHER ONCOL, V39, P155, DOI 10.1016/0167-8140(96)01732-X
   OBE G, 1992, MUTAGENESIS, V7, P3, DOI 10.1093/mutage/7.1.3
   OLEINICK NL, 1990, RADIAT RES, V124, P1, DOI 10.2307/3577686
   Olive PL, 1999, INT J RADIAT BIOL, V75, P395, DOI 10.1080/095530099140311
   OVERGAARD J, 1994, ONCOL RES, V6, P509
   OVERGAARD J, 1993, BASIC CLIN RADIOBIOL, P163
   Platzer I, 1998, RADIAT PHYS CHEM, V51, P73, DOI 10.1016/S0969-806X(97)00105-9
   POLLARD E, 1983, PRESERVATION FOOD IO, V2, P219
   RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741
   ROGERS DWO, 1991, APPL RADIAT ISOTOPES, V42, P965
   ROSENWALD JC, 1993, PATHOL BIOL, V41, P115
   Rowley R, 1999, INT J RADIAT BIOL, V75, P267, DOI 10.1080/095530099140456
   Sachs RK, 1997, INT J RADIAT BIOL, V72, P351
   SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600
   SCHULTEFROHLINDE D, 1989, FREE RADICAL RES COM, V6, P181, DOI 10.3109/10715768909073465
   SEYMOUR CB, 1989, INT J RADIAT BIOL, V56, P999, DOI 10.1080/09553008914552451
   Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468
   SHARPATYI VA, 1995, HIGH ENERG CHEM+, V29, P77
   Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130
   SpotheimMaurizot M, 1995, NUCL INSTRUM METH B, V105, P308, DOI 10.1016/0168-583X(95)00552-8
   STEEL G, 1993, BASIC CLIN RADIOBIOL, P211
   STEEL G, 1999, PHYS MED BIOL, V41, P205
   Steele RJC, 1998, BRIT J SURG, V85, P1460
   THAMES HD, 1987, FRACTIONATION RADIOT
   THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160
   Tomita H, 1997, RADIAT ENVIRON BIOPH, V36, P105, DOI 10.1007/s004110050061
   TURNER JE, 1992, RAD PROTECT MANAGEME, V9, P25
   TURNER JE, 1995, ATOMS RAD RAD PROTEC
   VANLAERE K, 1993, APPL RADIAT ISOTOPES, V44, P33, DOI 10.1016/0969-8043(93)90192-D
   VONSONNTAG C, 1991, ANGEW CHEM INT EDIT, V30, P1229, DOI 10.1002/anie.199112291
   VONSONNTAG C, 1994, INT J RADIAT BIOL, V65, P19, DOI 10.1080/09553009414550031
   VONSONNTAG C, 1987, CHEM BASIS RAD ACTIO
   WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251
   WEICHSELBAUM RR, 1991, J NATL CANCER I, V83, P480, DOI 10.1093/jnci/83.7.480
   Wetmore SD, 1998, J PHYS CHEM B, V102, P9332, DOI 10.1021/jp982437n
   Wetmore SD, 1998, J PHYS CHEM B, V102, P10602, DOI 10.1021/jp982417l
   *WHO, 1984, COD GEN STAND IRR FO
   Woods R, 1994, APPL RAD CHEM RAD PR
NR 118
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-7091-0
J9 FOCUS BIOTECHNOL
PY 2001
VL 7
BP 249
EP 276
PG 28
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BS91G
UT WOS:000171368300010
DA 2018-10-19
ER

PT B
AU Lahorte, P
   Mondelaers, W
AF Lahorte, P
   Mondelaers, W
BE DeCuyper, M
   Bulte, JWM
TI Radiation-induced bioradicals: Technologies and research
SO PHYSICS AND CHEMISTRY BASIS OF BIOTECHNOLOGY, VOL 7
SE FOCUS ON BIOTECHNOLOGY
LA English
DT Proceedings Paper
CT 9th European Congress on Biotechnology (ECB9)
CY JUL 11-15, 1999
CL BRUSSELS, BELGIUM
SP Commiss European Comm, Gen Director Technol, Res & Energy Wallonia Reg, J Chabert, Minist Econ Brussels Capit Reg
ID ELECTRON-SPIN-RESONANCE; MOLECULAR-ORBITAL CALCULATIONS; FREE-RADICAL
   FORMATION; DENSITY-FUNCTIONAL THEORY; NUCLEAR DOUBLE-RESONANCE;
   IRRADIATED SINGLE-CRYSTALS; HYPERFINE COUPLING-CONSTANTS; GUANINE
   HYDROBROMIDE MONOHYDRATE; FOOD-PACKAGING MATERIALS; PROTON-TRANSFER
   BEHAVIOR
AB This chapter represents the second part of a review in which the production and application of radiation-induced radicals in biological matter are discussed. In part one the general aspects of the four stages (physical, physicochemical, chemical and biological) of interaction of radiation with matter in general and biological matter in particular, were discussed. Here an overview is presented of modern technologies and theoretical methods available for studying these radiation effects. The relevance is highlighted of electron paramagnetic resonance spectroscopy and quantum chemical calculations with respect to obtaining structural information on bioradicals, and a survey is given of the research studies in this field. We also discuss some basic aspects of modem accelerator technologies which can be used for creating radicals and we conclude with an overview of applications of radiation processing in biology and related fields such as biomedical and environmental engineering, food technology, medicine and pharmacy.
C1 Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, B-9000 Ghent, Belgium.
RP Lahorte, P (reprint author), Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, Proeftuinstr 86, B-9000 Ghent, Belgium.
RI Bulte, Jeff/A-3240-2008
OI Bulte, Jeff/0000-0003-1202-1610
CR Ambroz HB, 1998, RADIAT PHYS CHEM, V53, P491, DOI 10.1016/S0969-806X(98)00209-6
   Atherton N. M., 1993, PRINCIPLES ELECT SPI
   ATHERTON NM, 1996, ELECT SPIN RESONANCE, V15
   Baerends EJ, 1997, J PHYS CHEM A, V101, P5383, DOI 10.1021/jp9703768
   Ban FQ, 1999, J PHYS CHEM A, V103, P4303, DOI 10.1021/jp990257n
   Barbarin N, 1996, RADIAT PHYS CHEM, V48, P787, DOI 10.1016/S0969-806X(96)00056-4
   BARNES J, 1994, J PHYS CHEM-US, V98, P10969, DOI 10.1021/j100093a045
   BARNES J, 1991, RADIAT RES, V126, P104, DOI 10.2307/3578177
   BARNES JP, 1995, J PHYS CHEM-US, V99, P11248, DOI 10.1021/j100028a028
   BARNES JP, 1995, RADIAT RES, V143, P85, DOI 10.2307/3578929
   Barone V., 1995, RECENT ADV DENSITY 1, P287
   Basly JP, 1996, INT J PHARM, V142, P125, DOI 10.1016/0378-5173(96)04654-6
   Basly JP, 1997, PHARMACEUT RES, V14, P810, DOI 10.1023/A:1012119026422
   Basly JP, 1997, INT J PHARM, V152, P201, DOI 10.1016/S0378-5173(97)00084-7
   Basly JP, 1998, ANALYST, V123, P1753, DOI 10.1039/a802719f
   Basly JP, 1997, PHARMACEUT RES, V14, P1186, DOI 10.1023/A:1012102806800
   Basly JP, 1998, INT J RADIAT BIOL, V74, P521
   Basly JP, 1998, J PHARMACEUT BIOMED, V17, P871, DOI 10.1016/S0731-7085(98)00014-4
   Basly JP, 1996, INT J PHARM, V139, P219, DOI 10.1016/0378-5173(96)04597-8
   Basly JP, 1999, INT J RADIAT BIOL, V75, P259, DOI 10.1080/095530099140726
   Basly JP, 1998, INT J PHARM, V170, P265, DOI 10.1016/S0378-5173(98)00152-5
   Basly JP, 1998, FREE RADICAL RES, V29, P67, DOI 10.1080/10715769800300081
   Basly JP, 1998, ANAL CHIM ACTA, V372, P373, DOI 10.1016/S0003-2670(98)00319-5
   Basly JP, 1998, ANAL CHIM ACTA, V359, P107, DOI 10.1016/S0003-2670(97)00672-7
   Basly JP, 1997, INT J PHARM, V158, P241, DOI 10.1016/S0378-5173(97)00257-3
   Basly JP, 1997, PHARMACEUT RES, V14, P1192, DOI 10.1023/A:1012154823638
   Basly JP, 1997, INT J PHARM, V149, P85, DOI 10.1016/S0378-5173(96)04855-7
   Basly JP, 1997, J PHARMACEUT BIOMED, V15, P1137, DOI 10.1016/S0731-7085(96)01947-4
   Basly JP, 1997, INT J PHARM, V154, P109, DOI 10.1016/S0378-5173(97)00119-1
   Basly JP, 1996, J CHIM PHYS PCB, V93, P1
   Becker D, 1996, RADIAT RES, V146, P361, DOI 10.2307/3579297
   BECKER D, 1993, ADV RADIAT BIOL, V17, P121
   BECKER D, 1994, RADIAT RES, V140, P123, DOI 10.2307/3578577
   BERNHARD WA, 1994, RADIAT RES, V140, P199, DOI 10.2307/3578904
   BERNHARD WA, 1989, J PHYS CHEM-US, V93, P2187, DOI 10.1021/j100343a003
   BERNHARD WA, 1994, INT J RADIAT BIOL, V66, P491, DOI 10.1080/09553009414551511
   BERTHOMIEU C, 1995, BIOSPECTROSCOPY, V1, P187, DOI 10.1002/bspy.350010304
   Binks PR, 1996, J CHEM TECHNOL BIOT, V67, P319
   Boess C, 1996, DRUG DEV IND PHARM, V22, P495, DOI 10.3109/03639049609108354
   Bohm P, 1998, Z ORTHOP GRENZGEB, V136, P197, DOI 10.1055/s-2008-1054222
   Bolch WE, 1998, RADIAT ENVIRON BIOPH, V37, P157, DOI 10.1007/s004110050111
   BOX HC, 1990, J CHEM PHYS, V93, P55, DOI 10.1063/1.459556
   Briden PE, 1999, RADIAT ENVIRON BIOPH, V38, P175, DOI 10.1007/s004110050153
   BUCHALLA R, 1993, J FOOD PROTECT, V56, P998, DOI 10.4315/0362-028X-56.11.998
   Buchalla R, 1999, RADIAT PHYS CHEM, V56, P353, DOI 10.1016/S0969-806X(99)00311-4
   BURG KJL, 1996, ADV FOOD IRRADIATION, P254
   Cadet J, 1998, FREE RADICAL RES, V29, P541, DOI 10.1080/10715769800300581
   Cadet J, 1999, NUCL INSTRUM METH B, V151, P1, DOI 10.1016/S0168-583X(99)00117-2
   Capizzi S, 1999, RADIAT PHYS CHEM, V56, P591, DOI 10.1016/S0969-806X(99)00271-6
   CARENZA M, 1994, J CONTROL RELEASE, V29, P187, DOI 10.1016/0168-3659(94)90135-X
   Chalak L, 1997, SCI HORTIC-AMSTERDAM, V68, P83, DOI 10.1016/S0304-4238(96)00976-4
   Claverie JM, 1999, HUM MOL GENET, V8, P1821, DOI 10.1093/hmg/8.10.1821
   Close DM, 1998, J PHYS CHEM A, V102, P6737, DOI 10.1021/jp981610c
   CLOSE DM, 1993, RADIAT RES, V135, P1, DOI 10.2307/3578390
   Close DM, 1997, RADIAT RES, V147, P663, DOI 10.2307/3579478
   CLOSE DM, 1994, RADIAT RES, V137, P300, DOI 10.2307/3578703
   CLOSE DM, 1989, FREE RADICAL RES COM, V6, P83, DOI 10.3109/10715768909073433
   CLOSE DM, 1988, RADIAT RES, V116, P379, DOI 10.2307/3577382
   COLSON AO, 1992, J PHYS CHEM-US, V96, P9787, DOI 10.1021/j100203a039
   Colson AO, 1996, J PHYS CHEM-US, V100, P4420, DOI 10.1021/jp953032v
   COLSON AO, 1992, J PHYS CHEM-US, V96, P661, DOI 10.1021/j100181a028
   COLSON AO, 1993, J PHYS CHEM-US, V97, P13852, DOI 10.1021/j100153a067
   COLSON AO, 1995, J PHYS CHEM-US, V99, P3867, DOI 10.1021/j100011a064
   COLSON AO, 1995, J PHYS CHEM-US, V99, P13033, DOI 10.1021/j100034a051
   COLSON AO, 1993, J PHYS CHEM-US, V97, P8092, DOI 10.1021/j100132a045
   COLSON AO, 1995, INT J RADIAT BIOL, V67, P627, DOI 10.1080/09553009514550751
   CRUCQ AS, 1995, FREE RADICAL BIO MED, V18, P841, DOI 10.1016/0891-5849(94)00204-W
   Crucq AS, 1996, FREE RADICAL BIO MED, V21, P827, DOI 10.1016/0891-5849(96)00181-5
   Cullis PM, 1996, J AM CHEM SOC, V118, P2775, DOI 10.1021/ja9536025
   CULLIS PM, 1992, J CHEM SOC PERK T 2, P1409, DOI 10.1039/p29920001409
   CULLIS PM, 1995, J PHYS CHEM-US, V99, P9293, DOI 10.1021/j100022a051
   CULLIS PM, 1992, J CHEM SOC PERK T 2, P1695, DOI 10.1039/p29920001695
   Davies MJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P163, DOI 10.1006/abbi.1996.0545
   DAVIES MJ, 1993, RES CHEM INTERMEDIAT, V19, P669, DOI 10.1163/156856793X00307
   DAVIES MJ, 1995, J CHEM SOC PERK T 2, P13, DOI 10.1039/p29950000013
   Demertzis PG, 1999, PACKAG TECHNOL SCI, V12, P119, DOI 10.1002/(SICI)1099-1522(199905/06)12:3<119::AID-PTS460>3.0.CO;2-G
   DEWITTE K, 1994, EUPHYTICA, V77, P141, DOI 10.1007/BF02551477
   Dodd NJF, 1995, BIOCHEM SOC SYMP, P247
   DORE C, 1993, PLANT BREEDING, V111, P142, DOI 10.1111/j.1439-0523.1993.tb00620.x
   Duroux JL, 1996, APPL RADIAT ISOTOPES, V47, P1565, DOI 10.1016/S0969-8043(96)00208-4
   Duroux JL, 1997, J CHIM PHYS PCB, V94, P405, DOI 10.1051/jcp/1997940405
   Dyer MR, 1999, DRUG DISCOV TODAY, V4, P109, DOI 10.1016/S1359-6446(99)01310-0
   EATON SS, 1996, ELECT SPIN RESONANCE, V15, P169
   FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3
   FALQUE M, 1994, EUPHYTICA, V75, P19, DOI 10.1007/BF00024527
   Fattibene P, 1996, APPL RADIAT ISOTOPES, V47, P1375, DOI 10.1016/S0969-8043(96)00254-0
   Fauconnet AL, 1996, INT J PHARM, V144, P123, DOI 10.1016/S0378-5173(96)04724-2
   Garde JA, 1998, J FOOD PROTECT, V61, P1000, DOI 10.4315/0362-028X-61.8.1000
   GIBELLA M, 1993, J CHIM PHYS PCB, V90, P1041, DOI 10.1051/jcp/1993901041
   GIBELLA M, 1994, J CHIM PHYS PCB, V91, P1868, DOI 10.1051/jcp/1994911868
   GOLDFARB D, 1996, ELECT SPIN RESONANCE, V15, P186
   GOPAL NGS, 1988, RADIAT PHYS CHEM, V32, P619
   Gordy W., 1980, THEORY APPL ELECT SP
   Goulas AE, 1996, Z LEBENSM UNTERS FOR, V202, P250, DOI 10.1007/BF01263549
   Haire DL, 1997, FOOD RES INT, V30, P249, DOI 10.1016/S0963-9969(97)00036-7
   Hamm RN, 1998, RADIAT ENVIRON BIOPH, V37, P151, DOI 10.1007/s004110050110
   Hawkins CL, 1998, J CHEM SOC PERK T 2, P1937, DOI 10.1039/a802949k
   Herak JN, 1997, RADIAT PHYS CHEM, V50, P141, DOI 10.1016/S0969-806X(97)00027-3
   Herak JN, 1999, RADIAT RES, V151, P319, DOI 10.2307/3579944
   HERAK JN, 1994, INT J RADIAT BIOL, V66, P3, DOI 10.1080/09553009414550891
   Hill MA, 1999, RADIAT MEAS, V31, P15, DOI 10.1016/S1350-4487(99)00090-6
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   Hole EO, 1998, RADIAT RES, V149, P109, DOI 10.2307/3579919
   HOLE EO, 1991, J PHYS CHEM-US, V95, P1494, DOI 10.1021/j100156a086
   HOLE EO, 1995, RADIAT RES, V144, P258, DOI 10.2307/3578944
   HOLE EO, 1989, FREE RADICAL RES COM, V6, P87, DOI 10.3109/10715768909073434
   HOLE EO, 1992, RADIAT RES, V129, P1, DOI 10.2307/3577897
   HOLE EO, 1991, RADIAT RES, V125, P119, DOI 10.2307/3577878
   HOLE EO, 1992, RADIAT RES, V129, P119, DOI 10.2307/3578149
   HOLE EO, 1992, RADIAT RES, V130, P148, DOI 10.2307/3578271
   Huang WD, 1998, NUCL INSTRUM METH B, V140, P137, DOI 10.1016/S0168-583X(97)00552-1
   *IAEA, IAEATECDOC1023
   IAEA, 1997, IAEATECDOC971
   Ibrahim R, 1998, PLANT CELL TISS ORG, V54, P37, DOI 10.1023/A:1006072205608
   ILIAKIS G, 1991, BIOESSAYS, V13, P641
   JACOBS GP, 1995, J BIOMATER APPL, V10, P59, DOI 10.1177/088532829501000104
   Jacobs GP, 1998, RADIAT PHYS CHEM, V53, P511, DOI 10.1016/S0969-806X(98)00185-6
   JACOBS GP, 1988, RADIAT PHYS CHEM, V31, P685
   Jensen F., 1999, INTRO COMPUTATIONAL
   KABILJO Z, 1990, INT J RADIAT BIOL, V58, P439, DOI 10.1080/09553009014551791
   Kaetsu I, 1996, RADIAT PHYS CHEM, V47, P419, DOI 10.1016/0969-806X(95)00129-L
   Kaetsu I, 1999, RADIAT PHYS CHEM, V55, P193, DOI 10.1016/S0969-806X(98)00326-0
   KIM H, 1989, J CHEM PHYS, V90, P1448, DOI 10.1063/1.456086
   Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   Koppen G, 1999, MECH AGEING DEV, V110, P13, DOI 10.1016/S0047-6374(99)00038-X
   KRZYMINIEWSKI R, 1995, RADIAT PHYS CHEM, V45, P883, DOI 10.1016/0969-806X(94)E0041-G
   KRZYMINIEWSKI R, 1990, J MOL STRUCT, V240, P133, DOI 10.1016/0022-2860(90)80504-D
   Kubli-Garfias C, 1999, INT J QUANTUM CHEM, V71, P433, DOI 10.1002/(SICI)1097-461X(1999)71:5<433::AID-QUA4>3.0.CO;2-1
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V425, P171, DOI 10.1016/S0166-1280(97)00212-1
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V454, P267, DOI 10.1016/S0166-1280(98)00296-6
   Kubli-Garfias C, 1998, THEOCHEM-J MOL STRUC, V422, P167, DOI 10.1016/S0166-1280(97)00116-4
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V452, P175, DOI 10.1016/S0166-1280(98)00149-3
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V428, P189, DOI 10.1016/S0166-1280(97)00278-9
   Kumagai J, 2000, RADIAT PHYS CHEM, V57, P75, DOI 10.1016/S0969-806X(99)00306-0
   Lahorte P, 1999, RADIAT PHYS CHEM, V55, P761, DOI 10.1016/S0969-806X(99)00226-1
   Lahorte P, 1999, J PHYS CHEM A, V103, P6650, DOI 10.1021/jp990942u
   Lahorte P, 1999, J PHYS CHEM A, V103, P11130, DOI 10.1021/jp992489s
   Langer-Safer PR, 1997, DRUG DEVELOP RES, V41, P173, DOI 10.1002/(SICI)1098-2299(199707/08)41:3/4<173::AID-DDR7>3.0.CO;2-I
   Lardon A, 1999, GENETICS, V151, P1173
   Lassmann G, 1999, J PHYS CHEM A, V103, P1283, DOI 10.1021/jp9843454
   LETT JT, 1994, RENAISSANCE BASIC CE, P181
   Levine IN, 1991, QUANTUM CHEM
   Lin WZ, 1998, RADIAT PHYS CHEM, V53, P651, DOI 10.1016/S0969-806X(97)00271-5
   Luo N, 1999, J PHYS CHEM A, V103, P592, DOI 10.1021/jp982799v
   Mader K, 1998, PHYS MED BIOL, V43, P1931, DOI 10.1088/0031-9155/43/7/014
   Malkin V. G., 1995, MODERN DENSITY FUNCT, P273
   MALONE ME, 1995, J PHYS CHEM-US, V99, P9299, DOI 10.1021/j100022a052
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   MCLAUGHLIN WL, 1993, RADIAT PROT DOSIM, V47, P255
   Mehnert R, 1996, NUCL INSTRUM METH B, V113, P81, DOI 10.1016/0168-583X(95)01344-X
   MIASKIEWICZ K, 1994, J AM CHEM SOC, V116, P232, DOI 10.1021/ja00080a027
   MIYAZAKI T, 1994, J PHARM SCI, V83, P68, DOI 10.1002/jps.2600830116
   MIYAZAKI T, 1994, J PHARM SCI, V83, P1643, DOI 10.1002/jps.2600831122
   Moiseenko VV, 1998, RADIAT ENVIRON BIOPH, V37, P167, DOI 10.1007/s004110050112
   Moiseenko VV, 1998, INT J RADIAT BIOL, V74, P533, DOI 10.1080/095530098141113
   MONDELAERS W, 1993, NUCL INSTRUM METH B, V79, P898, DOI 10.1016/0168-583X(93)95494-P
   Mondelaers W, 1998, NUCL INSTRUM METH B, V139, P43, DOI 10.1016/S0168-583X(97)00944-0
   MONK JD, 1995, J FOOD PROTECT, V58, P197, DOI 10.4315/0362-028X-58.2.197
   Moroff G, 1997, TRANSFUSION, V37, P1084, DOI 10.1046/j.1537-2995.1997.371098016450.x
   MROCZKA NE, 1995, RADIAT RES, V144, P251, DOI 10.2307/3578943
   Mroczka NE, 1997, RADIAT RES, V147, P560, DOI 10.2307/3579622
   Musial K, 1998, ANN BOT-LONDON, V82, P747, DOI 10.1006/anbo.1998.0747
   Musial K, 1999, SEX PLANT REPROD, V12, P110, DOI 10.1007/s004970050179
   Naess SK, 1998, EUPHYTICA, V99, P57, DOI 10.1023/A:1018372709235
   NELSON WH, 1992, RADIAT RES, V131, P272, DOI 10.2307/3578416
   NELSON WH, 1989, FREE RADICAL RES COM, V6, P81, DOI 10.3109/10715768909073432
   Nelson WH, 1998, RADIAT RES, V149, P75, DOI 10.2307/3579684
   NELSON WH, 1992, RADIAT RES, V131, P10, DOI 10.2307/3578310
   NELSON WH, 1988, INT J RADIAT BIOL, V54, P963, DOI 10.1080/09553008814552361
   Onori S, 1996, APPL RADIAT ISOTOPES, V47, P1569, DOI 10.1016/S0969-8043(96)00210-2
   PATTERSON LK, 1987, RAD CHEM PRINCIPLES, P65
   PODMORE ID, 1991, J CHEM SOC FARADAY T, V87, P3647, DOI 10.1039/ft9918703647
   Pouget JP, 1999, J CHIM PHYS PCB, V96, P143, DOI 10.1051/jcp:1999122
   Pouget JP, 1999, INT J RADIAT BIOL, V75, P51, DOI 10.1080/095530099140807
   Prise KM, 1998, INT J RADIAT BIOL, V74, P173, DOI 10.1080/095530098141564
   RAFFI J, 1993, J CHIM PHYS PCB, V90, P1009, DOI 10.1051/jcp/1993901009
   Riganakos KA, 1999, RADIAT PHYS CHEM, V54, P527, DOI 10.1016/S0969-806X(98)00263-1
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Sabo D, 1999, UNFALLCHIRURG, V102, P580, DOI 10.1007/s001130050453
   SAGSTUEN E, 1992, J PHYS CHEM-US, V96, P8269, DOI 10.1021/j100200a014
   Sagstuen E, 1997, J PHYS CHEM A, V101, P9763, DOI 10.1021/jp972158k
   SAGSTUEN E, 1988, RADIAT RES, V116, P196, DOI 10.2307/3577457
   SAGSTUEN E, 1989, FREE RADICAL RES COM, V6, P91, DOI 10.3109/10715768909073435
   SAGSTUEN E, 1989, J PHYS CHEM-US, V93, P5974, DOI 10.1021/j100353a008
   SAGSTUEN E, 1992, J PHYS CHEM-US, V96, P1121, DOI 10.1021/j100182a019
   SAGSTUEN E, 1986, J PHYS CHEM-US, V90, P5584, DOI 10.1021/j100280a022
   Sagstuen E, 1996, RADIAT RES, V146, P425, DOI 10.2307/3579304
   Sagstuen E, 1998, RADIAT RES, V149, P120, DOI 10.2307/3579920
   Sanderud A, 1998, J PHYS CHEM B, V102, P9353, DOI 10.1021/jp982932j
   Sankovic K, 1996, INT J RADIAT BIOL, V70, P603
   SANKOVIC K, 1991, RADIAT RES, V128, P119, DOI 10.2307/3578128
   Sauvaigo S, 1998, ANAL BIOCHEM, V259, P1, DOI 10.1006/abio.1998.2628
   SCHARF WH, 1994, BIOMEDICAL PARTICLE, P45
   SEMINARIO JM, 1995, MODERN DENSITY FUNCT, P1
   Sendra E, 1996, FOOD SCI TECHNOL INT, V2, P1, DOI 10.1177/108201329600200101
   SEVILLA MD, 1991, J PHYS CHEM-US, V95, P3409, DOI 10.1021/j100161a080
   SEVILLA MD, 1989, FREE RADICAL RES COM, V6, P99, DOI 10.3109/10715768909073439
   SEVILLA MD, 1995, J PHYS CHEM-US, V99, P1060, DOI 10.1021/j100003a032
   Shalaby SW, 1996, ACS SYM SER, V620, P246
   Shao C, 1999, RADIAT PHYS CHEM, V56, P547, DOI 10.1016/S0969-806X(99)00296-0
   SIGNORETTI EC, 1993, DRUG DEV IND PHARM, V19, P1693, DOI 10.3109/03639049309050161
   SIGNORETTI EC, 1994, DRUG DEV IND PHARM, V20, P2493, DOI 10.3109/03639049409042653
   SPALLETTA RA, 1993, RADIAT RES, V133, P143, DOI 10.2307/3578349
   Steel G. G., 1993, BASIC CLIN RADIOBIOL
   Stehlik D, 1997, ANNU REV PHYS CHEM, V48, P745, DOI 10.1146/annurev.physchem.48.1.745
   Swarts SG, 1996, RADIAT RES, V145, P304, DOI 10.2307/3578986
   SWARTS SG, 1992, RADIAT RES, V129, P333, DOI 10.2307/3578034
   SZYCZEWSKI A, 1994, J MOL STRUCT, V318, P87, DOI 10.1016/0022-2860(93)07909-G
   Szyczewski A, 1996, APPL RADIAT ISOTOPES, V47, P1675, DOI 10.1016/S0969-8043(96)00234-5
   Szyczewski A, 1998, APPL RADIAT ISOTOPES, V49, P59, DOI 10.1016/S0969-8043(97)00215-7
   TALROSE VL, 1995, RADIAT PHYS CHEM, V46, P633, DOI 10.1016/0969-806X(95)00232-M
   THAKUR BR, 1994, FOOD REV INT, V10, P437, DOI 10.1080/87559129409541012
   Tilquin B, 1999, J CHIM PHYS PCB, V96, P167, DOI 10.1051/jcp:1999126
   TRIOLET J, 1992, FREE RADICAL RES COM, V16, P183, DOI 10.3109/10715769209049171
   TRIOLET J, 1990, FREE RADICAL RES COM, V10, P57, DOI 10.3109/10715769009145933
   TRIOLET J, 1992, MAGN RESON CHEM, V30, P1051, DOI 10.1002/mrc.1260301105
   TRIOLET J, 1991, J CHIM PHYS PCB, V88, P1237, DOI 10.1051/jcp/1991881237
   Turro NJ, 1999, RES CHEM INTERMEDIAT, V25, P505, DOI 10.1163/156856799X00536
   Van Lancker M, 1999, NUCL INSTRUM METH B, V151, P242, DOI 10.1016/S0168-583X(99)00099-3
   Vanhaelewyn GCAM, 1999, RADIAT RES, V151, P590, DOI 10.2307/3580035
   Ventura ON, 1997, ADV QUANTUM CHEM, V28, P293, DOI 10.1016/S0065-3276(08)60222-1
   VONSONNTAG C, 1995, RADIAT PHYS CHEM, V46, P527, DOI 10.1016/0969-806X(95)00209-G
   WANG W, 1994, INT J RADIAT BIOL, V66, P683
   Wang W, 1997, INT J RADIAT BIOL, V71, P387
   WANG WD, 1994, RADIAT RES, V137, P2, DOI 10.2307/3578784
   WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251
   WARDMAN P, 1991, FREE RADICAL BIO MED, V10, P243, DOI 10.1016/0891-5849(91)90081-D
   WARDMAN P, 1994, INT J RADIAT BIOL, V65, P35, DOI 10.1080/09553009414550051
   Weil J. A, 1994, ELECT PARAMAGNETIC R
   Weiland B, 1996, INT J RADIAT BIOL, V70, P327, DOI 10.1080/095530096145067
   Wetmore SD, 1998, J PHYS CHEM B, V102, P7484, DOI 10.1021/jp981691c
   Wetmore SD, 1998, J PHYS CHEM B, V102, P5369, DOI 10.1021/jp9809078
   Wetmore SD, 1998, J PHYS CHEM B, V102, P9332, DOI 10.1021/jp982437n
   Wetmore SD, 1998, J PHYS CHEM B, V102, P7674, DOI 10.1021/jp9824407
   Wetmore SD, 1998, J PHYS CHEM B, V102, P10602, DOI 10.1021/jp982417l
   Woods R, 1994, APPL RAD CHEM RAD PR
   YAN MY, 1992, J PHYS CHEM-US, V96, P1983, DOI 10.1021/j100183a082
NR 239
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-7091-0
J9 FOCUS BIOTECHNOL
PY 2001
VL 7
BP 277
EP 303
PG 27
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BS91G
UT WOS:000171368300011
DA 2018-10-19
ER

PT S
AU Perichon, S
   Lysenko, V
   Remaki, B
   Barbier, D
AF Perichon, S
   Lysenko, V
   Remaki, B
   Barbier, D
BE Bonnaud, O
   MohammedBrahim, T
   Strunk, HP
   Werner, JH
TI Porous silicon in microsystems: Thermal isolation applications
SO POLYCRYSTALLINE SEMICONDUCTORS IV MATERIALS, TECHNOLOGIES AND LARGE AREA
   ELECTRONICS
SE SOLID STATE PHENOMENA
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Polycrystalline Semiconductors
CY SEP 03-07, 2000
CL ST MALO, FRANCE
SP Ctr Natl Rech Sci, Reg Bretagne, Conseil Gen Vilaine, Univ Rennes 1, STMicroelectr Rennes, STMicroelectr Tours, SOPRA, KarlSuss
DE microsystems; porous silicon; thermal conductivity
ID MICRO-RAMAN SCATTERING; HEAT-CONDUCTION; LAYERS; TECHNOLOGY;
   MICROSENSOR; SENSORS; DESIGN; FILMS
AB Porous silicon morphology confers on this new silicon structure astonishing properties leading to numerous applications in microsystems (Silicon On Insulator structures, gas and biochemical sensors, optical devices, etc.). A distinctive application of porous silicon is related to its low thermal conductivity (about two orders of magnitude lower than that of mono-silicon) ensuring a new thermal insulation strategy for thermal effects microsystems. The basic phenomena responsible for such a low thermal conductivity are described. A new measurement method based on micro-Raman scattering is used to relate technological and morphological parameters of this material to its thermal properties. Finally a biomedical microsensor based on a porous silicon thermal insulation was realized.
C1 Inst Natl Sci Appl Lyon, Phys Mat Lab, FR-69621 Villeurbanne, France.
RP Perichon, S (reprint author), Inst Natl Sci Appl Lyon, Phys Mat Lab, Bat 502,20 Ave A Einstein, FR-69621 Villeurbanne, France.
RI Lysenko, Vladimir/G-6376-2014; Lacour, Stephanie/E-6375-2010
OI Lysenko, Vladimir/0000-0003-1076-7064
CR BARRET S, 1992, SENSOR ACTUAT A-PHYS, V33, P19, DOI 10.1016/0924-4247(92)80218-R
   BEALE MIJ, 1985, J CRYST GROWTH, V73, P622, DOI 10.1016/0022-0248(85)90029-6
   Benedetto G, 1997, APPL PHYS A-MATER, V64, P155, DOI 10.1007/s003390050457
   Betzner TM, 1996, J MICROMECH MICROENG, V6, P217, DOI 10.1088/0960-1317/6/2/003
   Bomchil G., 1988, Microelectronic Engineering, V8, P293, DOI 10.1016/0167-9317(88)90022-6
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Chen G, 1996, J HEAT TRANS-T ASME, V118, P539, DOI 10.1115/1.2822665
   CruzOrea A, 1996, J APPL PHYS, V79, P8951, DOI 10.1063/1.362626
   Drost A., 1995, Sensors and Materials, V7, P111
   Edelberg E, 1996, APPL PHYS LETT, V68, P1415, DOI 10.1063/1.116098
   ELBEL T, 1994, SENSOR ACTUAT A-PHYS, V41, P493
   Foucaran A, 1997, THIN SOLID FILMS, V297, P317, DOI 10.1016/S0040-6090(96)09437-0
   FULKERSON W, 1968, PHYS REV, V167, P765, DOI 10.1103/PhysRev.167.765
   Gesele G, 1997, J PHYS D APPL PHYS, V30, P2911, DOI 10.1088/0022-3727/30/21/001
   Gruning U, 1996, APPL PHYS LETT, V68, P747, DOI 10.1063/1.116729
   Halimaoui A, 1995, POROUS SILICON SCI T, P33
   HERINO R, 1987, J ELECTROCHEM SOC, V134, P1994, DOI 10.1149/1.2100805
   Hilbrich S, 1997, THIN SOLID FILMS, V297, P250, DOI 10.1016/S0040-6090(96)09364-9
   IMAI K, 1984, IEEE T ELECTRON DEV, V31, P297, DOI 10.1109/T-ED.1984.21518
   Jones LA, 1996, J VAC SCI TECHNOL A, V14, P1505, DOI 10.1116/1.579977
   KATO Y, 1989, APPL SURF SCI, V41-2, P614, DOI 10.1016/0169-4332(89)90131-1
   Lang W, 1996, MAT SCI ENG R, V17, P1, DOI 10.1016/0927-796X(96)00190-8
   Lang W, 1995, SENSOR ACTUAT A-PHYS, V51, P31, DOI 10.1016/0924-4247(96)80048-3
   Loni A, 1996, THIN SOLID FILMS, V276, P143, DOI 10.1016/0040-6090(95)08075-9
   Luth H, 2000, MAT SCI ENG B-SOLID, V69, P104, DOI 10.1016/S0921-5107(99)00275-5
   Lysenko V, 1999, MICROELECTR J, V30, P1141, DOI 10.1016/S0026-2692(99)00077-4
   Lysenko V, 1999, J APPL PHYS, V86, P6841, DOI 10.1063/1.371760
   Lysenko V, 2000, ADV MATER, V12, P516, DOI 10.1002/(SICI)1521-4095(200004)12:7<516::AID-ADMA516>3.0.CO;2-G
   MAJUMDAR A, 1993, J HEAT TRANS-T ASME, V115, P7, DOI 10.1115/1.2910673
   MOREL M, 2000, IN PRESS MAT SC MICR
   Obraztsov AN, 1997, SEMICONDUCTORS+, V31, P534, DOI 10.1134/1.1187209
   Perichon S, 1999, J APPL PHYS, V86, P4700, DOI 10.1063/1.371424
   Roussel P, 1999, SENSOR ACTUAT A-PHYS, V74, P100, DOI 10.1016/S0924-4247(98)00330-6
   Smith L., 1992, J APPL PHYS, V71, pR1
   SMITH RL, 1990, SENSOR ACTUAT A-PHYS, V21, P825
NR 35
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1012-0394
BN 3-908450-63-2
J9 SOL ST PHEN
PY 2001
VL 80-81
BP 417
EP 427
DI 10.4028/www.scientific.net/SSP.80-81.417
PG 11
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA BS91J
UT WOS:000171369300060
DA 2018-10-19
ER

PT J
AU Araujo, MA
   Vaz, CM
   Cunha, AM
   Mota, M
AF Araujo, MA
   Vaz, CM
   Cunha, AM
   Mota, M
TI In-vitro degradation behaviour of starch/EVOH biomaterials
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE biodegradable polymer; in-vitro degradation; biomedical;
   starch/poly(ethylene-vinyl alcohol)
ID POLYMERS; BLENDS; BIODEGRADATION
AB Blends of corn starch with poly(ethylene-vinyl alcohol) copolymer (SEVA-C) were aged up to 120 days on NaCl sterile isotonic solution (9 g/l) and the degradation solutions were analysed by several techniques. Mechanical properties (i.e. strength, stiffness and ductility), weight loss, and water uptake were also assessed. The evolution of the material structure was followed by scanning electron microscopy (SEM), contact angle measurements and thermogravimetric analysis (TGA). The degradation solutions were monitored with anionic chromatography (HPAE-PAD), colorimetric methods, and Fourier transformed infra-red spectrophotomety (FT-IR) in order to quantify the amount of plasticisers and sugars. SEVA-C micrographs presented an increase in the surface porosity as a function of immersion time. The main compound released to the solution is glycerol, the other degradation products are low molecular weight polymeric chains. From the physical-chemical point of view the material degradation is principally associated with the leaching of glycerol, since the other metabolites were not released. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Minho, Ctr Engn Biol, IBQF, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Mota, M (reprint author), Univ Minho, Ctr Engn Biol, IBQF, Campus Gualtar, P-4710057 Braga, Portugal.
OI Cunha M., Antonio/0000-0003-3860-7732; Mota, Manuel/0000-0002-1084-2688
CR ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   BASTIOLI C, 1994, RHEOL ACTA, V33, P307, DOI 10.1007/BF00366957
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   Bastiolli C, 1995, J ENVIRON POLYM DEGR, V3, P2
   Bastiotti C, 1991, PCT International Patent Appl., Patent No. [9102025, WO 91/02025]
   BAUMGART FW, 1994, AM SOC TEST MATER, V1217, P42, DOI 10.1520/STP12220S
   BHATTACHARYA M, 1995, J APPL POLYM SCI, V57, P539, DOI 10.1002/app.1995.070570504
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   GRIFFIN GJL, 1994, POLYM DEGRAD STABIL, V45, P241, DOI 10.1016/0141-3910(94)90141-4
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1996, BIOMATERIALS SCI INT, P201
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   Soest JJG, 1996, POLYMER, V37, P3543
   Tjong SC, 1998, POLYM ENG SCI, V38, P3
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WOOL R, 1995, SCI ENG POLYM COMPOS, P138
   Zaikov GE, 1989, DEGRADATION STABILIS, V2, P469
NR 21
TC 14
Z9 14
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PY 2001
VL 73
IS 2
BP 237
EP 244
PG 8
WC Polymer Science
SC Polymer Science
GA 452WQ
UT WOS:000169883000005
DA 2018-10-19
ER

PT B
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Processing and mechanical properties of Biocompatible cancellous
   titanium
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE sintering; titanium; biomaterials; bone; foams; mechanical properties
ID PORE-SIZE; CYTOCOMPATIBILITY; IMPLANTS; ALLOYS; FOAMS; METAL
AB Pure titanium and some of its alloys are currently considered as the most attractive metallic materials for biomedical applications due to their excellent mechanical properties, corrosion resistance, and biocompatibility. It has been demonstrated that titanium and some titanium-based alloys are well accepted by human tissues as compared to other metals such as SUS316L stainless steel and Co-Cr-Mo type alloys. Furthermore, open-cellular metallic foams with a pore size of 200-500 mu m are acknowledged as very promising biomaterial candidates for bone implants because its open-cellular structure permits the ingrowths of new-bone tissues and the transport, of body fluids. In the present study, highly porous titanium foams with a porosity of 80% are produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The porous titanium foams are characterized by using optical microscopy and scanning electron microscopy. Mechanical properties are investigated by compressive tests. These biocompatible porous titanium foams are expected to be used as implants for medical applications due to its porous structure permits the ingrowths of the new-bone tissues and the transport of the body fluids.
C1 Natl Inst Adv Ind Sci & Technol Chubu, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Technol Chubu, Inst Struct & Engn Mat, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237
CR ARDILL J, 1995, THESIS QUEENS U BELF
   *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   BANHART J, 1998, P 1998 POWD MET WORL, P201
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Dowson D., 1992, BIOMECHANICS DIARTHR, V2, P305
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Maine E, 2000, ADV ENG MATER, V2, P205, DOI 10.1002/(SICI)1527-2648(200004)2:4<205::AID-ADEM205>3.0.CO;2-J
   NAKAMURA Y, 1998, 3 WORLD BIOM C KYOT, P202
   Niinomi M, 2000, INT J FATIGUE, V22, P887, DOI 10.1016/S0142-1123(00)00058-X
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   SCHUMACHER HR, 1988, PRIMER RHEUMATIC DIS
   Steinemann S., 1980, EVALUATION BIOMATERI
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 20
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 247
EP 250
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600062
DA 2018-10-19
ER

PT B
AU Itoh, G
   Motohashi, Y
   Shiraishi, T
   Niinomi, M
AF Itoh, G
   Motohashi, Y
   Shiraishi, T
   Niinomi, M
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI High temperature deformation behavior in a beta-type Ti-29Nb-13Ta-5Zr
   alloy for biomedical applications
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE high temperature deformation; beta titanium alloy; biomedical
   application; strain to failure; superplasticity; stain-rate sensitivity
AB With increasing human lifetime, demands for artificially produced part of human body is growing rapidly. Artificial crotch joint is one of the most important and demand-growing parts. Metallic materials initially used for this application were Co-Cr alloys and stainless steels, but titanium alloys has now been highlighted because of their excellent corrosion resistance. However, since an artificial crotch joint is mounted in the human body usually for years, the alloying element is required preferably not to have poisoning effect on human body cells. To fulfill this requirement as well as that in mechanical properties, one of the authors (M. N.) developed a new beta titanium alloy, Ti-29Nb-13Ta-5Zr.
   High temperature deformation behavior, one of the most important aspects for fabricating the crotch joint, for this alloy has been studied in comparison with that for an Ti-15V-3Cr-3Sn-3Al alloy, one of the most popular beta-type alloys. The possibility of superplastic forming has been searched for. The alloy was induction-skull-melted, hot-forged, cold-rolled into 1.5mm. thickness, machined into tensile-test pieces, and finally tested at a temperature of 750 C at constant cross-head speeds (initial strain rates ranging from 10(-4)s(-1) to 10(-2)s(-1)). Nominal strain to failure was smaller in Ti-29Nb-13Ta-SZr alloy than in Ti-15V-3Cr-3Sn-3Al alloy, which was ascribed to the smaller strain-rate sensitivity exponent, m, and to the cracks on the specimen surface that were formed mostly perpendicular to the tensile direction. Strain to failure decreased as the crack depth increased with decreasing the strain rate.
C1 Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan.
RP Itoh, G (reprint author), Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan.
CR KUBOKI I, 1994, J JAPAN I LIGHT META, V44, P269
   KURODA D, 2000, 98 SPRING M JAP I LI, P29
NR 2
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 2089
EP 2092
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600529
DA 2018-10-19
ER

PT S
AU Tognola, G
   Parazzini, M
   Ravazzani, P
   Svelto, C
   Grandori, F
AF Tognola, G
   Parazzini, M
   Ravazzani, P
   Svelto, C
   Grandori, F
GP IEEE
   IEEE
   IEEE
TI 3D reconstruction of anatomical surfaces from unorganized range data
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE surface reconstruction; range data; geometrical deformable model;
   triangular mesh
AB Three-dimensional range data acquired through digital scanning of anatomical surfaces are used in this study as test material for the validation of an innovative approach for the reconstruction of closed surfaces. Although based on a straightforward theoretical approach, the proposed method exhibits an extreme accuracy in the reconstruction of a variety of target surfaces of different topologies. The method does not require any additional information about the target surface than the raw range data and is robust to noise. A triangular mesh approximates the target surface. Also, a few examples on the possible biomedical applications of the reconstructed surface are provided in this paper.
C1 Politecn Milan, CNR, Ctr Biomed Engn, I-20133 Milan, Italy.
RP Tognola, G (reprint author), Politecn Milan, CNR, Ctr Biomed Engn, I-20133 Milan, Italy.
RI Parazzini, Marta/J-8175-2014; Tognola, Gabriella/B-9025-2015; Ravazzani,
   Paolo/B-9139-2015
OI Parazzini, Marta/0000-0001-9008-7530; Tognola,
   Gabriella/0000-0002-2433-449X; Ravazzani, Paolo/0000-0003-0282-3329
CR Cignoni P, 1998, COMPUT GRAPH FORUM, V17, P167, DOI 10.1111/1467-8659.00236
   Cignoni P, 1998, COMPUT GRAPH-UK, V22, P37, DOI 10.1016/S0097-8493(97)00082-4
   Hoppe H., 1993, Computer Graphics Proceedings, P19, DOI 10.1145/166117.166119
   MENCL R, 1998, EUROGRAPHICS 98 STAT, P51
   MILLER JV, 1991, COMP GRAPH, V25, P217
   Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351
   TERZOPOULOS D, 1991, IEEE T PATTERN ANAL, V13, P703, DOI 10.1109/34.85659
NR 7
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 2534
EP 2536
PN 1-4
PG 3
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871900689
OA Green Published
DA 2018-10-19
ER

PT S
AU Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
AF Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
GP IEEE
   IEEE
   IEEE
TI Histological study on a novel bone graft substitute: Human derived
   tooth-hydroxyapatite compared with coralline hydroxyapatite
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE hydroxyapatite; grafting; bone graft; osteoconduction
ID BOVINE CANCELLOUS BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS;
   IN-VITRO; OSTEOINDUCTIVITY; CERAMICS; MATRIX
AB Different types of bone-graft substitutes have been developed, and are on the market worldwide to eliminate the drawbacks of autogenous grafting. They vary in composition, strength, osteoinductive and osteoconductive properties, mechanism and rates at which they are resorbed and remodelled. Of these, THA is a novel material produced by one of us (FNO). This study was performed to determine the histological properties of THA on animals, and to achieve this a standard on the market coralline HA (CHA) was used as control. 20 sheep were used in this study and divided into 2 groups. Human THA (Group-A) and CHA (Group-B) materials were implanted to the tibiae of 10 sheep in each group. The histological examinations of surrounding bone response of the implant materials were done 12 weeks after implantation. There was no significant difference histologically between groups A and B. All materials were found to be surrounded by new bone tissue. THA was found to be as efficient as standard CHA on histological basis. In addition, economical production of THA should be taken into consideration. In future, THA may be a viable alternative on bone grafting when clinical trials were completed.
C1 Marmara Univ, Biomed Equipment Technol Program, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Biomed Equipment Technol Program, Istanbul, Turkey.
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   Durucan C, 2000, J MATER SCI-MATER M, V11, P365, DOI 10.1023/A:1008934024440
   Guizzardi S, 2000, J BIOMED MATER RES, V53, P227, DOI 10.1002/(SICI)1097-4636(2000)53:3<227::AID-JBM7>3.3.CO;2-5
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Ikeda N, 1999, BIOMATERIALS, V20, P1087, DOI 10.1016/S0142-9612(99)00005-8
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Ohbayashi Y, 2000, BIOMATERIALS, V21, P501, DOI 10.1016/S0142-9612(99)00208-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1997, P NAT BIOM ENG S BIY, P54
   PONGKAO D, 1999, P 12 INT S CER MED, V12, P357
   VARGAS G, 1997, P 10 INT S CER MED, V10, P565
   VEHOF WM, 2000, BIOMATER, V21, P2001
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
NR 20
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 3005
EP 3008
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871900821
DA 2018-10-19
ER

PT S
AU Watson, S
   Williams, RJ
   Griffiths, H
   Gough, W
   Morris, A
AF Watson, S
   Williams, RJ
   Griffiths, H
   Gough, W
   Morris, A
GP IEEE
   IEEE
   IEEE
TI A transceiver for direct phase measurement Magnetic Induction Tomography
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE Magnetic Induction Tomography; Electrical Impedance Tomography
AB Magnetic Induction Tomography (MIT) is a technique for imaging the electromagnetic properties of materials. Excitation coils are used to induce eddy currents within the sample volume which are then sensed by receiver coils. The technique has attracted interest for biomedical application due to the non-contacting nature of the measurements, which may provide advantages over electrode based impedance tomography in certain applications.
   The paper describes a transceiver designed for use in a prototype biomedical MIT system operating with a single excitation frequency of 10MHz. To improve channel isolation and phase stability during signal distribution, the received signals undergo heterodyne downconversion to 10kHz, filtering and limiting at the transceiver. Direct phase measurement between the downconverted reference and received signals is then undertaken to measure the signal perturbation due to the induced conduction eddy currents.
C1 Univ Glamorgan, Sch Elect, Pontypridd CF37 1DL, M Glam, Wales.
RP Watson, S (reprint author), Univ Glamorgan, Sch Elect, Pontypridd CF37 1DL, M Glam, Wales.
EM swatson1@glam.ac.uk
RI Watson, Stuart/H-7124-2015
OI Watson, Stuart/0000-0002-9643-5580
CR Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x
   Korjenevsky A, 2000, PHYSIOL MEAS, V21, P89, DOI 10.1088/0967-3334/21/1/311
   Korzhenevskii A. V., 1997, Journal of Communications Technology and Electronics, V42, P469
   MORRIS A, 2000, P 2 EPSRC EGINEERING
   WATSON SA, UNPUB PHASE MEASUREM
NR 5
TC 4
Z9 4
U1 0
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 3182
EP 3184
PN 1-4
PG 3
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871900877
DA 2018-10-19
ER

PT S
AU Roback, K
   Hass, U
   Persson, J
AF Roback, K
   Hass, U
   Persson, J
GP IEEE
   IEEE
   IEEE
TI Transfer of health care technology in university-industry research
   collaboration environment
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE Technology transfer; innovation; medical devices; biomedical
   engineering; clinical procedures; qualitative study
AB The traditional innovation research has focused on the diffusion process and adoption of new technologies. This paper deals with health care technology in the early innovation stages preceding targeted development and marketing. A model of early research processes in the biomedical field and determinants of technology transfer will be presented. The study material is eleven projects in the Competence Center Noninvasive Medical Measurements (NIMED), Linkoping University, which is a collaboration center where academic researchers cooperate with industry and clinical departments. Data collection was made through semi-structured interviews. A qualitative approach has been adopted for data analysis. Research initiative of the investigated projects do in most. cases originate in the academic knowledge base and. earlier connections in industry and health care play an important role in formation of cooperation constellation. A number of internal factors are perceived as positive to project advancement, such as stable economy, proximity to clinical departments, and positive feedback from collaboration partners. Significant negative factors are all related to changes in cooperation structure. Clusters of related projects seem to be beneficial to research work and is an evident external factor which has to be added in a new model of technology transfer.
C1 Linkoping Univ, Competence Ctr Noninvas Med Measurements, Dept Biomed Engn, Linkoping, Sweden.
RP Roback, K (reprint author), Linkoping Univ, Competence Ctr Noninvas Med Measurements, Dept Biomed Engn, Linkoping, Sweden.
RI Hass, Ursula/I-4519-2012
OI Roback, Kerstin/0000-0002-1353-8059
CR BANTA D, 1990, LIFE CYCLES MED TECH, P21
   Battista R N, 1989, Int J Technol Assess Health Care, V5, P227
   BONAIR A, 1996, ASSESSMENT HLTH CARE, P17
   Edquist C., 1977, TEKNIK SAMHALLE ENER
   Ely M., 1991, DOING QUALITATIVE RE
   Gelijns A. C., 1990, MODERN METHODS CLIN
   Henrekson M., 2001, J TECHNOLOGY TRANSFE, V26, P207, DOI DOI 10.1023/A:1011153922906
   MAITAL S, 2001, J TECHNOLOGY TRANSFE, V26, P115
   OBERG A, 1995, BIOMED ENG HDB, P2549
   Rogers E., 1983, DIFFUSION INNOVAITON
   Schumpeter J. A., 1983, THEORY EC DEV INQUIR
   Starrin B, 1994, KVALITATIV METOD VET
   Usher Abbott P., 1988, HIST MECH INVENTIONS
NR 13
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 3938
EP 3941
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871901083
OA Green Published
DA 2018-10-19
ER

PT S
AU Koutsojannis, C
   Prentzas, J
   Hatzilygeroudis, I
AF Koutsojannis, C
   Prentzas, J
   Hatzilygeroudis, I
GP IEEE
   IEEE
   IEEE
TI A web-based intelligent tutoring system teaching nursing students
   fundamental aspects of biomedical technology
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE intelligent tutoring systems; health care technology
AB In this paper, we present the architecture of a Web-based Intelligent Tutoring System (ITS) for distant education of nursing students in fundamental aspects of the most common medical equipment. It offers course units covering the needs of users with different knowledge levels and characteristics. It tailors the presentation of the educational material to the users' diverse needs by using AI techniques to specify each user's model as well as to make pedagogical decisions. This is achieved via an expert system that uses a hybrid knowledge representation formalism integrating symbolic rules with neurocomputing.
C1 Univ Patras, Sch Engn, Dept Comp Engn & Informat, Patras, Greece.
RP Koutsojannis, C (reprint author), Univ Patras, Sch Engn, Dept Comp Engn & Informat, Patras, Greece.
CR Anderson JR, 1993, RULES MIND
   BECK J, 1996, APPL AI ED
   Brusilovsky P., 1998, ADAPTIVE HYPERTEXT H
   Brusilovsky P, 1996, LNCS, P261, DOI DOI 10.1007/3-540-61327-7
   Hanson A C, 1994, Comput Nurs, V12, P29
   Hatzilygeroudis I., 2000, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V9, P113, DOI 10.1142/S0218213000000094
   Hatzilygeroudis I., 2001, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V10, P87, DOI 10.1142/S021821300100043X
   Kommers P, 1996, HYPERMEDIA LEARNING
   Lappe J M, 1990, J Nurs Educ, V29, P244
   MITROVIC A, 2000, ITS 2000 WORKSH AD I, P37
   Ozbolt J G, 1985, J Med Syst, V9, P57, DOI 10.1007/BF00992522
   SALEEM N, 1994, COMPUT NURS, V121, P35
   STERN M, LECT NOTES COMPUTER, V1452, P98
   Vassileva J., 1997, Journal of Computing and Information Technology - CIT, V5, P87
   Woolf B., 1992, ENCY ARTIFICIAL INTE, P434
NR 15
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 4024
EP 4027
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871901107
DA 2018-10-19
ER

PT J
AU Minari, C
   Baleani, M
   Cristofolini, L
   Baruffaldi, F
AF Minari, C
   Baleani, M
   Cristofolini, L
   Baruffaldi, F
TI The effect on the fatigue strength of bone cement of adding sodium
   fluoride
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE acrylic cement; additives; sodium fluoride; fatigue
ID INITIATION; FAILURE
AB New bone cements that include several additives are currently being investigated and tested. One such additive is sodium fluoride (NaF), which promotes bone formation, facilitating implant integration and success. The influence of NaF on the fatigue performance of the cement as used in biomedical applications was tested in this paper. In fact fatigue failure of the cement mantle is a major factor limiting the longevity of a cemented implant.
   An experimental bone cement with added NaF (12 wt %) was investigated. The fatigue strength of the novel bone cement was evaluated in comparison with the cement without additives; fatigue tests were conducted according to current standards. The load levels were arranged based on a validated, statistically based optimization algorithm. The curve of stress against number of load cycles and the endurance limit were obtained and compared for both formulations. The results showed that the addition of NaF (12 wt %) to polymethylmethacrylate (PMMA) bone cement does not affect the fatigue resistance of the material. Sodium fluoride can safely be added to the bone cement without altering the fatigue performance of the PMMA bone cement.
C1 Ist Ortoped Rizzoli, Ist Tecnol Med, I-40136 Bologna, Italy.
   Univ Bologna, Fac Ingn, DIEM, Bologna, Italy.
RP Baleani, M (reprint author), Ist Ortoped Rizzoli, Ist Tecnol Med, Via Di Barbiano 1-10, I-40136 Bologna, Italy.
RI Cristofolini, Luca/C-4402-2013
OI Cristofolini, Luca/0000-0002-7473-6868; Baleani,
   Massimiliano/0000-0002-9759-6474
CR AMSTUTZ HC, 1991, HIP ARTHROPLASTY, V1
   Armitage P, 1994, STAT METHODS MED RES
   BHAMBRI SK, 1995, J BIOMED MATER RES, V29, P233, DOI 10.1002/jbm.820290214
   CRAWFORD RJ, 1975, POLYMER, V16, P908, DOI 10.1016/0032-3861(75)90212-8
   Cristofolini L, 2000, FATIGUE FRACT ENG M, V23, P953, DOI 10.1046/j.1460-2695.2000.00327.x
   Hertzberg R. W., 1980, FATIGUE ENG PLASTICS
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Magnan B, 1994, Acta Orthop Belg, V60, P72
   NAKAZAWA H, 1987, STAT RES FATIGUE FRA
   TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202
   TOPOLESKI LDT, 1993, BIOMATERIALS, V14, P1165, DOI 10.1016/0142-9612(93)90162-U
NR 12
TC 13
Z9 13
U1 0
U2 0
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE,, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2001
VL 215
IS H2
BP 251
EP 253
DI 10.1243/0954411011533643
PG 3
WC Engineering, Biomedical
SC Engineering
GA 435KM
UT WOS:000168880700014
PM 11382084
DA 2018-10-19
ER

PT J
AU Haight, RC
AF Haight, RC
TI Medium energy neutron and proton nuclear data for therapy
SO RADIOCHIMICA ACTA
LA English
DT Article
DE neutrons; protons; nuclear data; cross sections; standards; KERMA
   coefficient; dosimetry; benchmarks
ID TOTAL CROSS-SECTIONS; CHARGED-PARTICLE PRODUCTION; SIMPLE RAMSAUER
   MODEL; KERMA FACTORS; SCATTERING; BOMBARDMENT; OXYGEN; SI; CA; FE
AB The range and status of nuclear data on the interaction of medium-energy neutrons and protons with biomedical materials are discussed. Microscopic data (cross sections) include results of experimental measurements, indices and compilations of such data, and evaluated data. Experimental data, while usually available only in partial ranges of interest, are essential for validating and normalizing nuclear models used to produce comprehensive evaluated data libraries. Integral measurements of radiation transport such as depth-dose curves and of KERMA coefficients test the data and their application in transport calculations.
C1 Univ Calif Los Alamos Natl Lab, Los Alamos Neutron Sci Ctr, Los Alamos, NM 87545 USA.
RP Haight, RC (reprint author), Univ Calif Los Alamos Natl Lab, Los Alamos Neutron Sci Ctr, POB 1663, Los Alamos, NM 87545 USA.
CR ABFALTERER WP, IN PRESS PHYS REV C
   Bateman FB, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.064609
   Bauer RW, 1998, NUCL SCI ENG, V130, P348, DOI 10.13182/NSE98-A2011
   BAUHOFF W, 1986, ATOM DATA NUCL DATA, V35, P429, DOI 10.1016/0092-640X(86)90016-1
   Benck S, 1998, PHYS MED BIOL, V43, P3427, DOI 10.1088/0031-9155/43/12/003
   Benck S, 1998, PHYS REV C, V58, P1558, DOI 10.1103/PhysRevC.58.1558
   BERTRAND FE, 1973, PHYS REV C, V8, P1045, DOI 10.1103/PhysRevC.8.1045
   BHAT MR, 1980, P S NEUTR CROSS SECT
   BHAT MR, 1977, P S NEUTR CROSS SECT
   BORELI F, 1968, PHYS REV, V174, P1147, DOI 10.1103/PhysRev.174.1147
   BRADY FP, 1979, NEUTRON INDUCED REAC
   BROERSE JJ, 1997, TECDOC992 IAEA
   Carlson RF, 1996, ATOM DATA NUCL DATA, V63, P93, DOI 10.1006/adnd.1996.0010
   Chadwick MB, 1996, NUCL SCI ENG, V123, P17, DOI 10.13182/NSE96-A24210
   Chadwick MB, 1996, NUCL SCI ENG, V123, P1
   Chadwick MB, 1999, NUCL SCI ENG, V131, P293, DOI 10.13182/NSE98-48
   CONDE H, 1992, INDCSEC101 NEANDC
   CONDE H, 1992, NEANDC31 INDC
   *CSISRS, CROSS SECT INF STOR
   DEJUREN J, 1950, PHYS REV, V77, P606, DOI 10.1103/PhysRev.77.606
   FINLAY RW, 1993, PHYS REV C, V47, P237, DOI 10.1103/PhysRevC.47.237
   Grimes SM, 1998, NUCL SCI ENG, V130, P340, DOI 10.13182/NSE98-A2010
   HAIGHT RC, 1995, P SOC PHOTO-OPT INS, V2339, P256, DOI 10.1117/12.204165
   HAIGHT RC, 2000, LAUR00442 LOS AL NAT
   HARTMANN CL, 1992, RADIAT PROT DOSIM, V44, P25
   HJORT EL, 1994, PHYS REV C, V50, P275, DOI 10.1103/PhysRevC.50.275
   *ICRU, 2000, 63 ICRU
   ILJINOV AS, 1991, PRODUCTION RADIONU B, V13, P211
   ISHIBASHI K, 2000, COMMUNICATION
   Jones DTL, 2001, RADIOCHIM ACTA, V89, P265, DOI 10.1524/ract.2001.89.4-5.265
   KELLOGG DA, 1953, PHYS REV, V90, P224, DOI 10.1103/PhysRev.90.224
   Kelly JJ, 1996, PHYS REV C, V54, P2547, DOI 10.1103/PhysRevC.54.2547
   LEVKOVAKI VN, 1991, CROSS SECTIONS MEDIU
   LISOWSKI PW, 1991, P SPEC M NEUTR CROSS
   MACGREGOR MH, 1958, PHYS REV, V111, P1155, DOI 10.1103/PhysRev.111.1155
   Michel R, 1997, NUCL INSTRUM METH B, V129, P153, DOI 10.1016/S0168-583X(97)00213-9
   NELSON RO, IN PRESS NUCL SCI EN
   *NUCL EN AG, 1996, P SPEC M NUCL NUCL O
   *NUCL EN AG, 1991, P SPEC M NEUTR CROSS
   QAIM SM, 1978, NUCL PHYS A, V295, P150, DOI 10.1016/0375-9474(78)90026-X
   SCHIMMERLING W, 1971, PHYS LETT B, VB 37, P177, DOI 10.1016/0370-2693(71)90044-X
   SCHIMMERLING W, 1973, PHYS REV C, V7, P248, DOI 10.1103/PhysRevC.7.248
   SCHREWE UJ, 1995, RADIAT PROT DOSIM, V61, P275
   SCHREWE UJ, 1997, P INT C NUCL DAT SCI, P1643
   Shibata S, 1996, RADIOCHIM ACTA, V75, P1
   SHUBIN YN, IAEANDS204
   SLYPEN I, 1997, P INT C NUCL DAT SCI, P1640
   STEYN GF, 1990, APPL RADIAT ISOTOPES, V41, P315
   SUTTON M, 1998, COMMUNICATION
   VANZYL CP, 1956, PHILOS MAG, V1, P1003, DOI 10.1080/14786435608238182
   VOSS RGP, 1956, PROC R SOC LON SER-A, V236, P52, DOI 10.1098/rspa.1956.0112
   VOSS RGP, 1956, PROC R SOC LON SER-A, V236, P41, DOI 10.1098/rspa.1956.0111
   WILLIAMS IR, 1967, PHYS REV, V162, P1055, DOI 10.1103/PhysRev.162.1055
   WINFIELD JS, 1986, PHYS REV C, V33, P1, DOI 10.1103/PhysRevC.33.1
   ZANELLI CI, 1981, PHYS REV C, V23, P1015, DOI 10.1103/PhysRevC.23.1015
NR 55
TC 0
Z9 0
U1 0
U2 0
PU R OLDENBOURG VERLAG
PI MUNICH
PA LEKTORAT M/N, K BERBER-NERLINGER, POSTFACH 80 13 60, D-81613 MUNICH,
   GERMANY
SN 0033-8230
J9 RADIOCHIM ACTA
JI Radiochim. Acta
PY 2001
VL 89
IS 4-5
BP 289
EP 296
DI 10.1524/ract.2001.89.4-5.289
PG 8
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology
SC Chemistry; Nuclear Science & Technology
GA 441HT
UT WOS:000169225500012
DA 2018-10-19
ER

PT S
AU Tadigadapa, S
   Najafi, N
AF Tadigadapa, S
   Najafi, N
BE Ramesham, R
TI Reliability of microelectromechanical systems (MEMS)
SO RELIABILITY, TESTING AND CHARACTERIZATION OF MEMS/MOEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Reliability, Testing, and Characterization of MEMS/MOEMS
CY OCT 22-24, 2001
CL SAN FRANCISCO, CA
SP SPIE
DE microelectromechanical systems; packaging; reliability testing;
   capacitive pressure sensors; pressure sensor reliability; biomedical
   pressure sensors
ID SURFACE
AB Reliability is a key parameter for the eventual prevalence of microelectromechanical systems (MEMS) as either sub-components or as standalone products. Traditionally, micromachined components have been made by separating the micromachined chip design and fabrication processes from the packaging and reliability issues. This "evolutionary" partitioning of microsystems has led to long incubation times for the commercial success of MEMS based products. Packaging involves bringing together (i) multitude of design geometries of the various constituent parts, (ii) interfacing diverse materials, (iii) providing required input/output connections and (iv) optimization of all of these for performance, cost and reliability. On the other hand, reliability depends on (i) the mutual compatibility of the various parts with respect to the desired functionality, and (ii) the designs and materials from the standpoint of long-term repeatability and performance accuracy. Reliability testing provides techniques for compensation, and an understanding of the catastrophic failure mechanisms in microsystems. It is imperative that the successful design and realization of microsystems or MEMS products must include all levels of packaging and reliability issues from the onset of the project. Although, such a holistic top-down approach poses formidable technical challenges, the problem can be simplified by using the rapidly evolving MEMS infrastructure in the areas of materials, fabrication and design. This paper will discuss, overall MEMS reliability issues and present results on reliability testing of micromachined capacitive pressure sensors for high vacuum and biomedical applications currently being commercialized at Integrated Sensing Systems Inc.
C1 Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP Tadigadapa, S (reprint author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
OI Tadigadapa, Srinivas/0000-0002-8700-2476
CR Adams A. C., 1983, VLSI technology, P93
   BART S, 1995, IEEE INT REL PHYS P, P311
   BRATTER RL, 2000, IEEE INT C OPT MEMS, P29
   BROWN S, 1996, IEEE DESIGN TEST WIN, P9
   BROWN SB, 1997, P INT SOL STAT SENS, P591
   DELAMBILLY H, 1996, P SENS EXP, P173
   Douglass M.R., 1998, P 36 ANN INT REL PHY, P9
   Dyrbye K, 1996, J MICROMECH MICROENG, V6, P187, DOI 10.1088/0960-1317/6/1/038
   EDELL D, COMMUNICATION
   French PJ, 1998, J MICROMECH MICROENG, V8, P45, DOI 10.1088/0960-1317/8/2/002
   GIANCHANDANI YB, 1995, P TRANSD 95 EUR STOC, V9, P79
   HARTZELL A, 1999, 37 INT REL PHYS S IR, P202
   HILTMANN KM, 1997, P IEEE INT C SOL STA, P1157
   Kazinczi R, 1999, P SOC PHOTO-OPT INS, V3875, P174, DOI 10.1117/12.360469
   KOVACS GTA, 1998, MICROMACHINES TRANSD
   Maboudian R, 1997, J VAC SCI TECHNOL B, V15, P1, DOI 10.1116/1.589247
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MALLON J, 1988, 3 IEEE SOL STAT SENS, P123
   MARXER C, 1998, SENSOR ACTUAT A-PHYS, V71, P153
   MILLER SL, 1995, IEEE INT RELIABILITY, P311
   MONK DJ, 1996, P SOL STAT SENS ACT
   NAGEL DJ, 1998, ADV PACKAGING    MAR
   NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102
   Patton S.T., 1999, P IEEE 37 ANN INT RE, P179
   Ramesham R, 2000, P ELECTR C, P666, DOI 10.1109/ECTC.2000.853230
   RISTIC L, 1994, SENSOR TECHNOLOGY DE
   ROMIG AD, 1997, MICROELECTRON RELIAB, V37, P10
   SENTURIA SD, 1988, SENSOR ACTUATOR, V15, P221, DOI 10.1016/0250-6874(88)87012-4
   Tadigadapa S., 1999, Proceedings SENSORS EXPO Baltimore, P389
   TADIGADAPA S, 2000, GOMAC 2000 C AN CA M
   Tanner D. M., 2000, P 22 INT C MICR NIS, P97
   Tanner D. M., 2000, 38 ANN INT REL PHYS, P139
   YU HG, 2001, P SPIE S MICR MICR S
   ZHANG Y, 1995, P TRANSD 95 EUR STOC, V9, P608
NR 34
TC 14
Z9 17
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4286-0
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4558
BP 197
EP 205
DI 10.1117/12.443002
PG 9
WC Materials Science, Characterization & Testing
SC Materials Science
GA BT48E
UT WOS:000173103600024
DA 2018-10-19
ER

PT S
AU Nicolau, DV
   Cross, R
   Taguchi, T
AF Nicolau, DV
   Cross, R
   Taguchi, T
BE Wilson, AR
   Asanuma, H
TI Protein and cell patterning using bilayer lithography and confocal
   microscopy
SO SMART MATERIALS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Symposium on Smart Materials and MEMS
CY DEC 13-15, 2000
CL MELBOURNE, AUSTRALIA
SP SPIE, Dept Def, Australia, Def Sci & Technol Org, State Govt Victoria, Australia, Victorian Dept State & Reg Dev, Swinburne Univ Technol
DE protein immobilization; confocal microscopy; biosensors; cellular
   engineering
AB Protein patterns were printed using conventional microlithographic materials in a bilayer arrangement and unconventional exposure tools. The bilayer resist stack consists of a bottom Poly(tertButylMethAcrylate) layer and a top DNQ/novolak layer. The protein features were printed in "step & repeat" mode, that is a flow-cell, "real-time" process, as follows: (i) the exposure step is carried out by the focused beam of a confocal microscope tuned to 488nm wavelength; (ii) the development step is performed flowing the photoresist developer through the cell; (iii) the selective deposition of the protein (a green fluorescent protein, FITC avidin for visualisation) is achieved via the flow of the protein solution through the cell until a desired contrast has been reached; (iv) the control step consists of an on-line monitoring of the red fluorescence for the control of the development of the top layer, and of the green fluorescence for the control of the protein patterning, respectively. The techniques have of a seamless portability in a biomedical environment, and for "step & repeat" protein patterning the advantage of a high and controllable resolution. The process can be applied for the in-house fabrication of model biomolecular and cellular devices. Examples for the patterning of neuronal cells are also given.
C1 Ind Res Inst Swinburne, Hawthorn, Vic 3122, Australia.
RP Nicolau, DV (reprint author), Ind Res Inst Swinburne, Hawthorn, Vic 3122, Australia.
CR ALLEN RD, 1994, ACS SYM SER, V537, pCH11
   DAMMEL R, 1993, DIAZONAPHTOQUINOE BA
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001
   HATZAKIS M, 1969, J ELECTROCHEM SOC, V116, P1033, DOI 10.1149/1.2412145
   McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555
   Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g
   Nicolau DV, 1999, LANGMUIR, V15, P3845, DOI 10.1021/la980914n
   Nicolau DV, 2000, BIOSENS BIOELECTRON, V15, P85, DOI 10.1016/S0956-5663(99)00072-X
NR 9
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3908-8
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4234
BP 244
EP 248
DI 10.1117/12.424413
PG 5
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BS26C
UT WOS:000169262800033
DA 2018-10-19
ER

PT B
AU Niinomi, M
AF Niinomi, M
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Recent biocompatible metallic materials
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID MECHANICAL-PROPERTIES; AMORPHOUS-ALLOYS; TITANIUM-ALLOYS; IMPLANT ALLOY;
   CR; MARTENSITE; DESIGN
AB Biocompatible metallic materials are mainly used for replacing failed hard tissue. Main biocompatible metallic materials, that is, metallic biomaterials are stainless steels, Co based alloys, and titanium and its alloys. Recently titanium alloys are getting much attention for biomaterials. The various kinds of new high strength alpha + beta and low modulus beta type titanium alloys composed of non-toxic elements like Nb, Ta, Zr, etc are developed for biomedical applications because of the toxicity of alloying elements and lack of mechanical biocompatibility of conventional titanium alloys like Ti6Al-4V: Recent research and development in the other metallic alloys like stainless steels, Co based alloys etc, will be also discussed.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
RI BAI, JIE/D-7448-2016
CR ALABDULLAT Y, 2000, J JAPAN DENT MAT, V19, P95
   BERLIN RM, 1999, ASTM STP, V1365, P89
   Berry G, 1999, AM SOC TEST MATER, V1365, P11, DOI 10.1520/STP14260S
   BROWN RS, 2000, 6 WORLD BIOM C KAM H, P828
   Doi H, 1998, J JPN SOC DENT MAT D, V17, P247
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Garcia ADJS, 1999, METALL MATER TRANS A, V30, P1177, DOI 10.1007/s11661-999-0267-6
   Gilbert CJ, 1999, METALL MATER TRANS A, V30, P1739, DOI 10.1007/s11661-999-0173-y
   HANADA S, 1999, FALL M JAP I MET, P299
   Hiromoto S, 1999, J JPN I MET, V63, P352, DOI 10.2320/jinstmet1952.63.3_352
   Huang P, 1999, MATER SCI TECH-LOND, V15, P157, DOI 10.1179/026708399101505699
   IGUCHI Y, 1999, B ISIJ, V4, P9
   KATO S, 1997, J JAPANESE SOC DENT, V16, P45
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEMONS JE, 1986, PERSPECTIVES BIOMATE, P1
   MARUYAMA N, 2000, P ANN M JAP SOC MECH, P433
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   NIINOMI M, IN PRESS RES SIGNPOS
   PAN J, 1999, ELECTROCHEMICAL SOC, V9817, P383
   Papakyriacou M, 1999, FATIGUE '99: PROCEEDINGS OF THE SEVENTH INTERNATIONAL FATIGUE CONGRESS, VOLS 1-4, P1789
   PARK JB, 2000, BIOMEDICAL ENG HDB, V1
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   Speidel M O, 1992, P HIGH MANG HIGH NIT, P135
   TAKAYA M, 2000, J JAPAN I LIGHT META, V50, P343
   Tandon R, 1999, AM SOC TEST MATER, V1365, P3, DOI 10.1520/STP14259S
   Tesk JA, 1999, AM SOC TEST MATER, V1365, P32, DOI 10.1520/STP14261S
   UGGOWITZER PJ, 1997, ADV POWDER METAL PAR, V3, P18113
   Whitcher FD, 1997, COMPUT STRUCT, V64, P1005, DOI 10.1016/S0045-7949(97)00014-X
   Yamamuro T, 1989, J JPN SOC BIOMATER, V7, P19
   YOKOYAMA K, 2000, 6 WORLD BIOM C T MAY
   ZENBO N, 1999, STENT GRAFTING AORTI, P10
NR 32
TC 12
Z9 12
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 3
EP 14
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700001
DA 2018-10-19
ER

PT B
AU Kuroda, D
   Niinomi, M
   Akahori, T
   Fukui, H
   Suzuki, A
   Hasegawa, J
AF Kuroda, D
   Niinomi, M
   Akahori, T
   Fukui, H
   Suzuki, A
   Hasegawa, J
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Mechanical performance of newly developed beta-type titanium alloy,
   Ti-29Nb-13Ta-4.6Zr, for biomedical applications
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
AB Titanium and its alloys have been used as most attractive bio-compatible metallic materials due to their excellent combination of strength, corrosion resistance and bio-compatibility. beta -type titanium alloy, Ti-29Nb-13Ta-4.6Zr, which composed of non-toxic elements with low modulus of elasticity is newly developed for biomedical applications. Forging, cold rolling and heat treatments were conducted with Ti-29Nb-13Ta-4.6Zr in order to achieve excellent mechanical performance. The tensile tests, fatigue tests, measurements of modulus of elasticity and evaluation of cyto-toxicity were carried out in order to investigate the basic mechanical and biological properties of Ti-29Nb-13Ta-4.6Zr. The balance of strength and ductility, and fatigue ratio of Ti-29Nb-13Ta-4.6Zr are equivalent or greater, and the modulus of elasticity and cyto-toxicity of Ti-29Nb-13Ta-4.6Zr are equivalent or lower comparing with those of conventional biomedical titanium alloys. Newly developed beta -type titanium alloy, Ti-29Nb-13Ta-4.6Zr, is, therefore, judged to be suitable for biomedical applications.
C1 Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Kuroda, D (reprint author), Toyohashi Univ Technol, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
CR Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   KUDO S, 1990, J CERAM SOC JPN, V98, P653
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
NR 4
TC 8
Z9 8
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 99
EP 106
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700011
DA 2018-10-19
ER

PT B
AU Kobayashi, E
   Mochizuki, H
   Doi, H
   Yoneyama, T
   Otsuka, M
   Hamanaka, H
AF Kobayashi, E
   Mochizuki, H
   Doi, H
   Yoneyama, T
   Otsuka, M
   Hamanaka, H
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Mechanical properties of Ti-6Al-7Nb and Ti-5Al-13Ta alloys under
   combined (tensile/torsional) stress
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
AB Evaluation of mechanical properties of biomedical materials in the simulated environment and situation became important. Considering the mechanical situation in the living body as a field under complex stresses, e.g. consisting of tensile and torsional stresses, biomedical materials are required to have sufficient torsional strength together with enough tensile strength. In the present study, mechanical properties of a biomedical Ti-6Al-7Nb alloy and Ti-5Al-13Ta alloy were evaluated by the tensile/torsional test.
   Mechanical properties of the alloys under tensile/torsional stress were evaluated using a multi-axial testing machine. The strength of the alloys under combined stress was estimated by applying of von Mises-type yield condition and effective stress. In the complex stress (tensile/torsional) tests, mechanical properties in tensile direction, such as strength and elongation to rupture, decrease with increasing torsional rate applied. Torsional rate dependence of maximum torsional shear stress is clearly seen. It is considered that it might be caused from sudden decreasing of shear stress by tensile yielding. By applying effective (equivalent) stress of suitable yield condition to the results of tensile and torsional tests, it is considered to be possible to estimate of yield strength of Ti-6Al-7Nb alloy and Ti-5Al-13Ta alloy under the complex stress.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Kobayashi, E (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadi, Tokyo 1010062, Japan.
CR DOI H, 1998, J JAPANESE SOC DENT, V17, P452
   *INT ORG STAND, 1994, 68711 ISO INT ORG ST
   KOBAYASHI E, 1999, J JAPANESE SOC DENT, V18, P359
   KOBAYASHI E, 2000, T 6 WORLD BIOM C MIN, P925
   SOGA Y, 2000, J JAPANESE SOC DENT, V19, P145
   ZARDIACKAS LD, 1991, J BIOMED MATER RES, V25, P281, DOI 10.1002/jbm.820250302
NR 6
TC 1
Z9 1
U1 0
U2 0
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 115
EP 119
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700013
DA 2018-10-19
ER

PT B
AU Al-Watban, AS
AF Al-Watban, AS
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Friction and wear behavior of diamond films compared with bulk diamond
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID CARBON-FILMS; DEPOSITION
AB The superior technical properties of bulk diamond in wear-resistant application have driven the expectation that diamond film and diamondlike carbon films (DLC) could posses similar properties. Coated diamond and diamondlike films have great application in biomedical instrumentation sector. They can be used as optical, friction-reducing, corrosion-preventing and wear-resistant coatings. Since the properties of synthesized materials are in large measure determined not only by their compositions, but also by the method of processing and their resultant microstructure, it is of interest to compare the tribological properties of PCD and DLC films with those of natural diamond, Most of the tribological studies have indicated the strong effect of several scales of surface roughness on friction. For example, the sliding friction coefficients of certain PCD surfaces against steel and sapphire can be ten times higher than that of smooth diamond surfaces under similar conditions. The residual stresses on the surface of the coating layer and the integrity between the substrate and the coating have great impact on their wear properties. The purpose of this study is to compare the tribological properties of diamond films with those of bulk diamond.
C1 Riyadh Tech Coll, Riyadh 11593, Saudi Arabia.
RP Al-Watban, AS (reprint author), Riyadh Tech Coll, POB 53699, Riyadh 11593, Saudi Arabia.
CR ALWATBAN AS, 2000, C PROC MAT PROP SAN, V2
   Blau P. J., 1990, MECHANICS COATINGS, P399
   BLAU PJ, 1992, NATO ADV SCI I E-APP, V220, P523
   BOWDEN FP, 1951, PROC R SOC LON SER-A, V208, P444, DOI 10.1098/rspa.1951.0173
   BOWDEN FP, 1958, PROC R SOC LON SER-A, V248, P350, DOI 10.1098/rspa.1958.0248
   BOWDEN FP, 1966, PROC R SOC LON SER-A, V295, P244, DOI 10.1098/rspa.1966.0238
   BOWDEN FP, 1964, FRICTION LUBRICATION, V11, P169
   BOWDEN FP, 1964, FRICTION LUBRICATION, V11, P174
   BRAZA JF, 1992, ENCY MAT SCI ENG S, V3, P1609
   Brookes C. A., 1994, Journal of Hard Materials, V5, P77
   CASEY M, 1973, J PHYS D APPL PHYS, V6, P1772, DOI 10.1088/0022-3727/6/15/303
   DUGGER MT, 1992, ADV TRIBOLOGY
   ENOMOTO Y, 1980, NATURE, V283, P51, DOI 10.1038/283051a0
   GARDOS MK, 1990, MECH COATINGS, P154
   GARDOS MN, 1989, 1 INT S DIAM DIAM LI, P18
   HARKER AB, 1990, R D MAGAZINE     MAR, P84
   HEINZELMANN H, 1989, WEAR, V135, P109, DOI 10.1016/0043-1648(89)90099-9
   JAHANMIR S, 1989, WEAR, V133, P73, DOI 10.1016/0043-1648(89)90114-2
   KOKAKU Y, 1989, J VAC SCI TECHNOL A, V7, P2311, DOI 10.1116/1.575934
   KONIG W, 1993, WEAR, V162, P12, DOI 10.1016/0043-1648(93)90479-6
   MATSUMOTO S, MAT SCI LETT, V4, P600
   MEMMING R, 1986, THIN SOLID FILMS, V143, P31, DOI 10.1016/0040-6090(86)90144-6
   MIYOSHI K, 1980, APPL SURF SCI, V6, P161, DOI 10.1016/0378-5963(80)90142-7
   OKADA K, 1989, J VAC SCI TECHNOL A, V7, P132, DOI 10.1116/1.575741
   RUDDER RA, 1992, MATER RES SOC SYMP P, V242, P23, DOI 10.1557/PROC-242-23
   SAMUELS B, 1988, J MATER SCI, V23, P2846, DOI 10.1007/BF00547459
   SATO Y, 1992, PROPERTIES NATURAL S
   SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4
   TABOR D, 1979, PROPERTIES DIAMOND, P547
   TSAI HC, 1987, J VAC SCI TECHNOL A, V5, P3287, DOI 10.1116/1.574188
   WONG MS, 1989, MATER RES SOC S P, V140, P483
   1991, MAT ALERT        JUN, P5
NR 32
TC 0
Z9 0
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 181
EP 191
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700021
DA 2018-10-19
ER

PT B
AU Leng, Y
   Zhang, C
AF Leng, Y
   Zhang, C
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Mechanical integrity of hydroxyapatite coatings on titanium implants
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID STABILITY
AB Hydroxyapatite (I-IA) coated Ti alloy is a promising material for biomedical implants. The successful applications of such implants rely on fundamental understandings of mechanical behavior of the HA coatings, particularly, the fatigue resistance. In this work the mechanical stability of IFA coatings under cyclic loading was systematically investigated using four-point bending tests and the indentation tests in both air and simulated body fluid (SBF). Also, a shear cyclic test was developed for the coatings, considering the coatings of implants often failure under shearing loading in human body. Experiments revealed the conventional cyclic bending tests could not effectively evaluate the fatigue resistance of the HA coatings on Ti substrates. The contact fatigue under indentation might represent the worst service conditions of coatings. The cyclic indentation revealed that the fatigue damages in the HA coatings were severer in SBF than in air, and thin HA coatings exhibited less fatigue damages than the thick ones. The newly developed shear test for the coatings successfully generated similar shear loading as the conventional ones, however it is easier for alignment and for adapting coating thickness variation. Using the new method, the coating resistance to cyclic shear loading was evaluated with S-N curves. Also the tests revealed the existence of threshold stress which was required to generate fatigue damages in the coating.
C1 Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Leng, Y (reprint author), Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
CR KUMMER FJ, 1992, J APPL BIOMATER, V3, P211, DOI 10.1002/jab.770030308
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   MANELY MT, 1987, CLIN ORTHOP RELAT R, V157, P293
   Reis RL, 1996, J MATER SCI-MATER M, V7, P407, DOI 10.1007/BF00122009
   REIS RL, 1994, J MATER SCI-MATER M, V5, P457, DOI 10.1007/BF00058983
   ZHANG C, 2000, THESIS HONG KONG U S, P99
NR 6
TC 0
Z9 0
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 221
EP 228
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700025
DA 2018-10-19
ER

PT S
AU Erdemir, A
AF Erdemir, A
BE Meng, WJ
   Kumar, A
   Doll, GL
   Cheng, YT
   Veprek, S
   Chung, YW
TI Superlubricity and wearless sliding in diamondlike carbon films
SO SURFACE ENGINEERING 2001 - FUNDAMENTALS AND APPLICATIONS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Advances in Surface Engineering - Fundamentals and
   Applications held at the 2001 MRS Fall Meeting
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
ID TRIBOLOGICAL PROPERTIES; SUPERLOW FRICTION; COATINGS; PERFORMANCE;
   ENVIRONMENT; BEHAVIOR
AB Diamondlike carbon (DLC) films have attracted great interest in recent years mainly because of their unusual optical, electrical, mechanical, and tribological properties. Such properties are currently being exploited for a wide range of engineering applications including magnetic hard disks, gears, sliding and roller bearings, scratch resistant glasses, biomedical implants, etc. Systematic studies on carbon-based materials in our laboratory have led to the development of a new class of amorphous DLC films that provide extremely low friction and wear coefficients of 0.001 to 0.005 and 10(-11) to 10(-10) mn(3)/N.m, respectively, when tested in inert-g as or high-vacuum environments. These films were produced in highly hydrogenated gas discharge plasmas by a plasma enhanced chemical vapor deposition process at room temperature. The carbon source gases used in the deposition of these films included methane, acetylene, and ethylene. Tribological studies in our laboratory have established a very close correlation between the composition of the plasmas and the friction and wear coefficients of the resultant DLC films. Specifically, the friction and wear coefficients of DLC films grown in plasmas with higher hydrogen-to-carbon ratios were much lower than films derived from source gases with lower hydrogento-carbon ratios. Fundamental tribological and surface analytical studies have led us to conclude that hydrogen (within the film, as well as on the sliding surfaces) is extremely important for the superlubricity and wearless sliding behavior of these films. Based on these studies, a mechanistic model is proposed to explain the superlow friction and wear properties of the new DLC films.
C1 Argonne Natl Lab, Div Energy Technol, Argonne, IL 60439 USA.
RP Erdemir, A (reprint author), Argonne Natl Lab, Div Energy Technol, 9700 S Cass Ave, Argonne, IL 60439 USA.
RI Erdemir, Ali/P-7643-2018
OI Erdemir, Ali/0000-0002-6489-9620
CR BHUSHAN B, 1993, APPL PHYS LETT, V62, P3253, DOI 10.1063/1.109090
   BOWDEN FP, 1951, PROC R SOC LON SER-A, V208, P444, DOI 10.1098/rspa.1951.0173
   CHANDRASEKAR S, 1992, WEAR, V153, P79, DOI 10.1016/0043-1648(92)90262-7
   DONNET C, 1994, SURF COAT TECH, V68, P626, DOI 10.1016/0257-8972(94)90228-3
   Donnet C, 1997, SURF COAT TECH, V94-5, P456, DOI 10.1016/S0257-8972(97)00275-2
   DUGGER MT, 1992, ACS SYM SER, V485, P72
   ERDEMIR A, 1991, SURF COAT TECH, V50, P17, DOI 10.1016/0257-8972(91)90187-2
   Erdemir A, 1996, TRIBOL T, V39, P735, DOI 10.1080/10402009608983591
   Erdemir A, 2000, DIAM RELAT MATER, V9, P632, DOI 10.1016/S0925-9635(99)00361-1
   Erdemir A, 2000, J VAC SCI TECHNOL A, V18, P1987, DOI 10.1116/1.582459
   Erdemir A, 1997, SURF COAT TECH, V94-5, P537, DOI 10.1016/S0257-8972(97)00496-9
   ERDEMIR A, 2000, MODERN TRIBOLOGY HDB, P871
   ERDEMIR A, 2001, P 44 ANN M SOC VAC C, P397
   ERDEMIR A, 1999, SURF COAT TECH, V121, P565
   ERDEMIR A, 1999, SURF COAT TECH, V121, P589
   ERDEMIR A, 1993, DIAM RELAT MATER, V3, P119
   ERDEMIR A, 2001, Patent No. 6255234
   Ersoy DA, 2000, TRIBOL T, V43, P809, DOI 10.1080/10402000008982412
   Falvo MR, 1999, NATURE, V397, P236
   FUSARO RL, 1970, ASLE TRANS, V13, P56
   GARDOS MN, 1990, J MATER RES, V5, P2599, DOI 10.1557/JMR.1990.2599
   Gardos MN, 1999, SURF COAT TECH, V113, P183, DOI 10.1016/S0257-8972(98)00842-1
   GUPTA BK, 1994, J TRIBOL-T ASME, V116, P445, DOI 10.1115/1.2928862
   HAYWARD IP, 1992, WEAR, V157, P215, DOI 10.1016/0043-1648(92)90063-E
   Heimberg JA, 2001, APPL PHYS LETT, V78, P2449, DOI 10.1063/1.1366649
   KIM DS, 1991, SURF COAT TECH, V49, P537, DOI 10.1016/0257-8972(91)90113-B
   Liu Y, 1996, SURF COAT TECH, V82, P48, DOI 10.1016/0257-8972(95)02623-1
   Liu Y, 1997, SURF COAT TECH, V94-5, P463, DOI 10.1016/S0257-8972(97)00450-7
   MIYOSHI K, 1993, J APPL PHYS, V74, P4446, DOI 10.1063/1.354386
   MIYOSHI K, 1989, MATER SCI FORUM, V52, P645
   Olsen JE, 1996, WEAR, V200, P233, DOI 10.1016/S0043-1648(96)07295-X
   RONKAINEN H, 1994, DIAM RELAT MATER, V3, P1329, DOI 10.1016/0925-9635(94)90147-3
   SAVAGE RH, 1948, J APPL PHYS, V19, P1, DOI 10.1063/1.1697867
   TABOR D, 1979, PROPERTIES DIAMOND, P325
NR 34
TC 1
Z9 1
U1 0
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-633-8
J9 MATER RES SOC SYMP P
PY 2001
VL 697
BP 391
EP 403
PG 13
WC Materials Science, Coatings & Films
SC Materials Science
GA BV23W
UT WOS:000178303600059
DA 2018-10-19
ER

PT J
AU Jones, FH
AF Jones, FH
TI Teeth and bones: applications of surface science to dental materials and
   related biomaterials
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID X-RAY PHOTOELECTRON; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   SCANNING-TUNNELING-MICROSCOPY; ION MASS-SPECTROMETRY; OSTEOBLAST-LIKE
   CELLS; LASER-DESORPTION IONIZATION; CALCIUM-PHOSPHATE COATINGS; BOVINE
   SERUM-ALBUMIN; PHOTON-STIMULATED DESORPTION
AB Recent years have seen a considerable upsurge in publications concerning the surface structure and chemistry of materials with biological or biomedical applications. Within the body, gas-solid interactions become relatively less significant and solid-liquid or solid-solid interfaces dominate, providing new challenges for the surface scientist. The current paper aims to provide a timely review of the use of surface analysis and modification techniques within the biomaterials field. A broad overview of applications in a number of related areas is given with particular attention focusing on those materials commonly encountered in dentistry and oral or maxillofacial implantology. Several specific issues of current interest are discussed. The interaction between synthetic and natural solids, both in the oral environment and elsewhere in the body is important in terms of adhesion, related stresses and strains and ultimately the longevity of a dental restoration, biomedical implant, or indeed the surrounding tissue. Exposure to body fluids, of course, can also affect stability, leading to the degradation or corrosion of materials within the body. Whilst this could potentially be harmful, e.g., if cytotoxic elements are released, it may alternatively provide a route to the preferential release of beneficial substances. Furthermore, in some cases, the controlled disintegration of a biomaterial is desirable, allowing the removal of an implant, e.g., without the need for further surgery, The presence of cells in the immediate bioenvironment additionally complicates the situation. A considerable amount of current research activity is targeted at the development of coatings or surface treatments to encourage tissue growth. Lf this is to be achieved by stimulating enhanced cell productivity, determination of the relationship between cell function and surface composition is essential. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 UCL, Dept Biomat, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England.
RP Jones, FH (reprint author), UCL, Dept Biomat, Eastman Dent Inst Oral Hlth Care Sci, 256 Grays Inn Rd, London WC1X 8LD, England.
EM f.jones@eastman.ucl.ac.uk
CR ABBOTT NL, 1994, CHEM MATER, V6, P596, DOI 10.1021/cm00041a007
   ABIKO Y, 1993, CELL MATER, V3, P161
   Abrahams I, 1997, J MATER CHEM, V7, P1573, DOI 10.1039/a608325k
   Adler HJ, 1999, ACTA POLYM, V50, P232, DOI 10.1002/(SICI)1521-4044(19990701)50:7<232::AID-APOL232>3.3.CO;2-4
   ADURU S, 1987, LANGMUIR, V3, P543, DOI 10.1021/la00076a017
   Afanasyeva NI, 1999, SURF INTERFACE ANAL, V27, P204, DOI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
   ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   ALBREKTSSON T, 1991, ACTA ORTHOP SCAND, V17, P132
   ALBREKTSSON T, 1982, CLIN APPL BIOMATERIA
   ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8
   Allen GC, 1996, NUCL INSTRUM METH B, V116, P457, DOI 10.1016/0168-583X(96)00088-2
   Allen S, 1997, TRENDS BIOTECHNOL, V15, P101, DOI 10.1016/S0167-7799(97)01015-9
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   *AM SOC TEST MAT, 1991, SURF INTERFACE ANAL, V17, P893
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   AMEEN AP, 1993, CLIN ORAL IMPLAN RES, V4, P144, DOI 10.1034/j.1600-0501.1993.040305.x
   Ameen AP, 1996, J MATER SCI-MATER M, V7, P195, DOI 10.1007/BF00119730
   AMRAHBOUALI S, 1994, BIOMATERIALS, V15, P269, DOI 10.1016/0142-9612(94)90050-7
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   ANDRADE JD, 1985, PROTEIN ADSORPTION S, V2
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   ANUSAVICE KJ, 1996, PHILLIPS SCI DENTAL
   AOBA T, 1991, ACS SYM SER, V444, P85
   APARICIO C, 1992, International Journal of Oral and Maxillofacial Implants, V7, P94
   ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   ARENDS J, 1985, CARIES RES, V19, P450, DOI 10.1159/000260880
   Armstrong SR, 1998, DENT MATER, V14, P91, DOI 10.1016/S0109-5641(98)00014-1
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ARSOV L, 1975, VIDE A, V30, P114
   Arwin H, 1998, THIN SOLID FILMS, V313, P764, DOI 10.1016/S0040-6090(97)00993-0
   Arys A, 1998, J BIOMED MATER RES, V43, P300, DOI 10.1002/(SICI)1097-4636(199823)43:3<300::AID-JBM11>3.0.CO;2-J
   Ashino M, 2000, PHYS REV B, V61, P13955, DOI 10.1103/PhysRevB.61.13955
   ASMUSSEN E, 1987, J DENT RES, V66, P1386, DOI 10.1177/00220345870660082001
   ATANASOSKA LL, 1978, SURF SCI, V72, P189, DOI 10.1016/0039-6028(78)90388-6
   AVERY JK, 1994, ORAL DEV HISTOLOGY
   Azoulay A, 1997, SURF SCI, V370, P1, DOI 10.1016/S0039-6028(96)00927-2
   Azoulay A, 1999, SURF SCI, V422, P141, DOI 10.1016/S0039-6028(98)00923-6
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BACKMAN B, 1993, ACTA ODONTOL SCAND, V51, P79, DOI 10.3109/00016359309041152
   BADDILEY J, 1973, NATURE, V243, P43, DOI 10.1038/243043a0
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAKKE R, 1990, BIOFILMS
   BALL V, 1994, P NATL ACAD SCI USA, V91, P7330, DOI 10.1073/pnas.91.15.7330
   Ball V, 1996, LANGMUIR, V12, P1614, DOI 10.1021/la950735v
   Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O
   Bar G, 1996, J VAC SCI TECHNOL A, V14, P1794, DOI 10.1116/1.580338
   Bar G, 1997, LANGMUIR, V13, P373, DOI 10.1021/la960935m
   Baranauskas V, 1998, APPL BIOCHEM BIOTECH, V69, P91, DOI 10.1007/BF02919391
   Barlow SM, 1998, SURF SCI, V401, P322, DOI 10.1016/S0039-6028(97)01086-8
   BARO AM, 1986, BIOMATERIALS, V7, P463, DOI 10.1016/0142-9612(86)90036-0
   Barron AE, 1999, CURR OPIN CHEM BIOL, V3, P681, DOI 10.1016/S1367-5931(99)00026-5
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bartzoka V, 1998, LANGMUIR, V14, P1892, DOI 10.1021/la9711138
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Bates SP, 1998, SURF SCI, V409, P336, DOI 10.1016/S0039-6028(98)00278-7
   Baty AM, 1997, LANGMUIR, V13, P5702, DOI 10.1021/la9610720
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Beech IB, 1999, J MICROBIOL METH, V36, P3, DOI 10.1016/S0167-7012(99)00005-6
   Behm JM, 1996, LANGMUIR, V12, P2121, DOI 10.1021/la950811u
   BennaniZiatni M, 1997, ANN CHIM-SCI MAT, V22, P537
   Bennett RA, 1999, FARADAY DISCUSS, V114, P267, DOI 10.1039/a903731d
   Bennett RA, 1999, PHYS REV LETT, V82, P3831, DOI 10.1103/PhysRevLett.82.3831
   Bennett RA, 1999, PHYS REV B, V59, P10341, DOI 10.1103/PhysRevB.59.10341
   Bentaleb A, 1998, J BIOMED MATER RES, V40, P449, DOI 10.1002/(SICI)1097-4636(19980605)40:3<449::AID-JBM16>3.0.CO;2-E
   Bentaleb A, 1997, LANGMUIR, V13, P729, DOI 10.1021/la9605192
   BERGER H, 1993, J CRYST GROWTH, V130, P108, DOI 10.1016/0022-0248(93)90842-K
   BERNDT R, 1994, SURF SCI, V310, P85, DOI 10.1016/0039-6028(94)91373-0
   BERTEL E, 1984, SURF SCI, V141, P355, DOI 10.1016/0039-6028(84)90137-7
   BERUBE YG, 1968, J COLLOID INTERF SCI, V27, P305, DOI 10.1016/0021-9797(68)90038-6
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   BETON PH, 1995, APPL PHYS LETT, V67, P1075, DOI 10.1063/1.114469
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BIERBAUM K, 1995, LANGMUIR, V11, P512, DOI 10.1021/la00002a025
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120
   BIWER BM, 1986, SURF SCI, V167, P207, DOI 10.1016/0039-6028(86)90795-8
   BLAISE G, 1978, SURF SCI, V71, P630
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Blomberg E, 1998, BIOMATERIALS, V19, P371, DOI 10.1016/S0142-9612(97)00114-2
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Bohm I, 1999, APPL SURF SCI, V141, P237, DOI 10.1016/S0169-4332(98)00510-8
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   BONNELL DA, 2000, SCANNING TUNNELING M
   Booth NA, 1998, SURF SCI, V397, P258, DOI 10.1016/S0039-6028(97)00742-5
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   BOSKEY AL, 1976, J PHYS CHEM-US, V80, P40, DOI 10.1021/j100542a009
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BotteroCornillac MJ, 1995, SCANNING MICROSCOPY, V9, P1179
   Bowen WH, 1993, CARIOLOGY 90S
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1995, CELL MATER, V5, P323
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyde A, 1997, CIBA F SYMP, V205, P18
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BREARLEY W, 1977, SURF SCI, V64, P372, DOI 10.1016/0039-6028(77)90284-9
   BREDOW T, 1995, SURF SCI, V327, P398, DOI 10.1016/0039-6028(94)00851-5
   Briggs D., 1992, PRACTICAL SURFACE AN, V2
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   BRINK C, 1992, COLLOID SURFACE, V66, P149, DOI 10.1016/0166-6622(92)80131-K
   Brinkley D, 1998, SURF SCI, V395, P292, DOI 10.1016/S0039-6028(97)00633-X
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Brown WA, 2000, J PHYS CHEM B, V104, P2578, DOI 10.1021/jp9930907
   BRUGNIAU D, 1984, SURF SCI, V141, P639, DOI 10.1016/0039-6028(84)90154-7
   BRUNER RJ, 1993, T SOC BIOMATER, V16, P219
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUCHS J, 1988, APPL MICROBIOL BIOT, V29, P119
   BUMGARDNER JD, 1993, DENT MATER, V9, P252, DOI 10.1016/0109-5641(93)90070-7
   BUMGARDNER JD, 1994, J APPL BIOMATER, V5, P203, DOI 10.1002/jab.770050305
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUSSCHER HJ, 1990, SURF INTERFACE ANAL, V15, P344, DOI 10.1002/sia.740150508
   BUSTILLO FJ, 1989, VACUUM, V39, P659, DOI 10.1016/0042-207X(89)90010-9
   BUSTILLO FJ, 1990, VACUUM, V41, P19, DOI 10.1016/0042-207X(90)90258-Z
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   CARLEY AF, 1987, J CHEM SOC FARAD T 1, V83, P351, DOI 10.1039/f19878300351
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CASSINELLI C, 1994, J MATER SCI-MATER M, V5, P606, DOI 10.1007/BF00120339
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   CHANDER S, 1985, COLLOID SURFACE, V13, P137
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i
   Characklis W. G., 1990, BIOFILMS
   Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B, 1995, CELL MATER, V5, P334
   CHEN CJ, 1993, OXFORD SERIES OPTICA, V4
   CHEN O, 1999, PHYS CHEM COMMUN, V9
   CHEN S, 1993, J VAC SCI TECHNOL A, V11, P2419, DOI 10.1116/1.578587
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   CHERNOFF EAG, 1992, J VAC SCI TECHNOL A, V10, P596, DOI 10.1116/1.577736
   CHIEGO DJ, 1994, ORAL DEV HISTOLOGY
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CHOW LC, 1988, J DENT RES, V67, P1058, DOI 10.1177/00220345880670070901
   CHRISTENSEN BE, 1990, BIOFILMS
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Clasen ABS, 1997, ACTA ODONTOL SCAND, V55, P339
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   COLBOURN EA, 1992, SURF SCI REP, V15, P281, DOI 10.1016/0167-5729(92)90013-2
   Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748
   Combe E C, 1999, DENTAL BIOMATERIALS
   Combes C, 1999, J MATER SCI-MATER M, V10, P231, DOI 10.1023/A:1008922029096
   Combes C, 1995, J MATER SCI-MATER M, V6, P699, DOI 10.1007/BF00134304
   Combes C, 1998, COLLOID SURFACE B, V11, P15, DOI 10.1016/S0927-7765(98)00014-9
   Conesa JC, 2000, RES CHEM INTERMEDIAT, V26, P103, DOI 10.1163/156856700X00138
   Connor PA, 1999, LANGMUIR, V15, P2402, DOI 10.1021/la980855d
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Cooper E, 1997, J MATER CHEM, V7, P435, DOI 10.1039/a607204f
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   CORBRIDGE DEC, 1990, STUDIES INORGANIC CH, V10
   CORNELL RM, 1975, J COLLOID INTERF SCI, V53, P6, DOI 10.1016/0021-9797(75)90028-4
   CORPRON RE, 1992, J DENT RES, V71, P828, DOI 10.1177/002203459207100S07
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   COWLEY JM, 1995, HDB SURFACE IMAGING, P148
   CULLEN DC, 1994, J COLLOID INTERF SCI, V166, P102, DOI 10.1006/jcis.1994.1276
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   CUTRESS TW, 1972, ARCH ORAL BIOL, V17, P93, DOI 10.1016/0003-9969(72)90137-9
   Czajkowsky DM, 2000, J ELECTRON MICROSC, V49, P395, DOI 10.1093/oxfordjournals.jmicro.a023821
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   deBeer D, 1995, WATER SCI TECHNOL, V32, P11, DOI 10.1016/0273-1223(96)00002-9
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DELAMAR M, 1990, J ELECTRON SPECTROSC, V53, pC11, DOI 10.1016/0368-2048(90)80335-8
   DELMAESTRO RF, 1980, ACTA PHYSIOL SCAND, P153
   DENBESTEN PK, 1986, J DENT RES, V65, P1272, DOI 10.1177/00220345860650101401
   DENGIS PB, 1995, COLLOID SURFACE B, V4, P199, DOI 10.1016/0927-7765(94)01171-Z
   Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8
   Dengis PB, 1997, YEAST, V13, P931, DOI 10.1002/(SICI)1097-0061(199708)13:10<931::AID-YEA149>3.0.CO;2-T
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Diebold U, 1998, SURF SCI, V411, P137, DOI 10.1016/S0039-6028(98)00356-2
   Diebold U, 1996, PHYS REV LETT, V77, P1322, DOI 10.1103/PhysRevLett.77.1322
   DIEBOLD U, 2000, COMMUNICATION
   Dieluweit S, 1998, SUPRAMOL SCI, V5, P15, DOI 10.1016/S0968-5677(97)00073-4
   DMYTRYK JJ, 1990, J PERIODONTOL, V61, P491, DOI 10.1902/jop.1990.61.8.491
   do Serro APVA, 1997, COLLOID SURFACE B, V10, P95, DOI 10.1016/S0927-7765(97)00060-X
   Dombrowski KE, 1996, FASEB J, V10, P2854
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P125, DOI 10.1016/S0022-0248(97)00330-8
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P133, DOI 10.1016/S0022-0248(97)00331-X
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   DUCKWORTH RM, 1992, J DENT RES, V71, P934, DOI 10.1177/002203459207100S29
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P271, DOI 10.1016/0927-7765(96)01295-7
   Dufrene YF, 1996, CAN J MICROBIOL, V42, P548, DOI 10.1139/m96-074
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   Dufrene YF, 1996, BIOFOULING, V9, P307, DOI 10.1080/08927019609378312
   Dunn AW, 1996, J VAC SCI TECHNOL B, V14, P1596, DOI 10.1116/1.589197
   DUNN GA, 1986, J CELL SCI, V83, P313
   Dupraz AMP, 1996, J BIOMED MATER RES, V30, P231, DOI 10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P
   DURINCK G, 1991, SOLID STATE COMMUN, V80, P579, DOI 10.1016/0038-1098(91)90155-O
   Eck W, 2000, ADV MATER, V12, P805, DOI 10.1002/(SICI)1521-4095(200006)12:11<805::AID-ADMA805>3.3.CO;2-S
   EDGAR WM, 1990, SALIVA ORAL HLTH
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   Egdell RG, 1998, J MATER CHEM, V8, P469, DOI 10.1039/a706191i
   Eick J D, 1993, Quintessence Int, V24, P632
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   Eick JD, 1996, J DENT RES, V75, P1027, DOI 10.1177/00220345960750040501
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   EIKENBERRY EF, 1980, J MOL BIOL, V144, P397, DOI 10.1016/0022-2836(80)90098-4
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P132
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   EJOV AA, 1994, J VAC SCI TECHNOL B, V12, P1547, DOI 10.1116/1.587283
   Ektessabi AM, 1996, NUCL INSTRUM METH B, V109, P278, DOI 10.1016/0168-583X(95)00922-1
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.0.CO;2-L
   ELDER B, 1993, CARIOLOGY 90S
   Eley BM, 1997, BRIT DENT J, V183, P11, DOI 10.1038/sj.bdj.4809419
   Elftonson JE, 1996, J ADHES SCI TECHNOL, V10, P761, DOI 10.1163/156856196X00643
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Eliades T, 1997, INT J ORAL MAX IMPL, V12, P621
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Elliott JC, 1997, CIBA F SYMP, V205, P54
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   EMSLEY J, 1976, CHEM PHOSPHOROUS ENV
   ERIKSEN S, 1987, SPECTROCHIM ACTA A, V43, P1535, DOI 10.1016/S0584-8539(87)80043-0
   Es-Souni M, 1999, COLLOID POLYM SCI, V277, P382, DOI 10.1007/s003960050396
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   Evans GT, 1998, J CHEM PHYS, V109, P2519, DOI 10.1063/1.476824
   Evans S, 1997, SURF INTERFACE ANAL, V25, P924, DOI 10.1002/(SICI)1096-9918(199711)25:12<924::AID-SIA317>3.0.CO;2-2
   FAHMI A, 1994, SURF SCI, V304, P343, DOI 10.1016/0039-6028(94)91345-5
   Farina M, 1999, J STRUCT BIOL, V125, P39, DOI 10.1006/jsbi.1998.4069
   FEJERSKOV O, 1996, FLUORIDE DENTISTRY
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Feng QL, 1999, J CRYST GROWTH, V200, P550, DOI 10.1016/S0022-0248(98)01402-X
   Fenter P, 2000, J COLLOID INTERF SCI, V225, P154, DOI 10.1006/jcis.2000.6756
   Fernandes MH, 1999, J BIOMATER APPL, V14, P113, DOI 10.1177/088532829901400202
   FERRER S, 1980, SURF SCI, V94, P41, DOI 10.1016/0039-6028(80)90155-7
   Ferris KF, 1998, J VAC SCI TECHNOL A, V16, P956, DOI 10.1116/1.581219
   Feugeas F, 1997, J PHYS III, V7, P631, DOI 10.1051/jp3:1997147
   FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011
   Fincham AG, 1997, CIBA F SYMP, V205, P118
   Fischer D, 1997, J VAC SCI TECHNOL A, V15, P2173, DOI 10.1116/1.580529
   FISCHER S, 1995, SURF SCI, V337, P17, DOI 10.1016/0039-6028(95)00572-2
   FISHER SJ, 1987, ARCH ORAL BIOL, V32, P509, DOI 10.1016/S0003-9969(87)80013-4
   FITZPATRICK H, 1992, J COLLOID INTERF SCI, V149, P1, DOI 10.1016/0021-9797(92)90384-X
   FLAVELL WR, 1997, SURFACE ANAL PRINCIP, P376
   FLEISCH H, 1981, J CRYST GROWTH, V53, P120, DOI 10.1016/0022-0248(81)90059-2
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FLOWER HM, 1974, ACTA METALL MATER, V22, P1339, DOI 10.1016/0001-6160(74)90034-0
   FOX SC, 1990, J PERIODONTOL, V61, P485, DOI 10.1902/jop.1990.61.8.485
   FRANCIS MD, 1971, CALC TISS RES, V6, P335
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FRISBIE CD, 1995, LANGMUIR, V11, P2563, DOI 10.1021/la00007a040
   FRITSCH HW, 1993, INT J MASS SPECTROM, V126, P191, DOI 10.1016/0168-1176(93)80084-R
   Fukui K, 1997, PHYS REV LETT, V79, P4202, DOI 10.1103/PhysRevLett.79.4202
   GABRIEL BL, 1994, BIOMATERIALS, V15, P628, DOI 10.1016/0142-9612(94)90214-3
   GANGLER P, 1993, SCAND J DENT RES, V101, P345
   GARRETT SJ, 1990, J ELECTRON SPECTROSC, V54, P1065, DOI 10.1016/0368-2048(90)80296-M
   GEIGER SB, 1993, DENT MATER, V9, P33, DOI 10.1016/0109-5641(93)90102-V
   Gellings PJ, 2000, CATAL TODAY, V58, P1, DOI 10.1016/S0920-5861(00)00240-6
   GILLEN G, 1994, ANAL CHEM, V66, P2170, DOI 10.1021/ac00085a036
   Gimzewski JK, 1997, SURF SCI, V386, P101, DOI 10.1016/S0039-6028(97)00301-4
   GLIMCHER MJ, TREATISE COLLAGEN B, V2
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOLDSTEIN JI, 1994, SCANNING ELECT MICRO
   Goniakowski J, 1996, SURF SCI, V350, P145, DOI 10.1016/0039-6028(95)01252-4
   GONIAKOWSKI J, 1995, SURF SCI, V330, P337, DOI 10.1016/0039-6028(95)00348-7
   GONIAKOWSKI J, 1993, SURF SCI, V284, P315, DOI 10.1016/0039-6028(93)90502-B
   GOODMAN DW, 1994, SURF SCI, V299, P837, DOI 10.1016/0039-6028(94)90701-3
   Gotfredsen K, 1992, Clin Oral Implants Res, V3, P77, DOI 10.1034/j.1600-0501.1992.030205.x
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Greenspan DC, 1999, CURR OPIN SOLID ST M, V4, P389, DOI 10.1016/S1359-0286(99)00021-2
   GRIESSER HJ, 2000, BIOM SURF AN NEW MIL
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Gun'ko VM, 1999, LANGMUIR, V15, P6405, DOI 10.1021/la9809372
   Guo Q, 1996, PHYS REV LETT, V77, P3851, DOI 10.1103/PhysRevLett.77.3851
   GUY SC, 1993, J PERIODONTOL, V64, P542, DOI 10.1902/jop.1993.64.6.542
   GUYOTSIONNEST P, 1987, PHYS REV LETT, V59, P1597, DOI 10.1103/PhysRevLett.59.1597
   Gwinnett A J, 1994, Am J Dent, V7, P144
   Haber J, 1996, ACS SYM SER, V638, P20
   HADJIIVANOV KI, 1996, CHEM SOC REV, V25, P66
   HAHNER G, 1992, J VAC SCI TECHNOL A, V10, P2758
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1989, J JPN SOC DENT MATER, V8, P832
   HANSON DM, 1981, PHYS REV B, V24, P5513, DOI 10.1103/PhysRevB.24.5513
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Hartman L C, 1989, Int J Oral Maxillofac Implants, V4, P11
   Hasselstrom J, 1998, SURF SCI, V407, P221, DOI 10.1016/S0039-6028(98)00190-3
   Hautaniemi JA, 1996, SURF INTERFACE ANAL, V24, P763, DOI 10.1002/(SICI)1096-9918(199610)24:11<763::AID-SIA178>3.0.CO;2-E
   HAUTANIEMI JA, 1995, SURF INTERFACE ANAL, V23, P833, DOI 10.1002/sia.740231206
   HAY DI, 1967, ARCH ORAL BIOL, V12, P937, DOI 10.1016/0003-9969(67)90088-X
   HAY DI, 1979, J DENT RES, V58, P930, DOI 10.1177/00220345790580024701
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Heiz U, 2000, J PHYS D APPL PHYS, V33, pR85, DOI 10.1088/0022-3727/33/11/201
   HENCH LJ, 1991, BIOCERAMICS MRS B, V9, P62
   Hench LL, 1999, MRS BULL, V24, P13
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1996, BIOMATERIALS SCI INT, P75
   Henderson B, 1999, CELLULAR MICROBIOLOG
   Henderson MA, 1996, SURF SCI, V355, P151, DOI 10.1016/0039-6028(95)01357-1
   Henderson MA, 1996, LANGMUIR, V12, P5093, DOI 10.1021/la960360t
   HENDERSON MA, 1995, SURF SCI, V343, pL1156, DOI 10.1016/0039-6028(95)00849-7
   Henderson MA, 1999, FARADAY DISCUSS, V114, P313, DOI 10.1039/a902070e
   HENGLEIN A, 1987, ULTRASONICS, V25, P6, DOI 10.1016/0041-624X(87)90003-5
   HENRICH VE, 1977, SOLID STATE COMMUN, V24, P623, DOI 10.1016/0038-1098(77)90376-3
   HERCULES DM, 1976, J DENT RES, V55, P829, DOI 10.1177/00220345760550051901
   Herman GS, 2000, SURF SCI, V447, P201, DOI 10.1016/S0039-6028(99)01186-3
   Herman GS, 2000, PHYS REV LETT, V84, P3354, DOI 10.1103/PhysRevLett.84.3354
   Hiemenz P. C., 1977, PRINCIPLES COLLOID S
   Himmelhaus M, 2000, J PHYS CHEM B, V104, P576, DOI 10.1021/jp992073e
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Holgers KM, 1994, INT J ORAL MAXILLOF, V9, P689
   Holmberg K, 1997, COLLOID SURFACE A, V123, P297, DOI 10.1016/S0927-7757(96)03810-1
   Horbett TA, 1995, ACS SYM SER, V602, P1
   HORBETT TA, 1982, ADV CHEM SER, P233
   Horbett Thomas A., 1996, P133
   Howard A, 2000, SURF SCI, V448, P131, DOI 10.1016/S0039-6028(99)01229-7
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   Howlett CR, 1999, J BIOMED MATER RES, V44, P352, DOI 10.1002/(SICI)1097-4636(19990305)44:3<352::AID-JBM14>3.0.CO;2-A
   Hristova E, 1997, J ELECTROCHEM SOC, V144, P2318, DOI 10.1149/1.1837811
   Hu K, 1997, J PHYS CHEM B, V101, P8298, DOI 10.1021/jp971887x
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   HUETZ P, 1995, LANGMUIR, V11, P3145, DOI 10.1021/la00008a046
   HUGENSCHMIDT MB, 1994, SURF SCI, V302, P329, DOI 10.1016/0039-6028(94)90837-0
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   IHS A, 1990, J COLLOID INTERF SCI, V140, P192, DOI 10.1016/0021-9797(90)90335-L
   IHS A, 1991, J COLLOID INTERF SCI, V144, P282, DOI 10.1016/0021-9797(91)90259-B
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Ishikawa K, 1997, J BIOMED MATER RES, V38, P129, DOI 10.1002/(SICI)1097-4636(199722)38:2<129::AID-JBM7>3.0.CO;2-S
   ISHIKAWA T, 1991, LANGMUIR, V7, P596, DOI 10.1021/la00051a031
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JANSEN JA, 1990, J MATER SCI-MATER M, V1, P192, DOI 10.1007/BF00701076
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JEON NL, 1995, LANGMUIR, V11, P3024, DOI 10.1021/la00008a029
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   JOBIN M, 1995, J APPL PHYS, V77, P5149, DOI 10.1063/1.359259
   JOHANSEN E, 1964, J DENT RES, V43, P1007, DOI 10.1177/00220345640430060201
   JOHANSSON CB, 1993, J MATER SCI-MATER M, V4, P132, DOI 10.1007/BF00120382
   Johnson MA, 1998, J PHYS CHEM B, V102, P6391, DOI 10.1021/jp9813995
   Jones DW, 1996, KEY ENG MATER, V122-1, P345, DOI 10.4028/www.scientific.net/KEM.122-124.345
   JONES FH, UNPUB
   JONKER BT, 1981, PHYS REV B, V24, P2951, DOI 10.1103/PhysRevB.24.2951
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   KANDORI K, 1995, J COLLOID INTERF SCI, V174, P124, DOI 10.1006/jcis.1995.1373
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   Kanzaki N, 1998, J PHYS CHEM B, V102, P6471, DOI 10.1021/jp981512r
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KASAS S, 1993, P SOC PHOTO-OPT INS, V1855, P17, DOI 10.1117/12.146381
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KASEMO B, 1999, ADV DENT RES, V13
   KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010
   Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l
   Kawahara D, 1996, Int J Oral Maxillofac Implants, V11, P435
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   KELLER JC, 1989, J ADHESION, V28, P115, DOI 10.1080/00218468908030878
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Kerber SJ, 1998, J MATER ENG PERFORM, V7, P334, DOI 10.1361/105994998770347774
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KIESWETTER K, 1994, BIOMATERIALS, V15, P183, DOI 10.1016/0142-9612(94)90065-5
   KILNER AMC, 1991, SURF INTERFACE ANAL, V17, P158, DOI 10.1002/sia.740170307
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Kim DG, 1999, BIO-MED MATER ENG, V9, P89
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 1997, J BIOMED MATER RES, V38, P121
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939
   Kirkham J, 1998, CONNECT TISSUE RES, V38, P91, DOI 10.3109/03008209809017025
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   Klee D, 1999, ADV POLYM SCI, V149, P1
   KNOBLER CM, 1991, CURR OPIN COLLOID IN, V4, P46
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Konishi K, 1987, J Osaka Dent Univ, V21, P1
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Korn D, 1997, J MATER SCI-MATER M, V8, P613, DOI 10.1023/A:1018567302700
   Kratz F, 1999, CRIT REV THER DRUG, V16, P245, DOI 10.1615/CritRevTherDrugCarrierSyst.v16.i3.10
   KREIS T, 1993, GUIDEBOOK EXTRACELLU
   KUBOKI Y, 1987, J DENT RES, V66, P1016, DOI 10.1177/00220345870660050401
   KUEMPEL DR, 1995, J PERIODONTOL, V66, P228, DOI 10.1902/jop.1995.66.3.228
   Kuliralo M, 1991, J Biol Buccale, V19, P247
   KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003
   KUMAR A, 1992, J AM CHEM SOC, V114, P9188, DOI 10.1021/ja00049a061
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Kurahashi M, 1999, J VAC SCI TECHNOL A, V17, P1047, DOI 10.1116/1.581681
   KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2
   Kusu F, 1998, ELECTROCHIM ACTA, V43, P1873, DOI 10.1016/S0013-4686(97)00308-3
   LakatosVarsanyi M, 1997, INT J ORAL MAX IMPL, V12, P387
   LANDIS WJ, 1984, J VAC SCI TECHNOL A, V2, P1108, DOI 10.1116/1.572680
   LANGE W, 1984, SURF SCI, V136, P419, DOI 10.1016/0039-6028(84)90621-6
   Larsen NB, 1997, J AM CHEM SOC, V119, P3017, DOI 10.1021/ja964090c
   LARSON I, 1993, J AM CHEM SOC, V115, P11885, DOI 10.1021/ja00078a029
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LARSSON SJ, 1977, CALC TISS RES, V24, P179, DOI 10.1007/BF02223313
   Lasserre A, 1998, CRIT REV THER DRUG, V15, P1
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lausmaa J, 1999, J BIOMED MATER RES, V44, P227, DOI 10.1002/(SICI)1097-4636(19990305)44:3<227::AID-JBM1>3.0.CO;2-H
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lavelle C L, 1981, J Oral Implantol, V9, P357
   Lawrence JR, 1999, METHOD ENZYMOL, V310, P131
   Leadley SR, 1997, BIOMATERIALS, V18, P311, DOI 10.1016/S0142-9612(96)00134-2
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   LEFEVRE R, 1976, CALC TISS RES, V19, P251
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   Leggett GJ, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P393
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonhard A, 1995, MICROB ECOL HEALTH D, V8, P293, DOI 10.3109/08910609509140108
   LEONHARDT A, 1995, J DENT RES, V74, P1607, DOI 10.1177/00220345950740091701
   LERCEL MJ, 1994, APPL PHYS LETT, V65, P974, DOI 10.1063/1.113012
   LERCEL MJ, 1994, J VAC SCI TECHNOL B, V12, P3663, DOI 10.1116/1.587635
   LERCEL MJ, 1995, MICROELECTRON ENG, V27, P43, DOI 10.1016/0167-9317(94)00052-V
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Li M, 1999, SURF SCI, V437, P173, DOI 10.1016/S0039-6028(99)00720-7
   Li M, 1998, SURF SCI, V414, pL951, DOI 10.1016/S0039-6028(98)00549-4
   Li M, 1999, FARADAY DISCUSS, V114, P245, DOI 10.1039/a903598b
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Li XD, 1997, BIOMATERIALS, V18, P1487, DOI 10.1016/S0142-9612(97)00085-9
   Li XL, 1999, CHINESE J ANAL CHEM, V27, P47
   Li YM, 1998, J AM DENT ASSOC, V129, P494
   LIEDBERG B, 1984, J BIOCHEM BIOPH METH, V9, P233, DOI 10.1016/0165-022X(84)90028-9
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   Lindan PJD, 1996, CHEM PHYS LETT, V261, P246, DOI 10.1016/0009-2614(96)00934-7
   Lindan PJD, 1998, PHYS REV LETT, V80, P762, DOI 10.1103/PhysRevLett.80.762
   Lisle JT, 1999, METHOD ENZYMOL, V310, P166
   Liu FY, 1998, APPL RADIAT ISOTOPES, V49, P67
   LO WJ, 1978, SURF SCI, V71, P199
   LODDING A, 1985, SCAND J DENT RES, V93, P315
   LODDING A, 1983, SCAN ELECTRON MICROS, P1229
   LODDING AR, 1990, ANAL CHIM ACTA, V241, P299, DOI 10.1016/S0003-2670(00)83660-0
   Lofgren P, 1997, SURF SCI, V370, P277, DOI 10.1016/S0039-6028(96)00961-2
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   LOWENBERG B, 1991, CELL MATER, V1, P177
   Lu HBB, 1999, ABSTR PAP AM CHEM S, V217, pU670
   Lundgren T, 1998, HISTOCHEM J, V30, P351, DOI 10.1023/A:1003284511863
   Lundgren T, 1998, ARCH ORAL BIOL, V43, P841, DOI 10.1016/S0003-9969(98)00074-0
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Mader C, 2000, BBA-BIOMEMBRANES, V1463, P142, DOI 10.1016/S0005-2736(99)00190-X
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   1998, MRS B, V23, P11
   1993, J APPL BACTERIOL S S, V74, pS87
   1973, J CLIN INVEST, V51, P741
   1996, J ELECT SPECTROSC RE, V81
   1975, J LAB CLIN MED, V85, P235
   1998, MRS B, V23, P14
   1998, BIOMATERIALS, V19
   AR Ten Cate, 1994, ORAL HISTOLOGY DEV S
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   Marshall GW, 1997, DENT MATER, V13, P338, DOI 10.1016/S0109-5641(97)80104-2
   MARSHALL GW, 1995, J BIOMED MATER RES, V29, P1381, DOI 10.1002/jbm.820291109
   MARSHALL KC, 1994, COLLOID SURFACE B, V2, P371, DOI 10.1016/0927-7765(94)80050-2
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mathieu HJ, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P99
   Matkovic P, 1998, METALURGIJA, V37, P15
   MATTHEWS RW, 1988, J CATAL, V111, P264, DOI 10.1016/0021-9517(88)90085-1
   MATTHEWS WG, 1993, ARCH ORAL BIOL, V38, P517, DOI 10.1016/0003-9969(93)90188-R
   McCafferty E, 1999, APPL SURF SCI, V143, P92, DOI 10.1016/S0169-4332(98)00927-1
   McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H
   McCafferty E, 1999, J ELECTROCHEM SOC, V146, P2849, DOI 10.1149/1.1392019
   McCANN HAROLD G., 1955, JOUR DENTAL RES, V34, P59, DOI 10.1177/00220345550340011601
   MCDOWELL SG, 1995, LETT APPL MICROBIOL, V21, P1, DOI 10.1111/j.1472-765X.1995.tb00992.x
   McKendry R, 1998, NATURE, V391, P566, DOI 10.1038/35339
   McLean KM, 2000, COLLOID SURFACE B, V17, P23, DOI 10.1016/S0927-7765(99)00055-7
   MEACHIN G, 1973, J BIOMED MATER RES, V7, P572
   MEISENHEIMER RG, 1976, BIOCHEM BIOPH RES CO, V68, P994, DOI 10.1016/0006-291X(76)91244-4
   Meschenmoser A, 1996, J PERIODONTOL, V67, P229, DOI 10.1902/jop.1996.67.3.229
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910
   MICHAELS C M, 1991, Journal of Oral Implantology, V17, P132
   MILLER RG, 1994, J DENT RES, V73, P1457, DOI 10.1177/00220345940730081001
   MILLER RG, 1993, J DENT MAT, V9, P280
   Mitchell RJ, 1996, CRIT REV ORAL BIOL M, V7, P12, DOI 10.1177/10454411960070010101
   Moffitt CE, 1998, BIOMATERIALS, V19, P1319, DOI 10.1016/S0142-9612(97)00169-5
   Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x
   MORENO EC, 1991, CALCIFIED TISSUE INT, V49, P6, DOI 10.1007/BF02555895
   Morita S, 1999, APPL SURF SCI, V140, P406, DOI 10.1016/S0169-4332(98)00563-7
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 1997, SURF INTERFACE ANAL, V25, P983, DOI 10.1002/(SICI)1096-9918(199712)25:13<983::AID-SIA345>3.0.CO;2-X
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   MORRIS VJ, 2000, ATOMIC FORCE MICROSC
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mount GJ, 1999, OPER DENT, V24, P115
   Mount GJ, 1998, PRESERVATION RESTORA
   MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6
   Mozes N., 1991, MICROBIAL CELL SURFA
   Mugele F, 2000, J PHYS CHEM B, V104, P3140, DOI 10.1021/jp9935236
   Muller HU, 1995, J VAC SCI TECHNOL B, V13, P2846, DOI 10.1116/1.588302
   MURGA R, 1995, BIOTECHNOL BIOENG, V45, P503, DOI 10.1002/bit.260450607
   MURRAY PW, 1992, PHYS REV B, V46, P12877, DOI 10.1103/PhysRevB.46.12877
   MURRAY PW, 1995, PHYS REV B, V51, P10989, DOI 10.1103/PhysRevB.51.10989
   MURRAY PW, 1994, SURF SCI, V321, P217, DOI 10.1016/0039-6028(94)90187-2
   MURRAY PW, 1994, PHYS REV LETT, V72, P689, DOI 10.1103/PhysRevLett.72.689
   NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Naray-Szabo S, 1930, Z KRISTALLOGR, V75, P387
   NAUJOKS R., 1967, CARIES RES, V1, P137
   NAYAK PL, 1999, CHEM PHYS C, V39, P481
   NEWMAN HN, 1999, DENTAL PLAQUE REVISI
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   Nicholson JW, 2000, INT J ADHES ADHES, V20, P11, DOI 10.1016/S0143-7496(99)00009-3
   Nilsson T, 1996, ARTIF INTELL MED, V8, P515, DOI 10.1016/S0933-3657(96)00350-8
   Nilsson T, 1998, CONNECT TISSUE RES, V38, P81, DOI 10.3109/03008209809017024
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.3.CO;2-3
   Nishimura N, 1998, J MATER SCI-MATER M, V9, P99, DOI 10.1023/A:1008851115846
   Nooney MG, 1998, LANGMUIR, V14, P2750, DOI 10.1021/la9702695
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   NOREN JG, 1984, CARIES RES, V18, P242, DOI 10.1159/000260772
   NOREN JG, 1983, CARIES RES, V17, P496, DOI 10.1159/000260709
   Norenberg H, 1999, PHYS REV B, V59, P9842, DOI 10.1103/PhysRevB.59.9842
   Norenberg H, 1998, SURF SCI, V396, P52, DOI 10.1016/S0039-6028(97)00658-4
   Norenberg H, 1998, SURF SCI, V402, P738, DOI 10.1016/S0039-6028(97)01000-5
   Noth U, 1999, BIOMED TECH, V44, P6, DOI 10.1515/bmte.1999.44.1-2.6
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   Nugues S, 1996, J ELECTROANAL CHEM, V408, P125, DOI 10.1016/0022-0728(96)04523-8
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   OKAMOTO Y, 1991, J ORAL REHABIL, V18, P507, DOI 10.1111/j.1365-2842.1991.tb00073.x
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   Okazaki M, 1999, BIOMATERIALS, V20, P1073, DOI 10.1016/S0142-9612(98)00244-0
   Okazaki M, 1997, BIOMATERIALS, V18, P795, DOI 10.1016/S0142-9612(97)00009-4
   OLIN H, 1992, ULTRAMICROSCOPY, V42, P567, DOI 10.1016/0304-3991(92)90325-E
   Oliver PM, 1997, J MATER CHEM, V7, P563, DOI 10.1039/a606353e
   OLSSON J, 1991, COLLOID POLYM SCI, V269, P1295, DOI 10.1007/BF00652539
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Ong JL, 1998, BIOMATERIALS, V19, P455, DOI 10.1016/S0142-9612(97)00224-X
   ONISHI H, 1994, CHEM PHYS LETT, V226, P111, DOI 10.1016/0009-2614(94)00712-8
   ONISHI H, 1995, B CHEM SOC JPN, V68, P2447, DOI 10.1246/bcsj.68.2447
   Onishi H, 1996, PHYS REV LETT, V76, P791, DOI 10.1103/PhysRevLett.76.791
   ONISHIM H, 1998, SURF SCI, V313, pL783
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Onuma K, 1996, J CRYST GROWTH, V167, P773, DOI 10.1016/0022-0248(96)00421-6
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   OREILLY BJ, 1991, J LARYNGOL OTOL, V105, P573, DOI 10.1017/S0022215100116640
   Orstavik D, 1973, J Oral Pathol, V2, P68, DOI 10.1111/j.1600-0714.1973.tb01675.x
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Palka V, 1998, J MATER SCI-MATER M, V9, P369, DOI 10.1023/A:1013275311692
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan S, 1998, LANGMUIR, V14, P3545, DOI 10.1021/la971212l
   Pang CL, 2000, PHYS REV B, V62, pR7775, DOI 10.1103/PhysRevB.62.R7775
   Pang CL, 1998, PHYS REV B, V58, P1586, DOI 10.1103/PhysRevB.58.1586
   Pang CL, 2000, APPL SURF SCI, V157, P233, DOI 10.1016/S0169-4332(99)00532-2
   PANTANO CG, 1981, APPL SURF SCI, V7, P115, DOI 10.1016/0378-5963(81)90065-9
   Pashley DH, 1997, J DENT, V25, P355, DOI 10.1016/S0300-5712(96)00057-7
   Patthey L, 1999, J CHEM PHYS, V110, P5913, DOI 10.1063/1.478491
   PATTHEY L, 1995, THESIS U LAUSANNE
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PEARCE EIF, 1988, J DENT RES, V67, P1056, DOI 10.1177/00220345880670070801
   PELBLE ME, 1997, SURFACE ANAL PRINCIP, P307
   Perera IK, 1995, J MASS SPECTROM, pS3
   Pertsin AJ, 1998, J PHYS CHEM B, V102, P4918, DOI 10.1021/jp9806617
   PETERSSON LG, 1995, SWED DENT J, V19, P83
   Peyton BM, 1996, WATER RES, V30, P29, DOI 10.1016/0043-1354(95)00110-7
   PICKART L, 1978, BIOCHIM BIOPHYS ACTA, V544, P138, DOI 10.1016/0304-4165(78)90217-9
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pierres A, 1998, CURR OPIN COLLOID IN, V3, P525, DOI 10.1016/S1359-0294(98)80028-9
   PIESCO NP, 1994, ORAL DEV HISTOLOGY
   Pohle W, 1999, VIB SPECTROSC, V19, P321, DOI 10.1016/S0924-2031(98)00067-8
   POPE NM, 1993, BIOCONJUGATE CHEM, V4, P166, DOI 10.1021/bc00020a009
   POSNER S, 1961, PHOSPHOROUS ITS COMP, V2
   PRAKOBPHOL A, 1993, CARIOLOGY 90S
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   PUM D, 1994, THIN SOLID FILMS, V244, P882, DOI 10.1016/0040-6090(94)90592-4
   Pum D, 1999, TRENDS BIOTECHNOL, V17, P8, DOI 10.1016/S0167-7799(98)01221-9
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   RACHINGER WA, 1982, CALCIFIED TISSUE INT, V34, P209, DOI 10.1007/BF02411235
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   RATEITSCHAK KH, 1989, COLOUR ATLAS DENTAL, V1
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1997, SURFACE ANAL PRINCIP, P44
   RATNER BD, 1988, SURFACE CHARACTERIZA
   Raval R, 1998, NUOVO CIMENTO D, V20, P553, DOI 10.1007/BF03185548
   Raza H, 1999, APPL SURF SCI, V140, P271, DOI 10.1016/S0169-4332(98)00539-X
   Raza H, 1999, PHYS REV LETT, V82, P5265, DOI 10.1103/PhysRevLett.82.5265
   REINTSEMA H, 1986, CARIES RES, V20, P419, DOI 10.1159/000260967
   Reusch B, 1997, FRESEN J ANAL CHEM, V358, P64, DOI 10.1007/s002160050346
   Reusch B, 1998, APPL PHYS A-MATER, V66, pS805, DOI 10.1007/s003390051246
   REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   RIEKE PC, 1994, LANGMUIR, V10, P619, DOI 10.1021/la00015a003
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Roberts MW, 2000, CATAL LETT, V69, P253, DOI 10.1023/A:1019063132413
   Roberts MW, 2000, CATAL LETT, V67, pI
   ROBINSON C, 1992, J DENT RES, V71, P1270, DOI 10.1177/00220345920710060101
   ROBINSON C, 1984, TOOTH ENAMEL, V4, P216
   Rodriguez-Clemente R, 1998, J EUR CERAM SOC, V18, P1351, DOI 10.1016/S0955-2219(98)00064-8
   ROHRER GS, 1990, SCIENCE, V250, P1239, DOI 10.1126/science.250.4985.1239
   ROHRER GS, 1992, SURF SCI, V278, P146, DOI 10.1016/0039-6028(92)90590-3
   ROLLA G, 1983, SCAND J DENT RES, V91, P186
   ROLLA G, 1994, COLLOID SURFACE B, V3, P177
   ROLLASON G, 1993, BIOMATERIALS, V14, P153, DOI 10.1016/0142-9612(93)90230-Y
   ROMAN E, 1990, VACUUM, V41, P40, DOI 10.1016/0042-207X(90)90265-Z
   ROSEN MJ, 1989, SURFACTANTS INTERFAC
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   ROUXHET PG, 1994, COLLOID SURFACE B, V2, P347, DOI 10.1016/0927-7765(94)80049-9
   RUSE ND, 1991, J DENT RES, V70, P1002, DOI 10.1177/00220345910700060101
   Russell BG, 1998, BIOSPECTROSCOPY, V4, P257, DOI 10.1002/(SICI)1520-6343(1998)4:4<257::AID-BSPY4>3.0.CO;2-#
   Rustad JR, 1996, GEOCHIM COSMOCHIM AC, V60, P1553, DOI 10.1016/0016-7037(96)00046-4
   Sakai N, 1998, LANGMUIR, V14, P5918, DOI 10.1021/la980623e
   SANDER M, 1994, SURF SCI, V302, pL263, DOI 10.1016/0039-6028(94)91086-3
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   SARID D, 1991, J VAC SCI TECHNOL B, V9, P431, DOI 10.1116/1.585585
   SARID D, 1994, SCANNING FORCE MICRO
   Sato H, 1999, J BIOMATER APPL, V14, P169, DOI 10.1177/088532829901400203
   Sato K, 2000, J COLLOID INTERF SCI, V224, P23, DOI 10.1006/jcis.1999.6623
   Sauberlich S, 1999, CLIN ORAL IMPLAN RES, V10, P379, DOI 10.1034/j.1600-0501.1999.100505.x
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   SCHAAD P, 1993, SCANNING MICROSCOPY, V7, P1149
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   SchenkMeuser K, 1997, FRESEN J ANAL CHEM, V358, P265, DOI 10.1007/s002160050402
   SCHIERBAUM KD, 1995, SENSOR ACTUAT B-CHEM, V24, P239, DOI 10.1016/0925-4005(95)85051-1
   SCHINDLER PW, 1972, KOLLOID Z Z POLYM, V250, P759, DOI 10.1007/BF01498568
   SCHMIDT CF, 1990, BIOPHYS J, V57, P577, DOI 10.1016/S0006-3495(90)82573-X
   SCHMIDT M, 1991, HELV PHYS ACTA, V64, P900
   Schreckenbach JP, 1999, J MATER SCI-MATER M, V10, P453, DOI 10.1023/A:1008988706980
   SCHULTZ JS, 1982, ADV CHEM SER, P43
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Seah MP, 1999, J ELECTRON SPECTROSC, V100, P55, DOI 10.1016/S0368-2048(99)00040-7
   SEAH MP, 1990, PRACTICAL SURFACE AN, V1
   Sennou HE, 1999, DENT MATER, V15, P229, DOI 10.1016/S0109-5641(99)00036-6
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Serro APV, 1997, COLLOID SURFACE A, V125, P209, DOI 10.1016/S0927-7757(97)00017-4
   Shapovalov V, 2000, CHEM PHYS LETT, V320, P186, DOI 10.1016/S0009-2614(00)00191-3
   SHARKNESS CM, 1993, J LONG-TERM EFF MED, V3, P237
   Shen TC, 1997, PHYS REV LETT, V78, P1271, DOI 10.1103/PhysRevLett.78.1271
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shiku H, 1999, ANAL CHEM, V71, p23A, DOI 10.1021/ac9900984
   SHIRKHANZADEH M, 1992, J MATER SCI-MATER M, V3, P322, DOI 10.1007/BF00705362
   Shirkhanzadeh M, 1997, J MATER SCI-MATER M, V8, P595, DOI 10.1023/A:1018563201792
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P355, DOI 10.1023/A:1008859131585
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Sigee DC, 1998, MIKROCHIM ACTA, P283
   Silikas N, 1999, J DENT, V27, P137, DOI 10.1016/S0300-5712(98)00032-3
   Simkiss K., 1989, BIOMINERALIZATION CE
   SIMMELINK JW, 1974, ARCH ORAL BIOL, V19, P183, DOI 10.1016/0003-9969(74)90213-1
   SIMMELINK JW, 1994, ORAL DEV HISTOLOGY
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Skjorland KK, 1995, ACTA ODONTOL SCAND, V53, P358, DOI 10.3109/00016359509006001
   Slack SM, 1995, ACS SYM SER, V602, P112
   SLACK SM, 1996, BIOMATERIALS SCI INT, P470
   Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#
   Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9
   Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9
   SMITH PB, 1987, SURF SCI, V188, P241, DOI 10.1016/S0039-6028(87)80155-3
   SODERHOLM KJM, 1909, DENT MATER, V7, P74
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   SOLLBOHMER O, 1995, THIN SOLID FILMS, V264, P176, DOI 10.1016/0040-6090(95)05847-8
   SOLOKOV IY, 1999, J APPL PHYS, V86, P5537
   SOMORJAI GA, 1981, PREFACE CHEM 2 DIMEN
   SOMORJAI GA, 2000, BIOM SURF AN NEW MIL
   SONG S, 1993, J PHYS CHEM-US, V97, P6564, DOI 10.1021/j100126a037
   SOSULNIKOV MI, 1992, RELAT PHENOM, V59, P101
   SPECTOR M, 1994, P 20 ANN M SOC BIOM, P330
   SPENCER P, 1992, DENT MATER, V8, P10, DOI 10.1016/0109-5641(92)90046-F
   SPIEKERMANN H, 1995, IMPLANTOLOGY COLOR A
   SRINIVASAN R, 1995, BIOTECHNOL BIOENG, V46, P553, DOI 10.1002/bit.260460608
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Stangel I, 1996, J BIOMED MATER RES, V31, P287, DOI 10.1002/(SICI)1097-4636(199606)31:2<287::AID-JBM17>3.0.CO;2-I
   STANGEL I, 1994, J ADHESION, V47, P133, DOI 10.1080/00218469408027095
   STARKEBAUM W, 1979, J BIOMED MATER RES, V13, P729, DOI 10.1002/jbm.820130506
   Stefanovich EV, 1997, J CHEM PHYS, V106, P7700, DOI 10.1063/1.473748
   STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9
   Stermer EM, 1996, EUR J ORAL SCI, V104, P253, DOI 10.1111/j.1600-0722.1996.tb00075.x
   Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9
   STOCKBAUER R, 1982, PHYS REV B, V26, P1885, DOI 10.1103/PhysRevB.26.1885
   STOCKBAUER RL, 1982, J VAC SCI TECHNOL, V20, P562, DOI 10.1116/1.571433
   Stone P, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/008
   STRANICK MA, 1991, COLLOID SURFACE, V55, P137, DOI 10.1016/0166-6622(91)80088-6
   STRONG RL, 1985, J VAC SCI TECHNOL A, V3, P1428, DOI 10.1116/1.572795
   STULTS JT, 1995, CURR OPIN STRUC BIOL, V5, P691, DOI 10.1016/0959-440X(95)80063-8
   Stumm W., 1992, CHEM SOLID WATER INT
   SUBIRADE M, 1994, THIN SOLID FILMS, V243, P442, DOI 10.1016/0040-6090(93)04014-J
   Suetsugu Y, 1996, J MATER SCI, V31, P4541, DOI 10.1007/BF00366349
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SUGIMURA H, 1993, APPL PHYS LETT, V63, P1288, DOI 10.1063/1.110771
   SUGIMURA H, 1994, J VAC SCI TECHNOL B, V12, P2884, DOI 10.1116/1.587208
   Sugimura W, 1997, JPN J APPL PHYS 1, V36, P7358, DOI 10.1143/JJAP.36.7358
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   SULJAK JP, 1995, J DENT, V23, P171, DOI 10.1016/0300-5712(95)93575-M
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   SWANCAR JR, 1971, TOOTH ENAMEL, V2
   Swart K M, 1992, J Oral Implantol, V18, P130
   Swift P, 1967, Br Dent J, V123, P326
   SZABO A, 1995, SURF SCI, V329, P241, DOI 10.1016/0039-6028(95)00050-X
   SZE SM, 1981, PHYSICS SEMICONDUCTO
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takamura R, 1997, J DENT RES, V76, P1177
   Talley CE, 1996, APPL PHYS LETT, V69, P3809, DOI 10.1063/1.117112
   TAM LE, 1994, J DENT RES, V73, P607, DOI 10.1177/00220345940730030601
   TANAKA K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/rcm.1290020802, DOI 10.1002/RCM.1290020802]
   TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P4025, DOI 10.1039/ft9908604025
   TANIZAWA Y, 1991, J CHEM SOC FARADAY T, V87, P2235, DOI 10.1039/ft9918702235
   TANIZAWA Y, 1993, J CHEM SOC FARADAY T, V89, P2901, DOI 10.1039/ft9938902901
   TANIZAWA Y, 1995, J CHEM SOC FARADAY T, V91, P3499, DOI 10.1039/ft9959103499
   TANIZAWA Y, 1998, J CHEM SOC FARADAY T, V86, P1071
   Tanner RE, 1998, SURF SCI, V412-13, P672, DOI 10.1016/S0039-6028(98)00464-6
   TANZER JM, 1995, J DENT RES, V74, P1536, DOI 10.1177/00220345950740090601
   TAO L, 1988, DENT MATER, V4, P208, DOI 10.1016/S0109-5641(88)80066-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   THOMPSON VP, 1992, J ADHESION, V39, P157, DOI 10.1080/00218469208026547
   THOMSEN P, 1989, J MATER SCI-MATER M, V8, P653
   Todd PJ, 1997, ANAL CHEM, V69, pA529, DOI 10.1021/ac971763g
   TORIYAMA M, 1995, NIPPON SERAM KYO GAK, V103, P46
   TORNKVIST C, 1991, LANGMUIR, V7, P479
   TORRISI L, 1992, NUCL INSTRUM METH B, V65, P139, DOI 10.1016/0168-583X(92)95026-N
   Tougaard S, 1997, SURF INTERFACE ANAL, V25, P404, DOI 10.1002/(SICI)1096-9918(199706)25:6<404::AID-SIA250>3.0.CO;2-A
   UDVAL K, 1992, J COLLOID INTERF SCI, V149, P162
   UDVAL K, 1990, J COLLOID INTERF SCI, V140, P207
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Valsami-Jones E, 1998, CHEM GEOL, V151, P215, DOI 10.1016/S0009-2541(98)00081-3
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404
   VANDERMEI HC, 1989, J DENT RES, V68, P620
   VANDERVEGT W, 1993, J COLLOID INTERF SCI, V156, P129, DOI 10.1006/jcis.1993.1091
   VANDERVEGT W, 1994, LANGMUIR, V10, P1314, DOI 10.1021/la00016a055
   VANMEERBEEK B, 1993, J DENT RES, V72, P1423, DOI 10.1177/00220345930720101201
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VANRAEMDONCK W, 1984, J AM CERAM SOC, V67, P381
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   VASQUEZ RP, 1990, THIN SOLID FILMS, V192, P173, DOI 10.1016/0040-6090(90)90489-Z
   VASUDEVAN TV, 1994, LANGMUIR, V10, P320, DOI 10.1021/la00013a047
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   Vereecke G, 1999, SURF INTERFACE ANAL, V27, P761, DOI 10.1002/(SICI)1096-9918(199908)27:8<761::AID-SIA570>3.3.CO;2-5
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   VICKERMAN JC, 1997, SURFACES ANAL PRINCI, P134
   Vittadini A, 1998, PHYS REV LETT, V81, P2954, DOI 10.1103/PhysRevLett.81.2954
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogtenhuber D, 1998, SURF SCI, V402, P798, DOI 10.1016/S0039-6028(97)01083-2
   Volkel B, 1997, J VAC SCI TECHNOL B, V15, P2877, DOI 10.1116/1.589748
   VONRECUM AF, 1990, CLIN IMPLANT MAT
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n
   Wakamura M, 1998, COLLOID SURFACE A, V142, P107, DOI 10.1016/S0927-7757(98)00486-5
   Wakamura M, 1997, POLYHEDRON, V16, P2047, DOI 10.1016/S0277-5387(96)00513-X
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang LQ, 1999, SURF SCI, V440, P60, DOI 10.1016/S0039-6028(99)00677-9
   Wang LQ, 1995, SURF SCI, V344, P237, DOI 10.1016/0039-6028(95)00859-4
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wang R, 1999, J PHYS CHEM B, V103, P2188, DOI 10.1021/jp983386x
   Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   WASSERMAN SR, 1989, J AM CHEM SOC, V111, P5852, DOI 10.1021/ja00197a054
   WATAHA JC, 1992, J DENT RES, V71, P1417, DOI 10.1177/00220345920710071101
   Wataha JC, 1996, J ORAL REHABIL, V23, P583, DOI 10.1046/j.1365-2842.1996.d01-204.x
   WATKINS RW, 1977, J BIOMED MATER RES, V11, P915, DOI 10.1002/jbm.820110611
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Weiner R, 1999, METHOD ENZYMOL, V310, P403
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   WEN HB, 1995, CARIES RES, V29, P122, DOI 10.1159/000262053
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   WENNERBERG A, 1995, J MATER SCI-MATER M, V6, P302, DOI 10.1007/BF00120275
   Wennerberg A, 1997, J MATER SCI-MATER M, V8, P757, DOI 10.1023/A:1018560528625
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Weygand M, 2000, J MATER CHEM, V10, P141, DOI 10.1039/a905196a
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   Whitford GM, 1997, CIBA F SYMP, V205, P226
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Wieliczka DM, 1996, J DENT RES, V75, P1865, DOI 10.1177/00220345960750110801
   Wiesendanger R., 1994, SCANNING PROBE MICRO
   Wieser E, 1999, SURF COAT TECH, V111, P103, DOI 10.1016/S0257-8972(98)00717-8
   Wiesmann HP, 1998, CELL TISSUE RES, V294, P93, DOI 10.1007/s004410051159
   WILBUR JL, 1995, LANGMUIR, V11, P825, DOI 10.1021/la00003a025
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLIAMS DF, 1981, BIOCOMPATIBILITY IMP
   Williams DF., 1986, MAT SCI IMPLANT ORTH, P107
   Williams J, 1996, SURF SCI, V368, P303, DOI 10.1016/S0039-6028(96)01067-9
   WILLIAMS JA, 1996, T 5 WORLD BIOM C TOR, V2, P762
   WILLIAMS RL, 1991, SURF INTERFACE ANAL, V17, P496, DOI 10.1002/sia.740170714
   WILSON R, 1997, SURFACES ANAL PRINCI, P10
   WILSON RG, 1989, SCONDARY ION MASS SP
   Wilson WD, 1997, J COLLOID INTERF SCI, V187, P201, DOI 10.1006/jcis.1996.4693
   WINTER GD, 1980, ADV BIOMATERIALS, V1
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   Wu W, 1997, LANGMUIR, V13, P861, DOI 10.1021/la960689e
   Wu WJ, 1997, J BIOMED MATER RES, V35, P93, DOI 10.1002/(SICI)1097-4636(199704)35:1<93::AID-JBM9>3.0.CO;2-H
   Wu WJ, 1997, COLLOID SURFACE B, V10, P87, DOI 10.1016/S0927-7765(97)00054-4
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xia YN, 1997, LANGMUIR, V13, P2059, DOI 10.1021/la960936e
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Yoshino N, 1997, J BIOMAT SCI-POLYM E, V8, P623, DOI 10.1163/156856297X00218
   Yoshino N, 1998, REACT FUNCT POLYM, V37, P271, DOI 10.1016/S1381-5148(97)00114-4
   Zablotsky M H, 1992, Implant Dent, V1, P253, DOI 10.1097/00008505-199200140-00004
   ZEGENHAGEN J, 1993, SURF SCI REP, V18, P199
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zenobi R, 1998, MASS SPECTROM REV, V17, P337, DOI 10.1002/(SICI)1098-2787(1998)17:5<337::AID-MAS2>3.0.CO;2-S
   Zhang LP, 1998, SURF SCI, V412-13, P242, DOI 10.1016/S0039-6028(98)00432-4
   Zhao XY, 1999, SURF SCI, V442, pL995, DOI 10.1016/S0039-6028(99)00970-X
   Zhao XY, 1999, SURF SCI, V424, pL347, DOI 10.1016/S0039-6028(99)00211-3
   Ziegler C, 1998, FRESEN J ANAL CHEM, V361, P547, DOI 10.1007/s002160050944
   Zolk M, 2000, LANGMUIR, V16, P5849, DOI 10.1021/la0003239
NR 890
TC 104
Z9 105
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
EI 1879-274X
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 2001
VL 42
IS 3-5
BP 79
EP 205
PG 127
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 431LK
UT WOS:000168632500001
DA 2018-10-19
ER

PT S
AU Murphy, ME
   Laugier, MT
   Beake, BD
   Newcomb, SB
AF Murphy, ME
   Laugier, MT
   Beake, BD
   Newcomb, SB
BE Brebbia, CA
TI Surface microstructural modification of biomedical grade alpha-alumina
   by ion implantation
SO SURFACE TREATMENT V: COMPUTER METHODS AND EXPERIMENTAL MEASUREMENTS
SE COMPUTATIONAL AND EXPERIMENTAL METHODS
LA English
DT Proceedings Paper
CT 5th International Conference on Computer Methods and Experimental
   Measurements for Surface Treatment Effects
CY JUN 20-22, 2001
CL SEVILLE, SPAIN
SP Wessex Inst Technol
ID MECHANICAL-PROPERTIES; RESIDUAL-STRESS; POLYCRYSTALLINE ALUMINA;
   CERAMICS; ALPHA-AL2O3; MODULUS
AB Biomedical grade (> 99.5% purity) polycrystalline alpha-alumina has been implanted with C ions (75 keV) at fluences ranging from 5x10(16) to 5x10(17) C ions/cm(2) and Zr ions (100 keV) at fluences ranging from 5x10(15) to 5x10(16) Zr ions/cm(2). The surfaces of the alumina have been examined in cross-section using transmission electron microscopy (TEM) and the data obtained correlated with both nanohardness measurements and computer based simulations (Transport and Range of Ions in Matter, TRIM). The nanohardness of the near-surface alumina was determined as a function of depth and was found to be strongly dependent on the fluence used. The data is discussed in relation to the mechanisms by which the properties of this material are modified by ion implantation.
C1 Univ Limerick, Dept Phys, Limerick, Ireland.
RP Murphy, ME (reprint author), Univ Limerick, Dept Phys, Limerick, Ireland.
CR Boudoukha L, 1997, J MATER SCI, V32, P2911, DOI 10.1023/A:1018632819115
   BURNETT PJ, 1984, J MATER SCI, V19, P3524, DOI 10.1007/BF00552266
   Canut B, 1997, NUCL INSTRUM METH B, V122, P335, DOI 10.1016/S0168-583X(96)00576-9
   Halitim F, 1997, J PHYS D APPL PHYS, V30, P330, DOI 10.1088/0022-3727/30/3/004
   Halitim F, 1997, THIN SOLID FILMS, V300, P197, DOI 10.1016/S0040-6090(96)09492-8
   Halitim F, 1997, CERAM INT, V23, P509, DOI 10.1016/S0272-8842(96)00062-4
   HIOKI T, 1986, J MATER SCI, V21, P1321, DOI 10.1007/BF00553270
   HIOKI T, 1984, J MATER SCI LETT, V3, P1099, DOI 10.1007/BF00719777
   MCHARGUE CJ, 1989, MAT SCI ENG A-STRUCT, V115, P361, DOI 10.1016/0921-5093(89)90704-1
   MCHARGUE CJ, 1984, J AM CERAM SOC, V67, P117, DOI 10.1111/j.1151-2916.1984.tb09627.x
   McHargue CJ, 1998, MAT SCI ENG A-STRUCT, V253, P94, DOI 10.1016/S0921-5093(98)00714-X
   Misra A, 1999, NUCL INSTRUM METH B, V148, P211, DOI 10.1016/S0168-583X(98)00780-0
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PALETTO S, 1996, NUCL INSTRUMENTS MET, V108, P87
   SMETHURST E, 1977, J MATER SCI, V12, P1781, DOI 10.1007/BF00566238
   Strobel M, 1998, COMP MATER SCI, V10, P457, DOI 10.1016/S0927-0256(97)00114-6
   Tian J, 1998, NUCL INSTRUM METH B, V143, P488
   Ziegler J. F., 1985, STOPPING RANGE IONS
   ZUMDAHL SS, 1993, CHEMISTRY
NR 19
TC 2
Z9 2
U1 0
U2 3
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1466-7266
BN 1-85312-873-2
J9 COMP EXPTL METHODS
PY 2001
VL 6
BP 13
EP 22
PG 10
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BT16C
UT WOS:000172146300002
DA 2018-10-19
ER

PT B
AU Kancharla, VV
   Chen, SC
   Zamzow, DS
   Baldwin, DP
AF Kancharla, VV
   Chen, SC
   Zamzow, DS
   Baldwin, DP
GP NAMRI/SME
   NAMRI/SME
TI Laser micromachining of a biodegradable polymer
SO TRANSACTIONS OF THE NORTH AMERICAN MANUFACTURING RESEARCH INSTITUTION OF
   SME, VOL XXIX, 2001
LA English
DT Proceedings Paper
CT 29th North American Manufacturing Research Conference (NAMRC XXIX)
CY MAY 22-25, 2001
CL GAINESVILLE, FL
SP Soc Mfg Engineers, N Amer Mfg Res Inst
AB This paper reports on UV laser micromachining of a biodegradable polymer for applications in biomedical engineering. Parametric studies have been conducted on Poly-vinyl Alcohol (PVA), a biodegradable polymer, to produce micro channels and micro holes. Laser micromachining of micro channels is studied using a XeCl excimer laser at 308 nm wavelength and laser micro drilling is studied using a Q-switched Nd:YAG laser at 266 nm wavelength. Feature sizes ranging from 4 to 10 mum were obtained for the micro holes and the features of micro channels ranged from 33 to 65 mum wide and 22 to 123 mum deep. This work demonstrated that UV laser micromachining is a well-suited technique for biodegradable polymers with minimum thermal damage to the surrounding material.
C1 Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
RP Kancharla, VV (reprint author), Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
CR Chen SC, 2000, J HEAT TRANS-T ASME, V122, P107, DOI 10.1115/1.521441
   CHEN YH, 1995, P SOC PHOTO-OPT INS, V3184, P202
   GANNEPALLI A, 1998, POLYM MAT SCI ENG P, V78, P3
   GARRISON BJ, 1984, APPL PHYS LETT, V44, P849, DOI 10.1063/1.94947
   Gower MC, 1999, P SOC PHOTO-OPT INS, V3618, P251, DOI 10.1117/12.352688
   KUMAR GS, 1986, BIODEGRADABLE POLYM
   Lin LW, 1999, J MICROELECTROMECH S, V8, P78, DOI 10.1109/84.749406
   Matsui S, 1995, MATER RES SOC SYMP P, V380, P49, DOI 10.1557/PROC-380-49
   SAUERBREY R, 1989, APPL PHYS LETT, V55, P421, DOI 10.1063/1.101884
   SCHWOPE AD, 1977, MIDLAND MACROMOLECUL, V5
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   SRINIVASAN V, 1986, J APPL PHYS, V59, P3861, DOI 10.1063/1.336728
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SOC MANUFACTURING ENGINEERS
PI DEARBORN
PA ONE SME DR, PO BOX 930, DEARBORN, MI 48128 USA
BN 0-87263-600-3
PY 2001
BP 407
EP 412
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical; Metallurgy &
   Metallurgical Engineering
SC Engineering; Metallurgy & Metallurgical Engineering
GA BV60L
UT WOS:000179483900054
DA 2018-10-19
ER

PT J
AU Jamitzky, F
   Stark, RW
   Bunk, W
   Thalhammer, S
   Rath, C
   Aschenbrenner, T
   Morfill, GE
   Heckl, WM
AF Jamitzky, F
   Stark, RW
   Bunk, W
   Thalhammer, S
   Rath, C
   Aschenbrenner, T
   Morfill, GE
   Heckl, WM
TI Scaling-index method as an image processing tool in scanning-probe
   microscopy
SO ULTRAMICROSCOPY
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Scanning Probe Microscopy, Sensors, and
   Nanostructures
CY MAY 28-31, 2000
CL HEIDELBERG, GERMANY
SP Ultramicroscopy
DE atomic force microscopy; image processing
ID ATOMIC-FORCE MICROSCOPE; HUMAN-CHROMOSOMES; PATTERNS
AB The scaling-index method (SIM) is a novel tool for image processing in scanning-probe microscopy. Originating from the theory of complex systems, the SIM can be used in order to extract structural information from arbitrary data sets. This method can readily be applied to the analysis of digital atomic-force microscopy (AFM) images. Especially for biomedical diagnostics, where genetic material is investigated by various microscopic methods, a reliable image segmentation based on the SIM algorithm is helpful. As a first application, AFM-images of CTC-banded human metaphase chromosomes (with G bands obtained by Trypsin using Giemsa) are compared with micrographs from conventional light microscopy by means of a scaling-index analysis. While the grey-level distributions of the optical and the AFM-images are largely different from each other, the scaling-index images are remarkably similar. Using this method, a fingerprint of an image can be produced which helps in the classification and interpretation of the measured data. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Max Planck Inst Extraterr Phys, D-85749 Garching, Germany.
   Univ Munich, Inst Kristallog & Angew Mineral, D-80333 Munich, Germany.
RP Jamitzky, F (reprint author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85749 Garching, Germany.
EM f.jamitzky@mpe-garching.mpg.de
RI Stark, Robert/A-2886-2008; Thalhammer, Stefan/C-1031-2011
OI Stark, Robert/0000-0001-8678-8449; 
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   *ISCN, 1995, INT SYST HUM CYT NOM, V21
   JAMITZKY F, IN PRESS J COMPUT AS
   Musio A, 1997, GENOME, V40, P127, DOI 10.1139/g97-018
   MUSIO A, 1994, CHROMOSOMA, V103, P225, DOI 10.1007/BF00368016
   PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712
   PUTMAN CAJ, 1992, P SOC PHOTO-OPT INS, V1639, P198, DOI 10.1117/12.58191
   PUTMAN CAJ, 1992, ULTRAMICROSCOPY, V42, P1549, DOI 10.1016/0304-3991(92)90481-X
   RASCH P, 1993, P NATL ACAD SCI USA, V90, P2509, DOI 10.1073/pnas.90.6.2509
   Rath C, 1997, J OPT SOC AM A, V14, P3208, DOI 10.1364/JOSAA.14.003208
   Stark RW, 1998, APPL PHYS A-MATER, V66, pS579, DOI 10.1007/s003390051205
   Tamayo J, 1999, J STRUCT BIOL, V128, P200, DOI 10.1006/jsbi.1999.4191
   Thalhammer S, 1997, J STRUCT BIOL, V119, P232, DOI 10.1006/jsbi.1997.3869
NR 13
TC 35
Z9 35
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD JAN
PY 2001
VL 86
IS 1-2
BP 241
EP 246
DI 10.1016/S0304-3991(00)00111-X
PG 6
WC Microscopy
SC Microscopy
GA 398AB
UT WOS:000166730600029
PM 11215629
DA 2018-10-19
ER

PT J
AU Howson, A
AF Howson, A
TI "Watching you - watching me": Visualising techniques and the cervix
SO WOMENS STUDIES INTERNATIONAL FORUM
LA English
DT Article
AB Feminist accounts of 1970s women's health activism in the Anglophone world highlight cervical self-examination as a means of reclaiming the female body from biomedical monopoly. Whilst cervical screening programmes have become part of health policy in the United Kingdom and other Western countries, cervical self-examination does not appear to be widespread. nor have many women seen their own cervix. Feminism has also drawn attention to the significance of biomedical imagery and discourse in the engendering of knowledge about one's own body, particularly through visualisation techniques. This paper presents interview material in which women describe the experience of cervical colposcopy and their responses to magnified images of their own cervix during this procedure. The data are used to consider how visualisation techniques shape bodily experience. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Aberdeen, Dept Sociol, Aberdeen AB24 3QY, Scotland.
RP Howson, A (reprint author), Univ Aberdeen, Dept Sociol, Edward Wright Bldg,Dunbar St, Aberdeen AB24 3QY, Scotland.
CR ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329
   Armstrong D., 1983, POLITICAL ANATOMY BO
   Arney W., 1982, POWER PROFESSION OBS
   Atkinson P, 1995, MED TALK MED WORK
   Bell Susan, 1988, GENDER DISCOURSE POW, P97
   Birke L., 1999, FEMINISM BIOL BODY
   Cartwright L., 1995, SCREENING BODY TRACI
   CROSSLEY N, 1995, BODY SOC, V1, P13
   CSORDAS TJ, 1990, ETHOS, V18, P5, DOI 10.1525/eth.1990.18.1.02a00010
   DALY A, 1991, WOMEN KNIFE HIST SUR
   Denzin N. K., 1988, INTERPRETIVE INTERAC
   Department of Health, 1989, GEN PRACT NAT HLTH S
   Diprose R., 1994, BODIES WOMEN ETHICS
   Douglas M., 1996, PURITY DANGER ANAL P
   DOYAL L, 1983, CRITICAL SOCIAL  SUM, P21
   DUNCAN ID, 1992, GUIDELINES CLIN PRAC
   Ehrenreich B., 1979, HER OWN GOOD 150 YEA
   EVANS DMD, 1986, J CLIN PATHOL, V39, P933, DOI 10.1136/jcp.39.9.933
   Foucault Michel, 1973, BIRTH CLIN
   FRANKFORT E, 1972, SEIZING OUR BODIES, P263
   GARDNER K, 1981, WOMEN HLTH REPROD, P129
   Graham H., 1981, WOMEN HLTH REPROD, P50
   Grosz Elizabeth, 1994, VOLATILE BODIES CORP
   HOPWOOD J, 1990, BACKGROUND COLPOSCOP
   HOWSON A, 1996, THESIS U EDINBURGH
   Howson A., 1998, HEALTH, V2, P195
   ILLICH I, 1986, LANCET, V2, P1325
   Kavanagh AM, 1997, BRIT MED J, V314, P1388
   Kitzinger S., 1992, WOMENS HLTH MATTERS, P63
   Kristeva J., 1982, POWERS HORROR ESSAY
   Lane K, 1995, MED HLTH RISK SOCIOL, P53
   Laqueur T., 1991, MAKING SEX BODY GEND
   Lawler J., 1991, SCREENS NURSING SOMO
   Laws S, 1990, ISSUES BLOOD POLITIC
   LEWIN E, 1985, WOMEN HLTH HEALING N
   MARTIN E, 1984, SOC SCI MED, V19, P1201, DOI 10.1016/0277-9536(84)90371-X
   Martin E., 1989, WOMAN BODY
   Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP
   Moscucci O., 1990, SCI WOMAN GYNAECOLOG
   Oakley A, 1998, WOMEN STUD INT FORUM, V21, P133, DOI 10.1016/S0277-5395(98)00005-3
   OAKLEY A, 1984, CAPTURED WOMB
   Patterson JT, 1987, DREAD DIS CANC MODER
   PHILLIPS A, 1971, OUR BODIES OURSELVES
   Poovey Mary, 1987, MAKING MODERN BODY S, P137
   POSNER T, 1988, PATIENTS VIEW
   RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0
   Ruzek Sheryl Burt, 1978, WOMENS HLTH MOVEMENT
   SCULLY D, 1978, CULTURAL CRISIS MODE, P212
   Shildrick M., 1997, LEAKY BODIES BOUNDAR
   Singleton V., 1995, GENDER TECHNOLOGY RE, P146
   Stabile C., 1994, FEMINISM TECHNOLOGIC
   STAFFORD B, 1991, BODY CRITICISM IMAGI
   Thomas H., 1992, TIME HLTH MED, P56
   Turner B, 1987, MED POWER SOCIAL KNO
   Young I. M., 1990, THROWING GIRL OTHER
NR 55
TC 13
Z9 13
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-5395
J9 WOMEN STUD INT FORUM
JI Women Stud. Int. Forum
PD JAN-FEB
PY 2001
VL 24
IS 1
BP 97
EP 109
DI 10.1016/S0277-5395(00)00162-X
PG 13
WC Women's Studies
SC Women's Studies
GA 432MJ
UT WOS:000168695400008
DA 2018-10-19
ER

PT J
AU Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
AF Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
TI Surface hardness changes induced by O-, Ca- or P-ion implantation into
   titanium
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article; Proceedings Paper
CT 9th RIKEN Symposium on Surface Modification and Characterization by Ion
   Beams/5th RIKEN-OKAYAMA Joint Forum
CY 1999
CL INST PHYS & CHEM RES, SAITAMA, JAPAN
HO INST PHYS & CHEM RES
DE hardness; ion implantation; titanium
ID NITROGEN
AB Titanium or titanium alloys are very attractive biomedical materials. Biocompatible elements of oxygen, calcium and phosphorus were implanted into titanium and changes of surface hardness were measured using an ultra micro indenter (UMIS-2000). A multiple load-partial unload procedure that can reveal a hardness versus depth profile was adopted. Depth profiles of concentration of implanted ions were obtained by SIMS measurement. For O and P implantation, it is observed that the hardness increases with the increases in the dose. O implantation produced the largest increase in hardness, up to 2.2 times higher than the unimplanted titanium. On the other hand, Ca implantation produced only a small increase in the hardness that was independent of the ion dose. The surface oxide layer of a Ca implanted titanium sample was much thicker than the unimplanted samples or those implanted with O and P ions. The depth of maximum hardness increases with increasing energy of implanted ions. The depths of the maximum hardness occur at indentation depths of one-third to one-eighth of the mean ranges of implanted ions. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Natl Ind Res Inst Nagoya, Kita Ku, Nagoya, Aichi 4628510, Japan.
   CSIRO, Div Telecommun & Ind Phys, Lindfield, NSW 2070, Australia.
CR Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   Bell TJ, 1998, MATER RES SOC SYMP P, V522, P15, DOI 10.1557/PROC-522-15
   FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297
   GANIA A, 1997, SURF COAT TECH, V97, P499
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   Krupa D, 1997, SURF COAT TECH, V96, P223, DOI 10.1016/S0257-8972(97)00107-2
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Sarkissian AH, 1998, SURF COAT TECH, V98, P1336, DOI 10.1016/S0257-8972(97)00399-X
   Seidel F, 1998, SURF COAT TECH, V98, P1174, DOI 10.1016/S0257-8972(97)00148-5
   YOKOGAWA Y, 1999, PHOSPHORUS RES B, V10, P301
   ZIEGLER JF, 1985, STOPPING RANGE ION S
NR 11
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 20
PY 2000
VL 19
IS 3
BP 263
EP 268
DI 10.1016/S0927-7765(00)00164-8
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 366WZ
UT WOS:000090030400008
DA 2018-10-19
ER

PT J
AU Snellings, GMBF
   Vansteenkiste, SO
   Corneillie, SI
   Davies, MC
   Schacht, EH
AF Snellings, GMBF
   Vansteenkiste, SO
   Corneillie, SI
   Davies, MC
   Schacht, EH
TI Protein adhesion at poly(ethylene glycol) modified surface
SO ADVANCED MATERIALS
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SCANNING PROBE MICROSCOPY; HUMAN-PLASMA;
   ADSORPTION
AB The inhibition of protein adsorption to the surfaces of biomedical devices is a crucial requirement for avoiding implant-associated infections or thrombus formation on blood-contacting artificial surfaces and thus for increasing the long-term biocompatibility of the devices. Here, the use of surface plasmon resonance and scanning force microscopy using protein-modified tips (see Figure) to study protein adhesion on poly (ethylene glycol) grafted polymer materials is discussed. The PEG-grafted materials are revealed to have significantly reduced affinity to proteins.
C1 State Univ Ghent, Dept Organ Chem, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
   Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Schacht, EH (reprint author), State Univ Ghent, Dept Organ Chem, Polymer Mat Res Grp, Krijgslaan 281, B-9000 Ghent, Belgium.
OI Davies, Martyn/0000-0001-7695-0596
CR Bain C. D., 1989, ANGEW CHEM, V101, P522
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   Bottomley LA, 1996, ANAL CHEM, V68, pR185, DOI 10.1021/a1960008+
   BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chen X, 1997, LANGMUIR, V13, P4106, DOI 10.1021/la970172i
   CORNEILLIE SI, 1998, MED DEVICE TECHN JAN, P28
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GRAINGER DW, 1997, PROG COLL POL SCI S, V103, P243
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   HARRIS JM, 1992, PEG CHEM BIOTECHNICA
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   LEE UG, 1994, SCIENCE, V6, P771
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   NAKAGAWA T, 1994, J VAC SCI TECHNOL B, V12, P2215, DOI 10.1116/1.587744
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PERRY SS, 1994, ANAL CHEM, V66, pA403, DOI 10.1021/ac00079a001
   Ratner B. D., 1981, BIOCOMPATIBILITY CLI
   Snelting G., 2000, Proceedings of the Fourth European Conference on Software Maintenance and Reengineering, P3, DOI 10.1109/CSMR.2000.827299
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   VINCKIER A, 1995, ULTRAMICROSCOPY, V57, P337, DOI 10.1016/0304-3991(94)00194-R
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 28
TC 41
Z9 41
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD DEC 15
PY 2000
VL 12
IS 24
BP 1959
EP +
DI 10.1002/1521-4095(200012)12:24<1959::AID-ADMA1959>3.3.CO;2-M
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 393XM
UT WOS:000166495000018
DA 2018-10-19
ER

PT J
AU Iwasaki, Y
   Aiba, Y
   Morimoto, N
   Nakabayashi, N
   Ishihara, K
AF Iwasaki, Y
   Aiba, Y
   Morimoto, N
   Nakabayashi, N
   Ishihara, K
TI Semi-interpenetrating polymer networks composed of biocompatible
   phospholipid polymer and segmented polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydrogel; phospholipid polymer; segmented polyurethane; interpenetrating
   polymer networks; protein adsorption; biocompatibility
ID IMPROVED BLOOD COMPATIBILITY; PROTEIN ADSORPTION; POLAR GROUP;
   ADDITIVES; HYDROGELS; MEMBRANE; SURFACE
AB 2-Methacryloyloxyethyl phosphorylcholine (MPC) polymers, which have excellent biocompatibility, have been receiving increasing attention in biomedical and bioengineering fields; however, the mechanical strength of the hydrated MPC polymers is not sufficient for use in these fields as a bulk material. Therefore, we hypothesized that a novel material might be realized by reinforcing the MPC polymer network with segmented polyurethane (SPU). Semi-interpenetrating polymer networks (IPNs) composed of crosslinked MPC polymer and SPU were prepared. The mechanical properties of the IPN membrane were significantly improved compared with those of the MPC polymer membrane. Three-dimensional polymer networks of the MPC polymer in the IPNs were observed after solvent extraction of SPU. An X-ray photoelectron spectrum analysis revealed that the MPC units were exposed on the IPN surface. When the IPN was alternately soaked in water and ethanol, the swelling ratio was found to be completely reversible and no disintegration of the network structure was observed. The permeation coefficient of 1,4-di(2-hydroxyethoxy)benzene through the IPN membrane was 1.11 x 10(-7) cm(-2)s(-1). The amount of adsorbed protein and the number of adherent platelets on the IPN membrane were effectively reduced compared with those on SPU. We concluded that IPNs composed of the MPC polymer and SPU are a new bulk biomaterial, which possesses both blood compatibility and good mechanical properties. (C) 2000 John Wiley & Sons, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
RP Iwasaki, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR FRISCH HL, 1985, BRIT POLYM J, V17, P149, DOI 10.1002/pi.4980170212
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kawano H, 1998, KOBUNSHI RONBUNSHU, V55, P334, DOI 10.1295/koron.55.334
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   TSURUTA T, 1996, ADV POLYM SCI, P1
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   UEDA T, 1990, MAKROMOL CHEM-RAPID, V11, P345
   ZHOU PU, 1992, J POLYM SCI POL CHEM, V30, P835, DOI 10.1002/pola.1992.080300514
NR 18
TC 50
Z9 51
U1 2
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 701
EP 708
DI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600015
PM 11033553
DA 2018-10-19
ER

PT J
AU Asoo, B
   McNaney, JM
   Mitamura, Y
   Ritchie, RO
AF Asoo, B
   McNaney, JM
   Mitamura, Y
   Ritchie, RO
TI Cyclic fatigue-crack propagation in sapphire in air and simulated
   physiological environments
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE heart valve prostheses; sapphire; static fatigue; cyclic fatigue; crack
   growth
ID STRESS-CORROSION; MECHANISM; CERAMICS; BEHAVIOR; GROWTH; MODEL
AB Single-crystal aluminas are being considered for use in the manufacture of prosthetic heart valves. To characterize such materials for biomedical application, subcritical crack growth by stress corrosion (static fatigue) and by cyclic fatigue has been examined in sapphire along (1 (1) over bar 00) planes in 24 degrees C humid air and 37 degrees C Ringer's solution (the latter as a simulated physiological environment). The relationships between crack-propagation rates and the linear-elastic stress intensity have been determined for the first time in sapphire for both modes of subcritical cracking. It was found that growth rates were significantly faster at a given stress intensity in the Ringer's solution compared to the humid air environment. Mechanistically, a true cyclic fatigue effect was not found in sapphire as experimentally measured cyclic fatigue-crack growth rates could be closely predicted simply by integrating the static fatigue-crack growth data over the cyclic lending cycle. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
   Hokkaido Univ, Dept Biomed Syst Engn, Sapporo, Hokkaido 0608628, Japan.
RP Ritchie, RO (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RI McNaney, James/F-5258-2013; Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR [Anonymous], 1993, ANN BOOK ASTM STAND
   BECHER PF, 1976, J AM CERAM SOC, V59, P59
   DAUSKARDT RH, 1993, ACTA METALL MATER, V41, P2765, DOI 10.1016/0956-7151(93)90145-I
   DAUSKARDT RH, 1989, CLOSED LOOP, V17, P7
   EVANS AG, 1974, METALL TRANS, V5, P27
   GILBERT CJ, 1995, J AM CERAM SOC, V78, P2291, DOI 10.1111/j.1151-2916.1995.tb08660.x
   IWASA M, 1984, ADV CERAM, V10, P767
   KIMURA Y, 1993, P 5 INT C FAT FAT TH, V3, P1331
   LATHABAI S, 1991, J AM CERAM SOC, V74, P1348
   MAI YW, 1987, J AM CERAM SOC, V70, P289, DOI 10.1111/j.1151-2916.1987.tb04983.x
   MICHALSKE TA, 1983, J AM CERAM SOC, V66, P284, DOI 10.1111/j.1151-2916.1983.tb15715.x
   MITAMURA Y, 1994, J BIOMED MATER RES, V28, P813, DOI 10.1002/jbm.820280708
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   TANAKA T, 1985, RES REP KOGAKUIN U, V78, P55
   TZOU JL, 1985, ACTA METALL MATER, V33, P117, DOI 10.1016/0001-6160(85)90225-1
   VEKINIS G, 1990, ACTA METALL MATER, V38, P1151, DOI 10.1016/0956-7151(90)90188-M
   WIEDERHORN SM, 1970, J AM CERAM SOC, V53, P543, DOI 10.1111/j.1151-2916.1970.tb15962.x
   WIEDERHORN SM, 1969, J AM CERAM SOC, V52, P485, DOI 10.1111/j.1151-2916.1969.tb09199.x
   Yi KS, 1997, ACTA MATER, V45, P2671, DOI 10.1016/S1359-6454(96)00408-9
NR 19
TC 16
Z9 16
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2000
VL 52
IS 3
BP 488
EP 491
DI 10.1002/1097-4636(20001205)52:3<488::AID-JBM6>3.0.CO;2-W
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 356CQ
UT WOS:000089427100006
PM 11007616
DA 2018-10-19
ER

PT J
AU Gonzales, RJ
   Carter, RW
   Kanagy, NL
AF Gonzales, RJ
   Carter, RW
   Kanagy, NL
TI Laboratory demonstration of vascular smooth muscle function using rat
   aortic ring segments
SO ADVANCES IN PHYSIOLOGY EDUCATION
LA English
DT Article
DE endothelial cell; teaching; physiology
ID CONTRACTION; ARTERY; CELLS
AB This laboratory exercise uses a simple preparation and a straightforward protocol to illustrate many of the basic principles of vascular biology covered in an introductory physiology course. The design of this laboratory allows students to actively participate in an exercise demonstrating the regulation of arterial tone by endothelial and extrinsic factors. In addition, this hands-on laboratory allows students to gather data using well-known basic biomedical research techniques. Specifically, students are introduced to an isolated organ-chamber technique that is widely used to study cellular mechanisms of many tissues including vascular smooth muscle contraction and dilation. On the basis of student evaluations, participation in the experiments and interpreting data reinforce lecture materials on smooth muscle and endothelial cell function and illustrate mechanisms regulating vascular tone. Students come away with a greater understanding of vascular biology, a deeper appreciation of integrative physiology, and an understanding of the process of conducting tissue-chamber experiments.
C1 Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp,Biomed Res Facil 237, Albuquerque, NM 87131 USA.
RP Kanagy, NL (reprint author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp,Biomed Res Facil 237, Albuquerque, NM 87131 USA.
CR ALEXANDER PB, 1994, EUR J PHARM-MOLEC PH, V288, P79, DOI 10.1016/0922-4106(94)90012-4
   Barany M., 1996, BIOCH SMOOTH MUSCLE
   BLATTER LA, 1995, AM J PHYSIOL-CELL PH, V268, pC503
   BOLTON TB, 1996, SMOOTH MUSCLE EXCITI
   FREHN C, 1991, AM HEART J, V121, P958
   FUKUIZUMI Y, 1995, BRIT J PHARMACOL, V114, P329, DOI 10.1111/j.1476-5381.1995.tb13231.x
   GONZALES RJ, 1999, CARDIOVASC PHARM THE, V4, P227
   HIINURA JT, 1990, AM J PHYSIOL-HEART C, V259, pH2
   Ishibashi Y, 1997, CIRC RES, V80, P196, DOI 10.1161/01.RES.80.2.196
   Kanagy NL, 1997, AM J PHYSIOL-HEART C, V273, pH2756
   KITAZAWA T, 1991, J BIOL CHEM, V266, P1708
   Lamb FS, 1998, AM J PHYSIOL-HEART C, V275, pH151, DOI 10.1152/ajpheart.1998.275.1.H151
   MORGAN JP, 1991, AM HEART J, V121, P961, DOI 10.1016/0002-8703(91)90227-9
   NAHORSKI SR, 1994, J HYPERTENS, V12, pS133
   Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341
   Tseng CML, 2000, J PHARMACOL EXP THER, V292, P737
   VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315
   WALSH MP, 1995, CAN J PHYSIOL PHARM, V73, P565, DOI 10.1139/y95-072
   XIONG ZL, 1995, J MOL CELL CARDIOL, V27, P75, DOI 10.1016/S0022-2828(08)80009-0
NR 19
TC 12
Z9 12
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1043-4046
J9 ADV PHYSIOL EDUC
JI Adv. Physiol. Educ.
PD DEC
PY 2000
VL 24
IS 1
BP 13
EP 21
PG 9
WC Education, Scientific Disciplines; Physiology
SC Education & Educational Research; Physiology
GA 378NN
UT WOS:000165590600004
PM 11209559
DA 2018-10-19
ER

PT J
AU Ferrari, M
AF Ferrari, Mauro
TI Nanomechanics, and Biomedical Nanomechanics: Eshelby's Inclusion and
   Inhomogeneity Problems at the Discrete/Continuum Interface
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE nanomechanics; continuum/discrete; multi-side; inclusion; inhomogeneity;
   Eshelby
AB The solution of the problem of a large elastostatic matrix, with an embedded eigenstraining inclusion is presented. The inclusion is modeled as an array of discrete points, in accordance with the theory of doublet mechanics (DM), while the matrix is viewed as a conventional continuum. The integration of the two representations affords the simultaneous access to atomic-scale stress and deformation analysis, and retention of the modeling benefits associated with the macroscopic continuum treatment of non-critical material regions. Thus, the theory presented appears suitable for the analysis of the mechanical states in nanotechnological devices, embedded within constraining matrices, biological and otherwise. The linear eigenstrain model employed is applicable to the analysis of nanomechanical states arising from thermal expansion, phase changes, crystallization, differential hygral absorption, and environmental effects such as changes in pH, all occurring within a small subdomain of an homogeneous medium. In parallel with the celebrated approach employed by J. Eshelby in the theory of linear continuum elastostatics, the solution to the nanomechanical inclusion problem is also used to solve the nanomechanical inhomogeneity problem. This consists of a nanoscale material domain embedded within a large volume of a different material, treated herein as a continuum-level matrix. The assembly is loaded by homogeneous displacement conditions at the outer boundary. Modeling the inhomogeneity as an array of discrete nodes, again following the methods of DM, and employing a stress equivalence approach, the nanomechanical states within the inhomogeneity are determined.
C1 Ohio State Univ, Ctr Biomed Engn, Columbus, OH 43210 USA.
RP Ferrari, M (reprint author), Ohio State Univ, Ctr Biomed Engn, Columbus, OH 43210 USA.
CR Boley B.A., 1985, THEORY THERMAL STRES, P1
   CHOPRA NG, 1997, LECT N PH M, V45, P189
   CHU W, 1998, Patent No. 5798042
   Chu WH, 1999, J MICROELECTROMECH S, V8, P34, DOI 10.1109/84.749400
   DESAI TA, 1999, J MEMBRANE SCI, V4132, P1
   Desai TA, 1999, BIOMED MICRODEVICES, V2, P11, DOI 10.1023/A:1009903215959
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   FERRARI M, 1994, COMPOS ENG, V4, P37, DOI 10.1016/0961-9526(94)90005-1
   FERRARI M, 1994, MAT SCI ENG A-STRUCT, V175, P21, DOI 10.1016/0921-5093(94)91040-5
   Ferrari M., 1997, LECT N PH M, V45, P1
   Imam A., 1997, LECT NOTES PHYS M, V45, P177
   MADDALENA F, 1995, MECH MATER, V20, P241, DOI 10.1016/0167-6636(94)00064-6
   Madou M.J, 1997, FUNDAMENTALS MICROFA, P1
   Matalon O., 1999, THESIS
   Moorthy S, 1998, COMPUT METHOD APPL M, V151, P377, DOI 10.1016/S0045-7825(97)00160-6
   Mura T., 1991, MICROMECHANICS DEFEC, P1
   Nadeau JC, 1998, J ELASTICITY, V52, P43, DOI 10.1023/A:1007539929374
   NADEAU JC, 1997, LECT N PH M, V45, P157
   Peppas NA, 1987, HYDROGELS MED PHARM, P109
   Roco MC, 1999, NAN RES DIR VIS NAN
   Tu JK, 1999, BIOMED MICRODEVICES, V1, P113, DOI 10.1023/A:1009944423778
   Zdeblick M.J., 1993, DESIGN NEWS, P67
NR 22
TC 14
Z9 16
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2000
VL 2
IS 4
BP 273
EP 281
DI 10.1023/A:1009903205275
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33LB
UT WOS:000209019200006
DA 2018-10-19
ER

PT J
AU Goldman, M
   Hedetniemi, JN
   Herbert, ER
   Sassaman, JS
   Walker, BC
AF Goldman, M
   Hedetniemi, JN
   Herbert, ER
   Sassaman, JS
   Walker, BC
TI Community outreach at biomedical research facilities
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Leadership Conference on Biomedical Research and the Environment
CY NOV 01-02, 1999
CL BETHESDA, MARYLAND
SP Natl Assoc Physicians Environm, Assoc Higher Educ Facil Officers, US Natl Inst Environm Hlth Sci, W Alton Jones Fdn, Mitchell Kapor Fdn, Shulsky Fdn, Hahn Family Fdn, Baxter Int Inc
DE active and informed public outreach; community involvement; defusing
   public outrage; public/private partnerships
AB For biomedical researchers to fulfill their responsibility for protecting the environment, they must do more than meet the scientific challenge of reducing the number and volume of hazardous materials used in their laboratories and the engineering challenge of reducing pollution and shifting to cleaner energy sources. They must also meet the public relations challenge of informing and involving their neighbors in these efforts. The experience of the Office of Community Liaison of the National Institutes of Health (NIH) in meeting the latter challenge offers a model and several valuable lessons for other biomedical research facilities to follow. This paper is based on presentations by an expert panel during the Leadership Conference on Biomedical Research and the Environment held 1-2 November 1999 at NIH, Bethesda, Maryland. The risks perceived by community members are often quite different from those identified by officials at the biomedical research facility. The best antidote for misconceptions is more and better information. If community organizations are to be informed participants in the decision-making process, they need a simple but robust mechanism for identifying and evaluating the environmental hazards in their community. Local government can and should be an active and fully informed partner in planning and emergency preparedness. In some cases this can reduce the regulatory burden on the biomedical research facility. In other cases it might simplify and expedite the permitting process or help the facility disseminate reliable information to the community. When a particular risk, real or perceived, is of special concern to the community, community members should be involved in the design, implementation, and evaluation of targeted risk assessment activities. Only by doing so will the community have confidence in the results of those activities. NIH has involved community members in joint efforts to deal with topics as varied as recycling and soil testing. These ad hoc efforts are more likely to succeed if community members and groups have also been included in larger and longer term advisory committees. These committees institutionalize the outreach process. This can provide the facility with vocal and influential allies who create an independent line of communication with the larger community.
C1 NIH, Off Community Liaison, Bethesda, MD 20892 USA.
   Dept Environm Protect, Rockville, MD USA.
   Opus Grp LLC, Chapel Hill, NC USA.
   Howard Univ, Med Ctr, Off Environm & Occupat Med, Washington, DC 20059 USA.
RP Hedetniemi, JN (reprint author), NIH, Off Community Liaison, Bldg 1,Rm 259, Bethesda, MD 20892 USA.
CR SASSAMAN JF, 1981, MTR80W298 US EPA
NR 1
TC 0
Z9 0
U1 0
U2 1
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD DEC
PY 2000
VL 108
SU 6
BP 1009
EP 1013
DI 10.1289/ehp.00108s61009
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 386TP
UT WOS:000166077900009
PM 11124126
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Dufault, R
   Abelquist, E
   Crooks, S
   Demers, D
   DiBerardinis, L
   Franklin, T
   Horowitz, M
   Petullo, C
   Sturchio, G
AF Dufault, R
   Abelquist, E
   Crooks, S
   Demers, D
   DiBerardinis, L
   Franklin, T
   Horowitz, M
   Petullo, C
   Sturchio, G
TI Reducing environmental risk associated with laboratory decommissioning
   and property transfer
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Leadership Conference on Biomedical Research and the Environment
CY NOV 01-02, 1999
CL BETHESDA, MARYLAND
SP Natl Assoc Physicians Environm, Assoc Higher Educ Facil Officers, US Natl Inst Environm Hlth Sci, W Alton Jones Fdn, Mitchell Kapor Fdn, Shulsky Fdn, Hahn Family Fdn, Baxter Int Inc
DE assessment; characterization; decommissioning; decontamination;
   demolition; environmental; laboratory; liability; remediation;
   renovation
AB The need for more or less space is a common laboratory problem. Solutions may include renovating existing space, leaving or demolishing old space, or acquiring new space or property for building. All of these options carry potential environmental risk. Such risk can be the result of activities related to the laboratory facility or property (e.g., asbestos, underground storage tanks, lead paint), or the research associated with it (e.g., radioactive, microbiological, and chemical contamination). Regardless of the option chosen to solve the space problem, the potential environmental risk must be mitigated and the laboratory space and/or property must be decommissioned or rendered safe prior to any renovation, demolition, or property transfer activities. Not mitigating the environmental risk through a decommissioning process can incur significant financial liability for any costs associated with future decommissioning cleanup activities. Out of necessity, a functioning system, environmental due diligence auditing, has evolved over time to assess environmental risk and reduce associated financial liability. This system involves a 4-phase approach to identify, document, manage, and clean up areas of environmental concern or liability, including contamination. Environmental due diligence auditing includes a) historical site assessment, b) characterization assessment, c) remedial effort and d) final status survey. General practice standards from the American Society for Testing and Materials are available for conducting the first two phases. However, standards have not yet been developed for conducting the third and final phases of the environmental due diligence auditing process. Individuals involved in laboratory decommissioning work in the biomedical research industry consider this a key weakness.
C1 US FDA, Div Facilities Planning Engn & Safety, Rockville, MD 20857 USA.
   Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA.
   MIT, Cambridge, MA 02139 USA.
   USDA, Beltsville, MD USA.
   Analog Devices Inc, Cambridge, MA USA.
   US EPA, Las Vegas, NV 89193 USA.
   Merck Res Labs, Rahway, NJ USA.
RP Dufault, R (reprint author), US FDA, Div Facilities Planning Engn & Safety, HFA-34,5630 Fishers Lane, Rockville, MD 20857 USA.
CR *ASTM, 1997, STAND PRACT ENV SIT, pE1903
   *ASTM, 2000, STAND PRACT ENV STAT, pE1527
   *ASTM, 1999, D3987 ASTM
   Bader M, 1999, Appl Occup Environ Hyg, V14, P369
   Edwards R., 1999, CHEM HLTH SAFE, V6, P4
   *MASCO, 1998, INFR SUBC MAINT GUID
   *NAT AC SCI, 1995, PRUD PRACT HANDL STO
   *NAT I OCC SAF HLT, 1998, NIOSH MAN AN METH
   Ness S., 1994, SURFACE DERMAL MONIT
   Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8
   SHLEIEN B, 1992, HLTH PHYSICS RADIOLO
   TURNER R, 1995, WATER AIR SOIL PLANT, V80, P1295
   U. S. EPA, 1992, 1311 EPA
   *US EPA, MULT AG RAD SURV SIT
   *US EPA, 1992, 2455 EPA NAT TECHN I
   *US EPA, 1992, 822R93001AB EPA NAT
   *US NUCL REG COMM, 1998, FED REGISTER, V63, P64134
   *US NUCL REG COMM, REG GUID 1 86
NR 18
TC 2
Z9 2
U1 0
U2 1
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD DEC
PY 2000
VL 108
SU 6
BP 1015
EP 1022
DI 10.1289/ehp.00108s61015
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 386TP
UT WOS:000166077900010
PM 11121365
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Guzman, NA
AF Guzman, NA
TI Determination of immunoreactive gonadotropin-releasing hormone in serum
   and urine by on-line immunoaffinity capillary electrophoresis coupled to
   mass spectrometry
SO JOURNAL OF CHROMATOGRAPHY B
LA English
DT Review
DE gonadotropin-releasing hormone; immunoaffinity capillary
   electrophoresis; on-line preconcentration CE
ID ZONE-ELECTROPHORESIS; CLINICAL-CHEMISTRY; LIQUID-CHROMATOGRAPHY; ONLINE
   PRECONCENTRATION; SAMPLE PRECONCENTRATION; FLUORESCENCE MICROSCOPY;
   BIOMEDICAL APPLICATIONS; PROTEIN IDENTIFICATION; GEL-ELECTROPHORESIS;
   BIOLOGICAL-FLUIDS
AB The need for urgent diagnoses has propelled the development of automated analyses that can be performed in a short time at reasonable cost. One such method is immunoaffinity capillary electrophoresis. This emerging hybrid technology employs two powerful techniques coupled on-line for the direct and rapid determination of analytes present in biological fluids. The first technique, immunoaffinity, is used for the selective extraction of a molecule present in a complex matrix, utilizing a microscale-format chamber affinity device. An analyte (affinity target) present in serum or urine is captured by an immobilized molecular recognition antibody molecule (affinity ligand) bound to a solid support constituent (glass beads or an appropriate porous structure) of a microchamber affinity device. The second technique, capillary electrophoresis, is used for the high-resolution analytical separation of the purified and concentrated affinity target material after elution from the microchamber affinity device. In this work, immunoaffinity capillary electrophoresis was developed for the identification and characterization of a single constituent of a complex matrix. Immunoreactive gonadotropin-releasing hormone was determined in serum and urine specimens derived from a normal individual and from a patient suffering from benign prostatic hyperplasia. Furthermore, the on-line immune-separation system was coupled in tandem to mass spectrometry to obtain molecular mass information of the affinity isolated and CE separated neuropeptide. This hybrid immune-analytical technology is simple, rapid, selective and sensitive. In addition, an attempt was also made to characterize other urinary constituents by CE-MS that may lead to marker activity in the urine of the diseased subject. The hyphenation of analytical techniques has proved valuable in enhancing their individual features. The future of bioanalysis using miniaturized affinity systems is discussed in this paper. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 RW Johnson Pharmaceut Res Inst, Raritan, NJ 08896 USA.
RP Guzman, NA (reprint author), RW Johnson Pharmaceut Res Inst, Room B-356, Raritan, NJ 08896 USA.
CR ADVIS JP, 1993, J LIQ CHROMATOGR, V16, P2129, DOI 10.1080/10826079308019920
   Altria KD, 1999, LC GC-MAG SEP SCI, V17, P28
   Altria KD, 1999, J CHROMATOGR A, V856, P443, DOI 10.1016/S0021-9673(99)00830-4
   Anderson BB, 1999, J PHARMACEUT BIOMED, V19, P15, DOI 10.1016/S0731-7085(98)00088-0
   Baba Y, 1999, J BIOCHEM BIOPH METH, V41, P91, DOI 10.1016/S0165-022X(99)00040-8
   Baldwin RP, 1999, J PHARMACEUT BIOMED, V19, P69, DOI 10.1016/S0731-7085(98)00135-6
   Banks JF, 1997, ELECTROPHORESIS, V18, P2255, DOI 10.1002/elps.1150181216
   Bao JJ, 1997, J CHROMATOGR B, V699, P481, DOI 10.1016/S0378-4347(96)00244-7
   Bardelmeijer HA, 1997, ELECTROPHORESIS, V18, P2214, DOI 10.1002/elps.1150181212
   Bardelmeijer HA, 1998, J CHROMATOGR A, V807, P3, DOI 10.1016/S0021-9673(98)00230-1
   Barroso MB, 1998, J CAPILLARY ELECTROP, V5, P1
   Barroso MB, 1999, J AM SOC MASS SPECTR, V10, P1271
   Basso D, 2000, UROLOGY, V55, P710, DOI 10.1016/S0090-4295(99)00596-8
   Bateman KP, 1998, J MASS SPECTROM, V33, P1109, DOI 10.1002/(SICI)1096-9888(199811)33:11<1109::AID-JMS728>3.0.CO;2-1
   BEATTIE JH, 1995, ELECTROPHORESIS, V16, P322, DOI 10.1002/elps.1150160153
   BIGGINS JA, 1984, J NEUROL SCI, V66, P47, DOI 10.1016/0022-510X(84)90140-0
   BLANC T, 1997, ANAL INSTRUM, P1351
   Blaschke G, 2000, J CHROMATOGR A, V875, P3, DOI 10.1016/S0021-9673(00)00134-5
   BOURGUIGNON JP, 1979, J CLIN ENDOCR METAB, V48, P78, DOI 10.1210/jcem-48-1-78
   BURGI DS, 1991, ANAL CHEM, V63, P2042, DOI 10.1021/ac00018a028
   CHIEN RL, 1991, J CHROMATOGR, V559, P141, DOI 10.1016/0021-9673(91)80066-P
   CHIEN RL, 1992, ANAL CHEM, V64, pA489, DOI 10.1021/ac00032a002
   COHEN SM, 1995, FOOD CHEM TOXICOL, V33, P715, DOI 10.1016/0278-6915(95)00040-9
   Colyer CL, 1997, ELECTROPHORESIS, V18, P1733, DOI 10.1002/elps.1150181006
   CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391
   CONN PM, 1991, NEW ENGL J MED, V324, P93
   Cook T, 2000, Oncologist, V5, P162, DOI 10.1634/theoncologist.5-2-162
   Dalluge JJ, 1998, ANAL CHEM, V70, P5339, DOI 10.1021/ac980773u
   de Boer T, 1999, ELECTROPHORESIS, V20, P2989, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<2989::AID-ELPS2989>3.0.CO;2-X
   De Lorenzi E, 1999, Boll Chim Farm, V138, P332
   Dean P.D.G., 1985, AFFINITY CHROMATOGRA
   Dermaux A, 1999, ELECTROPHORESIS, V20, P3027, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3027::AID-ELPS3027>3.0.CO;2-Z
   DEYL Z, 1994, J CHROMATOGR B, V656, P3, DOI 10.1016/0378-4347(94)00035-2
   DICE JF, 1987, FASEB J, V1, P349
   Ding JM, 1999, ANAL CHEM, V71, p378A, DOI 10.1021/ac9904415
   Dolnik V, 2000, ELECTROPHORESIS, V21, P41, DOI 10.1002/(SICI)1522-2683(20000101)21:1<41::AID-ELPS41>3.0.CO;2-7
   Effenhauser CS, 1997, ELECTROPHORESIS, V18, P2203, DOI 10.1002/elps.1150181211
   EGGERS M, 1995, HEMATOL PATHOL, V9, P1
   Ensing K, 1996, J PHARMACEUT BIOMED, V14, P305, DOI 10.1016/0731-7085(95)01607-4
   Figeys D, 1997, J CHROMATOGR A, V763, P295, DOI 10.1016/S0021-9673(96)00847-3
   Figeys D, 1998, ELECTROPHORESIS, V19, P885, DOI 10.1002/elps.1150190603
   Figeys D, 1996, NAT BIOTECHNOL, V14, P1579, DOI 10.1038/nbt1196-1579
   Figeys D, 1998, ELECTROPHORESIS, V19, P2338, DOI 10.1002/elps.1150191314
   GELLER J, 1989, UROLOGY, V34, P57, DOI 10.1016/0090-4295(89)90235-5
   Guetens G, 2000, J CHROMATOGR B, V739, P139, DOI 10.1016/S0378-4347(99)00553-8
   Guzman N.A., 1993, CAPILLARY ELECTROPHO, P643
   GUZMAN NA, 1991, J LIQ CHROMATOGR, V14, P997, DOI 10.1080/01483919108049300
   GUZMAN NA, 1995, J LIQ CHROMATOGR, V18, P3751, DOI 10.1080/10826079508014623
   GUZMAN NA, 1990, J LIQ CHROMATOGR, V13, P3833, DOI 10.1080/01483919008049573
   Guzman NA, 1999, LC GC-MAG SEP SCI, V17, P16
   Guzman NA, 1997, J CHROMATOGR B, V697, P37, DOI 10.1016/S0378-4347(97)00275-2
   GUZMAN NA, 1992, J CELL BIOCHEM, V48, P172, DOI 10.1002/jcb.240480209
   Guzman NA, 1998, CHEM ANAL SERIES MON, V146, P879
   GUZMAN NA, 1989, TECHNIQUES PROTEIN C, P456
   Haginaka J, 2000, J CHROMATOGR A, V875, P235, DOI 10.1016/S0021-9673(99)01168-1
   He JY, 1996, ANAL SCI, V12, P177, DOI 10.2116/analsci.12.177
   Heegaard NHH, 1998, J CHROMATOGR B, V715, P29, DOI 10.1016/S0378-4347(98)00258-8
   Heiger D. N., 1992, HIGH PERFORMANCE CAP
   Hempel G, 2000, ELECTROPHORESIS, V21, P691, DOI 10.1002/(SICI)1522-2683(20000301)21:4<691::AID-ELPS691>3.0.CO;2-U
   HERNANDEZ L, 1991, J CHROMATOGR, V559, P183, DOI 10.1016/0021-9673(91)80069-S
   HERNANDEZ L, 1990, J CHROMATOGR, V502, P247, DOI 10.1016/S0021-9673(01)89589-3
   Herring CJ, 1999, RAPID COMMUN MASS SP, V13, P1, DOI 10.1002/(SICI)1097-0231(19990115)13:1<1::AID-RCM435>3.0.CO;2-A
   HOYT AM, 1993, J MICROCOLUMN SEP, V5, P325, DOI 10.1002/mcs.1220050405
   Jankowiak R, 2000, ELECTROPHORESIS, V21, P1251, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1251::AID-ELPS1251>3.0.CO;2-D
   JELLUM E, 1994, J CAPILLARY ELECTROP, V1, P97
   Jenkins MA, 1997, J CHROMATOGR B, V699, P257, DOI 10.1016/S0378-4347(97)00180-1
   Jenkins MA, 1996, J CHROMATOGR B, V682, P23, DOI 10.1016/0378-4347(95)00552-8
   Jonler Morten, 1994, Drugs, V47, P66
   Kasicka V, 1999, ELECTROPHORESIS, V20, P3084, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3084::AID-ELPS3084>3.0.CO;2-4
   KIESEL L, 1989, J CLIN ENDOCR METAB, V68, P1167, DOI 10.1210/jcem-68-6-1167
   King C, 1998, Clin Lab Sci, V11, P44
   Kinoshita M, 2000, J CHROMATOGR A, V866, P261, DOI 10.1016/S0021-9673(99)01080-8
   Knudsen CB, 1997, J CHROMATOGR A, V792, P463, DOI 10.1016/S0021-9673(97)00857-1
   Kricka LJ, 1998, CLIN CHEM, V44, P2008
   Kutter D, 1998, CLIN CHEM LAB MED, V36, P929, DOI 10.1515/CCLM.1998.161
   LANDERS JP, 1995, CLIN CHEM, V41, P495
   Lehmann R, 1997, J CHROMATOGR B, V697, P3, DOI 10.1016/S0378-4347(97)00183-7
   Lehmann R, 1996, J CAPILLARY ELECTROP, V3, P89
   Lorincz AE, 1999, ANN CLIN LAB SCI, V29, P169
   Manetto G, 2000, THER DRUG MONIT, V22, P84, DOI 10.1097/00007691-200002000-00018
   Marshall T, 1998, ELECTROPHORESIS, V19, P1752, DOI 10.1002/elps.1150191037
   MCDERMOTT JR, 1983, PEPTIDES, V4, P25, DOI 10.1016/0196-9781(83)90160-2
   MCDERMOTT JR, 1981, REGUL PEPTIDES, V2, P69, DOI 10.1016/0167-0115(81)90001-X
   METCALF G, 1982, BRAIN RES REV, V4, P389, DOI 10.1016/0165-0173(82)90012-1
   Miller C, 1998, J PEPT RES, V51, P444
   Misdraji J, 1996, Postgrad Med, V100, P173
   NERENBER C, 1984, ANAL BIOCHEM, V15, P10
   PARK SS, 1996, METHODS MOL BIOL NEU, P101
   PAVONEMACALUSO M, 1991, EUR UROL, V1, P41
   Perrett D, 1999, ANN CLIN BIOCHEM, V36, P133, DOI 10.1177/000456329903600202
   Phillips TM, 1998, ELECTROPHORESIS, V19, P2991, DOI 10.1002/elps.1150191632
   PHILLIPS TM, 1994, BIOMED CHROMATOGR, V8, P242, DOI 10.1002/bmc.1130080509
   REISSMANN T, 1995, HUM REPROD, V10, P1974, DOI 10.1093/oxfordjournals.humrep.a136219
   Schally AV, 1999, PEPTIDES, V20, P1247, DOI 10.1016/S0196-9781(99)00130-8
   SCHALLY AV, 1978, SCIENCE, V202, P18, DOI 10.1126/science.99816
   SCHLEGEL PN, 1994, ADV INTERNAL MED, V39, P569
   Settlage RE, 1998, J MICROCOLUMN SEP, V10, P281, DOI 10.1002/(SICI)1520-667X(1998)10:3<281::AID-MCS7>3.0.CO;2-C
   STRAUSBAUCH MA, 1995, J CHROMATOGR A, V717, P279, DOI 10.1016/0021-9673(95)00743-6
   Strausbauch MA, 1996, ANAL CHEM, V68, P306, DOI 10.1021/ac9503217
   STRAUSBAUCH MA, 1995, ELECTROPHORESIS, V16, P541, DOI 10.1002/elps.1150160189
   SWARTZ ME, 1993, J CHROMATOGR, V632, P209, DOI 10.1016/0021-9673(93)80046-B
   Swinney K, 2000, ELECTROPHORESIS, V21, P1239, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1239::AID-ELPS1239>3.0.CO;2-6
   Swinney K, 2000, CRIT REV ANAL CHEM, V30, P1, DOI 10.1080/10408340091164162
   Timerbaev AR, 1998, J CAPILLARY ELECTROP, V5, P185
   Tomlinson AJ, 1996, J CHROMATOGR A, V744, P3, DOI 10.1016/0021-9673(96)00332-9
   Tomlinson AJ, 1995, J CAPILLARY ELECTROP, V2, P247
   Tong W, 1999, ANAL CHEM, V71, P2270, DOI 10.1021/ac9901182
   UENO H, 1991, J CHROMATOGR-BIOMED, V566, P57, DOI 10.1016/0378-4347(91)80110-X
   von Heeren F, 1997, ELECTROPHORESIS, V18, P2415, DOI 10.1002/elps.1150181232
   von Schalburg KR, 1999, BIOL REPROD, V60, P1338, DOI 10.1095/biolreprod60.6.1338
   Wan H, 1999, ELECTROPHORESIS, V20, P2705, DOI 10.1002/(SICI)1522-2683(19990901)20:13<2705::AID-ELPS2705>3.3.CO;2-7
   Wijnen PAHM, 1996, EUR J CLIN CHEM CLIN, V34, P535
   Yahalom D, 2000, MOL PHARMACOL, V57, P718
   Yang Q, 1999, ANAL CHEM, V71, p183A, DOI 10.1021/ac990246q
   Zaugg S, 2000, J CHROMATOGR A, V875, P27, DOI 10.1016/S0021-9673(99)01042-0
NR 115
TC 61
Z9 62
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4347
J9 J CHROMATOGR B
JI J. Chromatogr. B
PD DEC 1
PY 2000
VL 749
IS 2
BP 197
EP 213
DI 10.1016/S0378-4347(00)00410-2
PG 17
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 378MM
UT WOS:000165588200007
PM 11145057
DA 2018-10-19
ER

PT J
AU Sepulveda, P
   Ortega, FS
   Innocentini, MDM
   Pandolfelli, VC
AF Sepulveda, P
   Ortega, FS
   Innocentini, MDM
   Pandolfelli, VC
TI Properties of highly porous hydroxyapatite obtained by the gelcasting of
   foams
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID CELLULAR CERAMICS
AB Open-cell hydroxyapatite (HA) foams, produced through the novel technique of gelcasting foams with relative porosities ranging from 0.72 to 0.90, were characterized for pore-size distribution, surface area, permeability, compressive strength, elastic modulus, and microstructural features. The porous structure, which is composed of an array of spherical cells interconnected through windows, had a mode pore diameter in the range 17-122 mum, as demonstrated by mercury porosimetry, The BET specific surface area increased from 1.5 to 3.8 m(2)/g as the sample porosity increased. The compressive strength and elastic modulus were in the range 1.6-5.8 MPa and 3.6-21.0 GPa, respectively. The permeability constants, k(1) (Darcian) and k(2) (non-Darcian), were strongly dependent on porosity fraction and varied widely, from 1.22 x 10(-11) to 4.31 x 10(-10) m(2) and from 1.75 x 10(-6) to 8.06 x 10(-5) m, respectively. This combination of properties make the HA foams suitable for a variety of potential applications in the biomedical field, preferentially nonloading, including materials for bone repair, carriers for controlled drug-delivery systems, and matrixes for tissue engineering.
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Sepulveda, P (reprint author), Univ London Imperial Coll Sci Technol & Med, London, England.
RI Sepulveda, Pilar/D-4093-2009; Ortega, Fernando/J-9762-2012; Innocentini,
   Murilo/B-8775-2012
OI Ortega, Fernando/0000-0001-5915-2453; Innocentini,
   Murilo/0000-0002-5396-7798
CR Brezny R., 1987, J AM CERAM SOC, V70, P827
   FABRI M, 1995, BIOMATERIALS, V16, P225
   Gibson LJ, 1997, CAMBRIDGE SOLID STAT
   HENCH LL, 1993, INTRO BIOCERAMICS
   Innocentini MDM, 1998, J AM CERAM SOC, V81, P3349, DOI 10.1111/j.1151-2916.1998.tb02782.x
   INNOCENTINI MDM, 1999, B AM CERAM SOC, V78, P78
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
NR 11
TC 161
Z9 178
U1 3
U2 45
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, PO BOX 6136, WESTERVILLE, OH 43081-6136 USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD DEC
PY 2000
VL 83
IS 12
BP 3021
EP 3024
DI 10.1111/j.1151-2916.2000.tb01677.x
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 381DD
UT WOS:000165746300020
DA 2018-10-19
ER

PT J
AU Ektessabi, AM
   Yamaguchi, K
AF Ektessabi, AM
   Yamaguchi, K
TI Changes in chemical states of PET films due to low and high energy
   oxygen ion beam
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 27th International Conference on Metallurgical Coatings and Thin Films
CY APR 10-14, 2000
CL SAN DIEGO, CALIFORNIA
SP Amer Vacuum Soc, Adv Surface Engn Div
DE oxygen ion beam irradiation; polymer; XPS; high energy ion beam
ID POLY(METHYL METHACRYLATE); SURFACE; XPS; POLYSTYRENE; IRRADIATION;
   POLYIMIDE; AFM
AB The effects of low (1.0, 3.0 keV) and high (1.0 MeV) energy reactive oxygen ion beam irradiation on surface nano-morphology and chemical state of the constituent elements in the surface layer of a polyethylene terephthalate thin him (thickness 25 mum) are studied in this paper. PET thin film, which has a high potential as a material for biomedical and electrical industries, was irradiated by oxygen ions of variable doses. The treated films were investigated by Atomic Force Microscopy (AFM) and X-ray Photoelectron Spectroscopy (XPS). AFM observation revealed that an increase in dose increased the surface roughness. The significant changes in the chemical composition of the surface layer were confirmed by XPS quantitatively. The scission of the chains in the surface layer of PET film was induced by oxygen ion beam irradiation, and the atomic ratio (O1s/C1s) was decreased. The selective sputtering of oxygen atoms in PET film was occurred. This phenomenon is responsible for the creation of carbon-rich surface layer. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Kyoto Univ, Grad Sch Engn, Dept Precis Engn, Sakyo Ku, Kyoto 6068501, Japan.
RP Ektessabi, AM (reprint author), Kyoto Univ, Grad Sch Engn, Dept Precis Engn, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.
CR BOULANGER P, 1993, J ELECTRON SPECTROSC, V63, P53, DOI 10.1016/0368-2048(93)85014-C
   BRIGGS D, 1990, PRACTICAL SURFACE AN
   CALCAGNO L, 1993, J APPL PHYS, V74, P7572, DOI 10.1063/1.354983
   CALCAGNO L, 1992, PHYS REV B, V46, P10573, DOI 10.1103/PhysRevB.46.10573
   De Bonis A, 1999, NUCL INSTRUM METH B, V151, P101, DOI 10.1016/S0168-583X(99)00135-4
   Eckstein W., 1991, COMPUTER SIMULATION
   Ektessabi AM, 2000, REV SCI INSTRUM, V71, P1012, DOI 10.1063/1.1150375
   Ektessabi AM, 2000, THIN SOLID FILMS, V377, P621, DOI 10.1016/S0040-6090(00)01444-9
   GODOVSKY YK, 1992, THERMOPHYSICAL PROPE, pCH2
   Hayes NW, 1996, SURF INTERFACE ANAL, V24, P723, DOI 10.1002/(SICI)1096-9918(19960930)24:10<723::AID-SIA186>3.0.CO;2-Y
   LIDE DR, 1992, CRC HDB CHEM PHYSICS
   MARLETTA G, 1990, NUCL INSTRUM METH B, V46, P295, DOI 10.1016/0168-583X(90)90716-8
   PAPALEO RM, 1996, PHYS REV B, V53
   Pignataro B, 1997, NUCL INSTRUM METH B, V131, P141, DOI 10.1016/S0168-583X(97)00297-8
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   SOMMER F, 1995, LANGMUIR, V11, P440, DOI 10.1021/la00002a013
   Svorcik V, 1998, NUCL INSTRUM METH B, V142, P349, DOI 10.1016/S0168-583X(98)00288-2
   Svorcik V, 1999, POLYM DEGRAD STABIL, V65, P131, DOI 10.1016/S0141-3910(98)00228-6
   Svorcik V, 1998, MATER LETT, V36, P128, DOI 10.1016/S0167-577X(98)00030-5
   UENO K, 1991, NUCL INSTRUM METH B, V59, P1263
   VENKATESAN T, 1987, ION BEAM MODIFICATIO, V2, P8
   Voronin G, 2000, NUCL INSTRUM METH B, V161, P1118, DOI 10.1016/S0168-583X(99)00988-X
   VORONIN G, 2000, METHODS PHYS RES B, V161, P1118
   WONG PC, 1995, APPL SURF SCI, V84, P245, DOI 10.1016/0169-4332(94)00549-4
NR 24
TC 44
Z9 45
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD DEC 1
PY 2000
VL 377
BP 793
EP 797
DI 10.1016/S0040-6090(00)01454-1
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 385VD
UT WOS:000166024600135
DA 2018-10-19
ER

PT J
AU Teoh, SH
AF Teoh, SH
TI Fatigue of biomaterials: a review
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Review
DE fatigue; biomaterials; wear debris; host tissue reaction; fatigue and
   wear resistant
ID CARBON-COATED GRAPHITE; MECHANICAL HEART-VALVE; CYCLIC FATIGUE;
   BIOMEDICAL APPLICATIONS; FRACTURE-TOUGHNESS; CRACK PROPAGATION; LIFE
   PREDICTION; WEAR; POLYETHYLENE; BEHAVIOR
AB Fatigue fracture and wear have been identified as some of the major problems associated with implant failure of medical devices. The actual in vivo mechanisms are complex and involve the hostile body environment. The response of the host tissue to wear debris is a real issue. Fatigue-wear corrosion and environmental stress cracking are common. Although fatigue fracture and wear are frequently reported in orthopaedic applications such as hip joint prostheses, they can be fatal in mechanical heart valves. While it is not possible to avoid failure, recent work has focused on predictive tools to enable more accurate prediction so as to avoid catastrophic failure in vivo. This paper presents an overview of fatigue fracture problems in metallic, polymeric and ceramic implant materials, looks at some recent techniques of testing and discusses the future development of fracture and wear resistant biomaterials. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Ctr Biomed Mat Applicat & Technol, Lab Biomed Engn,Inst Engn Sci, Singapore 119260, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Dept Mech & Prod Engn, Ctr Biomed Mat Applicat & Technol, Lab Biomed Engn,Inst Engn Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   BERGER G, 1989, P 15 INT C GLASS A, V3, P120
   Black J, 1998, HDB BIOMATERIALS P 2
   Black J, 1999, BIOL PERFORMANCE MAT
   CAI HD, 1994, J MATER RES, V9, P762, DOI 10.1557/JMR.1994.0762
   CHO SJ, 1989, J AM CERAM SOC, V72, P249
   CHOW AB, 1994, T 20 ANN M SOC BIOM, P434
   CLARKE I, 1980, MECH PROPERTIES BIOM, P27
   DAUSKARDT RH, 1994, J BIOMED MATER RES, V28, P791, DOI 10.1002/jbm.820280706
   DUMBLETON JH, 1979, ASTM STP, V684, P41
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   EVAN AG, 1980, INT J FRACTURE, V108, P153
   FRANZEN H, 1990, ACTA ORTHOP SCAND, V61, P499, DOI 10.3109/17453679008993570
   GIBBSON DF, 1979, ASTM STP, V684, P20
   Greco R., 1994, IMPLANTATION BIOL HO
   KELLY JR, 1995, DENT MATER, V11, P103, DOI 10.1016/0109-5641(95)80043-3
   KELPETKO V, 1989, J THORAC CARDIOVASC, V97, P90
   Kepner J, 1996, J HEART VALVE DIS, V5, pS50
   KOKUBO T, 1989, MULTIPHASE BIOMEDICA
   LI J, 1998, HDB BIOMATERIALS PRO, P341
   LLOYD CH, 1984, J ORAL REHABIL, V11, P257, DOI 10.1111/j.1365-2842.1984.tb00575.x
   LUCKEY HA, 1980, MECH PROPERTIES BIOM, P311
   MANSON SS, 1971, ASTM STP, V495, P254
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Medley JB, 1997, P I MECH ENG H, V211, P89, DOI 10.1243/0954411971534719
   Paris P, 1963, J BASIC ENG, V85, P528, DOI DOI 10.1115/1.3656900
   Pruitt L, 1998, POLYMER, V39, P1545, DOI 10.1016/S0032-3861(97)00448-5
   Reul H, 1996, J HEART VALVE DIS, V5, pS97
   RITCHIE RO, 1991, NIPPON SERAM KYO GAK, V99, P1047
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   RITCHIE RO, 1991, P ENG FDN INT C SANT, P485
   SAIKAYA M, 1992, STRUCTURE CELLULAR S, pCH1
   SEMLITSCH M, 1984, METAL CERAMIC BIOMAT, V2, P1
   STJOHN KR, 1992, ASTM STP, V1144
   Suresh S., 1998, FATIGUE MAT
   SYRETT BC, 1979, ASTM STP, V684
   TAIRA M, 1992, J BIOMED MATER RES, V26, P1131, DOI 10.1002/jbm.820260903
   Teoh S H, 1993, ASAIO J, V39, P929
   Teoh S. H., 1992, International Journal of Damage Mechanics, V1, P245, DOI 10.1177/105678959200100205
   Teoh S H, 1990, ASAIO Trans, V36, pM417
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   Teoh SH, 1998, WEAR, V214, P237, DOI 10.1016/S0043-1648(97)00231-7
   TEOH SH, 1994, AM SOC TEST MATER, V1173, P77, DOI 10.1520/STP18095S
   TEOH SH, 1993, BIOMATERIALS, V14, P132, DOI 10.1016/0142-9612(93)90226-R
   TEOH SH, 1990, POLYMER, V31, P2260, DOI 10.1016/0032-3861(90)90311-L
   TEOH SH, 1994, AM SOC TEST MATER, V1173, P43, DOI 10.1520/STP18092S
   TRAINOR A, 1980, MECH PROPERTIES BIOM, P65
   TRUONG VT, 1988, DENT MATER, V4, P318, DOI 10.1016/S0109-5641(88)80044-7
   TSURUTA T, 1989, MULIPHASE BIOMEDICAL
   *US DHHS, 1994, REPL HEART VALV GUID
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Yamada H, 1970, STRENGTH BIOL MAT
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
NR 54
TC 187
Z9 188
U1 1
U2 77
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD NOV
PY 2000
VL 22
IS 10
BP 825
EP 837
DI 10.1016/S0142-1123(00)00052-9
PG 13
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 373WU
UT WOS:000165313700002
DA 2018-10-19
ER

PT J
AU Niinomi, M
   Saga, A
   Fukunaga, K
AF Niinomi, M
   Saga, A
   Fukunaga, K
TI Long crack growth behavior of implant material Ti-5Al-2.5Fe in air and
   simulated body environment related to microstructure
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Article
DE Ti-5Al-2.5Fe; Ti-6Al-4V ELI; SUS 316L stainless steel; implant material;
   fatigue crack propagation; crack closure; secondary crack; fracture
   surface roughness; microstructure
ID FATIGUE
AB The fatigue crack propagation behavior of Ti-5Al-2.5Fe with various microstructures for biomedical applications was investigated in air and in a simulated body environment, Ringer's solution, in comparison with that of Ti-6Al-4V ELI and that of SUS 316L stainless steel. The crack propagation rate, da/dN, of Ti-5Al-2.5Fe in the case of each microstructure is greater than that of the Widmanstatten alpha structure in Ti-6Al-4V ELI in air whereas da/dN of Ti-5Al-2.5Fe is nearly equal to that of the equiaxed a structure in Ti-6Al-4V ELI in air when da/dN is plotted versus the nominal cyclic stress intensity factor range, DeltaK. da/dN of the equiaxed a structure and that of the Widmanstatten a structure in Ti-5Al-2.5Fe are nearly the same in air when da/dN is plotted Versus DeltaK. da/dN of Ti-5Al-2.5Fe is nearly equal to that of SUS 316L stainless steel in the Paris Law region, whereas da/dN of Ti-5Al-2.5Fe is greater than that of SUS 316L stainless steel in the threshold region in air, when da/dN is plotted versus DeltaK. da/dN of Ti-5Al-2.5Fe or Ti-6Al-4V ELI is nearly the same in air and in Ringer's solution when da/dN is plotted versus the effective cyclic stress intensity factor range, DeltaK(eff), whereas da/dN of Ti-5Al-2.5Fe or Ti-6Al-4V ELI is greater in Ringer's solution than in air when da/dN is plotted versus DeltaK. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR *ASTM, 1997, E64795A ASTM
   *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   *ASTM, 1992, F129592 ASTM
   CHOI SD, 1997, J JAPAN SOC MECH ENG, V63, P2387
   *ISO, 1994, 583211 ISO
   *ISO, 1994, 583210 ISO
   MCCARVER JF, 1982, MATER SCI ENG, V55, P63, DOI 10.1016/0025-5416(82)90084-2
   MINAKAWA K, 1989, TETSU TO HAGANE, V75, P1104, DOI 10.2355/tetsutohagane1955.75.7_1104
   SUMITA M, 1988, TETSU TO HAGANE, V74, P1854, DOI 10.2355/tetsutohagane1955.74.9_1854
   ZWICKER R, 1980, TITANIUM 80 SCI TECH, P505
NR 11
TC 10
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD NOV
PY 2000
VL 22
IS 10
BP 887
EP 897
DI 10.1016/S0142-1123(00)00058-X
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 373WU
UT WOS:000165313700008
DA 2018-10-19
ER

PT J
AU Johnson, GS
   Mucalo, MR
   Lorier, MA
   Gieland, U
   Mucha, H
AF Johnson, GS
   Mucalo, MR
   Lorier, MA
   Gieland, U
   Mucha, H
TI The processing and characterization of animal-derived bone to yield
   materials with biomedical applications. Part II: milled bone powders,
   reprecipitated hydroxyapatite and the potential uses of these materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMMOBILIZATION
AB Further studies on the processing and use of animal-bone-derived calcium phosphate materials in biomedical applications are presented. Bone powders sourced either from the direct crushing and milling of bovine, ovine and cervine bone or after being subjected to defatting and acid digestion/NaOH reprecipitation and sodium hypochlorite hydrogen peroxide treatment of animal bones were characterized using Fourier transform infra-red (FTIR) spectroscopy, C-13 solid state magic angle spinning (MAS) nuclear magnetic resonance (NMR) spectroscopy, atomic absorption (AA) and inductively coupled plasma (ICP) spectrometric techniques. Bone powders were trialled for their potential use as a substrate for phosphine coupling and enzyme immobilization as well as a feedstock powder for plasma spraying on titanium metal substrates. Results indicated that enzyme immobilization by phosphine coupling could be successfully achieved on milled cervine bone with the immobilized enzyme retaining some activity. It was found that the presence of impurities normally carried down with the processing of the bone materials (viz., fat and collagen) played an important role in influencing the adsorbency and reactivity of the powders. Plasma spraying studies using reprecipitated bovine-derived powders produced highly adherent coatings on titanium metal, the composition of which was mostly hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) with low levels of alpha-tricalcium phosphate (alpha-Ca-3(PO4)(2)) and tetracalcium phosphate (Ca4P2O9) also detected. In general, animal derived calcium phosphate materials constitute a potentially cheaper source of calcium phosphate materials for biomedical applications and make use of a largely under-utilized resource from abattoir wastes. (C) 2000 Kluwer Academic Publishers.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
   MIRINZ Food Technol & Res Ltd, Hamilton, New Zealand.
   Chemnitz Tech Univ, Inst Verbundwerkstoffe, D-09125 Chemnitz, Germany.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR *ASS OFF AN CHEM, 1995, AOAC INT, V2, P7
   *ASTEMF, 118588 ASTEMF
   Cochrane FC, 1996, ENZYME MICROB TECH, V18, P373, DOI 10.1016/0141-0229(95)00134-4
   EVERSE J, 1981, METHOD BIOCHEM ANAL, P135
   FRAYSSINET P, 1995, J MATER SCI-MATER M, V6, P473, DOI 10.1007/BF00123372
   HENCH L, 1993, ADV SERIES CERAMICS, V1, P154
   HENDERSON W, 1994, J CHEM SOC CHEM COMM, P1863, DOI 10.1039/c39940001863
   HENDERSON W, 1994, EUR POLYM J, V31, P981
   HENDERSON W, COMMUNICATION
   JOHNSON GS, IN PRESS J MAT SCI M
   KANO S, 1992, APATITE, V1, P91
   KEMP W, 1986, NMR CHEM MULTINUCLEA, P217
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   PETACH HH, 1994, J CHEM SOC CHEM COMM, P2181, DOI 10.1039/c39940002181
   Savarino L, 1998, J MATER SCI-MATER M, V9, P109, DOI 10.1023/A:1008855216755
   *US PHARM CONV INC, 1985, US PHARM 21 REV, P1104
   Weil E. D., 1992, HDB ORGANOPHOSPHORUS
   YETERDAL BF, 1992, P INT CER C AUSTR 19, P617
NR 18
TC 22
Z9 24
U1 2
U2 15
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2000
VL 11
IS 11
BP 725
EP 741
DI 10.1023/A:1008979929632
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359KX
UT WOS:000089611000009
PM 15348079
DA 2018-10-19
ER

PT J
AU Anderson, LA
   Mucalo, MR
   Johnson, GS
   Lorier, MA
AF Anderson, LA
   Mucalo, MR
   Johnson, GS
   Lorier, MA
TI The processing and characterization of animal-derived bone to yield
   materials with biomedical applications. Part III: material and
   mechanical properties of fresh and processed bovine cancellous bone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BEHAVIOR; MODULUS
AB Conversion of bovine cancellous bone to a useful biomedical xenograft material involves several processing steps which include boiling, defatting and deproteination (i.e. bleaching). This study has shown how these processes can influence cancellous bone modulus and strength. It was found that prolonged boiling in water for six hours followed by NaOCI bleaching had a deleterious effect on the overall strength of the bovine bone. In contrast, bone samples subjected to only moderate boiling (1.5 hours) exhibited a 22% stiffness increase due mainly to the effects of drying. The same stiffened samples, when subjected to the bleaching procedure, retained some strength with only a small reduction in moduli values. It can be concluded that careful control of defatting and bleaching procedures on bovine bone is able to give a strong, albeit, brittle material with preservation of the original bone architecture. The bone xenograft materials are worthy of further investigation in in vivo clinical trials to assess their performance in contact with biological fluids. (C) 2000 Kluwer Academic Publishers.
C1 Ind Res Ltd, Engn Dynam Team, Auckland, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
   MIRINZ Food Technol & Res Ltd, Hamilton, New Zealand.
RP Anderson, LA (reprint author), Ind Res Ltd, Engn Dynam Team, POB 2225, Auckland, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR *AM SOC MET, MET HDB, V2, P117
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   Evans F. G., 1973, MECH PROPERTIES BONE
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   GONG JK, 1964, ANAT REC, V149, P325, DOI 10.1002/ar.1091490303
   JOHNSON GS, 2000, IN PRESS J MAT SCI M
   KEAVENY TM, 1994, J BIOMECH, V27, P1137, DOI 10.1016/0021-9290(94)90054-X
   LINDE F, 1989, J BIOMECH, V22, P485, DOI 10.1016/0021-9290(89)90209-1
   PIEKARSKI K, 1973, INT J ENG SCI, V11, P557, DOI 10.1016/0020-7225(73)90018-9
   SINGH I, 1978, J ANAT, V127, P305
   TOWNSEND PR, 1975, J BIOMECH, V8, P199, DOI 10.1016/0021-9290(75)90025-1
   TURNER C H, 1989, Journal of Biomechanical Engineering, V111, P256
   TURNER CH, 1988, J BIOMECH ENG-T ASME, V110, P213, DOI 10.1115/1.3108433
NR 13
TC 15
Z9 15
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2000
VL 11
IS 11
BP 743
EP 749
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359KX
UT WOS:000089611000010
PM 15348080
DA 2018-10-19
ER

PT J
AU El Fray, M
   Bartkowiak, A
   Prowans, P
   Slonecki, J
AF El Fray, M
   Bartkowiak, A
   Prowans, P
   Slonecki, J
TI Physical and mechanical behavior of electron-beam irradiated and
   ethylene oxide sterilized multiblock polyester
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLYACTIVE(TM); COPOLYMERS
AB The effect of two sterilization treatments (electron-beam radiation and ethylene oxide gas) on the structure and mechanical properties of a multiblock copolymer were investigated to establish the effects of the sterilizing procedures on potential biomedical material. The material was exposed for different radiation doses in order to find an optimum dose of electron-beam radiation. Characterization techniques employed include gel permeation chromatography, infrared spectroscopy, differential scanning calorimetry, dynamic mechanical thermal analysis and tensile testing. The optimal dose of radiation at which no change in structure and mechanical properties occurred was found as 25 kGy. Ethylene oxide gas treatment also did not affect the structure and properties of the polymer and it can be recommended as an alternative sterilization route for the studied polymer. (C) 2000 Kluwer Academic Publishers.
C1 Tech Univ Szczecin, Sect Elastomers & Polymer Fibers Technol, PL-70322 Szczecin, Poland.
   Tech Univ Szczecin, Inst Polymer, PL-70322 Szczecin, Poland.
   Pomeranian Acad Med, Szczecin, Poland.
RP El Fray, M (reprint author), Tech Univ Szczecin, Sect Elastomers & Polymer Fibers Technol, Pulaskiego 10 Str, PL-70322 Szczecin, Poland.
RI Bartkowiak, Artur/C-3322-2011; El Fray, Miroslawa/J-4128-2016; Prowans,
   Piotr/B-5495-2015
OI Prowans, Piotr/0000-0002-6102-364X; El Fray,
   Miroslawa/0000-0002-2474-3517
CR ADAMS RK, 1996, THERMOPLASTIC ELASTO, P192
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BAKKUM EA, 1995, J MATER SCI-MATER M, V6, P41, DOI 10.1007/BF00121246
   Bouwmeester SJM, 1998, J MATER SCI-MATER M, V9, P181, DOI 10.1023/A:1008875821298
   CAMBERLIN Y, 1984, J POLYM SCI POL PHYS, V22, P1835, DOI 10.1002/pol.1984.180221011
   Domb AJ, 1994, BIOMEDICAL POLYM, P69
   El Fray M, 1998, J MACROMOL SCI PHYS, VB37, P143
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   ELFRAY M, 1996, KAUTSCH GUMMI KUNSTS, V10, P691
   Hoeschele G K, 1976, Patent No. [US 3954689, 3954689]
   LEMBICZ F, 1991, KAUT GUMMI KUNSTST, V44, P668
   Lembicz F, 1998, J MACROMOL SCI PHYS, VB37, P161, DOI 10.1080/00222349808220464
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   MacRae HM, 1997, SURGERY, V122, P335, DOI 10.1016/S0039-6060(97)90025-8
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   RADDER AM, 1995, J MATER SCI-MATER M, V6, P510, DOI 10.1007/BF00151031
   Shivers Jr J. C., 1962, US patent, Patent No. [3,023,192, 3023192]
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
NR 18
TC 22
Z9 22
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2000
VL 11
IS 11
BP 757
EP 762
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359KX
UT WOS:000089611000012
PM 15348082
DA 2018-10-19
ER

PT J
AU Cooper, LF
AF Cooper, LF
TI A role for surface topography in creating and maintaining bone at
   titanium endosseous implants
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Review
ID OSTEOBLAST-LIKE CELLS; SINGLE-TOOTH IMPLANTS; ACID-ETCHED SURFACE;
   RABBIT INTRAMEDULLARY MODEL; COMMERCIALLY PURE TITANIUM; SCREW-SHAPED
   IMPLANTS; DENTAL IMPLANTS; IN-VIVO; HISTOMORPHOMETRIC EVALUATION;
   MINIATURE PIGS
AB Statement of problem. A variety of claims are made regarding the effects of surface topography on implant osseointegration. Many in vivo and in vitro experimental observations have key limitations in their interpretations.
   Purpose. This review considers the major claims made concerning the effects of commercially pure (cp) titanium implant surface topography on osseointegration. Important findings of consensus are highlighted, and, existing controversies are revealed.
   Material and methods. This review considers many of the research publications listed in MEDLINE and presented in biomedical research publications and textbooks.
   Results. Implant surface topography is not well defined in the marketplace or consistently reported among experimental studies. Many in vitro evaluations art. not predictive of or correlated with in vivo outcomes. In some culture models, increased surface topography positively affects pro-osteogenic cellular activities. Animal models reveal modest increases in bone-to-implant contact and increases in the biomechanical interlock of the implant with bone for implants of increased surface topography. Existing information fails to define increased surface topography as a risk factor for peri-implant inflammation.
   Conclusion. Increased cp titanium implant surface topography improves the bone-to-implant contact and the mechanical properties of the enhanced interface. Growing clinical evidence for increased bone-to-implant: contact at altered cp titanium implants confirms the temporally limited observations made in preclinical studies. In the absence of controlled comparative clinical trials, the aggregate experimental evidence supports the use of cp titanium implants with increased surface topography.
C1 Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA.
RP Cooper, LF (reprint author), Univ N Carolina, Sch Dent, Dept Prosthodont, 404 Brauer Hall,CB 7450, Chapel Hill, NC 27599 USA.
OI Cooper, Lyndon/0000-0002-6577-781X
CR ABRON A, IN PRESS J PROSTHET
   ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Babbush C A, 1993, Int J Oral Maxillofac Implants, V8, P245
   Baker D, 1999, INT J ORAL MAX IMPL, V14, P722
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BRUNSKI JB, 1979, J DENT RES, V58, P1953, DOI 10.1177/00220345790580100201
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Chen GF, 1998, BIO-MED MATER ENG, V8, P61
   Clokie C M, 1995, Int J Oral Maxillofac Implants, V10, P155
   Cochran DL, 1996, CLIN ORAL IMPLAN RES, V7, P240, DOI 10.1034/j.1600-0501.1996.070306.x
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Cole BJ, 1997, CLIN ORTHOP RELAT R, P219
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   Cooper LF, 1998, J PROSTHET DENT, V80, P439, DOI 10.1016/S0022-3913(98)70009-5
   D'Lima DD, 1998, J ARTHROPLASTY, V13, P928, DOI 10.1016/S0883-5403(98)90201-7
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deporter D, 1999, CLIN ORAL IMPLAN RES, V10, P95, DOI 10.1034/j.1600-0501.1999.100203.x
   Deporter D A, 1996, Int J Oral Maxillofac Implants, V11, P87
   Drummond J F, 1995, J Oral Implantol, V21, P295
   Edge M J, 1988, Int J Oral Maxillofac Implants, V3, P57
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   ERICSSON I, 1994, CLIN ORAL IMPLAN RES, V5, P202, DOI 10.1034/j.1600-0501.1994.050402.x
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   FROUM SJ, 2000, 86 ANN M AM AC PER H
   Garetto L P, 1995, Implant Dent, V4, P235, DOI 10.1097/00008505-199500440-00002
   Goodman S, 1996, ACTA ORTHOP SCAND, V67, P599, DOI 10.3109/17453679608997764
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Haas R, 1996, Int J Oral Maxillofac Implants, V11, P581
   Hammerle CHF, 1996, CLIN ORAL IMPLAN RES, V7, P111, DOI 10.1034/j.1600-0501.1996.070204.x
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5
   Hansson S, 1999, CLIN ORAL IMPLAN RES, V10, P394, DOI 10.1034/j.1600-0501.1999.100506.x
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Hure G, 1996, Int J Oral Maxillofac Implants, V11, P506
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   Karabuda C, 1999, INT J ORAL MAX IMPL, V14, P510
   Karlsson U, 1997, INT J PROSTHODONT, V10, P318
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KELLER J C, 1985, Dental Materials, V1, P41, DOI 10.1016/S0109-5641(85)80022-1
   Kemppainen P, 1997, J PROSTHET DENT, V77, P382, DOI 10.1016/S0022-3913(97)70163-X
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   KOVACS EJ, 1994, FASEB J, V8, P854
   La Budde J K, 1994, J Arthroplasty, V9, P291, DOI 10.1016/0883-5403(94)90084-1
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Lekholm U, 1996, Int J Oral Maxillofac Implants, V11, P599
   Levy D, 1996, J CLIN PERIODONTOL, V23, P517, DOI 10.1111/j.1600-051X.1996.tb01819.x
   Li JG, 1997, BIO-MED MATER ENG, V7, P379
   Li JG, 1997, BIOMATERIALS, V18, P691, DOI 10.1016/S0142-9612(96)00185-8
   Liao HH, 1997, CLIN ORAL IMPLAN RES, V8, P68, DOI 10.1111/j.1600-0501.1997.tb00009.x
   Lifland M. I., 1993, Clinical Materials, V14, P13, DOI 10.1016/0267-6605(93)90042-6
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Luthy H, 1987, Int J Oral Maxillofac Implants, V2, P197
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Masuda T, 1998, INT J ORAL MAX IMPL, V13, P17
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   Meredith N, 1998, CRIT REV BIOMED ENG, V26, P275, DOI 10.1615/CritRevBiomedEng.v26.i4.20
   MUSTAFA K, 2000, J DENT RES, V79, P101
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Norton MR, 1998, CLIN ORAL IMPLAN RES, V9, P91, DOI 10.1034/j.1600-0501.1998.090204.x
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Ohtsu A, 1997, J PERIODONTOL, V68, P270, DOI 10.1902/jop.1997.68.3.270
   Ong JL, 1997, INT J ORAL MAX IMPL, V12, P649
   OSBORN JF, 1990, ADV BIOMAT, V9, P75
   Palmer RM, 1997, CLIN ORAL IMPLAN RES, V8, P173, DOI 10.1034/j.1600-0501.1997.080303.x
   Pebe P, 1997, Implant Dent, V6, P259
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Ramp LC, 2000, INT J ORAL MAX IMPL, V15, P197
   Rasmusson L, 1998, INT J ORAL MAX SURG, V27, P229, DOI 10.1016/S0901-5027(98)80019-2
   Rimondini L, 1997, J PERIODONTOL, V68, P556, DOI 10.1902/jop.1997.68.6.556
   Roberts W E, 1988, J Dent Educ, V52, P804
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   Schliephake H, 1993, Int J Oral Maxillofac Implants, V8, P502
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   Smith DC, 1997, INT J ORAL MAX IMPL, V12, P828
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Stanford CM, 1999, J PROSTHET DENT, V81, P553, DOI 10.1016/S0022-3913(99)70209-X
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   TORGERSEN S, 1995, ACTA ODONTOL SCAND, V53, P65, DOI 10.3109/00016359509005948
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   Vaillancourt H, 1996, Int J Oral Maxillofac Implants, V11, P351
   Wang JC, 1999, SPINE, V24, P899, DOI 10.1097/00007632-199905010-00011
   WENNEBERG A, IN PRESS CLIN ORAL I
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
   Wennerberg A., 1996, THESIS U GOTHENBURG
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P340
   Wiskott HWA, 1999, CLIN ORAL IMPLAN RES, V10, P429, DOI 10.1034/j.1600-0501.1999.100601.x
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   YAMANAKA E, 1992, TRANSPLANTS IMPLANTS, V2, P245
NR 129
TC 194
Z9 202
U1 2
U2 37
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-3913
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD NOV
PY 2000
VL 84
IS 5
BP 522
EP 534
DI 10.1067/mpr.2000.111966
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 380JA
UT WOS:000165697000008
PM 11105008
DA 2018-10-19
ER

PT J
AU Biederman, H
AF Biederman, H
TI RF sputtering of polymers and its potential application
SO VACUUM
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Sputtering and Plasma Precesses (ISSP 99)
CY JUN 16-18, 1999
CL KANAZAWA, JAPAN
SP Japan Soc Appl Phys
ID PLASMA POLYMERIZATION; FILMS
AB Plasma polymerization processes are commonly used for the deposition of thin films of plasma polymers that have been proposed for a variety of applications ranging from surface modifications for biomedical purposes to optical coatings and variable and protective films in electronics. RF sputtering of polymeric materials in an inert gas (Ar) or in its own fragmented polymer vapours can be applied in order to avoid the conventional supply of gaseous monomer. Volatile fragments of polymeric target serve as plasma polymerization precursors in the case of RF sputtering. RF sputtering of polytetrafluoroethylene (PTFE), polyimide (PI), etc. are reviewed. Recent results from our laboratory on balanced and unbalanced magnetron RF sputtering of polytetrafluoroethylene and polyethylene (PE) are presented. The dependence of structure and morphology Of RF sputtered plasma polymers on plasma parameters and substrate temperature is discussed. In conclusion potential applications are summarized. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Charles Univ, Fac Math & Phys, Dept Macromol Phys, CR-18000 Prague 8, Czech Republic.
RP Biederman, H (reprint author), Charles Univ, Fac Math & Phys, Dept Macromol Phys, V Holesovickach 2, CR-18000 Prague 8, Czech Republic.
OI Biederman, Hynek/0000-0003-4061-8481
CR BIEDERMAN H, 1978, THIN SOLID FILMS, V55, pL11, DOI 10.1016/0040-6090(78)90170-0
   BIEDERMAN H, 1977, THIN SOLID FILMS, V41, P329, DOI 10.1016/0040-6090(77)90319-4
   Biederman H, 1997, J NON-CRYST SOLIDS, V218, P44, DOI 10.1016/S0022-3093(97)00196-8
   BIEDERMAN H, 1983, NUCL INSTRUM METHODS, V212, P497, DOI 10.1016/0167-5087(83)90735-4
   BIEDERMAN H, 1981, VACUUM, V31, P285, DOI 10.1016/S0042-207X(81)80498-8
   BIEDERMAN H, 1998, 3 C P PHYS CHEM MOL, P35
   BIEDERMAN H, 1992, PLAMA POLYMERISATION
   BIEDERMAN H, 1997, P ISPC 13, V3, P1264
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   HARROP R, 1969, THIN SOLID FILMS, V3, P109, DOI 10.1016/0040-6090(69)90083-2
   HISMEH GA, 1996, J VAC SCI TECHNOL A, V14, P1330
   HOLLAND L, 1997, THIN SOLID FILMS, V35, P19
   Kitoh M, 1995, THIN SOLID FILMS, V271, P92, DOI 10.1016/0040-6090(95)06697-7
   LEHMANN HW, 1978, THIN SOLID FILMS, V52, P231, DOI 10.1016/0040-6090(78)90141-4
   MARECHAL N, 1992, J VAC SCI TECHNOL A, V10, P477, DOI 10.1116/1.578174
   MORRISON DT, 1973, THIN SOLID FILMS, V15, P87, DOI 10.1016/0040-6090(73)90207-1
   PRATT IH, 1972, THIN SOLID FILMS, V10, P151, DOI 10.1016/0040-6090(72)90281-7
   ROY RA, 1983, THIN SOLID FILMS, V109, P27, DOI 10.1016/0040-6090(83)90028-7
   RYAN ME, 1995, J PHYS CHEM-US, V99, P7060, DOI 10.1021/j100018a044
   TIBBITT JM, 1975, THIN SOLID FILMS, V39, pL43
   YAMADA Y, 1990, SURF COAT TECH, V43-4, P618, DOI 10.1016/0257-8972(90)90006-X
NR 21
TC 63
Z9 64
U1 2
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD NOV-DEC
PY 2000
VL 59
IS 2-3
BP 594
EP 599
DI 10.1016/S0042-207X(00)00321-3
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 371BE
UT WOS:000165157100031
DA 2018-10-19
ER

PT J
AU Barroso, RC
   Lopes, RT
   Goncalves, OD
   de Jesus, EFO
AF Barroso, RC
   Lopes, RT
   Goncalves, OD
   de Jesus, EFO
TI Angle-dispersive diffraction with synchrotron radiation at Laboratorio
   Nacional de Luz Sincrotron (Brazil): potential for use in biomedical
   imaging
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article; Proceedings Paper
CT 4th Topical Meeting on the Industrial Radiation and Radioisotope
   Measurement Applications (IRRMA 99)
CY OCT 03-07, 1999
CL RALEIGH, NORTH CAROLINA
SP Amer Nuclear Soc, Isotopes & Radiat Div, Amer Nuclear Soc, Eastern Carolinas Sect, N Carolina State Univ, Ctr Engn Applicat Radioisotopes, Quantum Res Serv Inc
DE synchrotron radiation; X-ray diffraction; computed tomography; medical
   imaging
ID RAY-SCATTERING; TOMOGRAPHY
AB At low angles the scattering of X-rays in the diagnostic energy range (low-momentum transfer), it is probable that the scattering interaction will be coherent, This coherence gives rise to interference effects resulting in X-ray diffraction patterns that are characteristic of the scattering material. The usefulness of coherent scattering is not limited to crystallography. It can provide information about biological material as well. The interatomic and intermolecular co-operative effects which modify the Free-atom coherent scattering process are well known for highly ordered structures such as crystalline materials but are important for amorphous solids and liquids where short-range ordering occurs.
   X-ray diffraction using synchrotron radiation has became a well established technique. This work introduces a non-destructive synchrotron radiation X-ray diffraction imaging technique. The feasibility of the X-ray diffraction computed microtomography using synchrotron radiation has been investigated. This research was carried out at the X-ray diffraction beam line of the National Synchrotron Light Laboratory supported by the National Council for Scientific and Technological Development (LNLS/CNPq) in Brazil.
   These experimental patterns were carried out with a 500 mu m slit in front of the detector and an 11.101 keV beam (lambda=1.117 Angstrom) monochromatic beam from the double crystal monochromator. The diffracted beam was detected by a fast scintillation detector (10(6) counts s(-1)) designed specifically to meet the needs of high quality X-ray diffraction and synchrotron radiation experiments. The data were recorded at rates of one second per degree of 2 theta (angular steps equal to 0.05 +/- 0.010) and registered by a multichannel analyzer.
   These experimental data could be used to evaluate the scattering properties of different tissue-substitute (water, lucite, nylon, plastic and polystyrene) and bone-substitute (hydroxyapatite and aluminum) materials. The data are in good agreement with those obtained by other authors, indicating the feasibility of the imaging technique. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, COPPE, Lab Instrumentacao Nucl, BR-21945970 Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.
RP Lopes, RT (reprint author), Univ Fed Rio de Janeiro, COPPE, Lab Instrumentacao Nucl, POB 68-509, BR-21945970 Rio De Janeiro, Brazil.
RI Goncalves, Odair/J-2457-2016
CR Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   Barroso RC, 1999, NUCL INSTRUM METH A, V422, P718, DOI 10.1016/S0168-9002(98)01024-9
   BRADLEY DA, 1989, MED PHYS, V16, P851, DOI 10.1118/1.596310
   CARLSSON CA, 1999, PHYS MED BIOL, V44, pR23
   Csonka PL, 1999, NUCL INSTRUM METH A, V431, P306, DOI 10.1016/S0168-9002(99)00260-0
   Cusatis C, 1998, J SYNCHROTRON RADIAT, V5, P491, DOI 10.1107/S0909049598000685
   Elleaume H, 1999, NUCL INSTRUM METH A, V428, P513, DOI 10.1016/S0168-9002(99)00167-9
   GRANT JA, 1993, MEAS SCI TECHNOL, V4, P83, DOI 10.1088/0957-0233/4/1/014
   HARDING G, 1987, MED PHYS, V14, P515, DOI 10.1118/1.596063
   Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471
   ROYLE GJ, 1991, PHYS MED BIOL, V36, P383, DOI 10.1088/0031-9155/36/3/006
   SWANSON T, 1953, 539 NATL BUR STAND
   Westera G, 1996, EUR J NUCL MED, V23, P5, DOI 10.1007/BF01736983
NR 13
TC 3
Z9 4
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD OCT-NOV
PY 2000
VL 53
IS 4-5
BP 717
EP 724
DI 10.1016/S0969-8043(00)00211-6
PG 8
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 345TE
UT WOS:000088830600030
PM 11003511
DA 2018-10-19
ER

PT J
AU Lee, HJ
   Park, KD
   Park, HD
   Lee, WK
   Han, DK
   Kim, SH
   Kim, YH
AF Lee, HJ
   Park, KD
   Park, HD
   Lee, WK
   Han, DK
   Kim, SH
   Kim, YH
TI Platelet and bacterial repellence on sulfonated poly(ethylene
   glycol)-acrylate copolymer surfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE sulfonated-PEG acrylate copolymers; platelet adhesion; bacterial
   adhesion
ID POLYETHYLENE OXIDE; POLYURETHANE SURFACES; PROTEIN ADSORPTION;
   OXIDE)-GRAFTED POLYURETHANE; ADHESION; BIOCOMPATIBILITY; POLYMERS;
   TISSUES
AB Novel poly(ethylene glycol) (PEG) and sulfonated PEG (PEG-SO3) acrylate copolymers have been prepared and characterized to apply as coating and blending materials for biomedical applications. The modified surfaces using acrylate copolymers demonstrated increased hydrophilicity, possibly due to the hypothesized reorientation of PEG/PEG-SO3 chains into water phase. All copolymer surfaces demonstrated less platelet adhesion than control. In addition, platelet adhesion on copolymer surfaces decreased as the chain length of PEG and sulfonated PEG in copolymers increases. All copolymer surfaces reduced bacterial adhesion significantly and the adhesion level differs depending on surfaces as well as media. The obtained results attest to the usefulness of these copolymers as a coating or additive material to improve the blood compatibility of blood contacting devices. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
EM kdp@kist.re.kr
RI Park, Hee-Deung/D-2596-2013
OI Han, Dong Keun/0000-0003-4641-7883; Kim, Soo Hyun/0000-0002-8391-3686
CR BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HAN DK, 1993, ASAIO J, V39, P537
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kim YH, 1997, MACROMOL SYMP, V118, P565, DOI 10.1002/masy.19971180174
   KIM YH, 1997, SULFONATED POLYETHYL, P53
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   NAGAOKA S, 1995, ASAIO J, V41, pM365, DOI 10.1097/00002480-199507000-00032
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PARK KD, 1996, ASAIO J, V42, P876
   PARK KD, 1994, ASAIO J, V40, P377
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   SCHIERHOLZ J, 1991, NEW POLYM MAT, V3, P61
   SIOSHANISI P, 1993, MED PLASTICS BIOMATE, P50
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   Woodyard LL, 1996, J CONTROL RELEASE, V40, P23, DOI 10.1016/0168-3659(95)00135-2
NR 26
TC 36
Z9 37
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT
PY 2000
VL 18
IS 3-4
BP 355
EP 370
DI 10.1016/S0927-7765(99)00161-7
PG 16
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 345HG
UT WOS:000088810100017
DA 2018-10-19
ER

PT J
AU Barron, V
   Buggy, M
   Mas, A
   Schue, F
AF Barron, V
   Buggy, M
   Mas, A
   Schue, F
TI Durability of APC2/polyurethane adhesive joints for biomedical
   applications
SO INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES
LA English
DT Article
DE polyurethane (A); surface treatment by excited gases (B); contact angle
   (C); durability (D); carbon fibre-reinforced polyetheretherketone
ID THERMOPLASTIC FIBER COMPOSITES; CORONA-TREATED POLYPROPYLENE;
   PLASMA-TREATMENT; POLY(ETHYLENE-TEREPHTHALATE); PEEK
AB Thermoplastic polyurethane elastomer was thermally bonded to carbon fibre-reinforced polyetheretherketone (APC2) in the development of a biomedical device. Argon plasma treatment of the APC2 substrate was investigated as a means of enhancing bonding. Contact angle measurements were used to optimise the surface treatment and, it was observed that the wettability decreased on ageing. Kinetic analysis gave an activation energy of 25 kJ/mol, which was consistent with a bond rotation mechanism. Optimally treated substrates were bonded to polyurethane and bond stability at 37 degrees C was evaluated. While the bond was stable in air for over 1 year, storage in aqueous media lead to rapid deterioration of bond strength. This phenomenon was observed both in distilled water and in Ringer's solution. Measured diffusion rates for both environments were very similar and it is suggested that the observed faster rate of loss of bond strength in Ringer's solution is by the interaction of buffered components from the Ringers or solubilisation of low molecular weight material by the Ringers. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Limerick, Dept Mat Sci & Technol, Limerick, Ireland.
   Univ Montpellier 2, Lab Chim Macromol, F-34095 Montpellier 5, France.
RP Barron, V (reprint author), Univ Limerick, Dept Mat Sci & Technol, Limerick, Ireland.
RI Barron, Valerie/A-1468-2013; Barron, Valerie/C-5941-2014; Irish Centre
   for Composites, Research (ICOMP)/D-4887-2011
OI Barron, Valerie/0000-0001-5520-0649; 
CR Ameen AP, 1996, POLYM DEGRAD STABIL, V51, P179, DOI 10.1016/0141-3910(95)00187-5
   BARRON V, 1998, THESIS U LIMERICK
   BARRON VM, 1998, P AMPT 98 KUAL LUMP, P290
   BLACKMAN BRK, 1994, COMPOSITES, V25, P332, DOI 10.1016/S0010-4361(94)80003-0
   Bowditch MR, 1996, INT J ADHES ADHES, V16, P73, DOI 10.1016/0143-7496(96)00001-2
   BRENNAN WJ, 1991, POLYMER, V32, P1527, DOI 10.1016/0032-3861(91)90436-M
   CHATELIER RC, 1995, LANGMUIR, V11, P2576, DOI 10.1021/la00007a042
   Comyn J, 1996, INT J ADHES ADHES, V16, P97, DOI 10.1016/0143-7496(96)89798-3
   Comyn J., 1983, DURABILITY STRUCTURA, P85, DOI DOI 10.1002/(SICI)1099-0488(19971130)35:16<2659::AIDPOLB9>3.0.CO;2-K
   DAVIES P, 1991, J MATER SCI LETT, V10, P335, DOI 10.1007/BF00719701
   Hill JM, 1995, J ADHES SCI TECHNOL, V9, P1575, DOI 10.1163/156856195X00211
   *ICI, 1988, APC22 ICI FIB CORP P
   KINLOCH AJ, 1992, PHILOS T ROY SOC A, V338, P83, DOI 10.1098/rsta.1992.0004
   KINLOCH AJ, 1992, POLYM SCI ENG, V67, P19
   MOORE WJ, 1972, PHYSICAL CHEM, P766
   MUNRO HS, 1988, J COATINGS TECH, P41
   STROBEL JM, 1991, J ADHES SCI TECHNOL, V5, P119, DOI 10.1163/156856191X00080
   STROBEL M, 1992, J ADHES SCI TECHNOL, V6, P429, DOI 10.1163/156856192X00764
NR 18
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-7496
J9 INT J ADHES ADHES
JI Int. J. Adhes. Adhes.
PD OCT
PY 2000
VL 20
IS 5
BP 361
EP 366
DI 10.1016/S0143-7496(00)00009-9
PG 6
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 341BX
UT WOS:000088572100004
DA 2018-10-19
ER

PT J
AU Salih, V
   Franks, K
   James, M
   Hastings, GW
   Knowles, JC
   Olsen, I
AF Salih, V
   Franks, K
   James, M
   Hastings, GW
   Knowles, JC
   Olsen, I
TI Development of soluble glasses for biomedical use Part II: The
   biological response of human osteoblast cell lines to phosphate-based
   soluble glasses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RELEASE
AB Soluble glasses are considered to be of potential clinical value in orthopaedic and dental surgery. However, the biological response to these materials is not well understood. To determine the effects of these glasses, two human osteoblast cell lines, MG63 and HOS (TE85), were incubated in vitro in the presence of increasing concentrations of extracts of the glasses. The effects of the extracts on cell growth was measured using the MTT assay and an ELISA assay was used to measure the expression of bone sialoprotein (BSP), osteonectin (ON) and fibronectin (FN), antigens which play a fundamental part in the integrity and function of hard connective tissue. The results showed that the proliferation of the cells was adversely affected only by the more soluble glasses, which also down-regulated the expression of the bone-associated proteins. In contrast, the extract of the glass with the lowest dissolution rate, which contains relatively elevated levels of Ca2+, was found to enhance bone cell growth and antigen expression. These findings suggest that the compositions of these glasses at least partly determine the response of cells and thus, that the glasses could be modified to elicit a more optimal biological response and clinical efficacy. (C) 2000 Kluwer Academic Publishers.
C1 Univ London, Eastman Dent Inst, Dept Biomat, London WC1X 8LD, England.
   Univ London, Eastman Dent Inst, Dept Periodontol, London WC1X 8LD, England.
   Natl Univ Singapore, Inst Mat Res & Engn, Singapore 119260, Singapore.
RP Knowles, JC (reprint author), Univ London, Eastman Dent Inst, Dept Biomat, 256 Grays Inn Rd, London WC1X 8LD, England.
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
CR BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   BURNIE J, 1983, CERAMICS SURG, P169
   CALGUT P, 1990, BIOMATERIALS, V11, P561
   Cartmell SH, 1998, J MATER SCI-MATER M, V9, P773, DOI 10.1023/A:1008923523428
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   FRANKS K, 2000, J MAT SCI
   Haberland A, 1999, BBA-GENE STRUCT EXPR, V1445, P21, DOI 10.1016/S0167-4781(99)00017-2
   Han WP, 1999, J NEUROSCI, V19, P900
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Knabe C, 1998, J MATER SCI-MATER M, V9, P337, DOI 10.1023/A:1008854930676
   Mamoshin VL, 1997, GLASS CERAM+, V54, P45, DOI 10.1007/BF02767143
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   OTAIGBE JU, 1997, TRIP, V11, P369
   SHAND EB, 1954, J AM CERAM SOC, V37, P52, DOI 10.1111/j.1151-2916.1954.tb14005.x
   Uo M, 1998, BIOMATERIALS, V19, P2277, DOI 10.1016/S0142-9612(98)00136-7
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P241
NR 19
TC 120
Z9 120
U1 0
U2 22
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2000
VL 11
IS 10
BP 615
EP 620
DI 10.1023/A:1008901612674
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 348JH
UT WOS:000088981400003
PM 15348085
DA 2018-10-19
ER

PT J
AU Lutz, PJ
AF Lutz, PJ
TI Control of macromolecular architectures by various polymerization
   methods: Advantages and drawbacks
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 39th Microsymposium of the Prague Meetings on Macromolecules Advances in
   Polymerization Methods/Controlled Synthesis of Functionalized Polymers
CY JUL 12-15, 1999
CL PRAGUE, CZECH REPUBLIC
SP Unipetrol Inc, Sigma-Aldrich Ltd, Eastman Chem Europe BV, Bayer AG, Exxon Chem Europe
ID TRANSFER RADICAL POLYMERIZATION; ANIONIC-POLYMERIZATION; MACROMONOMERS;
   COPOLYMERIZATION; METHACRYLATE; POLYSTYRENE; POLYMERS
AB The present work compares the efficiency of various polymerization methods in macromolecular engineering and discusses advantages and drawbacks of different approaches. Anionic polymerization remains the method of choice to synthesize cyclic polymers, functional polymers including macromonomers or functional star-shaped polymers. The controlled radical polymerization is an interesting alternative to anionic polymerization for the controlled homopolymerization of macromonomers yielding well-defined branched species. By combining classic radical polymerization with a heterogeneous reaction, networks were synthesized by homopolymerization of bifunctional poly(ethylene oxide) macromonomers. The resulting hydrogels, obtained directly in water, are new materials for biomedical applications.
C1 Inst Charles Sadron, CNRS, UPR 22, F-67083 Strasbourg, France.
RP Lutz, PJ (reprint author), Inst Charles Sadron, CNRS, UPR 22, 6 Rue Boussingault, F-67083 Strasbourg, France.
CR Angot S, 1998, MACROMOLECULES, V31, P7218, DOI 10.1021/ma980712y
   AUDOUIN F, UNPUB MACROMOL CHEM
   BAMFORD CH, 1954, NATURE, V176, P778
   Carrot G, 1998, POLYM BULL, V40, P181, DOI 10.1007/s002890050240
   DEFFIEUX A, 1996, POLYM MAT ENCY, P3887
   Ederle Y, 1998, MACROMOL SYMP, V132, P197, DOI 10.1002/masy.19981320119
   EDERLE Y, 1999, MAT SCI TECHNOLOGY C, P622
   GILLMANN KF, 1967, POLYM LETT, V5, P477
   Gnanou Y, 1996, J MACROMOL SCI R M C, VC36, P77
   Hild G, 1998, PROG POLYM SCI, V23, P1019, DOI 10.1016/S0079-6700(97)00055-5
   JACOB S, 1998, ADV POLYM SCI, V146, P1
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Knischka R, 1999, LANGMUIR, V15, P4752, DOI 10.1021/la981594a
   KNISCHKA R, UNPUB MACROMOLECULES
   MISHRA M, 1999, STARS HYBERBRANCHED, P59
   NARAGHI KS, 1998, POLYM PREPR AM CHEM, V39, P196
   NARAGHI KS, 1999, MACROMOL RAPID COMM, V199, P569
   NARAGHI KS, UNPUB
   Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866
   PLENTZMENEGHETT.S, 1999, STARS HYPERBRANCHED, P27
   REMPP P, 1994, J MACROMOL SCI PURE, VA31, P891
   REMPP PF, 1984, ADV POLYM SCI, V58, P1
   Riess G., 1985, ENCY POLYM SCI ENG, V2, P324
   SCHMITT B, 1995, MACROMOL SYMP, V93, P117, DOI 10.1002/masy.19950930116
   SCHULZ GO, 1982, J APPL POLYM SCI, V27, P4773, DOI 10.1002/app.1982.070271222
   SEMLYEN JA, 1997, LARGE RING MOL, P1
   Szwarc M., 1968, CARBANIONS LIVING PO
   TSUKAHARA Y, 1999, MACROMOLECULAR DESIG, P161
   WEBSTER OW, 1992, MAKROMOL CHEM-M SYMP, V60, P287, DOI 10.1002/masy.19920600126
NR 29
TC 7
Z9 7
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD OCT
PY 2000
VL 161
BP 53
EP 61
DI 10.1002/1521-3900(200010)161:1<53::AID-MASY53>3.0.CO;2-3
PG 9
WC Polymer Science
SC Polymer Science
GA 386ML
UT WOS:000166065600007
DA 2018-10-19
ER

PT J
AU Nakabayashi, N
AF Nakabayashi, N
TI Preparation of new biomedical materials and their application in clinics
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 7th Society-of-Polymer-Science-Japan International Polymer Conference
CY OCT 26-29, 1999
CL YOKOHAMA, JAPAN
SP Soc Polymer Sci Japan
AB Biomaterials - tissues interaction is important to study in biomaterials science. The information is indispensable to make medical devises and artificial organs and to predict their performance. It is also very useful to consider a hypothesis to design new biomaterials. New materials have brought big progress in the society as we know. There are few biomaterials specially designed to use in biomedical fields. The most important effort must be preparation of biocompatible materials, that must be essential to develop new type high performance devices and artificial organs. Preparation of new dental biomaterials used in bonding of prostheses to dentinal tissues that require fundamental change in modern dentistry and a new methacrylate, MPC, to develop promising several kinds of biomaterials with unusually excellent biocompatibility and functions are going to present. Topics in tissue engineering are also discussed.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Nakabayashi, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
CR DOI K, 1996, AM SOC ARTIF INT ORG, V42, P394
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   NAKABAYASHI N, 1998, HYBRIDIZATION DENTAL
   Yoneyama T, 1998, J BIOMED MATER RES, V43, P15, DOI 10.1002/(SICI)1097-4636(199821)43:1<15::AID-JBM2>3.0.CO;2-P
NR 4
TC 2
Z9 2
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD OCT
PY 2000
VL 159
BP 27
EP 34
DI 10.1002/1521-3900(200010)159:1<27::AID-MASY27>3.0.CO;2-H
PG 8
WC Polymer Science
SC Polymer Science
GA 386MJ
UT WOS:000166065300005
DA 2018-10-19
ER

PT J
AU Suter, M
   Jacob, SWA
   Synal, HA
AF Suter, M
   Jacob, SWA
   Synal, HA
TI Tandem AMS at sub-MeV energies - Status and prospects
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Accelerator Mass Spectrometry
CY SEP 06-10, 1999
CL VIENNA, AUSTRIA
DE accelerator mass spectrometry; radiocarbon dating
ID ACCELERATOR MASS-SPECTROMETRY; ION-SOURCE; ENVIRONMENTAL MATERIALS;
   BIOMEDICAL APPLICATIONS; C-14; SYSTEM; CA-41; FUTURE; CARBON; FOILS
AB Recently new small and compact accelerator mass spectrometry (AMS) facilities for radiocarbon analysis came into operation, using terminal voltages below 1 MV and ions in charge state 1(+) or 2(+). A special method is applied to eliminate interfering molecules. The present status of this new technique is summarized and the associated problems are described. The potential and the limitations of this technique for analyzing other radionuclides are also discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 ETH Honggerberg, Inst Particle Phys, CH-8093 Zurich, Switzerland.
   ETH Honggerberg, Paul Scherrer Inst, CH-8093 Zurich, Switzerland.
RP Suter, M (reprint author), ETH Honggerberg, Inst Particle Phys, E114, CH-8093 Zurich, Switzerland.
EM suter@particle.phys.ethz.ch
CR BELSHAW NS, 1995, INT J MASS SPECTROM, V142, P55, DOI 10.1016/0168-1176(94)04125-Q
   BRONK CR, 1990, NUCL INSTRUM METH B, V52, P322, DOI 10.1016/0168-583X(90)90430-3
   DittrichHannen B, 1996, NUCL INSTRUM METH B, V113, P453, DOI 10.1016/0168-583X(95)01302-4
   FINK D, 1990, NUCL INSTRUM METH B, V52, P572, DOI 10.1016/0168-583X(90)90479-E
   Freeman SPHT, 1997, NUCL INSTRUM METH B, V123, P266, DOI 10.1016/S0168-583X(96)00701-X
   GARTENMANN P, 1999, THESIS ETH ZURICH
   HEINEMEIER J, 1977, NUCL INSTRUM METHODS, V141, P183, DOI 10.1016/0029-554X(77)90764-9
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P153, DOI 10.1016/S0168-583X(96)00420-X
   Hughey BJ, 2000, NUCL INSTRUM METH B, V172, P40, DOI 10.1016/S0168-583X(00)00118-X
   Hughey BJ, 1997, NUCL INSTRUM METH B, V123, P186, DOI 10.1016/S0168-583X(96)00408-9
   Hvelplund P., 1970, Nuclear Instruments and Methods, V90, P315, DOI 10.1016/0029-554X(70)90688-9
   Jacob SAW, 2000, NUCL INSTRUM METH B, V172, P235, DOI 10.1016/S0168-583X(00)00205-6
   KILIUS LR, 1987, NUCL INSTRUM METH B, V29, P72, DOI 10.1016/0168-583X(87)90207-2
   Kilius LR, 1997, NUCL INSTRUM METH B, V123, P10, DOI 10.1016/S0168-583X(96)00421-1
   LENNARD WN, 1981, NUCL INSTRUM METHODS, V179, P413, DOI 10.1016/0029-554X(81)90166-X
   LITHERLAND AE, 1984, NUCL INSTRUM METH B, V5, P100, DOI 10.1016/0168-583X(84)90491-9
   MIDDLETON R, 1989, NUCL INSTRUM METH B, V43, P231, DOI 10.1016/0168-583X(89)90043-8
   Mous DJW, 1997, NUCL INSTRUM METH B, V123, P159, DOI 10.1016/S0168-583X(96)00423-5
   Mous DJW, 1998, RADIOCARBON, V40, P283
   Mous DJW, 1999, AIP CONF PROC, V475, P657
   Ognibene TJ, 2000, NUCL INSTRUM METH B, V172, P47, DOI 10.1016/S0168-583X(00)00151-8
   PURSER KH, 1994, NUCL INSTRUM METH B, V92, P201, DOI 10.1016/0168-583X(94)96005-4
   PURSER KH, 1990, NUCL INSTRUM METH B, V52, P424, DOI 10.1016/0168-583X(90)90450-9
   Raisbeck G, 1981, P S ACCELERATOR MASS, P426
   RAISBECK GM, 1984, NUCL INSTRUM METH B, V5, P175, DOI 10.1016/0168-583X(84)90505-6
   RYDING G, 1970, PHYS REV A, V188, P1081
   Schneider RJ, 1997, NUCL INSTRUM METH B, V123, P546, DOI 10.1016/S0168-583X(96)00607-6
   Suter M, 1997, NUCL INSTRUM METH B, V123, P148, DOI 10.1016/S0168-583X(96)00613-1
   Suter M, 1999, AIP CONF PROC, V475, P665
   Suter M, 1998, NUCL INSTRUM METH B, V139, P150, DOI 10.1016/S0168-583X(97)00945-2
   Synal HA, 2000, NUCL INSTRUM METH B, V161, P29, DOI 10.1016/S0168-583X(99)00881-2
   Synal HA, 2000, NUCL INSTRUM METH B, V172, P1, DOI 10.1016/S0168-583X(00)00376-1
   von Blanckenburg F, 1996, CHEM GEOL, V129, P93, DOI 10.1016/0009-2541(95)00157-3
NR 33
TC 41
Z9 41
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT
PY 2000
VL 172
BP 144
EP 151
DI 10.1016/S0168-583X(00)00359-1
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 372JR
UT WOS:000165231000026
DA 2018-10-19
ER

PT J
AU Nishiizumi, K
   Caffee, MW
   DePaolo, DJ
AF Nishiizumi, K
   Caffee, MW
   DePaolo, DJ
TI Preparation of Ca-41 AMS standards
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Accelerator Mass Spectrometry
CY SEP 06-10, 1999
CL VIENNA, AUSTRIA
DE cosmogenic nuclide; standard; surface ionization mass spectrometry;
   Ca-41
ID ACCELERATOR MASS-SPECTROMETRY; HALF-LIFE; COSMOGENIC CA-41; BE-10
AB Absolute accelerator mass spectrometry (AMS) measurements require reliable standards for calibration. The Space Sciences Laboratory at the University of California, Berkeley, and the Center for Accelerator Mass Spectrometry at Lawrence Livermore National Laboratory (LLNL) have prepared new Ca-41 AMS standards. The highly enriched (CaCO3)-Ca-41 was obtained from Oak Ridge National Laboratory. After purification of the CaCO3, the precise Ca-41/Ca ratio in the original material was determined by surface ionization mass spectrometry. The Ca-41 was sequentially diluted with natural Ca to obtain Ca-41/Ca ratios of 1.155 x 10(-10) 9.755 x 10(-12) 5.139 x 10(-12) 1.095 x 10(-12) and 5.884 x 10(-13). A solution with a Ca-41/Ca ratio of 10(-6) was also prepared for biomedical research. The solutions having Ca-41/Ca ratios between 10(-10) and 10(-12) were measured by AMS. Although the present blank level, 5 x 10(-14) Ca-41/Ca, was higher than anticipated, excellent linearity was obtained from 6 x 10(-13) to 1.2 x 10(-10) Ca-41/Ca. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.
   Univ Calif Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA.
   Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA.
   EO Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.
RP Nishiizumi, K (reprint author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.
RI Caffee, Marc/K-7025-2015
OI Caffee, Marc/0000-0002-6846-8967
CR DAVIS JC, 1990, NUCL INSTRUM METH B, V52, P269, DOI 10.1016/0168-583X(90)90419-U
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINK D, 1990, NUCL INSTRUM METH B, V47, P79, DOI 10.1016/0168-583X(90)90049-Z
   Fink D, 1998, GEOCHIM COSMOCHIM AC, V62, P2389, DOI 10.1016/S0016-7037(98)00134-3
   KLEIN J, 1991, EARTH PLANET SC LETT, V103, P79, DOI 10.1016/0012-821X(91)90151-7
   KUBIK PW, 1986, NATURE, V319, P568, DOI 10.1038/319568a0
   MABUCHI H, 1974, J INORG NUCL CHEM, V36, P1687, DOI 10.1016/0022-1902(74)80493-8
   Nishiizumi K, 1997, EARTH PLANET SC LETT, V148, P545, DOI 10.1016/S0012-821X(97)00051-4
   NISHIIZUMI K, 1984, EARTH PLANET SC LETT, V70, P157, DOI 10.1016/0012-821X(84)90001-3
   Nishiizumi K, 1998, METEORIT PLANET SCI, V33, pA117
   PAUL M, 1991, Z PHYS A-HADRON NUCL, V340, P249, DOI 10.1007/BF01294672
   RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9
   SHARMA P, 1990, NUCL INSTRUM METH B, V52, P410, DOI 10.1016/0168-583X(90)90447-3
   Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1
   SOUTHON JR, 1994, NUCL INSTRUM METH B, V92, P489, DOI 10.1016/0168-583X(94)96060-7
NR 15
TC 36
Z9 37
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT
PY 2000
VL 172
BP 399
EP 403
DI 10.1016/S0168-583X(00)00150-6
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 372JR
UT WOS:000165231000069
DA 2018-10-19
ER

PT J
AU Jackson, GS
   Elmore, D
   Rickey, FA
   Musameh, SM
   Sharma, P
   Hillegonds, D
   Coury, L
   Kissinger, P
AF Jackson, GS
   Elmore, D
   Rickey, FA
   Musameh, SM
   Sharma, P
   Hillegonds, D
   Coury, L
   Kissinger, P
TI The PRIME lab biomedical program
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Accelerator Mass Spectrometry
CY SEP 06-10, 1999
CL VIENNA, AUSTRIA
DE tracers; bone resorption; vaccines; implant materials; biomedical
   accelerator mass spectrometry
ID ACCELERATOR MASS-SPECTROMETRY; SAMPLE PREPARATION; CA-41 AMS; SCIENCES
AB The biomedical accelerator mass spectrometry (AMS) initiative at PRIME Lab including the status of equipment and sample preparation is described. Several biomedical projects are underway involving one or more of the nuclides: C-14, Al-26 and Ca-41. Routine production of CaF2 and graphite is taking place. Finally, the future direction and plans for improvement of the biomedical program at PRIME Lab are discussed. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Purdue Univ, Dept Phys, PRIME Lab, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Bioanlyt Syst Inc, W Lafayette, IN 47906 USA.
   An Najah Univ, Dept Phys, Nablus, West Bank, Israel.
RP Elmore, D (reprint author), Purdue Univ, Dept Phys, PRIME Lab, 1396 Phys Bldg, W Lafayette, IN 47907 USA.
CR ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1990, NUCL INSTRUM METH B, V52, P531, DOI 10.1016/0168-583X(90)90471-6
   FLAREND R, COMMUNICATION
   Flarend RE, 1997, VACCINE, V15, P1314, DOI 10.1016/S0264-410X(97)00041-8
   FREEMAN SPHT, 1995, INT J MASS SPECTROM, V143, P247, DOI 10.1016/0168-1176(95)04157-G
   FREEMAN SPHT, 1995, NUCL INSTRUM METH B, V99, P557, DOI 10.1016/0168-583X(95)00342-8
   Koslowsky VT, 1997, NUCL INSTRUM METH B, V123, P203, DOI 10.1016/S0168-583X(96)00628-3
   SHARMA P, 1990, ANAL CHIM ACTA, V233, P101, DOI 10.1016/S0003-2670(00)83465-0
   SHARMA P, 1987, NUCL INSTRUM METH B, V29, P63, DOI 10.1016/0168-583X(87)90205-9
   TAYLOR GW, COMMUNICATION
   VOGEL JS, 1992, RADIOCARBON, V34, P344
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   VOGEL JS, 1990, RADIOCARBON, V32, P81
   VOGEL JS, 1994, NUCL INSTRUM METH B, V92, P445, DOI 10.1016/0168-583X(94)96052-6
NR 14
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD OCT
PY 2000
VL 172
BP 899
EP 903
DI 10.1016/S0168-583X(00)00231-7
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 372JR
UT WOS:000165231000151
DA 2018-10-19
ER

PT J
AU Wang, DA
   Ji, J
   Feng, LX
AF Wang, DA
   Ji, J
   Feng, LX
TI Various-sized stearyl poly(ethylene oxide) coupling-polymer blending
   poly(ether urethane) material for surface study and biomedical
   applications
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID BLOOD COMPATIBILITY; PROTEIN ADSORPTION; POLYURETHANES; SPECTROSCOPY;
   COPOLYMERS; BLOCK
AB Three types of stearyl poly(ethylene oxide) with different values of M-n, 2300, 6000 and 12000, were synthesized by an anion polymerization from the ethylene oxide (EO) monomer with the initiator, sodium salt of stearyl alcohol. Consequently the amphiphilic coupling polymers of 4,4'-diphenylmethane diiso-cyanate (MDI)-SPEO (SPEO-MDI-SPEO, MSPEO 2300, 6000 and 12000) were synthesized and the blended polyurethane) samples of PELMSPEOs (PEL-MSPEO 6000 and 12000) were prepared via a solution process. The surface analysis with ATR-FTIR, angle-dependent XPS and two methods of contact angle measurements (sessile drop and captive bubble) were performed. The results of the analysis indicate that the dominant factor for the monoblock behavior of long-chained MSPEO 12000 is the PEO chain. However, for shea-chained MSPEO the factor is C-18 and the dominant effect is not so overwhelming compared to that of PEO for long-chained MSPEO. Simultaneously, the size of the molecule will also dramatically affect MSPEOs' kinetic behavior including the monoblock mobility and the reconstructing of the surface a, i.e. the smaller the size, the faster the The static test of clotting time, PRT, was also med The results indicated that the modified surface resist the clotting much more effectively than thatof the untreated surface.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Feng, LX (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RI Wang, Dong-an/G-6195-2010
OI Ji, Jian/0000-0001-9870-4038
CR ANDRADE JD, 1985, SURFACE INTERFACIAL, V1, P270
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   GREGONIS DE, 1982, MACROMOLECULAR SOLUT, P120
   HARTHCOCK MA, 1989, POLYMER, V30, P1234, DOI 10.1016/0032-3861(89)90041-4
   Jannasch P, 1998, MACROMOLECULES, V31, P1341, DOI 10.1021/ma971351+
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LELAH MD, 1986, POLYURETHANES MED, P57
   MACRONI M, 1994, MACROMOL CHEM PHYS, V185, P875
   MUNRO MS, 1983, ASAIO J, V6, P65
   OHTA K, 1985, APPL SPECTROSC, V39, P418, DOI 10.1366/0003702854248719
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   WANG DA, 1999, UNPUB MACROMOLECULES
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
NR 19
TC 13
Z9 15
U1 1
U2 11
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD SEP 28
PY 2000
VL 201
IS 14
BP 1574
EP 1584
DI 10.1002/1521-3935(20000901)201:14<1574::AID-MACP1574>3.0.CO;2-B
PG 11
WC Polymer Science
SC Polymer Science
GA 363LZ
UT WOS:000089838300002
DA 2018-10-19
ER

PT J
AU Udipi, K
   Ornberg, RL
   Thurmond, KB
   Settle, SL
   Forster, D
   Riley, D
AF Udipi, K
   Ornberg, RL
   Thurmond, KB
   Settle, SL
   Forster, D
   Riley, D
TI Modification of inflammatory response to implanted biomedical materials
   in vivo by surface bound superoxide dismutase mimics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE superoxide dismutase mimics; ultrahigh molecular weight polyethylene;
   polyurethane; inflammatory response
ID DNA-BINDING ACTIVITY; NITRIC-OXIDE; REDOX REGULATION; IN-VIVO; INJURY;
   PEROXYNITRITE; BIOSTABILITY; TRANSCRIPTION; POTENTIATION; ACTIVATION
AB The healing response to implanted biomedical materials involves varying degrees and stages of inflammation and healing which in some cases leads to device failure. In this article, we describe synthetic methods and in vivo results of a novel surface treatment for biomedical materials involving covalent conjugation of a low molecular weight superoxide dismutase mimic (SODm), which imparts antiinflammatory character to the material. SODm investigated in this study are a new class of anti-inflammatory drugs consisting of a Mn(II) complex of a macrocyclic polyamine ring that catalyze the dismutation of superoxide at rates equivalent to that of native enzyme. The SODms were covalently linked to small disks of ultra-high molecular weight polyethylene, poly(etherurethane urea), and tantalum metal at two concentrations and implanted in a subcutaneous rat implant model for 3, 7, 14, and 28 days. Histological examination of the implant tissue performed at 3 and 28 days revealed striking anti-inflammatory effects on both acute and chronic inflammatory responses. At 3 days, the formation of a neutrophil-rich acute inflammatory infiltrate seen in control implants was inhibited for all three materials treated with SODm. At 28 days, foreign body giant cell formation (number of FBGCs per field) and fibrous capsule formation (mean thickness of implant capsule) were also significantly inhibited over untreated control implants. A mechanism based on our current understanding of superoxide as an inflammatory mediator at implanted biomedical materials is proposed. (C) 2000 John Wiley & Sons, Inc.
C1 Metaphore Pharmaceut Inc, St Louis, MO 63114 USA.
   GD Searle Monsanto Co, Monsanto Corp Res, Chesterfield, MO 63017 USA.
   GD Searle Monsanto Co, Discovery Oncol, Chesterfield, MO 63017 USA.
RP Udipi, K (reprint author), Metaphore Pharmaceut Inc, 1910 Innerbelt Business Ctr Dr, St Louis, MO 63114 USA.
CR ABATE C, 1990, CELL GROWTH DIFFER, V1, P455
   ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   AIKENS J, 1991, J BIOL CHEM, V266, P15091
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ARCHAMBAULT JG, 1998, T 24 ANN M SOC BIOM, P251
   BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330
   BLACK SC, 1994, J PHARMACOL EXP THER, V270, P1208
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405
   Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57
   Crow J P, 1995, Adv Pharmacol, V34, P17
   CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5
   Crow JP, 1996, ADV EXP MED BIOL, V387, P147
   Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6
   FREDERICKS GS, 1993, FASEB J, V7, P2457
   FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761
   Glowinski J, 1997, EUR SURG RES, V29, P368, DOI 10.1159/000129545
   HARDY MM, 1994, J BIOL CHEM, V15, P269
   JORAL A, 1993, J INVEST ALLERG CLIN, V3, P103
   Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3
   KASTEN TP, 1995, P SOC EXP BIOL MED, V208, P170
   KILGORE KS, 1994, J MOL CELL CARDIOL, V26, P995, DOI 10.1006/jmcc.1994.1120
   Land W, 1997, TRANSPLANT P, V29, P2567, DOI 10.1016/S0041-1345(97)00509-5
   Lefaix JL, 1996, INT J RADIAT ONCOL, V35, P305, DOI 10.1016/0360-3016(96)00061-2
   Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245
   Mates Jose M., 1999, Frontiers in Bioscience, V4, pD339, DOI 10.2741/Mates
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MENG YY, 1995, J AM COLL CARDIOL, V25, P269, DOI 10.1016/0735-1097(94)00349-U
   Oury TD, 1996, LAB INVEST, V75, P617
   RILEY DP, 1994, J AM CHEM SOC, V116, P387, DOI 10.1021/ja00080a051
   ROOS D, 1980, CELL BIOL INFLAMMATI, P337
   Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Sen CK, 1996, FASEB J, V10, P709
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   VENTURINI CM, 1994, BIOL NITRIC OXIDE, V3, P65
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   Weiss RH, 1996, J BIOL CHEM, V271, P26149, DOI 10.1074/jbc.271.42.26149
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698
NR 43
TC 45
Z9 49
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2000
VL 51
IS 4
BP 549
EP 560
DI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 330PK
UT WOS:000087970300002
PM 10880102
DA 2018-10-19
ER

PT J
AU Carew, EO
   Barber, JE
   Vesely, I
AF Carew, EO
   Barber, JE
   Vesely, I
TI Role of preconditioning and recovery time in repeated testing of aortic
   valve tissues: Validation through quasilinear viscoelastic theory
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE soft tissue modeling; predictive model; strain history; porcine
ID QUASI-LINEAR THEORY; MUSCLE; RESPONSES; BEHAVIOR; FRESH
AB We investigated how preconditioning history and specimen recovery time affect the accuracy of measurements of mechanical properties obtained from sequential, repeated materials testing of porcine aortic valve (PAV) cusps. Strain history protocols were modeled by quasilinear viscoelastic theory and the results compared with the experimental data. Assuming that the model was predictive, the accuracy of predicting experimental data was related to the suitability of the materials testing protocol. We found that the preconditioned state of the PAV material was not unique but was a function of the deformation history that had occurred before the preconditioning cycles. Preconditioning without an adequate rest period between tests increased predictive errors, whereas allowing the material to rest without preconditioning reduced errors. Modeling more of the strain history reduced errors for specimens briefly rested between tests but had no impact on specimens with long rest periods. The smallest predictive errors were obtained for a loading protocol with a 24 h specimen recovery period followed by material preconditioning. We recommend the use of this protocol for estimating material properties of PAV tissues. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00509-9].
C1 Cleveland Clin Fdn, Dept Biomed Engn ND20, Lerner Res Inst, Cleveland, OH 44195 USA.
RP Vesely, I (reprint author), Cleveland Clin Fdn, Dept Biomed Engn ND20, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.
FU NHLBI NIH HHS [HL57236]
CR BEST TM, 1994, J BIOMECH, V27, P413, DOI 10.1016/0021-9290(94)90017-5
   Carew EO, 1999, J BIOMECH ENG-T ASME, V121, P386, DOI 10.1115/1.2798335
   Fung Y.C., 1993, BIOMECHANICS MECH PR, P277
   HAUT RC, 1972, J BIOMECH, V5, P423, DOI 10.1016/0021-9290(72)90001-2
   HUYGHE JM, 1991, J BIOMECH, V24, P841, DOI 10.1016/0021-9290(91)90309-B
   KWAN MK, 1993, J BIOMECH, V26, P447, DOI 10.1016/0021-9290(93)90008-3
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   MYERS BS, 1991, J BIOMECH, V24, P811, DOI 10.1016/0021-9290(91)90306-8
   PINTO JG, 1980, J BIOMECH ENG-T ASME, V102, P57, DOI 10.1115/1.3138199
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   SAUREN AAHJ, 1983, J BIOMECH, V16, P327, DOI 10.1016/0021-9290(83)90016-7
   TALMAN E, 1997, ASME BED, V36, P55
   Vesely I, 1996, ASAIO J, V42, P993, DOI 10.1097/00002480-199642060-00012
   VESELY I, 1993, J BIOMECH, V26, P121, DOI 10.1016/0021-9290(93)90043-E
   VESELY I, 1998, P 3 WORLD C BIOM SAP, P193
   VESELY I, 1997, ASME BIOENG DIV PUBL, V36, P57
   WOO SLY, 1980, J BIOMECH ENG-T ASME, V102, P85, DOI 10.1115/1.3138220
   WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295
NR 18
TC 62
Z9 63
U1 1
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP
PY 2000
VL 28
IS 9
BP 1093
EP 1100
DI 10.1114/1.1310221
PG 8
WC Engineering, Biomedical
SC Engineering
GA 379LN
UT WOS:000165643700005
PM 11132193
DA 2018-10-19
ER

PT J
AU Whyne, CM
   Hu, SS
   Workman, KL
   Lotz, JC
AF Whyne, CM
   Hu, SS
   Workman, KL
   Lotz, JC
TI Biphasic material properties of lytic bone metastases
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biomechanics; poroelasticity; tumor; hydraulic permeability; aggregate
   modulus
ID ARTICULAR-CARTILAGE; INTERVERTEBRAL DISC; DRUG-DELIVERY; COMPRESSION;
   MODELS; CREEP; FLUID
AB It is necessary to prescribe the mechanical properties of timer tissue when modeling the metastatically involved skeleton for clarifying the mechanisms of fracture. This study provides mechanical property data for lytic bone metastases. Specimens of human lytic tumor were tested under a confined compression uniaxial creep protocol and the mechanical behavior of the tumor tissue was modeled using linear biphasic theory. The tumor tissue was found to have an aggregate modulus (H-A) of 3.6 +/- 1.6 kPa and a hydraulic permeability (k) of 0.59 +/- 0.46 mm(4)N(-1)s(-1). Tumors with a higher percentage of stromal content were found to be stiffer and more permeable than those with a more cellular composition. No significant differences in aggregate modulus or hydraulic permeability were found between lyric metastases of different types. These data are useful for the development of models to simulate the behavior of the metastatically involved skeleton using theoretical or finite-element analysis techniques and also have significance for developing effective tumor-drug-transport models. We anticipate that specification of the mechanical behavior of this tissue may help to better focus future treatment of lyric bony metastases through better assessment of fracture risk and improved drug delivery. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00909-7].
C1 Univ Calif San Francisco, Dept Orthopaed Surg, Orthopaed Bioengn Lab, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, UC Berkeley, UDSF Joint Grad Grp Bioengn, San Francisco, CA 94143 USA.
   Sunnybrook & Womens Coll, Hlth Sci Ctr, Orthopaed Biomech Lab, Toronto, ON, Canada.
RP Lotz, JC (reprint author), Univ Calif San Francisco, Dept Orthopaed Surg, Orthopaed Bioengn Lab, 533 Parnassus Ave, San Francisco, CA 94143 USA.
CR Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   Bass EC, 1997, SPINE, V22, P2867, DOI 10.1097/00007632-199712150-00009
   BIOT MA, 1955, J APPL PHYS, V26, P182, DOI 10.1063/1.1721956
   Boucher Y, 1998, BRIT J CANCER, V78, P1442, DOI 10.1038/bjc.1998.705
   DIRESTA GR, 1993, MICROVASC RES, V46, P158, DOI 10.1006/mvre.1993.1044
   El-Kareh AW, 1997, CRIT REV BIOMED ENG, V25, P503, DOI 10.1615/CritRevBiomedEng.v25.i6.20
   JAIN RK, 1987, CANCER RES, V47, P3039
   KLISH S, 1999, THESIS UC BERKELEY
   Krol A, 1999, CANCER RES, V59, P4136
   LAIBLE JP, 1993, SPINE, V18, P659, DOI 10.1097/00007632-199304000-00019
   MCGOWAN DP, 1993, J SPINAL DISORD, V6, P130
   MIZRAHI J, 1992, J BIOMED ENG, V14, P467, DOI 10.1016/0141-5425(92)90098-6
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Netti P. A., 1995, Biorheology, V32, P346, DOI 10.1016/0006-355X(95)92330-D
   ROONEY F, 1996, MATH MODEL SCI COMPU, V6, P715
   SARNTINORANONT M, 1999, THESIS UC BERKELEY
   SARNTINORANONT M, 1996, THESIS UC BERKELEY
   Silva M J, 1993, Eur Spine J, V2, P118, DOI 10.1007/BF00301407
   SIMON BR, 1985, SPINE, V10, P494, DOI 10.1097/00007632-198507000-00003
   SWABB EA, 1974, CANCER RES, V34, P2814
NR 21
TC 22
Z9 23
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP
PY 2000
VL 28
IS 9
BP 1154
EP 1158
DI 10.1114/1.1313773
PG 5
WC Engineering, Biomedical
SC Engineering
GA 379LN
UT WOS:000165643700011
PM 11132199
DA 2018-10-19
ER

PT J
AU Sanchez-Carbayo, MS
   Bornmann, W
   Cordon-Cardo, C
AF Sanchez-Carbayo, MS
   Bornmann, W
   Cordon-Cardo, C
TI DNA microchips: Technical and practical considerations
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
ID GENE-EXPRESSION PATTERNS; CDNA MICROARRAYS; MESSENGER-RNA; HUMAN GENOME;
   OLIGONUCLEOTIDE MICROARRAYS; GEL-ELECTROPHORESIS; COMPLEMENTARY-DNA;
   LARGE-SCALE; CANCER; HYBRIDIZATION
AB The development of high throughput techniques, such as DNA microarrays, engages interest in many biomedical research fields. They are becoming one of the preferred methods for large-scale expression analyses. The power of this technology is that it allows the profiling of thousands of genes in one single experiment. There are two main array-based technologies: cDNA and oligonucleotide arrays. cDNA arrays consist of microscope slides or nylon membranes containing hundreds to thousands of immobilized DNA probes, which are hybridized to fluorescent or radioactive complementary cDNA obtained from a target sample. Oligonucleotide chips differ in that probes are 20-25 mer selected oligonucleotides, which are bound to glass substrates and that the DNA obtained from a target sample can only be fluorescently labeled. In this review, we describe the different types of DNA-chips, the steps involved in the production of microchips, the methodological and technical aspects of microchip utilization, and their potential applications including some practical considerations utilizing clinical material.
C1 Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA.
   Mem Sloan Kettering Canc Ctr, Organ Chem Facil Core, New York, NY 10021 USA.
RP Sanchez-Carbayo, MS (reprint author), Mem Sloan Kettering Canc Ctr, Div Mol Pathol, 1275 York Ave, New York, NY 10021 USA.
CR ALIDAZEH AA, 2000, NATURE, V403, P503
   ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350
   AMBELE M, 1999, ANAL CELL PATHOL, V19, P53
   Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478
   BAXEVANIS AD, 1998, BIOINFORMATICS PRACT
   Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1
   BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0
   Bernard K, 1996, NUCLEIC ACIDS RES, V24, P1435, DOI 10.1093/nar/24.8.1435
   Bertucci F, 1999, HUM MOL GENET, V8, P1715, DOI 10.1093/hmg/8.9.1715
   BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332
   Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   BROWNSTEIN MJ, 1998, FUNCTIONAL GENOMICS, P27
   Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758
   Chen JJW, 1998, GENOMICS, V51, P313, DOI 10.1006/geno.1998.5354
   CHEN Y, 1997, BIOMED OPTICS, V2, P364
   Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439
   *CLONT, ATL ARR
   Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466
   Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475
   DeRisi J, 1996, NAT GENET, V14, P457
   DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680
   Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434
   Eberwine J, 1996, BIOTECHNIQUES, V20, P584
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ekins R, 1997, J Int Fed Clin Chem, V9, P100
   Elek J, 2000, IN VIVO, V14, P173
   Ermolaeva O, 1998, NAT GENET, V20, P19
   Ferea TL, 1999, CURR OPIN GENET DEV, V9, P715, DOI 10.1016/S0959-437X(99)00033-7
   Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3
   *GEN SYST, GEN DISC ARR
   Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531
   Granjeaud S, 1996, GENET ANAL-BIOMOL E, V12, P151, DOI 10.1016/1050-3862(95)00128-X
   GRANJEAUD S, 1999, BIOESSAYS, V21, P1
   Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142
   Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469
   Harris TM, 2000, NAT BIOTECHNOL, V18, P384, DOI 10.1038/74435
   Heiskanen MA, 2000, CANCER RES, V60, P799
   Imbert MC, 1999, NUCLEIC ACIDS RES, V27, P601, DOI 10.1093/nar/27.2.601
   KANEHISA M, 1998, DATABASES BIOL INFOR, P24
   Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007
   Kaufman L, 1990, FINDING GROUPS DATA
   Khan J, 1999, ELECTROPHORESIS, V20, P223, DOI 10.1002/(SICI)1522-2683(19990201)20:2<223::AID-ELPS223>3.0.CO;2-A
   Khan J, 1998, CANCER RES, V58, P5009
   KLIMECKI WT, 1994, BIOTECHNIQUES, V16, P1021
   Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Lieberman R, 1998, CLIN CHEM, V44, P420
   Lin BY, 1999, CANCER RES, V59, P4180
   Lin BY, 2000, CANCER RES, V60, P858
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Loftus SK, 1999, P NATL ACAD SCI USA, V96, P9277, DOI 10.1073/pnas.96.16.9277
   Marshall A, 1998, NAT BIOTECHNOL, V16, P27, DOI 10.1038/nbt0198-27
   McEntyre J, 1998, TRENDS GENET, V14, P39, DOI 10.1016/S0168-9525(97)01325-5
   Nelson N, 1996, J NATL CANCER I, V88, P1803, DOI 10.1093/jnci/88.24.1803
   NGUYEN C, 1995, GENOMICS, V29, P207, DOI 10.1006/geno.1995.1233
   Okamoto T, 2000, NAT BIOTECHNOL, V18, P438
   Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212
   Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104
   Ramsay W., 1898, FENNIA, V16, P1
   *RES GEN, GEN FILT
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Schuler GD, 1996, METHOD ENZYMOL, V266, P141
   Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540
   Sgroi DC, 1999, CANCER RES, V59, P5656
   Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639
   Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664
   Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Thorp HH, 1998, TRENDS BIOTECHNOL, V16, P117, DOI 10.1016/S0167-7799(97)01162-1
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   VOLLRATH D, 1987, NUCLEIC ACIDS RES, V15, P7865, DOI 10.1093/nar/15.19.7865
   Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077
   Wang E, 2000, NAT BIOTECHNOL, V18, P457
   Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10
   ZHAO ND, 1995, GENE, V156, P207, DOI 10.1016/0378-1119(95)00023-Y
NR 81
TC 16
Z9 17
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 1385-2728
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PD SEP
PY 2000
VL 4
IS 9
BP 945
EP 971
DI 10.2174/1385272003375987
PG 27
WC Chemistry, Organic
SC Chemistry
GA 357TB
UT WOS:000089516000005
DA 2018-10-19
ER

PT J
AU Bishop, JW
   Marshall, CJ
   Bentz, JS
AF Bishop, JW
   Marshall, CJ
   Bentz, JS
TI New technologies in gynecologic cytology
SO JOURNAL OF REPRODUCTIVE MEDICINE
LA English
DT Article; Proceedings Paper
CT International Consensus Conference on the Fight Against Cervical Cancer
CY MAR 18-22, 2000
CL CHICAGO, ILLINOIS
SP IAC Task Force
DE cytology; biomedical technology; cervix neoplasms; cervical smears
ID INVASIVE CERVICAL-CANCER; AUTOPAP-300 QC SYSTEM; SQUAMOUS-CELL
   CARCINOMA; PAPNET TESTING SYSTEM; MULTICENTER CLINICAL-TRIALS;
   HUMAN-PAPILLOMAVIRUS DNA; FALSE-NEGATIVE SMEARS; PAPANICOLAOU SMEAR;
   QUALITY-CONTROL; SCREENING SYSTEM
AB New technologies are trying to make significant changes in the way we perform the Pap smear test, a test that has undergone no significant modification since its inception. Efforts have focused on improving sampling with liquid-based methods, improving detection of abnormal cells with automated screening and improving the detection of human papillomavirus with assays practical for use in routine clinical material. This article reviews the performance of the new technologies to date, with an emphasis on those that are currently approved for cervical cytology testing. In the aggregate, these technologies call have a positive impact on cervical disease detection and intervention.
C1 Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA.
   Univ Utah, Dept Pathol, Salt Lake City, UT USA.
RP Bishop, JW (reprint author), Univ Calif Davis, Med Ctr, Dept Pathol, 4400 V St, Sacramento, CA 95817 USA.
CR ADAMI HO, 1994, CANCER-AM CANCER SOC, V73, P140, DOI 10.1002/1097-0142(19940101)73:1<140::AID-CNCR2820730124>3.0.CO;2-2
   *AG HLTH CAR POL R, 1999, EV REP EV CERV CYT
   ALBERT A, 1981, JNCI-J NATL CANCER I, V67, P571
   ANDERSON GH, 1992, OBSTET GYNECOL, V80, P1
   [Anonymous], 1986, BMJ-BRIT MED J, V293, P659
   APONTECIPRIANI SL, 1995, ACTA CYTOL, V39, P623
   Ashfaq R, 1999, ACTA CYTOL, V43, P81, DOI 10.1159/000330872
   ASHFAQ R, 1995, DIAGN CYTOPATHOL, V13, P188
   ATTWOOD ME, 1985, ACTA CYTOL, V29, P108
   Austin RM, 1999, ACTA CYTOL, V43, P4, DOI 10.1159/000330535
   AUSTOKER J, 1994, BRIT MED J, V309, P241, DOI 10.1136/bmj.309.6949.241
   AUSTOKER J, 1994, BRIT MED J, V309, P452
   AWEN C, 1994, DIAGN CYTOPATHOL, V11, P33, DOI 10.1002/dc.2840110109
   Baldauf JJ, 1997, ACTA CYTOL, V41, P1431, DOI 10.1159/000332855
   BARRETT DL, 1977, J HISTOCHEM CYTOCHEM, V25, P495, DOI 10.1177/25.7.893998
   Bartels PH, 1999, ACTA CYTOL, V43, P7, DOI 10.1159/000330554
   BENEDET JL, 1981, GYNECOL ONCOL, V12, pS280, DOI 10.1016/0090-8258(81)90081-0
   BENOIT AG, 1984, AM J OBSTET GYNECOL, V148, P690, DOI 10.1016/0002-9378(84)90775-0
   BERKELEY AS, 1980, LANCET, V2, P375
   BERKOWITZ RS, 1979, GYNECOL ONCOL, V8, P311, DOI 10.1016/0090-8258(79)90040-4
   Bibbo M, 1999, ACTA CYTOL, V43, P23, DOI 10.1159/000330863
   Bibbo M, 1999, ACTA CYTOL, V43, P27, DOI 10.1159/000330864
   Birdsong GG, 1996, HUM PATHOL, V27, P468, DOI 10.1016/S0046-8177(96)90090-8
   Bishop JW, 1998, ACTA CYTOL, V42, P189, DOI 10.1159/000331545
   Bishop JW, 1997, ACTA CYTOL, V41, P15, DOI 10.1159/000332299
   Bishop JW, 1999, ACTA CYTOL, V43, P34, DOI 10.1159/000330866
   Bishop JW, 2000, ACTA CYTOL, V44, P128, DOI 10.1159/000326349
   BOGDANICH W, 1987, WALL STREET J   1102, P1
   Bolick DR, 1998, ACTA CYTOL, V42, P209, DOI 10.1159/000331548
   BOON ME, 1994, MODERN PATHOL, V7, P957
   BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
   BOSCH MMC, 1992, ACTA CYTOL, V36, P711
   BOYES DA, 1977, AM J OBSTET GYNECOL, V128, P692, DOI 10.1016/0002-9378(77)90223-X
   BOYES DA, 1982, CLIN INVEST MED, V5, P1
   BRINTON LA, 1993, GYNECOL ONCOL, V51, P301, DOI 10.1006/gyno.1993.1294
   BUR M, 1995, ACTA CYTOL, V39, P631
   CARMICHAEL JA, 1984, AM J OBSTET GYNECOL, V148, P685, DOI 10.1016/0002-9378(84)90774-9
   Carpenter AB, 1999, CANCER CYTOPATHOL, V87, P105, DOI 10.1002/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z
   CECCHINI S, 1985, ACTA CYTOL, V29, P329
   CHRISTOPHERSON WM, 1970, CANCER-AM CANCER SOC, V26, P808, DOI 10.1002/1097-0142(197010)26:4<808::AID-CNCR2820260411>3.0.CO;2-S
   CHRISTOPHERSON WM, 1970, CANCER-AM CANCER SOC, V26, P29, DOI 10.1002/1097-0142(197007)26:1<29::AID-CNCR2820260104>3.0.CO;2-G
   Clavel C, 1999, BRIT J CANCER, V80, P1306, DOI 10.1038/sj.bjc.6690523
   COLGAN TJ, 1995, ACTA CYTOL, V39, P1191
   Colgan TJ, 1997, ACTA CYTOL, V41, P50, DOI 10.1159/000332305
   COPPLESON LW, 1974, AM J OBSTET GYNECOL, V119, P953, DOI 10.1016/0002-9378(74)90013-1
   Corkill M, 1998, J Low Genit Tract Dis, V2, P12, DOI 10.1097/00128360-199801000-00003
   Corkill M, 1997, ACTA CYTOL, V41, P39, DOI 10.1159/000332303
   CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B
   Davey DD, 1996, ARCH PATHOL LAB MED, V120, P440
   Denaro TJ, 1997, ACTA CYTOL, V41, P65, DOI 10.1159/000332307
   DEVESA SS, 1987, J NATL CANCER I, V79, P701
   Diaz-Rosario LA, 1999, ARCH PATHOL LAB MED, V123, P817
   DICKINSON L, 1972, MAYO CLIN PROC, V47, P534
   Doornewaard H, 1997, CYTOPATHOLOGY, V8, P313, DOI 10.1111/j.1365-2303.1997.tb00555.x
   DUNN JE, 1981, AM J OBSTET GYNECOL, V139, P868, DOI 10.1016/0002-9378(81)90951-0
   Dupree WB, 1998, CANCER CYTOPATHOL, V84, P202, DOI 10.1002/(SICI)1097-0142(19980825)84:4<202::AID-CNCR4>3.0.CO;2-O
   ELIAS A, 1983, ACTA CYTOL, V27, P225
   FAHEY MT, 1995, AM J EPIDEMIOL, V141, P680, DOI 10.1093/oxfordjournals.aje.a117485
   Ferenczy A, 1996, ACTA CYTOL, V40, P1136
   Ferenczy A, 1996, AM J OBSTET GYNECOL, V175, P651
   Fetherston W C, 1983, Clin Obstet Gynecol, V26, P929, DOI 10.1097/00003081-198312000-00017
   Fetterman B, 1999, ACTA CYTOL, V43, P13, DOI 10.1159/000330862
   FIDLER H. K., 1968, J OBSTET GYNAECOL BRIT COMMONW, V75, P392
   Fiel-Gan MD, 1999, ACTA CYTOL, V43, P1034, DOI 10.1159/000331350
   FIGGE DC, 1970, AM J OBSTET GYNECOL, V108, P422, DOI 10.1016/0002-9378(70)90425-4
   GAY JD, 1985, ACTA CYTOL, V29, P1043
   GEYER JW, 1993, DIAGN CYTOPATHOL, V9, P417, DOI 10.1002/dc.2840090409
   Goodman A, 1996, J REPROD MED, V41, P239
   Greer BE, 1997, ARCH PATHOL LAB MED, V121, P246
   Guidos BJ, 1999, DIAGN CYTOPATHOL, V20, P70, DOI 10.1002/(SICI)1097-0339(199902)20:2<70::AID-DC5>3.0.CO;2-E
   GUZICK DS, 1978, AM J PUBLIC HEALTH, V68, P125, DOI 10.2105/AJPH.68.2.125
   HAKAMA M, 1976, AM J EPIDEMIOL, V103, P512, DOI 10.1093/oxfordjournals.aje.a112253
   HAMMOND EC, 1968, CANCER, V22, P1096, DOI 10.1002/1097-0142(196811)22:6<1096::AID-CNCR2820220604>3.0.CO;2-7
   Henry JA, 1996, ACTA CYTOL, V40, P529
   Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5
   Howell LP, 1998, ACTA CYTOL, V42, P171, DOI 10.1159/000331542
   Howell LP, 1999, ACTA CYTOL, V43, P58, DOI 10.1159/000330869
   Huang TW, 1999, ACTA CYTOL, V43, P363, DOI 10.1159/000331082
   HUSAIN OAN, 1974, J CLIN PATHOL, V27, P935, DOI 10.1136/jcp.27.12.935
   HUTCHINSON ML, 1991, AM J CLIN PATHOL, V96, P300
   HUTCHINSON ML, 1992, ACTA CYTOL, V36, P499
   HUTCHINSON ML, 1994, AM J CLIN PATHOL, V101, P215, DOI 10.1093/ajcp/101.2.215
   Hutchinson ML, 1999, CANCER CYTOPATHOL, V87, P48, DOI 10.1002/(SICI)1097-0142(19990425)87:2<48::AID-CNCR2>3.0.CO;2-D
   Hutchison Martha, 1992, Acta Cytologica, V36, P577
   INHORN SL, 1998, J LOWER GENITAL TRAC, V2, P208
   JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791
   JONES B, 1994, CERVICAL BIOPSY CYTO, P93
   Jones BA, 1995, ARCH PATHOL LAB MED, V119, P1097
   Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5
   Koss LG, 1997, HUM PATHOL, V28, P1196, DOI 10.1016/S0046-8177(97)90258-6
   KOSS LG, 1993, CANCER, V71, P1406, DOI 10.1002/cncr.2820710405
   KOSS LG, 1994, AM J CLIN PATHOL, V101, P220, DOI 10.1093/ajcp/101.2.220
   Krieger P, 1997, ACTA CYTOL, V41, P11, DOI 10.1159/000332298
   KRISTENSEN GB, 1991, ACTA CYTOL, V35, P47
   KUNKEL WB, 1948, J APPL PHYS, V19, P1056, DOI 10.1063/1.1698010
   KUNZ J, 1998, SCHWEIZ RUNDSCH MED, V87, P1434
   LAARA E, 1987, LANCET, V1, P1247
   Laverty CR, 1997, ANAL QUANT CYTOL, V19, P239
   LAVERTY CRA, 1995, CYTOPATHOLOGY, V6, P140, DOI 10.1111/j.1365-2303.1995.tb00466.x
   Lee JSJ, 1997, ACTA CYTOL, V41, P56, DOI 10.1159/000332306
   Lee JSJ, 1998, ACTA CYTOL, V42, P221, DOI 10.1159/000331550
   Lee KR, 1997, OBSTET GYNECOL, V90, P278, DOI 10.1016/S0029-7844(97)00228-7
   LENTRICHIA BB, 2000, OBSTET GYNECOL S1, V95, pS3
   Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954
   LYNGE E, 1989, CANCER RES, V49, P2157
   MACGREGOR JE, 1986, IARC SCI PUBL, V76, P25
   MANGO LJ, 1994, CANCER LETT, V77, P155, DOI 10.1016/0304-3835(94)90098-1
   Mango LJ, 1998, ACTA CYTOL, V42, P227, DOI 10.1159/000331551
   Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605
   Marshall CJ, 1999, DIAGN CYTOPATHOL, V20, P170, DOI 10.1002/(SICI)1097-0339(199903)20:3<170::AID-DC12>3.3.CO;2-Y
   MARTIN PL, 1972, AM J OBSTET GYNECOL, V113, P541, DOI 10.1016/S0002-9378(15)32505-9
   Martinez I, 1984, Bol Asoc Med P R, V76, P100
   McGoogan E, 1996, ACTA CYTOL, V40, P107
   Minge L, 2000, J REPROD MED, V45, P179
   MITCHELL H, 1990, BRIT MED J, V300, P1622, DOI 10.1136/bmj.300.6740.1622
   MORELL ND, 1982, OBSTET GYNECOL, V60, P41
   NIELSEN NH, 1993, APMIS, V101, P290, DOI 10.1111/j.1699-0463.1993.tb00113.x
   Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X
   OTTO K, 1979, ANAL QUANT CYTOL, V1, P127
   OUD PS, 1984, CYTOMETRY, V5, P509, DOI 10.1002/cyto.990050512
   OUWERKERKNOORDAM E, 1994, CYTOPATHOLOGY, V5, P211, DOI 10.1111/j.1365-2303.1994.tb00422.x
   Papanicolaou GN, 1941, AM J OBSTET GYNECOL, V42, P193
   Papillo JL, 1998, ACTA CYTOL, V42, P203, DOI 10.1159/000331547
   PATERSON MEL, 1984, BRIT MED J, V289, P896, DOI 10.1136/bmj.289.6449.896
   Patten SF, 1996, ACTA CYTOL, V40, P45
   Patten SF, 1997, CANCER CYTOPATHOL, V81, P337, DOI 10.1002/(SICI)1097-0142(19971225)81:6<337::AID-CNCR7>3.0.CO;2-I
   Patten SF, 1997, CANCER CYTOPATHOL, V81, P343, DOI 10.1002/(SICI)1097-0142(19971225)81:6<343::AID-CNCR8>3.0.CO;2-M
   PETERS RK, 1988, AM J OBSTET GYNECOL, V158, P926, DOI 10.1016/0002-9378(88)90096-8
   PRENDIVILLE W, 1980, LANCET, V2, P853
   REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305
   RIES L, 1994, SEER CANC STAT REV 1
   ROBERTS AW, 1985, MED J AUSTRALIA, V143, P333
   Roberts JM, 1997, MED J AUSTRALIA, V167, P466
   Rosenthal DL, 1996, ACTA CYTOL, V40, P120
   ROSENTHAL DL, 1987, ANAL QUANT CYTOL, V9, P55
   ROSENTHAL DL, 1979, ANAL QUANT CYTOL, V1, P84
   RUBIO CA, 1981, ACTA CYTOL, V25, P199
   RUBIO CA, 1977, OBSTET GYNECOL, V49, P576
   RYLANDER E, 1977, ACTA OBSTET GYN SCAN, V56, P115, DOI 10.3109/00016347709158352
   RYLANDER E, 1976, ACTA OBSTET GYN SCAN, V55, P361, DOI 10.3109/00016347609158514
   Sampson AJ, 1997, ARCH PATHOL LAB MED, V121, P241
   Sato S, 1998, ACTA CYTOL, V42, P299, DOI 10.1159/000331607
   Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6
   Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87
   SCHWARZ G, 1983, ANAL QUANT CYTOL, V5, P189
   SFAMENI SF, 1989, AUST NZ J OBSTET GYN, V29, P40, DOI 10.1111/j.1479-828X.1989.tb02874.x
   Sherman ME, 1998, MODERN PATHOL, V11, P837
   Sherman ME, 1997, CANCER CYTOPATHOL, V81, P89
   SHERMAN ME, 1994, MODERN PATHOL, V7, P578
   Shield PW, 1999, MED J AUSTRALIA, V170, P255
   SLAGEL DD, 1995, DIAGN CYTOPATHOL, V13, P26, DOI 10.1002/dc.2840130107
   Sprenger E, 1996, ACTA CYTOL, V40, P81
   Stanley MW, 1998, AM J CLIN PATHOL, V109, P6
   STENKVIST B, 1984, JAMA-J AM MED ASSOC, V252, P1423, DOI 10.1001/jama.252.11.1423
   Stevens MW, 1997, DIAGN CYTOPATHOL, V16, P505, DOI 10.1002/(SICI)1097-0339(199706)16:6<505::AID-DC7>3.0.CO;2-8
   Stevens MW, 1998, DIAGN CYTOPATHOL, V18, P236, DOI 10.1002/(SICI)1097-0339(199803)18:3<236::AID-DC15>3.0.CO;2-L
   Takahashi M, 1998, ACTA CYTOL, V42, P185, DOI 10.1159/000331544
   Takahashi M, 1997, ACTA CYTOL, V41, P1785
   TANAKA N, 1981, ANAL QUANT CYTOL, V3, P96
   TEZUKA F, 1995, ACTA CYTOL, V39, P837
   Tezuka F, 1996, ACTA CYTOL, V40, P513
   VANDRIELKULKER AMJ, 1980, ANAL QUANT CYTOL, V2, P243
   Varner CD, 1997, ARCH PATHOL LAB MED, V121, P315
   Vassilakos P, 1998, ACTA CYTOL, V42, P198, DOI 10.1159/000331546
   Vassilakos P, 2000, J REPROD MED, V45, P11
   Vassilakos P, 1996, ACTA CYTOL, V40, P496
   Vassilakos P, 1999, ACTA CYTOL, V43, P65, DOI 10.1159/000330870
   Vassilakos P, 1998, INT J GYNECOL OBSTET, V61, P45, DOI 10.1016/S0020-7292(98)00012-5
   VOOIJS PG, 1985, ACTA CYTOL, V29, P323
   WAIN GV, 1992, MED J AUSTRALIA, V157, P14
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
   WALKER EM, 1983, BRIT J OBSTET GYNAEC, V90, P1087, DOI 10.1111/j.1471-0528.1983.tb06449.x
   WALTON RJ, 1976, CAN MED ASSOC J, V114, P981
   Wang TY, 1999, J FORMOS MED ASSOC, V98, P500
   Weintraub J, 2000, DIAGN CYTOPATHOL, V22, P52, DOI 10.1002/(SICI)1097-0339(200001)22:1<52::AID-DC14>3.0.CO;2-#
   WEINTRAUB J, 1997, REF GYNECOL OBSTET, V5, P2
   Wertlake P, 1999, J REPROD MED, V44, P11
   WHEELESS LL, 1974, J HISTOCHEM CYTOCHEM, V22, P522, DOI 10.1177/22.7.522
   Wilbur DC, 1997, ACTA CYTOL, V41, P24, DOI 10.1159/000332300
   WILBUR DC, 1994, AM J CLIN PATHOL, V101, P209, DOI 10.1093/ajcp/101.2.209
   Wilbur DC, 1998, ACTA CYTOL, V42, P214, DOI 10.1159/000331549
   Wilbur DC, 1996, DIAGN CYTOPATHOL, V14, P201, DOI 10.1002/(SICI)1097-0339(199604)14:3<201::AID-DC2>3.3.CO;2-2
   Wilbur DC, 1996, ACTA CYTOL, V40, P127
   Wilbur DC, 1999, CANCER CYTOPATHOL, V87, P354
   WOODMAN CBJ, 1989, LANCET, V2, P88
   Wright TC, 1998, AM J OBSTET GYNECOL, V178, P962, DOI 10.1016/S0002-9378(98)70531-9
NR 186
TC 13
Z9 13
U1 0
U2 0
PU SCI PRINTERS & PUBL INC
PI ST LOUIS
PA P.O. DRAWER 12425 8342 OLIVE BLVD, ST LOUIS, MO 63132 USA
SN 0024-7758
J9 J REPROD MED
JI J. Reprod. Med.
PD SEP
PY 2000
VL 45
IS 9
BP 701
EP 719
PG 19
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 359UB
UT WOS:000089629500003
PM 11027079
DA 2018-10-19
ER

PT J
AU Wang, YJ
AF Wang, YJ
TI Development of new polycations for cell encapsulation with alginate
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Bionic Design Workshop
CY FEB 22-23, 1999
CL TOKYO, JAPAN
DE microcapsules; mechanical strength; cross-linking; polycations; alginate
ID LIVING CELLS; MICROENCAPSULATION; MICROCAPSULES; MEMBRANES
AB Microencapsulation is one of the most important techniques used in immobilizing cells for biomedical applications. Of the many microcapsules derived from various materials, the one formed by alginate and poly(L-lysine) is probably the most common. These microcapsules, prepared under mild conditions, provide an adequate environment for cell growth. Unfortunately, they usually lack mechanical strength due to the ionic interaction, instead of covalent bonding, between alginate and polycations.
   In order to improve the mechanical strength, we have investigated the feasibility of using poly(vinylamine) and poly(allylamine) to replace the conventional poly(L-lysine). Of these two polycations, poly(allylamine) formed microcapsules of about the same strength as that prepared from poly(L-lysine). On the other hand, microcapsules prepared from alginate and poly(vinylamine) have about 40% of capsules weaker than that prepared from poly(L-lysine). However, the remaining 60% of its population remained intact even after 48 h of mechanical vibration test.
   An alternative strengthening method is to cross-link poly(L-lysine) by chemical or photochemical process. The chemical method was conducted by treating microcapsules with tosylated poly(vinylalcohol). This treatment resulted in the cross-linking of poly(L-lysine) in the capsular membrane and therefore, a significant improvement of capsular strength. For the photochemical method, a photosensitive polycation was prepared by partially modifying the amino groups of the poly(L-lysine) with alpha -phenylcinnamyldieneacetyl chloride. The capsules formed from alginate and this photosensitive polymer yield the highest mechanical strength after irradiation of light at similar to 320 nm. All microcapsules investigated were permeable to the proteins of mid-size molecular weight such as myoglobin. Cells can be entrapped and cultured by using this encapsulation technology. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Wang, YJ (reprint author), Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
CR BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BAYER E, 1980, MAKROMOL CHEM, V181, P503
   Chang SJ, 1999, J BIOMAT SCI-POLYM E, V10, P531
   Chang T M, 1992, ASAIO J, V38, P128, DOI 10.1097/00002480-199204000-00013
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   HALLE JP, 1993, TRANSPLANTATION, V55, P350, DOI 10.1097/00007890-199302000-00023
   KUNG IM, 1995, BIOMATERIALS, V16, P649, DOI 10.1016/0142-9612(95)93863-9
   LIM F, 1981, J PHARM SCI, V70, P351, DOI 10.1002/jps.2600700402
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   TANAKA H, 1972, J POLYM SCI A1, V10, P1729, DOI 10.1002/pol.1972.150100614
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   ULUDAG H, 1992, BIOTECHNOL BIOENG, V39, P672, DOI 10.1002/bit.260390612
   WANG FF, 1992, BIOTECHNOL BIOENG, V40, P1115, DOI 10.1002/bit.260400916
   Zekorn T, 1995, TRANSPLANT P, V27, P3362
NR 15
TC 25
Z9 28
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP 1
PY 2000
VL 13
IS 1-2
SI SI
BP 59
EP 63
DI 10.1016/S0928-4931(00)00177-6
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 367BA
UT WOS:000090040600010
DA 2018-10-19
ER

PT J
AU Eastwood, S
   Derish, PA
   Berger, MS
AF Eastwood, S
   Derish, PA
   Berger, MS
TI Biomedical publication for neurosurgery residents: A program and guide
SO NEUROSURGERY
LA English
DT Article
DE biomedical publication; biomedical writing; critical appraisal skills;
   professional training; publication ethics
ID REQUIRING PROLONGED OBSERVATION; RANDOMIZED CONTROLLED TRIALS;
   CRITICAL-APPRAISAL SKILLS; JOURNAL CLUB; EMERGENCY-MEDICINE; ATTITUDES;
   KNOWLEDGE; IMPACT; INTERVENTION; CURRICULUM
AB ONE OF THE most pressing obligations in academic neurosurgery is the publication of clinical and basic science research results. Publication documents intellectual property and communicates findings among researchers working to improve neurosurgical treatment. It documents productivity, justifies funding for research, creates reputations, and builds careers. Nonetheless, the actual writing of reports is a skill often learned by osmosis in academic medicine. To give residents the tools necessary to negotiate the biomedical publication process successfully, we developed a publications program based on the premise that residents seeking an academic career must be prepared to generate publishable reports with maximum efficiency. The program consists of a "publication kit," a series of seminars, and one-on-one tutorials with academic biomedical editors that permit residents individually to improve the quality of their reporting. We describe this program, provide guidelines that can help residents write high-quality papers and publish their work more efficiently, and summarize important content regarding the framework for a successful paper, the elements of a conventional research report, brief guidelines for specific types of papers, reporting standards for clinical trials and meta-analyses, keys to citation in bibliographic indexes, and ethical and legal considerations related to research approval, confidentiality requirements, copyright law, permission to use previously published material, and conflict of interest. Residents who are able to view their work with a sharp critical focus and are educated about the standards of biomedical publication are better prepared to succeed in building a career in academic medicine.
C1 Univ Calif San Francisco, Dept Neurol Surg, Div Publ & Grants Writing, Sch Med, Emeryville, CA 94662 USA.
RP Eastwood, S (reprint author), Univ Calif San Francisco, Dept Neurol Surg, Div Publ & Grants Writing, Sch Med, POB 8099, Emeryville, CA 94662 USA.
CR Alguire PC, 1998, J GEN INTERN MED, V13, P347, DOI 10.1046/j.1525-1497.1998.00102.x
   Avery L, 1996, NATURE, V379, P293, DOI 10.1038/379293b0
   Bailar III J. C., 1992, MED USES STAT
   BARR SI, 1989, J CAN DIET ASSOC, V50, P219
   Bazarian JJ, 1999, ANN EMERG MED, V34, P148, DOI 10.1016/S0196-0644(99)70222-2
   Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637
   BENNETT KJ, 1987, JAMA-J AM MED ASSOC, V257, P2451, DOI 10.1001/jama.257.18.2451
   BENZEL EC, 1999, CHANGING FACE ACAD P
   Blanda M, 1999, ACAD EMERG MED, V6, P286, DOI 10.1111/j.1553-2712.1999.tb00390.x
   BROWNER WS, 1999, PUBLISHING PRESENTIN
   Burstein JL, 1996, AM J EMERG MED, V14, P561, DOI 10.1016/S0735-6757(96)90099-6
   CASSUTO L, 1998, CHRONICLE HIGHE 1127, pB4
   Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006
   COHEN SJ, 1985, SOC SCI MED, V21, P909, DOI 10.1016/0277-9536(85)90147-9
   Coleridge S T, 1993, J Am Osteopath Assoc, V93, P936
   Cox DR, 1984, ANAL SURVIVAL DATA
   Dawson-Saunders B, 1994, BASIC CLIN BIOSTATIS
   DICHIRO G, 1989, RADIOLOGY, V170, P569, DOI 10.1148/radiology.170.2.2911688
   Eastwood S, 2000, ETHICAL ISSUES IN BIOMEDICAL PUBLICATION, P250
   EASTWOOD S, 1993, PANEL SCI RESPONSIBI, V2
   Eastwood Susan, 1996, Sci Eng Ethics, V2, P89, DOI 10.1007/BF02639320
   EDWARDS CG, 1999, HMS BEAGLE 63
   Fackler ML, 1996, ANN INTERN MED, V124, P741, DOI 10.7326/0003-4819-124-8-199604150-00007
   Fish JS, 1998, PLAST RECONSTR SURG, V101, P1400, DOI 10.1097/00006534-199804050-00043
   Franck G, 1999, SCIENCE, V286, P53, DOI 10.1126/science.286.5437.53
   FYE WB, 1990, ANN INTERN MED, V113, P317, DOI 10.7326/0003-4819-113-4-317
   Glass G. V., 1977, REV RES EDUC, V5, P351, DOI [DOI 10.3102/0091732X005001351, 10.2307/1167179]
   GLAZER S, 1997, CQ RES, V7, P3
   Green ML, 1997, J GEN INTERN MED, V12, P742, DOI 10.1046/j.1525-1497.1997.07159.x
   Greenhalgh T., 1997, READ PAPER BASICS EV
   Heiligman R M, 1991, Fam Med, V23, P152
   Huth E. J., 1990, WRITE PUBLISH PAPERS
   JONES J, 1987, ANN EMERG MED, V16, P347, DOI 10.1016/S0196-0644(87)80186-5
   KITCHENS JM, 1989, J GEN INTERN MED, V4, P384, DOI 10.1007/BF02599686
   KROGH CL, 1985, MED EDUC, V19, P392, DOI 10.1111/j.1365-2923.1985.tb01343.x
   LANDRY FJ, 1994, J GEN INTERN MED, V9, P436, DOI 10.1007/BF02599058
   LINZER M, 1988, JAMA-J AM MED ASSOC, V260, P2537, DOI 10.1001/jama.260.17.2537
   MARKERT RJ, 1989, ACAD MED, V64, P223, DOI 10.1097/00001888-198904000-00014
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Morris B A, 1994, Fam Med, V26, P579
   *NAT I HLTH REM UP, 1992, NIH GUIDE GRANTS CON, V21, P2
   National Asthma Education and Prevention Program, 1997, EX SUMM NIH REP, P6
   NIEDERHUBER JE, 1996, ONCOLOGIST, V1, pR7
   Norman GR, 1998, CAN MED ASSOC J, V158, P177
   *OFF RES INT US PU, 1993, ORI NEWSLETTER, V1, P8
   ORDWAY S, 1994, GUIDE PUBLISHING BIO
   PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1
   PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220
   SEELIG CB, 1991, J GEN INTERN MED, V6, P330
   SIPE TA, 1995, THESIS U MICROFILMS
   Smith R, 1998, BRIT MED J, V316, P949, DOI 10.1136/bmj.316.7136.949
   Spickard A, 1996, J GEN INTERN MED, V11, P475, DOI 10.1007/BF02599042
   Spillane AJ, 1998, AUST NZ J SURG, V68, P288, DOI 10.1111/j.1445-2197.1998.tb02085.x
   STERN DT, 1995, ACAD MED, V70, P152, DOI 10.1097/00001888-199502000-00021
   Stevermer JJ, 1999, ACAD MED, V74, P70
   Supino PG, 1999, ACAD EMERG MED, V6, P280, DOI 10.1111/j.1553-2712.1999.tb00389.x
   TAUBES G, 1995, SCIENCE, V268, P1711, DOI 10.1126/science.7792592
   TAUBES G, 1995, SCIENCE, V268, P1714, DOI 10.1126/science.7605516
   Valentini RP, 1997, POSTGRAD MED J, V73, P81, DOI 10.1136/pgmj.73.856.81
   Williams RL, 1998, ACAD MED, V73, P333, DOI 10.1097/00001888-199803000-00023
   Woodford F. P., 1999, TEACH SCI COMMUNICAT
   Zeiger M., 1991, ESSENTIALS WRITING B
   1988, C NEUR SURG BYL C NE
   1996, NATURE, V384, P497
NR 64
TC 18
Z9 18
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-396X
J9 NEUROSURGERY
JI Neurosurgery
PD SEP
PY 2000
VL 47
IS 3
BP 739
EP 748
DI 10.1097/00006123-200009000-00043
PG 10
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 349GJ
UT WOS:000089037100095
PM 10981762
DA 2018-10-19
ER

PT J
AU Cui, FZ
   Li, DJ
AF Cui, FZ
   Li, DJ
TI A review of investigations on biocompatibility of diamond-like carbon
   and carbon nitride films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd Asian-European International Conference on Plasma Surface
   Engineering (AEPSE '99)
CY SEP 15-19, 1999
CL BEIJING, PEOPLES R CHINA
SP Tsinghua Univ, Taiyuan Univ Technol, Dalian Univ Technol, Natl Adv Mat Comm China, Natl Nat Sci Fdn China, Surface & Coatings Technol & Thin Solid Films, European Joint Comm Plasma & Ion Surface Engn
DE diamond-like carbon; carbon nitride; biocompatibility
ID BEAM-ASSISTED DEPOSITION; THIN-FILMS; LOW-TEMPERATURE; WEAR;
   BIOMATERIALS; MACROPHAGES; CULTURE; PLASMA
AB This paper reviews the present status of studies of biocompatibility of diamond-like carbon (DLC) and carbon nitride (CN) coatings. DLC and CN coatings, due to their novel mechanical and tribological properties, chemical inertness, electrical and optical properties, and biocompatibility, are excellent candidates for biomedical applications. A number of clinical applications for DLC are now being considered by commercial manufacturers of surgical implants. Preliminary studies have shown that DLC coating can be adherent on a range of biomaterials with desirable bulk properties, no toxicity toward living cells, no inflammatory response or loss of cell integrity, as well no cellular damage. Despite only a few reports about biocompatibility of CN coating, which, with its mechanical and chemical properties comparable with DLC, is a very attraction coating material for future biomedical applications. This paper outlines the present level of research and suggests areas for future research, these include in vivo tests and a more detailed investigation of coating bond structure or properties. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   Tianjin Normal Univ, Dept Phys, Tianjin 300074, Peoples R China.
RP Cui, FZ (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@sun.ihep.ac.cn
CR AISENBERG S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   AMARATUNGA G, 1989, APPL PHYS LETT, V55, P634, DOI 10.1063/1.101808
   ANDERSSON LP, 1981, THIN SOLID FILMS, V86, P193, DOI 10.1016/0040-6090(81)90288-1
   ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   BULL SJ, 1992, DIAM RELAT MATER, V1, P1049, DOI 10.1016/0925-9635(92)90075-Y
   CATHERINE Y, 1991, NATO ADV SCI I B-PHY, V266, P193
   CHARNLEY J, 1975, CLIN ORTHOP RELAT R, V112, P170
   CHO NH, 1990, J MATER RES, V5, P2543, DOI 10.1557/JMR.1990.2543
   Clay KJ, 1998, DIAM RELAT MATER, V7, P1100, DOI 10.1016/S0925-9635(98)00159-9
   COURTNEY JM, 1993, MANAGEMENT BLEEDING, P236
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   CUOMO JJ, 1991, APPL PHYS LETT, V58, P466, DOI 10.1063/1.104609
   De Giorgi ML, 1998, APPL SURF SCI, V127, P481, DOI 10.1016/S0169-4332(97)00678-8
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   FUJIMOTO F, 1993, JPN J APPL PHYS 2, V32, pL420, DOI 10.1143/JJAP.32.L420
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   HAN HX, 1988, SOLID STATE COMMUN, V65, P921, DOI 10.1016/0038-1098(88)90732-6
   HARRIS SJ, 1993, SURF COAT TECH, V62, P550, DOI 10.1016/0257-8972(93)90298-3
   He XM, 1996, J VAC SCI TECHNOL A, V14, P2039, DOI 10.1116/1.580079
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   LI D, 1993, J APPL PHYS, V74, P219, DOI 10.1063/1.355304
   Li DJ, 1999, APPL SURF SCI, V137, P30, DOI 10.1016/S0169-4332(98)00485-1
   Li DJ, 1999, J ADHES SCI TECHNOL, V13, P169, DOI 10.1163/156856199X00370
   LI HD, 1994, B MATER SCI, V17, P1415, DOI 10.1007/BF02747239
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   MARTON D, 1994, PHYS REV LETT, V73, P118, DOI 10.1103/PhysRevLett.73.118
   MAYA L, 1991, J AM CERAM SOC, V74, P1686, DOI 10.1111/j.1151-2916.1991.tb07161.x
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   Michler T, 1998, DIAM RELAT MATER, V7, P459, DOI 10.1016/S0925-9635(97)00236-7
   MIN Z, 1992, VACUUM, V43, P945, DOI 10.1016/0042-207X(92)90004-G
   MIYOSHI K, 1992, SURF COAT TECH, V55, P428, DOI 10.1016/S0257-8972(07)80061-2
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NIU CM, 1993, SCIENCE, V261, P334, DOI 10.1126/science.261.5119.334
   OJHA SM, 1977, THIN SOLIF SILMS, V40, pL13
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   PARKER TL, 1993, DIAMOND FILMS, V93, P118
   Patil DS, 1998, J ALLOY COMPD, V278, P130, DOI 10.1016/S0925-8388(98)00601-X
   Quiros C, 1999, VACUUM, V52, P199, DOI 10.1016/S0042-207X(98)00220-6
   ROBERTSON J, 1994, PURE APPL CHEM, V66, P1789, DOI 10.1351/pac199466091789
   SAVVIDES N, 1986, J VAC SCI TECHNOL A, V4, P504, DOI 10.1116/1.573869
   SAVVIDES N, 1985, J APPL PHYS, V58, P518, DOI 10.1063/1.335656
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   SONG HW, 1994, J PHYS-CONDENS MAT, V6, P6125, DOI 10.1088/0953-8984/6/31/011
   SPENCER EG, 1976, APPL PHYS LETT, V29, P118, DOI 10.1063/1.88963
   Su XW, 1996, SURF COAT TECH, V84, P388, DOI 10.1016/S0257-8972(95)02809-9
   Su XW, 1996, NUCL INSTRUM METH B, V111, P59, DOI 10.1016/0168-583X(95)01300-8
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   TORNG CJ, 1990, J MATER RES, V5, P2490, DOI 10.1557/JMR.1990.2490
   WEISSMANTEL C, 1981, J VAC SCI TECHNOL, V18, P179, DOI 10.1116/1.570719
   WEISSMANTEL C, 1981, THIN SOLID FILMS, V61, pL1
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WOLTER JR, 1990, BIOMATERIALS OPHTHAL
NR 57
TC 275
Z9 286
U1 3
U2 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP 1
PY 2000
VL 131
IS 1-3
BP 481
EP 487
DI 10.1016/S0257-8972(00)00809-4
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 377WA
UT WOS:000165548200093
DA 2018-10-19
ER

PT J
AU Lin, J
AF Lin, J
TI Recent development and applications of optical and fiber-optic pH
   sensors
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE pH sensors; fiber-optic pH sensors; optical pH sensors
ID GEL IMMOBILIZATION TECHNIQUE; EVANESCENT-WAVE ABSORPTION; SINGLE LIVING
   CELLS; CARBON-DIOXIDE; IMAGING FIBER; SENSITIVITY ENHANCEMENT;
   FLUORESCENCE LIFETIMES; CHEMICAL-ANALYSIS; PEBBLE SENSORS; FILM SENSORS
AB This article provides a brief review on the development and applications of optical and fiber-optic pH sensors in the 1990s. Various methods and materials for immobilization of pH indicators are surveyed. Different spectroscopic methods used for measurement with pH sensors are briefly discussed. Several special optical and fiber-optic pH sensors ave reviewed, including pH sensors based on conductive polymers, imaging fibers, microparticles and nanospheres, as well as micron and sub-micron fiber-optic pH sensors, distributed fiber-optic pH sensors, pH sensors for high acidity and alkalinity, pH sensors with broad dynamic range and linear response, and CO2 and NH3 sensors based on pH indicators. Applications of fiberoptic sensors in environmental detection, biomedical research, medical monitoring and industrial process control are summarized. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Portland State Univ, Dept Chem, Portland, OR 97207 USA.
RP Lin, J (reprint author), Portland State Univ, Dept Chem, Portland, OR 97207 USA.
CR AHARONSON N, 1994, MATER RES SOC SYMP P, V346, P519
   Allain LR, 1997, ANAL CHEM, V69, P3076, DOI 10.1021/ac970258g
   Allain LR, 2000, ANAL CHEM, V72, P1078, DOI 10.1021/ac990908b
   ALLAIN LR, 1998, J PROCESS ANAL CHEM, V3, P98
   BACCI M, 1991, APPL SPECTROSC, V45, P1508, DOI 10.1366/0003702914335472
   BAKKER E, 1993, ANAL CHIM ACTA, V278, P211, DOI 10.1016/0003-2670(93)85102-P
   BALDINI F, 1994, APPL SPECTROSC, V48, P549, DOI 10.1366/0003702944924871
   BALDINI F, 1993, SENSOR ACTUAT A-PHYS, V37-8, P180, DOI 10.1016/0924-4247(93)80031-B
   BARNARD SM, 1991, NATURE, V353, P338, DOI 10.1038/353338a0
   Blue R, 1997, ELECTRON LETT, V33, P526, DOI 10.1049/el:19970321
   BRINKER CJ, 1990, SOL GEL SCI PHYSICS
   BRONK KS, 1994, ANAL CHEM, V66, P3519, DOI 10.1021/ac00092a035
   BRONK KS, 1995, ANAL CHEM, V67, P2750, DOI 10.1021/ac00113a005
   Browne CA, 1996, ANAL CHEM, V68, P2289, DOI 10.1021/ac960078r
   BUTLER TM, 1995, P SOC PHOTO-OPT INS, V2508, P168, DOI 10.1117/12.221730
   CARDWELL TJ, 1993, TALANTA, V40, P765, DOI 10.1016/0039-9140(93)80293-Z
   Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   CUI DF, 1993, SENSOR ACTUAT B-CHEM, V12, P29
   DEBOUX BJC, 1995, J LIGHTWAVE TECHNOL, V13, P1407, DOI 10.1109/50.400705
   deMarcos S, 1996, ANAL CHIM ACTA, V334, P149, DOI 10.1016/S0003-2670(96)00290-5
   DING JY, 1991, ELECTRON LETT, V27, P1560, DOI 10.1049/el:19910978
   DRAXLER S, 1993, SENSOR ACTUAT B-CHEM, V11, P421
   DRAXLER S, 1995, P SOC PHOTO-OPT INS, V2388, P363, DOI 10.1117/12.208494
   Dybko A, 1998, SENSOR ACTUAT B-CHEM, V51, P208, DOI 10.1016/S0925-4005(98)00192-0
   Dybko A., 1992, International Journal of Optoelectronics, V7, P443
   DYBKO A, 1993, SPIE, V2085, P131
   DYBKO A, 1997, SENSOR ACTUAT B-CHEM, V38, P207
   Egami C, 1997, JPN J APPL PHYS 1, V36, P2902, DOI 10.1143/JJAP.36.2902
   Egami C, 1996, OPT COMMUN, V122, P122, DOI 10.1016/0030-4018(95)00536-6
   Ensafi AA, 1999, MICROCHEM J, V63, P381, DOI 10.1006/mchj.1999.1757
   Ferguson JA, 1997, ANAL CHIM ACTA, V340, P123, DOI 10.1016/S0003-2670(96)00510-7
   Flannery D, 1997, OPT LETT, V22, P567, DOI 10.1364/OL.22.000567
   GABOR G, 1995, ANAL CHIM ACTA, V313, P131, DOI 10.1016/0003-2670(95)00248-X
   GABOR G, 1991, ANAL CHEM, V63, P793, DOI 10.1021/ac00008a011
   GE ZF, 1993, ANAL CHEM, V65, P2335, DOI 10.1021/ac00065a028
   Grant SA, 1997, SENSOR ACTUAT B-CHEM, V45, P35, DOI 10.1016/S0925-4005(97)00263-3
   Grummt UW, 1997, ANAL CHIM ACTA, V357, P253, DOI 10.1016/S0003-2670(97)00572-2
   Gupta BD, 1998, OPT COMMUN, V154, P282, DOI 10.1016/S0030-4018(98)00321-6
   HAO TY, 1993, SENSOR ACTUAT B-CHEM, V10, P155, DOI 10.1016/0925-4005(93)80040-I
   Healey BG, 1997, ANAL CHEM, V69, P2213, DOI 10.1021/ac961058s
   HOLOBAR A, 1993, SENSOR ACTUAT B-CHEM, V11, P425, DOI 10.1016/0925-4005(93)85283-G
   IGARASHI S, 1994, ANAL SCI, V10, P821, DOI 10.2116/analsci.10.821
   JONES TP, 1991, APPL SPECTROSC, V45, P1271, DOI 10.1366/0003702914335814
   KOSTOV Y, 1993, ANAL CHIM ACTA, V280, P15, DOI 10.1016/0003-2670(93)80235-D
   KOSTOV YV, 1992, SENSOR ACTUAT B-CHEM, V8, P99, DOI 10.1016/0925-4005(92)85015-O
   Kuswandi B, 1999, FRESEN J ANAL CHEM, V364, P605, DOI 10.1007/s002160051394
   LEINER MJP, 1991, FIBER OPTIC CHEM SEN, V1, P359
   Lin J, 2000, ANAL CHIM ACTA, V408, P49, DOI 10.1016/S0003-2670(99)00840-5
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Lobnik A, 1998, ANAL CHIM ACTA, V367, P159, DOI 10.1016/S0003-2670(97)00708-3
   MACCRAITH BD, 1991, ELECTRON LETT, V27, P1247, DOI 10.1049/el:19910781
   MAHER MH, 1993, J TEST EVAL, V21, P448
   McCulloch S, 1997, IEE P-OPTOELECTRON, V144, P162, DOI 10.1049/ip-opt:19971269
   Mendoza EA, 1996, P SOC PHOTO-OPT INS, V2836, P242, DOI 10.1117/12.260598
   Michael KL, 1999, ANAL BIOCHEM, V273, P168, DOI 10.1006/abio.1999.4173
   Michael KL, 1999, ANAL CHEM, V71, P2766, DOI 10.1021/ac990085q
   MIGNANI AG, 1995, J LIGHTWAVE TECHNOL, V13, P1396, DOI 10.1109/50.400704
   Millar D, 1998, CHEM COMMUN, P477, DOI 10.1039/a708160j
   MILLS A, 1992, ANAL CHEM, V64, P1383, DOI 10.1021/ac00037a015
   MOHR GJ, 1994, ANAL CHIM ACTA, V292, P41, DOI 10.1016/0003-2670(94)00096-4
   MOTELLIER S, 1995, SENSOR ACTUAT B-CHEM, V29, P345, DOI 10.1016/0925-4005(95)01705-4
   MOTELLIER S, 1993, SENSOR ACTUAT B-CHEM, V11, P467, DOI 10.1016/0925-4005(93)85289-M
   MULLEN KI, 1992, ANAL CHEM, V64, P930, DOI 10.1021/ac00032a018
   MULLER C, 1994, P SOC PHOTO-OPT INS, V2131, P555
   Narang U, 1996, J SOL-GEL SCI TECHN, V6, P113, DOI 10.1007/BF00402594
   NIWA M, 1991, J CHEM SOC CHEM COMM, P444, DOI 10.1039/c39910000444
   Noire MH, 1998, SENSOR ACTUAT B-CHEM, V51, P214, DOI 10.1016/S0925-4005(98)00193-2
   Panova AA, 1997, ANAL CHEM, V69, P1635, DOI 10.1021/ac961025c
   PANTANO P, 1995, ANAL CHEM, V67, pA481, DOI 10.1021/ac00111a002
   Papkovsky DB, 1997, J PHOTOCH PHOTOBIO A, V104, P151, DOI 10.1016/S1010-6030(97)04592-9
   PARKER JW, 1993, ANAL CHEM, V65, P2329, DOI 10.1021/ac00065a027
   Plaschke M, 1997, P SOC PHOTO-OPT INS, V3105, P31, DOI 10.1117/12.276178
   Price JM, 1998, ANAL CHEM, V70, P265, DOI 10.1021/ac9707848
   Pringsheim E, 1997, ANAL CHIM ACTA, V357, P247, DOI 10.1016/S0003-2670(97)00563-1
   RAO BS, 1991, J APPL POLYM SCI, V43, P925, DOI 10.1002/app.1991.070430510
   Rottman C, 1998, J SOL-GEL SCI TECHN, V13, P17, DOI 10.1023/A:1008630701220
   Safavi A, 1996, ANAL CHIM ACTA, V335, P227, DOI 10.1016/S0003-2670(96)00357-1
   Safavi A, 1998, ANAL CHIM ACTA, V367, P167, DOI 10.1016/S0003-2670(98)00079-8
   SAMUEL J, 1994, MATER LETT, V21, P431, DOI 10.1016/0167-577X(94)90254-2
   SCHULMAN SG, 1995, ANAL CHIM ACTA, V304, P165, DOI 10.1016/0003-2670(94)00631-U
   SERRA G, 1990, ANAL CHIM ACTA, V232, P337, DOI 10.1016/S0003-2670(00)81251-9
   SHAHRIARI MR, 1994, SOL GEL OPTICS PROCE, P279
   SHAKHSHER Z, 1994, ANAL CHEM, V66, P1731, DOI 10.1021/ac00082a021
   SHAPIRO B A, 1992, Respiratory Care, V37, P165
   Shi YN, 1997, CHEM MATER, V9, P821, DOI 10.1021/cm960495k
   Song A, 1997, ANAL CHEM, V69, P863, DOI 10.1021/ac960917+
   Sotomayor MDT, 1997, ANAL CHIM ACTA, V353, P275
   SZMACINSKI H, 1993, ANAL CHEM, V65, P1668, DOI 10.1021/ac00061a007
   Tabacco MB, 1999, ANAL CHEM, V71, P154, DOI 10.1021/ac980513c
   TAKAI N, 1993, SENSOR ACTUAT B-CHEM, V13, P427, DOI 10.1016/0925-4005(93)85418-A
   TAN WH, 1992, ANAL CHEM, V64, P2985, DOI 10.1021/ac00047a019
   TAN WH, 1992, SCIENCE, V258, P778, DOI 10.1126/science.1439785
   THOMPSON RB, 1993, ANAL CHEM, V65, P853, DOI 10.1021/ac00055a005
   Trinkel M, 1996, ANAL CHIM ACTA, V320, P235, DOI 10.1016/0003-2670(95)00540-4
   Vishnoi G, 1999, P SOC PHOTO-OPT INS, V3538, P319, DOI 10.1117/12.335760
   VISHNOI G, 1998, P SOC PHOTO-OPT INS, V3538, P319
   Wallace PA, 1997, J LUMIN, V72-4, P1017, DOI 10.1016/S0022-2313(97)80797-1
   Wallace PA, 1998, P SOC PHOTO-OPT INS, V3483, P128, DOI 10.1117/12.309656
   WEIGL BH, 1995, ANAL CHIM ACTA, V302, P249, DOI 10.1016/0003-2670(94)00473-Y
   WERNER T, 1995, ANALYST, V120, P1627, DOI 10.1039/an9952001627
   WERNER T, 1993, FRESEN J ANAL CHEM, V346, P564, DOI 10.1007/BF00321245
   Werner T, 1997, FRESEN J ANAL CHEM, V359, P150, DOI 10.1007/s002160050552
   WOLFBEIS OS, 1992, MIKROCHIM ACTA, V108, P133, DOI 10.1007/BF01242422
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V1
   WOLFBEIS OS, 1996, STRUCT BOND, V85, P51
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V2
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN, V1, P267
   Wroblewski W, 1998, SENSOR ACTUAT B-CHEM, V48, P471, DOI 10.1016/S0925-4005(98)00087-2
   Xu WY, 1999, P SOC PHOTO-OPT INS, V3534, P456, DOI 10.1117/12.339027
   Xu Z, 1998, J BIOMED MATER RES, V39, P9, DOI 10.1002/(SICI)1097-4636(199801)39:1<9::AID-JBM2>3.0.CO;2-U
   YANG L, 1995, ANAL CHEM, V67, P1307, DOI 10.1021/ac00104a002
   Zhang L, 1997, TALANTA, V44, P1691, DOI 10.1016/S0039-9140(97)00080-5
   ZHANG S, 1995, MED BIOL ENG COMPUT, V33, P152, DOI 10.1007/BF02523033
   ZUSMAN R, 1990, J NONCRYST SOLIDS, V122, P109
NR 115
TC 179
Z9 183
U1 7
U2 143
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0165-9936
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD SEP
PY 2000
VL 19
IS 9
BP 541
EP 552
DI 10.1016/S0165-9936(00)00034-0
PG 12
WC Chemistry, Analytical
SC Chemistry
GA 354GT
UT WOS:000089321900003
DA 2018-10-19
ER

PT J
AU Sousa, RA
   Kalay, G
   Reis, RL
   Cunha, AM
   Bevis, MJ
AF Sousa, RA
   Kalay, G
   Reis, RL
   Cunha, AM
   Bevis, MJ
TI Injection molding of a starch/EVOH blend aimed as an alternative
   biomaterial for temporary applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE starch; biodegradable; biomaterial; injection molding; SCORIM; design of
   experiments
ID SHEAR CONTROLLED ORIENTATION; PHYSICAL PROPERTY RELATIONSHIPS; MOLDED
   ISOTACTIC POLYPROPYLENE; BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES;
   DEGRADATION; INVITRO
AB Biodegradable polymers show great potential to be used as materials for temporary implants and bone replacement applications in orthopedics. However, its use in high load-bearing applications will depend on the successful development of biodegradable implants with a mechanical performance matching that of human bone. This article describes the optimization of the injection molding process of an alternative biodegradable starch-based polymer aimed at biomedical applications. A blend of starch with a copolymer of ethylene-vinyl alcohol (SEVA-C) was studied. Both conventional injection molding and shear controlled orientation (SCORIM) were optimized with the support of design of experiments and analysis of variance techniques. The mechanical characterization was performed by tensile testing. The structure developed within the moldings was assessed by wide-angle X-ray diffraction and differential scanning calorimetry. Increases up to 30% in the tangent modulus and 20% in the ultimate tensile strength compared with conventional molding were achieved with the application of SCORIM. The holding pressure and the frequency of the shear applied have the strongest influence on the morphology development and consequently on the mechanical performance. The solidification of SEVA-C at high cavity pressures enhances stiffness for long durations of the shearing stage in SCORIM. However, the effect of viscous heating of SEVA-C is important and ought to be considered. A decrease of the material phase miscibility in SEVA-C occurs as result of the shear fields imposed. The microstructure evaluation suggests that the mechanical properties enhancement in SCORIM molded SEVA-C is attributable to preferred orientation developed during processing. (C) 2000 John Wiley & Sons, Inc.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
   Univ Minho, Dept Polymer Engn, P-4800 Guimaraes, Portugal.
RP Kalay, G (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Sousa,
   Rui/0000-0003-0362-7418; Cunha M., Antonio/0000-0003-3860-7732
CR Allan P. S., 1990, COMPOSITES MANUFACTU, V1, P79
   ALLAN PS, 1987, PLAST RUB PROC APPL, V7, P3
   ALLAN PS, Patent No. 2170140
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   Bonfield W., 1996, BIOCERAMICS, V9, P11
   HASTINGS G, 1991, COMPOSITES MAT BIOME, P23
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Isaac D. H., 1994, Clinical Materials, V15, P79, DOI 10.1016/0267-6605(94)90073-6
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P241, DOI 10.1002/(SICI)1099-0488(19970130)35:2<241::AID-POLB5>3.0.CO;2-V
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P265
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P415, DOI 10.1002/(SICI)1099-0488(199702)35:3<415::AID-POLB2>3.0.CO;2-R
   Kalay G, 1996, POLYMER, V37, P2077, DOI 10.1016/0032-3861(96)85852-6
   Kalay G, 1997, KUNSTST-PLAST EUR, V87, P768
   KNOWLES JC, 1992, J MATER SCI-MATER M, V3, P352, DOI 10.1007/BF00705367
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   Montgomery D. C., 1991, DESIGN ANAL EXPT
   OGBONNA CI, 1995, J APPL POLYM SCI, V58, P2131, DOI 10.1002/app.1995.070581126
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Reis R. L., 1997, MED PLAST BIOMATER, V4, P46
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, 1998, ANTEC 98 PLASTICS MY
   REIS RL, 1997, ADV POLYM TECHNOL, V4, P276
   ROKKANEN PU, 1991, ANN MED, V23, P109, DOI 10.3109/07853899109148033
   ROSS JP, 1998, TAGUCHI TECHNIQUES Q
   SCHMIDT SR, 1994, UNDERSTANDING IND DE
   SIMMONS S, 1995, J APPL POLYM SCI, V58, P2259, DOI 10.1002/app.1995.070581215
   SOLTESZ U, 1988, ANN NY ACAD SCI, P137
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   Williams D., 1990, CONCISE ENCY MED DEN
   1991, Patent No. 2025
NR 33
TC 35
Z9 35
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 8
PY 2000
VL 77
IS 6
BP 1303
EP 1315
DI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
PG 13
WC Polymer Science
SC Polymer Science
GA 320BF
UT WOS:000087380600015
DA 2018-10-19
ER

PT J
AU Mazhari, R
   McCulloch, AD
AF Mazhari, R
   McCulloch, AD
TI Integrative models for understanding the structural basis of regional
   mechanical dysfunction in ischemic myocardium
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Physiome Symposium on Integrated Biology of the Heart
CY SEP 09-11, 2000
CL SEATTLE, WASHINGTON
DE stunned myocardium; finite-element model; diastolic properties;
   functional border zone; transmural function; regional blood flow
ID CANINE LEFT-VENTRICLE; STUNNED MYOCARDIUM; BLOOD-FLOW; CONTRACTILE
   FUNCTION; NONISCHEMIC MYOCARDIUM; CORONARY OCCLUSIONS; COLLAGEN MATRIX;
   BORDER ZONE; WALL STRESS; RAT HEARTS
AB Myocardial ischemia and many other cardiac pathologies are associated with regional ventricular dysfunction. Since the distributions of stress and material properties cannot be measured directly in intact myocardium, understanding how regional alterations in myocardial strain or segment function are related to underlying cellular dysfunction must be deduced from theoretical models. Here, we describe how anatomically detailed, three-dimensional computational models can be used in conjunction with experimental or clinical studies to elucidate the structural basis of regional dysfunction in acutely ischemic and ischemic-reperfused ("stunned") myocardium in vivo. Integrative experimental and computational analysis shows that: (1) in acutely ischemic myocardium, the transition from abnormal systolic strain in the ischemic region to normal shortening in adjacent, normally perfused tissue is governed primarily by systolic blood pressure and regional fiber orientation rather than the geometry of the perfusion boundary; and (2) in stunned myocardium, the degree of reperfusion injury to the contractile apparatus may be uniform across the wall thickness despite observations that the extent of ischemia and the impairment of regional strain during reperfusion are both significantly greater in the subendocardium. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)01208-X].
C1 Univ Calif San Diego, Dept Bioengn, Whitaker Inst Biomed Engn, La Jolla, CA 92093 USA.
RP McCulloch, AD (reprint author), Univ Calif San Diego, Dept Bioengn, Whitaker Inst Biomed Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
FU NHLBI NIH HHS [HL07089-24, HL-41603, HL0708923]
CR ALLEN DG, 1987, CIRC RES, V60, P153, DOI 10.1161/01.RES.60.2.153
   Armour JA, 1999, CARDIOVASC RES, V41, P41, DOI 10.1016/S0008-6363(98)00252-1
   BOGEN DK, 1980, CIRC RES, V47, P728, DOI 10.1161/01.RES.47.5.728
   BOLLI R, 1988, AM J PHYSIOL, V254, pH102
   BOLLI R, 1989, AM J PHYSIOL, V257, pH375
   BOLLI R, 1990, CIRCULATION, V82, P723, DOI 10.1161/01.CIR.82.3.723
   Bovendeerd PHM, 1996, AM J PHYSIOL-HEART C, V270, pH398
   Bradley CP, 1997, ANN BIOMED ENG, V25, P96, DOI 10.1007/BF02738542
   BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146
   CANTY JM, 1988, CIRC RES, V63, P821, DOI 10.1161/01.RES.63.4.821
   CHARNEY RH, 1992, CIRCULATION, V85, P1483, DOI 10.1161/01.CIR.85.4.1483
   Costa KD, 1996, J BIOMECH ENG-T ASME, V118, P464, DOI 10.1115/1.2796032
   DOWNEY JM, 1974, CIRC RES, V34, P286, DOI 10.1161/01.RES.34.3.286
   EDWARDS NC, 1992, AM J PHYSIOL, V262, pH568
   Ehring T, 1993, Am J Cardiovasc Pathol, V4, P358
   ELBEERY JR, 1992, AM J PHYSIOL, V263, pH559
   EMERY LJ, 1997, AM J PHYSIOL, V272, pH2299
   GALLAGHER KP, 1987, AM J PHYSIOL, V253, pH826
   GALLAGHER KP, 1986, CIRC RES, V58, P570, DOI 10.1161/01.RES.58.4.570
   GALLAGHER KP, 1980, CIRCULATION, V62, P1266, DOI 10.1161/01.CIR.62.6.1266
   GALLAGHER KP, 1987, AM J PHYSIOL, V252, pH826
   GALLAGHER KP, 1984, AM J PHYSIOL, V247, pH727
   GALLAGHER KP, 1987, CIRC 60 SCI SESS, P373
   Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47
   Gao WD, 1996, CIRCULATION, V94, P2597, DOI 10.1161/01.CIR.94.10.2597
   Gao WD, 1996, CIRC RES, V78, P455
   GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036
   GOTO Y, 1986, AM J PHYSIOL, V250, pH151
   GROSSMAN W, 1980, AM J MED, V69, P576, DOI 10.1016/0002-9343(80)90471-4
   GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084
   GUCCIONE JM, 1995, J BIOMECH, V28, P1167, DOI 10.1016/0021-9290(94)00174-3
   GUTH BD, 1984, AM HEART J, V107, P458, DOI 10.1016/0002-8703(84)90086-3
   Hampton TG, 1998, AM J PHYSIOL-HEART C, V274, pH1821, DOI 10.1152/ajpheart.1998.274.5.H1821
   HASHIMA AR, 1993, J BIOMECH, V26, P19, DOI 10.1016/0021-9290(93)90610-Q
   HEARSE D J, 1986, Canadian Journal of Cardiology, V2, P48
   HEARSE DJ, 1977, J MOL CELL CARDIOL, V9, P605, DOI 10.1016/S0022-2828(77)80357-X
   HEYNDRICKX GR, 1978, AM J PHYSIOL, V234, pH653
   HOIT BD, 1988, AM J PHYSIOL, V254, pH1065
   HUISMAN RM, 1980, CARDIOVASC RES, V14, P142, DOI 10.1093/cvr/14.3.142
   Hunter PJ, 1998, PROG BIOPHYS MOL BIO, V69, P289, DOI 10.1016/S0079-6107(98)00013-3
   KERBER RE, 1975, CIRCULATION, V52, P1097, DOI 10.1161/01.CIR.52.6.1097
   Kloner RA, 1998, CIRCULATION, V97, P1848, DOI 10.1161/01.CIR.97.18.1848
   KUSUOKA H, 1992, ANNU REV PHYSIOL, V54, P243, DOI 10.1146/annurev.ph.54.030192.001331
   KUSUOKA H, 1990, CIRC RES, V66, P1268, DOI 10.1161/01.RES.66.5.1268
   LEW WYW, 1985, CIRC RES, V56, P351, DOI 10.1161/01.RES.56.3.351
   LEW WYW, 1991, ACUTE MYOCARDIAL INF, V7, P112
   LIMA JAC, 1985, CIRCULATION, V71, P1048, DOI 10.1161/01.CIR.71.5.1048
   Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021
   LONGHURST JC, 1984, PROG CARDIOVASC DIS, V27, P201, DOI 10.1016/0033-0620(84)90005-7
   MACKENNA DA, 1994, AM J PHYSIOL, V266, pH1007
   MALLIANI A, 1983, J AUTONOM NERV SYST, V7, P295, DOI 10.1016/0165-1838(83)90082-6
   Mazhari R, 1998, ANN BIOMED ENG, V26, P743, DOI 10.1114/1.74
   MAZHARI R, 1999, REGIONAL FLOW FUNCTI
   MAZHARI R, 1999, P ASME 4 SUMM BIOENG, V4, P43
   McCulloch AD, 1998, CARDIOVASC RES, V37, P636, DOI 10.1016/S0008-6363(97)00290-3
   MURDOCK RH, 1983, CIRC RES, V52, P451, DOI 10.1161/01.RES.52.4.451
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   OPIE LH, 1997, HEART PHYSL CELL CIR
   PARMLEY WW, 1973, AM J CARDIOL, V32, P889, DOI 10.1016/S0002-9149(73)80153-5
   PINZEN FW, 1989, EUR J PHYSL, V415, P220
   PRINZEN FW, 1984, J BIOMECH, V17, P801, DOI 10.1016/0021-9290(84)90111-8
   PRZYKLENK K, 1989, AM J CARDIOL, V64, pF18, DOI 10.1016/0002-9149(89)90741-8
   PZYKLENK K, 1987, AM J CARDIOL, V60, P1211
   ROSS J, 1991, CIRCULATION, V83, P1076, DOI 10.1161/01.CIR.83.3.1076
   RYNNING SE, 1993, ACTA PHYSIOL SCAND, V149, P441, DOI 10.1111/j.1748-1716.1993.tb09641.x
   SAKAI K, 1985, AM J PHYSIOL, V249, pH88
   STREETER DD, 1973, CIRC RES, V33, P656, DOI 10.1161/01.RES.33.6.656
   Stuyvers BDMY, 1997, J PHYSIOL-LONDON, V502, P661, DOI 10.1111/j.1469-7793.1997.661bj.x
   Tennant R, 1935, AM J PHYSIOL, V112, P351
   Thames MD, 1996, CLIN EXP PHARMACOL P, V23, P709, DOI 10.1111/j.1440-1681.1996.tb01763.x
   TORRY RJ, 1991, AM HEART J, V122, P1292, DOI 10.1016/0002-8703(91)90568-3
   TYBERG JV, 1969, CIRC RES, V25, P569, DOI 10.1161/01.RES.25.5.569
   TYBERG JV, 1974, CIRCULATION, V49, P748
   Van Eyk JE, 1998, CIRC RES, V82, P261
   VANLEUVEN SL, 1994, AM J PHYSIOL-HEART C, V267, pH2348
   VATNER SF, 1980, CIRC RES, V47, P201, DOI 10.1161/01.RES.47.2.201
   VILLARREAL FJ, 1991, CIRC RES, V68, P368, DOI 10.1161/01.RES.68.2.368
   WEIGNER AW, 1978, AM J PHYSIOL, V4, pH776
   WEINTRAUB WS, 1981, CIRC RES, V48, P430, DOI 10.1161/01.RES.48.3.430
   WEISMAN HF, 1987, PROG CARDIOVASC DIS, V30, P73, DOI 10.1016/0033-0620(87)90004-1
   Westerhof N, 1997, ADV EXP MED BIOL, V430, P111
   WHITTAKER P, 1991, AM HEART J, V121, P434, DOI 10.1016/0002-8703(91)90709-Q
   WIJNS W, 1986, J AM COLL CARDIOL, V7, P455, DOI 10.1016/S0735-1097(86)80453-3
   WYATT HL, 1976, AM J CARDIOL, V37, P366, DOI 10.1016/0002-9149(76)90285-X
   YELLON DM, 1981, AM J CARDIOL, V47, P1233, DOI 10.1016/0002-9149(81)90252-6
   YIN FCP, 1981, CIRC RES, V49, P829, DOI 10.1161/01.RES.49.4.829
   YOUNG AA, 1992, RADIOLOGY, V185, P241, DOI 10.1148/radiology.185.1.1523316
   ZHAO MJ, 1987, J AM COLL CARDIOL, V10, P1322, DOI 10.1016/S0735-1097(87)80137-7
NR 88
TC 19
Z9 19
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2000
VL 28
IS 8
BP 979
EP 990
DI 10.1114/1.1308502
PG 12
WC Engineering, Biomedical
SC Engineering
GA 378UZ
UT WOS:000165604200018
PM 11144683
DA 2018-10-19
ER

PT J
AU Bassingthwaighte, JB
AF Bassingthwaighte, JB
TI Strategies for the physiome project
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Physiome Symposium on Integrated Biology of the Heart
CY SEP 09-11, 2000
CL SEATTLE, WASHINGTON
DE simulation analysis; biological systems modeling; complexity; chaos;
   dynamic systems; milieu interieure; homeodynamics; homeostasis;
   metabolism; control
ID DYNAMIC-MODEL; FIBERS; HEART; FLOW
AB The physiome is the quantitative description of the functioning organism in normal and pathophysiological states. The human physiome can be regarded as the virtual human. It is built upon the morpheme,the quantitative description of anatomical structure, chemical and biochemical composition, and material properties of an intact organism, including its genome, proteome, cell, tissue, and organ structures up to those of the whole intact being. The Physiome Project is a multicentric integrated program to design, develop, implement, test and document, archive and disseminate quantitative information, and integrative models of the functional behavior of molecules, organelles, cells, tissues, organs, and intact organisms from bacteria to man. A fundamental and major feature of the project is the databasing of experimental observations for retrieval and evaluation. Technologies allowing many groups to work together are being rapidly developed. Internet II will facilitate this immensely. When problems are huge and complex, a particular working group can be expert in only a small part of the overall project. The strategies to be worked out must therefore include how to pull models composed of many submodules together even when the expertise in each is scattered amongst diverse institutions. The technologies of bioinformatics will contribute greatly to this effort. Developing and implementing code for large-scale systems has many problems. Most of the submodules are complex, requiring consideration of spatial and temporal events and processes. Submodules have to be linked to one another in a way that preserves mass balance and gives an accurate representation of variables in nonlinear complex biochemical networks with many signaling and controlling pathways. Microcompartmentalization vitiates the use of simplified model structures. The stiffness of the systems of equations is computationally costly. Faster computation is needed when using models as thinking tools and for iterative data analysis. Perhaps the most serious problem is the current lack of definitive information on kinetics and dynamics of systems, due in part to the almost total lack of databased observations, but also because, though we are nearly drowning in new information being published each day, either the information required for the modeling cannot be found or has never been obtained. "Simple" things like tissue composition, material properties, and mechanical behavior of cells and tissues are not generally available. The development of comprehensive models of biological systems is a key to pharmaceutics and drug design, for the models will become gradually better predictors of the results of interventions, both genomic and pharmaceutic. Good models will be useful in predicting the side effects and long term effects of drugs and toxins, and when the models are really good, to predict where genomic intervention will be effective and where the multiple redundancies in our biological systems will render a proposed intervention useless. The Physiome Project will provide the integrating scientific basis for the Genes to Health initiative, and make physiological genomics a reality applicable to whole organisms, from bacteria to man. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)02208-6].
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Bassingthwaighte, JB (reprint author), Univ Washington, Dept Bioengn, Box 35-7962, Seattle, WA 98195 USA.
FU NCRR NIH HHS [P41 RR001243, RR1243, P41 RR001243-21]; NIBIB NIH HHS [R01
   EB001973-22, R01 EB001973]; NHLBI NIH HHS [HL07403, T32 HL007403]
CR BASSINGTHWAIGHT.JB, 1972, ELECTRICAL PHENOMENA, P353
   BASSINGTHWAIGHT.JB, 1998, WHOLE ORGAN APPROACH, P575
   Bassingthwaighte J.B., 1994, FRACTAL PHYSL, P364, DOI [DOI 10.1007/978-1-4614-7572-9, 10.1007/978-1-4614-7572-9]
   BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P578, DOI 10.1161/01.RES.65.3.578
   BASSINGTHWAIGHTE JB, 1995, CIRC RES, V77, P1212, DOI 10.1161/01.RES.77.6.1212
   BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P997, DOI 10.1161/01.RES.65.4.997
   Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499
   Beard DA, 2000, J VASC RES, V37, P282, DOI 10.1159/000025742
   Beard DA, 2000, ANN BIOMED ENG, V28, P253, DOI 10.1114/1.273
   BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853
   BLINKS JR, 1978, J PHYSIOL-LONDON, V277, P291, DOI 10.1113/jphysiol.1978.sp012273
   BOYD CAR, 1993, LOGIC LIFE CHALLENGE, P226
   CALDWELL JH, 1994, AM J PHYSIOL, V267, pH654
   Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6
   Cowley AW, 2000, PHYSIOL GENOMICS, V2, P107
   DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001
   Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161
   Gillis HL, 1999, J APPL PHYSIOL, V86, P2001
   Glass L, 1991, THEORY HEART BIOMECH, P611
   GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305
   HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764
   HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310
   Jafri MS, 1998, BIOPHYS J, V74, P1149, DOI 10.1016/S0006-3495(98)77832-4
   JALIFE J, 1991, J CARDIOVASC ELECTR, V2, pS133
   KASSAB GS, 1993, AM J PHYSIOL, V265, pH350
   Koshland DE, 1998, SCIENCE, V280, P852, DOI 10.1126/science.280.5365.852
   KOSHLAND DE, 1987, TRENDS BIOCHEM SCI, V12, P225, DOI 10.1016/0968-0004(87)90114-9
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   LUO CH, 1994, CIRC RES, V74, P1097, DOI 10.1161/01.RES.74.6.1097
   LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071
   MCCULLOCH A, 1998, COMPUTATIONAL BIOL H, V69, P151
   MONTANI JP, 1989, INT J BIOMED COMPUT, V24, P41, DOI 10.1016/0020-7101(89)90006-8
   NOBLE D, 1969, J PHYSIOL-LONDON, V200, P205, DOI 10.1113/jphysiol.1969.sp008689
   PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347
   Ringer S, 1883, J Physiol, V4, P29
   SCHOMBURG D, 1990, ENZYME HDB
   Vetter FJ, 2000, ANN BIOMED ENG, V28, P781, DOI 10.1114/1.1289469
   Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6
   WEIDMANN S, 1952, J PHYSIOL-LONDON, V118, P348, DOI 10.1113/jphysiol.1952.sp004799
   Wilson E. O., 1998, CONSILIENCE UNITY KN, P332
   Winslow RL, 2000, ANNU REV BIOMED ENG, V2, P119, DOI 10.1146/annurev.bioeng.2.1.119
   Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571
   WOOD EH, 1969, CIRC RES, V24, P409, DOI 10.1161/01.RES.24.3.409
   ZAMIR M, 1987, BLOOD VESSELS, V24, P76
NR 44
TC 121
Z9 126
U1 0
U2 23
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD AUG
PY 2000
VL 28
IS 8
BP 1043
EP 1058
DI 10.1114/1.1313771
PG 16
WC Engineering, Biomedical
SC Engineering
GA 378UZ
UT WOS:000165604200025
PM 11144666
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Alanazi, A
   Nojiri, C
   Kido, T
   Noguchi, T
   Ohgoe, Y
   Matsuda, T
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
AF Alanazi, A
   Nojiri, C
   Kido, T
   Noguchi, T
   Ohgoe, Y
   Matsuda, T
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
TI Engineering analysis of diamond-like carbon coated polymeric materials
   for biomedical applications
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 7th Congress of the International-Society-for-Rotary-Blood-Pumps
CY AUG 26-27, 1999
CL TOKYO, JAPAN
SP Int Soc Rotary Blood Pumps
DE diamond-like carbon; blood compatibility
ID EPIFLUORESCENT VIDEO MICROSCOPY
AB Diamond-like carbon (DLC) films have received much attention recently owing to their properties, which are similar to diamond: hardness, thermal conductivity, corrosion resistance against chemicals, abrasion resistance, good biocompatibility, and uniform flat surface. Furthermore, DLC films can be deposited easily on many substrates for wide area coat at room temperature. DLC films were developed for applications as biomedical materials in blood contacting-devices (e.g., rotary blood pump) and showed good biocompatibility for these applications. In this study, we investigated the surface roughness by Atomic Force Microscopy (AFM) and Hi-vision camera, SEM for surface imaging. The DLC films were produced by radio frequency glow discharge plasma decomposed of hydrocarbon gas at room temperature and low pressure (53 Pa) on several kinds of polycarbonate substrates. For the evaluation of the relation between deposition rate and platelet adhesion that we investigated in a previous study, DLC films were deposited at the same methane pressure for several deposition times, and film thickness was investigated, in addition, the deposition rate of DLC films on polymeric substrates is similar to the deposition rate of those deposited on Si substrates. There were no significant differences in substrates' surface roughness that were coated by DLC films in different deposition rates (16-40 nm). The surface energy and the contact angle of the DLC films were investigated. The chemical bond of DLC films also was evaluated. The evaluation of surface properties by many methods and measurements and the relationship between the platelet adhesion and film thickness is discussed. Finally, the presented DLC films appear to be premising candidates for biomedical applications and merit investigation.
C1 Tokyo Denki Univ, Fac Sci & Engn, Dept Appl Syst Engn, Hatoyama, Saitama 3500394, Japan.
   Waseda Univ, Tokyo, Japan.
   Terumo Corp, Inst Biomed Sci, Kanagawa, Japan.
   D Ctr, Kanagawa, Japan.
RP Alanazi, A (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Dept Appl Syst Engn, Hatoyama, Saitama 3500394, Japan.
CR ALANAZI A, 1997, J SOC APPL PHYS, V58
   ALANAZI A, 1999, INT S ADV BIOM TISS
   ALANAZI A, 1998, VACUUM, V51, P363
   ALANAZI A, 1999, ASAIO J, P45
   KAWAGOISHI N, 1994, ARTIF ORGANS, V18, P588, DOI 10.1111/j.1525-1594.1994.tb03383.x
   KOBAYASHI K, 1988, THIN SOLID FILMS, V158, P233, DOI 10.1016/0040-6090(88)90025-9
   KURODA S, 1996, HEART REPLACEMENT AR, V5, P21
   Mizumoto D, 1997, ASAIO J, V43, pM500
   NOJIRI C, 1989, T ASAIO, V35, P357
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
NR 10
TC 46
Z9 54
U1 0
U2 13
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 2000
VL 24
IS 8
BP 624
EP 627
DI 10.1046/j.1525-1594.2000.06576.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 349PM
UT WOS:000089054900009
PM 10971249
DA 2018-10-19
ER

PT J
AU Emrich, J
   Lambert, K
AF Emrich, J
   Lambert, K
TI Radiation safety education for laboratory animal science
SO HEALTH PHYSICS
LA English
DT Article
DE operational topics; laboratory animals; education; radiation, biology
AB Students enrolled in the laboratory animal science graduate program at MCP Hahnemann University seek to gain entrance to veterinary school or to manage an animal facility within an academic institution, pharmaceutical or biotechnology company conducting biomedical research. Ongoing interaction between faculty in the radiation oncology, radiation safety, and lab animal science disciplines revealed an acute need for radiation safety education for laboratory animal science students who will likely interact with researchers either designing and writing protocols for animal studies using radiation or radioactive materials, or veterinary staff who will use sources of radiation to diagnose and/or treat possible animal injuries and diseases. A core course in the Radiation Sciences graduate program was modified to address the needs of these students, instructing them in radiation safety, detection and counting instrumentation, and radiation biology. These fundamental areas were integrated to help the students gain a sound, basic knowledge of radiation and radioactive materials used in biomedical research.
C1 Med Coll Penn & Hahnemann Univ, Dept Radiat Oncol, Philadelphia, PA 19102 USA.
   Med Coll Penn & Hahnemann Univ, Dept Radiat Phys & Safety, Philadelphia, PA 19102 USA.
EM emrichj@drexel.edu
NR 0
TC 2
Z9 2
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD AUG
PY 2000
VL 79
IS 2
SU S
BP S12
EP S16
DI 10.1097/00004032-200008001-00005
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 335PA
UT WOS:000088250800004
PM 10910396
DA 2018-10-19
ER

PT J
AU McDermott, PJ
AF McDermott, PJ
TI Rutgers University case study: A guide to non-routine high dose rate
   procedures for biomedical facilities
SO HEALTH PHYSICS
LA English
DT Article
DE operational topics; Co-60; shielding radioactive materials
AB Non-routine potentially high dose rate procedures occasionally present themselves at biomedical facilities. Lacking significant operational experience, many biomedical facilities decide to contract out the work to consulting firms without seriously considering doing the work themselves. This study shares the University's experiences during a non-routine procedure to extract a Co-60 irradiation source from an underground storage facility and relocate it to an above-ground shielded storage cask.
C1 Rutgers State Univ, Piscataway, NJ 08854 USA.
EM mcdermott@rehs.rutgers.edu
CR CEMBER H, 1989, INTRO HLTH PHYSICS
   *KNOLLS AT POW LAB, 1988, CHART NUCL
NR 2
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD AUG
PY 2000
VL 79
IS 2
SU S
BP S6
EP S11
DI 10.1097/00004032-200008001-00004
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 335PA
UT WOS:000088250800003
PM 10910395
DA 2018-10-19
ER

PT J
AU Ilev, IK
   Waynant, RW
   Ediger, MN
   Bonaguidi, MA
AF Ilev, IK
   Waynant, RW
   Ediger, MN
   Bonaguidi, MA
TI Ultraviolet laser delivery using an uncoated hollow taper
SO IEEE JOURNAL OF QUANTUM ELECTRONICS
LA English
DT Article
DE laser beam focusing; laser biomedical applications; multimode
   transmission lines; optical fiber couple; optical materials; optical
   waveguide components; ultraviolet imaging
ID FIBER
AB We demonstrate a simple grazing-incidence-based method for ultraviolet (UV) laser delivery and direct laser-to-taper coupling using an uncoated glass hollow taper. The taper serves as a mode homogenizer that converts the strongly multimode distribution of the input laser emission into a high-quality smooth profile at the taper output. An uncoated pyrex-glass hollow taper is used for direct launching, without any intermediate focusing elements, of UV laser emission from the third harmonic (lambda = 355 nm) of a Q-switched Nd:YAG laser into the taper. The linear hollow taper provides a laser-to-taper coupling efficiency exceeding 70%.
C1 US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.
   Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53201 USA.
RP Ilev, IK (reprint author), US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.
CR AMITAY N, 1987, J LIGHTWAVE TECHNOL, V5, P70, DOI 10.1109/JLT.1987.1075414
   ARNOLD WH, 1995, IEEE J SEL TOP QUANT, V1, P765
   BORN M, 1964, PRINCIPLES OPTICS
   DRISCOLL WG, 1978, HDB OPTICS
   ILEV IK, 1991, OPT QUANT ELECTRON, V23, P1011, DOI 10.1007/BF00611437
   Ilev IK, 1999, APPL PHYS LETT, V74, P2921, DOI 10.1063/1.123966
   KOPRINKOV IG, 1992, J LIGHTWAVE TECHNOL, V10, P135, DOI 10.1109/50.120567
   Marcuse D, 1974, THEORY DIELECTRIC OP
   Matsuura Y, 1997, OPT LETT, V22, P1308, DOI 10.1364/OL.22.001308
   Matsuura Y, 1997, APPL OPTICS, V36, P7818, DOI 10.1364/AO.36.007818
   PRESBY HM, 1989, J LIGHTWAVE TECHNOL, V7, P274, DOI 10.1109/50.17767
   REN QS, 1990, IEEE J QUANTUM ELECT, V26, P2284, DOI 10.1109/3.64366
   Snyder A. W., 1983, OPTICAL WAVEGUIDE TH
   Welford WT, 1989, HIGH COLLECTION NONI
NR 14
TC 13
Z9 13
U1 1
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9197
J9 IEEE J QUANTUM ELECT
JI IEEE J. Quantum Electron.
PD AUG
PY 2000
VL 36
IS 8
BP 944
EP 948
DI 10.1109/3.853551
PG 5
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 339YK
UT WOS:000088505300007
DA 2018-10-19
ER

PT J
AU Li, BY
   Rong, LJ
   Li, YY
   Gjunter, VE
AF Li, BY
   Rong, LJ
   Li, YY
   Gjunter, VE
TI A recent development in producing porous Ni-Ti shape memory alloys
SO INTERMETALLICS
LA English
DT Article
DE intermetallics, miscellaneous; powder metallurgy; biomedical
   applications; shape-memory alloy applications
AB Porous Ni-Ti shape memory alloys (SMAs) are promising candidates for biomedical materials. In the present study, a bulk porous Ni-Ti SMA with a banded structure of channels and 54 vol.% porosity has been successfully prepared by self-propagating high-temperature synthesis (SHS). The Ni-Ti SMA synthesized has an open porous structure, also its pores and channels with various size and shape are three-dimensionally interconnected. Compared to the conventional pou der sintering method, the present method extends the porosity range of porous Ni-Ti SMAs. A schematic representation of SHS synthesized Ni-Ti SMAs has been suggested. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110015, Peoples R China.
   VD Kuznetsov Siberian Phys Tech Inst, Tomsk 634050, Russia.
RP Li, BY (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110015, Peoples R China.
RI Li, Bingyun/P-5320-2018; Li, Bingyun/A-9484-2009; Gunther,
   Viktor/O-6678-2014
OI Li, Bingyun/0000-0002-5766-5666; 
CR FUNAMI K, 1984, J JPN I MET, V48, P1113, DOI 10.2320/jinstmet1952.48.11_1113
   JARDINE AP, 1990, SCRIPTA METALL MATER, V24, P2391
   Li BY, 1998, J MATER RES, V13, P2847, DOI 10.1557/JMR.1998.0389
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   OTAGUCHI M, 1990, JAPAN I METALS, V54, P21
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   PAKHOMENKO JS, 1996, P INT C JUN 1996 TOM, P20
   PILLIAR RMJ, 1998, BIOMED MAT RES, V21, P1
   YI HC, 1988, SCRIPTA METALL MATER, V22, P1889, DOI 10.1016/S0036-9748(88)80232-1
NR 9
TC 83
Z9 91
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD AUG
PY 2000
VL 8
IS 8
BP 881
EP 884
DI 10.1016/S0966-9795(00)00024-8
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 348LV
UT WOS:000088987000006
DA 2018-10-19
ER

PT J
AU Verne, E
   Brovarone, CV
   Milanese, D
AF Verne, E
   Brovarone, CV
   Milanese, D
TI Glass-matrix biocomposites: Synthesis and characterization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactivity; glasses; coatings; biocomposites; sintering
ID PLASMA SPRAY DEPOSITION; BIOACTIVE GLASS; COMPOSITES; COATINGS
AB CaO-SiO(2) base glass-matrix/Ti particle biocomposite coatings on Ti6A14V substrates have been prepared by means of Vacuum Plasma Spray. The base glass is considered bioactive, because, when soaked in a fluid that simulates the inorganic ion concentration of human plasma (SBF), it develops a bonelike apatite layer on its surface. The aim of this research activity was to toughen this brittle bioactive material and to broaden its biomedical applications. Pure titanium was chosen as toughening phase because of its well-known biocompatibility, and Ti6A14V alloy as substrate because of both its biocompatibility and its mechanical reliability. At first the composites were prepared as bulk materials, by means of a simple sintering process. Then, by ball-milling the sintered composite, the as-obtained "composite powders" were sprayed by Vacuum Plasma Spray (VPS) on the substrate. By means of Differential Thermal Analysis (DTA) and Differential Scanning Calorimetry (DSC), the characteristic temperatures of the base glasses were determined. The thermal properties of mixtures of glass powders and different vol% Ti particles were studied by means of DTA, DSC, hot-stage microscopy, and dilatometry, with the aim of optimizing the sintering conditions. Both the bulk and the coated samples have been characterized by means of X-ray diffraction (XRD), scanning electron microscopy (SEM), compositional analysis (EDS), Vickers indentations, and leaching tests after soaking in a simulated body fluid (SBF). (C) 2000 John Wiley & Sons, Inc.
C1 Politecn Torino, Dept Chem Engn & Mat Sci, I-10129 Turin, Italy.
RP Verne, E (reprint author), Politecn Torino, Dept Chem Engn & Mat Sci, C Duca degli Abruzzi 24, I-10129 Turin, Italy.
EM verne@athena.polito.it
RI Milanese, Daniel/A-7366-2015
OI Vitale-Brovarone, Chiara/0000-0003-2413-5594; Milanese,
   Daniel/0000-0002-6257-3600; Verne, Enrica/0000-0002-8649-4739
CR FAUCHAIS P, 1996, CERAM INT, V22, P293
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1996, J EUR CERAM SOC, V16, P421, DOI 10.1016/0955-2219(95)00114-X
   Ferraris M, 1996, J AM CERAM SOC, V79, P1515, DOI 10.1111/j.1151-2916.1996.tb08759.x
   FERRARIS M, 1995, MAT CLIN APPL ADV SC, P281
   FERRARIS M, 1997, BIOCERAMICS, V10, P195
   FERRARIS M, 1998, P ECCM 8 3 6 JUN 199, V1, P359
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   LIN CK, 1995, J AM CERAM SOC, V78, P1406, DOI 10.1111/j.1151-2916.1995.tb08505.x
   LOEHMAN RE, 1996, CERAMIC JOINING SHOR
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Sbaizero O, 1996, J EUR CERAM SOC, V16, P813, DOI 10.1016/0955-2219(96)00005-2
   Verne E, 1999, J EUR CERAM SOC, V19, P2039, DOI 10.1016/S0955-2219(99)00036-9
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   VERNE E, 1995, BIOCERAMICS, V8, P147
   VERNE E, 1999, MAT CLIN APPL ADV SC, V28, P223
   VERNE E, 1997, BIOCERAMICS COATINGS, P37
   VERNE E, 1995, CERAMIC ORAL SURG, P231
NR 21
TC 7
Z9 10
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2000
VL 53
IS 4
BP 408
EP 413
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 336MU
UT WOS:000088307500015
PM 10898882
DA 2018-10-19
ER

PT J
AU Magnani, A
   Rappuoli, R
   Lamponi, S
   Barbucci, R
AF Magnani, A
   Rappuoli, R
   Lamponi, S
   Barbucci, R
TI Novel polysaccharide hydrogels: Characterization and properties
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE synthesis; polysaccharide; hydrogels; physicochemical properties; cell
   adhesion
ID CARBOXYMETHYLCELLULOSE
AB New chemical hydrogels, potentially suitable for biomedical applications, have been synthesized and characterized by C-13 NMR, and FT-IR spectroscopy. The polysaccharide components of these hydrogels are hyaluronane, alginate and carboxymethylcellulose, while the novel cross-linking procedure consists of activating the carboxylate moieties by 2-chloro-1-methylpyridinium iodide CMPJ and using 1,3-diaminopropane as a chemical bridge. Varying the amount of CMPJ three series of hydrogels were obtained with different cross-linking degrees (5, 50, 100%). their percentages were determined by C-13 NMR and FT-IR analysis. The morphology of the gels was studies by scanning electron-microscopy and the pore sizes were determined in order to find a relationship with the swelling properties.
   Cell adhesion,using human hepatocytes, abd platelet adhesion studies on the different series of cross-linked compounds allowed us to envisage their utilization as extracellular matrix materials and cardiovascular biomaterials. Copyright (C) 2000 John Wiley & Sons, Ltd.
C1 Univ Siena, CRISMA, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, CRISMA, Via Ettore Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BARBUCCI R, 2000, IN PRESS J BIOMAT SC
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HEIDRICK GW, 1994, J REPROD MED, V39, P575
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   KITANO T, 1991, SPINE, V16, P820, DOI 10.1097/00007632-199107000-00023
   LAURENT TC, 1998, CHEM BIOL ITS DERIVA
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
NR 10
TC 24
Z9 26
U1 1
U2 14
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD AUG-DEC
PY 2000
VL 11
IS 8-12
BP 488
EP 495
DI 10.1002/1099-1581(200008/12)11:8/12<488::AID-PAT995>3.0.CO;2-5
PG 8
WC Polymer Science
SC Polymer Science
GA 374DK
UT WOS:000165329000018
DA 2018-10-19
ER

PT J
AU Gower, MC
AF Gower, MC
TI Industrial applications of laser micromachining
SO OPTICS EXPRESS
LA English
DT Article
ID EXCIMER-LASER
AB The use of pulsed lasers for microprocessing material in several manufacturing industries is presented. Microvia, ink jet printer nozzle and biomedical catheter hole drilling, thin-film scribing and micro-electromechanical system (MEMS) fabrication applications are reviewed. (C)2000 Optical Society of America.
C1 Exitech Ltd, Oxford OX8 8LH, England.
RP Gower, MC (reprint author), Exitech Ltd, Hanborough Pk, Oxford OX8 8LH, England.
CR ALLEN SD, 1982, CLEO C SUMM
   BACHER W, 1995, IEEE T IND ELECTRON, V42, P431, DOI 10.1109/41.464604
   Bachmann F., 1989, Chemtronics, V4, P149
   BLOEMBERGEN N, 1994, AIP C P, V288
   FRAZIER AB, 1995, IEEE T IND ELECTRON, V42, P423, DOI 10.1109/41.464603
   Gifford R. S., 1998, OPN Optics & Photonics News, V9, P27
   GOWER MC, 1996, NANOTECHNOLOGY MED B
   Harvey EC, 1997, P SOC PHOTO-OPT INS, V3223, P26, DOI 10.1117/12.284497
   HOLDEN H, 1997, FUTURE CIRCUITS INT, V1, P71
   KAWAMURA Y, 1982, APPL PHYS LETT, V40, P374, DOI 10.1063/1.93108
   Kiyama S., 1990, JSPE, V11, P2069
   LANKARD JR, 1992, APPL PHYS A-MATER, V54, P355, DOI 10.1007/BF00324201
   MCKEOWN P, 1997, EMERGING TECHNOLOGY, V1
   Miller J.C., 1994, LASER ABLATION PRINC
   PATEL RS, 1996, LASER FOCUS WORL JAN
   Pethig R, 1998, J MICROMECH MICROENG, V8, P57, DOI 10.1088/0960-1317/8/2/004
   ROWAN C, 1995, LASER FOCUS WORL AUG
   South A, 1998, Med Device Technol, V9, P30
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   Watson M. N., 1984, Circuit World, V11, P13, DOI 10.1108/eb043747
NR 20
TC 128
Z9 132
U1 3
U2 37
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD JUL 17
PY 2000
VL 7
IS 2
BP 56
EP 67
DI 10.1364/OE.7.000056
PG 12
WC Optics
SC Optics
GA 335XC
UT WOS:000088269500004
PM 19404370
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Bradley, CP
   Pullan, AJ
   Hunter, PJ
AF Bradley, CP
   Pullan, AJ
   Hunter, PJ
TI Effects of material properties and geometry on electrocardiographic
   forward simulations
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE forward problem; electrocardiographic simulation; conductivity effects;
   geometric effects; coupled FEM/BEM; high order interpolation
ID ECCENTRIC SPHERES MODEL; EPICARDIAL POTENTIALS; INVERSE PROBLEM;
   FINITE-ELEMENT; BODY-SURFACE; TORSO INHOMOGENEITIES; REALISTIC HEART;
   CONDUCTIVITY; DISTRIBUTIONS; FORMULATION
AB This paper investigates the effect on torso potentials of changes in the material properties of the torso volume conductor and changes in the relative geometry of the heart and torso. The investigations are performed using a number of forward simulations with a high-order coupled finite element/boundary clement torso model. This torso model contains descriptions of the epicardium, lungs, skeletal muscle (with a continuously varying fiber field) and subcutaneous fat. The number of nodes, elements and solution degrees-of-freedom used in the computational torso model are considerably smaller than previous torso models of similar complexity. The successful forward simulations in this paper hence demonstrate the use of the high-order coupled approach with realistic problems. The results of the torso simulations show that the torso inhomogeneities do affect the torso potentials but do not affect the distribution or pattern of the torso potentials. The inhomogeneities considered are found to have a varying, but important, effect on the torso potentials. The effect of the subcutaneous fat is found to be more important and the effect of the skeletal muscle is found to be less important than previous reports in the literature. The results also show that the relative geometry of the heart and torso is very important in determining the torso potential magnitudes and distributions. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00407-0].
C1 Univ Auckland, Dept Engn Sci, Auckland, New Zealand.
RP Pullan, AJ (reprint author), Univ Auckland, Dept Engn Sci, Private Bag 92019, Auckland, New Zealand.
OI Bradley, Chris/0000-0001-6554-1463; Hunter, Peter/0000-0001-9665-4145
CR AKIYAMA T, 1978, CARDIOVASC RES, V12, P697, DOI 10.1093/cvr/12.12.697
   Bradley CP, 1997, ANN BIOMED ENG, V25, P96, DOI 10.1007/BF02738542
   BRADLEY CP, 1998, UNPUB IEEE T BIOMED
   BRODY DA, 1956, CIRC RES, V4, P731, DOI 10.1161/01.RES.4.6.731
   BUDGETT DM, 1993, J ELECTROCARDIOL, V26, P165
   CLAYDON FJ, 1988, IEEE T BIO-MED ENG, V35, P981, DOI 10.1109/10.8680
   Czapski P, 1996, IEEE T BIO-MED ENG, V43, P95, DOI 10.1109/10.477705
   DOWNER CE, 1980, CLIN CARDIOL, V3, P87
   FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25
   GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537
   GREEN LS, 1991, CIRCULATION, V84, P2513, DOI 10.1161/01.CIR.84.6.2513
   GREENSITE F, 1994, ANN BIOMED ENG, V22, P172, DOI 10.1007/BF02390375
   GULRAJANI RM, 1988, CRIT REV BIOMED ENG, V16, P1
   GULRAJANI RM, 1983, CIRC RES, V52, P45, DOI 10.1161/01.RES.52.1.45
   HUISKAMP G, 1989, IEEE T BIO-MED ENG, V36, P827, DOI 10.1109/10.30808
   Hunter P., 1997, COMPUTATIONAL BIOL H, P345
   HUNTER PJ, 1988, PROG BIOPHYS MOL BIO, V52, P101, DOI 10.1016/0079-6107(88)90004-1
   HUNTER PJ, 1997, COMPUTATIONAL BIOL H, P171
   JOHNSON CR, 1992, COMPUT BIOL MED, V22, P305, DOI 10.1016/0010-4825(92)90020-N
   JORGENSON DB, 1995, IEEE T BIO-MED ENG, V42, P172, DOI 10.1109/10.341830
   KARLON WJ, 1994, IEEE T BIO-MED ENG, V41, P1010, DOI 10.1109/10.335838
   Klepfer RN, 1997, IEEE T BIO-MED ENG, V44, P706, DOI 10.1109/10.605427
   KRASSOWSKA W, 1994, IEEE T BIO-MED ENG, V41, P143, DOI 10.1109/10.284925
   LORANGE M, 1993, J ELECTROCARDIOL, V26, P263, DOI 10.1016/0022-0736(93)90048-I
   MCFEE R, 1968, AM HEART J, V76, P48, DOI 10.1016/0002-8703(68)90294-9
   MESSINGERRAPPORT BJ, 1986, IEEE T BIO-MED ENG, V33, P667, DOI 10.1109/TBME.1986.325756
   MESSINGERRAPPORT BJ, 1990, CIRC RES, V66, P1023, DOI 10.1161/01.RES.66.4.1023
   Pullan A, 1996, IEEE T BIO-MED ENG, V43, P292, DOI 10.1109/10.486286
   Pullan AJ, 1996, COMPUT MECH, V18, P356
   RUDY Y, 1982, CIRCULATION, V65, P440, DOI 10.1161/01.CIR.65.3.440
   RUDY Y, 1979, CIRC RES, V44, P104, DOI 10.1161/01.RES.44.1.104
   RUDY Y, 1980, CIRC RES, V46, P283, DOI 10.1161/01.RES.46.2.283
   RUDY Y, 1979, IEEE T BIO-MED ENG, V26, P392, DOI 10.1109/TBME.1979.326417
   RUDY Y, 1988, CRIT REV BIOMED ENG, V16, P215
   RUSH S, 1963, CIRC RES, V12, P40, DOI 10.1161/01.RES.12.1.40
   SPACH MS, 1977, CIRCULATION, V55, P268, DOI 10.1161/01.CIR.55.2.268
   STANLEY PC, 1991, IEEE T BIO-MED ENG, V38, P1069, DOI 10.1109/10.99070
   STANLEY PC, 1986, IEEE T BIO-MED ENG, V33, P273, DOI 10.1109/TBME.1986.325711
   Tomlinson K, 1996, INT J NUMER METH ENG, V39, P451, DOI 10.1002/(SICI)1097-0207(19960215)39:3<451::AID-NME863>3.0.CO;2-1
   UIJEN GJH, 1988, P 14 INT C EL
   VANOOSTEROM A, 1989, J ELECTROCARDIOL, V22, P53, DOI 10.1016/0022-0736(89)90023-X
   WALKER SJ, 1987, CIRC RES, V61, P504, DOI 10.1161/01.RES.61.4.504
   WEI DM, 1995, IEEE T BIO-MED ENG, V42, P343, DOI 10.1109/10.376128
NR 43
TC 40
Z9 42
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2000
VL 28
IS 7
BP 721
EP 741
DI 10.1114/1.1289467
PG 21
WC Engineering, Biomedical
SC Engineering
GA 357GM
UT WOS:000089490200003
PM 11016411
DA 2018-10-19
ER

PT J
AU Vetter, FJ
   McCulloch, AD
AF Vetter, FJ
   McCulloch, AD
TI Three-dimensional stress and strain in passive rabbit left ventricle: A
   model study
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE ventricular mechanics; scalable parallel computation; finite element
   analysis
ID FINITE-ELEMENT MODEL; WALL MECHANICS; MYOCARDIUM; HEART; DEFORMATIONS
AB To determine regional stress and strain distributions in rabbit ventricular myocardium, an anatomically detailed finite element model was used to solve the equations of stress equilibrium during passive filling of the left ventricle. Computations were conducted on a scalable parallel processing computer and performance was found to scale well with the number of processors used, so that stimulations previously requiring approximately 60 min were completed in just over 5 min. Epicardial strains from the model analysis showed good agreement (RMSE=0.007332) with experimental measurements when material properties were chosen such that cross fiber strain was more heterogeneous than fiber strain, which is also consistent with experimental observations in other species. (C) 2000 Biomedical Engineering Society, [S0090-6964(00)00507-5].
C1 Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP McCulloch, AD (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
FU NCRR NIH HHS [RR08065]
CR BOVENDEERD PHM, 1994, J BIOMECH, V27, P941, DOI 10.1016/0021-9290(94)90266-6
   Bovendeerd PHM, 1996, AM J PHYSIOL-HEART C, V270, pH398
   BOVENDEERD PHM, 1992, J BIOMECH, V25, P1129, DOI 10.1016/0021-9290(92)90069-D
   BRADFIELD JWB, 1977, BRIT HEART J, V39, P806
   COSTA K, 1996, THESIS U CALIFORNIA
   Costa KD, 1996, J BIOMECH ENG-T ASME, V118, P464, DOI 10.1115/1.2796032
   Costa KD, 1997, AM J PHYSIOL-HEART C, V273, pH1968
   Dias da Cunha R., 1994, Advances in Computational Mathematics, V2, P261
   Emery JL, 1997, AM J PHYSIOL-HEART C, V272, pH2299
   Gallagher AM, 1997, CARDIOVASC PATHOBIOL, V2, P25
   GRAY RA, 1995, CIRCULATION, V91, P2454, DOI 10.1161/01.CIR.91.9.2454
   GREEN AE, 1970, LARGE ELAST DEFORMAT
   GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084
   GUCCIONE JM, 1995, J BIOMECH, V28, P1167, DOI 10.1016/0021-9290(94)00174-3
   Holmes JW, 1997, AM J PHYSIOL-HEART C, V272, pH2123
   HUGHES TJR, 1983, COMPUT METHOD APPL M, V36, P241, DOI 10.1016/0045-7825(83)90115-9
   HUMPHREY JD, 1989, CIRC RES, V65, P805, DOI 10.1161/01.RES.65.3.805
   HUTCHINSON SA, 1998, AZTEC USERS GUIDE VE
   HUYGHE JM, 1991, J BIOMECH, V24, P527, DOI 10.1016/0021-9290(91)90286-V
   HUYGHE JM, 1992, AM J PHYSIOL, V262, pH1256
   JONES MT, 1997, 9548 ARG NAT LAB
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   ODELL WG, 1998, ADV BIOENG BED, V39, P1
   ODELL WG, 1998, P 1998 ASME INT MECH
   OMENS JH, 1991, AM J PHYSIOL, V261, pH918
   OMENS JH, 1993, J BIOMECH, V26, P665, DOI 10.1016/0021-9290(93)90030-I
   SAAD Y, 2000, 55455 MN U MINN DEP
   Streeter D. D, 1979, HDB PHYSL 2, P61
   Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6
   WALDMAN LK, 1991, THEORY OF HEART, P145
   WATHEN AJ, 1989, COMPUT METHOD APPL M, V74, P271, DOI 10.1016/0045-7825(89)90052-2
   WATKINS MW, 1992, AM J PHYSIOL, V263, pH1811
   Yeckel A, 1997, PARALLEL COMPUT, V23, P1379, DOI 10.1016/S0167-8191(97)00059-8
   Yin FCP, 1996, AM J PHYSIOL-HEART C, V271, pH1864
NR 36
TC 90
Z9 94
U1 0
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2000
VL 28
IS 7
BP 781
EP 792
DI 10.1114/1.1289469
PG 12
WC Engineering, Biomedical
SC Engineering
GA 357GM
UT WOS:000089490200007
PM 11016415
DA 2018-10-19
ER

PT J
AU Alanazi, A
   Nojiri, C
   Noguchi, T
   Kido, T
   Komatsu, Y
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
AF Alanazi, A
   Nojiri, C
   Noguchi, T
   Kido, T
   Komatsu, Y
   Hirakuri, K
   Funakubo, A
   Sakai, K
   Fukui, Y
TI Improved blood compatibility of DLC coated polymeric material
SO ASAIO JOURNAL
LA English
DT Article
ID SURFACES; INVITRO
AB There is currently an increasing interest in the use of DLC (diamond like carbon) films in biomedical applications. These investigations making use of DLC in the biomedical area indicate its attractive properties. In this study, we succeeded in depositing DLC on polymer substrates and found the best conditions and method for this application. We evaluated the blood compatibility of polycarbonate substrates coated by DLC (PC-DLC) under different conditions by using epifluorescent video microscopy (EVM) combined with a parallel plate flow chamber. Segmented polyurethane (SPU), which has been used to fabricate medical devices including an artificial heart, and proven to have acceptable blood compatibility, was compared with polycarbonate substrates coated with DLC film. The EVM system measured platelet adhesion on the surface of the DLC, by using whole human blood containing Mepacrine labeled platelets perfuse at a wall shear rate of 100 s(-1) at 1 min intervals for a period of 20 min. PC-DLC demonstrated that Tecoflex showed higher complement activation than PC-DLC. There were significant differences between the PC-DLC substrates. On the basis of these results, it is recommended for use as a coating material in implantable blood contacting devices such as artificial hearts, pacemakers, and other devices. This DLC seems to be a promising candidate for biomaterials applications and merits further investigation.
C1 Tokyo Denki Univ, Dept Appl Syst Engn, Fac Sci & Engn, Hatoyama, Saitama 3500394, Japan.
   Terumo Co Ltd, R&D Ctr, Inst Biomed Sci, Kanagawa, Japan.
   Waseda Univ, Shinjyuku Ku, Tokyo, Japan.
RP Alanazi, A (reprint author), Tokyo Denki Univ, Dept Appl Syst Engn, Fac Sci & Engn, Hatoyama, Saitama 3500394, Japan.
CR ALANAZI A, J SOC APPL PHYS  AUT, P58
   ALANAZI A, 1999, INT S ADV BIOM TISS
   ALANAZI A, 1998, VACUUM, V49, P1
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   HOLLAND L, 1976, THIN SOLID FILMS, V38, pL17, DOI 10.1016/0040-6090(76)90214-5
   HOLLAND L, 1977, J VAC SCI TECHNOL, V14, P5, DOI 10.1116/1.569159
   KAWAGOISHI N, 1994, ARTIF ORGANS, V18, P588, DOI 10.1111/j.1525-1594.1994.tb03383.x
   KIM SW, 1987, ANN NY ACAD SCI, V516, P116, DOI 10.1111/j.1749-6632.1987.tb33035.x
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KOBAYASHI K, 1988, THIN SOLID FILMS, P158
   KURODA S, 1996, HEART REPLACEMENT AR, V5, P21
   LINDON JN, 1978, J LAB CLIN MED, V92, P904
   Mizumoto D, 1997, ASAIO J, V43, pM500
   NDRADE JD, 1987, ASAIO J, V10, P75
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1995, ARTIF ORGANS, V19, P32, DOI 10.1111/j.1525-1594.1995.tb02241.x
   NOJIRI C, 1990, ASAIO J T, V36, P168
   NOJIRI C, 1987, T AM SOC ART INT ORG, V33, P596
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TURITTO VT, 1982, PROG HEMOST THROMB, V6, P139
NR 20
TC 25
Z9 27
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1058-2916
EI 1538-943X
J9 ASAIO J
JI Asaio J.
PD JUL-AUG
PY 2000
VL 46
IS 4
BP 440
EP 443
DI 10.1097/00002480-200007000-00014
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 368VX
UT WOS:000090139100014
PM 10926142
OA Bronze
DA 2018-10-19
ER

PT J
AU Sawyer-Glover, AM
   Shellock, FG
AF Sawyer-Glover, AM
   Shellock, FG
TI Pre-MRI procedure screening: Recommendations and safety considerations
   for biomedical implants and devices
SO JOURNAL OF MAGNETIC RESONANCE IMAGING
LA English
DT Review
DE Magnetic Resonance Imaging; safety; screening; bioeffects; implants
ID NUCLEAR MAGNETIC-RESONANCE; CLIP VARIABILITY ISSUES; ANEURYSM CLIP;
   FERROMAGNETIC PROPERTIES; CARDIAC-PACEMAKERS; PULSE GENERATORS;
   ARTIFACTS; COMPATIBILITY; TITANIUM; PATIENT
AB Maintaining a safe MR environment is a daily challenge for MR healthcare workers, especially in consideration of the increasing number of clinical MR applications and the large and growing variety of biomedical implants and devices that are currently used in patients. This review article presents policies and procedures that should be used to screen all patients and individuals before allowing them to enter the magnetic resonance (MR) environment. Information pertaining to MR safety and the relative risk factors for implants, devices and materials is discussed. A comprehensive pre-MRI procedure screening form that is recommended for use by MR facilities is also included. (C) 2000 Wiley-Liss, Inc.
C1 Stanford Univ, Sch Med, Radiol Sci Lab, Richard M Lucas Ctr MRSI,Dept Radiol, Stanford, CA 94305 USA.
RP Sawyer-Glover, AM (reprint author), Stanford Univ, Sch Med, Radiol Sci Lab, Richard M Lucas Ctr MRSI,Dept Radiol, Mail Code 5488,Room P273,1201 Welch Rd, Stanford, CA 94305 USA.
CR ALAGONA P, 1989, PACE, V12, P619, DOI 10.1111/j.1540-8159.1989.tb02707.x
   *ASTM, 1994, ANN BOOK AM SOC TEST
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BONNET CA, 1990, AM HEART J, V120, P696, DOI 10.1016/0002-8703(90)90031-R
   Dujovny M, 1997, RADIOLOGY, V202, P637, DOI 10.1148/radiology.202.3.9051008
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   DUJOVNY M, 1985, CEREBRAL VASCULAR SU, P1
   *ECRI, 1998, NEW MRI COMPL
   ERLEBACHER JA, 1986, AM J CARDIOL, V57, P437, DOI 10.1016/0002-9149(86)90768-X
   *FDA, 1988, PREM NOT 510 REG REQ
   FETTER J, 1984, PACE, V7, P720, DOI 10.1111/j.1540-8159.1984.tb05602.x
   Fleckenstein JL, 1997, RADIOLOGY, V202, P640, DOI 10.1148/radiology.202.3.9051009
   GANGAROSA RE, 1987, MAGN RESON IMAGING, V5, P287, DOI 10.1016/0730-725X(87)90006-3
   GEGAUFF AG, 1990, J ORAL REHABIL, V17, P403, DOI 10.1111/j.1365-2842.1990.tb01411.x
   HAYES DL, 1987, J AM COLL CARDIOL, V10, P782, DOI 10.1016/S0735-1097(87)80270-X
   HOLMES DR, 1986, PACE, V9, P360, DOI 10.1111/j.1540-8159.1986.tb04490.x
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E, 1997, RADIOLOGY, V202, P641, DOI 10.1148/radiology.202.3.641
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   Kanal E, 1997, RADIOLOGY, V202, P638, DOI 10.1148/radiology.202.3.638
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   PAVLICEK W, 1983, RADIOLOGY, V147, P149, DOI 10.1148/radiology.147.1.6828720
   PERSSON BRR, 1989, HLTH SAFETY CLIN NMR
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   Shellock F. G., 1996, MAGNETIC RESONANCE B
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114
   Shellock FG, 1998, RADIOLOGY, V207, P587, DOI 10.1148/radiology.207.3.9609877
   Shellock FG, 2000, POCKET GUIDE MR PROC
   SHELLOCK FG, 1992, REV MAGN RESON IMAGI, V4, P21
   Shellock FG, 1997, POCKET GUIDE MR PROC
   Wichmann W, 1997, AM J NEURORADIOL, V18, P939
   ZIMMERMANN BH, 1984, DIAGN IMAG CLIN MED, V53, P53
NR 38
TC 62
Z9 65
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1053-1807
J9 J MAGN RESON IMAGING
JI J. Magn. Reson. Imaging
PD JUL
PY 2000
VL 12
IS 1
BP 92
EP 106
DI 10.1002/1522-2586(200007)12:1<92::AID-JMRI11>3.0.CO;2-7
PG 15
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 477PZ
UT WOS:000171294600011
PM 10931569
DA 2018-10-19
ER

PT J
AU Johnson, GS
   Mucalo, MR
   Lorier, MA
AF Johnson, GS
   Mucalo, MR
   Lorier, MA
TI The processing and characterization of animal-derived bone to yield
   materials with biomedical applications - Part 1: Modifiable porous
   implants from bovine condyle cancellous bone and characterization of
   bone materials as a function of processing
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; RAY PHOTOELECTRON-SPECTROSCOPY;
   RAMAN-SPECTROSCOPY; CALCIUM-PHOSPHATE; MAGNETIC-RESONANCE; EARLY
   DEPOSITS; SOLID-PHASE; PO4 DOMAIN; HYDROXYAPATITE; ENAMEL
AB A study on the development of a process to form materials suitable for biomedical xenograft implants from bovine cancellous bone is presented. Bone cubes cut from the condyle portion of bovine femurs sourced from abattoir waste were subjected to a defatting and subsequent deproteination procedure to produce shape-modifiable materials in which the biocompatible mineral calcium hydroxycarbonate apatite component was preserved in the original osseous architecture of the bovine bone. Optimum defatting was achieved by (1) thawing of the precut bone cubes in water, (2) pressure cooking at 15 psi in water, (3) soaking in 0.1 mol l(-1) NaOH followed by a thorough rinse under running water, (4) microwave heating of the bone cubes in water, (5) refluxing in methyl acetate and finally (6) removal of internal liquid from the cubes by shaking and then air drying. Subsequent deproteination of the defatted bone cubes was optimally achieved by (1) soaking in 5% sodium hypochlorite solution at ambient temperature using ultrasonication, (2) thorough rinsing of the cubes in water followed by drying. The final product is a defatted/deproteinated, bleached material that can be molded into various shapes for implant use in the body. The bone specimens were characterized by a suite of analytical techniques (i.e. infrared, P-31 and C-13 solid magic-angle spinning (MAS) nuclear magnetic resonance (NMR), X-ray photoelectron spectroscopies, atomic absorption (AA) spectrometry, inductively coupled plasma (ICP) spectrometry, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM)) in order to follow compositional changes during the various stages of processing. In general, bovine condyles proved to be the best source of xenograft materials with condyles from other animal species (i.e. deer, sheep and ostrich) being too small to constitute a utilizable source of cancellous bone. This study shows how value can be added to a hitherto underutilized abattoir by-product by using simple processing techniques. (C) 2000 Kluwer Academic Publishers.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
   MIRINZ Food Technol & Res Ltd, Hamilton, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR ABDELFATTAH WI, 1993, THERMOCHIM ACTA, V218, P465, DOI 10.1016/0040-6031(93)80445-G
   AKAZAWA T, 1991, PHOSPHORUS RES B, V1, P215
   *ASS OFF AN CHEM, 1995, AOAC INT, V2, P7
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BEM H, 1982, ANAL CHIM ACTA, V135, P129, DOI 10.1016/S0003-2670(01)85272-7
   BERTOLUZZA A, 1994, J RAMAN SPECTROSC, V25, P109, DOI 10.1002/jrs.1250250116
   BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   CRAIG NL, 1975, ANAL LETT, V8, P831, DOI 10.1080/00032717508059056
   CUNNINGHAM WT, 1980, ORAL SURG ORAL MED O, V49, P175, DOI 10.1016/0030-4220(80)90313-8
   ELLIOT JC, 1994, STUDIES INORGANIC CH, V18, P229
   FRAYSSINET P, 1995, J MATER SCI-MATER M, V6, P473, DOI 10.1007/BF00123372
   GANZLER K, 1986, J CHROMATOGR, V371, P299, DOI 10.1016/S0021-9673(01)94714-4
   GELINAS Y, 1992, ANAL CHIM ACTA, V269, P115, DOI 10.1016/0003-2670(92)85140-2
   GRYNPAS MD, 1987, BIOL TRACE ELEM RES, V13, P333, DOI 10.1007/BF02796644
   HASEGAWA K, 1994, CALCIFIED TISSUE INT, V55, P381, DOI 10.1007/BF00299319
   HERCULES DM, 1976, J DENT RES, V55, P829, DOI 10.1177/00220345760550051901
   JOBLING A, 1983, P EAST SCH AGR SCI U, V36, P183
   KANO S, 1991, P 1 INT S AP MISH JU, P91
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   LANDIS WJ, 1982, MICROBEAN ANAL, P121
   LEUNG YC, 1995, J BIOMED MATER RES, V29, P591, DOI 10.1002/jbm.820290506
   MINGOS DMP, 1991, CHEM SOC REV, V20, P12
   MOORE JR, 1995, MAGNET RESON MED, V33, P293, DOI 10.1002/mrm.1910330303
   OTTER M, 1988, J ORTHOP RES, V6, P346, DOI 10.1002/jor.1100060306
   RADU GL, 1993, J MOL STRUCT, V293, P265, DOI 10.1016/0022-2860(93)80064-3
   REHMAN I, 1995, J BIOMED MATER RES, V29, P1287, DOI 10.1002/jbm.820291016
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   SAUER GR, 1994, CALCIFIED TISSUE INT, V54, P414, DOI 10.1007/BF00305529
   Savarino L, 1998, J MATER SCI-MATER M, V9, P109, DOI 10.1023/A:1008855216755
   SHARP DJ, 1990, J BIOMECH, V23, P853, DOI 10.1016/0021-9290(90)90032-X
   SWAN JE, 1991, 883 MIRINZ
   WALSH WR, 1994, J MATER SCI-MATER M, V5, P72, DOI 10.1007/BF00121694
   WALTERS MA, 1991, CALCIFIED TISSUE INT, V48, P368, DOI 10.1007/BF02556157
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
NR 38
TC 39
Z9 43
U1 0
U2 13
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2000
VL 11
IS 7
BP 427
EP 441
DI 10.1023/A:1008987908917
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 321NF
UT WOS:000087461000004
PM 15348008
DA 2018-10-19
ER

PT J
AU Albertsson, AC
   Edlund, U
   Stridsberg, K
AF Albertsson, AC
   Edlund, U
   Stridsberg, K
TI Controlled ring-opening polymerization of lactones and lactides
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT International Symposium on Ionic Polymerization (IP 99)
CY JUL 19-23, 1999
CL KYOTO, JAPAN
SP Int Union Pure & Appl Chem, Macromolec Div, Chem Soc Japan, Soc Polymer Sci, Japan Chem Innovat Inst
ID POLYMERS
AB 1,5-dioxepan-2-one (DXO) is presented as a versatile component in biodegradable polymers for biomedical applications. Copolymerization of DXO and L-lactide yielded a semi-crystalline, yet flexible, material where the extent of crystallinity and erosion characteristics were controlled by an appropriate choice of copolymer composition. Crosslinked PDXO was polymerized as a novel biodegradable elastomer. The degradation behavior of these materials were explored in vitro. Microspheres from poly(DXO-co-L-LA) were prepared and shown to be promising candidates for controlled release. The polymer composition and drug solubility provided effective means of controlling the drug delivery pattern.
C1 Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143; /0000-0002-1631-1781
CR ALBERTSSON AC, 1995, J MACROMOL SCI PURE, VA32, P41, DOI 10.1080/10601329508011063
   ALBERTSSON AC, 1995, J APPL POLYM SCI, V57, P87, DOI 10.1002/app.1995.070570109
   ALBERTSSON AC, 1998, ENCY ENV ANAL REMEDI
   Edlund U, 1999, J POLYM SCI POL CHEM, V37, P1877, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1877::AID-POLA17>3.0.CO;2-4
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   STRIDSBERG K, IN PRESS J POLYM SCI
NR 6
TC 20
Z9 20
U1 0
U2 13
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JUL
PY 2000
VL 157
BP 39
EP 46
DI 10.1002/1521-3900(200007)157:1<39::AID-MASY39>3.0.CO;2-1
PG 8
WC Polymer Science
SC Polymer Science
GA 359VF
UT WOS:000089632200006
DA 2018-10-19
ER

PT J
AU de Certaines, JD
   Chauvel, BP
   Bouk'hil, H
   Cathelineau, G
AF de Certaines, JD
   Chauvel, BP
   Bouk'hil, H
   Cathelineau, G
TI A safety approach of magnetic compatibility of metallic biomaterials in
   Magnetic Resonance Imaging
SO PHYSICA MEDICA
LA English
DT Article
DE Magnetic Resonance Imaging; metallic implants; biohazards; safety
ID MR PROCEDURES; BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS; FOREIGN-BODIES;
   ANEURYSM CLIPS; ARTIFACTS; NMR; DEVICES; FERROMAGNETISM; THRESHOLDS
AB Interactions of metallic implants and monitoring devices with magnetic field must be an important safety consideration for both patients and staff in Magnetic Resonance Imaging. Metallic materials can be a contra-indication for MRI when it leads to safety issue (biohazards) or image misinterpretation (artefacts). Tests and safety guidelines are proposed concerning the MRI compatibility of non-active metallic materials. The evolution of laws concerning health and medical attitudes leads to set up standardized tests as a pre-requisite before marketing new medical implants or instruments. Furthermore, for not yet registered or miscellaneous materials, implanted or not, a clinical safety attitude is proposed and has to be respected by the MRI staff to detect and identify them in order to avoid potential accidents.
C1 Univ Rennes 1, Lab Resonance Magnet Biol & Med, Fac Med, F-35000 Rennes, France.
   Univ Rennes 1, Lab Biomat Site Osseux, Fac Med, F-35000 Rennes, France.
CR ADAIR E R, 1986, Magnetic Resonance Imaging, V4, P321, DOI 10.1016/0730-725X(86)91042-8
   ATHEY TW, 1992, ANN NY ACAD SCI, P649
   BOTTOMLEY PA, 1992, ANN NY ACAD SCI, V649, P144, DOI 10.1111/j.1749-6632.1992.tb49604.x
   BOUTIN RD, 1994, AM J ROENTGENOL, V162, P189, DOI 10.2214/ajr.162.1.8273663
   BUCHLI R, 1998, MAGNET RESON MED, V18, P255
   BUDINGER TF, 1992, ANN NY ACAD SCI, V649, P1, DOI 10.1111/j.1749-6632.1992.tb49592.x
   BUDINGER TF, 1981, J COMPUT ASSIST TOMO, V5, P800, DOI 10.1097/00004728-198112000-00003
   Chauvel B, 1996, JMRI-J MAGN RESON IM, V6, P936, DOI 10.1002/jmri.1880060615
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   Elmquist C, 1995, JMRI-J MAGN RESON IM, V5, P784, DOI 10.1002/jmri.1880050629
   ELSTER AD, 1994, AM J ROENTGENOL, V162, P195, DOI 10.2214/ajr.162.1.8273665
   *FDAS GOOD GUID PR, 1997, PRIM MED DEV INT MAG
   GO KG, 1989, CLIN NEUROL NEUROSUR, V91, P109, DOI 10.1016/S0303-8467(89)80030-7
   GRANDOLFO M, 1990, BIOELECTROMAGNETICS, V11, P117, DOI 10.1002/bem.2250110203
   HARAMATI N, 1994, JMRI-J MAGN RESON IM, V4, P209, DOI 10.1002/jmri.1880040219
   JOHNSON GC, 1993, RADIOLOGY, V188, P287, DOI 10.1148/radiology.188.1.8511314
   Jolesz FA, 1998, JMRI-J MAGN RESON IM, V8, P8, DOI 10.1002/jmri.1880080105
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E., 1988, MAGN RESON IMAGIN S1, V7, P106
   KANAL E, 1990, SOC MAGN RES, V1, P274
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   LECERF J, 1994, ITBM, V15, pP5
   MCROBBIE D, 1984, CLIN PHYS PHYSIOL M, V5, P67, DOI 10.1088/0143-0815/5/2/002
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   *NRPB, 1981, RADIOGRAPHY, V47, P258
   POHOST GM, 1992, NY ACAD SCI, P302
   Pusey E, 1986, Radiographics, V6, P891
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   Schueler BA, 1999, JMRI-J MAGN RESON IM, V9, P596, DOI 10.1002/(SICI)1522-2586(199904)9:4<596::AID-JMRI14>3.0.CO;2-T
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1994, JMRI-J MAGN RESON IM, V4, P749, DOI 10.1002/jmri.1880040519
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1992, ANN NY ACAD SCI, V649, P260, DOI 10.1111/j.1749-6632.1992.tb49615.x
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1999, AM J ROENTGENOL, V173, P543, DOI 10.2214/ajr.173.3.10470877
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   SHELLOCK FG, 1992, APPL RADIOL      NOV, P44
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TENFORDE TS, 1986, MED MONOGRAPH, V14, P493
   TIMMS WE, 1992, J MED ENG TECHNOL, V16, P69, DOI 10.3109/03091909209021963
   VOGL T, 1988, MED PHYS, V15, P562, DOI 10.1118/1.596207
   WALKER PM, 1989, PHYS MED BIOL, V34, P5, DOI 10.1088/0031-9155/34/1/002
   Wickersheim K A, 1982, Prog Clin Biol Res, V107, P547
   WILLIAMS DF, 1987, PROG BIOMED ENG, V4, P4
   1993, J OFFICIEL COMMUNAUT
NR 48
TC 1
Z9 1
U1 0
U2 2
PU ISTITUTI EDITORIALI E POLGRAFICI INTERNAZIONALI
PI PISA
PA CASELLA POSTALE N 1, SUCCURSALE N 8, 56123 PISA, ITALY
SN 1120-1797
J9 PHYS MEDICA
JI Phys. Medica
PD JUL-SEP
PY 2000
VL 16
IS 3
BP 97
EP 106
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 378EL
UT WOS:000165572000001
DA 2018-10-19
ER

PT J
AU Chan, B
   Donzelli, PS
   Spilker, RL
AF Chan, B
   Donzelli, PS
   Spilker, RL
TI A mixed-penalty biphasic finite element formulation incorporating
   viscous fluids and material interfaces
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biphasic finite element formulation; fluid viscosity; material
   interface; Couette flow
ID ARTICULAR-CARTILAGE; CONTACT; OSTEOARTHRITIS; LUBRICATION; COMPRESSION;
   TISSUES; LAYERS
AB The fluid viscosity term of the fluid phase constitutive equation and the interface boundary conditions between biphasic, solid and fluid domains have been incorporated into a mixed-penalty finite element formulation of the linear biphasic theory for hydrated soft tissue. The finite element code can now model a single-phase viscous incompressible fluid, or a single-phase elastic solid, as limiting cases of a biphasic material. Interface boundary conditions allow the solution of problems involving combinations of biphasic, fluid and solid regions. To incorporate these conditions, the volume-weighted mixture velocity is introduced as a degree of freedom at interface nodes so that the kinematic continuity conditions are satisfied by conventional finite element assembly techniques. Results comparing our numerical method with an independent, analytic solution for the problem of Couette flow over rigid and deformable porous biphasic layers show that the finite element code accurately predicts the viscous fluid flows and deformation in the porous biphasic region. Thus, the analysis can be used to model the interface between synovial fluid and articular cartilage in diarthrodial joints. This is an important step toward modeling and understanding the mechanisms of joint lubrication and another step toward fully modeling the in vivo behavior of a diarthrodial joint. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00506-3].
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Dept Mech Engn Aeronaut Engn & Mech, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Sci Computat Res Ctr, Troy, NY 12180 USA.
RP Spilker, RL (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, JEC 7049, Troy, NY 12180 USA.
FU NIAMS NIH HHS [R01 AR42850]
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   ATESHIAN G, 1991, THESIS COLUMBIA U NE
   ATESHIAN GA, 1994, J BIOMECH, V27, P1347, DOI 10.1016/0021-9290(94)90044-2
   ATESHIAN GA, 1995, J BIOMECH, V28, P1341, DOI 10.1016/0021-9290(95)00008-6
   CHAN B, 1991, THESIS RENNSELAER PO
   Donzelli PS, 1998, COMPUT METHOD APPL M, V153, P63, DOI 10.1016/S0045-7825(97)00065-0
   Freeman MAR, 1979, ADULT ARTICULAR CART, P487
   GUILAK F, 1994, J ORTHOPAED RES, V12, P474, DOI 10.1002/jor.1100120404
   HLAVACEK M, 1995, J BIOMECH, V28, P1199, DOI 10.1016/0021-9290(94)00178-7
   HOU J, 1989, INTERFACE CONDITIONS, P175
   HOU JS, 1989, J BIOMECH ENG-T ASME, V111, P78, DOI 10.1115/1.3168343
   HOWELL DS, 1992, OSTEOARTHRITIS DIAGN, pCH9
   Hughes T., 1987, FINITE ELEMENT METHO
   JIN Z, 1992, P I MECH ENG C-MECH, V209, P117
   LAI WM, 1980, BIORHEOLOGY, V17, P111
   LAI WM, 1978, J BIOMECH ENG-T ASME, V100, P169, DOI 10.1115/1.3426208
   Mankin H. J., 1986, J RHEUMATOL, V13, P1130
   MAXIAN TA, 1989, 6 NODE TRIANGULAR EL
   Moskowitz RW, 1992, OSTEOARTHRITIS DIAGN
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   RADIN EL, 1972, LANCET, V1, P519
   Spilker R.L., 1988, COMPUTATIONAL METHOD, P81
   SPILKER RL, 1990, INT J NUMER METH ENG, V30, P1063, DOI 10.1002/nme.1620300508
   SPILKER RL, 1987, 1987 BIOM S NEW YORK, P49
   SPILKER RL, 1990, BIOMECHANICS DIARTHR, P401
   SUH JK, 1989, 1989 ADV BIOENGINEER
   VANDERVOET A, 1993, RECENT ADV COMPUTER
   VERMILYEA ME, 1990, 1990 ADV BIOENGINEER, P211
NR 28
TC 8
Z9 9
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2000
VL 28
IS 6
BP 589
EP 597
DI 10.1114/1.1305529
PG 9
WC Engineering, Biomedical
SC Engineering
GA 349LF
UT WOS:000089046000001
PM 10983705
DA 2018-10-19
ER

PT J
AU McGuire, J
   Bower, CK
   Bothwell, MK
AF McGuire, J
   Bower, CK
   Bothwell, MK
TI On the molecular origins of protein structure and function at interfaces
SO AUSTRALIAN JOURNAL OF DAIRY TECHNOLOGY
LA English
DT Editorial Material
ID AIR-WATER-INTERFACE; BROMIDE-MEDIATED ELUTABILITY; SYNTHETIC STABILITY
   MUTANTS; SILANIZED SILICA SURFACES; SOLID LIQUID INTERFACES; T4 PHAGE
   LYSOZYME; BACTERIOPHAGE-T4 LYSOZYME; COLLOIDAL SILICA; WILD-TYPE;
   COMPARATIVE ADSORPTION
AB Protein films can profoundly affect the properties of materials onto which they adsorb. This can lead to serious consequences in a number of applications in food, pharmaceutical, and biomedical technology. To study the behaviour of proteins at interfaces, we used bacteriophage T4 lysozyme variants that differed at the molecular level by only one amino acid residue. The results from this research suggest that adsorbed protein can be adequately described as existing in one of two conformational states, that differ in occupied area and binding strength. The competitive adsorption behaviour of a protein, as well as its biological function, are inextricably linked to protein structure at the interface. By quantifying protein-surface interactions, it should be possible to predict and control protein interfacial function in practical circumstances.
C1 Oregon State Univ, Corvallis, OR 97331 USA.
RP McGuire, J (reprint author), Oregon State Univ, 116 Gilmore Hall, Corvallis, OR 97331 USA.
CR ALBER T, 1987, METHOD ENZYMOL, V154, P511
   Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   ARAI T, 1990, COLLOID SURFACE, V51, P17, DOI 10.1016/0166-6622(90)80128-Q
   ARAI T, 1990, COLLOID SURFACE, V51, P1, DOI 10.1016/0166-6622(90)80127-P
   BANIJABER A, 2000, IN PRESS J FOOD SCI
   BILLSTEN P, 1995, J COLLOID INTERF SCI, V175, P77, DOI 10.1006/jcis.1995.1431
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Bower CK, 1998, J DAIRY SCI, V81, P2771, DOI 10.3168/jds.S0022-0302(98)75835-7
   BOWER CK, 1995, J IND MICROBIOL, V15, P227, DOI 10.1007/BF01569829
   Bower CK, 1998, BIOTECHNOL BIOENG, V58, P658, DOI 10.1002/(SICI)1097-0290(19980620)58:6<658::AID-BIT13>3.0.CO;2-3
   Bower CK, 1999, BIOTECHNOL BIOENG, V64, P373, DOI 10.1002/(SICI)1097-0290(19990805)64:3<373::AID-BIT14>3.0.CO;2-J
   BOWER CK, 1995, APPL ENVIRON MICROB, V61, P992
   Brash J. L., 1995, ACS SYM SER, V602, P1
   ELWING H, 1988, J COLLOID INTERF SCI, V123, P306, DOI 10.1016/0021-9797(88)90249-4
   Froberg JC, 1998, LANGMUIR, V14, P456, DOI 10.1021/la970674w
   GRUTTER MG, 1982, J MOL BIOL, V154, P525, DOI 10.1016/S0022-2836(82)80011-9
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   HORSLEY D, 1987, ACS SYM SER, V343, P290
   KATO A, 1988, PROTEIN ENG, V2, P153, DOI 10.1093/protein/2.2.153
   KONDO A, 1992, BIOTECHNOL BIOENG, V40, P889, DOI 10.1002/bit.260400804
   KONDO A, 1991, J COLLOID INTERF SCI, V143, P214, DOI 10.1016/0021-9797(91)90454-G
   Lakamraju M, 1996, J COLLOID INTERF SCI, V178, P495, DOI 10.1006/jcis.1996.0144
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   Lee WK, 1999, J COLLOID INTERF SCI, V213, P265, DOI 10.1006/jcis.1999.6135
   LUEY JK, 1991, J COLLOID INTERF SCI, V143, P489, DOI 10.1016/0021-9797(91)90282-D
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   MATSUMURA M, 1988, NATURE, V334, P406, DOI 10.1038/334406a0
   MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125
   MATTHEWS BW, 1973, J MOL BIOL, V78, P575, DOI 10.1016/0022-2836(73)90478-6
   McGuire J, 1995, ACS SYM SER, V602, P52
   MCGUIRE J, 1995, J COLLOID INTERF SCI, V170, P193, DOI 10.1006/jcis.1995.1088
   MCGUIRE J, 1995, J COLLOID INTERF SCI, V170, P182, DOI 10.1006/jcis.1995.1087
   MCGUIRE J, 1999, ENCY BIOPROCESS TECH, P42
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Podhipleux N, 1999, COLLOID SURFACE B, V13, P167, DOI 10.1016/S0927-7765(99)00008-9
   Podhipleux N, 1996, FOOD HYDROCOLLOID, V10, P285, DOI 10.1016/S0268-005X(96)80003-8
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Singla B, 1996, J COLLOID INTERF SCI, V182, P292, DOI 10.1006/jcis.1996.0463
   SUTTIPRASIT P, 1993, FOOD HYDROCOLLOID, V7, P241, DOI 10.1016/S0268-005X(09)80175-6
   Suvajittanont W, 2000, BIOTECHNOL BIOENG, V67, P12, DOI 10.1002/(SICI)1097-0290(20000105)67:1<12::AID-BIT2>3.0.CO;2-#
   Tian MH, 1998, J COLLOID INTERF SCI, V200, P146, DOI 10.1006/jcis.1997.5348
   Wang J, 1997, J COLLOID INTERF SCI, V185, P317, DOI 10.1006/jcis.1996.4619
   WEI AP, 1990, DEV BIOTHER, V1, P305
   XU SQ, 1993, J COLLOID INTERF SCI, V159, P124, DOI 10.1006/jcis.1993.1304
NR 46
TC 5
Z9 5
U1 0
U2 1
PU DAIRY INDUSTRY ASSOC AUSTRALIA
PI NORTH MELBOURNE
PA PO BOX 351, 1FL4, 484 WILLIAM ST, NORTH MELBOURNE, VIC 3051, AUSTRALIA
SN 0004-9433
J9 AUST J DAIRY TECHNOL
JI Aust. J. Dairy Technol.
PD JUN
PY 2000
VL 55
IS 2
BP 65
EP 70
PG 6
WC Agriculture, Dairy & Animal Science; Food Science & Technology
SC Agriculture; Food Science & Technology
GA 336NM
UT WOS:000088309200007
DA 2018-10-19
ER

PT J
AU Chance, JJ
   Li, DJ
   Sokoll, LJ
   Silberman, MA
   Engelstad, ME
   Nichols, JH
   Liu, XH
   Mohammad, AA
   Petersen, JR
   Okorodudu, AO
AF Chance, JJ
   Li, DJ
   Sokoll, LJ
   Silberman, MA
   Engelstad, ME
   Nichols, JH
   Liu, XH
   Mohammad, AA
   Petersen, JR
   Okorodudu, AO
TI Multiple site analytical evaluation of a portable blood gas/electrolyte
   analyzer for point of care testing
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE critical care medicine; point of care testing; blood gases;
   electrolytes; portable; tonometry; cost; correlation
ID CLINICAL ANALYZER; UNIT
AB Objective: To evaluate the analytical performance of the SenDx 100 portable blood gas and electrolyte analyzer (SenDx Medical, Carlsbad, CA).
   Design: Accuracy was evaluated by correlation of whole blood patient samples with the Nova Stat Profile 5 (Nova Biomedical, Waltham, MA) and the Ciba Coming 865 (Chiron Diagnostics, Medford, MA). Precision was evaluated using quality control materials (RNA Medical, Acton, MA).
   Setting: Critical care laboratories and operating rooms in two institutions.
   Measurements and Main Results:Precision studies performed at three different concentration levels for each analyte demonstrated intra-assay precision of less than or equal to 2.5% coefficient of variation and interassay precision of less than or equal to 4.0% coefficient of variation in all cases. Analysis of patient specimens in general showed good to excellent correlation to reference analyzers. Regression Variables are tabulated.
   Conclusions: The SenDx 100 portable blood gas and electrolyte analyzer is a simple and easy to use analyzer demonstrating acceptable performance compared with reference methods.
C1 Johns Hopkins Hosp, Dept Pathol, Div Clin Chem, Baltimore, MD 21287 USA.
   Univ Texas, Med Branch, Dept Pathol, Div Clin Chem, Galveston, TX 77550 USA.
RP Nichols, JH (reprint author), Johns Hopkins Hosp, Dept Pathol, Div Clin Chem, 600 N Wolfe St,Meyer B-125, Baltimore, MD 21287 USA.
CR BURKE MD, 1993, AM J CLIN PATHOL, V100, P89
   *COLL AM PATH, 1998, CRIT CAR AQ BLOOD GA
   Gault MH, 1996, CLIN BIOCHEM, V29, P117, DOI 10.1016/0009-9120(96)02028-0
   HERR DM, 1995, AM J CLIN PATHOL, V104, pS54
   JACOBS E, 1993, CLIN CHEM, V39, P1890
   Lamb L S Jr, 1995, Am J Crit Care, V4, P429
   Murthy JN, 1997, CLIN BIOCHEM, V30, P385, DOI 10.1016/S0009-9120(97)00046-5
   WONG RJ, 1994, CLIN CHEM, V40, P124
NR 8
TC 7
Z9 7
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD JUN
PY 2000
VL 28
IS 6
BP 2081
EP 2085
DI 10.1097/00003246-200006000-00069
PG 5
WC Critical Care Medicine
SC General & Internal Medicine
GA 324YF
UT WOS:000087649000063
PM 10890668
DA 2018-10-19
ER

PT J
AU Stieglitz, T
   Beutel, H
   Meyer, JU
AF Stieglitz, T
   Beutel, H
   Meyer, JU
TI "Microflex" - A new assembling technique for interconnects
SO JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES
LA English
DT Article
ID HISTOLOGICAL REACTION; POLYIMIDE; STIMULATION; ELECTRODES; FILMS
AB A new interconnection technique has been developed that allows versatile multiple strand connections between microsensors, sensor arrays, and chips designed for wire bonding. The new technique has been termed "Microflex interconnection" technique (MFI).
   Conventional wire bonding technique is commonly restricted to planar interconnects with a limited degree of freedom for placing microsystem components in hybrid assemblies. The MFI technique has overcome this limitation by interconnecting microsystem components through custom designed flexible substrates with embedded metallized conductors, pad arrays for integrated circuits' assembly and substrate integrated electrodes. Standard CMOS components without additional pad metallization can be used. The integration density of the MFI technique corresponds to one of the flip-chip technology. Special advantages of the MFI technique are three-dimensional interconnects, the flexibility in design and shape, and easy visual inspection of alignment qualities. The method is especially suitable for small volumes of customer specified devices and biomedical implants because all materials used are biocompatible.
   Within this paper, the MFI technique is introduced, described in detail, and tested according to international standards. The evaluation of the electrical and mechanical properties of the interconnection sites exhibited promising results regarding stability and reliability. First applications in the biomedical field were presented on the example of a neural implant and a sensorized cardiac catheter.
C1 Fraunhofer Inst Biomed Engn, Sensor Syst Microsyst Dept, D-66386 Sankt Ingbert, Germany.
RP Stieglitz, T (reprint author), Fraunhofer Inst Biomed Engn, Sensor Syst Microsyst Dept, Ensheimer Str 48, D-66386 Sankt Ingbert, Germany.
EM thomas.stieglitz@ibmt.fhg.de
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
CR BEEBE DJ, 1994, SENSOR ACTUAT A-PHYS, V44, P57, DOI 10.1016/0924-4247(93)00775-Y
   BEUTEL H, Patent No. 19730388
   CHANG LH, 1991, METALLIZATION PERFOR, V1596, P34
   CHMIEL G, 1994, MICR SYST TECHN 94 I, P587
   FRAZIER BA, 1995, SENSOR ACTUAT A-PHYS, V45, P47
   HAGGERTY HS, 1989, ACTA OTO-LARYNGOL, V107, P13, DOI 10.3109/00016488909127474
   HETKE JF, 1990, SENSOR ACTUAT A-PHYS, V23, P999, DOI 10.1016/0924-4247(90)87076-U
   KIM YW, 1991, IEEE T ELECTRON DEV, P651
   KOENINGER V, VERBINDNGSTECHNIK EL, P193
   KOOPMAN NG, 1989, MICROELECTRONICS PAC, P366
   KOOPMAN NG, 1989, MICROELECTRONICS PAC, P391
   LOEB GE, 1977, J BIOMED MATER RES, V11, P195, DOI 10.1002/jbm.820110206
   Navarro X, 1998, J PERIPHER NERV SYST, V3, P91
   RICHARDSON RR, 1993, J BIOMAT, P627
   Rodriguez FJ, 2000, J NEUROSCI METH, V98, P105, DOI 10.1016/S0165-0270(00)00192-8
   ROSSI RD, 1990, SOLID STATE TECHNOL, P21
   Stieglitz T, 1998, TOP CURR CHEM, V194, P131
   Stieglitz T, 1997, P ANN INT IEEE EMBS, V19, P2307, DOI 10.1109/IEMBS.1997.758825
   Stieglitz T, 1997, SENSOR ACTUAT A-PHYS, V60, P240, DOI 10.1016/S0924-4247(97)01494-5
   VANDERPUIJE PD, 1989, ANN OTO RHINOL LARYN, V98, P466, DOI 10.1177/000348948909800614
NR 20
TC 29
Z9 29
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1045-389X
EI 1530-8138
J9 J INTEL MAT SYST STR
JI J. Intell. Mater. Syst. Struct.
PD JUN
PY 2000
VL 11
IS 6
BP 417
EP 425
AR PII R7BV511B21RJR2FA
DI 10.1106/R7BV-511B-21RJ-R2FA
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 413QR
UT WOS:000167623700001
DA 2018-10-19
ER

PT J
AU Rheinlander, T
   Roessner, D
   Weitschies, W
   Semmler, W
AF Rheinlander, T
   Roessner, D
   Weitschies, W
   Semmler, W
TI Comparison of size-selective techniques for the fractionation of
   magnetic fluids
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE magnetic fluid; field-flow fractionation; size-exclusion chromatography;
   magnetic relaxation
ID SUPERPARAMAGNETIC IRON-OXIDE; FIELD-FLOW FRACTIONATION;
   LIGHT-SCATTERING; PARTICLES; SYSTEM
AB Nanoparticles in magnetic fluids commonly display a broad distribution of magnetic and nonmagnetic parameters such as particle size. Nevertheless, magnetic fluids are used in many fields of application like material separation and biomedicine. Thereby, it is often the case that only a small number of particles contribute to the desired magnetic effect. Two fractionation methods, which separate according to the particle size, were tested in order to optimize magnetic fluids for applications. On the one hand, flow field-flow fractionation was used with an online multi-angle laser light-scattering detector that measures the particle size independently. For comparison, on the other hand, well-known size-exclusion chromatography was performed. The fractions obtained by both methods were magnetically characterized by magnetorelaxometry, a biomedical application of magnetic nanoparticles. The fractionations yielded are similar, independent of the method used. In this respect, flow field-flow fractionation has several advantages over size-exclusion chromatography in analytical use. Thus, flow field-flow fractionation requires neither the addition of electrolytes nor column materials. The fractions obtained display distinctly different magnetic properties compared to the original sample and are therefore especially suited for applications like magnetorelaxometry. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Inst Diagnost Forsch GMBH, D-14050 Berlin, Germany.
   Wyatt Technol Deutschland GMBH, D-57614 Woldert, Germany.
   Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
   Deutsch Krebsforschungszentrum, Abt Biophys & Med Strahlenphys, D-69120 Heidelberg, Germany.
RP Rheinlander, T (reprint author), Mifa AG, Rheinstr 99, CH-4402 Frenkendorf, Switzerland.
OI Weitschies, Werner/0000-0003-3492-7747
CR FRIJA G, 1994, INVEST RADIOL, V29, pS75, DOI 10.1097/00004424-199406001-00025
   GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990
   Haller A, 1999, SUPERCOND SCI TECH, V12, P956, DOI 10.1088/0953-2048/12/11/378
   HASEGAWA M, 1987, Patent No. 4101435
   Jiang Y, 1999, J MAGN MAGN MATER, V194, P53, DOI 10.1016/S0304-8853(98)00577-0
   KOCH H, 1991, IEEE T MAGN, V27, P2793, DOI 10.1109/20.133788
   LEWIS JM, 1990, Patent No. 9001899
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   Neel L., 1949, ANN GEOPHYS, V5, P99
   NUNES AC, 1989, J MAGN MAGN MATER, V78, P241, DOI 10.1016/0304-8853(89)90274-6
   Rheinlander T, 2000, COLLOID POLYM SCI, V278, P259, DOI 10.1007/s003960050041
   RHEINLANDER T, 1999, IEEE T MAGN, V34, P4055
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   THIELKING H, 1995, ANAL CHEM, V67, P3229, DOI 10.1021/ac00114a020
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Weitschies W., 1997, Pharmaceutical and Pharmacological Letters, V7, P5
   WILLIAMS SKR, 1990, J MAGN MAGN MATER, V194, P248
   WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S
NR 18
TC 21
Z9 21
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD JUN
PY 2000
VL 214
IS 3
BP 269
EP 275
DI 10.1016/S0304-8853(00)00198-0
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 317ZW
UT WOS:000087259500015
DA 2018-10-19
ER

PT J
AU Yoneyama, T
   Doi, H
   Kobayashi, E
   Hamanaka, H
   Tanabe, Y
   Bonfield, W
AF Yoneyama, T
   Doi, H
   Kobayashi, E
   Hamanaka, H
   Tanabe, Y
   Bonfield, W
TI Stress transmission through Ti-Ni alloy, titanium and stainless steel in
   impact compression test
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SHAPE-MEMORY
AB Impact stress transmission of Ti-Ni alloy was evaluated for biomedical stress shielding. Transformation temperatures of the alloy were investigated by means of DSC. An impact compression test was carried out with use of split-Hopkinson pressure-bar technique with cylindrical specimens of Ti-Ni alloy, titanium and stainless steel. As a result, the transmitted pulse through Ti-Ni alloy was considerably depressed as compared with those through titanium and stainless steel. The initial stress reduction was large through Ti-Ni alloy and titanium, but the stress reduction through Ti-Ni alloy was more continuous than titanium. The maximum value in the stress difference between incident and transmitted pulses through Ti-Ni alloy or titanium was higher than that through stainless steel, while the stress reduction in the maximum stress through Ti-Ni alloy was statistically larger than that through titanium or stainless steel. Ti-Ni alloy transmitted less impact stress than titanium or stainless steel, which suggested that the loading stress to adjacent tissues could be decreased with use of Ti-Ni alloy as a component material in an implant system. (C) 2000 Kluwer Academic Publishers.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Div Biomat,Chiyoda Ku, Tokyo 1010062, Japan.
   Niigata Univ, Dept Mech Engn, Niigata 9502181, Japan.
   Queen Mary Univ London, IRC Biomed Mat, London E1 4NS, England.
RP Yoneyama, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Met, Div Biomat,Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM yoneyama@i-mde.tmd.ac.jp
CR CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   DOTTER CT, 1983, RADIOLOGY, V147, P259, DOI 10.1148/radiology.147.1.6828741
   HAMANAKA H, 1989, J DENT RES, V68, P1529, DOI 10.1177/00220345890680111201
   HUANG Y, 1985, SCRIPTA METALL MATER, V19, P1033, DOI 10.1016/0036-9748(85)90004-3
   JAMES DW, 1969, MATER SCI ENG, V4, P1, DOI 10.1016/0025-5416(69)90033-0
   LIN HC, 1993, METALL TRANS A, V24, P2189, DOI 10.1007/BF02648593
   LING HC, 1980, METALL TRANS A, V11, P77, DOI 10.1007/BF02700440
   MIURA F, 1986, AM J ORTHOD DENTOFAC, V90, P1, DOI 10.1016/0889-5406(86)90021-1
   MIURA H, 1996, J JPN DENT MAT, V15, P559
   OONISHI H, 1982, T 8 ANN M SOC BIOM O, pP8
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   SUZUKI K, 1984, NIPPON DENT REV, V506, P14
   Takahashi J, 1985, Dent Mater J, V4, P146
   TANABE YJ, 1994, J MATER SCI-MATER M, V5, P397, DOI 10.1007/BF00058972
   WALIA H, 1988, J ENDODONT, V14, P346, DOI 10.1016/S0099-2399(88)80196-1
   YONEYAMA T, 1994, BIOMATERIALS, V15, P71, DOI 10.1016/0142-9612(94)90201-1
   YONEYAMA T, 1988, J JPN DENT MAT, V7, P262
NR 18
TC 5
Z9 6
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2000
VL 11
IS 6
BP 333
EP 336
DI 10.1023/A:1008991405784
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 319XW
UT WOS:000087371700001
PM 15348013
DA 2018-10-19
ER

PT J
AU Barns, I
   Schibeci, R
   Davison, A
   Shaw, R
AF Barns, I
   Schibeci, R
   Davison, A
   Shaw, R
TI "What do you think about genetic medicine?" - Facilitating sociable
   public discourse on developments in the new genetics
SO SCIENCE TECHNOLOGY & HUMAN VALUES
LA English
DT Article
ID BIOTECHNOLOGY; TECHNOLOGY; DEBATE
AB An important aspect of any meaningful public discussion about developments in gene technology is the provision of opportunities for interested publics to engage in sociable public discourse with other lay people and with experts. This article reports on a series of peer group conversations conducted in late 1996 and early 1997 with sixteen community groups in Perth, Western Australia, interested in gene therapy technology. With the case of cystic fibrosis as a particular focus, and using background resource material as a stimulus for discussion, the participating groups explored a range of value issues arising from the new genetic medicine. This more discursive context enabled participants to express a number of background or life-world concerns about genetic medicine, concerns that are often obscured by the dominant biomedical and bioethical discourses.
C1 Murdoch Univ, Sch Educ, Perth, WA, Australia.
   Murdoch Univ, Inst Sustainabil & Technol Policy, Perth, WA, Australia.
RP Barns, I (reprint author), Murdoch Univ, Sch Educ, Perth, WA, Australia.
RI Davison, Aidan/N-3863-2013
OI Davison, Aidan/0000-0002-5618-7068
CR Borgmann A., 1984, TECHNOLOGY CHARACTER
   Boyte H. C., 1996, BUILDING AM DEMOCRAT
   COX E, 1995, TRULY CIVIL SOC 1995
   DRAPER E, 1991, RISKY BUSINESS EXLUS
   Emanuel E., 1991, ENDS HUMAN LIFE MED
   Frank Arthur W, 1995, WOUNDED STORYTELLER
   FRIEDMANN T, 1997, SCI AM, V276, P80
   FRIEDMANN T, 1994, GENE THERAPY FACT FI
   Gamson W. A, 1992, TALKING POLITICS
   GOLDBLATT J, 1996, GENETICS RESOURCE BO
   GOLDMAN AE, 1987, GROUP DEPTH INTERVIE
   HARRIS J, 1995, PUBLIC UNDERST SCI, V4, P232
   Hauerwas S., 1990, NAMING SILENCES GOD
   Hepburn ER, 1996, J MED ETHICS, V22, P105, DOI 10.1136/jme.22.2.105
   *INT ASS CYST FIBR, 1997, 47 INT ASS CYST FIBR
   JENNINGS B, 1987, HASTINGS CTR REP JAN, P1
   JOSS S, 1995, PUBLIC PARTICIPATION
   Kerr A, 1998, PUBLIC UNDERST SCI, V7, P41, DOI 10.1088/0963-6625/7/1/004
   KOMERSAROFF P, TROUBLED BODIES CRIT
   LEEDER S, 1996, CURRENT AFFAIRS  JUN, P18
   MACER D, 1990, BIOETHICS PEOPLE PEO
   MACER DRJ, 1995, HUM GENE THER, V6, P791, DOI 10.1089/hum.1995.6.6-791
   MATTHEWS T, 1988, AUST J PUBL ADMIN, V47, P147, DOI 10.1111/j.1467-8500.1988.tb01053.x
   MESSER M, 1996, P LECT SER COMM NEW
   Michael M, 1997, PUBLIC UNDERST SCI, V6, P1, DOI 10.1088/0963-6625/6/1/001
   MORGAN DL, 1988, FOCUS GROUPS QUALITY
   *NAT HLTH MED RES, 1994, HUM GEN THER REL PRO
   Orkin S. H., 1995, REPORT RECOMMENDATIO
   PRIEST SH, 1995, J COMMUN, V45, P39, DOI 10.1111/j.1460-2466.1995.tb00713.x
   PRIEST SH, 1994, SCI COMMUN, V16, P166, DOI 10.1177/0164025994016002004
   *PRIV COMM, 1996, 5 AUSTR GOV PUBL SER
   Putnam R., 1993, MAKING DEMOCRACY WOR
   Redding P., 1995, TROUBLED BODIES CRIT, P87
   RIHCARDS M, 1996, TROUBLED HELIX SOCIA, P3
   Schibeci R, 1997, PUBLIC UNDERST SCI, V6, P167, DOI 10.1088/0963-6625/6/2/004
   Schibeci R, 1998, SCI COMMUN, V20, P204, DOI 10.1177/1075547098020002003
   SHAKESPEARE T, 1995, CRIT SOC POLICY, V44, P22, DOI DOI 10.1177/026101839501504402
   Stewart D. W., 1990, FOCUS GROUPS THEORY
   VINES G, 1995, NEW SCI, P14
   WALTERS L, 1997, ETHICS GENE THERAPY
   Walzer M, 1991, DISSENT          SPR, P293
   Weston Anthony, 1991, J Soc Philos, V22, P109, DOI 10.1111/j.1467-9833.1991.tb00042.x
   Wingerson L., 1990, MAPPING OUR GENES GE
   WINNER L, 1992, INQUIRY, V35, P341, DOI 10.1080/00201749208602298
   Winner L, 1986, WHALE REACTOR SEARCH, P3
   Wynne Brian, 1998, RISK ENV MODERNITY N, P44, DOI DOI 10.4135/9781446221983.N3
   YESLEY M, 1992, BIBLIO ETHICAL LEGAL
NR 47
TC 28
Z9 28
U1 1
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0162-2439
J9 SCI TECHNOL HUM VAL
JI Sci. Technol. Hum. Values
PD SUM
PY 2000
VL 25
IS 3
BP 283
EP 308
DI 10.1177/016224390002500302
PG 26
WC Social Issues
SC Social Issues
GA 330HH
UT WOS:000087956400002
PM 15362239
DA 2018-10-19
ER

PT J
AU Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
AF Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
TI Increase of surface hardness induced by O, Ca or P ion implantation into
   titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Surface Modification of Metals by Ion
   Beams (SMMIB-99)
CY SEP 19-24, 1999
CL BEIJING, PEOPLES R CHINA
SP Beijing Normal Univ, Tsinghua Univ, Chinese Acad Sci, Shanghai Inst Met, Chinese Mat Res Soc
DE ion implantation; titanium; hardness
ID NITROGEN
AB Titanium or titanium alloys are very attractive materials for use as biomedical materials. Non-toxic elements of oxygen, calcium and phosphorus were implanted into titanium and the changes of surface hardness were measured using an ultra microindenter (UMIS-2000) with the multiple load-unload procedure. Depth profiles of implanted ions were obtained by SIMS measurement. O implantation resulted in the greatest improvement in hardness, up to 2.2 times higher than the unimplanted titanium at the peak. Ca implantation did not improve the hardness as much. The cause may be the formation of a glass-like layer of CaTiO3 and TiO2 on the surface. For P implantation, the depth of maximum hardness increased with increasing implantation energy. The depth of the peak hardness was approximately one-third to one-eighth of the projected range of the implanted ions. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Natl Ind Res Inst Nagoya, Kita Ku, Nagoya, Aichi 4628510, Japan.
   CSIRO, Div Telecommun & Ind Phys, Lindfield, NSW 2070, Australia.
RP Ikeyama, M (reprint author), Natl Ind Res Inst Nagoya, Kita Ku, Hirate Cho 1-1, Nagoya, Aichi 4628510, Japan.
CR Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   Bell TJ, 1998, MATER RES SOC SYMP P, V522, P15, DOI 10.1557/PROC-522-15
   FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297
   GARIA A, 1997, SURF COAT TECH, V97, P499
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   Krupa D, 1997, SURF COAT TECH, V96, P223, DOI 10.1016/S0257-8972(97)00107-2
   Sarkissian AH, 1998, SURF COAT TECH, V98, P1336, DOI 10.1016/S0257-8972(97)00399-X
   Seidel F, 1998, SURF COAT TECH, V98, P1174, DOI 10.1016/S0257-8972(97)00148-5
   ZIEGLER JF, 1985, STOPPING RANGE ION S
NR 9
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN-JUL
PY 2000
VL 128
BP 400
EP 403
DI 10.1016/S0257-8972(00)00617-4
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 329FY
UT WOS:000087897500073
DA 2018-10-19
ER

PT J
AU Grimes, RN
AF Grimes, RN
TI Metallacarboranes in the new millennium
SO COORDINATION CHEMISTRY REVIEWS
LA English
DT Review
DE metallacarboranes; carborane ligands; milennium
ID NEUTRON-CAPTURE THERAPY; ORGANOTRANSITION-METAL METALLACARBORANES;
   ALKYNE INSERTION REACTIONS; VENUS FLYTRAP CLUSTER; SOLID-STATE
   SYNTHESIS; L = CO; MOLECULAR-STRUCTURE; COBALT DICARBOLLIDE; SANDWICH
   COMPOUNDS; METALLOSUPRAMOLECULAR CHEMISTRY
AB The field of metallacarborane chemistry has grown in many different directions and now interfaces with several other disciplines including metal cluster and organometallic chemistry, transition-metal catalysis, materials science, environmental science, and biomedical applications. In this turn-of-the-century overview, some of the more significant recent developments and trends in this area are selectively examined and an attempt is made to project some useful directions in which this chemistry might develop over the next decade or two. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA.
RP Grimes, RN (reprint author), Univ Virginia, Dept Chem, Mccormick Rd, Charlottesville, VA 22901 USA.
CR ALLCOCK HR, 1992, SCIENCE, V255, P1106, DOI 10.1126/science.255.5048.1106
   AMATO I, 1993, SCIENCE, V260, P753, DOI 10.1126/science.260.5109.753
   Armspach D, 1998, J ORGANOMET CHEM, V550, P193, DOI 10.1016/S0022-328X(97)00238-6
   BAKER RT, 1978, J AM CHEM SOC, V100, P8266, DOI 10.1021/ja00494a041
   BARNUM BA, 1995, ORGANOMETALLICS, V14, P4463, DOI 10.1021/om00010a008
   Base K, 1999, INORG CHEM, V38, P287, DOI 10.1021/ic980872q
   BEER DC, 1973, J AM CHEM SOC, V95, P3046, DOI 10.1021/ja00790a070
   BEHNKEN PE, 1983, ANGEW CHEM INT EDIT, V22, P722, DOI 10.1002/anie.198307221
   Bei XH, 1998, ORGANOMETALLICS, V17, P1085, DOI 10.1021/om970962n
   BICERANO J, 1978, INORG CHEM, V17, P3443, DOI 10.1021/ic50190a028
   BICERANO J, 1978, INORG CHEM, V17, P2041, DOI 10.1021/ic50185a079
   Boring E, 1997, ORGANOMETALLICS, V16, P3993, DOI 10.1021/om9703447
   Boring E, 1998, ORGANOMETALLICS, V17, P3865, DOI 10.1021/om980242w
   Bould J, 1998, INORG CHEM COMMUN, V1, P365, DOI 10.1016/S1387-7003(98)00091-4
   Boyd ASF, 1998, POLYHEDRON, V17, P2627, DOI 10.1016/S0277-5387(98)00011-4
   BROWN LD, 1977, INORG CHEM, V16, P2989, DOI 10.1021/ic50178a001
   CARR N, 1990, J CHEM SOC DALTON, P2253, DOI 10.1039/dt9900002253
   CHEETHAM AK, 1994, SCIENCE, V264, P794, DOI 10.1126/science.264.5160.794
   CHIN TM, UNPUB
   Chin TT, 1999, INORG CHEM, V38, P93, DOI 10.1021/ic980382y
   Chizhevsky IT, 1999, ORGANOMETALLICS, V18, P726, DOI 10.1021/om9806592
   Chizhevsky IT, 1997, J ORGANOMET CHEM, V536, P223, DOI 10.1016/S0022-328X(96)06724-1
   CONSTABLE EC, 1994, CHEM IND-LONDON, P56
   COTTON FA, 1999, ADV INORG CHEM, P659
   Cuadrado I, 1997, J AM CHEM SOC, V119, P7613, DOI 10.1021/ja971496w
   Cuadrado I, 1996, ORGANOMETALLICS, V15, P5278, DOI 10.1021/om9605948
   Curtis MA, 1998, J ORGANOMET CHEM, V550, P469, DOI 10.1016/S0022-328X(97)00555-X
   Curtis MA, 1996, INORG CHEM, V35, P6703, DOI 10.1021/ic960691t
   Curtis MA, 1998, INORG CHEM, V37, P102, DOI 10.1021/ic971297d
   CURTIS MA, UNPUB
   CURTIS MA, 1996, BUSA MEX C BOR CHEM
   DOXSEE KM, 1993, ORGANOMETALLICS, V12, P4682, DOI 10.1021/om00035a066
   DUBAY WJ, 1994, J ORG CHEM, V59, P6898, DOI 10.1021/jo00102a009
   Dunn S, 1997, ANGEW CHEM INT EDIT, V36, P645, DOI 10.1002/anie.199706451
   Evans W. J., 1974, J CHEM SOC CHEM COMM, P38
   Fino SA, 1997, INORG CHEM, V36, P4604, DOI 10.1021/ic961182u
   Galsworthy JR, 1997, J ORGANOMET CHEM, V531, P165, DOI 10.1016/S0022-328X(96)06706-X
   Garrioch RM, 1999, J ORGANOMET CHEM, V575, P57, DOI 10.1016/S0022-328X(98)00957-7
   Goeta AE, 1998, CHEM COMMUN, P1713, DOI 10.1039/a804305a
   GREEN M, 1987, J CHEM SOC DALTON, P61, DOI 10.1039/dt9870000061
   Greenwood N.N., 1973, CHEM BORON
   Grimes RN, 1999, J ORGANOMET CHEM, V581, P1, DOI 10.1016/S0022-328X(99)00050-9
   GRIMES RN, 1995, COORDIN CHEM REV, V143, P71, DOI 10.1016/0010-8545(94)07006-6
   Grimes RN, 1996, APPL ORGANOMET CHEM, V10, P209, DOI 10.1002/(SICI)1099-0739(199604)10:3/4<209::AID-AOC469>3.0.CO;2-Q
   GRIMES RN, 1983, ADV INORG CHEM RAD, V26, P55, DOI 10.1016/S0898-8838(08)60091-4
   GRIMES RN, 1992, CHEM REV, V92, P251, DOI 10.1021/cr00010a004
   GRIMES RN, 1982, COMPREHENSIVE ORGANO
   GRIMES RN, 1995, COMPREHENSIVE ORGA 2, V1, P373
   GRIMES RN, 1999, P IMEBORON 10 INT M
   Hagenau U, 1996, INORG CHEM, V35, P7863, DOI 10.1021/ic960443x
   Hall IH, 2000, APPL ORGANOMET CHEM, V14, P108, DOI 10.1002/(SICI)1099-0739(200002)14:2<108::AID-AOC963>3.0.CO;2-4
   HALL IH, UNPUB
   HART DW, 1975, J AM CHEM SOC, V97, P679, DOI 10.1021/ja00836a056
   HARWELL DE, 1995, CAN J CHEM, V73, P1044, DOI 10.1139/v95-129
   HAWTHORNE MF, 1965, J AM CHEM SOC, V87, P1818, DOI 10.1021/ja01086a053
   HAWTHORNE MF, 1968, J AM CHEM SOC, V90, P896, DOI 10.1021/ja01006a009
   Hawthorne MF, 1998, MOL MED TODAY, V4, P174, DOI 10.1016/S1357-4310(98)01226-X
   HAWTHORNE MF, 1990, J AM CHEM SOC, V112, P5365, DOI 10.1021/ja00169a062
   HAWTHORNE MF, 1988, ADV BORON BORANES, P225
   Herberich GE, 1996, ORGANOMETALLICS, V15, P5236, DOI 10.1021/om960536m
   HERBERICH GE, 1981, ANGEW CHEM INT EDIT, V20, P472, DOI 10.1002/anie.198104721
   HERBERICH GE, 1995, COMPREHENSIVE ORGANO, V2, pCH1
   HLATKY GG, 1989, J AM CHEM SOC, V111, P2728, DOI 10.1021/ja00189a064
   HONG E, 1999, 10 INT C BOR CHEM IM
   Hosmane N.S., 1997, ADV BORON CHEM, P349
   Hosmane NS, 1999, J ORGANOMET CHEM, V581, P13, DOI 10.1016/S0022-328X(99)00089-3
   Hosmane NS, 1996, ORGANOMETALLICS, V15, P626, DOI 10.1021/om950691l
   HOSMANE NS, 1993, J CLUST SCI, V4, P297
   HOUSEKNECHT KL, 1995, J AM CHEM SOC, V117, P1163, DOI 10.1021/ja00108a047
   HOWARD JW, 1972, INORG CHEM, V11, P263, DOI 10.1021/ic50108a013
   Hughes DL, 1996, ORGANOMETALLICS, V15, P663, DOI 10.1021/om9507843
   HURLBURT PK, 1995, INORG CHEM, V34, P5215, DOI 10.1021/ic00125a021
   JEFFERY JC, 1993, J CHEM SOC DALTON, P1083, DOI 10.1039/dt9930001083
   Jeffery JC, 1996, ORGANOMETALLICS, V15, P4737, DOI 10.1021/om9604435
   JELLISS PA, 1995, J ORGANOMET CHEM, V500, P307, DOI 10.1016/0022-328X(95)00502-H
   Kabalka GW, 1998, EXPERT OPIN THER PAT, V8, P545, DOI 10.1517/13543776.8.5.545
   KABALKA GW, 1994, CURRENT TOPICS CHEM
   Kawamura K, 1998, INORG CHEM, V37, P608, DOI 10.1021/ic9712784
   Kim JH, 1997, CHEM COMMUN, P1761, DOI 10.1039/a704161f
   Kim JH, 1996, INORG CHEM, V35, P5112, DOI 10.1021/ic960223j
   KOPFMAIER P, 1984, ANGEW CHEM INT EDIT, V23, P456, DOI 10.1002/anie.198404561
   KOPFMAIER P, 1984, J CANCER RES CLIN, V108, P336, DOI 10.1007/BF00390468
   Lebedev VN, 1997, J ORGANOMET CHEM, V536, P537, DOI 10.1016/S0022-328X(96)06600-4
   Lebedev VN, 1997, RUSS CHEM B+, V46, P550, DOI 10.1007/BF02495414
   LIAO YH, 1995, ORGANOMETALLICS, V14, P2130, DOI 10.1021/om00005a002
   Liu GX, 1996, ORGANOMETALLICS, V15, P5257, DOI 10.1021/om960716w
   LYNCH TJ, 1989, ORGANOMETALLICS, V8, P1959, DOI 10.1021/om00110a018
   Mashima K, 1997, ORGANOMETALLICS, V16, P1345, DOI 10.1021/om9610051
   MAXWELL WM, 1977, J AM CHEM SOC, V99, P4008, DOI 10.1021/ja00454a020
   McKinney JD, 1997, J ORGANOMET CHEM, V547, P253, DOI 10.1016/S0022-328X(97)00386-0
   MENG XS, 1993, J AM CHEM SOC, V115, P6143, DOI 10.1021/ja00067a033
   MERKERT JW, 1991, ORGANOMETALLICS, V10, P3545, DOI 10.1021/om00056a026
   MILLER VR, 1977, J AM CHEM SOC, V99, P5646, DOI 10.1021/ja00459a020
   MINGOS DMP, 1990, INTRO CLUSTER CHEM
   MIRABELLI MGL, 1986, ORGANOMETALLICS, V5, P1510, DOI 10.1021/om00138a040
   Mortimer MD, 1996, INORG CHEM, V35, P5750, DOI 10.1021/ic960353s
   MOTOHASHI N, 1991, J ORGANOMET CHEM, V418, P107
   Nemoto H, 1999, J ORGANOMET CHEM, V581, P170, DOI 10.1016/S0022-328X(99)00049-2
   NEUSE EW, 1985, TRANSIT METAL CHEM, V10, P135, DOI 10.1007/BF00641583
   NEUSE EW, 1990, APPL ORGANOMET CHEM, V4, P19, DOI 10.1002/aoc.590040105
   NICOUD JF, 1994, SCIENCE, V263, P636, DOI 10.1126/science.263.5147.636
   OKI AR, 1992, ANGEW CHEM INT EDIT, V31, P432, DOI 10.1002/anie.199204321
   OKI AR, 1991, J AM CHEM SOC, V113, P8351
   Parker KG, 1999, COLLECT CZECH CHEM C, V64, P819, DOI 10.1135/cccc19990819
   PARKINSON B, 1995, SCIENCE, V270, P1157, DOI 10.1126/science.270.5239.1157
   PAXTON RJ, 1991, P NATL ACAD SCI USA, V88, P3387, DOI 10.1073/pnas.88.8.3387
   PETASIS NA, 1993, ORGANOMETALLICS, V12, P3776, DOI 10.1021/om00033a059
   PETASIS NA, 1993, J AM CHEM SOC, V115, P7208, DOI 10.1021/ja00069a018
   PIEPGRASS KW, 1993, INORG CHEM, V32, P2156, DOI 10.1021/ic00062a046
   PIPAL JR, 1993, ORGANOMETALLICS, P4452
   PIPAL JR, 1993, ORGANOMETALLICS, P4459
   Pisareva LV, 1998, INORG CHIM ACTA, V280, P233
   PLESEK J, 1978, COLLECT CZECH CHEM C, V43, P1325, DOI 10.1135/cccc19781325
   PLESEK J, 1992, CHEM REV, V92, P269, DOI 10.1021/cr00010a005
   PLESEK J, 1995, COLLECT CZECH CHEM C, V60, P1297, DOI 10.1135/cccc19951297
   Plesek J, 1998, ACTA CRYSTALLOGR C, V54, P36, DOI 10.1107/S0108270197012742
   PLUMB CA, 1992, ORGANOMETALLICS, V11, P1665, DOI 10.1021/om00040a042
   POOL R, 1992, SCIENCE, V255, P1077, DOI 10.1126/science.255.5048.1077
   Rabinovich D, 1996, INORG CHEM, V35, P1425, DOI 10.1021/ic951444c
   RAIS J, 1976, J INORG NUCL CHEM, V38, P1376, DOI 10.1016/0022-1902(76)80156-X
   Rosair GM, 1998, ORGANOMETALLICS, V17, P3227, DOI 10.1021/om980353v
   RUSSELL JA, UNPUB
   Schleyer PV, 1998, INORG CHEM, V37, P6765, DOI 10.1021/ic980359c
   SCRIBNER BA, UNPUB
   Service RF, 1996, SCIENCE, V271, P920, DOI 10.1126/science.271.5251.920
   SERVICE RF, 1994, SCIENCE, V265, P316, DOI 10.1126/science.8023152
   SIEBERT W, 1993, ADV ORGANOMET CHEM, V35, P187, DOI 10.1016/S0065-3055(08)60491-8
   SIEBERT W, 1988, PURE APPL CHEM, V60, P1345, DOI 10.1351/pac198860081345
   SIEBERT W, 1985, ANGEW CHEM INT EDIT, V24, P943, DOI 10.1002/anie.198509431
   SIEBERT W, 1994, CURRENT TOPICS CHEM, P275
   Siebert W., 1997, ADV BORON CHEM
   Soloway AH, 1999, J ORGANOMET CHEM, V581, P150, DOI 10.1016/S0022-328X(99)00085-6
   Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u
   STEIN A, 1993, SCIENCE, V259, P1558, DOI 10.1126/science.259.5101.1558
   Stibr B, 1995, COLLECT CZECH CHEM C, V60, P2023, DOI 10.1135/cccc19952023
   Valerio C, 1997, J AM CHEM SOC, V119, P2588, DOI 10.1021/ja964127t
   Vanura P, 1998, COLLECT CZECH CHEM C, V63, P338, DOI 10.1135/cccc19980338
   Vinas C, 1998, INORG CHEM, V37, P3640, DOI 10.1021/ic971467m
   Vinas C, 1999, J ORGANOMET CHEM, V581, P188, DOI 10.1016/S0022-328X(99)00057-1
   Vinas C., 1998, DALTON T, P2849
   WANG XT, 1994, J AM CHEM SOC, V116, P2687, DOI 10.1021/ja00085a086
   Wasczcak MD, 1997, ANGEW CHEM INT EDIT, V36, P2228, DOI 10.1002/anie.199722281
   Weller AS, 1999, ORGANOMETALLICS, V18, P853, DOI 10.1021/om980814c
   Wrackmeyer B, 1999, EUR J INORG CHEM, P533
   Yoshida M, 1997, ORGANOMETALLICS, V16, P4508, DOI 10.1021/om970752a
   Yoshida M, 1997, ORGANOMETALLICS, V16, P1349, DOI 10.1021/om970058v
   ZAKHARKIN LI, 1982, J ORGANOMET CHEM, V226, P217, DOI 10.1016/S0022-328X(00)83405-1
   Zakharkin LI, 1998, RUSS CHEM B+, V47, P1222, DOI 10.1007/BF02503502
   ZHANG HM, 1995, ACTA CRYSTALLOGR C, V51, P635, DOI 10.1107/S0108270194008164
   ZHIGAREVA GG, 1994, RUSS J GEN CHEM+, V64, P564
   1991, PURE APPL CHEM, V63
NR 151
TC 176
Z9 177
U1 2
U2 47
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0010-8545
J9 COORDIN CHEM REV
JI Coord. Chem. Rev.
PD MAY
PY 2000
VL 200
BP 773
EP 811
DI 10.1016/S0010-8545(00)00262-9
PG 39
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 345HC
UT WOS:000088809700024
DA 2018-10-19
ER

PT J
AU Haase, WC
   Seeberger, PH
AF Haase, WC
   Seeberger, PH
TI Recent progress in polymer-supported synthesis of oligosaccharides and
   carbohydrate libraries
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Review
ID SOLID-PHASE-SYNTHESIS; ORTHOGONAL GLYCOSYLATION STRATEGY;
   PHYTOALEXIN-ELICITOR ACTIVITY; BETA-LINKED OLIGOSACCHARIDES; GLYCAL
   ASSEMBLY METHOD; N-PENTENYL GLYCOSIDES; CONTROLLED-PORE GLASS;
   COMBINATORIAL CHEMISTRY; ORGANIC-SYNTHESIS; HIGH-RESOLUTION
AB Glycobiology is a rapidly evolving field and tackles many phenomena of biomedical importance. Driven by the need to create more efficient methods for the synthesis of complex oligosaccharides, the last few years have seen a major push toward a general approach amenable to solid-phase synthesis. Different strategies have been explored and a host of glycosylating agents have been investigated. New linker systems, different solid support materials and a variety of protective groups have been evaluated. The development of on-resin analytical techniques such as MAS-NMR have greatly facilitated the development of new methods for solid-phase oligosaccharide synthesis. These methodological advances have been demonstrated by preparation of several complex oligosaccharides. As the coupling yields have been improved to 95% and above, the desired products could be obtained in good yield even after seven glycosylations.
   In addition to single target structures, carbohydrates have generated rapidly increasing interest with respect to sets of diverse, carbohydrate containing molecules. These efforts are of increasing importance for providing molecular tools to elucidate biological processes.
   While much has been achieved to date, the difficulties encountered in the solid-phase assembly of oligosaccharides underscore the need for the developments of all facets of carbohydrate chemistry. Given the rapid progress in the past eight years, it is conceivable that the synthesis of 'simple' oligosaccharides may soon be automated. Careful investigations into many parameters will eventually allow the synthetic chemist to enable even non-specialists to create important tools for biochemical, biophysical, and medical applications.
C1 MIT, Dept Chem, Cambridge, MA 02139 USA.
RP Seeberger, PH (reprint author), MIT, Dept Chem, Cambridge, MA 02139 USA.
CR Adinolfi M, 1996, TETRAHEDRON LETT, V37, P5007, DOI 10.1016/0040-4039(96)01020-9
   Adinolfi M, 1998, TETRAHEDRON LETT, V39, P1953, DOI 10.1016/S0040-4039(98)00103-8
   Allen H.J., 1992, GLYCOCONJUGATES COMP
   ANDERSON RC, 1995, J ORG CHEM, V60, P2650, DOI 10.1021/jo00114a003
   Andrade RB, 1999, ORG LETT, V1, P1811, DOI 10.1021/ol991071+
   Arya P, 1997, ANGEW CHEM INT EDIT, V36, P1280, DOI 10.1002/anie.199712801
   Atherton E, 1989, SOLID PHASE PEPTIDE
   BAYER E, 1991, ANGEW CHEM INT EDIT, V30, P113, DOI 10.1002/anie.199101133
   BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146
   Brill WKD, 1998, SYNLETT, P1085
   CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253
   CHAN TH, 1985, J CHEM SOC CHEM COMM, P909, DOI 10.1039/c39850000909
   Czarnik A. W., 1997, PRACTICAL GUIDE COMB, P123
   DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573
   Danishefsky SJ, 1996, ANGEW CHEM INT EDIT, V35, P1380, DOI 10.1002/anie.199613801
   FITCH WL, 1994, J ORG CHEM, V59, P7955, DOI 10.1021/jo00105a006
   FRASERREID B, 1992, SYNLETT, P927
   Frechet J. M., 1980, POLYM SUPPORTED REAC, P407
   FRECHET JM, 1972, J AM CHEM SOC, V94, P604, DOI 10.1021/ja00757a047
   FRECHET JM, 1971, J AM CHEM SOC, V93, P492
   Fukase K, 1997, MOL DIVERS, V2, P182, DOI 10.1007/BF01715633
   Fukase K, 1999, SYNLETT, P1074
   Garegg PJ, 1997, ADV CARBOHYD CHEM BI, V52, P179, DOI 10.1016/S0065-2318(08)60091-8
   GIRALT E, 1984, TETRAHEDRON, V40, P4141, DOI 10.1016/0040-4020(84)85095-4
   GRIFFITH DA, 1990, J AM CHEM SOC, V112, P5811, DOI 10.1021/ja00171a021
   GUTHRIE RD, 1971, J CHEM SOC C, P2690, DOI 10.1039/j39710002690
   GUTRIE RD, 1973, J CHEM SOC P1, P2414
   HALCOMB RL, 1989, J AM CHEM SOC, V111, P6661, DOI 10.1021/ja00199a028
   HAMADA T, 1986, J AM CHEM SOC, V108, P140, DOI 10.1021/ja00261a023
   Heckel A, 1998, SYNLETT, P171
   HINDSGAUL O, 1998, GLYCOIMMUNOLOGY, V2, P219
   HIRABAYASHI Y, 1990, J BIOL CHEM, V265, P8144
   Hummel G, 1999, ANGEW CHEM INT EDIT, V38, P1782, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1782::AID-ANIE1782>3.0.CO;2-1
   Hunt JA, 1996, J AM CHEM SOC, V118, P9998, DOI 10.1021/ja962128f
   Ito Y, 1998, CURR OPIN CHEM BIOL, V2, P701, DOI 10.1016/S1367-5931(98)80106-3
   Ito Y, 1996, ANGEW CHEM INT EDIT, V35, P2510, DOI 10.1002/anie.199625101
   Ito Y, 1997, J AM CHEM SOC, V119, P5562, DOI 10.1021/ja964093p
   JENNIFER R, 1999, J AM CHEM SOC, V121, P10875
   Jensen KJ, 1998, J AM CHEM SOC, V120, P5441, DOI 10.1021/ja974116f
   Kahne D, 1997, CURR OPIN CHEM BIOL, V1, P130, DOI 10.1016/S1367-5931(97)80119-6
   KAHNE D, 1989, J AM CHEM SOC, V111, P6881, DOI 10.1021/ja00199a081
   Kallus C, 1999, TETRAHEDRON LETT, V40, P7783, DOI 10.1016/S0040-4039(99)01690-1
   KANEMITSU T, 1998, ANGEW CHEM INT EDIT, V37, P3418
   KANIE O, 1994, J AM CHEM SOC, V116, P12073, DOI 10.1021/ja00105a066
   Keifer PA, 1996, J MAGN RESON SER A, V119, P65, DOI 10.1006/jmra.1996.0052
   Khan S. H., 1996, MODERN METHODS CARBO
   Knerr L, 1999, SYNLETT, P1802
   KOBATA A, 1993, ACCOUNTS CHEM RES, V26, P319, DOI 10.1021/ar00030a004
   LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808
   LEE YC, 1994, NEOGLYCOCONJUGATES P
   Lerchen HG, 1999, ANGEW CHEM INT EDIT, V38, P3680, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3680::AID-ANIE3680>3.0.CO;2-9
   LEVY DE, 1994, ANNU REP MED CHEM, V29, P215
   Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520
   Lloyd K. O., 1991, CANCER BIOL, V2, P421
   MELEAN LG, UNPUB
   MERRIFIELD RB, 1985, ANGEW CHEM INT EDIT, V24, P799, DOI 10.1002/anie.198507993
   Merritt JR, 1996, J CARBOHYD CHEM, V15, P65, DOI 10.1080/07328309608005425
   MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0
   MROSS E, 1999, POSTER EUROCARB, V10
   MURRAY RW, 1985, J ORG CHEM, V50, P2847, DOI 10.1021/jo00216a007
   NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891
   NICOLAOU KC, 1992, J AM CHEM SOC, V114, P3126, DOI 10.1021/ja00034a063
   Nicolaou KC, 1997, J AM CHEM SOC, V119, P449, DOI 10.1021/ja963482g
   Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P1559, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1559::AID-ANIE1559>3.0.CO;2-E
   Nukada T, 1999, J ORG CHEM, V64, P9030, DOI 10.1021/jo990712b
   Nunns CL, 1999, TETRAHEDRON LETT, V40, P9341, DOI 10.1016/S0040-4039(99)01978-4
   OHLMEYER MHJ, 1993, P NATL ACAD SCI USA, V90, P10922, DOI 10.1073/pnas.90.23.10922
   OPDENAKKER G, 1993, FASEB J, V7, P1330
   Osborn HMI, 1999, TETRAHEDRON, V55, P1807, DOI 10.1016/S0040-4020(98)01200-9
   OSSOWSKI P, 1983, ANGEW CHEM INT EDIT, V22, P793, DOI 10.1002/anie.198307931
   PETRAKOVA E, 1992, CAN J CHEM, V70, P233, DOI 10.1139/v92-034
   PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274
   Plante OJ, 1999, ORG LETT, V1, P211, DOI 10.1021/ol9905452
   POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224
   PPLANTE OJ, UNPUB
   Race RR, 1975, BLOOD GROUPS MAN
   Rademann J, 1996, TETRAHEDRON LETT, V37, P3989, DOI 10.1016/0040-4039(96)00763-0
   Rademann J, 1998, ANGEW CHEM INT EDIT, V37, P1241, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1241::AID-ANIE1241>3.0.CO;2-6
   Rademann J, 1999, J AM CHEM SOC, V121, P5459, DOI 10.1021/ja984355i
   Rademann J, 1997, J ORG CHEM, V62, P3650, DOI 10.1021/jo970087f
   RANDOLPH JT, 1994, ANGEW CHEM INT EDIT, V33, P1470, DOI 10.1002/anie.199414701
   RANDOLPH JT, 1995, J AM CHEM SOC, V117, P5712, DOI 10.1021/ja00126a012
   ROBERGE JY, 1995, SCIENCE, V269, P202, DOI 10.1126/science.7618080
   Rodebaugh R, 1999, J ORG CHEM, V64, P1758, DOI 10.1021/jo9718509
   Rodebaugh R, 1997, J ORG CHEM, V62, P5660, DOI 10.1021/jo970216s
   Sarkar SK, 1996, J AM CHEM SOC, V118, P2305, DOI 10.1021/ja952434d
   SCHMIDT RR, 1994, ADV CARBOHYD CHEM BI, V50, P21, DOI 10.1016/S0065-2318(08)60150-X
   SCHULZE IT, 1992, GLYCOCONJUGATE J, V9, P63, DOI 10.1007/BF00731698
   Schweizer F, 1999, CURR OPIN CHEM BIOL, V3, P291, DOI 10.1016/S1367-5931(99)80045-3
   Seeberger PH, 1997, ANGEW CHEM INT EDIT, V36, P491, DOI 10.1002/anie.199704911
   Seeberger PH, 1997, J AM CHEM SOC, V119, P10064, DOI 10.1021/ja971640d
   Seeberger PH, 1997, ALDRICHIM ACTA, V30, P75
   Seeberger PH, 1998, ACCOUNTS CHEM RES, V31, P685, DOI 10.1021/ar9600648
   SHARON N, 1986, LECTINS, P494
   Shimizu H, 1996, BIOORG MED CHEM LETT, V6, P2841, DOI 10.1016/S0960-894X(96)00535-5
   SHOOLERY JN, 1977, PROG NUCL MAG RES SP, V11, P79, DOI 10.1016/0079-6565(77)80003-4
   Sofia MJ, 1999, J MED CHEM, V42, P3193, DOI 10.1021/jm990212a
   Sofia MJ, 1998, MOL DIVERS, V3, P75, DOI 10.1023/A:1009650424835
   Sofia MJ, 1998, COMBINATORIAL CHEMISTRY AND MOLECULAR DIVERSITY IN DRUG DISCOVERY, P243
   SPOHR U, 1988, CARBOHYD RES, V174, P211, DOI 10.1016/0008-6215(88)85093-6
   Tolborg JF, 2000, CHEM COMMUN, P147, DOI 10.1039/a908446k
   TOSHIMA K, 1993, CHEM REV, V93, P1503, DOI 10.1021/cr00020a006
   UGI I, 1982, ANGEW CHEM INT EDIT, V21, P810, DOI 10.1002/anie.198208101
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Veeneman GH, 1998, CARBOHYDRATE CHEMISTRY, P98
   VERDUYN R, 1993, RECL TRAV CHIM PAY B, V112, P464
   Wong CH, 1998, J AM CHEM SOC, V120, P7137, DOI 10.1021/ja9813616
   Wunberg T, 1998, ANGEW CHEM INT EDIT, V37, P2503, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2503::AID-ANIE2503>3.0.CO;2-R
   YAKI T, 1986, J BIOL CHEM, V261, P3075
   YAN L, 1994, J AM CHEM SOC, V116, P6953, DOI 10.1021/ja00094a067
   ZEMLYANUKHINA TV, 1990, BIOORG KHIM+, V16, P1096
   ZHENG C, 1998, ANGEW CHEM INT EDIT, V37, P789
   Zheng CS, 1998, J ORG CHEM, V63, P1126, DOI 10.1021/jo971606h
   Zhu T, 1998, ANGEW CHEM INT EDIT, V37, P1898, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1898::AID-ANIE1898>3.0.CO;2-T
NR 114
TC 40
Z9 40
U1 1
U2 20
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 1385-2728
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PD MAY
PY 2000
VL 4
IS 5
BP 481
EP 511
DI 10.2174/1385272003376193
PG 31
WC Chemistry, Organic
SC Chemistry
GA 310NH
UT WOS:000086833900003
DA 2018-10-19
ER

PT J
AU Tsap, LV
   Goldgof, DB
   Sarkar, S
AF Tsap, LV
   Goldgof, DB
   Sarkar, S
TI Nonrigid motion analysis based on dynamic refinement of finite element
   models
SO IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE
LA English
DT Article
DE physically-based vision; deformable models; nonrigid motion analysis;
   biomedical applications; finite element analysis
ID INTERFACE; IMAGES
AB In this paper, we propose new algorithms for accurate nonrigid motion tracking. Given an initial model representing general knowledge of the object, a set of sparse correspondences, and incomplete or missing information about geometry or material properties, we can recover dense motion vectors using finite element models. The method is based on the iterative analysis of the differences between the actual and predicted behavior. Large differences indicate that an object's properties are not captured properly by the model describing it. Feedback from the images during the motion allows the refinement of the model by minimizing the error between the expected and true position of the object's points. These errors are due to flaws in the model parameter estimation such as geometry and material properties. Unknown parameters are recovered using an iterative descent search for the best nonlinear finite element model that approximates nonrigid motion of the given object. During this search process, we not only estimate material properties. but also infer dense point correspondences from our initial set of sparse correspondences. Thus, during tracking, the model is refined which, in turn, improves tracking quality. As a result, we obtain a more precise description of nonrigid motion. Experimental results demonstrate the success of the proposed algorithm. The method was applied to man-made elastic materials and human skin to recover unknown elasticity. to complex 3D objects to find details of their geometry, and to a hand motion analysis application. Our work demonstrates the possibility of accurate quantitative analysis of nonrigid motion in range image sequences with objects consisting of multiple materials and 3D volumes.
C1 Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94551 USA.
   Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA.
RP Tsap, LV (reprint author), Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94551 USA.
EM tsap1@llnl.gov; goldgof@bigpine.csee.usf.edu;
   sarkar@bigpine.csee.usf.edu
RI Sarkar, Sudeep/A-8213-2009
OI Sarkar, Sudeep/0000-0001-7332-4207
CR Aggarwal JK, 1997, IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS, P90, DOI 10.1109/NAMW.1997.609859
   Alexander R.M., 1992, HUMAN MACHINE
   Basu S, 1997, IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS, P46, DOI 10.1109/NAMW.1997.609851
   BRAUER JR, 1993, WHAT EVERY ENG SHOUL
   BRIDGEMAN GB, 1979, BRIDGEMANS COMPLETE
   Burnett D., 1988, FINITE ELEMENT ANAL
   Davis MH, 1997, IEEE T MED IMAGING, V16, P317, DOI 10.1109/42.585766
   DECARLO D, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P834, DOI 10.1109/ICCV.1995.466851
   Delingette H., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P152, DOI 10.1109/MNRAO.1994.346242
   Fung YC, 1993, BIOMECHANICS MECH PR
   HUANG WC, 1993, P AS C COMP VIS OS J, P256
   HUGHES T, 1984, THEORETICAL FDN LARG
   Kita Y, 1996, IEEE T PATTERN ANAL, V18, P1150, DOI 10.1109/34.546253
   KUCH JJ, 1995, VISION BASED HAND MO, P666
   LARRABEE WF, 1986, LARYNGOSCOPE, V96, P399
   MAENO T, 1996, P 10 C EUR C BIOM, P3122
   Metaxas D., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P337, DOI 10.1109/CVPR.1991.139712
   METAXAS D, 1993, SPIE, V2031, P160
   Nastar C, 1996, IEEE T PATTERN ANAL, V18, P1067, DOI 10.1109/34.544076
   Neuenschwander W., 1995, Proceedings. Fifth International Conference on Computer Vision (Cat. No.95CB35744), P828, DOI 10.1109/ICCV.1995.466852
   OOMENS CWJ, 1985, THESIS TH TWENTE NET
   PRESS WH, 1988, NUMERICAL RECIPES C
   REHG JM, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P612, DOI 10.1109/ICCV.1995.466882
   REHG JM, 1994, P EUR C COMP VIS, V2, P35
   Sclaroff S., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P158, DOI 10.1109/MNRAO.1994.346241
   SilverThorn MB, 1996, J REHABIL RES DEV, V33, P253
   *SWANS AN SYST INC, 1996, ANSYS US MAN REV 5 3
   TERZOPOULOS D, 1993, IEEE T PATTERN ANAL, P580
   THACKER JG, 1976, THESIS U VIRGINIA
   TODD BA, 1994, J REHABIL RES DEV, V31, P111
   Tsap LV, 1998, IEEE T MED IMAGING, V17, P620, DOI 10.1109/42.730406
   Tsap LV, 1999, IMAGE VISION COMPUT, V17, P997, DOI 10.1016/S0262-8856(98)00185-1
   Tsap LV, 1998, COMPUT VIS IMAGE UND, V69, P330, DOI 10.1006/cviu.1998.0663
   VANNAH WM, 1993, J REHABIL RES DEV, V30, P205
   WEISS JA, 1995, P 2 WORLD C BIOM AMS, P149
   Young A., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P399, DOI 10.1109/CVPR.1992.223158
   ZHANG M, 1995, MED ENG PHYS, V17, P559, DOI 10.1016/1350-4533(95)00002-5
NR 37
TC 46
Z9 49
U1 0
U2 3
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN 0162-8828
EI 1939-3539
J9 IEEE T PATTERN ANAL
JI IEEE Trans. Pattern Anal. Mach. Intell.
PD MAY
PY 2000
VL 22
IS 5
BP 526
EP 543
DI 10.1109/34.857007
PG 18
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA 337FV
UT WOS:000088347500008
DA 2018-10-19
ER

PT J
AU Licciulli, A
   Greco, A
   Maffezzoli, A
AF Licciulli, A
   Greco, A
   Maffezzoli, A
TI Development of a pre-ceramic suspension for free form fabrication of
   ceramic parts by stereolithography
SO INDUSTRIAL CERAMICS
LA English
DT Article
AB Laser Stereolithography represents one the most widely used processes for rapid prototyping with new equipments and materials covering each year new applications. Recently the application of stereolithography to the production of ceramic objects for engineering and biomedical applications has been proposed. In this work the development of UV curable pre-ceramic suspensions for free form fabrication of aluminosilicate ceramic parts by stereolithography is presented. The ceramic green is obtained in a stereo:lithographic system operating with a He-Cd laser (325 nm). The suspensions is characterised by at least 50% by volume of pou der content and by a viscosity similar to that one of commercial resins. The building of ceramic objects a described in detail for each stage of the process. Finally; some characterisation of the macroscopic properties and microstructure of samples is also presented.
C1 CNRSM, PASTIS, Brindisi, Italy.
   Univ Lecce, Dipartimento Sci Mat, I-73100 Lecce, Italy.
RI maffezzoli, alfonso/L-7217-2015
OI maffezzoli, alfonso/0000-0002-6371-4030; Licciulli, Antonio
   Alessandro/0000-0002-0505-5268
CR Agarwala M, 1995, RAPID PROTOTYPING J, V1, P26, DOI 10.1108/13552549510078113
   Burns M, 1993, AUTOMATED FABRICATIO
   Callister W. D., 1990, MAT SCI ENG
   Edirisinghe M, 1997, MATER WORLD, V5, P138
   GRIFFITH ML, 1995, INT SAMPE TECH C, V27, P970
   Jacobs P. F., 1992, RAPID PROTOTYPING MA
NR 6
TC 5
Z9 5
U1 0
U2 7
PU TECHNA SRL
PI FAENZA
PA PO BOX 174, 48018 FAENZA, ITALY
SN 1121-7588
J9 IND CERAM
JI Ind. Ceram.
PD MAY-AUG
PY 2000
VL 20
IS 2
BP 97
EP 99
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA 373GZ
UT WOS:000165282100007
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   van der Mei, HC
   Busscher, HJ
AF Gottenbos, B
   van der Mei, HC
   Busscher, HJ
TI Initial adhesion and surface growth of Staphylococcus epidermidis and
   Pseudomonas aeruginosa on biomedical polymers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial-centered infections; biofilm formation; bacterial adhesion;
   bacterial surface growth; parallel plate flow chamber
ID MICROBIAL ADHESION; BACTERIAL ADHESION; FLOW CHAMBER; INTERFACES;
   INFECTION
AB The infection risk of biomaterials implants varies between different materials and is determined by an interplay of adhesion and surface growth of the infecting organisms. In this study, we compared initial adhesion and surface growth of Staphylococcus epidermidis HBH2 102 and Pseudomonas aeruginosa AK1 on poly(dimethylsiloxane), Teflon, polyethylene, polypropylene, polyurethane, poly(ethylene terephthalate), poly(methyl methacrylate), and glass. Initial adhesion was measured in situ in a parallel plate now chamber with microorganisms suspended in phosphate-buffered saline, while subsequent surface growth was followed in full and in 20 times diluted growth medium, initial adhesion of both bacterial strains was similar to all biomaterials in full growth medium, generation times of surface growing S. epidermidis ranged from 17 to 38 min with no relation to wettability, while in diluted growth medium generation times increased from 44 to 98 min with increasing surface wettability. For P. aeruginosa no influence of surface wettability on generation times was observed, but generation times increased with decreasing desorption rates, maximal generation times being 47 min and minimal values down to 30 min. Generally, generation times of adhering bacteria were shorter than of planktonic bacteria. In conclusion, surface grow th of initially adhering bacteria is influenced by biomaterials surface properties to a greater extent than initial adhesion. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Groningen, Dept Biomed Engn, NL-9712 KZ Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Bloemsingel 10, NL-9712 KZ Groningen, Netherlands.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anwar H., 1992, ASM NEWS, V58, P665
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BOUTTIER S, 1994, COLLOID SURFACE B, V2, P57, DOI 10.1016/0927-7765(94)80018-9
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   ESCHER A, 1990, BIOFILMS, P445
   GEESEY GG, 1990, ANNU REV MICROBIOL, V44, P579
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash MB, 1997, MICROBIOL-UK, V143, P2569, DOI 10.1099/00221287-143-8-2569
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HOEDEMAKER HOT, 1997, BIOMEDICAL MAT RES G, P109
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
NR 16
TC 117
Z9 121
U1 3
U2 32
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2000
VL 50
IS 2
BP 208
EP 214
DI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288BH
UT WOS:000085541600016
PM 10679686
DA 2018-10-19
ER

PT J
AU Hellstrom, WJG
   Reddy, S
AF Hellstrom, WJG
   Reddy, S
TI Application of pericardial graft in the surgical management of
   Peyronie's disease
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Urological-Association
CY MAY 01-06, 1999
CL DALLAS, TEXAS
SP Amer Urol Assoc
DE penile induration; penis; transplants; pericardium
ID TUNICA ALBUGINEA; NATURAL-HISTORY; PENIS
AB Purpose: We investigated the use of Tutoplast dagger cadaveric pericardium as an alternative material for grafting the tunica albuginea defect after Peyronie's plaque excision.
   Materials and Methods: A total of 11 patients with significant penile curvature interfering with sexual intercourse were evaluated after at least 12 months of conservative therapy. Preoperative evaluation in all cases included penile duplex Doppler ultrasound studies. Chemically processed and gamma irradiated pericardium was used to graft the cavernosal defect after surgical excision of the penile plaque. In 3 patients se penile prosthesis was simultaneously placed secondary to documented erectile dysfunction at duplex Doppler ultrasound evaluation.
   Results: Penile curvature resolved in all patients, allowing for normal sexual function after a mean followup of 14 months (range 9 to 19). No postoperative evidence of tissue rejection or infection was noted. In 1 patient urethro-corporal communication developed and a single penile cylinder was explanted. Another patient had a mild dorsal bulge at the site of graft placement when the prosthesis was fully inflated.
   Conclusions: Polymeric silicone material used to provide satisfactory results in the surgical treatment of Peyronie's disease but it is no longer available for biomedical use. We demonstrate the effective use of cadaveric pericardium as a graft material for cavernosal defects after Peyronie's plaque excision. Overall patient satisfaction, absence of a second surgical incision, relative low risk and ease of surgical placement make this material ideal for the surgical treatment of this disease process.
C1 Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA.
RP Hellstrom, WJG (reprint author), Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA.
CR Akkus E, 1997, BRIT J UROL, V79, P47, DOI 10.1046/j.1464-410X.1997.26511.x
   Brock G, 1997, J UROLOGY, V157, P276, DOI 10.1016/S0022-5347(01)65359-X
   Carrieri MP, 1998, J CLIN EPIDEMIOL, V51, P511, DOI 10.1016/S0895-4356(98)00015-8
   Davis CJ, 1997, J UROLOGY, V157, P282, DOI 10.1016/S0022-5347(01)65360-6
   DESANCTIS PN, 1967, J UROLOGY, V97, P114, DOI 10.1016/S0022-5347(17)62993-8
   Devine CJ, 1997, J UROLOGY, V157, P285, DOI 10.1016/S0022-5347(01)65361-8
   DEVINE CJ, 1974, J UROLOGY, V111, P44, DOI 10.1016/S0022-5347(17)59886-9
   GELBARD MK, 1990, J UROLOGY, V144, P1376, DOI 10.1016/S0022-5347(17)39746-X
   GELBARD MK, 1991, J UROLOGY, V145, P772, DOI 10.1016/S0022-5347(17)38447-1
   GELBARD MK, 1985, J UROLOGY, V134, P280, DOI 10.1016/S0022-5347(17)47123-0
   HELLSTROM WJG, 1994, INT J IMPOT RES, V6, P32
   LEVINE LA, 1994, J UROLOGY, V151, P1522, DOI 10.1016/S0022-5347(17)35291-6
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   NESBIT RM, 1965, J UROLOGY, V93, P230, DOI 10.1016/S0022-5347(17)63751-0
   PESCH HJ, 1985, FACIAL NERVE, P506
   PRYOR JP, 1979, J UROLOGY, V122, P622, DOI 10.1016/S0022-5347(17)56530-1
   Raviv T, 1998, J GLAUCOMA, V7, P27
   Sibayan SAB, 1997, OPHTHALMIC SURG LAS, V28, P334
   SOMERS KD, 1989, J UROLOGY, V141, P629, DOI 10.1016/S0022-5347(17)40920-7
   WEGNER HEH, 1995, EUR UROL, V28, P236
   WILLIAMS JL, 1970, J UROLOGY, V103, P75, DOI 10.1016/S0022-5347(17)61894-9
   WILSON SK, 1994, J UROLOGY, V152, P1121, DOI 10.1016/S0022-5347(17)32519-3
   YACHIA D, 1993, J UROLOGY, V149, P869, DOI 10.1016/S0022-5347(17)36243-2
NR 23
TC 63
Z9 65
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2000
VL 163
IS 5
BP 1445
EP 1447
DI 10.1016/S0022-5347(05)67639-2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 303HN
UT WOS:000086416600011
PM 10751854
DA 2018-10-19
ER

PT J
AU Fu, YQ
   Yan, BB
   Loh, NL
   Sun, CQ
   Hing, P
AF Fu, YQ
   Yan, BB
   Loh, NL
   Sun, CQ
   Hing, P
TI Characterization and tribological evaluation of MW-PACVD diamond
   coatings deposited on pure titanium
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE diamond; MW-PACVD; titanium; tribology; wear; coefficient of friction
ID CHEMICAL-VAPOR-DEPOSITION; THIN-FILMS; INTERNAL-STRESS; WEAR; FRICTION;
   RAMAN; BEHAVIOR; ALLOYS; GROWTH; STEEL
AB Titanium alloys are widely used in aerospace and biomedical conditions, however, they are notorious for the poor tribological properties. The deposition of a well adherent diamond coating is a promising way to solve this problem. Ln this study, diamond coatings were deposited on pure titanium using microwave plasma assisted chemical vapour deposition (MW-PACVD). Characterisation of diamond coatings was performed using scanning electron microscopy (SEM), laser profilometry, Raman spectroscopy, grazing incidence X-ray diffraction (GIXD) and atomic force microscopy (AFM). Tribological properties of diamond coatings were evaluated using a ball-on-disk wear tester (sliding with Al2O3 balls) and a scratch tester (sliding with diamond pin). Results showed that the friction and wear properties of polycrystalline diamond coatings as well as the wear of the counterface were dependent significantly on the surface roughness, the morphology and crystalline structure of diamond coatings as well as the counterface materials. For (111)-textured diamond coatings with rough surface and sharp asperities sliding with Al2O3 balls, the coefficient of friction was much higher than that of (100)-textured coatings, and the wear of the counterface material was quite high. After polishing the diamond coating, the surface roughness, coefficient of friction and wear of counterface decreased significantly. If sliding with diamond pins, the coefficient of friction of diamond coating shows a quite low and stable value. To improve the tribological properties, a three-step deposition method was proposed to obtain a smooth and nano-crystalline diamond layer on bulk diamond coatings. The so-formed diamond coating showed the highest load bearing capacity, the lowest coefficient of friction and the lowest wear of the counterface. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Nanyang Technol Univ, Mat Lab, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Appl Sci, Singapore 639798, Singapore.
RP Fu, YQ (reprint author), Nanyang Technol Univ, Mat Lab, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RI Sun, Chang/B-8698-2008; Hing, Peter/G-2945-2010; FU, Richard, Yong
   Qing/D-2723-2009
OI Sun, Chang/0000-0003-2076-1133; FU, Richard, Yong
   Qing/0000-0001-9797-4036
CR Avigal Y, 1997, DIAM RELAT MATER, V6, P381, DOI 10.1016/S0925-9635(96)00625-5
   BACHMANN PK, 1994, DIAM RELAT MATER, V3, P1308, DOI 10.1016/0925-9635(94)90143-0
   BHUSHAN B, 1993, J APPL PHYS, V74, P4174, DOI 10.1063/1.354421
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   BULL SJ, 1994, SURF COAT TECH, V68, P603, DOI 10.1016/0257-8972(94)90224-0
   BULL SJ, 1992, DIAM RELAT MATER, V1, P1049, DOI 10.1016/0925-9635(92)90075-Y
   DION I, 1993, INT J ARTIF ORGANS, V16, P623
   Fan WD, 1997, SURF COAT TECH, V91, P32, DOI 10.1016/S0257-8972(96)03107-6
   Fu YQ, 1999, J MATER SCI, V34, P2269, DOI 10.1023/A:1004569406535
   GANGOPADHYAY AK, 1993, WEAR, V169, P221, DOI 10.1016/0043-1648(93)90302-3
   Gilbert DR, 1998, J MATER RES, V13, P1735, DOI 10.1557/JMR.1998.0240
   Grogler T, 1998, INT J REFRACT MET H, V16, P217, DOI 10.1016/S0263-4368(98)00021-3
   Grogler T, 1998, DIAM RELAT MATER, V7, P1342, DOI 10.1016/S0925-9635(98)00202-7
   Habig KH, 1995, SURF COAT TECH, V76-77, P540, DOI 10.1016/0257-8972(95)02548-0
   Heinrich G, 1997, SURF COAT TECH, V94-5, P514, DOI 10.1016/S0257-8972(97)00459-3
   Hogmark S, 1996, WEAR, V200, P225, DOI 10.1016/S0043-1648(96)07279-1
   Khurshudov A., 1996, Tribology Letters, V2, P13
   Liu E, 1996, SURF COAT TECH, V80, P264, DOI 10.1016/0257-8972(95)02460-3
   Miyoshi K, 1996, MAT SCI ENG A-STRUCT, V209, P38, DOI 10.1016/0921-5093(95)10114-4
   Molinari A, 1997, WEAR, V208, P105, DOI 10.1016/S0043-1648(96)07454-6
   Morrison NA, 1996, DIAM RELAT MATER, V5, P1118, DOI 10.1016/0925-9635(96)00532-8
   Nakamura Y, 1997, THIN SOLID FILMS, V308, P249, DOI 10.1016/S0040-6090(97)00383-0
   NAMBA Y, 1992, J APPL PHYS, V72, P1748, DOI 10.1063/1.351698
   NEMANICH RJ, 1988, J VAC SCI TECHNOL A, V6, P1783, DOI 10.1116/1.575297
   Nistor LC, 1997, DIAM RELAT MATER, V6, P159, DOI 10.1016/S0925-9635(96)00743-1
   OKUZUMI F, 1995, P 3 INT C APPL DIAM, P201
   Park JB., 1984, BIOMATERIALS SCI ENG, P193
   PARK SS, 1991, J APPL PHYS, V69, P2618, DOI 10.1063/1.348653
   Ralchenko V. G., 1995, Proceedings of the Applied Diamond Conference 1995. Applications of Diamond Films and Related Materials: Third International Conference (NIST SP 885), P225
   Rats D, 1997, SURF COAT TECH, V94-5, P555, DOI 10.1016/S0257-8972(97)00465-9
   Schmitt M, 1998, THIN SOLID FILMS, V332, P124, DOI 10.1016/S0040-6090(98)00986-9
   SKOPP A, 1997, TRIBOTEST, V4, P3
   Stals LMM, 1997, SURF COAT TECH, V91, P230, DOI 10.1016/S0257-8972(96)03119-2
   Stockel R, 1998, J APPL PHYS, V83, P531, DOI 10.1063/1.366667
   Stoneham AM, 1998, MRS BULL, V23, P28, DOI 10.1557/S0883769400029328
   WANG WL, 1992, THIN SOLID FILMS, V215, P174
   WU RLC, 1993, SURF COAT TECH, V62, P589, DOI 10.1016/0257-8972(93)90304-7
   Yang BX, 1995, THIN SOLID FILMS, V270, P210, DOI 10.1016/0040-6090(95)06859-7
   Zuiker C, 1995, THIN SOLID FILMS, V270, P154, DOI 10.1016/0040-6090(95)06882-1
NR 39
TC 34
Z9 36
U1 2
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 30
PY 2000
VL 282
IS 1-2
BP 38
EP 48
DI 10.1016/S0921-5093(99)00782-0
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 295LB
UT WOS:000085966600006
DA 2018-10-19
ER

PT J
AU Stroup, DF
   Berlin, JA
   Morton, SC
   Olkin, I
   Williamson, GD
   Rennie, D
   Moher, D
   Becker, BJ
   Sipe, TA
   Thacker, SB
AF Stroup, DF
   Berlin, JA
   Morton, SC
   Olkin, I
   Williamson, GD
   Rennie, D
   Moher, D
   Becker, BJ
   Sipe, TA
   Thacker, SB
CA MOOSE Grp
TI Meta-analysis of observational studies in epidemiology - A proposal for
   reporting
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID SYSTEMATIC REVIEWS; ORAL-CONTRACEPTIVES; CONTROLLED TRIALS;
   METAANALYSIS; QUALITY; HEALTH; HETEROGENEITY; EXPOSURE; CANCER; BIAS
AB Objective Because of the pressure for timely, informed decisions in public health and clinical practice and the explosion of information in the scientific literature, research results must be synthesized. Meta-analyses are increasingly used to address this problem, and they often evaluate observational studies. A workshop was held in Atlanta, Ga, in April 1997, to examine the reporting of meta-analyses of observational studies and to make recommendations to aid authors, reviewers, editors, and readers.
   Participants Twenty-seven participants were selected by a steering committee, based on expertise in clinical practice, trials, statistics, epidemiology, social sciences, and biomedical editing. Deliberations of the workshop were open to other interested scientists. Funding for this activity was provided by the Centers for Disease Control and Prevention.
   Evidence We conducted a systematic review of the published literature on the conduct and reporting of meta-analyses in observational studies using MEDLINE, Educational Research Information Center (ERIC), PsycLIT, and the Current Index to Statistics. We also examined reference lists of the 32 studies retrieved and contacted experts in the field. Participants were assigned to small-group discussions on the subjects of bias, searching and abstracting, heterogeneity, study categorization, and statistical methods.
   Consensus Process From the material presented at the workshop, the authors developed a checklist summarizing recommendations for reporting meta-analyses of observational studies. The checklist and supporting evidence were circulated to all conference attendees and additional experts. All suggestions for revisions were addressed.
   Conclusions The proposed checklist contains specifications for reporting of meta-analyses of observational studies in epidemiology, including background, search strategy, methods, results, discussion, and conclusion. Use of the checklist should improve the usefulness of meta-analyses for authors, reviewers, editors, readers, and decision makers. An evaluation plan is suggested and research areas are explored.
C1 Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
   Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
   RAND Corp, Santa Monica, CA USA.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
   Stanford Univ, Stanford, CA 94305 USA.
   JAMA, Chicago, IL USA.
   Childrens Hosp Eastern Ontario, Res Inst, Thomas C Chalmers Ctr Systemat Rev, Ottawa, ON, Canada.
   Michigan State Univ, E Lansing, MI 48824 USA.
   Georgia State Univ, Atlanta, GA 30303 USA.
RP Stroup, DF (reprint author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mail Stop C09, Atlanta, GA 30333 USA.
RI Sipe, Theresa/C-2262-2012; Karayel, Bora/E-2173-2017
OI Karayel, Bora/0000-0001-5997-1424; Moher, David/0000-0003-2434-4206;
   Becker, Betsy Jane/0000-0003-3438-560X
CR Badgett RG, 1997, ANN INTERN MED, V126, P886, DOI 10.7326/0003-4819-126-11-199706010-00006
   BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645
   Berlin JA, 1999, JAMA-J AM MED ASSOC, V281, P830, DOI 10.1001/jama.281.9.830
   Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5
   Berlin JA, 1999, JAMA-J AM MED ASSOC, V282, P1083, DOI 10.1001/jama.282.11.1083
   Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007
   Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1
   Chalmers T C, 1993, Stat Methods Med Res, V2, P161
   COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644
   Cole MG, 1997, CAN MED ASSOC J, V157, P1055
   COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M
   Dickersin K, 1993, ONLINE J CURR C 0428
   EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y
   Egger M, 1998, BRIT MED J, V316, P140
   EMERSON JD, 1990, CONTROL CLIN TRIALS, V11, P339, DOI 10.1016/0197-2456(90)90175-2
   FRANCESCHI S, 1986, TUMORI, V72, P21
   FRIEDENREICH CM, 1994, EPIDEMIOLOGY, V5, P66, DOI 10.1097/00001648-199401000-00011
   FRUMKIN H, 1988, AM J IND MED, V14, P79, DOI 10.1002/ajim.4700140110
   GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248
   GREENLAND S, 1987, EPIDEMIOL REV, V9, P1
   HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662, DOI 10.1080/10473289.1992.10467018
   HEDGES L, 1985, STAT METHODS META AN
   HETHERINGTON J, 1989, PEDIATRICS, V84, P374
   Huston P, 1996, CAN MED ASSOC J, V155, P1697
   Huston P, 1996, CAN MED ASSOC J, V154, P1389
   Ioannidis J P, 1999, Jt Comm J Qual Improv, V25, P462
   Jadad A, 2000, ANN M AM AC ALL ASTH
   Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054
   Kheifets LI, 1997, J OCCUP ENVIRON MED, V39, P1074, DOI 10.1097/00043764-199711000-00008
   LANG TA, 1997, REPORT STAT MED
   Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7
   Lipsett M, 1999, AM J PUBLIC HEALTH, V89, P1009, DOI 10.2105/AJPH.89.7.1009
   MANN CC, 1994, SCIENCE, V266, P960, DOI 10.1126/science.7973676
   McManus RJ, 1998, BRIT MED J, V317, P1562, DOI 10.1136/bmj.317.7172.1562
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Ohlsson A, 1994, Scand J Clin Lab Invest Suppl, V219, P25
   Peipert JF, 1998, CLIN OBSTET GYNECOL, V41, P235, DOI 10.1097/00003081-199806000-00004
   PETITTI D, 1994, META ANAL DECISION A
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037//0033-2909.86.3.638
   Saag KG, 1996, ARTHRITIS RHEUM, V39, P1818, DOI 10.1002/art.1780391107
   Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   SHAPIRO S, 1994, AM J EPIDEMIOL, V140, P771, DOI 10.1093/oxfordjournals.aje.a117324
   Sipe T., 1997, INT J EDUC RES, V25, P583, DOI [10.1016/S0883-0355(96)80001-2, DOI 10.1016/S0883-0355(96)80001-2]
   Steinberg K, 1997, AM J EPIDEMIOL, V145, P1917
   STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K
   STROUP DF, 1997, INT C BIOM PEER REV
   THACKER SB, 1988, JAMA-J AM MED ASSOC, V259, P1685, DOI 10.1001/jama.259.11.1685
   Vickers A, 1997, INT J TECHNOL ASSESS, V13, P111, DOI 10.1017/S0266462300010278
NR 50
TC 8005
Z9 8117
U1 52
U2 570
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0098-7484
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD APR 19
PY 2000
VL 283
IS 15
BP 2008
EP 2012
DI 10.1001/jama.283.15.2008
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 303RC
UT WOS:000086436600037
PM 10789670
DA 2018-10-19
ER

PT J
AU Meijer, HAJ
   Neubert, REM
   Visser, GH
AF Meijer, HAJ
   Neubert, REM
   Visser, GH
TI Cross contamination in dual inlet isotope ratio mass spectrometers
SO INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
LA English
DT Article
DE gas isotope ratio mass spectrometry; stable isotopes; cross
   contamination; normalization; isotopic reference materials
ID NATURAL-WATERS; DEUTERIUM
AB Since the early days of geochemical isotope ratio mass spectrometry there has always been the problem of cross contamination, i.e. the contamination of the sample gas with traces of reference gas land vice versa) in a dual inlet system and the analyzer itself. This was attributable to valve leakages and could be corrected for. In modem leak-free machines this problem still influences the measurements by scale contraction. It limits the interlaboratory comparability to values unacceptable for, e.g. global carbon cycle investigations on atmospheric delta(13)CO(2), with the need to integrate global datasets at a 0.01 parts per thousand precision level. No matter what the reason of apparent cross contamination (physical leakage, low pump efficiency, gas-wall interactions), we present a method to measure the actual cross contamination as well as algorithms to correct for it. By using isotopically enriched sample gas the effect on the reference gas is directly shown. Especially for biomedical applications, employing highly enriched materials, the nonlinear correction has to be applied. A long-time record of two machines shows the influence of vacuum breakage and the inlet system setup. We present a survey of cross contamination in some of the frequently used machines. The relatively poor raw results of two recent interlaboratory comparison experiments are explained in terms of cross contamination. Whereas the linear two-point normalization procedure considered by itself may be appropriate for some routine applications at natural isotope abundances, it always relies on relative delta values of two reference materials. There is an urgent need to establish absolute values for all scale-determining reference materials. We recommend the use of cross contamination measurements to at least determine the isotopic composition of all normalization materials as long as absolute measurements are not available. In principle, the cross contamination measurements should be used as a diagnostic tool on a regular basis. (C) 2000 Elsevier Science B.V.
C1 Univ Groningen, Ctr IsotopenOnderzoek, NL-9747 AG Groningen, Netherlands.
RP Neubert, REM (reprint author), Univ Groningen, Ctr IsotopenOnderzoek, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM neubert@phys.rug.nl
RI Neubert, Rolf/U-2766-2017; Meijer, Harro/A-5787-2012
OI Neubert, Rolf/0000-0001-8848-4721; 
CR ALLISON CE, 1995, P CONS M VIENN 1 3 D
   BOHLKE JK, 1995, P CONS M VIENN 1 3 D
   BRAND WA, 1999, IN PRESS D H RING TE
   DeWit J.C., 1980, GEOSTANDARD NEWSLETT, V4, P33, DOI DOI 10.1111/J.1751-908X.1980.TB00270.X
   FRANCEY RJ, 1994, IAEA CRP M VIENN 7 1
   GONFIANTINI R, 1978, NATURE, V271, P534, DOI 10.1038/271534a0
   Gonfiantini R, 1997, INT J MASS SPECTROM, V171, P231, DOI 10.1016/S0168-1176(97)00129-8
   Gonfiantini R, 1984, REPORT DIRECTOR GEN
   HAGEMANN R, 1970, TELLUS, V22, P712
   HUT G, 1987, REPORT DIRECTOR GENE
   MCKINNEY CR, 1950, REV SCI INSTRUM, V21, P724, DOI 10.1063/1.1745698
   Neubert R., 1998, THESIS U HEIDELBERG
   NIELSEN H, 1984, REPORT DIRECTOR GEN
   Robinson B. W., 1995, P CONS M VIENN 1 3 D
   STICHLER W, 1995, P CONS M VIENN 1 3 D
   TSE RS, 1980, ANAL CHEM, V52, P2445, DOI 10.1021/ac50064a053
   *U GRON, 1998, 7 IAEA CONS M REF MA
   Verkouteren RM, 1999, ANAL CHEM, V71, P4740, DOI 10.1021/ac990233c
   VERKOUTEREN RM, 1995, P CONS M VIENN 1 3 D
   VISSER GH, CIO INTERNAL REPORT
NR 20
TC 60
Z9 60
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-3806
J9 INT J MASS SPECTROM
JI Int. J. Mass Spectrom.
PD APR 14
PY 2000
VL 198
IS 1-2
BP 45
EP 61
DI 10.1016/S1387-3806(99)00266-3
PG 17
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA 302GU
UT WOS:000086358000005
OA Green Published
DA 2018-10-19
ER

PT J
AU Seliktar, D
   Black, RA
   Vito, RP
   Nerem, RM
AF Seliktar, D
   Black, RA
   Vito, RP
   Nerem, RM
TI Dynamic mechanical conditioning of collagen-gel blood vessel constructs
   induces remodeling in vitro
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE tissue engineering; vascular; mechanical properties; cyclic strain;
   remodeling
ID HYBRID VASCULAR TISSUE; SMOOTH-MUSCLE CELLS; IN-VITRO; MATRIX
   REORGANIZATION; FIBROBLASTS; CONTRACTION; LATTICES; MEDIA;
   RECONSTRUCTION; EQUIVALENTS
AB Dynamic mechanical conditioning is investigated as a means of improving the mechanical properties of tissue-engineered blood vessel constructs composed of living cells embedded in a collagen-gel scaffold. This approach attempts to elicit a unique response from the embedded cells so as to reorganize their surrounding matrix, thus improving the overall mechanical stability of the constructs. Mechanical conditioning, in the form of cyclic strain, was applied to the tubular constructs at a frequency of 1 Hz for 4 and 8 days. The response to conditioning thus evinced involved increased contraction and mechanical strength, as compared to statically cultured controls. Significant increases in ultimate stress and material modulus were seen over an 8 day culture period. Accompanying morphological changes showed increased circumferential orientation in response to the cyclic stimulus. We conclude that dynamic mechanical conditioning during tissue culture leads to an improvement in the properties of tissue-engineered blood vessel constructs in terms of mechanical strength and histological organization. This concept, in conjunction with a proper biochemical environment, could present a better model for engineering vascular constructs. (C) 2000 Biomedical Enginerring Society.
C1 Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Univ Liverpool, Dept Clin Engn, Liverpool L69 3GA, Merseyside, England.
RP Seliktar, D (reprint author), Georgia Inst Technol, Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.
OI Seliktar, Dror/0000-0001-6964-8567
FU NIGMS NIH HHS [GM08433]
CR Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   Eastwood M, 1996, J CELL PHYSIOL, V166, P33, DOI 10.1002/(SICI)1097-4652(199601)166:1<33::AID-JCP4>3.0.CO;2-H
   EHRLICH HP, 1986, J CELL SCI, V82, P281
   Fung Y, 1993, BIOMECHANICS MECH PR, P261
   GILLERY P, 1986, EXP CELL RES, V167, P29, DOI 10.1016/0014-4827(86)90201-6
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   GIRTON TS, IN PRESS J BIOMECH E
   Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693
   Hirai J, 1994, ASAIO J, V40, pM383, DOI 10.1097/00002480-199407000-00027
   HIRAI J, 1995, CELL TRANSPLANT, V4, P597, DOI 10.1016/0963-6897(95)00029-1
   KANDA K, 1994, CELL TRANSPLANT, V3, P537, DOI 10.1177/096368979400300611
   Kanda K, 1993, ASAIO J, V39, pM561
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   L'Heureux N, 1998, FASEB J, V12, P47
   Langelier E, 1999, ANN BIOMED ENG, V27, P67, DOI 10.1114/1.166
   LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Matsuda T, 1989, ASAIO Trans, V35, P553, DOI 10.1097/00002480-198907000-00123
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OAKES BW, 1982, EUR J CELL BIOL, V27, P34
   Ogle BM, 1999, TISSUE ENG, V5, P387, DOI 10.1089/ten.1999.5.387
   SCHNETZER KJ, 1996, THESIS GEORGIA I TEC
   Spina M, 1999, BIOPOLYMERS, V49, P255, DOI 10.1002/(SICI)1097-0282(199903)49:3<255::AID-BIP6>3.0.CO;2-2
   STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8
   Tranquillo RT, 1999, BIOCHEM SOC SYMP, V65, P27
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   YAMATO M, 1995, J BIOCHEM-TOKYO, V117, P940, DOI 10.1093/oxfordjournals.jbchem.a124824
   ZIEGLER T, 1995, ANN BIOMED ENG, V23, P216, DOI 10.1007/BF02584424
NR 31
TC 375
Z9 389
U1 1
U2 66
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD APR
PY 2000
VL 28
IS 4
BP 351
EP 362
DI 10.1114/1.275
PG 12
WC Engineering, Biomedical
SC Engineering
GA 322PT
UT WOS:000087518500001
PM 10870892
DA 2018-10-19
ER

PT J
AU Huczko, A
AF Huczko, A
TI Template-based synthesis of nanomaterials
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Review
ID FILLING CARBON NANOTUBES; ATOMIC-SCALE MANIPULATION; ALUMINUM-OXIDE;
   ELECTRONIC-PROPERTIES; SUBSTITUTION-REACTION; MAGNETIC-PROPERTIES;
   METALLIC NANOWIRES; NITRIDE NANORODS; NANOMETER-SCALE; FIELD-EMISSION
AB The large interest in nanostructures results from their numerous potential applications in various areas such as materials and biomedical sciences, electronics, optics, magnetism, energy storage, and electrochemistry. Ultrasmall building blocks have been found to exhibit a broad range of enhanced mechanical, optical, magnetic, and electronic properties compared to coarser-grained matter of the same chemical composition. In this paper various template techniques suitable for nanotechnology applications with emphasis on characterization of created arrays of tailored nanomaterials have been reviewed. These methods involve the fabrication of the desired material within the pores or channels of a nanoporous template. Track-etch membranes, porous alumina, and other nanoporous structures have been characterized as templates. They have been used to prepare nanometer-sized fibrils, rods, and tubules of conductive polymers, metals, semiconductors, carbons, and other solid matter. Electrochemical and electroless depositions, chemical polymerization, sol-gel deposition, and chemical vapour deposition have been presented as major template synthetic strategies. In particular, the template-based synthesis of carbon nanotubes has been demonstrated as this is the most promising class of new carbon-based materials for electronic and optic nanodevices as well as reinforcement nanocomposites.
C1 Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland.
RP Huczko, A (reprint author), Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland.
EM ahuczko@chem.uw.edu.pl
OI Huczko, Andrzej/0000-0003-3688-1121
CR AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0
   AJAYAN PM, 1995, NATURE, V375, P564, DOI 10.1038/375564a0
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   Ajiki H, 1997, SOLID STATE COMMUN, V102, P135, DOI 10.1016/S0038-1098(96)00707-7
   ALMAWLAWI D, 1991, J APPL PHYS, V70, P4421, DOI 10.1063/1.349125
   ANDERSON MW, 1993, CHEM COMMUN, P533
   Anthony TR, 1996, CARBON, V34, P1323, DOI 10.1016/S0008-6223(96)00060-7
   BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472
   Bandosz TJ, 1996, CHEM MATER, V8, P2023, DOI 10.1021/cm960233i
   Barbara B, 1997, CURR OPIN SOLID ST M, V2, P220, DOI 10.1016/S1359-0286(97)80069-1
   BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1
   Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826
   BRUMLIK CJ, 1994, J MATER RES, V9, P1174, DOI 10.1557/JMR.1994.1174
   BRUMLIK CJ, 1991, J AM CHEM SOC, V113, P3174, DOI 10.1021/ja00008a057
   CAI ZH, 1991, CHEM MATER, V3, P960, DOI 10.1021/cm00017a036
   CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077
   Cassell AM, 1998, ANGEW CHEM INT EDIT, V37, P1528, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1528::AID-ANIE1528>3.0.CO;2-Q
   Cepak VM, 1997, CHEM MATER, V9, P1065, DOI 10.1021/cm970014c
   Che G, 1998, CHEM MATER, V10, P260, DOI 10.1021/cm970412f
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Chen XH, 1999, THIN SOLID FILMS, V339, P6, DOI 10.1016/S0040-6090(98)00809-8
   Chernozatonskii LA, 1998, CHEM PHYS LETT, V297, P257, DOI 10.1016/S0009-2614(98)01100-2
   CHERNOZATONSKII LA, 1995, PHYS LETT A, V197, P40, DOI 10.1016/0375-9601(94)00885-S
   Chu A, 1996, CHEM MATER, V8, P2751, DOI 10.1021/cm960246w
   Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100
   COOK J, 1996, CHEM IND 600
   CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218
   DAGANI R, 1999, CHEM ENG NEWS, P25
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   DAI HJ, 1995, NATURE, V375, P769, DOI 10.1038/375769a0
   DAIMON H, 1993, J APPL PHYS, V73, P5391, DOI 10.1063/1.353742
   DAVIS WR, 1953, NATURE, V171, P756, DOI 10.1038/171756a0
   De Vito S, 1998, CHEM MATER, V10, P1738, DOI 10.1021/cm9801690
   DEHEER WA, 1995, SCIENCE, V268, P845, DOI 10.1126/science.268.5212.845
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   Demoncy N, 1998, EUR PHYS J B, V4, P147, DOI 10.1007/s100510050363
   DICKEY FH, 1949, P NATL ACAD SCI USA, V35, P227, DOI 10.1073/pnas.35.5.227
   Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0
   DIMITRYEV SN, 1997, KHIM VYS ENERG, V31, P286
   DRESSELHAUS MS, 1993, MATER SCI ENG, V354, P192
   DREW SM, 1991, J ELECTROANAL CHEM, V317, P117, DOI 10.1016/0022-0728(91)85007-C
   DUJARDIN E, 1994, SCIENCE, V265, P1850, DOI 10.1126/science.265.5180.1850
   EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0
   ENZEL P, 1992, CHEM COMMUN, P633
   Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512
   Feldheim DL, 1998, CHEM SOC REV, V27, P1
   Fleisher R. L., 1975, NUCL TRACKS SOLIDS
   Frackowiak E, 1999, CARBON, V37, P61, DOI 10.1016/S0008-6223(98)00187-0
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   Freemantle M, 1997, CHEM ENG NEWS, V75, P33, DOI 10.1021/cen-v075n038.p033
   Gadd GE, 1997, SCIENCE, V277, P933, DOI 10.1126/science.277.5328.933
   GARCIA RG, 1992, APPL PHYS LETT, V60, P1960, DOI 10.1063/1.107137
   GE MH, 1993, SCIENCE, V260, P515, DOI 10.1126/science.260.5107.515
   GE MH, 1994, APPL PHYS LETT, V64, P710, DOI 10.1063/1.111042
   HADJIPANAYIS GC, 1994, NANOPHASE MAT SYNTHE, P260
   Han WQ, 1997, SCIENCE, V277, P1287, DOI 10.1126/science.277.5330.1287
   Han WQ, 1999, CHEM PHYS LETT, V299, P368, DOI 10.1016/S0009-2614(98)01307-4
   Han WQ, 1997, APPL PHYS LETT, V71, P2271, DOI 10.1063/1.120550
   Han WQ, 1998, APPL PHYS LETT, V73, P3085, DOI 10.1063/1.122680
   HEATH JR, 1995, SCIENCE, V270, P1315, DOI 10.1126/science.270.5240.1315
   Hernadi K, 1996, SYNTHETIC MET, V77, P31, DOI 10.1016/0379-6779(96)80051-8
   HODES G, 1992, J ELECTROCHEM SOC, V139, P3136, DOI 10.1149/1.2069045
   HOTCHANDANI S, 1992, J ELECTROCHEM SOC, V139, P1630, DOI 10.1149/1.2069468
   HSU WK, 1995, NATURE, V377, P687, DOI 10.1038/377687a0
   Hsu WK, 1996, CHEM PHYS LETT, V262, P161, DOI 10.1016/0009-2614(96)01041-X
   Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   IVANOV V, 1994, CHEM PHYS LETT, V223, P329, DOI 10.1016/0009-2614(94)00467-6
   Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655
   JONAS S, 1995, SZKLO CERAMIKA, V46, P25
   KARPINSKI ZJ, 1993, J ELECTROANAL CHEM, V349, P285, DOI 10.1016/0022-0728(93)80179-L
   KIVELSON S, 1988, SYNTHETIC MET, V22, P371, DOI 10.1016/0379-6779(88)90108-7
   KLEIN JD, 1993, CHEM MATER, V5, P902, DOI 10.1021/cm00031a002
   Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632
   KYOTANI T, 1988, NATURE, V331, P331, DOI 10.1038/331331a0
   Kyotani T, 1996, CHEM MATER, V8, P2109, DOI 10.1021/cm960063+
   Kyotani T, 1997, CHEM COMMUN, P701, DOI 10.1039/a608439g
   Lago R. M., 1995, CHEM COMMUN, P1355
   Lakshmi BB, 1997, CHEM MATER, V9, P2544, DOI 10.1021/cm970268y
   LANDAUER R, 1989, J PHYS-CONDENS MAT, V1, P8099, DOI 10.1088/0953-8984/1/43/011
   LANDMAN U, 1991, J VAC SCI TECHNOL B, V9, P414, DOI 10.1116/1.585583
   Lange H, 1998, CHEM PHYS LETT, V289, P174, DOI 10.1016/S0009-2614(98)00382-0
   LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287
   LEI JT, 1992, SYNTHETIC MET, V46, P53, DOI 10.1016/0379-6779(92)90318-D
   Li FY, 1998, CHEM MATER, V10, P2470, DOI 10.1021/cm980163a
   Li WZ, 1996, SCIENCE, V274, P1701, DOI 10.1126/science.274.5293.1701
   LIANG WB, 1990, J AM CHEM SOC, V112, P9666, DOI 10.1021/ja00182a051
   LIN M, 1995, CARBON, V33, P225
   LYO IW, 1991, SCIENCE, V253, P173, DOI 10.1126/science.253.5016.173
   Marinakos SM, 1998, CHEM MATER, V10, P1214, DOI 10.1021/cm980059t
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   Martin CR, 1996, CHEM MATER, V8, P1739, DOI 10.1021/cm960166s
   MATTHEW RW, 1987, J PHYS CHEM-US, V91, P238
   MEYER GJ, 1993, ELECTROCHEMICAL SOC, V23
   Monty C.J.A., 1994, HIGH TEMP CHEM PROCE, V3, P467
   MULLEN K, 1988, PHYS REV B, V37, P98, DOI 10.1103/PhysRevB.37.98
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   Murray PW, 1998, PHYS REV LETT, V80, P988, DOI 10.1103/PhysRevLett.80.988
   Nishizawa M, 1997, J ELECTROCHEM SOC, V144, P1923, DOI 10.1149/1.1837722
   PARTHASARATHY RV, 1995, ADV MATER, V7, P896, DOI 10.1002/adma.19950071103
   PASCUAL JI, 1995, SCIENCE, V267, P1793, DOI 10.1126/science.267.5205.1793
   Piraux L, 1997, NUCL INSTRUM METH B, V131, P357, DOI 10.1016/S0168-583X(97)00363-7
   POSSIN GE, 1970, REV SCI INSTRUM, V41, P772, DOI 10.1063/1.1684640
   Raman NK, 1996, CHEM MATER, V8, P1682, DOI 10.1021/cm960138+
   REIHS K, 1995, THIN SOLID FILMS, V264, P135, DOI 10.1016/0040-6090(95)05857-5
   Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105
   RODRIGUEZ NM, 1993, J MATER RES, V8, P3233, DOI 10.1557/JMR.1993.3233
   ROHRER H, 1994, NUOVO CIMENTO A, V107, P989, DOI 10.1007/BF02730855
   Routkevitch D, 1997, ELEC SOC S, V97, P350
   Saito Y, 1998, APPL PHYS A-MATER, V67, P95, DOI 10.1007/s003390050743
   Sakaki H, 1996, CURR OPIN SOLID ST M, V1, P17, DOI 10.1016/S1359-0286(96)80004-0
   Satishkumar BC, 1997, J MATER RES, V12, P604, DOI 10.1557/JMR.1997.0089
   SCHMID G, 1997, SOLID STATE MAT SCI, V2, P204
   Schonenberger C, 1997, J PHYS CHEM B, V101, P5497, DOI 10.1021/jp963938g
   Service RF, 1998, SCIENCE, V281, P940, DOI 10.1126/science.281.5379.940
   SIEGEL RW, 1993, MAT SCI ENG B-SOLID, V19, P37, DOI 10.1016/0921-5107(93)90162-G
   Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521
   SMITH RL, 1992, J APPL PHYS, V71, pR1, DOI 10.1063/1.350839
   Sohn LL, 1998, NATURE, V394, P131, DOI 10.1038/28058
   SONG XY, 1995, J MATER RES, V10, P251, DOI 10.1557/JMR.1995.0251
   SONOBE N, 1988, J PHYS CHEM-US, V92, P7029, DOI 10.1021/j100335a037
   Sun HD, 1999, SOLID STATE COMMUN, V109, P365, DOI 10.1016/S0038-1098(98)00588-2
   Tang BZ, 1999, MACROMOLECULES, V32, P2569, DOI 10.1021/ma981825k
   Tang ZK, 1998, APPL PHYS LETT, V73, P2287, DOI 10.1063/1.121704
   Terrones M, 1997, NATURE, V388, P52, DOI 10.1038/40369
   TOMASSI P, 1998, 11 SEM TEMP JEP 0903
   TOMITA A, 1997, Patent No. 09142819
   TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0
   VLACHOPOULOS N, 1988, J AM CHEM SOC, V110, P1216, DOI 10.1021/ja00212a033
   Wei B, 1997, J MATER SCI LETT, V16, P402, DOI 10.1023/A:1018519016775
   White CT, 1998, NATURE, V393, P240, DOI 10.1038/30420
   WHITNEY TM, 1993, SCIENCE, V261, P1316, DOI 10.1126/science.261.5126.1316
   Wong EW, 1996, CHEM MATER, V8, P2041, DOI 10.1021/cm960083b
   Wong SS, 1998, NATURE, V394, P52
   WU CG, 1994, SCIENCE, V264, P1757, DOI 10.1126/science.264.5166.1757
   Zelenski CM, 1998, J AM CHEM SOC, V120, P734, DOI 10.1021/ja972170q
   ZHANG XB, 1994, EUROPHYS LETT, V27, P141, DOI 10.1209/0295-5075/27/2/011
   ZHU J, 1999, J MATER RES, V14, P7
NR 138
TC 482
Z9 501
U1 18
U2 447
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD APR
PY 2000
VL 70
IS 4
BP 365
EP 376
DI 10.1007/s003390051050
PG 12
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 307HT
UT WOS:000086648400001
DA 2018-10-19
ER

PT J
AU Lopes, MA
   Silva, RF
   Monteiro, FJ
   Santos, JD
AF Lopes, MA
   Silva, RF
   Monteiro, FJ
   Santos, JD
TI Microstructural dependence of Young's and shear moduli of P2O5 glass
   reinforced hydroxyapatite for biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE Young's modulus; shear modulus; Duckworth-Knudsen model; hydroxyapatite
   glass composites
ID MECHANICAL-PROPERTIES; SINTERED HYDROXYAPATITE
AB P2O5 glass reinforced hydroxyapatite composite materials were prepared through a liquid-phase sintering process. Secondary phases, beta- and alpha-tricalcium phosphates (beta-TCP and alpha-TCP), were formed in the microstructure of the composites, due to the reaction between the liquid glassy phase and the hydroxyapatite matrix. The dynamic Young's modulus (E) and shear modulus (G) of these composites were determined using an impulse excitation method. By applying the Duckworth-Knudsen equation, the elastic property results were correlated with the relative proportion of beta-TCP and alpha-TCP phases and with the porosity percentage present in the microstructure. Glass reinforced hydroxyapatite composites showed lower Young's and shear moduli than unmodified hydroxyapatite, mainly due to the presence of beta-TCP phase. The Duckworth-Knudsen model demonstrated an exponential dependence of E and G modulus with porosity and mathematical equations were derived for composite materials with porosity correction factors (b) of 4.04 and 4.11, respectively, indicating that porosity largely decreased both E and G moduli. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Inst Biomed Engn, Lab Biomat, P-4150 Porto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4099 Oporto, Portugal.
   Univ Aveiro, Dept Ceram & Glass Engn, UIMC, P-3810193 Aveiro, Portugal.
RP Santos, JD (reprint author), Inst Biomed Engn, Lab Biomat, Rua Campo Alegre 823, P-4150 Porto, Portugal.
RI Lopes, Cristina/A-4241-2010; Lopes, Maria A./P-4442-2014; Silva,
   Rui/B-8208-2008
OI Lopes, Maria A./0000-0003-4105-8148; Silva, Rui/0000-0002-2584-1792;
   Monteiro, Fernando/0000-0002-1361-4605; Santos, Jose
   Domingos/0000-0002-6871-9850
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   AOKI H, 1991, SCI MED APPL HYDROXY
   BURSTEIN AH, 1994, FUNDAMENTALS ORTHOPA
   CARTER DR, 1991, BONE-BIOMATERIAL INTERFACE, P367
   CHATAL V, 1990, LINEAR PROGRAMMING
   DEWITH G, 1981, J MATER SCI, V16, P1592
   *ENV, 1995, 8432 ENV 2
   KATZ JL, 1989, BIOCERAMICS, V1, P86
   Knowles JC, 1996, BIOMATERIALS, V17, P1437, DOI 10.1016/0142-9612(96)87287-5
   KNOWLES JC, 1994, BRIT CERAM T, V93, P100
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   LOPES MA, 1998, BIOCERAMICS, V10, P575
   MURTAGE B, 1981, ADV LINEAR PROGRAMMI
   Rice R.W., 1977, TREATISE MATERIALS S, VII, P200
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SAX M, 1995, CERAMIC PROCESSING S, V51, P701
   SCHREIBER E, 1989, ELASTIC CONSTANT THE
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
NR 19
TC 41
Z9 42
U1 3
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2000
VL 21
IS 7
BP 749
EP 754
DI 10.1016/S0142-9612(99)00248-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 288TZ
UT WOS:000085581700010
PM 10711972
DA 2018-10-19
ER

PT J
AU Sepulveda, P
   Binner, JGP
   Rogero, SO
   Higa, OZ
   Bressiani, JC
AF Sepulveda, P
   Binner, JGP
   Rogero, SO
   Higa, OZ
   Bressiani, JC
TI Production of porous hydroxyapatite by the gel-casting of foams and
   cytotoxic evaluation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE porous ceramics; hydroxyapatite; gel-cast foams; cytotoxicity; bone
   implants
ID CERAMICS; POROSITY
AB This study presents the manufacture of highly porous hydroxyapatite by a novel technique that employs the foaming of suspensions prior to the in situ polymerization of organic monomers contained in the compositions. This method produces strong gelled bodies with up to 90% porosity that can withstand machining in the green state. Complex-shaped components can be obtained if the process comprises casting in one of the processing steps. The organic additives are eliminated at temperatures above 300 degrees C, and sintering is carried out for consolidation of the ceramic matrix. Spherical interconnected cells with sizes ranging from 20 to 1000 mu m characterize the porous structure, depending on the specimen density. Cytotoxicity tests were conducted on extracts from sintered HA foams based on a quantitative method of cell colony formation and the determination of cell death after indirect contact of the porous material with mammalian cells. This in vitro test of biological evaluation revealed that the original purity of the biomedical-grade hydroxyapatite powder was affected neither through processing nor by the employed reagents. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   Univ Nottingham, Dept Mat Engn & Mat Design, Nottingham NG7 2RD, England.
   IPEN CNEN SP, Sao Paulo, Brazil.
RP Sepulveda, P (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
RI Sepulveda, Pilar/D-4093-2009; Bressiani, Jose/I-1426-2012; Binner,
   Jon/H-1007-2011
CR ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   Constantino PD, 1994, OTOLARYNGOL CLIN N A, V27, P1037
   FABRI M, 1995, BIOMATERIALS, V16, P225
   *INT STAND, 1993, BIOL EV MED DEV 5, V10, P993
   IOKU K, 1994, P 7 INT S CER MED TU, V7
   Janney M. A., 1991, US pat, Patent No. [5 028 362, 5028362, US 5028362 A.]
   Liu DM, 1996, KEY ENG MAT, V115, P209, DOI 10.4028/www.scientific.net/KEM.115.209
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   MIQUEL JL, 1990, COLLOID SURFACE, V45, P427, DOI 10.1016/0166-6622(90)80041-2
   ODIAN G, 1991, PRINCIPLES POLYM
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   ROSEN MJ, 1989, SURFACTANTS INTERFAC, P277
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   YOUNG AC, 1991, J AM CERAM SOC, V74, P612, DOI 10.1111/j.1151-2916.1991.tb04068.x
NR 15
TC 157
Z9 164
U1 3
U2 49
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 2000
VL 50
IS 1
BP 27
EP 34
DI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 274NP
UT WOS:000084772200005
PM 10644960
DA 2018-10-19
ER

PT J
AU Boelens, JJ
   Dankert, J
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dingemans, KP
   Koole, L
   Laman, JD
   Zaat, SAJ
AF Boelens, JJ
   Dankert, J
   Murk, JL
   Weening, JJ
   van der Poll, T
   Dingemans, KP
   Koole, L
   Laman, JD
   Zaat, SAJ
TI Biomaterial-associated persistence of Streptococcus epidermidis in
   pericatheter macrophages
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 39th Interscience Conference on Antimicrobial Agents and Chemotherapy
CY SEP 26-29, 1998
CL SAN FRANCISCO, CALIFORNIA
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTIONS;
   TUMOR-NECROSIS-FACTOR; BIOMEDICAL POLYMERS; INTERFERON-GAMMA;
   INTERLEUKIN-10; ADHESION; MODEL; PATHOGENESIS; NEUTROPHILS
AB Biomaterial surfaces may be modified to reduce bacterial adhesion. The susceptibility in mice to Staphylococcus epidermidis infection in tissue surrounding the commonly used catheter materials-silicon elastomer (SE), polyamide (PA), and their surface-modified polyvinylpyrrolidone (PVP)-grafted derivatives, SE-PVP and PA-PVP, respectively-was assessed. Abscesses developed around SE-PVP Around SE, PA, and PA-PVP catheters, no signs of infection were observed, although mice carrying PA-PVP developed septicemia after 14-21 days. S. epidermidis was cultured from the tissue surrounding PA-PVP segments. Cells around PA-PVP segments containing large numbers of bacteria were identified as macrophages by use of immunohistochemistry and electron microscopy. This persistence of intracellular bacteria was also observed around SE-PVP, SE, and PA, catheters, although to a lesser extent. The cytokine profiles around the 4 materials were different. Implanted biomaterial induces an inflammatory response favorable to the persistence of S. epidermidis. Intracellular persistence of bacteria inside macrophages may be a pivotal process in the pathogenesis of biomaterial-associated infection.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   Maastricht Ctr Biomat Res, Maastricht, Netherlands.
   Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands.
RP Boelens, JJ (reprint author), Leiden Univ, Med Ctr, Dept Pediat, J6-S-208,POB 9600, NL-2300 RC Leiden, Netherlands.
OI Boelens, Jaap Jan/0000-0003-2232-6952
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   BADDOUR LM, 1984, J INFECT DIS, V150, P721, DOI 10.1093/infdis/150.5.721
   Bisno AL, 1994, INFECT ASS INDWELLIN
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   BOELENS J, 1998, 38 INT C ANT AG CHEM
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   COSTERTON J, 1975, J ANTIMICROB CHEMOTH, V4, P363
   COSTERTON JW, 1981, CRC CR REV MICROBIOL, V8, P303, DOI 10.3109/10408418109085082
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DUQUID I, 1992, J ANTIMICROB CHEMOTH, V30, P803
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   EMILIE D, 1995, REV RHUM, V62, P229
   Fleer A, 1989, J Invest Surg, V2, P391, DOI 10.3109/08941938909018264
   GRAY ED, 1987, ZBL BAKT S, V16, P45
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   HERRMANN M, 1990, J CLIN INVEST, V86, P942
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   JOHNSON GM, 1987, ZENTRALBLATT BAKTE S, V16, P33
   Kanangat S, 1999, INFECT IMMUN, V67, P2834
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAUFMANN S, 1993, LEPROSY, P57
   Kaufmann SHE, 1995, CIBA F SYMP, V195, P123
   KLOCK JC, 1976, BLOOD, V48, P149
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9
   LAMAN J, 1998, J NEUROIMMUNOL, V86, P303
   LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   NOBLE WC, 1965, BRIT J EXP PATHOL, V46, P254
   OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676
   PAUL WE, 1993, FUNDAMENTAL IMMUNOLO
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Seifert H., 1997, CATHETER RELATED INF
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   TAUBLER JH, 1966, J INFECT DIS, V116, P257, DOI 10.1093/infdis/116.3.257
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9
   VAUDAUX P, 1992, J INFECT DIS, V166, P58, DOI 10.1093/infdis/166.1.58
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 56
TC 72
Z9 73
U1 2
U2 10
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR
PY 2000
VL 181
IS 4
BP 1337
EP 1349
DI 10.1086/315369
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 311KT
UT WOS:000086883900014
PM 10762565
OA Bronze
DA 2018-10-19
ER

PT J
AU Li, SM
   Chen, XH
   Gross, RA
   McCarthy, SP
AF Li, SM
   Chen, XH
   Gross, RA
   McCarthy, SP
TI Hydrolytic degradation of PCL/PEO copolymers in alkaline media
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MASSIVE POLY(ALPHA-HYDROXY ACIDS); STRUCTURE-PROPERTY RELATIONSHIPS;
   BLOCK-COPOLYMERS; AQUEOUS-MEDIA; POLY(ETHYLENE GLYCOL); MULTIBLOCK
   COPOLYMERS; POLYETHYLENE GLYCOLS; POLY(DL-LACTIC ACID); L-LACTIDE
AB PCL/PEO copolymers with different compositions were obtained from ring opening polymerization of epsilon-caprolactone in the presence of ethylene oxide and characterized by various analytical techniques. Data collected from DSC and X-ray diffractometry suggested that the copolymer chains possess a blocky structure, leading to both PCL and PEO-type crystalline structures. Hydrolytic degradation of these copolymers was carried out in a pH=10.6 carbonate buffer solution at 37 degrees C. Comparison was made with a PCL homopolymer and a PCL/PEG blend which had the same gross composition as one of the copolymers. The results showed that the presence of PEO sequences considerably enhanced the hydrophilicity of the copolymers as compared with PCL homopolymer. Nevertheless, the degradability of PCL chains was not enhanced due to the phase separation between the two components. These materials should be of great interest for biomedical uses such as matrices for sustained drug delivery because of the presence of both hydrophilic and hydrophobic microdomains. (C) 2000 Kluwer Academic Publishers.
C1 Univ Massachusetts, Dept Plast Engn, Lowell, MA 01851 USA.
   Univ Massachusetts, Dept Chem, Lowell, MA 01851 USA.
RP Li, SM (reprint author), Fac Pharm, Res Ctr Artificial Biopolymers, 15 Ave Charles Flahault, F-34060 Montpellier, France.
RI Li, Suming/D-1300-2014; Li, Suming/J-2868-2013
OI Li, Suming/0000-0002-3345-1479; Li, Suming/0000-0002-3345-1479
CR CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   CHEN X, IN PRESS
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   Dunn Richard L., 1995, P17
   HARRIS JM, 1985, J MACROMOL SCI R M C, VC25, P325, DOI 10.1080/07366578508081960
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   Li SM, 1998, J APPL POLYM SCI, V68, P989, DOI 10.1002/(SICI)1097-4628(19980509)68:6<989::AID-APP12>3.0.CO;2-J
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LI SM, 1994, MACROMOLECULES, V27, P3107, DOI 10.1021/ma00089a031
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LI YX, 1994, J CONTROL RELEASE, V32, P121
   MANOLOVA N, 1993, EUR POLYM J, V29, P721, DOI 10.1016/0014-3057(93)90134-2
   PAUL DR, 1978, POLYM BLENDS, P56
   Petrova T, 1998, POLYM INT, V45, P419
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1992, BIODEGRADABLE POLYM, P1
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
   WANG WQ, 1993, CHINESE CHEM LETT, V4, P363
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 29
TC 42
Z9 43
U1 1
U2 19
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2000
VL 11
IS 4
BP 227
EP 233
DI 10.1023/A:1008920326988
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289LU
UT WOS:000085623900006
PM 15348037
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI New director of biomedical materials
SO MATERIALS WORLD
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0967-8638
J9 MATER WORLD
JI Mater. World
PD APR
PY 2000
VL 8
IS 4
BP 8
EP 8
PG 1
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 302ZC
UT WOS:000086395500021
DA 2018-10-19
ER

PT J
AU Chauhan, GS
   Dhiman, SK
   Guleria, LK
   Misra, BN
   Kaur, I
AF Chauhan, GS
   Dhiman, SK
   Guleria, LK
   Misra, BN
   Kaur, I
TI Polymers from renewable resources: kinetics of 4-vinyl pyridine
   radiochemical grafting onto cellulose extracted from pine needles
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID ISOTACTIC POLYPROPYLENE; METHYL ACRYLATE; COPOLYMERIZATION;
   DESALINATION; MEMBRANES; MONOMERS; GELATIN; FIBER; WOOL
AB In view of the marked thrust of research activities in the area of biodegradable polymers use of pine needles as renewable stock of polymeric materials has been made to synthesize graft copolymers for biomedical and industrial applications. 4-Vinyl pyridine (4-VP) has been radiochemically grafted onto cellulose extracted from pine needles using simultaneous irradiation method in limited aqueous medium. Optimum grafting conditions and kinetic parameters such as percent grafting, grafting efficiency, total conversion of monomer and rates of polymerization, homopolymerization and grafting have been evaluated as a function of total dose, monomer concentration and amount of water. It is observed that variation in both total dose and monomer concentration leads to inconsistent increase and decrease of the grafting parameters. However, rate of polymerization shows unsteady but regular increase with increasing monomer concentration and total dose radiation. While optimum amount of water is required for maximum percent grafting, addition of methanol on the other hand leads to regular decrease in percent grafting as a consequence of fall in the rate of grafting contrary to some earlier reported studies. Evidence of grafting has been based on the comparative studies of cellulose and grafted cellulose by infrared spectroscopy, elemental analysis and thermal analysis. Grafting enhances thermal stability of cellulose backbone. The trends in the results have been explained by kinetic interpretation and suitable mechanism for grafting has been proposed. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Himachal Pradesh Univ, Dept Chem, Simla 171005, Himachal Prades, India.
RP Chauhan, GS (reprint author), Himachal Pradesh Univ, Dept Chem, Summer Hill, Simla 171005, Himachal Prades, India.
OI Chauhan, Ghanshyam/0000-0002-5032-5706
CR Bojanic V, 1996, J APPL POLYM SCI, V60, P1719, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1719::AID-APP24>3.0.CO;2-Y
   Chauhan GS, 1998, CHEM PAP-CHEM ZVESTI, V52, P182
   Chauhan GS, 1999, J POLYM SCI POL CHEM, V37, P1763, DOI 10.1002/(SICI)1099-0518(19990615)37:12<1763::AID-POLA5>3.3.CO;2-J
   Chauhan GS, 1997, J APPL POLYM SCI, V65, P191
   GARNETT JL, 1976, J POLYM SCI POL LETT, V14, P35, DOI 10.1002/pol.1976.130140107
   KANBARA T, 1992, J POLYM SCI A, V35, P2787
   Kaur I, 1997, DESALINATION, V110, P115, DOI 10.1016/S0011-9164(97)00091-X
   Kaur I, 1997, POLYM POLYM COMPOS, V5, P291
   Kaur I, 1998, POLYM INT, V46, P275, DOI 10.1002/(SICI)1097-0126(199808)46:4<275::AID-PI991>3.0.CO;2-0
   Kaur I, 1997, DESALINATION, V110, P129, DOI 10.1016/S0011-9164(97)00092-1
   Mark HF, 1968, ENCY POLYM SCI TECHN
   MASSON JF, 1991, MACROMOLECULES, V24, P5914, DOI 10.1021/ma00022a004
   MEHTA IK, 1994, J APPL POLYM SCI, V54, P1171, DOI 10.1002/app.1994.070540820
   MEHTA IK, 1990, J APPL POLYM SCI, V41, P1171, DOI 10.1002/app.1990.070410526
   Misra BN, 1996, COLLECT CZECH CHEM C, V61, P259, DOI 10.1135/cccc19960259
NR 15
TC 32
Z9 32
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD APR
PY 2000
VL 58
IS 2
BP 181
EP 190
DI 10.1016/S0969-806X(99)00363-1
PG 10
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 311KR
UT WOS:000086883800010
DA 2018-10-19
ER

PT J
AU Thomann, UI
   Uggowitzer, PJ
AF Thomann, UI
   Uggowitzer, PJ
TI Wear-corrosion behavior of biocompatible austenitic stainless steels
SO WEAR
LA English
DT Article
DE wear-corrosion; biocompatible; nickel-free; stainless steel
ID NITROGEN; CRACKING; DEVICES
AB The present work compares 316L and Rex734 stainless steels - currently used for biomedical applications - with the recently developed P558 alloy in terms of mechanical properties, corrosion and dry wear resistance as well as the combined wear-corrosion behavior. Pin-on-drum tests were conducted to determine the dry wear resistance of test materials. Wear-corrosion behavior was studied in slurry tests and pin-on-disk experiments in distilled water, Hank's artificial physiological solution, and 22% NaCl aqueous solution. Corrosion resistance was determined by potentiodynamic tests and critical crevice corrosion temperature measurements. Due to its combination of outstanding mechanical properties and excellent corrosion resistance, P558 performed much better than 316L in all tests. P558 also proved to be more resistant against dry wear, wear-corrosion, and crevice corrosion than Rex734. The resistance of P558 against pitting corrosion was found to be equal to the resistance of Rex734. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 ETH Zurich, Inst Met, Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland.
RP Thomann, UI (reprint author), Swiss Fed Inst Technol, Inst Design & Construct Methods, Wagistr 6,Postfach, CH-8952 Schlieren, Switzerland.
RI Uggowitzer, Peter/H-3581-2012
OI Uggowitzer, Peter/0000-0002-9504-5652
CR BALL A, 1983, WEAR, V91, P201, DOI 10.1016/0043-1648(83)90254-5
   BLICKENSDERFER R, 1988, J TEST EVAL, V16, P516
   BULARD SJ, 1996, NACE INT ANN C EXP C
   Eckenrod J., 1979, ASTM STP, V679, P17
   HEATHCOCK CJ, 1982, WEAR, V81, P311, DOI 10.1016/0043-1648(82)90278-2
   HOLCOMB GR, 1997, MICROSTRUCT SCI, V25, P191
   *ISIJ, 1996, HIGH NITR STEELS, V36
   KAIN RM, 1990, J TEST EVAL, V18, P309
   KEARNS JR, 1985, J MAT ENG, V7, P16
   MADSON BW, 1986, NACE INT ANN C EXP C
   Mills DJ, 1998, WEAR, V215, P83, DOI 10.1016/S0043-1648(97)00273-1
   MOZHI TA, 1986, CORROSION, V42, P197, DOI 10.5006/1.3585997
   MULLNER P, 1993, MAT SCI ENG A-STRUCT, V164, P164, DOI 10.1016/0921-5093(93)90655-X
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   OGAWA T, 1982, WELD J, V61, P139
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Robinson PW, 1985, J HEAT TREATING, V4, P69
   SIVAKUMAR M, 1992, J MATER SCI LETT, V11, P1039, DOI 10.1007/BF00729754
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   SPEIDEL MO, 1993, P MAT WEEK 92 CHIC, P135
   SPEIDEL MO, 1998, MAT MED, P191
   Truman JE., 1989, P INT C HIGH NITR ST, P225
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 24
TC 82
Z9 94
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD APR
PY 2000
VL 239
IS 1
BP 48
EP 58
DI 10.1016/S0043-1648(99)00372-5
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 307ZC
UT WOS:000086683200006
DA 2018-10-19
ER

PT J
AU Mukkamala, R
   Kushner, AM
   Bertozzi, CR
AF Mukkamala, R
   Kushner, AM
   Bertozzi, CR
TI Hydrogel polymers from alkylthio acrylates for biomedical applications:
   Effect of sulfur oxidation state on materials' properties.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 26
PY 2000
VL 219
MA 529-POLY
BP U445
EP U445
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 317UW
UT WOS:000087246202477
DA 2018-10-19
ER

PT J
AU Morita, A
   Fukui, H
   Tadano, H
   Hayashi, S
   Hasegawa, J
   Niinomi, M
AF Morita, A
   Fukui, H
   Tadano, H
   Hayashi, S
   Hasegawa, J
   Niinomi, M
TI Alloying titanium and tantalum by cold crucible levitation melting
   (CCLM) furnace
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT International-Union-of-Materials-Research-Societies International
   Conference on Advanced Materials (IUMRS-ICAM 99)
CY JUN 13-18, 1999
CL BEIJING, PEOPLES R CHINA
SP Int Union Mat Res Soc
DE biomedical titanium alloys; alloying titanium and tantalum; cold
   crucible levitation melting; CCLM; making an alloy of base metals;
   single melting (no re-melting) process
AB Recently, titanium alloys have been studied as implant materials for dental and orthopedic surgery. Titanium alloys have distinguished characteristics of biocompatibility, corrosion resistance and mechanical properties. Having non-poisonous character to a living body, Ta, Zr and Nb have been used for addition to titanium alloys, which are free of vanadium and aluminum. It is well-known that titanium and tantalum are difficult metals to alloy in usual furnaces as these are very reactive metals, having great differences in melting point anti specific gravity. To produce an alloy of titanium and tantalum, cold crucible levitation melting (CCLM) is effective in obtaining a uniform composition. Notable features of CCLM are that it can (1) melt metals with a high melting point, (2) create an alloy of uniform composition with a strong stirring effect by an electromagnetic force and (3) allow metals to be melted without contamination. We have melted 850 g of titanium and 150 g of tantalum by a CCLM furnace and have successfully made 1.0 kg of uniform composite Ti-15wt.% Ta alloy. It is noteworthy that the alloy was produced from pure base metals which were not alloyed beforehand and was made by a single melting (no re-melting) process. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Fuji Elect Furnace Co Ltd, Suzuka, Mie 5138633, Japan.
   Aichi Gakuin Univ, Sch Dent, Dept Dent Mat, Chikusa Ku, Nagoya, Aichi 464, Japan.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418550, Japan.
RP Tadano, H (reprint author), Fuji Elect Furnace Co Ltd, 5520 Minami Tamagaki Cho, Suzuka, Mie 5138633, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR FUKUI H, 1999, P 9 WORLD C TIT ST P
   FUKUZAWA A, 1994, P INT S ELECTROMAGNE, P172
   IMAM A, 1996, ASTM STP, V1272, P3
   KANIUMA K, 1996, P 13 INT C EL APPL B, pMII9
   Mishra A. K., 1996, ASTM STP, V1272, P96
   NAKAMURA Y, 1998, 3 WORLD BIOM C KYOT, P202
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1998, NON-AEROSPACE APPLICATIONS OF TITANIUM, P217
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Steinemann S., 1980, EVALUATION BIOMATERI
   TADANO H, 1994, IEEE T MAGN, V30, P4740, DOI 10.1109/20.334207
   TADANO H, 1997, P 2 INT C EL PROC MA, V1, P377
   Wang KK, 1996, ASTM STP, V1272, P76
   Zardiackas L., 1996, ASTM STP, P60
NR 14
TC 41
Z9 41
U1 1
U2 22
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAR 15
PY 2000
VL 280
IS 1
BP 208
EP 213
DI 10.1016/S0921-5093(99)00668-1
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 293FA
UT WOS:000085839800036
DA 2018-10-19
ER

PT J
AU Dai, LM
   Mau, AWH
AF Dai, LM
   Mau, AWH
TI Surface and interface control of polymeric biomaterials, conjugated
   polymers, and carbon nanotubes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Review
ID LIGHT-EMITTING-DIODES; SELF-ASSEMBLED MONOLAYERS; ORGANIC
   ELECTROLUMINESCENT DEVICES; TRIBLOCK COPOLYMER CHAINS;
   THIN-FILM-TRANSISTOR; PHENYLENE VINYLENE OLIGOMER; SCANNING FORCE
   MICROSCOPY; LARGE-SCALE SYNTHESIS; CONDUCTING POLYMERS;
   ELECTROCHEMICAL-CELLS
AB Surface and interface play an important role in controlling the properties of a broad range of materials. With the recent development of various advanced surface analytical techniques, our understanding of material surfaces and interfaces has been significantly increased, as with our ability to control and even to tailor the surface and interfacial characteristics for specific applications. This is a very broad field which includes material synthesis, structural determination, surface/interface design and modification. In this article, we present some of the important issues concerning the surface and interface control of polymeric biomaterials, conjugated polymers, and carbon nanotubes for biomedical and optoelectronic applications and describe the use of X-ray photoelectron spectroscopy (XPS), surface force apparatus (SFA), and neutron reflectometry (NR) for elucidation of the surface and interface structures.
C1 CSIRO, Clayton S, Vic 3169, Australia.
RP Dai, LM (reprint author), CSIRO, Bag 10, Clayton S, Vic 3169, Australia.
CR AJAYAN PM, 1995, ADV MATER, V7, P489, DOI 10.1002/adma.19950070520
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   AJAYAN PM, 1997, REP PROG PHYS, V60, P1026
   AJAYAN PM, 1994, SCIENCE, V265, P1211
   AKARI S, 1995, ADV MATER, V7, P549, DOI 10.1002/adma.19950070607
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Anastassopoulos DL, 1998, MACROMOLECULES, V31, P9369, DOI 10.1021/ma980379y
   Armes SP, 1996, CURR OPIN COLLOID IN, V1, P214, DOI 10.1016/S1359-0294(96)80007-0
   AUROY P, 1992, MACROMOLECULES, V25, P4134, DOI 10.1021/ma00042a014
   BAKER GL, 1988, ADV CHEM SER, V218
   Baldo MA, 1998, NATURE, V395, P151
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5
   BAUGHMAN RH, 1990, SCI APPL CONDUCTING
   Beamson G., 1992, HIGH RESOLUTION XPS
   BERGGREN M, 1994, J APPL PHYS, V76, P7530, DOI 10.1063/1.357984
   BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0
   BIGGS S, 1995, LANGMUIR, V11, P156, DOI 10.1021/la00001a028
   BIRKETT PR, 1999, CHEM BR          MAY, P45
   Bjorling M, 1998, MACROMOLECULES, V31, P9033, DOI 10.1021/ma971732n
   Black J., 1992, BIOL PERFORMANCE MAT
   Bonard JM, 1998, ULTRAMICROSCOPY, V73, P7, DOI 10.1016/S0304-3991(97)00129-0
   BORISOV OV, 1995, MACROMOLECULES, V28, P7180, DOI 10.1021/ma00125a021
   BORMAN S, 1990, CHEM ENG NEWS   0507, P53
   BOWDEN MJ, 1988, ADV CHEM SER, V218
   Bradley D.D.C., 1995, ORGANIC ELECTROLUMIN
   Braithwaite GJC, 1996, LANGMUIR, V12, P4224, DOI 10.1021/la960154l
   Bredas J. L., 1991, CONJUGATED POLYM
   BROCHARDWYART F, 1994, MACROMOL SYMP, V79, P1, DOI 10.1002/masy.19940790103
   BROWN AR, 1992, APPL PHYS LETT, V61, P2793, DOI 10.1063/1.108094
   BROWN AR, 1996, SYNTHETIC MET, V80, P119
   BUM PL, 1992, NATURE, V356, P47
   Burghard M, 1998, ADV MATER, V10, P584, DOI 10.1002/(SICI)1521-4095(199805)10:8<584::AID-ADMA584>3.3.CO;2-0
   BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0
   CALVERT P, 1988, NATURE, V333, P296, DOI 10.1038/333296a0
   Campbell SE, 1996, NATURE, V382, P520, DOI 10.1038/382520a0
   Cazabat AM, 1997, INTERFACE SCI, V5, P129, DOI 10.1023/A:1008657225779
   Chambers A, 1998, J PHYS CHEM B, V102, P4253, DOI 10.1021/jp980114l
   Chan C. M, 1994, POLYM SURFACE MODIFI
   CHATELIER R, Patent No. 9406485
   CHATELIER RC, 1995, LANGMUIR, V11, P2585, DOI 10.1021/la00007a043
   Chavrolin J., 1990, LIQUIDS INTERFACES
   Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694
   Chen P, 1999, SCIENCE, V285, P91, DOI 10.1126/science.285.5424.91
   Chien J. C. W., 1984, POLYACETYLENE CHEM P
   CHO I, 1995, MACROMOL RAPID COMM, V16, P851, DOI 10.1002/marc.1995.030161111
   Choong V, 1996, APPL PHYS LETT, V69, P1492, DOI 10.1063/1.116918
   Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373
   CONWELL EM, 1993, SPIE P, V1910
   COSGROVE T, 1991, MACROMOLECULES, V24, P94, DOI 10.1021/ma00001a015
   Courvoisier A, 1998, LANGMUIR, V14, P3727, DOI 10.1021/la971041k
   CROWLEY TL, 1991, COLLOID SURFACE, V52, P85, DOI 10.1016/0166-6622(91)80007-B
   Curran SA, 1998, ADV MATER, V10, P1091, DOI 10.1002/(SICI)1521-4095(199810)10:14<1091::AID-ADMA1091>3.0.CO;2-L
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   DAGANI R, 1995, C E NEWS        0424, P42
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   DAI L, 1991, EUROPHYS LETT, V16, P331, DOI 10.1209/0295-5075/16/4/003
   DAI L, 1997, MACROMOL CHEM PHYS, V189, P1723
   DAI L, 1996, SURFACE MODIFICATION
   DAI L, 1999, ACS S SER, V735
   DAI L, 1995, CHIN J MAT RES ENG, V9, P397
   DAI L, 1989, SYNTHETIC MET, V28, P69
   Dai LM, 1999, POLYM ADVAN TECHNOL, V10, P357, DOI 10.1002/(SICI)1099-1581(199907)10:7<357::AID-PAT886>3.0.CO;2-9
   Dai LM, 1999, J MACROMOL SCI R M C, VC39, P273
   Dai LM, 1996, MACROMOLECULES, V29, P282, DOI 10.1021/ma951054+
   DAI LM, 1991, POLYMER, V32, P2120, DOI 10.1016/0032-3861(91)90034-G
   Dai LM, 1997, POLYMER, V38, P775, DOI 10.1016/S0032-3861(96)00573-3
   Dai LM, 1997, J PHYS CHEM B, V101, P9548, DOI 10.1021/jp970562d
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Dai LM, 1998, J PHYS CHEM B, V102, P4049, DOI 10.1021/jp980410y
   DAI LM, 1993, EUR POLYM J, V29, P645, DOI 10.1016/0014-3057(93)90122-V
   DAI LM, 1994, MACROMOLECULES, V27, P6728, DOI 10.1021/ma00101a008
   DAI LM, 1992, J PHYS CHEM-US, V96, P6469, DOI 10.1021/j100194a067
   DAI LM, 1993, J POLYM SCI POL PHYS, V31, P3, DOI 10.1002/polb.1993.090310102
   Dai LM, 1997, SYNTHETIC MET, V85, P1379, DOI 10.1016/S0379-6779(97)80281-0
   DAI LM, 1995, MACROMOLECULES, V28, P5512, DOI 10.1021/ma00120a015
   DAI LM, 1992, MACROMOLECULES, V25, P6000, DOI 10.1021/ma00048a022
   DANNETUM P, 1994, ORGANIC MAT ELECT CO
   DANNETUN P, 1993, MOL CRYST LIQ CRYST, V228, P43, DOI 10.1080/10587259308032141
   DANNETUN P, 1993, SYNTHETIC MET, V55, P212, DOI 10.1016/0379-6779(93)90935-P
   DEGENNES PG, 1985, CR ACAD SCI II, V300, P839
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   deGennes PG, 1979, SCALING CONCEPTS POL
   DEHEER WA, 1995, SCIENCE, V268, P845, DOI 10.1126/science.268.5212.845
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   deHeer WA, 1997, ADV MATER, V9, P87, DOI 10.1002/adma.19970090122
   DELLACHERIE E, 1993, POLYM BULL, V31, P145, DOI 10.1007/BF00329959
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0
   DORGAN JR, 1993, MACROMOLECULES, V26, P5321, DOI 10.1021/ma00072a008
   Dresselhaus M. S., 1996, SCI FULLERENES CARBO
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0
   Ebbesen TW, 1996, PHYS TODAY, V49, P26, DOI 10.1063/1.881603
   Ebbsen T., 1997, CARBON NANOTUBES
   Edelmann FT, 1999, ANGEW CHEM INT EDIT, V38, P1381, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1381::AID-ANIE1381>3.0.CO;2-V
   FAN FRF, 1985, CHEM PHYS LETT, V116, P400, DOI 10.1016/0009-2614(85)80192-5
   Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512
   FEIJEN J, 1994, J MACROMOL SCI PURE, VA31, P1153
   FERNANDEZ ML, 1988, POLYMER, V29, P1923, DOI 10.1016/0032-3861(88)90162-0
   FERREIRA M, 1995, MACROMOLECULES, V28, P7107, DOI 10.1021/ma00125a012
   FERREIRA M, 1994, THIN SOLID FILMS, V244, P806, DOI 10.1016/0040-6090(94)90575-4
   FIELD JB, 1992, J PHYS II, V2, P2221
   FIELD JB, 1992, MACROMOLECULES, V25, P434, DOI 10.1021/ma00027a067
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   Gadd GE, 1997, SCIENCE, V277, P933, DOI 10.1126/science.277.5328.933
   GALAEV IY, 1995, RUSS CHEM REV, V64, P471
   GAO Y, 1993, J APPL PHYS, V73, P7894, DOI 10.1063/1.353941
   GARNIER F, 1990, ADV MATER, V2, P592, DOI 10.1002/adma.19900021207
   Graupner W, 1996, PHYS REV LETT, V76, P847, DOI 10.1103/PhysRevLett.76.847
   Greenham N. C., 1995, SOLID STATE PHYS, V49, P1
   GREENHAM NC, 1993, NATURE, V365, P628, DOI 10.1038/365628a0
   GRIESSER H, 1998, MITTAL FESTSCHRIFT A
   GRIESSER HJ, 1991, LANGMUIR, V7, P2484, DOI 10.1021/la00059a015
   Guffond MC, 1997, LANGMUIR, V13, P5691, DOI 10.1021/la970377r
   Guo ZJ, 1998, ADV MATER, V10, P701, DOI 10.1002/(SICI)1521-4095(199806)10:9<701::AID-ADMA701>3.0.CO;2-4
   Gyoutoku A, 1997, SYNTHETIC MET, V91, P73, DOI 10.1016/S0379-6779(98)80067-2
   HADZIIOANNOU G, 1986, J AM CHEM SOC, V108, P2869, DOI 10.1021/ja00271a014
   Haliloglu T, 1997, MACROMOL THEOR SIMUL, V6, P667, DOI 10.1002/mats.1997.040060306
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   HALPERIN A, 1991, MACROMOLECULES, V24, P5393, DOI 10.1021/ma00019a029
   Hamaguchi M, 1996, APPL PHYS LETT, V69, P143, DOI 10.1063/1.116901
   Harlev E, 1996, ADV MATER, V8, P994, DOI 10.1002/adma.19960081211
   Harrison JA, 1997, J PHYS CHEM B, V101, P9682, DOI 10.1021/jp972261+
   HAYASHI T, 1993, BIOMEDICAL APPL POLY
   HEVENS OS, 1965, OPTICAL PROPERTIES T
   Hiberer A., 1997, MACROMOL CHEM PHYS, V198, P2211
   Hide F, 1997, ACCOUNTS CHEM RES, V30, P430, DOI 10.1021/ar950191o
   Higgins J. S., 1994, POLYM NEUTRON SCATTE
   HOLMES AB, 1993, SYNTHETIC MET, V55, P4031
   Holzer L, 1999, SYNTHETIC MET, V100, P71, DOI 10.1016/S0379-6779(98)00171-4
   Hong HP, 1998, ADV MATER, V10, P1104, DOI 10.1002/(SICI)1521-4095(199810)10:14<1104::AID-ADMA1104>3.3.CO;2-6
   Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U
   Hoyer P, 1996, ADV MATER, V8, P857, DOI 10.1002/adma.19960081022
   Hsieh BR, 1996, SYNTHETIC MET, V78, P269, DOI 10.1016/0379-6779(96)80149-4
   Hu B, 1998, SYNTHETIC MET, V92, P157, DOI 10.1016/S0379-6779(98)80105-7
   Hu B, 1998, CHEM PHYS, V227, P263, DOI 10.1016/S0301-0104(97)00306-6
   Huang SM, 1999, J MATER CHEM, V9, P1221, DOI 10.1039/a901839e
   Huang SM, 1999, J PHYS CHEM B, V103, P4223, DOI 10.1021/jp990342v
   Huang ZY, 1997, LANGMUIR, V13, P6480, DOI 10.1021/la970537z
   HUGHES AE, 1988, J ELECTRON SPECTROSC, V46, P31, DOI 10.1016/0368-2048(88)80003-3
   HUGHES DJ, 1954, NEUTRON OPTICS
   Hung LS, 1997, APPL PHYS LETT, V70, P152, DOI 10.1063/1.118344
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   IMANISHI Y, 1992, SYNTHESIS BIOCOMPOSI
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Ito Y, 1997, J AM CHEM SOC, V119, P1619, DOI 10.1021/ja963418z
   IWAO T, 1993, MATER RES SOC S P, V290, P311
   Jabbour GE, 1997, APPL PHYS LETT, V71, P1762, DOI 10.1063/1.119392
   JACKMAN RJ, 1999, CHEMTECH         MAY, P18
   JEON H, 1992, APPL PHYS LETT, V60, P892, DOI 10.1063/1.106496
   Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655
   Kaner R. B., 1988, SCI AM           FEB, P106
   KAO K, 1993, P 7 INT C POL MED SU, P193
   Karg S, 1996, SYNTHETIC MET, V80, P111, DOI 10.1016/S0379-6779(96)03690-9
   Katz HE, 1997, J MATER CHEM, V7, P369, DOI 10.1039/a605274f
   Kim YE, 1996, APPL PHYS LETT, V69, P599, DOI 10.1063/1.117919
   KLEIN J, 1991, NATURE, V352, P143, DOI 10.1038/352143a0
   KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0
   Klein J., 1988, MOL CONFORMATION DYN
   KONSTADINIDIS K, 1995, J APPL PHYS, V77, P5642, DOI 10.1063/1.359206
   KOSMAS M, 1994, J PHYS II, V4, P501, DOI 10.1051/jp2:1994140
   Kraft A, 1998, ANGEW CHEM INT EDIT, V37, P402, DOI 10.1002/(SICI)1521-3773(19980302)37:4<402::AID-ANIE402>3.0.CO;2-9
   Kugler T, 1999, ACCOUNTS CHEM RES, V32, P225, DOI 10.1021/ar980041o
   Kugler T, 1999, SYNTHETIC MET, V100, P163, DOI 10.1016/S0379-6779(98)00162-3
   KUMAR A, 1994, SCIENCE, V263, P60, DOI 10.1126/science.263.5143.60
   Kusunoki M, 1997, APPL PHYS LETT, V71, P2620, DOI 10.1063/1.120158
   Kyotani T, 1996, CHEM MATER, V8, P2109, DOI 10.1021/cm960063+
   LAI PY, 1992, MACROMOLECULES, V25, P6693, DOI 10.1021/ma00050a045
   LEKNER J, 1987, THEOY REFLECTION
   LEKNER J, 1987, THEORY REFLECTION
   Leyden D.E., 1988, CHEM MODIFIED SURFAC
   Li WZ, 1996, SCIENCE, V274, P1701, DOI 10.1126/science.274.5293.1701
   LIANG WB, 1992, POLYMER, V35, P3101
   Lidzey DG, 1996, SYNTHETIC MET, V82, P141, DOI 10.1016/S0379-6779(96)03781-2
   LIN H, 1995, MACROMOLECULES, V28, P1470, DOI 10.1021/ma00109a018
   Liu J, 1999, CHEM PHYS LETT, V303, P125, DOI 10.1016/S0009-2614(99)00209-2
   Liu J, 1997, NATURE, V385, P780, DOI 10.1038/385780b0
   LOPEZ GP, 1993, LANGMUIR, V9, P1513, DOI 10.1021/la00030a015
   Lovinger AJ, 1996, J MATER RES, V11, P1581, DOI 10.1557/JMR.1996.0198
   LUCKHAM PF, 1993, ADV COLLOID INTERFAC, V44, P183, DOI 10.1016/0001-8686(93)80024-6
   MACDIARMID AG, 1995, SYNTHETIC MET, V69, P85, DOI 10.1016/0379-6779(94)02374-8
   MacDiarmid AG, 1999, SYNTHETIC MET, V100, P131, DOI 10.1016/S0379-6779(98)00164-7
   MacDiarmid AG, 1997, SYNTHETIC MET, V84, P27, DOI 10.1016/S0379-6779(97)80658-3
   MACDIARMID AG, 1996, ACS MONOGRAPH
   MANSFIELD TL, 1995, MACROMOLECULES, V28, P492, DOI 10.1021/ma00106a012
   MARCIANO Y, 1995, MACROMOLECULES, V28, P985, DOI 10.1021/ma00108a028
   Marks RN, 1997, PHILOS T R SOC A, V355, P763, DOI 10.1098/rsta.1997.0042
   Martin JI, 1996, LANGMUIR, V12, P4950, DOI 10.1021/la960305k
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   MATSUDA T, 1995, LANGMUIR, V11, P2267
   MATTOUSSI H, 1993, J CHEM PHYS, V99, P9188, DOI 10.1063/1.465534
   MESSERSCHMIDT GL, 1988, J CLIN ONCOL, V6, P203, DOI 10.1200/JCO.1988.6.2.203
   MILLER JS, 1993, ADV MATER, V5, P671, DOI 10.1002/adma.19930050918
   MILLER JS, 1993, ADV MATER, V5, P587, DOI 10.1002/adma.19930050718
   MILLER JS, 1994, ANGEW CHEM INT EDIT, V33, P385, DOI 10.1002/anie.199403851
   MILLIARAS GG, 1993, ADV MATER, V10, P721
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   MILNER ST, 1988, EUROPHYS LETT, V5, P413, DOI 10.1209/0295-5075/5/5/006
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   MILNER ST, 1992, MACROMOLECULES, V25, P5495, DOI 10.1021/ma00046a057
   MISRA S, 1994, MACROMOLECULES, V27, P5037, DOI 10.1021/ma00096a028
   MISRA S, 1994, MACROMOLECULES, V27, P2058, DOI 10.1021/ma00086a013
   Mukerjee P., 1971, 36 NSRDSNBS US DEP C
   MYLNIKOV VS, 1994, ADV POLYM SCI, V115
   NAKAYAMA T, 1993, APPL PHYS LETT, V63, P594, DOI 10.1063/1.109959
   Nalwa H.S., 1997, HDB ORGANIC CONDUCTI
   NEUSCH F, 1997, ADV MATER, V9, P222
   Nguyen TP, 1995, SYNTHETIC MET, V75, P175, DOI 10.1016/0379-6779(96)80004-X
   Nguyen TP, 1996, VACUUM, V47, P1153, DOI 10.1016/0042-207X(96)00179-0
   NGUYEN TP, 1995, SYNTHETIC MET, V72, P35, DOI 10.1016/0379-6779(94)02312-M
   NguyenMisra M, 1996, MACROMOLECULES, V29, P1407, DOI 10.1021/ma950802s
   NGUYENMISRA M, 1995, MACROMOLECULES, V28, P6976, DOI 10.1021/ma00124a039
   NISHIDE H, 1995, ADV MATER, V7, P937, DOI 10.1002/adma.19950071116
   Niu CM, 1997, APPL PHYS LETT, V70, P1480, DOI 10.1063/1.118568
   Noach S, 1996, APPL PHYS LETT, V69, P3650, DOI 10.1063/1.117012
   OHKAWA K, 1991, JPN J APPL PHYS 1, V30, P3873, DOI 10.1143/JJAP.30.3873
   OKAHATA Y, 1986, MACROMOLECULES, V19, P494
   Orita K, 1997, SYNTHETIC MET, V91, P155, DOI 10.1016/S0379-6779(98)80078-7
   OSHEA SJ, 1993, LANGMUIR, V9, P1826, DOI 10.1021/la00031a034
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Pan ZW, 1998, NATURE, V394, P631, DOI 10.1038/29206
   Park Y, 1997, PHYS REV LETT, V78, P3955, DOI 10.1103/PhysRevLett.78.3955
   PATEL S, 1989, ANNU REV PHYS CHEM, P40
   PATTIL AO, 1988, CHEM REV, V88, P183
   PAUCK T, 1995, CHEM PHYS LETT, V244, P171, DOI 10.1016/0009-2614(95)00867-4
   Pei Q, 1997, SYNTHETIC MET, V85, P1229, DOI 10.1016/S0379-6779(97)80216-0
   Pei QB, 1996, J AM CHEM SOC, V118, P3922, DOI 10.1021/ja953695q
   PEI QB, 1995, SCIENCE, V269, P1086, DOI 10.1126/science.269.5227.1086
   Penfold J, 1997, J CHEM SOC FARADAY T, V93, P3899, DOI 10.1039/a702836i
   PERKINS TT, 1995, SCIENCE, V268, P83, DOI 10.1126/science.7701345
   PLANEIX JM, 1994, J AM CHEM SOC, V116, P7935, DOI 10.1021/ja00096a076
   Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513
   Prasad P. N., 1991, FRONTIERS POLYM RES
   PRITCHARD DJ, 1995, ANGEW CHEM INT EDIT, V34, P91, DOI 10.1002/anie.199500911
   PYRAMITSYU VA, 1987, MODERN PROBLEMS PHYS
   RABIN Y, 1990, EUROPHYS LETT, V13, P49, DOI 10.1209/0295-5075/13/1/009
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RAO CNR, 1998, J CHEM SOC CHEM COMM, V1525
   Ratner B. D., 1996, SURFACE MODIFICATION
   Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105
   RICHARDS RW, 1994, TRENDS POLYM SCI, V2, P5
   Romero DB, 1996, ADV MATER, V8, P899, DOI 10.1002/adma.19960081105
   ROTHMAN T, 1988, SCI AM           AUG, P12
   ROZSNYAI LF, 1995, LANGMUIR, V11, P3913, DOI 10.1021/la00010a048
   ROZSNYAI LF, 1994, J AM CHEM SOC, V116, P5993, DOI 10.1021/ja00092a070
   RUSSELL TP, 1991, ANNU REV MATER SCI, V21, P249
   RUSSELL TP, 1988, MACROMOLECULES, V21, P1890, DOI 10.1021/ma00184a066
   Saito R., 1998, PHYSICAL PROPERTIES
   Saito Y, 1997, JPN J APPL PHYS 2, V36, pL1340, DOI 10.1143/JJAP.36.L1340
   Salaneck W. R., 1996, CONJUGATED POLYM SUR
   Salaneck WR, 1996, ADV MATER, V8, P48, DOI 10.1002/adma.19960080108
   SARICIFTCI NS, 1994, INT J MOD PHYS B, V8, P237, DOI 10.1142/S0217979294000105
   Sarid D., 1991, SCANNING FORCE MICRO
   SAVILLE PM, 1994, J PHYS CHEM-US, V98, P5935, DOI 10.1021/j100074a020
   SCHERF U, 1999, CARBON RICH COMPOUND, V2
   SCHEUTJENS JMHM, 1979, J PHYS CHEM-US, V83, P1619, DOI 10.1021/j100475a012
   Schick M. J., 1987, NONIONIC SURFACTANTS
   SCHIERBAUM KD, 1994, SCIENCE, V265, P1413, DOI 10.1126/science.265.5177.1413
   Schmid H, 1997, APPL PHYS LETT, V70, P2679, DOI 10.1063/1.118978
   SCHMID W, 1993, ACTA POLYM, V44, P208, DOI 10.1002/actp.1993.010440407
   SCHMID W, 1996, LAMBDA HIGHLIGHTS, V42, P4
   SCHUHMANN W, 1995, BIOSENS BIOELECTRON, V10, P181, DOI 10.1016/0956-5663(95)96805-9
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Scott JC, 1996, J APPL PHYS, V79, P2745, DOI 10.1063/1.361096
   SEIDLE P, 1995, LANGMUIR, V11, P1065
   Service RF, 1998, SCIENCE, V279, P1135
   SINGH J, 1992, J MACROMOL SCI R M C, VC32, P521, DOI 10.1080/15321799208021431
   Sinitsyn NI, 1997, APPL SURF SCI, V111, P145, DOI 10.1016/S0169-4332(96)00695-2
   Skotheim T.A, 1998, HDB CONDUCTING POLYM
   Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724
   Spatz JP, 1997, MACROMOLECULES, V30, P3874, DOI 10.1021/ma9607372
   SRINIVASAN R, 1989, CHEM REV, V89, P1303, DOI 10.1021/cr00096a003
   STAMM M, 1991, EUROPHYS LETT, V14, P1441
   STAMM M, 1992, ADV POLYM SCI, V100, P419
   STUART JK, 1995, LANGMUIR, V11, P1368, DOI 10.1021/la00004a051
   STUCKY DG, 1991, ACS S SERIES, V455
   SUGAWARA T, 1994, MACROMOLECULES, V27, P7809, DOI 10.1021/ma00104a040
   Sun RG, 1996, JPN J APPL PHYS 2, V35, pL1506, DOI 10.1143/JJAP.35.L1506
   Takikawa H, 1998, JPN J APPL PHYS 2, V37, pL187, DOI 10.1143/JJAP.37.L187
   Tang H, 1997, APPL PHYS LETT, V71, P2560, DOI 10.1063/1.119325
   Tang WH, 1996, MACROMOLECULES, V29, P4412, DOI 10.1021/ma951547e
   Tans SJ, 1998, NATURE, V393, P49
   Tasch S, 1999, SYNTHETIC MET, V102, P1046, DOI 10.1016/S0379-6779(98)00229-X
   TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033
   TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0
   Terrones M, 1997, NATURE, V388, P52, DOI 10.1038/40369
   Terrones M, 1996, PHILOS T R SOC A, V354, P2025, DOI 10.1098/rsta.1996.0090
   Terrones M, 1998, CHEM PHYS LETT, V285, P299, DOI 10.1016/S0009-2614(98)00093-1
   THAKUR M, 1988, MACROMOLECULES, V21, P661, DOI 10.1021/ma00181a021
   TOPRAKCIOGLU C, 1993, PROG COLL POL SCI S, V91, P83
   TRIPP CP, 1994, LANGMUIR, V10, P4031, DOI 10.1021/la00023a022
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   TURNBULL MM, 1996, ACS S SERIES, V644
   ULMAN A, 1990, ADV MATER, V2, P573, DOI 10.1002/adma.19900021203
   VANLENT B, 1989, MACROMOLECULES, V22, P1931, DOI 10.1021/ma00194a069
   Vargo T. G., 1995, SUPRAMOL SCI, V2, P169
   VOIVODOV K, 1993, MAKROMOL CHEM-M SYMP, V70-1, P275, DOI 10.1002/masy.19930700129
   Walls J., 1990, METHODS SURFACE ANAL
   Wang HL, 1996, SYNTHETIC MET, V80, P97, DOI 10.1016/S0379-6779(96)03688-0
   Wang HL, 1996, SYNTHETIC MET, V78, P33, DOI 10.1016/0379-6779(95)03569-6
   Wang QH, 1997, APPL PHYS LETT, V70, P3308, DOI 10.1063/1.119146
   Wang YZ, 1997, APPL PHYS LETT, V70, P3215, DOI 10.1063/1.119129
   Wang YZ, 1996, APPL PHYS LETT, V68, P894, DOI 10.1063/1.116222
   Wei PK, 1996, ADV MATER, V8, P573, DOI 10.1002/adma.19960080708
   WIJMANS CM, 1994, J COLLOID INTERF SCI, V167, P124, DOI 10.1006/jcis.1994.1340
   WILLIAMS DRM, 1993, MACROMOLECULES, V26, P5806, DOI 10.1021/ma00073a040
   WILLIAMS EW, 1987, LUMINESCENCE LIGHT E
   Winkler B, 1999, CHEM MATER, V11, P704, DOI 10.1021/cm980570m
   WINKLER B, 2000, PHYS CHEM CHEM PHYS, V2, P29
   Wirth MJ, 1997, SCIENCE, V275, P44, DOI 10.1126/science.275.5296.44
   Wong SS, 1998, NATURE, V394, P52
   Wong SS, 1998, J AM CHEM SOC, V120, P603, DOI 10.1021/ja9737735
   Wu CC, 1997, APPL PHYS LETT, V70, P1348, DOI 10.1063/1.118575
   XU X, 1995, P INT WORKSH EL EL 9
   Yakobson BI, 1997, AM SCI, V85, P324
   YAKOBSON BI, 1997, AM SCI, V85, P325
   YAMAKAWA H, 1971, MODERN THEORY POLYM
   YAN M, 1995, PHYS REV LETT, V75, P1992, DOI 10.1103/PhysRevLett.75.1992
   YANG Y, 1994, MOL CRYST LIQ CRYS A, V256, P537, DOI 10.1080/10587259408039288
   YANG Y, 1994, NATURE, V372, P344, DOI 10.1038/372344a0
   Yang Y, 1996, APPL PHYS LETT, V68, P2708, DOI 10.1063/1.116316
   Yang YY, 1999, J AM CHEM SOC, V121, P10832, DOI 10.1021/ja992945q
   YANG Z, 1995, MACROMOLECULES, V28, P6151, DOI 10.1021/ma00122a023
   YANG Z, 1993, MACROMOLECULES, V26, P6570, DOI 10.1021/ma00076a040
   Yang Z, 1998, J MACROMOL SCI PURE, VA35, P233, DOI 10.1080/10601329808001975
   YANG Z, 1993, MACROMOLECULES, V26, P1188, DOI 10.1021/ma00057a047
   YANG Z, 1997, MACROMOL S, V83, P83
   Yasuda H., 1985, PLASMA POLYM
   Yoshida M, 1996, APPL PHYS LETT, V69, P734, DOI 10.1063/1.117874
   Yoshida M, 1996, JPN J APPL PHYS 2, V35, pL397, DOI 10.1143/JJAP.35.L397
   ZHAO W, 1994, MACROMOLECULES, V27, P2933, DOI 10.1021/ma00089a007
   Zhulina E, 1996, MACROMOLECULES, V29, P2667, DOI 10.1021/ma951396f
   ZYSS J, 1987, NONLINEAR OPTICAL PR
   1992, CHEM ENG NEWS    JUL, P4
   1998, CHEM ENG NEWS   0612
   1988, NEW SCI         0728, P39
NR 340
TC 49
Z9 50
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAR 9
PY 2000
VL 104
IS 9
BP 1891
EP 1915
DI 10.1021/jp9926793
PG 25
WC Chemistry, Physical
SC Chemistry
GA 291ZT
UT WOS:000085770200002
DA 2018-10-19
ER

PT J
AU Tapia, A
   Mejina, D
   Rengifo, M
   Blanch, A
   Ferreira, B
AF Tapia, A
   Mejina, D
   Rengifo, M
   Blanch, A
   Ferreira, B
TI Improving the aesthetics of the cheek bone projection during facial
   lifting
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE zygomatic prominence; rhytidectomy; facelift; SMAS; nasogenian fold
ID MALAR; RHYTIDECTOMY; AUGMENTATION; IMPLANTS; FACE
AB This paper shows how one of the flaps of the SMAS, which is normally eliminated during a facelift as excess tissue, can be folded up and used to improve the projection of cheekbone. The improvement of the projection of this facial area enhances the aesthetic result, when the desired aesthetic result is discreet, in rhytidectomy without having to resort to biomedical material or complex surgical techniques. Our technique, which is safe and easy to handle, simplifies this procedure, providing a long-lasting satisfactory result for both the patient and the surgeon. Our report was done following rhytidectomy on 126 female patients and after an approximately 3-year follow-up.
RP Tapia, A (reprint author), C Balmes 203,4 2A, Barcelona 08006, Spain.
CR Bonnefon A, 1995, Ann Chir Plast Esthet, V40, P327
   FURNAS DW, 1989, PLAST RECONSTR SURG, V83, P11, DOI 10.1097/00006534-198901000-00003
   GONZALEZULLOA M, 1974, PLAST RECONSTR SURG, V53, P293, DOI 10.1097/00006534-197403000-00007
   HAMRA ST, 1990, PLAST RECONSTR SURG, V86, P53, DOI 10.1097/00006534-199007000-00008
   HINDERER UT, 1975, PLAST RECONSTR SURG, V56, P157, DOI 10.1097/00006534-197508000-00007
   JOST G, 1984, PLAST RECONSTR SURG, V74, P42, DOI 10.1097/00006534-198407000-00006
   MITZ V, 1986, ANN PLAS SURG, V17, P184, DOI 10.1097/00000637-198609000-00004
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   OWSLEY JQ, 1993, RECONSTR SURG, V91, P464
   PERPERE C H, 1992, Annales de Chirurgie Plastique et Esthetique, V37, P95
   SIEMIAN WR, 1988, PLAST RECONSTR SURG, V82, P395, DOI 10.1097/00006534-198809000-00003
   STUZIN JM, 1992, PLAST RECONSTR SURG, V89, P441, DOI 10.1097/00006534-199203000-00007
   STUZIN JM, 1990, ANN M AM SOC AESTH P
   TAPIA A, 1992, 10 C INT CONF PLAST, V1, P475
   TAPIA A, 1993, AESTH PLAST SURG
   TAPIA A, 1999, IN PRESS PLAST RECON
   WHITAKER LA, 1987, PLAST RECONSTR SURG, V80, P337, DOI 10.1097/00006534-198709000-00001
   WILKINSON TS, 1983, PLAST RECONSTR SURG, V71, P643, DOI 10.1097/00006534-198305000-00011
NR 18
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD MAR-APR
PY 2000
VL 24
IS 2
BP 85
EP 89
DI 10.1007/s002660010016
PG 5
WC Surgery
SC Surgery
GA 311VY
UT WOS:000086907600001
PM 10833230
DA 2018-10-19
ER

PT J
AU Wu, JZ
   Herzog, W
AF Wu, JZ
   Herzog, W
TI Finite element simulation of location- and time-dependent mechanical
   behavior of chondrocytes in unconfined compression tests
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biphasic; poroelastic; cartilage; finite element analysis; cell
   mechanics; tissue growth; adaptation
ID BOVINE ARTICULAR-CARTILAGE; LOCAL TISSUE STRAIN; DIFFERENTIAL SCHEME;
   AGAROSE CULTURE; DEFORMATION; MATRIX; BIOSYNTHESIS; MODULI
AB Experimental evidence suggests that cells are extremely sensitive to their mechanical environment and react directly to mechanical stimuli. At present, it is technically difficult to measure fluid pressure, stress, and strain in cells, and to determine the time-dependent deformation of chondrocytes. For this reason, there are no data in the published Literature that show the dynamic behavior of chondrocytes in articular cartilage. Similarly, the dynamic chondrocyte mechanics have not been calculated using theoretical models that account for the influence of cell volumetric fraction on cartilage mechanical properties. In the present investigation, the location- and time-dependent stress-strain state and fluid pressure distribution in chondrocytes in unconfined compression tests were simulated numerically using a finite element method. The technique involved two basic steps: first, cartilage was approximated as a macroscopically homogenized material and the mechanical behavior of cartilage was obtained using the homogenized model; second, the solution of the time-dependent displacements and fluid pressure fields of the homogenized model was used as the time-dependent boundary conditions for a microscopic submodel to obtain average location- and time-dependent mechanical behavior of cells. Cells and extracellular matrix were assumed to be biphasic materials composed of a fluid phase and a hyperelastic solid phase. The hydraulic permeability was assumed to be deformation dependent and the analysis was performed using a finite deformation approach. Numerical tests were made using configurations similar to those of experiments described in the literature. Our simulations show that the mechanical response of chondrocytes to cartilage loading depends on time, fluid boundary conditions, and the locations of the cells within the specimen. The present results are the first to suggest that chondrocyte deformation in a stress-relaxation type test may exceed the imposed system deformation by a factor of 3-4, that chondrocyte deformations are highly dynamic and do not reach a steady state within about 20 min of steady compression (in an unconfirmed test), and that cell deformations are very much location dependent. (C) 2000 Biomedical Engineering Society [S0090694(00)00303-3].
C1 Univ Calgary, Fac Kinesiol, Human Performance Lab, Dept Mech Engn, Calgary, AB T2N 1N4, Canada.
RP Herzog, W (reprint author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Dept Mech Engn, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
CR Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Bachrach NM, 1995, J BIOMECH, V28, P1561, DOI 10.1016/0021-9290(95)00103-4
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Christensen RM, 1991, MECH COMPOSITE MAT
   CLARK AL, 1999, P 17 C INT SOC BIOM, P339
   ESHELBY JD, 1956, SOLID STATE PHYS, V3, P79
   Glanz J, 1997, SCIENCE, V276, P678
   GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602
   Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   GUILAK F, 1992, ADV BIOENG, V22, P21
   HASHIN Z, 1962, J APPL PHYS, V33, P3125, DOI 10.1063/1.1728579
   HOLMES MH, 1990, J BIOMECH, V23, P1145, DOI 10.1016/0021-9290(90)90007-P
   HOLMES MH, 1986, J BIOMECH ENG-T ASME, V108, P372, DOI 10.1115/1.3138633
   HOU JS, 1989, J BIOMECH ENG-T ASME, V111, P78, DOI 10.1115/1.3168343
   *IMSL, 1990, US MAN IMSL MATH LIB, pCH5
   Jones WR, 1997, T ORTHOPAEDIC RES SO, V22, P199
   LAI WM, 1981, J BIOMECH ENG-T ASME, V103, P61, DOI 10.1115/1.3138261
   MCLAUGHLIN R, 1977, INT J ENG SCI, V15, P237, DOI 10.1016/0020-7225(77)90058-1
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P345
   NORRIS AN, 1985, MECH MATER, V4, P1, DOI 10.1016/0167-6636(85)90002-X
   SAAMANEN AM, 1987, CONNECT TISSUE RES, V16, P163, DOI 10.3109/03008208709002004
   SAH RLY, 1991, ARTICULAR CARTILAGE, P373
   Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404
   SCHNEIDERMAN R, 1986, J ORTHOPAED RES, V4, P393, DOI 10.1002/jor.1100040402
   Shin D, 1997, T ORTHOPAEDIC RES SO, V22, P352
   Stockwell RA., 1979, BIOL CARTILAGE CELLS
   Torzilli PA, 1997, J BIOMECH, V30, P1, DOI 10.1016/S0021-9290(96)00117-0
   Wong M, 1997, J ORTHOPAED RES, V15, P189, DOI 10.1002/jor.1100150206
   Wu JZ, 1998, J BIOMECH, V31, P165
   Wu JZ, 1999, J BIOMECH, V32, P563, DOI 10.1016/S0021-9290(99)00034-2
   ZIMMERMAN RW, 1991, MECH MATER, V12, P17, DOI 10.1016/0167-6636(91)90049-6
NR 35
TC 77
Z9 79
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2000
VL 28
IS 3
BP 318
EP 330
DI 10.1114/1.271
PG 13
WC Engineering, Biomedical
SC Engineering
GA 316EA
UT WOS:000087153600010
PM 10784096
DA 2018-10-19
ER

PT J
AU de Lima, CJ
   Sathaiah, S
   Silveira, L
   Zangaro, RA
   Pacheco, MTT
AF de Lima, CJ
   Sathaiah, S
   Silveira, L
   Zangaro, RA
   Pacheco, MTT
TI Development of catheters with low fiber background signals for Raman
   spectroscopic diagnosis applications
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 1st Latin American Congress for Artificial Organs and Biomaterials
CY DEC 10-13, 1998
CL BELO HORIZONT, BRAZIL
SP Int Soc Artificial Organs, Financier Studies & Projects, Fdn Res Support St Minas Gerais, Fed Univ Minas Gerais, Brizilian Inst Biomat
DE multifiber catheters; fiber optics
ID FLUORESCENCE; SYSTEM
AB Utilization of optical-fiber catheters can turn the Raman spectroscopy system into a powerful remote biomedical diagnostic probe. An in vivo (a qualitative and a quantitative) biochemical diagnosis of biotissues is possible by developing the Raman-fiber probes with a good flexibility and less background signals generated in the probes themselves. Considering the isotropic nature of Raman scattering, the amount of Raman signal guided through the fiber is expected to depend on the numerical aperture (NA) of the fiber. To study the dependence for catheter probes experimentally, various flexible probes (with small diameter fibers) with different combinations of numerical apertures and with different assembling materials (biocompatible) have been developed. The catheter probes have been characterized by collecting the near infrared excited Raman scattered light from cholesterol powder. The results demonstrate that the catheters with a combination of lower NA (0.12) fibers used for laser excitation and relatively higher NA (0.22) fibers for Raman signal collection will have lower background signals generated in the probes. Furthermore, the catheters with a black Teflon tubing cover and black epoxy resin adhesives were found to give better results.
C1 UNIVAP, Inst Pesquisas & Desenvolvimento, BR-12244400 Sao Jose Dos Campos, Brazil.
RP Zangaro, RA (reprint author), UNIVAP, Inst Pesquisas & Desenvolvimento, Av Shishima Hifumi 2911, BR-12244400 Sao Jose Dos Campos, Brazil.
RI Silveira, Landulfo/I-2474-2012; Pacheco, Marcos/B-7991-2012
OI Silveira, Landulfo/0000-0002-6616-3334; Pacheco,
   Marcos/0000-0002-1725-4803
CR ARCHIBALD DD, 1988, APPL SPECTROSC, V42, P1558, DOI 10.1366/0003702884429643
   BRENNAN JF, 1993, APPL SPECTROSC, V47, P2081, DOI 10.1366/0003702934066505
   CHAVANTES MC, 1998, VATS 97 4 INT S THOR, P89
   CHAVANTES MC, 1996, LASER SURG MED, V8, P1
   CHONG CK, 1992, VIB SPECTROSC, V3, P35
   DALY JC, 1984, FIBER OPTICS, V3, P70
   GILMORE DA, 1995, APPL SPECTROSC, V49, P508, DOI 10.1366/0003702953964390
   GIOZZA WF, 1991, FIBRAS OPTICAS TECHN
   HOYT CC, 1988, LASER SURG MED, V8, P1, DOI 10.1002/lsm.1900080104
   IAN RL, 1996, APPL SPEC, V50, pA12
   SATHAIAH S, 1996, P INT C RAM SPECTR U, V15, P1120
   SCHWAB SD, 1984, ANAL CHEM, V56, P2199, DOI 10.1021/ac00276a049
   Zangaro RA, 1996, APPL OPTICS, V35, P5211, DOI 10.1364/AO.35.005211
NR 13
TC 17
Z9 17
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAR
PY 2000
VL 24
IS 3
BP 231
EP 234
DI 10.1046/j.1525-1594.2000.06525.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 300GL
UT WOS:000086244500016
PM 10759647
DA 2018-10-19
ER

PT J
AU Schroeder, A
   Francz, G
   Bruinink, A
   Hauert, R
   Mayer, J
   Wintermantel, E
AF Schroeder, A
   Francz, G
   Bruinink, A
   Hauert, R
   Mayer, J
   Wintermantel, E
TI Titanium containing amorphous hydrogenated carbon films (a-C : H/Ti):
   surface analysis and evaluation of cellular reactions using bone marrow
   cell cultures in vitro
SO BIOMATERIALS
LA English
DT Article
DE a-C : H; bone; culture; titanium
ID DIAMOND-LIKE CARBON; IN-VITRO; STROMAL CELLS; COATINGS; IMPLANTS; WEAR;
   BIOCOMPATIBILITY; MACROPHAGES; PHOSPHATASE; RESORPTION
AB Amorphous hydrogenated carbon (a-C:H) coatings, also called diamond-like carbon (DLC), have many properties required for a protective coating material in biomedical applications. The purpose of this study is to evaluate a new surface coating for bone-related implants by combining the hardness and inertness of a-C : H films with the biological acceptance of titanium. For this purpose, different amounts of titanium were incorporated into a-C:H films by a combined radio frequency (rf) and magnetron sputtering set-up. The X-ray photoelectron spectroscopy (XPS) of air-exposed a-C:H/titanium (a-C:H/Ti) films revealed that the films were composed of TiO2 and TiC embedded in and connected to an a-C:H matrix. Cell culture tests using primary adult rat bone marrow cell cultures (BMC) were performed to determine effects on cell number and on osteoblast and osteoclast differentiation, By adding titanium to the carbon matrix, cellular reactions such as increased proliferation and reduced osteoclast-like cell activity could be obtained, while these reactions were not seen on pure a-C :H films and on glass control samples. In summary, a-C:H/Ti could be a valuable coating for bone implants, by supporting bone cell proliferation while reducing osteoclast-like cell activation. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Swiss Fed Inst Technol, Chair Biocompat Mat Sci & Engn, CH-8952 Zurich, Switzerland.
   EMPA, Swiss Fed Labs Mat Testing & Res, Dubendorf, Switzerland.
RP Wintermantel, E (reprint author), Swiss Fed Inst Technol, Chair Biocompat Mat Sci & Engn, Wagistr 23, CH-8952 Zurich, Switzerland.
OI Hauert, Roland/0000-0001-6154-9337
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   Betts F, 1992, Clin Orthop Relat Res, P75
   BOAYN B, 1996, BIOMATERIALS, V17, P137
   BODO P, 1988, J VAC SCI TECHNOL A, V6, P2396, DOI 10.1116/1.575562
   Bruinink A, 1992, BRAIN BITS PIECES, P23
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Butter R. S., 1995, Journal of Chemical Vapor Deposition, V3, P182
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   Dearnaley G., 1993, Clinical Materials, V12, P237, DOI 10.1016/0267-6605(93)90078-L
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Firkins P, 1998, J MATER SCI-MATER M, V9, P597, DOI 10.1023/A:1008917727604
   Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.0.CO;2-U
   FratzlZelman N, 1997, BONE, V20, P225, DOI 10.1016/S8756-3282(96)00367-5
   GOODMAN SB, 1993, BIOMATERIALS, V14, P522, DOI 10.1016/0142-9612(93)90241-S
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   McColl I. R., 1994, T IMF, V<bold>72</bold>, P120, DOI 10.1080/00202967.1994.11871035
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MIYOSHI K, 1989, MATER SCI FORUM, V52, P645
   Moulder J.F., 1992, HDB XRAY PHOTOELECTR, P213
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Nichols KG, 1997, J BIOMED MATER RES, V35, P265
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   RAMQVIST L, 1969, J PHYS CHEM SOLIDS, V30, P1835, DOI 10.1016/0022-3697(69)90252-2
   Scheven BAA, 1997, BIOCHEM BIOPH RES CO, V231, P231, DOI 10.1006/bbrc.1996.6040
   SCHIER V, 1993, FRESEN J ANAL CHEM, V346, P227, DOI 10.1007/BF00321420
   SIMON D, 1976, J MICROSC SPECT ELEC, V1, P175
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   WAGNER CD, 1980, ANAL CHEM, V52, P1445, DOI 10.1021/ac50059a017
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
NR 40
TC 123
Z9 124
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2000
VL 21
IS 5
BP 449
EP 456
DI 10.1016/S0142-9612(99)00135-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 280YN
UT WOS:000085131500003
PM 10674809
DA 2018-10-19
ER

PT J
AU Rheinlander, T
   Kotitz, R
   Weitschies, W
   Semmler, W
AF Rheinlander, T
   Kotitz, R
   Weitschies, W
   Semmler, W
TI Different methods for the fractionation of magnetic fluids
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE magnetic fluids; magnetic nanoparticles; magnetic fractionation;
   size-exclusion chromatography; magnetic relaxation
ID SUPERPARAMAGNETIC IRON-OXIDE; PARTICLES; SIZE
AB Magnetic fluids are used in many fields of application, such as material separation and biomedicine. Magnetic fluids consist of magnetic nanoparticles, which commonly display a broad distribution of magnetic and nonmagnetic parameters. Therefore, upon application only a small number of particles contribute to the desired magnetic effect. In order to optimize magnetic fluids for applications preference is given to methods that separate magnetic nanoparticles according to their magnetic properties. Hence, a magnetic method was developed for the fractionation of magnetic fluids. Familiar size-exclusion chromatography of two different magnetic fluids was carried out for comparison. The fractions obtained and the original samples were also magnetically characterized by magnetic resonance and magnetorelaxometry, two biomedical applications. The size-exclusion fractions are similar to those of magnetic fractionation, despite the different separation mechanisms. In this respect, magnetic fractionation has several advantages in practical use over size-exclusion chromatography: the magnetic method is faster and has a higher capacity. The fractions obtained by both methods show distinctly different magnetic properties compared to the original samples and are therefore especially suited for applications such as magnetorelaxometry.
C1 Free Univ Berlin, Inst Diagnost Forsch GmbH, D-14050 Berlin, Germany.
   Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany.
RP Rheinlander, T (reprint author), Free Univ Berlin, Inst Diagnost Forsch GmbH, Spandauer Damm 130, D-14050 Berlin, Germany.
CR FRIJA G, 1994, INVEST RADIOL, V29, pS75, DOI 10.1097/00004424-199406001-00025
   HASEGAWA S, 1987, FISH PHYSIOL BIOCHEM, V4, P101, DOI 10.1007/BF02044319
   KIRPOTIN D, Patent No. 5411730
   KOCH H, 1991, IEEE T MAGN, V27, P2793, DOI 10.1109/20.133788
   LEWIS JM, 1990, Patent No. 01899
   MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203
   MULLER RN, 1991, MAGNET RESON MED, V22, P178, DOI 10.1002/mrm.1910220203
   Neel L., 1949, ANN GEOPHYS, V5, P99
   NUNES AC, 1989, J MAGN MAGN MATER, V78, P241, DOI 10.1016/0304-8853(89)90274-6
   OGRADY K, 1986, IEEE T MAGN, V22, P1134, DOI 10.1109/TMAG.1986.1064450
   RHEINLANDER T, 1999, IEEE T MAGN, V35, P40551
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   Stierstadt K., 1990, Physikalische Blaetter, V46, P377
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Weitschies W., 1997, Pharmaceutical and Pharmacological Letters, V7, P5
   1992, Patent No. 5160725
NR 16
TC 12
Z9 12
U1 0
U2 3
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD MAR
PY 2000
VL 278
IS 3
BP 259
EP 263
DI 10.1007/s003960050041
PG 5
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 295CT
UT WOS:000085949500011
DA 2018-10-19
ER

PT J
AU Ellertson, C
   Shochet, T
   Blanchard, K
   Trussell, J
AF Ellertson, C
   Shochet, T
   Blanchard, K
   Trussell, J
TI Emergency contraception: A review of the programmatic and social science
   literature
SO CONTRACEPTION
LA English
DT Review
DE emergency contraception; delivery of health care; contraceptives;
   postcoital
ID POSTCOITAL CONTRACEPTION; WOMENS KNOWLEDGE; GENERAL-PRACTICE; YUZPE
   REGIMEN; REQUESTING TERMINATION; TEENAGERS KNOWLEDGE; PILLS; PREGNANCY;
   ATTITUDES; POPULATION
AB Many biomedical aspects of emergency contraception have been investigated and documented for >30 years now. A large number of social science questions, however, remain to be answered. In this article, WE review the rapidly growing but geographically lopsided literature on this topic. Using computer database searches supplemented by reference reviews and professional correspondence with those active iu the field, we gathered literature on the social science and service delivery aspects Of emergency contraception published in English zip through December 1998, as well as a few unpublished papers from the same time and slightly later, representing regions where published material is practically nonexistent. Methodologically acceptable papers are summarized in our tables and text, and form the basis for suggested improvements in existing emergency contraceptive services, The review also offers ideas for designing new emergency contraception services where they do not yet exist. WE conclude by proposing an agenda for further social science research in this area. CONTRACEPTION 2000;61:145-186 (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
   Col Villa Coyoacan, Populat Council, Mexico City, DF, Mexico.
   Populat Council, Johannesburg, South Africa.
RP Trussell, J (reprint author), Princeton Univ, Off Populat Res, 21 Prospect Ave, Princeton, NJ 08544 USA.
EM trussell@princeton.edu
CR Adinma J. I. B., 1993, Advances in Contraception, V9, P341, DOI 10.1007/BF01983213
   AHMED Y, 1999, SETTING NEW AGENDA R
   *AM COLL OBST GYN, 1996, EM OR CONTR ACOG PRA
   Bako A. U., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P151
   BIRD ST, 1998, J AM MED WOMENS A S2, V53, P262
   Blanchard K, 1998, J Am Med Womens Assoc (1972), V53, P238
   BRACKEN MB, 1990, OBSTET GYNECOL, V76, P552
   Breitbart V, 1998, J Am Med Womens Assoc (1972), V53, P255
   BREITBART V, 1998, J AM MED WOM ASS S2, V53, P265
   BROMHAM DR, 1993, BRIT MED J, V306, P556, DOI 10.1136/bmj.306.6877.556
   Brown JW, 1998, AM J PUBLIC HEALTH, V88, P1380, DOI 10.2105/AJPH.88.9.1380
   Bullock J, 1997, Community Nurse, V3, P28
   BURTON R, 1990, BR J FAM PLANN, V15, P119
   Camp S I, 1998, J Am Med Womens Assoc (1972), V53, P225
   CAMP SL, 1994, STUDY TOUR REPORT EM
   Cheng YM, 1997, CONTRACEPTION, V55, P15
   CHRISTENSEN A, 1995, PLANN PARENTHOOD EUR, V24, P18
   Cohall A T, 1998, J Am Med Womens Assoc (1972), V53, P258
   Crosier A, 1996, BRIT J FAM PLAN, V22, P87
   Crosier A., 1997, EMERGENCY CONTRACEPT
   Delbanco S F, 1998, J Am Med Womens Assoc (1972), V53, P242
   Delbanco SF, 1998, ARCH PEDIAT ADOL MED, V152, P727
   Delbanco SF, 1997, OBSTET GYNECOL, V89, P1006, DOI 10.1016/S0029-7844(97)00142-7
   DUNCAN G, 1990, BRIT J FAM PLANN, V15, P112
   Ellertson C, 1998, J Am Med Womens Assoc (1972), V53, P226
   ELLERTSON C, 1997, CONT OB GYN, V42, P102
   Ellertson C., 1998, J AM MED WOM ASS S2, V53, P232
   *FOOD DRUG ADM, 1997, FED REGISTER, V62, P8610
   Galvao L, 1999, INT FAM PLAN PERSPEC, V25, P168, DOI 10.2307/2991880
   Gbolade BA, 1996, BRIT J FAM PLAN, V22, P120
   GEORGE J, 1994, BRIT J GEN PRACT, V44, P451
   Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101
   Glasier A, 1996, FAM PLANN PERSPECT, V28, P49, DOI 10.2307/2136123
   Glasier A, 1998, J Am Med Womens Assoc (1972), V53, P219
   Glasier A, 1996, INT FAM PLAN PERSPEC, V22, P57, DOI 10.2307/2950732
   Gold MA, 1997, FAM PLANN PERSPECT, V29, P15, DOI 10.2307/2953348
   Gooder P, 1996, BRIT J FAM PLAN, V22, P81
   Goodyear L, 1998, J Am Med Womens Assoc (1972), V53, P266
   GORDON AF, 1998, J OBSTET GYNAECOL, V18, P93
   Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567
   Griffiths M, 1990, BRIT J FAM PLANN, V16, P16
   GROU F, 1994, AM J OBSTET GYNECOL, V171, P1529, DOI 10.1016/0002-9378(94)90396-4
   Harper C, 1995, Fam Plann Perspect, V27, P149, DOI 10.2307/2136258
   HARPER CC, 1995, AM J OBSTET GYNECOL, V173, P1438, DOI 10.1016/0002-9378(95)90630-4
   HOUGHTON A, 1994, BRIT J FAM PLAN, V20, P69
   Hughes H, 1996, BRIT J FAM PLAN, V22, P77
   Hutchings J, 1998, J Am Med Womens Assoc (1972), V53, P230
   *INT PLANN PAR FED, 1994, IPPF MED B, V28, P1
   JOHNSTON TA, 1985, BRIT MED J, V290, P1040, DOI 10.1136/bmj.290.6474.1040-a
   Kishen M, 1996, BRIT J FAM PLAN, V22, P25
   Kosunen E, 1997, CONTRACEPTION, V55, P153, DOI 10.1016/S0010-7824(97)00022-X
   Lahteenmaki P, 1995, Plan Parent Eur, V24, P13
   Langer A, 1999, CONTRACEPTION, V60, P233, DOI 10.1016/S0010-7824(99)00088-8
   Lewis C, 1996, BRIT J FAM PLAN, V22, P16
   Lewis C, 1996, BRIT J FAM PLAN, V22, P52
   LING WY, 1979, FERTIL STERIL, V32, P297
   Little P, 1998, BRIT MED J, V316, P1948, DOI 10.1136/bmj.316.7149.1948
   Maxwell M, 1996, BRIT J FAM PLAN, V22, P79
   Muia E, 1999, CONTRACEPTION, V60, P223, DOI 10.1016/S0010-7824(99)00089-X
   MUIA E, 1998, J OBSTET GYNAECOL E, V14, P25
   Nanthakumaran H, 1998, INT J STD AIDS, V9, P48, DOI 10.1258/0956462981920865
   Ngoc NTN, 1997, INT FAM PLAN PERSPEC, V23, P68, DOI 10.2307/2950826
   ni Riain A, 1998, Eur J Contracept Reprod Health Care, V3, P124
   Olaitan A, 1996, BRIT J FAM PLAN, V22, P127
   Pappenheim K, 1995, Plan Parent Eur, V24, P20
   PEARSON VAH, 1995, BRIT MED J, V310, P1644, DOI 10.1136/bmj.310.6995.1644
   PERCIVALSMITH RKL, 1988, CONTRACEPTION, V37, P425, DOI 10.1016/0010-7824(88)90119-9
   PEREZ MR, 1995, PLANN PARENTHOOD EUR, V24, P11
   Petitti D B, 1998, J Am Med Womens Assoc (1972), V53, P251
   Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3
   Price SJ, 1997, PUBLIC HEALTH, V111, P377
   Priddy A, 1996, BRIT J FAM PLAN, V21, P139
   Pyett PM, 1996, AUST NZ J OBSTET GYN, V36, P347, DOI 10.1111/j.1479-828X.1996.tb02726.x
   Renne E.P., 1998, REPROD HEALTH MATTER, V6, P107
   ROBERTS RN, 1995, BRIT J FAM PLAN, V21, P22
   Rogala C, 1995, Plan Parent Eur, V24, P15
   Rowlands S, 1998, J ROY SOC MED, V91, P297, DOI 10.1177/014107689809100603
   ROWLANDS S, 1991, BR J FAM PLANN, V17, P23
   Rutgers RAK, 1998, S AFR MED J, V88, P143
   Sawyer RG, 1996, J AM COLL HEALTH, V44, P139, DOI 10.1080/07448481.1996.9937520
   Sawyer RG, 1996, J AM COLL HEALTH, V44, P145, DOI 10.1080/07448481.1996.9937521
   Schilling L H, 1984, J Am Coll Health, V32, P244
   Seamark CJ, 1997, J ROY SOC MED, V90, P443, DOI 10.1177/014107689709000807
   Senanayake P, 1996, INT FAM PLAN PERSPEC, V22, P69, DOI 10.2307/2950735
   Simmonte M, 1996, BRIT J FAM PLAN, V22, P139
   Skibiak J, 1999, TESTING STRATEGIES I
   Skolnick AA, 1997, JAMA-J AM MED ASSOC, V278, P101, DOI 10.1001/jama.278.2.101
   Smith BH, 1996, BRIT J OBSTET GYNAEC, V103, P1109, DOI 10.1111/j.1471-0528.1996.tb09592.x
   SMITH LFP, 1995, BRIT J GEN PRACT, V45, P409
   Society for Family Health, 1998, EM CONTR NIG
   Stevenson J, 1996, BRIT J FAM PLAN, V22, P75
   Swahn ML, 1996, ACTA OBSTET GYN SCAN, V75, P738, DOI 10.3109/00016349609065738
   THOMPSON E, 1994, BR J FAM PLANN, V19, P278
   *TOR DEP HLTH, 1996, UPD EM CONTR CAMP
   TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857
   Trussell J, 1998, J Am Med Womens Assoc (1972), V53, P247
   Trussell J, 1999, OBSTET GYNECOL, V93, P872, DOI 10.1016/S0029-7844(98)00380-9
   Trussell J, 1998, CONTRACEPTION, V57, P363, DOI 10.1016/S0010-7824(98)00042-0
   Trussell J, 1995, FERTILITY CONTROL RE, V4, P8
   Tyden T, 1998, ADV CONTRACEPT, V14, P171, DOI 10.1023/A:1006604214517
   *UK FAM PLANN RES, 1993, BR J FAM PLANN, V19, P218
   VAUGHAN B, 1998, UNPUB TABULATIONS 19
   VERNON R, 1997, EMERGENCY CONTRACEPT
   WALSH J, 1995, BRIT J FAM PLAN, V20, P121
   Walsh J, 1996, BRIT J FAM PLAN, V22, P27
   Webb A., 1993, Advances in Contraception, V9, P75, DOI 10.1007/BF02115904
   Webb A., 1995, FERTILITY CONTROL RE, V4, P16
   WEBB A, 1993, BR J FAMILY PLANNING, V18, P113
   WEISBERG E, 1995, MED J AUSTRALIA, V162, P136
   Wells ES, 1998, FAM PLANN PERSPECT, V30, P288, DOI 10.2307/2991505
   WELLS ES, 1997, INVESTIGATION USE PH
   Westley E, 1998, J Am Med Womens Assoc (1972), V53, P215
   Westley E, 1998, J AM MED WOM ASS S2, P37
   WESTLEY E, 1999, DELIVERANCE DANGER C
   *WHO, 1996, WHOFRHFPP969
   WILSON S, 1994, CONTRACEPTION, V50, P77, DOI 10.1016/0010-7824(94)90082-5
   YELLIN S, 1993, BR J FAM PLAN, V19, P160
   YOUNG L, 1995, NEW ZEAL MED J, V108, P145
   Ziebland S, 1998, FAM PRACT, V15, P449, DOI 10.1093/fampra/15.5.449
   Ziebland S, 1996, BRIT J FAM PLAN, V22, P84
NR 120
TC 66
Z9 66
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD MAR
PY 2000
VL 61
IS 3
BP 145
EP 186
DI 10.1016/S0010-7824(00)00091-3
PG 42
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 314KY
UT WOS:000087056000001
PM 10827331
DA 2018-10-19
ER

PT J
AU Tsap, LV
   Goldgof, DB
   Sarkar, S
   Powers, PS
AF Tsap, LV
   Goldgof, DB
   Sarkar, S
   Powers, PS
TI A method for increasing precision and reliability of elasticity analysis
   in complicated burn scar cases
SO INTERNATIONAL JOURNAL OF PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE
LA English
DT Article
DE physically-based vision; deformable models; nonrigid motion analysis;
   active contours; biomedical applications; iterative descent search;
   finite element analysis
ID DEFORMATIONS; CONTOURS; TRACKING; MODEL
AB In this paper we propose a method for increasing precision and reliability of elasticity analysis in complicated burn scar cases. The need for a technique that would help physicians by objectively assessing elastic properties of scars, motivated our original algorithm. This algorithm successfully employed active contours for tracking and finite element models for strain analysis. However, the previous approach considered only one normal area and one abnormal area within the region of interest, and scar shapes which were somewhat simplified. Most burn scars have rather complicated shapes and may include multiple regions with different elastic properties. Hence, we need a method capable of adequately addressing these characteristics. The new method can split the region into more than two localities with different material properties, select and quantify abnormal areas, and apply different forces if it is necessary for a better shape description of the scar.
   The method also demonstrates the application of scale and mesh refinement techniques in this important domain. It is accomplished by increasing the number of Finite Element Method (FEM) areas as well as the number of elements within the area. The method is successfully applied to elastic materials and real burn scar cases. We demonstrate all of the proposed techniques and investigate the behavior of elasticity function in a 3-D space. Recovered properties of elastic materials are compared with those obtained by a conventional mechanics-based approach. Scar ratings achieved with the method are correlated against the judgments of physicians.
C1 Univ Calif Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, Livermore, CA 94551 USA.
   Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA.
   Univ S Florida, Dept Psychiat, Tampa Bay Reg Burn Ctr, Tampa, FL 33620 USA.
RP Tsap, LV (reprint author), Univ Calif Lawrence Livermore Natl Lab, Ctr Appl Sci Comp, POB 5508, Livermore, CA 94551 USA.
RI Sarkar, Sudeep/A-8213-2009
OI Sarkar, Sudeep/0000-0001-7332-4207
CR Amini AA, 1998, IEEE T MED IMAGING, V17, P344, DOI 10.1109/42.712124
   Basu S, 1997, IEEE NONRIGID AND ARTICULATED MOTION WORKSHOP, PROCEEDINGS, P46, DOI 10.1109/NAMW.1997.609851
   Chandran S, 1998, IEEE T PATTERN ANAL, V20, P546, DOI 10.1109/34.682184
   Davis MH, 1997, IEEE T MED IMAGING, V16, P317, DOI 10.1109/42.585766
   DECARLO D, 1995, P 5 INT C COMP VIS B, P834
   Fung YC, 1993, BIOMECHANICS MECH PR
   Gunn SR, 1997, IEEE T PATTERN ANAL, V19, P63, DOI 10.1109/34.566812
   HUGHES T, 1984, THEORETICAL FDN LARG
   *INC SWANS AN SYST, 1996, ANSYS US MAN REV 5 3
   Kallel F, 1996, IEEE T MED IMAGING, V15, P299, DOI 10.1109/42.500139
   Kass M., 1988, INT J COMPUT VISION, V1, P321, DOI DOI 10.1007/BF00133570
   KUMAR S, 1994, IEEE T MED IMAGING, V13, P122, DOI 10.1109/42.276150
   LARRABEE WF, 1986, LARYNGOSCOPE, V96, P413
   Luenberger DG, 1984, LINEAR NONLINEAR PRO
   Martin J, 1998, IEEE T PATTERN ANAL, V20, P97, DOI 10.1109/34.659928
   McEachen JC, 1997, IEEE T MED IMAGING, V16, P270, DOI 10.1109/42.585761
   McHugh A. A., 1997, Journal of Burn Care and Rehabilitation, V18, P104, DOI 10.1097/00004630-199703000-00003
   Metaxas D., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P337, DOI 10.1109/CVPR.1991.139712
   METAXAS D, 1993, SPIE, V2031, P160
   Powers PS, 1999, J BURN CARE REHABIL, V20, P54, DOI 10.1097/00004630-199901001-00011
   Sclaroff S., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P158, DOI 10.1109/MNRAO.1994.346241
   Singh A., 1998, DEFORMABLE MODELS ME
   SULLIVAN T, 1990, Journal of Burn Care and Rehabilitation, V11, P256, DOI 10.1097/00004630-199005000-00014
   Tagare HD, 1997, IEEE T MED IMAGING, V16, P108, DOI 10.1109/42.552060
   TERZOPOULOS D, 1993, IEEE T PATTERN ANAL, V15, P569, DOI 10.1109/34.216726
   Tsap LV, 1998, IEEE T MED IMAGING, V17, P620, DOI 10.1109/42.730406
   Tsap LV, 1998, COMPUT VIS IMAGE UND, V69, P330, DOI 10.1006/cviu.1998.0663
   TSAP LV, 1998, P IEEE WORKSH BIOM I, P193
   WEISS JA, 1995, P 2 WORLD C BIOM AMS, P149
   WILLIAMS DJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P14, DOI 10.1016/1049-9660(92)90003-L
   Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665
   Young A., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P399, DOI 10.1109/CVPR.1992.223158
NR 32
TC 2
Z9 2
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE
SN 0218-0014
J9 INT J PATTERN RECOGN
JI Int. J. Pattern Recognit. Artif. Intell.
PD MAR
PY 2000
VL 14
IS 2
BP 189
EP 210
DI 10.1142/S0218001400000131
PG 22
WC Computer Science, Artificial Intelligence
SC Computer Science
GA 312QX
UT WOS:000086955100005
DA 2018-10-19
ER

PT J
AU Erlat, AG
   Wang, BC
   Spontak, RJ
   Tropsha, Y
   Mar, KD
   Montgomery, DB
   Vogler, EA
AF Erlat, AG
   Wang, BC
   Spontak, RJ
   Tropsha, Y
   Mar, KD
   Montgomery, DB
   Vogler, EA
TI Morphology and gas barrier properties of thin SiOx coatings on
   polycarbonate: Correlations with plasma-enhanced chemical vapor
   deposition conditions
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID FILMS; PERMEATION; OXYGEN; HEXAMETHYLDISILOXANE; DIFFUSION
AB Plasma-enhanced chemical vapor deposition of SiOx coatings on thermoplastics provides a viable route for production of transparent composite materials with high fracture toughness and high gas barrier properties, which are important considerations in the food packaging and biomedical device industries. By examining several series of systematically varied SiOx/polycarbonate composites, we have identified design correlations between coating characteristics (thickness, density, surface roughness, and O-2 transmission) and deposition conditions (time, power, pressure, and flow rates). Of particular interest is the observation that the thermal activation energy for O-2 permeation through these composites increases (by up to 17 kJ/mol) as their barrier efficacy increases.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
   Becton Dickinson Technol, Polymer Sci & Technol Dept, Res Triangle Pk, NC 27709 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
CR *ASM INT, 1988, ENG PLAST ENG MAT HD, V2, P151
   BARKER CP, 1995, THIN SOLID FILMS, V46, P259
   BATEY J, 1986, J APPL PHYS, V60, P3136, DOI 10.1063/1.337726
   Bauer T, 1998, MACROMOLECULES, V31, P7651, DOI 10.1021/ma9808169
   Benmalek M, 1995, SURF COAT TECH, V76-77, P821, DOI 10.1016/0257-8972(95)02601-0
   BOGART KHA, 1995, J VAC SCI TECHNOL A, V13, P476, DOI 10.1116/1.579382
   BORN M, 1965, PRINCIPLES OPTICS, P83
   CHAHROUDI D, 1991, SVC 34 ANN TECHN C P, P130
   CHAHROUDI D, 1988, SVC 31 ANN TECHN C P, P145
   CHAHROUDI D, 1989, SVC 32 ANN TECHN C P, P29
   CHANG RPH, 1983, J VAC SCI TECHNOL B, V1, P935, DOI 10.1116/1.582715
   COSTELLO LM, 1994, J POLYM SCI POL PHYS, V32, P701, DOI 10.1002/polb.1994.090320412
   DOREMUS RH, 1973, GLASS SCI, P213
   EDEN JG, 1991, THIN FILM PROCESSES, V2, P443
   Erlat AG, 1999, J PHYS CHEM B, V103, P6047, DOI 10.1021/jp990737e
   FELTS JR, 1990, SOC VACC COAT 33 ANN, P184
   FELTS JT, 1992, J VAC SCI TECHNOL A, V10, P1675, DOI 10.1116/1.577768
   FELTS JT, 1991, SOC VAC COAT 34 ANN, P99
   GarciaAyuso G, 1996, SURF COAT TECH, V80, P203, DOI 10.1016/0257-8972(95)02712-2
   HERRAK TV, 1990, J APPL PHYS, V67, P6347
   JAMIESON EHH, 1983, J MATER SCI, V18, P64, DOI 10.1007/BF00543811
   JANSEN F, 1996, AVS SHORT COURS PROG
   KEISER J, 1984, THIN SOLID FILMS, V118, P203
   KNOLL RW, 1995, SOC VAC COAT 38 ANN, P425
   KORZEC D, 1995, SURF COAT TECH, V74-5, P67, DOI 10.1016/0257-8972(95)08223-9
   KORZEC D, 1995, J VAC SCI TECHNOL A, V13, P2074, DOI 10.1116/1.579523
   KRUG T, 1993, SVC 36 ANN TECH C P, P302
   KRUG TG, 1990, SOC VACUUM COATERS, P163
   LEE JH, 1996, J ELECTROCHEM SOC, V143, P1442
   Magonov SN, 1997, SURF SCI, V375, P385
   MENGES G, 1989, COATINGS, V22, P2
   MERCEA PV, 1991, J MEMBRANE SCI, V59, P353, DOI 10.1016/S0376-7388(00)80822-4
   MONTGOMERY BD, 1998, Patent No. 5766362
   NELSON RJ, 1992, SVC 35 ANN TECHN C P, P75
   NORTON FJ, 1961, NATURE, V191, P701, DOI 10.1038/191701a0
   NORTON FJ, 1953, J AM CERAM SOC, V36, P90, DOI 10.1111/j.1151-2916.1953.tb12843.x
   PERKINS WG, 1971, J CHEM PHYS, V54, P1683, DOI 10.1063/1.1675072
   Philips R. W., 1993, SVC 36 ANN TECHN C P, P293
   *PLAST DES LIBR, 1995, PERM OTH FILM PROP P, P113
   ROBERTS AP, UNPUB
   SAHLI S, 1994, THIN SOLID FILMS, V250, P206, DOI 10.1016/0040-6090(94)90187-2
   SHELEKHIN AB, 1995, AICHE J, V41, P58, DOI 10.1002/aic.690410107
   Shepard TA, 1997, J POLYM SCI POL PHYS, V35, P2617, DOI 10.1002/(SICI)1099-0488(19971130)35:16<2617::AID-POLB5>3.0.CO;2-M
   Stannett V., 1968, DIFFUSION POLYM, P41
   THEIL JA, 1994, J VAC SCI TECHNOL A, V12, P1365, DOI 10.1116/1.579323
   TROPSHA YG, 1997, J PHYS CHEM B, V101, P2239
   Wang BC, 1999, J MATER SCI LETT, V18, P311, DOI 10.1023/A:1006687324051
   WANG BC, 1997, AM CHEM SOC POLYM PR, V38, P1018
   YANAKA M, IN PRESS THIN SOLID
   YASUDA H, 1985, PLASMAS POLYM, P277
NR 50
TC 45
Z9 45
U1 2
U2 20
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD MAR
PY 2000
VL 15
IS 3
BP 704
EP 717
DI 10.1557/JMR.2000.0103
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 290VK
UT WOS:000085698400018
DA 2018-10-19
ER

PT J
AU Armani, DK
   Liu, C
AF Armani, DK
   Liu, C
TI Mircofabrication technology for polycaprolactone, a biodegradable
   polymer
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID GOLD
AB In this paper, we report the development of micromachining techniques for a biodegradable polymer for the first time. By virtue of their ability to naturally degrade in tissues, biodegradable polymers hold immense promise as new materials for implantable biomedical microdevices. This work focuses on the establishment of microfabrication processes for biodegradable microstructures and microdevices. Three unique fabrication processes have been established: (1) a micro-molding process to form 3D microstructures in polycaprolactone (PCL) via a silicon micromachined mold, (2) a method of transferring metal patterns to surfaces of PCL substrates, (3) techniques for sealing both dry and liquid-filled PCL micro-cavities with a metal thin Nm (e.g. gold). The chemical compatibility of PCL with common micromachining chemicals have been investigated.
C1 Univ Illinois, MASS Grp, Microelect Lab, Urbana, IL 61801 USA.
RP Liu, C (reprint author), 313 Microelect Lab,208 N Wright St, Urbana, IL 61801 USA.
RI Liu, Chang/B-7249-2009
CR ANDERSON RC, 1998, IEEE WORKSH SOL STAT, P7
   Armani D, 1999, 12 IEEE INT C MICR E, P222
   BOONE T, 1998, INT WORKSH SOL STAT, P87
   FRANKENTHAL RP, 1982, J ELECTROCHEM SOC, V129, P1192, DOI 10.1149/1.2124085
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   Koleske J. V., 1978, POLYM BLENDS, V2, P369
   Lanza R P, 1998, PRINCIPLES TISSUE EN
   MAN PF, 1997, 10 INT WORKSH MEMS M, P311
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Merchant B, 1998, BIOLOGICALS, V26, P49, DOI 10.1006/biol.1997.0123
   Pitt C. G., 1983, J APPL POLYM SCI, V28, P3779
   PITT CG, 1987, ACS SYM SER, V348, P49
   Santini J. T., 1999, 10 INT C SOL STAT SE, P746
   Wilbur JL, 1996, NANOTECHNOLOGY, V7, P452, DOI 10.1088/0957-4484/7/4/028
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   POLYCAPROLACTONE
NR 17
TC 89
Z9 92
U1 2
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD MAR
PY 2000
VL 10
IS 1
BP 80
EP 84
DI 10.1088/0960-1317/10/1/311
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 317BV
UT WOS:000087206400011
DA 2018-10-19
ER

PT J
AU Furuta, M
   Ohashi, I
   Oka, M
   Hayashi, T
AF Furuta, M
   Ohashi, I
   Oka, M
   Hayashi, T
TI Irradiation effects on hydrases for biomedical applications
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 11th International Meeting on Radiation Processing (IMRP-11)
CY MAR 14-19, 1999
CL MELBOURNE, AUSTRALIA
DE irradiation; Co-60-gamma rays; papain; residual activity; sterilization
AB To apply an irradiation technique to sterilize "Hybrid" biomedical materials including enzymes, we selected papain, a well-characterized plant endopeptidase as a model to examine durability of enzyme activity under the practical irradiation condition in which limited data were available for irradiation inactivation of enzymes. Dry powder and frozen aqueous solution of papain showed significant durability against Co-60-gamma irradiation suggesting that, the commercial irradiation sterilizing method is applicable without modification. Although irradiation of unfrozen aqueous papain solution showed an unusual change of the enzymatic activity with the increasing doses, and was totally inactivated at 15 kGy, we managed to keep the residual activity more than 50% of initial activity after 30-kGy irradiation, taking such optimum conditions as increasing enzyme concentration from 10 to 100 mg/ml and purging with N-2 gas to suppress the formation of free radicals. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Osaka Prefecture, Adv Sci & Technol Res Inst, Sakai, Osaka 5998570, Japan.
RP Furuta, M (reprint author), Univ Osaka Prefecture, Adv Sci & Technol Res Inst, 1-2 Gakuen Cho, Sakai, Osaka 5998570, Japan.
CR *AAMI, 1991, PROC CONTR GUID GAMM
   Arnon R., 1970, METHOD ENZYMOL, V19, P226, DOI DOI 10.1016/0076-6879(70)19017-3
   FURUTA J, 1970, ANN REP RAD CTR OSAK, V10, P65
   LIN WS, 1975, CAN J BIOCHEM CELL B, V53, P298, DOI 10.1139/o75-042
   SATTAR A, 1983, LEBENSM WIS U TECHNO, V21, P319
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
NR 6
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAR
PY 2000
VL 57
IS 3-6
BP 455
EP 457
DI 10.1016/S0969-806X(99)00414-4
PG 3
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 307LA
UT WOS:000086653700056
DA 2018-10-19
ER

PT J
AU Nie, X
   Leyland, A
   Matthews, A
AF Nie, X
   Leyland, A
   Matthews, A
TI Deposition of layered bioceramic hydroxyapatite/TiO2 coatings on
   titanium alloys using a hybrid technique of micro-arc oxidation and
   electrophoresis
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1999 E-MRS Conference, Symposium B: Protective Coatings and Thin Films
CY JUN 01-04, 1999
CL STRASBOURG, FRANCE
SP French Minist Def, DGA/DPS, USN, Off Res Int Field Off, Europe European Off Aerosp Res & Dev, French Minist Natl Educ Res & Technol
DE biomaterials; biomedical implant; electrophoretic deposition;
   hydroxyapatite; micro-arc oxidation; titanium oxide
AB Titanium alloys have been used with some success in several bioimplant applications. However, they can suffer certain disadvantages, such as poor osteoinductive properties and low corrosive-wear resistance. Attempts to overcome the first of these drawbacks have involved coating the metal with the bioceramic material hydroxyapatite (HA), a primary component of bone and a very good osteoinductor. Since TiO2 coatings are also known to be effective as chemical barriers against the in-vivo release of metal ions from the implants, a double layer HA-TiO2 coating on titanium alloys with HA as the top layer and a dense TiO2 film as the inner layer should possess a very good combination of bioactivity, chemical stability and mechanical integrity.
   This paper describes efforts to improve implant biocompatibility and durability by applying a hybrid treatment of micro-are discharge oxidation (MDO) and electrophoretic deposition. The most common structural titanium alloy (Ti-6Al-4V) was used as the substrate material. A phosphate salt solution and an HA powder aqueous suspension were used as the electrolyte for micro-arc oxidation and the solution for HA electrophoretic deposition, respectively. It is shown that a relatively thick and hard TiO2 coating can be produced by anodic micro-are oxidation of titanium, and an HA coating incorporated on top of the TiO2 layer can simultaneously be formed using a combination of plasma electrolysis and electrophoresis, with the suspension held at high values of pH.
   X-ray diffraction (XRD), scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) have been used to investigate the microstructure and morphology of the coatings. The adhesive strength between the coating and substrate has been assessed using scratch adhesion testing. The corrosion resistance of the specimens was examined using potentiodynamic tests in a buffered physiological solution. The results indicate that a hybrid combination of micro-are oxidation and electrophoretic deposition can provide a phase-pure HA top layer and anticorrosive TiO2 interlayer, which should show good mechanical and biochemical stability in the corrosive environment of the human body. (C) 2000 Elsevier Science S.A. All rights reserved.
C1 Univ Hull, Res Ctr Surface Engn, Hull HU6 7RX, N Humberside, England.
RP Nie, X (reprint author), Univ Hull, Res Ctr Surface Engn, Hull HU6 7RX, N Humberside, England.
RI Leyland, Adrian/A-4714-2009; Matthews, Allan/H-2394-2012
OI Leyland, Adrian/0000-0002-5569-7293; Matthews, Allan/0000-0002-9282-1425
CR CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   Ding SJ, 1999, J BIOMED MATER RES, V44, P266, DOI 10.1002/(SICI)1097-4636(19990305)44:3<266::AID-JBM5>3.0.CO;2-4
   FU XQ, 1998, SURF COAT TECH, V107, P133
   Heimann RB, 1997, EUR J MINERAL, V9, P597
   Kurzweg H, 1998, BIOMATERIALS, V19, P1507, DOI 10.1016/S0142-9612(98)00067-2
   Li P, 1996, J SOL-GEL SCI TECHN, V7, P27, DOI 10.1007/BF00401880
   NIE X, 1999, SURF COAT TECH, V116, P1061
   Ogiso M, 1998, J LONG-TERM EFF MED, V8, P193
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Slosarczyk A, 1998, J MATER SCI-MATER M, V9, P103, DOI 10.1023/A:1008803232685
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   Yang CY, 1996, J MATER SCI-MATER M, V7, P167, DOI 10.1007/BF00121256
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   YEROKHIN AL, UNPUB SURF COAT TECH
   Zhang Y, 1998, ACTA PHYS-CHIM SIN, V14, P68, DOI 10.3866/PKU.WHXB19980113
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 19
TC 305
Z9 338
U1 10
U2 163
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAR
PY 2000
VL 125
IS 1-3
BP 407
EP 414
DI 10.1016/S0257-8972(99)00612-X
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 295BG
UT WOS:000085945600074
DA 2018-10-19
ER

PT J
AU Bae, YH
   Huh, KM
   Kim, Y
   Park, KH
AF Bae, YH
   Huh, KM
   Kim, Y
   Park, KH
TI Biodegradable amphiphilic multiblock copolymers and their implications
   for biomedical applications
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 5th Symposium on Controlled Drug Delivery
CY APR 01-03, 1998
CL NOORDWIJK AAN ZEE, NETHERLANDS
SP Alza Corp, 3M Medica GmbH, N V Organon, Akzo Nobel, Cordis Corp, Depotech Corp, DSM Fine Chem, Emisphere Technol Inc, Janssen Pharmaceut, Merck KgaA, Novaritis Pharms AG, Pharmacia & Upjohn AB, Inst Rech Int Servier, TheraTech
DE poly(ethylene oxide); poly(epsilon-caprolactone); poly(l-lactic acid);
   alternating multiblock copolymers; physical crosslinking; thermoplastic
   biodegradable hydrogel; wound healing
ID FIBROBLAST GROWTH-FACTOR; IN-VITRO; RELEASE; HYDROGELS
AB Alternating multiblock copolymers composed of short blocks of poly(ethylene oxide) (PEO) and poly(epsilon-caprolactone) (PCL) or poly(L-lactic acid) (PLLA) were synthesized by a coupling reaction. The block copolymers of relatively high molecular weights (M-n > 20,000) formed a physically crosslinked thermoplastic network, while low molecular weight polymers were water-soluble. The block copolymers demonstrated solubility in a variety of solvents including acetone, tetrahydrofuran, methylene chloride, dioxane, water/acetone mixtures, and water/ethanol mixtures. The degree of swelling, optical transparency, and mechanical property of the films, prepared by a solvent casting method, were affected by the nature of the hydrophobic block used, polymer composition, temperature, and thermal history. The crystalline melting temperatures of PCL and PLLA in the block copolymers were significantly lowered due to the chemical structure of difunctional PCL and PLLA, and partial phase mixing with PEO segments. The properties of the block copolymers may be useful for biomedical applications as well as controlled drug release formulations. When PEO/PLLA multiblock copolymers were applied as a wound healing material loaded with basic fibroblast growth factor (bFGF), the feasibility study showed improved wound healing when compared to controls of no treatment and the same wound covering without bFGF, indicating that a certain degree of the bioactivity of bFGF is preserved. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangsan Ku, Kwangju 506712, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangsan Ku, 572 Sangam Dong, Kwangju 506712, South Korea.
EM yhbae@matla.kjist.ac.kr
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bae YH, 1997, CONTROLLED DRUG DELI, P147
   BUCKLEYSTURROCK A, 1989, J CELL PHYSIOL, V138, P70, DOI 10.1002/jcp.1041380111
   Chen XH, 1997, MACROMOLECULES, V30, P4295, DOI 10.1021/ma970385e
   DELGUERRA RS, 1994, J MATER SCI-MATER M, V5, P891, DOI 10.1007/BF01172032
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   FALCONE DJ, 1993, J BIOL CHEM, V268, P11951
   GAJDUSEK CM, 1993, J CELL PHYSIOL, V157, P133, DOI 10.1002/jcp.1041570118
   GOSPODAROWICZ D, 1975, J CELL BIOL, V66, P451, DOI 10.1083/jcb.66.2.451
   GUENET JMM, 1992, THERMOREVERSIBLE GEL
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   HUH KM, 1999, IN PRESS POLYMER
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   MORRISER, 1978, BRIT MED BULL, V34, P49
   PARK K, 1993, BIODEGRADABLE HYDROG
   PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   TANAKA F, 1992, MACROMOLECULES, V25, P1516, DOI 10.1021/ma00031a024
   VILLASCHI S, 1993, AM J PATHOL, V143, P181
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
NR 20
TC 135
Z9 138
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB 14
PY 2000
VL 64
IS 1-3
BP 3
EP 13
DI 10.1016/S0168-3659(99)00126-1
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 285FK
UT WOS:000085378900002
PM 10640641
DA 2018-10-19
ER

PT J
AU Thomas, CA
   Zong, K
   Schottland, P
   Reynolds, JR
AF Thomas, CA
   Zong, K
   Schottland, P
   Reynolds, JR
TI Poly(3,4-alkylenedioxypyrrole)s as highly stable aqueous-compatible
   conducting polymers,vith biomedical implications
SO ADVANCED MATERIALS
LA English
DT Article
ID REDUCTION; FILMS
AB Polypyrrole (PPy) may be set to revolutionize biological applications such as tissue engineering and biosensors due to its high electroactivity/conductivity and the water compatibility of its films. However, inherent weaknesses in PPy-based materials arise from defect sites along the PPy polymer backbone, and its instability to reduction by biologically relevant reducing agents such as dithiothreitol (DTT) and glutathione. Here is presented a family of electron-rich poly(3,4-alkylenedioxypyrrole)s that address these structural weaknesses and are stable in the conducting, oxidized form, rendering them immune to strong biological reducing agents.
C1 Univ Florida, Dept Chem, Ctr Macromol Sci & Engn, Gainesville, FL 32611 USA.
RP Reynolds, JR (reprint author), Univ Florida, Dept Chem, Ctr Macromol Sci & Engn, Gainesville, FL 32611 USA.
CR Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Cosnier S, 1999, ELECTROCHIM ACTA, V44, P1833, DOI 10.1016/S0013-4686(98)00294-1
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Granstrom M, 1997, SUPRAMOL SCI, V4, P27, DOI 10.1016/S0968-5677(96)00050-8
   Guiseppi-Elie A., 1998, HDB CONDUCTING POLYM, P963
   Hukins DWL, 1999, J MATER CHEM, V9, P629, DOI 10.1039/a807411i
   LAMOUREUX GV, 1993, J ORG CHEM, V58, P633, DOI 10.1021/jo00055a015
   MERZ A, 1995, SYNTHESIS-STUTTGART, P795
   MILLER LL, 1987, MACROMOLECULES, V20, P1594, DOI 10.1021/ma00173a027
   MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060
   Pande R, 1998, BIOMATERIALS, V19, P1657, DOI 10.1016/S0142-9612(98)00043-X
   PERNAUT JM, 1989, J ELECTROANAL CHEM, V274, P225, DOI 10.1016/0022-0728(89)87043-3
   PFLUGER P, 1984, J CHEM PHYS, V80, P544, DOI 10.1063/1.446428
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Savage D., 1997, US patent, Patent No. [5,665,498, 5665498]
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SKOTEHEIM TA, 1998, HDB CONDUCTING POLYM
   VALDES LB, 1954, P IRE, V42, P420, DOI 10.1109/JRPROC.1954.274680
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   ZOTTI G, 1995, SYNTHETIC MET, V72, P275, DOI 10.1016/0379-6779(95)03280-0
NR 20
TC 85
Z9 89
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD FEB 3
PY 2000
VL 12
IS 3
BP 222
EP +
DI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 281CT
UT WOS:000085141100016
DA 2018-10-19
ER

PT J
AU Soltz, MA
   Ateshian, GA
AF Soltz, MA
   Ateshian, GA
TI Interstitial fluid pressurization during confined compression cyclical
   loading of articular cartilage
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biphasic theory; diarthrodial joints; cartilage stresses
ID BIOSYNTHETIC RESPONSE; MECHANICAL-PROPERTIES; DYNAMIC COMPRESSION;
   STRESS-RELAXATION; BEHAVIOR; MATRIX; DEFORMATION; EXPLANTS; CONTACT;
   MODEL
AB The objective of this study was to experimentally verify the well-accepted but untested hypothesis that cartilage interstitial fluid pressurizes variously under the action of an applied cyclical stress in confined compression over a range of loading frequencies, contributing significantly to the cartilage dynamic stiffness. Eighteen bovine cartilage cylindrical samples were tested under load control using a porous indenter in a confined compression chamber fitted with a microchip pressure transducer at its bottom. Over a static stress of 130 kPa. a cyclical stress of amplitude 33 kPa was applied with the indenter at frequencies ranging from 0.0001 to 0.1 Hz. The cartilage interstitial fluid pressure and deformation were measured simultaneously as a function of time. The displacement response at the lowest tested frequency was curvefitted in the time domain to determine the linear biphasic material properties, H-A=0.70 +/- 0.10 MPa and k(o) = 2.4 x 10(-16) +/- 0.64 x 10(-16) m(4)/N s. These properties were employed in the biphasic theory to predict the interstitial fluid pressure response and compare it to experiment, resulting in nonlinear coefficients of determination ranging from r(2)=0.89 +/- 0.15 to 0.96 +/- 0.03 depending on frequency. It was found for the samples of this study that above a characteristic frequency of 0.000 44 Hz, the magnitude and phase of fluid pressurization marched the applied stress, reducing the tissue strain at the impermeable bottom surface to nearly zero. The findings of this study verify the hypothesis that cartilage dynamic stiffness derives primarily from flow-dependent viscoelasticity as predicted by the linear biphasic theory; they demonstrate experimentally the significance of interstitial fluid pressurization as the fundamental mechanism of cartilage load support over a wide range of frequencies. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00202-2].
C1 Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.
RP Ateshian, GA (reprint author), Columbia Univ, Dept Mech Engn, 500 W 120th St,Rm 220 Mudd Bldg, New York, NY 10027 USA.
FU NIAMS NIH HHS [1R29-AR43628]
CR Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   ATESHIAN GA, 1995, J BIOMECH, V28, P1341, DOI 10.1016/0021-9290(95)00008-6
   Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Bachrach NM, 1998, J BIOMECH, V31, P445, DOI 10.1016/S0021-9290(98)00035-9
   Brooks SV, 1998, J MUSCLE RES CELL M, V19, P179, DOI 10.1023/A:1005364713451
   Buschmann MD, 1998, J BIOMECH, V31, P171
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   BUSCHMANN MD, 1996, J BIOMECH, V30, P197
   FRANK EH, 1987, J BIOMECH, V20, P629, DOI 10.1016/0021-9290(87)90283-1
   FUNG YCB, BIOMECHANICS MECH PR, V181, P226
   GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602
   GUILAK F, 1989, ASME BIOM S AMD, V98, P113
   GUILAK F, IN PRESS J BIOMECH E
   Higginson G. R., 1979, Engineering in Medicine, V8, P11
   HOLMES MH, 1985, J BIOMECH ENG-T ASME, V107, P206
   Kelkar R, 1999, J APPL MECH-T ASME, V66, P137, DOI 10.1115/1.2789140
   KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704
   LEE RC, 1981, J BIOMECH ENG-T ASME, V103, P280, DOI 10.1115/1.3138294
   MACIROWSKI T, 1994, ASME, V116, P11
   MAK AF, 1986, J BIOMECH ENG-T ASME, V108, P123, DOI 10.1115/1.3138591
   MANSOUR JM, 1998, T ORTHOP RES SOC, V23, P479
   MCCUTCHEN CW, 1962, WEAR, V5, P1, DOI DOI 10.1016/0043-1648(62)90176-X
   MEYERLEHNERT H, 1994, EXP NEPHROL, V2, P101
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1990, BIOMECHANICS DIARTHR, V2, P215
   OLOYEDE A, 1991, CLIN BIOMECH, V6, P206, DOI 10.1016/0268-0033(91)90048-U
   PARKKINEN JJ, 1992, J ORTHOPAED RES, V10, P610, DOI 10.1002/jor.1100100503
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   Schinagl RM, 1996, ANN BIOMED ENG, V24, P500, DOI 10.1007/BF02648112
   SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   SUH JK, 1995, J BIOMECH, V28, P357, DOI 10.1016/0021-9290(94)00103-B
   Suh JK, 1996, BIORHEOLOGY, V33, P289, DOI 10.1016/0006-355X(96)00023-6
   Torzilli PA, 1997, J BIOMECH, V30, P1, DOI 10.1016/S0021-9290(96)00117-0
   WAYNE JS, 1995, ANN BIOMED ENG, V23, P40, DOI 10.1007/BF02368299
NR 36
TC 117
Z9 120
U1 0
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2000
VL 28
IS 2
BP 150
EP 159
DI 10.1114/1.239
PG 10
WC Engineering, Biomedical
SC Engineering
GA 287TT
UT WOS:000085523100002
PM 10710186
DA 2018-10-19
ER

PT J
AU Sobel, ME
AF Sobel, ME
TI New challenges for biomedical research utilizing human biological
   materials
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Article
ID TISSUE
C1 NCI, Pathol Lab, NIH, Mol Pathol Sect, Bethesda, MD 20892 USA.
RP Sobel, ME (reprint author), NCI, Pathol Lab, NIH, Mol Pathol Sect, Bldg 10,Rm 2A33,10 Ctr Dr MSC 1500, Bethesda, MD 20892 USA.
CR Andrews L, 1998, LANCET, V351, P53, DOI 10.1016/S0140-6736(05)78066-1
   Grizzle W, 1999, ARCH PATHOL LAB MED, V123, P296
   *INT MIL TRIB, 1950, TRIALS WAR CRIM NUR
   KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806
   Merz JF, 1999, SCIENCE, V283, P1647, DOI 10.1126/science.283.5408.1647
   *NAT BIOETH ADV CO, 1999, RES INV HUM BIOL MAT, V1
   Shuster E, 1997, NEW ENGL J MED, V337, P1436, DOI 10.1056/NEJM199711133372006
   Sobel ME, 1999, ARCH PATHOL LAB MED, V123, P1076
   1979, RED REG         0418
NR 9
TC 5
Z9 5
U1 0
U2 4
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 1525-1578
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD FEB
PY 2000
VL 2
IS 1
BP 1
EP 4
DI 10.1016/S1525-1578(10)60608-3
PG 4
WC Pathology
SC Pathology
GA 365EG
UT WOS:000089935000001
PM 11272896
OA Green Published
DA 2018-10-19
ER

PT J
AU Bansal, R
AF Bansal, R
TI Studying biomedical issues of high-frequency radiation
SO MICROWAVES & RF
LA English
DT Article
AB STORIES about potential health risks from (and occasionally about medical applications of) electromagnetic (EM) fields can be found everywhere from technical journals to supermarket tabloids. In the 1970s and 1980s, microwave radar and communication antennas received a lot of alarming press and more recently, the EM fields from cellular telephones have come under heavy scrutiny. This primer is intended to provide a basic framework for tackling bioelectromagnetic issues. It is by no means an all-encompassing study of the biomedical effects of EM radiation, but is meant to include only those ideas which may one day be useful for performing quick calculations of EM radiation and safety. The interested reader can, of course, consult the references for additional details or data as there is no shortage of specialized material (see, for example, references 2 and 3).
C1 Univ Connecticut, Dept Elect & Syst Engn, Storrs, CT 06269 USA.
RP Bansal, R (reprint author), Univ Connecticut, Dept Elect & Syst Engn, U-157,260 Glenbrook Rd, Storrs, CT 06269 USA.
CR BANSAL R, 1997, IEEE AP S MAGAZI APR, V39, P96
   BANSAL R, 1997, IEEE POTENTIALS  AUG, P3
   *EPRI, 1989, EL MAGN FIELD FUND E
   FISCHETTI M, 1993, IEEE SPECTRUM    JUN, P48
   FOSTER KR, 1986, SCI AM           SEP, P32
   Gandhi O. P., 1990, BIOL EFFECTS MED APP
   *IEE, C9511991 IEEE
   JOHNSON CC, 1972, PR INST ELECTR ELECT, V60, P692, DOI 10.1109/PROC.1972.8728
   Kumar A, 1996, MICROWAVES RF, V35, P157
   Osepchuk J. M., 1983, BIOL EFFECTS ELECTRO
   OSEPCHUK JM, 1978, MICROWAVE J      OCT, P18
   POZAR DM, 1990, MICROWAVE ENG A W
   STUCHLY MA, 1987, IEEE ENG MED BIOL, V6, P15, DOI 10.1109/MEMB.1987.5006368
   *US DOE, 1995, QUEST ANSW EMF EL MA
   WHITE JF, 1981, MICROWAVE J      JAN, P16
NR 15
TC 1
Z9 1
U1 0
U2 1
PU PENTON MEDIA, INC
PI CLEVELAND
PA 1100 SUPERIOR AVE, CLEVELAND, OH 44114-2543 USA
SN 0745-2993
J9 MICROWAVES RF
JI Microw. RF
PD FEB
PY 2000
VL 39
IS 2
BP 105
EP 106
PG 2
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA 287MG
UT WOS:000085509200026
DA 2018-10-19
ER

PT J
AU Allen, BW
   Piantadosi, CA
   Coury, LA
AF Allen, BW
   Piantadosi, CA
   Coury, LA
TI Electrode materials for nitric oxide detection
SO NITRIC OXIDE-BIOLOGY AND CHEMISTRY
LA English
DT Article
ID RELEASE
AB Nitric oxide oxidation signals were compared for uniform test electrodes of platinum, iridium, palladium, rhodium, ruthenium, gold, graphite, and a nickel-porphyrin on graphite in deaerated phosphate-buffered saline (pH 7.0) at 35 degrees C. All tested materials detected NO. amperometrically, Current densities (A/M/cm(2) +/- S.D.) were Ir (0.021 +/- 0.002), Rh (0.088 +/- 0.012), graphite (0.117 +/- 0.018), Pd (0.118 +/- 0.033), Au (0.149 +/- 0.039), Pt (0.237 +/- 0.117), Ni (II)-tetra(3-methoxy-4-hydroxyphenyl) porphyrin on graphite (0.239 +/- 0.009), and Ru (0.680 +/- 0.058). NO. oxidation current on ruthenium was maximal at 675 mV (vs Ag/AgCl), nearly three times that on the next-best materials, platinum and Ni-porphyrin on graphite poised at 800 mV, The measured limit of detection for NO. on Ru was below 3 nM, Enhanced NO. oxidation current on ruthenium is apparently due to formation of nitrosyl-or chloronitrosyl-ruthenium complexes at the electrode surface. At fixed potentials above 675 mV, ruthenium exhibited an even larger NO. response, characterized by current flow opposite in polarity to an oxidation, which we hypothesize reflects suppression of the oxidative background current (presumably due to chloride oxidation or to the electrolysis of water) by a film consisting of nitrosyl- or chloronitrosyl-ruthenium complexes. The sensitive response of the ruthenium electrode to the direct oxidation of NO. may be useful in sensors for biomedical applications. (C) 2000 Academic Press.
C1 Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
   Duke Univ, Dept Chem, Durham, NC 27708 USA.
RP Allen, BW (reprint author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3823, Durham, NC 27710 USA.
FU NHLBI NIH HHS [2P01 HL42444-06]
CR ALI H, 1997, ADV RHEUMATOLOGY, P1
   Barker SLR, 1998, ANAL CHEM, V70, P971, DOI 10.1021/ac970706k
   BEDIOUI F, 1994, J ELECTROANAL CHEM, V377, P295, DOI 10.1016/0022-0728(94)03642-X
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189
   EVANS MO, 1978, LANCET          1230, P1371
   GRIFFITH WP, 1967, CHEMISTRY RARER PLAT, P174
   HOARE JP, 1968, ELECTROCHEMISTRY OXY, P423
   Kudo S, 1997, ANAL BIOCHEM, V247, P193, DOI 10.1006/abio.1997.2097
   LLOPIS JF, 1976, RUTHENIUM ENCY ELECT, V6
   MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0
   MIYOSHI H, 1994, FEBS LETT, V345, P47, DOI 10.1016/0014-5793(94)00417-X
   PARIENTE F, 1994, J ELECTROANAL CHEM, V379, P191, DOI 10.1016/0022-0728(94)87138-8
   Pourbaix M., 1966, ATLAS ELECTROCHEMICA, P644
   RICHTERADDO CB, 1992, METAL NITROSYLS
   Saito Y., 1968, REV POLAROGR JAPAN, V15, P177
   SEDDON EA, 1984, CHEM RUTHEMIUM TOPIC, V19, P1369
   SHI YA, 1993, J PEDIATR-US, V123, P435, DOI 10.1016/S0022-3476(05)81753-6
   SHIBUKI K, 1990, NEUROSCI RES, V9, P69, DOI 10.1016/0168-0102(90)90048-J
   TRASATTI S, 1980, STUDIES PHYSICAL THE, VA, pR5
   VADIMSKY RG, 1979, J ELECTROCHEM SOC, V126, P2017, DOI 10.1149/1.2128846
   Wink David A., 1995, Methods (Orlando), V7, P71, DOI 10.1006/meth.1995.1010
   YEAGER HL, 1981, J ELECTROCHEM SOC, V128, P1880, DOI 10.1149/1.2127757
NR 22
TC 24
Z9 26
U1 0
U2 14
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1089-8603
J9 NITRIC OXIDE-BIOL CH
JI Nitric Oxide-Biol. Chem.
PD FEB
PY 2000
VL 4
IS 1
BP 75
EP 84
DI 10.1006/niox.2000.0273
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 323GL
UT WOS:000087557700009
PM 10733875
DA 2018-10-19
ER

PT J
AU Lee, KY
   Bouhadir, KH
   Mooney, DJ
AF Lee, KY
   Bouhadir, KH
   Mooney, DJ
TI Degradation behavior of covalently cross-linked poly(aldehyde
   guluronate) hydrogels
SO MACROMOLECULES
LA English
DT Article
ID SYNTHETIC EXTRACELLULAR MATRICES; SWELLING BEHAVIOR; ACID; WATER
AB There is a significant need in the biomedical field for hydrogels with controllable mechanical and degradative properties. We now report the degradation behavior of novel hydrogels formed by the cross-linking of poly(aldehyde guluronate) (PAG). PAG was prepared from alginate by acid hydrolysis and oxidation and was covalently cross-linked with adipic acid dihydrazide (AAD) to form hydrogels. These hydrogels were degradable in aqueous media due to the hydrolysis of hydrazone bonds formed between the aldehyde of PAG and the hydrazide of AAD. We confirmed the degradation behavior of FAG hydrogels cross-linked with different concentrations of AAD by monitoring the changes of dry weight, modulus, and degree of swelling. The degradation behavior generally depends on the cross-linking density as calculated from the Flory-Rehner equation. However, hydrogels with many dangling single-end molecules showed a retarded degradation behavior irrespective of their low initial modulus and low degree of cross-linking density. We hypothesize this is due to re-cross-linking of dangling single-end molecules during degradation. The mechanical properties and degradation time of hydrogels typically increase or decrease together as the degree of cross-linking is varied. However, the findings of the current study suggest that the mechanical properties and degradation time can be decoupled by utilizing partially bound cross-linking molecules that are capable of reversibly cross-linking the polymer to form the hydrogel. This approach to control the properties of hydrogels may find wide utility in the biomedical field and other applications of these materials.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Chem Engn, 3074 HH Dow Bldg,2300 Hayward St, Ann Arbor, MI 48109 USA.
OI Lee, Kuen Yong/0000-0002-5759-5952
CR ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   BOUHADIR KH, UNPUB
   DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   DRAGET KI, 1990, TIBTECH, V8, P71
   Dubrovskii SA, 1997, MACROMOLECULES, V30, P7478, DOI 10.1021/ma970788e
   DUBROVSKII SA, 1992, POLYM BULL, V29, P587, DOI 10.1007/BF00296722
   EDWARDSLEVY F, 1993, INT J PHARM, V96, P85, DOI 10.1016/0378-5173(93)90215-2
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Figuly GD, 1997, MACROMOLECULES, V30, P6174, DOI 10.1021/ma9702509
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   INGBER D, 1993, PHYS FORCES MAMMALIA, pCH2
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Mark J. E., 1988, RUBBER ELASTICITY MO
   MORGAN SM, 1995, INT J PHARM, V122, P121, DOI 10.1016/0378-5173(95)00059-R
   PATEL SK, 1992, MACROMOLECULES, V25, P2541
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   TRELORA LRG, 1975, PHYSICS RUBBER ELAST
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
NR 32
TC 135
Z9 138
U1 2
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 11
PY 2000
VL 33
IS 1
BP 97
EP 101
DI 10.1021/ma991286z
PG 5
WC Polymer Science
SC Polymer Science
GA 275BJ
UT WOS:000084799300017
DA 2018-10-19
ER

PT J
AU Hu, ZH
   Srinivasan, MP
   Ni, YM
AF Hu, ZH
   Srinivasan, MP
   Ni, YM
TI Preparation of mesoporous high-surface-area activated carbon
SO ADVANCED MATERIALS
LA English
DT Article
ID UNIQUE ADSORPTION
AB A simple, cost effective method for producing carbons with high mesopore content is presented. The effect of the ratio of activating agent (ZnCl2) to carbon precursor (coconut shell) on pore size is investigated as is the nitrogen adsorption isotherm of these carbonaceous materials at 77 K. The mesoporosity is substantiated by the absorption capacity for phenol, methylene blue, and erythrosine red. Mesoporous high-surface-area activated carbons. which up to now have proved difficult to prepare, have applications as catalytic, battery electrode, capacitor, gas storage, and biomedical engineering materials.
C1 Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.
   Natl Univ Singapore, Dept Chem Engn, Singapore 119260, Singapore.
RP Hu, ZH (reprint author), Tongji Univ, Dept Chem, 1239 Spring Rd, Shanghai 200092, Peoples R China.
RI MP, Srinivasan/E-6068-2011
OI MP, Srinivasan/0000-0002-3440-1422
CR Bansal R.C., 1988, ACTIVE CARBON, P121
   Choma J, 1997, POL J CHEM, V71, P380
   Gregg S J, 1982, ADSORPTION SURFACE A, P90
   Hussein MZ, 1996, CARBON, V34, P1447, DOI 10.1016/0008-6223(96)88755-0
   Leboda R, 1997, LANGMUIR, V13, P1211, DOI 10.1021/la951564x
   LOPEZGONZALEZ JD, 1980, CARBON, V18, P413
   Lu W, 1997, CARBON, V35, P427, DOI 10.1016/S0008-6223(97)89614-5
   Tamai H, 1997, ADV MATER, V9, P55
   Tamai H, 1996, CHEM MATER, V8, P454, DOI 10.1021/cm950381t
   TorregrosaMacia R, 1997, CARBON, V35, P447, DOI 10.1016/S0008-6223(97)83724-4
   VANSANT EF, 1994, SEPAR TECHNOL, P229
   YAMADA Y, 1996, PREPR AM CHEM SOC DI, V41, P274
   Yoshizawa N, 1997, ENERG FUEL, V11, P327, DOI 10.1021/ef9601475
NR 13
TC 145
Z9 148
U1 5
U2 84
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JAN 7
PY 2000
VL 12
IS 1
BP 62
EP +
DI 10.1002/(SICI)1521-4095(200001)12:1<62::AID-ADMA62>3.0.CO;2-B
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 271RB
UT WOS:000084606300016
DA 2018-10-19
ER

PT B
AU Neuman, MR
   Lindner, E
   Cristalli, A
   Gyurcsanyi, RE
   Cheema, K
   Pandolf, M
AF Neuman, MR
   Lindner, E
   Cristalli, A
   Gyurcsanyi, RE
   Cheema, K
   Pandolf, M
BE Dittmar, A
   Beebe, D
TI Thin- and thick-film structures for miniature biomedical sensors
SO 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
LA English
DT Proceedings Paper
CT 1st Annual International IEEE-EMBS Special Topic Conference on
   Microtechnologies in Medicine & Biology
CY OCT 12-14, 2000
CL LYON, FRANCE
SP IEEE, Engn Med & Biol Soc
AB Physical and chemical miniature biomedical sensors can be fabricated using thin- and thick-film technology. Devices such as biopotential electrodes; temperature, force, and compliant strain gauge sensors; and ion-selective electrodes have been designed, constructed, and applied to biomedical problems. Some times there are advantages to depositing non-conventional materials, thicker films, and thin-thick-film hybrid structures in fabricating biomedical sensors.
C1 Univ Memphis, Herff Coll Engn, Joint Program Biomed Engn, Memphis, TN 38152 USA.
RP Neuman, MR (reprint author), Univ Memphis, Herff Coll Engn, Joint Program Biomed Engn, Memphis, TN 38152 USA.
RI Gyurcsanyi, Robert/F-5865-2010
CR BAIRD TM, 1992, 14 ANN INT C IEEE EN
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   JANZ GJ, 1968, ANN NY ACAD SCI, V148, P210, DOI 10.1111/j.1749-6632.1968.tb20350.x
   NEUMAN MR, 1994, IEEE ENG MED BIOL, V13, P409, DOI 10.1109/51.294013
   NEUMAN MR, 1973, INT C MED BIOL ENG
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6603-4
PY 2000
BP 211
EP 215
DI 10.1109/MMB.2000.893774
PG 5
WC Engineering, Multidisciplinary; Engineering, Biomedical; Instruments &
   Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT71M
UT WOS:000173833000046
DA 2018-10-19
ER

PT B
AU Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
AF Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
BE Dittmar, A
   Beebe, D
TI Laser microfabricated polymer surfaces: Effect of microtopography on
   cell growth
SO 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON
   MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS
LA English
DT Proceedings Paper
CT 1st Annual International IEEE-EMBS Special Topic Conference on
   Microtechnologies in Medicine & Biology
CY OCT 12-14, 2000
CL LYON, FRANCE
SP IEEE, Engn Med & Biol Soc
ID EXCIMER-LASER; MICROARCHITECTURAL DESIGN; BIOMEDICAL APPLICATIONS
AB The relatively recent introduction of microelectronics technology into the area of biological sciences has drastically revolutionized the field. New foreseeable applications include miniaturized, multiparametric biosensors for high performance multianalyte assays or DNA sequencing, biocomputers, and substrates for controlled cell growth (i.e. tissue engineering). The objectives of this work were to investigate new methods combining microphotolithographical techniques with high energy KrF excimer laser beam technology to create surfaces with well defined 3-D microdomains in order to delineate critical microscopic topographical surface features that are relevant in governing material-cell interaction. Another obvious application of this study pertains to the fabrication of cell-based biosensors. Reproducible submicron features could also be obtained using this method. Subsequently, model osteoblast-like cells plated onto the laser modified surfaces showed preferential cell deposition on surfaces presenting "smooth" microtopographical transitions. This system may provide an interesting model for further insights into correlations between 3-D surface microtopography and cell response with new applications in the field of biosensor, biomaterial and pharmaceutical engineering sciences (e.g. new cell based biosensors, controlled synthesis of immobilized cell derived active ingredients).
C1 Univ Bordeaux 2, Natl Inst Hlth & Med Res, INSERM, U443, F-33076 Bordeaux, France.
RP Duncan, AC (reprint author), Univ Bordeaux 2, Natl Inst Hlth & Med Res, INSERM, U443, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
CR CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   LAZARE S, 1989, LASER CHEM, V10, P25, DOI 10.1155/1989/18750
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-6603-4
PY 2000
BP 542
EP 544
DI 10.1109/MMB.2000.893843
PG 3
WC Engineering, Multidisciplinary; Engineering, Biomedical; Instruments &
   Instrumentation
SC Engineering; Instruments & Instrumentation
GA BT71M
UT WOS:000173833000115
DA 2018-10-19
ER

PT B
AU Lithgow, BJ
   Zakis, JD
AF Lithgow, BJ
   Zakis, JD
BE Pudlowski, ZJ
   Jensen, HP
TI Modern biomedical engineering curriculum design
SO 4TH BALTIC REGION SEMINAR ON ENGINEERING EDUCATION, SEMINAR PROCEEDINGS
SE MONASH ENGINEERING EDUCATION SERIES
LA English
DT Proceedings Paper
CT 4th Baltic Region Seminar on Engineering Education
CY SEP 01-03, 2000
CL TECH UNIV DENMARK, COPENHAGEN, DENMARK
SP UNESCO, Int Ctr Engn Educ, Int Liaison Grp Engn Educ, UNESCO
HO TECH UNIV DENMARK
AB This paper details the formative forces impacting on the development of biomedical engineering curricula. These formative forces include those from professional societies, Government policy, funding allocation priorities, academic research direction, industry developments and university academic profile. European and American biomedical engineering curricula are compared with those in Australia. All three regions recognise the need to include subject material in the newly developing areas of biomedical engineering such as biomolecular engineering. A modern postgraduate curriculum is presented together with two new subjects representing some of the newly developing areas in biomedical engineering, namely current biomedical engineering research as well as bioelectromagnetism.
C1 Monash Univ, Melbourne, Vic 3004, Australia.
RP Lithgow, BJ (reprint author), Monash Univ, Melbourne, Vic 3004, Australia.
CR BARBENEL J, 1999, EUROPEAN COMMISSION
   BURKE G, EXPENDITURE ED TRAIN, P159
   Lithgow B J, 1993, J Clin Eng, V18, P335
   LITHGOW BJ, 1999, PROCEEE 99, P156
   Stokely E, 2000, IEEE ENG MED BIOL, V19, P12
NR 5
TC 0
Z9 0
U1 0
U2 0
PU UICEE, FACULTY ENGINEERING
PI CLAYTON
PA MONASH UNIVERSITY, CLAYTON, MELBOURNE VIC 3168, AUSTRALIA
BN 0-7326-2143-7
J9 MONAS ENGN EDUC SER
PY 2000
BP 121
EP 125
PG 3
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA BR26K
UT WOS:000165966000028
DA 2018-10-19
ER

PT J
AU Spearing, SM
AF Spearing, SM
TI Materials issues in microelectromechanical systems (MEMS)
SO ACTA MATERIALIA
LA English
DT Review
DE microelectromechanical systems; scaling; microfabrication; material
   selection; mechanical properties
ID ELECTROSTATIC-COMB DRIVE; THIN-FILMS; SILICON-CARBIDE; MICROSTRUCTURES;
   MICROACTUATORS; MICROSYSTEMS; FABRICATION; CHALLENGES; TECHNOLOGY;
   MODULUS
AB Microelectromechanical systems (MEMS) have recently become an important area of technology, building on the success of the microelectronics industry over the past 50 years. MEMS combine mechanical and electrical function in devices at very small scales. Examples include pressure sensors, accelerometers, gyroscopes and optical devices, as well as chemical, biomedical and fluidic applications. The status of MEMS technology is reviewed with particular emphasis on materials issues therein. The materials issues in MEMS are divided into three categories, the MEMS material set, microfabrication processes, and material characterization and design. Each of these areas is addressed, with particular emphasis on the potential impact of materials solutions. A discussion of the future of MEMS and the role of materials in that Future is given. (C) 2000 Acta Metallurgica Inc. Published by Elsevier Science Ltd. All rights reserved.
C1 MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA.
RP Spearing, SM (reprint author), MIT, Dept Aeronaut & Astronaut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
CR Ahn CH, 1998, IEEE T IND ELECTRON, V45, P866, DOI 10.1109/41.735330
   ALLEN MG, 1987, APPL PHYS LETT, V51, P241, DOI 10.1063/1.98460
   ALLEN MG, 1988, J ADHESION, V25, P303, DOI 10.1080/00218468808071269
   ANTHONY TR, 1983, J APPL PHYS, V54, P2419, DOI 10.1063/1.332357
   Arzt E, 1998, ACTA MATER, V46, P5611, DOI 10.1016/S1359-6454(98)00231-6
   Ashby M. F., 1992, MAT SELECTION MECH D
   Ayon AA, 1999, J ELECTROCHEM SOC, V146, P339, DOI 10.1149/1.1391611
   BAGCHI A, 1994, J MATER RES, V9, P1734, DOI 10.1557/JMR.1994.1734
   Balaraju JN, 1998, J MATER SCI LETT, V17, P1297, DOI 10.1023/A:1006528229614
   Ballarini R, 1998, MATER RES SOC SYMP P, V518, P137, DOI 10.1557/PROC-518-137
   BARRETT DL, 1993, J CRYST GROWTH, V128, P358, DOI 10.1016/0022-0248(93)90348-Z
   BASSOUS E, 1977, APPL PHYS LETT, V31, P135, DOI 10.1063/1.89587
   BENGTSSON S, 1992, J ELECTRON MATER, V21, P841
   Berlin AA, 1997, IEEE COMPUT SCI ENG, V4, P12, DOI 10.1109/99.590851
   BHUSAN B, 1998, TRIBOLOGY ISSUES OPP
   Bisson C., 1998, P SOL STAT SENS ACT, P1
   BOONE TD, 1988, P SOL STAT SENS ACT, P87
   Brittain S, 1998, PHYS WORLD, V11, P31
   BROWN S, 1998, MAT RES SOC S P, V518
   BUSCHVISHNIAC IJ, 1992, SENSOR ACTUAT A-PHYS, V33, P207, DOI 10.1016/0924-4247(92)80168-3
   Bustillo JM, 1998, P IEEE, V86, P1552, DOI 10.1109/5.704260
   Butler JE, 1998, MRS BULL, V23, P22, DOI 10.1557/S0883769400029316
   Chaudhuri B, 1998, MICROSYST TECHNOL, V4, P159, DOI 10.1007/s005420050121
   CHEN KS, 1999, MATER RES SOC S P, V546, P51
   CHEN KS, IN PRESS J AM CERAM
   Choyke W J, 1997, SILICON CARBIDE REV, VII
   Choyke W J, 1997, SILICON CARBIDE REV, VI
   Cornella G, 1998, MATER RES SOC SYMP P, V518, P81, DOI 10.1557/PROC-518-81
   Daschner W, 1995, J VAC SCI TECHNOL B, V13, P2729, DOI 10.1116/1.588254
   DEWA AS, 1997, P TRANSD 97 CHIC JUN, P757
   DREXEL KE, 1992, NANOSYSTEMS MOL MACH
   EHRFELD W, 1997, MICROMECHANICS MEMS, P623
   Epstein AH, 1997, SCIENCE, V276, P1211, DOI 10.1126/science.276.5316.1211
   Epstein AH, 1997, 28 AIAA FLUID DYN C
   Esashi M, 1998, P IEEE, V86, P1627, DOI 10.1109/5.704268
   EVANS AG, 1995, ACTA METALL MATER, V43, P2507, DOI 10.1016/0956-7151(94)00444-M
   FITZGERALD AM, 1999, IN PRESS P TRANSD 99
   Flannery AF, 1998, SENSOR ACTUAT A-PHYS, V70, P48, DOI 10.1016/S0924-4247(98)00111-3
   Flynn A. M., 1992, Journal of Microelectromechanical Systems, V1, P44, DOI 10.1109/84.128055
   FREUND LB, 1987, J APPL MECH-T ASME, V54, P553, DOI 10.1115/1.3173068
   FUKUDA T, 1998, HDB SENSORS ACTUATOR, V6
   Gabriel KJ, 1998, P IEEE, V86, P1534, DOI 10.1109/5.704257
   GHANDHI SK, 1994, VLSI FABRICATION PRI
   Gui C, 1998, J ELECTROCHEM SOC, V145, P2198, DOI 10.1149/1.1838616
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   HEUER AH, 1999, MAT RES SOC S P, V546
   HIRATA Y, 1995, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE PROCEEDINGS, 1995, P191, DOI 10.1109/MEMSYS.1995.472581
   Hommel M, 1999, MATER RES SOC SYMP P, V546, P133
   Horsley DA, 1998, IEEE-ASME T MECH, V3, P175, DOI 10.1109/3516.712113
   Huff M. A., 1993, Journal of Microelectromechanical Systems, V2, P74, DOI 10.1109/84.232603
   HUI EE, 1998, SOL STAT SENS ACT WO, P256
   IMTHURN GP, 1992, J APPL PHYS, V72, P2526, DOI 10.1063/1.352345
   Kahn H, 1998, J MICROMECH MICROENG, V8, P213, DOI 10.1088/0960-1317/8/3/007
   KELLER CG, 1995, TRANSDUCERS 95, P99
   Keller RM, 1998, J MATER RES, V13, P1307, DOI 10.1557/JMR.1998.0186
   Kitabatake M, 1999, SENSOR MATER, V11, P1
   Ko W. H., 1985, MICROMACHINING MICRO, P41
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   KRULEVITCH P, 1996, DSC 59 MICROELECTROM, P301
   Lee I, 1999, EXP FLUIDS, V26, P27, DOI 10.1007/s003480050262
   Lee SH, 1998, MATER RES SOC SYMP P, V518, P143, DOI 10.1557/PROC-518-143
   LIN CC, 1998, SOL STAT SENS ACT WO, P25
   Lu MSC, 1998, MATER RES SOC SYMP P, V518, P27, DOI 10.1557/PROC-518-27
   MADOU M, 1997, FUNDAMENTALS MICROFA, P405
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MASZARA WP, 1991, J ELECTROCHEM SOC, V138, P341, DOI 10.1149/1.2085575
   MASZARA WP, 1993, MICROELECTRON ENG, V22, P299, DOI 10.1016/0167-9317(93)90178-8
   MEHREGANY M, 1992, IEEE T ELECTRON DEV, V39, P2060, DOI 10.1109/16.155878
   Mehregany M, 1998, P IEEE, V86, P1594, DOI 10.1109/5.704265
   Mohr J, 1998, SENSOR MATER, V10, P363
   Muhlstein C.L., 1998, TRIBOLOGY ISSUES OPP, P529
   Nix WD, 1997, MAT SCI ENG A-STRUCT, V234, P37
   NIX WD, 1989, METALL TRANS A, V20, P2217, DOI 10.1007/BF02666659
   Ohring M., 1992, MAT SCI THIN FILMS, P413
   Okojie RS, 1997, P TRANSD 97 IEEE, P1407
   Olivas JD, 1998, JOM-J MIN MET MAT S, V50, P38, DOI 10.1007/s11837-998-0066-3
   Osterberg PM, 1997, J MICROELECTROMECH S, V6, P107, DOI 10.1109/84.585788
   PALMOUR JW, 1995, COMPOUND SEMICONDUCT, V141, P377
   Park JY, 1998, J MICROMECH MICROENG, V8, P307, DOI 10.1088/0960-1317/8/4/008
   RAJAN N, 1998, P SOL STAT SENS ACT, P31
   REMBETSKI JF, 1995, SOLID STATE TECHNOL, V38, P67
   RISTIC LJ, 1994, SENSOR TECHNOLOGY DE, pCH5
   ROMBACH R, 1994, SENSOR ACTUAT A-PHYS, V41, P410
   ROSLER J, 1990, ACTA METALL MATER, V38, P671, DOI 10.1016/0956-7151(90)90223-4
   Ruprecht R, 1998, MICROSYST TECHNOL, V5, P44, DOI 10.1007/s005420050139
   Rymuza Z, 1999, MICROSYST TECHNOL, V5, P173, DOI 10.1007/s005420050160
   Saito T, 1998, J APPL ELECTROCHEM, V28, P559, DOI 10.1023/A:1003233715362
   Schmidt MA, 1998, P IEEE, V86, P1575, DOI 10.1109/5.704262
   Senturia SD, 1998, P IEEE, V86, P1611, DOI 10.1109/5.704266
   SENTURIA SD, 1997, MICROMECHANICS MEMS, P659
   SENTURIA SD, 1998, SENSOR ACTUAT A-PHYS, P1
   Sharpe WN, 1998, MATER RES SOC SYMP P, V518, P57, DOI 10.1557/PROC-518-57
   Sharpe WN, 1999, EXP MECH, V39, P162, DOI 10.1007/BF02323548
   Smith D. L., 1995, THIN FILM DEPOSITION, P196
   Sniegowski JJ, 1996, IEEE ELECTR DEVICE L, V17, P366, DOI 10.1109/55.506369
   SOULOFF RE, 1998, TRIBOLOGY ISSUES OPP
   SPEARING S M, 1997, CERAM ENG SCI P, V18, P11
   SRINIVASAN R, 1997, P INT C SOL STAT SEN, P163
   Tada H, 1998, MATER RES SOC SYMP P, V518, P161, DOI 10.1557/PROC-518-161
   TANG WC, 1990, SENSOR ACTUAT A-PHYS, V21, P328, DOI 10.1016/0924-4247(90)85065-C
   Taniguchi J, 1997, JPN J APPL PHYS 1, V36, P7691, DOI 10.1143/JJAP.36.7691
   Tian CY, 1998, SENSOR ACTUAT B-CHEM, V52, P119, DOI 10.1016/S0925-4005(98)00265-2
   Tong Q.-Y., 1998, SEMICONDUCTOR WAFER
   Trimmer W., 1997, MICROMECHANICS MEMS
   TURNER K, 1998, MATER RES SOC S P, V518, P191
   Van Kessel PF, 1998, P IEEE, V86, P1687, DOI 10.1109/5.704274
   VLASSAK JJ, 1992, J MATER RES, V7, P3242, DOI 10.1557/JMR.1992.3242
   Wang SN, 1998, SENSOR MATER, V10, P375
   Whitesides G, 1998, TECHNOL REV, V101, P84
   WIESNER JR, 1993, SOLID STATE TECHNOL, V36, P63
   Wilson CJ, 1996, J MICROELECTROMECH S, V5, P142, DOI 10.1109/84.536620
   Wise KD, 1998, P IEEE, V86, P1531
   WOLFFENBUTTEL RF, 1994, SENSOR ACTUAT A-PHYS, V43, P223, DOI 10.1016/0924-4247(93)00653-L
   Ye WJ, 1998, J MICROELECTROMECH S, V7, P16, DOI 10.1109/84.661380
   Yoshino Y, 1998, MATER RES SOC SYMP P, V518, P9, DOI 10.1557/PROC-518-9
   Zhang X, 1998, THIN SOLID FILMS, V335, P97, DOI 10.1016/S0040-6090(98)00952-3
   Ziebart V, 1999, MATER RES SOC SYMP P, V546, P103
NR 117
TC 448
Z9 474
U1 12
U2 239
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6454
EI 1873-2453
J9 ACTA MATER
JI Acta Mater.
PD JAN 1
PY 2000
VL 48
IS 1
BP 179
EP 196
DI 10.1016/S1359-6454(99)00294-3
PG 18
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 281ZN
UT WOS:000085191500011
DA 2018-10-19
ER

PT J
AU Peppas, NA
   Huang, Y
   Torres-Lugo, M
   Ward, JH
   Zhang, J
AF Peppas, NA
   Huang, Y
   Torres-Lugo, M
   Ward, JH
   Zhang, J
TI Physicochemical, foundations and structural design of hydrogels in
   medicine and biology
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE controlled release; diffusion; polymer network; responsive hydrogels;
   swelling
ID DEXTRAN HYDROGELS; SENSITIVE HYDROGELS; COPOLYMER NETWORKS;
   CONTROLLED-RELEASE; PHASE-TRANSITIONS; ORAL DELIVERY; DRUG-DELIVERY;
   GELS; POLYMER; PH
AB Hydrogels are cross-linked hydrophilic polymers that can imbibe water or biological fluids. Their biomedical and pharmaceutical applications include a very wide range of systems and processes that utilize several molecular design characteristics. This review discusses the molecular structure, dynamic behavior, and structural modifications of hydrogels as well as the various applications of these biohydrogels.
   Recent advances in the preparation of three-dimensional structures with exact chain conformations, as well as tethering of functional groups, allow for the preparation of promising new hydrogels. Meanwhile, intelligent biohydrogels with pH- or temperature-sensitivity continue to be important materials in medical applications.
C1 Purdue Univ, Sch Chem Engn, Program Therapeut & Diagnost Devices, Biomat & Drug Delivery Labs, W Lafayette, IN 47907 USA.
RP Peppas, NA (reprint author), Purdue Univ, Sch Chem Engn, Program Therapeut & Diagnost Devices, Biomat & Drug Delivery Labs, W Lafayette, IN 47907 USA.
EM peppas@ecn.purdue.edu
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   ANDRADE JD, 1976, HYDROGELS MED RELATE, V31
   ANDREWS AT, 1986, ELECTROPHORESIS
   Ansell RJ, 1996, CURR OPIN BIOTECH, V7, P89, DOI 10.1016/S0958-1669(96)80101-7
   ANSETH KS, 1994, CHEM ENG SCI, V49, P2207, DOI 10.1016/0009-2509(94)E0055-U
   BAE YH, 1997, CONTROLLED DRUG DELI, V8, P147
   BELL CL, 1995, ADV POILYMN SCI, V122, P126
   BRANNONPEPPAS L, 1990, ABSORBENT POLYM TECH, P67
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   Chaikof EL, 1996, CHEMTECH, V26, P17
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   CHEN J, 1998, P INT S CONTR REL BI, V25, P60
   Cheong SH, 1997, MACROMOLECULES, V30, P1317, DOI 10.1021/ma961014l
   Cormack PAG, 1999, REACT FUNCT POLYM, V41, P115, DOI 10.1016/S1381-5148(99)00024-3
   Dillow AK, 1998, CURR OPIN SOLID ST M, V3, P252, DOI 10.1016/S1359-0286(98)80099-5
   DUKE T, 1994, BIOPOLYMERS, V34, P239, DOI 10.1002/bip.360340210
   Dvornic PR, 1996, CURR OPIN COLLOID IN, V1, P221, DOI 10.1016/S1359-0294(96)80008-2
   Escobedo FA, 1999, PHYS REP, V318, P86, DOI 10.1016/S0370-1573(99)00012-5
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   GALAEV IY, 1995, RUSS CHEM REV, V64, P471
   GRIFFITH L, 1995, MACROMOLECULES, V28, P6787
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Hayakawa M, 1997, LANGMUIR, V13, P3595, DOI 10.1021/la970195x
   Hennink WE, 1996, J CONTROL RELEASE, V39, P47, DOI 10.1016/0168-3659(95)00132-8
   Hennink WE, 1997, J CONTROL RELEASE, V48, P107, DOI 10.1016/S0168-3659(97)00047-3
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HOFFMAN AS, 1995, POLYM MAT ENCY, P3282
   HOLLY FJ, 1976, HYDROGELS MED RELATE, P252
   Holtz JH, 1997, NATURE, V389, P829
   Horbett T. A., 1986, HYDROGELS MED PHARM, V1, P127
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hubert SJ, 1998, MACROMOLECULES, V31, P181, DOI 10.1021/ma970763f
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Kaneko Y, 1996, MACROMOL SYMP, V109, P41, DOI 10.1002/masy.19961090105
   KINNEY AB, 1994, ACS SYM SER, V480, P2
   KOHN J, 1996, BIOMATERIALS SCI INT, V2, P64
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lowman AM, 1997, MACROMOLECULES, V30, P4959, DOI 10.1021/ma970399k
   LOWMAN AM, 1998, A BENZON S, V43, P206
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   LUMPKIN OJ, 1985, BIOPOLYMERS, V24, P1573, DOI 10.1002/bip.360240812
   MALLAPRAGADA SK, 1999, HDB BIOMATERIAL EVAL, V27, P425
   Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Moriyama K, 1996, J CONTROL RELEASE, V42, P237, DOI 10.1016/0168-3659(96)01456-3
   Mosbach K, 1998, J MOL RECOGNIT, V11, P62, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<62::AID-JMR391>3.0.CO;2-5
   MUHR AH, 1982, POLYMER, V23, P1012, DOI 10.1016/0032-3861(82)90402-5
   Nakayama Y, 1999, LANGMUIR, V15, P1667, DOI 10.1021/la981169h
   OKANO T, 1998, BIORELATED POLYM
   Okay O, 1999, J APPL POLYM SCI, V74, P2181, DOI 10.1002/(SICI)1097-4628(19991128)74:9<2181::AID-APP8>3.0.CO;2-J
   Osada Y, 1998, ADV MATER, V10, P827, DOI 10.1002/(SICI)1521-4095(199808)10:11<827::AID-ADMA827>3.0.CO;2-L
   PANDE VS, 1994, P NATL ACAD SCI USA, V91, P12976, DOI 10.1073/pnas.91.26.12976
   Park TG, 1999, BIOMATERIALS, V20, P517, DOI 10.1016/S0142-9612(98)00197-5
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1, P57
   Peppas N. A., 1986, HYDROGELS MED PHARM, VI, P1
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Peppas NA, 1986, HYDROGELS MED PHARM, V1, P27
   PEPPAS NA, 1964, BIOMATERIALS SCI, P60
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   RAMKISSOONGANOR.C, 1999, J CONTROL RELEASE, V59, P87
   Ratner B. D., 1986, HYDROGELS MED PHARM, V1, P85
   RICKA J, 1984, MACROMOLECULES, V17, P2916, DOI 10.1021/ma00142a081
   Schwarte LM, 1998, POLYMER, V39, P6057, DOI 10.1016/S0032-3861(98)00087-1
   SCHWARTE LM, 1998, TAILORED POLYM MAT C, V3, P57
   Shakhnovich EI, 1998, FOLD DES, V3, pR45, DOI 10.1016/S1359-0278(98)00021-2
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   TANAKA N, 1989, ADV CHROMATOGR, V30, P81
   TANAKA T, 1979, POLYMER, V20, P1404, DOI 10.1016/0032-3861(79)90281-7
   Tanaka T, 1998, BER BUNSEN PHYS CHEM, V102, P1529, DOI 10.1002/bbpc.19981021103
   Tanaka T, 1995, FARADAY DISCUSS, V101, P201, DOI 10.1039/fd9950100201
   TIRRELL JG, 1994, CHEM ENG NEWS, V72, P40, DOI 10.1021/cen-v072n051.p040
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Vakkalanka SK, 1996, J BIOMAT SCI-POLYM E, V8, P119, DOI 10.1163/156856296X00192
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   ZHU S, 1993, MAKROMOL CHEM-THEOR, V2, P587
NR 84
TC 613
Z9 624
U1 4
U2 153
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1523-9829
EI 1545-4274
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2000
VL 2
BP 9
EP 29
DI 10.1146/annurev.bioeng.2.1.9
PG 21
WC Engineering, Biomedical
SC Engineering
GA 364HR
UT WOS:000089887400002
PM 11701505
DA 2018-10-19
ER

PT B
AU Piconi, C
   Casarci, M
AF Piconi, C
   Casarci, M
BE Rammlmair, D
   Mederer, J
   Oberthur, T
   Heimann, RB
   Pentinghaus, H
TI Purification of chemicals for production of biomedical grade YTZP
   ceramics
SO APPLIED MINERALOGY, VOLS 1 AND 2: RESEARCH, ECONOMY, TECHNOLOGY, ECOLOGY
   AND CULTURE
LA English
DT Proceedings Paper
CT 6th International Congress on Applied Mineralogy (ICAM 2000)
CY JUL 17-19, 2000
CL GOTTINGEN, GERMANY
SP German Mineral Soc, Deutsch Forsch Gemeinschaft, BEB Erdgas & Erdol GmbH, Hannover, UTR Umwelt GmbH, Gladbeck, PPM Pure Metals GmbH, Langelsheim, Int Council Appl Mineral, Fed Inst Geosci & Nat Resources, Geol Survey State Lower Saxony, Univ Gottingen, Dept Mineral, Agcy Technol Transfer & Innovat Lower Saxony
AB Total Hip Replacements (THR) lifetime is limited principally by the body reaction to the wear debris of Ultra High Molecular Weight Polyethylene (UHMWPE) sockets used in the acetabular component. Ceramic ball heads made of alumina or zirconia greatly reduce the wear volume of UHMWPE sockets, enhancing THRs lifetime. Today, more than 500.000 zirconia ball heads were implanted worldwide, and new breakthroughs are expected in the future, such as the introduction of zirconia components in knee replacements.
   A main problem in the development of zirconia for biomedical application was its content of radioactive impurities. In this work, cation exchange in a Continuous Annular Chromatograph (CAC) was used to purify zirconium chemical precursors. The multi-component liquid chromatographic separations was obtained using a slowly rotating annular bed of sorbing material. The CAC throughput can be significantly increased using thicker columns: the effects of this variation on the separation efficiency are being investigated.
CR CANON RM, 1980, SEPAR SCI TECHNOL, V15, P655, DOI 10.1080/01496398008068502
   CANON RM, 1978, J LIQ CHROMATOGR, V1, P427, DOI 10.1080/01483917808060009
   HURST FJ, 1983, HYDROMETALLURGY, V10, P1, DOI 10.1016/0304-386X(83)90072-5
   MARTIN AJP, 1949, DISCUSS FARADAY SOC, P332
   SCOTT CD, 1976, J CHROMATOGR, V126, P381, DOI 10.1016/S0021-9673(01)84087-5
NR 5
TC 2
Z9 2
U1 0
U2 0
PU A A BALKEMA PUBLISHERS
PI LEIDEN
PA SCHIPHOLWEG 107C, PO BOX 447, 2316 XC LEIDEN, NETHERLANDS
BN 90-5809-163-5
PY 2000
BP 205
EP 207
PG 3
WC Mineralogy
SC Mineralogy
GA BQ78W
UT WOS:000089525700054
DA 2018-10-19
ER

PT B
AU Lei, PP
   Ferrari, M
   Vogel, V
   Baker, JR
AF Lei, PP
   Ferrari, M
   Vogel, V
   Baker, JR
BE Kraft, DH
TI The frontiers of nanotechnology and nanomedicine
SO ASIS 2000: PROCEEDINGS OF THE 63RD ASIS ANNUAL MEETING, VOL 37, 2000
SE PROCEEDINGS OF THE ASIS ANNUAL MEETINGS
LA English
DT Proceedings Paper
CT 63rd Annual Meeting of the American-Society-for-Information-Science
CY NOV 12-16, 2000
CL CHICAGO, IL
SP Amer Soc Informat Sci
AB The future of medicine is slowly migrating to the use of nanotechnology to manipulate biomolecules that regulate life and death. Nanotechnology is the fabrication of objects and devices on the scale of nanometers for whatever purpose they serve. Within the past four years, there are five nanotechnology centers established in the United States doing nanoresearch on better health care delivery. The hottest nanoresearch areas presently are on gene therapy, cancer detection, and to regulate better drug delivery to stubborn diseases such as diabetes. Hopefully by the end of this decade, patients will be wearing minuscule "smart bombs" that find cancer cells, kill them with the help of lasers and report the kills. Or patients will be implanted a miniaturized sensor for diabetes that mimics the glucose-detection system and monitors the brood-sugar levels and releases insulin as needed. Other nanodevices for drug delivery will be microchips that will hold nanoliters of anything from painkillers to antibiotics for releases into the hunan body. These are some of the examples of how nanotechnology and nanomedicine are linked. The three speakers, listed above, who graciously have agreed to speak at ASIS, are pioneers in nanomedicine. They believe that nanomedicine will bring safer and more effective way to repair genes and treat ailments. They also believe in using nonbiological substances that will not trigger an immune response in the human body. Both Dr. Baker and Dr. Ferrari were profiled in Technology Review from MIT and Dr. Baker was also written up in Newsweek. Dr. Vogel's interest is on molecular bioengineenng and the engineering of manmade devices and materials on the molecular level. She is well known in her field of research. All these three researchers received grants from NIH for their innovative nanoresearch. This proposal will surely bring interests to members of ASIS, including the biomedical professionals, because this will touch on everyone's future health concerns. Knowledge is power, ASIS can be the first to disseminate what is new in technology.
C1 Univ Arizona, Arizona Hlth Sci Lib, Tucson, AZ 85724 USA.
NR 0
TC 0
Z9 0
U1 2
U2 10
PU INFORMATION TODAY INC
PI MEDFORD
PA 143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA
BN 1-57387-108-7
J9 P ASIS ANN
PY 2000
VL 37
BP 496
EP 496
PG 1
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA BR69E
UT WOS:000167173500072
DA 2018-10-19
ER

PT S
AU Malafaya, PB
   Stappers, F
   Reis, RL
AF Malafaya, PB
   Stappers, F
   Reis, RL
BE Giannini, S
   Moroni, A
TI Emulsion crosslinking as a new manufacturing route to produce
   hydroxylapatite particulates in a network of starch
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE bioactive; calcium phosphate; carrier; fillers; particulate;
   reinforcement
AB Bioactive particulates with tailored resorption rates can be very useful on biomedical applications such as filling of bone and dentistry defects, carriers for controlled release of bioactive agents and reinforcement in polymer/bioceramic orthopaedic composites. The aim of the present study was to develop a new processing route to produce composite particulates based on hydroxylapatite (HA) and starch. The newly proposed processing route consists on the crosslinking of starch that is able to encapsulate the IIA particles creating a composite material with different sizes (from 3000-700 mum) which is resorbable and bioactive. This work also involves the characterization of the developed material, as well as the study of the in-vitro degradation and bioactive behaviour of the particulates. The particulate biomaterials have shown to be bioactive even after small immersion periods on a simulated body fluid (SBF). The obtained results (in vitvo) indicate that particulates will be expected to be resorbed when implanted. The developed materials present an interesting combination of morphological and chemical properties that make them potential biomaterials to be used as fillers of bone defects, drug delivery carriers or as reinforcement of bioactive starch-based composites.
C1 Univ Minho, Dept Polymer Engn, PT-4710057 Braga, Portugal.
RP Malafaya, PB (reprint author), Univ Minho, Dept Polymer Engn, Campus Gualtar, PT-4710057 Braga, Portugal.
RI Malafaya, Patricia/M-3994-2013; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012
OI Malafaya, Patricia/0000-0002-7916-5910; Reis, Rui
   L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456
CR GATTI AM, 1992, BIOMATERIALS HARD TI, P97
   GOMES ME, 2000, IN PRESS BIOMATERIAL
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Lemons J E, 1988, Ann N Y Acad Sci, V523, P278, DOI 10.1111/j.1749-6632.1988.tb38521.x
   MENDES S, 1998, 24 ANN M SOC BIOM SA, P9
   Oonishi H., 1992, BIOMATERIALS HARD TI, P17
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Reis RL, 1997, POLYM INT, V43, P347
   Reis RL, 1997, J MATER SCI-MATER M, V8, P897, DOI 10.1023/A:1018514107669
NR 9
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 243
EP 246
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700061
DA 2018-10-19
ER

PT S
AU Feng, LY
   Li, SP
   Yan, YH
   Liu, CS
AF Feng, LY
   Li, SP
   Yan, YH
   Liu, CS
BE Giannini, S
   Moroni, A
TI The effect of CaCO3 and TiO2 nanometer particles on A(549) and L-929
   cells
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE biological effect; cell culture; morphology; nano-meter particles
AB Biomedical nanometer materials are a new field of biomaterials. In this work, CaCO3 and TiO2 nanometer particles were prepared by sol-gel and chemical homogeneous precipitation reaction with ultrasonic wave irradiation. Cell proliferation was measured by MTT method. It is shown that in vitro CaCO3 particles inhibited significantly on growth and proliferation of lung cancer cells A(549), but improved slightly the growth of L-929 cells. On the other hand, TiO2 particles had the same effect of inhibition on A549 cells, however, it obviously restrained the growth of L929 SEM observation demonstrated that L929 cells faded somehow after treatment of TiO2 particles, but the morphology of L-929 cells was not changed after treatment of CaCO3 particles. A(549) cells became the typical apoptosis body after treated by TiO2 and CaCO3 particles.
C1 Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, Wuhan 430070, Peoples R China.
RP Feng, LY (reprint author), Wuhan Univ Technol, Biomed Mat & Engn Res Ctr, 122 Luoshi Rd, Wuhan 430070, Peoples R China.
CR ABRAHAM T, 1996, CERAMIC T, V62, P3
   Aoki H., 1991, SCI MED APPL HYDROXY, P13
   FENG LY, 1998, CHINESE J BIOMED ENG, V17, P374
   Li S., 1996, BIOCERAMICS, V9, P225
   YAMASHITAK U, 1992, J CERAMIC SOC JPN, V100, P426
NR 5
TC 0
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 325
EP 328
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700081
DA 2018-10-19
ER

PT S
AU Burger, W
   Richter, HG
AF Burger, W
   Richter, HG
BE Giannini, S
   Moroni, A
TI High strength and toughness alumina matrix composites by transformation
   toughening and 'in situ' platelet reinforcement (ZPTA) - The new
   generation of bioceramics
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE Al2O3 : Cr; bioceramics; 'in situ' platelet formation; SrAl12-xCrxO19;
   tetragonal zirconia; transformation toughening; ZPTA; ZTA
ID CERAMICS
AB High purity alumina ceramics have been used for more than 25 years in biomedical applications due to their excellent wear behaviour and high strength. Nevertheless great effort have been undertaken to develop a material with increased strength combined with excellent wear properties. One candidate material family is ZTA-ceramics. Out of this family a new generation of that material is available now in which high strength, high toughness, high hardness and wear properties are combined. This material is a zirconia and platelet reinforced alumina ceramic (ZPTA).
   In more details ZPTA-ceramics are based on an alumina matrix containing homogeneously distributed metastable zirconia particles and "in situ" formed hexagonal ternary aluminate platelets of a length of about 3 mum and a thickness of 0.3 mum The chemical composition and the microstructure were optimised to achieve a ceramic material combining all required properties: strength of more than 1200 MPa, fracture toughness of 6,5 MPa rootm and Vickers hardness HV1 of 1975 are typical. Extremely low wear rates have been detected in ring-on-disc and HIP simulator tests.
C1 CeramTec AG, Cent Dev Dept, DE-73201 Plochingen, Germany.
RP Burger, W (reprint author), CeramTec AG, Cent Dev Dept, POB 1149, DE-73201 Plochingen, Germany.
CR BURGER W, 1998, KERAM Z, V50, P18
   Dworak U., 1978, Berichte der Deutschen Keramischen Gesellschaft, V55, P98
   Gregori G, 1999, MAT SCI ENG A-STRUCT, V271, P401, DOI 10.1016/S0921-5093(99)00383-4
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
NR 4
TC 9
Z9 9
U1 1
U2 10
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 545
EP 548
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700130
DA 2018-10-19
ER

PT S
AU Friberg, J
   Fernandez, E
   Sarda, S
   Nilsson, M
   Ginebra, MP
   Martinez, S
   Planell, JA
AF Friberg, J
   Fernandez, E
   Sarda, S
   Nilsson, M
   Ginebra, MP
   Martinez, S
   Planell, JA
BE Giannini, S
   Moroni, A
TI An experimental approach to the study of the rheology behaviour of
   synthetic bone calcium phosphate cements
SO BIOCERAMICS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Ceramic in Medicine /Symposium on
   Ceramic Materials in Orthopaedic Surgery: Clinical Results in the Year
   2000
CY NOV 22-26, 2000
CL BOLOGNA, ITALY
SP Bologna Univ, Ilalian Soc Orthopaed & Tranumatol, European Federat Natl Assoc Orthoped & Traumatol, Japanese Soc Orthoped Implants, Italian Soc Biomat, Soc Biomat, Korean Soc Biomat, Japanese Soc Biomat, Australian Soc Biomat, Ceramic Soc Japan, Int & Amer Assoc Dental Res
DE calcium phosphate cement; injectability; viscosity; alpha-tricalcium
   phosphate
ID SETTING REACTION; CLINICAL-APPLICATIONS; SYSTEM
AB Calcium phosphate cements were developed to fit surgical needs in biomedical fields such as odontology or traumatology. Nowadays, a broad field of new applications have been found for this kind of materials. Drug delivery systems, tissue-engineering scaffolds and osteoporotic bone filling applications are some of the new fields that are being benefited with these materials. Looking at both, commercial and new experimental calcium phosphate cements it is found that cr-tricalcium phosphate is the main reactive powder responsible for the setting and the hardening of the cement. Thus, it is important to know how alpha -tricalcium phosphate affects injectability of these cements. The aim of this study was to investigate the theological behaviour of alpha -tricalcium phosphate slurries in order to know how the cement injectability should be modified. Factors such as liquid to powder ratio, particle size of the main reactive powder and the addition of dispersants have been considered. The results showed that viscosity decreased when particle size of reactant was increased and when liquid to powder ratio was increased. It was also found that a minimum of viscosity exists at an optimum value of the weight percentage of dispersant.
C1 Univ Politecn Catalunya, Dept Mat Sci & Met Engn, CREB, ES-08028 Barcelona, Spain.
   Univ Barcelona, Dept Cristallog Mineral & Recursos Minerals, ES-08028 Barcelona, Spain.
RP Friberg, J (reprint author), Univ Politecn Catalunya, Dept Mat Sci & Met Engn, CREB, Av Diagonal 647, ES-08028 Barcelona, Spain.
RI Ginebra, Maria-Pau/J-8149-2017; Martinez, Salvador/L-5777-2014
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Martinez,
   Salvador/0000-0002-3346-3947
CR Fernandez E, 1998, J MATER SCI-MATER M, V9, P789, DOI 10.1023/A:1008979708407
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fernandez E, 1998, J BIOMED MATER RES, V42, P403, DOI 10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.3.CO;2-0
   Fernandez E, 1999, J BIOMED MATER RES, V47, P466, DOI 10.1002/(SICI)1097-4636(19991215)47:4<466::AID-JBM2>3.0.CO;2-R
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P177, DOI 10.1023/A:1008989525461
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   KHAIROUN I, 1999, P 15 EUR C BIOM SEPT
NR 9
TC 1
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-866-4
J9 KEY ENG MAT
PY 2000
VL 192-1
BP 777
EP 780
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BS01D
UT WOS:000168303700185
DA 2018-10-19
ER

PT J
AU Dhawan, R
   Kadijk, MGA
   Joikinen, TJ
   Feng, M
   Ansell, SM
AF Dhawan, R
   Kadijk, MGA
   Joikinen, TJ
   Feng, M
   Ansell, SM
TI Synthesis of polyamide oligomers based on
   14-amino-3,6,9,12-tetraoxatetradecanoic acid
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID POLY(ETHYLENE GLYCOL); CIRCULATION TIME; LIPOSOMES; CONJUGATION;
   POLYMERS; PROLONG; FUSION
AB A series of oligomers of polyamides based on 14-amino-3,6,9,12-tetraoxatetradecanoic acid monomers (ATTAn) was synthesized. These materials were designed as monodisperse analogues of poly(ethylene glycol) for use in biomedical applications where reproducible behavior is important. Synthesis of the monomer was evaluated using two routes. For small-scale preparations, tetraethylene glycol (TEG) was monoprotected with dihydropyran, converted to an alkoxide, and alkylated with ethyl bromoacetate. On larger scales, TEG was alkylated directly by treatment with sodium, followed by ethyl bromoacetate. The amine function was introduced by mesylation followed by treatment with sodium azide. Reduction of the azide to amino groups was performed over Pd/C using either hydrogen or formic acid as proton sources. Assembly of the oligomers was accomplished using standard DCC/ NHS chemistry and an iterative dimerization sequence after appropriate deprotection of a pair of monomers. The amino group was protected by retaining the azido group as a latent amine. A series of ATTAn oligomers was prepared (n = 1-8). A lipid conjugate of the octamer, ATTA8-DSPE,was synthesized.
C1 Inex Pharmaceut Corp, Burnaby, BC V5J 5J8, Canada.
RP Ansell, SM (reprint author), Inex Pharmaceut Corp, 100-8900 Glenlyon Pkwy, Burnaby, BC V5J 5J8, Canada.
CR Adlakha-Hutcheon G, 1999, NAT BIOTECHNOL, V17, P775
   AGBACK H, 1991, Patent No. 9100497
   ALLEN TM, 1994, ADV DRUG DELIVER REV, V13, P285, DOI 10.1016/0169-409X(94)90016-7
   Ansell SM, 1999, BIOCONJUGATE CHEM, V10, P653, DOI 10.1021/bc990005p
   BERTOZZI CR, 1991, J ORG CHEM, V56, P4326, DOI 10.1021/jo00013a053
   Bradley AJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P185, DOI 10.1006/abbi.1998.0798
   Chen YY, 1999, J ORG CHEM, V64, P6870, DOI 10.1021/jo990620m
   HARASYM TO, 1995, BIOCONJUGATE CHEM, V6, P187, DOI 10.1021/bc00032a006
   Holland JW, 1996, BIOCHEMISTRY-US, V35, P2618, DOI 10.1021/bi952000v
   KEEGSTRA EMD, 1992, J ORG CHEM, V57, P6678, DOI 10.1021/jo00050a065
   KINUGASA S, 1992, MACROMOLECULES, V25, P4848, DOI 10.1021/ma00045a003
   KLIBANOV AL, 1991, BIOCHIM BIOPHYS ACTA, V1062, P142, DOI 10.1016/0005-2736(91)90385-L
   Lasic DD, 1995, CHEM REV, V95, P2601, DOI 10.1021/cr00040a001
   Mayer LD, 1998, MEDICAL APPLICATIONS OF LIPOSOMES, P231, DOI 10.1016/B978-044482917-7/50014-4
   Mori A, 1998, J LIPOSOME RES, V8, P195, DOI 10.3109/08982109809035526
   PARR MJ, 1994, BBA-BIOMEMBRANES, V1195, P21, DOI 10.1016/0005-2736(94)90004-3
   Rose K, 1999, J AM CHEM SOC, V121, P7034, DOI 10.1021/ja9909879
   Schwabacher AW, 1998, J ORG CHEM, V63, P1727, DOI 10.1021/jo971802o
   Torchilin Vladimir P., 1996, Journal of Liposome Research, V6, P99, DOI 10.3109/08982109609037204
   TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P11, DOI 10.1016/0005-2736(94)90003-5
   Webb MS, 1998, BBA-BIOMEMBRANES, V1372, P272, DOI 10.1016/S0005-2736(98)00077-7
   Wheeler JJ, 1999, GENE THER, V6, P271, DOI 10.1038/sj.gt.3300821
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 24
TC 2
Z9 2
U1 1
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JAN-FEB
PY 2000
VL 11
IS 1
BP 14
EP 21
DI 10.1021/bc9801427
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 279EH
UT WOS:000085031100004
PM 10639080
DA 2018-10-19
ER

PT J
AU Mowery, KA
   Schoenfisch, MH
   Saavedra, JE
   Keefer, LK
   Meyerhoff, ME
AF Mowery, KA
   Schoenfisch, MH
   Saavedra, JE
   Keefer, LK
   Meyerhoff, ME
TI Preparation and characterization of hydrophobic polymeric films that are
   thromboresistant via nitric oxide release
SO BIOMATERIALS
LA English
DT Article
DE nitric oxide; polymer materials; blood compatibility; biomaterial
   surfaces
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PLATELET-AGGREGATION; IN-VIVO;
   9-FLUORENYLMETHYL CHLOROFORMATE; PRECOLUMN DERIVATIZATION; VASCULAR
   ENDOTHELIUM; MEMBRANE-ELECTRODE; HEPARIN; SENSORS; BIOCOMPATIBILITY
AB The preparation of hydrophobic polymer films (polyurethane and poly(vinyl chloride)) containing nitric oxide (NO)-releasing diazeniumdiolate functions is reported as a basis for improving the thromboresistivity of such polymeric materials for biomedical applications. Several different approaches for preparing NO-releasing polymer films are presented, including: (1) dispersion of diazeniumdiolate molecules within the polymer matrix; (2) covalent attachment of the diazeniumdiolate to the polymer backbone; and (3) ion-pairing of a diazeniumdiolated heparin species to form an organic soluble complex that can be blended into the polymer. Each approach is characterized in terms of NO release rates and in vitro biocompatibility. Results presented indicate that the polymer films prepared by each approach release NO for variable periods of time (10-72 h), although they differ in the mechanism, location and amount of NO released. In vitro platelet adhesion studies demonstrate that the localized NO release may prove to be an effective strategy for improving blood compatibility of polymer materials for a wide range of medical devices. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Frederick, MD 21702 USA.
   NCI, Frederick Canc Res & Dev Ctr, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.
RI Keefer, Larry/N-3247-2014
OI Keefer, Larry/0000-0001-7489-9555
FU NCI NIH HHS [N01-CO-56000]; NIGMS NIH HHS [GM 56991]
CR ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   ANNICH GM, 1999, IN PRESS CRIT CARE M
   Banerjee R, 1997, J BIOMATER APPL, V12, P57, DOI 10.1177/088532829701200104
   BENMAKROHA Y, 1995, MED BIOL ENG COMPUT, V33, P811, DOI 10.1007/BF02523013
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   DAVIDSON GWR, 1984, BIOMATERIALS, V5, P227, DOI 10.1016/0142-9612(84)90020-6
   DAVSON H, 1952, PERMEABILITY NATURAL, P38
   ESPADASTORRE C, 1995, ANAL CHEM, V67, P3108, DOI 10.1021/ac00114a003
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   FU B, 1995, MACROMOLECULES, V28, P5834, DOI 10.1021/ma00121a021
   FU B, 1994, ANAL CHEM, V66, P2250, DOI 10.1021/ac00086a009
   Hanson S R, 1995, Adv Pharmacol, V34, P383
   Hrabie JA, 1999, ORG PREP PROCED INT, V31, P189, DOI 10.1080/00304949909355709
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   HULANICKI A, 1987, ANAL CHIM ACTA, V194, P119, DOI 10.1016/S0003-2670(00)84765-0
   IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103
   Keefer LK, 1996, METHOD ENZYMOL, V268, P281
   KELM M, 1996, METHODS NITRIC OXIDE, P47
   KUSY RP, 1994, POLYMER, V35, P2141, DOI 10.1016/0032-3861(94)90241-0
   KYROLAINEN M, 1995, ACTA ANAESTH SCAND, V39, P55, DOI 10.1111/j.1399-6576.1995.tb04255.x
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   Li Z, 1996, ANAL CHEM, V68, P1717, DOI 10.1021/ac950557a
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LOEPPKY RN, 1994, ACS SYM SER, V553, P1
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Merchant K, 1996, CHEM RES TOXICOL, V9, P891, DOI 10.1021/tx950102g
   MEYERHOFF ME, 1993, TRAC-TREND ANAL CHEM, V12, P257, DOI 10.1016/0165-9936(93)87065-6
   MIWA H, 1994, J VASC SURG, V19, P658, DOI 10.1016/S0741-5214(94)70039-7
   MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955
   MONROE JM, 1980, BIOMATER ARTIF CELL, V8, P103, DOI 10.3109/10731198009118976
   Mowery KA, 1999, POLYMER, V40, P6203, DOI 10.1016/S0032-3861(99)00187-1
   MOWERY KA, 1999, IN PRESS ELECTROANAL
   Pasic M, 1996, EUR J CARDIO-THORAC, V10, P372, DOI 10.1016/S1010-7940(96)80097-2
   RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x
   RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Ramamurthy N, 1998, CLIN CHEM, V44, P606
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   SAAVEDRA JE, 1992, J ORG CHEM, V57, P6134, DOI 10.1021/jo00049a017
   SAAVEDRA JE, 1999, IN PRESS J ORG CHEM
   SABRI MI, 1989, J NEUROSCI METH, V29, P27, DOI 10.1016/0165-0270(89)90105-2
   SALVEMINI D, 1990, BRIT J PHARMACOL, V101, P991, DOI 10.1111/j.1476-5381.1990.tb14194.x
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   SCHMIDT HHH, 1996, METHODS NITRIC OXIDE, P491
   SCHOENFISCH MH, 1998, 216 ACS NAT M BOST M
   SCHOENFISCH MH, UNPUB IMPROVING THRO
   SCHWAKE A, 1997, P EUROSENSORS 11, V1, P243
   SINEY L, 1992, EUR J PHARMACOL, V229, P223, DOI 10.1016/0014-2999(92)90559-M
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Stead DA, 1996, J CHROMATOGR B, V675, P295, DOI 10.1016/0378-4347(95)00355-X
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   THOMSON C, 1973, CLIN SCI MOL MED, V45, P485, DOI 10.1042/cs0450485
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Weerwind PW, 1998, INT J ARTIF ORGANS, V21, P291
   YANG VC, 1993, CHEMTECH, V23, P25
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   YUN JH, 1993, ELECTROANAL, V5, P719, DOI 10.1002/elan.1140050903
NR 58
TC 151
Z9 157
U1 0
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2000
VL 21
IS 1
BP 9
EP 21
DI 10.1016/S0142-9612(99)00127-1
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 266FW
UT WOS:000084290800003
PM 10619674
DA 2018-10-19
ER

PT S
AU Faris, GW
   Dyer, MJ
AF Faris, GW
   Dyer, MJ
GP OSA
   OSA
TI Upconverting chelates for biomedical diagnostics
SO BIOMEDICAL TOPICAL MEETINGS, TECHNICAL DIGEST
SE OSA TRENDS IN OPTICS AND PHOTONICS
LA English
DT Proceedings Paper
CT Biomedical Topical Meeting
CY APR 02-05, 2000
CL MIAMI BEACH, FL
ID FIBER LASER
AB We are developing a new type of reporter for biomedical diagnostics. Upconverting chelates consist of lanthanide ions in an organic ligand. These materials have narrow emission features and no autofluorescent background. (C) 1999 Optical Society of America.
C1 SRI Int, Mol Phys Lab, Menlo Pk, CA 94025 USA.
RP Faris, GW (reprint author), SRI Int, Mol Phys Lab, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.
CR ALLAIN JY, 1990, ELECTRON LETT, V26, P261, DOI 10.1049/el:19900174
   ALLAIN JY, 1990, ELECTRON LETT, V26, P166, DOI 10.1049/el:19900113
   AUZEL FE, 1973, P IEEE, V61, P758, DOI 10.1109/PROC.1973.9155
   Chen YH, 1999, PROC SPIE, V3600, P151, DOI 10.1117/12.351025
   Faris G. W., 1996, OSA Trends in Optics and Photonics on Biomedical Optical Spectroscopy and Diagnostics. Vol.3. From the Topical Meeting, P225
   MACFARLANE RM, 1988, APPL PHYS LETT, V52, P1300, DOI 10.1063/1.99681
   MCFARLANE RA, 1989, APPL PHYS LETT, V54, P2301, DOI 10.1063/1.101108
NR 7
TC 0
Z9 0
U1 0
U2 1
PU OPTICAL SOC AMERICA
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-5695
BN 1-55752-632-X
J9 OSA TRENDS OPT PHOTO
PY 2000
VL 38
BP 241
EP 241
PG 1
WC Optics; Spectroscopy
SC Optics; Spectroscopy
GA BU51D
UT WOS:000176203200070
DA 2018-10-19
ER

PT S
AU Hassan, CM
   Peppas, NA
AF Hassan, CM
   Peppas, NA
BE Abe, A
TI Structure and applications of poly(vinyl alcohol) hydrogels produced by
   conventional crosslinking or by freezing/thawing methods
SO BIOPOLYMERS/PVA HYDROGELS/ANIONIC POLYMERISATION NANOCOMPOSITES
SE Advances in Polymer Science
LA English
DT Review
DE poly(vinyl alcohol); hydrogels; freezing/thawing; crystallinity;
   biomedical applications; crosslinking; crystallites
ID DIFFERENTIAL SCANNING CALORIMETRY; DIMETHYLSULFOXIDE WATER SOLUTIONS;
   ACID) INTERPENETRATING NETWORKS; CONTROLLED RELEASE SYSTEMS; SMALL-ANGLE
   NEUTRON; POLY(ACRYLIC ACID); POLYVINYL-ALCOHOL; DRUG-DELIVERY; POLYMER
   SYSTEMS; MOLECULAR MOBILITY
AB Poly(vinyl alcohol) (PVA) is a polymer of great interest because of its many desirable characteristics specifically for various pharmaceutical and biomedical applications. The crystalline nature of PVA has been of specific interest particularly for physically crosslinked hydrogels prepared by repeated cycles of freezing and thawing. This review includes details on the structure and properties of PVA, the synthesis of its hydrogels, the crystallization of PVA, as well as its applications. An analysis of previous work in the development of freezing and thawing processes is presented focusing on the implications of such materials for a variety of applications. PVA blends that have been developed with enhanced properties for specific applications will also be discussed briefly. Finally, the future directions involving the further development of freeze/thawed PVA hydrogels are addressed.
C1 Purdue Univ, Sch Chem Engn, Polymer Sci Lab, W Lafayette, IN 47907 USA.
   Purdue Univ, Sch Chem Engn, Engn Lab, W Lafayette, IN 47907 USA.
RP Hassan, CM (reprint author), Purdue Univ, Sch Chem Engn, Polymer Sci Lab, W Lafayette, IN 47907 USA.
CR Argade AB, 1998, J APPL POLYM SCI, V70, P817, DOI 10.1002/(SICI)1097-4628(19981024)70:4<817::AID-APP23>3.0.CO;2-S
   BAO QB, 1991, Patent No. 5047055
   BERGHMANS H, 1986, INTEGRATION FUNDAMEN, P218
   BUNN CW, 1948, NATURE, V161, P929, DOI 10.1038/161929a0
   CHA WI, 1991, KOBUNSHI RONBUNSHU, V48, P425, DOI 10.1295/koron.48.425
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Cha WI, 1996, MACROMOL SYMP, V109, P115, DOI 10.1002/masy.19961090111
   DANNO A, 1958, J PHYS SOC JPN, V13, P722, DOI 10.1143/JPSJ.13.722
   DIEU J, 1959, LARGE RAD SOURCES IN, V1, P341
   FICEK BJ, 1993, J CONTROL RELEASE, V27, P259, DOI 10.1016/0168-3659(93)90156-Y
   FICEK BJ, 1994, MATER RES SOC SYMP P, V331, P223
   Finch C. A., 1973, POLYVINYL ALCOHOL PR
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Fujii K, 1973, PVA PROPERTIES APPL, P203
   FUJIMOTO K, 1994, ACS SYM SER, V540, P228
   GANDER B, 1989, PHARMACEUT RES, V6, P578, DOI 10.1023/A:1015949330425
   GANDER B, 1983, P INT S CONTR REL PH, P5
   GANDER B, 1988, P INT S CONTR REL BI, V15, P109
   GUDEMAN LF, 1995, J MEMBRANE SCI, V107, P239, DOI 10.1016/0376-7388(95)00120-7
   GUDEMAN LF, 1995, J APPL POLYM SCI, V55, P919, DOI 10.1002/app.1995.070550610
   HARRIS HE, 1966, J POLYM SCI A1, V4, P665, DOI 10.1002/pol.1966.150040320
   Hassan CM, 1998, WATER SOLUBLE POLYMERS: SOLUTION PROPERTIES AND APPLICATIONS, P31
   HASSAN CM, 1998, POLYM MAT SCI ENG P, V79, P473
   HASSAN CM, 1998, P INT S CONTROL REL, V25, P50
   HATAKEYAMA T, 1987, EUR POLYM J, V23, P361, DOI 10.1016/0014-3057(87)90164-9
   HICKEY AS, 1995, J MEMBRANE SCI, V107, P229, DOI 10.1016/0376-7388(95)00119-0
   Hickey AS, 1997, POLYMER, V38, P5931, DOI 10.1016/S0032-3861(97)00163-8
   HIRAI T, 1992, J APPL POLYM SCI, V46, P1449, DOI 10.1002/app.1992.070460815
   HIRAI T, 1992, J APPL POLYM SCI, V45, P1849, DOI 10.1002/app.1992.070451019
   HIRAI T, 1991, POLYM PREPR JPN, V40, P1297
   HIRAI T, 1990, POLYM PREPR JPN, V39, P942
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   HYON SH, 1989, KOBUNSHI RONBUNSHU, V46, P673, DOI 10.1295/koron.46.673
   HYON SH, 1987, Patent No. 4663358
   HYON SH, 1993, POLYM PREPR JPN, P42
   Inamura I, 1997, POLYM J, V29, P119, DOI 10.1295/polymj.29.119
   INAMURA I, 1986, POLYM J, V18, P269, DOI 10.1295/polymj.18.269
   KANAYA T, 1995, MACROMOLECULES, V28, P3168, DOI 10.1021/ma00113a019
   KANAYA T, 1994, MACROMOLECULES, V27, P5609, DOI 10.1021/ma00098a014
   KELLER A, 1957, PHILOS MAG, V2, P1171, DOI 10.1080/14786435708242746
   KIM CJ, 1990, POLYM MAT SCI ENG, V63, P64
   KORSMEYER RW, 1981, J MEMBRANE SCI, V9, P211, DOI 10.1016/S0376-7388(00)80265-3
   KURIAKI M, 1989, KOBUNSHI RONBUNSHU, V46, P739, DOI 10.1295/koron.46.739
   LLANOS GR, 1991, MACROMOLECULES, V24, P6066
   LOZINSKY VI, 1992, J APPL POLYM SCI, V44, P1423, DOI 10.1002/app.1992.070440813
   LOZINSKY VI, 1986, POLYM BULL, V15, P333
   LOZINSKY VI, 1995, J APPL POLYM SCI, V58, P171, DOI 10.1002/app.1995.070580119
   Lozinsky VI, 1996, J APPL POLYM SCI, V61, P1991, DOI 10.1002/(SICI)1097-4628(19960912)61:11<1991::AID-APP13>3.0.CO;2-2
   Lozinsky VI, 1998, RUSS CHEM REV, V67, P573, DOI DOI 10.1070/RC1998V067N07ABEH000399
   LUTTRELL AS, 1994, ABSTR AICHE M, pC202
   Mallapragada S. K., 1995, POLYM MAT SCI ENG P, V73, P22
   Mallapragada SK, 1997, J BIOMED MATER RES, V36, P125, DOI 10.1002/(SICI)1097-4636(199707)36:1<125::AID-JBM15>3.0.CO;2-H
   Mallapragada SK, 1997, J CONTROL RELEASE, V45, P87, DOI 10.1016/S0168-3659(96)01549-0
   Mallapragada SK, 1997, AICHE J, V43, P870, DOI 10.1002/aic.690430403
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   MALLAPRAGADA SK, 1996, POLYM MAT SCI ENG P, V74, P416
   Mandelkern L., 1967, J POLYM SCI C, V18, P51
   MANO I, 1986, MAGNET RESON MED, V3, P921, DOI 10.1002/mrm.1910030612
   Masaro L, 1998, MACROMOLECULES, V31, P3880, DOI 10.1021/ma9710242
   Mongia NK, 1996, J BIOMAT SCI-POLYM E, V7, P1055, DOI 10.1163/156856296X00543
   MORIMOTO K, 1989, CHEM PHARM BULL, V37, P2491
   MORIMOTO K, 1989, PHARMACEUT RES, V6, P338, DOI 10.1023/A:1015958710435
   MURASE K, 1991, POLYM PREPR JPN, V40, P952
   NAMBU M, 1984, Patent No. 4472542
   Narasimhan B, 1999, MACROMOLECULES, V32, P704, DOI 10.1021/ma981382k
   NISHINARI K, 1983, POLYM COMMUN, V24, P345
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   OHKURA M, 1992, POLYMER, V33, P5044, DOI 10.1016/0032-3861(92)90056-3
   OHKURA M, 1992, POLYMER, V33, P3686, DOI 10.1016/0032-3861(92)90656-H
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   OKAZAKI M, 1995, J APPL POLYM SCI, V58, P2235, DOI 10.1002/app.1995.070581212
   Peppas N. A., 1987, HYDROGELS MED PHARM, V2, P1
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P305, DOI 10.1016/0168-3659(91)90007-Z
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   PEPPAS NA, 1975, MAKROMOL CHEM, V176, P3433
   Peppas NA, 1997, EUR J PHARM BIOPHARM, V43, P51, DOI 10.1016/S0939-6411(96)00010-0
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   PEPPAS NA, 1992, J CONTROL RELEASE, V18, P95, DOI 10.1016/0168-3659(92)90178-T
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   PEPPAS NA, 1982, J APPL POLYM SCI, V27, P4787, DOI 10.1002/app.1982.070271223
   Peppas NA, 1998, EUR J PHARM BIOPHARM, V46, P15, DOI 10.1016/S0939-6411(97)00113-6
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   PEPPAS NA, 1976, EUR POLYM J, V12, P495, DOI 10.1016/0014-3057(76)90004-5
   PEPPAS NA, 1977, MAKROMOL CHEM, V178, P595
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   PEPPAS NA, 1980, BIOMATERIALS, V1, P158, DOI 10.1016/0142-9612(80)90039-3
   PEPPAS NA, 1980, P IUPAC, V27, P28
   PEPPAS NA, 1979, P IUPAC, V26, P1539
   PEPPAS NA, 1996, REORT POVAL COMMITTE, V108, P96
   PEPPAS NA, 1974, TECN CHRON, V43, P559
   PEPPAS NA, 1996, P INT S CONTR REL BI, V23, P157
   PEPPAS NA, 1996, P INT S CONTR REL BI, V23, P145
   PEPPAS NA, 1996, P TOP C PROC STRUCT, V1, P321
   PEPPAS NA, 1977, CHEM PROPERTIES CROS, P469
   PEPPAS NA, 1976, ORG COAT PLAST CHEM, V36, P541
   PEPPAS NA, 1997, BIOMATERIALS CARRIER, P328
   Peppas NA, 1979, P IUPAC MEMBR S MAR, V26, P1108
   PEPPAS NA, 1995, P WORLD M APGI APV, V1, P817
   PEPPAS NA, 1996, T WORLD BIOMATER C, V5, P643
   PEPPAS NA, 1977, POLYM PREP AM CHEM S, V18, P794
   RAY JC, 1973, J APPL POLYM SCI, V17, P3781
   REINHART CT, 1981, INT J PHARM TECHN PR, V2, P9
   SAITO O, 1959, J PHYS SOC JPN, V14, P792, DOI 10.1143/JPSJ.14.792
   SAKURADA I, 1959, SEN-I GAKKAISHI, V15, P948
   Sakurada I., 1955, KOBUNSHI KAGAKU, V12, P510
   SAWATARI C, 1996, TOYOTA KENKYU HOKOKU, V49, P77
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   Shin HS, 1997, J APPL POLYM SCI, V65, P685
   Shin HS, 1998, J APPL POLYM SCI, V69, P479, DOI 10.1002/(SICI)1097-4628(19980718)69:3<479::AID-APP7>3.0.CO;2-D
   Snaar JEM, 1998, MAGN RESON IMAGING, V16, P691, DOI 10.1016/S0730-725X(98)00021-6
   SONE Y, 1953, KOBUNSHI KAGAKU, V10, P7
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Suzuki M, 1996, MACROMOL SYMP, V109, P55, DOI 10.1002/masy.19961090106
   SUZUKI M, 1991, POLYM PREPR JPN, V40, P953
   TADOKORO H, 1961, B CHEM SOC JPN, V34, P1504, DOI 10.1246/bcsj.34.1504
   TAKAMURA A, 1987, YAKUGAKU ZASSHI, V107, P233, DOI 10.1248/yakushi1947.107.3_233
   TAKAMURA A, 1992, J CONTROL RELEASE, V20, P21, DOI 10.1016/0168-3659(92)90135-E
   TAKAMURA A, 1991, YAKUGAKU ZASSHI, V111, P45, DOI 10.1248/yakushi1947.111.1_45
   TAKESHITA H, 1995, POLYM PREPR JPN, V44, P139
   TAMURA K, 1986, T AM SOC ART INT ORG, V32, P605
   TANIGAMI T, 1994, POLYMER, V35, P2573, DOI 10.1016/0032-3861(94)90381-6
   TANIGAMI T, 1995, POLYMER, V36, P2941, DOI 10.1016/0032-3861(95)94343-R
   TANIGAMI T, 1995, J MATER SCI, V30, P5110, DOI 10.1007/BF00356057
   TAZAKI M, 1989, KOBUNSHI RONBUNSHU, V46, P733, DOI 10.1295/koron.46.733
   TRIEU HH, 1994, COLLOID POLYM SCI, V272, P301, DOI 10.1007/BF00655501
   TSUTSUMI K, 1994, STP PHARMA SCI, V4, P230
   TUBBS RK, 1966, J POLYM SCI A1, V4, P623, DOI 10.1002/pol.1966.150040316
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   URUSHIZAKI F, 1986, YAKUGAKU ZASSHI, V106, P491, DOI 10.1248/yakushi1947.106.6_491
   WATASE M, 1985, J POLYM SCI POL PHYS, V23, P1803, DOI 10.1002/pol.1985.180230906
   WATASE M, 1989, MAKROMOL CHEM, V190, P155
   Yamaura K, 1998, J APPL POLYM SCI, V70, P1661, DOI 10.1002/(SICI)1097-4628(19981128)70:9<1661::AID-APP3>3.0.CO;2-T
   YAMAURA K, 1995, J APPL POLYM SCI, V58, P1787, DOI 10.1002/app.1995.070581017
   Yamaura K, 1997, J APPL POLYM SCI, V64, P1283, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1283::AID-APP6>3.0.CO;2-F
   YOKOYAMA F, 1986, COLLOID POLYM SCI, V264, P595, DOI 10.1007/BF01412597
NR 136
TC 694
Z9 711
U1 19
U2 258
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 3-540-67313-X
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2000
VL 153
BP 37
EP 65
PG 29
WC Polymer Science
SC Polymer Science
GA BR11L
UT WOS:000165688300002
DA 2018-10-19
ER

PT B
AU Barbucci, R
   Lamponi, S
   Magnani, A
AF Barbucci, R
   Lamponi, S
   Magnani, A
BE Fabbrizzi, L
   Poggi, A
TI Biological performance of materials
SO CHEMISTRY AT THE BEGINNING OF THE THIRD MILLENNIUM: MOLECULAR DESIGN,
   SUPRAMOLECULES, NANOTECHNOLOGY AND BEYOND
LA English
DT Proceedings Paper
CT German-Italian Meeting of Coimbra Group Universities Meeting on
   Chemistry at the Beginning of the 3rd Millennium
CY OCT 07-10, 1999
CL PAVIA, ITALY
SP Coimbra Grp Univ
ID BLOOD COMPATIBILITY; POLYMER SURFACES; HYDROGELS; SCIENCE; BIOMATERIALS;
   PRECURSORS; MONOLAYERS; TOPOGRAPHY; ACTIVATION; CHEMISTRY
AB The biomaterial science, the study of the application of materials to biological and biomedical problems is a field characterised by medical needs, basic research, advanced technological development, industrial involvement, ethical considerations and regulations. The biological performance of materials largely depends on their bulk and surface properties.
   Some general concepts necessary to define the biological performance of materials are discussed. Current approaches of surface modification of materials and methods of synthesis for creating surfaces with specific biofuncionality are reviewed.
C1 Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, I-53100 Siena, Italy.
RP Barbucci, R (reprint author), Univ Siena, Dipartimento Sci & Tecnol Chim & Biosistemi, Via E Bastianini 12, I-53100 Siena, Italy.
RI Magnani, Agnese/E-7999-2017
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   BRANKER JH, 1995, J BIOMED MATER RES, V29, P1517
   CHAMILTON D, UNPUB IMPLICATIONS C
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   Curtis A, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P158
   CURTIS ASG, 1988, TOPOGRAPHY CONTROL C, V7, P141
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FERGUSON GS, 1993, MACROMOLECULES, V26, P5870, DOI 10.1021/ma00074a007
   FOWKES FM, 1988, ENCY POLYM SCI ENG S, P1
   GARBASSI F, 1989, SURF INTERFACE ANAL, V14, P585, DOI 10.1002/sia.740141004
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   GRIESSER HJ, 1990, J APPL POLYM SCI APP, V46, P361
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1985, POLYM MED, V2, P157
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   LAURENT TC, 1998, CHEM BIOL HYALURONAN
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   MAGNANI A, 1995, J MATER CHEM, V5, P1321, DOI 10.1039/jm9950501321
   MAGNANI A, 1993, TEST PROCEDURES BLOO, P171
   MAGNANI A, UNPUB IN VITRO STUDY
   MAGNANI A, IN PRESS NOVEL POLYS
   MALLIK S, 1994, NEW J CHEM, V18, P299
   NOCENTINI M, 1993, TEST PROCEDURES BLOO, P151
   OKANO T, 1993, J BIOMED MATER RES, V27, P1519, DOI 10.1002/jbm.820271208
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   PLATE NA, 1986, ADV POLYM SCI, V79, P95
   PRITCHARD DJ, 1995, ANAL CHEM, V67, P3605, DOI 10.1021/ac00115a034
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNER BD, 1993, CARDIOVASC PATHOL S, V2, P875
   RATNER BD, 1993, ACS POLYM PREPR, V34, P643
   RATNER BD, 1988, POLYM SURFACE DYNAMI, P137
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   ROZSNYAI LF, 1995, LANGMUIR, V11, P3913, DOI 10.1021/la00010a048
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   SOMORJAI GA, 1990, J PHYS CHEM-US, V94, P1013, DOI 10.1021/j100366a001
   SOMORJAI GA, 1991, LANGMUIR, V7, P3176, DOI 10.1021/la00060a043
   SUM F, 1994, J VAC SCI TECHNOL A, V12, P2499
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Williams D, 1988, ADV BIOMATER, V8, P11
   WOICIAKSTOTHARD B, 1997, DEV BIOL ANIMAL, V33, P110
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wu S., 1982, POLYM INTERFACE ADHE
NR 58
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-67460-8
PY 2000
BP 161
EP 183
PG 23
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic; Chemistry, Physical
SC Chemistry
GA BQ71C
UT WOS:000089239800008
DA 2018-10-19
ER

PT S
AU Tuchin, VV
   Zimnykov, DA
   Gaianzha, EI
   Ulianov, SS
   Sinichkin, YP
   Mishin, AB
   Chaussky, AA
   Ryabukho, VP
AF Tuchin, VV
   Zimnykov, DA
   Gaianzha, EI
   Ulianov, SS
   Sinichkin, YP
   Mishin, AB
   Chaussky, AA
   Ryabukho, VP
BE Tuchin, VV
   Izatt, JA
   Fujimoto, JG
TI Dynamical and structural diagnostics of living tissues using speckle
   techniques
SO COHERENCE DOMAIN OPTICAL METHODS IN BIOMEDICAL SCIENCE AND CLINICAL
   APPLICATIONS IV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Coherence Domain Optical Methods in Biomedical Science and
   Clinical Applications IV
CY JAN 24-26, 2000
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE speckles; interferometry; scattering,. tissue; blood; lymph; visual
   acuity
ID OPTICAL COHERENCE TOMOGRAPHY; BLOOD-FLOW; BIOLOGICAL TISSUE; LASER
   SPECKLE; SCATTERING MEDIUM; POLARIZED-LIGHT; LYMPH-FLOW; DOPPLER; SKIN;
   PHOTONS
AB Basing on such fundamental optical phenomena as elastic and quasi-elastic light scattering, diffraction, and interference of optical fields we have designed coherent optical methods offering much promise for biomedical applications. The scope of research includes the development of photon-correlation spectroscopy, speckle-interferometry, coherent micro-topography of living tissues, and study of optical images contrasting due to reduction of scattering properties of surrounding medium using immersion liquids.
   It was shown that speckle methods can be used as high resolution and high-performance tomographic techniques for imaging of both anatomical (on a micro- and nano-scale) and functional (blood and lymph flow) states of a tissue. Many advantages can be achieved in the field of speckle-polarization effects providing additional selectivity and sensitivity to tissue structure and material anisotropy. Speckle techniques using focused laser beams, including speckle-correlometry, speckle-interferometry, and spatial-domain laser technique, for tissue structure monitoring with a subcellular resolution and in vivo study of changes of velocity of blood and lymph in microvessels were developed. In vivo experimental study of optical and structural properties of such living tissues as skin, impregnated by glycerol and some other ointments were done.
C1 Saratov NG Chernyshevskii State Univ, Saratov 410026, Russia.
RP Tuchin, VV (reprint author), Saratov NG Chernyshevskii State Univ, 83 Astrakhanskaya, Saratov 410026, Russia.
EM tuchin@sgu.ssu.runnet.ru
RI Tuchin, Valery/C-7865-2013; Ryabukho, Vladimir/D-5227-2013
OI Tuchin, Valery/0000-0001-7479-2694; Ryabukho,
   Vladimir/0000-0002-1849-7380
CR AIZU Y, 1991, OPT LASER TECHNOL, V23, P205, DOI 10.1016/0030-3992(91)90085-3
   AIZU Y, 1992, APPL OPTICS, V31, P3020, DOI 10.1364/AO.31.003020
   BERKOVITS R, 1990, PHYS REV LETT, V65, P3120, DOI 10.1103/PhysRevLett.65.3120
   BICOUT D, 1994, PHYS REV E, V49, P1767, DOI 10.1103/PhysRevE.49.1767
   BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855
   Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359
   Briers JD, 1996, J OPT SOC AM A, V13, P345, DOI 10.1364/JOSAA.13.000345
   Briers JD, 1999, J BIOMED OPT, V4, P164, DOI 10.1117/1.429903
   deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934
   Demos SG, 1997, APPL OPTICS, V36, P150, DOI 10.1364/AO.36.000150
   Fercher A F, 1996, J Biomed Opt, V1, P157, DOI 10.1117/12.231361
   FREUND I, 1990, PHYS REV B, V42, P2613, DOI 10.1103/PhysRevB.42.2613
   Hielscher AH, 1997, APPL OPTICS, V36, P125, DOI 10.1364/AO.36.000125
   HORINAKA H, 1995, OPT LETT, V20, P1501, DOI 10.1364/OL.20.001501
   Izatt J., 1997, OPT PHOTONICS NEWS, V8, P41
   IZATT JA, 2000, P SPIE, V4001
   JACQUES SL, 2000, P SPIE, V4001
   KONISHI N, 1995, OPT ENG, V34, P753, DOI 10.1117/12.195203
   KOROLEVICH AN, 1994, OPT SPEKTROSK+, V77, P278
   Morgan SP, 1997, APPL OPTICS, V36, P1560, DOI 10.1364/AO.36.001560
   MUELLER G, 1993, SPIE
   RACOVIC MJ, 1999, APPL OPTICS, V38, P3399
   RUTH B, 1994, MED ENG PHYS, V16, P105, DOI 10.1016/1350-4533(94)90023-X
   Ryabukho V. P., 1995, Photonics and Optoelectronics, V3, P77
   Ryabukho VP, 1998, P SOC PHOTO-OPT INS, V3251, P247, DOI 10.1117/12.306064
   RYABUKHO VP, 1996, P SOC PHOTO-OPT INS, V2732, P100
   SCHMITT JM, 1992, APPL OPTICS, V31, P6535, DOI 10.1364/AO.31.006535
   Shepherd A.P, 1990, LASER DOPPLER BLOOD
   Tuchin V V, 1997, J Biomed Opt, V2, P401, DOI 10.1117/12.281502
   Tuchin VV, 1998, LASER PHYS, V8, P807
   Tuchin VV, 1999, J BIOMED OPT, V4, P106, DOI 10.1117/1.429926
   Ulyanov SS, 1998, J BIOMED OPT, V3, P237, DOI 10.1117/1.429879
   ULYANOV SS, 1995, OPT ENG, V34, P2850, DOI 10.1117/12.210740
   UlYanov SS, 1996, LASER MED SCI, V11, P97, DOI 10.1007/BF02133206
   ULYANOV SS, 1994, OPT ENG, V33, P3179
   WARDELL K, 1994, MICROVASC RES, V48, P26, DOI 10.1006/mvre.1994.1036
   YAMAMOTO T, 1990, J CLIN MED SURG, V8, P35
   Yao G, 1999, OPT LETT, V24, P537, DOI 10.1364/OL.24.000537
   ZANG B, 1994, APPL OPTICS, V33, P231
   Zimnyakov DA, 1996, APPL OPTICS, V35, P4325, DOI 10.1364/AO.35.004325
   Zimnyakov DA, 1997, APPL OPTICS, V36, P5594, DOI 10.1364/AO.36.005594
   ZIMNYAKOV DA, 1994, OPT SPEKTROSK+, V76, P838
   ZIMNYAKOV DA, 1999, P SPIE, V3599
NR 43
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3531-7
J9 PROC SPIE
PY 2000
VL 3915
BP 137
EP 151
DI 10.1117/12.384151
PG 15
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BQ40F
UT WOS:000088256000018
DA 2018-10-19
ER

PT J
AU Phillips, WM
AF Phillips, WM
TI Biomedical engineering: Issues and opportunity
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT 18th Southern Biomedical Engineering Conference/2nd International
   Conference on Ethical Issues in Biomedical Engineering
CY MAY 21-23, 1999
CL CLEMSON UNIV, CLEMSON, SOUTH CAROLINA
HO CLEMSON UNIV
AB As defined by the National Institutes of Health (NIH), bioengineering is an interdisciplinary field that applies physical, chemical, and mathematical sciences and engineering principles to the study of biology, medicine, behavior, and health. It advances knowledge from the molecular to the organ systems level, and develops new and novel biologics, materials, processes, implants, devices, and informational approaches for the prevention, diagnosis, and treatment of disease for patient rehabilitation and for improving health.
C1 Univ Florida, Grad Sch, Gainesville, FL 32611 USA.
RP Phillips, WM (reprint author), Univ Florida, Grad Sch, Gainesville, FL 32611 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892 USA
SN 0278-940X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 2000
VL 28
IS 1-2
BP 1
EP 2
PG 2
WC Engineering, Biomedical
SC Engineering
GA 352ZA
UT WOS:000089248200002
PM 10999356
DA 2018-10-19
ER

PT J
AU Cammas-Marion, S
   Guerin, P
AF Cammas-Marion, S
   Guerin, P
TI 4-alkyloxycarbonyl-2-oxetanones and
   3-alkyl-4-alkyloxycarbonyl-2-oxetanones as versatile chiral precursors
   in the design of functionalized polyesters with a controlled
   architecture
SO DESIGNED MONOMERS AND POLYMERS
LA English
DT Article
DE 4-alkyloxycarbonyl-2-oxetanones; 3-alkyl-4-alkyloxycarbonyl;
   2-oxetanones; beta-substituted; beta-lactones; poly(beta-malic acid)
   derivatives; functionalized polyesters; biomedical field
ID RADIOLABELED POLY(BETA-MALIC ACID); RING-OPENING POLYMERIZATION; 2
   STEREOGENIC CENTERS; DRUG CARRIER; INVIVO FATE; POLYMERS; DERIVATIVES;
   POLYSTEREOISOMERS; ESTERS; ROUTE
AB The necessity for accessing a very large variety of high-molecular-weight racemic and optically active polyesters aimed at biomedical or chemical al,plications has lied to the growth of a large series of racemic and optically active 4-alkyloxycarbonyl-2-oxetanones and 3-alkyl-4-alkyloxycarbonyl-2-oxetanones. Different synthesis routes have been established to prepare these monomers according to the bound ester group structure and the required enantiomeric or diastereomeric excess. The basic molecules were aspartic acid, malic acid or their 3-alkyl derivatives. The introduced ester group can be chiral, reactive, hydrophobic, hydrophilic or bioactive. The major interest in this enlarged monomer family lies in the possibility of have at one's disposal beta-substituted beta-lactones with very strict control of the stereogenic center configuration. This property is important with regard to the tailoring of well-defined polymeric materials. A second benefit lies in the tailor-making of complex architectures by the copolymerization of two or more beta-substituted beta-lactones. In al cases, the resulting materials have the composition of the monomer feed and a completely controlled configurational structure.
C1 Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, F-94320 Thiais, France.
RP Cammas-Marion, S (reprint author), Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, 2-8 Rue Henry Dunant, F-94320 Thiais, France.
CR ARNOLD SC, 1986, MAKROMOL CHEM-M SYMP, V6, P285, DOI 10.1002/masy.19860060128
   BARBAUD C, IN PRESS POLYM B
   Bear MM, 1998, MACROMOL SYMP, V132, P337, DOI 10.1002/masy.19981320131
   Bear MM, 1997, CR ACAD SCI II B, V325, P165, DOI 10.1016/S1251-8069(97)86832-7
   BEAR MM, IN PRESS ENANTIOMER
   BOUTAULT K, 1995, MACROMOLECULES, V28, P3516, DOI 10.1021/ma00114a004
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   BRAUD C, 1988, POLYM PREPR AM CHEM, V29, P600
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   CAMMAS S, 1993, TETRAHEDRON-ASYMMETR, V4, P1925, DOI 10.1016/S0957-4166(00)80433-4
   CAMMAS S, 1994, TETRAHEDRON-ASYMMETR, V5, P1589, DOI 10.1016/0957-4166(94)80129-0
   CAMMASMARION S, IN PRESS MACROMOL CH
   CARON A, 1990, POLYMER, V31, P1797, DOI 10.1016/0032-3861(90)90205-D
   FOURNIE P, 1992, J BIOACT COMPAT POL, V7, P113, DOI 10.1177/088391159200700201
   FOURNIE P, 1990, J BIOACT COMPAT POL, V5, P381, DOI 10.1177/088391159000500401
   FUJINO T, 1985, POLYM PRPR JPN, V35, P2330
   FUJISHIRO K, 1992, LIQ CRYST, V12, P417, DOI 10.1080/02678299208031058
   GUERIN P, 1986, MAKROMOL CHEM-M SYMP, V6, P305, DOI 10.1002/masy.19860060129
   GUERIN P, 1985, POLYM BULL, V14, P187, DOI 10.1007/BF00708479
   Jeanbat-Mimaud V, 1999, CR ACAD SCI II C, V2, P393, DOI 10.1016/S1387-1609(00)88551-5
   LeboucherDurand MA, 1996, POLYM BULL, V36, P35, DOI 10.1007/BF00296005
   LeboucherDurand MA, 1996, REACT FUNCT POLYM, V31, P57, DOI 10.1016/1381-5148(96)00048-X
   Moine L, 1997, POLYMER, V38, P3121, DOI 10.1016/S0032-3861(96)01097-X
   Moine L, 1998, MACROMOL SYMP, V130, P45, DOI 10.1002/masy.19981300105
   Monne C, 1996, CHIRALITY, V8, P300, DOI 10.1002/(SICI)1520-636X(1996)8:4<300::AID-CHIR2>3.0.CO;2-J
   OUCHI T, 1990, J CONTROL RELEASE, V12, P143, DOI 10.1016/0168-3659(90)90090-G
   RAMIANDRASOA P, 1993, POLYM BULL, V30, P501, DOI 10.1007/BF00296467
   Renard E, 1996, POLYM BULL, V36, P585, DOI 10.1007/BF00342450
   RENARD I, 1996, ACS POLYM PREPRINTS, V37, P137
   VERT M, 1986, MAKROMOL CHEM-M SYMP, V6, P109, DOI 10.1002/masy.19860060113
   Vert M., 1979, ACS POLYM PREPT, V20, P608
   VERT M, 1986, CRITICAL REV THERAPE, P291
NR 32
TC 10
Z9 10
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 1385-772X
J9 DES MONOMERS POLYM
JI Des. Monomers Polym.
PY 2000
VL 3
IS 1
BP 77
EP 93
DI 10.1163/156855500750198744
PG 17
WC Polymer Science
SC Polymer Science
GA 346CN
UT WOS:000088853100007
DA 2018-10-19
ER

PT S
AU Chan, RC
   Kaufhold, J
   Lees, RS
   Karl, WC
AF Chan, RC
   Kaufhold, J
   Lees, RS
   Karl, WC
BE Suresh, R
   Pien, HH
TI Ultrasound analysis of vascular structure and deformation
SO DIGITIZATION OF THE BATTLESPACE V AND BATTLEFIELD BIOMEDICAL
   TECHNOLOGIES II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 5th Battlespace Digitization Conference
CY APR 24-27, 2000
CL ORLANDO, FL
SP SPIE
DE ultrasound; blood vessels; carotid artery; border detection;
   segmentation; motion tracking; change detection; vascular injury;
   battlefield biomedical imaging
ID OPTICAL-FLOW; MODEL; SEGMENTATION; MOTION; SIMULATION; EVOLUTION;
   TRACKING; IMAGES; FIELD
AB Low-power, portable ultrasound imaging devices are well-suited for the diagnostic requirements of healthcare delivery on the modern battlefield. The non-invasiveness and good spatiotemporal resolution of ultrasonography allow for early detection of changes in tissue anatomy and material behavior that signal the presence of injury from exposure to biological hazards or disease processes that can jeopardize the performance of personnel in the field. This potential has not been fully realized however due to the presence of image degrading factors that make ultrasound imagery notoriously difficult to interpret. To detect and quantify tissue pathology from ultrasound, anatomical boundaries and tissue deformation in the images must be estimated accurately; this requires image processing in a way that suppresses noise while retaining salient tissue borders in the imagery. We focus here on detecting abnormalities in cross-sections of the carotid vessel which often exhibits early changes in response to injurious stimuli. We present a novel approach to vessel boundary extraction and deformation tracking over time for the purpose of detecting abnormal tissue characteristics. We validate this concept in noisy simulated images derived from finite-element models of normal and abnormal Vessel cross-sections, and in real ultrasound images from a human subject.
C1 Boston Heart Fdn, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02142 USA.
RP Chan, RC (reprint author), Boston Heart Fdn, Harvard MIT Div Hlth Sci & Technol, 139 Main St, Cambridge, MA 02142 USA.
CR Akgul YS, 1999, IEEE T MED IMAGING, V18, P1035, DOI 10.1109/42.811315
   BAMBER JC, 1980, PHYS MED BIOL, V25, P463, DOI 10.1088/0031-9155/25/3/006
   CHIN TM, 1994, IEEE T IMAGE PROCESS, V3, P773, DOI 10.1109/83.336247
   Delfino A, 1997, J BIOMECH, V30, P777, DOI 10.1016/S0021-9290(97)00025-0
   Dutt V, 1996, IEEE T MED IMAGING, V15, P802, DOI 10.1109/42.544498
   HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2
   KIMIA BB, 1992, J MATH ANAL APPL, V163, P438, DOI 10.1016/0022-247X(92)90260-K
   Lefebvre F, 1998, IEEE T MED IMAGING, V17, P45, DOI 10.1109/42.668693
   MAILLOUX GE, 1989, IEEE T MED IMAGING, V8, P143, DOI 10.1109/42.24862
   MALLADI R, 1995, IEEE T PATTERN ANAL, V17, P158, DOI 10.1109/34.368173
   Meairs S, 1999, STROKE, V30, P1807, DOI 10.1161/01.STR.30.9.1807
   MEUNIER J, 1995, IEEE T MED IMAGING, V14, P293, DOI 10.1109/42.387711
   Mikic I, 1998, IEEE T MED IMAGING, V17, P274, DOI 10.1109/42.700739
   RICHARDSON PD, 1989, LANCET, V2, P941
   Sethian JA, 1996, CAMBRIDGE MONOGRAPHS, V3
   Shah J, 1996, PROC CVPR IEEE, P136, DOI 10.1109/CVPR.1996.517065
   Vogel CR, 1998, IEEE T IMAGE PROCESS, V7, P813, DOI 10.1109/83.679423
   Yeung F, 1998, ULTRASOUND MED BIOL, V24, P427, DOI 10.1016/S0301-5629(97)00281-0
   Yezzi A, 1997, IEEE T MED IMAGING, V16, P199, DOI 10.1109/42.563665
NR 19
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3663-1
J9 P SOC PHOTO-OPT INS
PY 2000
VL 4037
BP 233
EP 244
DI 10.1117/12.395046
PG 12
WC Engineering, Biomedical; Multidisciplinary Sciences
SC Engineering; Science & Technology - Other Topics
GA BR35L
UT WOS:000166174000026
DA 2018-10-19
ER

PT J
AU McDonald, JC
   Duffy, DC
   Anderson, JR
   Chiu, DT
   Wu, HK
   Schueller, OJA
   Whitesides, GM
AF McDonald, JC
   Duffy, DC
   Anderson, JR
   Chiu, DT
   Wu, HK
   Schueller, OJA
   Whitesides, GM
TI Fabrication of microfluidic systems in poly(dimethylsiloxane)
SO ELECTROPHORESIS
LA English
DT Review
DE microfluidics; rapid prototyping; poly(dimethylsiloxane); review
ID INTEGRATED CAPILLARY ELECTROPHORESIS; ORGANIC POLYMER CAPILLARIES;
   PROTEIN CHARGE LADDERS; SEPARATION SYSTEMS; DNA ANALYSIS; GLASS CHIPS;
   MICROCHIP; INJECTION; DEVICES; MICROFABRICATION
AB Microfluidic devices are finding increasing application as analytical systems, biomedical devices, tools for chemistry and biochemistry, and systems for fundamental research. Conventional methods of fabricating microfluidic devices have centered on etching in glass and silicon. Fabrication of microfluidic devices in poly(dimethylsiloxane) (PMS) by soft lithography provides faster, less expensive routes than these conventional methods to devices that handle aqueous solutions. These soft-lithographic Cambridge, MA, USA methods are based on rapid prototyping and replica molding and are more accessible to chemists and biologists working under benchtop conditions than are the microelectronics-derived methods because, in soft lithography, devices do not need to be fabricated in a cleanroom. This paper describes devices fabricated in PDMS for separations, patterning of biological and nonbiological material, and components for integrated systems.
C1 Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.
   Gamera Biosci, Medford, MA USA.
RP Whitesides, GM (reprint author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.
FU NIGMS NIH HHS [GM51559]
CR Bakajin O., 1998, SOLID STATE SENSOR A, P116
   Bayer H, 1996, J MICROCOLUMN SEP, V8, P479
   Braxton S, 1998, CURR OPIN BIOTECH, V9, P643, DOI 10.1016/S0958-1669(98)80144-4
   Brody JP, 1996, BIOPHYS J, V71, P3430, DOI 10.1016/S0006-3495(96)79538-3
   Burggraf N, 1998, ANALYST, V123, P1443, DOI 10.1039/a801478g
   Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484
   Burns MA, 1996, P NATL ACAD SCI USA, V93, P5556, DOI 10.1073/pnas.93.11.5556
   Carbeck JD, 1998, ACCOUNTS CHEM RES, V31, P343, DOI 10.1021/ar970255q
   CHAUDHURY MK, 1991, LANGMUIR, V7, P1013, DOI 10.1021/la00053a033
   CHAUDHURY MK, 1992, SCIENCE, V255, P1230, DOI 10.1126/science.255.5049.1230
   Cheng J, 1998, ANAL BIOCHEM, V257, P101, DOI 10.1006/abio.1997.2531
   Chiem N, 1997, ANAL CHEM, V69, P373, DOI 10.1021/ac9606620
   Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11
   Colton IJ, 1997, J AM CHEM SOC, V119, P12701, DOI 10.1021/ja9723491
   Colyer CL, 1997, ELECTROPHORESIS, V18, P1733, DOI 10.1002/elps.1150181006
   DeBusschere B.D., 1998, SOL STAT SENS ACT C, P358
   Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   Dorre K., 1997, Bioimaging, V5, P139, DOI 10.1002/1361-6374(199709)5:3<139::AID-BIO8>3.3.CO;2-R
   Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Effenhauser CS, 1997, ELECTROPHORESIS, V18, P2203, DOI 10.1002/elps.1150181211
   Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919
   Ermakov SV, 1998, ANAL CHEM, V70, P4494, DOI 10.1021/ac980551w
   ERMAKOV SV, 1998, ANAL CHEM, V70, P4504
   Fluri K, 1996, ANAL CHEM, V68, P4285, DOI 10.1021/ac9604090
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   Ford SM, 1999, J BIOMECH ENG-T ASME, V121, P13, DOI 10.1115/1.2798035
   Freemantle M, 1999, CHEM ENG NEWS, V77, P27, DOI 10.1021/cen-v077n008.p027
   Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   Jacobson SC, 1998, ANAL CHEM, V70, P3476, DOI 10.1021/ac980349t
   Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83
   Khandurina J, 1999, ANAL CHEM, V71, P1815, DOI 10.1021/ac981161c
   Konrad R., 1998, MICROREACTION TECHNO, P348
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Kovacs GTA., 1998, MICROMACHINED TRANSD
   Kricka LJ, 1998, CLIN CHEM, V44, P2008
   Kricka LJ, 1996, PURE APPL CHEM, V68, P1831, DOI 10.1351/pac199668101831
   Kutter JP, 1998, ANAL CHEM, V70, P3291, DOI 10.1021/ac971367y
   Lauks IR, 1998, ACCOUNTS CHEM RES, V31, P317, DOI 10.1021/ar9700670
   Li PCH, 1997, ANAL CHEM, V69, P1564, DOI 10.1021/ac9606564
   Liang ZH, 1996, ANAL CHEM, V68, P1040, DOI 10.1021/ac950768f
   Liu SR, 1999, ANAL CHEM, V71, P566, DOI 10.1021/ac980783v
   MAMMEN M, 1995, ANAL CHEM, V67, P3526, DOI 10.1021/ac00115a023
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I
   MANZ A, 1993, ADV CHROMATOGR, V33, P1
   MANZ A, 1997, INT C SOL STAT SENS, P915
   Martynova L, 1997, ANAL CHEM, V69, P4783, DOI 10.1021/ac970558y
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   Northrup MA, 1998, ANAL CHEM, V70, P918, DOI 10.1021/ac970486a
   Ogura M, 1998, CLIN CHEM, V44, P2249
   Peled N, 1996, PURE APPL CHEM, V68, P1837, DOI 10.1351/pac199668101837
   Qin D, 1998, TOP CURR CHEM, V194, P1
   Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110
   RAMSEY JM, 1995, NAT MED, V1, P1093, DOI 10.1038/nm1095-1093
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   ROHLICEK V, 1994, J CHROMATOGR A, V662, P369, DOI 10.1016/0021-9673(94)80523-7
   SalimiMoosavi H, 1997, J AM CHEM SOC, V119, P8716, DOI 10.1021/ja971735f
   Santini JT, 1999, NATURE, V397, P335
   Schueller OJA, 1999, ADV MATER, V11, P37, DOI 10.1002/(SICI)1521-4095(199901)11:1<37::AID-ADMA37>3.0.CO;2-0
   SCHUELLER OJA, 1999, IN PRESS SENS ACTU A
   SCHUTZNER W, 1992, ANAL CHEM, V64, P1991, DOI 10.1021/ac00041a039
   SEILER K, 1993, ANAL CHEM, V65, P1481, DOI 10.1021/ac00058a029
   Shaw JM, 1997, IBM J RES DEV, V41, P81, DOI 10.1147/rd.411.0081
   Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   TORTORA GJ, 1996, PRINCIPLES ANATOMY P
   VANDENBERG A, 1993, SENSOR ACTUAT B-CHEM, V13, P396, DOI 10.1016/0925-4005(93)85410-C
   VANDENBERG A, 1995, MICRO TOTAL ANAL SYS
   Waters LC, 1998, ANAL CHEM, V70, P5172, DOI 10.1021/ac980447e
   Weigl BH, 1999, SCIENCE, V283, P346, DOI 10.1126/science.283.5400.346
   Woolley AT, 1998, ANAL CHEM, V70, P684, DOI 10.1021/ac971135z
   WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yao S, 1999, P NATL ACAD SCI USA, V96, P5372, DOI 10.1073/pnas.96.10.5372
   ZHU HP, 1994, ANAL CHEM, V66, P1941, DOI 10.1021/ac00085a004
NR 80
TC 2146
Z9 2180
U1 91
U2 1617
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD JAN
PY 2000
VL 21
IS 1
BP 27
EP 40
DI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
PG 14
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 279VM
UT WOS:000085065800004
PM 10634468
DA 2018-10-19
ER

PT J
AU Hamosh, A
   Scott, AF
   Amberger, J
   Valle, D
   McKusick, VA
AF Hamosh, A
   Scott, AF
   Amberger, J
   Valle, D
   McKusick, VA
TI Online Mendelian Inheritance in Man (OMIM)
SO HUMAN MUTATION
LA English
DT Article
DE MDI; OMIM; MIM; central database; medical genetics; electronic
   publication; mutation database; clinical genetics
AB Online Mendelian Inheritance In Man (OMIM) is a public database of bibliographic information about human genes and genetic disorders. Begun by Dr. Victor McKusick as the authoritative reference Mendelian Inheritance in Man, it is now distributed electronically by the National Center for Biotechnology Information (NCBI). Material in OMIM is derived from the biomedical literature and is written by Dr. McKusick and his colleagues at Johns Hopkins University and elsewhere. Each OMIM entry has a full text summary of a genetic phenotype and/or gene and has copious links to other genetic resources such as DNA and protein sequence, PubMed references, mutation databases, approved gene nomenclature, and more. In addition, NCBI's neighboring feature allows users to identify related articles from PubMed selected on the basis of key words in the OMIM entry. Through its many features, OMIM is increasingly becoming a major gateway for clinicians, students, and basic researchers to the ever growing literature and resources of human genetics. Hum Mutat 15:57-61, 2000. (C) 2000 Wiley-Liss, Inc.
C1 Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA.
RP Scott, AF (reprint author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Blalock 1033, Baltimore, MD 21287 USA.
CR AITSCHUL SF, 1990, J MOL BIOL, V215, P403
   Cuticchia AJ, 2000, HUM MUTAT, V15, P62, DOI 10.1002/(SICI)1098-1004(200001)15:1<62::AID-HUMU13>3.0.CO;2-R
   Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T
   MCKUSICK V, 1997, MENDELIAN INHERITANC
   Scriver CR, 2000, HUM MUTAT, V15, P99, DOI 10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P
NR 5
TC 169
Z9 172
U1 1
U2 16
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1059-7794
J9 HUM MUTAT
JI Hum. Mutat.
PY 2000
VL 15
IS 1
BP 57
EP 61
DI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA 271VE
UT WOS:000084613900011
PM 10612823
OA Bronze
DA 2018-10-19
ER

PT B
AU Hafez, M
   Benjamin, S
   Sidler, T
AF Hafez, M
   Benjamin, S
   Sidler, T
BE Christensen, P
TI Compact laser system for micro-processing applications.
SO ICALEO (R)'99: PROCEEDING OF THE LASER MATERIALS PROCESSING CONFERENCE,
   VOL 87, PTS 1 AND 2
SE LASER INSTITUTE OF AMERICA - PROCEEDINGS
LA English
DT Proceedings Paper
CT Laser Materials Processing Conference (ICALEO(R)99)
CY NOV 15-18, 1999
CL SAN DIEGO, CA
SP Laser Inst Amer
AB We propose a compact laser system for micro-machining and micro-fabrication applications. The system is mainly composed of a laser source and a beam handling system for 2D scanning combined with an auto focus allowing a third degree of freedom.
   The laser source is a high power direct diode side-pumped pulsed solid state laser, which produces a high quality and high intensity laser beam. The crystal is a Nd:YAG emitting at 1.06 mu m for industrial micro-material processing, at 1.35 mu m and also at 1.44 mu m for tissue treatments in biomedical applications.
   The beam handling system consists of a very compact, highly innovative two-axis tilt laser scanner. Electromagnetic actuators drive the mirror and its suspension is based on a cone-ball bearing. It achieves a scan range of +/-3 degrees around x and y with an accuracy better than 0.1%. Such a system finds diverse applications: in the field of industrial cutting, drilling and welding. Furthermore, its small volume allows an easy integration in fabrication processes.
C1 Ecole Polytech Fed Lausanne, Inst Appl Opt, CH-1015 Lausanne, Switzerland.
RP Hafez, M (reprint author), Ecole Polytech Fed Lausanne, Inst Appl Opt, CH-1015 Lausanne, Switzerland.
CR FREITAG I, 1995, LASER OPTOELECTRONIC, V27
   GOLLA D, 1993, LASER OPTOELECTRONIC, V25
   HAFEZ M, 1999, S INT SYST ADV MAN 9
   HATTORI S, 1987, Patent No. 4660941
   LAKERVELD HG, 1978, Patent No. 4073567
   MASOTTI L, 1997, Patent No. 0790512
   Smith S. T., 1992, FDN ULTRAPRECISION M
   UMEKI N, 1979, Patent No. 4175832
   ZAGO L, 1997, SPAC MICR ACC CONTR
NR 9
TC 0
Z9 0
U1 0
U2 2
PU LASER INST AMERICA
PI ORLANDO
PA 12424 RESEARCH PKWY, STE 130, ORLANDO, FL 32826 USA
BN 0-912035-60-9
J9 LIA P
PY 2000
VL 87
BP A115
EP A123
PN 1&2
PG 5
WC Metallurgy & Metallurgical Engineering; Optics; Physics, Applied
SC Metallurgy & Metallurgical Engineering; Optics; Physics
GA BQ62Z
UT WOS:000089016200014
DA 2018-10-19
ER

PT B
AU Yu, Q
   Takeda, T
   Yuasa, T
   Hasegawa, Y
   Zeniya, T
   Hyodo, K
   Itai, Y
   Akatsuka, T
AF Yu, Q
   Takeda, T
   Yuasa, T
   Hasegawa, Y
   Zeniya, T
   Hyodo, K
   Itai, Y
   Akatsuka, T
BE Zheng, XX
   He, B
   Zhang, YT
TI Minimal detectability of contrast materials in fluorescent x-ray
   computed tomography using synchrotron radiation
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
DE fluorescent X-ray; synchrotron radiation; computed tomography; minimal
   detectability
AB Fluorescent x-ray computed tomography (FXCT) with synchrotron radiation is being developed to depict the distribution of high Z elements within the biomedical specimens. Minimal detectability limit of iodine was investigated in the FXCT with a 10-mm-diameter phantom with the spatial resolution of 100 x 100 mu m(2). We can conclude FXCT could detect 1 mu g/ml specific elements within biomedical specimens.
C1 Yamagata Univ, Dept Biosyst Engn, Yamagata 990, Japan.
RP Yu, Q (reprint author), Yamagata Univ, Dept Biosyst Engn, Yamagata 990, Japan.
CR Rust GF, 1998, IEEE T NUCL SCI, V45, P75, DOI 10.1109/23.659557
   Takeda T, 1996, P SOC PHOTO-OPT INS, V2708, P685, DOI 10.1117/12.237832
   Takeda T, 1999, P SOC PHOTO-OPT INS, V3772, P258, DOI 10.1117/12.363728
   TAKEDA T, IN PRESS CELLULAR MO
   YU Q, UNPUB MED IMAGING TE
   Yuasa T, 1997, IEEE T NUCL SCI, V44, P54, DOI 10.1109/23.554824
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 230
EP 231
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500110
DA 2018-10-19
ER

PT B
AU McQuiston, BK
AF McQuiston, BK
BE Zheng, XX
   He, B
   Zhang, YT
TI Emerging technologies in biomedical engineering
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
DE biosensors; chip; microfluidics; fluidic; Biochemical
AB Recent advances in chip based chemistry has been made in the area of microfluidics chip based technology for advanced bio-chemical analysis. These technologies take advantage of IC chip processing techniques, sophisticated integrated platform design, and new materials, advanced manufacturing processes and unique sensor designs. Microfluidic technology can produce a highly integrated measurement system for the long-term monitoring of physiological conditions and various measurements relevant to bioprocessing. YSI has developed biosensors including the first glucose, lactate, oxygen and a chip-based system that utilizes biosensor technology based on the YSI amperometric biosensor technology. These sensor measurements are used for continuous monitoring of pharmaceutical, food and biotechnology industrial applications. This microfluidic design is a monolithic structure with a miniature Flow Injection Analysis system formed in plastic. Biosensors are formed within this structure and created with a general morphology that benefits for the unique dynamics produced through miniaturization and unique understanding of microfluidic flow. This paper will review the design of this disposable chip including the functional features that make up the monolithic device. Review of the enzymatic sensor design and unique sensor morphology will also be discussed. Careful examples will be presented on design considerations, system performance characteristics and applications.
C1 YSI, Yellow Springs, OH 45387 USA.
RP McQuiston, BK (reprint author), YSI, 1700 Brannum Lane,POB 279, Yellow Springs, OH 45387 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 698
EP 699
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500347
DA 2018-10-19
ER

PT B
AU Asim, R
   Harris, MB
   Sikander, AS
   Masroor, AK
   Fahd, U
AF Asim, R
   Harris, MB
   Sikander, AS
   Masroor, AK
   Fahd, U
BE Zheng, XX
   He, B
   Zhang, YT
TI New design of Biomedical electrodes for physiological data acquisition
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
AB The study has been made on Biomedical electrode function and their adverse effect on the biological system. From material point of view these sensors have been classified according to application and various applications are studied. The possibility of producing these electrodes domestically i.e. in Pakistan with a new design and with the provision of improving the quality and life for the existing electrodes has been modeled. New proposed model is subjected to make the non repairable electrodes not only disposable but cheaper.
C1 Sir Syed Univ Engn & Technol, Dept Biomed Engn, Karachi, Pakistan.
RP Asim, R (reprint author), Sir Syed Univ Engn & Technol, Dept Biomed Engn, Karachi, Pakistan.
CR ARTHUR C, 1986, MED PHYSL
   CROMWELL L, 1993, BIOMEDICAL INSTRUMEN
   HENCH LL, 1982, BIOMATERIALS
   JANZ GJ, 1968, ANN NY ACAD SCI, V148, P210, DOI 10.1111/j.1749-6632.1968.tb20350.x
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 749
EP 750
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500372
DA 2018-10-19
ER

PT B
AU Qin, SJ
   Li, WJ
AF Qin, SJ
   Li, WJ
BE Zheng, XX
   He, B
   Zhang, YT
TI 3-D micro channel system in a quartz cube for biomedical applications
SO IEEE-EMBS ASIA PACIFIC CONFERENCE ON BIOMEDICAL ENGINEERING -
   PROCEEDINGS, PTS 1 & 2
LA English
DT Proceedings Paper
CT IEEE-EMBS Asia-Pacific Conference on Biomedical Engineering
CY SEP 26-28, 2000
CL HANGZHOU, PEOPLES R CHINA
SP IEEE, Engn Med & Biol Soc, EMB, Asia-Pacific Congress Biomed Engn, KC Wong Educ Fdn, Natl Nat Sci Fdn China, Minist Educ China, Hong Kong Inst Engn, Biomed Div, IEEE, State Dev Planning Commiss, Dept High Tech Ind, Chinese Inst Electr, Biomed Electr Soc, Chineses Soc Biomed Engn, Japan Soc Med Electr & Biol Engn, Publ Hlth Bur Zhenjiang Province, Zhejiang Soc Med, Zhejiang Soc Biomed Engn, Zhejiang Sci & Technol Exchange Ctr Foreign Countries, Zhejiang Univ, Chinese Univ Hong Kong
DE micro channel; laser micro-machining; quartz
AB A novel technology is presented to create three dimensional (3-D) micro channel systems bounded by a solid 3-D quartz substrate by means of a special laser micromachining process in this paper. The special process was developed to surmount the problems of using Nd:YAG laser to micro-machine transparent materials. This technology allows the rapid construction of complex 3-D channel paths inside the quartz cube without damaging the surface and neighboring area due to quartz's transparency at the Nd:YAG laser wavelength. The dimension of the micro channels can be controlled from 50 mum to 200 mum. Channels in different directions can be connected easily. The performance of the micro channels is carried out by resistance measurement. The behavior of laser micro-machining on quartz is also investigated.
C1 Chinese Univ Hong Kong, Dept Automat & Comp Aided Engn, Adv Microsyst Lab, Hong Kong, Hong Kong, Peoples R China.
RP Qin, SJ (reprint author), Chinese Univ Hong Kong, Dept Automat & Comp Aided Engn, Adv Microsyst Lab, Hong Kong, Hong Kong, Peoples R China.
RI Li, Wen Jung/M-9995-2013; Li, Wen Jung/A-6153-2010
OI Li, Wen Jung/0000-0001-9616-6213; Li, Wen Jung/0000-0001-9616-6213
CR KIKUCHI T, 1999, MICROPROCESSES NANOT, P179
   Nakanishi H, 1997, PROC IEEE MICR ELECT, P299, DOI 10.1109/MEMSYS.1997.581834
   NONHOF CJ, 1988, MAT PROCESSING ND LA
NR 3
TC 0
Z9 0
U1 0
U2 0
PU WORLD PUBLISHING CORPORATION
PI BEIJING
PA 137 CHAONEI DAJIE, BEIJING 100010, PEOPLES R CHINA
BN 7-5062-4828-X
PY 2000
BP 792
EP 793
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR17W
UT WOS:000165806500394
DA 2018-10-19
ER

PT J
AU Ang, BY
   Chua, CK
   Du, ZH
AF Ang, BY
   Chua, CK
   Du, ZH
TI Study of trapped material in rapid prototyping parts
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE algorithm; rapid prototyping; remedies; trapped material; trapped
   volume; warping
AB Since the launch of the first commercial system in 1988, rapid prototyping (RP) technology is fast being accepted in the fields of product design and development, in the tool and die making industry and recently, for biomedical applications. Although, in theory, RP is able to produce an object of any complexity, problems such as having material trapped inside parts with hollow features till frequently occur during normal operation. this research project seeks to achieve a better understanding of the formation of trapped material inside RP parts, with the eventual aim of developing an algorithm to avoid this problem. In this paper, the causes and effects of trapped material will be discussed for stereolithography apparatus (SLA), solid ground curing (SGC), selective laser sintering (SLS), and laminated object manufacturing (LOM). Finally, current remedies will be presented.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Chua, Chee Kai/B-6171-2009
CR *ALL, 1998, EX HTG 324
   *ALL, 1998, EX HTG 35X
   *CAD CAM PUBL, 1997, RAPID PROTOTYPING RE, V7, P3
   *CAD CAM PUBL, 1996, RAPID PROTOTYPING RE, V6, P6
   CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P12
   CHUA CK, 1994, COMPUT CONTROL ENG J, V5, P200, DOI 10.1049/cce:19940407
   CHUA CK, 1995, RAPID PROTOTYPING J, V1, P4
   DAVIS M, 1998, RECOATER PROBLEMS
   DURHAM M, 1996, SLS SLA DIFFERENT TE
   *ENN FABR TECHN, 1996, RAPID PROTOTYPING RE, V6, P2
   Frank D., 1994, Proceedings of The Fifth International Conference on Rapid Prototyping - 1994
   JACOBS PF, 1992, RAPID PROTOTYPING MA, P14
   MATHEWSON BB, 1995, P SOL FREEF FABR S A, P253
   MCCLURKIN J, 1996, VARIATION 2 CIBA GIE
   MCCLURKIN J, 1996, VARIATION 3 CIBA GIE
   MILLER MW, 1998, RE HOLLOW SLAS
   Newman WS, 1996, ROBOT CIM-INT MANUF, V12, P293, DOI 10.1016/S0736-5845(96)00022-1
   OKKEMA B, 1998, RE RECOATER PROBLEMS
   PERSALL E, 1996, TRAPPED V S
   STAHLHUT T, 1996, SLA ASTERISK AMPERSA
   SUH YS, 1995, P SOL FREEF FABR AUS, P334
   WEI P, 1997, P 6 EUR C RAP PROT M, P95
   Wohlers T., 1997, RAPID PROTOTYPING ST
   Xu F, 1997, RAPID PROTOTYPING J, V3, P76, DOI 10.1108/13552549710185644
NR 24
TC 20
Z9 21
U1 0
U2 6
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2000
VL 16
IS 2
BP 120
EP 130
DI 10.1007/s001700050017
PG 11
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 283FR
UT WOS:000085266200007
DA 2018-10-19
ER

PT J
AU Ang, BY
   Chua, CK
   Du, ZH
AF Ang, BY
   Chua, CK
   Du, ZH
TI Development of an advisory system for trapped material in rapid
   prototyping parts
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE feature recognition; rapid prototyping; trapped material; trapped
   volume; user function
AB Since the launch of the first commercial system in 1988, rapid prototyping (RP) technology is fast being accepted in the fields of product design and development, tool and die making, and recently, for biomedical applications. Although RP is able to produce objects of any complexities in theory, problems such as having material trapped inside parts with hollow features still occur frequently during normal operation. This could result in a distorted part being built, or the system being damaged. To reduce such occurrences, the purpose of this project was to develop an application program using the Unigraphics CAD/CAM system, to search automatically for the problematic features in a CAD file, and to provide the necessary modifications or recommendations. The initial focus has been on providing solutions for objects produced by stereolithography apparatus (SLA) and selective laser sintering (SLS). Provision has been made through the use of modular programming to allow more upgrades in future to other RP systems.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Chua, Chee Kai/B-6171-2009
CR ANG BY, 1998, IN PRESS INT J ADV M
   CAMPBELL RI, 1998, P 1 INT C RAP PROT M, P632
   CHUA CK, 1997, RAPID PROTOTYPING J
   DURHAM M, 1996, SLS SLA DIFFERENT TE
   *EL DAT SYST CORP, 1995, US FUNCT SYST OV
   Guo YH, 2003, INT J ADV MANUF TECH, V21, P596, DOI 10.1007/s00170-002-1315-1
   JACOBS PF, 1992, RAPID PROTOTYPING MA, P14
   Wohlers T., 1997, RAPID PROTOTYPING ST
   1996, RAPID PROTOTYPING RE, P6
NR 9
TC 7
Z9 7
U1 0
U2 6
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2000
VL 16
IS 10
BP 733
EP 738
PG 6
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 355ZN
UT WOS:000089418600007
DA 2018-10-19
ER

PT J
AU Thomas, M
   Valette, P
   Mausset, AL
   Dejardin, P
AF Thomas, M
   Valette, P
   Mausset, AL
   Dejardin, P
TI High molecular weight kininogen adsorption on hemodialysis membranes:
   influence of pH and relationship with contact phase activation of blood
   plasma. Influence of pre-treatment with poly(ethyleneimine)
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE hemodialysis; kininogen; contact phase; adsorption
ID SOLID-SURFACES; FIBRINOGEN; PROTEIN
AB Protein adsorption is an essential parameter for the evaluation of the hemocompatibility of biomedical materials. In effect, protein adsorption often generates unfavorable, complex, biochemical reactions and precedes cell adhesion on artificial interfaces. It is therefore necessary to modify the surface in contact with blood in order to minimize the onset of undesirable, biochemical, cascade reactions. Adsorption of high molecular weight kininogen (HK), which participates in the contact phase activation of the endogenous blood coagulation cascade, was evaluated at 37 degrees C. This paper also presents the results of contact phase activation tests carried out in vitro with 1:20 diluted human plasma flowing through minidialyzers containing hollow fibers of synthetic hemodialysis. membranes. These tests showed that contact phase activation is strongly dependent on pH around the physiological value (ranging from 7.35 to 7.80) for negatively-charged membranes. The same pH effect was observed on the AN69(R) membrane as regards HK adsorption from binary labeled solutions of I-125-HK and I-131-Fibrinogen at concentrations corresponding to 1% diluted plasma. It is suggested that the influence of pH could be related to imidazole pK(a) values in histidine residues of kininogen D5(H), domain. The same study was also conducted with hemodialysis membranes pretreated with poly(ethyleneimine). Both HK adsorption and contact phase activation proved to be greatly reduced, irrespective of the pH value (between 7.0 and 7.8). Hence, positively-charged poly(ethyleneimine) adsorbed on the membrane through strong ionic interactions with sulfonate groups of the surface probably constitutes a repelling, wafer-swollen layer for the kininogen en molecule. In addition, the advantages of the high levels of adsorbance of small molecules on the AN69(R) membrane leading to blood epuration, due to its high porosity and for some of them to its charge density should not be lost by such a surface treatment.
C1 Univ Montpellier 2, Lab Mat & Procedes Membranaires, CNRS,UMR 5635, ENSCM,UM 2, F-34095 Montpellier, France.
   Gambro Grp, Hosp R&D Int, Lyon, France.
RP Dejardin, P (reprint author), Univ Montpellier 2, Lab Mat & Procedes Membranaires, CNRS,UMR 5635, ENSCM,UM 2, 2 Pl Eugene Bataillon, F-34095 Montpellier, France.
RI Dejardin, Philippe/C-5845-2008
CR ANFINSEN CB, 1972, BIOCHEM J, V128, P737, DOI 10.1042/bj1280737
   Bouman CSC, 1998, BLOOD PURIFICAT, V16, P261, DOI 10.1159/000014343
   BOUMAZA F, 1992, BIOPHYS CHEM, V42, P87, DOI 10.1016/0301-4622(92)80010-3
   BRASH JL, 1988, BLOOD, V71, P932
   Colman RW, 1997, BLOOD, V90, P3819
   CREIGHTON TE, 1996, PROTEINS STRUCTURES, P13
   Dejardin P, 1998, POLYMERS AND SURFACES: A VERSATILE COMBINATION, P211
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   FRIBERGER P, 1979, KININS, V2, P67
   FURLAND M, 1992, HUMAN PROTEIN DATA
   Le MT, 1998, LANGMUIR, V14, P3356, DOI 10.1021/la9713513
   MULLER EW, 1992, HUMAN PROTEIN DATA
   Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123
   REGOECZI E, 1984, IODINE LABELED PLASM, P49
   Renaux JL, 1999, KIDNEY INT, V55, P1097, DOI 10.1046/j.1523-1755.1999.0550031097.x
   SADLER PJ, 1993, EUR J BIOCHEM, V212, P811, DOI 10.1111/j.1432-1033.1993.tb17722.x
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   Tishmack PA, 1997, BIOCHEMISTRY-US, V36, P11984, DOI 10.1021/bi9712448
   Valette P, 1999, BIOMATERIALS, V20, P1621, DOI 10.1016/S0142-9612(99)00070-8
   VROMAN L, 1980, BLOOD, V55, P156
   YAN F, 1992, J BIOMAT SCI-POLYM E, V3, P3811
   YU LP, 1994, BBA-PROTEIN STRUCT M, V1209, P24, DOI 10.1016/0167-4838(94)90132-5
NR 22
TC 37
Z9 39
U1 1
U2 5
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JAN
PY 2000
VL 23
IS 1
BP 20
EP 26
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 287WT
UT WOS:000085530200004
PM 12118833
DA 2018-10-19
ER

PT J
AU Britchi, M
   Olteanu, M
   Jitianu, G
   Branzei, M
   Gheorghe, D
   Nita, P
AF Britchi, M
   Olteanu, M
   Jitianu, G
   Branzei, M
   Gheorghe, D
   Nita, P
TI Vitroceramic coatings on metallic supports with biomedical applications
SO INTERNATIONAL JOURNAL OF MATERIALS & PRODUCT TECHNOLOGY
LA English
DT Article
DE bioactive materials; biocompatible; Cr-Niaustenitic steels; enamelling
   process; titanium; vitroceramic coatings
ID GLASS-CERAMICS; CRYSTALLIZATION; BIOMATERIALS
AB Vitroceramic coatings from the oxidic system SiO2-CaO-B2O3-TiO2-R2O (R = Na and K) were applied on metallic supports (titanium and austenitic steels with high Cr and Ni contents). The coating procedure was classical enamelling. The metals were coated by either immersion or by painting over a thin layer from a mixture of frit (having the best composition For each metallic support) with a liquid mixture (triethanol amine : ethyl alcohol 1 : 10), which was subsequently fired at the enamelling temperature. A good adherence between the two different materials has been thus achieved. Vitroceramic coating - metallic support couples were then characterized by optical microscopy (OM), electronic microscopy (EDS and WDS), and X-ray diffraction (XRD). The adherence of the vitroceramic layers onto metallic supports was tested by microhardness trials at the interface. The processes at the interface, i. e. gas bubble evolution, micropore formation, chemical bonding and diffusion, were evidenced. These coating layers can be employed as both bioactive and biocompatible materials.
C1 Romanian Acad, Inst Phys Chem IG Murgulescu, Bucharest, Romania.
   Politehn Univ Bucharest, Sci & Engn Mat Fac, Bucharest, Romania.
   Aviat Met METAV SA, Bucharest, Romania.
RI BRANZEI, MIHAI/C-7101-2012
CR BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   COLAN H, 1968, STUDIUL METALELOR, P117
   DAVID HK, 1998, CURRENT OPINION SOLI, V3, P309
   FRIGGE M, 1996, MIKROCHIM ACTA S, V13, P299
   FUJIO T, 1982, Patent No. 2080281
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1995, J NON-CRYST SOLIDS, V180, P292, DOI 10.1016/0022-3093(94)00464-1
   JAMES PF, 1995, J NON-CRYST SOLIDS, V181, P1, DOI 10.1016/0022-3093(94)00515-X
   Kasuga T, 1999, BIOMATERIALS, V20, P1415, DOI 10.1016/S0142-9612(99)00047-2
   LUPESCU M, 1997, THESIS BUCHAREST
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Saha SK, 1998, PHYS CHEM GLASSES, V39, P118
   Saha SK, 1996, SURF INTERFACE ANAL, V24, P113, DOI 10.1002/(SICI)1096-9918(199602)24:2<113::AID-SIA100>3.0.CO;2-C
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   YOKOKAWA H, 1993, J ELECTROCHEM SOC, V140, P3565, DOI 10.1149/1.2221127
NR 16
TC 3
Z9 3
U1 1
U2 2
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0268-1900
J9 INT J MATER PROD TEC
JI Int. J. Mater. Prod. Technol.
PY 2000
VL 15
IS 6
BP 446
EP 457
DI 10.1504/IJMPT.2000.001257
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 387VH
UT WOS:000166142200001
DA 2018-10-19
ER

PT B
AU Raghunathan, R
   Sitaraman, SK
AF Raghunathan, R
   Sitaraman, SK
BE Kromann, GB
   Culham, JR
   Ramakrishna, K
TI Qualification guidelines for automotive packaging devices
SO ITHERM 2000: SEVENTH INTERSOCIETY CONFERENCE ON THERMAL AND
   THERMOMECHANICAL PHENOMENA IN ELECTRONIC SYSTEMS, VOL I, PROCEEDINGS
LA English
DT Proceedings Paper
CT 7th Intersociety Conference on Thermal and Thermomechanical Phenomena in
   Electronic Systems
CY MAY 23-26, 2000
CL LAS VEGAS, NV
SP IEEE, CPMT, Amer Soc Mechan Engineers, US Natl Inst Stand & Technol, Int Microelectr & Packaging Soc
DE FCOB; FCCSP; qualification guidelines; thermal cycling; accumulated
   equivalent inelastic strain; strain energy density; power-law creep
   model; Anand's visco-plastic model; die cracking
AB With the continued demand for miniaturization, with the advent of new materials and processes, and with increased demand for better performance and lower cost, reliability of microelectronic devices continues to be a major concern. As microelectronic packages are used in a wide range of applications from automotive to aerospace to telecommunications to biomedical devices, there is a need for developing suitable qualification standards for these application domains. The ongoing work at Georgia Tech aims to develop a comprehensive virtual qualification system taking into consideration the process mechanics of substrate fabrication and component assembly, time- and temperature-dependent material behavior, process-induced defects, and critical geometric features of the assembly.
   The objective of this paper is to present one such virtual qualification technique for microelectronic packages used in automotive applications. Numerical models have been developed that take into account the creep behavior of the solder joints, the viscoelastic behavior of the underfill and the temperature-dependent orthotropic properties of the substrate. The models account for the solder reflow process and underfill cure process. They also account for multiple reflow and burn-in testing of the devices. Based on the information collected in terms of weather, underhood conditions, and driving profiles, qualification temperature cycling guidelines have been developed for automotive devices. The possibility of backside die cracking due to tensile stresses has also been investigated. The results from the models are being compared against experimental data from in-house as well as industrial sources.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Comp Aided Simulat Packaging Reliabil Lab, Atlanta, GA 30332 USA.
RP Raghunathan, R (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Comp Aided Simulat Packaging Reliabil Lab, Atlanta, GA 30332 USA.
CR BROWN SB, 1989, INT J PLASTICITY, V5, P95, DOI 10.1016/0749-6419(89)90025-9
   *EL IND ASS, 1989, JESD22A104A EL IND A
   ENGELMAIER W, 1983, IEEE T COMPONENTS HY, V6, P52
   HANNA CE, 1999, P 49 EL COMP TECHN C, P1001
   JU SH, 1994, AM SOC TEST MATER, V1153, P1, DOI 10.1520/STP23913S
   Knecht S., 1991, SOLDER JOINT RELIABI, P508
   Michaelides S, 1999, IEEE TRANS ADV PACK, V22, P602, DOI 10.1109/6040.803452
   *MIL STAND, 1987, MILSTD883E
   PANG HL, 1998, 48 EL COMP TECHN C I, P878
   SOLOMON HD, 1985, ASTM SPECIAL TECHNIC, P342
   SYED A, 1999, P 49 EL COMP TECHN C, P111
   van Kessel C. G. M., 1983, Proceedings of the 33rd Electronic Components Conference, P237
   Wilde J, 1999, INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, PROCEEDINGS, P144, DOI 10.1109/ISAPM.1999.757302
   YEO CK, 1996, IEEE P 46 ECTC, P1222
NR 14
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-5912-7
PY 2000
BP 385
EP 392
DI 10.1109/ITHERM.2000.866851
PG 8
WC Thermodynamics; Engineering, Electrical & Electronic
SC Thermodynamics; Engineering
GA BQ63S
UT WOS:000089019500050
DA 2018-10-19
ER

PT J
AU Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
AF Bacon, JR
   Crain, JS
   Van Vaeck, L
   Williams, JG
TI Atomic mass spectrometry
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Review
ID INDUCTIVELY-COUPLED PLASMA; DYNAMIC REACTION CELL; LA-ICP-MS; ISOTOPE
   RATIO MEASUREMENTS; LONG-LIVED RADIONUCLIDES; AIRBORNE PARTICULATE
   MATTER; TRACE-ELEMENT DETERMINATION; PAIR LIQUID-CHROMATOGRAPHY;
   QUADRUPOLE ION-TRAP; GC-C-IRMS
AB This Update follows on from last year's, but only covers a period of approximately ten months as the production schedule has been brought forward by two months. The format remains the same with some minor changes in the section headings. Although an attempt is made to consider all relevant refereed papers, conference abstracts, reports, book chapters and patents for inclusion, this review does not aim at being comprehensive in its coverage. The selection of papers is based on criteria applied to focus sharply on the most significant developments in instrumentation and methodology or improved understanding of the fundamental phenomena involved in the MS process. Routine applications of atomic MS are not covered in this Update and readers are referred to the Updates on Industrial analysis: metals, chemicals and advanced materials, Environmental analysis and Clinical and biological materials, foods and beverages.
   Trends noted in last year's Update have generally been maintained. Although the scope of this review includes the rapidly increasing use of MS for speciation analysis, reported developments should involve or be intended for studies of speciation in natural systems. However, some degree of judgement has still been required to set the limits. Attention has continued to be paid mainly to sample preparation and introduction, in particular to meet the need for analysis of smaller samples. The sensitivity of many of the MS techniques is exemplified by the growing use of AMS in biomedical and pharmaceutical studies, made possible through the use of such low levels of radiocarbon tracers that the doses fall below natural background levels and regulatory limits. The overall trend in published material on ICP-MS continues to grow mainly in the applications and sample introduction areas, at the expense of fundamental studies. The exception to this is a considerable activity in the development and application of collision and reaction cells for reduction or removal of polyatomic species. Many applications exploit the isotope capability of MS, identified in last year's review as a growth area for ICP-MS.
C1 Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
   Union Carbide Corp, Ctr Tech, S Charleston, WV 25303 USA.
   Univ Instelling Antwerp, Dept Chem, Micro & Trace Anal Ctr, B-2610 Antwerp, Belgium.
   Kingston Univ, Sch Geol Sci, Ctr Earth & Environm Sci Res, NERC ICP MS Facil, Kingston upon Thames KT1 2EE, Surrey, England.
RP Bacon, JR (reprint author), Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland.
CR Adriaens A, 1999, MASS SPECTROM REV, V18, P48, DOI 10.1002/(SICI)1098-2787(1999)18:1<48::AID-MAS2>3.3.CO;2-9
   Al-Ammar A, 1999, SPECTROCHIM ACTA B, V54, P1077, DOI 10.1016/S0584-8547(99)00045-2
   Al-Ammar AS, 1999, J ANAL ATOM SPECTROM, V14, P793, DOI 10.1039/a808391f
   Amoruso S, 1999, APPL SURF SCI, V138, P250, DOI 10.1016/S0169-4332(98)00402-4
   Andrews AH, 1999, CAN J FISH AQUAT SCI, V56, P1329, DOI 10.1139/cjfas-56-8-1329
   ARAMAKI T, 1999, JAERI RES, V1
   Aurisicchio C, 1999, EUR J MINERAL, V11, P237
   Avci R, 1999, SURF INTERFACE ANAL, V27, P789
   Bacon JR, 1999, J ANAL ATOM SPECTROM, V14, P1633, DOI 10.1039/a905419g
   Baker SA, 1999, APPL SPECTROSC, V53, P471, DOI 10.1366/0003702991946767
   Baldwin MJ, 1999, THIN SOLID FILMS, V345, P108, DOI 10.1016/S0040-6090(99)00066-8
   Bandura DR, 1999, ATOM SPECTROSC, V20, P69
   Bantan T, 1999, J ANAL ATOM SPECTROM, V14, P1743, DOI 10.1039/a904213j
   Baranov VI, 1999, J ANAL ATOM SPECTROM, V14, P1133, DOI 10.1039/a809889a
   Barker J, 1999, RAPID COMMUN MASS SP, V13, P285, DOI 10.1002/(SICI)1097-0231(19990228)13:4<285::AID-RCM469>3.0.CO;2-R
   Barshick CM, 1999, ANAL CHEM, V71, P483, DOI 10.1021/ac980854q
   Barwick VJ, 1999, ANAL CHIM ACTA, V394, P281, DOI 10.1016/S0003-2670(99)00302-5
   Bayon MM, 1999, J ANAL ATOM SPECTROM, V14, P1317, DOI 10.1039/a901760g
   Becker JS, 1999, J ANAL ATOM SPECTROM, V14, P933, DOI 10.1039/a809252d
   Becker JS, 1999, J ANAL ATOM SPECTROM, V14, P1493, DOI 10.1039/a901762c
   Bellino M, 1999, AIP CONF PROC, V475, P644
   Ben Younes ME, 1999, J ANAL ATOM SPECTROM, V14, P1703, DOI 10.1039/a903269j
   Biersack J, 1999, NUCL INSTRUM METH B, V153, P398, DOI 10.1016/S0168-583X(98)01029-5
   Bisling P, 1999, FRESEN J ANAL CHEM, V364, P79, DOI 10.1007/s002160051304
   Bogaerts A, 1999, FRESEN J ANAL CHEM, V364, P367, DOI 10.1007/s002160051352
   Bogaerts A, 1999, J ANAL ATOM SPECTROM, V14, P1375, DOI 10.1039/a900772e
   Bollhofer A, 1999, ANAL CHIM ACTA, V390, P227, DOI 10.1016/S0003-2670(99)00182-8
   Booth CA, 1999, FUEL, V78, P1665, DOI 10.1016/S0016-2361(99)00113-1
   Borisov OV, 1999, SPECTROCHIM ACTA B, V54, P1351, DOI 10.1016/S0584-8547(99)00083-X
   Boue-Bigne F, 1999, J ANAL ATOM SPECTROM, V14, P1665, DOI 10.1039/a905479k
   Brauer RD, 1999, NUCL INSTRUM METH B, V152, P129, DOI 10.1016/S0168-583X(98)01092-1
   Brazier JL, 1999, ANALUSIS, V27, P218, DOI 10.1051/analusis:1999270218
   Brede C, 2000, J ANAL ATOM SPECTROM, V15, P55, DOI 10.1039/a904211c
   Brede C, 1999, J CHROMATOGR A, V849, P553, DOI 10.1016/S0021-9673(99)00561-0
   Brenninkmeijer CAM, 1999, RAPID COMMUN MASS SP, V13, P2028, DOI 10.1002/(SICI)1097-0231(19991030)13:20<2028::AID-RCM751>3.0.CO;2-J
   Buchholz BA, 1999, ANAL BIOCHEM, V269, P348, DOI 10.1006/abio.1999.4041
   Bushaw BA, 1999, SPECTROCHIM ACTA B, V54, P321, DOI 10.1016/S0584-8547(98)00250-X
   Butler IB, 1999, EARTH PLANET SC LETT, V167, P335, DOI 10.1016/S0012-821X(99)00038-2
   Campbell AJ, 1999, ANAL CHEM, V71, P939, DOI 10.1021/ac9808425
   Campbell MJ, 1999, J ANAL ATOM SPECTROM, V14, P1313, DOI 10.1039/a901639b
   Casiot C, 1999, ANAL COMMUN, V36, P77, DOI 10.1039/a900319c
   Cave MR, 2000, J ANAL ATOM SPECTROM, V15, P181, DOI 10.1039/b000063i
   Chartier F, 1999, J ANAL ATOM SPECTROM, V14, P1461, DOI 10.1039/a902318f
   Chatterjee A, 1999, J ANAL ATOM SPECTROM, V14, P1853, DOI 10.1039/a905078g
   Chen P, 1999, J AM SOC MASS SPECTR, V10, P153, DOI 10.1016/S1044-0305(98)00133-0
   Chen ZX, 1999, J ANAL ATOM SPECTROM, V14, P1823, DOI 10.1039/a903272j
   Chin CJ, 1999, J ANAL ATOM SPECTROM, V14, P663, DOI 10.1039/a807275b
   Clifford AJ, 1998, ADV EXP MED BIOL, V445, P239
   Coedo AG, 1999, ANAL CHIM ACTA, V389, P247, DOI 10.1016/S0003-2670(99)00125-7
   Collon P, 1999, RADIOCHIM ACTA, V85, P13
   Compston W, 1999, MINERAL MAG, V63, P297, DOI 10.1180/002646199548475
   Cuynen E, 1999, RAPID COMMUN MASS SP, V13, P2287, DOI 10.1002/(SICI)1097-0231(19991215)13:23<2287::AID-RCM788>3.0.CO;2-J
   Dagnac T, 1999, TALANTA, V48, P763, DOI 10.1016/S0039-9140(98)00093-9
   Dangin M, 1999, AM J PHYSIOL-ENDOC M, V276, pE212, DOI 10.1152/ajpendo.1999.276.1.E212
   Daolio S, 1999, RAPID COMMUN MASS SP, V13, P782, DOI 10.1002/(SICI)1097-0231(19990515)13:9<782::AID-RCM564>3.3.CO;2-C
   Debrah E, 1999, ATOM SPECTROSC, V20, P73
   DEBRAH E, 1999, SPEC PUBL R SOC CHEM, V241, P20
   Dennapanray PNK, 1999, J APPL PHYS, V85, P3993, DOI 10.1063/1.370302
   Devos W, 1999, J ANAL ATOM SPECTROM, V14, P621, DOI 10.1039/a900073i
   Douglas DJ, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P615
   Douglas MA, 1998, SURF INTERFACE ANAL, V26, P984, DOI 10.1002/(SICI)1096-9918(199812)26:13<984::AID-SIA446>3.0.CO;2-K
   DOUTHITT CB, 1999, ICP INFORM NEWSL, V25, P90
   Du ZH, 1999, J ANAL ATOM SPECTROM, V14, P1111, DOI 10.1039/a804022b
   Duersch BS, 1999, SPECTROCHIM ACTA B, V54, P545, DOI 10.1016/S0584-8547(99)00012-9
   Duersch BS, 1999, J ANAL ATOM SPECTROM, V14, P615, DOI 10.1039/a809063g
   Dunemann L, 1999, FRESEN J ANAL CHEM, V363, P466, DOI 10.1007/s002160051224
   Durrant SF, 1999, J ANAL ATOM SPECTROM, V14, P1385, DOI 10.1039/a901765h
   Eccles AJ, 1999, APPL SURF SCI, V144-45, P106, DOI 10.1016/S0169-4332(98)00776-4
   Eiden GC, 1999, J ANAL ATOM SPECTROM, V14, P1129, DOI 10.1039/a806433d
   Fairman B, 1999, J ANAL ATOM SPECTROM, V14, P1937, DOI 10.1039/a908094e
   Farquhar J, 1999, EARTH PLANET SC LETT, V171, P607, DOI 10.1016/S0012-821X(99)00177-6
   Feldmann I, 1999, FRESEN J ANAL CHEM, V365, P422, DOI 10.1007/s002160051634
   Feldmann I, 1999, FRESEN J ANAL CHEM, V365, P415, DOI 10.1007/s002160051633
   Fifield LK, 1999, REP PROG PHYS, V62, P1223, DOI 10.1088/0034-4885/62/8/202
   Fried M, 1998, J LUMIN, V80, P147, DOI 10.1016/S0022-2313(98)00086-6
   GALER SJG, 1998, MINERAL MAG A, V62, P491, DOI DOI 10.1180/MINMAG.1998.62A.1.260
   Gammelgaard B, 1999, J ANAL ATOM SPECTROM, V14, P867, DOI 10.1039/a900940j
   Gautier B, 1998, SURF INTERFACE ANAL, V26, P974, DOI 10.1002/(SICI)1096-9918(199812)26:13<974::AID-SIA445>3.3.CO;2-F
   Gavrilov KL, 1999, J AM CERAM SOC, V82, P1001, DOI 10.1111/j.1151-2916.1999.tb01866.x
   Gebhardt O, 1999, FRESEN J ANAL CHEM, V365, P117, DOI 10.1007/s002160051456
   Gerlock JL, 1999, POLYM DEGRAD STABIL, V65, P37, DOI 10.1016/S0141-3910(98)00214-6
   Ghazi AM, 2000, ANALYST, V125, P205, DOI 10.1039/a908980b
   Gillen G, 1999, J VAC SCI TECHNOL A, V17, P845, DOI 10.1116/1.581657
   Gillman L, 1999, MATH INTELL, V21, P3, DOI 10.1007/BF03025407
   Gilmore IS, 1999, APPL SURF SCI, V144-45, P113, DOI 10.1016/S0169-4332(98)00779-X
   Gleixner G, 1999, RAPID COMMUN MASS SP, V13, P1278, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1278::AID-RCM649>3.0.CO;2-N
   Gleixner G, 1998, ACS SYM SER, V707, P34
   GOMEZARIZA JL, 1998, ANALYST CAMBRIDGE, V124, P75
   Gonzalez J, 1999, J AGR FOOD CHEM, V47, P2316, DOI 10.1021/jf981093v
   Goschnick J, 1999, SURF INTERFACE ANAL, V28, P56
   Goschnick J, 1999, APPL SURF SCI, V144-45, P201, DOI 10.1016/S0169-4332(98)00797-1
   Goschnick J, 1998, THIN SOLID FILMS, V332, P215, DOI 10.1016/S0040-6090(98)00990-0
   Goschnick J, 1999, APPL SURF SCI, V144-45, P31, DOI 10.1016/S0169-4332(98)00758-2
   Goss SH, 1999, PHYS REV B, V59, P10662, DOI 10.1103/PhysRevB.59.10662
   Gregoire DC, 1999, SPECTROCHIM ACTA B, V54, P773, DOI 10.1016/S0584-8547(99)00008-7
   Grotti M, 1999, J ANAL ATOM SPECTROM, V14, P1171, DOI 10.1039/a902625h
   Guevremont R, 2000, J ANAL ATOM SPECTROM, V15, P37, DOI 10.1039/a903914g
   Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1369, DOI 10.1039/a901649j
   Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1363, DOI 10.1039/a901648a
   Gunther D, 1999, SPECTROCHIM ACTA B, V54, P381, DOI 10.1016/S0584-8547(99)00011-7
   Guzowski JP, 1999, J ANAL ATOM SPECTROM, V14, P1121, DOI 10.1039/a903113h
   Halas S, 1999, ANAL CHEM, V71, P3254, DOI 10.1021/ac9900174
   Hall JA, 1999, RAPID COMMUN MASS SP, V13, P1231, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1231::AID-RCM579>3.0.CO;2-B
   Hamester M, 1999, FRESEN J ANAL CHEM, V364, P495, DOI 10.1007/s002160051374
   Hamoudi S, 1999, J CATAL, V185, P333, DOI 10.1006/jcat.1999.2519
   Hang W, 1999, J ANAL ATOM SPECTROM, V14, P1523, DOI 10.1039/a902211b
   HARUHARA Y, 1998, TOK DAIG GENSH KENK, P169
   He C, 1999, J APPL PHYS, V86, P3463, DOI 10.1063/1.371230
   Held A, 1999, J ANAL ATOM SPECTROM, V14, P1075, DOI 10.1039/a809098j
   Hellborg R, 1999, AIP CONF PROC, V475, P636
   Herec J, 1999, NUKLEONIKA, V44, P103
   Herec J, 1999, NUKLEONIKA, V44, P119
   Higashi Y, 1999, SPECTROCHIM ACTA B, V54, P109, DOI 10.1016/S0584-8547(98)00193-1
   HIGASHI Y, 1999, J SURF ANAL, V5, P136
   Hilkert AW, 1999, RAPID COMMUN MASS SP, V13, P1226, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1226::AID-RCM575>3.0.CO;2-9
   HILL SJ, 1999, INDUCTIVELY COUPLED, P208
   Hinz KP, 1999, J AM SOC MASS SPECTR, V10, P648, DOI 10.1016/S1044-0305(99)00028-8
   Hirata T, 1999, J ANAL ATOM SPECTROM, V14, P1455, DOI 10.1039/a901389j
   Hongo C, 1999, APPL SURF SCI, V144-45, P306, DOI 10.1016/S0169-4332(98)00815-0
   Horlick G, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P503
   HOSHI T, 1999, J SURF ANAL, V5, P132
   Hoskin PWO, 1999, GEOSTANDARD NEWSLETT, V23, P69, DOI 10.1111/j.1751-908X.1999.tb00560.x
   Hou HB, 1999, ATOM SPECTROSC, V20, P20
   Hou HB, 1999, ANAL SCI, V15, P911, DOI 10.2116/analsci.15.911
   INFANTE HG, 1959, J ANAL ATOM SPECTROM, V14, P143
   Ingram JC, 1999, ANAL CHEM, V71, P1712, DOI 10.1021/ac9811571
   Inoue M, 1999, ANAL CHIM ACTA, V395, P165, DOI 10.1016/S0003-2670(99)00334-7
   Ivanov VP, 1999, INT J MASS SPECTROM, V188, P183, DOI 10.1016/S1387-3806(99)00036-6
   Iwamura T, 1999, BUNSEKI KAGAKU, V48, P555
   Jackson SM, 1999, RAPID COMMUN MASS SP, V13, P1329
   Jenett H, 1999, NUCL INSTRUM METH B, V155, P13, DOI 10.1016/S0168-583X(99)00291-8
   Jiang ZX, 1999, SURF INTERFACE ANAL, V27, P125, DOI 10.1002/(SICI)1096-9918(199903)27:3<125::AID-SIA490>3.3.CO;2-#
   Johnson CM, 1999, INT J MASS SPECTROM, V193, P87, DOI 10.1016/S1387-3806(99)00158-X
   Jones AM, 1999, CHEM GEOL, V153, P241, DOI 10.1016/S0009-2541(98)00162-4
   JONES VD, 1998, ASTM SPEC TECH PUBL, V1344, P41
   KANEKO N, 1999, CHISHITSU CHOSASHO G, V50, P383
   Kang HJ, 1999, NUCL INSTRUM METH B, V153, P429, DOI 10.1016/S0168-583X(98)01021-0
   Kawai Y, 1999, INT J MASS SPECTROM, V193, P29, DOI 10.1016/S1387-3806(99)00134-7
   KAWASHIMA Y, 1999, J SURF ANAL, V5, P116
   KINOSHITA J, 1999, J SURF ANAL, V5, P185
   Konarski P, 1999, NUKLEONIKA, V44, P143
   Kornexl BE, 1999, RAPID COMMUN MASS SP, V13, P1685
   Kornexl BE, 1999, RAPID COMMUN MASS SP, V13, P1248, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1248::AID-RCM560>3.0.CO;2-H
   Kotrebai M, 1999, ANAL COMMUN, V36, P249, DOI 10.1039/a902770j
   Kotrebai M, 2000, ANALYST, V125, P71, DOI 10.1039/a906320j
   Kotrebai M, 1999, SPECTROCHIM ACTA B, V54, P1573, DOI 10.1016/S0584-8547(99)00086-5
   KRUEGER D, 1998, DIFFUS DEFECT DATA B, V63, P465
   Kurt R, 1999, FRESEN J ANAL CHEM, V363, P179, DOI 10.1007/s002160051167
   LaFuente JMG, 1999, TALANTA, V50, P207, DOI 10.1016/S0039-9140(99)00121-6
   Lam JW, 1999, ATOM SPECTROSC, V20, P79
   Lam JWH, 1999, SPECTROCHIM ACTA B, V54, P443, DOI 10.1016/S0584-8547(98)00255-9
   Langer D, 1999, APPL SPECTROSC, V53, P1244, DOI 10.1366/0003702991945489
   Leach AM, 2000, J ANAL ATOM SPECTROM, V15, P151, DOI 10.1039/a905825g
   Lee KM, 1999, ANAL CHIM ACTA, V395, P179, DOI 10.1016/S0003-2670(99)00319-0
   Lewis CL, 1999, ANAL CHEM, V71, P230, DOI 10.1021/ac9806916
   Liang HD, 1999, CHINESE SCI BULL, V44, P1242, DOI 10.1007/BF02885975
   Litherland AE, 1999, AIP CONF PROC, V473, P426
   Liu Yonghao, 1999, Nuclear Science and Techniques, V10, P116
   Loader NJ, 1999, RAPID COMMUN MASS SP, V13, P1828, DOI 10.1002/(SICI)1097-0231(19990930)13:18<1828::AID-RCM724>3.0.CO;2-G
   Lochner F, 1999, ANAL CHIM ACTA, V401, P299, DOI 10.1016/S0003-2670(99)00476-6
   Lofthouse SD, 1999, J ANAL ATOM SPECTROM, V14, P1839, DOI 10.1039/a907308f
   Loger RL, 1999, AIP CONF PROC, V475, P640
   Lopez-Gutierrez JM, 1999, APPL RADIAT ISOTOPES, V51, P315, DOI 10.1016/S0969-8043(98)00201-2
   Mahoney PP, 1999, ANAL CHEM, V71, P1378, DOI 10.1021/ac9811625
   Makarov VV, 1999, SURF INTERFACE ANAL, V27, P801, DOI 10.1002/(SICI)1096-9918(199909)27:9<801::AID-SIA575>3.0.CO;2-Z
   Mank AJG, 1999, J ANAL ATOM SPECTROM, V14, P1143, DOI 10.1039/a903304a
   Marcus RK, 2000, J ANAL ATOM SPECTROM, V15, P1, DOI 10.1039/a907692a
   Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0
   Mason PM, 1998, ANALYST, V123, P2405, DOI 10.1039/a805529g
   MATSUZAKI H, 1998, TOK DAIG GENSH KENK, P173
   MAXWELL SL, 1998, NUCL MAT MANAGE, V27, P1190
   Mazeas L, 1999, ANALUSIS, V27, P200, DOI 10.1051/analusis:1999270200
   McConville C, 1999, RAPID COMMUN MASS SP, V13, P1339, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1339::AID-RCM559>3.0.CO;2-N
   McSheehy Shona, 2000, Journal of Analytical Atomic Spectrometry, V15, P79, DOI 10.1039/a906890b
   Meier-Augenstein W, 1999, J CHROMATOGR A, V842, P351, DOI 10.1016/S0021-9673(98)01057-7
   Merchel S, 1999, RADIOCHIM ACTA, V84, P215
   MERREN TO, 1999, Patent No. 302963
   MERREN TO, 1998, Patent No. 831920
   MERREN TO, 1999, Patent No. 952607
   Mester Z, 1999, RAPID COMMUN MASS SP, V13, P1999, DOI 10.1002/(SICI)1097-0231(19991030)13:20<1999::AID-RCM744>3.0.CO;2-C
   Mester Z, 1999, J CHROMATOGR A, V832, P183, DOI 10.1016/S0021-9673(98)01011-5
   Metges C. C., 1999, METH NUTR SER, P121
   Metson JB, 1999, SURF INTERFACE ANAL, V28, P159, DOI 10.1002/(SICI)1096-9918(199908)28:1<159::AID-SIA597>3.3.CO;2-W
   Michalke B, 1999, FRESEN J ANAL CHEM, V363, P456, DOI 10.1007/s002160051222
   Miller MF, 1999, RAPID COMMUN MASS SP, V13, P1211, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1211::AID-RCM576>3.0.CO;2-M
   Montaser A, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P809
   Montaser A, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P1
   MOON DW, 1999, J SURF ANAL, V6, P34
   Moor C, 2000, J ANAL ATOM SPECTROM, V15, P143, DOI 10.1039/a909296j
   Muller U, 1999, SURF INTERFACE ANAL, V27, P904
   Neubauer K, 1999, ATOM SPECTROSC, V20, P64
   Nohda S, 1999, GEOCHEM J, V33, P133, DOI 10.2343/geochemj.33.133
   OCONNOR G, 1999, INDUCTIVELY COUPLED, P119
   OHLSSON KEA, 1998, ANALYST CAMBRIDGE, V124, P571
   Okamoto Y, 1999, J ANAL ATOM SPECTROM, V14, P1631, DOI 10.1039/a905374c
   Okuyama F, 1999, INT J MASS SPECTROM, V189, P173, DOI 10.1016/S1387-3806(99)00070-6
   OLESIK JW, 1999, SPEC PUBL R SOC CHEM, V241, P3
   Ormsby TJ, 1999, APPL SURF SCI, V144-45, P292, DOI 10.1016/S0169-4332(98)00812-5
   Pakhomov AV, 1999, APPL SPECTROSC, V53, P979, DOI 10.1366/0003702991947649
   Park CJ, 1999, J ANAL ATOM SPECTROM, V14, P1061, DOI 10.1039/a902882j
   Parks CC, 1999, J VAC SCI TECHNOL A, V17, P1130, DOI 10.1116/1.581785
   Patterson JE, 1999, SPECTROCHIM ACTA B, V54, P537, DOI 10.1016/S0584-8547(99)00013-0
   PERGANTIS SA, 1999, EUR WINT C PLASM SPE
   Pfander JA, 1999, FRESEN J ANAL CHEM, V364, P376, DOI 10.1007/s002160051353
   Pratt AR, 1999, CR ACAD SCI II A, V328, P309, DOI 10.1016/S1251-8050(99)80122-0
   Pretty JR, 1998, RAPID COMMUN MASS SP, V12, P1644, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1644::AID-RCM377>3.0.CO;2-7
   Prohaska T, 1999, J ANAL ATOM SPECTROM, V14, P1501, DOI 10.1039/a901973a
   PUPYSHEV A, 1998, P SEM AT SPECTR 14 S, P330
   Pupyshev AA, 1999, J ANAL ATOM SPECTROM, V14, P1485, DOI 10.1039/a902167a
   Ramakumar KL, 1999, INT J MASS SPECTROM, V184, P109, DOI 10.1016/S1387-3806(98)14273-2
   Ramanujam VMS, 1999, BIOL TRACE ELEM RES, V68, P143, DOI 10.1007/BF02784403
   Ranville JF, 1999, ANAL CHIM ACTA, V381, P315, DOI 10.1016/S0003-2670(98)00702-8
   RAR A, 1999, J SURF ANAL, V6, P29
   Rau I, 1999, NUCL INSTRUM METH B, V155, P53, DOI 10.1016/S0168-583X(99)00227-X
   Richter S, 1999, J ANAL ATOM SPECTROM, V14, P889, DOI 10.1039/a900774a
   Richter S, 1999, FRESEN J ANAL CHEM, V364, P478, DOI 10.1007/s002160051371
   Richter S, 1999, INT J MASS SPECTROM, V193, P9, DOI 10.1016/S1387-3806(99)00102-5
   ROSENBERG E, 1999, INSTRUMENTAL METHODS
   ROSENBERG E, 1999, EUR WINT C PLASM SPE
   Rucklidge JC, 1999, AIP CONF PROC, V475, P629
   Russow R, 1999, RAPID COMMUN MASS SP, V13, P1334
   Russow R, 1998, ARCH AGRON SOIL SCI, V43, P349
   Sah RN, 1998, BIOL TRACE ELEM RES, V66, P39, DOI 10.1007/BF02783124
   Saprykin AI, 1999, J ANAL CHEM+, V54, P671
   Saprykin AI, 1999, FRESEN J ANAL CHEM, V364, P763, DOI 10.1007/s002160051429
   Saprykin AI, 1999, IND LAB+, V65, P83
   Sartoros C, 1999, SPECTROCHIM ACTA B, V54, P1557, DOI 10.1016/S0584-8547(99)00089-0
   Sato T, 1999, SURF SCI, V433, P711, DOI 10.1016/S0039-6028(99)00159-4
   Schaumloffel D, 1999, FRESEN J ANAL CHEM, V364, P452, DOI 10.1007/s002160051366
   Schenkel T, 1999, PHYS SCRIPTA, VT80A, P73, DOI 10.1238/Physica.Topical.080a00073
   Schneider RJ, 1999, AIP CONF PROC, V473, P422
   Schramel O, 1999, J ANAL ATOM SPECTROM, V14, P1339, DOI 10.1039/a900494g
   Schramel O, 1999, FRESEN J ANAL CHEM, V363, P452, DOI 10.1007/s002160051221
   Schuhmacher M, 1999, FRESEN J ANAL CHEM, V365, P12, DOI 10.1007/s002160051438
   SCHWIETERS J, 1998, MINERAL MAG 3, V62, P1360
   Seki S, 1999, APPL SURF SCI, V147, P14, DOI 10.1016/S0169-4332(99)00124-5
   SHAKRA FA, 1999, SPEC PUBL R SOC CHEM, V241, P120
   Shepherd TJ, 1998, EUR J MINERAL, V10, P1097
   SHICHI H, 1999, J SURF ANAL, V5, P212
   Shimizu K, 1998, CAN J CHEM, V76, P1796, DOI 10.1139/cjc-76-12-1796
   Shimizu N, 1999, ANAL SCI, V15, P685, DOI 10.2116/analsci.15.685
   Sich I, 1999, RAPID COMMUN MASS SP, V13, P1325, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1325::AID-RCM622>3.0.CO;2-K
   Sie SH, 1999, AIP CONF PROC, V475, P648
   Slaets S, 1999, J ANAL ATOM SPECTROM, V14, P851, DOI 10.1039/a809296f
   SMEHTKOWSKI VS, 1999, J VAC SCI TECHNOL A, V17, P2634
   Socki RA, 1999, ANAL CHEM, V71, P2250, DOI 10.1021/ac981140i
   Song K, 1999, J KOREAN PHYS SOC, V35, P217
   Stevie FA, 1999, J VAC SCI TECHNOL B, V17, P2476, DOI 10.1116/1.591115
   Stewart II, 1999, J AM SOC MASS SPECTR, V10, P159, DOI 10.1016/S1044-0305(98)00136-6
   Stewart II, 1999, SPECTROCHIM ACTA B, V54, P1649, DOI 10.1016/S0584-8547(99)00110-X
   STIRLING CH, 1998, MINERAL MAG 3, V62, P1462
   Stoll B, 1999, FRESEN J ANAL CHEM, V364, P380, DOI 10.1007/s002160051354
   Stone JA, 1999, INT J MASS SPECTROM, V185, P227, DOI 10.1016/S1387-3806(98)14063-0
   Striegel AM, 1999, J AM SOC MASS SPECTR, V10, P254, DOI 10.1016/S1044-0305(98)00140-8
   Suess DT, 1999, CHEM REV, V99, P3007, DOI 10.1021/cr980138o
   Sundquist ML, 1999, AIP CONF PROC, V475, P661
   SUTTON KL, 1999, INDUCTIVELY COUPLED, P245
   SUZUKI S, 1999, J SURF ANAL, V5, P278
   Tanner SD, 1999, ATOM SPECTROSC, V20, P45
   Tanner SD, 1999, J AM SOC MASS SPECTR, V10, P1083, DOI 10.1016/S1044-0305(99)00081-1
   TANNER SD, 1999, SPEC PUBL R SOC CHEM, V241, P46
   Taylor A, 2000, J ANAL ATOM SPECTROM, V15, P451, DOI 10.1039/b000839g
   Taylor HE, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P681
   Thomas KV, 1999, J CHROMATOGR A, V833, P105, DOI 10.1016/S0021-9673(98)01009-7
   Tian XD, 1999, J ANAL ATOM SPECTROM, V14, P1807, DOI 10.1039/a906762k
   Tian XD, 1999, ATOM SPECTROSC, V20, P127
   Todoli JL, 1999, SPECTROCHIM ACTA B, V54, P895, DOI 10.1016/S0584-8547(99)00041-5
   Tomascak PB, 1999, GEOCHIM COSMOCHIM AC, V63, P907, DOI 10.1016/S0016-7037(98)00318-4
   Tomascak PB, 1999, CHEM GEOL, V158, P145, DOI 10.1016/S0009-2541(99)00022-4
   TOMASCAK PB, 1998, MINERAL MAG A 1, V62, P1523
   Toniazzo V, 1999, APPL SURF SCI, V143, P229, DOI 10.1016/S0169-4332(98)00918-0
   Toyoda S, 1999, ANAL CHEM, V71, P4711, DOI 10.1021/ac9904563
   Turner IL, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P265
   Turner PJ, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P421
   Uggerud HT, 1999, SPECTROCHIM ACTA B, V54, P1625, DOI 10.1016/S0584-8547(99)00093-2
   Valkiers S, 1999, INT J MASS SPECTROM, V193, P1, DOI 10.1016/S1387-3806(99)00101-3
   van der Heide PAW, 1999, NUCL INSTRUM METH B, V157, P126, DOI 10.1016/S0168-583X(99)00453-X
   Van Vaeck L, 1999, MASS SPECTROM REV, V18, P1
   Vanhaecke F, 1999, FRESEN J ANAL CHEM, V364, P440, DOI 10.1007/s002160051365
   VANHAECKE F, 1999, INDUCTIVELY COUPLED, P145
   Verkleij D, 1999, MICRON, V30, P227, DOI 10.1016/S0968-4328(99)00007-4
   Verkouteren RM, 1999, ANAL CHEM, V71, P4740, DOI 10.1021/ac990233c
   Verlinden G, 1999, J AM SOC MASS SPECTR, V10, P1016, DOI 10.1016/S1044-0305(99)00064-1
   Vickers PE, 1999, APPL SURF SCI, V150, P244, DOI 10.1016/S0169-4332(99)00250-0
   VOLIKOPF U, 1999, SPEC PUBL R SOC CHEM, V241, P63
   Vollkopf U, 1999, ATOM SPECTROSC, V20, P53
   Waggoner JW, 2000, J ANAL ATOM SPECTROM, V15, P13, DOI 10.1039/a905906g
   Wang CF, 1999, ANAL CHIM ACTA, V389, P257, DOI 10.1016/S0003-2670(99)00162-2
   Wang HJ, 1999, ANAL CHEM, V71, P4166, DOI 10.1021/ac981375u
   Wang L, 1999, J ELECTRON MATER, V28, P793, DOI 10.1007/s11664-999-0072-4
   Wanner B, 1999, SPECTROCHIM ACTA B, V54, P289, DOI 10.1016/S0584-8547(98)00245-6
   Wassenaar LI, 1999, ANAL CHEM, V71, P4965, DOI 10.1021/ac9903961
   Wayne DM, 1999, APPL SPECTROSC, V53, P266, DOI 10.1366/0003702991946640
   Wei MT, 1999, J ANAL ATOM SPECTROM, V14, P1177, DOI 10.1039/a903199e
   Wen B, 1999, ANALYST, V124, P621, DOI 10.1039/a809854i
   Wendt K, 1999, FRESEN J ANAL CHEM, V364, P471, DOI 10.1007/s002160051370
   Wendt K, 1999, J KOREAN PHYS SOC, V35, P143
   Wennrich R, 1999, CHEM ANAL-WARSAW, V44, P523
   Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C
   WHITAKER TJ, 1999, ADV SCI TECHNOL, V19, P97
   Wiedemann B, 1999, FRESEN J ANAL CHEM, V364, P768, DOI 10.1007/s002160051430
   Wiedemann B, 1999, FRESEN J ANAL CHEM, V364, P772, DOI 10.1007/s002160051431
   Wieser ME, 1999, RAPID COMMUN MASS SP, V13, P1218, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1218::AID-RCM652>3.0.CO;2-C
   Willey KF, 1999, J VAC SCI TECHNOL A, V17, P1127, DOI 10.1116/1.581908
   Willey KF, 1999, APPL SURF SCI, V144-45, P36, DOI 10.1016/S0169-4332(98)00760-0
   Wittmaack K, 1999, SURF SCI, V429, P84, DOI 10.1016/S0039-6028(99)00341-6
   Wittmaack K, 1999, APPL PHYS LETT, V74, P3969, DOI 10.1063/1.124239
   Wolkenstein M, 1999, FRESEN J ANAL CHEM, V365, P63, DOI 10.1007/s002160051446
   Woll DM, 1999, FRESEN J ANAL CHEM, V365, P70, DOI 10.1007/s002160051447
   Xu GH, 1999, MATER RES SOC SYMP P, V563, P257, DOI 10.1557/PROC-563-257
   Yan XP, 1998, ANAL CHEM, V70, P4736, DOI 10.1021/ac980654e
   Yang DW, 1999, J MASS SPECTROM, V34, P1130
   YONEDA S, 1998, B NATL SCI MUS TOK E, V21, P1
   Yorozu M, 1999, APPL PHYS B-LASERS O, V69, P129, DOI 10.1007/s003400050784
   Young ED, 1998, GEOCHIM COSMOCHIM AC, V62, P3161, DOI 10.1016/S0016-7037(98)00216-6
   Yu LL, 1999, J ANAL ATOM SPECTROM, V14, P669, DOI 10.1039/a809797f
   Yue RF, 1999, SURF INTERFACE ANAL, V27, P98
   Zapata AM, 1999, J ANAL ATOM SPECTROM, V14, P1187, DOI 10.1039/a902656h
   Zhang BL, 1999, ANAL CHEM, V71, P2301, DOI 10.1021/ac9812375
   Zhang H, 1998, INDUCTIVELY COUPLED PLASMAS MASS SPECTROMETRY, P891
   Zhao JT, 1999, J RARE EARTH, V17, P1
NR 321
TC 10
Z9 10
U1 2
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0267-9477
EI 1364-5544
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PY 2000
VL 15
IS 8
BP 1025
EP 1053
DI 10.1039/b004111o
PG 29
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA 339FU
UT WOS:000088467600020
DA 2018-10-19
ER

PT J
AU Petrini, P
   Tanzi, MC
   Visai, L
   Casolini, F
   Speziale, P
AF Petrini, P
   Tanzi, MC
   Visai, L
   Casolini, F
   Speziale, P
TI Novel poly(urethane-aminoamides): an in vitro study of the interaction
   with heparin
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE segmented polyurethanes; poly(urethane-amides); radiolabelled heparin;
   heparin adsorption; heparin release; coagulation tests
ID IMMOBILIZED HEPARIN; THROMBIN
AB In order to obtain heparin-binding polyurethanes, tertiary amino-groups have been introduced in the polymer backbone by attributing a key-role to the chain extender, i.e. substituting butane diol, commonly used in polyurethane synthesis, with a tailor-made diamino-diamide-diol. In this work a poly(ether-urethane-aminoamide) (PEU/PIME/al) was obtained with poly(oxytetramethylene) glycol 2000, 1,6-hexamethylene-diisocyanate and the new chain extender, in the molar ratio 1 :2: 1. The heparin binding capacity of PEU/PIME/al was evaluated with I-125 labelled heparin, using for comparison the analogous polymer obtained with a diamide-diol (i.e. the poly(ether-urethane-amide) PEU/PIBLO/al), and two commercially available biomedical polyurethanes (Pellethane 2363 and Corethane). pH and ionic strength dependence of the heparin uptake were investigated by treating all the polyurethanes with solutions of I-125 heparin into buffers from pH 4 to 9 or NaCl molarity from 0.0 to 1.0. The stability of the interaction with bound heparin was investigated by sequential washing treatments (PBS, 1 N NaOH, 2% SDS solution), then analysing the residual radioactivity on the materials.
   Results indicated that the heparin binding of PEU/PIME/al is significantly higher and more stable than that of the other polyurethanes, with a time-dependent kinetic. The interaction with heparin appears to bi prevalently ionic, with the contribution of other electrostatic and hydrophobic interactions. Activated partial thromboplastin time (APTT), performed on human plasma with polyurethane-coated, heparinized test tubes, indicated that bound heparin maintains its biological activity after the adsorption.
C1 Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy.
   Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
RP Tanzi, MC (reprint author), Politecn Milan, Dipartimento Bioingn, Piazza L da Vinci 32, I-20133 Milan, Italy.
RI Tanzi, Maria Cristina/I-4620-2013; Petrini, Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   Byun Y, 1996, J BIOMED MATER RES, V30, P423, DOI 10.1002/jbm.820300403
   BYUN Y, 1994, J BIOMATER SCI POLYM, V6
   DIDISHEIM P, 1989, T AM SOC ART INT ORG, V35, P54
   Eloy R, 1988, J Biomater Appl, V2, P475
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LIN S, 1985, J ELASTOM PLAST, V17, P140
   OLSON ST, 1991, J BIOL CHEM, V266, P6353
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PLATE NA, 1986, ADV POLYM SCI BIOPOL
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNER BD, 1996, BIOMATERIAL SCI INTR, V7, P298
   ROSEMBERG RD, 1983, HEPARIN, V2
   TANZI MC, 1992, BIOMATERIALS, V13
   TANZI MC, 1999, Patent No. 5955560
   VanDelden CJ, 1996, J BIOMAT SCI-POLYM E, V7, P989, DOI 10.1163/156856296X00390
NR 21
TC 8
Z9 9
U1 0
U2 4
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2000
VL 11
IS 4
BP 353
EP 365
DI 10.1163/156856200743751
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 331AB
UT WOS:000087993600003
PM 10903035
DA 2018-10-19
ER

PT J
AU Mukherjee, C
   Case, ED
   Lee, A
AF Mukherjee, C
   Case, ED
   Lee, A
TI Silica coatings on bismaleimide (BMI) polymeric substrates
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID INDENTATION; SYSTEM; FILMS; PMMA
AB For many years, ceramics have been added to polymeric materials as reinforcements or extenders. Recently, thin ceramic coatings have been applied to polymers for biomedical applications, and in this paper ceramic coatings are applied to an aerospace polymer, bismaleimide (BMI). Unreinforced BMI specimens were coated with a thin, protective layer of a dense silicate ceramic material. Vickers indentation testing on the coated and uncoated BMI specimens indicated that the coatings adhere surprisingly well to the substrate, with cracking of the coating taking place only within a diamond-shaped region with diagonal dimensions equivalent to the Vickers indentation impression. (C) 2000 Kluwer Academic Publishers.
C1 Michigan State Univ, Dept Mech & Mat Sci, E Lansing, MI 48824 USA.
RP Case, ED (reprint author), Michigan State Univ, Dept Mech & Mat Sci, E Lansing, MI 48824 USA.
CR CHAUDHARI M, 1985, SAMPE J, V21, P17
   CRAWFORD J, 1987, PLASTICS ENG
   DIAO DF, 1994, J TRIBOL-T ASME, V116, P860, DOI 10.1115/1.2927346
   DOREMUS RH, 1973, GLASS SCI, P284
   DUCHATELARD P, 1995, J DENT RES, V74, P940
   DUCHATELARD P, 1994, THIN SOLID FILMS, V250, P142, DOI 10.1016/0040-6090(94)90178-3
   Flores A, 1998, J MATER SCI, V33, P3567, DOI 10.1023/A:1004643026386
   GAMLEN CA, 1991, APPL PHYS LETT, V59, P2529, DOI 10.1063/1.105942
   LAWN BR, 1983, FRACTURE MECHANICS C, V5, P1
   LEE BH, 1988, POLYM NEWS, V13, P297
   LEE DG, 1998, SURF COAT TECH, V101, P187
   LI J, 1998, J ENG MATER-T ASME, V120, P152
   LINCOLN JE, UNPUB SAMPE J ADV MA
   Liu C, 1997, EXP TECHNIQUES, V21, P28, DOI 10.1111/j.1747-1567.1997.tb00506.x
   LIU C, 1997, EXPT MECH, V37, P179
   Low IM, 1998, J APPL POLYM SCI, V70, P2349, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2349::AID-APP6>3.0.CO;2-T
   MORGAN RJ, 1993, POLYMER, V34, P835, DOI 10.1016/0032-3861(93)90371-G
   MORGAN RJ, 1997, THERMAL CHARACTERIZA, pCH9
   MORGAN RJ, 1994, CHARACTERIZATION CRI
   MORGAN RJ, 1985, ADV POLYM SCI, V12, pCH1
   MOSKOWITZ M, 1993, PLAST WORLD, V51, P47
   PARK JB, 1992, BIOMATERIALS INTRO, P154
   Pharr GM, 1998, MAT SCI ENG A-STRUCT, V253, P151, DOI 10.1016/S0921-5093(98)00724-2
   SHIN EE, 1997, P AM SOC COMP 12 TEC, P1113
   Suwanprateeb J, 1998, POLYM TEST, V17, P495, DOI 10.1016/S0142-9418(97)00040-8
   Ward LP, 1996, J MATER PROCESS TECH, V56, P364, DOI 10.1016/0924-0136(95)01850-6
NR 26
TC 4
Z9 4
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PY 2000
VL 35
IS 6
BP 1389
EP 1396
DI 10.1023/A:1004746528322
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 281XD
UT WOS:000085186000012
DA 2018-10-19
ER

PT S
AU Chu, C
   Bachman, M
   Chiang, YM
   Gonzales, F
   Li, GP
AF Chu, C
   Bachman, M
   Chiang, YM
   Gonzales, F
   Li, GP
BE DeBoer, MP
   Heuer, AH
   Jacobs, SJ
   Peeters, E
TI Characterizations of metallized plastic MEMS
SO MATERIALS SCIENCE OF MICROELECTROMECHANICAL SYSTEMS (MEMS) DEVICES II
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium MM on Materials Science of Microelectromechanical Systems
   (MEMS) Devices II held at the 1999 MRS Fall Meeting
CY NOV 29-DEC 01, 1999
CL BOSTON, MA
SP Mat Res Soc
AB Metallization of plastic devices is of interest to newer non-silicon based MEMS which are being developed for biomedical and other applications. The electrical properties of the metallization will depend, in part, on the material on which they are patterned and the method of deposition. Of interest are the electrical characterizations during usage which must be studied to allow plastic MEMS designs to proceed wisely. Flexible microdevices may develop open circuits or shorts after excessive bending; joule heating may adversely affect the plastic substrates, leading to failure. We present some experimental studies on electrical characterization of metallized plastics as it relates to various processing conditons and usage scenarios.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RP Chu, C (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RI Li, Guann-Pyng/B-8466-2009
CR AVIRAM A, 1984, Patent No. 4440801
   BERNARD A, 1998, LANGMUIR, V14
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   GOLDIE W, 1969, METALLIC COATING PLA, V1
   GOLDIE W, 1969, METALLIC COATING PLA, V2
   Ogura M, 1998, CLIN CHEM, V44, P2249
   LOCTITE DESIGN GUIDE, V2
NR 7
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-513-7
J9 MATER RES SOC SYMP P
PY 2000
VL 605
BP 97
EP 102
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Materials Science, Characterization & Testing
SC Engineering; Materials Science
GA BR05E
UT WOS:000165506600014
DA 2018-10-19
ER

PT S
AU Rodriguez, GP
   Calderon, A
   Hernandez, RAM
   Orea, AC
   Mendez, M
   Sinencio, FS
AF Rodriguez, GP
   Calderon, A
   Hernandez, RAM
   Orea, AC
   Mendez, M
   Sinencio, FS
BE AlvaradoGil, JJ
   Contreras, JG
   Corral, GH
TI Microstructure and thermal characterization of dense bone and metals for
   biomedical use
SO MEDICAL PHYSICS
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 4th Mexican Symposium on Medical Physics
CY MAR 01-04, 2000
CL MERIDA, MEXICO
SP CINVESTAV Gen Directorate, Natl Univ, Coordinat Sci Res, Natl Univ, Phys Inst
ID DIFFUSIVITY; SILICON
AB We present a microstructural study and thermal diffusivity measurements at room temperature in two different sections of bull dense bone, bull bone and commercial hydroxyapatite, the last two in powder form. A comparison was realised between these measured values and those obtained from metallic samples frequently used in implants, as high purity titanium and 316L stainless steel. Our results show that the porosity and its orientation in the bone are two important factors for the heat flux through the bone. On the other hand, we obtained that the hydroxyapatite, in compact powder form, presents a thermal diffusivity value close to those obtained for the samples of bone which gives a good thermal agreement between these materials. Finally, it was obtained at one order of magnitude difference between the thermal diffusivity values of metallic samples and those corresponding values to bone and hydroxyapatite being this difference greater in titanium than in stainless steel.
C1 IPN, Escuela Super Fis & Matemat, Mexico City 07300, DF, Mexico.
RP Rodriguez, GP (reprint author), IPN, Escuela Super Fis & Matemat, AP 75526,Colonia Lindavisia, Mexico City 07300, DF, Mexico.
CR Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1998, J APPL PHYS, V84, P6327, DOI 10.1063/1.368957
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   GOMEZ ML, 1994, THESIS UNAM
   MARQUEZINI MV, 1991, MEAS SCI TECHNOL, V2, P396, DOI 10.1088/0957-0233/2/4/020
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   ROSENSWAIG A, 1980, PHOTOACOUSTIC PHOTOA
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 9
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-963-7
J9 AIP CONF PROC
PY 2000
VL 538
BP 192
EP 195
PG 4
WC Engineering, Biomedical; Physics, Applied
SC Engineering; Physics
GA BR18J
UT WOS:000165808400022
DA 2018-10-19
ER

PT B
AU Loo, GS
AF Loo, GS
BE Valafar, F
TI Information technology in biomedicine: Recognition of noxious plants
   (ITBRONP)
SO METMBS'00: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MATHEMATICS
   AND ENGINEERING TECHNIQUES IN MEDICINE AND BIOLOGICAL SCIENCES, VOLS I
   AND II
LA English
DT Proceedings Paper
CT International Conference on Mathematics and Engineering Techniques in
   Medicine and Biological Sciences (METMBS 00)
CY JUN 26-29, 2000
CL LAS VEGAS, NV
SP Comp Sci, Res, Educ & Applicat Press, Int Technol Inst, Korea Informat Processing Soc, PDPTA
DE biomedical; image database; inference engine; ingested herbaceous
   matter; noxious plants; restructuring modelling
AB This paper presents a medical simulation system that allows training in the recognition of poisonous plants and presents personnel with a simulation of a patient case who has ingested poisonous plant matter. Currently it is difficult for clinicians to make identification of the source of poisoning from ingesting herbaceous matter. Patients presenting symptoms of poisoning often cannot identify the herbaceous material by name, but are usually able to give a description and sometimes arrive at the admitting hospital/clinic with a sample of the plant matter.
   ITBRONP has the fundamental structure of many expert systems. The methodology of Restructuring Modelling is used, allowing the successful completion of a simulation situation through the choice of several paths. ITBRONP consists of a knowledge base that contains rules and facts, art inference engine and underlying explanation, knowledge acquisition and user interface subsystems. An image database of plants enables rite health personnel to identify the treatment for the particular type of poison.
   The experimental system designed and developed is a biomedical system for the education of medical personnel. It has two components: the Plant Identification System (PIS), and the Medical Simulation System (MSS).
C1 Univ Auckland, Dept Management Sci & Informat Syst, Auckland 1, New Zealand.
RP Loo, GS (reprint author), Univ Auckland, Dept Management Sci & Informat Syst, Private Bag 92019, Auckland 1, New Zealand.
CR FOUKARIDIS G, 1995, S AFR J SCI, V951, P570
   *IPC, 1995, INTOX SYST US MAN PO
   KERSTEN G, 1994, P 2 WORLD C EXP SYST, P1130
   KERSTEN GE, 1991, MANAGE SCI, V37, P1269, DOI 10.1287/mnsc.37.10.1269
   *POIS UN GUYS ST T, 1995, POIS PLANTS BRIT IR
   SAFETY 2000 PRESCHOO
NR 6
TC 0
Z9 0
U1 0
U2 0
PU C S R E A PRESS
PI ATHENS
PA 115 AVALON DR, ATHENS, GA 30606 USA
BN 1-892512-62-9
PY 2000
BP 353
EP 359
PG 7
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical; Mathematics,
   Interdisciplinary Applications
SC Computer Science; Engineering; Mathematics
GA BR81W
UT WOS:000167662700053
DA 2018-10-19
ER

PT B
AU Walker, FL
   Thoma, GR
AF Walker, FL
   Thoma, GR
BE Williams, ME
TI Read it to me!
SO NATIONAL ONLINE MEETING, PROCEEDINGS 2000
LA English
DT Proceedings Paper
CT 21st National Online Meeting
CY MAY 16-18, 2000
CL NEW YORK, NY
SP Informat Today Inc, Lexis Nexis
DE DocMorph Server; speech synthesis; image processing; World Wide Web;
   TIFF; PDF; OCR; DocView; NLM; Ariel; Internet
AB New technology and software such as Ariel and DocView have made it possible for libraries to distribute information to patrons over the Internet. Ariel, a product of the Research Libraries Group, converts paper-based documents to monochrome bitmapped images, and delivers them over the Internet, while the National Library of Medicine's DocView enables library patrons to receive, display and manage documents received from Ariel systems. While libraries and their patrons are beginning to reap the benefits of this new technology, both technological and social barriers still exist that lead to difficulties in the use of library document information. For example, the formats of files received through the Internet may not be usable on the recipient's computer. In addition, disadvantaged groups of people such as the blind and visually impaired often have difficulties in reading either printed or electronic information. To investigate solutions to some of these barriers, the Communications Engineering Branch of the Lister Hill National Center for Biomedical Communications, an R&D division of NLM, has developed a web site called the DocMorph Server. This is part of an ongoing R&D program in document imaging that has spanned many aspects of electronic document conversion and preservation, Internet document transmission and document usage. The DocMorph Server web site allows users to upload document image files via the Internet for conversion to alternative formats (e.g., TIFF to PDF), thereby enabling wider delivery and easier usage of library document information. A recent development in the DocMorph Server is speech synthesis to permit users to convert scanned images of the printed word into the spoken word. From any place on the Internet, a user can upload scanned images of a book, for example, and have DocMorph return a web page that allows the user's computer to read the material out loud. This reading facility enables certain groups of people to read material that would otherwise be difficult or impossible to read. This paper describes the architecture of the prototype DocMorph Server and the design of its computer-assisted reading facility.
C1 Natl Lib Med, Bethesda, MD 20894 USA.
CR *ALD CORP, 1992, TIFF REV 6 0
   Berger M. A., 1996, College & Undergraduate Libraries, V3, P49, DOI 10.1300/J106v03n02_05
   BORENSTEIN N, 1992, MIME MULTIPURPOSE IN
   *CDCP, 1995, TRENDS HLTH OLD AM U
   Postel J, 1985, FILE TRANSFER PROTOC
   *URL, INF GROUP EL DOC INT
   WALKER FL, 1996, P IOLS 96, P107
   WALKER FL, 1995, P IOLS 95, P165
   WALKER FL, 2000, P IS T SPIE C INT IM, P268
NR 9
TC 0
Z9 0
U1 0
U2 1
PU INFORMATION TODAY INC
PI MEDFORD
PA 143 OLD MARLTON PIKE, MEDFORD, NJ 08055 USA
BN 1-57387-102-8
PY 2000
BP 473
EP 483
PG 11
WC Information Science & Library Science
SC Information Science & Library Science
GA BR04Z
UT WOS:000165502800047
DA 2018-10-19
ER

PT S
AU Suslick, KS
AF Suslick, KS
BE Lauterborn, W
   Kurz, T
TI Sonochemistry: A physical perspective
SO NONLINEAR ACOUSTICS AT THE TURN OF THE MILLENNIUM
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 15th International Symposium on Nonlinear Acoustics
CY SEP 01-04, 1999
CL GOTTINGEN, GERMANY
SP Int Union Pure & Appl Phys, Deutsch Forsch Gemeinsch, WE Heraeus Stiftung, State Niedersachsen
ID AMORPHOUS IRON; ULTRASOUND; SONOLUMINESCENCE
AB Both sonochemistry and sonoluminescence derive from acoustic cavitation. Bubble collapse in liquids results in an enormous concentration of energy from the conversion of the kinetic energy of liquid motion into heating of the contents of the bubble. The high local temperatures and pressures, combined with extraordinarily rapid cooling, provide a unique means for driving chemical reactions under extreme conditions. A diverse set of applications of ultrasound to enhance chemical reactivity has been explored, with important applications in mixed phase synthesis, materials chemistry, and biomedical uses. For example, the sonochemical decomposition of volatile organometallic precursors in low-volatility solvents produces nanostructured materials in various forms with high catalytic activities. Nanostructured metals, alloys, carbides and sulfides, nanometer colloids, and nanostructured supported-catalysts can all be prepared by this general route.
C1 Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.
RP Suslick, KS (reprint author), Univ Illinois, Sch Chem Sci, 600 S Mathews Av, Urbana, IL 61801 USA.
RI Suslick, Kenneth/C-3281-2011
OI Suslick, Kenneth/0000-0001-5422-0701
CR BELLISSENT R, 1993, PHYS REV B, V48, P15797, DOI 10.1103/PhysRevB.48.15797
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   FLINT EB, 1989, J AM CHEM SOC, V111, P6987, DOI 10.1021/ja00200a014
   FLINT EB, 1991, SCIENCE, V253, P1325
   GATES BC, 1992, CATALYTIC CHEM, P387
   GRINSTAFF MW, 1993, PHYS REV B, V48, P269, DOI 10.1103/PhysRevB.48.269
   JEFFRIES JB, 1992, SCIENCE, V256, P248, DOI 10.1126/science.256.5054.248
   Leighton T., 1994, ACOUSTIC BUBBLE
   Mason T. J., 1996, CHEM EXTREME NONCLAS, P317
   Mdleleni MM, 1998, J AM CHEM SOC, V120, P6189, DOI 10.1021/ja9800333
   Moser W. R., 1996, ADV CATALYSTS NANOST
   PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1
   Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681
   Richards WT, 1927, J AM CHEM SOC, V49, P3086, DOI 10.1021/ja01411a015
   Suslick K.S., 1990, ADV SONOCHEMISTRY, V1, P197
   Suslick K. S., 1998, KIRKOTHMER ENCY CHEM, V26, P517
   Suslick K.S, 1997, HDB HETEROGENEOUS CA, V3, P1350
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   Suslick KS, 1998, HANDBOOK OF ACOUSTICS, P243
   Suslick KS, 1996, J AM CHEM SOC, V118, P11960, DOI 10.1021/ja961807n
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0
   SUSLICK KS, 1995, MRS BULL, V20, P29, DOI 10.1557/S088376940004464X
   SUSLICK KS, 1993, J PHYS CHEM-US, V97, P3098, DOI 10.1021/j100115a007
   SUSLICK KS, 1994, ENCY INORGANIC CHEM, V7, P3890
NR 27
TC 3
Z9 3
U1 0
U2 9
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-945-9
J9 AIP CONF PROC
PY 2000
VL 524
BP 95
EP 104
PG 10
WC Acoustics; Mechanics; Physics, Fluids & Plasmas
SC Acoustics; Mechanics; Physics
GA BQ75G
UT WOS:000089403000010
DA 2018-10-19
ER

PT J
AU Corey, JP
   Mamikoglu, B
   Akbar, I
   Houser, SM
   Gungor, A
AF Corey, JP
   Mamikoglu, B
   Akbar, I
   Houser, SM
   Gungor, A
TI ImmunoCAP and HY.TEC enzyme immunoassays in the detection of
   allergen-specific IgE compared with serial skin end-point titration by
   receiver operating characteristic analysis
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   American-Academy-of-Otolaryngology-Head-and-Neck-Surgery
CY SEP 13-16, 1998
CL SAN ANTONIO, TEXAS
SP Amer Acad Otolaryngol Head & Neck Surg
ID ROC
AB OBJECTIVES: In this study we compared 2 different immunoassays, HY IEC enzyme immunoassay (Hycor Biomedical Inc, Garden Grove, CA) and Pharmacia Upjohn ImmunoCAP (Pharmacia and Upjohn, Kalamazoo, MI) using skin end-point titration as a gold standard by receiver operating chatacteristic analysis.
   MATERIALS: One hundred patients were enrolled in this study and were tested with the above 3 modalities. The results were analyzed by receiver operating characteristic analysis, in which the curves give a decision criterion for any diagnostic test relative to its sensitivity and specificity against an accepted gold standard test. Only inhalant allergens (Dermatophagoides pteronyssinos, Dermatophagoides farina, cat dander, giant ragweed, English plantain weed, timothy grass, Alternaria tenuis, Aspergillus fumigatus, meadow fescue, oak tree, white ash tree, and lamb's-quarter weed) were studied.
   RESULTS: The results obtained with both ImmunoCAP and HY.TEC showed a good correlation with skin end-point titration for D pteronyssinus, D farina, cat dander, giant ragweed, timothy grass, A tenuis, and meadow fescue, with sensitivities ranging from 71% to 88%. However, the sensitivity of both tests to English plantain weed, lamb's-quarter weed, oak free, and white ash tree was lower (66% down to 39%). Additionally, HY.TEC results were not satisfactory for detecting specific IgE to A fumigatus (30% sensitivity). The overall sensitivity for each test was 65.67% for the HY.TEC and 71.25% for the ImmunoCAP.
   CONCLUSION: The 2 in vitro testing systems are comparable for most of the allergens, except for A fumigatus, English plantain, lamb's-quarter, and white ash tree; ImmunoCAP and HY.TEC would benefit from improved technology for detecting these specific IgE antibodies. The HY.TEC assay did not give acceptable results for A fumigatus. The overall assay characteristics were good to excellent for each system tested.
C1 Univ Chicago Hosp, Otolaryngol Sect, Dept Surg, Chicago, IL 60637 USA.
   Univ Chicago Hosp, Otolaryngol Sect, Nasal Physiol & Allergy Lab, Chicago, IL 60637 USA.
RP Corey, JP (reprint author), Univ Chicago Hosp, Otolaryngol Sect, Dept Surg, 5841 S Maryland Ave,MC 1035, Chicago, IL 60637 USA.
CR ALANSO R, 1995, J INVESTIG ALLERGOL, V5, P156
   COREY JP, 1995, OTOLARYNG HEAD NECK, V112, P665, DOI 10.1016/S0194-5998(95)70173-7
   GLEESON M, 1996, CLIN EXP ALLERGY, V26, P597
   Kontis K J, 1997, Allergol Immunopathol (Madr), V25, P63
   Mabry R. L., 1994, AAOA MONOGRAPH SERIE
   METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
   METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009
   Nolte H, 1997, ANN ALLERG ASTHMA IM, V79, P27, DOI 10.1016/S1081-1206(10)63080-3
   OWNBY DR, 1992, ANN ALLERGY, V68, P3
NR 9
TC 6
Z9 6
U1 0
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD JAN
PY 2000
VL 122
IS 1
BP 64
EP 70
DI 10.1016/S0194-5998(00)70146-X
PG 7
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 274LX
UT WOS:000084768300013
PM 10629485
DA 2018-10-19
ER

PT J
AU Wu, LM
   You, B
   Li, D
   Qian, F
AF Wu, LM
   You, B
   Li, D
   Qian, F
TI The in vitro and in vivo stability of poly(urethaneurea)s as biomedical
   materials
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE PDMS; PEUU; hydration; implantation
ID DEGRADATION; BIOSTABILITY; MORPHOLOGY
AB The in vitro and in vivo stability of poly(ether urethaneurea) (PEUU) films and blood sacs with or without chemically modification by poly(dimethyl siloxane) (PDMS) has been investigated, respectively. Gel permeation chromatography (GPC) experiments showed an increase in average molecular weight for both films hydrated in saline solution at 37 degrees C and the blood sacs utilized in electric total artificial hearts implanted in calves duo to the possible leaching of low molecular weight species and the chain extensions of residual free isocyanate groups. Correspondingly, hydration and implantation displayed an increase in mechanical strength. But excessive implantation for PDMS-modified PEUU blood sacs (such as over similar to 100 day implantation) still caused possible decrease in average molecular weight and mechanical strength duo to more and more chemical degradation, just as observed in PEUU blood sacs without being modified by PDMS. Dynamical mechanical analysis (DMA) showed an increasing phase separation between hard and soft segments after immersion. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Fudan Univ, Dept Mat Sci, Shanghai 200433, Peoples R China.
RP Wu, LM (reprint author), Fudan Univ, Dept Mat Sci, Shanghai 200433, Peoples R China.
CR HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   ISHIHARA H, 1984, J MACROMOL SCI PHYS, VB22, P713, DOI 10.1080/00222348308215209
   JOHNSON DH, 1954, J PHYS CHEM-US, V58, P1073, DOI 10.1021/j150522a006
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   Noll W., 1968, CHEM TECHNOLOGY SILI
   SRICHATRAPIMUK VW, 1978, J MACROMOL SCI PHYS, VB15, P267, DOI 10.1080/00222347808212599
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA AJ, 1995, J BIOMED MATER RES, V19, P13
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wu LM, 1999, J BIOMED MATER RES, V44, P371, DOI 10.1002/(SICI)1097-4636(19990315)44:4<371::AID-JBM2>3.0.CO;2-I
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   XI TF, 1994, J BIOMED MATER RES, V28, P483, DOI 10.1002/jbm.820280411
NR 14
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PY 2000
VL 70
IS 1
BP 65
EP 69
DI 10.1016/S0141-3910(00)00089-6
PG 5
WC Polymer Science
SC Polymer Science
GA 350MM
UT WOS:000089105300010
DA 2018-10-19
ER

PT S
AU Lenart, M
   Tarjan, PP
AF Lenart, M
   Tarjan, PP
BE Enderle, JD
TI Cardiovascular anatomy, physiology and engineering - A distance learning
   course
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE distance learning; physiology and anatomy
AB A pilot study in the development of a Computer Supported Distance Learning (CSDL) course was completed. Its subject was cardiovascular physiology, anatomy as well as diagnostic and therapeutic devices, Its target was a class of first veer graduate students in biomedical engineering with undergraduate degrees in other engineering disciplines. The format of CSDL seems to overcome many of the problems of our conventional course: Unified Medical Sciences, a course team-taught by physicians anti life scientists, as the CSDL format allows self-paced study, exploration of unfamiliar areas, skipping unneeded reviews and assisting the students to dig deeper with guidance and possibly with editorial assistance from the developers of the course. - Knowledge of the way living systems have evolved to solve challenges may become more necessary for engineers in other disciplines. The pilot study should provide a springboard far the development of suitable course material for such a course.
C1 Univ Miami, Dept Biomed Engn, Coll Engn, Coral Gables, FL 33124 USA.
RP Lenart, M (reprint author), Univ Miami, Dept Biomed Engn, Coll Engn, POB 248294, Coral Gables, FL 33124 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 1023
EP 1025
PN 1-4
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300286
DA 2018-10-19
ER

PT S
AU Devey, GB
AF Devey, GB
BE Enderle, JD
TI Undergraduate and graduate design projects
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
AB The National Science Foundation (NSF) was established in 1950 as an independent Agency of the Federal Government with the broad mission to promote and advance scientific progress in the U.S. This is accomplished primarily by supporting research and education in ail disciplines of the natural and social sciences, mathematics, and engineering, Support is provided principally in the form of grants awarded on a competitive basis under a rigorous peer review process; NSF does not conduct research itself. In 1992, NSF defined a project eligible for support as bioengineering research as one "... with diagnosis or treatment-related goals, that applies engineering principles to problems in biology and medicine while advancing engineering knowledge is eligible for support. Bioengineering research to aid persons with disabilities is also eligible".(1) Bioengineering at NSF has two defined programs: 1- "Biochemical Engineering", and 2- a two-component activity "Biomedical Engineering" (BME) and "Research to Aid Persons with Disabilities" (RAPD), The material that follows describes the Undergraduate and Graduate Design Projects, which is part of the RAPD component of the bioengineering program.
C1 Rensselaer Polytech Inst, Troy, NY 12181 USA.
RP Devey, GB (reprint author), Rensselaer Polytech Inst, Troy, NY 12181 USA.
CR *REN POLYT I, CURR FAC SUP REH ENG
   *US NAT SCI FDN, 992 NSF, pCH1
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2373
EP 2374
PN 1-4
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300661
DA 2018-10-19
ER

PT S
AU Khoo, M
   Liu, C
AF Khoo, M
   Liu, C
BE Enderle, JD
TI A novel micromachined magnetic membrane microfluid pump
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE micropump; microfluidic system; membrane; magnetic actuation; silicone
   elastomer
AB We present results on the design, fabrication, and testing of a new, micromachined magnetic pump for integrated microfluidic systems. Structurally, the pump consists of a magnetic microactuator and two polymer-based one-way diffuser valves. The microactuator is based on a thin membrane made of polydimethyl siloxane (PDMS), a soft silicone elastomer. Membrane displacement is caused by the interaction between ferromagnetic pieces (embedded within the thickness of the membrane) and an external magnet. This novel mechanism reduces fabrication and packaging complexity, and allows for remote operation of the micropump without any tether wires for power input. The operation is simple as no precise alignment is required between the external magnet and the pump. PDMS is bio-compatible compared to silicon. One future application of this tetherless micropump is implanted biomedical microfluidic systems.
   We developed a novel micromachining process for embedding ferromagnetic materials (Permalloy, Ni(80)Pe(20)) within a thin, spin-casted PDMS membrane. Unique pump and diffuser mechanisms that allow for continuous pumping are also developed. Diffuser elements containing no moving parts are fabricated using polymer micromachining techniques, Micro Permalloy pieces are strategically positioned within a 2x2mm(2), 40-mum-thick PDMS membrane, Dimensions and locations of the membrane and the Permalloy pieces are optimized using computer simulations for maximum membrane vertical displacement under a given magnetic field. Experimentally, we have demonstrated successful on-chip, fluid pumping. In the presence of an oscillating 2.85x10(5)-A/m external magnetic field, a 1.2-mul/min flow rate was measured for an actuation frequency of 2.9-Hz. The flow rate can be easily varied by the frequency.
C1 Univ Illinois, Microelect Lab, Micro Actuators Sensors & Syst MASS Grp, Urbana, IL 61801 USA.
RP Khoo, M (reprint author), Univ Illinois, Microelect Lab, Micro Actuators Sensors & Syst MASS Grp, 208 N Wright St, Urbana, IL 61801 USA.
CR BIEIDER C, 1995, TRANSD 95 INT C SOL, V2, P284
   ELWENSPOEK M, 1994, J MICROMECH MICROENG, V4, P227, DOI 10.1088/0960-1317/4/4/008
   JEONG OC, 1999, TRANSD 99 INT C SOL, V2, P1780
   Koch M, 1998, J MICROMECH MICROENG, V8, P119, DOI 10.1088/0960-1317/8/2/019
   Liu C, 1998, MECHATRONICS, V8, P613, DOI 10.1016/S0957-4158(98)00016-6
   Olsson A, 1996, SENSOR ACTUAT A-PHYS, V57, P137, DOI 10.1016/S0924-4247(97)80104-5
   OLSSON A, 1997, TRANSD 97 INT C SOL, V2, P1039
   Sadler DJ, 1998, P SOC PHOTO-OPT INS, V3515, P46, DOI 10.1117/12.322094
   YANG Y, 1995, TRANSD 95 INT C SOL, V3, P81
   ZERLENGE R, 1992, IEEE MICRO STRUCTURE, P19
   ZHANG W, 1996, 1996 SOL STAT SENS A, P94
NR 11
TC 15
Z9 15
U1 2
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2394
EP 2397
PN 1-4
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300667
DA 2018-10-19
ER

PT S
AU Otsuka, H
   Nagasaki, Y
   Okano, T
   Kataoka, K
AF Otsuka, H
   Nagasaki, Y
   Okano, T
   Kataoka, K
BE Enderle, JD
TI Functionalization of polylactide(PLA) surface using heterobifunctional
   PEG/PLA block copolymers for the control of cell behavior at surfaces
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE poly(ethylene glycol)(PEG); polylactide(PLA); aldehyde; hepatocyte
ID POLY(ETHYLENE
AB This paper deals with novel approaches established by our group for the construction of a functionalized poly(ethylene glycol) (PEG) layer, PEG-brushed layer possessing a reactive group at the free end of tethered PEG chain, on substrates. An AB-type block copolymer composed of alpha -acetal-poly(ethylene glycol) (PEG) as the hydrophilic segment and polylactide (PLA) as the hydrophobic segment was synthesized, and utilized to construct the functionalized PEG layer on the biodegradable polylactide surface by simple coating. In this way, a PEG-brushed layer with a terminal aldehyde group was readily prepared which may have both non-fouling and ligand-binding properties. Non-fouling property of PEG strands eliminates nonspecific and uncontrolled interactions of the surface with biological components, including cells and proteins, while presentation of tethered ligands attached to the chain end of PEG brush allows cell behavior at the surface to be modulated in a specific manner via receptor-mediated signaling. Based on the characterization of these PEGylated surfaces from a physiochemical (contact angle, atomic force microscopy, electron spin resonance) as well as biological (protein adsorption/cell adhesion) point of view, our strategy to construct a functionalized PEG layer was confirmed. Active functional groups were present at the tethered PEG-chain end, these materials will provide new insights into controlling cell behavior at surfaces for tissue engineering and biomedical applications.
C1 Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Tokyo 1138656, Japan.
RP Otsuka, H (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Hongo 7-3-1, Tokyo 1138656, Japan.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Feast W. J., 1993, POLYM SURFACES INTER
   GOOD RJ, 1979, SURFACE COLLOID SCI, V11
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Nagasaki Y, 1997, MACROMOLECULES, V30, P6489, DOI 10.1021/ma9705026
   OTSUKA H, IN PRESS ACS S SERIE
   OTSUKA H, UNPUB SCI TECHNOLOGY
   OTSUKA H, UNPUB BIOMACROMOLECU
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TERAYA T, 1990, POLYMER, V31, P1149, DOI 10.1016/0032-3861(90)90265-Z
NR 12
TC 0
Z9 0
U1 2
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2936
EP 2939
PN 1-4
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300818
DA 2018-10-19
ER

PT S
AU van Alste, JA
AF van Alste, JA
BE Enderle, JD
TI A new educational program on Biomedical Engineering
SO PROCEEDINGS OF THE 22ND ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 22nd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY JUL 23-28, 2000
CL CHICAGO, IL
SP IEEE, Engn Med & Biol Soc, Amer Assoc Physicists Med, Amer Inst Med & Biol Engn, Int Union Phys & Engn Sci Med, Int Federat Med & Biol Engn, Int Org Med Phys
DE biomedical engineering; education; healthcare technology; materials and
   tissue engineering; restoration of human function
AB At the University of Twente together with, the Free University of Amsterdam a new educational program on Biomedical Engineering will be developed, The academic program with a five-year duration will start in September 2001. After a general, broad education in Biomedical Engineering in the first three years, the students specialise in one of the following areas: Materials and Tissue engineering; Technology for restoration of human function; healthcare technology.
C1 Univ Twente, NL-7500 AE Enschede, Netherlands.
RP van Alste, JA (reprint author), Univ Twente, POB 217, NL-7500 AE Enschede, Netherlands.
CR Enderle J., 2000, INTRO BIOMEDICAL ENG
   *U TWENT, 1998, INT BIOM ENG REST HU
   VANALSTE JA, 1999, BIOMEDISCHE TECHNOLO
   WILLEMS, 1999, HET ARBEIDSPERSPECTI
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-6466-X
J9 P ANN INT IEEE EMBS
PY 2000
VL 22
BP 2952
EP 2954
PN 1-4
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BR59S
UT WOS:000166896300823
DA 2018-10-19
ER

PT S
AU Russell, GK
AF Russell, GK
BE Balls, M
   VanZeller, AM
   Halder, ME
TI Alternatives in the teaching of biology at secondary and university
   levels: an ongoing success story
SO PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL
   EXPERIMENTATION
SE DEVELOPMENTS IN ANIMAL AND VETERINARY SCIENCES
LA English
DT Proceedings Paper
CT 3rd World Congress on Alternatives and Animal Use in the Life Science
CY AUG 29-SEP 02, 1999
CL BOLOGNA, ITALY
SP Colgate Palmolive Co, European Commiss, Environm DIrector Gen, European Commiss, Joint Res Ctr, Toiletry & Perfumery Assoc, European Cosmet, Gillette Co, Glaxo Wellcome, Int Fdn Eth Res, Kimberly Clark Corp, L Oreal, Procter & Gamble Co, Unilever Res, Utrecht Congress
AB Increasingly, humane alternatives are being developed to teach fundamental concepts of biology in secondary schools and universities. Basic principles of physiology, including cardiac and pulmonary function, muscle action and elements of exercise physiology, galvanic skin responses, and numerous other processes can be investigated by using the students themselves as experimental subjects. At least one manufacturer of physiology apparatus for instructional purposes has established an on-line user sire for the sharing of experience and the collection of useful ideas and innovations. Cell cultures, computer simulations and video/CD-ROM materials, as well as numerous other alternatives, can be adopted for a wide variety of classroom and laboratory exercises. Meaningful alternatives to animal dissection are also available. Taught by such methods, students can study biology in a manner that is pedagogically sound, but does not involve unnecessary destruction of animal life. In many learning situations, however, the ethical context is omitted from classroom discussion and students fail to evaluate the ethical dimensions of animal studies. The use of alternatives in pedagogy provides the framework for the development of a new ethos involving animal use, not only in a learning environment, but also in biomedical research and in society.
C1 Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.
RP Russell, GK (reprint author), Adelphi Univ, Dept Biol, Garden City, NY 11530 USA.
CR Balcombe JP, 1997, DEV AN VET, V27, P441
   BALCOMBE JP, COMP STUDIES DISSECT, P96
   *HUM SOC US, 1998, DISS WANT KNOW SIMPL
   *INT SCI ENG FAIR, 1999, GUID SCI PROJ
   KRUTCH JW, 1956, GREAT CHAIN LIFE
   MAYER WV, 1973, AM BIOL TEACH, V35, P27, DOI 10.2307/4444187
   *NAT ASS BIOL TEAC, 1995, US AN BIOL ED
   Orlans FB, 1993, NAME SCI ISSUES RESP
   RUSSELL GK, 1972, AM BIOL TEACH, V34, P254, DOI 10.2307/4443923
   RUSSELL GK, 1988, ORION, V7, P48
   RUSSELL GK, 1978, LAB INVESTIGATIONS H
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Singer Peter, 1990, ANIMAL LIBERATION
   ZINKO U, 1997, GUINEA PIG COMPUTER
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5168
BN 0-444-50529-6
J9 DEV AN VET
JI Dev. Anim. Vet. Sci.
PY 2000
VL 31
BP 79
EP 90
PN A & B
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BS42Q
UT WOS:000169797500009
DA 2018-10-19
ER

PT S
AU Duffee, NE
   Fallon, MT
   Laber, KE
AF Duffee, NE
   Fallon, MT
   Laber, KE
BE Balls, M
   VanZeller, AM
   Halder, ME
TI A multi-media training program for biomedical researchers: working with
   laboratory animals
SO PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL
   EXPERIMENTATION
SE DEVELOPMENTS IN ANIMAL AND VETERINARY SCIENCES
LA English
DT Proceedings Paper
CT 3rd World Congress on Alternatives and Animal Use in the Life Science
CY AUG 29-SEP 02, 1999
CL BOLOGNA, ITALY
SP Colgate Palmolive Co, European Commiss, Environm DIrector Gen, European Commiss, Joint Res Ctr, Toiletry & Perfumery Assoc, European Cosmet, Gillette Co, Glaxo Wellcome, Int Fdn Eth Res, Kimberly Clark Corp, L Oreal, Procter & Gamble Co, Unilever Res, Utrecht Congress
AB A project supported by two funding sources will produce computer-based and videotape training materials to address the training needs of researchers using laboratory animals. By June 2000, the first of 13 modules will be completed, Working M with the Laboratory Dog. Information on these programs and the progress of this project is available on a Web site (http://www.wwla.org). A self-assessment Web server is also being developed to administer content examinations that cover these modules.
C1 Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
RP Duffee, NE (reprint author), Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA.
CR LIVINGSTON S, 1982, PASSING SCORES
   Russell WMS, 1959, PRINCIPLES HUMANE EX
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5168
BN 0-444-50529-6
J9 DEV AN VET
PY 2000
VL 31
BP 1415
EP 1421
PN A & B
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BS42Q
UT WOS:000169797500141
DA 2018-10-19
ER

PT S
AU Stitzel, JD
   Bowlin, GL
   Mansfield, K
   Wnek, GE
   Simpson, DG
AF Stitzel, JD
   Bowlin, GL
   Mansfield, K
   Wnek, GE
   Simpson, DG
BE Adams, PJ
   Elsworth, SA
   Petkauskos, MJ
   Walton, TC
TI Electrospraying and electrospinning of polymers for biomedical
   applications. Poly(lactic-co-glycolic acid) and
   poly(ethylene-co-vinylacetate)
SO REVOLUTIONARY MATERIALS: TECHNOLOGY AND ECONOMICS
SE INTERNATIONAL SAMPE TECHNICAL CONFERENCE SERIES
LA English
DT Proceedings Paper
CT 32nd International SAMPE Technical Conference
CY NOV 05-09, 2000
CL BOSTON, MA
SP Soc Advancement Mat & Process Engn
DE biomaterials; applications-medical; fibers
ID DIAMETER FIBERS
AB Significant opportunities exist for the processing of polymers (homopolymers and blends) using electric fields. Specific attention is given here to electrospinning, but we note that electroaerosol formation and field-modulated film casting represent additional processing options. Of particular interest is the ability to generate polymer fibers of sub-micron dimensions using electrospinning, down to about 0.05 microns (50 nm), a size range that has been traditionally difficult to access. In our work, poly(lactic-co-glycolic acid), PLA/PGA, poly(lactic acid) PLA, and poly(ethylene-co-vinylacetate) (PEVA) have been deposited from solutions in methylene chloride or chloroform by electrospraying or electrospinning to afford morphologically tailored materials for tissue engineering and related applications. Low solution concentrations tend to favor electrostatic spraying ('electro-aerosolization') while higher concentrations lead to spinning on fibrous mats. Preliminary observations of muscle cell growth on PLA electrospun mats are reported.
C1 Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.
RP Stitzel, JD (reprint author), Virginia Commonwealth Univ, Dept Biomed Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
RI Bowlin, Gary/E-8617-2010
CR Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Cockshott I.D., 1977, U.S. Patent, Patent No. [4043331, 4,043,331]
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Mooney D. J., 1995, BIOMEDICAL ENG HDB
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   REYDERMAN L, 1995, INT J PHARM, V124, P75, DOI 10.1016/0378-5173(95)00078-W
NR 7
TC 17
Z9 17
U1 1
U2 21
PU SOC ADVANCEMENT MATERIAL & PROCESS ENGINEERING
PI COVINA
PA 1161 PARKVIEW DR,, COVINA, CA 91724-3748 USA
SN 0892-2624
BN 0-938994-89-1
J9 INT SAMPE TECH CONF
PY 2000
VL 32
BP 205
EP 211
PG 5
WC Engineering, Aerospace; Materials Science, Multidisciplinary; Materials
   Science, Characterization & Testing; Materials Science, Coatings &
   Films; Materials Science, Composites
SC Engineering; Materials Science
GA BR79P
UT WOS:000167557000020
DA 2018-10-19
ER

PT B
AU Abe, M
   Nishimura, K
   Kitamoto, Y
AF Abe, M
   Nishimura, K
   Kitamoto, Y
BE Mishra, B
   Yamauchi, C
TI Ferrite thin film devices fabricated by low temperature processing in
   aqueous solution
SO SECOND INTERNATIONAL CONFERENCE ON PROCESSING MATERIALS FOR PROPERTIES
LA English
DT Proceedings Paper
CT 2nd International Conference on Processing Materials for Properties
CY NOV 05-08, 2000
CL SAN FRANCISCO, CA
SP Minerals, Met & Mat Soc, Min & Mat Proc Inst Japan
ID HIGH COERCIVITY; CO; MICROSPHERES; MAGNETITE; NI
AB Ferrite plating is a chemical processing which utilizes Fe2+ --> Fe3+ oxidation to synthesizing polycrystalline films of ferromagnetic spinels (MFe2O4, M = Fe, Co, Ni, Zn, Al, Cr, Ti, etc.) directly from an aqueous solution at 24 - 100 degreesC. This low temperature process allows us to fabricate new ferrite film devices on substrates of such non-heat-resistant materials as plastics, GaAs integrated circuits, and biomaterials. Synthesized from an aqueous solution the ferrite plated films are highly biocompatible. Thus various magnetic device and biomedical applications have been proposed and realized using ferrite-plated films. Ferrite-encapsulated polymer microspheres are applied to antibody carries for enzyme immunoassay, and also to toners/carriers for photocopying. Perpendicular magnetic recording media utilizing plated CoNi ferrite films are proposed. The low-temperature synthesized films of NiZn and Co ferrites are potentially used as soft-magnetic and/or insulating layers, respectively at high/microwave frequencies.
C1 Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.
RP Abe, M (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Ookayama, Tokyo 1528552, Japan.
RI Dom, Rekha/B-7113-2012
CR Abe M, 1997, J PHYS IV, V7, P467, DOI 10.1051/jp4:19971190
   Abe M, 1997, IEEE T MAGN, V33, P3649, DOI 10.1109/20.619526
   ABE M, 1987, IEEE T MAGN, V23, P3432, DOI 10.1109/TMAG.1987.1065550
   ABE M, 1983, JPN J APPL PHYS 2, V22, pL511, DOI 10.1143/JJAP.22.L511
   ABE M, 1992, THIN SOLID FILMS, V216, P155, DOI 10.1016/0040-6090(92)90887-H
   Abe M, 1996, IEEE T MAGN, V32, P4183, DOI 10.1109/20.539331
   ABE M, 1991, MATER RES SOC SYMP P, V232, P107, DOI 10.1557/PROC-232-107
   ABE M, 1992, FERRITES, P472
   ABE M, 2000, 8 INT C FERR ICF 8 K
   HORI S, 1992, JPN J APPL PHYS 1, V31, P1185, DOI 10.1143/JJAP.31.1185
   ITOH T, 1991, J APPL PHYS, V69, P5911, DOI 10.1063/1.347837
   Kitamoto Y, 1999, IEEE T MAGN, V35, P2694, DOI 10.1109/20.800954
   Kitamoto Y, 1999, J APPL PHYS, V85, P4708, DOI 10.1063/1.370455
   KITAMOTO Y, 1998, J MAGN SOC JPN SS1, V22, P167
   MIYAWAKI F, 1998, 3 WORLD C BIOM WCB 9, P365
   Nishimura K, 1999, IEEE T MAGN, V35, P3043, DOI 10.1109/20.801079
   NISHIMURA K, 2000, 8 INT C FERR ICF 8 K
   NISHIZONO I, 1991, CLIN CHEM, V37, P1639
   Ojima M, 1999, IEEE T MAGN, V35, P4118, DOI 10.1109/20.800774
   POURBAIX M, 1966, ATLAS ELECTROCHEMICA, P312
   SAKAI S, 2000, 8 INT C FERR ICF 8 K
   TALISA SH, 1988, J APPL PHYS, V64, P5819, DOI 10.1063/1.342217
   ZAAG PJ, 1999, IEEE T MAGN, V35, P3436
   Zhang F, 1999, IEEE T MAGN, V35, P2751, DOI 10.1109/20.800974
   ZHANG F, 2000, 8 INT C FERR ICF 8 K
   Zhang MJ, 1997, JPN J APPL PHYS 1, V36, P243, DOI 10.1143/JJAP.36.243
NR 26
TC 1
Z9 1
U1 1
U2 4
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-495-X
PY 2000
BP 219
EP 224
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mining &
   Mineral Processing
GA BR45F
UT WOS:000166445900041
DA 2018-10-19
ER

PT S
AU Carter, GE
   Casady, JB
   Bonds, J
   Okhuysen, ME
   Scofield, JD
   Saddow, SE
AF Carter, GE
   Casady, JB
   Bonds, J
   Okhuysen, ME
   Scofield, JD
   Saddow, SE
BE Carter, CH
   Devaty, RP
   Rohrer, GS
TI Preliminary investigation of SiC on silicon for biomedical applications
SO SILICON CARBIDE AND RELATED MATERIALS - 1999 PTS, 1 & 2
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Conference on Silicon Carbide and Related Materials
CY OCT 10-15, 1999
CL RES TRIANGLE PK, NORTH CAROLINA
SP NASA, Glenn Res Ctr, USAF, Res Lab, mat & Mfg Directoirate, USN, Off Res, Def Res & Engn, Cree Inc, Charles & Colvard Inc, ABB Semicond, Sterling Semicond Inc, ATMI Inc, Epigress AB, Aixtron AG, Northrop Grumman, Siemens AG, EMCORE Inc, GE, Corp R & D, Litton Airton, II-VI Inc
DE 3C; biomedical probe; MEMS; microelectromechanical; reactive ion
   etching; RIE; SF6
ID SYSTEM
AB Reactive ion etching experiments were conducted with the intent of constructing a 3C-SiC on silicon heart probe to be used for biomedical applications. Experiments were performed with 3C-SiC as well as 4H-SiC in order to optimize the process for the heart probe construction. The heart probes were patterned on 3C-SiC on silicon to create a hybrid device that would combine the strength and inertness of the 3C-SiC material with the electronic compatibility of Si material to provide a complete probe suitable for reliable and disposable use required by the medical industry.
C1 Mississippi State Univ, Dept Elect & Comp Engn, Emerging Mat Res Lab, Mississippi State, MS 39762 USA.
   USAF, Res Lab, Wright Patterson AFB, OH 45433 USA.
RP Carter, GE (reprint author), Mississippi State Univ, Dept Elect & Comp Engn, Emerging Mat Res Lab, Mississippi State, MS 39762 USA.
CR Casady JB, 1996, J ELECTROCHEM SOC, V143, P1750, DOI 10.1149/1.1836711
   Chandra K, 1998, MATER SCI FORUM, V264-2, P635, DOI 10.4028/www.scientific.net/MSF.264-268.635
   Hong LS, 1996, INST PHYS CONF SER, V142, P93
   MASTROTOTARO JJ, 1992, IEEE T BIO-MED ENG, V39, P271, DOI 10.1109/10.125012
   Moller H, 1996, INST PHYS CONF SER, V142, P497
   OKHUYSEN ME, 1998, MAT RES SOC
   PADIYATH R, 1991, APPL PHYS LETT, V58, P1053, DOI 10.1063/1.104420
   Samant AV, 1998, MATER SCI FORUM, V264-2, P627, DOI 10.4028/www.scientific.net/MSF.264-268.627
   SCOFIELD JD, 1998, APPL PHYS LETT  0706
   Yih PH, 1997, PHYS STATUS SOLIDI B, V202, P605, DOI 10.1002/1521-3951(199707)202:1<605::AID-PSSB605>3.0.CO;2-Y
NR 10
TC 12
Z9 12
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2000
VL 338-3
BP 1149
EP 1152
DI 10.4028/www.scientific.net/MSF.338-342.1149
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films
SC Materials Science
GA BR27W
UT WOS:000165996700280
DA 2018-10-19
ER

PT S
AU Slaughter, JC
   Dapino, MJ
   Smith, RC
   Flatau, AB
AF Slaughter, JC
   Dapino, MJ
   Smith, RC
   Flatau, AB
BE Werely, NM
TI Modeling of a Terfenol-D ultrasonic transducer
SO SMART STRUCTURES AND MATERIAL 2000: SMART STRUCTURES AND INTEGRATED
   SYSTEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2000 Conference
CY MAR 05-09, 2000
CL NEWPORT BEACH, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engn, BFGoodrich, Def Adv Res Projects Agcy, USA Res Off, USAF Res Lab, Ceram Soc Japan, Intelligent Mat Forum, Japan
DE Terfenol-D; transducer model; ultrasonic; magnetostrictive; giant
   magnetostrictive material
ID HYSTERESIS
AB A large variety of applications exist which take advantage of the high dynamic strain and high energy coupling factor exhibited by "giant" magnetostrictive materials. One such material is the rare earth-iron compound Terfenol-D (Tb0.3DY0.7Fe1.95), which is being increasingly used in industrial, biomedical and defense applications. In order to fully realize the performance of this material, it is necessary to accurately model magnetostrictive transducer behavior from DC through the low ultrasonic regimes where the material is used. This paper has been motivated by the need for physically-based performance models of magnetostrictive materials as used in transducers. To this end, a recent magnetoelastic model for magnetostrictive transducers is employed to characterize the magnetization and strain behavior of Terfenol-D at frequencies from 1 Hz to 30 kHz. Model simulations were compared to experimental measurements at various drive levels and frequencies of operation, both under magnetically unbiased and biased conditions. The model provides an accurate characterization of the magnetization and strain for all operating conditions studied. However, further progress in strain simulations may be achieved through improvements in minor loop closure techniques and additional parameter identification.
C1 ETREMA Prod Inc, Ames, IA 50010 USA.
RP Slaughter, JC (reprint author), ETREMA Prod Inc, Ames, IA 50010 USA.
CR ADLY AA, 1996, IEEE T MAGN, V32, P4473
   Basso V, 1996, IEEE T MAGN, V32, P4210, DOI 10.1109/20.539336
   CALKINS FT, 1999, THESIS IOWA STATE U
   CARMAN GP, 1995, J INTEL MAT SYST STR, V6, P673, DOI 10.1177/1045389X9500600508
   CRAWFORD AE, 1955, ULTRASONIC ENG PARTI, P47
   DAPINO MJ, 1999, THESIS IOWA STATE U
   DAPINO MJ, 1999, WILEY ENCY ELECT ELE, P292
   DAPINO MJ, 1999, IN PRESS P ACTIVE 99
   DUENAS TA, 1996, ADV SMART MAT FUNDAM
   ENGDAHL G, 1997, J APPL PHYS, V79, P4689
   FREDERICK JR, 1965, ULTRASONIC ENG, P60
   JILES DC, 1995, J PHYS D APPL PHYS, V28, P1537, DOI 10.1088/0022-3727/28/8/001
   JILES DC, 1986, J MAGN MAGN MATER, V61, P48, DOI 10.1016/0304-8853(86)90066-1
   JILES DC, 1994, IEEE T MAGN, V30, P4326, DOI 10.1109/20.334076
   KANNAN KS, 1995, AD MAT S SUMM M ASME
   *NIST ADV TECHN PR, 97010023 NIST
   RESTORFF JB, 1990, J APPL PHYS, V67, P5016, DOI 10.1063/1.344708
   SABLIK MJ, 1993, IEEE T MAGN, V29, P2113, DOI 10.1109/20.221036
   SABLIK MJ, 1988, J APPL PHYS, V64, P5402, DOI 10.1063/1.342383
   Smith RC, 1997, P SOC PHOTO-OPT INS, V3041, P243, DOI 10.1117/12.275690
NR 20
TC 23
Z9 27
U1 1
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3603-8
J9 P SOC PHOTO-OPT INS
PY 2000
VL 3985
BP 366
EP 377
DI 10.1117/12.388838
PG 12
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Materials Science, Ceramics
SC Automation & Control Systems; Engineering; Materials Science
GA BQ59C
UT WOS:000088899900033
DA 2018-10-19
ER

PT S
AU Jeong, HK
   Jeong, OC
   Yang, SS
AF Jeong, HK
   Jeong, OC
   Yang, SS
BE Varadan, VK
TI Fabrication of an electromagnetic actuator with the planar coil
SO SMART STRUCTURES AND MATERIALS 2000: SMART ELECTRONICS AND MEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2000 Conference
CY MAR 05-09, 2000
CL NEWPORT BEACH, CA
SP SPIE, Soc Exptl Mech, Amer Soc Mech Engn, BFGoodrich, Def Adv Res Projects Agcy, USA Res Off, USAF Res Lab, Ceram Soc Japan, Intelligent Mat Forum, Japan
DE electromagnetic actuator; copper coil; parylene C diaphragm;
   electroplating
AB This paper first presents the fabrication of an electromagnetic microactuator using an electroplated spiral copper coil on a parylene C diaphragm. The parylene is a bio-compatible material and has a very low Young's modulus less than 2.8 Cpa, which makes the large deflection for the low power consumption. The actuator consists of an electroplated coil on the parylene C diaphragm, a small-size permanent magnet and a core. The diaphragm is actuated by the Lorenz force generated by the current through the coil in the magnetic field of the magnet. The size of the actuator diaphragm is 4 x 4 mm(2) and 5 mu m thick. The resistance and inductance of the copper spiral coil are 2 Omega and 11 mu H at 100 Hz, respectively. The center deflection of the actuator diaphragm is measured with a the laser vibrometer. When the current through the coil is 380 mA, the peak-to-peak deflection of the actuator is 143 Fun below the resonant frequency of 35 Hz. The mechanical sensitivity of the actuator diaphragm is 900 mu m/A and 3200 mu m/A at 10 Hz and 35 Hz, respectively. An electromagnetic microactuator using the electroplated copper coil on the parylene diaphragm is expected to be useful in making a micropump for the biomedical use.
C1 Ajou Univ, Sch Elect Engn, Paldal Gu, Suwon 442749, South Korea.
RP Jeong, HK (reprint author), Ajou Univ, Sch Elect Engn, Paldal Gu, San 5 Wonchun Dong, Suwon 442749, South Korea.
OI Jeong, Ok Chan/0000-0002-2089-000X
CR LAMMERINK TSJ, 1993, P IEEE MEMS WORKSH F, P25
   OLSSON A, 1995, IEEE INT C SOL STAT, V2, P291
   Park J. Y., 1997, THESIS GEORGIA I TEC
   RYU JC, 1999, P 1 KOR MEMS C APR 1, P29
   Shinozawa Y, 1997, PROC IEEE MICR ELECT, P233, DOI 10.1109/MEMSYS.1997.581809
   Yang EH, 1995, SENSOR ACTUAT A-PHYS, V50, P151, DOI 10.1016/0924-4247(96)80100-2
NR 6
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3608-9
J9 P SOC PHOTO-OPT INS
PY 2000
VL 3990
BP 272
EP 280
DI 10.1117/12.388905
PG 9
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BQ59W
UT WOS:000088917700030
DA 2018-10-19
ER

PT S
AU Healey, G
   Slater, D
AF Healey, G
   Slater, D
BE Bearman, GH
   Cabib, D
   Levenson, RM
TI Lessons learned: Technology transfer from terrestrial spectroscopy to
   biomedicine
SO SPECTRAL IMAGING: INSTRUMENTATION, APPLICATIONS, AND ANALYSIS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation, Applications, and
   Analysis
CY JAN 25, 2000
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
ID IMAGING SPECTROMETER AVIRIS; SURFACE-REFLECTANCE; RETINEX THEORY;
   ILLUMINATION; RECOGNITION; SPECTRA
AB The spectral radiance measured by an imaging spectrometer for a material on the earth's surface has significant dependence on environmental factors such as the illumination environment and the atmospheric conditions. This dependence has limited the success of material identification algorithms that rely on hyperspectral image data without associated ground truth information. An important advantage of hyperspectral data is that the sensor spectral dimensionality typically exceeds the dimensionality of the signature variability for any material of interest. We have shown, for example, that the set of observed 0.4-2.5 mu m spectral radiance vectors for a material on the earth's surface lies in a low-dimensional subspace of the hyperspectral measurement space. This analysis has led to robust algorithms for invariant subpixel image analysis that have been applied to a number of remote sensing applications. Similar computational methods can be applied to biomedical images by introducing variability models for the signatures of interest. We present results for material identification in remote sensing images as well as for the quantification of cell populations in 3-D brain tissue samples.
C1 Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
RP Healey, G (reprint author), Univ Calif Irvine, Dept Elect & Comp Engn, Irvine, CA 92697 USA.
EM healey@ece.uci.edu; dslater@ece.uci.edu
CR Aldrich WS, 1996, P SOC PHOTO-OPT INS, V2758, P354, DOI 10.1117/12.243230
   BASEDOW RW, 1995, P SOC PHOTO-OPT INS, V2480, P258, DOI 10.1117/12.210881
   Berk A., 1989, GLTR890122
   BRAINARD DH, 1986, J OPT SOC AM A, V3, P1651, DOI 10.1364/JOSAA.3.001651
   CHRIEN TG, 1990, SPIE, V1298, P37
   CONEL J, 1987, SPIE P, V834, P140
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Gaddis LR, 1996, IEEE T GEOSCI REMOTE, V34, P163, DOI 10.1109/36.481901
   GAO BC, 1993, REMOTE SENS ENVIRON, V44, P165, DOI 10.1016/0034-4257(93)90014-O
   GOETZ AFH, 1985, SCIENCE, V228
   Golub G. H., 1983, MATRIX COMPUTATIONS
   GREEN R, 1998, JPL AIRB EARTH SCI W, P193
   GREEN RO, 1993, P SOC PHOTO-OPT INS, V1937, P2, DOI 10.1117/12.157054
   Healey G, 1997, IEEE T IMAGE PROCESS, V6, P1002, DOI 10.1109/83.597275
   HEALEY G, 1995, J OPT SOC AM A, V12, P1877, DOI 10.1364/JOSAA.12.001877
   HEALEY G, 1994, J OPT SOC AM A, V11, P3003, DOI 10.1364/JOSAA.11.003003
   Healey G, 1999, IEEE T GEOSCI REMOTE, V37, P2706, DOI 10.1109/36.803418
   Healey G, 1998, J OPT SOC AM A, V15, P2216, DOI 10.1364/JOSAA.15.002216
   HEALEY G, 1999, HDB PATTERN RECOGNIT, P283
   HEALEY GE, 1992, PHYSICS BASED VISION
   JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031
   KRUSE FA, 1988, REMOTE SENS ENVIRON, V24, P31, DOI 10.1016/0034-4257(88)90004-1
   LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001
   PARKKINEN JPS, 1989, J OPT SOC AM A, V6, P318, DOI 10.1364/JOSAA.6.000318
   Slater D, 1998, J OPT SOC AM A, V15, P2913, DOI 10.1364/JOSAA.15.002913
   Slater D, 1998, J IMAGING SCI TECHN, V42, P234
   SLATER D, 1999, SPIE C ALG MULT HYP, V5
   SLATER D, 1999, SPIE P, V3753, P308
   SUEN P, 1999, SPIE P, V3753
   THAI B, 1999, SPIE P, V3717
   VANE G, 1993, REMOTE SENS ENVIRON, V44, P127, DOI 10.1016/0034-4257(93)90012-M
NR 31
TC 0
Z9 0
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-3536-8
J9 PROG BIOM O
PY 2000
VL 1
BP 2
EP 13
DI 10.1117/12.379583
PG 12
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BP87U
UT WOS:000086469300001
DA 2018-10-19
ER

PT S
AU Smith, RD
   Nelson, MP
   Treado, PJ
AF Smith, RD
   Nelson, MP
   Treado, PJ
BE Bearman, GH
   Cabib, D
   Levenson, RM
TI Raman chemical imaging using flexible fiberscope technology
SO SPECTRAL IMAGING: INSTRUMENTATION, APPLICATIONS, AND ANALYSIS
SE PROGRESS IN BIOMEDICAL OPTICS
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation, Applications, and
   Analysis
CY JAN 25, 2000
CL SAN JOSE, CA
SP SPIE, Int Biomed Opt Soc
DE Raman spectroscopy; chemical imaging; fiberscope; endoscope; remote
   inspection
AB Raman chemical imaging microscopy has been proven to be a powerful methodology for analyzing a wide range of solid state materials. For biomedical applications, Raman chemical imaging has been shown to be effective in assessing clinical samples including breast tissue lesions and arterial plaques. With Raman chemical imaging systems based on microscopes, materials can be analyzed with molecular specificity, without labor intensive sample preparation or the use of dyes and stains at diffraction limited spatial resolution (<250nm). However, microscopes cannot readily be used to perform in vivo measurements. With the recent development of flexible fiberscope technology, Raman chemical imaging can be applied within remote and confined environments and the potential exists for in vivo use. This manuscript provides the first description of novel Raman chemical imaging fiberscope technology, including data analysis strategies for extracting information from Raman chemical imaging data sets.
C1 Chemicon Inc, Pittsburgh, PA 15208 USA.
RP Smith, RD (reprint author), Chemicon Inc, Pittsburgh, PA 15208 USA.
CR Morris HR, 1999, LANGMUIR, V15, P2961, DOI 10.1021/la980653h
   Morris HR, 1996, APPL SPECTROSC, V50, P805, DOI 10.1366/0003702963905655
   Schaeberle MD, 1999, ANAL CHEM, V71, p175A, DOI 10.1021/ac990251u
   ZUGATES CT, 1999, INTERNET J VIB SPECT, V2
NR 4
TC 28
Z9 28
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 1017-2661
BN 0-8194-3536-8
J9 PROG BIOM O
PY 2000
VL 1
BP 14
EP 20
DI 10.1117/12.379593
PG 7
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BP87U
UT WOS:000086469300002
DA 2018-10-19
ER

PT J
AU Paul, W
   Sharma, CP
AF Paul, W
   Sharma, CP
TI Chitosan, a drug carrier for the 21st century: a review
SO STP PHARMA SCIENCES
LA English
DT Review
DE chitosan; toxicity; drug delivery; pharmaceutics; microspheres; films;
   gels; implants; transdermal delivery systems; nasal administration;
   ocular administration
ID IN-VITRO EVALUATION; CISPLATIN ALBUMIN MICROSPHERES; PREDNISOLONE
   SODIUM-PHOSPHATE; SUSTAINED-RELEASE FORMULATION; DIRECTLY COMPRESSED
   TABLETS; MOLECULAR-WEIGHT CHITOSAN; EHRLICH ASCITES-CARCINOMA; POORLY
   ABSORBABLE DRUGS; NASAL DELIVERY SYSTEM; ALGINATE GEL BEADS
AB Chitosan, a polysaccharide with structural characteristics similar to glycosamino glycan, was studied for various biomedical applications including membranes in hemodialysis, artificial skin or bioactive wound dressings, as an excipient in drug delivery systems as a matrix in perfusion columns and as a material possessing hemostatic potential to promote nerve growth. Chitosan is, in fact, prescribed for obesity since it is an excellent fat binder. With these multiple applications, chitosan - a biodegradable and naturally available material - will emerge as a household name and as an important biomedical material of the 21(st) century. In this paper, we aim to present the various drug delivery applications of this interesting biopolymer.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Thiruvananthapuram 695012, Kerala, India.
RP Sharma, CP (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Biosurface Technol, Thiruvananthapuram 695012, Kerala, India.
RI Paul, Willi/D-2438-2009; Sharma, Chandra/A-4140-2009
OI Paul, Willi/0000-0002-0398-4258; Sharma, Chandra/0000-0002-6982-0926
CR ACARTURK F, 1993, PHARMAZIE, V48, P605
   ACARTURK F, 1989, PHARMAZIE, V44, P547
   ACARTURK F, 1993, STP PHARMA SCI, V3, P369
   Acikgoz M, 1996, J MICROENCAPSUL, V13, P141, DOI 10.3109/02652049609052903
   Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   AKBUGA J, 1994, INT J PHARM, V111, P217, DOI 10.1016/0378-5173(94)90344-1
   Akbuga J, 1996, J MICROENCAPSUL, V13, P161, DOI 10.3109/02652049609052904
   Al-Helw AA, 1998, J MICROENCAPSUL, V15, P373, DOI 10.3109/02652049809006864
   ALAMELU S, 1991, J MICROENCAPSUL, V8, P505, DOI 10.3109/02652049109021874
   ALEXAKIS T, 1995, APPL BIOCHEM BIOTECH, V50, P93, DOI 10.1007/BF02788043
   ALONSO FMJ, 1997, Patent No. 0771566
   ALONSO MJ, 1998, Patent No. 0860166
   ARAI K, 1968, B TOKAI REGIONAL FIS, V56, P89
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   ASPDEN TJ, 1995, P 22 INT S CONTR REL, P550
   Bayomi M A, 1998, Pharm Acta Helv, V73, P187, DOI 10.1016/S0031-6865(98)00020-X
   BEENA MS, 1995, ARTIF CELL BLOOD SUB, V23, P175, DOI 10.3109/10731199509117937
   BENNY KJ, 1993, THESIS U KERALA
   Bernkop-Schnurch A, 1998, J DRUG TARGET, V6, P207, DOI 10.3109/10611869808997895
   Bernkop-Schnurch A, 1998, PHARMACEUT RES, V15, P263, DOI 10.1023/A:1011970703087
   Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3
   Bernkop-Schnurch A, 1998, J PHARM SCI, V87, P430, DOI 10.1021/js970410u
   Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   BLOCK LH, 1998, Patent No. 5830883
   BODMEIER R, 1989, PHARMACEUT RES, V6, P413, DOI 10.1023/A:1015987516796
   Braconnot H., 1811, ANN CHIM PHYS, V79, P265
   Bugamelli F, 1998, ARCH PHARM, V331, P133, DOI 10.1002/(SICI)1521-4184(199804)331:4<133::AID-ARDP133>3.0.CO;2-H
   Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225
   CALVO P, 1997, COLLOID POLY SCI, V275, P45
   CALVO P, 1998, P 2 WORLD M APGI APV, P111
   *CENTR DRUG RES I, 1998, 73602 CDRI
   Chanda J, 1996, BIOMATERIALS, V17, P1087, DOI 10.1016/0142-9612(96)85909-6
   CHANDY T, 1991, BIOMAT ARTIF CELL IM, V19, P745, DOI 10.3109/10731199109117852
   Chandy T, 1996, BIOMATERIALS, V17, P577, DOI 10.1016/0142-9612(96)88708-4
   CHANDY T, 1992, BIOMATERIALS, V13, P949, DOI 10.1016/0142-9612(92)90119-9
   CHANDY T, 1993, BIOMATERIALS, V14, P939, DOI 10.1016/0142-9612(93)90136-P
   Chandy T, 1996, BIOMATERIALS, V17, P61, DOI 10.1016/0142-9612(96)80756-3
   CHANDY T, 1993, BIOMATER LIVING SYST, V1, P163
   CHANDY T, 1990, BIOMATER ARTIF CELLS, V8, P1
   CHEIN YW, 1983, DRUG DEV IND PHARM, V9, P1291
   Dangprasirt P, 1998, DRUG DEV IND PHARM, V24, P947, DOI 10.3109/03639049809097274
   Dumitriu S., 1997, US Patent, Patent No. 5620706
   El Fattah EA, 1998, DRUG DEV IND PHARM, V24, P541
   El-Samaligy MS, 1996, DRUG DELIV, V3, P93
   Elcin YM, 1996, ARTIF CELL BLOOD SUB, V24, P257, DOI 10.3109/10731199609117438
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   FilipovicGrcic J, 1996, INT J PHARM, V135, P183, DOI 10.1016/0378-5173(96)04470-5
   FRIEDMAN D, 1998, Patent No. 5744155
   GENTA I, 1995, STP PHARMA SCI, V5, P202
   Genta I, 1997, J PHARM PHARMACOL, V49, P737, DOI 10.1111/j.2042-7158.1997.tb06103.x
   Genta I, 1998, DRUG DEV IND PHARM, V24, P779, DOI 10.3109/03639049809082726
   GENTA I, 1996, P 23 INT S CONTR REL, P135
   Giunchedi P, 1998, BIOMATERIALS, V19, P157, DOI 10.1016/S0142-9612(97)00181-6
   GOSCONDA SR, 1993, DRUG DEV IND PHARM, V19, P915
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   Hari PR, 1996, J APPL POLYM SCI, V59, P1795
   HASSAN EE, 1992, PHARMACEUT RES, V9, P390, DOI 10.1023/A:1015803321609
   Hassan EE, 1993, J DRUG TARGET, V1, P7, DOI 10.3109/10611869308998759
   Henriksen I, 1996, INT J PHARM, V145, P231, DOI 10.1016/S0378-5173(96)04776-X
   HILLYARD IW, 1964, P SOC EXP BIOL MED, V115, P1108
   Hoppe-Seiler F., 1994, BER DTSCH CHEM GES, V27, P3329
   HOU WM, 1985, CHEM PHARM BULL, V33, P3986
   Huang RG, 1999, PHARM DEV TECHNOL, V4, P107, DOI 10.1081/PDT-100101345
   Ichikawa H, 1993, Drug Des Discov, V10, P343
   Illum L, 1996, BIOPHARM DRUG DISPOS, V17, P717, DOI 10.1002/(SICI)1099-081X(199611)17:8<717::AID-BDD985>3.0.CO;2-I
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   ILLUM L, 1998, Patent No. 5744166
   Inouye K, 1988, Drug Des Deliv, V2, P165
   Inouye K, 1987, Drug Des Deliv, V1, P297
   Inouye K, 1989, Drug Des Deliv, V4, P55
   Jabbal-Gill I, 1998, VACCINE, V16, P2039, DOI 10.1016/S0264-410X(98)00077-2
   JAMEELA SR, 1994, J BIOMAT SCI-POLYM E, V6, P621, DOI 10.1163/156856294X00563
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4
   Jameela SR, 1996, J PHARM PHARMACOL, V48, P685, DOI 10.1111/j.2042-7158.1996.tb03951.x
   Jing SB, 1997, J PHARM PHARMACOL, V49, P721, DOI 10.1111/j.2042-7158.1997.tb06099.x
   JOHN J, 1994, THESIS U KERALA
   Johnson JD, 1995, TRENDS CARBOHYDRATE, P133
   KANKE M, 1989, CHEM PHARM BULL, V37, P523
   KAWASHIMA Y, 1985, CHEM PHARM BULL, V33, P2107
   KAWASHIMA Y, 1985, CHEM PHARM BULL, V33, P2469
   KAWASHIMA Y, 1985, J PHARM SCI, V74, P264, DOI 10.1002/jps.2600740308
   KAWASHIMA Y, 1983, J PHARM SCI, V72, P514, DOI 10.1002/jps.2600720509
   KIM JH, 1992, J APPL POLYM SCI, V44, P1823, DOI 10.1002/app.1992.070441015
   KNAPCZYK J, 1989, CHITIN CHITOSAN SOUR, P757
   Knapczyk J., 1989, CHITIN CHITOSAN SOUR, P665
   Kotze AF, 1999, J PHARM SCI, V88, P253, DOI 10.1021/js980233c
   Kuribayashi R, 1996, ARTIF ORGANS, V20, P761, DOI 10.1111/j.1525-1594.1996.tb04537.x
   Lee BJ, 1998, J MICROENCAPSUL, V15, P775, DOI 10.3109/02652049809008260
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   LEE YC, 1990, POLLIMO, V14, P342
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Li Y., 1991, STP PHARMA SCI, V1, P363
   LIN SY, 1992, STP PHARMA SCI, V2, P500
   LIU LS, 1995, P 22 INT S CONTR REL, P542
   LIU X J, 1991, Yaoxue Xuebao, V26, P782
   Lorenz D. H., 1995, US Patent, Patent No. [5,420,197, 5420197]
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   LYMAN DJ, 1971, FED PROC, V30, P658
   Machida Y, 1986, Drug Des Deliv, V1, P119
   MACHIDA Y, 1993, YAKUGAKU ZASSHI, V113, P356, DOI 10.1248/yakushi1947.113.5_356
   Macleod GS, 1999, J CONTROL RELEASE, V58, P303, DOI 10.1016/S0168-3659(98)00168-0
   Maysinger D, 1996, EXP NEUROL, V141, P47, DOI 10.1006/exnr.1996.0138
   MCCURDY JD, 1992, ADVANCES IN CHITIN AND CHITOSAN, P659
   Mi FL, 1997, J MICROENCAPSUL, V14, P577, DOI 10.3109/02652049709006811
   Miekka SI, 1998, HAEMOPHILIA, V4, P436, DOI 10.1046/j.1365-2516.1998.440436.x
   MITTAL S, 1994, NEUROREPORT, V5, P2577, DOI 10.1097/00001756-199412000-00043
   MIURA T, 1995, BIOL PHARM BULL, V18, P1623
   Miwa A, 1998, PHARMACEUT RES, V15, P1844, DOI 10.1023/A:1011901921995
   MIYAZAKI S, 1988, J PHARM PHARMACOL, V40, P642, DOI 10.1111/j.2042-7158.1988.tb05325.x
   MIYAZAKI S, 1981, CHEM PHARM BULL, V29, P3067
   MIYAZAKI S, 1995, INT J PHARM, V118, P257, DOI 10.1016/0378-5173(94)00396-M
   MIYAZAKI S, 1988, CHEM PHARM BULL, V36, P4033
   MIYAZAKI S, 1994, BIOL PHARM BULL, V17, P745
   MIYAZAKI S, 1990, ACTA PHARM NORDICA, V2, P401
   Miyazaki T, 1990, EISEI SHIKENJO HOKOK, V108, P95
   Mooren FC, 1998, PHARMACEUT RES, V15, P58, DOI 10.1023/A:1011996619500
   MURATA Y, 1993, INT J PHARM, V96, P139, DOI 10.1016/0378-5173(93)90221-Z
   Murata Y, 1996, J CONTROL RELEASE, V38, P101, DOI 10.1016/0168-3659(95)00098-4
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Muzzarelli R.A.A., 1977, CHITIN, P45
   Nagai T., 1984, CHITIN CHITOSAN RELA, P21
   Needleman IG, 1997, J CLIN PERIODONTOL, V24, P394, DOI 10.1111/j.1600-051X.1997.tb00203.x
   Needleman IG, 1998, J CLIN PERIODONTOL, V25, P74, DOI 10.1111/j.1600-051X.1998.tb02366.x
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   NISHIOKA Y, 1992, CHEM PHARM BULL, V40, P267, DOI 10.1248/cpb.40.267
   NISHIOKA Y, 1989, CHEM PHARM BULL, V37, P3074
   NISHIOKA Y, 1990, CHEM PHARM BULL, V38, P2871, DOI 10.1248/cpb.38.2871
   Ohe T, 1996, SCI TOTAL ENVIRON, V181, P1, DOI 10.1016/0048-9697(95)04949-5
   OHYA Y, 1993, J MICROENCAPSUL, V10, P1, DOI 10.3109/02652049309015307
   Okhamafe AO, 1996, J MICROENCAPSUL, V13, P497, DOI 10.3109/02652049609026035
   Ormrod DJ, 1998, ATHEROSCLEROSIS, V138, P329, DOI 10.1016/S0021-9150(98)00045-8
   OUCHI T, 1989, MAKROMOL CHEM, V190, P1817
   OUCHI T, 1988, T SOC BIOMED, V11, P232
   Patashnik S, 1997, J DRUG TARGET, V4, P371, DOI 10.3109/10611869709017894
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   Paul W, 1995, J MATER SCI LETT, V14, P1792, DOI 10.1007/BF00271009
   PAVANETTO F, 1995, P 10 INT S MICR AUST, P49
   POLK A, 1984, J PHARM SCI, V83, P178
   Ramdas M, 1999, J BIOMATER APPL, V13, P290, DOI 10.1177/088532829901300402
   RAMDAS M, 1999, P INT C POL 99 IIT D, P835
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Remunan-Lopez C, 1998, J CONTROL RELEASE, V55, P143, DOI 10.1016/S0168-3659(98)00044-3
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   ROBERTS G. A. F, 1992, CHITIN CHEM, V1st, P1
   Rouget C., 1859, CR HEBD ACAD SCI, V48, P792
   Roy K, 1999, NAT MED, V5, P387
   SABINIS S, 1997, PHARM DEV TECHNOL, V2, P243
   SAVAGE P, 1995, CHITIN KEY LOW COST
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4216
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4213
   SAWAYANAGI Y, 1983, CHEM PHARM BULL, V31, P2507
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P3297
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P2935
   Sawayanagi Y, 1983, CHEM PHARM BULL, V31, P2062, DOI [10.1248/cpb.31.2064, DOI 10.1248/CPB.31.2064]
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4454
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   SEZER AD, 1995, INT J PHARM, V121, P113, DOI 10.1016/0378-5173(94)00413-Y
   SEZERA D, 1999, J MICROENCAPSUL, V16, P195
   SHETH PR, 1984, DRUG DEV IND PHARM, V10, P313, DOI 10.3109/03639048409064653
   SHIRAISHI S, 1990, CHEM PHARM BULL, V38, P185
   SHIRAISHI S, 1993, J CONTROL RELEASE, V25, P217, DOI 10.1016/0168-3659(93)90080-O
   Singh UV, 1998, J MICROENCAPSUL, V15, P581, DOI 10.3109/02652049809008242
   Skaugrud Oyvind, 1995, P96
   Soane RJ, 1999, INT J PHARM, V178, P55, DOI 10.1016/S0378-5173(98)00367-6
   Song YH, 1996, J CONTROL RELEASE, V42, P93, DOI 10.1016/0168-3659(96)01372-7
   Sugimoto K, 1998, BIOL PHARM BULL, V21, P1202
   Szymonowicz M, 1997, Polim Med, V27, P17
   TAKAYAMA K, 1990, CHEM PHARM BULL, V38, P1993
   TAKEUCHI H, 1994, CHEM PHARM BULL, V42, P1954
   Takeuchi H, 1996, PHARMACEUT RES, V13, P896, DOI 10.1023/A:1016009313548
   Tanaka Y, 1997, BIOMATERIALS, V18, P591, DOI 10.1016/S0142-9612(96)00182-2
   Tasker RAR, 1997, J VET PHARMACOL THER, V20, P362, DOI 10.1046/j.1365-2885.1997.00072.x
   Tasker RAR, 1998, LAB ANIM, V32, P270, DOI 10.1258/002367798780559220
   THACHARODI D, 1995, BIOMATERIALS, V16, P145, DOI 10.1016/0142-9612(95)98278-M
   THACHARODI D, 1993, J CHEM TECHNOL BIOT, V58, P177
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   THANOO BC, 1992, J PHARM PHARMACOL, V44, P283, DOI 10.1111/j.2042-7158.1992.tb03607.x
   Tian XX, 1999, J PHARM PHARMACOL, V51, P151, DOI 10.1211/0022357991772268
   Torzsas TL, 1996, FOOD CHEM TOXICOL, V34, P73, DOI 10.1016/0278-6915(95)00083-6
   Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g
   Uchegbu IF, 1998, J PHARM PHARMACOL, V50, P453, DOI 10.1111/j.2042-7158.1998.tb06185.x
   Vasudev SC, 1997, BIOMATERIALS, V18, P375, DOI 10.1016/S0142-9612(96)00131-7
   VURAL I, 1991, CHIMICAOGGI, V9, P49
   WAN LSC, 1994, STP PHARMA SCI, V4, P195
   Wang Y. M., 1995, Yaoxue Xuebao, V30, P891
   Watts PJ, 1998, Drug delivery composition containing chitosan or derivative thereof having a defined z. potential, Patent No. [US5840341, 5840341]
   Yagi M, 1998, NEPHRON, V78, P433, DOI 10.1159/000044973
   YAMOTA C, 1994, YAKUGAKU ZASSHI, V114, P257
   Yao T, 1997, CHEM PHARM BULL, V45, P1510
   ZHANG Y, 1997, CHUNG KUO HSIU FU CH, V11, P309
   1996, Patent No. 5554388
NR 198
TC 229
Z9 241
U1 0
U2 53
PU EDITIONS SANTE
PI PARIS
PA 47 RUE GALILEE, 75116 PARIS, FRANCE
SN 1157-1489
J9 STP PHARMA SCI
JI STP Pharma Sci.
PD JAN-FEB
PY 2000
VL 10
IS 1
BP 5
EP 22
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 294CC
UT WOS:000085891500001
DA 2018-10-19
ER

PT S
AU Afanasyeva, N
   Kolyakov, S
   Bruch, R
   Gummuluri, S
AF Afanasyeva, N
   Kolyakov, S
   Bruch, R
   Gummuluri, S
BE Nguyen, C
TI Biomedical, environmental and industrial application of fiberoptical
   infrared spectroscopy
SO SUBSURFACE SENSING TECHNOLOGIES AND APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 2nd International Conference on Subsurface Sensing Technologies and
   Applications
CY JUL 31-AUG 03, 2000
CL SAN DIEGO, CA
SP SPIE
DE infrared interferometry; fiber optics; noninvasive in vivo diagnostics;
   medicine; environment; and industry
ID FEW-FTIR SPECTROSCOPY; EVANESCENT-WAVE SPECTROSCOPY; BREAST-CANCER
   TISSUES; DIAGNOSTICS IN-VIVO; STRUCTURAL-ANALYSIS; POLYMER SURFACES;
   LIVING TISSUE; DNA; CHEMICALS; MODELS
AB An advanced infrared (IR) interferometric method using fiber optics has been developed for biomedical, environmental and industrial applications. The fiberoptic Evanescent Wave Fourier Transform Infrared (FEW-FTIR) spectroscopy method has been applied to diagnostics of numerous materials including living tissue without sample preparation. This highly sensitive diagnostics tool can conduct surface and subsurface analysis at the molecular level on such diverse materials as human tissue and body fluids, plants, soil, rocks, chemicals, oil, paper and polymers nondestructively, noninvasively in vivo. Operating in the attenuated total reflection (ATR) regime in the middle-infrared (MIR) range, the FEW-FTIR technique provides direct contact between the fiber probe and any surface. Our fiber optical spectroscopic device is compact, portable for any application and operates upto a distance of three meters with extremely low loss and nontoxic fibers. This method allows the detection of functional chemical groups and bonds directly from a surface by soft touching of a surface for 15sec. Applications of this method include (i) early diagnostics of precancerous conditions and other diseases, (ii) sun, laser radiation and the influence of other environmental factors (water, pollution and weather). (iii) quality control during manufacturing processes, in process analysis.
C1 Univ Nevada, Dept Phys, Reno, NV 89557 USA.
RP Afanasyeva, N (reprint author), Univ Nevada, Dept Phys, Reno, NV 89557 USA.
CR Afanasyeva N, 1999, P SOC PHOTO-OPT INS, V3752, P90, DOI 10.1117/12.365688
   AFANASYEVA N, 1995, MACROMOL SYMP, V94, P269, DOI 10.1002/masy.19950940124
   Afanasyeva N, 1999, P SOC PHOTO-OPT INS, V3596, P152, DOI 10.1117/12.346712
   Afanasyeva NI, 1999, SURF INTERFACE ANAL, V27, P204, DOI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
   Afanasyeva NI, 1999, MACROMOL SYMP, V141, P117, DOI 10.1002/masy.19991410112
   Afanasyeva NI, 1999, P SOC PHOTO-OPT INS, V3590, P472, DOI 10.1117/12.351003
   Afanasyeva NI, 1996, P SOC PHOTO-OPT INS, V2928, P154, DOI 10.1117/12.259954
   Afanasyeva NI, 1997, P SOC PHOTO-OPT INS, V2979, P478, DOI 10.1117/12.280279
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3250, P140, DOI 10.1117/12.305383
   Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3257, P260, DOI 10.1117/12.306092
   AFANASYEVA NI, 1997, P SOC PHOTO-OPT INS, V3195, P314
   AFANASYEVA NI, 1994, SPIE, V2089, P354
   AFANESYEVA NI, 1999, MACR S, V119, P207
   ARTJUSHENKO VG, 1994, P SOC PHOTO-OPT INS, V2321, P758
   Bellamy L. J., 1980, INFRARED SPECTRA COM
   Bormashenko E, 1999, P SOC PHOTO-OPT INS, V3570, P100, DOI 10.1117/12.336947
   Brooks A, 1999, SURF INTERFACE ANAL, V27, P221, DOI 10.1002/(SICI)1096-9918(199904)27:4<221::AID-SIA547>3.0.CO;2-V
   Brooks A, 1999, P SOC PHOTO-OPT INS, V3596, P140, DOI 10.1117/12.346711
   Coates J, 2000, SPECTROSCOPY, V15, P19
   Eytan O, 1999, P SOC PHOTO-OPT INS, V3596, P74, DOI 10.1117/12.346718
   Harrick N. J, 1967, INTERNAL REFLECTION
   KRIMM S, 1987, VIB SPECTRA STRUCT, V16, P1
   LIPPINCOTT E, 1961, ANAL CHEM, V33, P137, DOI 10.1021/ac60169a044
   Malins DC, 1997, NAT MED, V3, P927, DOI 10.1038/nm0897-927
   Malins DC, 1997, P NATL ACAD SCI USA, V94, P3611, DOI 10.1073/pnas.94.8.3611
   MALINS DC, 1994, P NATL ACAD SCI USA, V91, P13038, DOI 10.1073/pnas.91.26.13038
   MANTSH H, 1996, INFRARED SPECTROSCOP, pCH11
   Marechal Y., 1987, Vibrational spectra and structure. A series of Advances. Vol.16, P311
   Nakamoto K., 1997, INFRARED RAMAN SPECT
   Nakanishi K., 1997, INFRARED ABSORPTION
   PARKER FS, 1971, INFRARED SPECTROSCOP
   Ryland S.G., 1995, PRACTICAL GUIDE INFR
   STARK PB, 1993, APPL SPECTROSC, V47, P1820, DOI 10.1366/0003702934066163
   Weiner S., 1990, SPECTROSCOPY, V5, P46
NR 34
TC 1
Z9 1
U1 3
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3774-3
J9 P SOC PHOTO-OPT INS
PY 2000
VL 4129
BP 272
EP 283
DI 10.1117/12.390624
PG 12
WC Instruments & Instrumentation; Optics; Spectroscopy
SC Instruments & Instrumentation; Optics; Spectroscopy
GA BR51N
UT WOS:000166690700028
DA 2018-10-19
ER

PT J
AU van der Mei, HC
   de Vries, J
   Busscher, HJ
AF van der Mei, HC
   de Vries, J
   Busscher, HJ
TI X-ray photoelectron spectroscopy for the study of microbial cell
   surfaces
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; GRAM-POSITIVE BACTERIA;
   SACCHAROMYCES-CEREVISIAE; ORAL STREPTOCOCCI; ESCHERICHIA-COLI;
   YEAST-CELLS; ELEMENTAL COMPOSITION; BIOCHEMICAL-ANALYSIS; CULTURE
   CONDITIONS; VOICE PROSTHESES
AB X-ray photoelectron spectroscopy (XPS) is well known for the characterisation of material surfaces, but at first glance, is an unexpected technique to study the composition of microbial cell surfaces. Despite the fact that intimate contact between materials and microbial cell surfaces occurs in many situations, such as on oil-platforms, in water pipelines and bioreactors or on biomedical implants, XPS studies on the composition of microbial cell surfaces are less known, but equally relevant. In this review, microbial sample preparations are discussed, as well as relationships between microbial compositions using XPS. Biochemical and physical properties, such as microbial cell surface charge and hydrophobicity are also discussed. A reference guide, giving the overall cell surface composition of 210 strains determined by XPS, as collected from the literature is given. Hierarchical cluster analysis on these data reveals interesting new insights on staphylococcal cell surfaces, as well as a distinction between staphylococci, yeasts and other microorganisms. It is concluded that XPS on microbial cell surfaces yields useful information, complementing other biochemical and physical cell surface characterisations. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AMORY DE, 1988, BIOCHIM BIOPHYS ACTA, V938, P61, DOI 10.1016/0005-2736(88)90122-8
   AMORY DE, 1988, SURF INTERFACE ANAL, V11, P478, DOI 10.1002/sia.740110904
   AMORY DE, 1988, FEMS MICROBIOL LETT, V49, P107, DOI 10.1016/0378-1097(88)90110-3
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   Bos R, 1996, COLLOID SURFACE B, V7, P101, DOI 10.1016/0927-7765(96)01293-3
   BOTT TR, 1992, APPL SCI, V223, P3
   BRUNETT JH, 1968, FUNDAMENTALS MYCOLOG
   BUCHS J, 1988, APPL MICROBIOL BIOT, V29, P119
   BUSSCHER HJ, 1994, COLLOID SURFACE B, V2, P73, DOI 10.1016/0927-7765(94)80020-0
   BUSSCHER HJ, 1990, J MICROBIOL METH, V12, P101, DOI 10.1016/0167-7012(90)90020-7
   BUSSCHER HJ, 1995, COLLOID SURFACE B, V5, P111, DOI 10.1016/0927-7765(95)01224-7
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUSSCHER HJ, 1991, MICROBIAL CELL SURFA
   CAPDEVILLE B, 1992, APPL SCI, V223, P13
   COWAN MM, 1992, J GEN MICROBIOL, V138, P2707, DOI 10.1099/00221287-138-12-2707
   COWAN MM, 1992, APPL ENVIRON MICROB, V58, P1326
   CUPERUS PL, 1992, CELL MATER, V2, P271
   CUPERUS PL, 1993, J COLLOID INTERF SCI, V156, P319, DOI 10.1006/jcis.1993.1118
   CUPERUS PL, 1995, MICROBIOS, V82, P49
   DENGIS PB, 1995, COLLOID SURFACE B, V4, P199, DOI 10.1016/0927-7765(94)01171-Z
   Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8
   Dengis PB, 1997, YEAST, V13, P931, DOI 10.1002/(SICI)1097-0061(199708)13:10<931::AID-YEA149>3.0.CO;2-T
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   DILLON JK, 1986, J MICROBIOL METH, V6, P13, DOI 10.1016/0167-7012(86)90027-8
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P271, DOI 10.1016/0927-7765(96)01295-7
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   GEERTSEMADOORNBUSCH GI, 1993, J MICROBIOL METH, V18, P61, DOI 10.1016/0167-7012(93)90072-P
   GOLDMANN DA, 1993, CLIN MICROBIOL REV, V6, P176
   GRISTINA AG, 1989, MOL MECHANISMS MICRO
   Hammond S.M., 1984, BACTERIAL CELL SURFA
   Harkes G, 1992, Cell Biophys, V20, P17, DOI 10.1007/BF02782652
   HEDMAN P, 1991, J INFECTION, V23, P145, DOI 10.1016/0163-4453(91)92045-7
   HERBEN PFG, 1990, BIOCHIM BIOPHYS ACTA, V1033, P184, DOI 10.1016/0304-4165(90)90010-T
   JAMES AM, 1991, MICROBIAL CELL SURFA
   JONSSON P, 1983, CURR MICROBIOL, V8, P347
   Kiely LJ, 1997, COLLOID SURFACE B, V9, P297, DOI 10.1016/S0927-7765(97)00037-4
   Lalande M., 1989, Biofouling, V1, P233
   LATRACHE H, 1994, COLLOID SURFACE B, V2, P47, DOI 10.1016/0927-7765(94)80017-0
   LINDAHL M, 1981, BIOCHIM BIOPHYS ACTA, V677, P471, DOI 10.1016/0304-4165(81)90261-0
   Lynch J.L., 1988, Biofouling, V1, P147
   Marsh P, 1992, ORAL MICROBIOLOGY
   MARSHALL KC, 1994, COLLOID SURFACE B, V2, P371, DOI 10.1016/0927-7765(94)80050-2
   MARTIN AH, 1992, APPL SCI, V223, P461
   Matsumura M, 1997, J FERMENT BIOENG, V84, P144, DOI 10.1016/S0922-338X(97)82544-5
   MEDRZYCKA KB, 1991, COLLOID POLYM SCI, V269, P85, DOI 10.1007/BF00654663
   MILLARD MM, 1977, ANAL CHEM, V49, P1290, DOI 10.1021/ac50017a004
   Millsap KW, 1997, CAN J MICROBIOL, V43, P284, DOI 10.1139/m97-039
   MIORNER H, 1982, INFECT IMMUN, V36, P227
   MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6
   MOZES N, 1989, COLLOID SURFACE, V42, P313
   MOZES N, 1995, MICROBIOL-SGM, V141, P11, DOI 10.1099/00221287-141-1-11
   MOZES N, 1987, J MICROBIOL METH, V6, P99, DOI 10.1016/0167-7012(87)90058-3
   MOZES N, 1994, COLLOID SURFACE B, V3, P63
   NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V
   NICKEL JC, 1989, UROLOGY, V34, P284
   NODA Y, 1986, J BACTERIOL, V167, P1016, DOI 10.1128/jb.167.3.1016-1019.1986
   NORDSTROM KM, 1994, COLLOID SURFACE B, V2, P67, DOI 10.1016/0927-7765(94)80019-7
   Richmond M.D., 1991, Biofouling, V3, P151
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   ROUXHET PG, 1994, COLLOID SURFACE B, V2, P347, DOI 10.1016/0927-7765(94)80049-9
   Schakenraad J M, 1992, Cell Biophys, V20, P57, DOI 10.1007/BF02782654
   SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263
   STRAVER MH, 1994, COLLOID SURFACE B, V2, P173, DOI 10.1016/0927-7765(94)80032-4
   TENBOSCH JJ, 1991, BIOFOULING, V4, P141
   TIMPERLEY DA, 1992, APPL SCI, V223, P379
   TYBUSSEK R, 1994, APPL MICROBIOL BIOT, V41, P13, DOI 10.1007/s002530050100
   van der Mei H C, 1997, Adv Dent Res, V11, P388
   van der Mei H C, 1992, Cell Biophys, V20, P99
   van der Mei HC, 1997, MICROBIOL-UK, V143, P3861, DOI 10.1099/00221287-143-12-3861
   VANDERMEI HC, 1991, CURR MICROBIOL, V23, P337, DOI 10.1007/BF02104136
   VANDERMEI HC, 1989, BIOCHIM BIOPHYS ACTA, V991, P395, DOI 10.1016/0304-4165(89)90063-9
   VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404
   VANDERMEI HC, 1989, ARCH ORAL BIOL, V34, P889, DOI 10.1016/0003-9969(89)90146-5
   VANDERMEI HC, 1988, COLLOID SURFACE, V32, P297, DOI 10.1016/0166-6622(88)80024-6
   vanderMei HC, 1996, EUR J ORAL SCI, V104, P48
   VANDERMEI HC, 1988, J BACTERIOL, V170, P2462, DOI 10.1128/jb.170.6.2462-2466.1988
   VANDERMEI HC, 1989, APPL ENVIRON MICROB, V55, P2806
   VANDERMEI HC, 1992, CAN J MICROBIOL, V38, P1033
   VANDERMEI HC, 1993, APPL ENVIRON MICROB, V59, P4305
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P77
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   Zhong W, 1998, APPL ENVIRON MICROB, V64, P2418
NR 83
TC 25
Z9 25
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 2000
VL 39
IS 1
BP 3
EP 24
PG 22
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 329YR
UT WOS:000087936500001
DA 2018-10-19
ER

PT B
AU El Fray, M
AF El Fray, M
BE Yagci, Y
   Mishra, MK
   Nuyken, O
   Ito, K
   Wnek, G
TI Selection of polymeric materials for biomedical applications
SO TAILORED POLYMERS & APPLICATIONS
LA English
DT Proceedings Paper
CT 3rd International Symposium on Advanced Polymers via Macromolecular
   Engineering
CY JUL 31-AUG 04, 1999
CL WILLIAMSBURG, VA
DE sterilization methods; degradation of polymers; synthetic polyesters
ID DEGRADATION; ADHESION
C1 Tech Univ Szczecin, Dept Chem Fibers & Phys Chem Polymers, PL-70322 Szczecin, Poland.
RP El Fray, M (reprint author), Tech Univ Szczecin, Dept Chem Fibers & Phys Chem Polymers, Pulaskiego Str 10, PL-70322 Szczecin, Poland.
RI El Fray, Miroslawa/J-4128-2016
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BAKKUM EA, 1995, J MATER SCI-MATER M, V6, P41, DOI 10.1007/BF00121246
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   Dawids S. G., 1993, TEST PROCEDURES BLOO
   Domb AJ, 1998, ACTA POLYM, V49, P526, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<526::AID-APOL526>3.0.CO;2-C
   DOMB AJ, 1994, BIOMEDICAL POLYM DES
   DUMITRIU S, 1994, POLYM BIOMATERIALS
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   ELFRAY M, IN PRESS J MAT SCI M
   ELFRAY M, 1998, Patent No. 329794
   Kroschwitz J I, 1989, POLYM BIOMATERIALS M
   Mazurkiewicz S, 1999, POLIMERY-W, V44, P403
   RADDER AM, 1995, J MATER SCI-MATER M, V6, P510, DOI 10.1007/BF00151031
   Schnabel W., 1981, POLYM DEGRADATION PR
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
   VELD PJA, 1982, ADV BIOMATER, V10, P420
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1982, BIOCOMPATIBILITY CLI
   YUI N, 1984, POLYM J, V16, P119, DOI 10.1295/polymj.16.119
   1965, MEILLIAND TEXTILBERI, V9, P1008
NR 22
TC 1
Z9 1
U1 0
U2 0
PU VSP BV-C/O BRILL ACAD PUBL
PI LEIDEN
PA PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
BN 90-6764-326-2
PY 2000
BP 133
EP 138
PG 6
WC Polymer Science
SC Polymer Science
GA BW50N
UT WOS:000182233300010
DA 2018-10-19
ER

PT J
AU Vretzakis, G
   Papaziogas, B
   Matsaridou, E
   Vasiliadou, G
   Papadopoulos, G
   Patsialas, C
   Kostopoulou, F
AF Vretzakis, G
   Papaziogas, B
   Matsaridou, E
   Vasiliadou, G
   Papadopoulos, G
   Patsialas, C
   Kostopoulou, F
TI Continuous monitoring of arterial blood gases and pH during
   intraoperative rapid blood administration using a paratrend sensor
SO VOX SANGUINIS
LA English
DT Article
ID SYSTEM; MODEL
AB Background and Objectives: The aim of this study was to determine the effects of rapid transfusion of packed red cells on the arterial blood gases and acid-base status of the recipient. Materials and Methods: We studied 16 patients (mean age 66.3 +/- 9.9 years) who received rapid transfusion of 632.8 +/- 287.2 g of packed red cells in CPDA-1, stored before use for a period of 15.2 +/- 4.4 days. During transfusion, monitoring of pH, PCO2 and PO2 was continuous using an intra-arterial multiparameter sensor (Paratrend 7, Biomedical Sensors, UK), Results: The rate of the transfusion was 73.1 +/- 9.6 g/min and the duration of observation was 35.8 +/- 12.8 min. Arterial pH decreased from 7.446 +/- 0.023 to 7.385 +/- 0.034 (p < 0.001) and PCO2 increased from 32.31 +/- 1.35 to 36.41 +/- 1.86 mmHg (p<0.001). Delta pH and Delta PCO2 showed significant correlation to the weight and the age of the transfused blood (p<0.001 for both dependent variables). The rate of pH change was positively but insignificantly correlated to the rate of the transfusion. Base excess was significantly decreased and end-tidal CO2 (PetCO(2)) was increased from 25.8 +/- 2.0 to 28.1 +/- 2.3 mmHg (p < 0.05), significantly correlating to the amount and age of the administered component (p < 0.05), PetCO(2) was not elevated when PCO2 changes were minimal. Alterations in PO2 were not specific and our clinical impression was that they were related to unmeasured parameters. Conclusion: Our findings suggest that the fall in pH and the elevation in PCO2 which occur during rapid transfusion of packed red cells may go undetected or be misinterpreted if the acid-base status of the recipient is not monitored continously. These alterations are mainly of metabolic character and depend on the amount and age of the transfused component. Our data suggest that arterial sampling is essential during massive transfusions. Copyright (C) 2000 S. Karger AG, Basel.
C1 G Gennimatas Hosp, Dept Anaesthesiol, Salonika, Greece.
   Aristotelian Univ Salonika, Surg Clin 2, GR-54006 Salonika, Greece.
   Univ Ioannina, Anaesthesiol Clin, GR-45110 Ioannina, Greece.
RP Papaziogas, B (reprint author), Tsimiski St 128, GR-54621 Salonika, Greece.
CR GOOD M, 1990, ANESTHESIOLOGY REFRE
   Ishikawa S, 1998, CAN J ANAESTH, V45, P273, DOI 10.1007/BF03012916
   Miller R., 1986, ANESTHESIA
   Nose Y, 1996, J PAEDIATR CHILD H, V32, P177, DOI 10.1111/j.1440-1754.1996.tb00918.x
   Oropello JM, 1996, CHEST, V109, P1049, DOI 10.1378/chest.109.4.1049
   PALMER TEA, 1995, ANAESTH INTENS CARE, V23, P200
   PENG K, 1994, CHUN HUA HSUEH TSA C, V54, P73
   Roupie EE, 1996, INTENS CARE MED, V22, P1162, DOI 10.1007/BF01709330
   STOCKWELL MA, 1989, ANAESTH INTENS CARE, V17, P482
   VENKATESH B, 1995, RESUSCITATION, V29, P135, DOI 10.1016/0300-9572(95)00834-G
   VENKATESH B, 1994, CRIT CARE MED, V22, P588, DOI 10.1097/00003246-199404000-00013
   VLAHAKES GJ, 1990, J THORAC CARDIOV SUR, V100, P379
   WILSON RF, 1992, AM SURGEON, V58, P535
   Zollinger A, 1997, BRIT J ANAESTH, V79, P47
NR 14
TC 2
Z9 2
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0042-9007
J9 VOX SANG
JI Vox Sang.
PY 2000
VL 78
IS 3
BP 158
EP 163
PG 6
WC Hematology
SC Hematology
GA 314EV
UT WOS:000087043100004
PM 10838516
DA 2018-10-19
ER

PT S
AU Lai, B
   Kemner, KM
   Maser, J
   Schneegurt, MA
   Cai, Z
   Ilinski, PP
   Kulpa, CF
   Legnini, DG
   Nealson, KH
   Pratt, ST
   Rodrigues, W
   Tischler, ML
   Yun, W
AF Lai, B
   Kemner, KM
   Maser, J
   Schneegurt, MA
   Cai, Z
   Ilinski, PP
   Kulpa, CF
   Legnini, DG
   Nealson, KH
   Pratt, ST
   Rodrigues, W
   Tischler, ML
   Yun, W
BE Dunford, RW
   Gemmell, DS
   Kanter, EP
   Krassig, B
   Southworth, SH
   Young, L
TI High-resolution x-ray imaging for microbiology at the Advanced Photon
   Source
SO X-RAY AND INNER-SHELL PROCESSES
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 18th International Conference on X-ray and Inner-Shell Processes
CY AUG 23-27, 1999
CL CHICAGO, IL
SP Argonne Natl Lab, Natl Sci Fdn, Int Union Pure & Appl Phys, Roper Scientific
AB Exciting new applications of high-resolution x-ray imaging have emerged recently due to major advances in high-brilliance synchrotron sources and high-performance zone plate optics. Imaging with submicron resolution is now routine with hard x-rays: we have demonstrated 150 nm in the 6-10 keV range with x-ray microscopes at the Advanced Photon Source (APS), a third-generation synchrotron radiation facility. This has fueled interest in using x-ray imaging in applications ranging from the biomedical, environmental, and materials science fields to the microelectronics industry.
   One important application we have pursued at the APS is a study of the microbiology of bacteria and their associated extracellular material (biofilms) using fluorescence microanalysis. No microscopy techniques were previously available with sufficient resolution to study live bacteria (approximate to 1 mu m x 4 mu m in size) and biofilms in their natural hydrated state with better than part-per-million elemental sensitivity and the capability of determining chemical speciation, In vivo x-ray imaging minimizes artifacts due to sample fixation, drying, and staining. This provides key insights into the transport of metal contaminants by bacteria in the environment and potential new designs for remediation and sequestration strategies.
C1 Argonne Natl Lab, Argonne, IL 60439 USA.
RP Lai, B (reprint author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.
RI Maser, Jorg/K-6817-2013
CR ENG PJ, 1998, SPIE P, V3449, P145
   LAI B, 1992, APPL PHYS LETT, V61, P1877, DOI 10.1063/1.108400
   MACDOWELL A, 1998, SPIE P, V3449, P137
   Yun W, 1998, J SYNCHROTRON RADIAT, V5, P1390, DOI 10.1107/S0909049598007225
   Yun W, 1999, REV SCI INSTRUM, V70, P2238, DOI 10.1063/1.1149744
   1995, MOL ENV SCI SPECIATI
NR 6
TC 3
Z9 3
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 1-56396-713-8
J9 AIP CONF PROC
PY 2000
VL 506
BP 585
EP 589
PG 5
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA BP76A
UT WOS:000086079900045
DA 2018-10-19
ER

PT J
AU Werner, C
   Konig, U
   Augsburg, A
   Arnhold, C
   Korber, H
   Zimmermann, R
   Jacobasch, HJ
AF Werner, C
   Konig, U
   Augsburg, A
   Arnhold, C
   Korber, H
   Zimmermann, R
   Jacobasch, HJ
TI Electrokinetic surface characterization of biomedical polymers - a
   survey
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT Conference on Electrokinetic Phenomena
CY APR 14-17, 1998
CL SLAZBURG, AUSTRIA
SP Minist Sci & Transport, Salzburg, Reg & City, A Paar, BASF, Lenzing, Pall, Zumtobel, OMV
DE streaming potential measurements; biomedical polymers; blood
   compatibility; protein adsorption; surface conductivity
ID STREAMING POTENTIAL MEASUREMENTS; ADSORPTION; MEMBRANES; HEMODIALYSIS;
   KINETICS
AB The application of streaming potential measurements in support of the development of blood compatible polymers is reviewed. Current knowledge about the relevance of interfacial charge of materials with respect to thrombogenicity of and coagulation activation by medical devices is discussed.
   Potentialities of streaming potential measurements for the characterization of biomedical polymers comprise the distinction:between interfacial charge formation processes, the derivation of acid-base characteristics of surface functions, and the estimation of the relative contribution of known molecular surface sites to the interfacial charge density. Frequently, polymer surfaces consist of different types of surface sites. Beyond sites with Bronsted-acidic or -basic character the preferential adsorption of electrolyte ions onto indifferent surface sites may substantially contribute to the interfacial charge. Examples are given for the detection of acidic and basic properties of hemodialysis membranes of different shape made of poly(sulfone)/poly(vinylpyrrolidone) and cellulose derivates. For partially amine-modified cellulose flat membranes the percentage of basic surface sites is derived from the shift of the isoelectric paint.
   Further, the use of streaming potential measurements is demonstrated in the optimization of surface modifications of cardiovascular implant materials by low pressure plasma treatments. The introduction of basic groups into the poly(tetrafluoroethylene) implant surfaces by ammonia plasma treatments manifests itself in the shift of the isoelectric point.
   A correlation between hydrophobicity and charge formation of the polymer-solution interface by preferential ion adsorption is confirmed for polymers without dissociating functions. This is based on the comparison of water contact angles for a series of poly(styrene) derivates of different hydrophobicity and the maximum zeta potential of these polymer films in potassium hydroxide solutions.
   Advanced applications of streaming potential measurements for the characterization of biomedical polymers are comprise the:in situ characterization of protein adsorption processes onto polymer solids. This approach is demonstrated for the adsorption of the blood plasma proteins albumin and fibrinogen onto a fluorocarbon polymer substrate.
   The potentialities of a recently developed microslit electrokinetic setup are illustrated which permits to study simultaneously zeta potential and surface conductivity of flat polymer-liquid interfaces. Data gained by the microslit electrokinetic setup reveal the dramatic increase of the surface conductivity of a fluorocarbon polymer-solution interface caused by fibrinogen adsorption. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Inst Polymerforsch Dresden eV, D-01069 Dresden, Germany.
RP Werner, C (reprint author), Inst Polymerforsch Dresden eV, Hohe Str 6, D-01069 Dresden, Germany.
RI Werner, Carsten/F-8127-2010; Umlauf, Ursula/D-3356-2014
OI Werner, Carsten/0000-0003-0189-3448; 
CR Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   AUGSBURG A, 1998, IN PRESS ACTA POLYM
   BALDAMUS CA, 1990, IMPROVEMENT HEMODIAL
   BAMFORD CH, 1992, VROMAN EFFECT
   BARTHEL M, 1997, GERINNUNGSANALYSEN
   BAUMANN H, 1991, J MEMBRANE SCI, V61, P53
   BONOMI V, 1995, DIALYSIS MEMBRANES S
   Charef S, 1996, BIOMATERIALS, V17, P903, DOI 10.1016/0142-9612(96)83286-8
   CHENOWETH DE, 1987, ARTIF ORGANS, V11, P155, DOI 10.1111/j.1525-1594.1987.tb02649.x
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Dukhin S. S., 1974, SURF COLLOID SCI, V7
   ELGERSMA AV, 1992, COLLOID SURFACE, V65, P17, DOI 10.1016/0166-6622(92)80171-W
   FUERSTENAU DW, 1956, J PHYS CHEM-US, V60, P981, DOI 10.1021/j150541a039
   GALLIN JL, 1992, INFLAMMATION, pCH6
   GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054
   HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P303, DOI 10.1016/0001-8686(78)85002-7
   HINKE E, 1991, J APPL POLYM SCI, V42, P2951, DOI 10.1002/app.1991.070421112
   HUNTER RJ, 1981, ZETA POTENTIAL COLLO, pCH4
   HUNTER RJ, 1981, ZETA POTENTIAL COLLO, pCH7
   Ivanov VB, 1996, SURF INTERFACE ANAL, V24, P257, DOI 10.1002/(SICI)1096-9918(199604)24:4<257::AID-SIA107>3.0.CO;2-1
   Jacobasch H.-J., 1988, PROG COLLOID POLYM S, V77, P40
   Jacobasch H.-J., 1984, OBERFLACHENCHEMIE FA
   JACOBASCH HJ, 1985, COLLOID POLYM SCI, V263, P3, DOI 10.1007/BF01411243
   KONIG U, 1998, UNPUB BIOMATERIALS
   KORBER H, 1993, Patent No. 43312101
   KUEHN N, 1986, ACTA POLYM, V37, P394, DOI 10.1002/actp.1986.010370617
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   LaPorte R J, 1997, HYDROPHILIC POLYM CO
   LYKLEMA J, 1995, FUNDAMENTALS INTERFA, V2, pCH6
   NORDE W, 1990, J COLLOID INTERF SCI, V139, P169, DOI 10.1016/0021-9797(90)90454-V
   NORDE W, 1989, COLLOIDS SURFACE, V41, P1
   NYSTROM M, 1994, J MEMBRANE SCI, V87, P245, DOI 10.1016/0376-7388(94)87031-4
   PEPPAS N, 1995, SCIENCE, V263, P1715
   Put A. V. D., 1983, J COLLOID INTERF SCI, V92, P499
   RAGALLER M, 1998, KIDNEY INT, V53, P84
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Sabbatini L., 1993, SURFACE CHARACTERIZA
   SCHAEFER RM, 1987, BLOOD PURIFICAT, V5, P262, DOI 10.1159/000169475
   SCHULTZE G, 1986, BIOMAT MED EV ARTIF, V15, P195
   Stern O, 1924, Z ELKTROCHEM ANGEW P, V30, P508
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, pCH31
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   VANDENHOVEN TJJ, 1987, COLLOID SURFACE, V22, P187
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Vickerman J. C., 1996, SURFACE ANAL TECHNIQ
   VIENKEN J, 1995, ARTIF ORGANS, V19, P398, DOI 10.1111/j.1525-1594.1995.tb02349.x
   WACHTFOGEL YT, 1993, THROMB RES, V72, P1, DOI 10.1016/0049-3848(93)90168-N
   Weidenhammer P., 1996, POLYM PREPR AM CHEM, V37, P614
   Werner C, 1996, MACROMOL SYMP, V103, P43, DOI 10.1002/masy.19961030107
   Werner C, 1998, J COLLOID INTERF SCI, V208, P329, DOI 10.1006/jcis.1998.5787
   WERNER C, 1995, J BIOMAT SCI-POLYM E, V7, P61, DOI 10.1163/156856295X00832
   WERNER C, 1997, INT J ARTIF ORGANS, V20, P505
   ZEMBALA M, 1994, COLLOID SURFACE B, V3, P119
NR 53
TC 86
Z9 87
U1 2
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD DEC 5
PY 1999
VL 159
IS 2-3
BP 519
EP 529
DI 10.1016/S0927-7757(99)00290-3
PG 11
WC Chemistry, Physical
SC Chemistry
GA 260ZV
UT WOS:000083984100033
DA 2018-10-19
ER

PT J
AU Colombo, P
AF Colombo, P
TI Novel processing of silicon oxycarbide ceramic foams
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID PRECERAMIC POLYMER; POROUS CERAMICS; GLASSES
AB Cellular ceramics are the material of choice in various high temperature technological applications and new applications are now being found in the electronic and biomedical area. Paolo Colombo here describes a new direct foaming approach that allows the production of SiOC foams in a one-step process. Additionally, a great versatility in terms of foam morphology and possible shapes enables the synthesis of materials with tailored composition and properties.
C1 Univ Bologna, Dipartimento Chim Applicata & Sci Mat, I-40136 Bologna, Italy.
RP Colombo, P (reprint author), Univ Bologna, Dipartimento Chim Applicata & Sci Mat, V Risorgimento 2, I-40136 Bologna, Italy.
CR ASHBY MF, 1983, METALL TRANS A, V14, P1755, DOI 10.1007/BF02645546
   Colombo P, 1999, J SOL-GEL SCI TECHN, V14, P103, DOI 10.1023/A:1008736100788
   Colombo P, 1999, J AM CERAM SOC, V82, P573, DOI 10.1111/j.1151-2916.1999.tb01803.x
   FUJIU T, 1990, J AM CERAM SOC, V73, P85, DOI 10.1111/j.1151-2916.1990.tb05095.x
   MINNEAR WP, 1992, CERAMICS T, V26, P149
   Montanaro L, 1998, J EUR CERAM SOC, V18, P1339, DOI 10.1016/S0955-2219(98)00063-6
   Nettleship I, 1996, KEY ENG MATER, V122-1, P305, DOI 10.4028/www.scientific.net/KEM.122-124.305
   Pantano CG, 1999, J SOL-GEL SCI TECHN, V14, P7, DOI 10.1023/A:1008765829012
   RENLUND GM, 1991, J MATER RES, V6, P2723, DOI 10.1557/JMR.1991.2723
   SAGGIOWOYANSKY J, 1992, AM CERAM SOC BULL, V71, P1674
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   SHERMAN AJ, 1991, AM CERAM SOC BULL, V70, P1025
   Tulliani JM, 1999, J AM CERAM SOC, V82, P961, DOI 10.1111/j.1151-2916.1999.tb01860.x
NR 13
TC 10
Z9 11
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD DEC
PY 1999
VL 1
IS 3-4
BP 203
EP 205
DI 10.1002/(SICI)1527-2648(199912)1:3/4<203::AID-ADEM203>3.0.CO;2-M
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 357JM
UT WOS:000089494800019
DA 2018-10-19
ER

PT J
AU Zheng, YP
   Maev, RG
   Solodov, IY
AF Zheng, YP
   Maev, RG
   Solodov, IY
TI Nonlinear acoustic applications for material characterization: A review
SO CANADIAN JOURNAL OF PHYSICS
LA English
DT Review
ID DIAGNOSTIC MEDICAL ULTRASOUND; ZIRCONATE-TITANATE CERAMICS; HIGHER-ORDER
   NONLINEARITY; PULSED WAVE-PROPAGATION; HARMONIC-GENERATION; BIOLOGICAL
   MEDIA; 2ND-HARMONIC GENERATION; BIOMEDICAL FREQUENCIES; CONTACT
   INTERFACE; PRESSURE FIELD
AB The nonlinear acoustic applications for material characterization are reviewed. The general theoretical analysis of the effects of nonlinearity, dissipation, dispersion, and diffraction on intense acoustic-wave propagation is given. Acoustic nonlinear parameters and their determination methods are introduced. The investigations of nonlinear acoustic applications for solid material evaluation are discussed for different levels of disruption, from asymmetry of lattice structure and dislocation in crystals to disbonds and cracks in engineering materials. The experimental methods involved in these investigations are also considered. The techniques used for nonlinear acoustic imaging are divided into two categories, concerned with resolution improvement by using higher harmonics, and nonlinear parametric imaging. The nonlinear acoustic applications in biomedical imaging, acoustic microscopy, and nonlinear nondestructive evaluation are presented. Finally, the issues that need further investigations in this area are discussed.
C1 Univ Windsor, Dept Phys, Ultrason Res Lab, Windsor, ON N9B 3P4, Canada.
   Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119899, Russia.
RP Maev, RG (reprint author), Univ Windsor, Dept Phys, Ultrason Res Lab, Windsor, ON N9B 3P4, Canada.
RI CHEN, Jiangang/A-1549-2011
OI Zheng, Yong-Ping/0000-0002-3407-9226; Solodov, Igor/0000-0002-1361-9780
CR AANONSEN SI, 1984, J ACOUST SOC AM, V75, P749, DOI 10.1121/1.390585
   Achenbach J. D., 1982, J NONDESTRUCT EVAL, V3, P229
   Adler L, 1995, P SOC PHOTO-OPT INS, V2643, P228, DOI 10.1117/12.222748
   ALLISON SG, 1984, P IEEE ULTR S NEW HO, P997
   ARMYAKOV DV, 1998, DEFEKTOSKOPIYA, V12, P34
   ASAINOV AF, 1992, SOV PHYS ACOUST+, V38, P293
   ASAINOV AF, 1993, ACOUST PHYS+, V39, P311
   Baker AC, 1996, J ACOUST SOC AM, V100, P2062, DOI 10.1121/1.417916
   BAKER AC, 1991, PHYS MED BIOL, V36, P1457, DOI 10.1088/0031-9155/36/11/005
   BAKER AC, 1995, J ACOUST SOC AM, V97, P3510, DOI 10.1121/1.412437
   BAKER AC, 1992, J ACOUST SOC AM, V91, P713, DOI 10.1121/1.402533
   BATEMAN T, 1961, J APPL PHYS, V32, P928, DOI 10.1063/1.1736135
   BEYER RT, 1960, J ACOUST SOC AM, V32, P719, DOI 10.1121/1.1908195
   BIRCH F, 1966, HDB PHYSICAL CONSTAN, P97
   BOINOTT GN, 1993, LAUR933839 LOS AL NA, P121
   BREAZEAL.MA, 1965, J APPL PHYS, V36, P3486, DOI 10.1063/1.1703023
   Breazeale M. A., 1981, METHODS EXPT PHYSICS, V19, P67
   BREAZEALE MA, 1963, APPL PHYS LETT, V3, P77, DOI 10.1063/1.1753876
   BRIGGS A., 1992, ACOUSTIC MICROSCOPY
   BRYSEV AP, 1984, FIZ TVERD TELA+, V26, P2104
   BUCK O, 1978, APPL PHYS LETT, V33, P371, DOI 10.1063/1.90399
   BUCK O, 1979, PHYS STATUS SOLIDI A, V55, P223, DOI 10.1002/pssa.2210550125
   CAIN CA, 1986, J ACOUST SOC AM, V80, P28, DOI 10.1121/1.394186
   CANTRELL JH, 1994, PHILOS MAG A, V69, P315, DOI 10.1080/01418619408244346
   Cantrell JH, 1997, J APPL PHYS, V81, P2957, DOI 10.1063/1.364327
   CANTRELL JH, 1994, J APPL PHYS, V76, P3372, DOI 10.1063/1.357463
   CANTRELL JH, 1991, INT MATER REV, V36, P125, DOI 10.1179/imr.1991.36.1.125
   Cantrell JH, 1998, J APPL PHYS, V84, P5469, DOI 10.1063/1.368309
   CANTRELL JH, 1986, P IEEE ULTRASONICS S, P1075
   CARSTENSEN EL, 1980, ULTRASOUND MED BIOL, V6, P359, DOI 10.1016/0301-5629(80)90005-8
   CERVENKA P, 1990, J ACOUST SOC AM, V88, P473, DOI 10.1121/1.399926
   COOK BD, 1961, J ACOUST SOC AM, V33, P832, DOI 10.1121/1.1936786
   DACE GE, 1992, VIBROACOUSTIC CHARAC, V14, P221
   DARVENNES CM, 1990, J ACOUST SOC AM, V87, P1955, DOI 10.1121/1.399322
   DARVENNES CM, 1991, J ACOUST SOC AM, V89, P1028, DOI 10.1121/1.400645
   DU GH, 1987, J ACOUST SOC AM, V81, P51, DOI 10.1121/1.394932
   DU GH, 1986, J ACOUST SOC AM, V80, P212, DOI 10.1121/1.394166
   ERMILIN KK, 1974, PHYS MAT, V38, P880
   Fassbender SU, 1996, MATER SCI FORUM, V210-2, P783, DOI 10.4028/www.scientific.net/MSF.210-213.783
   Field EH, 1997, NATURE, V390, P599, DOI 10.1038/37586
   GARRETT GS, 1983, J ACOUST SOC AM, V74, P1013, DOI 10.1121/1.389933
   GEDROITS AA, 1963, DOKL AKAD NAUK SSSR+, V150, P515
   GEDROITS AA, 1963, SOV PHYS JETP-USSR, V16, P1122
   GERLICH D, 1988, J APPL PHYS, V63, P5712, DOI 10.1063/1.340308
   GERMAIN L, 1989, J ACOUST SOC AM, V86, P1560, DOI 10.1121/1.398716
   GERMAIN L, 1988, J ACOUST SOC AM, V83, P942, DOI 10.1121/1.395971
   GONG XF, 1989, J ACOUST SOC AM, V86, P1, DOI 10.1121/1.398326
   GRELSSON B, 1989, REV PROGR QUANTITATI, V9, P1441
   GUSEV VE, 1993, LASER ACOUSTICS
   Guyer RA, 1998, GEOPHYS RES LETT, V25, P1585, DOI 10.1029/98GL51231
   GUYER RA, 1995, PHYS REV LETT, V74, P3491, DOI 10.1103/PhysRevLett.74.3491
   HADIMIOGLU B, 1983, APPL PHYS LETT, V43, P1006, DOI 10.1063/1.94223
   HAMILTON MF, 1985, J ACOUST SOC AM, V78, P202, DOI 10.1121/1.392560
   HEYMAN JS, 1983, P S NDE APPL MAT PRO, P177
   HIKATA A, 1963, APPL PHYS LETT, V3, P195, DOI 10.1063/1.1753845
   HIROSE S, 1993, J ACOUST SOC AM, V93, P142, DOI 10.1121/1.405651
   HOLCOMB DJ, 1981, J GEOPHYS RES, V86, P6235, DOI 10.1029/JB086iB07p06235
   HUGHES DS, 1953, PHYS REV, V92, P1145, DOI 10.1103/PhysRev.92.1145
   Hurley DC, 1997, REV PROG Q, V16, P1383
   ICHIDA N, 1984, IEEE T SON ULTRASON, V31, P635, DOI 10.1109/T-SU.1984.31548
   ICHIDA N, 1983, ULTRASONIC IMAGING, V5, P295, DOI 10.1177/016173468300500401
   JIA X, 1993, APPL PHYS LETT, V63, P2192, DOI 10.1063/1.110550
   JOHNSON PA, 1991, J ACOUST SOC AM, V89, P598, DOI 10.1121/1.400384
   Johnson PA, 1996, J GEOPHYS RES-SOL EA, V101, P11553, DOI 10.1029/96JB00647
   KARAKI K, 1990, PHYSICA B, V165, P131
   KARAKI K, 1991, APPL PHYS LETT, V59, P909
   Kino G. S., 1980, Journal of Nondestructive Evaluation, V1, P67, DOI 10.1007/BF00566232
   KOMPFNER R, 1976, APPL PHYS LETT, V28, P295, DOI 10.1063/1.88759
   Korotkov A. S., 1994, AKUST ZH, V40, P84
   KOROTKOV AS, 1994, ACOUSTICS LETT, V18, P59
   Kuznetsov V. P., 1970, SOV PHYS ACOUST+, V16, P467
   Landau L.D., 1986, THEORY ELASTICITY
   LAW WK, 1985, ULTRASOUND MED BIOL, V11, P307, DOI 10.1016/0301-5629(85)90130-9
   LEN KS, 1991, SOV PHYS ACOUST+, V37, P610
   LEN KS, 1993, ACOUST PHYS+, V39, P149
   LEN KS, 1993, THESIS MOSCOW STATE
   LEN KS, 1994, ACAD SCI DPR KOREA, V3, P29
   LEVIN VM, 1991, ACOUST IMAGING, V19, P651
   Lyamov V. E., 1983, POLARIZATION EFFECTS
   MAEV RG, 1999, ABSTRACTS REV PROGR, P46
   MAEV RG, 1995, ACOUST IMAGING, V22, P323
   MAEV RG, 1995, ACOUST IMAGING, V22, P779
   MAEV RG, 1998, P IEEE ULTR S SEND J, V1, P707
   MAO YW, 1989, APPL PHYS LETT, V55, P2394, DOI 10.1063/1.102026
   MAYERGOYZ ID, 1985, J APPL PHYS, V57, P3803, DOI 10.1063/1.334925
   McCall K., 1996, NONLINEAR PROC GEOPH, V3, P89
   MCCALL KR, 1994, J GEOPHYS RES-SOL EA, V99, P23887, DOI 10.1029/94JB01941
   MEEGAN GD, 1993, J ACOUST SOC AM, V94, P3387, DOI 10.1121/1.407191
   MELNGAILIS J, 1963, PHYS REV, V131, P172
   MOREAU A, 1995, J ACOUST SOC AM, V98, P2745, DOI 10.1121/1.413240
   MORRIS WL, 1979, J APPL PHYS, V50, P6737, DOI 10.1063/1.325917
   MUIR TG, 1980, ULTRASOUND MED BIOL, V6, P345, DOI 10.1016/0301-5629(80)90004-6
   NA JK, 1994, J ACOUST SOC AM, V95, P3213, DOI 10.1121/1.409985
   Na JK, 1996, REV PROG Q, V15, P1347
   Nagy PB, 1998, ULTRASONICS, V36, P375, DOI 10.1016/S0041-624X(97)00040-1
   NAKAGAWA Y, 1984, P IEEE ULTR S, P673
   NAMKUNG M, 1985, REV PROGR QUANTITA B, V5, P1481
   NAZAROV VE, 1991, AKUST ZH, V37, P150
   OSTROVSKY LA, 1991, J ACOUST SOC AM, V90, P3332, DOI 10.1121/1.401444
   Papadakis E. P., 1976, PHYS ACOUSTICS, VXII, P277
   PETERS RD, 1968, APPL PHYS LETT, V12, P106, DOI 10.1063/1.1651894
   PODGORNOV AA, 1984, THESIS MOSCOW STATE
   Preisach F, 1935, Z PHYS, V94, P277, DOI 10.1007/BF01349418
   RAO RR, 1980, PHYS STATUS SOLIDI A, V58, P11, DOI 10.1002/pssa.2210580102
   RAZVI S, 1987, REV PROGR QUANTITA B, V6, P1403
   RICHARDSON JM, 1979, INT J ENG SCI, V17, P73, DOI 10.1016/0020-7225(79)90008-9
   RUDENKO OV, 1993, VESTN MOSK U FIZ AS+, V34, P94
   RUGAR D, 1984, J APPL PHYS, V56, P1338, DOI 10.1063/1.334124
   SALAMA K, 1980, J APPL PHYS, V51, P1505, DOI 10.1063/1.327800
   SATO T, 1992, ACOUST IMAG, V19, P363
   SATO T, 1985, ULTRASONIC IMAGING, V7, P49, DOI 10.1016/0161-7346(85)90015-X
   SCHNEIDER E, 1984, P IEEE ULTR S NEW YO, P944
   SEVERIN FM, 1988, VESTN MOSK U FIZ AS+, V29, P84
   SEVERIN FM, 1988, VESTN MOSK U FIZ AS+, V29, P94
   SEVERIN FM, 1990, THESIS MOSCOW STATE
   SEVERIN FM, 1999, VESTNIK MOSKOVSKOGO, V40, P34
   SEVERIN FM, 1999, REV PROGR QUANTITATI, P230
   SHAUN CT, 1993, J ACOUST SOC AM, V93, P148
   SHUI YG, 1988, J APPL PHYS, V64, P6155, DOI 10.1063/1.342120
   SOLODOV IY, 1993, ULTRASONICS, V31, P91, DOI 10.1016/0041-624X(93)90038-2
   Solodov IY, 1996, NON DESTRUCTIVE TESTING, P73
   SOLODOV IY, 1988, J APPL PHYS, V64, P2901, DOI 10.1063/1.341574
   SOLODOV IY, 1993, ACOUST PHYS+, V39, P476
   STARRITT HC, 1986, PHYS MED BIOL, V31, P1401, DOI 10.1088/0031-9155/31/12/007
   TAN MRT, 1985, J APPL PHYS, V57, P4931, DOI 10.1063/1.335317
   TenCate JA, 1996, J ACOUST SOC AM, V100, P1383, DOI 10.1121/1.415985
   Thompson R. B., 1984, Review of Progress in Quantitative Nondestructive Evaluation. Vol.3. Proceedings of the Tenth Annual Review, P207
   THOMPSON RB, 1984, NONDESTRUCTIVE METHO, P161
   THURSTON RN, 1967, J ACOUST SOC AM, V41, P1112, DOI 10.1121/1.1910443
   TIOTTA JN, 1988, J ACOUST SOC AM, V83, P487, DOI 10.1121/1.396143
   TJOTTA JN, 1981, J ACOUST SOC AM, V69, P1644, DOI 10.1121/1.385942
   TREBITS RN, 1972, THESIS GEORGIA I TEC
   Truell R., 1969, ULTRASONIC METHODS S
   Uhlendorf V, 1996, ACOUST IMAG, V22, P233
   VandenAbeele K, 1996, J ACOUST SOC AM, V99, P1430, DOI 10.1121/1.414722
   VandenAbeele KEA, 1997, J ACOUST SOC AM, V101, P1885, DOI 10.1121/1.418198
   VandenAbeele KEA, 1996, J ACOUST SOC AM, V99, P3346, DOI 10.1121/1.414891
   VandenAbeele KEA, 1996, J ACOUST SOC AM, V99, P3334, DOI 10.1121/1.414890
   VELLA PJ, 1974, J APPL PHYS, V45, P1993, DOI 10.1063/1.1663536
   Ward B, 1997, J ACOUST SOC AM, V101, P143, DOI 10.1121/1.417977
   WESTERVELT PJ, 1963, J ACOUST SOC AM, V35, P535, DOI 10.1121/1.1918525
   WICKRAMASINGHE HK, 1977, J APPL PHYS, V48, P4951, DOI 10.1063/1.323624
   Yakovkin I. B., 1979, LIGHT DIFFRACTION SU
   YOST WT, 1981, J APPL PHYS, V52, P126, DOI 10.1063/1.328443
   ZABOLOTSKAYA EA, 1969, SOV PHYS ACOUST+, V15, P35
   Zarembo L.K., 1966, Akusticheskii Zhurnal, V12, P486
   ZHOU SQ, 1995, J APPL PHYS, V78, P39, DOI 10.1063/1.360615
NR 147
TC 127
Z9 132
U1 2
U2 36
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0008-4204
J9 CAN J PHYS
JI Can. J. Phys.
PD DEC
PY 1999
VL 77
IS 12
BP 927
EP 967
DI 10.1139/cjp-77-12-927
PG 41
WC Physics, Multidisciplinary
SC Physics
GA 305JY
UT WOS:000086537400001
DA 2018-10-19
ER

PT J
AU Mitura, S
   Mitura, A
   Niedzielski, P
   Couvrat, P
AF Mitura, S
   Mitura, A
   Niedzielski, P
   Couvrat, P
TI Nanocrystalline diamond coatings
SO CHAOS SOLITONS & FRACTALS
LA English
DT Article
ID RF DENSE-PLASMA; CARBON COATINGS; BIOMEDICAL APPLICATIONS; FILMS; STEEL;
   CVD
AB Carbon-in the form of diamond coatings (nanocrystalline diamond-NCD) on suitable substrates-has attractive properties for biomedical applications. The excellent chemical inertness of NCD films makes them a promising material for medical implants, cardiovascular surgery and for coating of certain components of artificial heart valves.
   The medical applications of carbon films impose some special requirements on their quality, purity, phase content and the state of the surface. Of particular importance is the smoothness of the surface and good adhesion of the coatings to the substrate. We have investigated carbon films which were synthesized by Radio Frequency Plasma Chemical Vapour Deposition (RF-PCVD).
   The specimens obtained have been rested to show their structure and their biological, mechanical and chemical resistance. Additional investigations of the NCD films were carried out by micro-X-ray spectroscopy, Raman spectroscopy, AFM, Auger spectroscopy, corrosion tests, breakdown tests and clinical investigations. Nanocrystalline diamond (NCD) layers obtained by a new method of RF dense plasma CVD onto AISI-316L steel used in surgery were investigated to determine their suitability as biomaterials. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.
C1 Lodz Tech Univ, Inst Mat Sci & Engn, Div Thin Films, PL-90924 Lodz, Poland.
   Univ London Imperial Coll Sci Technol & Med, Blackett Lab, HEP Diamond Grp, London SW7 2BZ, England.
   Ecole Catholique Arts & Metiers, F-69321 Lyon, France.
RP Mitura, S (reprint author), Lodz Tech Univ, Inst Mat Sci & Engn, Div Thin Films, Stefanowskiegol 15, PL-90924 Lodz, Poland.
RI Mitura, Stanislaw/L-6013-2014; Karczemska, Anna/D-4893-2015
OI Mitura, Stanislaw/0000-0001-9280-3748; Karczemska,
   Anna/0000-0003-4635-8019; Niedzielski, Piotr/0000-0002-6966-9154
CR BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   CHANDRA L, 1994, DIAM RELAT MATER, V4, P852
   CHUAN CC, 1974, CHARACTERIZATION SOL, P535
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   Davis L. E., 1976, HDB AUGER ELECT SPEC
   DUSEK V, 1993, DIAM RELAT MATER, V2, P397, DOI 10.1016/0925-9635(93)90090-O
   Glozman O, 1997, DIAM RELAT MATER, V6, P796, DOI 10.1016/S0925-9635(96)00671-1
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MARCINIAK J, 1993, WERKST KORROS, V44, P379
   MERMOUX M, 1996, DIAM RELAT MATER, V1, P798
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   NIEDZIELSKI P, 1995, 2 INT C CBN D 95 JAB
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
NR 16
TC 47
Z9 49
U1 1
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0779
J9 CHAOS SOLITON FRACT
JI Chaos Solitons Fractals
PD DEC
PY 1999
VL 10
IS 12
BP 2165
EP 2176
DI 10.1016/S0960-0779(98)00251-3
PG 12
WC Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary;
   Physics, Mathematical
SC Mathematics; Physics
GA 228KK
UT WOS:000082135500012
DA 2018-10-19
ER

PT J
AU Hisaka, M
   Sugiura, T
   Kawata, S
AF Hisaka, M
   Sugiura, T
   Kawata, S
TI Ultrasound-assisted optical reflectometry in highly scattering media
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS
LA English
DT Article
DE optical reflectometry; scattering media; ultrasound; biomedical optics
ID TURBID MEDIA; TOMOGRAPHY; OBJECTS
AB We have developed an optical reflectometry system to investigate the inside of a scattering medium by using focused ultrasound wave to specify the measuring point. The reflected light is generated by the variation of the refractive indices induced by a focused ultrasound wave, The optical reflectometry technique enables us to observe an internal structure such as a human tissue noninvasively for biomedical applications. We have observed samples which consist of an agarose block with a cubic piece of agarose stained with a dye as an absorptive material, The intensity of the light reflected from the focal region of the ultrasound is decreased when the measuring point was in the stained agarose section because of absorption by the dye. Furthermore, we have observed a sample with a weak scattering object made of agarose surrounded by strong scattering agarose that contains poly(methyl methacrylate) (PMMA) particles.
C1 Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan.
RP Hisaka, M (reprint author), Osaka Univ, Dept Appl Phys, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
RI Kawata, Satoshi/N-7228-2013
CR BORN M, 1980, PRINCIPLES OPTICS, P593
   Fishkin JB, 1997, APPL OPTICS, V36, P10, DOI 10.1364/AO.36.000010
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Leveque S, 1999, OPT LETT, V24, P181, DOI 10.1364/OL.24.000181
   Wang LH, 1997, APPL OPTICS, V36, P7277, DOI 10.1364/AO.36.007277
   WANG LH, 1995, OPT LETT, V20, P629, DOI 10.1364/OL.20.000629
NR 6
TC 4
Z9 4
U1 0
U2 0
PU JAPAN J APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 2
JI Jpn. J. Appl. Phys. Part 2 - Lett.
PD DEC 1
PY 1999
VL 38
IS 12A
BP L1478
EP L1481
DI 10.1143/JJAP.38.L1478
PG 4
WC Physics, Applied
SC Physics
GA 268ZM
UT WOS:000084451100040
DA 2018-10-19
ER

PT J
AU Gordon, MJ
   Chu, KC
   Margaritis, A
   Martin, AJ
   Ethier, CR
   Rutt, BK
AF Gordon, MJ
   Chu, KC
   Margaritis, A
   Martin, AJ
   Ethier, CR
   Rutt, BK
TI Measurement of Gd-DTPA diffusion through PVA hydrogel using a novel
   magnetic resonance imaging method
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE diffusivity; diffusion; Gd-DTPA; polyvinyl alcohol cryogel (PVA-C);
   magnetic resonance (MR) imaging; isoconcentration contour; biomedical;
   biochemical applications
ID POLYVINYL-ALCOHOL GEL; DOSIMETRY GELS; MRI; TRANSPORT
AB Polyvinyl alcohol-cryogel (PVA-C) is a hydrogel that is an excellent tissue mimic. In order to characterize mass transfer in this material, as well as to demonstrate in principle the ability to noninvasively measure solute diffusion in tissue, we measured the diffusion coefficient of the magnetic resonance (MR) contrast agent gadolinium diethylene triaminopentaacetic acid (Gd-DTPA) through PVA-C using a clinical MR imager. The method involved filling thick-walled rectangular PVA-C "cups" with known concentrations of Gd-DTPA solutions. Then by using a fast inversion recovery spin echo MR imaging protocol, a signal "null" contour was created in the MR image that corresponded to a second, known concentration of Gd-DTPA. By collecting a series of MR images through the PVA-C wall as a function of time, the displacement of this second known isoconcentration contour could be tracked. Application of Fick's second law of diffusion yielded the diffusion coefficient. Seven separate experiments were performed using various combinations of initial concentrations of Gd-DTPA within the PVA-C cups (3.2, 25.6, or 125 mM) and tracked isoconcentrations contours (0.096, 0.182, or 0.435 mM Gd-DTPA). The experimental results and the predictions of Fick's law were in excellent agreement. The diffusivity of Gd-DTPA through 10% PVA hydrogel was found to be (2.6 +/- 0.04) x 10(-10) m(2)/s (mean +/- s.e.m.). Separate permeability studies showed that the diffusion coefficient of Gd-DTPA through this hydrogel did not change with an applied pressure of up to 7.1 kPa. Accurate measurements could be made within 30 min if suitable Gd-DTPA concentrations were selected. Due to the excellent repeatability and fast data acquisition time, this technique Is very promising for future in vivo studies of species transport in tissue. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Med Biophys, London, ON, Canada.
   Univ Western Ontario, Dept Diagnost Radiol, London, ON, Canada.
   Univ Western Ontario, John P Robarts Res Inst, London, ON, Canada.
RP Margaritis, A (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
OI Margaritis, Argyrios/0000-0003-1838-560X
CR ATALAR E, 1994, IEEE T MED IMAGING, V13, P152, DOI 10.1109/42.276154
   BALCOM BJ, 1995, PHYS MED BIOL, V40, P1665, DOI 10.1088/0031-9155/40/10/008
   BALCOM BJ, 1993, J AM CHEM SOC, V115, P3300, DOI 10.1021/ja00061a031
   Bertsch F, 1998, MAGN RESON IMAGING, V16, P393, DOI 10.1016/S0730-725X(97)00311-1
   Blanch H W, 1996, BIOCH ENG
   BOUCHARD LS, 1998, P CAN ORG MED PHYS, V1, P341
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   CRANK J, 1964, MATH DIFFUSION, P12
   Cussler E. L., 1997, DIFFUSION MASS TRANS
   DAVIDSON GS, 1995, AM J NEURORADIOL, V16, P843
   FISCHER AE, 1995, J PHYS D APPL PHYS, V28, P384, DOI 10.1088/0022-3727/28/2/023
   FISCHER AE, 1995, MAGN RESON IMAGING, V13, P819, DOI 10.1016/0730-725X(95)00040-N
   GEANKOPLIS CJ, 1978, TRANSPORT PROCESSES, P291
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   HENDERSON E, 1999, IN PRESS MAGN RESON, V17
   HONDA Y, 1986, DOC OPHTHALMOL, V63, P205, DOI 10.1007/BF00157132
   KESSLER L, 1992, BIOMATERIALS, V13, P44, DOI 10.1016/0142-9612(92)90094-5
   Kron T, 1997, MAGN RESON IMAGING, V15, P211, DOI 10.1016/S0730-725X(96)00352-9
   LAURENT TC, 1963, BIOCHIM BIOPHYS ACTA, V78, P351, DOI 10.1016/0006-3002(63)91645-7
   Lozinsky VI, 1989, POLYM SCI USSR, V31A, P1983
   MACFALL JR, 1987, MAGN RESON IMAGING, V5, P209, DOI 10.1016/0730-725X(87)90022-1
   MANO I, 1986, MAGNET RESON MED, V3, P921, DOI 10.1002/mrm.1910030612
   MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004
   MARTEN FL, 1997, KIRKOTHMER ENCY CHEM, P980
   MERCHANT FJA, 1987, BIOTECHNOL BIOENG, V30, P936, DOI 10.1002/bit.260300804
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   NAGURA M, 1989, POLYMER, V30, P762, DOI 10.1016/0032-3861(89)90169-9
   NAMBU M, 1990, Patent No. 4958626
   Pedersen TV, 1997, PHYS MED BIOL, V42, P1575, DOI 10.1088/0031-9155/42/8/008
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P302
   Pilkington FH, 1998, CRIT REV BIOTECHNOL, V18, P237
   Potter K, 1996, SOLID STATE NUCL MAG, V6, P323, DOI 10.1016/0926-2040(94)00053-0
   Rae WID, 1996, MED PHYS, V23, P15, DOI 10.1118/1.597787
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690
   Su MY, 1998, MAGN RESON MED, V39, P259, DOI 10.1002/mrm.1910390213
   SURRY KJM, 1998, P CAN ORG MED PHYS, V1, P145
   TANABE T, 1998, Patent No. 4734097
   TANFORD C, 1965, PHYSICAL CHEM MACROM
   WATASE M, 1983, POLYM COMMUN, V24, P52
   WATLER PK, 1988, BIOMATERIALS, V9, P150, DOI 10.1016/0142-9612(88)90114-7
   WILLARD HH, 1981, INSTRUMENTAL METHODS, P316
   WOOD LL, 1993, Patent No. 5260066
NR 45
TC 36
Z9 36
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD NOV 20
PY 1999
VL 65
IS 4
BP 459
EP 467
DI 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 244YN
UT WOS:000083078500010
PM 10506421
DA 2018-10-19
ER

PT J
AU Williams, C
   Ponten, F
   Moberg, C
   Soderkvist, P
   Uhlen, M
   Ponten, J
   Sitbon, G
   Lundeberg, J
AF Williams, C
   Ponten, F
   Moberg, C
   Soderkvist, P
   Uhlen, M
   Ponten, J
   Sitbon, G
   Lundeberg, J
TI A high frequency of sequence alterations is due to formalin fixation of
   archival specimens
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; DNA-POLYMERASE; P53 MUTATIONS; PLASMID DNA;
   AMPLIFICATION; FIDELITY; CANCER; KERATINOCYTES; GENE
AB Genomic analysis of archival tissues fixed in formalin Is of fundamental importance in biomedical research, and numerous studies have used such material. Although the possibility of polymerase chain reaction (PCR)-introduced artifacts is known, the use of direct sequencing has been thought to overcome such problems, Here we report the results from a controlled study, performed in parallel on frozen and formalin-fixed material, where a high frequency of nonreproducible sequence alterations was detected with the use of formalin-fixed tissues, Defined numbers of well-characterized tumor cells were amplified and anal);zed by direct DNA sequencing. No nonreproducible sequence alterations were found in frozen tissues. In formalin-fixed material up to one mutation artifact per 500 bases was recorded. The chance of such artificial mutations in formalin-fixed material was inversely correlated with the number of cells used in the PCR-the fewer cells, the more artifacts, A total of 28 artificial mutations were recorded, of which 27 were C-T or G-A transitions. Through confirmational sequencing of independent amplification products artifacts can be distinguished from true mutations, However, because this problem was not acknowledged earlier, the presence of artifacts may have profoundly influenced previously reported mutations in formalin-fixed material, including those inserted into mutation databases.
C1 KTH Royal Inst Technol, Dept Biotechnol, S-10044 Stockholm, Sweden.
   Univ Hosp, Dept Pathol, Uppsala, Sweden.
   Profess Genet Lab AB, Uppsala, Sweden.
   Linkoping Univ, Fac Hlth Sci, Dept Cell Biol, S-58185 Linkoping, Sweden.
RP Lundeberg, J (reprint author), KTH Royal Inst Technol, Dept Biotechnol, Teknikringen 30, S-10044 Stockholm, Sweden.
RI Williams, Cecilia/A-6677-2009
OI Williams, Cecilia/0000-0002-0602-2062
CR BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351, DOI 10.1177/39.3.1704393
   BERG C, 1995, CLIN CHEM, V41, P1461
   CHALKLEY R, 1975, P NATL ACAD SCI USA, V72, P1304, DOI 10.1073/pnas.72.4.1304
   Eckert K A, 1991, PCR Methods Appl, V1, P17
   HULTMAN T, 1991, BIOTECHNIQUES, V10, P84
   HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937
   LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y
   PAABO S, 1990, J BIOL CHEM, V265, P4718
   Ponten F, 1997, ONCOGENE, V15, P1059, DOI 10.1038/sj.onc.1201435
   Ponten F, 1997, MUTAT RES-GENOMICS, V382, P45, DOI 10.1016/S1383-5726(97)00008-3
   Ren ZP, 1996, ONCOGENE, V12, P765
   Ren ZP, 1997, AM J PATHOL, V150, P1791
   TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027
   Williams C, 1998, CANCER RES, V58, P2449
   Yagi N, 1996, BIOTECH HISTOCHEM, V71, P123, DOI 10.3109/10520299609117148
   Yngveson A, 1999, CANCER EPIDEM BIOMAR, V8, P433
NR 16
TC 331
Z9 335
U1 3
U2 7
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 1999
VL 155
IS 5
BP 1467
EP 1471
DI 10.1016/S0002-9440(10)65461-2
PG 5
WC Pathology
SC Pathology
GA 253ZT
UT WOS:000083587600011
PM 10550302
OA Green Published
DA 2018-10-19
ER

PT J
AU Sobel, ME
AF Sobel, ME
TI Ethical issues in molecular pathology - Paradigms in flux
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Article; Proceedings Paper
CT XXXIV Conference of the College-of-American-Pathologists on Molecular
   Pathology: Role in Improving Patient Outcome
CY FEB 26-28, 1999
CL BETHESDA, MARYLAND
SP Coll Amer Pathologists
ID INFORMED CONSENT; SAMPLES
AB Recent advances in molecular pathology and molecular genetics have created new concerns about the use of human biologic materials in research. Since researchers now have the ability to extract and amplify DNA from minuscule archived samples, virtually any human tissue sample can potentially become the template for a test that provides information that may relate to the inherited genes of an individual. Researchers using human biologic materials should follow the 3 basic principles that have been defined for all ethical human subjects research: respect for persons, beneficence, and justice. Institutional Review Boards are responsible for providing review of the risks and benefits of research proposals to safeguard the rights and welfare of human subjects. Currently, there is considerable debate concerning the role of informed consent procedures and the Institutional Review Board oversight process in situations when researchers use human biologic materials that have been anonymized or coded. In 1999, the National Bioethics Advisory Commission is expected to make recommendations to President Clinton and the National Science and Technology Council that are expected to clarify the balance between respect for personal autonomy and the societal need to pursue biomedical research to improve the health and welfare of all individuals.
C1 NCI, Mol Pathol Sect, Pathol Lab, Bethesda, MD 20892 USA.
RP Sobel, ME (reprint author), NCI, Mol Pathol Sect, Pathol Lab, 10 Ctr Dr,MSC 1500, Bethesda, MD 20892 USA.
CR CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786
   Grizzle W, 1999, ARCH PATHOL LAB MED, V123, P296
   GRODY WW, 1995, DIAGN MOL PATHOL, V4, P155, DOI 10.1097/00019606-199509000-00001
   HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391
   KANT JA, 1996, MOL DIAGN, V1, P79
   KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806
   Merz JF, 1999, SCIENCE, V283, P1647, DOI 10.1126/science.283.5408.1647
   *NAT COMM PROT HUM, 1979, FED REG         0418
   Strass E, 1996, AM J HUM GENET, V59, P471
   Taube SE, 1998, BREAST J, V4, P391
NR 10
TC 9
Z9 10
U1 0
U2 2
PU COLLEGE AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD NOV
PY 1999
VL 123
IS 11
BP 1076
EP 1078
PG 3
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA 253YD
UT WOS:000083584000021
PM 10539912
DA 2018-10-19
ER

PT J
AU Vazquez, B
   Ginebra, MP
   Gil, FJ
   Planell, JA
   Bravo, AL
   San Roman, J
AF Vazquez, B
   Ginebra, MP
   Gil, FJ
   Planell, JA
   Bravo, AL
   San Roman, J
TI Radiopaque acrylic cements prepared with a new acrylic derivative of
   iodo-quinoline
SO BIOMATERIALS
LA English
DT Article
DE acrylic bone cement; radiopaque agent; iodine compounds
ID BONE-CEMENT; POLY(METHYL METHACRYLATE); BIOMEDICAL APPLICATIONS;
   POLYMERIC BIOMATERIALS; MONOMERS
AB A novel iodine-containing methacrylate, 2,5-diiodo-8-quinolyl methacrylate, has been synthesized and used in the preparation of acrylic radiopaque cements. The effect of incorporation of this monomer to the self-curing resins, on the curing parameters, swelling behaviour and mechanical properties was studied. The incorporation of the radiopaque compound 2,5-diiodo-8-hydroxyquinoline to the solid phase was also carried out for comparative experiments. A decrease in the peak temperature and an increase in the setting time was observed with the addition of the radiopaque monomer, however, the curing parameters did not appreciably change with the addition of the radiopaque compound to the solid phase. Swelling of the modified cements was in the same range as that of the radiolucent cement; however, the diffusion coefficients calculated according to the Fick's law were higher for the iodine-containing materials. The addition of 5 wt% of the iodine-containing methacrylate provided a significant increase in the tensile properties with respect to either control radiolucent formulations or BaSO4-containing formulations. Biocompatibility of the modified cements was studied by implantation of rods of the cements into rats and histological analysis of the surrounding tissue. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 CSIC, Inst Ciencia & Tecnol Polimeros, Macromol Chem Dept, E-28006 Madrid, Spain.
   UPC, ETSEIB, Dep C Tecnol & Ing Met, Barcelona, Spain.
   Hosp Prov Avila, Avila, Spain.
RP San Roman, J (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Macromol Chem Dept, Juan Cierva 3, E-28006 Madrid, Spain.
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Vazquez,
   Blanca/0000-0001-5539-8026
CR BEAUMONT PWR, 1977, J MATER SCI, V12, P1845, DOI 10.1007/BF00566245
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   CRANK J, 1978, MATH DIFFUSION, P239
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DAVY KWM, 1982, J DENT, V10, P254, DOI 10.1016/0300-5712(82)90058-6
   Elvira C, 1996, J POLYM SCI POL CHEM, V34, P2783, DOI 10.1002/(SICI)1099-0518(19960930)34:13<2783::AID-POLA24>3.0.CO;2-7
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   OWEN AB, 1980, MECH PROPERTIES BIOM, P277
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202
   Vazquez B, 1997, J BIOMED MATER RES, V34, P129
   Vazquez B, 1997, J MATER SCI-MATER M, V8, P455, DOI 10.1023/A:1018565807727
   WIJN JRD, 1975, ACTA ORTHOP SCAND, V46, P38
NR 19
TC 27
Z9 28
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 21
BP 2047
EP 2053
DI 10.1016/S0142-9612(99)00108-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 245DC
UT WOS:000083090100008
PM 10535816
DA 2018-10-19
ER

PT J
AU Kalltorp, M
   Oblogina, S
   Jacobsson, S
   Karlsson, A
   Tengvall, P
   Thomsen, P
AF Kalltorp, M
   Oblogina, S
   Jacobsson, S
   Karlsson, A
   Tengvall, P
   Thomsen, P
TI In vivo cell recruitment, cytokine release and chemiluminescence
   response at gold, and thiol functionalized surfaces
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; chemiluminescence; interleukin-1; protein adsorption;
   surface modification; tumour necrosis factor alpha
ID NEUTROPHIL RESPIRATORY BURST; ADHERENT HUMAN-NEUTROPHILS; IMMUNE-COMPLEX
   ALVEOLITIS; SOFT-TISSUE; IN-VITRO; MONOCYTES MACROPHAGES; POLYSTYRENE
   SURFACES; BIOMEDICAL POLYMERS; HYDROGEN-PEROXIDE; ACTIVATION
AB Hydroxylated and methylated surfaces were prepared by the self-assembled monolayer technique (SAM) of alkane thiols on gold. The surfaces were used to evaluate the influence of implant surface chemistry on protein deposition and inflammatory cell response. Implants were inserted subcutaneously in the rat for 3 and 24 h. The surface chemical properties influenced the in vitro rat plasma protein adsorption (ellipsometry/antibody) with few exceptions (albumin not found and fibrinogen always found). The number of recruited cells and their distribution (DNA from implant versus from exudate) was influenced by the different chemistries at 24 h, but not at 3 h. HIS48+, ED1+, ED2+ and small numbers of CD5+ cells were present in the exudate at both time periods (flow cytometry), The cellular oxidative metabolism was low, although cells on -OH surfaces responded with the highest phorbol ester-stimulated chemiluminescence (CL)/DNA. The levels of cytokines IL-1 alpha, IL-1 beta and TNF alpha (ELISA) were not influenced by material surface chemistry. Sham operated sites had a higher cytokine concentration/DNA compared with exudates from an implant milieu. The results of this study show that surface chemical functionalization modifies specific events in the inflammatory response around implants in soft tissues. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Gothenburg, Biomat Res Grp, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden.
   Sahlgrens Univ Hosp, Dept Clin Chem, SE-41345 Gothenburg, Sweden.
   Sahlgrens Univ Hosp, Dept Med Microbiol & Immunol, SE-41345 Gothenburg, Sweden.
   Linkoping Univ, Appl Phys Lab, SE-58183 Linkoping, Sweden.
RP Kalltorp, M (reprint author), Univ Gothenburg, Biomat Res Grp, Inst Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.
RI Karlsson, Anna/A-4130-2012
OI Thomsen, Peter/0000-0003-3910-6665
CR ALLEN RC, 1986, METHOD ENZYMOL, V133, P449
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   Anderson James M., 1996, P165
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BONFIELD TL, 1994, J BIOMED MATER RES, V28, P137, DOI 10.1002/jbm.820280118
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91
   Dinarello Charles A., 1997, Cytokine and Growth Factor Reviews, V8, P253, DOI 10.1016/S1359-6101(97)00023-3
   Eriksson AS, 1996, J CELL PHYSIOL, V166, P138, DOI 10.1002/(SICI)1097-4652(199601)166:1<138::AID-JCP16>3.0.CO;2-B
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   GINIS I, 1990, BLOOD, V76, P1233
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Johnson R. J., 1996, BIOMATERIALS SCI, P173
   Kalltorp M, 1999, J BIOMED MATER RES, V44, P222
   KALLTORP M, 1998, UNPUB MORPHOMETRIC A
   KALLTORP M, 1999, IN PRESS J BIOMED MA
   Kanagaraja S, 1999, J BIOMED MATER RES, V46, P582, DOI 10.1002/(SICI)1097-4636(19990915)46:4<582::AID-JBM17>3.3.CO;2-X
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LESTELIU SM, 1994, J BIOMED MATER RES, V28, P871
   Lim F, 1996, J MATER SCI-MATER M, V7, P69, DOI 10.1007/BF00058717
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Liu L, 1996, J BIOMED MATER RES, V30, P535, DOI 10.1002/(SICI)1097-4636(199604)30:4<535::AID-JBM12>3.0.CO;2-G
   McCrackin F.L, 1969, FORTRAN PROGRAM ANAL
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   Mollnes TE, 1997, EXP CLIN IMMUNOGENET, V14, P24
   NATHAN CF, 1989, BLOOD, V73, P301
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P741
   NIMERI G, 1998, UNPUB INFLUENCE SURF
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   POOT A, 1992, 9 EUR C BIOM, V10, P253
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SHANLEY TP, 1995, MOL MED TODAY, V1, P40, DOI 10.1016/1357-4310(95)80019-0
   SISSON SD, 1989, HUMAN MONOCYTES, P183
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Tengvall P, 1996, J BIOMED MATER RES, V31, P305, DOI 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q
   THORNTON SC, 1990, J LEUKOCYTE BIOL, V47, P312
   USHIDA T, 1992, 9 EUR C BIOM, V10, P99
   WARREN JS, 1989, J CLIN INVEST, V84, P1873, DOI 10.1172/JCI114374
   WARREN JS, 1991, BIOCHEM BIOPH RES CO, V175, P604, DOI 10.1016/0006-291X(91)91608-F
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 58
TC 43
Z9 44
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1999
VL 20
IS 22
BP 2123
EP 2137
DI 10.1016/S0142-9612(99)00115-5
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 247UH
UT WOS:000083238000005
PM 10555080
DA 2018-10-19
ER

PT J
AU Caorsi, S
   Pastorino, M
   Raffetto, M
AF Caorsi, S
   Pastorino, M
   Raffetto, M
TI EM field prediction inside lossy multilayer elliptic cylinders for
   biological-body modeling and numerical-procedure testing
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE analytical solution; biological-body modeling; electromagnetic
   scattering; multilayer elliptic model
ID TIME-DOMAIN METHOD; ELECTROMAGNETIC SCATTERING; ILLUMINATION;
   ABSORPTION; BODIES
AB In this paper, a biological model made up of a multilayer elliptic cylinder is considered. This canonical scattering problem is solved by a recursive procedure, which has been generalized to the case of lossy materials by using the analytical properties of Mathieu functions. Although it is a simplified model, this stratified configuration may simulate better than circular cylinders the local behavior of biological subsystems. In addition, it represents an effective tool far producing analytical data far testing direct-scattering numerical codes in biomedical applications and for the evaluation of reconstruction procedures in medical imaging.
C1 Univ Pavia, Dept Elect, I-27100 Pavia, Italy.
   Univ Genoa, Dept Biophys & Elect Engn, I-16145 Genoa, Italy.
RP Caorsi, S (reprint author), Univ Pavia, Dept Elect, Via Ferrata 1, I-27100 Pavia, Italy.
CR BLANCH G, 1965, HDB MATH FUNCTIONS
   BORUP DT, 1984, IEEE T MICROW THEORY, V32, P355, DOI 10.1109/TMTT.1984.1132683
   BUSSEY HE, 1975, IEEE T ANTENN PROPAG, V23, P723, DOI 10.1109/TAP.1975.1141146
   CAORSI M, IN PRESS IEEE T ANTE
   CAORSI S, 1994, IEEE T BIO-MED ENG, V41, P406, DOI 10.1109/10.284973
   Caorsi S, 1997, IEEE T ANTENN PROPAG, V45, P926, DOI 10.1109/8.585739
   CAORSI S, 1996, P 3 INT C EUR BIOEL
   CERRI G, 1994, P COST 244 M REF MOD, P19
   GANDHI OP, 1995, RADIO SCI, V30, P161, DOI 10.1029/94RS01158
   JOFRE L, 1990, IEEE T BIO-MED ENG, V37, P303, DOI 10.1109/10.52331
   JOHNSON CC, 1972, PR INST ELECTR ELECT, V60, P692, DOI 10.1109/PROC.1972.8728
   KUWANO S, 1998, IEICE T COMMUN   JAN, P110
   NISHIZAWA S, 1997, P 27 EUR MICR C JER, V1, P589
   PICHOT C, 1985, IEEE T ANTENN PROPAG, V33, P416, DOI 10.1109/TAP.1985.1143603
   Reuter CE, 1998, IEEE T MICROW THEORY, V46, P313, DOI 10.1109/22.664132
   RICHMOND JH, 1988, RADIO SCI, V23, P1061, DOI 10.1029/RS023i006p01061
   SULLIVAN DM, 1987, IEEE T BIO-MED ENG, V34, P148, DOI 10.1109/TBME.1987.326039
   SULLIVAN DM, 1988, IEEE T BIO-MED ENG, V35, P179, DOI 10.1109/10.1360
   YEH C, 1963, J MATH PHYS, V4, P65, DOI 10.1063/1.1703890
   YUAN XC, 1990, IEEE T ANTENN PROPAG, V38, P386, DOI 10.1109/8.52246
NR 20
TC 7
Z9 7
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD NOV
PY 1999
VL 46
IS 11
BP 1304
EP 1309
DI 10.1109/10.797990
PG 6
WC Engineering, Biomedical
SC Engineering
GA 249PK
UT WOS:000083341300005
PM 10582415
DA 2018-10-19
ER

PT J
AU Smit, EE
   Erckens, RJ
   Hendrikse, F
   Motamedi, M
   Wicksted, JP
   March, WF
AF Smit, EE
   Erckens, RJ
   Hendrikse, F
   Motamedi, M
   Wicksted, JP
   March, WF
TI Identification of intraocular lens materials using confocal Raman
   spectroscopy
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID SILICONE OIL ADHESION; FLUID-AIR EXCHANGE; POSTERIOR SURFACE;
   CONDENSATION; SPECTRA
AB Purpose: To develop and test a noninvasive method to identify intraocular lens (IOL) materials in vitro.
   Setting: Center for Biomedical Engineering and the Department of Ophthalmology, University of Texas Medical Branch, Galveston, Texas, USA.
   Methods: A laser confocal Raman spectroscopy system (Conforam) was used for the noninvasive assessment of Raman spectra in the lower and the higher spectral regions (299.1 to 1833.7 cm(-1) and 2633.8 to 3819.6 cm(-1), respectively) of 4 IOL materials. silicone, poly(methyl methacrylate) (PMMA), acrylic, and hydrogel.
   Results: Each lens material showed a distinctive spectrum in both the higher and the lower spectral regions. Most materials had unique peaks and a distinct profile using 1 mW of laser power and a 1 second exposure time. AU materials still had a unique spectrum in both the higher and the lower region that allowed 1 material to be distinguished from the others.
   Conclusions: A Conforam differentiated silicone, PMMA, acrylic, and hydrogel lenses in vitro. Raman spectroscopy using the Conforam may provide a fast, safe, and reliable noninvasive method to gain information about the material of an implanted IOL and the stability of lens materials and their coatings, J Cataract Refract Surg 1999. 25. 1498-1504 (C) 1999 ASCRS and ESCRS.
C1 Univ Texas, Med Branch, Dept Ophthalmol, Galveston, TX 77550 USA.
RP March, WF (reprint author), Univ Texas, Med Branch, Dept Ophthalmol, 700 Univ Blvd, Galveston, TX 77550 USA.
CR Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   Apple DJ, 1997, J CATARACT REFR SURG, V23, P536, DOI 10.1016/S0886-3350(97)80210-6
   BARRETT GD, 1994, J CATARACT REFR SURG, V20, P18, DOI 10.1016/S0886-3350(13)80038-7
   BARTZSCHMIDT KU, 1995, KLIN MONATSBL AUGENH, V207, P162, DOI 10.1055/s-2008-1035362
   Bauer NJC, 1998, INVEST OPHTH VIS SCI, V39, P831
   Bauer NJC, 1999, J OCUL PHARMACOL TH, V15, P123, DOI 10.1089/jop.1999.15.123
   Dick B, 1997, KLIN MONATSBL AUGENH, V211, P192, DOI 10.1055/s-2008-1035121
   EATON AM, 1995, OPHTHALMOLOGY, V102, P733, DOI 10.1016/S0161-6420(95)30961-X
   GLICKMAN GM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1166
   GOETZ MJ, 1995, IEEE T BIO-MED ENG, V42, P728, DOI 10.1109/10.391172
   Hainsworth DP, 1996, OPHTHALMOLOGY, V103, P1410, DOI 10.1016/S0161-6420(96)30490-9
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Jongsma FHM, 1997, OPT ENG, V36, P3193, DOI 10.1117/1.601529
   KUTNER BN, 1995, OPHTHALMOLOGY, V102, P1412
   MIZUNO A, 1982, CURR EYE RES, V1, P609, DOI 10.3109/02713688109001862
   RIDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   Seward HC, 1997, BRIT J OPHTHALMOL, V81, P340, DOI 10.1136/bjo.81.5.340
   Stolba U, 1996, GRAEF ARCH CLIN EXP, V234, P55, DOI 10.1007/BF00186519
   WICKSTED JP, 1995, APPL SPECTROSC, V49, P987, DOI 10.1366/0003702953964912
NR 19
TC 5
Z9 5
U1 1
U2 4
PU AMER SOC CATARACT REFRACTIVE SURGERY
PI FAIRFAX
PA 4000 LEGATO RD, SUITE 850, FAIRFAX, VA 22030 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD NOV
PY 1999
VL 25
IS 11
BP 1498
EP 1504
DI 10.1016/S0886-3350(99)00239-4
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 251VR
UT WOS:000083467500017
PM 10569165
DA 2018-10-19
ER

PT J
AU Alikacem, N
   Marois, Y
   Zhang, Z
   Jakubiec, JB
   Roy, R
   King, MW
   Guidoin, R
AF Alikacem, N
   Marois, Y
   Zhang, Z
   Jakubiec, JB
   Roy, R
   King, MW
   Guidoin, R
TI Tissue reactions to polypyrrole-coated polyesters: A magnetic resonance
   relaxometry study
SO ARTIFICIAL ORGANS
LA English
DT Article
DE polypyrrole; woven polyester; magnetic resonance; in vivo; blood
   monocyte activation; histology
ID FIBROBLAST GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; BIOMEDICAL POLYMERS;
   VASCULAR PROSTHESIS; ENDOTHELIAL-CELLS; RELAXATION-TIMES; CHARGED
   SURFACES; SMALL-DIAMETER; IN-VITRO; GRAFTS
AB The electrically conductive properties of polypyrrole (PPy) as a coating on polyester material are very attractive for the manufacture of small diameter blood conduits. However, before these PPy-coated materials can be investigated for their capacity to generate endothelialized luminal surfaces, they must first be studied for their innocuousness in a living environment. The specific goal of the present study was to investigate the in vivo interactions of PPy-coated and noncoated woven polyester materials implanted subcutaneously in rats for prescheduled periods of 2, 5, 10, 20, and 30 days. The in vivo magnetic resonance (MR) relaxation times were computed for a small area of muscle tissue adjacent to the implants. A correlation was concurrently attempted with blood monocyte activation studies as well as histological observations of the tissue-material interface. The progressive pattern of the slower transversal relaxation time (T-2s) values revealed a more persistent tissue reaction for the most conductive PPy-coated materials and a shorter acute tissue response as the surface resistivity increased. Similarly, the blood monocyte activation studies indicated that the thickness of the PPy coating, which correlated with the conductivity, was directly related to tissue response. Furthermore, both the MR and biological studies showed that the PPy-coated material with a high surface resistivity displayed the lowest tissue reaction over the entire period of implantation. The results obtained from the blood monocyte activation studies and histological observations correlate well with the noninvasive MR measurements of the body's healing process. The conductive materials with high surface resistivities must be further investigated. Finally, the noninvasive nature of MR relaxometry reveals its outstanding potential for future in vivo investigations of the body's tissue interactions with polymers and nonferromagnetic biomaterials.
C1 Univ Laval, Expt Surg Lab, Fac Med, Dept Surg, Quebec City, PQ G1K 7P4, Canada.
   Quebec Biomat Inst, Quebec City, PQ, Canada.
   Rheumatol & Immunol Res Ctr, Quebec City, PQ, Canada.
RP Guidoin, R (reprint author), Univ Laval, Expt Surg Lab, Fac Med, Dept Surg, Room 1701,Serv Bldg, Quebec City, PQ G1K 7P4, Canada.
RI Zhang, Ze/A-7902-2008
CR ABRAGAM A, 1961, PRINCIPLES MAGNETIC
   ALIKACEM N, 1995, ASAIO J, V41, pM617, DOI 10.1097/00002480-199507000-00085
   ALIKACEM N, 1997, P INT SOC MAGN RES 5
   ALLCOCK HR, 1990, CONT POLYM CHEM, P570
   BERGSMA JE, 1995, J BIOMED MATER RES, V29, P173, DOI 10.1002/jbm.820290206
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535
   CENNI E, 1994, J APPL BIOMATER, V5, P47, DOI 10.1002/jab.770050107
   DESGRANGES P, 1992, INT J ARTIF ORGANS, V15, P722
   FEIFENG HE, 1995, J APPL POLYM SCI, V55, P283
   FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2
   GELBAND CH, 1992, CIRC RES, V71, P745, DOI 10.1161/01.RES.71.4.745
   GOSSELIN C, 1995, AM J SURG, V170, P126, DOI 10.1016/S0002-9610(99)80270-0
   GRAY JL, 1994, J SURG RES, V57, P596, DOI 10.1006/jsre.1994.1189
   GREISLER HP, 1992, SURGERY, V112, P244
   HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025
   HANSEN ME, 1993, CARDIOVASC INTER RAD, V16, P30, DOI 10.1007/BF02603034
   HIRKO MK, 1995, ASAIO J, V41, pM630, DOI 10.1097/00002480-199507000-00087
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   KANATZIDIS MG, 1990, CHEM ENG NEWS, V68, P36, DOI 10.1021/cen-v068n049.p036
   KAPUR R, 1993, BIOMATERIALS, V14, P854, DOI 10.1016/0142-9612(93)90007-O
   KATAOKA K, 1978, MAKROMOL CHEM, V179, P1121
   KEDDY K, 1981, J BIOMED MATER RES, V15, P335
   KUHN HH, 1991, TECH PAP SOC PLAST E, V37, P760
   LADO MD, 1992, INT J ARTIF ORGANS, V15, P727
   LEE YS, 1993, ASAIO, V39, P740
   LING CR, 1982, PHYS MED BIOL, V27, P853, DOI 10.1088/0031-9155/27/6/006
   Lowkis B, 1993, Polim Med, V23, P15
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MIWA H, 1993, ASAIO J, V39, P501
   MO M, 1995, ARTIF ORGANS, V19, P1185, DOI 10.1111/j.1525-1594.1995.tb02281.x
   MURPHY P, 1970, J MACROMOL SCI CHEM, VA  4, P561, DOI 10.1080/00222337008074363
   Niu S, 1993, ASAIO J, V39, pM750
   ROBINSON KA, 1995, ANGIOLOGY, V46, P107, DOI 10.1177/000331979504600203
   Ryu G, 1992, ASAIO J, V38, pM644
   SAWYER PN, 1953, SURGERY, V34, P491
   SAWYER PN, 1964, P NATL ACAD SCI USA, V51, P428, DOI 10.1073/pnas.51.3.428
   SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502
   SCHNEIDER A, 1992, J VASC SURG, V15, P649, DOI 10.1016/0741-5214(92)90010-6
   SHIOYA S, 1990, MAGNET RESON MED, V14, P358, DOI 10.1002/mrm.1910140220
   SIROIS E, 1993, INT J ARTIF ORGANS, V16, P609
   Spartera C, 1990, Eur J Vasc Surg, V4, P69, DOI 10.1016/S0950-821X(05)80041-6
   SRINIVASAN S, 1970, J MACROMOL SCI CHEM, VA  4, P545, DOI 10.1080/00222337008074362
   SUGIMURA K, 1992, BRIT J RADIOL, V65, P502, DOI 10.1259/0007-1285-65-774-502
   SWANSON JA, 1994, AM J PHYSIOL, V266, pH1300
   TAYLOR BC, 1971, T AM SOC ART INT ORG, V17, P22
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   VOGEL MK, 1970, J MACROMOL SCI CHEM, VA  4, P675, DOI 10.1080/00222337008074370
   VOLK KA, 1991, J PHYSIOL-LONDON, V439, P751, DOI 10.1113/jphysiol.1991.sp018691
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   WORLEY JF, 1991, AM J PHYSIOL, V261, pH1951
   YAMAMURA K, 1995, J BIOMED MATER RES, V29, P203, DOI 10.1002/jbm.820290210
NR 52
TC 17
Z9 18
U1 0
U2 4
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD OCT
PY 1999
VL 23
IS 10
BP 910
EP 919
DI 10.1046/j.1525-1594.1999.06231.x
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 246ZJ
UT WOS:000083195900004
PM 10564289
DA 2018-10-19
ER

PT J
AU Petrini, P
   Tanzi, MC
   Moran, CR
   Graham, NB
AF Petrini, P
   Tanzi, MC
   Moran, CR
   Graham, NB
TI Linear poly(ethylene oxide)-based polyurethane hydrogels:
   polyurethane-ureas and polyurethane-amides
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Over the last 30 years, water-swellable and water-insoluble hydrogels have been extensively investigated and developed, leading to a large family of materials which have found uses in a wide range of biomedical applications.
   While hydrogels usually present a crosslinked structure, linear polyurethane-ureas (PUUs) based on poly(ethylene oxide) have been shown to be able to absorb and swell with aqueous media without dissolving. This behavior is due to the phase separated domain morphology, where hydrogen bonded urethane/urea hard segment domains are dispersed in a PEO soft segment domain.
   This work investigates the possibility of obtaining linear poly(ethylene oxide)-based polyurethane-amide (PUA) hydrogels using two amide diols as chain extenders, a mono amide diol (AD) and a diamide diol (DD), and a dicarboxylic acid (maleic acid, MA). Poly(ethylene oxide) based PUAs were obtained using a "one-shot" bulk polymerization technique. The chemicophysical characterization and water-solubility tests showed that these materials, while having molecular weights similar to the PUUs, do not possess sufficient phase separation, hydrogen bonding and hydrophobicity of the hard segment domains to exhibit hydrogel behavior. Crosslinked PUAs using maleic acid as chain extender show interesting hydrogel properties. (C) 1999 Kluwer Academic Publishers.
C1 Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
   Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland.
RP Petrini, P (reprint author), Politecn Milan, Dept Bioengn, Piazza L Da Vinci 32, I-20133 Milan, Italy.
RI Tanzi, Maria Cristina/I-4620-2013; Petrini, Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254
CR COHEN D, 1990, CLIN IMPLANT MAT ADV, V9, P473
   GRAHAM NB, 1987, POLYMERS, V4, P95
   GRAHAM NB, 1993, POLYM MAT
   GRAHAM NB, 1998, MED DEVICE TECHN JAN, P18
   GRAHAM NB, 1998, MED DEVICE TECHN APR, P22
   Peppas NA, 1987, HYDROGELS MED PHARM
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   TANZI MC, 1997, P 13 EUR C BIOM GOT, P66
NR 9
TC 17
Z9 18
U1 0
U2 18
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT-NOV
PY 1999
VL 10
IS 10-11
BP 635
EP 639
DI 10.1023/A:1008939808819
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 243RX
UT WOS:000083012000009
PM 15347978
DA 2018-10-19
ER

PT J
AU Shelly, DC
   Brown, EM
AF Shelly, DC
   Brown, EM
TI Sampling strategies for infrared spectroscopic studies of raw, pickled,
   and in-process chrome tanned bovine hides
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID COLLAGEN
AB Infrared spectroscopy is a powerful research tool for studying structure and structural changes in complex biomaterials, such as animal hides and leather. Recent advances in optical design and materials have made available accessories that enable the sampling of biomaterials as liquids, gels, pastes, powders and porous solids. For this report, the Gemini, a new sampling device for Horizontal Attenuated Total Reflection (HATR) and Diffuse Reflectance (DR) FTIR spectroscopy was evaluated as an option for the study of bovine hides, in successive stages of chrome tanning. Specifically, raw, pickled and chrome sulfate-treated bovine hides were subjected to HATR FTIR analysis so that changes in collagen structure as a function of chemical treatment could be observed. Also, freeze dried hides were examined by DR FTIR in order to detect the presence and structure of collagen-chromium complexes. Comparisons of HATR and DR FTIR show that the expected chemical changes in the hide can be observed. The quality of the spectra obtained is comparable to that reported by biomedical research groups. The GEMINI shows excellent versatility for in-processing hide sampling, enabling the detailed study of many truly unique chemical and biochemical phenomena of the tanning process.
C1 Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.
   Texas Tech Univ, Leather Res Inst, Lubbock, TX 79409 USA.
   ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Shelly, DC (reprint author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.
CR Bajza Z, 1997, J SOC LEATH TECH CH, V81, P219
   BALSER C, 1996, PITTSB C AN CHEM APP
   DAGOSTINO J, 1992, AM LAB, V38, P13
   FORTE JN, 1997, 463 NIC
   Griebenow K, 1996, J AM CHEM SOC, V118, P11695, DOI 10.1021/ja961869d
   HEIDEMANN E, 1991, LEDER, V42, P21
   LEE DC, 1990, BIOCHEMISTRY-US, V29, P9185, DOI 10.1021/bi00491a012
   OZAKI Y, 1992, APPL SPECTROSC, V46, P626, DOI 10.1366/0003702924125104
   OZAKI Y, 1989, APPL SPECTROSC, V43, P138, DOI 10.1366/0003702894201789
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   *SPECTRATECH INC, 1997, GEM US MAN
   TAYLOR MM, JALCA, V93, P83
   YANG WJ, 1985, APPL SPECTROSC, V39, P282, DOI 10.1366/0003702854248917
NR 14
TC 6
Z9 6
U1 0
U2 4
PU AMER LEATHER CHEMISTS ASSN
PI CINCINNATI
PA ROOM 5 CAMPUS STATION-14 TANNER RES LAB, CINCINNATI, OH 45221 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD OCT
PY 1999
VL 94
IS 8
BP 315
EP 321
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 239QW
UT WOS:000082782000003
DA 2018-10-19
ER

PT J
AU Detweiler, J
   Peyton, C
AF Detweiler, J
   Peyton, C
TI Defining occupations - A chronotopic study of narrative genres in a
   health discipline's emergence
SO WRITTEN COMMUNICATION
LA English
DT Review
ID DISCOURSE; THERAPY; PHILOSOPHY; FRAMEWORK; EVOLUTION
AB Extending Bakhtin's chronotopic theory to the interpretation of nonfictional texts, this article examines the role of narrative conventions in the epistemological development of a health care field. The authors argue that changes marking the emergence of occupational therapy as an autonomous profession illustrate how explanatory narrative frames emerge from and embody assumptions about the world. Taking up pivotal lectures by key Figures in this Field as material for analysis, the authors demonstrate how biomedical, psychosocial, and dialogic-intersubjective narrative genres frame the dynamics of the therapeutic situation for clinical practitioners and other members of the field. By using chronotopic analysis to understand the narrative-epistemic transformation of academic and professional Fields, the authors provide new ways to think about the long-term dialogue between explanatory frameworks in knowledge-making communities.
C1 Univ Nevada, Dept English, Reno, NV 89557 USA.
   Creighton Univ, Dept Occupat Therapy, Omaha, NE 68178 USA.
RP Detweiler, J (reprint author), Univ Nevada, Dept English, Reno, NV 89557 USA.
CR *AOTA, 1985, PROF LEG EC SLAGL LE
   *AOTA, 1988, AM J OCCUPATIONAL TH, V42, P795
   ATKINSON P, 1995, HDB QUALITATIVE RES, P248
   AYRES AJ, 1985, PROFESSIONAL LEGACY, P127
   Bakhtin M., 1984, PROBLEMS DOSTOYEVSKY
   Bakhtin M. M., 1981, DIALOGIC IMAGINATION
   Bakhtin M. M., 1986, SPEECH GENRES OTHER
   Bakhtin MM, 1990, ART ANSWERABILITY EA
   Bateson M.C, 1990, COMPOSING LIFE
   Baur S., 1994, CONFIDING PSYCHOTHER
   Bazerman C, 1991, TEXTUAL DYNAMICS PRO
   Bazerman C., 1988, SHAPING WRITTEN KNOW
   BEARD GM, 1972, AM NERVOUSNESS ITS C
   Berkenkotter C, 1995, GENRE KNOWLEDGE DISC
   BIALOSTOSKY D, 1994, LEARNING TEACHING GE, P105
   Bialostosky Don, 1991, CONTENDING WORDS COM, P11
   BLAIR CP, 1988, COLL ENGL, V50, P383, DOI 10.2307/377610
   BOOTH W, 1984, PROBLEMS DOSTOYEVSKY
   Boris E., 1986, ART LABOR RUSKIN MOR
   BRODKEY L, 1987, WRIT COMMUN, V4, P25, DOI 10.1177/0741088387004001002
   BRUNER J, 1991, CRIT INQUIRY, V18, P1, DOI 10.1086/448619
   Bruner J., 1986, ACTUAL MINDS POSSIBL
   Bruner J., 1990, ACTS MEANING
   BURTON S, 1995, COMP LITERATURE, V48, P39
   Capra F., 1982, TURNING POINT SCI SO
   Christiansen C., 1991, OCCUPATIONAL THERAPY, P3
   CLARK F, 1993, AM J OCCUP THER, V47, P1067, DOI 10.5014/ajot.47.12.1067
   Clifford J., 1988, PREDICAMENT CULTURE
   Cooper Marilyn M, 1994, J ADV COMPOSITION, V14, P531
   COOPER MM, 1990, COLL ENGL, V52, P847, DOI 10.2307/377388
   Cross G. A., 1994, COLLABORATION CONFLI
   CROSS GA, 1990, RES TEACH ENGL, V24, P173
   Daniell B, 1999, COLL COMPOS COMMUN, V50, P393, DOI 10.2307/358858
   DANTO A, 1981, NARRATION KNOWLEDGE
   DAUTERMANN J, 1993, WRITING WORKPLACE NE, P98
   DETWEILER J, 1995, THESIS U LOUISVILLE
   DETWEILER J, 1997, GENRE WRITING ISSUES, P135
   Diasio Serrett K., 1985, OCCUPATIONAL THERAPY, V5, P1
   Doheny-Farina S., 1993, WRITING WORKPLACE NE, P253
   Dunton Jr W.R., 1918, P 1 ANN M NAT SOC PR, P26
   DURANARENAS L, 1991, SOC SCI MED, V32, P643, DOI 10.1016/0277-9536(91)90143-Z
   DWYER E, 1987, HOMES MAD LIFE 2 19
   Elshtain Jean Bethke, 1987, RHETORIC HUMAN SCI L, P319
   ENGLEHARDT HT, 1977, AM J OCCUPATIONAL TH, V31, P666
   EWALD HR, 1993, COLL COMPOS COMMUN, V44, P331, DOI 10.2307/358987
   Fabian J, 1983, TIME OTHER ANTHR MAK
   FARMER F, 1990, FRESHMAN ENGLISH NEW, V19, P16
   Farmer F., 1998, LANDMARK ESSAYS BAKH
   FORSYTH PB, 1985, WORK OCCUPATION, V12, P59, DOI 10.1177/0730888485012001004
   Freedman A., 1994, LEARNING TEACHING GE, P1
   FREEDMAN A, 1997, GENRE WRITING ISSUES, P177
   FRIEDSON E, 1986, PROFESSIONAL POWERS
   Geertz C., 1983, LOCAL KNOWLEDGE FURT
   Geertz C., 1988, WORKS LIVES ANTHR AU
   Giltrow J., 1994, LEARNING TEACHING GE, P47
   Goode W. J., 1969, SEMIPROFESSIONS THEI, P266
   Gould SJ, 1989, WONDERFUL LIFE BURGE
   Gritzer Glenn, 1985, MAKING REHABILITATIO
   Grob G. N., 1983, MENTAL ILLNESS AM SO
   Halasek K., 1999, PEDAGOGY POSSIBILITY
   Halasek Kay, 1992, RHETORIC SOC Q, V22, P63
   HALPERN SA, 1992, AM J SOCIOL, V97, P994, DOI 10.1086/229859
   Haraway Donna J., 1989, PRIMATE VISIONS GEND
   HARDCASTLE J, 1994, LEARNING TEACHING GE, P31
   HENRY J, 1994, COLL ENGL, V56, P810, DOI 10.2307/378487
   HERNDL CG, 1991, COLL ENGL, V53, P320, DOI 10.2307/378107
   HERRNSTEINSMITH B, 1985, NARRATIVE, P209
   Holquist M., 1990, DIALOGISM BAKHTIN HI
   HUNT R, 1994, LEARNING TEACHING GE, P243
   Illich I, 1977, MED NEMESIS EXPROPRI
   JOURNET D, 1990, WRIT COMMUN, V7, P171, DOI 10.1177/0741088390007002001
   JOURNET D, 1993, WRIT COMMUN, V10, P510, DOI 10.1177/0741088393010004002
   JOURNET D, 1991, WRIT COMMUN, V8, P446, DOI 10.1177/0741088391008004002
   Kahler Erich, 1973, INWARD TURN NARRATIV
   Kaplan Wendy, 1987, ART THAT IS LIFE ART
   Kermode F., 1967, STUDIES THEORY FICTI
   KIELHOFNER G, 1977, AM J OCCUP THER, V31, P675
   KIELHOFNER G, 1980, AM J OCCUP THER, V34, P572, DOI 10.5014/ajot.34.9.572
   KING LJ, 1985, PROFESSIONAL LEGACY, P311
   LANDAU M, 1984, AM SCI, V72, P262
   Landau Misia, 1991, NARRATIVES HUMAN EVO
   Lanham Richard A, 1991, HANDLIST RHETORICAL
   LEARS TJJ, 1981, NO PLACE GRACE
   Levine R., 1991, OCCUPATIONAL THERAPY, P591
   LEVINE R E, 1987, Occupational Therapy in Health Care, V4, P3, DOI 10.1080/J003v04n01_02
   LICHT S, 1948, OCCUPATIONAL THERAPY
   LUMERER KM, 1985, LEARNING HEAL DEV AM
   Lyotard Jean-Francois, 1985, POSTMODERN CONDITION
   MCCARTHY LP, 1991, RES TEACH ENGL, V25, P419
   McCarthy Lucille P., 1991, TEXTUAL DYNAMICS PRO, P358
   MECHANIC D, 1979, FUTURE ISSUES HLTH C
   Mink, 1978, WRITING HIST LIT FOR, P129
   MISHLER EG, 1990, HARVARD EDUC REV, V60, P415, DOI 10.17763/haer.60.4.n4405243p6635752
   MOORE J, 1985, PROFESSIONAL LEGACY, P277
   Morson G.S., 1990, M BAKHTIN CREATION P
   Morson G. S., 1994, NARRATIVE FREEDOM SH
   MOSEY A, 1990, PSYCHOSOCIAL COMPONE
   MOSEY AC, 1981, OCCUPATIONAL THERAPY
   Myers G, 1990, WRITING BIOL TEXTS S
   NELSON D, 1997, AM J OCCUPATIONAL TH, P11
   NEWKIRK T., 1992, METHODS METHODOLOGY, P130
   NORTH S, 1985, MAKING KNOWLEDGE COM
   NYSTRAND M, 1993, WRIT COMMUN, V10, P267, DOI 10.1177/0741088393010003001
   NYSTRAND M, 1997, OPENING DIALOGUE
   PADILLA R, 1997, NEUROSCIENCE OCCUPAT, P2
   PADILLA R, IN PRESS NEUROSCIENC
   Phelan James, 1989, READING PEOPLE READI
   Pierce D, 1999, AM J OCCUP THER, V53, P64, DOI 10.5014/ajot.53.1.64
   Polkinghorne D. E., 1988, NARRATIVE KNOWING HU
   PRIOR P, 1995, RES TEACH ENGL, V29, P288
   Prior P. A, 1998, WRITING DISCIPLINARI
   Quiroga VAM, 1995, OCCUPATIONAL THERAPY
   REILLY M, 1985, PROFESSIONAL LEGACY, P87
   Ricoeur P, 1984, TIME NARRATIVE, V1
   ROGERS JC, 1982, AM J OCCUP THER, V36, P709, DOI 10.5014/ajot.36.11.709
   Rosaldo R, 1987, RHETORIC HUMAN SCI L, P87
   Rosenberg C, 1987, CARE STRANGERS RISE
   Schafer R, 1981, NARRATIVE, P25
   Segal J., 1993, WRITING WORKPLACE NE, P84
   SHANNON PD, 1977, AM J OCCUP THER, V31, P229
   Simons H. W., 1990, RHETORICAL TURN INVE
   SLAGLE E, 1944, STATE NEW YORK DEP M
   Starr P, 1982, SOCIAL TRANSFORMATIO
   STATTEL F, 1985, PROFESSIONAL LEGACY, P1
   Taylor C., 1979, INTERPRETIVE SOCIAL, P25
   Van Maanen J, 1988, TALES FIELD WRITING
   Vogel MJ, 1980, INVENTION MODERN HOS
   Wagner Roy, 1975, INVENTION CULTURE
   WEGG L, 1985, PROFESSIONAL LEGACY, P57
   Welch N, 1998, COLL ENGL, V60, P374, DOI 10.2307/378908
   Welch N., 1993, J ADV COMPOSITION, V13, P494
   White H, 1987, CONTENT FORM NARRATI
   WHITE H, 1978, TOPICS DISCOURSE
   White Hayden, 1973, METAHISTORY HIST IMA
   YERXA E, 1985, PROFESSIONAL LEGACY, P155
   YERXA E, 1998, WILLARD SPACKMANS OC, P861
   YOUNG K, 1991, J NARRAT LIFE HIST, V1, P213
   Zimmerman M. E., 1985, PROFESSIONAL LEGACY, P69
NR 138
TC 14
Z9 14
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0741-0883
J9 WRIT COMMUN
JI Writ. Commun.
PD OCT
PY 1999
VL 16
IS 4
BP 412
EP 468
DI 10.1177/0741088399016004002
PG 57
WC Communication
SC Communication
GA 243EX
UT WOS:000082985000002
DA 2018-10-19
ER

PT J
AU Tan, J
   Saltzman, WM
AF Tan, J
   Saltzman, WM
TI Influence of synthetic polymers on neutrophil migration in
   three-dimensional collagen gels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE neutrophil; migration; collagen; polyethylene glycol; pluronic F68
ID EXTRACELLULAR-MATRIX; POLYETHYLENE-GLYCOL; POLY(ETHYLENE GLYCOL);
   CELL-AGGREGATION; NEURITE GROWTH; ANIMAL-CELLS; ADHESION; CHEMOTAXIS;
   MOTILITY; SURFACES
AB In vitro studies of cell migration within three-dimensional polymeric materials are essential for understanding cell behavior and for developing new biomedical materials. Human neutrophil motility was examined in hydrated collagen gels containing various synthetic polymers. Physical mixtures of collagen and certain water-soluble polymers formed stable gels that were good substrates for cell migration. Addition of either polyethylene glycol (PEG) or the pluronic(TM) copolymer F68 did not change the morphological or mechanical properties of collagen gels, as determined by SEM and oscillatory rheometry; however, addition of either polymer significantly inhibited cell motility in both a modified 96-well chemotaxis chamber assay and a direct visual assay. Although the mechanism for this observed polymer inhibition of neutrophil migration is not yet clear, these results suggest that PEG and F68, two widely used biomedical polymers that are considered to be relatively "inert," may cause significant inhibition of cell motility. (C) 1999 John Wiley & Sons, Inc.
C1 Cornell Univ, Sch Chem Engn, Ithaca, NY 14853 USA.
RP Saltzman, WM (reprint author), Cornell Univ, Sch Chem Engn, 120 Olin Hall, Ithaca, NY 14853 USA.
CR ALLEN TD, 1984, SCAN ELECTRON MICROS, P375
   Baldwin SP, 1996, INT J DEV NEUROSCI, V14, P351, DOI 10.1016/0736-5748(96)00018-4
   BELL E, 1991, J BIOMECH ENG-T ASME, V113, P113, DOI 10.1115/1.2891224
   BONI LT, 1984, BIOCHIM BIOPHYS ACTA, V775, P409, DOI 10.1016/0005-2736(84)90198-6
   BUETTNER HM, 1989, J IMMUNOL METHODS, V123, P25, DOI 10.1016/0022-1759(89)90026-4
   Caldwell KD, 1997, ACS SYM SER, V680, P400
   DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782
   DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DOILLON CJ, 1994, J BIOMAT SCI-POLYM E, V6, P715
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Edwards CM, 1997, ARTIF CELL BLOOD SUB, V25, P493, DOI 10.3109/10731199709118940
   Glauert AM, 1975, FIXATION DEHYDRATION
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   HAMED G, 1973, THESIS CORNELL U ITH
   HARVATH L, 1980, J IMMUNOL METHODS, V37, P39, DOI 10.1016/0022-1759(80)90179-9
   ISLAM LN, 1985, J IMMUNOL METHODS, V85, P137, DOI 10.1016/0022-1759(85)90282-0
   Knapp DM, 1997, J RHEOL, V41, P971, DOI 10.1122/1.550817
   KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471
   KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MICHAELS JD, 1991, J BIOTECHNOL, V19, P241, DOI 10.1016/0168-1656(91)90062-Z
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Orgill DP, 1998, J BIOMED MATER RES, V39, P358, DOI 10.1002/(SICI)1097-4636(19980305)39:3<358::AID-JBM3>3.0.CO;2-I
   PAPOUTSAKIS ET, 1991, TRENDS BIOTECHNOL, V9, P427, DOI 10.1016/0167-7799(91)90145-8
   PARKHURST MR, 1994, CELL IMMUNOL, V156, P77, DOI 10.1006/cimm.1994.1154
   PARKHURST MR, 1992, BIOPHYS J, V61, P306, DOI 10.1016/S0006-3495(92)81838-6
   PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0
   REID GG, 1991, CELL BIOL INT REP, V15, P711, DOI 10.1016/0309-1651(91)90071-P
   RHEE W, 1997, CHEM BIOL APPL, P420
   ROSENBLATT J, 1993, J APPL POLYM SCI, V50, P953, DOI 10.1002/app.1993.070500604
   SALTZMAN WM, 1992, ANN NY ACAD SCI, V665, P259, DOI 10.1111/j.1749-6632.1992.tb42590.x
   SALTZMAN WM, IN PRESS J LEUKOCYTE
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zalipsky S, 1997, ACS SYM SER, V680, P1
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   ZHANG Z, 1992, ENZYME MICROB TECH, V14, P980, DOI 10.1016/0141-0229(92)90081-X
NR 44
TC 28
Z9 29
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 1999
VL 46
IS 4
BP 465
EP 474
DI 10.1002/(SICI)1097-4636(19990915)46:4<465::AID-JBM4>3.0.CO;2-N
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 213WE
UT WOS:000081295600004
PM 10398007
DA 2018-10-19
ER

PT J
AU Kingshott, P
   St John, HAW
   Griesser, HJ
AF Kingshott, P
   St John, HAW
   Griesser, HJ
TI Direct detection of proteins adsorbed on synthetic materials by
   matrix-assisted laser desorption ionization-mass spectrometry
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE protein detection; protein adsorption; MALDI mass spectrometry;
   biofouling; surface analysis
ID GEL-ELECTROPHORESIS; ADSORPTION; SURFACES; MEMBRANE; BIOFILMS
AB The irreversible accumulation of biological material on synthetic surfaces ("biofouling") adversely affects for instance contact lenses, implantable biomedical devices, biosensors, water purification, transport and storage systems, and marine structures. It is shown here that proteins adsorbed on contact lenses can be detected directly, rapidly, and conveniently, with high sensitivity, by matrix-assisted laser desorption ionization (MALDI)-mass spectrometry, This new approach allows detection of minor (and major) proteinaceous constituents of biofouled layers on samples retrieved from clinical usage and in vitro protein adsorption studies, at levels substantially below monolayer coverage. Identification of the detected biological molecules can be done by comparison of the detected mass peaks with known protein molecular masses or with spectra recorded of pure compounds or by separate biochemical assays. The MALDI mass spectra re; corded on different contact lenses contain peaks assignable to lysozyme and a number of smaller proteins. Such sensitive characterization of the early stages of biofouling enhances the understanding of protein/materials interactions and assists in designing guided strategies toward control of biological adsorption processes. (C) 1999 Academic Press.
C1 CSIRO Mol Sci, Clayton, Vic 3169, Australia.
RP Griesser, HJ (reprint author), CSIRO Mol Sci, Private Bag 10,Clayton S MDC, Clayton, Vic 3169, Australia.
EM h.griesser@molsci.csiro.au
RI Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863; Kingshott, Peter/0000-0001-5882-5804
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   BLACKLEDGE JA, 1995, ANAL CHEM, V67, P843, DOI 10.1021/ac00101a009
   BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Fenselau C, 1997, ANAL CHEM, V69, pA661, DOI 10.1021/ac971831z
   FRANKLIN VJ, 1993, TRENDS POLYM SCI, V1, P9
   GRIESSER HJ, 1997, POLYM MAT SCI ENG, V76, P79
   HLADY V, 1993, CLIN MATER, V13, P85, DOI 10.1016/0267-6605(93)90094-N
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HORBETT TA, 1995, ACS S SER, V602
   Huang ZH, 1999, ANAL BIOCHEM, V268, P305, DOI 10.1006/abio.1998.3085
   KARAS M, 1989, BIOMED ENVIRON MASS, V18, P841, DOI 10.1002/bms.1200180931
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KINGSHOTT P, 1999, UNPUB
   MCLEAN KM, 1999, IN PRESS COLLOIDS B
   MIREJOVSKY D, 1991, OPTOMETRY VISION SCI, V68, P858, DOI 10.1097/00006324-199111000-00005
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   STJOHN HAW, 1997, POLYM MAT SCI ENG, V76, P83
   STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008
   VESTLING MM, 1994, ANAL CHEM, V66, P471, DOI 10.1021/ac00076a009
   WEDLER FC, 1982, BIOCOMPATIBILITY CLI, V11, P1
   Worrall TA, 1998, ANAL CHEM, V70, P750, DOI 10.1021/ac970969e
   YAN GY, 1993, INVEST OPHTH VIS SCI, V34, P1804
NR 23
TC 35
Z9 36
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD SEP 10
PY 1999
VL 273
IS 2
BP 156
EP 162
DI 10.1006/abio.1999.4201
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 238MA
UT WOS:000082713000003
PM 10469485
DA 2018-10-19
ER

PT J
AU Santin, M
   Motta, A
   Freddi, G
   Cannas, M
AF Santin, M
   Motta, A
   Freddi, G
   Cannas, M
TI In vitro evaluation of the inflammatory potential of the silk fibroin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE silk fibroin; inflammation; protein adsorption; macrophage adhesion;
   monocyte activation
ID COMPLEMENT ACTIVATION; FIBROBLAST CELLS; SOLID-SURFACES; HUMAN MONOCYTE;
   IN-VITRO; ADSORPTION; MEMBRANES; POLYMER; ALPHA-1-MICROGLOBULIN;
   BIOMATERIAL
AB Silk fibroin membranes recently have been suggested as matrices for biomedical applications,,such as guided tissue regeneration and burn wound dressings. The aim of this study was to evaluate the inflammatory potential of fibroin films and to compare the fibroin films with two model materials with completely different physico-chemical properties: poly(styrene) and poly(2-hydroxyethyl methacrylate). Fibroin bound lower levels of fibrinogen than did the two synthetic polymers while the same amounts of adsorbed human plasma complement fragment C3 and IgG were detected. Studies of the binding strength of C3 to fibroin, evaluated by a novel experimental procedure, indicated the occurrence of strong hydrophobic interactions at the interface. The activation of the mononuclear cells by fibroin, measured as interleukin 1 beta production,was lower than the reference materials. Adhesion experiments showed the ability of the macrophages to adhere to fibroin by filopodia without a complete spreading of the cells. The results achieved in this study demonstrate that the interactions of fibroin with the humoral components of the inflammatory system were comparable with those of the two model surfaces while the degree of activatiorr and adhesion of the immunocompetent cells appeared more limited. (C) 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 382-389, 1999.
C1 Univ E Peidmont A Avogadro, Dept Med Sci, I-28100 Novara, Italy.
   Univ Brighton, Sch Pharm & Biomol sci, Brighton BN2 4GJ, E Sussex, England.
   Expt Silk Stn, I-20133 Milan, Italy.
RP Cannas, M (reprint author), Univ E Peidmont A Avogadro, Dept Med Sci, Via Solaroli 17, I-28100 Novara, Italy.
OI Motta, Antonella/0000-0003-4893-6863
CR ANDERSON JM, 1988, ASAIO, V11, P101
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Jirouskova M, 1997, J MATER SCI-MATER M, V8, P19, DOI 10.1023/A:1018534111419
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Mahiout A, 1997, J MATER SCI-MATER M, V8, P287, DOI 10.1023/A:1018560211844
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
NR 24
TC 319
Z9 332
U1 3
U2 57
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 1999
VL 46
IS 3
BP 382
EP 389
DI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 209QY
UT WOS:000081061000011
PM 10397996
DA 2018-10-19
ER

PT J
AU Ryan, JM
   Humphrey, JD
AF Ryan, JM
   Humphrey, JD
TI Finite element based predictions of preferred material symmetries in
   saccular aneurysms
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE aneurysm mechanics; stress-strain relations; remodeling; collagen
   microstructure
ID CEREBRAL ANEURYSMS; INTRACRANIAL ANEURYSMS; ARTERIES; COLLAGEN; MATRIX;
   STRESSES; GROWTH; MODEL; WALL
AB Over the years, various hypotheses have implicated the role of structural instabilities in the expansion of intracranial saccular aneurysms. Recent nonlinear analyses suggest, however, that particular subclasses of aneurysms are structurally stable (in the mechanics sense) and that we must consider different hypotheses. Indeed, based on an ever-increasing database, it appears that aneurysms may well expand via the remodeling of their constituents. Although more data and a kinetics-based formulation of remodeling are needed to examine this hypothesis, we present results from quasistatic finite element analyses of 12 subclasses of lesions that support the remodeling hypothesis. Briefly, we identify regional variations in material symmetry, for a class of noncomplicated axisymmetric lesions subjected to a uniform distension pressure, that minimize local maxima in multiaxial stress and tend to homogenize the stress field. Such symmetries are termed preferred. It is shown that the numerical predictions are consistent with the teleological concept that some intracranial saccular aneurysms will seek to become spherical, since the sphere is an optimal geometry for resisting a distension pressure. To achieve this, however, different subclasses must develop differently. Lesions having an initially large neck:height ratio must increase in height and therefore may seek to become increasingly stiffer circumferentially from the fundus to the neck. Conversely, lesions having an initially small neck:height ratio must increase in breadth and therefore may seek to become increasingly stiffer meridionally from the fundus to the neck. We submit that these results demonstrate the need for a detailed histological examination of regional variations in collagen organization in human lesions, for it is upon data that an analysis of remodeling must be founded. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00405-1].
C1 Texas A&M Univ, Zachry Engn Ctr 233, Biomed Engn Program, College Stn, TX 77843 USA.
RP Humphrey, JD (reprint author), Texas A&M Univ, Zachry Engn Ctr 233, Biomed Engn Program, College Stn, TX 77843 USA.
EM jdh@acs.tamu.edu
FU NHLBI NIH HHS [HL-54957]
CR AKKAS N, 1990, NATO ADV SCI I A-LIF, V193, P303
   ASARI S, 1994, ACTA MED OKAYAMA, V48, P257
   AUSTIN GM, 1989, NEUROSURGERY, V24, P722, DOI 10.1227/00006123-198905000-00011
   Bruno G, 1998, J NEUROSURG, V89, P431, DOI 10.3171/jns.1998.89.3.0431
   Canham PB, 1996, J MICROSC-OXFORD, V183, P170, DOI 10.1046/j.1365-2818.1996.840642.x
   CARVER W, 1991, CIRC RES, V69, P116, DOI 10.1161/01.RES.69.1.116
   CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600
   Connolly ES, 1997, NEUROSURGERY, V40, P903, DOI 10.1097/00006123-199705000-00003
   DZAU VJ, 1993, J CARDIOVASC PHARM, V21, pS1, DOI 10.1097/00005344-199321001-00001
   Gaetani P, 1998, LIFE SCI, V63, P285, DOI 10.1016/S0024-3205(98)00272-0
   Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1
   HUNG EJN, 1963, SURGERY ST LOUIS, V54, P347
   Kim SC, 1997, NEUROSURGERY, V41, P642, DOI 10.1097/00006123-199709000-00027
   Kyriacou SK, 1997, J BIOMECH, V30, P761
   Kyriacou SK, 1996, COMPUT MECH, V18, P269
   LANGILLE BL, 1993, J CARDIOVASC PHARM, V21, pS11
   Mimata C, 1997, ACTA NEUROPATHOL, V94, P197, DOI 10.1007/s004010050694
   NIMNI ME, 1992, CARDIOVASCULAR BIOMA
   NISSEN R, 1978, P NATL ACAD SCI USA, V75, P451, DOI 10.1073/pnas.75.1.451
   Rachev A, 1998, J BIOMECH ENG-T ASME, V120, P9, DOI 10.1115/1.2834313
   SCOTT S, 1972, CAN J PHYSIOL PHARM, V50, P328, DOI 10.1139/y72-049
   Shah AD, 1998, COMPUT METHOD BIOMEC, V1, P109, DOI 10.1080/01495739708936698
   Simkins TE, 1973, LETT APPL ENG SCI, V1, P85
   Sumpio BE, 1993, HEMODYNAMIC FORCES V
   Taber LA, 1998, J BIOMECH ENG-T ASME, V120, P348, DOI 10.1115/1.2798001
NR 25
TC 28
Z9 31
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1999
VL 27
IS 5
BP 641
EP 647
DI 10.1114/1.208
PG 7
WC Engineering, Biomedical
SC Engineering
GA 270CN
UT WOS:000084518000006
PM 10548333
DA 2018-10-19
ER

PT J
AU Xu, W
   Frank, TG
   Stockham, G
   Cuschieri, A
AF Xu, W
   Frank, TG
   Stockham, G
   Cuschieri, A
TI Shape memory alloy fixator system for suturing tissue in minimal access
   surgery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE finite element modelling; suturing; endoscopy
ID NICKEL-TITANIUM ALLOY
AB A new technique for suturing human tissue is described in which tissue closure is achieved by means of small fixators made from shape memory alloy. The aim of the development is to provide an alternative to thread suturing in minimal access surgery, which is quicker and requires less skill to achieve the required suturing quality. The design of the fixators is described in terms of the thermal shape recovery of shape memory alloy and a novel form of finite element analysis, which uses a nonlinear elastic element for the material property. Thermal analysis of the fixators and surrounding tissue is used to predict the temperature distribution during and after the application of electric current heating. This was checked in an in vitro experiment, which confirmed that deployment caused no detectable collateral damage to surrounding tissue. In vivo animal studies on the use of the shape memory alloy fixator for suturing tissue are ongoing to establish safety and healing effects. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00805-X].
C1 Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg, Dundee DD1 9SY, Scotland.
RP Frank, TG (reprint author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg, Dundee DD1 9SY, Scotland.
RI Cuschieri, Alfred/A-7634-2013
FU Wellcome Trust
CR ABSTEN GT, 1988, LASERS MED SURG INTR
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Cuschieri A., 1995, TISSUE APPROXIMATION
   Duerig TW, 1996, BIO-MED MATER ENG, V6, P255
   Duering TW, 1990, ENG ASPECTS SHAPE ME
   FUNAKUBO H, 1984, SHAPE MEMORY ALLOYS
   LING HC, 1981, MATER SCI ENG, V48, P241, DOI 10.1016/0025-5416(81)90008-2
   *SWANS AN SYST INC, 1996, ANSYS MAN VERS 5 3
   Szabo Z, 1994, Endosc Surg Allied Technol, V2, P55
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P271, DOI 10.1299/jsmea1988.35.3_271
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   XU W, 1998, 6 INT C NEW ACT BREM, P494
NR 13
TC 31
Z9 32
U1 1
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP-OCT
PY 1999
VL 27
IS 5
BP 663
EP 669
DI 10.1114/1.216
PG 7
WC Engineering, Biomedical
SC Engineering
GA 270CN
UT WOS:000084518000009
PM 10548336
DA 2018-10-19
ER

PT J
AU Gott, VL
   Daggett, RL
AF Gott, VL
   Daggett, RL
TI Serendipity and the development of heparin and carbon surfaces
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT Symposium on the Celebration of the 80th Birthday of C Walton Lillehei
CY OCT 23-25, 1998
CL MINNEAPOLIS, MINNESOTA
AB In the early 1960s, bileaflet valves fabricated with polymer housings routinely thrombosed within a few hours after implantation in the canine heart. In a serendipitous series of events, the authors found a way to bond heparin to these bileaflet valves using a coating of graphite-carbon and benzalkonium chloride. Over the ensuing 30 years, improved heparin coatings have been developed by other investigators for bonding to various biomedical devices; currently, about 25% of oxygenators used in this country utilize heparin coatings to minimize surface activation of clotting factors. Also, and somewhat serendipitously, a pyrolytic carbon material developed in the 1960s as a coating for nuclear fuel rods was submitted to the authors' laboratory for possible coating with benzalkonium and heparin. This carbon coating, developed at Gulf General Atomic, Inc, would not bond heparin, but it proved to be the best rigid material available for prosthetic valve construction; more than one million pyrolytic carbon valves have been clinically implanted over the last 29 years. (C) 1999 by The Society of Thoracic Surgeons.
C1 Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.
RP Gott, VL (reprint author), Johns Hopkins Hosp, Dept Surg, 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA.
CR Abramson HA, 1925, J EXP MED, V41, P445, DOI 10.1084/jem.41.4.445
   Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
   BOKROS J C, 1970, Journal of Biomedical Materials Research, V4, P145, DOI 10.1002/jbm.820040202
   Gorman RC, 1996, J THORAC CARDIOV SUR, V111, P1, DOI 10.1016/S0022-5223(96)70395-1
   Gott V L, 1972, Ann Thorac Surg, V14, P219
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GOTT VL, 1989, ANN THORAC SURG, V48, P528
   GRODE GA, 1969, T AM SOC ART INT ORG, V15, P1
   HSU L-C, 1991, Perfusion (London), V6, P209, DOI 10.1177/026765919100600310
   KALKE BR, 1969, PROSTHETIC HEART VAL, P285
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   SAWYER PN, 1953, AM J PHYSIOL, V175, P113
   VERDANT A, 1995, ANN THORAC SURG, V60, P1151, DOI 10.1016/0003-4975(95)00172-H
   VONSEGESSER LK, 1994, ANN THORAC SURG, V58, P391
NR 14
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 1999
VL 68
IS 3
SU S
BP S19
EP S22
DI 10.1016/S0003-4975(99)00817-6
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 240AW
UT WOS:000082804300005
PM 10505985
DA 2018-10-19
ER

PT J
AU Lowe, KC
AF Lowe, KC
TI Perfluorinated blood substitutes and artificial oxygen carriers
SO BLOOD REVIEWS
LA English
DT Review
ID RESPIRATORY-DISTRESS SYNDROME; PARTIAL LIQUID VENTILATION;
   PERFLUOROCARBON EMULSION MIXTURES; PERFLUOROCHEMICAL EMULSIONS; TISSUE
   OXYGENATION; GAS-EXCHANGE; PERFLUBRON EMULSION; HUMAN HEMOGLOBIN;
   DRUG-DELIVERY; TRANSPORT
AB Blood transfusion is a remarkably safe, routine clinical procedure. However, the need for sophisticated blood processing, storage and cross-matching, coupled with increasing concerns about the safety of blood products, has fuelled the search for safe and efficacious substitutes. Candidate materials based on modified haemoglobin (including recombinant molecules) or highly inert, respiratory gas-dissolving perfluorinated liquids (perfluorochemicals) have been developed. The latter are immiscible in aqueous systems and must, therefore, be injected as emulsions. Second-generation perfluorochemical emulsions are available and in clinical trials as temporary intravascular oxygen carriers during surgery, thereby reducing patient exposure to donor blood. One commercial product is currently under Phase III clinical evaluation, with regulatory approval expected within 1-2 years. Other biomedical applications for perfluorochemicals and their emulsions include their use as pump-priming fluids for cardiopulmonary bypass, lung ventilation fluids, anti-cancer agents, organ perfusates and cell culture media supplements, diagnostic imaging agents and ophthalmologic tools. Novel applications for perfluorochemicals as immunomodulating agents are also being explored. (C) 1999 Harcourt Publishers Ltd.
C1 Univ Nottingham, Sch Biol Sci, Nottingham NG7 2RD, England.
RP Lowe, KC (reprint author), Univ Nottingham, Sch Biol Sci, Univ Pk, Nottingham NG7 2RD, England.
CR AUBUCHON JP, 1994, PRO TRANSFUSION, V34, P79
   Batman C, 1998, OPHTHALMIC SURG LAS, V29, P144
   BATRA S, 1996, ARTIF CELL BLOOD SUB, V24, P307
   BOLLANDS AD, 1989, BLOOD SUBSTITUTES, P451
   BRAUN RD, 1992, J APPL PHYSIOL, V72, P1960
   CHANG S, 1992, INT OPHTHALMOL CLIN, V32, P153, DOI 10.1097/00004397-199203220-00014
   Chang TMS, 1998, VOX SANG, V74, P233, DOI 10.1111/j.1423-0410.1998.tb05425.x
   Chang TMS, 1997, ARTIF CELL BLOOD SUB, V25, P1, DOI 10.3109/10731199709118893
   CHANG TMS, 1998, BLOOD SUBSTITUTES PR, V1
   CHANG TMS, 1998, BLOOD SUBSTITUTES PR, V2
   CHEN HS, 1989, BLOOD SUBSTITUTES, P403
   CLARK LC, 1966, SCIENCE, V152, P1755, DOI 10.1126/science.152.3730.1755
   CLARK LC, 1992, BIOMAT ARTIF CELL IM, V20, P1085, DOI 10.3109/10731199209119767
   CONE A, 1995, BRIT J HOSP MED, V54, P155
   Dieryck W, 1997, NATURE, V386, P29, DOI 10.1038/386029b0
   Dietz NM, 1996, ANESTH ANALG, V82, P390, DOI 10.1097/00000539-199602000-00032
   Eckmann DM, 1998, ARTIF CELL BLOOD SUB, V26, P359, DOI 10.3109/10731199809117677
   Eckmann DM, 1998, ARTIF CELL BLOOD SUB, V26, P259, DOI 10.3109/10731199809117457
   Edwards CM, 1997, ARTIF CELL BLOOD SUB, V25, P255, DOI 10.3109/10731199709118915
   FAITHFULL NS, 1992, BIOMAT ARTIF CELL IM, V20, P797, DOI 10.3109/10731199209119721
   FAITHFULL NS, 1994, ARTIF CELL BLOOD SUB, V22, P181, DOI 10.3109/10731199409117413
   FAITHFULL NS, 1994, OXYGEN TRANSPORT TIS, V16, P41
   Flaim S. F., 1997, ADV BLOOD SUBSTITUTE, P91
   FORMAN MB, 1992, J AM COLL CARDIOL, V19, P205, DOI 10.1016/0735-1097(92)90074-W
   FORMAN MB, 1992, CLIN HEMORHEOL, V12, P121
   FRATANTONI JC, 1998, BLOOD CELL SUBSTITUT, P29
   FUHRMAN BP, 1994, ARTIF CELL BLOOD SUB, V22, P1133, DOI 10.3109/10731199409138808
   Gerstmann DR, 1996, PEDIATRICS, V98, P1044
   GERVITS LL, 1994, FLUORINE MED 21 CENT, P197
   GILLON J, 1994, TRANSFUSION, V34, P269, DOI 10.1046/j.1537-2995.1994.34394196629.x
   Grauer SE, 1996, AM HEART J, V132, P938, DOI 10.1016/S0002-8703(96)90002-2
   Habler OP, 1998, TRANSFUSION, V38, P145, DOI 10.1046/j.1537-2995.1998.38298193096.x
   Hirschl RB, 1996, JAMA-J AM MED ASSOC, V275, P383, DOI 10.1001/jama.275.5.383
   HORSMAN MR, 1995, ACTA ONCOL, V34, P571, DOI 10.3109/02841869509094031
   Ivanitskii G. R., 1996, Biophysics (English Translation of Biofizika), V41, P189
   Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0
   KABALNOV A, 1995, LANGMUIR, V11, P2966, DOI 10.1021/la00008a020
   KAUFMAN RJ, 1995, BLOOD SUBSTITUTES, P53
   KEIPERT PE, 1995, ARTIF CELL BLOOD SUB, V23, P381, DOI 10.3109/10731199509117954
   KEIPERT PE, 1998, BLOOD SUBST PRINC ME, V2, P127
   KEIPERT PE, 1997, P 7 INT S BLOOD SUBS, P38
   KEIPERT PE, 1998, P 6 IBC C BLOOD SUBS
   KERINS DM, 1994, AM J MED SCI, V307, P218, DOI 10.1097/00000441-199403000-00009
   LANZA GM, 1997, CIRCULATION, V95, P3334
   LEACH C, 1996, NEW ENGL J MED, P761
   LEMON DD, 1996, ARTIF CELL BLOOD SUB, V24, P378
   Leonard RC, 1998, ANAESTH INTENS CARE, V26, P11
   LOPEZ R, 1992, AM J OPHTHALMOL, V113, P424, DOI 10.1016/S0002-9394(14)76166-5
   Lowe KC, 1998, TRENDS BIOTECHNOL, V16, P272, DOI 10.1016/S0167-7799(98)01205-0
   LOWE KC, 1994, VASC MED REV, V5, P15
   LOWE KC, 1988, OXYGEN TRANSPORT TIS, V10, P655
   LOWE KC, 1998, PRESENT FUTRE PERSPE, P327
   LOWE KC, 1998, ABC TRANSFUSION, P71
   Lowe Kenneth C., 1997, Science Progress, V80, P169
   MATTREY RF, 1994, ARTIF CELL BLOOD SUB, V22, P295, DOI 10.3109/10731199409117422
   MCGREGOR DP, 1996, BIOTECHNIQUES, V21, P672
   MEINERT H, 1992, BIOMAT ARTIF CELL IM, V20, P95, DOI 10.3109/10731199209117860
   Monk TG, 1995, AM J SURG, V170, pS69, DOI 10.1016/S0002-9610(99)80063-4
   MOORE RE, 1982, OXYGEN CARRYING COLL, P50
   MUKERJI B, 1991, TRANSFUSION, V31, P24
   Ni Y, 1996, ARTIF CELL BLOOD SUB, V24, P81, DOI 10.3109/10731199609118876
   OHYANAGI H, 1995, ARTIFICIAL RED CELLS, P199
   Patel S, 1998, ASAIO J, V44, P157, DOI 10.1097/00002480-199805000-00007
   Patel S, 1998, ASAIO J, V44, P144, DOI 10.1097/00002480-199805000-00006
   Perevedentseva EV, 1998, ARTIF CELL BLOOD SUB, V26, P223, DOI 10.3109/10731199809119780
   PEYMAN GA, 1995, SURV OPHTHALMOL, V39, P375
   QUAY SC, 1994, J ULTRAS MED, V13, P59
   RIESS JG, 1984, ARTIF ORGANS, V8, P44, DOI 10.1111/j.1525-1594.1984.tb04243.x
   Riess JG, 1996, CURR OPIN COLLOID IN, V1, P652, DOI 10.1016/S1359-0294(96)80104-X
   Riess JG, 1997, ARTIF CELL BLOOD SUB, V25, P43, DOI 10.3109/10731199709118896
   Riess JG, 1998, BIOMATERIALS, V19, P1529, DOI 10.1016/S0142-9612(98)00071-4
   RIESS JG, 1998, BLOOD SUBSTITUTES PR, V2, P101
   ROATH S, 1991, BRIT MED J, V303, P659, DOI 10.1136/bmj.303.6804.659
   ROCKWELL S, 1994, ARTIF CELL BLOOD SUB, V22, P1097, DOI 10.3109/10731199409138805
   Roddie PH, 1997, BLOOD REV, V11, P169, DOI 10.1016/S0268-960X(97)90017-5
   Rosoff JD, 1996, ANESTH ANALG, V82, pSC123
   Rossman JE, 1996, J PEDIATR SURG, V31, P1147, DOI 10.1016/S0022-3468(96)90105-0
   RUDOLPH AS, 1998, RED BLOOD CELL SUBST
   Saegusa A, 1998, NATURE, V392, P3, DOI 10.1038/31992
   SHAFFER TH, 1992, PEDIATR PULM, V14, P102, DOI 10.1002/ppul.1950140208
   Shah N, 1996, ASAIO J, V42, P181, DOI 10.1097/00002480-199605000-00011
   SHARMA SK, 1989, BLOOD SUBSTITUTES, P447
   Smith KM, 1997, CRIT CARE MED, V25, P1179, DOI 10.1097/00003246-199707000-00020
   SMITH TM, 1995, CRIT CARE MED, V231, P533
   Soheilian M, 1997, INT OPHTHALMOL, V20, P241
   SPENCE RK, 1996, PRINCIPLES TRANSFUSI, P189
   Spiess BD, 1996, J CARDIOTHOR VASC AN, V10, P83, DOI 10.1016/S1053-0770(96)80182-0
   Stavis RL, 1998, PEDIATR RES, V43, P132, DOI 10.1203/00006450-199801000-00020
   STEHLING L, 1994, PRO TRANSFUSION, V34, P265
   Sukumar M, 1998, J APPL PHYSIOL, V84, P327
   TEICHER BA, 1995, ARTIF CELL BLOOD SUB, V23, P395, DOI 10.3109/10731199509117955
   TEICHER BA, 1994, ARTIF CELL BLOOD SUB, V22, P1109, DOI 10.3109/10731199409138806
   TUTUNCU AS, 1993, CRIT CARE MED, V21, P962
   Vaslef S N, 1994, ASAIO J, V40, pM643, DOI 10.1097/00002480-199407000-00077
   Wahr JA, 1996, ANESTH ANALG, V82, P103, DOI 10.1097/00000539-199601000-00018
   Warden J, 1998, BRIT MED J, V317, P232, DOI 10.1136/bmj.317.7153.232a
   Wilbanks GA, 1996, CORNEA, V15, P329, DOI 10.1097/00003226-199605000-00017
   WINSLOW RM, 1995, NAT MED, V1, P1212, DOI 10.1038/nm1195-1212
   WINSLOW RM, 1996, BLOOD SUBSTITUTES
   WNSLOW RM, 1997, ADV BLOOD SUBSTITUTE
   WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1024
   ZARITSKII AR, 1993, RUSS J PHYS CHEM, V67, P533
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
   Zuckerman SH, 1998, ARTIF CELL BLOOD SUB, V26, P231, DOI 10.3109/10731199809117456
NR 104
TC 72
Z9 73
U1 2
U2 23
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0268-960X
J9 BLOOD REV
JI Blood Rev.
PD SEP
PY 1999
VL 13
IS 3
BP 171
EP 184
DI 10.1054/blre.1999.0113
PG 14
WC Hematology
SC Hematology
GA 243VR
UT WOS:000083018600005
PM 10527269
DA 2018-10-19
ER

PT J
AU Licht, PB
   Christensen, HW
   Svendsen, P
   Hoilund-Carlsen, PF
AF Licht, PB
   Christensen, HW
   Svendsen, P
   Hoilund-Carlsen, PF
TI Vertebral artery flow and cervical manipulation: An experimental study
SO JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS
LA English
DT Article
DE chiropractic manipulation; vertebral artery; volume flow; transit time;
   doppler
ID VERTEBROBASILAR INSUFFICIENCY; BLOOD-FLOW; SPINE
AB Background: Spinal manipulation therapy is used by millions of patients each year to relieve symptoms caused by biomechanical dysfunction of the spine. Cerebrovascular accidents in the posterior cerebral circulation are a feared complication, but little research has been done on vertebral artery hemodynamics during cervical manipulation.
   Objective: The purpose of this study was to develop an experimental model for investigations of volume blood flow changes in the vertebral arteries during premanipulative testing of these vessels and during spinal manipulation therapy of the cervical spine.
   Design and Setting: An experimental study in a university biomedical laboratory.
   Material and Methods: The vertebral arteries were exposed in 8 adult pigs after extensive mediastinal dissection. Volume blood now was measured on both sides simultaneously by advanced transit-time flowmetry.
   Results: After cervical manipulation, the vertebral artery volume blood flow increased significantly for 40 seconds before returning to baseline values in less than 3 minutes. We found no significant changes in volume blood flow during premanipulative testing of the vertebral arteries (DeKleyn's test).
   Conclusion: We present an experimental model for investigations of vertebral artery hemodynamics during biomechanical interventions. We found a modest and transient effect of cervical manipulation on vertebral artery Volume flow. The model may have further applications in future biomechanical research, for example, to determine whether any of several spinal manipulative techniques imposes less strain on the vertebral artery, thereby reducing possible future cerebrovascular accidents after such treatment.
C1 Odense Univ Hosp, Dept Clin Physiol & Nucl Med, DK-5000 Odense, Denmark.
   Nord Inst Chiropract & Clin Biomech, Odense, Denmark.
   Odense Univ, Biomed Lab, Odense, Denmark.
RP Licht, PB (reprint author), Odense Univ Hosp, Dept Clin Physiol & Nucl Med, Sonder Blvd 29, DK-5000 Odense, Denmark.
CR Alback A, 1996, ANN CHIR GYNAECOL FE, V85, P325
   AUSMAN JI, 1985, ARCH NEUROL-CHICAGO, V42, P803, DOI 10.1001/archneur.1985.04210090071021
   *AUSTR PHYS ASS, 1988, AUSTR J PHYSIOTHERAP, V34, P97
   BAUER R, 1961, ARCH NEUROL-CHICAGO, V4, P119, DOI 10.1001/archneur.1961.00450080001001
   BROWN BS, 1963, RADIOLOGY, V81, P80, DOI 10.1148/81.1.80
   CAREY PF, 1995, J CAN CHIROPR ASS, V39, P35
   CIPRIANO JJ, 1997, PHOTOGRAPHIC MANUAL, P31
   Cote P, 1996, J Manipulative Physiol Ther, V19, P159
   CRAWFORD JP, 1984, J MANIP PHYSIOL THER, V7, P149
   DVORAK J, 1991, MANUAL MED, V6, P117
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   FAST A, 1987, SPINE, V12, P840, DOI 10.1097/00007632-198711000-00003
   GEORGE PE, 1981, J CHIROPR, V15, P26
   Grant R, 1996, MANUAL THER, V1, P149
   HARDESTY WH, 1963, SURG GYNECOL OBSTET, V116, P662
   Haynes M J, 1996, J Manipulative Physiol Ther, V19, P378
   Hurwitz EL, 1996, SPINE, V21, P1746, DOI 10.1097/00007632-199608010-00007
   HUSNI EA, 1966, J AMER MED ASSOC, V196, P475, DOI 10.1001/jama.196.6.475
   Ivancic JJ, 1993, CHIROPR J AUST, V23, P59
   KAWCHUK GN, 1993, J MANIP PHYSIOL THER, V16, P573
   Kuether TA, 1997, NEUROSURGERY, V41, P427, DOI 10.1097/00006123-199708000-00019
   Kunnasmaa KTT, 1994, J ORTHOPAEDIC MED, V16, P17
   Laustsen J, 1996, EUR J VASC ENDOVASC, V12, P91, DOI 10.1016/S1078-5884(96)80282-6
   LEE KP, 1995, NEUROLOGY, V45, P1213, DOI 10.1212/WNL.45.6.1213
   Licht PB, 1998, J MANIP PHYSIOL THER, V21, P141
   LICHT PB, 1998, J MANIP PHYSIOL THER, V21, P29
   REFSHAUGE KM, 1994, J MANIP PHYSIOL THER, V17, P15
   RIVETT DA, 1998, MANUAL THER, V3, P102
   SAKAI F, 1988, STROKE, V19, P1426, DOI 10.1161/01.STR.19.11.1426
   STEVENS A, 1991, MANUAL MED, V6, P102
   THIEL H, 1994, CLIN BIOMECH, V9, P105, DOI 10.1016/0268-0033(94)90032-9
   TOOLE JF, 1960, ARCH NEUROL-CHICAGO, V2, P616, DOI 10.1001/archneur.1960.03840120022003
   Weingart JR, 1992, MANUELLE MED, V30, P62
   1934, JAMA, V103, P1260
NR 34
TC 15
Z9 15
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0161-4754
J9 J MANIP PHYSIOL THER
JI J. Manip. Physiol. Ther.
PD SEP
PY 1999
VL 22
IS 7
BP 431
EP 435
DI 10.1016/S0161-4754(99)70030-8
PG 5
WC Health Care Sciences & Services; Integrative & Complementary Medicine;
   Rehabilitation
SC Health Care Sciences & Services; Integrative & Complementary Medicine;
   Rehabilitation
GA 241XH
UT WOS:000082908800001
PM 10519558
DA 2018-10-19
ER

PT J
AU Korematsu, A
   Li, YJ
   Murakami, T
   Nakaya, T
AF Korematsu, A
   Li, YJ
   Murakami, T
   Nakaya, T
TI Synthesis and blood compatibilities of novel segmented polyurethanes
   containing phosphatidylcholine analogous moieties in the main chains and
   long-chain alkyl groups in the side chains
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID PHOSPHOLIPID POLYURETHANES; COMPATIBLE POLYURETHANES; BIOMEDICAL
   APPLICATIONS; POLY(BUTADIENE); POLYMERS; SURFACE
AB New segmented polyurethanes containing phospholipid moieties in the main chains and long-chain alkyl groups in the side chains were synthesized. The soft segments used in this study were poly(butadiene), poly(isoprene), hydrogenated poly(isoprene), and poly( 1,6-hexyl-1,2-ethylcarbonate) diol. The hard segments of these polyurethanes were 4,4'-methylenediphenyl diisocyanate, bis[2-(2-hydroxyethyLdimethylammonio)ethyl]2-cetyl-1,3-propanediphosphate, and 1,4-butanediol. The blood compatibilities of the new polymers were evaluated by platelet-rich plasma contact studies and viewed by scanning electron microscopy using medical grade BioSpan(R) and nonphospholipid polyurethane as references. These new materials have good surfaces in terms of platelet adhesion, and the morphology of adhered platelets undergoes a relatively low degree of variation.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, P 8 ANN SOC BIOM, P24
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   HARA K, 1993, SEIRIKASSEISHISHITSU, P112
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, HYOMEN, V28, P720
   Korematsu A, 1999, J MATER CHEM, V9, P647, DOI 10.1039/a806279j
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Li YJ, 1997, MACROMOL SYMP, V122, P363, DOI 10.1002/masy.19971220156
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   Nakabayashi N, 1996, MACROMOL SYMP, V101, P405, DOI 10.1002/masy.19961010146
   NAKATA M, 1997, KOBUNSHI, V46, P558
   NAKAYA T, 1987, KAGAKU, V42, P725
   NAKAYA T, 1986, Patent No. 207395
   SAKURAI I, 1992, MACROMOLECULES, V25, P7256, DOI 10.1021/ma00052a029
   Saunders J.H., 1962, POLYURETHANE CHEM 1
   SUNG CSP, 1979, J BIOMED MATER RES, V13, P161
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P19
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P835, DOI 10.1002/jbm.820290708
   WARD RS, 1994, P TOP S 8 MAT CLIN A
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
NR 32
TC 6
Z9 7
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD SEP
PY 1999
VL 14
IS 9
BP 3789
EP 3798
DI 10.1557/JMR.1999.0513
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 304RX
UT WOS:000086498900043
DA 2018-10-19
ER

PT J
AU Park, HJ
   Yoo, JJ
   Kershen, RT
   Moreland, R
   Atala, A
AF Park, HJ
   Yoo, JJ
   Kershen, RT
   Moreland, R
   Atala, A
TI Reconstitution of human corporal smooth muscle and endothelial cells in
   vivo
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Section on Urology, of the
   American-Academy-of-Pediatrics
CY OCT 17-19, 1998
CL SAN FRANCISCO, CALIFORNIA
SP Amer Acad Pediat, Sect Urol
DE penis; tissue; polymers; mice; nude; biomedical engineering
ID IN-VITRO; SYSTEM
AB Purpose: The availability of autologous erectile tissue composed of corporal smooth muscle and endothelial cells would be beneficial in patients undergoing penile reconstruction. We previously showed that cultured cavernous cells seeded on polymer scaffolds form corporal muscle when implanted in vivo. However, to reconstruct corporal tissue endothelial and corporal muscle cells are necessary. In this study we investigated the possibility of developing tissue composed of corporal cells in vivo by combining smooth muscle and endothelial cells.
   Materials and Methods: Human corporal smooth muscle and endothelial cells were seeded on biodegradable polyglycolic acid polymer scaffolds at concentrations of 20 X 10(6) and 10 x 10(6) cells per cm.(3), respectively. A total of 60 polymer scaffolds seeded with cells and 20 control polymers without cells were implanted in the subcutaneous space of 20 athymic mice. Mice were sacrificed 1, 3, 5, 7, 14, 21, 28 and 42 days, respectively, after implantation. Immunocytochemical and histochemical analyses were performed with antifactor VIII, antipancytokeratins and anti-alpha actin antibodies.
   Results: Histologically the retrieved polymers seeded with corporal smooth muscle and endothelial cells showed the formation of multilayered smooth muscle strips adjacent to endothelial cells 7 days after implantation. Increased organization of the smooth muscle tissue and accumulation of endothelium lining the luminal structures were evident by 14 days. A well organized tissue construct was noted 28 and 42 days after implantation. There was no evidence of tissue formation in controls. Immunocytochemical analysis using antifactor VIII to identify native vasculature only and antipancytokeratins to identify ECV 304 endothelial cells only distinguished the origin of the vascular structures in each construct. Anti-alpha-actin confirmed the smooth muscle phenotype.
   Conclusions: Human corporal smooth muscle and endothelial cells seeded on biodegradable polymer scaffolds formed vascularized corpus cavernosum muscle when implanted in vivo. To our knowledge this is the first demonstration in tissue engineering in which capillary formation was facilitated by the addition of endothelial cells in composite tissue in vivo.
C1 Childrens Hosp, Dept Urol, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Boston Univ, Dept Urol, Boston, MA 02215 USA.
RP Park, HJ (reprint author), Childrens Hosp, Dept Urol, Lab Tissue Engn & Cellular Therapeut, 300 Longwood Ave, Boston, MA 02115 USA.
OI Atala, Anthony/0000-0001-8186-2160
CR ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   Atala Anthony, 1997, P149
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   GOODWIN WE, 1952, J UROLOGY, V68, P903
   HERRING M, 1978, SURGERY, V84, P498
   HORTON CE, 1990, WORLD J SURG, V14, P757, DOI 10.1007/BF01670522
   Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168
   KERSHEN RT, 1998, J UROLOGY, V159, P156
   MACHLUF M, 1998, GRAFT, V1, P31
   MORELAND RB, 1995, J UROLOGY, V153, P826, DOI 10.1016/S0022-5347(01)67730-9
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   RIEHMANN M, 1993, J UROLOGY, V149, P1304, DOI 10.1016/S0022-5347(17)36375-9
   TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   WOODHOUSE CRJ, 1994, J UROLOGY, V152, P645, DOI 10.1016/S0022-5347(17)32673-3
   Yoo JJ, 1997, J UROLOGY, V158, P1066, DOI 10.1016/S0022-5347(01)64390-8
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 17
TC 84
Z9 87
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD SEP
PY 1999
VL 162
IS 3
BP 1106
EP 1109
DI 10.1016/S0022-5347(01)68084-4
PN 2
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 225NF
UT WOS:000081967100046
PM 10458441
DA 2018-10-19
ER

PT J
AU Nagpaul, PS
AF Nagpaul, PS
TI Transnational linkages of Indian science: A structural analysis
SO SCIENTOMETRICS
LA English
DT Article
ID INTERNATIONAL SCIENTIFIC COLLABORATION
AB This study analyzes the pattern of transnational linkages of Indian science in eleven scientific fields (Mathematics, Physics, Chemistry, Biology, Earth & Space Science, Agriculture, Clinical Medicine, Biomedical Research, Engineering & Technology, Computer Science, and Materials Science) during the five-year period: 1990-1994. The following indicators are constructed to examine inter-field and inter-country differences in India's transnational linkages: Internationalization index, Cooperation index, Cooperation extensiveness index and Affinity index. A four-category typology is proposed to classify the fields according to their propensities for attracting bilateral and multilateral cooperation with foreign countries.
   The structure of multidimensional system of relationships between India's thirty-five most significant partner countries and eleven scientific fields is analyzed through correspondence analysis. A series of correspondence analyses are carried out on subsets of the multidimensional data to reveal the fine-grained structure of India's cooperation links in clusters of specific fields and with clusters of specific countries.
C1 Natl Inst Sci Technol & Dev Studies, New Delhi 110012, India.
RP Nagpaul, PS (reprint author), Natl Inst Sci Technol & Dev Studies, Dr KS Krishnan Marg, New Delhi 110012, India.
CR Abd el Kader M, 1998, SCIENTOMETRICS, V42, P405, DOI 10.1007/BF02458379
   ARUNACHALAM S, 1994, SCIENTOMETRICS, V30, P7, DOI 10.1007/BF02017209
   BASU A, 1999, 7 INT INT C SCI INF
   *BIE, 1996, SCI SYST INT BENCHM
   BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806
   Braun T, 1996, SCIENTOMETRICS, V36, P247, DOI 10.1007/BF02017317
   DOBROV GM, 1990, SOCIOLOGY SCI RES
   ENGELSMAN EC, 1994, RES POLICY, V23, P1, DOI 10.1016/0048-7333(94)90024-8
   FEME G, 1989, RECHERCHE, V20, P428
   JAMBU M, 1991, EXPLORATORY MULTIVAR
   LUUKKONEN T, 1993, SCIENTOMETRICS, V28, P15, DOI 10.1007/BF02016282
   LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106
   NAGPAUL PS, 1994, SCIENTOMETRICS, V31, P97, DOI 10.1007/BF02018104
   NAGPAUL PS, 1997, TRANSNATIONAL LINKAG
   NAGPAUL PS, UNPUB EMERGING TREND
   Narin F., 1990, 12900 EUR EN COMM EU
   *OECD, 1992, SCI TECHN POL REV OU, P69
   Salomon Jean-Jacques, 1964, MINERVA, V2, P411
   TIJSSEN RJW, 1991, RES REPORT COMMISSIO
NR 19
TC 8
Z9 8
U1 4
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0138-9130
J9 SCIENTOMETRICS
JI Scientometrics
PD SEP
PY 1999
VL 46
IS 1
BP 109
EP 140
DI 10.1007/BF02766298
PG 32
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA 244DX
UT WOS:000083037500008
DA 2018-10-19
ER

PT J
AU Ohl, A
   Schroder, K
AF Ohl, A
   Schroder, K
TI Plasma-induced chemical micropatterning for cell culturing applications:
   a brief review
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Plasma Surface Engineering (PSE 98)
CY SEP 14-18, 1998
CL GARMISCH PARTENKI, GERMANY
SP European Joint Comm Plasma & Ion Surface Engn
DE biomaterials; cell culturing; low-temperature plasma; micropatterning;
   polymer scaffold; surface modification
ID COPLANAR MOLECULAR ASSEMBLIES; ETHYLENE-PROPYLENE FILMS; GLOW-DISCHARGE
   TREATMENT; VEIN ENDOTHELIAL-CELLS; BIOMEDICAL APPLICATIONS; SURFACE
   IMMOBILIZATION; RADIOFREQUENCY PLASMAS; BIOMATERIAL SURFACES;
   INTRAOCULAR LENSES; INITIAL ATTACHMENT
AB Plasma-induced chemical micropatterning for cell culturing is a new field of plasma surface modification of biomaterials. It is based on a trend to miniaturization of detailed structures of tissue culture scaffolds. In the present paper plasma methods are discussed with respect to other techniques which also induce micropatterned cell growth. Plasma-based methods might have certain advantages regarding modification of various biocompatible materials. Examples are given to demonstrate this. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Inst Low Temp Plasma Phys, D-17489 Greifswald, Germany.
RP Ohl, A (reprint author), Inst Low Temp Plasma Phys, FL Jahn Str 19, D-17489 Greifswald, Germany.
EM ohl@inp.greifswald.de
CR Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BHATIA SK, 1992, J AM CHEM SOC, V114, P4432, DOI 10.1021/ja00037a077
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P106, DOI 10.1007/BF00703468
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   Chau TT, 1996, BIOMATERIALS, V17, P1273, DOI 10.1016/S0142-9612(96)80003-2
   CHESMEL K, 1989, T ANN M SOC BIOMATER, V12, P1
   Chinn J. A., 1994, Journal of Tissue Culture Methods, V16, P155, DOI 10.1007/BF01540643
   CLARK P, 1992, J CELL SCI, V103, P287
   CLARK P, 1993, J CELL SCI, V105, P203
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   CONNOLLY P, 1994, TRENDS BIOTECHNOL, V12, P123, DOI 10.1016/0167-7799(94)90089-2
   CURTIS A, 1994, ENABLING TECHNOLOGIE, P99
   CURTIS ASG, 1992, J CELL SCI, V101, P427
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   DUNN GA, 1995, BIOMEDICAL ENG, P1679
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Flounders AW, 1997, BIOSENS BIOELECTRON, V12, P447, DOI 10.1016/S0956-5663(96)00064-4
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Fortsch M, 1993, Ophthalmologe, V90, P754
   FROMHERZ P, 1991, NEUROSCI LETT, V129, P77, DOI 10.1016/0304-3940(91)90724-8
   Fuhr G., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P47
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HOLLER C, 1993, ZBL HYG UMWELTMED, V194, P380
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JANSEN J, 1997, VACUUM SOLUTIONS, P25
   KAMEL I, 1994, Patent No. 5326584
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KESSLER L, 1995, BIOMATERIALS, V16, P185, DOI 10.1016/0142-9612(95)92116-N
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   Kiss E, 1987, PROG COLLOID POLYM S, V74, P113
   KLEE D, 1995, SPEKT WISS, V9, P90
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   KOHNEN W, 1994, BIOTECHNOLOGY AND BIOACTIVE POLYMERS, P317
   LaRocca P, 1996, CELL LINE, V6, P1
   Lhoest JB, 1996, J BIOMAT SCI-POLYM E, V7, P1039, DOI 10.1163/156856296X00534
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MAN N K, 1990, Artificial Organs, V14, P44
   MAROUDAS NG, 1973, NATURE, V244, P353, DOI 10.1038/244353a0
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Matsuda T, 1992, ASAIO J, V38, pM243, DOI 10.1097/00002480-199207000-00029
   MOY E, 1994, COLLOID POLYM SCI, V272, P1245, DOI 10.1007/BF00657777
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   OHL A, 1997, P 13 INT S PLASM CHE, V3, P1259
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   OKADA T, 1992, J BIOMED MATER RES, V26, P1569, DOI 10.1002/jbm.820261204
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   ROZSNYAI LF, 1992, ANGEW CHEM INT EDIT, V31, P759, DOI 10.1002/anie.199207591
   Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1
   Schnelle T, 1996, LANGMUIR, V12, P801, DOI 10.1021/la950065t
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SHAY JW, 1977, EXP CELL RES, V105, P1, DOI 10.1016/0014-4827(77)90146-X
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Steele JG, 1995, ACS SYM SER, V602, P436
   STENGER DA, 1992, J AM CHEM SOC, V114, P8435, DOI 10.1021/ja00048a013
   THELEN H, 1995, FRESEN J ANAL CHEM, V353, P290, DOI 10.1007/BF00322054
   TIDWELL CD, 1997, LANGMUIR, V13, P4304
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   YUAN S, 1993, J BIOMED MATER RES, V27, P811, DOI 10.1002/jbm.820270614
NR 85
TC 84
Z9 85
U1 1
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP
PY 1999
VL 116
BP 820
EP 830
DI 10.1016/S0257-8972(99)00150-4
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 259VG
UT WOS:000083914200130
DA 2018-10-19
ER

PT J
AU Van Alstine, JM
   Malmsten, M
   Long, MM
   Johnson, VK
   DeLucas, LJ
AF Van Alstine, JM
   Malmsten, M
   Long, MM
   Johnson, VK
   DeLucas, LJ
TI Polymer coatings for improved protein crystal growth
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE adsorption; crystal growth; DLVO; ellipsometry; PEG; polymer; protein
ID AIR-WATER-INTERFACE; POLYETHYLENE OXIDE; POLYSTYRENE SURFACES;
   POLY(ETHYLENE OXIDE); HYDROPHOBIC SURFACES; ADSORPTION BEHAVIOR;
   PLATELET-ADHESION; MOLECULAR-WEIGHT; BLOCK-COPOLYMERS; MICROGRAVITY
AB The ability to grow quality protein crystals is necessary to analyze protein structure by X-ray diffraction and related techniques. As such it plays a key role in enzymology, structure-based drug design, molecular biology, and other biomedical areas. It is also required for macromolecule purification by crystallization. Protein crystal growth (PCG) may be negatively influenced by various factors related to nonspecific adsorption and adherence at growth chamber surfaces. Such factors include nucleation and growth of flawed crystals at chamber walls, or wall growth blockage of optical monitoring paths. Surface localized poly(ethylene glycol) (PEG) and other neutral, hydrophilic polymers are known to significantly reduce nonspecific adsorption of biological macromolecules and particles. Preliminary studies, involving various PCG methods (temperature induction, vapor diffusion), apparatii (test tubes, cuvettes, and specialized PCG hardware), growth chamber materials (glass, polystyrene, polysulfone), chamber volumes (0.1-10 mi) and protein samples (lysozyme, thaumatin, insulin) indicate the potential of PEG coatings to significantly reduce problems related to adsorption in PCG. The results, which match the ability of such coatings to reduce protein adsorption as evaluated by both ellipsometry and enzyme linked immunoassay, are discussed in relation to colloidal stabilization theory and properties of PEG coated surfaces. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Royal Inst Technol, KET TS, Dept Chem Engn & Technol, SE-10044 Stockholm, Sweden.
   Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   Inst Surface Chem, SE-11486 Stockholm, Sweden.
   Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA.
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Azzam R. M. A., 1989, ELLIPSOMETRY POLARIZ
   BALL V, 1998, BIOPOLYMERS INTERFAC, P453
   BAMBERGER S, 1990, PROGR ASTRONAUTICS A, V130, P603
   BERGSTROM K, 1992, COLLOID SURFACE, V63, P273, DOI 10.1016/0166-6622(92)80249-2
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BOVIARD JH, 1982, CLIN CHEM, V28, P2423
   BOYCE JF, 1992, J COLLOID INTERF SCI, V149, P153, DOI 10.1016/0021-9797(92)90400-G
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   CARAVAJAL GS, 1988, ANAL CHEM, V60, P1776, DOI 10.1021/ac00168a027
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   COSGROVE T, 1990, COLLOID SURFACE, V51, P255, DOI 10.1016/0166-6622(90)80145-T
   DAY J, 1992, PROTEIN SCI, V1, P1254, DOI 10.1002/pro.5560011004
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Delgado C, 1997, J CHROMATOGR B, V692, P263, DOI 10.1016/S0378-4347(96)00522-1
   DELUCAS LJ, 1994, J CRYST GROWTH, V135, P183, DOI 10.1016/0022-0248(94)90740-4
   DELUCAS LJ, 1991, J CRYST GROWTH, V109, P12, DOI 10.1016/0022-0248(91)90151-T
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591
   Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m
   Emoto K, 1998, LANGMUIR, V14, P2722, DOI 10.1021/la971010p
   EMOTO K, 1998, J COLLOID ITNERFACE, V202, P507
   FLEER GJ, 1993, POLYM INTERFACES
   GEORGE JN, 1972, BLOOD-J HEMATOL, V40, P862
   GILGES M, 1994, ANAL CHEM, V66, P2038, DOI 10.1021/ac00085a019
   Golander C, 1992, POLYETHYLENE GLYCOL
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Harris JM, 1997, ACS S SERIES, V680
   Hayens C. A., 1994, COLLOID SURFACE B, V2, P517
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   HENDERSON JA, 1993, MACROMOLECULES, V26, P4591, DOI 10.1021/ma00069a027
   *HERRON JN, BIOPOLYMERS INTERFAC, P221
   HIATT CW, 1971, J CHROMATOGR, V56, P362, DOI 10.1016/S0021-9673(00)97825-7
   HOLMBERG K, BIOPOLYMERS INTERFAC, P561
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KNOX RJ, 1998, ANAL CHEM, V11, P2268
   KOOPAL LK, 1988, J COLLOID INTERF SCI, V121, P49, DOI 10.1016/0021-9797(88)90407-9
   LANDGREN M, 1993, J PHYS CHEM-US, V97, P1656, DOI 10.1021/j100110a030
   Lasic D. D., 1995, STEALTH LIPOSOMES
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Leyden D. E., 1985, SILANES SURFACES INT
   LITTKE W, 1984, SCIENCE, V225, P203, DOI 10.1126/science.225.4658.203
   Long MM, 1996, J CRYST GROWTH, V168, P233, DOI 10.1016/0022-0248(96)00325-9
   LONG MM, 1994, MICROGRAVITY SCI TEC, V7, P196
   MALMSTEN M, 1990, LANGMUIR, V6, P1572, DOI 10.1021/la00100a008
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P70, DOI 10.1006/jcis.1996.0007
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303
   Malmsten M, 1996, J COLLOID INTERF SCI, V178, P123, DOI 10.1006/jcis.1996.0100
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P502, DOI 10.1006/jcis.1996.0064
   Malmsten M, 1998, BIOPOLYMERS INTERFAC
   MCPHERSON A, 1988, J CRYST GROWTH, V90, P47, DOI 10.1016/0022-0248(88)90297-7
   McPherson A, 1997, TRENDS BIOTECHNOL, V15, P197, DOI 10.1016/S0167-7799(97)01041-X
   McPherson A., 1996, CRYSTALLOGR REV, V6, P157
   MCPHERSON A, 1982, PREPARATION ANAL PRO
   Napper DH, 1983, POLYM STABILIZATION
   NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021
   NAVIA M, 1990, COMMUNICATION
   NORDE W, 1998, BIOPOLYMERS INTERFAC
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PUSEY M, 1986, J CRYST GROWTH, V76, P593, DOI 10.1016/0022-0248(86)90176-4
   Rosenberger F, 1979, FUNDAMENTALS CRYSTAL, VI
   ROSENBERGER F, 1996, J CRYSTAL GROWTH
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   SMITH G, 1998, COMMUNICATION
   Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806
   SMITH GD, 1995, AIP C P, V325, P177
   TIBERG F, 1992, COLLOID POLYM SCI, V270, P1188, DOI 10.1007/BF01095059
   TIBERG F, 1993, LANGMUIR, V9, P927, DOI 10.1021/la00028a009
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VANALSTINE JM, 1989, ESA, P399
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1990, J MACROMOL SCI CHEM, VA27, P563
   VENDEL M, 1994, AICHEJ
   VENDEL M, 1996, THESIS ROYAL I TECHN
   VERWEY EJW, 1948, THEORY STABILITY LYO
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   XU B, 1988, J CHROMATOGR, V445, P1, DOI 10.1016/S0021-9673(01)84504-0
NR 89
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 15
PY 1999
VL 14
IS 1-4
BP 197
EP 211
DI 10.1016/S0927-7765(99)00036-3
PG 15
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 230UM
UT WOS:000082268800019
DA 2018-10-19
ER

PT J
AU Tsuda, T
   Nakamura, T
   Yamamoto, Y
   Teramachi, M
   Kiyotani, T
   Lee, YH
   Shimizu, Y
AF Tsuda, T
   Nakamura, T
   Yamamoto, Y
   Teramachi, M
   Kiyotani, T
   Lee, YH
   Shimizu, Y
TI Prevention of postoperative air leakage from lungs using a purified
   human collagen membrane-polyglycolic acid sheet
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
AB Background. Human amnion has useful biomedical applications because it contains a large amount of human collagen fibers. We prepared purified human collagen membrane (HCM) from human amnion and used it to develop a new sheet by combining it with synthetic bioabsorbable polyglycolic acid (PGA) mesh. We evaluated its efficacy in preventing air leakage from the lungs of dogs.
   Methods. In 20 dogs, HCM-PGA sheet (n = 5), sheets using fibrin glue with a separate application method (n = 5), a mixed application method (n = 5), and fibrin glue alone (n = 5), were used as dressing materials after partial lung resection.
   Results. The HCM-PGA sheet using fibrin glue with a separate application method was shown to be significantly more effective by an air leakage pressure test than the other three methods. These results indicate that the HCM-PGA sheet is useful for preventing air leakage from the lung.
   Conclusions. The HCM-PGA sheet is more effective than conventional fibrin glue for controlling postoperative air leakage. (C) 1999 by The Society of Thoracic Surgeons.
C1 Kyoto Univ, Biomed Engn Res Ctr, Dept Artificial Organs, Sakyo Ku, Kyoto 6068507, Japan.
RP Tsuda, T (reprint author), Kyoto Univ, Biomed Engn Res Ctr, Dept Artificial Organs, Sakyo Ku, 3 Kawahara Cho, Kyoto 6068507, Japan.
CR BERAL M, 1992, J PEDIAT SURG, V27, P597
   BURGER K, 1937, ZENTRALB GYNAECOL, V61, P2437
   ERDENER A, 1992, EUR J PEDIATR SURG, V2, P26, DOI 10.1055/s-2008-1063394
   Gharib M, 1975, MMW Munch Med Wochenschr, V117, P1555
   LIU B, 1989, ARCH DERMATOL, V125, P1084, DOI 10.1001/archderm.125.8.1084
   MASSEE JS, 1962, SURG FORUM, V13, P407
   MURALIDHARAN S, 1991, J BIOMED MATER RES, V25, P1201, DOI 10.1002/jbm.820251003
   NAKAMURA T, 1988, P 3 WORLD BIOM C APR, P277
   TRACER ML, 1979, OBSTET GYNECOL, V54, P345
   TRELFORD JD, 1973, J ONCOL, V28, P398
   Tsuda T., 1996, Japanese Journal of Artificial Organs, V25, P417
   WYNN RM, 1968, OBSTET GYNECOL, V31, P759
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
NR 13
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 1999
VL 68
IS 2
BP 339
EP 342
DI 10.1016/S0003-4975(99)00567-6
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 230LT
UT WOS:000082253200009
PM 10475392
DA 2018-10-19
ER

PT J
AU Recheis, W
   Weber, GW
   Schafer, K
   Knapp, R
   Seidler, H
   zur Nedden, D
AF Recheis, W
   Weber, GW
   Schafer, K
   Knapp, R
   Seidler, H
   zur Nedden, D
TI Virtual reality and anthropology
SO EUROPEAN JOURNAL OF RADIOLOGY
LA English
DT Article
DE CT; image processing; reconstructions; stereolithographic and fused
   deposition modeling; virtual reality; anthropology
ID CT-GUIDED STEREOLITHOGRAPHY; TOMOGRAPHY; IMAGES; SKULL
AB Since the discovery of the Tyrolean Iceman in 1991 advanced imaging and post processing techniques were successfully applied in anthropology. Specific techniques include spiral computed tomography and 3-dimensional reconstructions including stereolithographic and fused deposition modeling of volume data sets. The Iceman's skull was the first to be reproduced using stereolithography, before this method was successfully applied in preoperative planning. With the advent of high-end graphics workstations and biomedical image processing software packages, 3-dimensional reconstructions were established as a routine tool for analyzing volume data sets. These techniques opened totally new insights in the field of physical anthropology. Computed tomography became the ideal research tool to access the internal structures of various precious fossils without damaging or even touching them, Many of the most precious specimens from the species Autralopithecus (1.8-3.5 Myears). Homo heidelbergensis (200-600 kyears) or Homo neanderthalensis (40-100 kyears) were scanned during the last 5 years. Often the fossils are filled with a stone matrix or other materials. During the postprocessing routines highly advanced algorithms were used to remove virtually these incrustations. Thus it was possible to visualize the morphological structures that lie beneath the matrix. Some specimens were partially destroyed, so the missing parts were reconstructed on computer screen in order to get estimations of the brain volume and endocranial morphology, both major fields of interest in physical anthropology. Moreover the computerized form of the data allows new descriptions of morphologic structures by the means of 'geometric morphometrics'. Some of the results may change aspects and interpretations in human evolution. The introduction of new imaging and post processing techniques created a new field of research: Virtual Anthropology. (C) 1999 Elsevier Science ireland Ltd. All rights reserved.
C1 Univ Innsbruck Hosp Klin, Dept Radiol 2, A-6020 Innsbruck, Austria.
RP Recheis, W (reprint author), Univ Innsbruck Hosp Klin, Dept Radiol 2, Anichstr 35, A-6020 Innsbruck, Austria.
OI Schaefer, Katrin/0000-0002-0173-3092
CR ANDERL H, 1994, BRIT J PLAST SURG, V47, P60, DOI 10.1016/0007-1226(94)90121-X
   Conroy G.C., 1985, P419
   CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255
   CONROY GC, 1987, NATURE, V329, P625, DOI 10.1038/329625a0
   Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730
   Jacobs P. F., 1992, RAPID PROTOTYPING MA
   KALENDER WA, 1991, MED PHYS, V18, P910, DOI 10.1118/1.596607
   Kalender WA, 1989, RADIOLOGY, V173, P414
   Marcus L. F., 1996, ADV MORPHOMETRICS
   *MAYO FDN, 1995, BIOM IM RES
   PROSSINGER H, 1998, DUAL C SUN CIT
   PROSSINGER H, 1998, 67 ANN M AM ASS PHYS
   RECHEIS W, 1996, P MAN INT MAN LEIC, P105
   RECHEIS W, 1998, 67 ANN M AM ASS PHYS
   RECHEIS W, 1997, RAD SOC N AM ANN M C
   ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J
   Rubin GD, 1996, RADIOLOGY, V199, P321, DOI 10.1148/radiology.199.2.8668772
   SEIDLER H, 1992, SCIENCE, V258, P455, DOI 10.1126/science.1411539
   Seidler H, 1997, J HUM EVOL, V33, P691, DOI 10.1006/jhev.1997.0163
   UDUPA J, 1993, SPIE P, V1897, P47
   VANNIER MW, 1984, RADIOLOGY, V150, P179, DOI 10.1148/radiology.150.1.6689758
   VINING DJ, 1994, RADIOLOGY, V193, P446
   VINING DJ, 1994, RADIOLOGY, V193, P261
   Weber GW, 1998, COLLEGIUM ANTROPOL, V22, P575
   WILFING H, 1994, COLLEGIUM ANTROPOL, V18, P269
   ZONNEVELD F W, 1989, Medicamundi, V34, P117
   ZURNEDDEN D, 1994, RADIOLOGY, V193, P269, DOI 10.1148/radiology.193.1.8090905
NR 27
TC 16
Z9 17
U1 1
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0720-048X
J9 EUR J RADIOL
JI Eur. J. Radiol.
PD AUG
PY 1999
VL 31
IS 2
BP 88
EP 96
DI 10.1016/S0720-048X(99)00089-3
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 251RT
UT WOS:000083459200002
PM 10565508
DA 2018-10-19
ER

PT J
AU Chandra, N
   Rama, SC
   Chen, Z
AF Chandra, N
   Rama, SC
   Chen, Z
TI Critical issues in the industrial application of SPF-process modeling
   and design practices
SO MATERIALS TRANSACTIONS JIM
LA English
DT Article
DE superplasticity; process modeling; industrial application of
   superplastic forming; constitutive equation; superplastic forming design
ID SUPERPLASTIC FORMING PROCESSES; FINITE-ELEMENT METHOD; MICROMECHANICAL
   MODEL; SHEET-METAL; PRESSURE
AB With the continued use of superplastic forming (SPF) process in the manufacture of various aerospace and automotive components, there is an imminent need to accurately predict the process parameters for complex 3-D configurations. New SPF products are finding their way into architectural, rail, heavy industry, biomedical, sports and textile sectors apart from the traditional aero- and auto-industries. High fidelity process models in combination with other concurrent design tools (CAD, stress analysis, cost analysis) should be able to provide the platform necessary for the wider use of superplastic (SP) products across a range of industries. The objective of this paper is to first introduce the various industrial applications of SPF products and the design bottlenecks hindering their wider use. Practical considerations in the development of appropriate material constitutive models for superplastic materials and their relevance to numerical simulations are then discussed. Three different models including a micromechanics based model are used to describe the constitutive behavior of a selected SP material (Aluminum 5083). The performance of the models are then compared with respect to experimental results. The effect of the actual material parameters on the simulated results, and hence the design are outlined. Some of the commercial and other finite element codes used in SPF process modeling are enumerated, and the features of each of the codes with respect to the type of elements, contact/friction algorithms, and pressure-prediction schemes are compared. In closing, other practical considerations in the manufacture of SPF products, e.g., die materials, optimal SPF/DB design, alpha-casing, product thickness control are also discussed.
C1 Florida State Univ, Dept Mech Engn, Tallahassee, FL 32310 USA.
   Oakland Univ, Rochester, MI 48309 USA.
RP Chandra, N (reprint author), Florida State Univ, Dept Mech Engn, Tallahassee, FL 32310 USA.
CR ARGYRIS JH, 1984, COMPUT METHOD APPL M, V46, P83, DOI 10.1016/0045-7825(84)90130-0
   ASHBY MF, 1973, ACTA METALL MATER, V21, P149, DOI 10.1016/0001-6160(73)90057-6
   BELLET M, 1989, NUMIFORM 89, P401
   BONET J, 1990, INT J NUMER METH ENG, V30, P1719, DOI 10.1002/nme.1620300823
   BONET J, 1987, P INT C COMP PLAST M, P875
   CHANDRA N, 1992, J ENG IND-T ASME, V114, P452
   Chandra N, 1997, MAT SCI ENG A-STRUCT, V231, P134, DOI 10.1016/S0921-5093(97)00039-7
   CHANDRA N, 1994, MATER SCI FORUM, V170-, P577, DOI 10.4028/www.scientific.net/MSF.170-172.577
   CHANDRA N, 1995, SCRIPTA METALL MATER, V32, P1429, DOI 10.1016/0956-716X(95)00183-V
   CHANDRA N, 1988, INT J NUMER METH ENG, V26, P1925, DOI 10.1002/nme.1620260904
   Chandra N, 1997, SCRIPTA MATER, V36, P1327, DOI 10.1016/S1359-6462(96)00489-7
   CHANDRA N, 1991, SUPERPLASTICITY ADV, P765
   Chandra N, 1991, J MAT SHAPING TECHNO, V9, P27
   CHANDRASEKARAN N, 1987, INT J NUMER METH ENG, V24, P477, DOI 10.1002/nme.1620240302
   CORNFIELD GC, 1970, INT J MECH SCI, V12, P479, DOI 10.1016/0020-7403(70)90075-5
   Dang P, 1998, ACTA MATER, V46, P2851, DOI 10.1016/S1359-6454(97)00450-3
   GHOSH AK, 1982, METALL TRANS A, V13, P733, DOI 10.1007/BF02642386
   GHOSH AK, 1980, P ASM C PROC MOD, P420
   HAMILTON CH, 1982, SUPERPLASTIC FORMING, P173
   Hamilton CH, 1985, SUPERPLASTIC FORMING, P13
   Hamilton CH, 1988, SUPERPLASTICITY AERO, P29
   HOLT DL, 1970, INT J MECH SCI, V12, P491, DOI 10.1016/0020-7403(70)90076-7
   IWASAKI H, 1998, T JAPAN SOC MECH ENG, V64, P1390
   JOVANE F, 1968, INT J MECH SCI, V10, P403, DOI 10.1016/0020-7403(68)90005-2
   *MARC AN RES CORP, 1997, MARC FIN EL COD
   McLean D., 1957, GRAIN BOUNDARIES MET
   MURALI K, 1995, ACTA METALL MATER, V43, P1783, DOI 10.1016/0956-7151(94)00423-F
   NAKAMACHI E, 1988, INT J NUMER METH ENG, V25, P283, DOI 10.1002/nme.1620250121
   ONATE E, 1983, INT J MECH SCI, V25, P305, DOI 10.1016/0020-7403(83)90011-5
   RAMA SC, 1991, INT J NONLINEAR MECH, V26, P711, DOI 10.1016/0020-7462(91)90022-L
   RAMA SC, 1992, THESIS TEXAS A M U C
   SHERBY OD, 1994, MATER SCI FORUM, V170-, P13, DOI 10.4028/www.scientific.net/MSF.170-172.13
   VASTAVA RB, 1979, ACTA METALL MATER, V27, P251, DOI 10.1016/0001-6160(79)90103-2
   WEERTMAN J, 1955, J APPL PHYS, V26, P1213, DOI 10.1063/1.1721875
   WOOD RD, 1992, NUMIFORM 92, P843
   YANG HS, 1992, INT J MECH SCI, V34, P283, DOI 10.1016/0020-7403(92)90036-G
   ZHANG WC, 1986, P AL TECHN 86 LOND
NR 37
TC 12
Z9 13
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
SN 0916-1821
J9 MATER T JIM
JI Mater. Trans. JIM
PD AUG
PY 1999
VL 40
IS 8
BP 723
EP 736
DI 10.2320/matertrans1989.40.723
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 235AK
UT WOS:000082516400004
OA Bronze
DA 2018-10-19
ER

PT J
AU Harding, G
   Schreiber, B
AF Harding, G
   Schreiber, B
TI Coherent X-ray scatter imaging and its applications in biomedical
   science and industry
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID DIFFRACTION COMPUTED-TOMOGRAPHY; PHOTON SCATTERING;
   DIAGNOSTIC-RADIOLOGY; ANGLE; TISSUE; ENERGY; RADIATION; INTERFERENCE;
   OPTIMIZATION; SENSITIVITY
AB Coherent x-ray scatter (CXRS) imaging refers to the spatially-resolved measurement of the coherent scatter cross-section in localised volume elements ("voxels") of an extended object. Following a historical introduction to the subject of CXRS, an account is given of the physical principles on which it is based, Representative coherent scatter plots of materials of interest in medical and industrial applications ape presented. Several alternative measurement configurations based on angular-dispersive and energy-dispersive x-ray diffraction are described and reasons are discussed which have lead to the adoption of the latter in the bulk of published CXRS investigations.
   The coherent scatter signal is subject to various degrading effects, such as self-attenuation of the primary and scatter radiations within the object, multiple scatter and statistical (photon) noise. These effects are described and data processing procedures to account for them in order to derive useful quantitative are illustrated.
   The design of a CXRS device ("RayScan") in use at the Philips Research Labs is discussed in some detail and representative results obtained with it are presented. The utility of coherent scatter imaging is demonstrated with examples drawn from the fields of tissue characterization in the medical environment, explosives detection for airport security screening purposes and the detection of narcotics. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Philips Res Hamburg, Tech Syst Dept, D-22315 Hamburg, Germany.
RP Harding, G (reprint author), Philips Res Hamburg, Tech Syst Dept, Rontgenstr 24-26, D-22315 Hamburg, Germany.
CR ARMSTRONG R, 1993, SPIE, V2092, P411
   Barrett HH, 1981, RADIOLOGICAL IMAGING
   Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   BIRCH R, 1979, HPA SCI REPORT SERIE, V30
   BORDAS J, 1976, NATURE, V262, P541, DOI 10.1038/262541a0
   BRADLEY DA, 1984, PHYS MED BIOL, V29, P1385, DOI 10.1088/0031-9155/29/11/007
   BRADLEY DA, 1989, MED PHYS, V16, P851, DOI 10.1118/1.596310
   CHAMPENEY DC, 1973, FOURIER TRANSFORMS T
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   COOPER MJ, 1982, J PHYS E SCI INSTRUM, V15, P568, DOI 10.1088/0022-3735/15/5/022
   CORMACK AM, 1978, PHYS MED BIOL, V23, P1141, DOI 10.1088/0031-9155/23/6/010
   DYSON N. A., 1990, XRAYS ATOMIC NUCL PH
   EVANS SH, 1991, PHYS MED BIOL, V36, P7, DOI 10.1088/0031-9155/36/1/002
   GIGANTE GE, 1985, NUCL INSTRUM METH B, V12, P229, DOI 10.1016/0168-583X(85)90056-4
   GIGANTE GE, 1985, MED PHYS, V12, P321, DOI 10.1118/1.595795
   Gonzalez R. C., 1993, DIGITAL IMAGE PROCES
   GRANT JA, 1993, MEAS SCI TECHNOL, V4, P83, DOI 10.1088/0957-0233/4/1/014
   GUTKNECHT D, 1990, NUCL INSTRUM METH A, V288, P13, DOI 10.1016/0168-9002(90)90456-G
   HARDING G, 1991, PHYS MED BIOL, V36, P1573, DOI 10.1088/0031-9155/36/12/003
   HARDING G, 1990, PHYS MED BIOL, V35, P33, DOI 10.1088/0031-9155/35/1/004
   Harding G, 1997, RADIAT PHYS CHEM, V50, P91, DOI 10.1016/S0969-806X(97)00026-1
   HARDING G, 1989, NUCL INSTRUM METH A, V280, P517, DOI 10.1016/0168-9002(89)90964-9
   HARDING G, 1987, J OPT SOC AM A, V4, P933, DOI 10.1364/JOSAA.4.000933
   HARDING G, 1987, MED PHYS, V14, P515, DOI 10.1118/1.596063
   Harding G, 1995, MED PHYS, V22, P2007, DOI 10.1118/1.597497
   HARDING G, 1987, AGEING SPINE, P157
   HENTSCHEL MP, 1988, BAM MITTEILUNGSBLATT, V18, P374
   HOLT RS, 1983, PHYS MED BIOL, V28, P1435, DOI 10.1088/0031-9155/28/12/009
   Hounsfield G. N., 1973, BRIT J RADIOL, V46, P1023
   Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471
   HUBBELL JH, 1977, J PHYS CHEM REF DATA, V6, P615, DOI 10.1063/1.555554
   HUKINS DL, 1983, XRAY DIFFRACTION DIS
   JOHNS HE, 1980, PHYSICS RADIOLOGY
   JOHNS PC, 1983, MED PHYS, V10, P40, DOI 10.1118/1.595443
   JOHNS PC, 1982, MED PHYS, V9, P231, DOI 10.1118/1.595076
   JOSEPH PM, 1982, MED PHYS, V9, P464, DOI 10.1118/1.595111
   KARELLAS A, 1983, MED PHYS, V10, P605, DOI 10.1118/1.595330
   KERR SA, 1977, T AM NUCL SOC, V33, P253
   Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017
   Klug H. P., 1988, XRAY DIFFRACTION PRO
   KOSANETZKY J, 1987, MED PHYS, V14, P526, DOI 10.1118/1.596143
   Leliveld CJ, 1996, IEEE T NUCL SCI, V43, P3315, DOI 10.1109/23.552743
   LUGGAR RD, 1995, P SOC PHOTO-OPT INS, V2511, P46, DOI 10.1117/12.219602
   LUGGAR RD, 1995, P SOC PHOTO-OPT INS, V2511, P56, DOI 10.1117/12.219603
   LUGGAR RD, 1993, SPIE SUBSTANCE DETEC, V2092, P378
   MARTENS G, 1993, SPIE, V2092, P387
   MORIN LRM, 1983, PHYS MED BIOL, V28, P789, DOI 10.1088/0031-9155/28/7/002
   MUNTZ EP, 1983, MED PHYS, V10, P819, DOI 10.1118/1.595360
   NDLOVU AM, 1991, MED PHYS, V18, P985, DOI 10.1118/1.596614
   NEITZEL U, 1985, PHYS MED BIOL, V30, P1289, DOI 10.1088/0031-9155/30/12/002
   NEWTON M, 1992, PHYS MED BIOL, V37, P1339, DOI 10.1088/0031-9155/37/6/010
   Peiser H.S., 1960, XRAY DIFFRACTION POL
   Peplow DE, 1998, PHYS MED BIOL, V43, P2431, DOI 10.1088/0031-9155/43/9/001
   PUUMALAINEN P, 1979, NUCL INSTRUM METHODS, V163, P261, DOI 10.1016/0029-554X(79)90058-2
   PUUMALAINEN P, 1976, RADIOLOGY, V120, P723, DOI 10.1148/120.3.723
   PUUMALAINEN P, 1977, INT J APPL RADIAT IS, V28, P785, DOI 10.1016/0020-708X(77)90110-7
   ROYLE GJ, 1991, PHYS MED BIOL, V36, P383, DOI 10.1088/0031-9155/36/3/006
   SPELLER RD, 1989, J PHYS E SCI INSTRUM, V22, P202, DOI 10.1088/0022-3735/22/4/001
   SPELLER RD, 1993, SPIE, V2092, P366
   STRECKER H, 1993, SPIE, V2092, P399
   TARTARI A, 1994, PHYS MED BIOL, V39, P219, DOI 10.1088/0031-9155/39/2/001
   Tartari A, 1996, NUCL INSTRUM METH B, V117, P325, DOI 10.1016/0168-583X(96)00313-8
   Tartari A, 1997, PHYS MED BIOL, V42, P2551, DOI 10.1088/0031-9155/42/12/018
   Westmore MS, 1996, MED PHYS, V23, P723, DOI 10.1118/1.597720
   Westmore MS, 1997, MED PHYS, V24, P3, DOI 10.1118/1.597917
NR 65
TC 74
Z9 76
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1999
VL 56
IS 1-2
BP 229
EP 245
DI 10.1016/S0969-806X(99)00283-2
PG 17
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 251BZ
UT WOS:000083425900015
DA 2018-10-19
ER

PT J
AU Lahorte, P
   Mondelaers, W
   De Frenne, D
   Callens, F
   Vanhaelewyn, G
   Schacht, E
   Van Calenberg, S
   Van Cleemput, O
   Huyghebaert, A
AF Lahorte, P
   Mondelaers, W
   De Frenne, D
   Callens, F
   Vanhaelewyn, G
   Schacht, E
   Van Calenberg, S
   Van Cleemput, O
   Huyghebaert, A
TI Applied radiation research around a 15 MeV high-average-power linac
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 9th Tihany Symposium on Radiation Chemistry
CY AUG 29-SEP 03, 1998
CL TATABANYA, HUNGARY
ID MONTE-CARLO SIMULATION; EXTRACORPOREAL IRRADIATION; BREMSSTRAHLUNG
   CONVERTER; BONE-TUMORS; ALANINE; BEAMS; GENT; ESR
AB The Department of Subatomic and Radiation Physics of the University Gent is equipped with a 15 MeV 20 kW linear electron accelerator (linac) facility. In its present configuration the accelerator is used as a multipurpose apparatus for research in the fields of polymer chemistry, biomedical materials, medicine, food technology, dosimetry, solid state physics, agriculture and nuclear and radiation physics. We present an overview of both the various research projects around our linac facility involving radiation chemistry and physics and the specialised technologies facilitating this research. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 State Univ Ghent, Dept Subatom & Radiat Phys, B-9000 Ghent, Belgium.
   State Univ Ghent, Lab Crystallog & Study Solid State, B-9000 Ghent, Belgium.
   State Univ Ghent, Polymer Mat Res Grp, Dept Organ Chem, B-9000 Ghent, Belgium.
   State Univ Ghent, Dept Food Technol & Nutr, B-9000 Ghent, Belgium.
RP Mondelaers, W (reprint author), State Univ Ghent, Dept Subatom & Radiat Phys, Proeftuinstr 86, B-9000 Ghent, Belgium.
CR BAUWENS F, 1998, IN PRESS PHYS REV C
   Bertschy M, 1996, NUCL INSTRUM METH B, V113, P146, DOI 10.1016/0168-583X(95)01309-1
   Callens F, 1996, APPL RADIAT ISOTOPES, V47, P1241, DOI 10.1016/S0969-8043(96)00166-2
   GOVAERT K, 1994, NUCL INSTRUM METH A, V337, P265, DOI 10.1016/0168-9002(94)91094-4
   IBRAHIM R, 1998, J PLANT CELL TISSUE, V54, P37
   JOLIE J, 1997, P 9 INT S CAPT GAMM, V2, P873
   Materna T, 1999, NUCL INSTRUM METH B, V149, P141, DOI 10.1016/S0168-583X(98)00620-X
   Mehnert R, 1995, NUCL INSTRUM METH B, V105, P348, DOI 10.1016/0168-583X(95)00634-6
   Moerkerke R, 1998, MACROMOLECULES, V31, P2223, DOI 10.1021/ma971512+
   Mondelaers W, 1996, NUCL INSTRUM METH A, V368, P278, DOI 10.1016/0168-9002(95)00666-4
   MONDELAERS W, 1993, NUCL INSTRUM METH B, V79, P898, DOI 10.1016/0168-583X(93)95494-P
   Mondelaers W, 1998, NUCL INSTRUM METH B, V139, P43, DOI 10.1016/S0168-583X(97)00944-0
   Rakvin B, 1996, APPL RADIAT ISOTOPES, V47, P1251, DOI 10.1016/S0969-8043(96)00165-0
   Ramos MA, 1998, POWDER TECHNOL, V99, P79, DOI 10.1016/S0032-5910(98)00061-8
   Sagstuen E, 1997, J PHYS CHEM A, V101, P9763, DOI 10.1021/jp972158k
   SCHACHT E, 1998, UNPUB POLYMER
   UYTTENDAELE D, 1988, J BONE JOINT SURG BR, V70, P348
   Van Calenberg Sabine, 1998, Lebensmittel-Wissenschaft and Technologie, V31, P252, DOI 10.1006/fstl.1997.0352
   Van Laere K, 1998, J NUCL MED, V39, P1563
   VANHAELEWYN G, 1999, RADIAT RES, P152
   VANHAELEWYN G, 1998, IN PRESS APPL RAD IS
   VanLaere K, 1997, RADIAT PHYS CHEM, V49, P207, DOI 10.1016/S0969-806X(96)00061-8
   VanLaere K, 1997, RADIAT PHYS CHEM, V49, P307, DOI 10.1016/S0969-806X(96)00139-9
NR 23
TC 3
Z9 3
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1999
VL 55
IS 5-6
BP 761
EP 765
DI 10.1016/S0969-806X(99)00226-1
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 221YN
UT WOS:000081755600056
DA 2018-10-19
ER

PT J
AU Erlat, AG
   Spontak, RJ
   Clarke, RP
   Robinson, TC
   Haaland, PD
   Tropsha, Y
   Harvey, NG
   Vogler, EA
AF Erlat, AG
   Spontak, RJ
   Clarke, RP
   Robinson, TC
   Haaland, PD
   Tropsha, Y
   Harvey, NG
   Vogler, EA
TI SiOx gas barrier coatings on polymer substrates: Morphology and gas
   transport considerations
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; FILMS; PERMEATION; ALUMINA; OXYGEN; SCALE
AB Plasma-enhanced chemical vapor deposition (PECVD) of SiOx thin coatings on polymer surfaces yields tough hybrid materials with the gas barrier properties and transparency of glass. Combination of these properties makes these materials ideally suited for food packaging and biomedical device applications. In this study, we employ a Non-Parametric Response Surface Methods optimization to identify the Magnetron-PECVD conditions responsible for superlative SiOx, barrier coatings on poly(ethylene terephthalate) (PET). Oxygen and water vapor permeances of optimized PET/SiOx, composites produced by hexamethyldisiloxane and trimethylsilane have been measured as functions of temperature and are found to exhibit Arrhenius behavior. The thermal activation energy for water val,or permeation, unlike that for oxygen permeation, depends on barrier performance and increases by as much as 20 kJ/mol with an increase in barrier efficacy. Examination of these materials by phase-imaging atomic force microscopy and energy-filtered transmission electron microscopy reveals a correlation between SiOx, morphology (including defects) and barrier performance. Morphological and permeation results are compared to identify some of the physical factors governing water vapor permeation through SiOx-modified polymers.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
   Becton Dickinson Technol, Polymer Sci & Technol Dept, Res Triangle Pk, NC 27709 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
CR BARKER CP, 1995, THIN SOLID FILMS, V46, P259
   Benmalek M, 1995, SURF COAT TECH, V76-77, P821, DOI 10.1016/0257-8972(95)02601-0
   BODINO F, 1994, THIN SOLID FILMS, V241, P21, DOI 10.1016/0040-6090(94)90388-3
   CHAHROUDI D, 1991, SVC 34 ANN TECHN C P, P130
   CHAHROUDI D, 1988, SVC 31 ANN TECHN C P, P145
   CHAHROUDI D, 1989, SVC 32 ANN TECHN C P, P29
   Doremus R.H., 1973, GLASS SCI
   EISENBERG D, 1969, STRUCTURE PROPERTIES, P179
   ERLAT AG, UNPUB J MAT RES
   FELTS JR, 1990, SOC VACC COAT 33 ANN, P184
   FELTS JT, 1992, J VAC SCI TECHNOL A, V10, P1675, DOI 10.1116/1.577768
   GarciaAyuso G, 1996, SURF COAT TECH, V80, P203, DOI 10.1016/0257-8972(95)02712-2
   Green P., 1994, NONPARAMETRIC REGRES
   HAALAND PD, 1997, WORKSH TOP MOD FITT
   Henry B. M., 1998, SVC 41 ANN TECHN C P, P434
   JAMIESON EHH, 1983, J MATER SCI, V18, P64, DOI 10.1007/BF00543811
   JANSEN F, 1996, AM43 NAT S AM VAC SO
   KNOLL RW, 1995, SOC VAC COAT 38 ANN, P425
   KRUG T, 1993, SVC 36 ANN TECH C P, P302
   KRUG TG, 1990, SOC VACUUM COATERS, P163
   LANGOWSKI HC, 1996, SVC 39 ANN TECHN C P, P398
   LEE JH, 1996, J ELECTROCHEM SOC, V143, P1442
   Little LH, 1966, INFRARED SPECTRA ABS
   MALLIK RR, 1992, J VAC SCI TECHNOL A, V10, P2412, DOI 10.1116/1.577976
   MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807
   MCDONALD RS, 1958, J PHYS CHEM-US, V62, P1168, DOI 10.1021/j150568a004
   MERCEA PV, 1991, J MEMBRANE SCI, V59, P353, DOI 10.1016/S0376-7388(00)80822-4
   MICHALSKE TA, 1987, SCI AM, V257, P122, DOI 10.1038/scientificamerican1287-122
   MISIANO C, 1993, SOC VAC COAT 36 ANN, P307
   MISIANO C, 1992, P 6 INT C VAC WEB CO
   MOULSON AJ, 1961, T FARADAY SOC, V57, P1208, DOI 10.1039/tf9615701208
   NELSON RJ, 1992, SVC 35 ANN TECHN C P, P75
   PERKINS WG, 1971, J CHEM PHYS, V54, P1683, DOI 10.1063/1.1675072
   Philips R. W., 1993, SVC 36 ANN TECHN C P, P293
   REIMER L, 1995, ENERGY FILTERING TRA
   ROBERTS AP, UNPUB
   Robinson G. W. Z., 1996, WATER BIOL CHEM PHYS
   Singh A, 1996, IND ENG CHEM RES, V35, P1231, DOI 10.1021/ie950559l
   Stannett V., 1968, DIFFUSION POLYM, P41
   THEIL JA, 1994, J VAC SCI TECHNOL A, V12, P1365, DOI 10.1116/1.579323
   Thyen R., 1997, SURF COAT TECH, V97, P26
   TROPSHA YG, 1997, J PHYS CHEM B, V101, P2239
   Vossen J. L., 1991, THIN FILM PROCESSES, V2, P443
   Wang BC, 1999, J MATER SCI LETT, V18, P311, DOI 10.1023/A:1006687324051
   WANG BC, 1997, AM CHEM SOC POLYM PR, V38, P1018
   YASUDA H, 1985, PLASMAS POLYM, P277
   1994, Patent No. 5364666
NR 47
TC 177
Z9 178
U1 10
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1089-5647
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUL 22
PY 1999
VL 103
IS 29
BP 6047
EP 6055
DI 10.1021/jp990737e
PG 9
WC Chemistry, Physical
SC Chemistry
GA 222CM
UT WOS:000081765900020
DA 2018-10-19
ER

PT J
AU Rimmer, S
   Tattersall, P
   Ebdon, JR
   Fullwood, N
AF Rimmer, S
   Tattersall, P
   Ebdon, JR
   Fullwood, N
TI New strategies for the synthesis of amphiphilic networks
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Polymer-Based Technology (POC 98)
CY JUN 28-JUL 02, 1998
CL MAALE HACHAMISHA, ISRAEL
DE amphiphilic networks
ID RADICAL POLYMERIZATION; METHYL-METHACRYLATE; BIOCOMPATIBILITY; POLYMERS;
   RELEASE
AB Amphiphilic and hydrogel polymers are useful biomedical materials. This paper presents some recent work on new syntheses of such materials. Amphiphilic gels have been prepared by the Diels-Alder reaction of poly(ethylene glycol)s that contain acetylene dicarboxylate groups along the main chain, with furan-ended oligomers. Hexyl methacrylate oligomers with methacrylate end groups have been prepared. These have been copolymerized with hydrophilic monomers to yield segmented amphiphilic gels. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Lancaster, Ctr Polymer, Lancaster LA1 4YA, England.
RP Rimmer, S (reprint author), Univ Lancaster, Ctr Polymer, Lancaster LA1 4YA, England.
OI Fullwood, Nigel James/0000-0002-9405-8515; Ebdon,
   John/0000-0003-4176-3912
CR BLEZER R, 1995, POLYM BULL, V34, P101, DOI 10.1007/BF00294894
   Carrot G, 1998, POLYM BULL, V40, P181, DOI 10.1007/s002890050240
   CHEN D, 1988, J MACROMOL SCI CHEM, VA25, P389, DOI 10.1080/00222338808053376
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Dellerba M., 1997, MACROMOL RAPID COMM, V18, P723
   Ebdon JR, 1997, J POLYM SCI POL CHEM, V35, P3255, DOI 10.1002/(SICI)1099-0518(19971115)35:15<3255::AID-POLA19>3.3.CO;2-K
   EBDON JR, 1995, J MACROMOL SCI PURE, VA32, P603, DOI 10.1080/10601329508018949
   EBDON JR, 1991, NEW METHODS POLYM SY
   GADKARI A, 1989, POLYM BULL, V22, P25
   Haddleton DM, 1998, POLYMER, V39, P3119, DOI 10.1016/S0032-3861(97)10116-1
   IVAN B, 1990, ABSTR PAP AM CHEM S, V200, P302
   IVAN B, 1990, ABSTR PAP AM CHEM S, V200, P301
   Ivan B, 1996, MACROMOL SYMP, V102, P81, DOI 10.1002/masy.19961020112
   KENNEDY JP, 1994, J MACROMOL SCI PURE, VA31, P1771, DOI 10.1080/10601329408545881
   KESZLER B, 1992, POLYM BULL, V29, P681, DOI 10.1007/BF01041155
   KESZLER B, 1994, J POLYM SCI POL CHEM, V32, P3153, DOI 10.1002/pola.1994.080321616
   LEE HS, 1991, POLYM BULL, V26, P689, DOI 10.1007/BF00313225
   Listigovers NA, 1997, ABSTR PAP AM CHEM S, V214, P181
   Matyjaszewski K, 1998, J POLYM SCI POL CHEM, V36, P823, DOI 10.1002/(SICI)1099-0518(19980415)36:5<823::AID-POLA15>3.3.CO;2-D
   Park D, 1997, J APPL POLYM SCI, V66, P901, DOI 10.1002/(SICI)1097-4628(19971031)66:5<901::AID-APP10>3.0.CO;2-Q
   PARK D, 1995, MACROMOLECULES, V28, P2595, DOI 10.1021/ma00112a001
   Rimmer S, 1996, J POLYM SCI POL CHEM, V34, P3573, DOI 10.1002/(SICI)1099-0518(199612)34:17<3573::AID-POLA12>3.0.CO;2-B
   Rimmer S, 1996, J POLYM SCI POL CHEM, V34, P3591
   Shamlou S, 1997, J BIOMED MATER RES, V35, P157, DOI 10.1002/(SICI)1097-4636(199705)35:2<157::AID-JBM3>3.0.CO;2-M
   Ueda J, 1998, MACROMOLECULES, V31, P557, DOI 10.1021/ma970476b
   YU H, 1995, J CONTROL RELEASE, V34, P117, DOI 10.1016/0168-3659(94)00127-G
   1987, ICI POLYURETHANES
NR 27
TC 25
Z9 26
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD JUL 15
PY 1999
VL 41
IS 1-3
BP 177
EP 184
DI 10.1016/S1381-5148(99)00035-8
PG 8
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 218RD
UT WOS:000081564700021
DA 2018-10-19
ER

PT J
AU Rachev, A
   Hayashi, K
AF Rachev, A
   Hayashi, K
TI Theoretical study of the effects of vascular smooth muscle contraction
   on strain and stress distributions in arteries
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE vascular mechanics; active stress; residual strain; myogenic response
ID RESIDUAL-STRESSES; RABBIT; CONSTRICTION; MECHANICS; SEGMENTS; TISSUES;
   RAT
AB To study the effects of smooth muscle contraction and relaxation on the strain and stress distribution in the vascular wall, a mathematical model was proposed. The artery was assumed to be a thick-walled orthotropic tube made of nonlinear, incompressible elastic material. Considering that the contraction of smooth muscle generates an active circumferential stress in the wall, a numerical study was performed using data available in the literature. The results obtained showed that smooth muscle contraction affects the residual strains which exist in a ring segment cut out from the artery and exposed to no external load. When the ring specimen is cut radially, it springs open with an opening angle. The predicted monotonic increase of the opening angle with increasing muscular tone was in agreement with recent experimental results reported in the literature. It was shown that basal muscular tone, which exists under physiological conditions, reduces the strain gradient in the arterial wall and yields a near uniform stress distribution. During temporary changes in blood pressure, the increase in muscular tone induced by elevated pressure tends to restore the distribution of circumferential strain in the arterial wall, and to maintain the dow-induced wall shear stress to normal level. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00404-X].
C1 Bulgarian Acad Sci, Inst Mech, BU-1113 Sofia, Bulgaria.
   Osaka Univ, Div Mech Sci, Dept Syst & Human Sci, Grad Sch Engn Sci, Toyonaka, Osaka 560, Japan.
RP Rachev, A (reprint author), Bulgarian Acad Sci, Inst Mech, Acad G Bonchev Str,Bl 4, BU-1113 Sofia, Bulgaria.
CR Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220
   CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600
   CHUONG CJ, 1983, J BIOMECH ENG-T ASME, V105, P268, DOI 10.1115/1.3138417
   COX RH, 1978, AM J PHYSIOL, V234, pH280
   COX RH, 1978, AM J PHYSIOL, V234, pH542
   Dobrin P. B., 1973, AM J PHYSIOL, V225, P644
   Dobrin P. B., 1983, HDB PHYSL 2, V3, P65
   FUNG YC, 1989, CIRC RES, V65, P1340, DOI 10.1161/01.RES.65.5.1340
   FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301
   FUNG YC, 1984, BIODYNAMICS CIRCULAT
   HAYASHI K, 1993, P 3 C BIOM TOK JSME, P61
   Johnson PC., 1980, HDB PHYSL 2, VII, P409
   Matsumoto T, 1996, J BIOMECH ENG-T ASME, V118, P62, DOI 10.1115/1.2795947
   Matsumoto T., 1997, INT J CARDIOVASC MED, V1, P21
   MATSUMOTO T, 1996, AM J PHYSIOL, V271, pJ1711
   Rachev A, 1997, J BIOMECH, V30, P819, DOI 10.1016/S0021-9290(97)00032-8
   RODBARD S, 1970, PERSPECT BIOL MED, V13, P507
   Sipkema P, 1997, ANN BIOMED ENG, V25, P278, DOI 10.1007/BF02648042
   TAKAMIZAWA K, 1987, J BIOMECH, V20, P7, DOI 10.1016/0021-9290(87)90262-4
   TAKAMIZAWA K, 1992, AM J PHYSIOL, V263, pH30
   Vishnav R, 1983, BIOMEDICAL ENG, P330
   VITO RP, 1980, J BIOMECH, V13, P951, DOI 10.1016/0021-9290(80)90166-9
   Zeller PJ, 1998, J VASC RES, V35, P8, DOI 10.1159/000025560
NR 23
TC 154
Z9 157
U1 2
U2 10
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 1999
VL 27
IS 4
BP 459
EP 468
DI 10.1114/1.191
PG 10
WC Engineering, Biomedical
SC Engineering
GA 270CM
UT WOS:000084517900005
PM 10468230
DA 2018-10-19
ER

PT J
AU Yuan, HC
   Westwick, DT
   Ingenito, EP
   Lutchen, KR
   Suki, B
AF Yuan, HC
   Westwick, DT
   Ingenito, EP
   Lutchen, KR
   Suki, B
TI Parametric and nonparametric nonlinear system identification of lung
   tissue strip mechanics
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE stress relaxation; long memory; fractals; Wiener model; collagen fibers;
   elastin fibers; network
ID BIOLOGICAL-SYSTEMS; KERNEL ESTIMATION; FREQUENCY; VISCOELASTICITY;
   PARENCHYMA; VOLUME; MODEL; DOG
AB Lung parenchyma is a soft biological material composed of many interacting elements such as the interstitial cells, extracellular collagen-elastin fiber network, and proteoglycan ground substance. The mechanical behavior of this delicate structure is complex showing several mild but distinct types of nonlinearities and a fractal-like long memory stress relaxation characterized by a power-law function. To characterize tissue nonlinearity in the presence of such long memory, we investigated the robustness and predictive ability of several nonlinear system identification techniques on stress-strain data obtained from lung tissue strips with various input wave forms. We found that in general, for a mildly nonlinear system with long memory, a nonparametric nonlinear system identification in the frequency domain is preferred over time-domain techniques. More importantly, if a suitable parametric nonlinear model is available that captures the long memory of the system with only a few parameters, high predictive ability with substantially increased robustness can be achieved. The results provide evidence that the first-order kernel of the stress-strain relationship is consistent with a fractal-type long memory stress relaxation and the nonlinearity can be described as a Wiener-type nonlinear structure for displacements mimicking tidal breathing. (C) 1999 Biomedical Engineering Society. [S0090-6964(99)00804-8].
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Suki, B (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
OI Westwick, David/0000-0002-1470-6800
CR BARNAS GM, 1992, J APPL PHYSIOL, V72, P87
   BATES JHT, 1994, ANN BIOMED ENG, V22, P674, DOI 10.1007/BF02368292
   BATES JHT, 1998, ANN BIOMED ENG, V26, P1
   BAYLISS L. E., 1939, QUART JOUR EXP PHYSIOL, V29, P27
   Csendes T., 1988, Acta Cybernetica, V8, P361
   FREDBERG JJ, 1993, J APPL PHYSIOL, V74, P1387
   FUNG YC, 1972, BIOMECHANICS ITS FDN, P181
   HANTOS Z, 1992, J APPL PHYSIOL, V72, P168
   HILDEBRA.J, 1970, J APPL PHYSIOL, V28, P365
   HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779
   HILDEBRANDT J, 1969, J APPL PHYSIOL, V27, P246
   HUNTER IW, 1986, BIOL CYBERN, V55, P135
   Korenberg MJ, 1996, ANN BIOMED ENG, V24, P250, DOI 10.1007/BF02667354
   KORENBERG MJ, 1991, ANN BIOMED ENG, V19, P429, DOI 10.1007/BF02584319
   KORENBERG MJ, 1989, ADV METHODS PHYSL SY, V2, P165
   Ljung L., 1987, SYSTEM IDENTIFICATIO
   LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373
   Maksym GN, 1997, ANN BIOMED ENG, V25, P1000
   Maksym GN, 1997, J APPL PHYSIOL, V82, P32
   Maksym GN, 1998, ANN BIOMED ENG, V26, P242, DOI 10.1114/1.119
   MAKSYM GN, 1996, THESIS MCGILL U MONT
   MIJAILOVICH SM, 1994, J APPL PHYSIOL, V76, P773
   SALAZAR E, 1964, J APPL PHYSIOL, V19, P97
   SCHENTZEN M, 1989, VOLTERRA WIENER THEO
   SUKI B, 1995, J APPL PHYSIOL, V79, P660
   SUKI B, 1992, IEEE T BIO-MED ENG, V39, P1142, DOI 10.1109/10.168693
   SUKI B, 1994, J APPL PHYSIOL, V76, P2749
   VICTOR J, 1980, BIOPHYS J, V29, P459, DOI 10.1016/S0006-3495(80)85146-0
   WEST BJ, 1990, ANN BIOMED ENG, V18, P135, DOI 10.1007/BF02368426
   Westwick DT, 1997, ANN BIOMED ENG, V25, P802, DOI 10.1007/BF02684164
   Yuan HC, 1997, J APPL PHYSIOL, V83, P1420
   Zhang Q, 1998, ANN BIOMED ENG, V26, P103, DOI 10.1114/1.82
   Zhang Q, 1999, ANN BIOMED ENG, V27, P1, DOI 10.1114/1.186
NR 33
TC 18
Z9 18
U1 0
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 1999
VL 27
IS 4
BP 548
EP 562
DI 10.1114/1.217
PG 15
WC Engineering, Biomedical
SC Engineering
GA 270CM
UT WOS:000084517900014
PM 10468239
DA 2018-10-19
ER

PT J
AU Browne, M
   Langley, RS
   Gregson, PJ
AF Browne, M
   Langley, RS
   Gregson, PJ
TI Reliability theory for load bearing biomedical implants
SO BIOMATERIALS
LA English
DT Article
DE reliability theory; biomedical devices; tibial tray; lifetime prediction
ID 2ND-ORDER RELIABILITY; DESIGN; LEVEL
AB At present, load-bearing implants are designed on a deterministic basis int which the structural strength and applied loading are given fixed values, and global safety factors are applied to (i) cover any uncertainties in these quantities, and (ii) to design against failure of the component. This approach will become increasingly inappropriate as younger and more active patient demands become more exacting and as devices become more complex. The present work describes a preliminary investigation in which a scientific and probabilistic technique is applied to assess the structural integrity of the knee tibial tray. It is envisaged that by applying such a technique to other load bearing biomedical devices, reliability theory may aid in future lifing procedures and materials/design optimisation. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Univ Southampton, Dept Mat Engn, Southampton SO17 1BJ, Hants, England.
   Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.
RP Browne, M (reprint author), Univ Southampton, Dept Mat Engn, Southampton SO17 1BJ, Hants, England.
RI Browne, Martin/M-8229-2013
OI Browne, Martin/0000-0001-5184-050X
CR American Society for Testing and Materials (ASTM), 1997, ANN BOOK ASTM STAND
   [Anonymous], 148791 ISO
   BIRNBAUM ZW, 1969, J APPL PROBAB, V6, P319, DOI 10.2307/3212003
   Bogdanoff J. L, 1985, PROBABILISTIC MODELS
   Boyer C, 1997, RELIAB ENG SYST SAFE, V56, P273, DOI 10.1016/S0951-8320(96)00095-6
   Breitung K, 1996, MATH MODELS STRUCTUR, P227
   Cawlfield JD, 1997, J STAT COMPUT SIM, V57, P353, DOI 10.1080/00949659708811817
   Der Kiureghian A, 1998, STRUCT SAF, V20, P37, DOI 10.1016/S0167-4730(97)00026-X
   *DTI MTS, CAM2 DTIMTS
   Farhangdoost K, 1996, ENG FRACT MECH, V53, P687, DOI 10.1016/0013-7944(95)00131-X
   FREUDENTHAL AM, 1961, STRUCTURAL SAFETY CO, P61
   GALANTE JO, 1975, J BONE JOINT SURG AM, VA 57, P230, DOI 10.2106/00004623-197557020-00017
   KARAMCHANDANI A, 1992, STRUCT SAF, V11, P95, DOI 10.1016/0167-4730(92)90002-5
   Langley RS, 1995, P I MECH ENG G-J AER, V209, P291, DOI 10.1243/PIME_PROC_1995_209_303_02
   Madsen HO, 1986, METHODS STRUCTURAL S
   PARIS PC, 1963, T ASME D, V85, P528
   PAYNE AO, 1972, ASTM STP, V511, P106
   Pu Y, 1997, J OFFSHORE MECH ARCT, V119, P270, DOI 10.1115/1.2829107
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P635, DOI 10.1002/jbm.820120506
   SCOTT PM, 1981, FATIGUE ENG MATER, V4, P291, DOI 10.1111/j.1460-2695.1981.tb01127.x
   THROFTCHRISTENS.P, 1982, STRUCTURAL RELIABILI
   Yang J. N., 1987, PROBABILISTIC FRACTU, P171
NR 22
TC 23
Z9 23
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1999
VL 20
IS 14
BP 1285
EP 1292
DI 10.1016/S0142-9612(99)00027-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 207AD
UT WOS:000080912400005
PM 10403046
DA 2018-10-19
ER

PT J
AU Sumiyoshi, T
   Sekita, H
   Arai, T
   Sato, S
   Ishihara, M
   Kikuchi, M
AF Sumiyoshi, T
   Sekita, H
   Arai, T
   Sato, S
   Ishihara, M
   Kikuchi, M
TI High-power continuous-wave 3-and 2-mu m cascade Ho3+: ZBLAN fiber laser
   and its medical applications
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE holmium; infrared lasers; laser biomedical applications; laser
   materials-processing applications; optical fiber lasers; Raman lasers
ID MU-M; ERBIUM; WATER; CW; TRANSITIONS; OPERATION; GLASS
AB A new medical fiber laser oscillating at two useful wavelengths (3 and 2 mu m) is reported. We have demonstrated highly efficient and high-power continuous-wave cascade oscillation at room temperature with a holmium ion-doped fluoride glass fiber laser pumped with a 1.15-mu m fiber Raman laser. The simultaneous oscillation wavelengths were 3 and 2 mu m, and their combined output power was 3.0 W with a slope efficiency of 65%, To our best knowledge, this is the first achievement of watt-level-output power in the mid infrared region with ZrF4-BaF2-LaF3-AlF3-NaF (ZBLAN) glass fiber. In experiments to evaluate potential for medical applications, we tested the two-wavelength beam as a laser surgical knife on soft rabbit tissues and demonstrated that it had strong cutting capability, and that the coagulation layer thickness could be controlled by varying the power ratio of the two-wavelength laser.
C1 NEC Corp Ltd, Optoelect & High Frequency Device Res Labs, Miyamae Ku, Kawasaki, Kanagawa 2168555, Japan.
   Natl Def Med Coll, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Inst Res, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan.
RP Sumiyoshi, T (reprint author), NEC Corp Ltd, Optoelect & High Frequency Device Res Labs, Miyamae Ku, Kawasaki, Kanagawa 2168555, Japan.
CR BAYLY JG, 1963, INFRARED PHYS, V3, P211, DOI 10.1016/0020-0891(63)90026-5
   BUDNI PA, 1998, OSA TRENDS OPTICS PH, V19, P204
   Chernikov SV, 1998, ELECTRON LETT, V34, P680, DOI 10.1049/el:19980421
   DOWNING HD, 1975, J GEOPHYS RES, V80, P1656, DOI 10.1029/JC080i012p01656
   HAMILTON CE, 1994, OPT LETT, V19, P1627, DOI 10.1364/OL.19.001627
   Jensen T, 1996, OPT LETT, V21, P585, DOI 10.1364/OL.21.000585
   KINTZ GJ, 1987, APPL PHYS LETT, V50, P1553, DOI 10.1063/1.97777
   MUENDEL M, 1997, OSA TECH DIG SER, V10
   PAGE RH, 1997, OSA TRENDS OPTICS PH, V10, P214
   PASK HM, 1995, IEEE J SEL TOP QUANT, V1, P2, DOI 10.1109/2944.468377
   PERCIVAL RM, 1992, ELECTRON LETT, V28, P1866, DOI 10.1049/el:19921194
   Pollnau M, 1997, IEEE J QUANTUM ELECT, V33, P1982, DOI 10.1109/3.641313
   Pollnau M, 1997, OPT LETT, V22, P612, DOI 10.1364/OL.22.000612
   Pratisto H, 1996, APPL OPTICS, V35, P3328, DOI 10.1364/AO.35.003328
   PRATISTO H, 1995, APPL PHYS LETT, V67, P1963, DOI 10.1063/1.114580
   SCHNEIDER J, 1995, ELECTRON LETT, V31, P1250, DOI 10.1049/el:19950858
   SHNERDER J, 1995, IEEE PHOTONIC TECH L, V7, P354
   STONEMAN RC, 1992, OPT LETT, V17, P816, DOI 10.1364/OL.17.000816
   Sumiyoshi T, 1998, OPT LETT, V23, P1837, DOI 10.1364/OL.23.001837
   SUMIYOSHI T, 1997, P IEEE LEOS 1997 ANN
   TANIMURA K, 1984, PHYS REV B, V30, P2429, DOI 10.1103/PhysRevB.30.2429
   WAARTS R, 1994, OPT LETT, V19, P1738, DOI 10.1364/OL.19.001738
   WETENKAMP L, 1990, ELECTRON LETT, V26, P883, DOI 10.1049/el:19900577
   WETENKAMP L, 1992, J NON-CRYST SOLIDS, V140, P35, DOI 10.1016/S0022-3093(05)80737-9
NR 24
TC 71
Z9 75
U1 2
U2 22
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD JUL-AUG
PY 1999
VL 5
IS 4
BP 936
EP 943
DI 10.1109/2944.796314
PG 8
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 248CM
UT WOS:000083257800010
DA 2018-10-19
ER

PT J
AU Fried, NM
   Hung, VC
   Walsh, JT
AF Fried, NM
   Hung, VC
   Walsh, JT
TI Laser tissue welding: Laser spot size and beam profile studies
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE denaturation; laser biomedical applications; laser materials-processing
   applications; laser welding; Monte Carlo methods; optical propagation
ID OPTICAL PROPERTY CHANGES; CARBON-DIOXIDE LASER; MULTILAYERED TISSUES;
   ND-YAG; MYOCARDIUM; DIAMETER; CLOSURE; IRRADIATION
AB This paper evaluates the effect of laser spot diameter and beam profile on the shape of the thermal denaturation zone produced during laser tissue welding, 2-cm-long full-thickness incisions were made on the epilated backs of guinea pigs in vivo. India ink was used as an absorber and clamps were used to appose the incision edges. Welding was performed using continuous-wave 1.06-mu m, Nd:YAG laser radiation scanned over the incisions to produce similar to 100-ms pulses. Laser spot diameters of 1, 2, 4, and 6 mm were studied, With powers of 1, 4, 16, and 36 W, respectively. The irradiance remained constant at 127 W/cm(2). Monte Carlo simulations were also conducted to examine the effect of laser spot size and beam profile on the distribution of photons absorbed in the tissue, The laser spot diameter was varied from 1 to 6 mm, Gaussian, Bat-top, dual Gaussian, and dual flat-top beam profiles were studied. The experimental results showed that 1-, 2-,4-, and 6-mm-diameter spots produced thermal denaturation to an average depth of 570, 970, 1470, and 1900 mu m, respectively. Monte Carlo simulations demonstrated that the most uniform distribution of photon absorption is achieved using large diameter dual hat-top beams.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Fried, NM (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
RI Walsh, Joseph/B-7636-2009
CR ABERGEL RP, 1986, J DERMATOL SURG ONC, V12, P1181, DOI 10.1111/j.1524-4725.1986.tb02103.x
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   Cheong W., 1995, OPTICAL THERMAL RESP
   DERBYSHIRE GJ, 1990, LASER SURG MED, V10, P28, DOI 10.1002/lsm.1900100108
   Fried NM, 1998, J BIOMED OPT, V3, P401, DOI 10.1117/1.429850
   FRIED NM, IN PRESS SUTURELESS
   GARDEN JM, 1986, LASER SURG MED, V6, P67, DOI 10.1002/lsm.1900060114
   Jacques S. L., 1995, OPTICAL THERMAL RESP
   JACQUES SL, 1989, P IEEE EMBS, V11, P1199, DOI 10.1109/IEMBS.1989.96158
   JAYWANT S, 1993, P SOC PHOTO-OPT INS, V1882, P218, DOI 10.1117/12.148080
   KEIJZER M, 1989, LASER SURG MED, V9, P148, DOI 10.1002/lsm.1900090210
   KEIJZER M, 1991, LASER SURG MED, V11, P601, DOI 10.1002/lsm.1900110616
   Kienle A, 1997, LASER SURG MED, V20, P346, DOI 10.1002/(SICI)1096-9101(1997)20:3<346::AID-LSM14>3.0.CO;2-B
   KIM BM, 1995, P SOC PHOTO-OPT INS, V2391, P443, DOI 10.1117/12.209911
   PICKERING JW, 1993, APPL OPTICS, V32, P367, DOI 10.1364/AO.32.000367
   PICKERING JW, 1992, J PHOTOCH PHOTOBIO B, V16, P101, DOI 10.1016/1011-1344(92)80002-D
   PICKERING JW, 1994, LASER SURG MED, V15, P200, DOI 10.1002/lsm.1900150208
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   ROBINSON JK, 1987, ANN PLAS SURG, V18, P499, DOI 10.1097/00000637-198706000-00006
   ROGGAN A, 1995, LASER INDUCED INTERS
   SPLINTER R, 1991, LASER SURG MED, V11, P117, DOI 10.1002/lsm.1900110205
   TAN OT, 1988, J INVEST DERMATOL, V90, P877, DOI 10.1111/1523-1747.ep12462144
   THOMSEN S, 1993, P SOC PHOTO-OPT INS, V1882, P230, DOI 10.1117/12.147663
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7
   WIDER TM, 1991, PLAST RECONSTR SURG, V88, P1018, DOI 10.1097/00006534-199112000-00011
NR 26
TC 10
Z9 10
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1077-260X
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD JUL-AUG
PY 1999
VL 5
IS 4
BP 1004
EP 1012
DI 10.1109/2944.796323
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 248CM
UT WOS:000083257800019
DA 2018-10-19
ER

PT J
AU Zdrahala, RJ
   Zdrahala, IJ
AF Zdrahala, RJ
   Zdrahala, IJ
TI Biomedical applications of polyurethanes: A review of past promises,
   present realities, and a vibrant future
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID PACEMAKER LEADS; HEART-VALVE; CALCIFICATION; ELASTOMERS; CATHETERS
AB Polyurethanes, having extensive structure/property diversity, are one of the most bio- and blood-compatible materials known today. These materials played a major role in the development of many medical devices ranging from catheters to total artificial heart. Properties such as durability, elasticity, elastomer-like character, fatigue resistance, compliance, and acceptance or tolerance in the body during the healing, became often associated with polyurethanes. Furthermore, propensity for bulk and surface modification via hydrophilic/hydrophobic balance or by attachments of biologically active species such as anticoagulants or biorecognizable groups are possible via chemical groups typical for polyurethane structure. These modifications are designed to mediate and enhance the acceptance and healing of the device or implant. Many innovative processing technologies are used to fabricate functional devices, feeling and often behaving like natural tissue.
   The hydrolytically unstable polyester polyurethanes were replaced by more resistant but oxidation-sensitive polyether polyols based polyurethanes and their clones containing silicone and other modifying polymeric intermediates. Chronic in vivo instability, however, observed on prolonged implantation, became a major roadblock for many applications.
   Presently, utilization of more oxidation resistant polycarbonate polyols as soft segments, in combination with antioxidants such as Vitamin E, offer materials which can endure in the body for several years. The applications cover cardiovascular devices, artificial organs, tissue replacement and augmentation, performance enhancing coatings and many others. In situ polymerized, cross-linked systems could extend this biodurability even further.
   The future will expand this field by revisiting chemically-controlled biodegradation, in combination with a mini-version of RIM technology and minimally invasive surgical procedures, to form, in vivo, a scaffold, by delivery of reacting materials to the specific site in the body and polymerizing the mass in situ. This scaffold will provide anchor for tissue regeneration via cell attachment, proliferation, control of inflammation, and healing.
C1 R&I Consulting Int, Eden Prairie, MN 55346 USA.
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   BORETOS JW, 1975, J BIOMED MATER RES, V9, P327, DOI 10.1002/jbm.820090308
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1980, PURE APPL CHEM, V52, P1851, DOI 10.1351/pac198052071851
   BRASH JL, 1973, J BIOMED MATER RES, V7, P313, DOI 10.1002/jbm.820070405
   COLOVOS GC, 1977, SPE TECHN C DENV CO
   COOPER SL, 1966, J APPL POLYM SCI, V10, P1837, DOI 10.1002/app.1966.070101204
   CRITCHFIELD FE, 1971, RUBBER WORLD, V164, P61
   CRITCHFIELD FE, 1972, J ELASTOPLAST, V4, P22
   *ETH INC, 1975, TECHN PROD INF
   FELT JC, 1997, T 13 EUR C BIOM ESB, V13, pP152
   FELT JC, 1996, Patent No. 5556429
   FURMAN S, 1967, J THORAC CARDDIOVASC, V55, P727
   HARTHORNE JW, 1984, INT J CARDIOL, V6, P423, DOI 10.1016/0167-5273(84)90321-8
   IHLENFELD JV, 1979, THROMB RES, V14, P953, DOI 10.1016/0049-3848(79)90013-6
   IVES CL, 1992, J BIOMATER APPL, V6, P340
   JOSHI RR, 1994, J APPL BIOMATER, V5, P65, DOI 10.1002/jab.770050109
   KLEIN A, 1987, ANTEC 87, P1205
   Kolff T, 1973, Biomater Med Devices Artif Organs, V1, P669
   KOLFF WJ, 1959, T AM SOC ART INT ORG, V5, P298
   Lelah M. D., 1986, POLYURETHANES MED
   LYMAN DONALD J., 1967, J BIOMED MAT RES, V1, P17, DOI 10.1002/jbm.820010105
   Mackay TG, 1996, BIOMATERIALS, V17, P1857, DOI 10.1016/0142-9612(95)00242-1
   MARTINEZMARTINEZ L, 1990, J HOSP INFECT, V16, P311, DOI 10.1016/0195-6701(90)90003-7
   MCGEE GM, 1980, T AM SOC ART INT ORG, V26, P299
   MOBITZER J, 1972, J APPL POLYM SCI, V16, P2697
   NG HN, 1973, POLYMER, V14, P255, DOI 10.1016/0032-3861(73)90085-2
   NYILAS E, 1970, 23 C ENG MED BIOL, V12, P147
   PAUL D, 1989, PROG POLYM SCI, V14, P597, DOI 10.1016/0079-6700(89)90011-7
   PECHHOLD E, 1980, RUBBER CHEM TECHNOL, V55, P1032
   PENTZ WJ, 1975, RUBBER AGE, V12
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   PLANCK H, 1987, POLYURETHANES BIOMED, V2
   PLANCK H, 1984, POLYURETHANES BIOMED
   SCHNEIDER NS, 1977, POLYM ENG SCI, V17, P73, DOI 10.1002/pen.760170203
   Schollenberger C. S., 1959, US patent, Patent No. [2,871,218, 2871218]
   SCHOLLENBERGER CS, 1981, RUBBER CHEM TECHNOL, V55, P137
   SCHOLLENBERGER CS, 1975, J ELASTO PLAST, V7, P65
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P2503, DOI 10.1002/app.1975.070190913
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P3185, DOI 10.1002/app.1975.070191204
   Smith JC, 1996, BIOMATERIALS, V17, P1469, DOI 10.1016/0142-9612(96)89770-5
   SNOW J, 1981, T AM SOC ART INT ORG, V27, P485
   SOLOMON DD, 1986, T SOC BIOMATER, V9, P179
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   SZYCHER M, 1983, J ELASTOM PLAST, V15, P81, DOI 10.1177/009524438301500205
   SZYCHER M, 1977, 35 ANTEC SPE, V35, P743
   SZYCHER M, 1984, ELASTOMERICS, V7, P20
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   TINGEY KG, 1988, SURFACE CHARACTERIZA, P255
   ZDRAHAL RJ, 1988, IMPLANT MAT BIOFUNCT, P393
   ZDRAHAL RJ, 1987, BIOMATERIALS CLIN AP, P621
   Zdrahala R J, 1988, J Biomater Appl, V2, P544
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   ZDRAHALA RJ, 1980, J ELASTOM PLAST, V12, P225, DOI 10.1177/009524438001200404
   ZDRAHALA RJ, 1979, J APPL POLYM SCI, V24, P2041, DOI 10.1002/app.1979.070240912
   ZDRAHALA RJ, 1997, T 13 EUR C BIOM ESB, V13, P109
   ZDRAHALA RJ, 1986, MATER RES SOC S P, V55, P407
   ZDRAHALA RJ, 1981, REACTION INJECTION M, P63
   ZDRAHALA RJ, 1988, T SOC BIOMATER, V11, P425
   ZDRAHALA RJ, 1987, POLYURETHANES BIOMED, V2, P1
   ZDRAHALA RJ, 1998, 60 YEARS POLYURETHAN, P304
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   1985, DESERET MED TECHNICA
   1960, Patent No. 2929804
NR 65
TC 307
Z9 313
U1 11
U2 152
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 1999
VL 14
IS 1
BP 67
EP 90
DI 10.1177/088532829901400104
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 210AZ
UT WOS:000081084100004
PM 10405885
DA 2018-10-19
ER

PT J
AU Desai, TA
   Hansford, D
   Ferrari, M
AF Desai, TA
   Hansford, D
   Ferrari, M
TI Characterization of micromachined silicon membranes for immunoisolation
   and bioseparation applications
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE bioseparation; biotechnology; inorganic membranes; immunoisolation;
   membrane; micromachining; protein diffusion
ID PORCINE ISLETS; ENCAPSULATION; PANCREAS; BIOCAPSULES; INVITRO; RELEASE
AB The application of microfabrication technology to create precise separation and isolation membranes for biomedical applications is described. By utilizing fabrication techniques commonly employed in the microelectronics industry (MEMS), membranes can be fabricated with well-controlled and uniform pore sizes, allowing the optimization of membrane parameters for biomedical applications in cell immunoisolation and viral filtration. Using bulk and surface micromachining to create diffusion membranes, pore sizes down to 18 nm have been attained through deposition and subsequent etching of sacrificial layers on silicon. Membranes were shown to be sufficiently permeable to small biomolecules such as oxygen, glucose, and insulin, while excluding the passage of larger proteins such as immunoglobulin G (IgG). The semipermeability of microfabricated membranes, their biocompatibility, ease in sterilization, along with their thermal and chemical stability, may provide a significant advantages for biomedical applications. Microfabrication technology may also be applied to other materials of interest for the development of highly controlled membranes. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
   Univ Calif Berkeley, Biomed Microdevices Ctr, Berkeley, CA 94720 USA.
   Ohio State Univ, Ctr Bioengn, Columbus, OH 43210 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RI Hansford, Derek/B-5306-2012
CR BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8
   CHICHEPORTICHE D, 1988, DIABETOLOGIA, V31, P54
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   Chu W., 1995, SPIE P, V2593
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COLTON CK, 1991, T ASME, V113, P152
   Desai TA, 1997, P SOC PHOTO-OPT INS, V2978, P216, DOI 10.1117/12.269972
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Dionne KE, 1996, BIOMATERIALS, V17, P257, DOI 10.1016/0142-9612(96)85563-3
   Hellerstrom C, 1979, DIABETES, V28, P766
   HUGGETT ASG, 1957, LANCET, V2, P368
   Iwata H, 1995, TRANSPLANT P, V27, P3224
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   KESSLER L, 1991, HORM METAB RES, V23, P312, DOI 10.1055/s-2007-1003685
   Kuhtreiber W M, 1994, ASAIO J, V40, pM789, DOI 10.1097/00002480-199407000-00106
   Lanza R. P., 1995, SCI AM SCI MED, P16
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Maki T, 1996, TRANSPLANTATION, V62, P136, DOI 10.1097/00007890-199607150-00028
   NAKAMURA H, 1981, SEIKAGAKU DATABOOK, V2, P1107
   Sheppard NF, 1996, J CONTROL RELEASE, V42, P15, DOI 10.1016/0168-3659(96)01337-5
   Shoichet MS, 1996, BIOMATERIALS, V17, P285, DOI 10.1016/0142-9612(96)85566-9
   van Rijn C.J.M., 1995, IEEE P MEMS, P83
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   ZHANG PC, 1997, IEEE ENG MED BIO MAR
NR 24
TC 100
Z9 104
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD JUL 1
PY 1999
VL 159
IS 1-2
BP 221
EP 231
DI 10.1016/S0376-7388(99)00062-9
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 205GR
UT WOS:000080813400017
DA 2018-10-19
ER

PT J
AU Ishimaru, T
   Lew, D
   Haller, J
   Vannier, MW
AF Ishimaru, T
   Lew, D
   Haller, J
   Vannier, MW
TI Virtual arthroscopy of the visible human female temporomandibular joint
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID REALITY; ENDOSCOPY; SURGERY
AB Purpose: This study was designed to obtain views of the temporomandibular joint (TMJ) by means of computed arthroscopic simulation (virtual arthroscopy) using three-dimensional (3D) processing.
   Material and Methods: Volume renderings of the TMJ from very thin cryosection slices of the Visible Human Female were taken off the Internet. Analyze(AVW) software (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN) on a Silicon Graphics O2 workstation (Mountain View, CA) was then used to obtain 3D images and allow the navigation "fly-through" of the simulated joint.
   Results: Good virtual arthroscopic views of the upper and lower joint spaces of both TMJs were obtained by fly-through simulation from the lateral and endaural sides. It was possible to observe the presence of a partial defect in the articular disc and an osteophyte on the condyle. Virtual arthroscopy provided visualization of regions not accessible to real arthroscopy.
   Conclusion: These results indicate that virtual arthroscopy will be a new technique to investigate the TMJ of the patient with TMJ disorders in the near future.
C1 Yamaguchi Univ, Sch Med, Dept Oral & Maxillofacial Surg, Yamaguchi 7558505, Japan.
   Univ Iowa Hosp & Clin, Dept Hosp Dent, Div Oral & Maxillofacial Surg, Iowa City, IA 52242 USA.
   Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA.
RP Ishimaru, T (reprint author), Yamaguchi Univ, Sch Med, Dept Oral & Maxillofacial Surg, Yamaguchi 7558505, Japan.
OI Vannier, Michael/0000-0001-9898-384X
CR CHU SA, 1995, ORAL SURG ORAL MED O, V80, P604, DOI 10.1016/S1079-2104(05)80157-X
   COHEN ME, 1996, MACINTOSH BIBLE, P531
   DALGISH GM, 1997, RANDOM HOUSE WEBSTER, P827
   Gilani S, 1997, LARYNGOSCOPE, V107, P25, DOI 10.1097/00005537-199701000-00008
   Hansen D J, 1997, JAMA, V277, P434, DOI 10.1001/jama.277.5.434
   Hara AK, 1996, RADIOLOGY, V200, P49, DOI 10.1148/radiology.200.1.8657944
   MCGOVERN KT, 1994, BRIT MED J, V308, P1054, DOI 10.1136/bmj.308.6936.1054a
   Price C, 1992, Dentomaxillofac Radiol, V21, P148
   Rodenwaldt J, 1997, J COMPUT ASSIST TOMO, V21, P405, DOI 10.1097/00004728-199705000-00013
   SATAVA RM, 1995, CONTEMP SURG, V47, P204
   Vining DJ, 1996, RADIOLOGY, V200, P30, DOI 10.1148/radiology.200.1.8657938
   Volter S, 1995, Z ORTHOP GRENZGEB, V133, P492, DOI 10.1055/s-2008-1039928
   ZIEGLER R, 1995, COMPUT BIOL MED, V25, P193, DOI 10.1016/0010-4825(94)00038-R
NR 13
TC 8
Z9 8
U1 0
U2 58
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUL
PY 1999
VL 57
IS 7
BP 807
EP 811
DI 10.1016/S0278-2391(99)90820-0
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 212QE
UT WOS:000081227100014
PM 10416627
DA 2018-10-19
ER

PT J
AU Miyata, T
   Asami, N
   Uragami, T
AF Miyata, T
   Asami, N
   Uragami, T
TI A reversibly antigen-responsive hydrogel
SO NATURE
LA English
DT Article
ID PHASE-TRANSITIONS; POLYMER GEL; RELEASE; GLUCOSE; COLLAPSE; PH
AB Stimuli-responsive hydrogels that undergo abrupt changes in volume in response to external stimuli such as pH, temperature and solvent composition have potential applications in biomedicine and the creation of 'intelligent' materials systems, for example as media for drug delivery, separation processes and protein immobilization. Hydrogels have been reported that respond to pH(1-3), temperature(4-13), electric fields(14-16) and saccharides(17-22). For some biomedical applications it would be very useful to have a material whose swelling response was dictated by a specific protein. Here we report such a material, which swells reversibly in a buffer solution in response to a specific antigen. The hydrogel was prepared by grafting the antigen and corresponding antibody to the polymer network, so that binding between the two introduces crosslinks in the network. Competitive binding of the free antigen triggers a change in gel volume owing to breaking of these non-covalent crosslinks. In addition, we show that the hydrogel displays shape-memory behaviour, and that stepwise changes in antigen concentration can induce pulsatile permeation of a protein through the network.
C1 Kansai Univ, Fac Engn, Chem Branch, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan.
RP Miyata, T (reprint author), Kansai Univ, Fac Engn, Chem Branch, Osaka 5648680, Japan.
CR AOKI T, 1994, MACROMOLECULES, V27, P947, DOI 10.1021/ma00082a010
   Bae Y.H., 1988, MAKROMOL CHEM-RAPID, V9, P185
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   FEIL H, 1991, J MEMBRANE SCI, V64, P283, DOI 10.1016/0376-7388(91)80099-R
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0
   Lee SJ, 1996, J MOL RECOGNIT, V9, P549, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<549::AID-JMR299>3.0.CO;2-C
   Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P1111, DOI 10.1002/macp.1994.021950401
   MURAI N, 1995, J BIOL CHEM, V270, P19957, DOI 10.1074/jbc.270.34.19957
   NATSUME T, 1994, J BIOL CHEM, V269, P31224
   OBIDAT AA, 1996, PHARMACEUT RES, V13, P989
   OBIDAT AA, 1997, BIOMATERIALS, V18, P801
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   SHOEMAKER SG, 1987, APPL BIOCHEM BIOTECH, V15, P11, DOI 10.1007/BF02798503
   SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
NR 26
TC 775
Z9 788
U1 26
U2 501
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD JUN 24
PY 1999
VL 399
IS 6738
BP 766
EP 769
DI 10.1038/21619
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 210JP
UT WOS:000081101600049
PM 10391240
DA 2018-10-19
ER

PT J
AU Skett, P
   Roberts, P
   Khan, S
AF Skett, P
   Roberts, P
   Khan, S
TI Maintenance of steroid metabolism and hormone responsiveness in
   cryopreserved dog, monkey and human hepatocytes
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE liver; cryopreservation; human; monkey; dog; metabolism
ID DRUG-METABOLISM; PRIMARY CULTURE; RAT; PRESERVATION; STORAGE; LIVER
AB The efficient and effective use of hepatocytes from larger species and rare human material requires a reliable storage method for cells not needed on the day of preparation. Cryopreservation would seem to be the only viable alternative. In this study the suitability of a published cryopreservation technique on dog, monkey and human hepatocytes has been examined and the cells were tested for functionality directly after thawing and subsequent to culture using steroid metabolism and hormone responsiveness of glycogen phosphorylase a. Monkey and human hepatocytes appear to survive the freezing and thawing process better than dog cells-the latter losing the ability to respond to adrenergic stimuli and their ability to maintain steroid metabolism in culture. Although monkey and human cells do preserve their steroid metabolising capacity after freeze/thawing, there is not the significant increase in enzyme activity seen during culturing freshly isolated cells. It would appear, therefore, that some damage has occurred to the cells during the freeze/thaw process. As previously noted, Williams' medium E is superior to Ham's F-10 in maintaining enzyme activities in culture. It is suggested that cryopreservation is the way forward for the development of stockpiles of viable hepatocytes for biomedical and toxicological research and development but that further modifications to the process are still necessary to optimise the maintenance of liver-specific functions in the thawed cells. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.
RP Skett, P (reprint author), Univ Glasgow, Inst Biomed & Life Sci, W Med Bldg, Glasgow G12 8QQ, Lanark, Scotland.
CR BERRY MN, 1991, LAB TECHNIQUES BIOCH, V21, P1
   deSousa G, 1996, CELL BIOL TOXICOL, V12, P351, DOI 10.1007/BF00438170
   DESOUSA G, 1991, TOXICOL IN VITRO, V5, P483, DOI 10.1016/0887-2333(91)90077-Q
   DOU M, 1992, CRYOBIOLOGY, V29, P454, DOI 10.1016/0011-2240(92)90048-7
   EVANS PJ, 1994, CELL BIOL INT, V18, P999, DOI 10.1006/cbir.1994.1023
   FABRE G, 1988, BIOCHEM PHARMACOL, V37, P4389, DOI 10.1016/0006-2952(88)90622-3
   HUSSIN AH, 1990, BIOCHEM PHARMACOL, V40, P2285, DOI 10.1016/0006-2952(90)90724-Y
   KASAI S, 1993, CRYOBIOLOGY, V30, P1, DOI 10.1006/cryo.1993.1001
   Kravchenko L, 1996, CRYO-LETT, V17, P309
   KUNOS G, 1987, BIOCHEM PHARMACOL, V36, P1185, DOI 10.1016/0006-2952(87)90068-2
   LAWRENCE JN, 1991, TOXICOL IN VITRO, V5, P39, DOI 10.1016/0887-2333(91)90046-G
   LORETZ LJ, 1989, XENOBIOTICA, V19, P489, DOI 10.3109/00498258909042288
   POWIS G, 1987, DRUG METAB DISPOS, V15, P826
   RATANASAVANH D, 1991, HEPATOLOGY, V13, P1142, DOI 10.1016/0270-9139(91)92485-Q
   RIJNTJES PJM, 1986, J HEPATOL, V3, P7, DOI 10.1016/S0168-8278(86)80140-4
   ROGIERS V, 1990, BIOCHEM PHARMACOL, V40, P1701, DOI 10.1016/0006-2952(90)90345-L
   SKETT P, 1988, PHARMACOL THERAPEUT, V38, P269, DOI 10.1016/0163-7258(88)90007-1
   SKETT P, 1992, B91B43080015951, P1
   STALMANS W, 1975, EUR J BIOCHEM, V54, P341, DOI 10.1111/j.1432-1033.1975.tb04144.x
   SUN EL, 1990, IN VITRO CELL DEV, V25, P147
   THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9
NR 21
TC 17
Z9 19
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0009-2797
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD JUN 1
PY 1999
VL 121
IS 1
BP 65
EP 76
DI 10.1016/S0009-2797(99)00091-5
PG 12
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 212JQ
UT WOS:000081213900006
PM 10418971
DA 2018-10-19
ER

PT J
AU Cammas, S
   Bear, MM
   Moine, L
   Escalup, R
   Ponchel, G
   Kataoka, K
   Guerin, P
AF Cammas, S
   Bear, MM
   Moine, L
   Escalup, R
   Ponchel, G
   Kataoka, K
   Guerin, P
TI Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the
   design of biocompatible hydrolyzable devices
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article; Proceedings Paper
CT International Symposium on Biological Polyhydroxyalkanoates (ISBP 98)
CY SEP 09-11, 1998
CL RIKEN INST, SAITAMA, JAPAN
HO RIKEN INST
DE biomaterials; poly(beta-3-alkylmalic acid) derivatives; Poly(beta-malic
   acid) derivatives; synthetic PHAs
ID POLY(BETA-MALIC ACID); CYCLODEXTRIN INCLUSION; DRUG-DELIVERY;
   MICELLIZATION; MOLECULES; COMPLEXES; MICELLES; REPAIR
AB Poly(beta-malic acid) and poly(beta-3-alkylmalic acid) derivatives, as synthetic polyhydroxyalkanoates (PHAs), present several advantages as macromolecular materials for temporary biomedical applications. Indeed, such polymers, which can be synthesized through different chemical and biological routes, have cleavable ester beads in their backbone for hydrolytic degradation, stereogenic centres in the monomers units for controlling the macromolecular structure, bioassimilable or non-toxic repeating units and lateral chemical functions which can be adapted to specific requirements. The strategy for building such complex architectures, with one or several specific pendant groups, is based on the anionic ring-opening polymerization or copolymerization of the large family of malolactonic and 3-alkylmalolactonic acid esters. Because we are able to control the monomer synthesis and the polymerization step, we have been able to prepare different degradable materials for the biomedical field; such as: degradable associating networks made up by the association of random copolyesters containing a small percentage of hydrophobic moieties and beta-cyclodextrin copolymers; degradable macromolecular micelles constituted by degradable amphiphilic block copolymers of poly(beta-malic acid) as hydrophilic segments and poly(beta-alkylmalic acid alkyl esters) as hydrophobic blocks; and degradable nanoparticles made up by hydrophobic poly(beta-malic acid alkyl esters) derivatives. We have also prepared a terpolymer which exhibits growth factor-like properties in vivo. Finally, poly-(beta-malic acid) has been used as an additive in the preparation of peritoneal dialysis bags. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, F-94320 Thiais, France.
   Univ Paris Sud, Ctr Etud Pharmaceut, CNRS, URA 1218, F-92296 Chatenay Malabry, France.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
RP Cammas, S (reprint author), Univ Paris 12, Lab Rech Polymeres, CNRS, UMR C7581, 2-8 Rue Henry Dunant, F-94320 Thiais, France.
EM cammas@glvt-cnrs.fr
RI Kataoka, Kazunori/K-7108-2012
OI Kataoka, Kazunori/0000-0002-8591-413X
CR Amiel C, 1996, J INCLUS PHENOM MOL, V25, P61, DOI 10.1007/BF01041537
   ASTAFIEVA I, 1995, MACROMOLECULES, V28, P7127, DOI 10.1021/ma00125a015
   Blanquaert F, 1995, BONE, V17, P499, DOI 10.1016/8756-3282(95)00402-5
   BRANNONPEPPAS L, 1995, INT J PHARM, V116, P1, DOI 10.1016/0378-5173(94)00324-X
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   Cammas S, 1996, NATO ADV SCI INST SE, V327, P83
   CAMMAS S, IN PRESS MACROMOL CH
   CAMMAS S, IN PRESS J CONTROL R
   EFTINK MR, 1989, J AM CHEM SOC, V111, P6765, DOI 10.1021/ja00199a041
   FORT RC, 1964, CHEM REV, V64, P277, DOI 10.1021/cr60229a004
   FOURNIE P, 1992, J BIOACT COMPAT POL, V7, P113, DOI 10.1177/088391159200700201
   HARRISON JC, 1982, BIOPOLYMERS, V21, P1153, DOI 10.1002/bip.360210611
   Humberstone AJ, 1996, J PHARM SCI, V85, P525, DOI 10.1021/js950472p
   KATAOKA K, 1994, J MACROMOL SCI PURE, VA31, P1759, DOI 10.1080/10601329408545880
   KIZEROW D, 1992, MACROMOLECULES, V25, P461
   Kreuter J., 1994, COLLOIDAL DRUG DELIV, P219
   LAFONT J, 1994, CELL MATER, V4, P219
   LEBOUCHERDURAND MA, 1996, POLYM B, V35, P36
   MEDDAHI A, 1994, PATHOL RES PRACT, V190, P923
   Moffitt M, 1996, ACCOUNTS CHEM RES, V29, P95, DOI 10.1021/ar940080+
   Moine L, 1997, POLYMER, V38, P3121, DOI 10.1016/S0032-3861(96)01097-X
   Moine L, 1998, MACROMOL SYMP, V130, P45, DOI 10.1002/masy.19981300105
   MOINE L, UNPUB MACROMOLECULES
   PALEPU R, 1990, AUST J CHEM, V43, P2119, DOI 10.1071/CH9902119
   Renard E, 1997, EUR POLYM J, V33, P49, DOI 10.1016/S0014-3057(96)00123-1
   Renard I., 1996, POLYM PREPR, V37, P137
   SCHOLES PD, 1993, J CONTROL RELEASE, V25, P145, DOI 10.1016/0168-3659(93)90103-C
   STOLNIK S, 1994, J CONTROL RELEASE, V30, P57, DOI 10.1016/0168-3659(94)90044-2
   Szejtli J., 1988, CYCLODEXTRIN TECHNOL
   VERT M, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P291
   ZHANG LF, 1995, MACROMOLECULES, V28, P6055, DOI 10.1021/ma00122a010
NR 32
TC 56
Z9 61
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN-JUL
PY 1999
VL 25
IS 1-3
BP 273
EP 282
DI 10.1016/S0141-8130(99)00042-2
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 211HK
UT WOS:000081154700032
PM 10416675
DA 2018-10-19
ER

PT J
AU Teoh, SH
   Tang, ZG
   Ramakrishna, S
AF Teoh, SH
   Tang, ZG
   Ramakrishna, S
TI Development of thin elastomeric composite membranes for biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; BLOOD PUMP APPLICATIONS; SOFT SEGMENT
   LENGTH; POLYURETHANE ELASTOMERS; DRIED GELS; MORPHOLOGY; SERIES;
   STABILITY; POLYMERS; TENSILE
AB A breakthrough has been made in blending of two immiscible biocompatible polymers to form thin transparent interpenetrating network composite membranes (CM) with exceptional improvement in properties. Two immiscible polymers, namely the biaxially drawn ultra high molecular weight polyethylene (UHMWPE) film and polyether polyurethane (PU) were used. The fabrication included solution casting and heat compaction. During the fabrication, the CM still preserved the orientation of UHMWPE fibers but introduced the interpenetration of PU in UHMWPE film. The intimate interaction of PU with UHMWPE fibers was viewed through the transparency of CM. Differential scanning calorimetry (DSC) data showed the melting temperature (T-m) of UHMWPE increased by about 10 degrees C in CM and about 5 degrees C in heat-compacted membranes (HCM). Morphological observations indicated that CM presented a layered structure while HCM was a dense material without obvious void inclusions. The ultimate tensile strength and relative Young's modulus of CM are about 62 MPa and 460 MPa, respectively. They are about four times greater in strength and 150 times greater in modulus compared with those of PU. Heat compaction resulted in a membrane with nearly five times the tensile strength and 50 times the Young's modulus of PU. The engineered ultimate strain of CM is about 26%, 8% more than that of the porous UHMWPE film while about 70% of HCM, which is a 50% increase achieved through heat compaction. The tensile fracture toughness is about 93 mJ for CM and 211 mJ for HCM, two and five times that for the porous UHMWPE film, respectively. The significant modification on the properties of the heat-compacted composite may raise broad interest in using the CM to develop membrane-related devices and organ covers in biomedical applications. (C) 1999 Kluwer Academic Publishers.
C1 Natl Univ Singapore, Inst Mat Res & Engn, Ctr Biomed Mat Applicat & Technol, Dept Mech & Prod Engn, Singapore 119260, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Inst Mat Res & Engn, Ctr Biomed Mat Applicat & Technol, Dept Mech & Prod Engn, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR BRANDRUP J, 1975, POLYM HDB
   Brydson J. A., 1982, PLASTICS MAT
   CHENG YY, 1993, J MACROMOL SCI PHYS, VB32, P433, DOI 10.1080/00222349308215527
   CHERRY BW, 1981, POLYMER, V22, P1610, DOI 10.1016/0032-3861(81)90372-4
   COATES PD, 1995, CHEM ENG RES DES, V73, P753
   Fu YG, 1996, J MACROMOL SCI PHYS, VB35, P37, DOI 10.1080/00222349608220375
   GERRITS NSJA, 1991, POLYMER, V32, P1770, DOI 10.1016/0032-3861(91)90361-L
   GERRITS NSJA, 1990, POLYMER, V31, P231, DOI 10.1016/0032-3861(90)90111-B
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HAYASHI K, 1985, J BIOMED MATER RES, V19, P179, DOI 10.1002/jbm.820190207
   HAYASHI K, 1984, J BIOMED MATER RES, V18, P939, DOI 10.1002/jbm.820180808
   HAYASHI K, 1986, PROGR ARTIFICAL ORGA, P989
   HIN TS, 1984, POLYMER, V25, P727, DOI 10.1016/0032-3861(84)90044-2
   HOU M, 1995, PLAST RUB COMPOS PRO, V23, P279
   Jansen J, 1991, ASAIO Trans, V37, pM451
   Jar PYB, 1996, J POLYM SCI POL PHYS, V34, P707
   JONES AJ, 1988, POLYM BIOMATERIALS B
   Kienzle S. Y., 1988, POLYM BLENDS ALLOYS
   LEEPER HM, 1983, RUBBER CHEM TECHNOL, V56, P523, DOI 10.5254/1.3538140
   LEMM W, 1984, POLYURETHANES BIOMED, P103
   Mackay TG, 1996, ARTIF ORGANS, V20, P1017, DOI 10.1111/j.1525-1594.1996.tb04589.x
   Martin DJ, 1996, J APPL POLYM SCI, V60, P557, DOI 10.1002/(SICI)1097-4628(19960425)60:4<557::AID-APP9>3.0.CO;2-N
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Meeten G. H., 1986, OPTICAL PROPERTIES P
   Paris Edouard, 1994, P245
   PIENKOWSKI D, 1995, J BIOMED MATER RES, V29, P1167, DOI 10.1002/jbm.820291002
   PORTER RS, 1994, POLYMER, V35, P4979, DOI 10.1016/0032-3861(94)90652-1
   SAKAI Y, 1993, POLYMER, V34, P318, DOI 10.1016/0032-3861(93)90083-M
   SAKAI Y, 1988, POLYMER, V29, P1608, DOI 10.1016/0032-3861(88)90271-6
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES KB, 1984, 42 TECHN C APR 30 MA, P235
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   TANG ZG, 1997, 9 INT C BIOM ENG SIN, P563
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P270
   TEOH SH, 1997, KEYN LECT S EM PLAST
   TEOH SH, 1997, Patent No. 02630
   WEAVER KD, 1993, POLYM COMPOSITE, V14, P515, DOI 10.1002/pc.750140609
NR 43
TC 22
Z9 22
U1 3
U2 16
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 1999
VL 10
IS 6
BP 343
EP 352
DI 10.1023/A:1026421606939
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 204YJ
UT WOS:000080793300004
PM 15348135
DA 2018-10-19
ER

PT J
AU Vail, NK
   Swain, LD
   Fox, WC
   Aufdlemorte, TB
   Lee, G
   Barlow, JW
AF Vail, NK
   Swain, LD
   Fox, WC
   Aufdlemorte, TB
   Lee, G
   Barlow, JW
TI Materials for biomedical applications
SO MATERIALS & DESIGN
LA English
DT Article
DE ceramic matrix; lasers; sintering; rapid prototyping; biomedical
AB This paper discusses the physical and mechanical characterization of a calcium phosphate ceramic material system developed for biomedical applications in the repair of skeletal defects. The rapid prototyping process selective laser sintering (SLS) is the preferred forming process to produce complex porous ceramic matrices suitable for biomedical applications. The effects of SLS processing conditions on the properties of fabricated objects are quantified. The effects of post-processing conditions on the properties of SLS-fabricated objects are also quantified. SLS-fabricated implants are shown to perform well in vivo exhibiting excellent biocompatibility as well as showing considerable osseous integration and remodeling of the ceramic implant material. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Biomed Enterprises Inc, San Antonio, TX 78245 USA.
   Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
CR BALASUBRAMANIAN B, 1995, THESIS U TEXAS AUSTI
   *DTM CORP, 1998, GUID MAT
   ERICKSON D, 1997, COMMUNICATION
   FAUST GT, 1944, AM J SCI, V242, P447
   FOX WC, 1999, 45 ANN M ORTH RES SO
   Frenkel JJ, 1945, J PHYS USSR, V9, P385
   Holle J, 1996, PLAST RECONSTR SURG, V98, P542, DOI 10.1097/00006534-199609000-00031
   JACOBS PF, 1998, EFFECTS SHRINKAGE VA
   James WJ, 1998, J ORAL MAXIL SURG, V56, P512, DOI 10.1016/S0278-2391(98)90726-1
   LEE G, 1997, THESIS U TEXAS AUSTI
   LEE G, 1996, SOLID FREEFORM FAABR, V7, P15
   NELSON JC, 1995, IND ENG CHEM RES, V34, P1641, DOI 10.1021/ie00044a017
   NELSON JC, 1992, THESIS U TEXAS AUSTI
   NELSON JM, 1998, COMMUNICATION
   SUBRAMANIAN K, 1995, RAPID PROTOTYP J, V1, P13
   Vail NK, 1996, RAPID PROTOTYPING J, V2, P24, DOI 10.1108/13552549610129764
   VAIL NK, 1994, J APPL POLYM SCI, V52, P789, DOI 10.1002/app.1994.070520610
   VAIL NK, 1996, SOLID FREEFORM FABRI, V7, P481
   VAIL NK, 1994, THESIS U TEXAS AUSTI
   1986, ENCY POL SCI ENG
NR 20
TC 64
Z9 70
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD JUN
PY 1999
VL 20
IS 2-3
BP 123
EP 132
DI 10.1016/S0261-3069(99)00018-7
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 198RG
UT WOS:000080437300009
DA 2018-10-19
ER

PT J
AU Senuma, Y
   Hilborn, JG
AF Senuma, Y
   Hilborn, JG
TI Key parameters for monodispersed polymer microspheres with spinning disk
   atomization
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE monodispersed beads; polymer microspheres; atomization; drop formation;
   powder
ID DROP FORMATION; CONICAL TIPS; COPOLYMERIZATION; METHACRYLATE; PARTICLES
AB Spinning Disk Atomization has been developed to produce high quality powders in the form of narrowly dispersed or monosized spherical beads, in the size range of 50 to 500 mu m, that are hardly accessible by other techniques. This technology, that in principle can be applied to any kind of material, is described in this study for low molecular weight polymers, e.g. poly(ethyleneglycol). A description of the atomization equipment design, ensuring proper liquid distribution, is presented and the influence of key-parameters controlling the droplet formation, such as viscosity and rotation rate used to approach monodispersity, is discussed. Spheres, produced by spinning disk atomization, may find use in various areas from laboratory-scale to large-scale applications such as interlining adhesives, powder coatings, food powders, biomedical products, drug delivery systems, cosmetics, for example. The spinning disk atomization described here is studied and designed for future scale-up aiming at industrial production.
C1 Ecole Polytech Fed Lausanne, LP, DMX, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland.
RP Senuma, Y (reprint author), Ecole Polytech Fed Lausanne, LP, DMX, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland.
OI Hilborn, Jons/0000-0001-6947-9601
CR AKESSON NB, 1994, J ENVIRON SCI HEAL B, V29, P785, DOI 10.1080/03601239409372904
   Allen T., 1990, PARTICLE SIZE MEASUR
   ANDERSSON R, 1989, Patent No. 411478
   ANGERS R, 1992, POWD MET WORLD C SAN
   ARSHADY R, 1993, BIOMATERIALS, V14, P5, DOI 10.1016/0142-9612(93)90015-T
   ARSHADY R, 1989, POLYM ENG SCI, V29, P1746, DOI 10.1002/pen.760292404
   BABU SR, 1986, J PHYS CHEM-US, V90, P4337, DOI 10.1021/j100409a023
   BABU SR, 1987, J COLLOID INTERF SCI, V116, P359
   BABU SR, 1987, J COLLOID INTERF SCI, V116, P350
   BOUSFIELD DW, 1986, J NON-NEWTON FLUID, V21, P79, DOI 10.1016/0377-0257(86)80064-7
   BRENN G, 1995, J ADV SCI, V7, P197
   Denn M. M, 1980, PROCESS FLUID MECH
   DOGAN C, 1994, INT J POWDER METALL, V30, P419
   FRASER RP, 1963, CHEM ENG SCI, V18, P323, DOI 10.1016/0009-2509(63)80026-3
   GOEDDE EF, 1970, J FLUID MECH, V40, P495, DOI 10.1017/S0022112070000289
   HASHIMOTO H, 1987, AIAA J, V25, P727, DOI 10.2514/3.9689
   HILBORN JG, 1994, MRS FALL M BOST
   HORAK D, 1995, J POLYM SCI POL CHEM, V33, P2329, DOI 10.1002/pola.1995.080331405
   Ishizu K, 1997, POLYMER, V38, P5471, DOI 10.1016/S0032-3861(97)00085-2
   LU SM, 1989, AICHE J, V35, P1572, DOI 10.1002/aic.690350922
   NAKA Y, 1995, JAERI C 95
   NORASETTHEKUL S, 1995, J APPL POLYM SCI, V58, P2101, DOI 10.1002/app.1995.070581122
   OSBORNE MG, 1993, 1993 INT C EXH POWD
   PANAGIOTOU T, 1991, J APPL POLYM SCI, V43, P1549, DOI 10.1002/app.1991.070430818
   RUCKENSTEIN E, 1995, POLYMER, V36, P2857, DOI 10.1016/0032-3861(95)93669-D
   Sudol ED, 1997, NATO ADV SCI I E-APP, V335, P141
   Tuncel A, 1996, J POLYM SCI POL CHEM, V34, P45, DOI 10.1002/(SICI)1099-0518(19960115)34:1<45::AID-POLA4>3.0.CO;2-2
   Tuncel A., 1997, HDB ENG POLYM MAT, P189
   UGELSTAD J, 1982, EMULSION POLYM, P384
   YIM P, 1995, INT C EXH POWD MET P
   Yule A.J., 1994, ATOMIZATION MELTS PO
   ZWEIFEL Y, UNPUB POLYM ENG SCI
NR 32
TC 9
Z9 9
U1 2
U2 5
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD JUN
PY 1999
VL 3
IS 1
BP 42
EP 49
DI 10.1007/s100190050123
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 210RB
UT WOS:000081117500007
DA 2018-10-19
ER

PT J
AU Ramakrishna, S
   Huang, ZM
   Yew, HM
AF Ramakrishna, S
   Huang, ZM
   Yew, HM
TI Development of a novel flexible composite material
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE knitted fabric; flexible composites; composites; textile composites
ID MECHANICAL-PROPERTIES; TENSILE BEHAVIOR
AB The primary objective of this research work is to develop a thin and flexible composite material suitable for biomedical and electronic packing applications. A flexible composite of 0.2 mm thickness was developed using knitted polyester fiber interlock fabric as the reinforcement and polyurethane elastomer as the matrix. Details regarding composite fabrication and mechanical characterization are presented. The failure strain of this new flexible composite material is as high as 85-320%, depending on the fiber architecture. Another objective of this study is to identify the effect of pre-stretching of the knitted fabric on the composite tensile properties. For this purpose different composite specimens were made by reinforcing polyurethane with knitted fabrics that were pre-stretched differently prior to composite fabrication. Both the stiffness and strength of composite improved in the direction of fabric pre-stretch and they deteriorated in the direction normal to pre-stretch. However, the failure strain followed the opposite trend. These trends are attributed to the changes in the failure mechanisms with the pre-stretched condition of the fabric. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composites Lab, Singapore 119260, Singapore.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, Dept Mech & Prod Engn, Polymer & Text Composites Lab, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR deHaan J, 1996, ADV COMPOS LETT, V5, P9
   KargerKocsis J, 1997, APPL COMPOS MATER, V4, P209, DOI 10.1023/A:1008892619464
   LEONG KH, 1997, P ICCM 11 GOLD COAST, P201
   MAYER J, 1995, P EUROMAT 95 VEN PAD, P1
   RAMAKRISHNA S, 1994, COMPOS SCI TECHNOL, V50, P249, DOI 10.1016/0266-3538(94)90146-5
   RAMAKRISHNA S, 1994, COMPOS SCI TECHNOL, V50, P237, DOI 10.1016/0266-3538(94)90145-7
   RAMAKRISHNA S, 1993, COMPOS SCI TECHNOL, V49, P349, DOI 10.1016/0266-3538(93)90066-P
   RAMAKRISHNA S, 1994, COMP SCI TECHNOL, V57, P1
   RAMAKRISHNA S, 1993, P 3 JAP INT SAMPE S, P312
   RAMAKRISHNA S, 1995, P ICCM 10, V4, P245
   Ruan XP, 1996, COMPOS SCI TECHNOL, V56, P1391, DOI 10.1016/S0266-3538(96)00097-8
   RUDD CD, 1990, COMPOS SCI TECHNOL, V39, P261, DOI 10.1016/0266-3538(90)90045-7
   VERPOEST I, 1992, P 37 INT SAMPE S AN, P369
   Verpoest I., 1997, P ICCM 11 AUSTR, P1108
NR 14
TC 5
Z9 5
U1 1
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAY 19
PY 1999
VL 90
SI SI
BP 473
EP 477
DI 10.1016/S0924-0136(99)00056-4
PG 5
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 204JZ
UT WOS:000080762300080
DA 2018-10-19
ER

PT J
AU Quek, CH
   Khor, KA
   Cheang, P
AF Quek, CH
   Khor, KA
   Cheang, P
TI Influence of processing parameters in the plasma spraying of
   hydroxyapatite/Ti-6Al-4V composite coatings
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; plasma spraying parameters; bond strength; plasma spray
   systems
ID HEAT-TREATMENT; IMPLANTS; TITANIUM; APATITE; PHASES
AB Biomedical implants using metals, polymers, ceramics and composites are increasingly being designed to restore body function and to facilitate healing. It is often the material design aspects of such implants that will determine the stability of the device. A hydroxyapatite (HA) coating on Ti-6Al-4V alloy is a common implant used in orthopaedics applications. IIA being a bio-active material combined with non-toxicity and bio-inert Ti-6Al-4V provides an implant that is bio-compatible, light and stable. The plasma spray technique is a popular method of depositing HA onto Ti-6Al-4V. However, there are processing problems associated with this technique and as a result there are inconsistencies in the subsequent in vitro and in vivo investigations. Addressing these inconsistencies from a materials processing standpoint would help to alleviate the problems faced. This paper investigates the influence of plasma spraying parameters on the characteristics of the composite coatings. The plasma spraying parameters under study are the spraying current and the gun transverse speed. Under these spraying parameters, a comparison is made between two different kinds of composite feedstock, namely calcined HA and Ti-6Al-3V in the ratio of 80:20 wt% and 50:50 wt%, respectively. Composite powders in the size range of 75-106 mu m were prepared by the ceramic slurry mixing method. The powder was deposited onto Ti-6Al-4V substrate by means of a robot-controlled 100 kW plasma gun (Praxair Surface Technologies, USA) equipped with an advanced computerized closed-loop powder feed system. The mechanical properties of the individual layers were tested using the tensile adhesion test (ASTM C-633), The surface morphology and microstructure of the composite layers were examined by a back-scattered scanning electron microscope. The phase composition and crystallinity were determined by an X-ray diffractometer. The investigation shows that the as-sprayed coating of the individual layers possesses a higher porosity level in the HA-rich regions. In other words, a porous coating is achieved using composite powders in the ratio of 80:20 wt%. The tensile adhesion test revealed a higher bond strength for the composite coatings compared to that for pure HA coatings. A lower spraying current and a faster gun transverse speed are also considered accountable for the porous microstructure and low bonding strength, (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Appl Sci, Singapore 639798, Singapore.
RP Khor, KA (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR Aoki H, 1994, MED APPL HYDROXYAPAT
   BOERTZEN D, 1996, J BIOMED MATER RES, V30, P125
   Caulier H, 1997, J BIOMED MATER RES, V34, P121, DOI 10.1002/(SICI)1097-4636(199701)34:1<121::AID-JBM16>3.3.CO;2-2
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   CHEN WQ, 1993, BIOMEDICAL MATERIALS, P157
   FILIAGGI MJ, 1993, J BIOMED MATER RES, V27, P191, DOI 10.1002/jbm.820270208
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   JI HX, 1992, J MATER SCI-MATER M, V3, P283, DOI 10.1007/BF00705294
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   MALMBERG S, 1993, J THERM SPRAY TECHN, V2, P339
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   PARK JB, 1994, BIOMATERIALS SCI ENG
   Vu TA, 1997, J MATER SCI LETT, V16, P1680, DOI 10.1023/A:1018534300072
   WANG BC, 1995, J BIOMED MATER RES, V29, P1483, DOI 10.1002/jbm.820291204
   WANG CY, 1995, J MATER SCI, V6, P249
   Weng J, 1996, J BIOMED MATER RES, V30, P5
   WENG J, 1995, J MATER SCI LETT, V14, P211, DOI 10.1007/BF00318260
   WOJCIECH L, 1998, J AM CERAM SOC, V81, P765
   YANG CY, 1995, J MATER SCI-MATER M, V6, P258, DOI 10.1007/BF00120268
   Yip CS, 1997, J MATER PROCESS TECH, V65, P73, DOI 10.1016/0924-0136(95)02244-9
NR 21
TC 15
Z9 15
U1 0
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD MAY 19
PY 1999
VL 90
SI SI
BP 550
EP 555
PG 6
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 204JZ
UT WOS:000080762300094
DA 2018-10-19
ER

PT J
AU Niinomi, M
   Kuroda, D
   Fukunaga, K
   Morinaga, M
   Kato, Y
   Yashiro, T
   Suzuki, A
AF Niinomi, M
   Kuroda, D
   Fukunaga, K
   Morinaga, M
   Kato, Y
   Yashiro, T
   Suzuki, A
TI Corrosion wear fracture of new beta type biomedical titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Xian International Titanium Conference_on Metallurgy Technology and
   Applications of Titanim Alloys
CY SEP 15-18, 1998
CL XIAN, PEOPLES R CHINA
DE biomedical titanium alloys; biocompatibility; corrosion friction wear;
   mechanical properties; modulus of elasticity
ID STRENGTH; IMPLANTS
AB Metallic materials such as stainless steel, Co-Cr alloy, pure titanium and titanium alloys have been used for surgical implant materials. The alpha + beta type titanium alloy such as Ti-6Al-4V ELI has been most widely used as an implant material for artificial hip joint and dental implant because of its high strength and excellent corrosion resistance. Toxicity of alloying elements in conventional biomedical titanium alloys like Al and V, and the high modulus of elasticity of these alloy as compared to that of bone have been, however, pointed out [1,2]. New beta type titanium alloys composed of non-toxic elements like Nb, Ta, Zr, Mo and Sn with lower moduli of elasticity, greater strength and greater corrosion resistance were, therefore, designed in this study. The friction wear properties of titanium alloys are, however, low as compared to those of other conventional metallic implant materials such as stainless steels and Co-Cr alloy. Tensile tests and friction wear tests in Ringer's solution were conducted in order to investigate the mechanical properties of designed alloys. The friction wear characteristics of designed alloys and typical conventional biomedical titanium alloys were evaluated using a pin-on-disk type friction wear testing system and measuring the weight loss and width of groove of the specimen. (C) 1999 Elsevier Science S.A, Al rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4640814, Japan.
   Daido Steel Co Ltd, Market Dev Dept, Minato Ku, Nagoya, Aichi 4550022, Japan.
   Daido Steel Co Ltd, R&D Lab, Minami Ku, Nagoya, Aichi 4578545, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Tempaku Cho,1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   MORINAGA M, 1993, P 7 INT C TIT SAN DI, P276
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Steinemann S. G., 1980, CORROSION SURG IMPLA, P1
   Wang KK, 1996, ASTM STP, V1272, P76
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 7
TC 106
Z9 113
U1 5
U2 25
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 15
PY 1999
VL 263
IS 2
BP 193
EP 199
DI 10.1016/S0921-5093(98)01167-8
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 184NH
UT WOS:000079617900013
DA 2018-10-19
ER

PT J
AU Trevisan, A
   Bicciato, F
   Fanelli, G
   Stocco, E
   Paruzzolo, P
AF Trevisan, A
   Bicciato, F
   Fanelli, G
   Stocco, E
   Paruzzolo, P
TI Risk of hepatitis C virus infection in a population exposed to
   biological materials
SO AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
LA English
DT Article
DE hepatitis C infection; seroprevalence; biological exposure; liver
   involvement
ID HEALTH-CARE WORKERS; NEEDLESTICK INJURY; HOSPITAL EMPLOYEES;
   LIVER-DISEASE; HCV INFECTION; BLOOD-DONORS; ANTIBODIES; PREVALENCE;
   PERSONNEL
AB Background Hepatitis C virus is an important cause of acute and chronic hepatitis and it is an agent parenterally transmitted. Workers handling biological materials may be exposed to high concentration of virus-infected fluids.
   Methods The seroprevalence of hepatitis C virus antibodies was investigated in a population of 809 subjects exposed to varying levels of biological risk owing to the handling of human fluids or tissues and in 408 controls. The exposed group was subdivided in three subgroups according to low and occasional (262), intermediate but continuous (311), and high (236) exposure to biological materials.
   Results The seroprevalence of hepatitis C antibodies was low (1.40%) in all subjects. The risk groups showed no significant differences with respect to the control group; the most exposed group showed a seroprevalence of 1.274%. Age but not sex appeared significantly correlated with seroprevalence of positive antibodies (chi(2) = 5.949, P < 0.025). Aspartate aminotransferase and alanine aminotransferase showed a highly significant increase (P < 0.01 and P < 0.001, respectively) in subjects with posit ive hepatitis C antibodies, other than a high significant prevalence of values above the normal limit (chi(2) = 26.613, P < 0.001 and chi(2) = 39.164, P < 0.001, respectively). Among 17 positive hepatitis C virus subjects, 8 (47.1%) were positive for hepatitis B virus, but not for its antigen.
   Conclusions Hepatitis C virus infection appears to be a low risk for people employed in the biomedical field, yet infection is associated with a significant fiver involvement. Am. J. Ind. Med,35:532-535, 1999. (C) 1999 Wiley-Liss, Inc.
C1 Univ Padua, Inst Occupat Med, I-35128 Padua, Italy.
RP Trevisan, A (reprint author), Univ Padua, Inst Occupat Med, Via Giustiniani 2, I-35128 Padua, Italy.
RI Trevisan, Andrea/E-5325-2013
OI Trevisan, Andrea/0000-0002-0764-1084
CR ALBERTI A, 1991, ANN INTERN MED, V114, P1010, DOI 10.7326/0003-4819-114-12-1010
   ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702
   CAMPELLO C, 1992, INFECTION, V20, P224, DOI 10.1007/BF02033064
   CARIANI E, 1991, LANCET, V337, P850, DOI 10.1016/0140-6736(91)92555-G
   CHIARAMONTE M, 1991, ITAL J GASTROENTEROL, V23, P555
   DELUCA M, 1992, LANCET, V339, P1364
   Djeriri K, 1996, PRESSE MED, V25, P145
   ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443
   ESTEBAN JI, 1989, LANCET, V2, P294
   FRANCAVILLA E, 1992, INFECTION, V20, P295, DOI 10.1007/BF01710802
   GERMANAUD J, 1994, AM J PUBLIC HEALTH, V84, P122, DOI 10.2105/AJPH.84.1.122
   HERBERT AM, 1992, LANCET, V339, P305
   HOFMANN H, 1990, INFECTION, V18, P286, DOI 10.1007/BF01647006
   JOCHEN ABB, 1992, LANCET, V339, P304, DOI 10.1016/0140-6736(92)91373-G
   KIYOSAWA K, 1991, ANN INTERN MED, V115, P367, DOI 10.7326/0003-4819-115-5-367
   MARRANCONI F, 1992, INFECTION, V20, P111, DOI 10.1007/BF01711079
   MELE A, 1996, 963 ISTISAN
   MITSUI T, 1992, HEPATOLOGY, V16, P1109, DOI 10.1002/hep.1840160502
   PURO V, 1995, AM J PUBLIC HEALTH, V85, P1272, DOI 10.2105/AJPH.85.9.1272
   SCHLIPKOTER U, 1990, SCAND J INFECT DIS, V22, P757, DOI 10.3109/00365549009027136
   SEEFF LB, 1991, ANN INTERN MED, V115, P411, DOI 10.7326/0003-4819-115-5-411_1
   TREMOLADA F, 1991, ANN INTERN MED, V114, P277, DOI 10.7326/0003-4819-114-4-277
   VAGLIA A, 1990, LANCET, V336, P1315, DOI 10.1016/0140-6736(90)92997-V
   ZUCKERMAN J, 1994, LANCET, V343, P1618, DOI 10.1016/S0140-6736(94)93064-3
NR 24
TC 3
Z9 3
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0271-3586
J9 AM J IND MED
JI Am. J. Ind. Med.
PD MAY
PY 1999
VL 35
IS 5
BP 532
EP 535
DI 10.1002/(SICI)1097-0274(199905)35:5<532::AID-AJIM11>3.0.CO;2-V
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 183LN
UT WOS:000079555200011
PM 10212707
DA 2018-10-19
ER

PT J
AU Ikada, Y
AF Ikada, Y
TI Key factors in tissue engineering
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE tissue regeneration; tissue substitution; scaffold; release carrier of
   growth factor; barrier; blast cells
AB Tissue engineering is an emerging biomedical form of engineering aiming at regeneration of natural tissues or creation of biological substitutes for defective or lost tissues and organs using cells of different species. It is essential for time tissue self-regeneration, for instance, to provide a space necessary for regeneration with certain materials and technologies. This article overviews such key factors required for tissue engineering.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Ikada, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawara Cho, Kyoto 6068507, Japan.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD MAY
PY 1999
VL 22
IS 3
BP 627
EP 631
DI 10.1007/BF02749978
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 214EV
UT WOS:000081316400067
DA 2018-10-19
ER

PT J
AU Cerrai, P
   Guerra, GD
   Tricoli, M
   Krajewski, A
   Guicciardi, S
   Ravaglioli, A
   Maltinti, S
   Masetti, G
AF Cerrai, P
   Guerra, GD
   Tricoli, M
   Krajewski, A
   Guicciardi, S
   Ravaglioli, A
   Maltinti, S
   Masetti, G
TI New composites of hydroxyapatite and bioresorbable macromolecular
   material
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLY(ESTER-ETHER-ESTER) BLOCK-COPOLYMERS; IN-VITRO; POWDERS
AB Composite materials were prepared by mixing in different proportions of hydroxyapatite (HA) and poly(epsilon-caprolactone-oxyethylene-epsilon-caprolactone) block copolymer (PCL-POE-PCL) to produce a new resorbable material for biomedical applications. This material has proved to be very interesting for production of periodontal membranes. Mechanical properties are linearly proportional to the amount of HA introduced. Fourier transform infrared (FTIR) investigations have pointed out that HA is able to influence some close epsilon-caprolactone molecules to start its homopolymerization giving PCL with an end chain ionic bonding. HA grains are therefore surrounded by a film of PCL which grants close connection of HA grains within copolymeric matrix. This interface bond with PCL is, however, an interesting occurrence for preparations of HA/PCL composites. (C) 1999 Kluwer Academic Publishers.
C1 CNR, CSMM, I-56126 Pisa, Italy.
   CNR, IRTEC, I-48018 Faenza, Italy.
   Dipartimento Ingn Chim, I-56126 Pisa, Italy.
   CNR, IB, I-56127 Pisa, Italy.
   Univ Pisa, Dipartimento Fis, I-56126 Pisa, Italy.
RP Cerrai, P (reprint author), CNR, CSMM, Via Diotisalvi 2, I-56126 Pisa, Italy.
CR CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   DelGuerra RS, 1995, J MATER SCI-MATER M, V6, P824
   DELGUERRA RS, 1994, J MATER SCI-MATER M, V5, P891, DOI 10.1007/BF01172032
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   HASHIN Z, 1966, P 3 INT S CER MICR T
   Krajewski A, 1996, CRYST RES TECHNOL, V31, P637, DOI 10.1002/crat.2170310519
   KRAJEWSKI A, 1995, CRYST RES TECHNOL, V30, P843, DOI 10.1002/crat.2170300623
   MARTINETTI R, 1995, BIOMATERIALS, V9, P43
   ONDRACEK G, 1986, MATER CHEM PHYS, V15, P281, DOI 10.1016/0254-0584(86)90006-4
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
NR 10
TC 32
Z9 35
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1999
VL 10
IS 5
BP 283
EP 289
DI 10.1023/A:1008905529461
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 197VR
UT WOS:000080387000005
PM 15348145
DA 2018-10-19
ER

PT J
AU Rosiak, JM
   Yoshii, F
AF Rosiak, JM
   Yoshii, F
TI Hydrogels and their medical applications
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Ionizing Radiation and Polymers (IRaP 98)
CY SEP 19-24, 1998
CL WEINBOHLA, GERMANY
SP Inst Oberflachen Modifizier, Commissariat Energie Atom, Int Atomic Energy Agency, Gesell Schwerionenforsch, Deutsch Forsch Gemeinschaft, Sachsisches Minist Wissenschaft & Kultur
DE hydrogels; ionizing radiation; biomaterials; polymers
ID CROSS-LINKING COPOLYMERIZATION; PULSE-RADIOLYSIS; AQUEOUS-SOLUTION;
   BIOMEDICAL PURPOSES; POLYMERS; KINETICS; OXYGEN
AB Biomaterials play a key role in most approaches for engineering tissues as substitutes for functional replacement, for components of devices related to therapy and diagnosis, for drug delivery systems and supportive scaffolds for guided tissue growth. Modern biomaterials could be composed of various components, e.g. metals, ceramics, natural tissues, polymers. In this last group, the hydrogels, hydrophilic polymeric gels with requested biocompatibility and designed interaction with living surrounding seem to be one of the most promising group of biomaterials. Especially, if they are formed by means of ionizing radiation. In early 1950s, the pioneers of the radiation chemistry of polymers began some experiments with radiation crosslinking of hydrophilic polymers. However, hydrogels were analyzed mainly from the point of view of the phenomenon associated with radiation synthesis, with topology of network and relation between radiation parameters of the processes. Fundamental monographs on radiation polymer physics and chemistry written by A. Charlesby (Atomic Radition and polymers, Pergamon Press, Oxford, 1960) and A. Chapiro (Radiation Chemistry of Polymeric Systems, Interscience, New York, 1962) proceed from this time. The noticeable interest in the application of radiation techniques to obtain hydrogels for biomedical purposes began in the late sixties as a result of the papers and patents invented by Japanese and American scientists, headed by Kaetsu in Japan and Hoffman in USA. Immobilization of biologically active species in hydrogel matrices, their use as drug delivery systems and enzyme traps as well as the modification of material surfaces to improve biocompatibility and their ability to bond antigens and antibodies had been the main subjects of these investigations. In this article a brief summary of investigations on mechanism and kinetics of radiation formation of hydrogels as well as some examples of commercialized hydrogel biomaterials have been presented. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Lodz Tech Univ, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
   Japan Atom Energy Res Inst, Takasaki Radiat Chem Res Estab, Takasaki, Gumma 37012, Japan.
RP Rosiak, JM (reprint author), Lodz Tech Univ, Inst Appl Radiat Chem, Wroblewskiego St 15, PL-93590 Lodz, Poland.
CR Charlesby A, 1960, ATOMIC RAD POLYM
   FOX AS, Patent No. 5540033
   ISILDAR M, 1982, INT J RADIAT BIOL, V41, P525, DOI 10.1080/09553008214550601
   Janik I, 1997, J CHIM PHYS PCB, V94, P244, DOI 10.1051/jcp/1997940244
   Janik I, 1999, NUCL INSTRUM METH B, V151, P318, DOI 10.1016/S0168-583X(99)00079-8
   MAKUUCHI K, Patent No. 9262249
   MAKUUCHI K, Patent No. 9263671
   MAKUUCHI K, Patent No. 9262279
   MAKUUCHI K, Patent No. 967453
   MATHESON MS, 1973, J PHYS CHEM-US, V77, P2420, DOI 10.1021/j100639a011
   OLEJNICZAK J, UNPUB
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   RATNAR BR, 1996, BIOMATERIALS SCI INT
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   ROSIAK J, Patent No. 2200643
   ROSIAK J, Patent No. 3744289
   ROSIAK J, Patent No. 151581
   ROSIAK J, ACS S, V475, P271
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Rosiak JM, 1995, NUCL INSTRUM METH B, V105, P335, DOI 10.1016/0168-583X(95)00550-1
   ROSIAK JM, Patent No. 204866
   Szycher M., 1991, HIGH PERFORMANCE BIO
   *THET, 1996, 610 THET
   TOBITA H, 1993, MACROMOLECULES, V26, P836, DOI 10.1021/ma00056a039
   TOBITA H, 1993, MACROMOLECULES, V26, P5427, DOI 10.1021/ma00072a021
   Ulanski P, 1996, J CHEM SOC PERK T 2, P23, DOI 10.1039/p29960000023
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   ULANSKI P, 1995, RADIAT PHYS CHEM, V46, P913, DOI 10.1016/0969-806X(95)00291-5
NR 29
TC 219
Z9 222
U1 4
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 1999
VL 151
IS 1-4
BP 56
EP 64
DI 10.1016/S0168-583X(99)00118-4
PG 9
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 201PN
UT WOS:000080604100007
DA 2018-10-19
ER

PT J
AU McCarthy, DW
   Bass, LA
   Cutler, PD
   Shefer, RE
   Klinkowstein, RE
   Herrero, P
   Lewis, JS
   Cutler, CS
   Anderson, CJ
   Welch, MJ
AF McCarthy, DW
   Bass, LA
   Cutler, PD
   Shefer, RE
   Klinkowstein, RE
   Herrero, P
   Lewis, JS
   Cutler, CS
   Anderson, CJ
   Welch, MJ
TI High purity production and potential applications of copper-60 and
   copper-61
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE Cu-60; Cu-61; Cu-64; production; PET
ID POSITRON EMISSION TOMOGRAPHY; EXCITATION-FUNCTIONS; SMALL CYCLOTRON;
   NATURAL NICKEL; CU-64
AB Previously we described the high yield production of Cu-64 using a target system designed specifically for low energy, biomedical cyclotrons. In this study, the use of this target system for the production of Cu-60 and Cu-61 is described and the utility of these isotopes in the labeling of biomolecules for tumor and hypoxia imaging is demonstrated. Cu-60 and Cu-61 were produced by the Ni-60(p, n)Cu-60, Ni-61(p,n)Cu-61, and Ni-60(d,n)Cu-61 nuclear reactions. The nickel target (>99% enriched or natural nickel) was plated onto a gold disk as described previously (54-225 mu m thickness) and irradiated (14.7 MeV proton beam and 8.1 MeV deuteron beam). The copper isotopes were separated from the nickel via ion exchange chromatography and the radioisotopic purity was assessed by gamma spectroscopy. Yields of up to 865 mCi of Cu-60 have been achieved using enriched Ni-60. Cu-61 has been produced with a maximum yield of 144 mCi using enriched Ni-61 and 72 mCi using enriched Ni-60. Specific activities (using enriched material) ranged from 80 to 300 mCi/mu g Cu for Cu-60 and from 20 to 81 mCi/mu g Cu for Cu-61. Bombardments of natural Ni targets were performed using both protons and deuterons, Yields and radioisotopic impurities were determined and compared with that for enriched materials. Cu-60 was used to radiolabel diacetyl-bis(N-4-methylthiosemicarbazone), ATSM. Cu-60-ATSM was injected into rats that had an occluded left anterior descending coronary artery. Uptake of Cu-60-ATSM in the hypoxic region of the heart was visualized clearly using autoradiography. In addition, Cu-60-ATSM was injected into dogs and excellent images of the heart and heart walls were obtained using positron emission tomography (PET), Cu-61 was labeled to 1,4,8,11-tetraazacyclotetradecane-N,N',N ",N'''-tetraacetic acid-octreotide (TETA-octreotide) and the PET images of tumor-bearing rats were obtained up to 2 h postinjection. After decay of the Cu-61, the same rat was injected with Cu-64-TETA-octreotide and the images were compared. The tumor images obtained using Cu-61 were found to be superior to those using Cu-64 as predicted based on the larger abundance of positrons emitted by Cu-61 VS. Cu-64, NUCL MED BIOL 26;4:351-358, 1999. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, St Louis, MO 63110 USA.
   Newton Sci Inc, Cambridge, MA USA.
RP Welch, MJ (reprint author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Radiol Sci, 510 S Kingshighway Blvd, St Louis, MO 63110 USA.
OI Anderson, Carolyn/0000-0002-5663-282X; Lewis, Jason/0000-0001-7065-4534
FU NCI NIH HHS [CA64475]
CR ANDERS CJ, 1998, IN PRESS J NUCL MED
   ANDERSON CJ, 1995, J NUCL MED, V36, P2315
   DEHDASHTI F, 1997, J NUCL MED, V38, P103
   FUJIBAYASHI Y, 1991, Journal of Nuclear Medicine, V32, P974
   Fujibayashi Y, 1997, J NUCL MED, V38, P1155
   FUJIBAYASHI Y, 1998, IN PRESS NUCL MED BI
   GREEN M A, 1990, Journal of Nuclear Medicine, V31, P815
   GREEN MA, 1987, NUCL MED BIOL, V14, P59
   LACY JL, 1998, J NUCL MED, V39, P142
   LEDERER CM, 1978, TABLE ISOTOPES
   LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4
   Martin CC, 1995, IEEE T MED IMAGING, V14, P681, DOI 10.1109/42.476109
   MARTIN CC, 1992, THESIS U WISCONSIN M
   McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6
   PETERING HG, 1964, CANCER RES, V24, P367
   PIEL H, 1992, RADIOCHIM ACTA, V57, P1
   SZELECSENYI F, 1993, APPL RADIAT ISOTOPES, V44, P575, DOI 10.1016/0969-8043(93)90172-7
   Tolmachev V, 1998, APPL RADIAT ISOTOPES, V49, P79, DOI 10.1016/S0969-8043(97)00235-2
   WELCH MJ, 1998, EUR J NUCL MED, V25, P978
   ZWEIT J, 1991, APPL RADIAT ISOTOPES, V42, P193
   ZWEIT J, 1992, EUR J NUCL MED, V19, P418
NR 21
TC 112
Z9 113
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0969-8051
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD MAY
PY 1999
VL 26
IS 4
BP 351
EP 358
DI 10.1016/S0969-8051(98)00113-9
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 196JE
UT WOS:000080304600002
PM 10382836
DA 2018-10-19
ER

PT J
AU Roussel, P
   Lysenko, V
   Remaki, B
   Delhomme, G
   Dittmar, A
   Barbier, D
AF Roussel, P
   Lysenko, V
   Remaki, B
   Delhomme, G
   Dittmar, A
   Barbier, D
TI Thick oxidised porous silicon layers for the design of a biomedical
   thermal conductivity microsensor
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Proceedings Paper
CT Symposium H - Materials Aspects in Microsystem Technologies
CY JUN 16-19, 1998
CL STRASBOURG, FRANCE
DE porous silicon; thin film thermopile based microsensor; tissue blood
   micro-flow measurements
AB Porous silicon (PS) offers new possibilities to be applied as thermal insulating material for microsensor design due to its low thermal conductivity (TC) value compared with TC of SiO2. A biomedical TC microsensor based on differential thermoelectric measurements has been designed using a PS substrate. In order to ensure an efficient thermal isolation in the microsensor, main thermal and geometrical characteristics of the PS layers as well as of the whole microsensor have been numerically simulated. PS layers with low TC have to be thick and mechanically stable under further processing. To form thick (50-200 mu m) and stable PS layers, a new approach based on progressive changing of anodisation current density (from 100 to 25 mA/cm(2)) during PS formation has been elaborated. To find a suitable compromise between low TC and mechanical stability of thick PS layers, an adapted thermal oxidation recipe at moderate temperatures (500-600 degrees C) in dry oxygen atmosphere has been applied. It leads to 20-50% oxidation fraction in PS layers (measured by Energy Dispersive Spectroscopy) corresponding to SIO2 TC value. A test device has been realised and characterised. A Seebeck coefficient of 400 mu V/degrees C per junction has been measured for a Poly-Si/Al thermopile deposited on the PS layer. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Inst Natl Sci Appl, Phys Mat Lab, CNRS, UMR 5511, F-69621 Villeurbanne, France.
RP Roussel, P (reprint author), Inst Natl Sci Appl, Phys Mat Lab, CNRS, UMR 5511, 20 Av Albert Einstein,Bat 502, F-69621 Villeurbanne, France.
RI Delhomme, Georges/G-6094-2016; Lysenko, Vladimir/G-6376-2014
OI Delhomme, Georges/0000-0001-5272-8851; Lysenko,
   Vladimir/0000-0003-1076-7064
CR Benedetto G, 1997, APPL PHYS A-MATER, V64, P155, DOI 10.1007/s003390050457
   DELHOMME G, 1994, IEEE T BIO-MED ENG, V41, P656, DOI 10.1109/10.301732
   DITTMAR A, 1991, INNOV TECH BIOL MED, V12, P121
   Drost A., 1995, Sensors and Materials, V7, P111
   HALIMAOUI A, 1995, POROUS SILICON SCI T, P34
   Lysenko V, 1998, SENSOR ACTUAT A-PHYS, V67, P205, DOI 10.1016/S0924-4247(97)01777-9
   Lysenko V, 1998, APPL SURF SCI, V123, P458, DOI 10.1016/S0169-4332(97)00487-X
   Obraztsov AN, 1997, SEMICONDUCTORS+, V31, P534, DOI 10.1134/1.1187209
NR 8
TC 37
Z9 38
U1 1
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR 20
PY 1999
VL 74
IS 1-3
BP 100
EP 103
DI 10.1016/S0924-4247(98)00330-6
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 187ZZ
UT WOS:000079820200022
DA 2018-10-19
ER

PT J
AU Shi, HQ
   Tsai, WB
   Garrison, MD
   Ferrari, S
   Ratner, BD
AF Shi, HQ
   Tsai, WB
   Garrison, MD
   Ferrari, S
   Ratner, BD
TI Template-imprinted nanostructured surfaces for protein recognition
SO NATURE
LA English
DT Article
ID MOLECULAR RECOGNITION; BIOMATERIALS; ENTRAPMENT; ANTIBODIES; ADSORPTION;
   POLYMERS; WATER
AB Synthetic materials capable of selectively recognizing proteins are important in separations(1), biosensors(2) and the development of biomedical materials(3-5). The technique of molecular imprinting creates specific recognition sites in polymers by using template molecules(6-9). Molecular recognition is attributed to binding sites that complement molecules in size, shape and chemical functionality(10). But attempts to imprint proteins have met with only limited success(11-15). Here we report a method for imprinting surfaces with protein-recognition sites. We use radio-frequency glow-discharge plasma deposition to form polymeric thin films(16) around proteins coated with disaccharide molecules. The disaccharides become covalently attached to the polymer film, creating polysaccharide-like cavities that exhibit highly selective recognition for a variety of template proteins, including albumin, immunoglobulin G, lysozyme, ribonuclease and streptavidin, Direct imaging of template recognition is achieved by patterning a surface at the micrometre scale with imprinted regions.
C1 Univ Washington, Ctr Bioengn, Seattle, WA 98195 USA.
   Univ Trento, Trento, Italy.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, Ctr Bioengn, Box 351720, Seattle, WA 98195 USA.
RI Tsai, Wei-Bor/B-7953-2011
CR Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   BRASH JL, 1991, ACS ADV CHEM SERIES, V199, P3
   BYFIELD MP, 1994, BIOSENS BIOELECTRON, V9, P373, DOI 10.1016/0956-5663(94)80038-3
   CRAM DJ, 1988, SCIENCE, V240, P760, DOI 10.1126/science.3283937
   CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W
   GLAD M, 1985, J CHROMATOGR, V347, P11, DOI 10.1016/S0021-9673(01)95465-2
   Hjerten S, 1997, CHROMATOGRAPHIA, V44, P227, DOI 10.1007/BF02466386
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   KEMPE M, 1995, J MOL RECOGNIT, V8, P35, DOI 10.1002/jmr.300080106
   Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087
   MALLICK N, 1994, BIOMETALS, V7, P299
   Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163
   Nock S, 1997, FEBS LETT, V414, P233, DOI 10.1016/S0014-5793(97)01040-5
   NORDE W, 1992, COLLOID SURFACE, V66, P73, DOI 10.1016/0166-6622(92)80122-I
   Paleos CM, 1997, ADV MATER, V9, P695, DOI 10.1002/adma.19970090904
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   SHI H, UNPUB ADV MAT
   SHI H, IN PRESS J BIOMED MA
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Steinke J, 1995, ADV POLYM SCI, V123, P80
   VENTON DL, 1995, BBA-PROTEIN STRUCT M, V1250, P117, DOI 10.1016/0167-4838(95)00079-A
   VIJAYALAKSHMI MA, 1989, TRENDS BIOTECHNOL, V7, P71, DOI 10.1016/0167-7799(89)90067-X
   WEAVER DR, 1992, BIOMATERIALS, V13, P577, DOI 10.1016/0142-9612(92)90025-J
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Yu C, 1997, J ORG CHEM, V62, P4057, DOI 10.1021/jo961784v
NR 31
TC 514
Z9 555
U1 11
U2 224
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD APR 15
PY 1999
VL 398
IS 6728
BP 593
EP 597
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 186WX
UT WOS:000079754700050
PM 10217142
DA 2018-10-19
ER

PT J
AU Ong, YL
   Razatos, A
   Georgiou, G
   Sharma, MM
AF Ong, YL
   Razatos, A
   Georgiou, G
   Sharma, MM
TI Adhesion forces between E-coli bacteria and biomaterial surfaces
SO LANGMUIR
LA English
DT Article
ID SOLID-SURFACES; HYDROPHOBIC INTERACTIONS; FREE-ENERGY; MICROSCOPY;
   ATTACHMENT; PARTICLES; CELLS; SUBSTRATA; POLYMERS; DLVO
AB Bacterial infection of biomaterial surfaces is an important problem in the biomedical and health industries. The design of materials resistant to infections necessitates an understanding of the forces driving bacterial adhesion. Escherichia coli cells were immobilized onto the tip of a standard atomic force microscope (AFM) cantilever, and force measurements were performed by approaching the modified cantilever onto mica, hydrophilic glass, hydrophobic glass, polystyrene, and Teflon. Consistent with prior qualitative observations, we show that bacterial adhesion is indeed enhanced by the surface hydrophobicity of the substrate. The forces of interaction measured with the AFM are compared to those of model predictions based on an extended-DLVO approach. In this model, short-range acid-base and steric interactions are included with the conventional van der Waals attraction and electrostatic components. The theoretical predictions agree well with experimental data for E. coli D21f2, a strain whose outer surface consists of lipopolysaccharide molecules with severely truncated carbohydrate chains. However, the adhesive behavior off. coli strains with more complex cell surface structures was found to be more difficult to model because of the possible involvement of steric and bridging effects or specific receptor-ligand interactions that remain to be resolved.
C1 Univ Texas, Dept Petr Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cell Biol, Austin, TX 78712 USA.
RP Sharma, MM (reprint author), Univ Texas, Dept Petr Engn, Austin, TX 78712 USA.
CR BOMAN HG, 1975, J BACTERIOL, V121, P455
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   BUTT HJ, 1991, BIOPHYS J, V60, P777, DOI 10.1016/S0006-3495(91)82112-9
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225
   DUCKER WA, 1994, LANGMUIR, V10, P3279, DOI 10.1021/la00021a061
   DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   Freeman A, 1996, BIOTECHNOL BIOENG, V52, P625, DOI 10.1002/(SICI)1097-0290(19961205)52:5<625::AID-BIT10>3.3.CO;2-O
   FRIETAS AM, UNPUB
   Good R.J., 1991, FUNDAMENTALS ADHESIO
   GREGORY J, 1981, J COLLOID INTERF SCI, V83, P138, DOI 10.1016/0021-9797(81)90018-7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOH JH, 1994, J CELL SCI, V107, P1105
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   ISRAELACHVILI JN, 1974, Q REV BIOPHYS, V6, P341
   KLOTZ SA, 1990, MICROBIAL CELL SURFA
   MCELDOWNEY S, 1986, J GEN MICROBIOL, V132, P513
   MCELDOWNEY S, 1986, APPL ENVIRON MICROB, V52, P460
   MOZES N, 1987, BIOTECHNOL BIOENG, V30, P439, DOI 10.1002/bit.260300315
   NEIDHARDT FC, 1990, ESCHERICHIA COLI SAL
   OFEK I, 1994, BACTERIAL ADHESION C
   PASHLEY RM, 1984, J COLLOID INTERF SCI, V97, P446, DOI 10.1016/0021-9797(84)90316-3
   RAZATOS AP, IN PRESS J BIOMATER
   RAZATOS AP, UNPUB
   RUCKENSTEIN E, 1976, AICHE J, V22, P276, DOI 10.1002/aic.690220209
   SCHOENENBERGER CA, 1994, BIOPHYS J, V67, P929, DOI 10.1016/S0006-3495(94)80556-9
   SEEBERGH JE, 1995, COLLOID SURFACE A, V100, P139, DOI 10.1016/0927-7757(95)03155-7
   STICKLER DJ, 1995, CELL MATER, V5, P167
   UYEN HM, 1988, APPL ENVIRON MICROB, V54, P837
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
   Zita A, 1997, FEMS MICROBIOL LETT, V152, P299, DOI 10.1111/j.1574-6968.1997.tb10443.x
NR 37
TC 324
Z9 327
U1 12
U2 170
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 13
PY 1999
VL 15
IS 8
BP 2719
EP 2725
DI 10.1021/la981104e
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 187FF
UT WOS:000079775700018
DA 2018-10-19
ER

PT J
AU Catanese, J
   Cooke, D
   Maas, C
   Pruitt, L
AF Catanese, J
   Cooke, D
   Maas, C
   Pruitt, L
TI Mechanical properties of medical grade expanded polytetrafluoroethylene:
   The effects of internodal distance, density, and displacement rate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE expanded polytetrafluoroethylene (e-PTFE); implants; structure;
   mechanical properties
ID SURGERY; GRAFTS
AB Expanded polytetrafluoroethylene (e-PTFE) is used successfully in a multitude of biomedical and clinical applications, The success of this biomaterial is due to its microporous structure that allows biointegration for fixation, as well as overall mechanical integrity. The mechanical properties and degree of tissue ingrowth depend on the microstructure of the expanded polymer foam, yet little is known about the correlation of the internodal distance and other microstructural features with the monotonic tensile properties. Complete structure-property correlation can be used to provide invaluable knowledge for the design of biomedical devices, The purpose of this study was to investigate the monotonic tensile properties of e-PTFE over a range of medically relevant microstructural features and manufacturing parameters. The microstructural and manufacturing parameters considered were internodal distance, linear density, volumetric density, and reduction ratio. Additionally, the effect of displacement rate on mechanical properties was studied. We found that the ultimate stress and strain increased linearly with linear density (R-2 = 0.88 and 0.67, respectively). Surprisingly, elastic modulus did not correlate with any parameter measured and only weak correlations were found between all properties and internodal distance. The yield and ultimate stresses increased with increasing displacement rate (R-2 = 0.88 and 0.57, respectively), The findings from this study indicate that linear density is a better predictor of mechanical properties than internodal distance and may be the preferred parameter to control when specifying a material for implantation in load bearing situations. (C) 1999 John Wiley & Sons, Inc.
C1 Univ Calif Berkeley, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
   Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA.
RP Pruitt, L (reprint author), Univ Calif Berkeley, Joint Bioengn Grad Grp, Berkeley, CA 94720 USA.
EM lpruitt@euler.berkeley.edu
CR AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   Bolton W, 1983, Aktuelle Probl Chir Orthop, V26, P40
   Bolton W, 1983, Aktuelle Probl Chir Orthop, V25, P42
   BOYCE B, 1983, CONCISE ENCY MED DEN, pCH33
   Brun J. L., 1992, Bio-Medical Materials and Engineering, V2, P203
   CAMPBELL CD, 1975, ANN SURG, V182, P138, DOI 10.1097/00000658-197508000-00010
   COCHRAN RP, 1991, J CARDIAC SURG, V6, P508, DOI 10.1111/j.1540-8191.1991.tb00352.x
   Greene D, 1997, LARYNGOSCOPE, V107, P957, DOI 10.1097/00005537-199707000-00024
   KONIOR RJ, 1992, ARCH OTOLARYNGOL, V118, P1188
   MAAS CS, 1993, ARCH OTOLARYNGOL, V119, P1008
   MOLE B, 1992, PLAST RECONSTR SURG, V90, P200, DOI 10.1097/00006534-199290020-00007
   PAAVOLAINEN P, 1993, ACTA ORTHOP SCAND, V64, P323, DOI 10.3109/17453679308993636
   RITTGERS SE, 1985, J MED ENG TECHNOL, V9, P1, DOI 10.3109/03091908509018197
   SANTIAGO EJ, 1981, ANN ROY COLL SURG, V63, P253
   WATANABE T, 1984, J JPN SURG SOC, V85, P580
NR 16
TC 41
Z9 42
U1 4
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1999
VL 48
IS 2
BP 187
EP 192
DI 10.1002/(SICI)1097-4636(1999)48:2<187::AID-JBM13>3.3.CO;2-D
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 181HW
UT WOS:000079436800013
PM 10331912
DA 2018-10-19
ER

PT J
AU Afanasyeva, NI
   Bruch, RF
AF Afanasyeva, NI
   Bruch, RF
TI Biocompatibility of polymer surfaces interacting with living tissue
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT Surface Analysis 98
CY JUN 16-19, 1998
CL PACIFIC NW NATL LAB, RICHLAND, WA
SP Amer Vacuum Soc, Appl Surface Sci Div, Pacific NW Natl Lab, William R Wiley Environm Molec Sci Lab, Amer Vacuum Soc, Pacific NW Chapter
HO PACIFIC NW NATL LAB
DE FTIR; polymer; implant
AB The method of vibrational spectroscopy has been applied as a new tool for the biodiagnostics of polymer implants and tissue surfaces. In this study the spectral analysis of polymer implants has been accomplished by means of Fourier transform infrared spectroscopy (FTIR) to elucidate the long-term biocompatibility and quality control of biomedical materials. Surface analysis allows the determination of the specific molecular composition and structures most appropriate for long-term compatibility in humans.
   Important information associated with the bioinertness or bioactivity of implants has been obtained from the spectral features of the polymer material used, including the level of polymerization, Passivated surfaces of implants have also been obtained and analyzed by means of FTIR. Copyright (C) 1999 John Wiley & Sons, Ltd.
C1 Univ Nevada, Dept Phys, Reno, NV 89557 USA.
RP Afanasyeva, NI (reprint author), Univ Nevada, Dept Phys, Reno, NV 89557 USA.
CR AFANASIEVA N, 1991, MAKROMOL CHEM-M SYMP, V52, P191, DOI 10.1002/masy.19910520117
   AFANASYEVA NI, 1989, POLYM-PLAST TECHNOL, V28, P635
   AFANASYEVA NI, 1994, 11 EUR S POL SPECTR, P19
   AFANASYEVA NI, 1998, 13 EUR S POL SPEC LA
   AFANASYEVA NI, 1988, P EUR S POL SPECTR B, V8, P20
   AFANASYEVA NI, 1989, P 11 ANN INT C IEEE, V11, P1384
   AFANASYEVA NI, 1993, ESIS 93 LYON FRANC, P62
   AFANASYEVA NI, 1994, SPIE, V2089, P354
   AFANASYEVA NI, 1989, IEEE, V2087, P1684
   AFANASYEVA NI, 1992, EUR S POL SPECTR ESO, pA12
   AFANASYEVA NI, 1991, P 13 ANN INT C IEEE, V13, P1481
   ANDERSON B, 1998, RENO GAZETTE J   JUL
   BRUNETTI WH, 1993, ACHIEVING TOTAL QUAL
   CANNAS M, 1987, Italian Journal of Orthopaedics and Traumatology, V13, P387
   FEDOROV SN, 1985, ANN OPHTHALMOL, V101, P18
   FRAKER AC, 1985, CORROSION DEGRADATIO, P859
   Griffiths P. R, 1986, CHEM ANAL
   HOCKWIN O, 1984, SCI AM, V12, P46
   Kendrick T C, 1991, SILICON HETEROATOM B, P67
   MANDELL RB, 1998, CONTACT LENS PRACTIC
   MANTSCH H, 1998, BIOS 98 TECHNICAL PR, P51
   PATAI S, 1991, SILICON HETEROATOM B
   PAUL JP, 1995, BIOMATERIALS ARTIFIC
   SMITH BC, 1996, FUNDAMENTALS FOURIER, P87
   VORONKOV MG, 1990, SOVIET SCI REV B, V15, P1
   VORONKOV MG, 1978, SILOXANE BOND PHYSIC
   1995, WORLDS BEST ANATOMIC
   1998, VIBRATIONAL SPECTROS
NR 28
TC 8
Z9 8
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD APR
PY 1999
VL 27
IS 4
BP 204
EP 212
DI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
PG 9
WC Chemistry, Physical
SC Chemistry
GA 191GJ
UT WOS:000080014000007
DA 2018-10-19
ER

PT J
AU Mukkamala, R
   Kushner, AM
   Bertozzi, CR
AF Mukkamala, R
   Kushner, AM
   Bertozzi, CR
TI New poly(sulfoxide) hydrogels: High water content-low protein binding
   materials for biomedical applications.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 21
PY 1999
VL 217
MA 036-BTEC
BP U667
EP U667
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 176JP
UT WOS:000079148201999
DA 2018-10-19
ER

PT J
AU Schrooten, J
   Van Oosterwyck, H
   Vander Sloten, J
   Helsen, JA
AF Schrooten, J
   Van Oosterwyck, H
   Vander Sloten, J
   Helsen, JA
TI Adhesion of new bioactive glass coating
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bioactive glass; coating; plasma spraying; adhesion test; finite element
   analysis
ID SPRAYED COATINGS; SUBSTRATE
AB A valuable alternative to the existing biomedical implant coatings is a bioactive glass (BAG) coating that is produced by reactive plasma spraying. A mechanical performance requirement that is of the utmost importance is the adhesion strength of the coating. Considering the application as dental implant, a new adhesion test (shear test), which was close to the service conditions, was designed. A Ti6A14V rod (O3 mm) with a sprayed BAG coating of 50 mu m was glued with an epoxy glue to a hollow cylindrical counterpart and was used as such in the tensile machine. This test was evaluated by finite element analysis (FEA). Preliminary experiments showed that a conversion from shear to tensile adhesion strength is possible by using the Von Mises criterion (sigma = 3(1/2)tau), indicating that thin coatings of brittle materials can behave as a ductile material. The new coating technique was proved to produce a high quality coating with an adhesion strength of 40.1 +/- 4.8 MPa in shear and 69.4 +/- 8.4 MPa in tension. The FEA revealed that no one homogeneously distributed shear stress is present but several nonhomogeneously distributed stress components (shear and tensile) are present in the coating. This analysis indicated that real service conditions are much more complicated than standard adhesion tests. (C) 1999 John Wiley & Sons, Inc.
C1 Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   Katholieke Univ Leuven, Dept Mech, Div Biomech & Engn Design, B-3001 Heverlee, Belgium.
RP Schrooten, J (reprint author), Katholieke Univ Leuven, Dept Met & Mat Engn, De Croylaan 2, B-3001 Heverlee, Belgium.
RI Van Oosterwyck, Hans/C-2528-2016
OI Van Oosterwyck, Hans/0000-0002-2142-9717
CR AMBROZ O, 1992, P INT THERM SPRAY C, P921
   [Anonymous], 1990, MET HDB, V1, P871
   *ASM INT, 1990, MET HDB, V1, P621
   *ASTM, 1995, C116194 ASTM
   *ASTM, 1995, C125994 ASTM
   Bansal N. P., 1986, HDB GLASS PROPERTIES
   BARTH E, 1986, BIOMATERIALS, V7, P273, DOI 10.1016/0142-9612(86)90049-9
   BERNDT CC, 1990, J MATER ENG, V12, P151, DOI 10.1007/BF02834068
   BERNDT CC, 1993, J ADHES SCI TECHNOL, V7, P1235, DOI 10.1163/156856193X00088
   BERNDT CC, 1992, P INT THERM SPRAY C, P45
   CHALKER PR, 1991, MAT SCI ENG A-STRUCT, V140, P583, DOI 10.1016/0921-5093(91)90482-3
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   GREVING DJ, 1994, P 7 NAT THERM SPRAY, P639
   GRUTZNER H, 1991, SURF COAT TECH, V45, P317, DOI 10.1016/0257-8972(91)90238-R
   HAN W, 1993, J THERM SPRAY TECHN, V2, P145
   Helsen JA, 1997, J EUR CERAM SOC, V17, P147, DOI 10.1016/S0955-2219(96)00176-8
   KRAJEWSKI A, 1981, SCI CERAM, V11, P85
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   LEIGH SH, 1994, P 7 NAT THERM SPRAY, P655
   RECK R, 1985, AM J OTOL, V6, P280
   SCHEPERS E, 1996, 5 WORLD BIOM C, V1, P242
   SCHEPERS E, 1996, 5 WORLD BIOM C, V1, P1
   SCHROOTEN J, 1997, REACTIVE PLASMA SPRA
   SHIMIZU Y, 1991, P 4 NAT THERM SPRAY, P257
   WOLKE JGC, 1990, THERMAL SPRAY RES AP, P413
   1993, ACTA ORTHOP SCAND S, V255, P64
NR 26
TC 29
Z9 29
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR 5
PY 1999
VL 44
IS 3
BP 243
EP 252
DI 10.1002/(SICI)1097-4636(19990305)44:3<243::AID-JBM2>3.0.CO;2-O
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 154LK
UT WOS:000077890500002
PM 10397926
DA 2018-10-19
ER

PT J
AU Criscione, JC
   Lorenzen-Schmidt, I
   Humphrey, JD
   Hunter, WC
AF Criscione, JC
   Lorenzen-Schmidt, I
   Humphrey, JD
   Hunter, WC
TI Mechanical contribution of endocardium during finite extension and
   torsion experiments on papillary muscles
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE biomechanics; constitutive behavior; cardiac mechanics; myocardium
AB Finite extension and torsion tests on cardiac papillary muscles are presently the best way to directly measure the response to shear along myocardial fibers. Quantifying this response is necessary for determining the complete three-dimensional constitutive behavior of myocardium as a transversely isotropic material. Analysis of such tests is complicated, however, since papillary muscles are materially inhomogeneous, consisting of a myocardial core surrounded by an endocardial sheath that is rich in collagen. In this article, we show that the papillary muscle response to extension and torsion additively decouples into the response of the bare myocardial core plus the response of an endocardial sheath filled with fluid (assuming the muscle is a radially inhomogeneous and incompressible continuum with cylindrical symmetry). This result allows the endocardial response to be subtracted from the intact papillary muscle response to obtain the response of the bare myocardial core. An initial estimate suggests that the endocardial sheath affects the axial moment significantly (50% of torque for all twists at low stretch) but affects the axial force only slightly (<10% at moderate twists). (C) 1999 Biomedical Engineering Society. [S0090-6964(99)01302-8].
C1 Johns Hopkins Med Inst, Dept Biomed Engn, Baltimore, MD 21205 USA.
   Texas A&M Univ, Biomed Engn Program, College Stn, TX USA.
RP Hunter, WC (reprint author), Johns Hopkins Med Inst, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.
FU NHLBI NIH HHS [HL 30552]
CR BRUTSAERT DL, 1989, ANNU REV PHYSIOL, V51, P263, DOI 10.1146/annurev.physiol.51.1.263
   Fung YC, 1993, BIOMECHANICS MECH PR
   HUMPHREY JD, 1992, J BIOMECH ENG-T ASME, V114, P461, DOI 10.1115/1.2894095
   HUMPHREY JD, 1987, J BIOMECH ENG-T ASME, V109, P298, DOI 10.1115/1.3138684
   HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P340, DOI 10.1115/1.2891194
   HUMPHREY JD, 1992, J BIOMECH, V25, P541, DOI 10.1016/0021-9290(92)90094-H
   HUMPHREY JD, IN PRESS COMP METH B
   Kang T, 1996, AM J PHYSIOL-HEART C, V270, pH2169
   LORANG DM, 1995, THESIS
   MACKENNA DA, 1994, AM J PHYSIOL, V266, pH1007
   SPENCER AJM, 1980, CONTINUUM MECH, P160
   Yin FCP, 1996, AM J PHYSIOL-HEART C, V271, pH1864
NR 12
TC 12
Z9 12
U1 0
U2 4
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
   USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR-APR
PY 1999
VL 27
IS 2
BP 123
EP 130
DI 10.1114/1.218
PG 8
WC Engineering, Biomedical
SC Engineering
GA 270CJ
UT WOS:000084517600001
PM 10199688
DA 2018-10-19
ER

PT J
AU Li, YJ
   Hanada, T
   Nakaya, T
AF Li, YJ
   Hanada, T
   Nakaya, T
TI Surface modification of segmented polyurethanes by grafting
   methacrylates and phosphatidylcholine polar headgroups to improve
   hemocompatibility
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID CHAIN ALKYL-GROUPS; BLOOD-COMPATIBLE POLYURETHANES; POLY(ISOPRENE) SOFT
   SEGMENT; PHOSPHOLIPID POLYURETHANES; MAIN CHAINS; SIDE-CHAINS;
   BIOMEDICAL APPLICATIONS; ANALOGOUS MOIETIES; POLY(BUTADIENE);
   CHOLESTEROL
AB A new type of phosphatidylcholine-containing segmented polyurethane (SPU) surface was produced by grafting various methacrylates and phosphatidylcholine polar headgroups to a vinyl-group-containing segmented polyurethane (V-SPU) using alpha,alpha'-azobisisobutyronitrile (AIBN) as a radical initiator. 1,4-Butanediol (BD) as chain extender was used to synthesize the V-SPU, which is based on diphenylmethane diisocyanate (MDI) and vinyl-group-containing poly(butadiene) diol (PBD). Several methacrylates, such as methyl methacrylate (MMA), butyl methacrylate (BMA), stearyl methacrylate (SMA), and a phosphatidylcholine polar-headgroup-containing vinyl monomer, 2-(methacrylorloxy)ethyl-2-(trimethylammonium)ethyl phosphate (MTP), were grafted to the V-SPU. The bulk characteristics of the grafted V-SPUs were investigated by infrared (IR) spectroscopy, viscosity, and gel permeation chromatography (GPC) measurements. Mechanical properties of the typical SPU containing MMA were measured by dynamic viscoelasticity and tensile measurements. The phosphatidylcholine polar headgroups were oriented on the surface of these materials, as revealed by attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), electron spectroscopy for chemical analysis (ESCA), and contact angle measurements. The phosphatidylcholine polar-headgroup-grafted SPU surfaces showed slightly decreased water contact angles, also indicating that hydrophilic phosphatidylcholine polar headgroups are present at the surface. The hemocompatibility in vitro was evaluated with platelet-rich plasma (PRP) contact tests and viewed by scanning electron microscopy (SEM) using the ingrafted V-SPU as a reference. It was found that fewer platelets adhered to the modified surfaces and showed less shape variation than to the unmodified V-SPU. Platelet adhesion to phosphatidylcholine polar-headgroup-grafted polymers was inhibited 88-95% compared with unmodified V-SPU.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
EM nakaya@bioa.eng.osaka-cu.ac.jp
CR CHAPMAN D, 1984, Patent No. 199790
   Chen TM, 1996, MACROMOL CHEM PHYSIC, V197, P1587, DOI 10.1002/macp.1996.021970501
   DURANI AA, 1986, Patent No. 275293
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   KOEHLER AS, 1996, J BIOMED MATER RES, P237
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   LETOURNEUR D, 1991, J POLYM SCI POL CHEM, V29, P1367, DOI 10.1002/pola.1991.080291001
   Li YJ, 1997, MACROMOL SYMP, V122, P363, DOI 10.1002/masy.19971220156
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Li YJ, 1996, J BIOMAT SCI-POLYM E, V7, P893, DOI 10.1163/156856296X00066
   Nakaya T, 1997, MET MATER PROCESS, V9, P103
   NAKAYA T, IN PRESS PROG POLYM
   Ramesh S, 1998, J MACROMOL SCI R M C, VC38, P481
   REGEN SL, 1982, J AM CHEM SOC, V104, P791, DOI 10.1021/ja00367a023
   Saunders J.H., 1962, POLYURETHANE CHEM 1
   Sugiyama K, 1997, NIPPON KAGAKU KAISHI, P816, DOI 10.1246/nikkashi.1997.816
   UMEDA T, 1982, MAKROMOL CHEM-RAPID, V3, P457
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 30
TC 19
Z9 20
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAR
PY 1999
VL 11
IS 3
BP 763
EP 770
DI 10.1021/cm9806432
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 178BH
UT WOS:000079245400036
DA 2018-10-19
ER

PT J
AU Mardanov, S
   Seyfried, J
   Fatikow, S
AF Mardanov, S
   Seyfried, J
   Fatikow, S
TI An automated assembly system for a microassembly station
SO COMPUTERS IN INDUSTRY
LA English
DT Article
DE microassembly; microrobots; planning
AB The production of complex microsystems from a number of microcomponents made of different materials requires flexible, precise mechanisms, which can finely manipulate different types of objects. The microassembly has its specifics caused by the tiny dimensions of the robots, high accuracy and complicated vision and control systems required. This paper presents a concept of an intelligent microassembly planning system. This system has been implemented in a micromanipulation station with mobile piezoelectric microrobots, which has been developed at the Institute for Process Control and Robotics (IPR) at the University of Karlsruhe [S. Fatikow, U. Rembold, An automated microrobot-based desktop station for micro assembly and handling of microobjects, ETFA IEEE conference on Emerging Technologies and Factory Automation, Kauai Marriott, Kauai, Hawaii, November 18-21 1996, pp. 586-592; S. Fatikow, R. Munassypov, An intelligent micromanipulation cell for industrial and biomedical applications based on piezoelectric microrobot, Proc. Of the 5th Int. Conference on Micro Electro, Opto, Mechanical Systems and Components (MSTU96), Berlin, September 17-19 1996, pp. 826-828]. This research considers the assembly system as a complex system and represents a microassembly environment for the microassembly station. The information flow, interacting and functioning of separate parts of the micromanipulation station are determined and the integration of the assembly subsystem into the station are presented. The principal approaches for each part of the system are given. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Ufa State Aviat Tech Univ, Dept Tech Cybernet, Ufa 450000, Bashkortostan, Russia.
   Univ Karlsruhe, Inst Proc Control & Robot, D-76128 Karlsruhe, Germany.
RP Mardanov, S (reprint author), Ufa State Aviat Tech Univ, Dept Tech Cybernet, 12 K Marx Str, Ufa 450000, Bashkortostan, Russia.
EM mardanov@kmrb.bashnet.ru; seyfried@ira.uka.de; fatikow@ira.uka.de
CR BOURJAULT A, 1984, THESIS U FRANCE COMT
   DEFAZIO TL, 1987, IEEE T ROBOTIC AUTOM, V3, P640, DOI 10.1109/JRA.1987.1087132
   DEMELLO LH, 1990, IEEE T ROBOTICS  APR, P188
   DEMELLO LSH, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P56, DOI 10.1109/ROBOT.1989.99967
   FAITKOW S, 1996, P 5 INT C MICR OPT M, P826
   Fatikow S, 1996, ETFA '96 - 1996 IEEE CONFERENCE ON EMERGING TECHNOLOGIES AND FACTORY AUTOMATION, PROCEEDINGS, VOLS 1 AND 2, P586, DOI 10.1109/ETFA.1996.573951
   Fatikow S, 1998, J INTELL MANUF, V9, P73, DOI 10.1023/A:1008851409235
   GU P, 1995, INTELLIGENT MANUFACT, P62
   HATAMURA Y, 1994, CONSTRUCTION NANO MA, P37
   *ISO IS, 1994, 1030311 ISO IS
   KOKKINAKI AI, 1995, J INTELL ROBOT SYST, V13, P201, DOI 10.1007/BF01424008
   LEE S, 1993, J INTELLIGENT MANUFA, P183
   MARDANOV A, 1996, THESIS USATU UFA RUS
   *U KARLSR, 1995, ECCO TOOLK SCHEM MAP
   WOO TC, 1991, T ASME, P207
NR 15
TC 5
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3615
J9 COMPUT IND
JI Comput. Ind.
PD MAR
PY 1999
VL 38
IS 2
BP 93
EP 102
DI 10.1016/S0166-3615(98)00111-0
PG 10
WC Computer Science, Interdisciplinary Applications
SC Computer Science
GA 178BE
UT WOS:000079245000003
DA 2018-10-19
ER

PT J
AU Korematsu, A
   Li, YJ
   Murakami, T
   Sakurai, I
   Kodama, M
   Nakaya, T
AF Korematsu, A
   Li, YJ
   Murakami, T
   Sakurai, I
   Kodama, M
   Nakaya, T
TI Synthesis, characterization and blood compatibilities of novel segmented
   polyurethanes containing poly(butadiene) soft segments and
   phosphatidylcholine analogues in the main chains and long-chain alkyl
   groups in the side chains
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID PHOSPHOLIPID POLYURETHANES; COMPATIBLE POLYURETHANES; BIOMEDICAL
   APPLICATIONS; MOIETIES; SURFACE; CHOLESTEROL; POLYMERS
AB New segmented polyurethanes (SPUs) containing poly(butadiene) (PBD) soft segments and phospholipid moieties in the main chains and long-chain alkyl groups in the side chains were synthesized. The phospholipid moieties include bis[2-(2-hydroxyethyldimethylammonio)ethyl] 2-octylpropane-1,3-diyl bis(phosphate) (OcPDP), bis[2-(2-hydroxyethyldimethylammonio)ethyl] 2-oleylpropane-1,3-diyl bis(phosphate) (OlPDP) and bis[2-(2-hydroxyethyldimethylammonio)ethyl] 2-cetylpropane-1,3-diyl bis(phosphate) (CPDP). The bulk characterization of synthesized SPUs was investigated by infrared (IR) spectroscopy and gel-permeation chromatography (GPC). The mechanical properties were evaluated by dynamic viscoelasticity and tensile measurements. The existence of phospholipid analogous groups on the surface of these SPUs was revealed by attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy( XPS) and contact angle measurements. The blood compatibilities of the new polymers were evaluated by platelet rich plasma (PRP) contact studies and viewed by scanning electron microscopy (SEM) using medical grade BioSpan(R) and non-phospholipid polyurethane as references. These new materials have good surfaces in terms of platelet adhesion, and the morphology of adhered platelets undergoes a relatively low degree of variation.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
   RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan.
   Natl Inst Adv Interdisciplinary Res, Bion Design Grp, Tsukuba, Ibaraki 3050046, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, P 8 ANN SOC BIOM, P24
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   EDMUNDSON RS, 1962, CHEM IND-LONDON, P1828
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HARA K, 1993, SEIRIKASSEISHISHITSU, P112
   HSU CS, 1987, MAKROMOL CHEM-RAPID, V8, P331
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Li YJ, 1996, J BIOMAT SCI-POLYM E, V7, P893, DOI 10.1163/156856296X00066
   LUCAS HJ, 1950, J AM CHEM SOC, V72, P5491, DOI 10.1021/ja01168a032
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   NAKAYA T, 1989, MACROMOLECULES, V22, P3180, DOI 10.1021/ma00197a048
   NAKAYA T, 1987, KAGAKU, V42, P725
   NAKAYA T, 1986, Patent No. 61207395
   PLANCK H, 1987, POLYURETHANE BIOMEDI, V2
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   Saunders J.H., 1962, POLYURETHANE CHEM 1
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   SUGIYAMA K, 1986, MAKROMOL CHEM-RAPID, V7, P679
   SUNG CSP, 1979, J BIOMED MATER RES, V13, P161
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P19
   THUONG NT, 1974, B SOC CHIM FR II-CH, P667
   UMEDA T, 1985, MAKROMOL CHEM-RAPID, V6, P285
   WARD RS, 1994, P 8 CIMT FOR NEW MAT
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1723, DOI 10.1080/10601329508010017
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
NR 46
TC 21
Z9 22
U1 2
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD MAR
PY 1999
VL 9
IS 3
BP 647
EP 653
DI 10.1039/a806279j
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 177KZ
UT WOS:000079210300006
DA 2018-10-19
ER

PT J
AU Soten, I
   Ozin, GA
AF Soten, I
   Ozin, GA
TI Porous hydroxyapatite-dodecylphosphate composite film on
   titania-titanium substrate
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TRANSFORM INFRARED-SPECTROSCOPY; RAY PHOTOELECTRON-SPECTROSCOPY;
   CALCIUM-PHOSPHATE; OCTACALCIUM PHOSPHATE; EARLY DEPOSITS; SOLID-PHASE;
   PO4 DOMAIN; COATINGS; SURFACE; BONE
AB Synthetic analogues of bone are being actively pursued as materials for biomedical applications in the field of bone replacement, augmentation and repair. Numerous stringent criteria have to be met for a biomaterial to be considered as an acceptable bone implant, including the ability to integrate into bone and not cause any deleterious side effects. In this article we describe a materials chemistry approach to synthesizing a new type of bone implant material. The strategy involves the spontaneous growth, under aqueous physiological pH conditions, of an oriented hydroxyapatite film with micron dimension porosity, on the surface of a layer of TiO2, that has been sputter deposited on Ti metal. This procedure creates desirable co-crystallized phases of hydroxyapatite (OHAp) and octacalcium phosphate (OCP) with preferred orientation respectively along the [001] and [101] directions. Subsequently, a calcium dodecylphosphate mesolamellar phase has been grown within these oriented porous films to create a multilayered chemical composite CaDDP-OHAp-TiO2-Ti in which the CaDDP phase is stereochemically and charge matched with the OHAp.
C1 Univ Toronto, Lash Miller Chem Labs, Mat Chem Res Grp, Toronto, ON M5S 3H6, Canada.
RP Ozin, GA (reprint author), Univ Toronto, Lash Miller Chem Labs, Mat Chem Res Grp, 80 St George St, Toronto, ON M5S 3H6, Canada.
EM gozin@alchemy.chem.utoronto.ca
CR Brown PW, 1994, HYDROXYAPATITE RELAT
   Bullock EL, 1996, SURF SCI, V352, P504, DOI 10.1016/0039-6028(95)01188-9
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   CRUTCHFIELD MM, 1962, INORG CHEM, V1, P813, DOI 10.1021/ic50004a020
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ducheyne P., 1993, BIOCERAMICS, V6
   Elliot C., 1994, STRUCTURE CHEM APATI
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P129
   MISRA DN, 1984, ADSORPTION SURFACE C, P13
   ONG JL, 1994, COLLOID SURFACE A, V87, P151, DOI 10.1016/0927-7757(94)02774-9
   Ozin GA, 1997, J MATER CHEM, V7, P1601, DOI 10.1039/a702416i
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969
   ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020
   SHAM TK, 1979, CHEM PHYS LETT, V68, P426, DOI 10.1016/0009-2614(79)87231-0
   Silver FH., 1994, BIOMATERIALS MED DEV
   Sugiyama S, 1996, J MATER CHEM, V6, P459, DOI 10.1039/jm9960600459
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
NR 29
TC 26
Z9 27
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD MAR
PY 1999
VL 9
IS 3
BP 703
EP 710
DI 10.1039/a806045b
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 177KZ
UT WOS:000079210300014
DA 2018-10-19
ER

PT J
AU Festing, MFW
AF Festing, MFW
TI Warning: the use of heterogeneous mice may seriously damage your
   research
SO NEUROBIOLOGY OF AGING
LA English
DT Editorial Material
DE inbred strains; aging; genetic variation; outbred stocks; experimental
   design
ID INBRED STRAINS; VARIABILITY
AB Genetically heterogeneous (GH) mice and rats continue to be widely used in research even though the case for using isogenic strains has been argued repeatedly. The paper by Miller et al. in this issue appears to be the only one in the last 22 to attempt a scientific justification for the continued use of (a limited subset of) GH stocks. However, although they are to be commended for bravery, they fail to make their case. GH stocks represent poor material for controlled studies because genetic heterogeneity normally leads to phenotypic variability and a decline in experimental sensitivity. To counter this argument, Miller et al. claim that phenotypic variability may actually be smaller in GH animals than in their isogenic parents. Were this so (e.g., all mice being short lived, small, and aggressive), it, is difficult to see how the use of such a stock could increase the generality of research results based on it, as claimed by Miller et al. Isogenic strains are a vital, proven, and powerful resource for biomedical research, and should be used in preference to GH stocks by all scientists who use laboratory rodents. (C) 1999 Elsevier Science Inc. All rights reserved.
C1 Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
RP Festing, MFW (reprint author), Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England.
CR BONHOMME F, 1996, GENETIC VARIANTS STR, V2, P1577
   Crusio Wim E., 1992, V8, P231
   de Haan G, 1998, NAT GENET, V19, P114, DOI 10.1038/465
   Demant P., 1992, V8, P147
   Falconer D. S, 1981, INTRO QUANTITATIVE G
   Festing M., 1997, Mouse Genome, V95, P845
   FESTING MFW, 1974, BEHAV GENET, V4, P111, DOI 10.1007/BF01065752
   FESTING MFW, 1976, NATURE, V263, P230, DOI 10.1038/263230a0
   FESTING MFW, 1977, LAB ANIM, V11, P257, DOI 10.1258/002367777780936530
   Festing MFW, 1997, NATURE, V388, P321, DOI 10.1038/40964
   FESTING MFW, 1974, GENET RES, V24, P315, DOI 10.1017/S0016672300015317
   FESTING MFW, 1995, ENVIRON HEALTH PERSP, V103, P44, DOI 10.2307/3432255
   GAITONDE MK, 1976, BRAIN RES, V103, P617, DOI 10.1016/0006-8993(76)90465-0
   GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347
   GRUNEBERG H, 1952, GENETICS MOUSE
   MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3
   Mead R, 1988, DESIGN EXPT, V620
   Miller RA, 1999, NEUROBIOL AGING, V20, P217
   MORIWAKI K, 1994, GENETICS WILD MICE I, P333
   PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1
   SONTAG JA, 1976, CARCINOGENESIS TECHN, V1
   Takeda T., 1994, SAM MODEL SENESCENCE
   TAYLOR BA, 1972, J HERED, V63, P83, DOI 10.1093/oxfordjournals.jhered.a108235
   Taylor BA, 1996, GENETIC VARIANTS STR, V2, P1597
   TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153
   WOLFF GL, 1982, J TOXICOL ENV HEALTH, V10, P131, DOI 10.1080/15287398209530237
NR 26
TC 37
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0197-4580
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAR-APR
PY 1999
VL 20
IS 2
BP 237
EP 244
PG 8
WC Geriatrics & Gerontology; Neurosciences
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA 248JH
UT WOS:000083271000017
PM 10537033
DA 2018-10-19
ER

PT J
AU de Boer, JF
   Milner, TE
   Nelson, JS
AF de Boer, JF
   Milner, TE
   Nelson, JS
TI Determination of the depth-resolved Stokes parameters of light
   backscattered from turbid media by use of polarization-sensitive optical
   coherence tomography
SO OPTICS LETTERS
LA English
DT Article
AB Polarization-sensitive optical coherence tomography (PS-OCT) was used to characterize completely the polarization state of light backscattered from turbid media. Using a low-coherence light source, one can determine the Stokes parameters of backscattered light as a function of optical path in turbid media. To demonstrate the application of this technique we determined the birefringence and the optical axis in fibrous tissue (rodent muscle) and in vivo rodent skin. PS-OCT has potentially useful applications in biomedical optics by imaging simultaneously the structural properties of turbid biological materials and their effects on the polarization state of backscattered light. This method may also find applications in material science for investigation of polarization properties (e.g., birefringence) in opaque media such as ceramics and crystals. (C) 1999 Optical Society of America.
C1 Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92612 USA.
   Univ Texas, Biomed Engn Program, Austin, TX 78712 USA.
RP de Boer, JF (reprint author), Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92612 USA.
EM deboer@bli.uci.edu
RI de Boer, Johannes/B-7590-2012
OI de Boer, Johannes/0000-0003-1253-4950
CR de Boer JF, 1998, OPT EXPRESS, V3, P212, DOI 10.1364/OE.3.000212
   deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934
   Everett MJ, 1998, OPT LETT, V23, P228, DOI 10.1364/OL.23.000228
   HAZEBROEK HF, 1973, J PHYS E SCI INSTRUM, V6, P822, DOI 10.1088/0022-3735/6/9/013
   HEE MR, 1992, J OPT SOC AM B, V9, P903, DOI 10.1364/JOSAB.9.000903
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   MANDEL L, 1995, OPTICAL COHERENCE QU, pCH3
   MISHCHENKO MI, 1995, OPT LETT, V20, P1356, DOI 10.1364/OL.20.001356
   Schmitt JM, 1998, OPT LETT, V23, P1060, DOI 10.1364/OL.23.001060
NR 9
TC 245
Z9 247
U1 1
U2 24
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 0146-9592
J9 OPT LETT
JI Opt. Lett.
PD MAR 1
PY 1999
VL 24
IS 5
BP 300
EP 302
DI 10.1364/OL.24.000300
PG 3
WC Optics
SC Optics
GA 173GW
UT WOS:000078973600010
PM 18071486
DA 2018-10-19
ER

PT J
AU Kaniansky, D
   Masar, M
   Marak, J
   Bodor, R
AF Kaniansky, D
   Masar, M
   Marak, J
   Bodor, R
TI Capillary electrophoresis of inorganic anions
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Review
DE reviews; isotachophoresis; water analysis; environmental analysis;
   sample handling; food analysis; vegetables; cosmetics; soil;
   pharmaceutical analysis; inorganic anions
ID INDIRECT UV DETECTION; INDIRECT PHOTOMETRIC DETECTION; MODIFIED
   ELECTROOSMOTIC FLOW; FREE-ZONE ELECTROPHORESIS; CONTACTLESS CONDUCTIVITY
   DETECTION; HIGH-PERFORMANCE ELECTROPHORESIS; INDIRECT ULTRAVIOLET
   DETECTION; ION-SELECTIVE MICROELECTRODE; FUSED-SILICA CAPILLARIES;
   PLASMA-MASS SPECTROMETRY
AB This review deals with the separation mechanisms applied to the separation of inorganic anions by capillary electrophoresis (CE) techniques. It covers various CE techniques that are suitable for the separation and/or determination of inorganic anions in various matrices, including capillary zone electrophoresis, micellar electrokinetic chromatography, electrochromatography and capillary isotachophoresis. Detection and sample preparation techniques used in CE separations are also reviewed. An extensive part of this review deals with applications of CE techniques in various fields (environmental, food and plant materials, biological and biomedical, technical materials and industrial processes). Attention is paid to speciations of anions of arsenic, selenium, chromium, phosphorus, sulfur and halogen elements by CE. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Comenius Univ, Fac Nat Sci, Dept Analyt Chem, SK-84215 Bratislava, Slovakia.
RP Kaniansky, D (reprint author), Comenius Univ, Fac Nat Sci, Dept Analyt Chem, Mlynska Dolina CH-2, SK-84215 Bratislava, Slovakia.
RI Masar, Marian/L-8150-2016; Bodor, Robert/N-1885-2016
OI Masar, Marian/0000-0002-9287-1764; Bodor, Robert/0000-0002-5460-2619
CR Ahumada I, 1997, BOL SOC CHIL QUIM, V42, P527
   ALBERT M, 1992, ANALUSIS, V20, P383
   ALBERT M, 1993, ANALUSIS, V21, P403
   AMRAN MB, 1993, FRESEN J ANAL CHEM, V345, P420, DOI 10.1007/BF00325618
   AMRAN MB, 1995, CHEM ANAL-WARSAW, V40, P309
   Arce L, 1998, FRESEN J ANAL CHEM, V360, P697, DOI 10.1007/s002160050784
   Arce L, 1997, J CHROMATOGR A, V791, P279, DOI 10.1016/S0021-9673(97)00813-3
   Arellano M, 1997, J CHROMATOGR A, V765, P321, DOI 10.1016/S0021-9673(96)00972-7
   ARRELLANO M, 1997, AM J ENOL VITICULT, V48, P408
   AVDALOVIC N, 1993, ANAL CHEM, V65, P1470, DOI 10.1021/ac00058a027
   BACHMANN K, 1992, FRESEN J ANAL CHEM, V343, P901, DOI 10.1007/BF00321963
   BAO LY, 1992, ANAL CHEM, V64, P991, DOI 10.1021/ac00033a006
   Bazzanella A, 1997, CHROMATOGRAPHIA, V45, P59, DOI 10.1007/BF02505538
   BECKERS JL, 1990, J CHROMATOGR, V508, P19, DOI 10.1016/S0021-9673(00)91236-6
   BECKERS JL, 1990, J CHROMATOGR, V508, P3, DOI 10.1016/S0021-9673(00)91235-4
   BECKERS JL, 1991, J CHROMATOGR, V537, P429, DOI 10.1016/S0021-9673(01)88915-9
   Biesaga M, 1997, J CHROMATOGR A, V777, P375, DOI 10.1016/S0021-9673(97)00338-5
   BJERGEGAARD C, 1995, J CHROMATOGR A, V717, P409, DOI 10.1016/0021-9673(95)00554-1
   BLATNY P, 1994, J CHROMATOGR A, V670, P223, DOI 10.1016/0021-9673(94)80298-X
   BOCEK P, 1984, J CHROMATOGR, V313, P189
   BOCEK P, 1978, J CHROMATOGR, V151, P436
   Bocek P., 1988, ANAL ISOTACHOPHORESI
   Boden J, 1997, CHROMATOGRAPHIA, V45, P116, DOI 10.1007/BF02505547
   BODEN J, 1995, J CHROMATOGR A, V716, P311, DOI 10.1016/0021-9673(95)00468-3
   BODEN J, 1995, J CHROMATOGR A, V696, P321, DOI 10.1016/0021-9673(94)01227-6
   BONDOUX G, 1992, J CHROMATOGR, V602, P79, DOI 10.1016/0021-9673(92)80066-4
   BUCHBERGER W, 1992, J CHROMATOGR, V608, P59, DOI 10.1016/0021-9673(92)87105-H
   Burt H, 1996, J CHROMATOGR A, V739, P367, DOI 10.1016/0021-9673(96)00028-3
   CARPIO RA, 1992, ANAL CHEM, V64, P2123, DOI 10.1021/ac00042a017
   Chattopadhyay A, 1997, J CHROMATOGR A, V758, P255, DOI 10.1016/S0021-9673(96)00742-X
   Chien R. L., 1992, ANAL CHEM, V64, P489
   CHOI OK, 1995, ANAL SCI TECHNOL, V8, P835
   Colombara R, 1996, J CAPILLARY ELECTROP, V3, P147
   Corr JJ, 1996, ANAL CHEM, V68, P2155, DOI 10.1021/ac951053f
   COUSINS SM, 1994, J CHROMATOGR A, V671, P397, DOI 10.1016/0021-9673(94)80266-1
   Cowley EA, 1997, AM J PHYSIOL-LUNG C, V273, pL895, DOI 10.1152/ajplung.1997.273.4.L895
   Crompton T.R., 1996, DETERMINATION ANIONS
   Cruz L, 1997, J NEUROCHEM, V69, P110
   Dabek-Zlotorzynska E, 1998, ANAL CHIM ACTA, V359, P1, DOI 10.1016/S0003-2670(97)00635-1
   Dabek-Zlotorzynska E, 1997, ELECTROPHORESIS, V18, P2453, DOI 10.1002/elps.1150181235
   DabekZlotorzynska E, 1997, J CHROMATOGR A, V770, P349, DOI 10.1016/S0021-9673(97)00238-0
   DABEKZLOTORZYNSKA E, 1995, J CHROMATOGR A, V706, P469, DOI 10.1016/0021-9673(94)01108-Q
   DABEKZLOTORZYNSKA E, 1994, J CHROMATOGR A, V671, P389, DOI 10.1016/0021-9673(94)80265-3
   DASGUPTA PK, 1993, ANAL CHEM, V65, P1003, DOI 10.1021/ac00056a010
   DIAMOND RM, 1963, J PHYS CHEM-US, V67, P2513, DOI 10.1021/j100806a002
   Doble P, 1997, ANAL COMMUN, V34, P351, DOI 10.1039/a706001g
   Doble P, 1997, J CHROMATOGR A, V770, P291, DOI 10.1016/S0021-9673(96)01022-9
   DOBOS D, 1980, ELEKTROKHIMICHESKIYE
   DREW NJ, 1997, SPEC PUBL R SOC CHEM, V196, P160
   EHRMANN T, 1997, CHROMATOGRAPHIA, V45, P301
   EVANS KP, 1993, J CHROMATOGR, V636, P153, DOI 10.1016/0021-9673(93)80068-J
   EVERAERTS FM, 1979, J CHROMATOGR, V169, P21, DOI 10.1016/0021-9673(75)85030-8
   EVERAERTS FM, 1976, ISOTACHOPHORESIS
   Fabry L, 1997, ELEC SOC S, V97, P468
   Fernandes I, 1997, J CLIN INVEST, V100, P2196, DOI 10.1172/JCI119756
   Font J, 1996, J CHROMATOGR A, V740, P125, DOI 10.1016/0021-9673(96)00098-2
   FORET F, 1986, ELECTROPHORESIS, V7, P430, DOI 10.1002/elps.1150070909
   Francois C, 1996, HRC-J HIGH RES CHROM, V19, P5
   Friedberg MA, 1997, J CHROMATOGR A, V781, P491, DOI 10.1016/S0021-9673(97)00583-9
   Fukushi K, 1998, J CHROMATOGR A, V802, P211, DOI 10.1016/S0021-9673(97)01218-1
   FUKUSHI K, 1987, BUNSEKI KAGAKU, V36, P712
   FUKUSHI K, 1985, BUNSEKI KAGAKU, V34, P205
   FUKUSHI K, 1985, BUNSEKI KAGAKU, V34, P21
   FUKUSHI K, 1987, FRESEN Z ANAL CHEM, V328, P247, DOI 10.1007/BF00481630
   FUKUSHI K, 1990, J CHROMATOGR, V518, P189, DOI 10.1016/S0021-9673(01)93174-7
   Fukushi K, 1997, J CHROMATOGR A, V760, P253, DOI 10.1016/S0021-9673(96)00629-2
   FUKUSHI K, 1987, J CHROMATOGR, V393, P433, DOI 10.1016/S0021-9673(01)94241-4
   Fung YS, 1998, TALANTA, V45, P641, DOI 10.1016/S0039-9140(97)00284-1
   Galceran MT, 1996, J CHROMATOGR A, V732, P167, DOI 10.1016/0021-9673(95)01248-6
   GALER JM, 1997, SPEC PUBL R SOC CHEM, V196, P187
   GAS B, 1980, J CHROMATOGR, V192, P253, DOI 10.1016/S0021-9673(80)80001-X
   GAS B, 1980, CHEM LISTY, V74, P652
   GAS B, 1989, J CHROMATOGR, V470, P69, DOI 10.1016/S0021-9673(00)94200-6
   GEBAUER P, 1983, J CHROMATOGR, V267, P455, DOI 10.1016/S0021-9673(01)90870-2
   GEBAUER P, 1991, J CHROMATOGR, V545, P299, DOI 10.1016/S0021-9673(01)88720-3
   GEBAUER P, 1992, J CHROMATOGR, V608, P47, DOI 10.1016/0021-9673(92)87104-G
   Gebauer P, 1997, J CHROMATOGR A, V772, P63, DOI 10.1016/S0021-9673(97)00103-9
   GEISE RJ, 1993, J LIQ CHROMATOGR, V16, P3699, DOI 10.1080/10826079308019662
   Gilon N, 1996, J CHROMATOGR A, V732, P369, DOI 10.1016/0021-9673(95)01265-6
   Govindaraju K, 1997, ANAL CHEM, V69, P2793, DOI 10.1021/ac961249v
   GROH T, 1993, J CHROMATOGR, V646, P405, DOI 10.1016/0021-9673(93)83354-U
   GROH T, 1992, ELECTROPHORESIS, V13, P458, DOI 10.1002/elps.1150130196
   Guan FY, 1996, J CHROMATOGR A, V719, P427, DOI 10.1016/0021-9673(95)00735-0
   Guo Q, 1997, CHINESE CHEM LETT, V8, P65
   Haber C, 1998, ANAL CHEM, V70, P2261, DOI 10.1021/ac9712106
   Haber C, 1996, J CAPILLARY ELECTROP, V3, P1
   HADDAD PR, 1995, J CHROMATOGR A, V706, P571, DOI 10.1016/0021-9673(94)01049-K
   Haddad PR, 1997, J CHROMATOGR A, V770, P281, DOI 10.1016/S0021-9673(96)01085-0
   HADDAD PR, 1990, ION CHROMATOGRAPHY P
   Hagege A, 1997, MIKROCHIM ACTA, V127, P113, DOI 10.1007/BF01243174
   Harakuwe AH, 1997, ANAL COMMUN, V34, P67, DOI 10.1039/a607317d
   Harakuwe AH, 1998, J CHROMATOGR A, V793, P187, DOI 10.1016/S0021-9673(97)00878-9
   HARAKUWE AH, 1994, J CHROMATOGR A, V685, P161, DOI 10.1016/0021-9673(94)00671-7
   Harakuwe AH, 1996, ANAL COMMUN, V33, P103, DOI 10.1039/ac9963300103
   HARMS J, 1992, MIKROCHIM ACTA, V108, P251, DOI 10.1007/BF01242434
   HARROLD M, 1995, J CHROMATOGR A, V717, P371, DOI 10.1016/0021-9673(95)00762-X
   HARROLD MP, 1993, J CHROMATOGR, V640, P463, DOI 10.1016/0021-9673(93)80216-U
   Harwood JJ, 1997, J CHROMATOGR A, V788, P105, DOI 10.1016/S0021-9673(97)00706-1
   Hauser PC, 1995, J CAPILLARY ELECTROP, V2, P209
   HAUSER PC, 1994, ANAL CHIM ACTA, V295, P181, DOI 10.1016/0003-2670(94)80349-8
   Himeno S, 1998, ANAL SCI, V14, P369, DOI 10.2116/analsci.14.369
   HINE T, 1984, SHIMADZU REV, V41, P47
   HIROKAWA T, 1982, J CHROMATOGR, V242, P227, DOI 10.1016/S0021-9673(00)81698-2
   HIROKAWA T, 1983, J CHROMATOGR, V271, pD1, DOI 10.1016/S0021-9673(00)80225-3
   HJERTEN S, 1985, J CHROMATOGR, V347, P191, DOI 10.1016/S0021-9673(01)95485-8
   HJERTEN S, 1987, J CHROMATOGR, V403, P47, DOI 10.1016/S0021-9673(00)96340-4
   HONDA S, 1989, ANAL BIOCHEM, V177, P62, DOI 10.1016/0003-2697(89)90014-6
   Hsu JC, 1997, ANALYST, V122, P1393, DOI 10.1039/a700739f
   HUANG X, 1991, ANAL CHEM, V63, P2196
   HUANG XH, 1987, ANAL CHEM, V59, P2747, DOI 10.1021/ac00150a004
   JACKSON PE, 1993, J CHROMATOGR, V640, P481, DOI 10.1016/0021-9673(93)80218-W
   JANDIK P, 1991, J CHROMATOGR, V546, P431, DOI 10.1016/S0021-9673(01)93042-0
   JANDIK P, 1991, LC GC-MAG SEP SCI, V9, P634
   JANDIK P, 1993, CAPILLARY ELECTROPHO
   JANINI GM, 1994, J CHROMATOGR B, V657, P419, DOI 10.1016/0378-4347(94)00141-3
   Jensen BO, 1997, J BIOCHEM BIOPH METH, V35, P185, DOI 10.1016/S0165-022X(97)00046-8
   Jia L, 1996, J LIQ CHROMATOGR R T, V19, P565, DOI 10.1080/10826079608005520
   JIMIDAR M, 1995, J CHROMATOGR A, V706, P479, DOI 10.1016/0021-9673(94)01290-U
   JONES WR, 1992, J CHROMATOGR, V608, P385, DOI 10.1016/0021-9673(92)87146-Y
   JONES WR, 1991, J CHROMATOGR, V546, P445, DOI 10.1016/S0021-9673(01)93043-2
   JONES WR, 1993, J CHROMATOGR, V640, P387, DOI 10.1016/0021-9673(93)80207-O
   JONES WR, 1992, Patent No. 5104506
   JONES WR, 1992, Patent No. 5128005
   JONES WR, 1992, Patent No. 5156724
   JONES WR, 1992, Patent No. 5366601
   JONES WR, 1997, HDB CAPILLARY ELECTR, P155
   JORDAN JM, 1994, J CHROMATOGR A, V671, P445, DOI 10.1016/0021-9673(94)80272-6
   Jung GY, 1997, ANAL SCI, V13, P463, DOI 10.2116/analsci.13.463
   KANETA T, 1993, J CHROMATOGR A, V653, P313, DOI 10.1016/0021-9673(93)83189-Y
   KANETA T, 1992, ANAL CHEM, V64, P798, DOI 10.1021/ac00031a017
   KANIANSKY D, 1990, J CHROMATOGR, V498, P191, DOI 10.1016/S0021-9673(01)84247-3
   Kaniansky D, 1997, J CHROMATOGR A, V792, P483, DOI 10.1016/S0021-9673(97)00743-7
   Kaniansky D, 1996, ELECTROPHORESIS, V17, P1890, DOI 10.1002/elps.1150171214
   KANIANSKY D, 1994, ANAL CHEM, V66, P4258, DOI 10.1021/ac00095a022
   KANIANSKY D, IN PRESS J MICROCOL
   KANIANSKY D, 1981, THESIS COMENIUS U BR
   Kappes T, 1997, ANAL CHIM ACTA, V350, P141, DOI 10.1016/S0003-2670(97)00309-7
   Kar S, 1996, J MICROCOLUMN SEP, V8, P561, DOI 10.1002/(SICI)1520-667X(1996)8:8<561::AID-MCS6>3.0.CO;2-#
   KAR S, 1994, ANAL CHEM, V66, P2537, DOI 10.1021/ac00087a019
   KAROVICOVA J, 1990, NAHRUNG, V34, P765
   Kawamura Y, 1996, PLANT CELL PHYSIOL, V37, P878, DOI 10.1093/oxfordjournals.pcp.a029027
   Kelly RG, 1996, J CHROMATOGR A, V739, P191, DOI 10.1016/0021-9673(96)00223-3
   Kitagawa S, 1997, J MICROCOLUMN SEP, V9, P347, DOI 10.1002/(SICI)1520-667X(1997)9:5<347::AID-MCS2>3.0.CO;2-1
   KODAMA S, 1996, TOYAMA KEN EISEI KEN, V19, P217
   Kotrly S., 1985, HDB CHEM EQUILIBRIA
   Krivacsy Z, 1997, J CHROMATOGR A, V781, P223, DOI 10.1016/S0021-9673(97)00290-2
   Krokhin OV, 1997, J CHROMATOGR A, V776, P329, DOI 10.1016/S0021-9673(97)00420-2
   Krokhin OV, 1996, CHEM LETT, P1095, DOI 10.1246/cl.1996.1095
   Kuban P, 1997, J CHROMATOGR A, V770, P329, DOI 10.1016/S0021-9673(97)00030-7
   Kuban P, 1998, TRAC-TREND ANAL CHEM, V17, P34, DOI 10.1016/S0165-9936(97)00088-5
   Kuban P, 1998, TALANTA, V45, P477, DOI 10.1016/S0039-9140(97)00131-8
   Kuban P, 1997, ANAL CHIM ACTA, V337, P117, DOI 10.1016/S0003-2670(96)00339-X
   Kuban P, 1997, ANAL CHEM, V69, P1169, DOI 10.1021/ac960921l
   Kuban P, 1998, ANAL CHEM, V70, P360, DOI 10.1021/ac9706133
   KUNERT J, 1988, ARCH MICROBIOL, V150, P600, DOI 10.1007/BF00408257
   Lamb JD, 1996, J CHROMATOGR A, V739, P373, DOI 10.1016/0021-9673(96)00055-6
   Lee KW, 1997, ANAL SCI, V13, P247, DOI 10.2116/analsci.13.Supplement_247
   LEONE AM, 1994, BIOCHEM BIOPH RES CO, V200, P951, DOI 10.1006/bbrc.1994.1542
   LEONE AM, 1996, METHODS NITRIC OXIDE, P499
   Li DM, 1997, J CHROMATOGR B, V695, P169, DOI 10.1016/S0378-4347(97)00071-6
   LI J, 1997, CHINESE J ANAL CHEM, V25, P559
   LIN L, 1995, J CHROMATOGR SCI, V33, P177, DOI 10.1093/chromsci/33.4.177
   LIU Y, 1995, ANAL CHEM, V67, P2020, DOI 10.1021/ac00109a019
   Lurie IS, 1996, J CAPILLARY ELECTROP, V3, P237
   LURJE YY, 1979, SPRAVOTSHNIK ANALITI
   MADAJOVA V, 1992, J CHROMATOGR, V589, P329, DOI 10.1016/0021-9673(92)80040-2
   Magnuson ML, 1997, J ANAL ATOM SPECTROM, V12, P689, DOI 10.1039/a607730g
   Magnuson ML, 1997, ANALYST, V122, P1057, DOI 10.1039/a703039h
   Marshall PA, 1996, FOOD CHEM, V57, P339, DOI 10.1016/0308-8146(96)00002-7
   Marti MC, 1997, BIOTECHNOL TECH, V11, P163, DOI 10.1023/A:1018449429551
   MARTI V, 1995, J CHROMATOGR A, V709, P367, DOI 10.1016/0021-9673(95)00446-T
   MARTINEZ M, 1994, J CHROMATOGR A, V676, P443, DOI 10.1016/0021-9673(94)80445-1
   MASAR M, UNPUB J CHROMATOGR A
   MASSELTER SM, 1996, J HIGH RES CHROMATOG, V19, P101
   MATEJOVIC I, 1994, FRESEN J ANAL CHEM, V349, P559, DOI 10.1007/BF00323994
   Meissner T, 1998, FRESEN J ANAL CHEM, V361, P459, DOI 10.1007/s002160050926
   Meissner T, 1998, J CHROMATOGR A, V810, P201, DOI 10.1016/S0021-9673(98)00236-2
   MEISSNER T, 1997, GIT LABORFACHZ, V41, P728
   MEULEMANS A, 1994, J CHROMATOGR B, V660, P401, DOI 10.1016/0378-4347(94)00310-6
   Mihalyi B, 1996, ANN CHIM-ROME, V86, P439
   MIKKERS FEP, 1979, J CHROMATOGR, V169, P1, DOI 10.1016/0021-9673(75)85028-X
   MIKKERS FEP, 1979, J CHROMATOGR, V169, P11, DOI 10.1016/0021-9673(75)85029-1
   MORIN P, 1992, FRESEN J ANAL CHEM, V342, P357, DOI 10.1007/BF00322185
   Motellier S, 1997, J CHROMATOGR A, V770, P311, DOI 10.1016/S0021-9673(96)01021-7
   NAIR JB, 1993, J CHROMATOGR, V640, P445, DOI 10.1016/0021-9673(93)80215-T
   NANN A, 1994, J CHROMATOGR A, V676, P437, DOI 10.1016/0021-9673(94)80444-3
   Oehrle SA, 1996, J CHROMATOGR A, V733, P101, DOI 10.1016/0021-9673(95)00769-5
   OEHRLE SA, 1994, J CHROMATOGR A, V671, P383, DOI 10.1016/0021-9673(94)80264-5
   Oehrle SA, 1996, J CHROMATOGR A, V739, P413, DOI 10.1016/0021-9673(96)00026-X
   OEHRLE SA, 1994, J CHROMATOGR A, V680, P645, DOI 10.1016/0021-9673(94)85164-6
   Oehrle SA, 1996, J CHROMATOGR A, V745, P81, DOI 10.1016/0021-9673(96)00267-1
   OLESIK JW, 1995, ANAL CHEM, V67, P1, DOI 10.1021/ac00097a003
   Pacakova V, 1997, J CHROMATOGR A, V789, P169, DOI 10.1016/S0021-9673(97)00830-3
   Padarauskas A, 1998, J CHROMATOGR A, V800, P369, DOI 10.1016/S0021-9673(97)01108-4
   PANTSARKALLIO M, 1995, CHEMOSPHERE, V31, P3699, DOI 10.1016/0045-6535(95)00219-X
   PantsarKallio M, 1997, CHEMOSPHERE, V35, P1509, DOI 10.1016/S0045-6535(97)00227-0
   Park SW, 1997, ANAL SCI, V13, P243, DOI 10.2116/analsci.13.Supplement_243
   Perrin D., 1974, BUFFERS PH METAL ION
   PRETSWELL EL, 1993, ANALYST, V118, P1265, DOI 10.1039/an9931801265
   REIJENGA JC, 1983, J CHROMATOGR, V260, P241, DOI 10.1016/0021-9673(83)80034-X
   REIJENGA JC, 1994, J CHROMATOGR A, V659, P403, DOI 10.1016/0021-9673(94)85083-6
   REN H, 1996, HUANJING KEXUE, V17, P53
   RHEMREVBOOM MM, 1994, J CHROMATOGR A, V680, P675, DOI 10.1016/0021-9673(94)85168-9
   Robards K, 1994, PRINCIPLES PRACTICE
   ROHLICEK V, 1994, J CHROMATOGR A, V662, P369, DOI 10.1016/0021-9673(94)80523-7
   ROLANDGOSSELIN P, 1997, CAPILLARY ELECTROPHO, P445
   ROMANO J, 1991, J CHROMATOGR, V546, P411, DOI 10.1016/S0021-9673(01)93040-7
   ROMANO JP, 1992, J CHROMATOGR, V602, P205, DOI 10.1016/0021-9673(92)80082-6
   ROMANO JP, 1993, J CHROMATOGR, V640, P403, DOI 10.1016/0021-9673(93)80209-Q
   SAARINORDHAUS R, 1995, J CHROMATOGR A, V706, P563, DOI 10.1016/0021-9673(94)01106-O
   SALIMIMOOSAVI H, 1995, ANAL CHEM, V67, P1067, DOI 10.1021/ac00102a008
   SALOMON DR, 1992, J CHROMATOGR, V602, P219, DOI 10.1016/0021-9673(92)80084-8
   SanzAsensio J, 1997, ANAL CHIM ACTA, V343, P39, DOI 10.1016/S0003-2670(96)00584-3
   Sarmini K, 1997, J CHROMATOGR A, V792, P3, DOI 10.1016/S0021-9673(97)00720-6
   Schlegel D, 1996, FRESEN J ANAL CHEM, V354, P535
   SCHMITT M, 1993, J CHROMATOGR, V640, P419, DOI 10.1016/0021-9673(93)80211-P
   SCHOMBURG G, 1994, J CAPILLARY ELECTROP, V1, P219
   SCHUBERT BA, 1997, GIT FACHZ LAB, V41, P742
   SCHUTZNER W, 1992, ANAL CHEM, V64, P1991, DOI 10.1021/ac00041a039
   Schwedt G, 1996, J CHROMATOGR A, V736, P341, DOI 10.1016/0021-9673(95)01319-9
   Semenova OP, 1996, HRC-J HIGH RES CHROM, V19, P177
   SHAMSI SA, 1995, ANAL CHEM, V67, P1845, DOI 10.1021/ac00107a014
   SHAMSI SA, 1994, ANAL CHEM, V66, P3757, DOI 10.1021/ac00093a035
   Siren H, 1997, J CHROMATOGR A, V767, P293, DOI 10.1016/S0021-9673(96)01036-9
   Soga T, 1997, J AM SOC BREW CHEM, V55, P44
   Soga T, 1995, J CHROMATOGR A, V718, P421, DOI 10.1016/0021-9673(95)00704-0
   Soga T, 1997, J CHROMATOGR A, V767, P223, DOI 10.1016/S0021-9673(96)01055-2
   SONG LG, 1995, J CHROMATOGR A, V715, P376, DOI 10.1016/0021-9673(95)00605-M
   STAHL R, 1994, J CHROMATOGR A, V686, P143, DOI 10.1016/0021-9673(94)00074-3
   STATHAKIS C, 1994, ANAL CHEM, V66, P2110, DOI 10.1021/ac00085a029
   STATHAKIS C, 1995, J CHROMATOGR A, V699, P353, DOI 10.1016/0021-9673(95)00150-L
   STEPHEN SC, 1997, SPEC PUBL R SOC CHEM, V196, P124
   Stover FS, 1997, J CHROMATOGR A, V769, P349, DOI 10.1016/S0021-9673(97)00070-8
   STOVER FS, 1993, J CHROMATOGR A, V657, P450, DOI 10.1016/0021-9673(93)80302-O
   STOVER FS, 1990, ELECTROPHORESIS, V11, P750, DOI 10.1002/elps.1150110912
   STRANSKY Z, 1988, ZIVOCISNA VYROBA, V33, P211
   SWARTZ ME, 1993, J CHROMATOGR, V640, P441, DOI 10.1016/0021-9673(93)80214-S
   TAGA M, 1989, ANAL SCI, V5, P219
   Takayanagi T, 1996, ANAL SCI, V12, P575, DOI 10.2116/analsci.12.575
   Takayanagi T, 1996, BUNSEKI KAGAKU, V45, P697
   TAKAYANAGI T, 1995, KANKYO SEIGYO, V17, P49
   TALASEK T, 1994, MICROCONTAMINATION, V27, P56
   Tavares MFM, 1997, J CHROMATOGR A, V772, P171, DOI 10.1016/S0021-9673(96)00985-5
   TAZAKI M, 1982, CHEM LETT, P639, DOI 10.1246/cl.1982.639
   Tenberken B, 1997, J CHROMATOGR A, V775, P372, DOI 10.1016/S0021-9673(97)00259-8
   Tenberken B, 1996, J CHROMATOGR A, V745, P209, DOI 10.1016/0021-9673(96)00202-6
   THORMANN W, 1990, J CHROMATOGR, V516, P211
   Thornton MJ, 1997, J CHROMATOGR A, V770, P301, DOI 10.1016/S0021-9673(97)00170-2
   Tian XD, 1998, CHEM J CHINESE U, V19, P27
   Timerbaev AR, 1997, J CHROMATOGR A, V792, P495, DOI 10.1016/S0021-9673(97)00618-3
   Timerbaev AR, 1997, ELECTROPHORESIS, V18, P185, DOI 10.1002/elps.1150180203
   TINDALL GW, 1995, J CHROMATOGR A, V696, P349, DOI 10.1016/0021-9673(94)01229-8
   Trenerry VC, 1996, FOOD CHEM, V55, P299, DOI 10.1016/0308-8146(95)00117-4
   Trushina EV, 1997, ELECTROPHORESIS, V18, P1890, DOI 10.1002/elps.1150181027
   TSIKAS D, 1995, J CHROMATOGR A, V699, P363, DOI 10.1016/0021-9673(95)00119-8
   UEDA T, 1995, ELECTROPHORESIS, V16, P1002, DOI 10.1002/elps.11501601167
   UEDA T, 1996, SEIBUTSU BUTSURI KAG, V40, P175
   VACIK J, 1985, J CHROMATOGR, V320, P233, DOI 10.1016/S0021-9673(01)90500-X
   VACIK J, 1979, ELECTROPHORESIS SURV, P1
   Valsecchi S, 1997, J CHROMATOGR A, V760, P326, DOI 10.1016/S0021-9673(96)00798-4
   Van den Broeck K, 1998, MIKROCHIM ACTA, V128, P79, DOI 10.1007/BF01242194
   Van Holderbeke M., 1995, Biomedical Chromatography, V9, P281, DOI 10.1002/bmc.1130090617
   vandenHoop MAGT, 1997, J CHROMATOGR A, V770, P321, DOI 10.1016/S0021-9673(96)01000-X
   vandenHoop MAGT, 1996, J CHROMATOGR A, V739, P241, DOI 10.1016/0021-9673(96)00029-5
   VERHEGGEN TPEM, 1990, J CHROMATOGR, V503, P245, DOI 10.1016/S0021-9673(01)81506-5
   VERHEGGEN TPEM, 1993, J CHROMATOGR, V638, P147, DOI 10.1016/0021-9673(93)83423-P
   Verhelst V, 1997, J CHROMATOGR A, V770, P337, DOI 10.1016/S0021-9673(97)00176-3
   Vogt C, 1996, J CHROMATOGR A, V727, P301, DOI 10.1016/0021-9673(95)01131-5
   VOLGGER D, 1998, J HIGH RES CHROMATOG, V21, P3
   Walker EB, 1996, J CHROMATOGR A, V745, P111, DOI 10.1016/0021-9673(96)00378-0
   WANDERS BJ, 1993, THESIS U TECHNOLOGY
   Wang P, 1998, TALANTA, V45, P657, DOI 10.1016/S0039-9140(97)00296-8
   Wang P, 1997, J CHROMATOGR A, V765, P353, DOI 10.1016/S0021-9673(96)00926-0
   Wang TL, 1996, J CHROMATOGR A, V723, P197, DOI 10.1016/0021-9673(95)00824-1
   Wang TL, 1997, J CHROMATOGR A, V781, P457
   Wang TL, 1998, J CHROMATOGR A, V802, P159, DOI 10.1016/S0021-9673(97)01121-7
   WEAST RC, 1980, HDB CHEM PHYSICS
   Westergaard B, 1998, ANALYST, V123, P721, DOI 10.1039/a707497b
   WILDMAN BJ, 1991, J CHROMATOGR, V546, P411
   Williams R., 1997, J PHARM BIOMED ANAL, V16, P469
   WOJTUSIK MJ, 1994, J CHROMATOGR A, V671, P411, DOI 10.1016/0021-9673(94)80268-8
   Wu MJ, 1996, CHINESE J ANAL CHEM, V24, P1178
   YAMADA A, 1993, BUNSEKI KAGAKU, V42, P867
   YANG Y, 1997, CHINESE J ANAL CHEM, V25, P738
   YEUNG ES, 1989, ACCOUNTS CHEM RES, V22, P125, DOI 10.1021/ar00160a002
   YOSHIDA H, 1986, J CHROMATOGR, V351, P421
   Zaugg SE, 1997, ELECTROPHORESIS, V18, P202, DOI 10.1002/elps.1150180205
   ZELENSKY I, 1987, J CHROMATOGR, V390, P111, DOI 10.1016/S0021-9673(01)94365-1
   Zemann AJ, 1998, ANAL CHEM, V70, P563, DOI 10.1021/ac9707592
   Zemann AJ, 1997, J CHROMATOGR A, V787, P243, DOI 10.1016/S0021-9673(97)00645-6
   1960, LANDOLTBOERNSTEIN 7, V2
NR 291
TC 118
Z9 119
U1 1
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD FEB 26
PY 1999
VL 834
IS 1-2
BP 133
EP 178
DI 10.1016/S0021-9673(98)00789-4
PG 46
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 174VD
UT WOS:000079055900010
PM 10189691
DA 2018-10-19
ER

PT J
AU Suslick, KS
   Didenko, Y
   Fang, MM
   Hyeon, T
   Kolbeck, KJ
   McNamara, WB
   Mdleleni, MM
   Wong, M
AF Suslick, KS
   Didenko, Y
   Fang, MM
   Hyeon, T
   Kolbeck, KJ
   McNamara, WB
   Mdleleni, MM
   Wong, M
TI Acoustic cavitation and its chemical consequences
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE sonochemistry; sonoluminescence; materials; nanostructures; microspheres
ID SINGLE-BUBBLE SONOLUMINESCENCE; SONOCHEMICAL SYNTHESIS; AMORPHOUS IRON;
   NONAQUEOUS LIQUIDS; ULTRASOUND; TEMPERATURE; SPECTRA; MICROSPHERES;
   INTENSITY
AB Acoustic cavitation is responsible for both sonochemistry and sonoluminescence. Bubble collapse in liquids results in an enormous concentration of energy from the conversion of the kinetic energy of liquid motion into heating of the contents of the bubble. The high local temperatures and pressures, combined with extraordinarily rapid cooling, provide a unique means for driving chemical reactions under extreme conditions. A diverse set of applications of ultrasound to enhance chemical reactivity has been explored, with important applications in mixed-phase synthesis, materials chemistry, and biomedical uses. For example, the sonochemical decomposition of volatile organometallic precursors in low-volatility solvents produces nanostructured materials in various forms with high catalytic activities. Nanostructured metals, alloys, carbides and sulphides, nanometre colloids, and nanostructured supported catalysts can all be prepared by this general route. Another important application of sonochemistry to materials chemistry has been the preparation of biomaterials, most notably protein microspheres. Such microspheres have a wide range of biomedical applications, including their use as echo contrast agents for sonography, magnetic resonance imaging contrast enhancement, and oxygen or drug delivery.
C1 Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.
RP Suslick, KS (reprint author), Univ Illinois, Sch Chem Sci, 600 S Mathews Ave, Urbana, IL 61801 USA.
RI Suslick, Kenneth/C-3281-2011; Hyeon, Taeghwan/J-5315-2012
OI Suslick, Kenneth/0000-0001-5422-0701; Lee, Junyoung/0000-0001-6689-2759
CR BARBER BP, 1992, J ACOUST SOC AM, V91, P3061, DOI 10.1121/1.402942
   Barber BP, 1997, PHYS REP, V281, P65, DOI 10.1016/S0370-1573(96)00050-6
   BARBER BP, 1994, PHYS REV LETT, V72, P1380, DOI 10.1103/PhysRevLett.72.1380
   BARBER BP, 1992, PHYS REV LETT, V69, P3839, DOI 10.1103/PhysRevLett.69.3839
   BELLISSENT R, 1993, PHYS REV B, V48, P15797, DOI 10.1103/PhysRevB.48.15797
   Berkovsky B. M., 1993, MAGNETIC FLUIDS ENG
   Bernstein LS, 1996, J PHYS CHEM-US, V100, P6612, DOI 10.1021/jp953643n
   Cao X, 1997, J MATER RES, V12, P402, DOI 10.1557/JMR.1997.0058
   Cheeke JDN, 1997, CAN J PHYS, V75, P77, DOI 10.1139/cjp-75-2-77
   CRUM LA, 1994, J ACOUST SOC AM, V95, P559, DOI 10.1121/1.408351
   CRUM LA, 1994, PHYS TODAY, V47, P22, DOI 10.1063/1.881402
   DIDENKO YT, 1994, ULTRASONICS, V32, P71, DOI 10.1016/0041-624X(94)90083-3
   DIDENKO YT, 1994, ULTRASON SONOCHEM, V1, pS10
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   Eckburg JJ, 1996, J BIOMECH ENG-T ASME, V118, P193, DOI 10.1115/1.2795959
   FLINT EB, 1991, J PHYS CHEM-US, V95, P1484, DOI 10.1021/j100156a084
   FLINT EB, 1989, J AM CHEM SOC, V111, P6987, DOI 10.1021/ja00200a014
   FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397
   FLYNN HG, 1964, PHYS ACOUSTICS, V1, P157
   Frenzel H, 1934, Z PHYS CHEM B-CHEM E, V27, P421
   GATES BC, 1992, CATALYTIC CHEM, P387
   Gompf B, 1997, PHYS REV LETT, V79, P1405, DOI 10.1103/PhysRevLett.79.1405
   GRINSTAFF MW, 1993, PHYS REV B, V48, P269, DOI 10.1103/PhysRevB.48.269
   Henglein A., 1993, ADV SONOCHEMISTRY, V3, P17
   Hiller RA, 1998, PHYS REV LETT, V80, P1090, DOI 10.1103/PhysRevLett.80.1090
   HYEON T, 1995, MAT SCI ENG A-STRUCT, V204, P186
   Hyeon TH, 1996, J AM CHEM SOC, V118, P5492, DOI 10.1021/ja9538187
   JEFFRIES JB, 1992, SCIENCE, V256, P248, DOI 10.1126/science.256.5054.248
   KELLER MW, 1988, ECHOCARDIOGRAPHY COR
   Leighton T., 1994, ACOUSTIC BUBBLE, P531
   LIU KJ, 1994, BIOPHYS J, V67, P896, DOI 10.1016/S0006-3495(94)80551-X
   Lohse D, 1997, PHYS REV LETT, V78, P1359, DOI 10.1103/PhysRevLett.78.1359
   Long GJ, 1998, PHYS REV B, V57, P10716, DOI 10.1103/PhysRevB.57.10716
   Mason T., 1988, SONOCHEMISTRY THEORY
   Mason T. J., 1996, CHEM EXTREME NONCLAS, P317
   MATULA TJ, 1995, PHYS REV LETT, V75, P2602, DOI 10.1103/PhysRevLett.75.2602
   Mdleleni MM, 1998, J AM CHEM SOC, V120, P6189, DOI 10.1021/ja9800333
   Moser W. R., 1996, ADV CATALYSTS NANOST
   Moss WC, 1997, SCIENCE, V276, P1398, DOI 10.1126/science.276.5317.1398
   NEPPIRAS EA, 1980, PHYS REP, V61, P159, DOI 10.1016/0370-1573(80)90115-5
   PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1
   Preece CM, 1981, ADV MECH PHYS SURF, V1, P199
   PUTTERMAN SJ, 1995, SCI AM, V272, P46, DOI 10.1038/scientificamerican0295-46
   Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681
   Richards WT, 1927, J AM CHEM SOC, V49, P3086, DOI 10.1021/ja01411a015
   RIESZ P, 1985, ENVIRON HEALTH PERSP, V64, P233, DOI 10.2307/3430013
   Shafi KVPM, 1997, J APPL PHYS, V81, P6901, DOI 10.1063/1.365250
   Suslick K.S., 1990, ADV SONOCHEMISTRY, V1, P197
   Suslick K. S., 1998, KIRKOTHMER ENCY CHEM, V26, P517
   Suslick K.S, 1997, HDB HETEROGENEOUS CA, V3, P1350
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   Suslick KS, 1996, J AM CHEM SOC, V118, P11960, DOI 10.1021/ja961807n
   SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0
   SUSLICK KS, 1995, MRS BULL, V20, P29, DOI 10.1557/S088376940004464X
   SUSLICK KS, 1993, J PHYS CHEM-US, V97, P3098, DOI 10.1021/j100115a007
   Suslick KS, 1997, ENCY ACOUSTICS, V1, P271
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
   SUSLICK KS, 1994, ENCY INORGANIC CHEM, V7, P3890
   Webb AG, 1996, JMRI-J MAGN RESON IM, V6, P675, DOI 10.1002/jmri.1880060417
   WELLER H, 1993, ADV MATER, V5, P88, DOI 10.1002/adma.19930050204
   WONG M, 1995, MATER RES SOC SYMP P, V372, P89
NR 64
TC 391
Z9 395
U1 3
U2 85
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD FEB 15
PY 1999
VL 357
IS 1751
BP 335
EP 353
DI 10.1098/rsta.1999.0330
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 175NN
UT WOS:000079100700008
DA 2018-10-19
ER

PT J
AU Martin, DJ
   Meijs, GF
   Gunatillake, PA
   Yozghatlian, SP
   Renwick, GM
AF Martin, DJ
   Meijs, GF
   Gunatillake, PA
   Yozghatlian, SP
   Renwick, GM
TI The influence of composition ratio on the morphology of biomedical
   polyurethanes
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE Pellethane; degradation; morphology
ID SOFT-SEGMENT LENGTH; MECHANICAL-PROPERTIES; ELASTOMERS; HARD; MDI;
   SERIES; DEGRADATION; SEPARATION; BEHAVIOR; DIOLS
AB Two series of thermoplastic polyurethrtne elastomers were synthesized from 4,4'-methylenediphenyl diisocyanate (MDI), 1,4-butanediol (BDO) chain extender, and each of poly(tetramethylene oxide) (PTMO) and poly(hexamethylene oxide) (PHMO) macrodiols. The PTMO and PHMO molecular weights were kept constant at 993 and 852 g/mol, respectively. In the PTMO-based series, the composition ratio was varied between 48 and 58% (w/w) of macrodiol; 2 commercially available PTMO-based polymers were also included. These were Pellethane 2363 80A(R) and its harder counterpart, Pellethane 2363 55D(R). In the PHMO-based series, the composition ratio was varied between 50 and 60% (w/w) of macrodiol. The materials were characterized by differential scanning calorimetry (DSC), dynamic mechanical thermal analysis (DMTA), wide-angle X-ray diffraction (WAXD), and small-angle X-ray scattering (SAXS). Mechanical performance was also assessed by tensile testing, stress hysteresis, and hardness testing. Altering the composition ratio had a similar effect on morphology and properties for both the PTMO and PHMO-based series. An increase in hard segment content was associated with increased hard microdomain crystallinity, hardness, and stiffness. In both series, he beginning of hard microdomain interconnectivity was observed at a composition ratio of 52% soft segment. That is to say, for the processing and annealing conditions employed, macrodiol contents of 52% and below began to produce continuous, rather than discrete, hard microdomains. Pellethane 80A(R) was shown to have a discrete hard microdomain morphology, while Pellethane 55D(R) was shown to incorporate interconnecting hard microdomains. It is suggested that the superior biostability performance of Pellethane 55D relative to Pellethane 80A may be related to its interconnecting hard microdomain texture. (C) 1999 John Wiley & Sons, Inc.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   CSIRO, Clayton, Vic 3169, Australia.
   Univ Technol Sydney, Dept Mat Sci, Sydney, NSW 2007, Australia.
RP Martin, DJ (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RI Gunatillake, Pathiraja/A-1375-2008
OI Gunatillake, Pathiraja/0000-0002-7035-8214; Martin,
   Darren/0000-0002-8537-6765
CR ABOUZAHR S, 1982, POLYMER, V23, P1077, DOI 10.1016/0032-3861(82)90411-6
   Aldissi M., 1988, Materials Science Forum, V27-28, P437
   *ASTM, 1969, D284969 ASTM
   BLACKWELL J, 1984, J POLYM SCI POL PHYS, V22, P759, DOI 10.1002/pol.1984.180220417
   CHRISTENSON CP, 1986, J POLYM SCI POL PHYS, V24, P1401, DOI 10.1002/polb.1986.090240703
   FERGUSON J, 1972, EUR POLYM J, V8, P369, DOI 10.1016/0014-3057(72)90102-4
   GUNATILLAKE PA, 1992, POLYM INT, V27, P275, DOI 10.1002/pi.4990270313
   GUNATILLAKE PA, 1992, J APPL POLYM SCI, V46, P319, DOI 10.1002/app.1992.070460213
   GUNATILLAKE PA, 1993, J APPL POLYM SCI, V47, P199, DOI 10.1002/app.1993.070470202
   HARRIS RF, 1990, J APPL POLYM SCI, V41, P509, DOI 10.1002/app.1990.070410305
   HUH DS, 1971, POLYM ENG SCI, V11, P369, DOI 10.1002/pen.760110504
   HWANG KKS, 1984, J POLYM SCI POL CHEM, V22, P1677, DOI 10.1002/pol.1984.170220714
   KAZMIERCZAK ME, 1998, J POLYM SCI PP, V27, P2188
   KOBAYASHI S, 1968, MAKROMOL CHEM, V112, P225
   KOBERSTEIN JT, 1992, MACROMOLECULES, V25, P5618, DOI 10.1021/ma00047a010
   KOVERSTEIN JT, 1992, MACROMOLECULES, V25, P6195
   LEE HS, 1994, J POLYM SCI POL PHYS, V32, P2085, DOI 10.1002/polb.1994.090321215
   LEUNG LM, 1985, J POLYM SCI POL PHYS, V23, P1883, DOI 10.1002/pol.1985.180230912
   Martin DJ, 1996, J APPL POLYM SCI, V60, P557, DOI 10.1002/(SICI)1097-4628(19960425)60:4<557::AID-APP9>3.0.CO;2-N
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MEIJS GF, 1992, PROGR PACIFIC POLYM, V2
   PETROVIC ZS, 1989, J POLYM SCI POL PHYS, V27, P545, DOI 10.1002/polb.1989.090270305
   QUAY JR, 1990, POLYMER, V31, P1003, DOI 10.1016/0032-3861(90)90244-S
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P3185, DOI 10.1002/app.1975.070191204
   SEYMOUR RW, 1971, POLYM LETT, V9, P695
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES KB, 1985, PACEMAKER LEADS, P279
   VANBOGART JWC, 1983, J POLYM SCI POL PHYS, V21, P65, DOI 10.1002/pol.1983.180210106
   WAGENER KB, 1992, MACROMOLECULES, V25, P5591, DOI 10.1021/ma00047a005
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P632
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
NR 36
TC 66
Z9 69
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 7
PY 1999
VL 71
IS 6
BP 937
EP 952
PG 16
WC Polymer Science
SC Polymer Science
GA 151ZL
UT WOS:000077750600009
DA 2018-10-19
ER

PT J
AU Covacci, V
   Bruzzese, N
   Maccauro, G
   Andreassi, C
   Ricci, GA
   Piconi, C
   Marmo, E
   Burger, W
   Cittadini, A
AF Covacci, V
   Bruzzese, N
   Maccauro, G
   Andreassi, C
   Ricci, GA
   Piconi, C
   Marmo, E
   Burger, W
   Cittadini, A
TI In vitro evaluation of the mutagenic and carcinogenic power of high
   purity zirconia ceramic
SO BIOMATERIALS
LA English
DT Article
DE zirconia; ceramic; radiation; mutation; transformation
ID MOUSE EMBRYO CELLS; POSTCONFLUENCE INHIBITION; Y-TZP; TRANSFORMATION;
   FIBROBLASTS; DIVISION
AB Tetragonal zirconia polycrystal (TZP) is a new interesting ceramic for the manufacture of medical devices. Its wide use in orthopedic and odontoiatric implants was limited till now by the high chemical and radiochemical impurities of the raw materials. Purification processes now available allow to obtain high purity ceramic grade powders suitable for TZP ceramics manufacture, even if their possible mutagenic and transforming effects are still unclear. The aim of this work is to study in vitro the mutagenic and oncogenic effects of a new zirconia ceramic stabilized by yttria (Y-TZP). This ceramic was sintered from high purity powders obtained by a process developed under a project carried out within the Brite EuRam programme. For comparison, ceramics made from unpurified zirconia powder were also tested. Fibroblasts irradiated by a linear accelerator were used as positive control. The results obtained show that Y-TZP ceramic does not elicit either mutagenic or transforming effect on C3H/10-T-1/2 (10T(1/2)) cells and demonstrate that ceramic from high purity powders can be considered suitable for biomedical applications from the point of view of the effects of its radioactive impurity content. (C) 1999 Elsevier Science Ltd. All rights reserved.
C1 Catholic Univ, Sch Med, Inst Gen Pathol, Giovanni Canc Res Ctr 23, I-00168 Rome, Italy.
   ENEA, New Technol Dept, I-00060 Rome, Italy.
   FN Spa, I-15062 Bosco Marengo, AL, Italy.
   CeramTec AG, D-73207 Plochingen, Germany.
RP Covacci, V (reprint author), Catholic Univ, Sch Med, Inst Gen Pathol, Giovanni Canc Res Ctr 23, 1 Lgo F Vito, I-00168 Rome, Italy.
EM ibipg@rm.unicatt.it
OI MACCAURO, Giulio/0000-0002-7359-268X
CR Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   BURGER W, 1994, T 11 EUR C BIOM PIS, P177
   BURGER W, 1995, EURCERAMICS, V8, P29
   CALES B, 1990, BIOCERAMICS, V2, P152
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   Drouin JM, 1997, J BIOMED MATER RES, V34, P149, DOI 10.1002/(SICI)1097-4636(199702)34:2<149::AID-JBM2>3.0.CO;2-Q
   HAN A, 1979, CANCER RES, V39, P123
   KAKUNAGA T, 1985, TRANSFORMATION ASSAY, P9
   Landolph J R, 1985, Carcinog Compr Surv, V10, P211
   Landolph J. R., 1985, TRANSFORMATION ASSAY, P185
   LANDOLPH JR, 1983, MUTAT RES, V107, P447, DOI 10.1016/0027-5107(83)90183-5
   LANDOLPH JR, 1994, ENVIRON HEALTH PERSP, V102, P119, DOI 10.2307/3431774
   LITTLE JB, 1985, TRANSFORMATION ASSAY, P119
   PATIERNO SR, 1989, CANCER RES, V49, P1038
   Porstendorfer J, 1996, J BIOMED MATER RES, V32, P663, DOI 10.1002/(SICI)1097-4636(199612)32:4<663::AID-JBM20>3.0.CO;2-D
   Reitmair AH, 1997, CANCER RES, V57, P3765
   REZNIKOFF CA, 1973, CANCER RES, V33, P3231
   REZNIKOFF CA, 1973, CANCER RES, V33, P3239
   RICHTER HG, 1995, CERAM T, V48, P73
   VONHOFE E, 1991, RADIAT RES, V127, P220, DOI 10.2307/3577968
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
NR 23
TC 88
Z9 100
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1999
VL 20
IS 4
BP 371
EP 376
DI 10.1016/S0142-9612(98)00182-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 164CW
UT WOS:000078445700010
PM 10048410
DA 2018-10-19
ER

PT J
AU Desai, TA
   Hansford, DJ
   Kulinsky, L
   Nashat, AH
   Rasi, G
   Tu, J
   Wang, Y
   Zhang, M
   Ferrari, M
AF Desai, Tejal A.
   Hansford, Derek J.
   Kulinsky, Lawrence
   Nashat, Amir H.
   Rasi, Guido
   Tu, Jay
   Wang, Yuchun
   Zhang, Miqin
   Ferrari, Mauro
TI Nanopore Technology for Biomedical Applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE BioMEMS; nanotechnology; microfabrication; membranes; silicon
AB The ability to create well-defined and controlled interfaces has been an area of great interest over the last few years, particularly in the biomedical arena. This paper will describe the development of technology for the fabrication of nanopore membranes, and their operation in biological environments. With monodisperse pores sizes as small as 10 nanometers, these membranes offer advantages in their reproducibility, and their ability to be integrated with controlled biochemical surface modification protocols. A comprehensive review of results in the areas of nanopore and biocapsule microfabrication technologies, biocompatibility of nanomembrane materials, biologically appropriate post-processing protocols (bonding, sterilization), surface modification protocols, and appropriate mass transport models will be presented. The results point to the potential of using such technologies for therapeutic applications including immunoisolation biocapsules, drug delivery devices, and targeted biorecognition platforms.
C1 Univ Calif Berkeley, Biomed Microdevices Ctr, Dept Civil & Environm Engn, Dept Mat Sci & Mineral Engn,Bioengn Grad Grp, Berkeley, CA 94720 USA.
   [Desai, Tejal A.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
   [Hansford, Derek J.] Ohio State Univ, Ctr Biomed Engn, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
   [Kulinsky, Lawrence] Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
   [Nashat, Amir H.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Rasi, Guido] CNR, Ist Med Sperimentale, I-00137 Rome, Italy.
   [Tu, Jay] Alien Technol, Hayward, CA 94545 USA.
   [Wang, Yuchun] Appl Mat Inc, Chem Mech Polishing Div, Santa Clara, CA 95054 USA.
   [Zhang, Miqin] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   [Ferrari, Mauro] Ohio State Univ, Ctr Biomed Engn, Columbus, OH 43210 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RI Zhang, Miqin/F-5537-2010; Kulinsky, Lawrence/H-1314-2011
OI Zhang, Miqin/0000-0001-8974-1494; Kulinsky, Lawrence/0000-0002-1176-3578
FU MicroFab BioSystems of Vion Pharmaceuticals; National Science Foundation
   through MF's National Young Investigator Award
FX Financial support for the development of nanomembrane and biocapsule
   micromachining, biocompatibility, and characterization protocols (TD,
   MF, DH, LK, JT, YW, MZ) was provided by MicroFab BioSystems, a
   wholly-owned subsidiary of Vion Pharmaceuticals. The study of antibody
   grafting and their quantitative detection by confocal microscopy (MF,
   AN) was supported by the National Science Foundation, through MF's
   National Young Investigator Award. The authors gratefully acknowledge
   the support of others that have participated in the projects of UC
   Berkeley's Biomedical Microdevices Center, and have directly influenced
   the research presented herein: Ruby Chen, Wen-Hua Chu, Tony Huen, Mario
   Moronne, and Robert Szema.
CR Akerman B, 1997, J CHEM PHYS, V106, P6152, DOI 10.1063/1.473237
   AKIN T, 1994, IEEE T BIO-MED ENG, V41, P305, DOI 10.1109/10.284958
   ALDENHOFF YB, 1995, J BIOMED MAT, V29, P17
   ALTMAN JJ, 1991, PANCREATIC ISLET CEL, P216
   Anderson R.C., 1997, IEEE TRANSDUCERS 97, P477
   [Anonymous], 1995, MICR TECHN RES DIAGN
   AranhaCreado H, 1997, PDA J PHARM SCI TECH, V51, P208
   BAXTER GT, 1994, CLIN CHEM, V40, P1800
   Beamson G., 1992, HIGH RESOLUTION XPS
   Beyer D, 1996, LANGMUIR, V12, P2514, DOI 10.1021/la950459k
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BHATIA SK, 1993, ANAL BIOCHEM, V208, P197, DOI 10.1006/abio.1993.1027
   BOUSSE L, 1997, IEEE TRANSD, P499
   BRENDEL MD, 1994, CELL TRANSPLANT, V3, P427, DOI 10.1177/096368979400300510
   Brody JP, 1996, BIOPHYS J, V71, P3430, DOI 10.1016/S0006-3495(96)79538-3
   Brundle C. Richard, 1992, ENCY MAT CHARACTERIZ
   BRZOSKA JB, 1994, LANGMUIR, V10, P4367, DOI 10.1021/la00023a072
   BURCZAK K, 1994, BIOMATERIALS, V15, P231, DOI 10.1016/0142-9612(94)90072-8
   BURGREEN D, 1964, J PHYS CHEM-US, V68, P1084, DOI 10.1021/j100787a019
   CALAFIORE R, 1990, HORM METAB RES, V25, P213
   Calhan L.T., 1995, ADV MATER, V7, P1033
   Chan KC, 1997, J CHROMATOGR B, V695, P113, DOI 10.1016/S0378-4347(97)00257-0
   Chu W., 1996, SPIE P MICRO NANOFAB, V2978, P111
   Chu W., 1995, SPIE P, V2593
   CHU WH, 1995, P SOC PHOTO-OPT INS, P9
   Colton, 1991, T ASME, V113, P152
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Craig RG, 1993, RESTORATIVE DENT MAT
   Desai T., 1995, MAT DESIGN TECHNOLOG, P97
   Desai T.A., 1998, BIOMEDICAL IN PRESS
   Desai T.A., 1999, J MEMBRANE SCI
   Desai T.A., MICRO NANOFABRICATED
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Desai TA, 1998, PROG BIOM O, V3258, P40, DOI 10.1117/12.304387
   Dionne KE, 1996, BIOMATERIALS, V17, P257, DOI 10.1016/0142-9612(96)85563-3
   EDELL DJ, 1982, BIOMATER ARTIF CELL, V10, P103, DOI 10.3109/10731198209118775
   EFFENHAUSER CS, 1995, ANAL CHEM, V67, P2284, DOI 10.1021/ac00109a057
   Evans J., 1997, P IEEE MEMS, V97, P96
   Ferrari M, 1996, MATER RES SOC SYMP P, V414, P101
   Ferrari M., 1996, CISM COURSES LECT, V372, P559
   FLOUNDERS AW, 1995, APPL BIOCHEM BIOTECH, V50, P265, DOI 10.1007/BF02788097
   Fodor SPA, 1997, SCIENCE, V277, P393, DOI 10.1126/science.277.5324.393
   Furlong CD, 1997, P IEEE EMBS, V18, P248, DOI 10.1109/IEMBS.1996.656937
   GERASIMIDIVAZEOU A, 1992, TRANSPLANT P, V24, P667
   GOOSEN MFA, 1985, BIOTECHNOL BIOENG, V27, P146, DOI 10.1002/bit.260270207
   Gourley PL, 1996, NAT MED, V2, P942, DOI 10.1038/nm0896-942
   Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002
   Hansford D, 1998, PROG BIOM O, V3258, P164, DOI 10.1117/12.304376
   Hansford D., 1996, THESIS U CALIFORNIA
   HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895
   HARRISON DJ, 1993, IEEE TRANSD, P403
   Henry S., 1998, P IEEE MEMS, V98, P494
   Ho S.H., 1976, J CHROMATOGRPAHY, V120, P321
   Hsuie G., 1996, J BIOMAT SCI-POLYM E, V7, P839
   HUANG XHC, 1992, ANAL CHEM, V64, P2149, DOI 10.1021/ac00042a021
   JONSSON U, 1985, THIN SOLID FILMS, V124, P117, DOI 10.1016/0040-6090(85)90253-6
   Kamath KR, 1996, J BIOMAT SCI-POLYM E, V7, P977, DOI 10.1163/156856296X00381
   KOVACS GTA, 1994, IEEE T BIO-MED ENG, V41, P567, DOI 10.1109/10.293244
   KULINSKY L, 1998, THESIS U CALIFORNIA
   LACY P, 1992, SCIENCE, V254, P1728
   LAFFERTY KJ, 1989, DIABETES NUTR METAB, V2, P323
   Langer P., 1988, CHEM BIOCHEM ENG Q, V2, P242
   Lanza R. P., 1995, SCI AM SCI MED, P16
   LANZA RP, 1992, DIABETES, V41, P1503, DOI 10.2337/diabetes.41.12.1503
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Maboudian R, 1997, J VAC SCI TECHNOL B, V15, P1, DOI 10.1116/1.589247
   MacNair JE, 1997, RAPID COMMUN MASS SP, V11, P1279, DOI 10.1002/(SICI)1097-0231(199708)11:12<1279::AID-RCM18>3.0.CO;2-S
   Mala GM, 1997, INT J HEAT MASS TRAN, V40, P3079
   Man P.F, 1997, P IEEE MEMS, V97, P311
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   Morpurgo M, 1996, BIOCONJUGATE CHEM, V7, P363, DOI 10.1021/bc9600224
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nashat AH, 1998, BIOTECHNOL BIOENG, V60, P137, DOI 10.1002/(SICI)1097-0290(19981020)60:2<137::AID-BIT1>3.0.CO;2-O
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   PFAHLER J, 1990, SENSOR ACTUAT A-PHYS, V22, P431, DOI 10.1016/0924-4247(89)80008-1
   Piehler J, 1996, BIOSENS BIOELECTRON, V11, P579, DOI 10.1016/0956-5663(96)83293-3
   Renken J, 1996, ANAL CHEM, V68, P176, DOI 10.1021/ac9504777
   Reynaerts D, 1997, SENSOR ACTUAT A-PHYS, V61, P455, DOI 10.1016/S0924-4247(97)80305-6
   RICE CL, 1965, J PHYS CHEM-US, V69, P4017, DOI 10.1021/j100895a062
   Richter E, 1996, J MATER SCI-MATER M, V7, P85, DOI 10.1007/BF00058719
   ROBESON JL, 1995, BIOPHYS J, V68, P2145, DOI 10.1016/S0006-3495(95)80397-8
   Ross P.E., 1993, SCI AM, P18
   SALTHOUSE TN, 1975, BIOMATER ARTIF CELL, V3, P47, DOI 10.3109/10731197509118613
   Santini JT, 1999, NATURE, V397, P335
   SCHARP DW, 1984, WORLD J SURG, V8, P221, DOI 10.1007/BF01655139
   SCHNABEL R, 1991, J CHROMATOGR, V544, P137, DOI 10.1016/S0021-9673(01)83983-2
   Scott G, 1996, CURR EYE RES, V15, P461, DOI 10.3109/02713689609000757
   SHAH RK, 1975, INT J HEAT MASS TRAN, V18, P849, DOI 10.1016/0017-9310(75)90176-3
   SHOJI S, 1988, SENSOR ACTUATOR, V14, P101, DOI 10.1016/0250-6874(88)80057-X
   STRASSER CM, 1989, J BIOMED MATER RES, V23, P1385
   Sugamori M.E., 1989, ASAIO T, V35, P179
   TANG T, 1997, IEEE TRANSD, P523
   Tesk J.A., 1989, MATER RES SOC S P, V110, P177
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   Tu JK, 1998, PROG BIOM O, V3258, P148, DOI 10.1117/12.304374
   Turner T.C., 1995, BIOPHYS J, V69, P2782
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   VOLKMUTH WD, 1995, P NATL ACAD SCI USA, V92, P6887, DOI 10.1073/pnas.92.15.6887
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   WANG Y, 1998, THESIS U CALIFORNIA
   Wang YC, 1998, PROG BIOM O, V3258, P20, DOI 10.1117/12.304385
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WEBER CJ, 1991, PANCREATIC ISLET CEL, P177
   WEBSTER JR, 1997, INT C SOL STAT SENS, P503
   WILLIAMS RA, 1994, BIOSENS BIOELECTRON, V9, P159, DOI 10.1016/0956-5663(94)80108-8
   Wise K.D., 1990, ANN C IEEE ENG MED B, V12, P2334
   Woolley AT, 1997, ANAL CHEM, V69, P2181, DOI 10.1021/ac961237+
   WOOLLEY AT, 1994, P NATL ACAD SCI USA, V91, P11348, DOI 10.1073/pnas.91.24.11348
   Zhang MQ, 1998, BIOMED MICRODEVICES, V1, P81, DOI 10.1023/A:1009938507935
   Zhang MQ, 1997, BIOTECHNOL BIOENG, V56, P618, DOI 10.1002/(SICI)1097-0290(19971220)56:6<618::AID-BIT4>3.0.CO;2-Q
   Zhang MQ, 1998, PROG BIOM O, V3258, P15, DOI 10.1117/12.304384
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 114
TC 134
Z9 135
U1 2
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 1999
VL 2
IS 1
BP 11
EP 40
DI 10.1023/A:1009903215959
PG 30
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KY
UT WOS:000209018900003
DA 2018-10-19
ER

PT J
AU Grimes, CA
   Kouzoudis, D
   Ong, KG
   Crump, R
AF Grimes, Craig A.
   Kouzoudis, Dimitris
   Ong, Keat G.
   Crump, Rick
TI Thin-Film Magnetoelastic Microsensors for Remote Query Biomedical
   Monitoring
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE magnetoelastic; remote query; microdevice; sensor; glucose
AB Magnetoelastic thin-film sensors can be considered the magnetic analog of an acoustic bell: in response to an externally applied magnetic field impulse the sensors ring like a bell, emitting magnetic flux with a characteristic resonant frequency. The magnetic flux can be detected remotely, external to the test area, using a pick-up coil. By monitoring changes in the characteristic resonant frequency of the sensor multiple environmental parameters can be measured. In this work we report on application of magnetoelastic sensors for remote query measurement of temperature, pressure, viscosity and, in combination with a glucose-responding mass-changing polymer, in situ measurement of biological-level glucose concentrations. The advantage of using magnetoelastic sensors is that they are monitored remotely, without the need for direct physical connections such as wires or cables, nor line-of-sight alignment as needed with optical detection methods. The remote query capability allows the magnetoelastic sensors to be monitored from inside sealed, opaque containers. Depending upon the application magnetoelastic sensors can be sized from micrometer to millimeter dimensional scales, and have a material cost of approximately $0.001 allowing for their use on a disposable basis.
C1 [Grimes, Craig A.; Kouzoudis, Dimitris] Univ Kentucky, Dept Elect Engn, Lexington, KY 40506 USA.
   [Ong, Keat G.; Crump, Rick] SenTech Corp, Adv Sci & Technol Commercializat Ctr 350, Lexington, KY 40506 USA.
RP Grimes, CA (reprint author), Univ Kentucky, Dept Elect Engn, 453 Anderson Hall, Lexington, KY 40506 USA.
EM grimes@engr.uky.edu
FU Life Sciences Division of the National Aeronautics and Space
   Administration of the United States of America [NAG5-4594]; National
   Institutes of Health NIGMS [1-R21-GM057240-01]; National Science
   Foundation [ECS-9701733, ECS-9875104]
FX Support of this work by the Life Sciences Division of the National
   Aeronautics and Space Administration of the United States of America
   under grant NAG5-4594, by the National Institutes of Health NIGMS under
   contract 1-R21-GM057240-01, and by the National Science Foundation under
   contracts ECS-9701733 and ECS-9875104 is gratefully acknowledged.
CR ANDERSON PM, 1982, J APPL PHYS, V53, P8101, DOI 10.1063/1.330271
   [Anonymous], 1974, CRC HDB CHEM PHYS
   BAI MQ, 1994, TALANTA, V41, P993, DOI 10.1016/0039-9140(94)E0049-W
   Barandiaran JM, 1997, SENSOR ACTUAT A-PHYS, V59, P38, DOI 10.1016/S0924-4247(97)80145-8
   Bradbury T.C., 1981, THEORETICAL MECH
   GRATE JW, 1993, ANAL CHEM, V65, pA940, DOI 10.1021/ac00069a002
   GRATE JW, 1993, ANAL CHEM, V65, pA987, DOI 10.1021/ac00070a002
   Grimes CA, 1997, IEEE T MAGN, V33, P3412, DOI 10.1109/20.617961
   Grimes CA, 1999, J PHYS D APPL PHYS, V32, P1329, DOI 10.1088/0022-3727/32/12/308
   HEUSLER KE, 1988, BER BUNSEN PHYS CHEM, V92, P1218, DOI 10.1002/bbpc.198800301
   Jackson L.B., 1991, SIGNALS SYSTEMS TRAN, P171
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Kikuchi A, 1996, ANAL CHEM, V68, P823, DOI 10.1021/ac950748d
   LANDAU LD, 1986, THEORY ELASTICITY, pCH2
   LIVINGSTON JD, 1982, PHYS STATUS SOLIDI A, V70, P591, DOI 10.1002/pssa.2210700228
   MITCHELL EE, 1986, IEEE T IND ELECTRON, V33, P166, DOI 10.1109/TIE.1986.350212
   OGUEY HJ, 1960, REV SCI INSTRUM, V31, P701, DOI 10.1063/1.1717026
   RYAN J, 1997, SCI AM           MAY, P120
   SCHUMACHER R, 1990, ANGEW CHEM INT EDIT, V29, P329, DOI 10.1002/anie.199003293
   SHANA ZA, 1990, ANAL CHIM ACTA, V231, P317, DOI 10.1016/S0003-2670(00)86434-X
   Shinoda T, 1997, THIN SOLID FILMS, V293, P144, DOI 10.1016/S0040-6090(96)09107-9
   Stoyanov PG, 1998, IEEE T MAGN, V34, P1315, DOI 10.1109/20.706533
   THOMPSON M, 1986, ANAL CHEM, V58, P1206, DOI 10.1021/ac00297a051
   YAO SZ, 1988, ANAL CHIM ACTA, V212, P61, DOI 10.1016/S0003-2670(00)84129-X
NR 24
TC 8
Z9 8
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 1999
VL 2
IS 1
BP 51
EP 60
DI 10.1023/A:1009907316867
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KY
UT WOS:000209018900005
DA 2018-10-19
ER

PT J
AU Linton, CJ
   Sherriff, A
   Millar, MR
AF Linton, CJ
   Sherriff, A
   Millar, MR
TI Use of a modified Robbins device to directly compare the adhesion of
   Staphylococcus epidermidis RP62A to surfaces
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYSACCHARIDE INTERCELLULAR ADHESIN;
   TRANSPOSON MUTANTS; BIOFILM PRODUCTION; SLIME; HYDROPHOBICITY;
   EXPRESSION; BACTERIA; PROTEINS; CALCIUM
AB Staphylococcus epidermidis is a frequent cause of infection associated with the use of biomedical devices. Flow cell studies of the interaction between bacteria and surfaces do not generally allow direct comparison of different materials using the same bacterial suspension. The use of a modified Robbins Device (MRD) to compare the adhesion to different surfaces of Staph. epidermidis RP62A grown in continuous culture was investigated. Adhesion to glass was compared with siliconized glass, plasma-conditioned glass, titanium, stainless steel and Teflon. Attachment to siliconized glass was also compared with glass under differing ionic strength, and divalent cation concentrations. Both the differences in numbers adhering and changes in adhesion (slope) through the MRD were compared. There was a trend towards higher numbers adhering to the discs at the in-flow end of the MRD than at the outflow end, probably reflecting depletion of adherent bacteria in the interacting stream. Adhesion of Staph. epidermidis RP62A to siliconized glass and Teflon was reduced when compared to glass with increasing flow rates. Adhesion to stainless steel nias not affected by flow rate and titanium gave a different slope of adhesion through the MRD when compared with glass, suggesting an interaction with different sub-populations within the interacting stream. Differences between siliconized glass and glass at flow rates of 300 mi h(-1) were abolished by the addition of calcium or EDTA and reduced by the addition of magnesium. Increasing ionic strength reduced the statistical significance of the differences between glass and siliconized glass, Pre-conditioning of glass with pooled human plasma reduced adhesion compared with untreated glass and again gave a different slope to glass. The MRD linked to a chemostat call be used to compare directly bacterial adhesion to potential biomaterials. Variable depiction of the interacting stream should be taken into account in the interpretation of results. Divalent cation concentration, substrate properties and flow rate were important determinants of the comparative adhesion of Staph. epidermidiss RP62A to surfaces.
C1 Univ Bristol, Dept Pathol & Microbiol, Bristol BS2 8HW, Avon, England.
   Univ Bristol, Dept Paediat Epidemiol, Bristol BS2 8HW, Avon, England.
RP Millar, MR (reprint author), Univ Bristol, Bristol Royal Infirm, Dept Pathol & Microbiol, Level 8,Marlborough St, Bristol BS2 8HW, Avon, England.
CR Baldassarri L, 1996, INFECT IMMUN, V64, P3410
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P445
   CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P477
   DUNNE WM, 1992, MICROBIOL IMMUNOL, V36, P1019, DOI 10.1111/j.1348-0421.1992.tb02106.x
   EVANS E, 1994, MICROBIOL-UK, V140, P153, DOI 10.1099/13500872-140-1-153
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   GRINSTINA AG, 1987, ZENTRALBLATT BAK S16, V1, P143
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   Hussain M, 1997, INFECT IMMUN, V65, P519
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981
   LJUNGH A, 1995, MICROBIOL IMMUNOL, V39, P753, DOI 10.1111/j.1348-0421.1995.tb03267.x
   Lundberg F, 1997, INFECT IMMUN, V65, P897
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mackinnon LT, 1996, EXERC IMMUNOL REV, V2, P1
   MCDOWELL SG, 1995, LETT APPL MICROBIOL, V21, P1, DOI 10.1111/j.1472-765X.1995.tb00992.x
   MCELDOWNEY S, 1986, APPL ENVIRON MICROB, V52, P460
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   MULLER E, 1993, INFECT IMMUN, V61, P551
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   PITT WG, 1993, BIOMATERIALS, V14, P605, DOI 10.1016/0142-9612(93)90179-6
   PLOWMAN RM, 1997, HOSP ACQUIRED INFECT, P15
   Rupp ME, 1998, J ANTIMICROB CHEMOTH, V41, P155, DOI 10.1093/jac/41.2.155
   RUPP ME, 1995, J INFECT DIS, V172, P1509, DOI 10.1093/infdis/172.6.1509
   RUTTER P, 1980, J GEN MICROBIOL, V120, P301
   Sambrook J, 1989, MOL CLONING LAB MANU
   THOMAS VL, 1993, J GEN MICROBIOL, V139, P623, DOI 10.1099/00221287-139-3-623
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
NR 33
TC 15
Z9 15
U1 0
U2 7
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD FEB
PY 1999
VL 86
IS 2
BP 194
EP 202
DI 10.1046/j.1365-2672.1999.00650.x
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 170AL
UT WOS:000078782900004
PM 10063617
DA 2018-10-19
ER

PT J
AU O'Neill, PA
   Metcalfe, D
   David, TJ
AF O'Neill, PA
   Metcalfe, D
   David, TJ
TI The core content of the undergraduate curriculum in Manchester
SO MEDICAL EDUCATION
LA English
DT Article
DE competency-based education; curriculum; education, medical,
   undergraduate, methods; England
ID MEDICINE
AB Aim To identify the core content for the new undergraduate medical curriculum in Manchester.
   Method The initial step was to produce a list of 'index clinical situations' (ICSs), for which a newly graduated doctor must have a required level of competence. Using repeated consultation with consultants and general practitioners involved in medical education in the North-West of England, a list of 215 ICSs was agreed. Specialists and generalists were then asked to identify the components of the knowledge base and the performance (skills) base for each ICS. The knowledge base was divided into technical (biomedical facts/concepts) and contextual (effect/management of disease within the individual, family and society) domains. The performance base was divided into intellectual (problem solving and decision making) and interpersonal (history, examination, communication and procedural skills) domains.
   Results Forty specialities were consulted and 11021 items (defined as a piece of knowledge, a concept or a skill) were identified. There was considerable overlap in the items listed, such that when the returns for each ICS were amalgamated, the 215 ICSs contained 6434 items with a mean of 34 +/- 14.2 per situation (range 6-85).
   Utilisation We have used the defined ICSs in the design of the trigger material used in the weekly problem-based learning sessions. Over 4 years almost all (207/215, 96%) of the ICS are covered, with many being revisited at several points in the curriculum.
C1 Univ Manchester, Fac Med, Curriculum Dev Off, Dept Geriatr Med, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Dept Gen Practice, Manchester M13 9PT, Lancs, England.
   Univ Manchester, Dept Paediat & Child Hlth, Manchester M13 9PT, Lancs, England.
RP O'Neill, PA (reprint author), Univ Manchester, Fac Med, Curriculum Dev Off, Dept Geriatr Med, Manchester M13 9PT, Lancs, England.
CR Albano MG, 1996, MED EDUC, V30, P239, DOI 10.1111/j.1365-2923.1996.tb00824.x
   *ASS BRIT NEUR, 1994, TEACH NEUR 21 CENT
   *BRIT GER SOC, 1995, COR CONT UND CURR EL
   *BRIT ORTH ASS, 1992, MUSC ED UND
   *DEP HLTH, 1992, HLTH NAT STRAT HLTH
   *DEP HLTH NUTR TAS, 1994, NUTR COR CURR NUTR E
   *GEN MED COUNC ED, 1993, TOM DOCT REC UND MED
   Glick TH, 1996, MED EDUC, V30, P24, DOI 10.1111/j.1365-2923.1996.tb00713.x
   HARDEN RM, 1986, MED EDUC, V20, P458, DOI 10.1111/j.1365-2923.1986.tb01193.x
   Harden RM, 1997, MED EDUC, V31, P264, DOI 10.1111/j.1365-2923.1997.tb02923.x
   Huppatz C, 1996, MED EDUC, V30, P9, DOI 10.1111/j.1365-2923.1996.tb00710.x
   JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376
   MANDIN H, 1995, ACAD MED, V70, P186, DOI 10.1097/00001888-199503000-00008
   RAYNER HC, 1995, MED TEACH, V17, P409, DOI 10.3109/01421599509036777
   Smith K, 1996, TEACH LEARN MED, V8, P48, DOI 10.1080/10401339609539763
   SWANSON AG, 1993, ACAD MED, V68, pS7
   WALTON LA, 1993, AM J OBSTET GYNECOL, V169, P13, DOI 10.1016/0002-9378(93)90123-Z
   WRIGHT V, 1979, BRIT MED J, V1, P805, DOI 10.1136/bmj.1.6166.805
NR 18
TC 42
Z9 45
U1 0
U2 3
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0308-0110
J9 MED EDUC
JI Med. Educ.
PD FEB
PY 1999
VL 33
IS 2
BP 121
EP 129
PG 9
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA 169UA
UT WOS:000078765900008
PM 10211262
DA 2018-10-19
ER

PT J
AU Li, BY
   Rong, LJ
   Li, YY
AF Li, BY
   Rong, LJ
   Li, YY
TI Microstructure and superelasticity of porous NiTi alloy
SO SCIENCE IN CHINA SERIES E-TECHNOLOGICAL SCIENCES
LA English
DT Article
DE powder sintering; porous alloy; NiTi shape memory alloy; superelasticity
ID SHAPE-MEMORY
AB The microstructure, porosity, phase composition and superelasticity (SE) in porous NiTi alloys produced by elemental powder sintering are examined by SEM, image analysis and XRD. It is found that it is feasible to produce porous NiTi alloy by elemental powder sintering, and the porosity of sintered porous NiTi alloy is in the range of 36.0%-41.5%. The pores are interconnected and the microstructure is sponge-like. Meanwhile, porous NiTi alloy has good SE. XRD patterns show that there is no pure Ni in alloy sintered at 1 223 K-9 h. Compared with the biomedical criteria far choice of implanting materials, porous NiTi alloy is satisfying to a great degree.
C1 Chinese Acad Sci, Inst Met Res, Atom Imaging Solids Lab, Shenyang 110015, Peoples R China.
RP Li, BY (reprint author), Chinese Acad Sci, Inst Met Res, Atom Imaging Solids Lab, Shenyang 110015, Peoples R China.
RI Li, Bingyun/A-9484-2009; Li, Bingyun/P-5320-2018
OI Li, Bingyun/0000-0002-5766-5666
CR GYUNTER VE, 1992, SHAPE MEMORY EFFECTS
   GYUNTER VE, 1995, SUPERELASTIC SHAPE M, P14
   HEY JC, 1994, MAT SCI ENG A-STRUCT, V188, P291, DOI 10.1016/0921-5093(94)90384-0
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   LI BY, IN PRESS J MATER RES
   MARTYNOVA I, 1991, J PHYS IV, V1, P421, DOI 10.1051/jp4:1991463
   YAO DC, 1990, EXPT TECHNIQUE POWDE, P15
   1995, USERS MANUAL DENSITY
NR 8
TC 17
Z9 19
U1 0
U2 1
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9321
J9 SCI CHINA SER E
JI Sci. China Ser. E-Technol. Sci.
PD FEB
PY 1999
VL 42
IS 1
BP 94
EP 99
DI 10.1007/BF02917064
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 165LY
UT WOS:000078523700013
DA 2018-10-19
ER

PT J
AU Brown, IG
   Anders, A
   Dickinson, MR
   MacGill, RA
   Monteiro, OR
AF Brown, IG
   Anders, A
   Dickinson, MR
   MacGill, RA
   Monteiro, OR
TI Recent advances in surface processing with metal plasma and ion beams
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1st Asian-European International Conference on Plasma Surface
   Engineering
CY OCT 05-09, 1997
CL SEOUL, SOUTH KOREA
SP Korea Accelarator & Plasma Res Assoc, Korean Inst Surface Engn, European Joint Comm Plasma & Ion Surface Engn
DE ion implantation; metal plasma; plasma immersion; thin films
ID CATHODIC-ARC DEPOSITION; THIN-FILMS; VACUUM; IMPLANTATION; IMMERSION;
   TRANSPORT; COATINGS; FILTERS; SILICON
AB Surface processing by metal plasma and ion beams can be effected using the dense metal plasma formed in a vacuum are discharge embodied either in a "metal plasma immersion" configuration or as a vacuum are ion source, as well as by many other well-established methods. In the former case the substrate is immersed in the plasma and repetitively pulse-biased to accelerate the ions across the sheath and allow controlled ion energy implantation + deposition, and in the latter case a high energy metal ion beam is formed and ion implantation is done in a more-or-less conventional way. These methods have been used widely; here we limit consideration to work carried out at the Lawrence Berkeley National Laboratory. A number of advances have been made both in the plasma technology and in the surface modification procedures that enhance the effectiveness and versatility of the methods. Recent improvements in plasma technology include dual-source plasma mixing, ion charge state enhancement, and some scale-up of the hardware. We have made and explored some novel kinds of surface films and modified layers, including for example doped diamond-like carbon (DLC), novel multilayers, alumina and more complex ceramic materials such as mullite (3Al(2)O(3). 2SiO(2)), high temperature superconducting films, and others. Recent research has included investigations of these and other surface materials for many different basic and applied applications, such as for high temperature tolerant protective coatings, biomedical compatibility, surface resistivity tailoring of ceramics, novel catalytic surfaces, corrosion resistance of battery electrodes, and more. Here we briefly review the fundamentals of the techniques, and describe some of the applications to which the methods have been put at the Lawrence Berkeley National Laboratory. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
RP Brown, IG (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
EM ibrown@lbl.gov
RI Anders, Andre/B-8580-2009
OI Anders, Andre/0000-0002-5313-6505
CR ANDERS A, 1995, PLASMA SOURCES SCI T, V4, P1, DOI 10.1088/0963-0252/4/1/001
   ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   ANDERS A, 1994, J APPL PHYS, V75, P4900, DOI 10.1063/1.355777
   ANDERS S, 1994, SURF COAT TECH, V68, P388, DOI 10.1016/0257-8972(94)90191-0
   Boxman R.L., 1995, VACUUM ARC SCI TECHN
   Brown IG, 1996, SURF COAT TECH, V84, P550, DOI 10.1016/S0257-8972(95)02833-1
   BROWN IG, 1993, NUCL INSTRUM METH B, V80-1, P1281, DOI 10.1016/0168-583X(93)90782-2
   BROWN IG, 1994, REV SCI INSTRUM, V65, P3061, DOI 10.1063/1.1144756
   Brown IG, 1995, NUCL INSTRUM METH B, V106, P646, DOI 10.1016/0168-583X(95)00781-4
   BROWN IG, 1993, IEEE T PLASMA SCI, V21, P537, DOI 10.1109/27.249640
   BROWN IG, 1991, APPL PHYS LETT, V58, P1392, DOI 10.1063/1.104318
   Brown IG, 1998, SURF COAT TECH, V104, P293, DOI 10.1016/S0257-8972(98)00426-5
   Chae MS, 1996, PHYSICA C, V270, P173, DOI 10.1016/0921-4534(96)00504-7
   DelplanckeOgletree MP, 1997, MATER RES SOC SYMP P, V438, P639
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Liu F, 1998, SURF COAT TECH, V104, P46, DOI 10.1016/S0257-8972(98)00373-9
   MacGill RA, 1996, SURF COAT TECH, V78, P168, DOI 10.1016/0257-8972(95)02422-0
   Markovic NM, 1997, CATAL LETT, V43, P161, DOI 10.1023/A:1018907110025
   Monteiro OR, 1997, J MATER RES, V12, P2401, DOI 10.1557/JMR.1997.0318
   Pharr GM, 1996, APPL PHYS LETT, V68, P779, DOI 10.1063/1.116530
   Walter KC, 1996, SURF COAT TECH, V85, P1, DOI 10.1016/0257-8972(96)02886-1
   YU KM, 1991, NUCL INSTRUM METH B, V58, P27, DOI 10.1016/0168-583X(91)95674-3
   IN PRESS SURF COAT T
NR 23
TC 55
Z9 64
U1 0
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB
PY 1999
VL 112
IS 1-3
BP 271
EP 277
DI 10.1016/S0257-8972(98)00769-5
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 186DQ
UT WOS:000079712200054
DA 2018-10-19
ER

PT J
AU Cui, FZ
   Luo, ZS
AF Cui, FZ
   Luo, ZS
TI Biomaterials modification by ion-beam processing
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 1st Asian-European International Conference on Plasma Surface
   Engineering
CY OCT 05-09, 1997
CL SEOUL, SOUTH KOREA
SP Korea Accelarator & Plasma Res Assoc, Korean Inst Surface Engn, European Joint Comm Plasma & Ion Surface Engn
DE biomaterials; ion-beam process; mutation breeding; surface modification
ID DIAMOND-LIKE CARBON; ADHESIVE HYDROXYAPATITE COATINGS; ASSISTED
   DEPOSITION; SURFACE-TREATMENT; IMPLANTATION; BEHAVIOR;
   POLYETHERURETHANE; POLYURETHANE; CULTURE; METALS
AB Biomaterials modification by ion-beam processing is becoming popular for improving medical device function, biocompatibility and as a new mutation breeding method. Ion-beam-based processes, such as ion implantation and ion-beam assisted deposition (IBAD) can provide beneficial surface layers with desirable properties without detrimentally affecting the bulk properties. Ion implantation has been successful in biomaterials modification, such as in improving the wear resistance of artificial joint components, in improving wettability, anticoagulability, anticalcific behavior of biomedical polymers, and in minimizing biofouling of medical devices, etc. IBAD has been used to prepare hydroxyapatite coatings with high adhesive strength on substrates of several implant materials. Biocompatible diamond-like carbon coatings and C-N films, antibacterial coatings and sealant coatings have also been produced by this technique. This paper reviews the present status of applications of the ion-beam process in modifying the surface of biomaterials, as well as the effects induced by ion-beam irradiation to crop seeds, cells and microbes. (C) 1999 Elsevier Science S.A. All rights reserved.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Cui, FZ (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM cuifz@sun.ihep.ac.cn
CR Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   BAMBAUER R, 1995, DIALYSIS TRANSPLANT, V24, P228
   CHARNLEY J, 1975, CLIN ORTHOP RELAT R, P170
   CHEN QH, 1997, THESIS TSINGHUA U
   CROWNINSHIELD R, 1990, T 36 ANN M ORTH RES, V15, P470
   CUI FZ, 1983, NUCL INSTRUM METHODS, V209, P881
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   DEARNALEY G, 1981, NUCL INSTRUM METHODS, V189, P117, DOI 10.1016/0029-554X(81)90133-6
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   HE XM, 1993, NUCL INSTRUM METH B, V82, P528, DOI 10.1016/0168-583X(93)96006-X
   Kim TN, 1998, SURF COAT TECH, V99, P20, DOI 10.1016/S0257-8972(97)00121-7
   KIM TN, 1997, J KOREAN VAC SOC, V6, P27
   LI DJ, 1993, NUCL INSTRUM METH B, V82, P57
   Li DJ, 1997, CHINESE PHYS LETT, V14, P531
   LI DJ, 1994, APPL SURF SCI, V78, P195
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   RODRIGUEZ RJ, 1994, SPRINT DATA BASE ION
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V2425, P767
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   SUZUKI Y, 1989, MATER RES SOC S P, V110, P669
   TAYULOR SK, 1993, T 39 ANN M ORTH RES, V18, P503
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Yang JB, 1997, SCI CHINA SER C, V40, P107, DOI 10.1007/BF02879113
   YU L, 1993, RES BIOL EFFECTS IND, P1
   ZHANG JQ, 1986, MATER RES SOC S P, V55, P228
NR 32
TC 115
Z9 123
U1 2
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB
PY 1999
VL 112
IS 1-3
BP 278
EP 285
DI 10.1016/S0257-8972(98)00763-4
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 186DQ
UT WOS:000079712200055
DA 2018-10-19
ER

PT J
AU Leibfried-Rutledge, ML
AF Leibfried-Rutledge, ML
TI Factors determining competence of in vitro produced cattle embryos
SO THERIOGENOLOGY
LA English
DT Article; Proceedings Paper
CT IETS Post-Conference Satellite Symposium on the Development and
   Application of Embryo Biotechnology in Livestock
CY JAN   13, 1999
CL CHATEAU MONT ST ANNE, CANADA
ID FERTILIZED BOVINE EMBRYOS; OOCYTES MATURED INVITRO; IN-VITRO;
   DEVELOPMENTAL COMPETENCE; MEIOTIC RESUMPTION; PROTEIN-SYNTHESIS; NUCLEAR
   TRANSFER; IMPROVED YIELDS; CULTURE MEDIA; MATURATION
AB Concerns have developed in regard to problems associated with pregnancies and calves produced after use of cattle blastocysts made in the laboratory for embryo transfer. For both empirical studies and commercial purposes, there is a need for assurance that the product of these biotechnolgies results in a normally functioning entity of its kind. Ability to use more genetic material from a donor female and in producing blastocysts needs to be improved to increase the efficiency of utilizing in vitro biotechnologies in animal production agriculture and for biomedical purposes. The role of gametes used as raw materials for laboratory production cattle embryos and adequacy of culture systems in supporting development of embryos are discussed in relation to competency of embryos produced in vitro. (C) 1998 by Elsevier Science Inc.
C1 BOMED Inc, Madison, WI 53705 USA.
RP Leibfried-Rutledge, ML (reprint author), BOMED Inc, Madison, WI 53705 USA.
CR Agca Y, 1998, THERIOGENOLOGY, V50, P147, DOI 10.1016/S0093-691X(98)00121-6
   Agca Y, 1998, THERIOGENOLOGY, V50, P129, DOI 10.1016/S0093-691X(98)00120-4
   Aktas H, 1995, J REPROD FERTIL, V105, P227
   Aktas H, 1995, J REPROD FERTIL, V105, P237
   Arlotto T, 1996, THERIOGENOLOGY, V45, P943, DOI 10.1016/0093-691X(96)00024-6
   ARLOTTO TA, 1994, THESIS ANN ARBOR
   AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581
   BARRET GR, 1948, THESIS U WISCONSIN M
   BAVISTER BD, 1992, THERIOGENOLOGY, V37, P127, DOI 10.1016/0093-691X(92)90251-L
   Biggers J. D., 1987, MAMMALIAN PREIMPLANT, P1
   Blondin P, 1997, THERIOGENOLOGY, V47, P1061, DOI 10.1016/S0093-691X(97)00063-0
   BROWDER LW, 1985, DEV BIOL COMPREHENSI, V1
   CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0
   CHOUDARY JB, 1968, J ANIM SCI, V27, P468
   DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207
   DELOOS FAM, 1994, MOL REPROD DEV, V39, P162
   DOMINKO T, 1992, Theriogenology, V37, P203, DOI 10.1016/0093-691X(92)90272-S
   Duby RT, 1996, THERIOGENOLOGY, V45, P121, DOI 10.1016/0093-691X(95)00361-B
   EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0
   EID LN, 1994, BIOL REPROD, V51, P1232, DOI 10.1095/biolreprod51.6.1232
   EPPIG JJ, 1990, THERIOGENOLOGY, V33, P89, DOI 10.1016/0093-691X(90)90600-X
   EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77
   ERICKSON BH, 1966, J ANIM SCI, V25, P800
   EYESTONE W H, 1989, Theriogenology, V31, P191, DOI 10.1016/0093-691X(89)90599-2
   FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410
   First N L, 1987, J Reprod Fertil Suppl, V34, P151
   FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225
   FUHRER F, 1989, J VET MED A, V36, P285
   FUKUI Y, 1980, BIOL REPROD
   FULKA J, 1991, MOL REPROD DEV, V29, P379, DOI 10.1002/mrd.1080290410
   Gandolfi F, 1997, THERIOGENOLOGY, V48, P1153, DOI 10.1016/S0093-691X(97)00348-8
   Gardner DK, 1998, THERIOGENOLOGY, V49, P83, DOI 10.1016/S0093-691X(97)00404-4
   Garry FB, 1996, THERIOGENOLOGY, V45, P141, DOI 10.1016/0093-691X(95)00363-D
   GINTHER OJ, 1989, J REPROD FERTIL, V87, P223
   GORDON I, 1994, LAB PRODUCTION CATTL
   HAFEZ ESE, 1993, REPRODUCTION FARM AN
   HAMANO K, 1993, THERIOGENOLOGY, V3, P1421
   HASLER JF, 1995, THERIOGENOLOGY, V43, P141, DOI 10.1016/0093-691X(94)00020-U
   HASLER JR, 1997, ASAS BIENN S REPR NA
   HAWK HW, 1994, THERIOGENOLOGY, V41, P1571, DOI 10.1016/0093-691X(94)90822-Z
   HAWK HW, 1994, THERIOGENOLOGY, V41, P1585, DOI 10.1016/0093-691X(94)90823-2
   HAZELEGER NL, 1995, THERIOGENOLOGY, V43, P509, DOI 10.1016/0093-691X(94)00043-T
   HILLERYWEINHOLD F, 1991, THESIS U WISCONSIN M
   HUNTER AG, 1987, J DAIRY SCI, V70, P1646, DOI 10.3168/jds.S0022-0302(87)80192-3
   Jones R. E., 1978, VERTEBRATE OVARY
   Khatir H, 1996, MOL REPROD DEV, V45, P231, DOI 10.1002/(SICI)1098-2795(199610)45:2<231::AID-MRD17>3.0.CO;2-3
   Krisher RL, 1998, THERIOGENOLOGY, V49, P103, DOI 10.1016/S0093-691X(97)00405-6
   Kruip TAM, 1997, THERIOGENOLOGY, V47, P43, DOI 10.1016/S0093-691X(96)00338-X
   LEIBFRIED L, 1979, J ANIM SCI, V48, P76
   Leibfried-Rutledge M. L., 1989, The molecular biology of fertilization., P259
   LEIBFRIEDRUTLED.ML, 1995, ASAS BIENN REPR S OR
   LEIBFRIEDRUTLED.ML, 1997, REPROD TISSUE BANKIN, P23
   LEIBFRIEDRUTLEDGE ML, 1989, THERIOGENOLOGY, V31, P61, DOI 10.1016/0093-691X(89)90564-5
   LEIBFRIEDRUTLEDGE ML, 1987, BIOL REPROD, V36, P376, DOI 10.1095/biolreprod36.2.376
   LENZ RW, 1983, BIOL REPROD, V29, P173, DOI 10.1095/biolreprod29.1.173
   Lonergan P, 1997, J REPROD FERTIL, V109, P355
   Lonergan P, 1998, THERIOGENOLOGY, V50, P417, DOI 10.1016/S0093-691X(98)00149-6
   LONERGAN P, 1994, MOL REPROD DEV, V37, P48, DOI 10.1002/mrd.1080370107
   LOONEY CR, 1994, THERIOGENOLOGY, V41, P67, DOI 10.1016/S0093-691X(05)80050-0
   MADISON V, 1992, ANIM REPROD SCI, V27, P1, DOI 10.1016/0378-4320(92)90065-L
   MOTLIK J, 1986, THERIOGENOLOGY, V25, P87, DOI 10.1016/0093-691X(86)90185-8
   NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064
   Otoi T, 1997, THERIOGENOLOGY, V48, P769, DOI 10.1016/S0093-691X(97)00300-2
   PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9
   PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111
   Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665
   ROSE TA, 1992, MOL REPROD DEV, V31, P72, DOI 10.1002/mrd.1080310113
   SAACKE RG, 1994, THERIOGENOLOGY, V41, P45, DOI 10.1016/S0093-691X(05)80047-0
   Saeki K, 1997, THERIOGENOLOGY, V48, P1161, DOI 10.1016/S0093-691X(97)00349-X
   SHI D S, 1990, Theriogenology, V33, P324, DOI 10.1016/0093-691X(90)90748-I
   SIMON M, 1989, REPROD NUTR DEV, V29, P533, DOI 10.1051/rnd:19890502
   SIRARD MA, 1989, BIOL REPROD, V40, P1257, DOI 10.1095/biolreprod40.6.1257
   SIRARD MA, 1992, THERIOGENOLOGY, V37, P39, DOI 10.1016/0093-691X(92)90246-N
   Sirard MA, 1998, THERIOGENOLOGY, V49, P483, DOI 10.1016/S0093-691X(97)00420-2
   Sirard Marc-Andre, 1995, Journal of Reproduction and Development, V41, P255, DOI 10.1262/jrd.41.255
   SUSS U, 1988, BIOL REPROD, V38, P871, DOI 10.1095/biolreprod38.4.871
   TAKAGI Y, 1992, J ANIM SCI, V70, P1923
   Telfer EE, 1998, THERIOGENOLOGY, V49, P451, DOI 10.1016/S0093-691X(97)00417-2
   vandenHurk R, 1997, THERIOGENOLOGY, V47, P73, DOI 10.1016/S0093-691X(96)00341-X
   VANDESANDT JJM, 1990, MOL REPROD DEV, V25, P164, DOI 10.1002/mrd.1080250209
   1989, THERIOGENOLOGY, V31, P1
NR 81
TC 18
Z9 21
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0093-691X
J9 THERIOGENOLOGY
JI Theriogenology
PD JAN 15
PY 1999
VL 51
IS 2
BP 473
EP 485
DI 10.1016/S0093-691X(98)00241-6
PG 13
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 154BQ
UT WOS:000077868500004
PM 10729106
DA 2018-10-19
ER

EF